<SEC-DOCUMENT>0001047469-19-006237.txt : 20191112
<SEC-HEADER>0001047469-19-006237.hdr.sgml : 20191112
<ACCEPTANCE-DATETIME>20191112160437
ACCESSION NUMBER:		0001047469-19-006237
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		139
FILED AS OF DATE:		20191112
DATE AS OF CHANGE:		20191112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NextCure, Inc.
		CENTRAL INDEX KEY:			0001661059
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				475231247
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-234639
		FILM NUMBER:		191209250

	BUSINESS ADDRESS:	
		STREET 1:		9000 VIRGINIA MANOR ROAD, SUITE 200
		CITY:			BELTSVILLE
		STATE:			MD
		ZIP:			20705
		BUSINESS PHONE:		240-399-4900

	MAIL ADDRESS:	
		STREET 1:		9000 VIRGINIA MANOR ROAD, SUITE 200
		CITY:			BELTSVILLE
		STATE:			MD
		ZIP:			20705
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>a2240001zs-1.htm
<DESCRIPTION>S-1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<P><FONT SIZE=3 >
Use these links to rapidly review the document<BR>
<A HREF="#bg70301_table_of_contents">  TABLE OF CONTENTS</A> <BR>
<A HREF="#fa70301_index_to_financial_statements___ind02746">  INDEX TO FINANCIAL STATEMENTS As of and for the Years Ended December 31, 2017 and 2018</A><BR></font>
</P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>As filed with the Securities and Exchange Commission on November 12, 2019  </B></FONT></P>

<P ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><B> Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=1><B> &nbsp;<BR>  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=1><B> <div style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>  </B></FONT><FONT SIZE=1><B>Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" >


  </I></FONT><FONT SIZE=1><B>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>FORM S-1<BR>  </B></FONT><FONT SIZE=1><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF&nbsp;1933  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" >


  </I></FONT><FONT SIZE=1><B>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B>NextCure,&nbsp;Inc.<BR>  </B></FONT><FONT SIZE=1>(Exact name of registrant as specified in its charter) </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" >


 </I></FONT><FONT SIZE=1>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Delaware</B></FONT><FONT SIZE=1><BR>
(State or other jurisdiction of<BR>
incorporation or organization)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B> 2834</B></FONT><FONT SIZE=1><BR>
(Primary Standard Industrial<BR>
Classification Code Number)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B> 47-5231247</B></FONT><FONT SIZE=1><BR>
(I.R.S. Employer<BR>
Identification Number)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>9000 Virginia Manor Road, Suite&nbsp;200<BR>
Beltsville, Maryland 20705<BR>
(240)&nbsp;399-4900</B></FONT><FONT SIZE=1><BR>
(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><I>


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" >


 </I></FONT><FONT SIZE=1>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Michael Richman<BR>
Chief Executive Officer<BR>
NextCure,&nbsp;Inc.<BR>
9000 Virginia Manor Road, Suite&nbsp;200<BR>
Beltsville, Maryland 20705<BR>
(240)&nbsp;399-4900</B></FONT><FONT SIZE=1><BR>
(Name, address, including zip code, and telephone number, including area code, of agent for service) </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" >


 </I></FONT><FONT SIZE=1>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="46%" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="46%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Copies to:</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=1><B>Asher M. Rubin<BR>
William I. Intner<BR>
Hogan Lovells US&nbsp;LLP<BR>
100 International Drive, Suite&nbsp;2000<BR>
Baltimore, Maryland 21202<BR>
(410)&nbsp;659-2700</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><B><BR>&nbsp;</B></FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B><BR>
Divakar Gupta<BR>
Brent B. Siler<BR>
Joshua A. Kaufman<BR>
Madison A. Jones<BR>
Cooley&nbsp;LLP<BR>
55 Hudson Yards<BR>
New York, New York 10001<BR>
(212)&nbsp;479-6000</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="20%" ALIGN="CENTER" >


  </I></FONT><FONT SIZE=1>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Approximate date of commencement of proposed sale to the public:<BR>
As soon as practicable after the effective date of this registration statement.  </B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities Act of
1933 check the following box.&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this form is filed to register additional securities for an offering pursuant to Rule&nbsp;462(b) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this form is a post-effective amendment filed pursuant to Rule&nbsp;462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering.&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this form is a post-effective amendment filed pursuant to Rule&nbsp;462(d) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering.&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an
emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule&nbsp;12b-2 of the Exchange Act. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="116pt" style="font-family:times;"></TD>
<TD WIDTH="9%" style="font-family:times;"></TD>
<TD WIDTH="89pt" style="font-family:times;"></TD>
<TD WIDTH="9%" style="font-family:times;"></TD>
<TD WIDTH="110pt" style="font-family:times;"></TD>
<TD WIDTH="9%" style="font-family:times;"></TD>
<TD WIDTH="138pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>Large accelerated filer&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>Accelerated filer&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>Non-accelerated filer&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;text-align:center;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"text-align:center;" -->


 Smaller reporting company&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT></font> <p align=center style="font-family:times;margin-top:0pt;margin-left:0pt;"> <FONT SIZE=1> Emerging growth company&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>CALCULATION OF REGISTRATION FEE  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="65%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:4pt;text-indent:-4pt;"><FONT SIZE=1> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #000000 2.25pt;">&nbsp;</TD>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Title of Each Class of Securities<BR>
to be Registered</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Proposed Maximum<BR>
Aggregate Offering<BR>
Price<SUP>(1)</SUP></B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Amount of<BR>
Registration Fee</B></FONT><BR></TH>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:solid #000000 1.0pt;">&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:4pt;text-indent:-4pt;"><FONT SIZE=1><B> </B></FONT><FONT SIZE=1>Common stock, $0.001 par value per share</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$143,593,600.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>$18,638.45</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #000000 2.25pt;"><p style="font-family:times;margin-left:4pt;text-indent:-4pt;"> &nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=1>Estimated
solely for the purpose of calculating the registration fee pursuant to Rule&nbsp;457(o) under the Securities Act and includes the aggregate offering
price of shares that the underwriters have an option to purchase. </FONT></DD></DL>

<P style="font-family:times;text-align:justify"><FONT SIZE=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=1><B>The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall
file&nbsp;a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933, as
amended, or until the registration statement shall become effective on such date as the Commission acting pursuant to said Section&nbsp;8(a), may determine.  </B></FONT></P>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=1>

<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p>

<P style="font-family:times;text-align:justify"><FONT SIZE=1><div
style="width:100%;border-top:solid #000000 1.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #000000 3.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div> </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=428092,FOLIO='blank',FILE='DISK125:[19ZCO1.19ZCO70301]BA70301A.;25',USER='WWASSER',CD='12-NOV-2019;13:20' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT COLOR="#F1665F" SIZE=2>The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and
Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is
not permitted.</FONT></P>

<P style="font-family:times;text-align:justify"><FONT COLOR="#F1665F" SIZE=3><I>SUBJECT TO COMPLETION<BR>  </I></FONT><FONT COLOR="#F1665F" SIZE=2><I>DATE NOVEMBER&nbsp;12, 2019</I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=5><I>3,200,000&nbsp;Shares  </I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=5><B>
<IMG SRC="g79071.jpg" ALT="LOGO" WIDTH="373" HEIGHT="66">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=5><I>NextCure,&nbsp;Inc.  </I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><I>Common Stock  </I></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><B><I>NextCure,&nbsp;Inc. is offering 3,200,000 shares of common stock.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><B><I>Our common stock is listed on the Nasdaq Global Select Market under the symbol "NXTC". On November&nbsp;11, 2019, the last reported sale price of our
common stock on the Nasdaq Global Select Market was $39.02 per share. The final public offering price will be determined through negotiation between us and the lead underwriters in the offering and
the recent market price used throughout the prospectus may not be indicative of the actual offering price.</I></B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=3><B><I>We are an "emerging growth company" as defined under U.S. federal securities laws and will be subject to reduced public company
reporting
requirements. Investing in our common stock involves risks. See "Risk Factors" beginning on page 13.</I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p><div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <P style="font-family:times;text-align:justify"><FONT SIZE=2><I>


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


  </I></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B><I>Per&nbsp;Share

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </I></B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B><I>Total

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </I></B></FONT></DIV></TH>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:4pt;text-indent:-4pt;"><FONT SIZE=1><B><I> </I></B></FONT><FONT SIZE=2><I>Public Offering Price </I></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><I>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><I>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:5pt;text-indent:-5pt;"><FONT SIZE=2><I> </I></FONT><FONT SIZE=2><I>Underwriting Discounts and Commissions<SUP>(1)</SUP> </I></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><I>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><I>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:5pt;text-indent:-5pt;"><FONT SIZE=2><I> </I></FONT><FONT SIZE=2><I>Proceeds, before expenses, to us </I></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><I>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><I>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><I>(1)</I></FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2><I> We refer you to "Underwriters" for additional information regarding total underwriter compensation.</I></FONT></DD></DL>
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2><I>We have granted the underwriters an option for a period of 30&nbsp;days to purchase up to an additional 480,000 shares of our common stock.</I></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful
or complete. Any representation to the contrary is a criminal offense.</I></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><I>The underwriters expect to deliver the shares to purchasers on or about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019.</I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><I>Joint Book-Running Managers  </I></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p><div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <P style="font-family:times;text-align:justify"><FONT SIZE=2><I>


<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->


  </I></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="159pt" style="font-family:times;"></TD>
<TD WIDTH="9%" style="font-family:times;"></TD>
<TD WIDTH="183pt" style="font-family:times;"></TD>
<TD WIDTH="9%" style="font-family:times;"></TD>
<TD WIDTH="136pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=3><I>MORGAN STANLEY</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=3>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT SIZE=3><I>BofA SECURITIES</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=3>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=3><I>PIPER JAFFRAY</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><I>Co-Managers  </I></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p><div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <P style="font-family:times;text-align:justify"><FONT SIZE=2><I>


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


  </I></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><I>NEEDHAM &amp; COMPANY</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=3>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><I>BTIG</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2><I>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</i></font></p><p align=left style="font-family:times;"><font></FONT><FONT SIZE=2><I>The date of this prospectus is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019</I></FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=781402,FOLIO='blank',FILE='DISK125:[19ZCO1.19ZCO70301]BC70301A.;25',USER='LGADISH',CD='11-NOV-2019;22:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_bg70301_1_1"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="BG70301A_main_toc"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="bg70301_table_of_contents"> </A>
<BR></FONT><FONT SIZE=2><B>  TABLE OF CONTENTS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
<A NAME="BG70301_TOC"></A> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Page </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ca70301_prospectus_summary"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PROSPECTUS SUMMARY</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ca70301_prospectus_summary"><FONT SIZE=2>1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#cc70301_summary_financial_data"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SUMMARY FINANCIAL DATA</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#cc70301_summary_financial_data"><FONT SIZE=2>11</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dc70301_risk_factors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>RISK FACTORS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc70301_risk_factors"><FONT SIZE=2>13</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dm70301_special_note_regarding_forward-looking_statements"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dm70301_special_note_regarding_forward-looking_statements"><FONT SIZE=2>65</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dm70301_use_of_proceeds"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>USE OF PROCEEDS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dm70301_use_of_proceeds"><FONT SIZE=2>67</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dm70301_dividend_policy"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DIVIDEND POLICY</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dm70301_dividend_policy"><FONT SIZE=2>69</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#do70301_capitalization"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CAPITALIZATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#do70301_capitalization"><FONT SIZE=2>70</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#do70301_dilution"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DILUTION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#do70301_dilution"><FONT SIZE=2>72</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#do70301_selected_financial_data"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SELECTED FINANCIAL DATA</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#do70301_selected_financial_data"><FONT SIZE=2>74</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dq70301_management_s_discussion_and_an__man03466"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dq70301_management_s_discussion_and_an__man03466"><FONT SIZE=2>76</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ds70301_business"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BUSINESS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ds70301_business"><FONT SIZE=2>89</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ea70301_management"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>MANAGEMENT</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ea70301_management"><FONT SIZE=2>130</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ee70301_executive_compensation"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXECUTIVE COMPENSATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ee70301_executive_compensation"><FONT SIZE=2>141</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eg70301_certain_relationships_and_related_party_transactions"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eg70301_certain_relationships_and_related_party_transactions"><FONT SIZE=2>153</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ei70301_principal_stockholders"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PRINCIPAL STOCKHOLDERS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ei70301_principal_stockholders"><FONT SIZE=2>158</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ek70301_description_of_capital_stock"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ek70301_description_of_capital_stock"><FONT SIZE=2>161</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#em70301_material_u.s._federal_income_t__mat03024"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS OF COMMON
STOCK</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#em70301_material_u.s._federal_income_t__mat03024"><FONT SIZE=2>166</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eo70301_underwriters"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>UNDERWRITERS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eo70301_underwriters"><FONT SIZE=2>170</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eo70301_legal_matters"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>LEGAL MATTERS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eo70301_legal_matters"><FONT SIZE=2>176</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eo70301_experts"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXPERTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eo70301_experts"><FONT SIZE=2>176</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eo70301_where_you_can_find_more_information"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eo70301_where_you_can_find_more_information"><FONT SIZE=2>176</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#fa70301_index_to_financial_statements___ind02746"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>INDEX TO FINANCIAL STATEMENTS</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#fa70301_index_to_financial_statements___ind02746"><FONT SIZE=2>F-1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
we nor any of the underwriters has authorized anyone to provide you any information that is different than that contained in this prospectus or any free writing prospectus
prepared by or on behalf of us or to which we may have referred you in connection with this offering. We take no responsibility for, and can provide no assurance as to the reliability of, any other
information that others may give you. We and the underwriters are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. The information in this
prospectus is accurate only as of its date, regardless of the time of delivery of this prospectus or of any sale of shares of our common stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
action is being taken in any jurisdiction outside the United States to permit a public offering of our common stock or possession or distribution of this prospectus in that
jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States must inform themselves about, and observe any restrictions as to, this offering and the
distribution of this prospectus applicable to that jurisdiction. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>i</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=119930,FOLIO='i',FILE='DISK125:[19ZCO1.19ZCO70301]BG70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_ca70301_1_1"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><BR></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ca70301_prospectus_summary"> </A>
<A NAME="toc_ca70301_1"> </A></FONT> <FONT SIZE=2><B>  PROSPECTUS SUMMARY    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>This summary highlights information contained elsewhere in this prospectus and does not contain all of the information
that you should consider in making your investment decision. Before investing in our common stock, you should read this entire prospectus carefully, including the sections entitled "Risk Factors" and
"Management's Discussion and Analysis of Financial Condition and Results of Operations" and our financial statements and the related notes contained elsewhere in this prospectus. Unless the context
otherwise requires, references in this prospectus to the "company," "NextCure," "we," "us" and "our" refer to NextCure,&nbsp;Inc.</I></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer
and other immune-related diseases by restoring normal immune function. We view the immune system holistically and, rather than target one specific immune cell type, we focus on understanding
biological pathways, the interactions of cells and the role each interaction plays in an immune response. Through our proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or
FIND-IO, platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. We are
focused on patients who do not respond to current therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies. We are
committed to discovering and developing first-in-class immunomedicines, which are immunomedicines that use new or unique mechanisms of action to treat a medical condition, for these patients. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
lead product candidate, NC318, is a first-in-class immunomedicine targeting a novel immunomodulatory receptor called Siglec-15, or S15. In October 2018, we initiated a
Phase&nbsp;1/2 clinical trial of NC318 in patients with advanced or metastatic solid tumors. We completed enrollment of the Phase&nbsp;1 portion of this trial in August 2019 and preliminary data
from the Phase&nbsp;1 portion was presented at the Society for Immunotherapy of Cancer, or SITC, annual meeting in November 2019. We began enrolling patients in the Phase&nbsp;2 portion of the
trial in October&nbsp;2019 and expect to announce initial data from the Phase&nbsp;2 portion by the end of 2020. Our second product candidate, NC410, is a novel immunomedicine designed to block
immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1, or LAIR-1. We expect to submit an investigational new drug application, or IND, to the
U.S. Food and Drug Administration, or FDA, for NC410 in the first quarter of 2020. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
approach to identifying targets for new immunomedicines is based on our FIND-IO platform. FIND-IO embodies a rational approach to the discovery of novel cell surface and secretory
molecules that drive functional immune responses. We use our immunology knowledge, experience, capabilities and tools we have developed, including our FIND-IO platform, to support our discovery
efforts. We are working to discover novel targets that play a key role in mediating immune dysfunction that allows tumors to evade the immune system. We are seeking to identify and develop
immunomedicines that counteract these outcomes and to further validate and advance our product candidates. We have identified multiple novel targets using our FIND-IO platform, including those for
which certain of our research programs are being designed to target. In addition, the immunosuppressive properties of S15, the target of NC318, were discovered using a predecessor of our FIND-IO
platform. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
advancement of cancer to late stages indicates a failure of the immune system to mount an effective anti-tumor immune response. Immuno-oncology, which focuses on stimulating the
immune system to respond to cancer and includes checkpoint inhibitors targeting PD-L1, PD-1 and CTLA-4, is one of the most significant advances in the history of cancer treatment. In 2011, the first
checkpoint inhibitor was approved, and today, despite only a modest breadth of efficacy, this class of therapies is estimated to have had global sales of more than $17&nbsp;billion in 2018 and is
predicted to reach more than $33&nbsp;billion in </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=4,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=171349,FOLIO='1',FILE='DISK125:[19ZCO1.19ZCO70301]CA70301A.;32',USER='JTAYLORA',CD='12-NOV-2019;12:46' -->
<A NAME="page_ca70301_1_2"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>global
sales by 2022. However, despite the recent success of checkpoint inhibitors, efficacy has been limited. It is estimated that up to 60% to 70% of cancer patients, including those with melanoma,
renal cell cancer, colorectal cancer, non-small cell lung cancer, or NSCLC, urothelial cancer and head and neck squamous cell carcinoma, do not respond to single-agent therapy with checkpoint
inhibitors. In addition, some patients develop resistance after initial treatment with these therapies. As a result, the standard of care in cancer today leaves many patients underserved. We believe
broader efficacy and more meaningful clinical responses in oncology may be obtained by focusing on the tumor microenvironment, or TME. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are using our FIND-IO platform as our discovery engine to identify targets and develop immunomedicines that restore normal immune function in the TME through novel mechanisms of
action. Since our founding in 2015, we have developed, industrialized and optimized our FIND-IO platform based on the immunological expertise of our management team and the scientific leadership
of our scientific founder, Dr.&nbsp;Lieping Chen. Our approach in creating the FIND-IO platform, and how we apply it, reflects our belief in the importance of understanding biological pathways of
all cells in the immune system and restoring normal immune function. The platform uses our proprietary approaches to assess the suppressive or stimulatory function of immune pathways in T cells and
other immune cells, as measured by effects on proliferation or induction of molecules known to impact immune responses, such as cytokines, which are signaling molecules secreted by cells in the immune
system that mediate and regulate immunity and inflammation. We study primary immune cells from healthy donors and from patients with various diseases, as well as established cell lines from immune and
non-immune cell lineages, including T cell subsets, monocytes, macrophage subpopulations and cancer cell lines. In oncology, we are using the FIND-IO platform to discover immunomedicines with the
potential to intervene or modulate interactions of immune cells within the TME to restore anti-tumor activity. We are also expanding the functional screening approach of our FIND-IO platform for the
identification of novel targets in other serious illnesses outside of oncology, including autoimmune, inflammatory and neuro-inflammatory diseases. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2018, we entered into a multi-year collaboration agreement with Eli Lilly and Company, or Lilly, focused on the discovery and development of immunomedicines for oncology
using our FIND-IO platform. The collaboration seeks to discover novel cancer targets utilizing our platform and provides that we and Lilly will each receive options to exclusively develop antibodies
resulting from the collaboration. In connection with the agreement, we received an upfront payment of $25.0&nbsp;million in cash and an equity investment of $15.0&nbsp;million and are eligible to
receive development and regulatory milestones and sales milestones in an aggregate of up to $1.4&nbsp;billion, as well as royalty payments. </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=5,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=784614,FOLIO='2',FILE='DISK125:[19ZCO1.19ZCO70301]CA70301A.;32',USER='JTAYLORA',CD='12-NOV-2019;12:46' -->
<A NAME="page_ca70301_1_3"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Pipeline  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are leveraging our understanding of biological pathways and our FIND-IO platform to discover, validate and build a proprietary pipeline of
immunomedicine candidates. The figure below details our pipeline of product candidates and principal discovery and research programs. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g827084.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="367">
  </B></FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Programs  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NC318, our lead immunomedicine program, is a monoclonal antibody targeting S15, which is expressed on highly immunosuppressive cells called M2
macrophages and on tumor cells. The immunosuppressive properties of S15 were discovered in 2015 at Yale University by Dr.&nbsp;Chen. Dr.&nbsp;Chen was also the first to discover a molecule he
called B7-H1, which is now more widely known as PD-L1, or programmed cell death protein ligand 1, which is the ligand for PD-1, or programmed cell death 1. In preclinical research, we and others
observed that S15 promotes suppression of T cell proliferation and negatively regulates T cell function. NC318 is designed to block this S15-mediated immune suppression and restore T cell function and
anti-tumor immunity in the TME, which we believe will reduce and kill tumors. We believe NC318 has the potential to treat multiple cancer indications because S15 is expressed in multiple tumor types
and has a unique ability to modulate immune responses in the TME. In addition, because S15 and PD-L1 expression in tumors generally appear to be non-overlapping, we believe NC318 may be well suited to
treat patients who are not responding to PD-1/PD-L1 directed cancer therapies. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
preclinical studies, we evaluated the safety and efficacy of 5G12, the murine parent antibody of NC318, which has similar overall functional properties to NC318, and observed that
blocking the effects of S15 with 5G12 restored immune function and anti-tumor immunity, reduced tumor growth and increased survival. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
ongoing first-in-human trial is an open-label, Phase&nbsp;1/2 clinical trial designed to assess the safety and tolerability of NC318, to define the maximum tolerable dose or
pharmacologically active dose and to assess preliminary efficacy. Patients receive NC318 on day one of each cycle. We initiated the trial with 14-day cycles; however, we may explore alternate doses
and administration schedules depending on pharmacokinetics, pharmacodynamics, biomarker data, safety results and feedback from investigators. We designed this clinical trial with a robust biomarker
strategy to help evaluate clinical activity throughout the </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=6,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=644995,FOLIO='3',FILE='DISK125:[19ZCO1.19ZCO70301]CA70301A.;32',USER='JTAYLORA',CD='12-NOV-2019;12:46' -->
<A NAME="page_ca70301_1_4"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">


<P style="font-family:times;text-align:justify"><FONT SIZE=2>trial
by focusing on markers of pharmacodynamics. We are initially evaluating NC318 for the treatment of advanced or metastatic solid tumors, including NSCLC, ovarian cancer, head and neck squamous
cell carcinoma and triple-negative breast cancer, or TNBC. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
completed enrollment of the Phase&nbsp;1 portion of the trial in August 2019 and have dosed 49 patients across seven dose cohorts between 8 mg and 1,600 mg. The most common tumors
in the trial were NSCLC (13 patients), ovarian (seven patients), melanoma (seven patients), breast (four patients) and colorectal (three patients). Enrolled patients had all been subject to previous
cancer treatments, with a median of three prior therapies, and all 13 NSCLC patients were PD-1 refractory and had been treated with a median of four prior therapies. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preliminary
data from the Phase&nbsp;1 portion was presented in November 2019 at the SITC annual meeting. As of September 26, 2019, the cutoff date of the data discussed by the NC318
trial investigator at the SITC annual meeting, tumor responses were evaluable in 45 patients, and four patients had not yet been assessed. Treatment-related adverse events experienced by more than 5%
of patients as of that date were diarrhea (16%), infusion reactions (8%), fatigue (6%), headaches (6%), pruritis (6%), elevated amylase (8%) and elevated lipase (6%). </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of November&nbsp;9, 2019, NC318 has been well tolerated in the Phase&nbsp;1 portion of the trial and only one dose-limiting toxicity, a grade 3 pneumonitis at the highest dose
level, was observed. Treatment-related adverse events experienced by more than 5% of patients as of that date continued to be diarrhea, infusion reactions, fatigue, headaches, pruritis, elevated
amylase and elevated lipase. Most treatment-related adverse events have been easily manageable, asymptomatic or mild or moderate, with the exception of one case of grade 3 episcleritis/uveitis at the
400 mg dose level that resolved after steroid therapy and two cases of grade 3 pneumonitis (one at the 400 mg dose level and one at the 1,600 mg dose level). Data from the trial indicate activity in
multiple tumor types, including durable stable disease in patients with NSCLC, endometrial cell cancer, ovarian cancer, squamous cell carcinoma, Merkel cell cancer and head and neck cancer. As of
November&nbsp;9, 2019, durable responses observed include one complete response, which remains ongoing at 55&nbsp;weeks, and one partial response, which remains ongoing at 28&nbsp;weeks, both in
NSCLC patients, as well as 14 patients with stable disease, which remain ongoing for between 16 and 42 weeks. Among those 14 patients, four patients have NSCLC, with stable disease ongoing for between
16 and 40&nbsp;weeks. Three NSCLC patients (out of 13&nbsp;NSCLC patients in total) have not been in the study long enough to confirm the status of their disease. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
began enrolling patients in the Phase&nbsp;2 portion of the Phase&nbsp;1/2 clinical trial of NC318 in October 2019. The Phase&nbsp;2 portion of the trial is an open-label trial
designed to detect a relevant efficacy signal, or response rate, for each tumor type at a 400 mg dose administered every two weeks. In this portion, we will enroll up to 100 patients with tumor types
that, based on tumor bank analyses, have been shown to have elevated S15 expression, including NSCLC, ovarian cancer, head and neck squamous cell carcinoma and TNBC. We expect to announce initial data
from the Phase&nbsp;2 portion of the trial by the end of 2020. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the first half of 2020, we intend to initiate a Phase&nbsp;2 clinical trial to evaluate NC318 in combination with standard of care chemotherapies in patients with advanced or
metastatic solid tumors. This trial will be an open-label trial designed to assess the safety and tolerability of NC318 in combination with at least two different chemotherapy regimens and to define
the maximum tolerable dose of NC318 when administered with each chemotherapy. The trial will also be designed to assess preliminary efficacy of each combination in specific tumor types in a manner
that can potentially support the use of such combinations in first-line therapies of advanced or metastatic solid tumors. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NC410,
our second immunomedicine program, is a fusion protein designed to block immune suppression mediated by LAIR-1. LAIR-1 is expressed on T cells and antigen-presenting cells, known
as dendritic cells, that present tumor antigens to immune cells in order to generate immune responses. The binding of LAIR-1 to collagen or C1q results in loss of immune function in the TME and a
reduction in T&nbsp;cell function and dendritic cell activity. By blocking the binding of LAIR-1, NC410 can promote T&nbsp;cell </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=7,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=947832,FOLIO='4',FILE='DISK125:[19ZCO1.19ZCO70301]CA70301A.;32',USER='JTAYLORA',CD='12-NOV-2019;12:46' -->
<A NAME="page_ca70301_1_5"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>function
and dendritic cell activity, which could result in anti-tumor immune responses that eliminate cancer cells. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have conducted multiple preclinical studies to assess the activity of NC410 across a variety of preclinical models. These studies support our understanding that eliminating or
blocking the binding of LAIR-1 to collagen or C1q can restore normal immune function in multiple immune cells, including T cells and myeloid cells, resulting in activation of T cells and anti-tumor
immunity. We and others have
analyzed genomic and protein databases and observed that LAIR-1 expression levels negatively correlate with survival rates for several cancers, including brain, renal, colorectal, glioma, lung,
urothelial and ovarian cancers. These analyses support possible targeting of these tumor types as primary indications for therapeutic treatment with NC410. We are currently conducting IND-enabling
studies for NC410 and expect to submit an IND and initiate a Phase&nbsp;1/2 clinical trial in patients with advanced or metastatic solid tumors in the first quarter of 2020. We are currently focused
on opportunities for NC410 in ovarian cancer, NSCLC and renal cancer. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to NC318 and NC410, we are also pursuing discovery and preclinical evaluation of other potential novel immunomodulatory molecules. Among these is an antibody that targets a
novel member of the B7-family of immunomodulatory proteins. We also have an antibody in preclinical development targeting an immune modulator that is highly expressed in inflamed tissue and the TME in
multiple tumor types. In addition, based on our understanding of the LAIR pathway, including through our development of NC410, we are also pursuing monoclonal antibodies that target LAIR-1 and
directly block LAIR-1 signaling to prevent tumor growth or to eliminate the tumor. These novel LAIR-1 antibodies have unique functional properties that may provide additional opportunities in both
cancer and autoimmune disorders. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our FIND-IO Discovery Engine  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our FIND-IO platform is the result of our industrialization, expansion and optimization of a predecessor platform that Dr.&nbsp;Chen used to
discover the immunosuppressive properties of S15. Our FIND-IO platform applies a function-based screening approach to identify human proteins and to determine whether those proteins alter or stop an
immune response resulting in immune evasion. The platform is designed to identify novel cell surface molecular interactions that drive functional immune responses. Our FIND-IO platform broadly and
quantitatively evaluates interactions between relevant protein components and different cellular types over time in order to identify novel targets that either increase or decrease immune-related
functional responses associated with desired immune responses against tumors. By identifying novel immune modulators, proteins or other molecules through the FIND-IO platform, we aim to develop
next-generation immunomedicines that restore normal immune function in the TME. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Strategy  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our strategy is to use our fully integrated discovery and product development infrastructure to build a sustainable pipeline of product
candidates to treat cancer patients who are not adequately served by currently available therapies. The key elements of our strategy include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Advancing the clinical development of our lead product candidates, NC318 and NC410. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Building an oncology pipeline of novel targets for new immunomedicines focused on non-responders. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Leveraging our fully integrated development, quality systems and cGMP manufacturing capabilities. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Expanding our current focus and creating new opportunities outside of the oncology field, including through strategic partnerships. </FONT></DD></DL>
</UL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=8,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=691950,FOLIO='5',FILE='DISK125:[19ZCO1.19ZCO70301]CA70301A.;32',USER='JTAYLORA',CD='12-NOV-2019;12:46' -->
<A NAME="page_ca70301_1_6"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Team  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have assembled an experienced management team to execute on our mission to create novel immunomedicines. Our scientific founder and members
of our management team collectively have extensive experience in drug discovery and product development and are leaders in the immuno-oncology field. Members of our management team have experience
discovering, developing, manufacturing and commercializing biologics, including some of the earliest approved monoclonal antibodies, such as Synagis, as well as some of the first immune checkpoint
inhibitor monoclonal antibodies and fusion proteins targeting the PD-1/PD-L1 pathway and CTLA-4, including Yervoy. Within three years, we advanced our company from formation to antibody generation to
the clinic and constructed a manufacturing facility that complies with cGMP and that we have used to manufacture our preclinical and clinical drug supply. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Members
of our management team have a longstanding relationship with our scientific founder Dr.&nbsp;Chen, who is the United Technologies Corporation Professor in Cancer Research and
Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology) at Yale, and the Co-Director of the Cancer Immunology Program at Yale Cancer Center. Dr.&nbsp;Chen was the first to
discover PD-L1 and to show that it is expressed by multiple tumor types and its activity can cause the death of T cells, preventing those T cells from eliminating cancer cells. He also showed that
blocking the interaction between PD-1 and PD-L1 with monoclonal antibodies improved the immune system's ability to eliminate tumors. Dr.&nbsp;Chen's work provided an important foundation for the
subsequent development of immunotherapies that enable more effective immune treatments against cancer. Since then, his laboratory has identified and characterized various molecules in two of the major
families of immune modulating proteins, the B7-CD28 and the tumor necrosis factor receptor/ligand superfamilies, and elucidated their interactions and functions in controlling immune responses. The
immunosuppressive properties of S15, the target of our lead product candidate, NC318, were discovered in Dr.&nbsp;Chen's lab using a predecessor of our FIND-IO platform. In December 2015, we entered
into a license agreement with Yale, pursuant to which we obtained an exclusive, royalty-bearing, sublicensable worldwide license to products that either incorporate certain licensed patents used in
the discovery of targets or arise out of research and development of Dr.&nbsp;Chen's laboratory at Yale, including S15. We continue to collaborate with Dr.&nbsp;Chen on discovering novel
immunomedicines through an exclusive sponsored research agreement with Yale. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe the combination of our team's capabilities and focus on understanding the biological pathways of the immune system, our product development expertise and manufacturing
infrastructure, our partnership with Lilly and our relationship with Dr.&nbsp;Chen and Yale positions us to build a sustainable portfolio of first-in-class immunomedicines. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Associated with Our Business  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our ability to implement our business strategy is subject to numerous risks and uncertainties. You should carefully consider all of the
information set forth in this prospectus and, in particular, the information in the section entitled "Risk Factors" beginning on page&nbsp;13 before making an investment decision. Risks include,
among others, the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> We have a limited operating history and no products approved for commercial sale. We have a history of significant losses, expect to continue
to incur significant losses for the foreseeable future and may never achieve or maintain profitability. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Even with the expected net proceeds from this offering, we will require substantial additional financing to pursue our business objectives,
which may not be available on acceptable terms, or at all. A failure to obtain this necessary capital when needed could force us to delay, limit, reduce or terminate our product development,
commercial efforts or other operations. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Our business is dependent on our ability to advance our current and future product candidates through clinical trials, obtain marketing
approval and ultimately commercialize them. </FONT></DD></DL>
</UL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=9,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=914526,FOLIO='6',FILE='DISK125:[19ZCO1.19ZCO70301]CA70301A.;32',USER='JTAYLORA',CD='12-NOV-2019;12:46' -->
<A NAME="page_ca70301_1_7"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Our approach to the discovery and development of product candidates based on our FIND-IO platform is unproven and may not result in marketable
products. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Clinical development involves a lengthy and expensive process with uncertain outcomes. We may incur additional costs and experience delays in
developing and commercializing or be unable to develop or commercialize our current and future product candidates. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> The regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time-consuming and inherently unpredictable, and
we may ultimately be unable to obtain regulatory approval for our product candidates. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Positive results from preclinical studies and early-stage clinical trials may not be predictive of future results. Initial positive results in
any of our clinical trials may not be indicative of results obtained when the trial is completed or in later stage trials. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> We are highly dependent on our key personnel, and if we are not successful in attracting, motivating and retaining highly qualified personnel,
we may not be able to successfully implement our business strategy. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Given our limited operating history, our manufacturing experience as an organization and with our manufacturing facility is limited. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> We have filed patent applications for our lead product candidates, but no patent has yet issued from these applications. If we are unable to
obtain and maintain patent protection for our product candidates, or if the scope of the patent protection obtained is not sufficiently broad or robust, our competitors could develop and commercialize
products similar or identical to ours, and our ability to successfully commercialize our product candidates may be adversely affected. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> We may depend on Lilly, Yale or other third-party collaborators for the discovery, development and commercialization of our current and future
product candidates. If our collaborations are not successful, we may not be able to capitalize on the market potential of these product candidates. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> We face significant competition from other biotechnology and pharmaceutical companies, and our operating results will suffer if we fail to
compete effectively. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
additional information about the risks we face, see the section entitled "Risk Factors." </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Information  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We were incorporated in Delaware in September 2015. Our primary executive offices are located at 9000 Virginia Manor Road, Suite&nbsp;200,
Beltsville, Maryland 20705 and our telephone number is (240)&nbsp;399-4900. Our website address is </FONT><FONT SIZE=2><I>www.nextcure.com</I></FONT><FONT SIZE=2>. The information contained on, or
that can be accessed through, our website is not part of this prospectus and should not be considered as part of this prospectus or in deciding whether to purchase our common stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NextCure,
FIND-IO and our logo are some of our trademarks used in this prospectus. This prospectus also includes trademarks, tradenames and service marks that are the property of other
organizations. Solely for convenience, our trademarks and tradenames referred to in this prospectus may appear without the &reg; and &#153; symbols, but those references are not
intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks and tradenames. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Implications of Being an Emerging Growth Company and a Smaller Reporting Company  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and, as such, we have elected
to comply with certain reduced public company reporting requirements for our filings, including this prospectus. </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=10,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=826063,FOLIO='7',FILE='DISK125:[19ZCO1.19ZCO70301]CA70301A.;32',USER='JTAYLORA',CD='12-NOV-2019;12:46' -->
<A NAME="page_ca70301_1_8"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
so long as we remain an emerging growth company, we are permitted and intend to rely on certain exemptions from various public company reporting requirements, including not being
required to have our internal control over financial reporting audited by our independent registered public accounting firm pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act of 2002, reduced
disclosure obligations regarding executive compensation in our periodic reports and proxy statements, exemptions from the requirements of holding a nonbinding advisory vote on executive compensation
and any golden parachute payments not previously approved. In particular, in this prospectus, we have provided only two years of audited financial statements and have not included all of the executive
compensation related information that would be required if we were not an emerging growth company. Accordingly, the information contained herein may be different than the information you receive from
other public companies in which you hold stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will remain an emerging growth company until the earliest of (i)&nbsp;December&nbsp;31, 2024, (ii)&nbsp;the last day of the first fiscal year in which we have total annual gross
revenues of at least $1.07&nbsp;billion, (iii)&nbsp;the last day of the first fiscal year in which the market value of our common stock that is held by non-affiliates exceeds $700.0&nbsp;million
on June&nbsp;30th&nbsp;and (iv)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in non-convertible debt securities during the prior three-year period. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an
emerging growth company to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of this extended
transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (i)&nbsp;are
no longer an emerging growth company or (ii)&nbsp;affirmatively and irrevocably opt out of the extended transition period provided in the JOBS act. As a result, our financial statements may not be
comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are also a "smaller reporting company" and will remain a smaller reporting company while either (i)&nbsp;the market value of our stock held by non-affiliates was less than
$250&nbsp;million as of the last business day of our most recently completed second fiscal quarter or (ii)&nbsp;our annual revenue was less than $100&nbsp;million during our most recently
completed fiscal year and the market value of our stock held by non-affiliates was less than $700&nbsp;million as of the last business day of our most recently completed second fiscal quarter. If we
are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller
reporting companies, including many of the same exemptions from disclosure requirements as those that are available to emerging growth companies, such as reduced disclosure obligations regarding
executive compensation in this prospectus and our periodic reports and proxy statements. For so long as we remain a smaller reporting company, we are permitted and intend to rely on exemptions from
certain disclosure and other requirements that are applicable to other public companies that are not smaller reporting companies. </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=11,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=1048255,FOLIO='8',FILE='DISK125:[19ZCO1.19ZCO70301]CA70301A.;32',USER='JTAYLORA',CD='12-NOV-2019;12:46' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_cc70301_1_9"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><BR></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cc70301_the_offering"> </A>
<A NAME="toc_cc70301_1"> </A></FONT> <FONT SIZE=2><B>  THE OFFERING    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="32%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="64%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Common stock offered by us</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>3,200,000 shares</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Common stock to be outstanding immediately after this offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>25,939,345 shares (or 26,419,345 shares if the underwriters exercise their option to purchase additional shares in
full)</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Option to purchase additional shares offered by us</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>480,000 shares</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Use of proceeds</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>We estimate that the net proceeds from the sale of shares of our common stock in this offering will be approximately
$116.5&nbsp;million, or approximately $134.1&nbsp;million if the underwriters exercise their option to purchase additional shares in full, assuming an offering price of $39.02 per share, which is the last reported sale price of our common stock on
the Nasdaq Global Select Market on November&nbsp;11, 2019, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>We intend to use the net proceeds from this offering, together with our existing cash, cash equivalents and marketable
securities, to advance NC318 (i)&nbsp;through completion of our ongoing Phase&nbsp;1/2 clinical trial, (ii)&nbsp;through completion of our planned Phase&nbsp;2 combination clinical trial, (iii)&nbsp;through completion of additional Phase&nbsp;2
clinical trials and (iv)&nbsp;into Phase&nbsp;3 clinical trials, as well as to develop a complementary diagnostic for NC318 if we determine it is advisable.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>We also intend to use net proceeds and our existing cash, cash equivalents and marketable securities (i)&nbsp;to expand our
cGMP manufacturing capacity, including to provide drug supply of NC318 for future clinical trials, (ii)&nbsp;to advance NC410 through completion of a Phase&nbsp;1/2 clinical trial and into future clinical development, (iii)&nbsp;for research and
development activities related to our FIND-IO platform and discovery programs, including advancement of two discovery programs through submission of INDs and (iv)&nbsp;for personnel expenses, working capital and other general corporate
purposes.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>See the section entitled "Use of Proceeds" on page&nbsp;67 for a more complete description of the intended use of proceeds
from this offering.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk factors</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>You should carefully read the section entitled "Risk Factors" on page&nbsp;13 for a discussion of factors that you should
consider before deciding to invest in shares of our common stock.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Nasdaq Global Select Market symbol</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>"NXTC"</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=12,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=481179,FOLIO='9',FILE='DISK125:[19ZCO1.19ZCO70301]CC70301A.;27',USER='DSLOAN',CD='12-NOV-2019;05:50' -->
<A NAME="page_cc70301_1_10"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of shares of common stock to be outstanding after this offering is based on 22,739,345 shares of common stock outstanding as of September&nbsp;30, 2019, which includes
114,875 shares of restricted common stock that were unvested or subject to repurchase at September&nbsp;30, 2019 and excludes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 2,248,953 shares of our common stock issuable upon the exercise of stock options outstanding as of September&nbsp;30, 2019, with a weighted
average exercise price of $6.30 per share; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 2,653,969 shares of our common stock available for future issuance under our 2019 Omnibus Incentive Plan, or the 2019 Plan, as of
September&nbsp;30, 2019; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 240,000 shares of our common stock reserved for future issuance under our 2019 Employee Stock Purchase Plan, or the ESPP, as of
September&nbsp;30, 2019. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, unless we specifically state otherwise, all information in this prospectus reflects or assumes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> no exercise of outstanding stock options subsequent to September&nbsp;30, 2019; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> no exercise by the underwriters of their option to purchase up to an additional 480,000 shares of our common stock in this offering. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
we specifically state otherwise and unless the context requires, we refer to our previously outstanding Series&nbsp;A-1, Series&nbsp;A-2, Series&nbsp;A-3, Series&nbsp;B-1,
Series&nbsp;B-2 and Series&nbsp;B-3 Preferred Stock collectively as "preferred stock" in this prospectus. </FONT></P>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=13,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=1028433,FOLIO='10',FILE='DISK125:[19ZCO1.19ZCO70301]CC70301A.;27',USER='DSLOAN',CD='12-NOV-2019;05:50' -->
<A NAME="page_cc70301_1_11"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="cc70301_summary_financial_data"> </A>
<A NAME="toc_cc70301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  SUMMARY FINANCIAL DATA    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>The following tables present summary financial data for our business. We derived the statement of operations and
comprehensive loss data for the years ended December&nbsp;31, 2018 and 2017 from our audited financial statements appearing elsewhere in this prospectus. We derived the statement of operations data
for the six months ended September&nbsp;30, 2019 and 2018 and the balance sheet data as of September&nbsp;30, 2019 from our unaudited condensed financial statements appearing elsewhere in this
prospectus. These unaudited condensed financial statements have been prepared on a basis consistent with our audited financial statements and, in management's opinion, contain all adjustments,
consisting of normal and recurring adjustments, necessary for the fair statement of such financial data. Our historical results are not necessarily indicative of the results that may be expected in
any future period. You should read the following data together with our financial statements and the related notes, as well as the information included in the sections entitled "Selected Financial
Data" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" appearing elsewhere in this prospectus.</I></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(in thousands, except share and per share amounts)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Statement of Operations Data:</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue from research and development arrangement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>13,539</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,787</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,954</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,995</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,590</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,409</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,595 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>29,814</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16,129</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,196</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>15,249 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loss from operations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(25,472</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(16,129</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(23,196</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,549</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income, net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,662</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>192</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>397</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>80 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,810</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,937</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,469</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss per common share, basic and diluted<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.81</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(11.64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(16.64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(11.30</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Weighted average number of common shares, basic and diluted<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,609,219</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,212</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,846</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,212 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>See
Note&nbsp;12 to our audited financial statements and Note&nbsp;8 to our unaudited condensed financial statements included elsewhere in this prospectus for
further details on the calculations of our basic and diluted net loss per share and the weighted average number of shares used in the computation of the per share amounts.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
table below presents our balance sheet data as of September&nbsp;30, 2019:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> on an actual basis; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> on an as adjusted basis to give effect to the sale of 3,200,000&nbsp;shares of common stock in this offering, assuming an offering price of
$39.02 per share, which is the last reported sale price of our </FONT></DD></DL>
</UL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=14,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=920856,FOLIO='11',FILE='DISK125:[19ZCO1.19ZCO70301]CC70301A.;27',USER='DSLOAN',CD='12-NOV-2019;05:50' -->
<A NAME="page_cc70301_1_12"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><I> </i></font></p>
<DIV style="width:100%;box-sizing:border-box;border:#000000 solid 1.0pt;padding-top:12.0pt;padding-right:12.0pt;padding-bottom:12.0pt;padding-left:12.0pt;">

<UL>
<UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>common
stock on the Nasdaq Global Select Market on November&nbsp;11, 2019, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 </UL>
</UL>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="70pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of September&nbsp;30, 2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Actual </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As Adjusted<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(in thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Balance Sheet Data:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash, cash equivalents and marketable securities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>184,082</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>300,588</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Working capital<SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>176,541</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>293,047</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>205,124</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>321,630</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>34,475</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>34,475</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Preferred stock</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated deficit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(70,107</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(70,107</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total stockholders' equity</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>170,649</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>287,155</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>The
as adjusted information is illustrative only and will depend on the actual public offering price and the other terms of this offering determined at pricing. Each
$1.00 increase or decrease in the assumed public offering price of $39.02 per share, which is the last reported sale price of our common stock on the Nasdaq Global Select Market on November&nbsp;11,
2019, would increase or decrease, respectively, our as adjusted amounts of cash, cash equivalents and marketable securities, working capital, total assets and total stockholders' equity by
$3.0&nbsp;million, assuming that the number of shares offered by us, as set forth on the cover of this prospectus, remains the same and after deducting estimated underwriting discounts and
commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. An increase or decrease of 1.0&nbsp;million in the number of shares
we are offering in this offering would increase or decrease, respectively, our as adjusted amounts of cash, cash equivalents and marketable securities, working capital, total assets and total
stockholders' equity by $36.7&nbsp;million, assuming the assumed public offering price remains the same and after deducting estimated underwriting discounts and commissions and estimated offering
expenses payable by us.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>We
define working capital as current assets less current liabilities.  </FONT></DD></DL>
 </DIV>

 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=15,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=706856,FOLIO='12',FILE='DISK125:[19ZCO1.19ZCO70301]CC70301A.;27',USER='DSLOAN',CD='12-NOV-2019;05:50' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_dc70301_1_13"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dc70301_risk_factors"> </A>
<A NAME="toc_dc70301_1"> </A></FONT> <FONT SIZE=2><B>  RISK FACTORS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below
together with all of the other information in this prospectus, including our financial statements and the related notes and the information described in the section entitled "Management's Discussion
and Analysis of Financial Condition and Results of Operations," before deciding whether to invest in our common stock. If any of the events described below actually occurs, our business, results of
operations, financial conditions, cash flows or prospects could be harmed. If that were to happen,
the trading price of our common stock could decline, and you could lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem
immaterial may also impair our business operations.</I></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Financial Position and Need for Additional Capital  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have a limited operating history and no products approved for commercial sale. We have a history of
significant losses, expect to continue to incur significant losses for the foreseeable future and may never achieve or maintain profitability.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a clinical-stage biopharmaceutical company with a limited operating history. Since our founding in 2015, we have incurred significant net
losses. Our net losses were $22.8&nbsp;million for the year ended December&nbsp;31, 2018 and the nine months ended September&nbsp;30, 2019. As of September&nbsp;30, 2019, we had an accumulated
deficit of $70.1&nbsp;million. We have funded our operations to date primarily with proceeds from the sale of preferred stock, upfront fees received in connection with the Lilly agreement and
proceeds from the sale of our common stock in connection with our initial public offering, or IPO. Since commencing operations, we have devoted substantially all of our efforts and financial resources
to organizing and staffing our company, identifying business development opportunities, raising capital, securing intellectual property rights related to our product candidates, building and
optimizing our manufacturing capabilities and conducting discovery, research and development activities for our product candidates, our discovery programs and our FIND-IO platform. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
expect that it will be several years, if ever, before we have a commercialized product. We expect to continue to incur significant expenses and operating losses for the foreseeable
future. The net losses we incur may fluctuate significantly from quarter to quarter. We anticipate that our expenses will increase substantially if, and as,
we:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> continue to advance the preclinical and clinical development of our existing product candidates and our research programs; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> leverage our FIND-IO platform to advance additional product candidates into preclinical and clinical development; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> seek regulatory approvals for any product candidates that successfully complete clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> expand our current good manufacturing practice, or cGMP, manufacturing capacity, including to provide drug supply of NC318 for future clinical
trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> hire additional clinical, quality control, regulatory, scientific and administrative personnel; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> expand our operational, financial and management systems and increase personnel, including to support our clinical development, manufacturing
and commercialization efforts and our operations as a public company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> maintain, expand and protect our intellectual property portfolio; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> establish a marketing, sales, distribution and medical affairs infrastructure to commercialize any products for which we may obtain marketing
approval and commercialize, whether on our own or jointly with a partner; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=16,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=593927,FOLIO='13',FILE='DISK125:[19ZCO1.19ZCO70301]DC70301A.;13',USER='LGADISH',CD='11-NOV-2019;22:58' -->
<A NAME="page_dc70301_1_14"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> acquire or in-license other technologies or engage in strategic partnerships; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> incur additional legal, accounting or other expenses in operating our business, including the additional costs associated with operating as a
public company. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
become and remain profitable, we, whether on our own or jointly with Lilly or any potential future collaborator, must develop and eventually commercialize products with significant
market potential. This will require us to be successful in a range of challenging activities, including completing preclinical studies and clinical trials, obtaining marketing approval for product
candidates, manufacturing, marketing and selling products and satisfying any post-marketing requirements. We may never succeed in any or all of these activities and, even if we do, we may never
generate revenue that is significant or large enough to achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis.
Our failure to become and remain profitable would decrease the value of our company and could impair our ability to raise capital, maintain our research and development efforts, expand our business or
continue our operations. A decline in the value of our company could also cause you to lose all or part of your investment. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


We have never generated revenue from product sales and may never be profitable.  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our ability to generate revenue from product sales and achieve profitability depends on our ability, alone or with our collaboration partners,
to successfully complete the development of, and obtain the regulatory approvals necessary to commercialize, our product candidates. We do not anticipate generating revenue from product sales for the
next several years, if ever. Our ability to generate future revenue from product sales depends heavily on our, or our existing or future collaborators', success
in:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> completing preclinical studies and clinical trials of our product candidates, including our ongoing Phase 1/2 clinical trial for NC318 and
other planned clinical trials for NC318 and NC410; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> seeking and obtaining marketing approvals for any product candidates that we or our collaborators develop; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> receiving acceptance of the INDs for NC410 and future product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> identifying and developing new product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> launching and commercializing product candidates for which we obtain marketing approval by establishing a marketing, sales, distribution and
medical affairs infrastructure or, alternatively, collaborating with a commercialization partner; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> achieving coverage and adequate reimbursement by hospitals and third-party payors, including governmental authorities, such as Medicare and
Medicaid, private insurers and managed care organizations, for product candidates, if approved, that we or our collaborators develop; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> manufacturing cGMP supply of our product candidates for clinical trials and, if approved, commercial sales; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> obtaining market acceptance of product candidates, if approved, that we develop as viable treatment options; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> addressing any competing technological and market developments; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> negotiating favorable terms in any collaboration, licensing or other arrangements into which we may enter and performing our obligations under
such arrangements; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> maintaining, protecting and expanding our portfolio of intellectual property rights, including patents, trade secrets and know-how; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> defending against third-party interference or infringement claims, if any; and </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=17,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=627127,FOLIO='14',FILE='DISK125:[19ZCO1.19ZCO70301]DC70301A.;13',USER='LGADISH',CD='11-NOV-2019;22:58' -->
<A NAME="page_dc70301_1_15"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> attracting, hiring and retaining qualified personnel. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
anticipate incurring significant costs associated with commercializing any product candidate that is approved for commercial sale. Our expenses could increase beyond expectations if
we are required by the FDA or other regulatory agencies to perform clinical trials or studies in addition to those that we currently anticipate. Even if we are able to generate revenue from the sale
of any approved products, we may not become profitable and may need to obtain additional funding to continue operations. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Even with the expected net proceeds from this offering, we will require substantial additional financing to
pursue our business objectives, which may not be available on acceptable terms, or at all. A failure to obtain this necessary capital when needed could force us to delay, limit, reduce or terminate
our product development, commercialization efforts or other operations.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our operations have consumed substantial amounts of cash since inception. We expect to continue to spend substantial amounts to continue the
preclinical and clinical development of our current and future programs. If we receive marketing approval for any product candidates, including NC318 and NC410, we will require significant additional
amounts of cash in order to launch and commercialize such product candidates. In addition, other unanticipated costs may arise. Because the designs and outcomes of our planned and anticipated clinical
trials are highly uncertain, we cannot reasonably estimate the actual amounts necessary to successfully complete the development of and commercialize any product candidate we develop. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
future capital requirements depend on many factors, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the scope, progress, timing, results and costs of researching and developing NC318, NC410 and our other product candidates, including targets
identified through our FIND-IO platform, and of conducting preclinical studies and clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the timing of, and the costs involved in, obtaining marketing approval for NC318, NC410 and any future product candidates we develop, if
clinical trials are successful; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the success of our collaboration with Lilly, including whether Lilly exercises its licensing options under its collaboration agreement with us,
each of which would trigger additional payments to us; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the costs of manufacturing NC318, NC410 and any future product candidates for preclinical studies and clinical trials and in preparation for
marketing approval and commercialization; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the costs of commercialization activities, including marketing, sales and distribution costs, for NC318, NC410 and any future product
candidates we develop, whether alone or with a collaborator, if any of these product candidates are approved for sale; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the success of our corporate sponsored research agreement, or SRA, with Yale University; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our ability to establish and maintain additional strategic collaborations, licensing or other arrangements on favorable terms, if at all; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the costs involved in preparing, filing, prosecuting, maintaining, expanding, defending and enforcing patent claims, including litigation costs
and the outcome of any such litigation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our current collaboration and license agreements remaining in effect and our achievement of milestones and the timing and amount of milestone
payments we are required to make, or that we may be eligible to receive, under those agreements; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the timing, receipt and amount of sales of, or royalties on, our future products, if any; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the emergence of competing therapies and other adverse developments in the oncology market. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=18,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=516938,FOLIO='15',FILE='DISK125:[19ZCO1.19ZCO70301]DC70301A.;13',USER='LGADISH',CD='11-NOV-2019;22:58' -->
<A NAME="page_dc70301_1_16"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Until
we can generate sufficient product and royalty revenue to finance our cash requirements, which we may never do, we expect to finance our future cash needs through a combination of
public or private equity offerings, debt financings, marketing and distribution arrangements, other collaborations, strategic alliances and licensing arrangements. As of September&nbsp;30, 2019, we
had $184.1&nbsp;million in cash, cash equivalents and marketable securities. Based on our research and development plans, we expect that the net proceeds from this offering, together with our
existing cash, cash equivalents and marketable securities, will enable us to fund our operating expenses and capital expenditure requirements into the first half of 2023. This estimate is based on
assumptions that may prove to be wrong, and we could use our available capital resources sooner than we expect. Changes may occur beyond our control that would cause us to consume our available
capital before that time, including changes in and progress of our development activities, acquisitions of additional product candidates and changes in regulation. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we raise additional capital through marketing, sales and distribution arrangements or other collaborations, strategic alliances or licensing arrangements with third parties, we may
have to relinquish certain valuable rights to our product candidates, future revenue streams or research programs, technologies or grant licenses on terms that may not be favorable to us. If we raise
additional capital through public or private equity offerings, the terms of these securities may include liquidation or other preferences that adversely affect our stockholders' rights. Further, to
the extent that we raise additional capital through additional sales of common stock or securities convertible or exchangeable into common stock, your ownership interest will be diluted. See the
section entitled "Dilution" for a more detailed description of the dilution to investors in the offering. If we raise additional capital through debt financing, we would be subject to fixed payment
obligations and may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adequate
additional financing may not be available to us on acceptable terms, or at all. If we are unable to obtain additional financing on favorable terms when needed, we may be
required to delay, limit, reduce or terminate preclinical studies, clinical trials, or other research and development activities or one or more of our development programs. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to the Discovery and Development of Our Product Candidates  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our business is dependent on our ability to advance our current and future product candidates through
clinical trials, obtain marketing approval and ultimately commercialize them.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are early in our development efforts. We initiated our first clinical trial for NC318, our lead product candidate, in October 2018, and our
second product candidate, NC410, is in preclinical development. Our ability to generate product revenues, which we do not expect will occur for several years, if ever, will depend heavily on the
successful development and eventual commercialization of NC318, NC410 and any future product candidates we develop, which may never occur. Our current product candidates, including NC318 and NC410,
and any future product candidates we develop will require additional preclinical or clinical development, management of clinical, preclinical and manufacturing activities, marketing approval in the
United States and other jurisdictions, demonstration of effectiveness to pricing and reimbursement authorities, sufficient cGMP manufacturing supply for both preclinical and clinical development and
commercial production, building of a commercial organization and substantial investment and significant marketing efforts before we generate any revenues from product sales. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
clinical and commercial success of our current and future product candidates will depend on several factors, including the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> timely and successful completion of preclinical studies and our clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> sufficiency of our financial and other resources to complete the necessary preclinical studies and clinical trials; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=19,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=642844,FOLIO='16',FILE='DISK125:[19ZCO1.19ZCO70301]DC70301A.;13',USER='LGADISH',CD='11-NOV-2019;22:58' -->
<A NAME="page_dc70301_1_17"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> acceptance of the INDs for NC410 and future product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> successful enrollment in and completion of clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> successful data from our clinical program that supports an acceptable risk-benefit profile of our product candidates in the intended patient
populations; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our ability to consistently manufacture our product candidates on a timely basis or to establish agreements with third-party manufacturers, if
needed; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> whether we are required by the FDA or comparable foreign regulatory authorities to conduct additional clinical trials or other studies beyond
those planned or anticipated to support approval of our product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> acceptance of our proposed indications and the primary endpoint assessments evaluated in the clinical trials of our product candidates by the
FDA and comparable foreign regulatory authorities; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> receipt and maintenance of timely marketing approvals from applicable regulatory authorities; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> successfully launching commercial sales of our product candidates, if approved; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the prevalence, duration and severity of potential side effects or other safety issues experienced with our product candidates, if approved; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> entry into collaborations to further the development of our product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> obtaining and maintaining patent and trade secret protection or regulatory exclusivity for our product candidates; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> acceptance of the benefits and uses of our product candidates, if approved, by patients, the medical community and third-party payors; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> maintaining a continued acceptable safety, tolerability and efficacy profile of the product candidates following approval; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our compliance with any post-approval requirements imposed on our products, such as postmarketing studies, a Risk Evaluation and Mitigation
Strategy, or REMS, or additional requirements that might limit the promotion, advertising, distribution or sales of our products or make the products cost prohibitive; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> competing effectively with other therapies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> obtaining and maintaining healthcare coverage and adequate reimbursement from third-party payors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our ability to identify targets and immunomedicines, whether through our FIND-IO platform, through our relationships with Yale or otherwise;
and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> enforcing and defending intellectual property rights and claims. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
factors, many of which are beyond our control, could cause us to experience significant delays or an inability to obtain regulatory approvals or commercialize our current or future
product candidates, and could otherwise materially harm our business. Successful completion of preclinical studies and clinical trials does not mean that NC318, NC410 or any future product candidates
we develop will receive regulatory approval. Even if regulatory approvals are obtained, we could experience significant delays or an inability to successfully commercialize our current and any future
product candidates we develop, which would materially harm our business. If we are not able to generate sufficient revenue through the sale of any current or future product candidate, we may not be
able to continue our business operations or achieve profitability. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=20,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=701188,FOLIO='17',FILE='DISK125:[19ZCO1.19ZCO70301]DC70301A.;13',USER='LGADISH',CD='11-NOV-2019;22:58' -->
<A NAME="page_dc70301_1_18"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time-consuming
and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for our product candidates, our business will be materially harmed.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The time required to obtain approval by the FDA and comparable foreign authorities is unpredictable but typically takes many years following the
commencement of clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations or the type and
amount of clinical data necessary to gain approval may change during the course of a product candidate's clinical development and may vary among jurisdictions. We have not obtained regulatory approval
for any product candidate. Neither we nor any future collaborator is permitted to market any biological product in the United States until we or the future collaborator receives regulatory approval of
a biologics license application, or BLA, from the FDA. It is possible that none of our current or future product candidates will ever obtain regulatory approval from the FDA or comparable foreign
regulatory authorities. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
current and future product candidates could fail to receive regulatory approval for many reasons, including the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical trials; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that a product candidate is safe,
pure and potent for its proposed indication; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the results of clinical trials may not meet the level of statistical significance required by the FDA or comparable foreign regulatory
authorities for approval; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we may be unable to demonstrate that a product candidate's clinical and other benefits outweigh its safety risks; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from clinical trials or preclinical studies; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the data collected from clinical trials of our product candidates may not be sufficient to support the submission of a BLA to the FDA or
regulatory submissions to comparable regulatory authorities to obtain regulatory approval in such jurisdiction; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the FDA or comparable foreign regulatory authorities may find deficiencies with or fail to approve our manufacturing processes or facility or
the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
lengthy approval process as well as the unpredictability of clinical trial results may result in our failing to obtain regulatory approval to market any product candidate we
develop, which would significantly harm our business, results of operations and prospects. The FDA and other comparable foreign authorities have substantial discretion in the approval process and in
determining when or whether regulatory approval will be granted for any product candidate that we develop. Even if we believe the data collected from future clinical trials of our product candidates
are promising, such data may not be sufficient to support approval by the FDA or any other regulatory authority. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, even if we were to obtain approval, the FDA may approve any of our product candidates for fewer or more limited indications, or a more limited patient population, than we
request, may grant approval contingent on the performance of costly clinical trials or other postmarketing requirements, or may approve a product candidate with a label that does not include the
labeling claims we believe are necessary or desirable for the successful commercialization of such product candidates. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the FDA or comparable foreign regulatory authorities may change their policies, promulgate additional regulations, revise existing regulations or take other actions that may
prevent or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=21,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=760633,FOLIO='18',FILE='DISK125:[19ZCO1.19ZCO70301]DC70301A.;13',USER='LGADISH',CD='11-NOV-2019;22:58' -->
<A NAME="page_dc70301_1_19"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>delay
approval of our future products under development on a timely basis. Such policy or regulatory changes could impose additional requirements upon us that could delay our ability to obtain
approvals, increase the costs of compliance or restrict our ability to maintain any marketing authorizations we may have obtained. Any of the foregoing scenarios could materially harm the commercial
prospects for our product candidates. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Clinical development involves a lengthy and expensive process with uncertain outcomes. We may incur
additional costs and experience delays in developing and commercializing or be unable to develop or commercialize our current and future product candidates.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To obtain the requisite regulatory approvals to commercialize any of our product candidates, we must demonstrate through extensive preclinical
studies and clinical trials that our product candidates are safe, pure and potent in humans. Clinical testing is expensive and can take many years to complete, and its outcome is highly uncertain.
Failure can occur at any time during the clinical trial process and our future clinical trial results may not be successful. We may experience delays in completing our clinical trials or preclinical
studies and initiating or completing additional clinical trials. Although we initiated a Phase 1/2 clinical trial of NC318 in October 2018, we may experience delays in initiating or completing our
planned clinical trials and development efforts. Additionally, we cannot be certain the ongoing and planned preclinical studies or clinical trials for NC318, NC410 or any future product candidates
will begin on time, not require redesign, enroll an adequate number of subjects on time or be completed on schedule, if at all. We may also experience numerous unforeseen events during our clinical
trials that could delay or prevent our ability to receive marketing approval or commercialize the product candidates we develop, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> results from preclinical studies or clinical trials may not be predictive of results from later clinical trials of any product candidate; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the FDA or other regulatory authorities, Institutional Review Boards, or IRBs, or independent ethics committees may not authorize us or our
investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the FDA or other regulatory authorities may require us to submit additional data such as long-term toxicology studies, or impose other
requirements on us, before permitting us to initiate a clinical trial; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we may experience delays in reaching, or fail to reach, agreement on acceptable terms with prospective trial sites and prospective contract
research organizations, or CROs, as the terms of these agreements can be subject to extensive negotiation and vary significantly among different CROs and trial sites; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> clinical trials of any product candidate may fail to show safety, purity or potency, or may produce negative or inconclusive results, which may
cause us to decide, or regulators to require us, to conduct additional nonclinical studies or clinical trials or which may cause us to decide to abandon product candidate development programs; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the number of patients required for clinical trials may be larger than we anticipate, or we may have difficulty in recruiting and enrolling
patients to participate in clinical trials, including as a result of the size and nature of the patient population, the proximity of patients to clinical trial sites, eligibility criteria for the
clinical trial, the nature of the clinical trial protocol, the availability of approved effective treatments for the relevant disease and competition from other clinical trial programs for similar
indications and clinical trial subjects; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> it may be difficult to enroll a sufficient number of patients, enrollment in these clinical trials may be slower than we anticipate or
participants may drop out of these clinical trials or may fail to return for post-treatment follow-up at a higher rate than we anticipate; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=22,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=174523,FOLIO='19',FILE='DISK125:[19ZCO1.19ZCO70301]DC70301A.;13',USER='LGADISH',CD='11-NOV-2019;22:58' -->
<A NAME="page_dc70301_1_20"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our CROs and other third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a
timely manner, or at all, or may deviate from the clinical trial protocol or drop out of the trial, which may require that we add new clinical trial sites or investigators; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we may elect to, or regulators, IRBs or ethics committees may require that we or our investigators, suspend or terminate clinical research or
trials for various reasons, including noncompliance with regulatory requirements or a finding that participants are being exposed to unacceptable health risks; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> any of our product candidates could cause undesirable side effects that could result in significant negative consequences, including the
inability to enter clinical development or receive regulatory approval; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the cost of preclinical or nonclinical testing and studies and clinical trials of any product candidates may be greater than we anticipate; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we may face hurdles in addressing subject safety concerns that arise during the course of a trial, causing us or our investigators, regulators,
IRBs or ethics committees to suspend or terminate trials, or reports may arise from nonclinical or clinical testing of other cancer therapies that raise safety or efficacy concerns about our product
candidates; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the supply, quality or timeliness of delivery of materials for product candidates we develop or other materials necessary to conduct clinical
trials may be insufficient or inadequate. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
could encounter delays if a clinical trial is suspended or terminated by us, or by the IRBs of the institutions in which such trials are being conducted, ethics committees or the Data
Safety Monitoring Board, or DSMB, for such trial or by the FDA or other regulatory authorities. Such authorities may impose such a suspension or termination due to a number of factors, including
failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the
clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to
demonstrate a benefit from using a product candidate, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. Many of the factors that
cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of marketing approval of our product candidates. Further, the FDA or other
regulatory authorities may disagree with our clinical trial design and our interpretation of data from clinical trials, or may change the requirements for approval even after they have reviewed and
commented on the design for our clinical trials. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal
investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and may receive cash or equity compensation in connection with
such services. If these relationships and any related compensation result in perceived or actual conflicts of interest, or a regulatory authority concludes that the financial relationship may have
affected the interpretation of the trial, the integrity of the data generated at the applicable clinical trial site may be questioned and the utility of the clinical trial itself may be jeopardized,
which could result in the delay or rejection of the marketing application we submit. Any such delay or rejection could prevent or delay us from commercializing our current or future product
candidates. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we experience delays in the completion, or termination, of any clinical trial of our product candidates, the commercial prospects of our product candidates will be harmed and our
ability to generate product revenues from any of these product candidates will be delayed. In addition, any delays in completing our clinical trials will increase our costs, slow down the development
and approval process for our product candidates and jeopardize our ability to commence product sales and generate revenues. Significant clinical trial delays could also allow our competitors to bring
products to market before we do or shorten any periods during which we have the exclusive right to commercialize our product candidates. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=23,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=28586,FOLIO='20',FILE='DISK125:[19ZCO1.19ZCO70301]DC70301A.;13',USER='LGADISH',CD='11-NOV-2019;22:58' -->
<A NAME="page_dc70301_1_21"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>Any
such events would impair our ability to successfully commercialize our product candidates and may harm our business and results of operations. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or
completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates or result in the development of our product candidates stopping early. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Preclinical development is uncertain. Our preclinical programs may experience delays or may never advance to
clinical trials, which would adversely affect our ability to obtain regulatory approvals or commercialize these programs on a timely basis or at all.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With the exception of NC318, all of our product candidates are still in the preclinical discovery stage, and the risk of failure for such
product candidates is high. In order to obtain FDA approval to market a new biologic we must demonstrate proof of safety, purity and potency, including efficacy, in humans. To meet these requirements
we will have to conduct adequate and well-controlled clinical trials. Before we can commence clinical trials for a product candidate, we must complete extensive preclinical testing and studies that
support our planned clinical trials in humans. We cannot be certain of the timely completion or outcome of our preclinical testing and studies and cannot predict if the FDA will accept our proposed
clinical programs or if the outcome of our preclinical testing and studies will ultimately support the further development of our current or future product candidates. As a result, we cannot be sure
that we will be able to submit INDs or similar applications for our preclinical programs on the timelines we expect, if at all, and we cannot be sure that submission of INDs or similar applications
will result in the FDA or other regulatory authorities allowing clinical trials to begin. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conducting
preclinical testing is a lengthy, time-consuming and expensive process. The length of time of such testing may vary substantially according to the type, complexity and novelty
of the program, and often can be several years or more per program. Delays associated with programs for which we are conducting preclinical testing and studies may cause us to incur additional
operating expenses. Moreover, we may be affected by delays associated with the preclinical testing and studies of certain programs that are the responsibility of Lilly or our potential future
collaborators over which we have no control. The commencement and rate of completion of preclinical studies and clinical trials for a product candidate may be delayed by many factors, including but
not limited to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> an inability to generate sufficient preclinical or other </FONT><FONT SIZE=2><I>in vivo</I></FONT><FONT SIZE=2> or </FONT><FONT SIZE=2><I>in
vitro</I></FONT><FONT SIZE=2> data to support the initiation of clinical studies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> delays in reaching a consensus with regulatory agencies on study design; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the FDA not permitting the reliance on preclinical or other data from published scientific literature. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Positive results from preclinical studies and early-stage clinical trials may not be predictive of future
results. Initial positive results in any of our clinical trials may not be indicative of results obtained when the trial is completed or in later stage trials.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The results of preclinical studies may not be predictive of the results of clinical trials. Preclinical studies and early-stage clinical trials
are primarily designed to test safety, to study pharmacokinetics and pharmacodynamics and to understand the side effects of product candidates at various doses and schedules, and the results of any
early-stage clinical trials may not be predictive of the results of later-stage, large-scale efficacy clinical trials. In addition, initial success in clinical trials may not be indicative of results
obtained when such trials are completed. There can be no assurance that any of our current or future clinical trials will ultimately be successful or support further clinical development of any of our
product candidates. There is a high failure rate for drugs and biologics proceeding through clinical trials. A number of companies in the pharmaceutical and biotechnology industries have suffered
significant setbacks in </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=24,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=121504,FOLIO='21',FILE='DISK125:[19ZCO1.19ZCO70301]DC70301A.;13',USER='LGADISH',CD='11-NOV-2019;22:58' -->
<A NAME="page_dc70301_1_22"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>clinical
development even after achieving promising results in earlier studies, and any such setbacks in our clinical development could have a material adverse effect on our business and operating
results. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even
if our clinical trials are completed, the results may not be sufficient to obtain regulatory approval for our product candidates. Data obtained from preclinical and clinical
activities are subject to varying interpretations, which may delay, limit or prevent regulatory approval. In addition, the results of our preclinical studies may not be predictive of the results of
outcomes in human clinical trials. For example, our current or future product candidates may demonstrate different chemical, biological and pharmacological properties in patients than they do in
laboratory studies or may interact with human biological systems in unforeseen or harmful ways. Product candidates in later stages of clinical trials may fail to show desired pharmacological
properties or produce the necessary safety and efficacy results despite having progressed through preclinical studies and initial clinical trials. Even if we are able to initiate and complete clinical
trials, the results may not be sufficient to obtain regulatory approval for our product candidates. In addition, we may experience regulatory delays or rejections as a result of many factors,
including changes in regulatory policy during the period of our product candidate development. Any such delays could negatively impact our business, financial condition, results of operations and
prospects. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Interim and preliminary results from our clinical trials that we announce or publish from time to time may
change as more patient data become available and are subject to audit, validation and verification procedures that could result in material changes in the final data.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From time to time, we may publish interim data, including interim top-line results or preliminary results from our clinical trials. Interim data
and results from our clinical trials are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available.
Preliminary or top-line results also remain subject to audit, validation and verification procedures that may result in the final data being materially different from the interim and preliminary data
we previously published. As a result, interim and preliminary data may not be predictive of final results and should be viewed with caution until the final data are available. Differences between
preliminary or interim data and final data could significantly harm our business prospects and may cause the trading price of our common stock to fluctuate significantly. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our approach to the discovery and development of product candidates using our FIND-IO platform is unproven
and may not result in marketable products.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The success of our business depends in part upon our ability to identify targets based on our proprietary FIND-IO platform and to develop and
commercialize immunomedicines. Our approach to the discovery of targets using the FIND-IO platform is novel. We have not yet initiated or completed a clinical trial of any product candidate developed
for a target identified from the FIND-IO platform. The platform may fail to accurately identify targets that modulate the immune system and are appropriate for immunomedicines. Even if we are able to
identify targets from the FIND-IO platform and to develop corresponding product candidates, we cannot assure that such product candidates will achieve marketing approval to safely and effectively
treat cancer or other disease states. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we uncover any previously unknown risks related to our FIND-IO platform, or if we experience unanticipated problems or delays in developing our FIND-IO product candidates, we may be
unable to achieve our strategy of building an oncology pipeline of novel targets for new immunomedicines focused on non-responders, or meet our obligations under the Lilly Agreement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=25,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=126029,FOLIO='22',FILE='DISK125:[19ZCO1.19ZCO70301]DC70301A.;13',USER='LGADISH',CD='11-NOV-2019;22:58' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_de70301_1_23"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our current or future product candidates may cause undesirable side effects or have other properties when
used alone or in combination with other approved products or investigational new drugs that could halt their clinical development, delay or prevent their regulatory approval, limit their commercial
potential or result in significant negative consequences.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Before obtaining regulatory approvals for the commercial sale of our product candidates, we must demonstrate through lengthy, complex and
expensive preclinical testing and clinical trials that our product candidates are safe, pure and potent for use in each target indication, and
failures can occur at any stage of testing. As with most biologics, use of our current or future product candidates could be associated with side effects or adverse events which can vary in severity
from minor reactions to death and in frequency from infrequent to prevalent. There have been serious adverse side effects reported in response to immunotherapies in oncology. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
most common treatment-related adverse events reported in the Phase&nbsp;1 portion of the Phase 1/2 clinical trial of NC318 as of November&nbsp;9, 2019 have been diarrhea,
infusion reactions, fatigue, headaches, pruritis, elevated amylase and elevated lipase. Most treatment-related adverse events have been easily manageable, asymptomatic or mild or moderate, with the
exception of one case of grade 3 episcleritis/uveitis that resolved after steroid therapy and two cases of grade 3 pneumonitis. Immune-related adverse events that represent immune effects on normal
tissue and can result from misdirected stimulation of the immune system are a common class of toxicity in immunomedicines such as NC318. Immune-related adverse events reported in the Phase&nbsp;1
portion of the Phase 1/2 clinical trial of NC318 included diarrhea, elevated amylase and lipase, pruritis, episcleritis/uveitis, pneumonitis and vitiligo. Possible adverse side effects that could
occur with treatment with immunomedicines include an immunologic reaction early after administration which, while not necessarily adverse to the patient's health, could substantially limit the
effectiveness of the treatment. In addition to any potential side effects caused by the product or product candidate, the administration process or related procedures also can cause adverse side
effects. If unacceptable adverse events occur, our clinical trials or any future marketing authorization could be suspended or terminated. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
unacceptable side effects arise in the development of our product candidates, we, the FDA, the IRBs at the institutions in which our studies are conducted or the DSMB could suspend or
terminate our clinical trials or the FDA or comparable foreign regulatory authorities could order us to cease clinical trials or deny approval of our product candidates for any or all targeted
indications. Treatment-related side effects could also affect patient recruitment or the ability of enrolled patients to complete any of our clinical trials or result in potential product liability
claims. In addition, these side effects may not be appropriately recognized or managed by the treating medical staff. We expect to have to train medical personnel using our product candidates to
understand the side effect profiles for our clinical trials and upon any commercialization of any of our product candidates. Inadequate training in recognizing or managing the potential side effects
of our product candidates could result in patient injury or death. Any of these occurrences may harm our business, financial condition and prospects significantly. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
our current and future product candidates have undergone and will undergo safety testing to the extent possible and, where applicable, under such conditions discussed with
regulatory authorities, not all adverse effects of drugs can be predicted or anticipated. Immunomedicines and their method of action of harnessing the body's immune system are powerful and could lead
to serious side effects that we only discover in clinical trials or during commercial marketing. Unforeseen side effects could arise either during clinical development or after our product candidates
have been approved by regulatory authorities and the approved product has been marketed, resulting in the exposure of additional patients. So far, we have not demonstrated that NC318, NC410 or any
other product candidate is safe in humans, and we cannot predict if ongoing or future clinical trials will do so. If any of our current or future product candidates fail to demonstrate safety and
efficacy in clinical trials or do not gain marketing approval, we will not be able to generate revenue and our business will be harmed. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=26,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=178159,FOLIO='23',FILE='DISK125:[19ZCO1.19ZCO70301]DE70301A.;16',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_de70301_1_24"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, we intend to pursue NC318 in part in combination with other therapies and may develop NC410 and future product candidates in combination with other therapies, which exposes
us to additional risks relating to undesirable side effects or other properties. For example, the other therapies may lead to toxicities that are improperly attributed to our product candidates or the
combination of our product candidates with other therapies may result in toxicities that the product candidate or other therapy does not produce when used alone. The other therapies we are using in
combination may be removed from the market, or we may not be able to secure adequate quantities of such materials for which we have no guaranteed supply contract, and thus be unavailable for testing
or commercial use with any of our approved products. The other therapies we may use in combination with our product candidates may also be supplanted in the market by newer, safer or more efficacious
products or combinations of products. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even
if we successfully advance one of our product candidates through clinical trials, such trials will likely only include a limited number of subjects and limited duration of exposure
to our product candidates. As a result, we cannot be assured that adverse effects of our product candidates will not be uncovered when a significantly larger number of patients are exposed to the
product candidate. Further, any clinical trial may not be sufficient to determine the effect and safety consequences of taking our product candidates over a multi-year period. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any of our product candidates receives marketing approval, and we or others later identify undesirable side effects caused by such products, a number of potentially significant
negative consequences could result, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> regulatory authorities may withdraw their approval of the product; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we may be required to recall a product or change the way such product is administered to patients; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> additional restrictions may be imposed on the marketing of the particular product or the manufacturing processes for the product or any
component thereof; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> regulatory authorities may require the addition of labeling statements, such as a "black box" warning or a contraindication; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we may be required to implement a REMS or create a Medication Guide outlining the risks of such side effects for distribution to patients; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we could be sued and held liable for harm caused to patients; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the product may become less competitive; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our reputation may suffer. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
of the foregoing events could prevent us from achieving or maintaining market acceptance of the particular product candidate, if approved, and result in the loss of significant
revenues, which would materially harm our business. In addition, if one or more of our product candidates or our immunotherapeutic development approach generally prove to be unsafe, our entire
technology platform and pipeline could be affected, which would also materially harm our business. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


As an organization, we have limited experience designing and implementing clinical trials and we have never
conducted pivotal clinical trials. Failure to adequately design a trial, or incorrect assumptions about the design of the trial, could adversely affect the ability to initiate the trial, enroll
patients, complete the trial, or obtain regulatory approval on the basis of the trial results, as well as lead to increased or unexpected costs and in delayed timelines.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The design and implementation of clinical trials is a complex process. We have limited experience designing and implementing clinical trials,
and we may not successfully or cost-effectively design and implement clinical trials that achieve our desired clinical endpoints efficiently, or at all. A clinical trial that is not well designed may
delay or even prevent initiation of the trial, can lead to increased difficulty in enrolling patients, may make it more difficult to obtain regulatory approval for the product candidate on </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=27,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=1008730,FOLIO='24',FILE='DISK125:[19ZCO1.19ZCO70301]DE70301A.;16',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_de70301_1_25"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>the
basis of the study results, or, even if a product candidate is approved, could make it more difficult to commercialize the product successfully or obtain reimbursement from third-party payors.
Additionally, a trial that is not well-designed could be inefficient or more expensive than it otherwise would have been, or we may incorrectly estimate the costs to implement the clinical trial,
which could lead to a shortfall in funding. We also expect to continue to rely on third parties to conduct our pivotal clinical trials. See "&#151;Risks Related to Reliance on Third
Parties&#151;We rely or will rely on third parties to help conduct our ongoing and planned preclinical studies and clinical trials for NC318, NC410 and any future product candidates we develop.
If these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet expected deadlines, we may not be able to obtain marketing approval for or
commercialize NC318, NC410 and any future product candidates we develop and our business could be materially harmed." Consequently, we may be unable to successfully and efficiently execute and
complete clinical trials that are required for BLA submission and FDA approval of NC318, NC410 or future product candidates. We may require more time and incur greater costs than our competitors and
may not succeed in obtaining regulatory approvals of product candidates that we develop. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we or our collaborators encounter difficulties enrolling patients in our clinical trials, our clinical
development activities could be delayed or otherwise be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The successful and timely completion of clinical trials in accordance with their protocols depends on, among other things, our ability to enroll
a sufficient number of patients who remain in the trial until the trial's conclusion, including any follow-up period. We may experience
difficulties in patient enrollment in our clinical trials for a variety of reasons. The enrollment of patients depends on many factors, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the patient eligibility criteria defined in the protocol; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the nature and size of the patient population required for analysis of the trial's primary endpoints and the process for identifying patients; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the number and location of participating clinical sites or patients; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the design of the trial; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our ability to recruit clinical trial investigators with the appropriate competencies and experience; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> clinicians' and patients' perceptions as to the potential advantages and risks of the product candidate being studied in relation to other
available therapies, including any new products that may be approved for the indications we are investigating; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the availability of competing commercially available therapies and other competing drug candidates' clinical trials; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our ability to obtain and maintain patient informed consents for participation in our clinical trials; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the risk that patients enrolled in clinical trials will drop out of the trials before completion or, because they may be late-stage cancer
patients, will not survive the full terms of the clinical trials. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, our clinical trials will compete with other clinical trials for product candidates that are in the same therapeutic areas as our current and potential future product
candidates. This competition will reduce the number and types of patients available to us, because some patients who might have opted to enroll in our trials may instead opt to enroll in a trial
conducted by one of our competitors. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our
competitors use, which will reduce the number of patients who are available for our clinical trials at such sites. Moreover, because our current and potential future product candidates may represent a
departure from more commonly used methods for cancer treatment, potential </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=28,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=550945,FOLIO='25',FILE='DISK125:[19ZCO1.19ZCO70301]DE70301A.;16',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_de70301_1_26"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>patients
and their doctors may be inclined to use conventional therapies, such as chemotherapy, rather than enroll patients in our ongoing or any future clinical trial. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delays
of difficulties in patient enrollment may result in increased costs or may affect the timing, outcome or completion of clinical trials, which would adversely affect our ability to
advance the development of the product candidates we develop. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Because the number of subjects in our Phase&nbsp;1/2 clinical trial of NC318 is small, the results from
this trial, once completed, may be less reliable than results achieved in larger clinical trials.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A study design that is considered appropriate includes a sufficiently large sample size with appropriate statistical power, as well as proper
control of bias, to allow a meaningful interpretation of the results. The preliminary results of studies with smaller sample sizes, such as our ongoing Phase&nbsp;1/2 clinical trial of NC318, can be
disproportionately influenced by the impact the treatment had on a few individuals, which limits the ability to generalize the results across a broader community, thus making the study results less
reliable than studies with a larger number of subjects. As a result, there may be less certainty that NC318 would achieve a statistically significant effect in any future clinical trials. If we
conduct any future clinical trials of NC318, we may not achieve a statistically significant result or the same level of statistical significance seen, if any, in our Phase&nbsp;1/2 clinical trial.
Similarly, if we conduct a clinical trial of any other product candidate we develop, including NC410, with a smaller sample size, the results of any such trial may be less reliable than results
achieved in larger clinical trials and may provide less certainty of achieving statistically significant effects in any future clinical trials. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be required to suspend, repeat or terminate our clinical trials if they are not conducted in
accordance with regulatory requirements, the results are negative or inconclusive or the trials are not well designed.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clinical trials must be conducted in accordance with the FDA's current good clinical practices requirements, or cGCP, or analogous requirements
of applicable foreign regulatory authorities. Clinical trials are subject to oversight by the FDA, other foreign governmental agencies and IRBs or ethical committees at the study sites where the
clinical trials are conducted. In addition, clinical trials must be conducted with product candidates manufactured in accordance with applicable cGMP. Clinical trials may be suspended by the FDA,
other foreign regulatory authorities, us, or by an IRB or ethics committee with respect to a particular clinical trial site, for various reasons, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> deficiencies in the conduct of the clinical trials, including failure to conduct the clinical trial in accordance with regulatory requirements
or study protocols; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> deficiencies in the clinical trial operations or trial sites; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> unforeseen adverse side effects or the emergence of undue risks to study subjects; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> deficiencies in the trial design necessary to demonstrate efficacy; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the product candidate may not appear to offer benefits over current therapies; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the quality or stability of the product candidate may fall below acceptable standards. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have chosen to prioritize development of NC318 and NC410. We may expend our limited resources on product
candidates or indications that do not yield a successful product and fail to capitalize on other candidates or indications for which there may be a greater likelihood of success or may be more
profitable.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because we have limited resources, we have strategically determined to prioritize development of NC318 and NC410 rather than other product
candidates based, in part, on the significant resources required for developing and manufacturing immunomedicines. To date, no regulatory authority has granted approval for an immunomedicine targeting
S15 or the LAIR pathway. As a result, we may be foregoing other potentially more profitable immunomedicines or therapies or those with a greater </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=29,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=833299,FOLIO='26',FILE='DISK125:[19ZCO1.19ZCO70301]DE70301A.;16',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_de70301_1_27"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>likelihood
of success. Our decisions concerning the allocation of research, development, collaboration, management and financial resources toward particular product candidates or therapeutic areas may
not lead to the development of any viable commercial product and may divert resources away from better opportunities. Similarly, our potential decisions to delay, terminate or collaborate with third
parties with respect to, certain programs may subsequently also prove to be suboptimal and could cause us to miss valuable opportunities. If we make incorrect determinations regarding the viability or
market potential of any of our current or future product candidates or misread trends in the oncology or biopharmaceutical industry, our business, financial condition and results of operations could
be materially adversely affected. As a result, we may fail to capitalize on viable commercial products or profitable market opportunities, be required to forego or delay pursuit of opportunities with
other product candidates or other diseases and disease pathways that may later prove to have greater commercial potential than those we choose to pursue, or relinquish valuable rights to such product
candidates through collaboration, licensing or other royalty arrangements in cases in which it would have been advantageous for us to invest additional resources to retain development and
commercialization rights. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may need to develop, or enter into a collaboration or partnership to develop, complementary or companion
diagnostics for our current or future product candidates. If we, or our future collaborators, are unable to successfully develop such complementary or companion diagnostics, or experience significant
delays in doing so, we may not realize the full commercial potential of our current or future product candidates.  </I></B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;One of the key elements of our product development strategy is to identify cancer patient populations that may derive meaningful benefit from
our current or future product candidates. Because predictive biomarkers may be used to identify the right patients for current or future product candidates, we believe that our success may depend, in
part, on our ability to develop complementary or companion diagnostics in collaboration with partners. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have limited experience in the development of diagnostics and, as such, we expect to rely on future collaborators in developing appropriate diagnostics to pair with our current or
future product candidates. We have not yet begun substantial discussions with any potential partners with respect to the development of complementary or companion diagnostics and may be unsuccessful
in entering into collaborations for the development of any such diagnostics for our current or future product candidates. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Complementary
or companion diagnostics are subject to regulation by the FDA and similar comparable foreign regulatory authorities as medical devices and require separate regulatory
approval or clearance prior to commercialization. If we, our collaborators, or any third parties that we engage to assist us, are
unable to successfully develop complementary or companion diagnostics for our current or future product candidates or experience delays in doing so:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> development of our current or future product candidates may be adversely affected if we are unable to appropriately select patients for
enrollment in our clinical trials; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we may not realize the commercial potential of our current or future product candidates if, among other reasons, we are unable to appropriately
identify, or it takes us longer to identify, patients who are likely to benefit from therapy with our products, if approved. </FONT></DD></DL>
</UL>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any of these events were to occur, our business could be materially harmed. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=30,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=698731,FOLIO='27',FILE='DISK125:[19ZCO1.19ZCO70301]DE70301A.;16',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_de70301_1_28"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to the Regulatory Approval and Commercialization of Product Candidates and Other Legal
Compliance Matters  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be unable to obtain FDA approval of our product candidates under applicable regulatory requirements.
The denial or delay of any such approval would prevent or delay commercialization of our product candidates and adversely impact our potential to generate revenue, our business and our results of
operations.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To gain approval to market our product candidates in the United States, we must provide the FDA with clinical data that adequately demonstrate
the safety, purity and potency,
including efficacy, of the product candidate for the proposed indication or indications in a BLA submission. Product development is a long, expensive and uncertain process, and delay or failure can
occur at any stage of any of our clinical development programs. A number of companies in the biotechnology and pharmaceutical industries have suffered significant setbacks in clinical trials, even
after promising results in earlier preclinical studies or clinical trials. These setbacks have been caused by, among other things, preclinical findings made while clinical trials were underway and
safety or efficacy observations made in clinical trials, including previously unreported adverse events. Success in preclinical testing and early clinical trials does not ensure that later clinical
trials will be successful, and the results of clinical trials by other parties may not be indicative of the results in trials we may conduct. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have not previously submitted a BLA or any other marketing application to the FDA or similar filings to comparable foreign regulatory authorities. A BLA or other similar regulatory
filing requesting approval to market a product candidate must include extensive preclinical and clinical data and supporting information to establish that the product candidate is safe, pure and
potent for each desired indication. The BLA or other similar regulatory filing must also include significant information regarding the chemistry, manufacturing and controls for the product. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
research, testing, manufacturing, labeling, approval, marketing, sale and distribution of biological products are subject to extensive regulation by the FDA and other regulatory
authorities in the United States and other countries, and such regulations differ from country to country. We are not permitted to market our product candidates in the United States or in any foreign
countries until they receive the requisite approval from the applicable regulatory authorities of such jurisdictions. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA or comparable foreign regulatory authorities can delay, limit or deny approval of our product candidates for many reasons, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our inability to demonstrate to the satisfaction of the FDA or a comparable foreign regulatory authority that our product candidates are safe
and effective for the requested indication; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the FDA or a comparable foreign regulatory authority's disagreement with our trial protocol or the interpretation of data from preclinical
studies or clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our inability to demonstrate that the clinical and other benefits of our product candidates outweigh any safety or other perceived risks; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the FDA or a comparable foreign regulatory authority's requirement for additional preclinical studies or clinical trials; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the FDA or a comparable foreign regulatory authority's non-approval of the formulation, labeling, or specifications of our product candidates; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the FDA or a comparable regulatory authority's failure to approve our manufacturing processes and facilities or the manufacturing processes and
facilities of third-party manufacturers upon which we rely; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> potential for approval policies or regulations of the FDA or a comparable foreign regulatory authority to significantly change in a manner
rendering our clinical data insufficient for approval. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=31,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=917402,FOLIO='28',FILE='DISK125:[19ZCO1.19ZCO70301]DE70301A.;16',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_de70301_1_29"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even
if we eventually complete clinical testing and receive approval from the FDA or comparable foreign regulatory authorities for any of our product candidates, the FDA or comparable
foreign regulatory authorities may grant approval contingent on the performance of costly additional clinical trials which may be required after approval. The FDA or comparable foreign regulatory
authorities also may approve any of our product candidates for a more limited indication or a narrower patient population than we originally requested, and the FDA or comparable foreign regulatory
authorities may not approve any of our product candidates with the labeling that we believe is necessary or desirable for the successful commercialization of any such product candidates. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Of
the large number of biopharmaceutical products in development, only a small percentage successfully complete the FDA or other regulatory bodies' approval processes and are
commercialized. Any delay in obtaining, or inability to obtain, applicable regulatory approval would delay or prevent commercialization of our product candidates and would materially harm our
business. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Even if a current or future product candidate receives marketing approval, it may fail to achieve the degree
of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any current or future product candidate we develop receives marketing approval, whether as a single agent or in combination with other
therapies, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors, and others in the medical community. For example, current approved immunotherapies,
and other cancer treatments like chemotherapy and radiation therapy, are well established in the medical community, and doctors may continue to rely on these therapies. Our approach to targeting
different components of the tumor microenvironment is novel and unproven. In addition, adverse events in clinical trials testing our product candidates or in clinical trials of others developing
similar product candidates and the resulting publicity, as well as any other adverse events in the field of immuno-oncology that may occur in the future, could result in a decrease in demand for our
current or future product candidates. If public perception is influenced by claims that the use of cancer immunotherapies is unsafe, whether related to our immunomedicines or our competitors'
products, our products may not be accepted by the general public or the medical community. Future adverse events in immuno-oncology or the biopharmaceutical industry could also result in greater
governmental regulation, stricter labeling requirements and potential regulatory delays in the testing or approvals of our products. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
our current and any future product candidates we develop do not achieve an adequate level of acceptance, we may not generate significant product revenues and we may not become
profitable. The degree of market acceptance of our current and any future product candidates, if approved for commercial sale, will depend on a number of factors,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> efficacy and potential advantages compared to alternative treatments, including those that are not yet approved; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the ability to offer our products, if approved, for sale at competitive prices; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> convenience and ease of administration compared to alternative treatments; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the strength of marketing, sales and distribution support; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the ability to obtain sufficient third-party coverage and adequate reimbursement, including with respect to the use of the approved product as
a combination therapy; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the regulatory approval and adoption of a companion or complementary diagnostic, if needed; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the prevalence and severity of any side effects. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=32,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=997835,FOLIO='29',FILE='DISK125:[19ZCO1.19ZCO70301]DE70301A.;16',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_de70301_1_30"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The market opportunities for any current or future product candidate we develop, if approved, may be limited
to those patients who are ineligible for established therapies or for whom prior therapies have failed, and may be small.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any revenue we are able to generate in the future from product sales will be dependent, in part, upon the size of the market in the United
States and any other jurisdiction for which we gain regulatory approval and have commercial rights. If the markets or patient subsets that we are targeting are not as significant as we estimate, we
may not generate significant revenues from sales of such products, even if approved. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cancer
therapies are sometimes characterized as first-line, second-line or third-line, and the FDA often approves new therapies initially only for third-line use. When cancer is detected
early enough, first-line therapy, usually chemotherapy, hormone therapy, surgery, radiation therapy or a combination of these, is sometimes adequate to cure the cancer or prolong life without a cure.
Second- and third-line therapies are administered to patients when prior therapy is not effective. We may initially seek approval for NC318, NC410 and any other product candidates we develop as
second- or third-line therapies. If we do so, for those products that prove to be sufficiently beneficial, if any, we would expect potentially to seek approval as a first-line therapy, but there is no
guarantee that any product candidate we develop, even if approved, would be approved for first-line therapy, and, prior to any such approvals, we may have to conduct additional clinical trials. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of patients who have the types of cancer we are targeting may turn out to be lower than expected. Additionally, the potentially addressable patient population for our current
or future product candidates may be limited, if and when approved. Even if we obtain significant market share for any product candidate, if and when approved, if the potential target populations are
small, we may never achieve profitability without obtaining marketing approval for additional indications, including to be used as first- or second-line therapy. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We intend to develop NC318 in part in combination with other therapies and may develop NC410 and future
product candidates in combination with other therapies, which exposes us to additional regulatory risks.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We intend to develop NC318 in part in combination with other therapies and may develop NC410 and future product candidates in combination with
one or more currently approved cancer therapies. These combinations have not been tested before and may, among other things, fail to demonstrate synergistic activity, may fail to achieve superior
outcomes relative to the use of single agents or other combination therapies, or may fail to demonstrate sufficient safety or efficacy traits in clinical trials to enable us to complete those clinical
trials or obtain marketing approval for the combination therapy. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, we did not develop or obtain regulatory approval for, and we do not manufacture or sell, any of these approved therapeutics. Therefore, even if any product candidate we
develop were to receive marketing approval or be commercialized for use in combination with other existing therapies, we would continue to be subject to the risk that the FDA or comparable foreign
regulatory authorities could revoke approval of the therapy used in combination with our product candidate or that safety, efficacy, manufacturing or supply issues could arise with these existing
therapies. This could result in our own products being removed from the market or being less successful commercially. Combination therapies are commonly used for the treatment of cancer, and we would
be subject to similar risks if we develop any of our product candidates for use in combination with other drugs or for indications other than cancer. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may also evaluate NC318, NC410, or any future product candidate in combination with one or more other cancer therapies that have not yet been approved for marketing by the FDA or
comparable foreign regulatory authorities. We will not be able to market and sell NC318, NC410 or any product candidate we develop in combination with any such unapproved cancer therapies that do not
ultimately obtain marketing approval. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=33,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=876876,FOLIO='30',FILE='DISK125:[19ZCO1.19ZCO70301]DE70301A.;16',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_de70301_1_31"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the FDA or comparable foreign regulatory authorities do not approve these other biological products or revoke their approval of, or if safety, efficacy, manufacturing or supply issues
arise with, the biologics we choose to evaluate in combination with NC318, NC410 or any product candidate we develop, we may be unable to obtain approval of or market any such product candidate. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Even if we receive marketing approval of a product candidate, we will be subject to ongoing regulatory
obligations and continued regulatory review, which may result in significant additional expense. If we fail to comply or experience unanticipated problems with our products, we may be subject to
administrative and judicial enforcement, including monetary penalties, for non-compliance and our approved products, if any, could be deemed misbranded or adulterated and prohibited from continued
distribution.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any marketing approvals that we receive for any current or future product candidate may be subject to limitations on the approved indicated uses
for which the product may be marketed or the conditions of approval, or contain requirements for potentially costly post-market testing and surveillance to monitor the safety and efficacy of the
product candidate. The FDA may also require implementation of a REMS as a condition of approval of any product candidate, which could include requirements for a medication guide, physician
communication plans or additional elements to
ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. In addition, if the FDA or a comparable foreign regulatory authority approves a product
candidate, the manufacturing processes, labeling, packaging, distribution, adverse event and deviation reporting, storage, advertising, promotion, import and export and record keeping for the product
candidate will be subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as
continued compliance with cGMP and cGCP, for any clinical trials that we may conduct post-approval. Later discovery of previously unknown problems with any approved candidate, including adverse events
of unanticipated severity or frequency, or with our or our third-party manufacturers' manufacturing processes or facilities, or failure to comply with regulatory requirements, may result in, among
other things:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> suspension of, or imposition of restrictions on, the marketing or manufacturing of the product, withdrawal of the product from the market, or
product recalls; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Warning Letters or Untitled Letters, or holds on clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> refusal by the FDA to approve pending applications or supplements to approved applications we file, or suspension or revocation of approved
biologics licenses; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> product seizure or detention, monetary penalties, refusal to permit the import or export of the product, or placement on Import Alert; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> permanent injunctions and consent decrees including the imposition of civil or criminal penalties. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Given
the nature of biologics manufacturing, there is a risk of contamination. Any contamination could materially adversely affect our ability to produce product candidates on schedule
and could, therefore,
harm our results of operations and cause reputational damage. Some of the raw materials and other components required in our manufacturing process are derived from biologic sources. Such raw materials
are difficult to procure and may be subject to contamination or recall. A material shortage, contamination, recall or restriction on the use of biologically derived substances in the manufacture of
our product or product candidates could adversely impact or disrupt the commercial manufacturing or the production of clinical material, which could materially and adversely affect our development and
commercialization timelines and our business, financial condition, results of operations and prospects and could adversely affect our ability to meet our supply obligations. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=34,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=326292,FOLIO='31',FILE='DISK125:[19ZCO1.19ZCO70301]DE70301A.;16',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_dg70301_1_32"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moreover, the FDA strictly regulates the promotional claims that may be made about drug and biological products. In particular, an approved product may not be
promoted for uses that are not approved by the FDA as reflected in the product's approved labeling, or off-label uses. The FDA and other agencies actively enforce the laws and regulations prohibiting
the promotion of off-label uses. The FDA has issued guidance on the factors that it will consider in determining whether a firm's product communication is consistent with the FDA-required labeling for
that product, and those factors contain complexity and potential for overlap and misinterpretation. A company that is found to have improperly promoted off-label uses of their products may be subject
to significant civil, criminal and administrative penalties. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA and other regulatory authorities' policies may change and additional government regulations may be enacted that could prevent, limit or delay marketing approval of a product. We
cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we are slow or
unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we
may have obtained and we may not achieve or sustain profitability. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
government investigation of alleged violations of law could require us to expend significant time and resources in response, and could generate negative publicity. Any failure to
comply with ongoing regulatory requirements may significantly and adversely affect our ability to commercialize and generate revenue from our products. If regulatory sanctions are applied or if
regulatory approval is withdrawn, the value of our company and our operating results will be adversely affected. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
policies of the Trump Administration may impact our business and industry. President Trump has taken several executive actions, including the issuance of a number of Executive
Orders, that could impose significant burdens on, or otherwise materially delay, the FDA's ability to engage in routine oversight activities such as implementing statutes through rulemaking, issuance
of guidance, and review and approval of marketing applications. It is difficult to predict how these orders will be implemented, and the extent to which they will impact the FDA's ability to exercise
its regulatory authority. If these executive actions impose restrictions on the FDA's ability to engage in oversight and implementation activities in the normal course, our business may be negatively
impacted. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, if we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory
compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Obtaining and maintaining marketing approval of our current and future product candidates in one jurisdiction
does not mean that we will be successful in obtaining and maintaining marketing approval of our current and future product candidates in other jurisdictions.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Obtaining and maintaining marketing approval of our current and future product candidates in one jurisdiction does not guarantee that we will be
able to obtain or maintain marketing approval in any other jurisdiction, while a failure or delay in obtaining marketing approval in one jurisdiction may have a negative effect on the marketing
approval process in others. For example, even if the FDA grants marketing approval of a product candidate, comparable regulatory authorities in foreign jurisdictions must also approve the
manufacturing, marketing and promotion of the product candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods
different from, and greater than, those in the United States, including additional preclinical studies or clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in
other jurisdictions. In many jurisdictions outside the United States,
a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to
approval. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=35,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=152136,FOLIO='32',FILE='DISK125:[19ZCO1.19ZCO70301]DG70301A.;13',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dg70301_1_33"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may also submit marketing applications in other countries. Regulatory authorities in jurisdictions outside of the United States have requirements for approval of product candidates
with which we must comply prior to marketing in those jurisdictions. Obtaining foreign marketing approvals and compliance with foreign regulatory requirements could result in significant delays,
difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we fail to comply with the regulatory requirements in international markets or fail
to receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We depend on our information technology systems, and any failure of these systems could harm our business.
Security breaches, loss of data, and other disruptions could compromise sensitive information related to our business or prevent us from accessing critical information and expose us to liability,
which could adversely affect our business, results of operations and financial condition.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We collect and maintain information in digital form that is necessary to conduct our business, and we are dependent on our information
technology systems and those of third parties to operate our business. In the ordinary course of our business, we collect, store and transmit large amounts of confidential information, including
intellectual property, proprietary business information and personal information, and data to comply with cGMP and data integrity requirements. It is critical that we do so in a secure manner to
maintain data security and data integrity of such information. We have established physical, electronic and organizational measures to safeguard and secure our systems to prevent a data compromise. We
have also outsourced elements of our information technology infrastructure, and as a result a number of third-party vendors may or could have access to our confidential information. Our internal
information technology systems and infrastructure, and those of our current and any future collaborators, contractors and consultants and other third parties on which we rely, are vulnerable to damage
from computer viruses, malware, natural disasters, terrorism, war, telecommunication and electrical failures, cyber-attacks or cyber-intrusions, phishing, persons inside our organization or persons
with access to systems inside our organization. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
risk of a security breach or disruption or data loss, including by computer hackers, foreign governments and cyber terrorists, has generally increased as the number, intensity and
sophistication of attempted attacks and intrusions from around the world have increased. In addition, the prevalent use of mobile devices that access confidential information increases the risk of
data security breaches,
which could lead to the loss of confidential information or other intellectual property. The costs to us to mitigate network security problems, bugs, viruses, worms, malicious software programs and
security vulnerabilities could be significant, and while we have implemented security measures to protect our data security and information technology systems, our efforts to address these problems
may not be successful, and these problems could result in unexpected interruptions, delays, cessation of service and other harm to our business and our competitive position. If such an event were to
occur and cause interruptions in our operations, it could result in a material disruption of our product development programs. For example, the loss of clinical trial data from completed or ongoing or
planned clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we rely on third parties to conduct
clinical trials, and similar events relating to their computer systems could also have a material adverse effect on our business. Moreover, if a computer security breach affects our systems or results
in the unauthorized release of personally identifiable information, our reputation could be materially damaged. In addition, such a breach may require notification to governmental agencies, the media
or individuals pursuant to various federal and state privacy and security laws, if applicable, including the Health Insurance Portability and Accountability Act of 1996, or HIPAA, as amended, and its
implementing rules and regulations, as well as regulations promulgated by the Federal Trade Commission and state breach notification laws. We would also be exposed to a risk of loss or litigation and
potential liability, which could materially adversely affect our business, results of operations and financial condition. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=36,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=737293,FOLIO='33',FILE='DISK125:[19ZCO1.19ZCO70301]DG70301A.;13',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dg70301_1_34"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The successful commercialization of our product candidates will depend in part on the extent to which
third-party payors, including governmental authorities and private health insurers, provide coverage and adequate reimbursement levels, as well as implement pricing policies favorable for our product
candidates. Failure to obtain or maintain coverage and adequate reimbursement for our product candidates, if approved, could limit our ability to market those products and decrease our ability to
generate revenue.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The availability of coverage and adequacy of reimbursement by third-party payors, including managed care plans, governmental healthcare
programs, such as Medicare and Medicaid and private health insurers is essential for most patients to be able to afford medical services and pharmaceutical products such as our product candidates that
receive FDA approval. Our ability to achieve acceptable levels of coverage and reimbursement for our products or procedures using our products by third-party payors will have an effect on our ability
to successfully commercialize our product candidates. Obtaining coverage and adequate reimbursement for our products may be particularly difficult because of the higher prices often associated with
drugs administered under the supervision of a physician. Separate reimbursement for the product itself or the treatment or procedure in which our product is used may not be available. A decision by a
third-party payor not to cover or not to separately reimburse for our products or procedures using our products could reduce physician utilization of our products once approved. Assuming there is
coverage for our product candidates, or procedures using our product candidates by a third-party payor, the resulting reimbursement payment rates may not be adequate or may require co-payments that
patients find unacceptably high. We cannot be sure that coverage and reimbursement in the United States, the European Union or elsewhere will
be available for our current or future product candidates, or for any procedures using such product candidates, and any reimbursement that may become available may not be adequate or may be decreased
or eliminated in the future. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
ability to successfully commercialize any product candidate, whether as a single agent or combination therapy, will also depend in part on the extent to which coverage and
reimbursement for these product candidates and related treatments will be available from third-party payors. Third-party payors decide which medications they will pay for and establish reimbursement
levels. It is difficult to predict at this time what government authorities and third-party payors will decide with respect to coverage and reimbursement for our current and future product candidates. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, third-party payors are increasingly challenging prices charged for pharmaceutical and biological products and services, and many third-party payors may refuse to provide
coverage and reimbursement for particular drugs or biologics when an equivalent generic drug, biosimilar or a less expensive therapy is available. It is possible that a third-party payor may consider
our product candidates as substitutable and only offer to reimburse patients for the less expensive product. Even if we show improved efficacy or improved convenience of administration with our
product candidates, pricing of existing third-party therapeutics may limit the amount we will be able to charge for our product candidates. These third-party payors may deny or revoke the
reimbursement status of our product candidates, if approved, or establish prices for our product candidates at levels that are too low to enable us to realize an appropriate return on our investment.
If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize our product candidates, and may not be able to obtain a satisfactory
financial return on our product candidates. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
is significant uncertainty related to the insurance coverage and reimbursement of newly-approved products, especially novel products like our immunomedicines. To date, no
regulatory authority has granted approval for an immunomedicine targeting S15 or the LAIR pathway. The Medicare and Medicaid programs are increasingly used as models in the United States for how
private third-party payors and other governmental payors develop their coverage and reimbursement policies for drugs and biologics. Some third-party payors may require pre-approval of coverage for new
or innovative devices or drug therapies before they will reimburse healthcare providers who use such therapies. We cannot predict at this time what third-party payors will decide with respect to the
coverage and reimbursement for our product candidates. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=37,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=14068,FOLIO='34',FILE='DISK125:[19ZCO1.19ZCO70301]DG70301A.;13',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dg70301_1_35"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
uniform policy for coverage and reimbursement for products exist among third-party payors in the United States. Therefore, coverage and reimbursement for products can differ
significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that may require us to provide scientific and clinical support for the
use of our product candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied
consistently or obtained in the first instance. Furthermore, rules and regulations regarding reimbursement change frequently, in some cases on short notice, and we believe that changes in these rules
and regulations are likely. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
if we or our collaborators develop companion diagnostic tests for use with our product candidates, we, or our collaborators, will be required to obtain coverage and
reimbursement for these tests separate and apart from the coverage and reimbursement we seek for our product candidates, once approved. While we and our collaborators have not yet developed any
companion diagnostic test for our product candidates, if we or our collaborators do, there is significant uncertainty regarding the ability to obtain coverage and adequate reimbursement for the same
reasons applicable to our product candidates. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moreover,
increasing efforts by third-party payors in the United States and abroad to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of
reimbursement for newly approved products and, as a result, they may not cover or provide adequate payment for our product candidates. We expect to experience pricing pressures in connection with the
sale of our product candidates due to the trend toward managed health care, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on
healthcare costs in general, particularly prescription drugs and biologics and surgical procedures and other treatments, has become intense. As a result, increasingly high barriers are being erected
to the entry of new products. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Enacted healthcare legislation, changes in healthcare law and implementation of regulations, as well as
changes in healthcare policy, may increase the difficulty and cost for us to commercialize our product candidates, may impact our business in ways that we cannot currently predict, could affect the
prices we may set, and could have a material adverse effect on our business and financial condition.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare costs. In particular, there
have been and continue to be a number of initiatives at the U.S. federal and state levels that seek to reduce healthcare costs and improve the quality of healthcare. For example, in March 2010, the
Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively, the ACA, was passed, which substantially changes the way healthcare
is financed by both governmental and private insurers, and significantly impacts the U.S. pharmaceutical industry. The ACA, among other things, subjects biological products to potential competition by
lower-cost biosimilars, addresses a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled,
implanted or injected, increases the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extends the rebate program to individuals enrolled in Medicaid managed
care organizations, establishes annual fees and taxes on manufacturers of certain branded prescription drugs and creates a new Medicare Part&nbsp;D coverage gap discount program in which, as a
condition of coverage of its products under Medicare Part&nbsp;D, manufacturers must now agree to offer 70% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible
beneficiaries during their coverage gap period. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Some
of the provisions of the ACA have yet to be fully implemented, while certain provisions have been subject to judicial and Congressional challenges, as well as efforts by President
Trump's administration to repeal or replace certain aspects of the ACA, and to alter the implementation of the ACA and related laws. For example, Congress has considered legislation that would repeal
or repeal and replace all or part of the ACA. While Congress has not passed comprehensive repeal legislation, bills affecting the implementation of certain taxes under the ACA have been signed into
law. The Tax Cuts and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=38,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=373191,FOLIO='35',FILE='DISK125:[19ZCO1.19ZCO70301]DG70301A.;13',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dg70301_1_36"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>Jobs
Act of 2017, or the Tax Act, includes a provision repealing, effective January&nbsp;1, 2019, the tax-based shared responsibility payment imposed by the ACA on certain individuals who fail to
maintain qualifying health coverage for all or part of a year that is commonly referred to as the "individual mandate." On January&nbsp;22, 2018, the President signed a continuing resolution on
appropriations for fiscal year 2018 that delayed the implementation of certain ACA-mandated fees, including the so-called "Cadillac" tax on certain high cost employer-sponsored insurance plans, the
annual fee imposed on certain high cost employer-sponsored insurance plans, the annual fee imposed on certain health insurance providers based on market share and the medical device excise tax on
non-exempt medical devices. The Bipartisan Budget Act of 2018, among other things, amended the ACA, effective January&nbsp;1, 2019, to reduce the coverage gap in most Medicare drug plans, commonly
referred to as the "donut hole." Also, in 2018, the Centers for Medicare and Medicaid Services, or CMS, issued final rules permitting further collections and payments to and from certain ACA qualified
health plans and health insurance issuers under the ACA risk adjustment program in response to the outcome of federal district court litigation regarding the method CMS uses to determine this risk
adjustment. In December 2018, a United States District Court Judge for the Northern District of Texas ruled that the entire ACA is unconstitutional because the tax penalty associated with the
"individual mandate" was repealed by Congress as part of the Tax Act. This ruling is under appeal and stayed pending appeal. While the United States District Court Judge for the Northern District of
Texas, as well as the Trump Administration and CMS, have stated that the ruling will have no effect while this appeal is pending, it is unclear how this decision, subsequent appeals and other efforts
to invalidate the ACA, regulations promulgated under the ACA and related laws, or portions thereof will impact the ACA, its implementation and our business. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
legislative changes have been proposed and adopted in the United States since the ACA was enacted. On August&nbsp;2, 2011, the Budget Control Act of 2011, among other things,
created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013
through 2021, was unable to reach required goals, thereby triggering the legislation's automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to
providers of 2% per fiscal year. These reductions went into effect on April&nbsp;1, 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2027 unless
additional congressional action is taken. On January&nbsp;2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to
several types of providers. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moreover,
payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, effective January&nbsp;1, 2014, CMS began bundling into the
hospital outpatient prospective payment rate the Medicare payments for most laboratory tests ordered while a patient received services in a hospital outpatient setting. We expect that additional state
and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could
result in reduced demand for any product candidate we develop or complementary or companion diagnostics or additional pricing pressures. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CMS
may develop new payment and delivery models, such as bundled payment models. In addition, recently there has been heightened governmental scrutiny over the manner in which
manufacturers set prices for their marketed products, which has resulted in several U.S. Congressional inquiries and proposed and enacted federal and state legislation that legislators intend to,
among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under government payor programs, and review the relationship between pricing and manufacturer patient
programs. The Trump Administration's budget proposals for fiscal 2019 and 2020 contain drug price control measures, including measures to permit Medicare Part&nbsp;D plans to negotiate the price of
certain drugs under Medicare Part&nbsp;B, to allow some states to negotiate drug prices under Medicaid and to eliminate cost sharing for generic drugs for low-income patients. For example, the Trump
Administration released a "Blueprint" to lower drug prices and reduce out of pocket costs of drugs that contains additional proposals to increase </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=39,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=935170,FOLIO='36',FILE='DISK125:[19ZCO1.19ZCO70301]DG70301A.;13',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dg70301_1_37"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>manufacturer
competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out of pocket costs
of drug products paid by consumers. The U.S. Department of Health and Human Services has started soliciting feedback on some of these measures and, at the same, is implementing others under its
existing authority. For example, in May 2019, CMS issued a final rule to allow Medicare Advantage Plans the option of using step therapy for Part&nbsp;B drugs beginning January&nbsp;1, 2020. This
final rule codified CMS's policy change that was effective January&nbsp;1, 2019. Although a number of these and other proposed measures may require additional authorization to become effective,
Congress and the Trump Administration have each indicated that they will continue to seek new legislative and/or administrative measures to control drug costs. We expect that additional U.S. federal
healthcare reform measures will be adopted in the future, any of which could limit the extent to which the U.S. federal government covers particular healthcare products and services and could limit
the amounts that the U.S. federal government will pay for healthcare products and services. This could result in reduced demand for our product candidates or additional pricing pressures. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Individual
states in the United States have also increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including
price or patient reimbursement limitations, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage
importation from
other countries and bulk purchasing. Legally mandated price controls on payment amounts by third-party payors or other restrictions on coverage or access could harm our business, results of
operations, financial condition and prospects. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products
and which suppliers will be included in their prescription drug and other healthcare programs. This could reduce the ultimate demand for our product candidates that we successfully commercialize or
put pressure on our product pricing. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
on May&nbsp;30, 2018, the Trickett Wendler, Frank Mongiello, Jordan McLinn and Matthew Bellina Right to Try Act of 2017, or the Right to Try Act, was signed into law. The
law, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase&nbsp;1 clinical trial and that are
undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA
expanded access program. There is no obligation for a pharmaceutical manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action in the United States. If we or any third
parties we may engage are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we or such third parties are not able to maintain
regulatory compliance, our product candidates may lose any regulatory approval that may have been obtained and we may not achieve or sustain profitability. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our relationships with customers, third-party payors and others may be subject to applicable anti-kickback,
fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm, administrative burdens and diminished
profits and future earnings.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Healthcare providers, physicians and third-party payors in the United States and elsewhere will play a primary role in the recommendation and
prescription of any product candidates for which we obtain marketing approval. Our current and future arrangements with healthcare providers, third-party payors, customers, and others may expose us to
broadly applicable fraud and abuse and other healthcare laws and regulations, which may constrain the business or financial arrangements and relationships through which we research, as well as, sell,
market and distribute any products for which we obtain marketing approval. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=40,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=6282,FOLIO='37',FILE='DISK125:[19ZCO1.19ZCO70301]DG70301A.;13',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dg70301_1_38"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>The
applicable federal and state healthcare laws and regulations that may affect our ability to operate include, but are not limited to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> The federal Anti-Kickback Statute, which prohibits, among other things, knowingly and willfully soliciting, receiving, offering or paying any
remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the
purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under the Medicare and Medicaid programs or other federal healthcare
programs. A person or entity can be found guilty of violating the statute without actual knowledge of the statute or specific intent to violate it. The federal Anti-Kickback Statute has been
interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, purchasers and formulary managers on the other. Although there are a number of statutory
exceptions and regulatory safe harbors to the federal Anti-Kickback Statute protecting certain common business arrangements and activities from prosecution or regulatory sanctions, the exceptions and
safe harbors are drawn narrowly, and practices that involve remuneration to those who prescribe, purchase, or recommend pharmaceutical and biological products, including certain discounts, or engaging
such individuals as speakers or consultants, may be subject to scrutiny if they do not fit squarely within an exception or safe harbor. Our practices may not in all cases meet all of the criteria for
safe harbor protection from anti-kickback liability. Moreover, there are no safe harbors for many common practices, such as educational and research grants or patient or product assistance programs. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> The federal civil and criminal false claims laws and civil monetary penalty laws, including the civil False Claims Act, or FCA, which
prohibits, among other things, knowingly presenting, or causing to be presented, claims for payment of government funds that are false or fraudulent, or knowingly making, or using or causing to be
made or used, a false record or statement material to a false or fraudulent claim to avoid, decrease, or conceal an obligation to pay money to the federal government. Private individuals, commonly
known as "whistleblowers," can bring FCA qui tam actions, on behalf of the government and such individuals and may share in amounts paid by the entity to the government in recovery or settlement. In
addition, a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. FCA liability is
potentially significant in the healthcare industry because the statute provides for treble damages and significant mandatory penalties per false claim or statement for violations. Criminal penalties,
including imprisonment and criminal fines, are also possible for making or presenting a false, fictitious or fraudulent claim to the federal government. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> The HIPAA fraud provisions, which prohibit knowingly and willfully executing a scheme to defraud any healthcare benefit program, including
private third-party payors, and prohibit knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement or
representation, or making or using any false writing or document knowing the same to contain any materially false fictitious or fraudulent statement or entry in connection with the delivery of or
payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity can be found guilty of violating the HIPAA fraud provisions without actual
knowledge of the statutes or specific intent to violate them. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective
implementing regulations, also impose specified requirements relating to the privacy, security and transmission of individually identifiable health information held by covered entities, which include
health plans, healthcare clearinghouses and certain healthcare providers, and their business associates, individuals or entities that perform certain services on behalf of a covered entity that
involve the use or disclosure of individually identifiable health information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly
applicable to business associates and </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=41,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=1028921,FOLIO='38',FILE='DISK125:[19ZCO1.19ZCO70301]DG70301A.;13',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dg70301_1_39"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>gave
state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorneys' fees and costs associated with pursuing federal civil
actions; </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> The federal Physician Payments Sunshine Act, being implemented as the Open Payments Program, which requires manufacturers of drugs, devices,
biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children's Health Insurance Program (with certain exceptions) to report annually to CMS information
related to direct or indirect payments and other transfers of value to physicians and teaching hospitals, as well as ownership and investment interests held in a company by physicians and their
immediate family members. Beginning in 2022, applicable manufacturers will also be required to report information regarding payments and transfers of value provided to physician assistants, nurse
practitioners, clinical nurse specialists, certified nurse anesthetists and certified nurse-midwives; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Analogous U.S. state and local laws and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing
arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers; state laws that require pharmaceutical companies to comply
with the pharmaceutical industry's voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to
healthcare providers; state laws that restrict the ability of manufacturers to offer co-pay support to patients for certain prescription drugs; state laws that require drug manufacturers to report
information related to clinical trials, or information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; state laws that require
drug manufacturers to report information on the pricing of certain drugs; state laws and local ordinances that require identification or licensing of sales representatives; and state laws governing
the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance
efforts. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because
of the breadth of these laws and the narrowness of the statutory exceptions and regulatory safe harbors available under such laws, it is possible that some of our business
activities could be subject to challenge under one or more of such laws. The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of
healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between
healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Ensuring that our business
arrangements with third parties comply with applicable healthcare laws, as well as responding to investigations by government authorities, can be time and resource consuming and can divert
management's attention from the business. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
our operations are found to be in violation of any of the laws described above or any other government regulations that apply to us, we may be subject to penalties, including civil,
criminal and administrative penalties, damages, fines, disgorgement, individual imprisonment, possible exclusion from participation in federal and state funded healthcare programs, contractual damages
and the curtailment or restricting of our operations, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve
allegations of non-compliance with these laws. Further, if the physicians or other providers or entities with whom we expect to do business are found not to be in compliance with applicable laws, they
may be subject to criminal, civil and administrative sanctions, including exclusion from government funded healthcare programs. In addition, the approval and commercialization of any product candidate
we develop outside the United States will also likely subject us to foreign equivalents of the healthcare laws mentioned above, among other foreign laws. All of these could harm our ability to operate
our business and our financial results. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=42,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=656644,FOLIO='39',FILE='DISK125:[19ZCO1.19ZCO70301]DG70301A.;13',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dg70301_1_40"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are subject to certain U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions
and other trade laws and regulations. We can face serious consequences for violations.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Among other matters, U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions and other trade laws and regulations,
which are collectively referred to as Trade Laws, prohibit companies and their employees, agents, clinical research organizations, legal counsel, accountants, consultants, contractors and other
partners from authorizing, promising, offering, providing, soliciting, or receiving directly or indirectly, corrupt or improper payments or anything else of value to or from recipients in the public
or private sector. Violations of Trade Laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax reassessments, breach of contract
and fraud litigation, reputational harm and other consequences. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
business is heavily regulated and therefore involves significant interaction with public officials. We have direct or indirect interactions with officials and employees of government
agencies or government-affiliated hospitals, universities and other organizations. We also expect our non-U.S. activities to increase in time. Additionally, in many other countries, the health care
providers who prescribe pharmaceuticals are employed by their government, and the purchasers of pharmaceuticals are government entities; therefore, our dealings with these prescribers and purchasers
are subject to regulation under the U.S. Foreign Corrupt Practices Act of 1977, as amended, or FCPA. We plan to engage third parties for clinical trials and/or to obtain necessary permits, licenses,
patent registrations, and other regulatory approvals and we can be held liable for the corrupt or other illegal activities of our personnel, agents, or partners, even if we do not explicitly authorize
or have prior knowledge of such activities. In particular, our operations will be subject to FCPA, which prohibits, among other things, U.S. companies and their employees and agents from authorizing,
promising, offering, or providing, directly or indirectly, corrupt or improper payments or anything else of value to foreign government officials, employees of public international organizations and
foreign government-owned or affiliated entities, candidates for foreign political office, and foreign political parties or officials thereof. Recently, the SEC and Department of Justice have increased
their FCPA enforcement activities with respect to biotechnology and pharmaceutical companies. There is no certainty that all of our employees, agents, suppliers, manufacturers, contractors, or
collaborators, or those of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. Violations of these laws and regulations
could result in fines, criminal sanctions against us, our officers, or our employees, the closing down of facilities, including those of our suppliers and manufacturers, requirements to obtain export
licenses, cessation of business activities in sanctioned countries, implementation of compliance programs and prohibitions on the conduct of our business. Any such violations could also result in
prohibitions on our ability to offer our products in one or more countries as well as difficulties in manufacturing or continuing to develop our products, and could materially damage our reputation,
our brand, our international expansion efforts, our ability to attract and retain employees and our business, prospects, operating results and financial condition. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we fail to comply with environmental, health and safety laws and regulations, we could become subject to
fines or penalties or incur costs that could have a material adverse effect on the success of our business.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the
handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our
operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from
these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources.
We also could incur significant costs associated with civil or criminal fines and penalties. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=43,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=116025,FOLIO='40',FILE='DISK125:[19ZCO1.19ZCO70301]DG70301A.;13',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_di70301_1_41"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although we maintain workers' compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of
hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted
against us in connection with our storage or disposal of biological or hazardous materials. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Manufacturing  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Given our limited operating history, our manufacturing experience as an organization and with our
manufacturing facility is limited.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Manufacturing is a critical component of our approach to developing immunomedicines and we have invested significantly in our manufacturing
facility. We currently manufacture our product candidates for preclinical and clinical trials. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
manufacture of drugs for clinical trials and for commercial sale is subject to oversight by the FDA to ensure compliance with cGMP and by other regulatory authorities under other
laws, regulations and standards. We cannot assure you that we can successfully manufacture our products in compliance with cGMP and with any other applicable laws, regulations and standards in
sufficient quantities for clinical trials or for commercial sale, or in a timely or economical manner. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
manufacturing facility requires specialized personnel and is expensive to operate and maintain. Validation is an ongoing process that must be maintained to allow us to manufacture
under cGMP guidelines. We cannot guarantee that our facility will remain in compliance with cGMP. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
manufacture of pharmaceutical products is a highly complex process in which a variety of difficulties may arise from time to time. We are currently the sole manufacturer of NC318 and
NC410 and if anything were to interfere with our continuing manufacturing operations in our facility, it could materially adversely affect our business and financial condition. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we fail to develop sufficient manufacturing capacity and experience, whether internally or with a third party, or fail to manufacture our product candidates economically or on
reasonable scale or volumes, or in accordance with cGMP, our development programs and commercialization of any approved products will be materially adversely affected. This may result in delays in
commencing or continuing our clinical trials for NC318 or filing our IND for NC410. Any such delays could materially adversely affect our business and financial condition. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be unable to successfully scale-up manufacturing of our product candidates in sufficient quality and
quantity, which would delay or prevent us from developing and, if approved, commercializing our product candidates.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to conduct clinical trials of our product candidates, we will need to manufacture them in large quantities. Currently, our product
candidates are manufactured in small quantities for use in various preclinical studies and our ongoing Phase&nbsp;1/2 clinical trial of NC318. We intend to expand our manufacturing capacity,
including to provide drug supply of NC318 for future clinical trials. If one or more of our product candidates progress to late-stage development, we may incur additional significant expenses in the
further expansion and/or construction of manufacturing facilities and increases in personnel in order to manufacture product candidates in sufficient quantities. We cannot assure you that we will be
able to successfully manufacture product candidates at a larger scale in a timely or economical manner, or at all. If we are unable to successfully increase our manufacturing scale or capacity, the
development, testing and clinical trials of our current or future product candidates may be delayed or infeasible, and regulatory approval or commercial launch of any resulting product may be delayed
or not obtained, which could significantly harm our business. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=44,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=296883,FOLIO='41',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_42"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The loss of our third-party manufacturing partners or our, or our partners', failure to comply with
applicable regulatory requirements or to supply sufficient quantities at acceptable quality levels or prices, or at all, would materially and adversely affect our business.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although we currently manufacture our product candidates for preclinical and clinical trials, certain elements of manufacturing, including
Master Cell Bank manufacturing and fill-finish services, take place at qualified third-party contract manufacturing organizations, or CMOs. If approved, commercial supply of NC318, NC410 and any
future product candidates may be manufactured at a CMO or CMOs. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
facilities used by our CMOs to manufacture our product candidates are subject to various regulatory requirements and may be subject to the inspection of the FDA or other regulatory
authorities. We do not control the manufacturing process at our CMOs, and are completely dependent on them for compliance with current regulatory requirements. If we or our CMOs cannot successfully
manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or comparable regulatory authorities in foreign jurisdictions, we may not be able to rely on
their manufacturing facilities for the manufacture of elements of our product candidates. In addition, we have limited control over the ability of our CMOs to maintain adequate quality control,
quality
assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority finds our facilities or those of our CMOs inadequate for the manufacture of our product candidates or if such
facilities are subject to enforcement action in the future or are otherwise inadequate, we may need to find alternative manufacturing facilities, which would significantly impact our ability to
develop, obtain regulatory approval for or market our product candidates. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
our CMOs may experience manufacturing difficulties due to resource constraints or as a result of labor disputes or unstable political environments. If our CMOs were to
encounter any of these difficulties, our ability to provide our product candidate to patients in clinical trials, or to provide product for the treatment of patients once approved, would be
jeopardized. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Changes in methods of product candidate manufacturing or formulation may result in additional costs or delay.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As product candidates proceed through preclinical studies to late-stage clinical trials towards potential approval and commercialization, it is
common that various aspects of the development program, such as manufacturing methods and formulation, are altered along the way in an effort to optimize processes and results. Such changes carry the
risk that they will not achieve these intended objectives. Any of these changes could cause our product candidates to perform differently and affect the results of planned clinical trials or other
future clinical trials conducted with the materials manufactured using altered processes. Such changes may also require additional testing, FDA notification or FDA approval. This could delay
completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our product candidates
and jeopardize our ability to commence sales and generate revenue. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are subject to multiple manufacturing risks, any of which could substantially increase our costs and limit
supply of our product candidates.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The process of manufacturing immunomedicines, including our product candidates, is complex, time-consuming, highly regulated and subject to
several risks, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> product loss during the manufacturing process, including loss caused by contamination, equipment failure or improper installation or operation
of equipment, or operator error. Even minor deviations from normal manufacturing processes could result in reduced production yields, product defects and other supply disruptions. If microbial, viral
or other contaminations are discovered in our products or in the manufacturing facilities in which our products are made, such manufacturing facilities may need to be closed for an extended period of
time to investigate and remedy the contamination; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>42</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=45,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=684922,FOLIO='42',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_43"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the manufacturing facilities in which our products are made could be adversely affected by equipment failures, labor and raw material
shortages, natural disasters, power failures and numerous other factors; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> any adverse developments affecting manufacturing operations for our products may result in shipment delays, inventory shortages, lot failures,
product withdrawals or recalls, or other interruptions in the supply of our products. We may also have to take inventory write-offs and incur other charges and expenses for products that fail to meet
specifications, undertake costly remediation efforts or seek more costly manufacturing alternatives. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may also make changes to our manufacturing processes at various points during development, for a number of reasons, such as controlling costs, achieving scale, decreasing processing
time, increasing manufacturing success rate or other reasons. Such changes carry the risk that they will not achieve their intended objectives, and any of these changes could cause our product
candidates to perform differently and affect the results of our ongoing or future clinical trials. In some circumstances, changes in the manufacturing process may require us to perform ex vivo
comparability studies and to collect additional data from patients prior to undertaking more advanced clinical trials. For instance, changes in our process during the course of clinical development
may require us to show the comparability of the product used in earlier clinical phases or at earlier portions of a trial to the product used in later clinical phases or later portions of the trial. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We depend on third-party suppliers for key materials used in our manufacturing processes, and the loss of
these third-party suppliers or their inability to supply us with adequate materials could harm our business.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We rely on third-party suppliers for certain materials and components required for the production of our product candidates. Our dependence on
these third-party suppliers and the challenges we may face in obtaining adequate supplies of materials involve several risks, including limited control over pricing, availability, and quality and
delivery schedules. As a small company, our negotiation leverage is limited and we are likely to get lower priority than our competitors that are larger than we are. We cannot be certain that our
suppliers will continue to provide us with the quantities of these raw materials that we require or satisfy our anticipated specifications and quality requirements. Any supply interruption in limited
or sole sourced raw materials could materially harm our ability to manufacture our product candidates until a new source of supply, if any, could be identified and qualified. We may be unable to find
a sufficient alternative supply channel in a reasonable time or on commercially reasonable terms. Any performance failure on the part of our suppliers could delay the development and potential
commercialization of our product candidates, including limiting supplies necessary for clinical trials and regulatory approvals, which would have a material adverse effect on our business. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Intellectual Property  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have filed patent applications for our lead product candidates, but no patent has yet issued from these
applications. If we are unable to obtain and maintain patent protection for our product candidates, or if the scope of the patent protection obtained is not sufficiently broad or robust, our
competitors could develop and commercialize products similar or identical to ours, and our ability to successfully commercialize our product candidates may be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our success depends, in large part, on our ability to obtain and maintain patent protection in the United States and other countries with
respect to our product candidates. We and our licensors have sought, and intend to seek, to protect our proprietary position by filing patent applications in the United States and abroad related to
our product candidates and technology that are important to our business. No patent has yet issued from our patent applications. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has, in recent years, been the subject
of much litigation. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>43</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=46,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=501416,FOLIO='43',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_44"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>As
a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being
issued that protect our technology or product candidates or that effectively prevent others from commercializing competitive technologies and product candidates. Because patent applications in the
United States and most other countries are confidential for a period of time after filing, and some remain so until issued, we cannot be certain that we or our licensors were the first to
file&nbsp;a patent application relating to any particular aspect of a product candidate. Furthermore, if third parties have filed such patent applications, we may challenge their ownership, for
example in a derivation proceeding before the U.S. Patent and Trademark Office, or USPTO, to determine who has the right to the claimed subject matter in the applications. Similarly, if our patent
applications are challenged in a derivation proceeding, the USPTO may hold that a third-party is entitled to certain patent ownership rights instead of us. We may then be forced to seek a license from
the third party that may not be available on commercially favorable terms, or at all. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
patent prosecution process is expensive, time-consuming and complex, and we may not be able to file, prosecute, maintain, enforce or license all necessary or desirable patent
applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain
patent protection. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even
if the patent applications we license or own do issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors or other
third parties from competing with us or otherwise provide us with any competitive advantage. Our competitors or other third parties may be able to circumvent our patents by developing similar or
alternative technologies or products that do not infringe our patents. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are party to a license agreement with Yale University under which we acquired rights to intellectual
property related to certain of our product candidates. If we breach our obligations under this agreement, the agreement could be terminated, which would adversely affect our business and prospects.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a party to a license agreement with Yale pursuant to which we in-license patents and technology for certain of our product candidates.
This license imposes various diligence, milestone payment, royalty, insurance and other obligations on us. If we fail to comply with these and
other obligations or otherwise materially breach this license agreement, Yale may have the right to terminate the license. If this agreement is terminated, we may not be able to develop, manufacture,
market or sell the product candidates or products covered by the agreement, or we would have to negotiate a new or reinstated agreement, which may not be available to us on equally favorable terms, or
at all. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our intellectual property agreements with third parties may be subject to disagreements over contract
interpretation, which could narrow the scope of our rights to the relevant intellectual property or technology or increase our financial or other obligations to our licensors.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain provisions in our intellectual property agreements may be susceptible to multiple interpretations. The resolution of any contract
interpretation disagreement that may arise could affect the scope of our rights to the relevant intellectual property or technology, or affect financial or other obligations under the relevant
agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that we have
licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected product
candidates. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>44</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=47,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=777791,FOLIO='44',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_45"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Obtaining and maintaining our patent protection depends on compliance with various procedural, document
submission, fee payment and other requirements imposed by government patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Periodic maintenance fees, renewal fees, annuity fees and various other government fees on patents and/or applications will be due to be paid to
the USPTO and various government patent agencies outside of the United States over the lifetime of our licensed patents and/or applications and any patent rights we own or may own in the future. We
rely, in part, on our outside counsel or our licensing partners to pay these fees due to the USPTO and to non-U.S. patent agencies. The USPTO and various non-U.S. government patent agencies require
compliance with several procedural, documentary, fee payment and other similar provisions during the patent application process. In many cases, an inadvertent lapse can be cured by payment of a late
fee or by other means in accordance with the applicable rules. There are situations, however, in which non-compliance can result in abandonment or lapse of the patent or patent application, resulting
in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, potential
competitors might be able to enter the market and this circumstance could have a material adverse effect on our business. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may not be able to protect our intellectual property rights throughout the world.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filing, prosecuting and enforcing patents on product candidates in all countries throughout the world would be prohibitively expensive, and our
intellectual property rights in some countries outside the United States are and could remain less extensive than those in the United States. In addition, the laws of some foreign countries do not
protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may be less likely to be able to prevent third parties from infringing our
patents in all countries outside the United States, or from selling or importing products that infringe our patents in and into the United States or other jurisdictions. Competitors may use our
technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent
protection, but enforcement is not as strong as that in the United States. These products may compete with our products and our patents or other intellectual property rights may not be effective or
sufficient to prevent them from competing. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many
countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of
patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or any of
our licensors is forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired and our business, financial condition,
results of operations and prospects may be adversely affected. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Changes in patent law could diminish the value of patents in general, thereby impairing our ability to
protect our product candidates.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in either the patent laws or interpretation of the patent laws in the United States could increase the uncertainties and costs
surrounding the prosecution of patent applications and the enforcement or defense of issued patents. Assuming that other requirements for patentability are met, prior to March 2013, in the United
States, the first to invent the claimed invention was entitled to the patent, while outside the United States, the first to file&nbsp;a patent application was entitled to the patent. After March
2013, under the Leahy-Smith America Invents Act, or the America Invents Act, enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other
requirements for patentability are met, the first inventor to file&nbsp;a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to
invent the claimed invention. The America Invents Act also includes a number of significant changes that affect the way </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>45</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=48,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=769925,FOLIO='45',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_46"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>patent
applications are prosecuted and also may affect patent litigation. These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to
attack the validity or ownership of a patent by USPTO administered post-grant proceedings, including post-grant review, </FONT><FONT SIZE=2><I>inter partes</I></FONT><FONT SIZE=2> review and
derivation proceedings. The America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense
of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. Recent rulings from the U.S. Court of
Appeals for the Federal Circuit and the U.S. Supreme Court have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain
situations. This combination of events has created uncertainty with respect to the validity and enforceability of patents. Depending on future actions by the U.S. Congress, the federal courts and the
USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce
our intellectual property in the future. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may become involved in lawsuits to protect or enforce our intellectual property, which could be expensive,
time-consuming and unsuccessful.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Competitors may infringe our patents or the patents of our licensors, or we may be required to defend against claims of infringement. Countering
infringement or unauthorized use claims or defending against claims of infringement can be expensive and time-consuming. Even if resolved in our favor, litigation or other legal proceedings relating
to intellectual property claims may cause us to incur significant expenses and could distract our technical and management personnel from their normal responsibilities. In addition, there could be
public announcements of the results of hearings, motions or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a
substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development
activities or any future marketing, sales or distribution activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our
competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual
property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the
marketplace. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain
countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property, particularly those relating to biotechnology products,
which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent
rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or
interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages
or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant
commercial advantage from the intellectual property that we own, develop or license. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>46</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=49,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=63188,FOLIO='46',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_47"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Issued patents covering our product candidates could be found invalid or unenforceable if challenged in
court. We may not be able to protect our trade secrets in court.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we or one of our licensing partners initiate legal proceedings against a third party to enforce any patent that is issued covering one of our
product candidates, the defendant could counterclaim that the patent covering our product candidate is invalid or unenforceable. In patent litigation in the United States, defendant counterclaims
alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty,
obviousness, written description or non-enablement. In addition, patent validity challenges may, under certain circumstances, be based upon non-statutory obviousness-type double patenting, which, if
successful, could result in a finding that the claims are invalid for obviousness-type double patenting or the loss of patent term, including a patent term adjustment granted by the USPTO, if a
terminal disclaimer is filed to obviate a finding of obviousness-type double patenting. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the
patent withheld information material to patentability from the USPTO, or made a misleading statement, during prosecution. Third parties also may raise similar claims before administrative bodies in
the United States or abroad, even outside the context of litigation. Such mechanisms include re-examination, post grant review, </FONT><FONT SIZE=2><I>inter partes</I></FONT><FONT SIZE=2> review and
equivalent proceedings in foreign jurisdictions. Such proceedings could result in the revocation or cancellation of or amendment to our patents in such a way that they no longer cover our product
candidates. The outcome following legal assertions of invalidity and unenforceability is unpredictable. We cannot be certain that there is no invalidating prior art of which the patent examiner and we
or our licensing partners were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we could lose part, and perhaps all, of the patent
protection on one or more of our product candidates. Such a loss of patent protection could have a material adverse impact on our business. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the protection afforded by patents, we rely on trade secret protection and confidentiality agreements to protect proprietary know-how that is not patentable or that we
elect not to patent, processes for which patents are difficult to enforce and any other elements of our product candidate discovery and development processes that involve proprietary know-how,
information or technology that is not covered by patents, including portions of our FIND-IO platform. However, trade secrets can be difficult to protect, and some courts inside and outside the United
States are less willing or unwilling to protect trade secrets. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Third parties may initiate legal proceedings alleging that we are infringing their intellectual property
rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business and financial condition.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our commercial success depends upon our ability and the ability of any collaborators to develop, manufacture, market and sell our product
candidates and use our proprietary technologies without infringing the proprietary rights and intellectual property of third parties. We cannot provide any assurances that third-party patents do not
exist which might be enforced against our current manufacturing methods, product candidates or future methods or products, resulting in either an injunction prohibiting our manufacture or sales, or,
with respect to our sales, an obligation on our part to pay royalties and/or other forms of compensation to third parties. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
biotechnology and pharmaceutical industries are characterized by extensive and complex litigation regarding patents and other intellectual property rights. We may in the future
become party to, or be threatened with, adversarial proceedings or litigation regarding intellectual property rights with respect to our product candidates and technology, including post grant review
and </FONT><FONT SIZE=2><I>inter partes</I></FONT><FONT SIZE=2> review before the USPTO. The risks of being involved in such litigation and proceedings may also increase as our product candidates
approach commercialization and as we gain greater visibility as a public company. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in
the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>47</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=50,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=576504,FOLIO='47',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_48"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>future,
regardless of their merit. There is a risk that third parties may choose to engage in litigation with us to enforce or to otherwise assert their patent rights against us. Even if we believe
such claims are without merit, a court of competent jurisdiction could hold that these third-party patents are valid, enforceable and infringed, which could materially and adversely affect our ability
to commercialize any of our product candidates or technologies covered by the asserted third-party patents. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we are found to infringe a third party's valid and enforceable intellectual property rights, we could be required to obtain a license from such third party to continue developing,
manufacturing and marketing our product candidates and technology. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain
a license, it could be non-exclusive, thereby giving our competitors and other third parties access to the same technologies licensed to us, and it could require us to make substantial licensing and
royalty payments. We could be forced, including by court order, to cease developing, manufacturing and commercializing the infringing technology or product candidates. In addition, we could be found
liable for monetary damages, including treble damages and attorneys' fees, if we are found to have willfully infringed a patent or other intellectual property right. A finding of infringement could
prevent us from manufacturing and commercializing our product candidates or force us to cease some of our business operations, which could materially harm our business. Claims that we have
misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business, financial condition, results of operations and prospects. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Others may claim an ownership interest in our intellectual property and our product candidates, which could
expose us to litigation and have a significant adverse effect on our prospects.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While we are presently unaware of any claims or assertions by third parties with respect to our patents or other intellectual property, we
cannot guarantee that a third party will not assert a claim or an interest in any of such patents or intellectual property. For example, a third party may claim an ownership interest in one or more of
our, or our licensors', patents or other proprietary or intellectual property rights. A third party could bring legal actions against us to seek monetary damages or enjoin clinical testing,
manufacturing or marketing of the affected product candidate or product. If we become involved in any litigation, it could consume a substantial portion of our resources and cause a significant
diversion of effort by our technical and management personnel. If any such action is successful, in addition to any potential liability for damages, we could be required to obtain a license to
continue to manufacture or market the affected product candidate or product, in which case we could be required to pay substantial royalties or grant cross-licenses to patents. We cannot, however,
assure you that any such license would be available on acceptable terms, if at all. Ultimately, we could be prevented from commercializing a product, or forced to cease some aspect of our business
operations as a result of claims of patent infringement or violation of other intellectual property rights. Further, the outcome of intellectual property litigation is subject to uncertainties that
cannot be adequately quantified in advance, including the demeanor and credibility of witnesses and the identity of any adverse party. This is especially true in intellectual property cases, which may
turn on the testimony of experts as to technical facts upon which experts may reasonably disagree. Any of the foregoing could have a material adverse effect on our business, financial condition,
results of operations or prospects. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are unable to protect the confidentiality of our proprietary information, the value of our technology
and products could be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade secrets and know-how can be difficult to protect. To maintain the confidentiality of trade secrets and proprietary information, we enter
into confidentiality agreements with our employees, consultants, collaborators and others upon the commencement of their relationships with us. These agreements require that all confidential
information developed by the individual or made known to the individual by us during the course of the individual's relationship with us be kept confidential and not disclosed to third parties. Our
agreements with employees and our personnel policies also provide that any inventions conceived by </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>48</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=51,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=1032575,FOLIO='48',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_49"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>the
individual in the course of rendering services to us shall be our exclusive property. However, we cannot guarantee that we have entered into such agreements with each party that may have or have
had access to our trade secrets or proprietary technology and processes, and individuals with whom we have these agreements may not comply with their terms. Thus, despite such agreement, there can be
no assurance that such inventions will not be assigned to third parties. In the event of unauthorized use or disclosure of our trade secrets or proprietary information, these agreements, even if
obtained, may not provide meaningful protection, particularly for our trade secrets or other confidential information. To the extent that our employees, consultants or contractors use technology or
know-how owned by third parties in their work for us, disputes may arise between us and those third parties as to the rights in related inventions. To the extent that an individual who is not
obligated to assign rights in intellectual property to us is rightfully an inventor of intellectual property, we may need to obtain an assignment or a license to that intellectual property from that
individual, or a third party or from that individual's assignee. Such assignment or license may not be available on commercially reasonable terms or at all. We also seek to preserve the integrity and
confidentiality of our trade secrets by other means, including maintaining physical security of our premises and physical and electronic security of our information technology systems. However, these
security measures may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our
intellectual property. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adequate
remedies may not exist in the event of unauthorized use or disclosure of our proprietary information. The disclosure of our trade secrets would impair our competitive position
and may materially harm our business, financial condition and results of operations. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary
rights, and failure to maintain trade secret protection could adversely affect our competitive business position. In addition, others may independently discover or develop our trade secrets and
proprietary information, and the existence of our own trade secrets affords no protection against such independent discovery. For example, a public presentation in the scientific or popular press on
the properties of our product candidates could motivate a third party, despite any perceived difficulty, to assemble a team of
scientists having backgrounds similar to those of our employees to attempt to independently reverse engineer or otherwise duplicate our antibody technologies to replicate our success. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be subject to claims asserting that our employees, consultants or advisors have wrongfully used or
disclosed alleged trade secrets of their current or former employers.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many of our employees, consultants or advisors are currently, or were previously, employed at universities or other biotechnology or
pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants and advisors do not use the proprietary information or know-how
of others in their work for us, we may be subject to claims that these individuals, or we, have used or disclosed intellectual property, including trade secrets or other proprietary information, of
any such individual's current or former employer, or that patents and applications we have filed to protect inventions of these employees, even those related to one or more of our product candidates,
are rightfully owned by their former or current employer. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages,
we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to
management. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If our trademarks and trade names are not adequately protected, then we may not be able to build name
recognition in our markets of interest and our business may be adversely affected.  </I></B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any registered trademarks or trade names may be challenged, circumvented or declared generic or determined to be infringing on other marks. We
may not be able to protect our rights to these trademarks </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>49</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=52,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=916129,FOLIO='49',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_50"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>and
trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to ours,
thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of
other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long term, if we are unable to establish name recognition
based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to
trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely impact our
financial condition or results of operations. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Intellectual property rights do not necessarily address all potential threats.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations,
and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> others may be able to make products that are similar to our product candidates but that are not covered by the claims of the patents that we
own or license or may own in the future; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we, or any partners or collaborators, might not have been the first to make the inventions covered by the issued patent or pending patent
application that we license or may own in the future; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we, or any partners or collaborators, might not have been the first to file patent applications covering certain of our or their inventions; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our owned or
licensed intellectual property rights; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> it is possible that our pending licensed patent applications or those that we may own in the future will not lead to issued patents; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal challenges by our competitors; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information
learned from such activities to develop competitive products for sale in our major commercial markets; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we may not develop additional proprietary technologies that are patentable; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the patents of others may have an adverse effect on our business; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we may choose not to file&nbsp;a patent for certain trade secrets or know-how, and a third party may subsequently file&nbsp;a patent
covering such intellectual property. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Should
any of these events occur, they could significantly harm our business, financial condition, results of operations and prospects. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>50</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=53,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=26986,FOLIO='50',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_51"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Reliance on Third Parties  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We rely or will rely on third parties to help conduct our ongoing and planned preclinical studies and
clinical trials for NC318, NC410 and any future product candidates we develop. If these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or
meet expected deadlines, we may not be able to obtain marketing approval for or commercialize NC318, NC410 and any future product candidates we develop and our business could be materially harmed.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We currently do not have the ability to independently conduct preclinical studies that comply with the regulatory requirements known as current
good laboratory practice, or GLP, requirements. We also do not currently have the ability to independently conduct any clinical trials. The FDA and regulatory authorities in other jurisdictions
require us to comply with regulations and standards, including cGCP, or requirements for conducting, monitoring, recording and reporting the results of clinical trials, in order to ensure that the
data and results are scientifically credible and accurate and that the trial subjects are adequately informed of the potential risks of participating in clinical trials. We rely on medical
institutions, clinical investigators, contract laboratories and other third parties, such as CROs, to conduct GLP-compliant preclinical studies and cGCP-compliant clinical trials on our product
candidates properly and on time. While we have agreements governing their activities, we control only certain aspects of their activities and have limited influence over their actual performance. The
third parties with whom we contract for execution of our GLP-compliant preclinical studies and our cGCP-compliant clinical trials play a significant role in the conduct of these studies and trials and
the subsequent collection and analysis of data. These third parties are not our employees and, except for restrictions imposed by our contracts with such third parties, we have limited ability to
control the amount or timing of resources that they devote to our current or future product candidates. Although we rely on these third parties to conduct our GLP-compliant preclinical studies and
cGCP-compliant clinical trials, we remain responsible for ensuring that each of our preclinical studies and clinical trials is conducted in accordance with its investigational plan and protocol and
applicable laws and regulations, and our reliance on the CROs does not relieve us of our regulatory responsibilities. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many
of the third parties with whom we contract may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical
trials or other drug development activities that could harm our competitive position. Further, under certain circumstances, these third parties may terminate their agreements with us upon as little as
10&nbsp;days' prior written notice. Some of these agreements may also be terminated by such third parties under certain other circumstances. If the third parties conducting our preclinical studies
or our clinical trials do not adequately perform their contractual duties or obligations, experience significant business challenges, disruptions or failures, do not meet expected deadlines, terminate
their agreements with us or need to be replaced, or if the quality or accuracy of the data they obtain is compromised due to their failure to adhere to our protocols or to GLP and cGCP, or for any
other reason, we may need to enter into new
arrangements with alternative third parties. This could be difficult, costly or impossible, and our preclinical studies or clinical trials may need to be extended, delayed, terminated or repeated. As
a result, we may not be able to obtain regulatory approval in a timely fashion, or at all, for the applicable product candidate, our financial results and the commercial prospects for our product
candidates would be harmed, our costs could increase and our ability to generate revenues could be delayed. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may depend on Lilly, Yale or other third-party collaborators for the discovery, development and
commercialization of certain of our current and future product candidates. If our collaborations are not successful, we may not be able to capitalize on the market potential of these product
candidates.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In November 2018, we entered into the Lilly Agreement, which is focused on using our FIND-IO platform to identify novel oncology targets for
additional research and drug discovery by ourselves and Lilly. Pursuant to the Lilly Agreement, we granted Lilly the exclusive right to obtain worldwide exclusive licenses to research, develop,
manufacture and commercialize compounds and products directed to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>51</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=54,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=135804,FOLIO='51',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_di70301_1_52"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>oncology
targets identified through our research collaboration. Lilly will have the exclusive ability to control the development and commercialization of any targets it chooses to license on a global
basis. Our lack of control over the clinical development of certain programs under the Lilly Agreement could result in delays or other difficulties in the development and commercialization of product
candidates. Our right to receive certain milestone and royalty payments may be subsequently delayed, if we receive any at all. In the event Lilly terminates the Lilly Agreement, we would be prevented
from receiving any milestone payments, royalty payments and other benefits under that agreement, which would have a materially adverse effect on our results of operations. Furthermore, in the event
Lilly does not purchase and exercise any of its options, we will not be eligible to receive any future milestone payments under the Lilly Agreement, which could require us to seek additional funding
in order to avoid delaying, reducing the scope of, or suspending, one or more of our research and development programs or clinical trials. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have also entered into the SRA with Yale in which we agreed to provide funding for a research program aimed at discovering new targets for immunomedicines. We have and would expect to
have limited control over the amount and timing of resources that are employed in the research program. The research program may not be successful, and as a result, we may not be able to identify,
develop and commercialize products from this collaboration. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the future, we may form or seek other strategic alliances, joint ventures or collaborations, or enter into additional licensing arrangements with third parties that we believe will
complement or augment our development and commercialization efforts with respect to product candidates we develop. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
collaborations pose, and potential future collaborations involving our product candidates may pose, the following risks to us:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> collaborators may have significant discretion in determining the efforts and resources that they will apply to these collaborations; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our products or
product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> collaborators may not properly enforce, maintain or defend our intellectual property rights or may use our proprietary information in a way
that gives rise to actual or threatened litigation or that could jeopardize or invalidate our intellectual property or proprietary information, exposing us to potential litigation or other
intellectual property proceedings; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> disputes may arise between a collaborator and us that cause the delay or termination of the research, development or commercialization of the
product candidate, or that result in costly litigation or arbitration that diverts management attention and resources; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> a collaborator with marketing and distribution rights to one or more of our product candidates that achieve regulatory approval may not commit
sufficient resources to the marketing and distribution of such products; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> if a present or future collaborator of ours were to be involved in a business combination, the continued pursuit and emphasis on our product
development or commercialization program under such collaboration could be delayed, diminished or terminated; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> collaboration agreements may restrict our right to independently pursue new product candidates. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>52</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=55,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=124550,FOLIO='52',FILE='DISK125:[19ZCO1.19ZCO70301]DI70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_dk70301_1_53"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we enter into additional collaboration agreements and strategic partnerships or license our intellectual property, products or businesses, we may not be able
to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations, which could delay our timelines or otherwise adversely affect our business. We
also cannot be certain that, following a strategic transaction or license, we will achieve the revenue or net income that justifies such transaction. Any of the factors set forth above and any delays
in entering into new collaborations or strategic partnership agreements related to any product candidate we develop could delay the development and commercialization of our product candidates, which
would harm our business prospects, financial condition and results of operations. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may seek to establish additional collaborations, and, if we are not able to establish them on commercially
reasonable terms, we may have to alter our development and commercialization plans.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The advancement of our product candidates and development programs and the potential commercialization of our current and future product
candidates will require substantial additional cash to fund expenses. For some of our current or future product candidates, we may decide to collaborate with additional pharmaceutical and
biotechnology companies with respect to development and potential commercialization. Any of these relationships may require us to incur non-recurring and other charges, increase our near and long term
expenditures, issue securities that dilute our existing stockholders, or disrupt our management and business. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming and complex. Whether we reach a definitive agreement for other
collaborations will depend, among other things, upon our assessment of the collaborator's resources and expertise, the terms and conditions of the proposed collaboration and the collaborator's
evaluation of a number of factors. Those factors may include the design or results of clinical trials, the progress of our clinical trials, the likelihood of approval by the FDA or similar regulatory
authorities outside the United States, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the
potential of competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the
challenge and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate
on and whether such a collaboration could be more attractive than the one with us for our product candidate. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Further,
we may not be successful in our efforts to establish a strategic partnership or other alternative arrangements for future product candidates because they may be deemed to be at
too early of a stage of development for collaborative effort and third parties may not view them as having the requisite potential to demonstrate safety and efficacy. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may also be restricted under existing collaboration agreements from entering into future agreements on certain terms with potential collaborators. Such exclusivity could limit our
ability to enter into strategic collaborations with future collaborators. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that
have resulted in a reduced number of potential future collaborators. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product
candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope
of any marketing or sales activities, or increase our expenditures and undertake development or commercialization activities
at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us
on acceptable terms or at all. If </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>53</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=56,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=733096,FOLIO='53',FILE='DISK125:[19ZCO1.19ZCO70301]DK70301A.;16',USER='LGADISH',CD='11-NOV-2019;23:00' -->
<A NAME="page_dk70301_1_54"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>we
do not have sufficient funds, we may not be able to further develop our product candidates or bring them to market and generate product revenue. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Business  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are highly dependent on our key personnel, and if we are not successful in attracting, motivating and
retaining highly qualified personnel, we may not be able to successfully implement our business strategy.  </I></B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are highly dependent on members of our executive team. The loss of the services of any of them may adversely impact the achievement of our
objectives. Any of our executive officers could leave our employment at any time, as all of our employees are "at-will" employees. We currently only have "key person" insurance on Michael Richman, our
President and Chief Executive Officer, and on Dr.&nbsp;Lieping Chen, our scientific founder, in his role as consultant to us. The loss of the services of Mr.&nbsp;Richman, Dr.&nbsp;Chen or one
or more of our other executive officers could impede the achievement of our research, development and commercialization objectives. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
continue to work with Dr.&nbsp;Chen on discovering novel immunomedicines through his consulting agreement and our SRA with Yale. If we are no longer able to leverage our
relationships with Dr.&nbsp;Chen and Yale, our ability to discover additional targets for immunomedicines may be impeded, which may adversely impact the achievement of our objectives. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recruiting
and retaining qualified employees, consultants and advisors for our business, including scientific and technical personnel, will also be critical to our success. Competition
for skilled personnel is intense and the turnover rate can be high. We may not be able to attract and retain personnel on
acceptable terms given the competition among numerous pharmaceutical and biotechnology companies and academic institutions for skilled individuals. In addition, failure to succeed in preclinical
studies, clinical trials or applications for marketing approval may make it more challenging to recruit and retain qualified personnel. The inability to recruit, or the loss of services of certain
executives, key employees, consultants or advisors, may impede the progress of our research, development and commercialization objectives and have a material adverse effect on our business, financial
condition, results of operations and growth prospects. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We face significant competition from other biotechnology and pharmaceutical companies, and our operating
results will suffer if we fail to compete effectively.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The biotechnology industry is intensely competitive and subject to rapid and significant technological change. Our current or future product
candidates may face competition from major pharmaceutical companies, specialty pharmaceutical companies, universities and other research institutions and from products and therapies that currently
exist or are being developed, some of which products and therapies we may not currently know about. Many of our competitors have significantly greater financial, manufacturing, marketing, product
development, technical and human resources than we do. Large pharmaceutical companies, in particular, have extensive experience in clinical testing, obtaining marketing approvals, recruiting patients
and manufacturing pharmaceutical products, and they may also have products that have been approved or are in late stages of development, and collaborative arrangements in our target markets with
leading companies and research institutions. Established pharmaceutical companies may also invest heavily to accelerate discovery and development of novel compounds or to in-license novel compounds
that could make the product candidates that we develop obsolete. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among
a smaller number of our competitors. As a result of all of these factors, our competitors may succeed in obtaining patent protection and/or FDA or other regulatory approval or discovering, developing
and commercializing products in our field before we do, which could result in our competitors establishing a strong market position before we are able to enter the market. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>54</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=57,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=228902,FOLIO='54',FILE='DISK125:[19ZCO1.19ZCO70301]DK70301A.;16',USER='LGADISH',CD='11-NOV-2019;23:00' -->
<A NAME="page_dk70301_1_55"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
competitors may obtain FDA or other regulatory approval of their product candidates more rapidly than we may or may obtain patent protection or other intellectual property rights
that limit our ability to develop or commercialize our product candidates or platform technologies. Our competitors may also develop drugs or discovery platforms that are more effective, more
convenient, more widely used or less costly than our product candidates or our FIND-IO platform or, in the case of drugs, have a better safety profile than our product candidates. These competitors
may also be more successful than us in manufacturing and marketing their products, and have significantly greater financial resources and expertise in research and development. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are a large number of companies developing or marketing treatments for cancer, including many major pharmaceutical and biotechnology companies. Currently marketed oncology drugs
and therapeutics range from traditional cancer therapies, including chemotherapy, to antibody-drug conjugates, such as Genentech's Kadcyla, to immune checkpoint inhibitors targeting CTLA-4, such as
BMS' Yervoy, and PD-1/PD-L1, such as BMS' Opdivo, Merck&nbsp;&amp;&nbsp;Co.'s Keytruda and Genentech's Tecentriq, to T cell-engager immunotherapies, such as Amgen's Blincyto. In addition, numerous
compounds are in clinical development for cancer treatment. In addition, numerous compounds are in clinical development for cancer treatment. Many of these companies are well-capitalized and have
significant clinical experience. See "Business&#151;Competition." </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Smaller
and other early stage companies may also prove to be significant competitors. These third parties compete with us in recruiting and retaining qualified scientific and management
personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our current and future product
candidates. In addition, the biopharmaceutical industry is characterized by rapid technological change. If we fail to stay at the forefront of technological change, we may be unable to compete
effectively. Technological advances or products developed by our competitors may render our product candidates obsolete, less competitive or not economical. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects,
are more convenient, have a broader label, are marketed more effectively, are reimbursed or are less expensive than any products that we may develop. Our competitors may also obtain patent protection
or other intellectual property rights that limit our ability to develop or commercialize our product candidates or platform technologies. Even if our product candidates achieve marketing approval,
they may be priced at a significant premium over competitive products if any have been approved by then, resulting in reduced competitiveness. If we do not compete successfully, we may not generate or
derive sufficient revenue from any product candidate for which we obtain marketing approval and may not become or remain profitable. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We will need to grow the size of our organization, and we may experience difficulties in managing this
growth.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As our development plans and strategies develop, and as we transition into operating as a public company, we expect to need additional
managerial, operational, marketing, sales, financial and other personnel. Future growth would impose significant added responsibilities on members of management,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> identifying, recruiting, integrating, maintaining and motivating additional employees; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> managing our internal development efforts effectively, including the clinical and FDA review process for NC318, NC410 and any future product
candidates we develop, while complying with our contractual obligations to contractors and other third parties; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> improving our operational, financial and management controls, reporting systems and procedures. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
future financial performance and our ability to advance development of and, if approved, commercialize NC318, NC410 and any future product candidates we develop will depend, in part,
on our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>55</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=58,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=417286,FOLIO='55',FILE='DISK125:[19ZCO1.19ZCO70301]DK70301A.;16',USER='LGADISH',CD='11-NOV-2019;23:00' -->
<A NAME="page_dk70301_1_56"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>ability
to effectively manage any future growth, and our management may have to divert a disproportionate amount of its attention away from day-to-day activities in order to devote a substantial
amount of time to managing these growth activities. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
currently rely, and for the foreseeable future will continue to rely, in substantial part on certain independent organizations, advisors and consultants to provide certain services.
We cannot assure you that the services of independent organizations, advisors and consultants will continue to be available to us on a timely basis when needed, or that we can find qualified
replacements. In addition, if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by consultants is compromised for any reason, our
clinical trials may be extended, delayed or terminated, and we may not be able to obtain marketing approval of any current or future product candidates or otherwise advance our business. We cannot
assure you that we will be able to manage our existing consultants or find other competent outside contractors and consultants on economically reasonable terms, or at all. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors, we may not be able to successfully implement
the tasks necessary to further develop and commercialize NC318, NC410 and any future product candidates we develop and, accordingly, may not achieve our research, development and commercialization
goals. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are unable to establish marketing, sales and distribution capabilities for NC318, NC410 or any other
product candidate that may receive regulatory approval, we may not be successful in commercializing those product candidates if and when they are approved.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We do not have sales or marketing infrastructure. To achieve commercial success for NC318, NC410 and any other product candidate for which we
may obtain marketing approval, we will need to establish a sales and marketing organization. In the future, we expect to build a focused sales and marketing infrastructure to market some of our
product candidates in the United States, if and when they are approved. There are risks involved with establishing our own marketing, sales and distribution capabilities. For example, recruiting and
training a sales force is expensive and time consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing
capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if
we cannot retain or reposition our sales and marketing personnel. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Factors
that may inhibit our efforts to market our products on our own include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our inability to recruit, train and retain adequate numbers of effective sales and marketing personnel; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the inability of sales personnel to obtain access to physicians in order to educate physicians about our product candidates, once approved; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with
more extensive product lines; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> unforeseen costs and expenses associated with creating an independent sales and marketing organization. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we are unable to establish our own marketing, sales and distribution capabilities and are forced to enter into arrangements with, and rely on, third parties to perform these services,
our revenue and our profitability, if any, are likely to be lower than if we had developed such capabilities ourselves. In addition, we may not be successful in entering into arrangements with third
parties to sell, market and distribute our product candidates or may be unable to do so on terms that are favorable to us. We likely will have little control over such third parties, and any of them
may fail to devote the necessary resources and attention to sell and market our products effectively. If we do not establish marketing, sales and distribution </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>56</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=59,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=440844,FOLIO='56',FILE='DISK125:[19ZCO1.19ZCO70301]DK70301A.;16',USER='LGADISH',CD='11-NOV-2019;23:00' -->
<A NAME="page_dk70301_1_57"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>capabilities
successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our product candidates. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Product liability lawsuits against us could cause us to incur substantial liabilities and to limit
commercialization of our product candidates.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We face an inherent risk of product liability exposure related to the testing of our product candidates in human trials and may face greater
risk if we commercialize any products that we develop. Product liability claims may be brought against us by subjects enrolled in our trials, patients, healthcare providers or others using,
administering or selling our products. If we cannot successfully defend ourselves against such claims, we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims
may result in:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> decreased demand for any product candidate we may develop; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> withdrawal of trial participants; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> termination of clinical trial sites or entire trial programs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> injury to our reputation and significant negative media attention; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> initiation of investigations by regulators; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> significant time and costs to defend the related litigation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> substantial monetary awards to trial subjects or patients; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> diversion of management and scientific resources from our business operations; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the inability to commercialize any product candidates that we may develop. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
we currently hold trial liability insurance coverage consistent with industry standards, the amount of coverage may not adequately cover all liabilities that we may incur. We may
not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. We intend to expand our insurance coverage for products to include the
sale of commercial products if we obtain marketing approval for our product candidates, but we may be unable to obtain
commercially reasonable product liability insurance. A successful product liability claim or series of claims brought against us, particularly if judgments exceed our insurance coverage, could
decrease our cash and adversely affect our business and financial condition. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are subject to the periodic reporting requirements of the Exchange Act. We designed our disclosure controls and procedures to reasonably
assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the
time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can
provide only reasonable, not absolute, assurance that the objectives of the control system are met. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally,
controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations
in our control system, misstatements due to error or fraud may occur and not be detected. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>57</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=60,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=327160,FOLIO='57',FILE='DISK125:[19ZCO1.19ZCO70301]DK70301A.;16',USER='LGADISH',CD='11-NOV-2019;23:00' -->
<A NAME="page_dk70301_1_58"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our ability to use our net operating loss carryforwards to offset future taxable income may be subject to
certain limitations.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have incurred substantial losses during our history and do not expect to become profitable in the near future, and we may never achieve
profitability. To the extent that we continue to generate taxable losses, unused losses will carry forward to offset future taxable income, if any, until such unused losses expire. As of
September&nbsp;30, 2019, we had federal and state net operating loss carryforwards of $43.5&nbsp;million and $43.0&nbsp;million, respectively. The federal and state net operating loss
carryforwards will begin to expire, if not utilized, by 2036. Limitations imposed by the applicable jurisdictions on our ability to utilize net operating loss carryforwards could cause income taxes to
be paid earlier than would be paid if such limitations were not in effect and could cause such net operating loss carryforwards to expire unused, in each case reducing or eliminating the benefit of
such net operating loss carryforwards. Furthermore, we may not be able to generate sufficient taxable
income to utilize our net operating loss carryforwards before they expire. If any of these events occur, we may not derive some or all of the expected benefits from our net operating loss
carryforwards. In addition, we may experience ownership changes in the future as a result of subsequent shifts in our stock ownership, including this offering, some of which may be outside of our
control. As a result, even if we earn net taxable income, our ability to use our net operating loss and tax credit carryforwards may be materially limited, which could harm our future operating
results by effectively increasing our future tax obligations. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Common Stock and this Offering  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


An active trading market for our common stock may not be sustained and you may not be able to sell your
shares at or above the public offering price, or at all.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior to our IPO, there was no public market for shares of our common stock. Although our common stock is listed on the Nasdaq Global Select
Market, or Nasdaq, an active, liquid trading market for our shares may not be sustained. In the absence of an active trading market for our common stock, you may not be able to sell your common stock
at or above the public offering price or at the time that you would like to sell. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The price of our common stock may be volatile and fluctuate substantially, which could result in substantial
losses for purchasers of our common stock in this offering.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our stock price is likely to be volatile. The stock market in general and the market for biopharmaceutical companies in particular have
experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, you may not be able to sell your common stock at or
above the public offering price, or at all. The market price for our common stock may be influenced by many factors, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the commencement, enrollment or results of our ongoing or future clinical trials, or changes in the development status of our product
candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> any delay in our regulatory filings for our product candidates and any adverse development or perceived adverse development with respect to the
applicable regulatory authority's review of such filings, including without limitation the FDA's issuance of a "refusal to file" letter or a request for additional information; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> adverse results or delays in clinical trials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our decision to initiate a clinical trial, not to initiate a clinical trial or to terminate an existing clinical trial; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> adverse regulatory decisions, including failure to receive regulatory approval of our product candidates; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>58</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=61,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=149659,FOLIO='58',FILE='DISK125:[19ZCO1.19ZCO70301]DK70301A.;16',USER='LGADISH',CD='11-NOV-2019;23:00' -->
<A NAME="page_dk70301_1_59"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our failure to commercialize our product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> unanticipated serious safety concerns related to the use of our product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the size and growth of our target markets; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the success of competitive products or technologies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> regulatory actions with respect to our product candidates or our competitors' products or product candidates; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> announcements by us or our competitors of significant acquisitions, strategic collaborations, joint ventures, collaborations or capital
commitments; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> regulatory or legal developments in the United States and other countries applicable to our product candidates, including but not limited to
clinical trial requirements for approvals; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our inability to obtain adequate product supply for any approved product or inability to do so at acceptable prices; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> developments or disputes concerning patent applications, issued patents or other proprietary rights; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the recruitment or departure of key personnel; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the level of expenses related to our product candidates or clinical development programs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the results of our efforts to discover, develop, acquire or in-license product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts or
publications of research reports about us or our industry; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> variations in our annual or quarterly financial results or those of companies that are perceived by investors to be similar to us; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our cash position; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> fluctuations in the valuation of companies perceived by investors to be comparable to us; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> share price and volume fluctuations attributable to inconsistent trading volume levels of our shares; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> announcement or expectation of additional financing efforts; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> sales of our common stock by us, our directors, officers or their affiliated funds or our other stockholders; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> changes in the structure of healthcare payment systems; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> significant lawsuits, including patent or stockholder litigation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> market conditions in the pharmaceutical and biotechnology sectors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> general economic, industry and market conditions; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> other events or factors, many of which are beyond our control. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the stock market in general, and Nasdaq and biotechnology companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or
disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating
performance. The realization of any of the above risks or any of a broad range of other risks, including those described in
this "Risk Factors" section, could have a dramatic and material adverse impact on the market price of our common stock. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>59</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=62,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=314242,FOLIO='59',FILE='DISK125:[19ZCO1.19ZCO70301]DK70301A.;16',USER='LGADISH',CD='11-NOV-2019;23:00' -->
<A NAME="page_dk70301_1_60"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If securities analysts do not publish research or reports about our business or if they publish negative
evaluations of our stock, the price of our stock could decline.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The trading market for our common stock relies, in part, on the research and reports that industry or financial analysts publish about us or our
business. As a newly public company, we have only limited coverage by equity research analysts. If additional analysts do not commence coverage of us, the trading price of our stock could decrease. In
addition, if one or more of the analysts covering our business issue adverse reports about us or downgrade their evaluations of our stock, the price of our stock could decline. If one or more of these
analysts cease to cover our stock or fail to publish reports on us regularly, we could lose visibility in the market for our stock, which, in turn, could cause our stock price to decline. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If you purchase our common stock in this offering, you will incur immediate and substantial dilution in the
book value of your shares.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The public offering price of our common stock is substantially higher than the as adjusted net tangible book value per share of our common
stock. Therefore, if you purchase our common stock in this offering, you will pay a price per share that substantially exceeds the as adjusted net tangible book value per share after the closing of
this offering. To the extent outstanding options to purchase shares of our common stock are exercised, you will incur further dilution. Based on the assumed public offering price of $39.02 per share,
which is the last reported sale price of our common stock on the Nasdaq Global Select Market on November&nbsp;11, 2019, and our net tangible book value as of September&nbsp;30, 2019, you will
experience immediate dilution of $27.96 per share, representing the difference between our as adjusted net tangible book value per share after giving effect to this offering and the assumed public
offering price. See the section entitled "Dilution" for a more detailed description of the dilution to investors in the offering. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Sales of a substantial number of shares of our common stock in the public market could cause our stock price
to fall, even if our business is doing well.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market, the market
price of our common stock could decline. As of September&nbsp;30, 2019, we had outstanding a total of 22,739,345 shares of common stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
resales of 10,889,633 shares of our common stock are subject to lock-up agreements pertaining to this offering that will expire 90&nbsp;days from the date of this prospectus,
subject to earlier release of all or a portion of the shares subject to such agreements by the underwriters in this offering. After the lock-up agreements expire, substantially all of the shares of
common stock outstanding prior to this offering will be eligible for sale in the public market, subject to the applicable volume, manner of sale and other limitations imposed under the federal
securities laws. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have registered 5,167,502 shares of common stock on Registration Statements on Forms&nbsp;S-8 that were either subject to outstanding options or reserved for future issuance under
our existing equity incentive plans as of May&nbsp;13, 2019, and as a result these shares will become eligible for sale in the public market to the extent permitted by the provisions of various
vesting schedules and the lock-up agreements described above. If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the market price
of our common stock could decline. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, the holders of 6,336,439 shares, or approximately 27.87%, of our common stock outstanding as of September&nbsp;30, 2019 are entitled to rights with respect to the
registration of their shares under the Securities Act, subject to the lock-up agreements described above. See "Description of Capital Stock&#151;Registration Rights." Registration of these
shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares purchased by affiliates. Any sales of these
securities could have a material adverse effect on the market price of our common stock. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>60</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=63,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=103369,FOLIO='60',FILE='DISK125:[19ZCO1.19ZCO70301]DK70301A.;16',USER='LGADISH',CD='11-NOV-2019;23:00' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_dm70301_1_61"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us,
which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions in our amended and restated certificate of incorporation and amended and restated bylaws may delay or prevent an acquisition of us or
a change in our management. For example, our board of directors has the authority to issue up to 10,000,000 shares of preferred stock.
The board of directors can fix the price, rights, preferences, privileges and restrictions of the preferred stock without any further vote or action by our stockholders. The issuance of shares of
preferred stock may delay or prevent a change of control transaction. As a result, the market price of our common stock and the voting and other rights of our stockholders may be adversely affected.
An issuance of shares of preferred stock may result in the loss of voting control to other stockholders. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
provisions also include a classified board of directors, a prohibition on actions by written consent of our stockholders and the ability of our board of directors to issue
preferred stock without stockholder approval. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section&nbsp;203 of the Delaware General Corporation Law,
which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us. Although we believe these provisions collectively provide for an
opportunity to obtain greater value for stockholders by requiring potential acquirers to negotiate with our board of directors, they would apply even if an offer rejected by our board were considered
beneficial by some stockholders. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for
stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our executive officers, directors and current beneficial owners of 5% or more of our common stock and their
respective affiliates exercise significant influence over our company, which limits your ability to influence corporate matters and could delay or prevent a change in corporate control.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our executive officers, directors and current beneficial owners of 5% or more of our common stock and their respective affiliates beneficially
own, in the aggregate, a majority of our outstanding common stock. As a result, these stockholders, if they act together, will be able to influence our management and affairs and the outcome of
matters submitted to our stockholders for approval, including the election of directors and any sale, merger, consolidation or sale of all or substantially all of our assets. This concentration of
ownership might adversely affect the market price of our common stock by:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> delaying, deferring or preventing a change of control of us; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> impeding a merger, consolidation, takeover or other business combination involving us; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See
the section entitled "Principal Stockholders" for more information regarding the ownership of our outstanding common stock by our executive officers, directors and their affiliates. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are an emerging growth company, and we cannot be certain if the reduced reporting requirements applicable
to emerging growth companies will make our common stock less attractive to investors.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are an emerging growth company, as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take
advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including not being required to comply with the
auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in this prospectus and our periodic reports and proxy
statements and exemptions from the requirements of holding nonbinding advisory votes </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>61</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=64,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=723002,FOLIO='61',FILE='DISK125:[19ZCO1.19ZCO70301]DM70301A.;18',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_dm70301_1_62"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>on
executive compensation and stockholder approval of any golden parachute payments not previously approved. We will remain an emerging growth company until the earliest of
(i)&nbsp;December&nbsp;31, 2024, (ii)&nbsp;the last day of the first fiscal year in which we have total annual gross revenues of at least $1.07&nbsp;billion, (iii)&nbsp;the last day of the
first fiscal year in which the market value of our common stock that is held by non-affiliates exceeds $700.0&nbsp;million on June&nbsp;30th&nbsp;and (iv)&nbsp;the date on which we have issued
more than $1.0&nbsp;billion in non-convertible debt securities during the prior three-year period. We cannot predict if investors will find our common stock less attractive because we may rely on
these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have elected
to take advantage of this extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the
earlier of the date we (i)&nbsp;are no longer an emerging growth company or (ii)&nbsp;affirmatively and irrevocably opt out of the extended transition period provided in the JOBS act. As a result,
our financial statements may not
be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we fail to maintain proper and effective internal control over financial reporting, our ability to produce
accurate and timely financial statements could be impaired, investors may lose confidence in our financial reporting and the trading price of our common stock may decline.  </I></B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act, our management will be required to report upon the effectiveness of our internal
control over financial reporting beginning with the annual report for our fiscal year ending December&nbsp;31, 2020. When we lose our status as an "emerging growth company," our independent
registered public accounting firm will be required to attest to the effectiveness of our internal control over financial reporting. The rules governing the standards that must be met for management to
assess our internal control over financial reporting are complex and require significant documentation, testing and possible remediation. To comply with the requirements of being a reporting company
under the Exchange Act, we will need to implement additional financial and management controls, reporting systems and procedures and hire additional accounting and finance staff. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
cannot assure you that there will not be material weaknesses or significant deficiencies in our internal control over financial reporting in the future. Our independent registered
public accounting firm will not be required to provide an attestation report on the effectiveness of our internal control over financial reporting so long as we qualify as an "emerging growth
company," which may increase the risk that material weaknesses or significant deficiencies in our internal control over financial reporting go undetected. Any failure to maintain internal control over
financial reporting could severely inhibit our ability to accurately report our financial condition, results of operations or cash flows. If we are unable to conclude that our internal control over
financial reporting is effective, or if our independent registered public accounting firm determines we have a material weakness or significant deficiency in our internal control over financial
reporting, investors may lose confidence in the accuracy and completeness of our financial reports, the market price of our common stock could decline, and we could be subject to sanctions or
investigations by Nasdaq, the SEC or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective
control systems required of public companies, could also restrict our future access to the capital markets. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>62</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=65,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=814904,FOLIO='62',FILE='DISK125:[19ZCO1.19ZCO70301]DM70301A.;18',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_dm70301_1_63"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have broad discretion in how we use the net proceeds from this offering and may not use these proceeds
effectively, which could affect our results of operations and cause our stock price to decline.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our management will have broad discretion in the application of the net proceeds from this offering, including for any of the purposes described
in the section entitled "Use of Proceeds," and you will be relying on the judgment of our management regarding the application of these proceeds. You will not have the opportunity, as part of your
investment decision, to assess whether we are using the proceeds appropriately. Our management might not use the net proceeds from this offering in ways that ultimately increase the value of your
investment. If we do not use these proceeds in ways that enhance stockholder value, we may fail to achieve expected financial results or cause delays to our clinical development timelines, which could
cause our stock price to decline. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We do not intend to pay dividends on our common stock, so any returns will be limited to the value of our
stock.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate
declaring or paying any cash dividends for the foreseeable future. Any return to stockholders will therefore be limited to the appreciation of their stock. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have incurred and will continue to incur significantly increased costs as a result of operating as a
public company, and our management will be required to devote substantial time to new compliance initiatives.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As a public company, and particularly after we are no longer an emerging growth company, we have incurred and expect to continue to incur
significant legal, accounting, investor relations and other expenses that we did not incur as a private company, which we anticipate could be between $2.5&nbsp;million and $4.5&nbsp;million
annually. The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of Nasdaq and other applicable securities rules and regulations impose various
requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel devote a
substantial amount of time to these compliance initiatives. Moreover, we expect these rules and regulations to substantially increase our legal and financial compliance costs and to make some
activities more time consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability
insurance and we may be required to incur substantial costs to maintain sufficient coverage. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these
requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive
officers. Moreover, these rules and regulations are often subject to varying
interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies.
This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be subject to securities litigation, which is expensive and could divert management attention.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The market price of our common stock may be volatile, and in the past, companies that have experienced volatility in the market price of their
stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and
divert our management's attention from other business concerns, which could seriously harm our business. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>63</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=66,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=511193,FOLIO='63',FILE='DISK125:[19ZCO1.19ZCO70301]DM70301A.;18',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_dm70301_1_64"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our amended and restated bylaws designate the Court of Chancery of the State of Delaware or the United States
District Court for the District of Delaware as the exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders' ability
to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our amended and restated bylaws provide that, unless we consent in writing to an alternative forum, the Court of Chancery of the State of
Delaware or, if subject matter jurisdiction over the matter that is the subject of such action is vested exclusively in the federal courts, the United States District Court for the District of
Delaware will, to the fullest extent permitted by law, be the sole and exclusive forum for (i)&nbsp;any derivative action or proceeding brought on our behalf, (ii)&nbsp;any action asserting a
claim of breach of a fiduciary duty owed by any of our current or former directors, officers and employees, (iii)&nbsp;any action asserting a claim arising pursuant to any provision of the Delaware
General Corporation Law, our certificate of incorporation or our bylaws, (iv)&nbsp;any action or proceeding to interpret, apply, enforce or determine the validity of our certificate of incorporation
or the bylaws or (v)&nbsp;any action asserting a claim that is governed by the internal affairs doctrine, in each case subject to the Court of Chancery or the United States District Court for the
District of Delaware, as applicable, having personal jurisdiction over the indispensable parties named as defendants therein. In addition, any person holding, owning or otherwise acquiring any
interest in any of our securities shall be deemed to have notice of and to have consented to this provision of our bylaws. The choice of forum provision does not apply to any actions arising under the
Securities Act or the Exchange Act. The choice of
forum provision may limit a stockholder's ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or employees, which may discourage such
lawsuits against us and our directors, officers and employees even though an action, if successful, might benefit our stockholders. Stockholders who do bring a claim in the Court of Chancery or the
United States District Court for the District of Delaware could face additional litigation costs in pursuing any such claim, particularly if they do not reside in or near the jurisdiction. The Court
of Chancery or the United States District Court for the District of Delaware may also reach different judgments or results than would other courts, including courts where a stockholder considering an
action may be located or would otherwise choose to bring the action, and such judgments or results may be more favorable to us than to our stockholders. Alternatively, if a court were to find this
provision of our amended and restated bylaws inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs, which could
have a material adverse effect on our business, financial condition or results of operations. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>64</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=4,SEQ=67,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=901546,FOLIO='64',FILE='DISK125:[19ZCO1.19ZCO70301]DM70301A.;18',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_dm70301_1_65"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dm70301_special_note_regarding_forward-looking_statements"> </A>
<A NAME="toc_dm70301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus contains forward-looking statements, including with respect to our plans, objectives and expectations for our business,
operations and financial performance and condition. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. The forward-looking
statements are contained principally in the sections entitled "Prospectus Summary," "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and
"Business," but are also contained elsewhere in this prospectus. In some cases, you can identify forward-looking statements by terminology such as "aim," "anticipate," "assume," "believe," "continue,"
"could," "due," "estimate," "expect," "intend," "may," "objective," "plan," "predict," "potential," "positioned," "seek," "should," "target," "will," "would" and other similar expressions that are
predictions of or indicate future events and future trends, or the negative of these terms or similar language. These forward-looking statements include, but are not limited to, statements
about:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our expectations regarding the timing, progress and results of preclinical studies and clinical trials for NC318, NC410 and any other product
candidates we develop, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work, the period during which the results of the trials will
become available and our research and development programs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the timing or likelihood of regulatory filings for NC318, NC410 and any other product candidates we develop and our ability to obtain and
maintain regulatory approvals for such product candidates for any indication; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our manufacturing capabilities and strategy, including the scalability of our manufacturing methods and processes; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our expectations regarding the potential benefits, activity, effectiveness and safety of NC318, NC410 and any other product candidates we
develop; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our intentions and ability to successfully commercialize our product candidates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our expectations regarding the nature of the biological pathways we are targeting; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our expectations for our FIND-IO platform, including our ability to discover and advance product candidates using our FIND-IO platform; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the potential benefits of and our ability to maintain our relationships and collaborations with Yale, Dr.&nbsp;Lieping Chen and Lilly; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our estimates regarding our expenses, future revenues, capital requirements and our needs for or ability to obtain additional financing and the
period over which we expect the proceeds of this offering, together with our current cash, cash equivalents and marketable securities, to be sufficient to fund our operations; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our intended reliance on and the performance of third parties, including collaborators, contract research organizations and third-party
manufacturers; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our ability to protect and enforce our intellectual property protection and the scope and duration of such protection; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> developments and projections relating to our competitors and our industry, including competing therapies; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the impact of current and future laws and regulations; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our intended use of proceeds from this offering. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>65</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=68,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=429260,FOLIO='65',FILE='DISK125:[19ZCO1.19ZCO70301]DM70301A.;18',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_dm70301_1_66"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
statements are based on management's current expectations, estimates, forecasts and projections about our business and industry, are not guarantees of future performance and
involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control and that may cause our or our industry's actual results, levels of activity, performance or
achievements to be materially different from those anticipated by the forward-looking statements. We discuss many of these
risks in greater detail in the section entitled "Risk Factors" and elsewhere in this prospectus. While we believe that our internal expectations, estimates, forecasts and projections are reasonable,
no independent source has verified such expectations, estimates, forecasts and projections, as a result we cannot assure you that the forward-looking statements in this prospectus will prove to be
accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. Accordingly, you should not rely upon forward-looking statements as predictions of
future events. These forward-looking statements speak only as of the date of this prospectus, and except as required by law, after the date of this prospectus, we are under no duty to update or revise
any of the forward-looking statements, whether as a result of new information, future events or otherwise. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
should read this prospectus and the documents that we reference in this prospectus and have filed as exhibits to the registration statement, of which this prospectus is a part,
completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by the foregoing cautionary
statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>66</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=69,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=879668,FOLIO='66',FILE='DISK125:[19ZCO1.19ZCO70301]DM70301A.;18',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_dm70301_1_67"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dm70301_use_of_proceeds"> </A>
<A NAME="toc_dm70301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  USE OF PROCEEDS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We estimate that the net proceeds from the sale of shares of our common stock in this offering will be approximately $116.5&nbsp;million, or
approximately $134.1&nbsp;million if the underwriters exercise their option to purchase additional shares in full, assuming a public offering price of $39.02 per share, which is the last reported
sale price of our common stock on the Nasdaq Global Select Market on November&nbsp;11, 2019, and after deducting estimated underwriting discounts and commissions and estimated offering expenses
payable by us. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
$1.00 increase or decrease in the assumed public offering price of $39.02 per share, which is the last reported sale price of our common stock on the Nasdaq Global Select Market on
November&nbsp;11, 2019, would increase or decrease, respectively, the net proceeds from this offering by approximately $3.0&nbsp;million, assuming the number of shares offered by us, as set forth
on the cover of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease
the number of shares we are offering. An increase or decrease of 1.0&nbsp;million in the number of shares we are offering would increase or decrease, respectively, the net proceeds from this
offering, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, by approximately $36.7&nbsp;million, assuming the public offering price
remains the same. We do not expect that a change in the public offering price or the number of shares offered by us by these amounts would have a material
effect on our intended use of the net proceeds from this offering, although it may impact the amount of time prior to which we may need to seek additional capital. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of September&nbsp;30, 2019, we had $184.1&nbsp;million in cash, cash equivalents and marketable securities, excluding restricted cash. We intend to use the net proceeds from this
offering, together with our existing cash, cash equivalents and marketable securities, as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> approximately $160.7&nbsp;million to $184.8&nbsp;million to advance NC318 through completion of our ongoing Phase&nbsp;1/2 clinical
trial, our planned Phase&nbsp;2 clinical trial in combination with chemotherapies in patients with advanced or metastatic solid tumors and additional Phase&nbsp;2 clinical trials and into
Phase&nbsp;3 clinical trials, as well as to develop a complementary diagnostic for NC318 if we determine it is advisable; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> approximately $14.3&nbsp;million to $16.4&nbsp;million to expand our cGMP manufacturing capacity, including to provide the drug supply for
future clinical trials of NC318; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> approximately $56.1&nbsp;million to $64.5&nbsp;million to advance NC410 through completion of a Phase&nbsp;1/2 clinical trial and into
future clinical development; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the remainder for research and development activities related to our FIND-IO platform and discovery programs, including advancement of
additional discovery programs into clinical development, personnel expenses, working capital and other general corporate purposes. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
expected use of the net proceeds from this offering represents our intentions based upon our current plans and business conditions, which could change in the future as our plans and
business conditions evolve. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the closing of this offering or the
amounts that we will actually spend on the uses set forth above. The amounts and timing of our actual expenditures and the extent of our research and development activities may vary significantly
depending on numerous factors, including the progress of our development efforts, the timing and costs associated
with the manufacture and supply of any of our product candidates and any unforeseen cash needs. As a result, our management will have broad discretion over the use of the net proceeds from this
offering. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pending
the uses described above, we intend to invest the net proceeds from this offering in interest-bearing, investment-grade securities, certificates of deposit or government
securities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>67</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=70,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=1021092,FOLIO='67',FILE='DISK125:[19ZCO1.19ZCO70301]DM70301A.;18',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_dm70301_1_68"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that our existing cash, cash equivalents and marketable securities, together with the net proceeds from this offering, will be sufficient to fund our planned operations into
the first half of 2023. We have based this estimate on assumptions that may prove to be incorrect, and we could use our available capital resources sooner than we currently expect. After this
offering, we will require substantial additional capital in order to continue to advance NC318, NC410 and future product candidates through preclinical studies, clinical trials, regulatory approval
and commercialization. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>68</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=71,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=454079,FOLIO='68',FILE='DISK125:[19ZCO1.19ZCO70301]DM70301A.;18',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_dm70301_1_69"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dm70301_dividend_policy"> </A>
<A NAME="toc_dm70301_3"> </A>
<BR></FONT><FONT SIZE=2><B>  DIVIDEND POLICY    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have never declared or paid cash dividends on our capital stock, and we do not anticipate paying any cash dividends in the foreseeable
future. We currently intend to retain all available funds and any future earnings to support our operations and finance the growth and development of our business. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>69</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=72,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=611364,FOLIO='69',FILE='DISK125:[19ZCO1.19ZCO70301]DM70301A.;18',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_do70301_1_70"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="do70301_capitalization"> </A>
<A NAME="toc_do70301_1"> </A></FONT> <FONT SIZE=2><B>  CAPITALIZATION    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth our cash, cash equivalents and marketable securities and our capitalization as of September&nbsp;30,
2019:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> on an actual basis; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> on an as adjusted basis to give effect to the sale of 3,200,000 shares of common stock in this offering, assuming a public offering price of
$39.02 per share, which is the last reported sale price of our common stock on the Nasdaq Global Select Market on November&nbsp;11, 2019, after deducting estimated underwriting discounts and
commissions and estimated offering expenses payable by us. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
should read this table together with the sections entitled "Selected Financial Data" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and
our financial statements and the related notes and other financial information appearing elsewhere in this prospectus. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of September&nbsp;30,<BR>
2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Actual </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As<BR>
Adjusted<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(in thousands, except<BR>
share and per share<BR>
amounts)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash, cash equivalents and marketable securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>184,082</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>300,588 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Term loan</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,000 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stockholders' equity:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Common stock, par value $0.001 per share&#151;100,000,000 shares authorized, 22,739,345 shares issued and outstanding, actual; 25,939,345 shares issued
and outstanding, as adjusted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>26</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Preferred stock, par value $0.001 per share&#151;10,000,000 shares authorized, no shares issued or outstanding, actual and as adjusted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Additional paid-in capital</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>240,791</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>357,294</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated other comprehensive loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(70,107</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(70,107</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total stockholders' (deficit) equity</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>170,649</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>287,155 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total capitalization</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>175,649</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>292,155 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>The
as adjusted information is illustrative only and will depend on the actual public offering price and the other terms of this offering determined at pricing. Each
$1.00 increase or decrease in the assumed public offering price of $39.02 per share, which is the last reported sale price of our common stock on the Nasdaq Global Select Market on November&nbsp;11,
2019, would increase or decrease, respectively, our as adjusted amounts of cash, cash equivalents and marketable securities, additional paid-in capital, total assets and total stockholders' equity and
total capitalization by $3.0&nbsp;million, assuming that the number of shares offered by us, as set forth on the cover of this prospectus, remains the same and after deducting estimated underwriting
discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. An increase or decrease of 1.0&nbsp;million in the
number of shares we are offering in this offering would increase or decrease, respectively, our as adjusted amounts of cash, cash equivalents and marketable securities, additional paid-in capital,
total stockholders' equity and total capitalization by $36.7&nbsp;million, assuming the assumed public offering price remains the same and after deducting estimated underwriting discounts and
commissions and estimated offering expenses payable by us.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>70</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=73,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=285184,FOLIO='70',FILE='DISK125:[19ZCO1.19ZCO70301]DO70301A.;26',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_do70301_1_71"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
actual and as adjusted information set forth in the table above excludes the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 2,248,953 shares of our common stock issuable upon the exercise of stock options outstanding as of September&nbsp;30, 2019, with a weighted
average exercise price of $6.30 per share; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 2,653,969 additional shares of our common stock available for future issuance under the 2019 Plan as of September&nbsp;30, 2019; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 240,000 shares of our common stock reserved for future issuance under our ESPP as of September&nbsp;30, 2019. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>71</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=74,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=552228,FOLIO='71',FILE='DISK125:[19ZCO1.19ZCO70301]DO70301A.;26',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_do70301_1_72"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="do70301_dilution"> </A>
<A NAME="toc_do70301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  DILUTION    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you invest in our common stock in this offering, your ownership interest will be immediately diluted to the extent of the difference between
the public offering price per share of our common stock and the as adjusted net tangible book value per share of our common stock immediately after this offering. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of September&nbsp;30, 2019, we had a historical net tangible book value of $170.6&nbsp;million, or $7.50 per share of our common stock. Our net tangible book value per share
represents total tangible assets less total liabilities divided by the number of shares of common stock outstanding on September&nbsp;30, 2019, including 114,875&nbsp;shares of restricted common
stock that were unvested or subject to repurchase. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
giving effect to the sale of 3,200,000 shares of common stock in this offering, assuming a public offering price of $39.02 per share, which is the last reported sale price of our
common stock on the
Nasdaq Global Select Market on November&nbsp;11, 2019, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, our as adjusted net
tangible book value as of September&nbsp;30, 2019 would have been $287.0&nbsp;million, or $11.06 per share. This represents an immediate increase in net tangible book value of $3.57 per share to
existing stockholders and an immediate dilution of $27.96 per share to new investors participating in this offering. The following table illustrates this per share dilution to new investors: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Assumed public offering price per share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>39.02</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Historical net tangible book value per share as of September&nbsp;30, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7.50</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Increase in net tangible book value per share attributable to investors participating in this offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3.57</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>As adjusted net tangible book value per share after this offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11.06 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dilution per share to new investors participating in this offering</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>27.96 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
as adjusted information is illustrative only and will depend on the actual public offering price and the other terms of this offering determined at pricing. Each $1.00 increase or
decrease in the assumed public offering price of $39.02 per share, which is the last reported sale price of our common stock on the Nasdaq Global Select Market on November&nbsp;11, 2019, would
increase or decrease, respectively, our as adjusted net tangible book value as of September&nbsp;30, 2019 after this offering by $4.2&nbsp;million, or $0.16 per share, and would increase or
decrease, respectively, dilution to investors in this offering by $0.84 per share, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the
same, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. An
increase of 1.0&nbsp;million in the number of shares we are offering in this offering would increase our as adjusted net tangible book value as of September&nbsp;30, 2019 after this offering by
$36.7&nbsp;million, or $1.36 per share, and would decrease dilution to investors in this offering by $0.95 per share, and a decrease of 1.0&nbsp;million in the number of shares we are offering in
this offering would decrease our as adjusted net tangible book value as of September&nbsp;30, 2019 after this offering by $36.7&nbsp;million, or $1.47 per share, in each case each assuming the
assumed public offering price remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the underwriters exercise their option to purchase 480,000 additional shares of our common stock in full, the as adjusted net tangible book value after this offering would be $11.74
per share, the increase in net tangible book value per share would be $0.68 and the dilution per share to new investors would be $27.28 per share, assuming a public offering price of $39.02 per share,
which is the last reported sale price of our common stock on the Nasdaq Global Select Market on November&nbsp;11, 2019, and after deducting estimated underwriting discounts and commissions and
estimated offering expenses payable by us. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>72</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=75,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=687536,FOLIO='72',FILE='DISK125:[19ZCO1.19ZCO70301]DO70301A.;26',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_do70301_1_73"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of shares of our common stock reflected in this discussion is based on 22,739,345 shares of our common stock outstanding as of September&nbsp;30, 2019, which gives effect to
the adjustments described above and excludes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 2,248,953 shares of our common stock issuable upon the exercise of stock options outstanding as of September&nbsp;30, 2019, with a weighted
average exercise price of $6.30 per share; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 2,653,969 additional shares of our common stock available for future issuance under the 2019 Plan as of September&nbsp;30, 2019; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 240,000 shares of our common stock reserved for future issuance under the ESPP as of September&nbsp;30, 2019. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>73</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=76,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=779780,FOLIO='73',FILE='DISK125:[19ZCO1.19ZCO70301]DO70301A.;26',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_do70301_1_74"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="do70301_selected_financial_data"> </A>
<A NAME="toc_do70301_3"> </A>
<BR></FONT><FONT SIZE=2><B>  SELECTED FINANCIAL DATA    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>The following tables present our selected financial data for the periods and as of the dates indicated. We derived the
statement of operations and comprehensive loss data for the years ended December&nbsp;31, 2018 and 2017 and the balance sheet data as of December&nbsp;31, 2018 and 2017 from our audited financial
statements appearing elsewhere in this prospectus. We derived the statement of operations data for the nine months ended September&nbsp;30, 2019 and 2018 and the balance sheet data as of
September&nbsp;30, 2019 from our unaudited condensed financial statements appearing elsewhere in this prospectus. These unaudited condensed financial statements have been prepared on a basis
consistent with our audited financial statements and, in management's opinion, contain all adjustments, consisting of normal and recurring adjustments, necessary for the fair statement of such
financial data. Our historical results are not necessarily indicative of the results that may be expected in any future period. You should read the following data together with our financial
statements and the related notes appearing elsewhere in this prospectus and the section entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations." The selected
financial data in this section are not intended to replace the financial statements and are qualified in their entirety by the audited financial statements and the related notes appearing elsewhere in
this prospectus.</I></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(in thousands, except share and per share amounts)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Statement of Operations Data:</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue from research and development arrangement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>13,539</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,787</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,954</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,995</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,590</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,409</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,595 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>29,814</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16,129</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,196</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>15,249 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loss from operations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(25,472</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(16,129</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(23,196</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,549</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income, net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,662</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>192</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>397</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>80 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,810</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,937</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,469</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss per common share, basic and diluted<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.81</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(11.64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(16.64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(11.30</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Weighted average number of common shares, basic and diluted<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,609,219</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,212</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,846</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,212 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>See
Note&nbsp;12 to our audited financial statements and Note&nbsp;8 to our unaudited condensed financial statements included elsewhere in this prospectus for
further details on the calculations of our basic and diluted net loss per share and the weighted average number of shares used in the computation of the per share amounts.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
table below presents our balance sheet data as of September&nbsp;30, 2019:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> on an actual basis; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> on an as adjusted basis to give effect to the sale of 3,200,000 shares of common stock in this offering, assuming an offering price of $39.02
per share, which is the last reported sale price of our common stock on the Nasdaq Global Select Market on November&nbsp;11, 2019, and after deducting estimated underwriting discounts and
commissions and estimated offering expenses payable by us. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>74</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=77,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=864925,FOLIO='74',FILE='DISK125:[19ZCO1.19ZCO70301]DO70301A.;26',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_do70301_1_75"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
</UL>
</UL>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of<BR>
September&nbsp;30, 2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(in thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Balance Sheet Data</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash, cash equivalents and marketable securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>184,082</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>135,173</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,427</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Working capital<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>176,541</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>125,487</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,296</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>205,124</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>147,628</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,467</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>34,475</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32,349</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,879</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Preferred stock</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>162,223</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>40,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(70,107</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(47,297</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(24,498</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total stockholders' (deficit) equity</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>170,649</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(46,944</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(24,412</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>We
define working capital as current assets less current liabilities.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>75</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=78,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=455139,FOLIO='75',FILE='DISK125:[19ZCO1.19ZCO70301]DO70301A.;26',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_dq70301_1_76"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dq70301_management_s_discussion_and_an__man03466"> </A>
<A NAME="toc_dq70301_1"> </A></FONT> <FONT SIZE=2><B>  MANAGEMENT'S DISCUSSION AND ANALYSIS<BR>  OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>You should read the following discussion and analysis of our financial condition and results of operations together with
the section entitled "Selected Financial Data" and our financial statements and the related notes appearing elsewhere in this prospectus. This discussion and other parts of this prospectus contain
forward-looking statements, such as statements of our plans, objectives, expectations and intentions, that involve risks and uncertainties. Our actual results could differ materially from those
discussed in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the section entitled "Risk
Factors."</I></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer
and other immune-related diseases by restoring normal immune function. We view the immune system holistically and, rather than target one specific immune cell type, we focus on understanding
biological pathways, the interactions of cells and the role each interaction plays in an immune response. Through our proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or
FIND-IO, platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. We are
focused on patients who do not respond to current therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies. We are
committed to discovering and developing first-in-class immunomedicines, which are immunomedicines that use new or unique mechanisms of action to treat a medical condition, for these patients. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
lead product candidate, NC318, is a first-in-class immunomedicine against a novel immunomodulatory receptor called Siglec-15, or S15. In October 2018, we initiated a Phase&nbsp;1/2
clinical trial of NC318 in patients with advanced or metastatic solid tumors. We completed enrollment of the Phase&nbsp;1 portion of this trial in August 2019 and preliminary data was presented at
the Society for Immunotherapy of Cancer, or SITC, annual meeting in November 2019. We began enrolling patients in the Phase&nbsp;2 portion of the trial in October&nbsp;2019 and expect to announce
initial data from the Phase&nbsp;2 portion by the end of 2020. We expect to initiate an additional Phase 2 clinical trial to evaluate NC318 in combination with standard of care chemotherapies in
patients with advanced or metastatic solid tumors in the first half of 2020. Our second product candidate, NC410, is a novel immunomedicine designed to block immune suppression mediated by an immune
modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1, or LAIR-1. We expect to submit an investigational new drug application, or IND, to the U.S. Food and Drug Administration, or FDA,
for NC410 in the first quarter of 2020. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
May&nbsp;13, 2019, we closed our IPO, in which we sold 5,750,000 shares of our common stock, at a public offering price of $15.00 per share, for aggregate gross proceeds of
$86.3&nbsp;million. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Financial Overview  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since commencing operations in 2015, we have devoted substantially all of our efforts and financial resources to organizing and staffing our
company, identifying business development opportunities, raising capital, securing intellectual property rights related to our product candidates, building and optimizing our manufacturing
capabilities and conducting discovery, research and development activities for our product candidates, discovery programs and FIND-IO platform. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have not generated any revenue from product sales and only limited revenue from other sources and, as a result, we have never been profitable and have incurred net losses since the
commencement of our operations. Our net losses for the years ended December&nbsp;31, 2018 and 2017 were $22.8&nbsp;million and $15.5&nbsp;million, respectively, and our net losses for the nine
months ended September&nbsp;30, 2019 and 2018 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>76</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=79,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=446266,FOLIO='76',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_77"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>were
$22.8&nbsp;million and 15.9&nbsp;million, respectively. As of September&nbsp;30, 2019, we had an accumulated deficit of $70.1&nbsp;million, primarily as a result of research and
development and general and administrative expenses. We do not expect to generate product revenue unless and until we obtain marketing approval for and commercialize a product candidate, and we cannot
assure you that we will ever generate significant revenue or profits. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have funded our operations to date primarily with proceeds from the sale of preferred stock, proceeds from our multi-year research collaboration and development agreement with Eli
Lilly and Company, or Lilly, and proceeds from our IPO. From our inception through September&nbsp;30, 2019, we received gross proceeds of $164.4&nbsp;million through private placements of
preferred stock and an upfront payment of $25.0&nbsp;million in connection with our agreement with Lilly, or the Lilly Agreement. In April 2018, we received gross proceeds of $31.0&nbsp;million
from the sale and issuance of shares of our Series&nbsp;A-3 Preferred Stock, and in November 2018, we received gross proceeds of $93.4&nbsp;million from the sale and issuance of shares of our
Series&nbsp;B Preferred Stock, including $15.0&nbsp;million from Lilly as described below. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2018, we entered into a multi-year research and development collaboration agreement with Lilly, or the Lilly Agreement, pursuant to which we will use our FIND-IO platform to
identify novel oncology targets for additional collaborative research and drug discovery by us and Lilly. Under this agreement, we granted Lilly the exclusive option to obtain worldwide exclusive
licenses to research, develop, manufacture and commercialize multiple compounds and products directed to oncology targets identified through our research collaboration. In addition, Lilly granted us
the exclusive option to
obtain worldwide exclusive licenses to research, develop, manufacture and commercialize an equal number of compounds and products directed to oncology targets for which Lilly does not exercise its
option. The Lilly Agreement will expire upon the earlier of the exercise of all options granted to Lilly or four years from the date of the agreement. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
received an upfront payment of $25.0&nbsp;million in cash and an equity investment of $15.0&nbsp;million from Lilly upon entering into the Lilly Agreement, and we are eligible for
quarterly research and development support payments during a portion of the term of the Lilly Agreement, option exercise payments and milestone payments in an aggregate of up to $1.4&nbsp;billion,
as well as mid to high single-digit royalty payments on net sales for all products directed to each target optioned by Lilly. The milestone payment amount assumes that Lilly exercises all of the
options available to it, as well as the successful achievement of all clinical development and sales milestones for each target optioned by Lilly pursuant to the Lilly Agreement. If Lilly obtains
approval in additional indications in different therapeutic areas, then additional amounts may become due. Upon our exercise of an option with respect to a given target, we will owe Lilly option
exercise, milestone and royalty payments in amounts equivalent to a portion of the amounts payable by Lilly were Lilly to exercise an option. For more information on the Lilly Agreement, see
"Business&#151;Our Collaboration Agreements&#151;Research and Development Collaboration with Lilly." We expect to recognize revenue from this agreement, including deferred revenue
included on our balance sheets as of December&nbsp;31, 2018 of $26.7&nbsp;million, which consists of the $25.0&nbsp;million upfront payment plus $1.7&nbsp;million attributed as a premium on
the proceeds from Lilly's investment in shares of our Series&nbsp;B-3 Preferred Stock, on a proportional performance basis over the term of the Lilly Agreement. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2015, we entered into a license agreement with Yale University, or the Yale Agreement, pursuant to which we obtained a license to products that either incorporate certain
licensed patents used in the discovery of targets or arise out of research and development of Dr.&nbsp;Chen's laboratory at Yale, including S15. We are obligated to pay Yale low single-digit
royalties on sales of products, including NC318, that are either covered by the patents licensed to us under the Yale Agreement or arise out of Dr.&nbsp;Chen's laboratory, subject to minimum annual
royalty payments in the low to mid hundreds of thousands of dollars. Until we are required to pay royalties under the Yale Agreement, we must also pay an annual license maintenance fee in the mid to
high tens of thousands of dollars. In addition, we are obligated to pay Yale milestone payments in an aggregate of up to approximately $3.0&nbsp;million per product. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>77</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=80,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=218064,FOLIO='77',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_78"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the Yale Agreement, we also entered into a corporate sponsored research agreement with Yale, or the SRA, in which we agreed to provide an aggregate of up to
$12.4&nbsp;million to fund a research program under the direction and supervision of Dr.&nbsp;Chen aimed at discovering new targets for immunomedicines. As of December&nbsp;31, 2018, we have
made payments in an aggregate of $7.4&nbsp;million under the SRA, including $2.5&nbsp;million in the year ended December&nbsp;31, 2018. Pursuant to the SRA, we have the option to add any patents
invented pursuant to the research program as a licensed
patent under the Yale Agreement and the right to obtain a royalty-bearing, exclusive, worldwide license to any such patents. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
May&nbsp;13, 2019, we closed our IPO, in which we sold 5,750,000 shares of common stock, at a public offering price of $15.00 per share, for aggregate gross proceeds of
$86.3&nbsp;million. The net offering proceeds to us were approximately $77.0&nbsp;million after deducting underwriting discounts and commissions of $6.0&nbsp;million and offering expenses of
$3.4&nbsp;million. See Note&nbsp;1 to our unaudited condensed financial statements included elsewhere in this prospectus for more information. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of September&nbsp;30, 2019, we had cash, cash equivalents and marketable securities, excluding restricted cash, of $184.1&nbsp;million. We believe that our existing cash, cash
equivalents and marketable securities, together with the net proceeds from this offering, will be sufficient to fund our planned operations into the first half of 2023. We have based this estimate on
assumptions that may prove to be incorrect, and we could use our available capital resources sooner than we currently expect. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
expect to incur substantial expenditures in the foreseeable future as we advance our product candidates through clinical development, the regulatory approval process and, if approved,
commercialization, and as we expand our pipeline through research and development activities related to our FIND-IO platform and discovery programs. Specifically, in the near term, we expect to incur
substantial expenses relating to our ongoing Phase&nbsp;1/2 clinical trial and planned Phase&nbsp;2 clinical trial of NC318, preclinical studies and our planned Phase&nbsp;1/2 clinical trial of
NC410 and other research and development activities. We expect to incur significantly increased costs as a result of operating as a public company, including significant legal, accounting, investor
relations and other expenses that we did not incur as a private company. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will need substantial additional funding to support our continuing operations and to pursue our development strategy. Until such time as we can generate significant revenue from sales
of our product candidates, if ever, we expect to finance our operations through a combination of public or private equity offerings, debt financings, marketing and distribution arrangements, other
collaborations, strategic alliances and licensing arrangements. Adequate funding may not be available to us on acceptable terms, or at all. If we fail to raise capital or enter into such agreements as
and when needed, we may be required to delay, limit, reduce or terminate preclinical studies, clinical trials, or other research and development activities or one or more of our development programs. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Components of Our Results of Operations  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenue  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the three and nine months ended September&nbsp;30, 2019, we recognized $1.6&nbsp;million and $4.3&nbsp;million, respectively, in
revenue under the Lilly Agreement. Through September&nbsp;30, 2019, we have not generated any revenue from product sales. Through December&nbsp;31, 2018, we had not generated any revenue from
product sales or otherwise. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
additional information about our revenue recognition policy, see Note&nbsp;2 to our audited financial statements and Note 2 to our unaudited condensed financial statements included
elsewhere in this prospectus. For the foreseeable future, we expect all of our revenue will be generated from the Lilly Agreement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>78</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=81,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=909567,FOLIO='78',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_79"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Operating Expenses  </I></B></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses consist primarily of costs incurred for our discovery efforts, research activities, development and testing of
our product candidates as well as for clinical trials, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> salaries, benefits and other related costs, including stock-based compensation, for personnel engaged in research and development functions; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> expenses incurred under agreements with third parties, including agreements with third parties that conduct research, preclinical activities or
clinical trials on our behalf, such as the SRA and the Yale Agreement; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> costs of outside consultants, including their fees, stock-based compensation and related travel expenses; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the costs of laboratory supplies and acquiring, developing and manufacturing preclinical study and clinical trial materials; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> facility-related expenses, which include direct depreciation costs and allocated expenses for rent and maintenance of facilities and other
operating costs. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
expense research and development costs as incurred. Our expenses related to clinical trials are based on actual costs incurred and estimates of other incurred costs. These estimated
costs are based on several factors, including patient enrollment and related expenses at clinical investigator sites, contract services received, consulting agreement costs and efforts expended under
contracts with research institutions and third-party contract research organizations that conduct and manage clinical trials on our behalf. We generally accrue estimated costs related to clinical
trials based on contracted amounts applied to the level of patient enrollment and other activity according to the protocol. If future timelines or contracts are modified based on changes in the
clinical trial protocol or scope of work to be performed, we would modify our estimates of accrued expenses accordingly on a prospective basis. Historically, any such modifications have not been
material. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due
to the early-stage nature of our programs and the discovery-related nature of our efforts, we do not track costs on a program-by-program basis other than costs incurred for the Lilly
Agreement. However, as our current and future product candidates proceed along a development path further in clinical trials, we intend to track the costs of each program. We measure costs incurred
under the Lilly Agreement as an input to recording revenue from the Lilly Agreement. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research
and development activities are central to our business model. We expect that our research and development expenses will continue to increase substantially for the foreseeable
future as we advance our product candidates through development, including conducting our ongoing Phase&nbsp;1/2 clinical trial of NC318, our planned Phase&nbsp;2 clinical trial in combination
with standard of care chemotherapies and preclinical studies and a Phase&nbsp;1/2 clinical trial of NC410, as we develop a complementary diagnostic for NC318 if we determine it is advisable, and as
we expand our current good manufacturing practice, or cGMP, manufacturing capacity, including to provide drug supply of NC318 for future clinical trials and as we expand our pipeline through research
and development activities related to our FIND-IO platform and discovery programs. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
cannot determine with certainty the duration and costs of future clinical trials of NC318, NC410 or any other product candidate we may develop or if, when or to what extent we will
generate revenue from the commercialization and sale of any product candidate for which we may obtain marketing approval. We may never succeed in obtaining marketing approval for any product
candidate. The duration, costs and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>79</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=82,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=472579,FOLIO='79',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_80"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>timing
of clinical trials and development of NC318, NC410 and any other product candidate we may develop will depend on a variety of factors, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the scope, progress, results and costs of clinical trials of NC318 and NC410, as well as of any future clinical trials of other product
candidates and other research and development activities that we may conduct; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> uncertainties in selection of indications, clinical trial design and patient enrollment rates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the probability of success for our product candidates, including safety and efficacy, early clinical data, competition, ease and ability of
manufacturing and commercial viability; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> significant and changing government regulation and regulatory guidance; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the timing and receipt of any development or marketing approvals, including the IND for NC410; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the expense of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
change in the outcome of any of these variables with respect to the development of a product candidate could lead to a significant change in the costs and timing associated with the
development of that product candidate. For example, if the FDA or another regulatory authority were to require us to conduct clinical trials beyond those that we anticipate will be required for the
completion of clinical development of a product candidate, or if we experience significant delays in our clinical trials due to patient enrollment or other reasons, we would be required to expend
significant additional financial resources and time to complete clinical development for any such product candidate. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General and Administrative Expenses  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses consist primarily of personnel-related costs, including payroll and stock-based compensation, for personnel
in executive, finance, human resources, business and corporate development and other administrative functions, professional fees for legal, intellectual property, consulting and accounting services,
rent and other facility-related costs, depreciation and other general operating expenses not otherwise classified as research and development expenses. General and administrative expenses also include
all patent-related costs incurred in connection with filing and prosecuting patent applications, which are expensed as incurred. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
anticipate that our general and administrative expenses will increase substantially during the next few years as a result of staff expansion and additional occupancy costs, as well as
costs associated with being a public company, including higher legal and accounting fees, investor relations costs, higher insurance premiums and other compliance costs associated with being a public
company. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Income, Net  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income, net consists primarily of interest income earned U.S. Treasury obligations and payment of interest on our term loan with a
commercial bank, or the Term Loan. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>80</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=83,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=58299,FOLIO='80',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_81"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Results of Operations  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comparison of the Three and Nine Months Ended September&nbsp;30, 2019 and 2018  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes our results of operations for the periods indicated (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:67%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"120%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="120%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="16pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Three Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Change </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Change </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue from research and development arrangement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,583</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,583</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,663</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,895</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,768</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>13,539</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,280</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,622</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>925</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,697</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,995</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,590</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,405 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loss from operations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,702</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,820</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3,882</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(25,472</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(16,129</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,343</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income, net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,268</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>110</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,158</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,662</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>192</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,470 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8,434</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(2,724</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,810</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,937</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(6,873</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenue from Research and Development Arrangement  </I></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenue was $1.6&nbsp;million and $0&nbsp;million for the three months ended September&nbsp;30, 2019 and 2018, respectively, and
$4.3&nbsp;million and $0&nbsp;million for the nine months ended September&nbsp;30, 2019 and 2018, respectively. The increase in revenue is related to the recognition of a portion of the upfront
consideration under the Lilly Agreement and the premium on the proceeds from Lilly's investment in shares of our Series&nbsp;B-3 Preferred Stock. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses for the three months ended September&nbsp;30, 2019 increased by $3.8&nbsp;million to $8.7&nbsp;million
compared to $4.9&nbsp;million for the three months ended September&nbsp;30, 2018. The increase was driven primarily by $1.5&nbsp;million in personnel-related costs due to an increase in
headcount. Other significant components of the increase in research and development expenses included $1.1&nbsp;million in lab supplies and services for NC318, NC410, other early-stage programs and
discovery activities and $0.5&nbsp;million in clinical research costs related to advancing NC318. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research
and development expenses for the nine months ended September&nbsp;30, 2019 increased by $9.3&nbsp;million to $22.8&nbsp;million compared to $13.5&nbsp;million for the
nine months ended September&nbsp;30, 2018. The increase was driven primarily by $2.5&nbsp;million in personnel-related costs due to an increase in headcount. Other significant components of the
increase in research and development expenses included the following: $2.3&nbsp;million in lab supplies and services for NC318, NC410, other early-stage programs and discovery activities;
$1.9&nbsp;million in clinical research costs related to advancing NC318; a $0.5&nbsp;million payment to Yale University in connection with the closing of our IPO; and $0.6&nbsp;million related
to depreciation expense. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General and Administrative  </I></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses for the three months ended September&nbsp;30, 2019 increased by $1.7&nbsp;million to $2.6&nbsp;million
as compared to $0.9&nbsp;million for the three months ended September&nbsp;30, 2018. The increase was driven primarily by increases, in connection with our IPO, of $0.6&nbsp;million for
professional fees related to legal, finance and audit services, public relations, compensation and investor relations </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>81</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=84,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=92316,FOLIO='81',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_82"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>support,
$0.5&nbsp;million in insurance expenses and $0.4&nbsp;million in personnel-related costs due to an increase in headcount. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General
and administrative expenses for the nine months ended September&nbsp;30, 2019 increased by $4.4&nbsp;million to $7.0&nbsp;million as compared to $2.6&nbsp;million for the
nine months ended September&nbsp;30, 2018. The increase was driven primarily by increases, in connection with our IPO, of $2.0&nbsp;million for professional fees related to legal, finance and
audit services, public relations, compensation and investor relations support, $0.8&nbsp;million in personnel-related costs due to an increase in headcount and $0.8&nbsp;million in insurance
expenses in connection with our IPO as well as $0.5&nbsp;million for an unrestricted gift to an academic lab. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Income, Net  </I></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income, net for the three months ended September&nbsp;30, 2019 increased by $1.2&nbsp;million to $1.3&nbsp;million from $110,000 for
the three months ended September&nbsp;30, 2018. The increase was driven primarily by interest income earned on higher cash balances, partially offset by interest expense related to the Term Loan. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
income, net for the nine months ended September&nbsp;30, 2019 increased by $2.5&nbsp;million to $2.7&nbsp;million from $192,000 for the nine months ended September&nbsp;30,
2018. The increase was driven primarily by interest income earned on higher cash balances, partially offset by interest expense related to the Term Loan. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comparison of the Years Ended December&nbsp;31, 2018 and 2017  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes our results of operations for the periods indicated (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Change </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating expenses:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19,787</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12,954</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,833</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,409</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,595</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>814 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loss from operations</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(23,196</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(15,549</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(7,647</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income, net</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>397</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>80</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>317 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(22,799</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(15,469</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(7,330</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses for the year ended December&nbsp;31, 2018 increased by $6.8&nbsp;million to $19.8&nbsp;million compared
to $13.0&nbsp;million for the year ended December&nbsp;31, 2017. The increase was driven primarily by $2.7&nbsp;million of increased expenses for product development and clinical research costs,
which related to advancing NC318 through IND-enabling activities, the initiation of our Phase&nbsp;1/2 clinical trial of NC318 in patients with advanced or metastatic solid tumors, clinical material
production costs, commencement of NC410 preclinical studies and advancement of our
other early-stage programs and discovery activities, including payments pursuant to the SRA and other sponsored research agreements. Other significant components of the increase in research and
development expenses, each as a result of increased product development and clinical research costs, included the following: research and development compensation expense by $2.0&nbsp;million;
reflecting higher headcount; depreciation and amortization expense by $1.1&nbsp;million; lab supplies and services by $0.7&nbsp;million; facility-related expenses by $0.3&nbsp;million; and
research and development license costs by $0.1&nbsp;million. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>82</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=85,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=546845,FOLIO='82',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_83"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General and Administrative  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses for the year ended December&nbsp;31, 2018 increased by $0.8&nbsp;million to $3.4&nbsp;million as
compared to $2.6&nbsp;million for the year ended December&nbsp;31, 2017. The increase was driven primarily by an increase of $0.2&nbsp;million in personnel-related costs due to an increase in
headcount and an increase of $0.3&nbsp;million for professional fees related to legal and audit services. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Income, Net  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income, net for the year ended December&nbsp;31, 2018 increased by $0.3&nbsp;million to $0.4&nbsp;million from $80,000 for the year
ended December&nbsp;31, 2017. The increase was driven primarily by interest income earned on the proceeds of our Series&nbsp;A and B Preferred Stock financing, partially offset by interest expense
related to the Term Loan. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Liquidity and Capital Resources  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have financed our operations primarily through private placements of preferred stock, proceeds pursuant to the Lilly Agreement and our IPO.
On May&nbsp;13, 2019, we closed our IPO in which we sold 5,750,000 shares of common stock, at a public offering price of $15.00 per share, for aggregate gross proceeds of $86.3&nbsp;million. The
net offering proceeds to us were approximately $77.0&nbsp;million after deducting underwriting discounts and commissions of $6.0&nbsp;million and offering expenses of $3.4&nbsp;million. Since
inception, we have received aggregate gross proceeds of $164.4&nbsp;million from the sale and issuance of shares of our preferred stock. In addition, in November 2018, we received an upfront payment
of $25.0&nbsp;million in cash from Lilly pursuant to the Lilly Agreement. Our cash and cash equivalents are held in money market funds. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of September&nbsp;30, 2019, our principal source of liquidity was cash, cash equivalents and marketable securities of $184.1&nbsp;million. We believe that the net proceeds from
this public offering, together with our existing cash, cash equivalents and marketable securities, will be sufficient to fund our planned operations into the first half of 2023. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, in April 2016, we entered into the Term Loan to finance laboratory equipment purchases. In January 2019, we amended the Term Loan to increase our borrowing capacity from
$1.0&nbsp;million to $5.0&nbsp;million. As amended, the Term Loan matures in January 2023. Our obligations under the Term Loan are secured by a security interest in our certificates of deposit,
money market accounts, cash, securities, investment property and deposit or investment accounts. The Term Loan bears interest at a rate equal to the greater of (i)&nbsp;the prime rate less 1.0% and
(ii)&nbsp;4.25% and is subject to mandatory prepayment upon the occurrence of specified events, including failure to pay the Term Loan when due, uncured breach, bankruptcy or dissolution. Under the
Term Loan, we will make interest-only payments through January 2020 and 36 equal monthly payments of principal plus accrued interest thereafter through January 2023. As of September&nbsp;30, 2019,
our outstanding borrowings under the Term Loan were $5.0&nbsp;million. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will continue to require additional capital to develop our product candidates and fund operations for the foreseeable future. We may seek to raise capital through sale of equity, debt
financings, strategic alliances and licensing arrangements. Adequate additional funding may not be available to us on acceptable terms or at all. If we fail to raise capital or enter into such
agreements as and when needed, we may have to significantly delay, scale back or discontinue the development of our product candidates or delay our efforts to expand our pipeline of product
candidates. We anticipate that we will need to raise substantial additional capital, the requirements of which will depend on many factors, including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the scope, progress, results and costs of researching and developing NC318, NC410 and our other programs, including targets identified through
our FIND-IO platform, and of conducting preclinical studies and clinical trials; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>83</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=86,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=697611,FOLIO='83',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_84"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the timing of, and the costs involved in, obtaining marketing approvals for NC318, NC410 and any future product candidates we develop, if
clinical trials are successful; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the success of our collaboration with Lilly, including whether Lilly exercises its licensing options under its collaboration agreement with us,
each of which would trigger additional payments to us; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the costs of manufacturing NC318, NC410 and any future product candidates we develop for preclinical studies and clinical trials in preparation
for marketing approval and commercialization; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the costs of commercialization activities, including marketing, sales and distribution costs, for NC318, NC410 and any future product
candidates we develop, whether alone or with a collaborator, if any such product candidates are approved for sale, including marketing, sales and distribution costs; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the success of our SRA with Yale; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our ability to establish and maintain additional collaborations, licenses or other arrangements on favorable terms, if at all; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the costs involved in preparing, filing, prosecuting, maintaining, expanding, defending and enforcing patent claims, including litigation costs
and the outcome of any such litigation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> our current collaboration and license agreements remaining in effect and our achievement of milestones and the timing and amount of milestone
payments we are required to make, or that we may be eligible to receive, under those agreements; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the timing, receipt and amount of sales of, or royalties on, our future products, if any; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the emergence of competing therapies and other adverse developments in the oncology market. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us additional covenants
that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments and engage in certain merger,
consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. If we are unable to raise additional
funds when needed, we may be required to delay, reduce or terminate some or all of our development programs and clinical trials. We may also be required to sell or license to others rights to our
product candidates in certain territories or indications that we would prefer to retain for ourselves. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See
the section entitled "Risk Factors" for additional risks associated with our substantial capital requirements. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash Flows  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth the primary sources and uses of cash and cash equivalents for each of the periods presented below (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net cash provided by (used in):</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(25,632</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(14,479</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,992</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(12,514</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Investing activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(176,762</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1,159</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,063</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(8,652</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Financing activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>81,735</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>30,686</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>121,417</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>24,860 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net (decrease) increase in cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(120,659</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15,048</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>126,346</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,694 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>84</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=87,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=183957,FOLIO='84',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_85"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash Used in Operating Activities  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities was $25.6&nbsp;million for the nine months ended September&nbsp;30, 2019, which was primarily due to
our net loss of $22.8&nbsp;million. Net cash used in operating activities was $14.5&nbsp;million for the nine months ended September&nbsp;30, 2018, which was primarily due to our net loss of
$15.9&nbsp;million in connection with our research and development activities, partially offset by timing of cash payments. The amount of cash used in operating activities in any period is
influenced by the timing of cash payments for research-related expenses. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net
cash provided by operating activities was $8.0&nbsp;million for the year ended December&nbsp;31, 2018, which was primarily due to deferred revenue, including the
$25.0&nbsp;million upfront payment pursuant to the Lilly Agreement, as well as a non-cash charge for depreciation and amortization and the timing of cash payments, partially offset by our net loss
of $22.8&nbsp;million as we continued our research and development activities. Net cash used in operating activities was $12.5&nbsp;million for the year ended December&nbsp;31, 2017, which was
primarily due to our net loss of $15.5&nbsp;million in connection with our research and development activities, partially offset by a $1.6&nbsp;million increase in accrued liabilities caused by
the growth of our business as well as timing of cash payments. The amount of cash used in operating activities in any period is influenced by the timing of cash payments for research-related expenses. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash Used in Investing Activities  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash used in investing activities for the nine months ended September&nbsp;30, 2019 was $176.8&nbsp;million, which was primarily due to the
purchase of marketable securities. Cash used in investing activities for the nine months ended September&nbsp;30, 2018 was $1.2 million, which consisted in each case primarily of purchases of
property and equipment. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash
used in investing activities for the years ended December&nbsp;31, 2018 and 2017 was $3.1&nbsp;million and $8.7&nbsp;million, respectively, which consisted in each case
primarily of purchases of laboratory equipment. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash Provided by Financing Activities  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash provided by financing activities was $81.7&nbsp;million for the nine months ended September&nbsp;30, 2019, which consisted primarily of
net proceeds from the Company's public offering. Cash provided by financing activities was $30.7&nbsp;million for the nine months ended September&nbsp;30, 2018, which consisted of gross proceeds
from the sale and issuance of shares of our Series&nbsp;A-3 Preferred Stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash
provided by financing activities was $121.4&nbsp;million for the year ended December&nbsp;31, 2018, which consisted primarily of net proceeds from the issuance and sale of
shares of our Series&nbsp;A and B Preferred Stock, partially offset by issuance costs, deferred offering costs and payments under the Term Loan. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash
provided by financing activities was $24.9&nbsp;million for the year ended December&nbsp;31, 2017, which consisted primarily of net proceeds from the issuance and sale of shares
of our Series&nbsp;A Preferred Stock, partially offset by payments under the Term Loan. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Contractual Obligations and Commitments  </B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes our contractual obligations as of December&nbsp;31, 2018 (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Payments Due by Period </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Less than<BR>
1 Year </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>1&nbsp;-&nbsp;3<BR>
Years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>3&nbsp;-&nbsp;5<BR>
Years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>More Than<BR>
5 Years </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Long-term debt obligations</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>387</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>460</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating lease obligations</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>325</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>625</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>690</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>635</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,275 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>712</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>698</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>690</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>635</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,735 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>85</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=88,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=701701,FOLIO='85',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_86"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
had operating lease obligations consisting of an operating lease for our corporate headquarters, which includes both office and laboratory space, for approximately 25,000 square feet
as of December&nbsp;31, 2018. The term of the lease commenced in February 2016 and expires in August 2025. Under the terms of the lease as of December&nbsp;31, 2018, we will have lease obligations
aggregating $2.3&nbsp;million through 2025. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
contractual obligations table does not include any potential contingent payments upon the achievement by us of clinical, regulatory and commercial events, as applicable, or royalty
payments that we may be required to make under license agreements we have entered into with various entities pursuant to which we have in-licensed intellectual property, including our license
agreements with Lilly and Yale and our SRA with Yale. We excluded the contingent payments given that the timing and amount (if any) of any such payments cannot be reasonably estimated at this time.
See "Business&#151;Our Collaboration Agreements" for additional information. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
enter into contracts in the normal course of business with third-party contract organizations for clinical trials, non-clinical studies and testing, manufacturing and other services
and products for operating purposes. These contracts generally provide for termination following a certain period after notice, and therefore we believe that our non-cancelable obligations under these
agreements are not material. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
have been no material changes outside the ordinary course of business to our contractual obligations during the nine month period ended September&nbsp;30, 2019, as compared to
those set forth above. See Notes&nbsp;6 and 7 to our unaudited condensed financial statements included elsewhere in this prospectus for a discussion of our leases and the Term Loan, respectively. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Critical Accounting Policies, Significant Judgments and Use of Estimates  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our financial statements have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of our financial
statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial
statements, as well as the reported expenses incurred during the reporting periods. The most significant assumptions used in the financial statements are the underlying assumptions used in revenue
recognition and valuing share-based
compensation, including the fair value of our common stock in periods before our IPO. Our estimates are based on our historical experience and on various other factors that we believe are reasonable
under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. We evaluate our
estimates and assumptions on an ongoing basis. Actual results may differ from these estimates under different assumptions or conditions. We believe that the accounting policies discussed below are
critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management's judgments and estimates. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
our significant accounting policies are described in the notes to our financial statements, we believe that the following critical accounting policies are most important to
understanding and evaluating our reported financial results. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenditures, including payroll, contractor expenses and supplies, for research and development of product candidates are expensed as incurred.
Development costs incurred by third parties are expensed as the contracted work is performed. Where contingent milestone payments are due to third parties under research and development arrangements,
the milestone payment obligations are expensed when the milestone results are probable of being achieved. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>86</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=89,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=204457,FOLIO='86',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_87"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock-Based Compensation  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We account for stock-based compensation, including stock options and restricted stock units, based on the fair value of the award as of the
grant date. We utilize the Black-Scholes option-pricing model as the method for estimating the fair value of our stock option grants. The Black-Scholes option-pricing model requires the use of highly
subjective and complex assumptions, including the options' expected term and the price volatility of the underlying stock. The fair value of the portion of the award that is ultimately expected to
vest is recognized as compensation expense over the award's requisite service period. We recognize stock-based compensation to expense using the straight-line method. If there are any modifications or
cancelations of stock-based awards, we may be
required to accelerate, increase or decrease any remaining unrecognized stock-based compensation expense. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based
compensation expense, net of estimated forfeitures, is reflected in the statements of operations and comprehensive loss as follows (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development expense</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>182</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>41</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative expense</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>342</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>178</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>90 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total stock-based compensation expense</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>524</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>90</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>263</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>75 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of September&nbsp;30, 2019, total unamortized stock-based compensation was $7,365,199. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
intrinsic value of all outstanding stock options as of September&nbsp;30, 2019 was $55.3&nbsp;million. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Common Stock Valuations  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Before our IPO, there was no public market for our common stock to date and the estimated fair value of our common stock was determined by our
board of directors as of the date of each option grant, with input from management, considering our most recently available third-party valuations of common stock, and our board of directors'
assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most
recent valuation through the date of the grant. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants'
Accounting and Valuation Guide, </FONT><FONT SIZE=2><I>Valuation of Privately-Held-Company Equity Securities Issued as Compensation</I></FONT><FONT SIZE=2>. Our common stock valuations were prepared
using an option pricing method, or OPM, which used market approaches to estimate our enterprise value. The OPM treats common stock and preferred stock as call options on the total equity value of a
company, with exercise prices based on the value thresholds at which the allocation among the various holders of a company's securities changes. Under this method, the common stock has value only if
the funds available for distribution to stockholders exceeded the value of the preferred stock liquidation preferences at the time of the liquidity event, such as a strategic sale or a merger. A
discount for lack of marketability of the common stock is then applied to arrive at an indication of value for the common stock. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
the closing of our IPO, our board of directors has determined the fair value of our common stock based on the closing price of our common stock on the Nasdaq Global Select Market
as reported on the date of grant. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Income Taxes  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We use the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated
future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and
liabilities, which relate primarily to the carrying amount of our property and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>87</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=90,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=524957,FOLIO='87',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<A NAME="page_dq70301_1_88"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>equipment
and our net operating loss carryforwards, are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be
recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax
assets where, based upon the available evidence, management concludes that it is more likely than not that the deferred tax assets will not be realized. In evaluating our ability to recover deferred
tax assets, we consider all available positive and negative evidence, including our operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction
basis. Because of the uncertainty of the realization of deferred tax assets, we have recorded a full valuation allowance against our deferred tax assets. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reserves
are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more likely than not to be
sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the
provision of income taxes; however, we currently have no interest or penalties related to uncertain income tax benefits. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2018, our gross deferred tax assets were $15.8&nbsp;million. Due to our lack of earnings history and uncertainties surrounding our ability to generate future
taxable income, the net deferred tax assets have been fully offset by a valuation allowance. The deferred tax assets were primarily comprised of federal and state tax net operating losses, or NOLs.
Utilization of NOLs may be limited by the "ownership change" rules, as defined in Section&nbsp;382 of the Internal Revenue Code of 1986, as amended. Similar rules may apply under state tax laws. Our
ability to use our remaining NOLs may be further limited if we experience an ownership change in connection with this offering, future offerings or as a result of future changes in our stock
ownership. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Off-Balance Sheet Arrangements  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since our inception, we have not engaged in any off-balance sheet arrangements, as defined in the rules and regulations of the U.S. Securities
and Exchange Commission. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


JOBS Act Accounting Election  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Jumpstart Our Business Startups Act of 2012, or the JOBS Act, permits an "emerging growth company" such as us to take advantage of an
extended transition period to comply with new or revised accounting standards applicable to public companies. We have elected to take advantage of this extended transition period to enable us to
comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (i)&nbsp;are no longer an emerging growth
company or (ii)&nbsp;affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that
comply with new or revised accounting pronouncements as of public company effective dates. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
so long as we remain an emerging growth company, we are permitted and intend to rely on certain exemptions from various public company reporting requirements, including not being
required to have our internal control over financial reporting audited by our independent registered public accounting firm pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act of 2002. We will
remain an emerging growth
company until the earliest of (i)&nbsp;December&nbsp;31, 2024, (ii)&nbsp;the last day of the first fiscal year in which we have total annual gross revenues of at least $1.07&nbsp;billion,
(iii)&nbsp;the last day of the first fiscal year in which the market value of our common stock that is held by non-affiliates exceeds $700.0&nbsp;million on June&nbsp;30th&nbsp;and
(iv)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in non-convertible debt securities during the prior three-year period. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recent Accounting Pronouncements  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Note&nbsp;2 to our unaudited condensed financial statements included elsewhere in this prospectus. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>88</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=13,SEQ=91,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=522859,FOLIO='88',FILE='DISK125:[19ZCO1.19ZCO70301]DQ70301A.;33',USER='JTAYLORA',CD='12-NOV-2019;14:48' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_ds70301_1_89"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ds70301_business"> </A>
<A NAME="toc_ds70301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  BUSINESS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer
and other immune-related diseases by restoring normal immune function. We view the immune system holistically and, rather than target one specific immune cell type, we focus on understanding
biological pathways, the interactions of cells and the role each interaction plays in an immune response. Through our proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or
FIND-IO, platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. We are
focused on patients who do not respond to current therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies. We are
committed to discovering and developing first-in-class immunomedicines, which are immunomedicines that use new or unique mechanisms of action to treat a medical condition, for these patients. Our lead
product candidate, NC318, is a first-in-class immunomedicine targeting a novel immunomodulatory receptor called Siglec-15, or S15. In October 2018, we initiated a Phase 1/2 clinical trial of NC318 in
patients with advanced or metastatic solid tumors. We completed enrollment of the Phase&nbsp;1 portion of this trial in August 2019 and preliminary data from the Phase&nbsp;1 portion was presented
in November 2019 at the Society for Immunotherapy of Cancer, or SITC, annual meeting. We began enrolling patients in the Phase&nbsp;2 portion of the trial in October&nbsp;2019 and expect to
announce initial data from the Phase&nbsp;2 portion by the end of 2020. Our second product candidate, NC410, is a novel immunomedicine designed to block immune suppression mediated by an immune
modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1, or LAIR-1. We expect to submit an investigational new drug application, or IND, to the U.S. Food and Drug Administration, or FDA,
for NC410 in the first quarter of 2020. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
approach to identifying targets for new immunomedicines is based on our FIND-IO platform. FIND-IO embodies a rational approach to the discovery of novel cell surface and secretory
molecules that drive functional immune responses. We use our immunology knowledge, experience, capabilities and tools we have developed, including our FIND-IO platform, to support our discovery
efforts. We are working to discover novel targets that play a key role in mediating immune dysfunctions that allow tumors to evade the immune system. We are seeking to identify and develop
immunomedicines that counteract these outcomes and to further validate and advance our product candidates. We have identified multiple novel targets using our FIND-IO platform, including those for
which certain of our research programs are being designed to target. In addition, the immunosuppressive properties of S15, the target of NC318, were discovered using a predecessor of our FIND-IO
platform. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NC318,
our lead immunomedicine program, is a monoclonal antibody targeting S15, which is expressed on highly immunosuppressive cells called M2 macrophages and on tumor cells. The
immunosuppressive properties of S15 were discovered in 2015 at Yale University by our scientific founder Dr.&nbsp;Lieping Chen. Dr.&nbsp;Chen was also the first to discover a molecule he called
B7-H1, which is now more widely known as PD-L1, or programmed cell death protein ligand 1, which is the ligand for PD-1, or programmed cell death 1. In preclinical research, we and others have
observed that S15 promotes suppression of T&nbsp;cell proliferation and negatively regulates T&nbsp;cell function. NC318 is designed to block this S15-mediated immune suppression and restore
T&nbsp;cell function and anti-tumor immunity in the tumor microenvironment, or TME, which we believe will reduce and kill tumors. We believe NC318 has the
potential to treat multiple cancer indications because S15 is expressed in multiple tumor types and has a unique ability to modulate immune responses in the TME. In addition, because S15 and PD-L1
expression in tumors generally appear to be non-overlapping, we believe NC318 may be well suited to treat patients who are not responding to PD-1/PD-L1 directed cancer therapies. We are initially
evaluating NC318 for the treatment of advanced or metastatic solid tumors, including ovarian cancer, non-small cell lung cancer, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>89</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=92,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=366956,FOLIO='89',FILE='DISK125:[19ZCO1.19ZCO70301]DS70301A.;24',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ds70301_1_90"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>or
NSCLC, head and neck squamous cell carcinoma, or HNSCC, and triple-negative breast cancer, or TNBC. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NC410,
our second immunomedicine program, is a fusion protein designed to block immune suppression mediated by LAIR-1. LAIR-1 is expressed on T cells and antigen-presenting cells, known
as dendritic cells, that present tumor antigens to immune cells in order to generate immune responses. The binding of LAIR-1 to collagen or C1q results in loss of immune function in the TME and a
reduction in T&nbsp;cell function and dendritic cell activity. By blocking the binding of LAIR-1, NC410 can promote T&nbsp;cell function and dendritic cell activity, which could result in
anti-tumor immune responses that eliminate cancer cells. We are currently conducting IND-enabling studies for NC410 and expect to submit an IND and initiate a Phase 1/2 clinical trial in patients with
advanced or metastatic solid tumors in the first quarter of 2020. We are currently focused on opportunities for NC410 in ovarian cancer, NSCLC and renal cancer. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
advancement of cancer to late stages indicates a failure of the immune system to mount an effective anti-tumor immune response. Immuno-oncology, which focuses on stimulating the
immune system to respond to cancer and includes checkpoint inhibitors targeting PD-L1, PD-1 and cytotoxic T-lymphocyte antigen-4, or CTLA-4, is one of the most significant advances in the history of
cancer treatment. In 2011, the first checkpoint inhibitor was approved, and today, despite only a modest breadth of efficacy, this class of therapies is estimated to have had global sales of more than
$17&nbsp;billion in 2018 and is predicted to reach more than $33&nbsp;billion in global sales by 2022. However, despite the recent success of checkpoint inhibitors, efficacy has been limited. It
is estimated that up to 60% to 70% of cancer patients, including those with melanoma, renal cell cancer, colorectal cancer, NSCLC, urothelial cancer and HNSCC, do not respond to single-agent therapy
with checkpoint inhibitors. In addition, some patients develop resistance after initial treatment with these therapies. As a result, the standard of care in cancer today leaves many patients
underserved. We believe broader efficacy and more meaningful clinical responses in oncology may be obtained by focusing on the TME. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are using our FIND-IO platform as our discovery engine to identify targets and develop immunomedicines that restore normal immune function in the TME through novel mechanisms of
action. Since our founding in 2015, we have developed, industrialized and optimized our FIND-IO platform based on the immunological expertise of our management team and the scientific leadership of
Dr.&nbsp;Chen. Our approach in creating the FIND-IO platform, and how we apply it, reflects our belief
in the importance of understanding biological pathways of all cells in the immune system and restoring normal immune function. The platform uses our proprietary approaches to assess the suppressive or
stimulatory function of immune pathways in T cells and other immune cells, as measured by effects on proliferation or induction of molecules known to impact immune responses, such as cytokines, which
are signaling molecules secreted by cells in the immune system that mediate and regulate immunity and inflammation. We study primary immune cells from healthy donors and from patients with various
diseases, as well as established cell lines from immune and non-immune cell lineages, including T cell subsets, monocytes, macrophage subpopulations and cancer cell lines. In oncology, we are using
the FIND-IO platform to discover immunomedicines with the potential to intervene or modulate interactions of immune cells within the TME to restore anti-tumor activity. We are also expanding the
functional screening approach of our FIND-IO platform for the identification of novel targets in other serious illnesses outside of oncology, including autoimmune, inflammatory and neuro-inflammatory
diseases. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2018, we entered into a multi-year collaboration agreement with Eli Lilly and Company, or Lilly, focused on the discovery and development of immunomedicines for oncology
using our FIND-IO platform. The collaboration seeks to discover novel cancer targets utilizing our platform and provides that we and Lilly will each receive options to exclusively develop antibodies
resulting from the collaboration. In connection with the agreement, or the Lilly Agreement, we received an upfront payment of $25.0&nbsp;million in cash and an equity investment of
$15.0&nbsp;million and are eligible to receive development and regulatory milestones and sales milestones in an aggregate of up to $1.4&nbsp;billion, as well as royalty payments. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>90</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=93,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=194251,FOLIO='90',FILE='DISK125:[19ZCO1.19ZCO70301]DS70301A.;24',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ds70301_1_91"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have assembled an experienced management team to execute on our mission to create novel immunomedicines. Our scientific founder and members of our management team collectively have
extensive experience in drug discovery and product development and are leaders in the immuno-oncology field. Members of our management team have experience discovering, developing, manufacturing and
commercializing biologics, including some of the earliest approved monoclonal antibodies, such as Synagis, as well as some of the first immune checkpoint inhibitor monoclonal antibodies and fusion
proteins targeting the PD-1/PD-L1 pathway and CTLA-4, including Yervoy. Within three years, we advanced our company from formation to antibody generation to the clinic and constructed a manufacturing
facility that complies with current good manufacturing practice, or cGMP, and that we have used to manufacture our preclinical and clinical drug supply. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Members
of our management team have a longstanding relationship with our scientific founder Dr.&nbsp;Chen, who is the United Technologies Corporation Professor in Cancer Research and
Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology) at Yale, and the Co-Director of the Cancer Immunology Program at Yale Cancer Center. Dr.&nbsp;Chen was the first to
discover PD-L1, and to show that it is expressed by multiple tumor types and its activity can cause the death of T cells, preventing those T cells from eliminating cancer cells. He also showed that
blocking the interaction between PD-1 and PD-L1 with monoclonal antibodies improved the immune system's ability to
eliminate tumors. Dr.&nbsp;Chen's work provided an important foundation for the subsequent development of immunotherapies that enable more effective immune treatments against cancer. Since then, his
laboratory has identified and characterized various molecules in two of the major families of immune modulating proteins, the B7-CD28 and the tumor necrosis factor, or TNF, receptor/ligand
superfamilies, and elucidated their interactions and functions in controlling immune responses. The immunosuppressive properties of S15, the target of our lead product candidate, NC318, were
discovered in Dr.&nbsp;Chen's lab using a predecessor of our FIND-IO platform. We continue to collaborate with Dr.&nbsp;Chen on discovering novel immunomedicines through an exclusive sponsored
research agreement with Yale. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe the combination of our team's capabilities and focus on understanding the biological pathways of the immune system, our product development expertise and manufacturing
infrastructure, our partnership with Lilly and our relationship with Dr.&nbsp;Chen and Yale positions us to build a sustainable portfolio of first-in-class immunomedicines. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>91</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=3,SEQ=94,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=926460,FOLIO='91',FILE='DISK125:[19ZCO1.19ZCO70301]DS70301A.;24',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ds70301_1_92"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Pipeline  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are leveraging our understanding of biological pathways and our FIND-IO platform to discover, validate and build a proprietary pipeline of
immunomedicine candidates. The figure below details our pipeline of product candidates and principal discovery and research programs. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g827084.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="367">
  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Strategy  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our strategy is to use our fully integrated discovery and product development infrastructure to build a sustainable pipeline of product
candidates to treat cancer patients who are not adequately served by currently available therapies. The key elements of our strategy include: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2><B><I> Advancing the clinical development of our lead product candidates, NC318 and
NC410.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;In October 2018, we initiated a Phase 1/2 clinical trial evaluating NC318 in patients with advanced or metastatic solid tumors. We
completed enrollment of the Phase&nbsp;1 portion of this trial in August 2019 and preliminary data from the Phase&nbsp;1 portion was presented at the SITC annual meeting in November&nbsp;2019.
We began enrolling patients in the Phase&nbsp;2 portion of the trial in October&nbsp;2019 and expect to announce initial data from the Phase&nbsp;2 portion by the end of 2020. In the first half
of 2020, we intend to initiate a Phase 2 clinical trial to evaluate NC318 in combination with standard of care chemotherapies in patients with advanced or metastatic solid tumors. For NC410, we are
currently conducting IND-enabling studies, with the expectation of submitting an IND and initiating a Phase 1/2 clinical trial in the first quarter of 2020. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2><B><I>Building an oncology pipeline of novel targets for new immunomedicines focused on
non-responders</I></B></FONT><FONT SIZE=2>. We are leveraging our immunological expertise and our FIND-IO platform to identify novel targets relevant to overcoming immune suppression. We believe our
relationship with Lilly will promote the efficient development of antibodies for novel cancer targets identified using our FIND-IO platform. In addition to our internal discovery efforts, we also
expect to leverage our relationship with Dr.&nbsp;Chen's laboratory at Yale for the discovery of additional targets for immunomedicines. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2><B><I>Leveraging our fully integrated development, quality systems and cGMP manufacturing
capabilities.</I></B></FONT><FONT SIZE=2> Our approach is to integrate key aspects of product development within our organization. We have </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>92</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=95,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=603935,FOLIO='92',FILE='DISK125:[19ZCO1.19ZCO70301]DS70301A.;24',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ds70301_1_93"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>assembled
a team with extensive experience in identifying, characterizing and developing novel immunomedicines. We seek to couple discovery of important targets with the capability to rapidly
streamline target validation and conduct key IND-enabling studies, leading to clinical development of lead candidates. Our purpose-built, dedicated, state-of-the-art cGMP manufacturing facility
utilizes single-use technology to support development of our pipeline and advancement of our product candidates into and through clinical development. The facility has an initial production capacity
of 1,000 liters with additional room for expansion and is designed to operate as a multi-product facility. Compared to working with third-party manufacturers, we believe our facility provides better
quality assurance, greater control in scheduling and prioritizing manufacturing activities and enhanced capital efficiency. </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2><B><I>Expanding our current focus and creating new opportunities outside of the oncology field, including through strategic
partnerships</I></B></FONT><FONT SIZE=2>. While our primary focus is oncology, the functional screening approach and proprietary technology of our FIND-IO platform are broadly applicable to the
identification of positive and negative immune modulators, and therefore can be used and expanded to discover novel targets in other inflammatory diseases. Our goal is to enable next-generation
immunomedicines for other serious inflammatory diseases with significant unmet medical needs in fields beyond oncology. For example, we are developing our FIND-AI platform, a new platform focused on
discovery efforts in autoimmunity and inflammation. We expect to explore a variety of alternatives for our platforms and future product candidates outside of oncology, including the pursuit of
strategic partnerships. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Immuno-Oncology Background  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The immune system has powerful biological mechanisms to defend and protect the body from pathogens, such as viruses, parasites and bacteria. It
also provides surveillance against cancers by recognizing and responding to antigens that are uniquely or highly expressed on cancer cells. In cancer, complex interactions between immune cells and
growing tumor cells can prevent an immune response by blocking cellular interactions, resulting in immunosuppression in the TME. This phenomenon, referred to as immune evasion, is a hallmark of cancer
where the tumor can prevent tumor-specific immune cells called T cells from functioning within the TME or gaining access to the tumor site, which allows the tumor to continue to grow, leading to
disease progression. Tumors in
advanced cancer have multiple mechanisms of evasion in the TME that can differ from tumor to tumor. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
TME is the cellular environment in which the tumor exists and encompasses the surrounding blood vessels, a variety of immune cells, fibroblasts, bone marrow-derived inflammatory
cells, lymphocytes, signaling molecules and the extracellular matrix, or ECM. Immune cell types in the TME include T cells, natural killer, or NK, cells, dendritic cells, macrophages, suppressive
myeloid cells and neutrophils. The tumor and the surrounding microenvironment interact constantly. Tumors and immune cells can express co-inhibitory proteins known as checkpoints that lead to immune
tolerance by the tumor and/or immune cells, allowing the tumor to grow by evading the host immune response. In addition to modulating immune function, immune cells in the TME can also promote a
pro-tumorigenic environment that fosters the growth and evolution of cancer cells. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Remodeling
the TME and overcoming its immunosuppressive properties is a major focus of cancer research and drug development. Checkpoint inhibitors are a drug class designed to counteract
certain tumor defenses against the immune system. Currently approved checkpoint inhibitors were developed for the treatment of cancer based on the belief that inactivation of the immune system by
checkpoints could be reversed to reactivate the immune system to recognize and attack the tumor. Therapies against checkpoints, such as PD-L1, PD-1 and CTLA-4, have produced impressive results in the
clinic across an array of cancers and have been approved for several malignancies. However, despite the recent success of these checkpoint inhibitors, efficacy has been limited. It is estimated that
up to 60% to 70% of cancer patients, including those with melanoma, renal cell cancer, colorectal cancer, NSCLC, urothelial cancer </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>93</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=96,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=125013,FOLIO='93',FILE='DISK125:[19ZCO1.19ZCO70301]DS70301A.;24',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ds70301_1_94"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>and
HNSCC, do not respond to single-agent therapy with checkpoint inhibitors. Many of the patients who are non-responders possess so called "cold" tumors that do not contain meaningful numbers of T
cells that recognize their tumors. In addition, some patients develop resistance after initial treatment with these checkpoint inhibitors. This limited efficacy highlights the importance of our effort
to identify novel targets and molecular pathways responsible for tumor immune evasion mechanisms that we believe will work independently from current targets for cancer immunotherapy. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Approach to Developing Immunomedicines for Cancer  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our approach to identifying targets for new immunomedicines in cancer is based on the combination of our FIND-IO platform, our immunological
expertise and our belief in the
importance of understanding biological pathways and the normal function of the immune system in the TME. Rather than focusing on a specific type of immune cell, we are targeting molecules that
modulate the immune system in ways that we believe may provide new treatment opportunities for patients that are differentiated from currently marketed targeted therapies as well as those in
development. Our primary goal is to develop immunomedicines that increase response rates, efficacy and durable overall survival among patients who do not respond to current therapies, patients whose
cancer progresses despite treatment and patients with cancer types that are not adequately addressed by currently available therapies. We design our product candidates either to restore the normal
effects of the immune system to promote elimination of the tumors or to counteract tumor immune evasion mechanisms. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
FIND-IO platform applies a function-based screening approach to identify human proteins and to determine whether those proteins alter or stop an immune response resulting in immune
evasion. The platform is designed to identify novel cell surface molecular interactions that drive functional immune responses. Our FIND-IO platform broadly and quantitatively evaluates interactions
between relevant protein components and different cellular types over time in order to identify novel targets that either increase or decrease immune-related functional responses associated with
desired immune responses against tumors. By identifying novel immune modulators through the FIND-IO platform, we aim to develop next-generation immunomedicines that restore normal immune function in
the TME. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
create our FIND-IO platform, we industrialized, expanded and optimized the T Cell Activity Array, or the TCAA, a predecessor of the FIND-IO platform that Dr.&nbsp;Chen used to
discover the immunosuppressive properties of S15. Our work in developing the FIND-IO platform beyond the TCAA includes using different and expanded gene libraries, adding biological pathways and
reporters, expanding immune cell types and, most importantly, increasing the repertoire of functional assay readouts. We also broadened the platform to look at signaling within both the immune cell
and the cell expressing the library gene. By transfecting cells with library genes, which encode membrane-bound or soluble proteins, FIND-IO is designed to determine whether the genes have signaling
functions when interacting with an immune cell. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
FIND-IO technology includes proprietary approaches to functionally assess immune pathways in both primary immune cells and established cell lines from immune lineages, including T
cell subsets, monocytes, macrophage subpopulations, dendritic cells, cancer cell lines and cells isolated from diseased patients. This platform allows us to identify proteins that can be targeted with
novel immunomedicines to repair and maintain anti-tumor immunity. By focusing on understanding the TME in oncology, we believe we can identify multiple new positive and negative modulators of immune
cells, including T cells, NK cells, macrophages and myeloid-derived suppressor cells. As shown in the figure below, our product candidates target a variety of cell types in the immune system. For
example, NC318 targets macrophages and tumor cells and prevents suppressive myeloid cells from negatively regulating T cells. NC410 targets the negative signaling of dendritic cells, macrophages and T
cells mediated by the binding of LAIR-1 to its ligands collagen and C1q. We also have earlier stage discovery programs that are investigating the negative effects of NK cells and other immune cells in
the TME on T cells. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>94</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=97,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=496461,FOLIO='94',FILE='DISK125:[19ZCO1.19ZCO70301]DS70301A.;24',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ds70301_1_95"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ds70301_expanding_t&#97;rgets_beyond_t_cells"> </A>
<A NAME="toc_ds70301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Expanding Targets Beyond T Cells    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g370233.jpg" ALT="GRAPHIC" WIDTH="547" HEIGHT="531">
  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Programs  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


NC318  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NC318 is a monoclonal antibody that binds specifically to human S15 with high affinity. We have observed in preclinical studies that blocking
S15 improved the immune response in multiple animal models. We believe that NC318 may help promote an effective anti-tumor immune response by targeting multiple cell types in the TME that express S15,
including macrophages and S15-positive tumor cells. Based on the results of our preclinical studies, we initiated a Phase 1/2 clinical trial of NC318 in patients with advanced or metastatic solid
tumors in October 2018. We completed enrollment of the Phase&nbsp;1 portion of this trial in August 2019 and preliminary data from the Phase&nbsp;1 portion was presented at the SITC annual meeting
in November&nbsp;2019. We began enrolling patients in the Phase&nbsp;2 portion of the trial in October&nbsp;2019 and expect to announce initial data from the Phase&nbsp;2
portion by the end of 2020. In addition, we may develop a complementary diagnostic for NC318 if we determine it is advisable. We have exclusive worldwide rights to NC318. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>95</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=98,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=673859,FOLIO='95',FILE='DISK125:[19ZCO1.19ZCO70301]DS70301A.;24',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_du70301_1_96"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


S15 Background  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;S15 is a member of the sialic acid-binding immunoglobulin lectins, or Siglec, family, a distinct subgroup of the immunoglobulin superfamily of
proteins. Siglecs are expressed on most white blood cells of the immune system, except for T cells. Siglecs recognize and bind to a sugar structure called sialic acid that coats proteins and fatty
acids found on the surface of all mammalian cells. This binding can affect cell signaling on immune cells. Several Siglecs play key roles in helping
immune cells distinguish between self and non-self and modulating immune responses. In 2015, Dr.&nbsp;Chen discovered the immunosuppressive properties of S15 using the TCAA. S15 is expressed on
tumor cells and, importantly, on M2 macrophages, which are highly immunosuppressive in the TME. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;S15
molecules on M2 macrophages, as well as on tumors themselves, appear to interact with unidentified receptors on T cells and inhibit T cell proliferation and functions, leading to
decreased anti-tumor immune response. It also appears that S15 interacts with myeloid cells to promote their survival and differentiation so that they contribute to the overall immunosuppressive tumor
environment through production of cytokines, such as IL-6, IL-1<FONT FACE="SYMBOL">b</FONT> and TNF-<FONT FACE="SYMBOL">a</FONT>, that are tumor-promoting and immunosuppressive
in the context of the TME. As shown in the figure below, the presence of S15 on either tumor cells or M2 macrophages can lead to an immunosuppressive TME, resulting in tumor growth. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="du70301_s15_is_highly_immunosuppressive_in_the_tme"> </A>
<A NAME="toc_du70301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  S15 is Highly Immunosuppressive in the TME    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g622550.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="411">
  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
mechanism of action of NC318 prevents immune suppression caused by S15 and promotes anti-tumor activity. As the figure below shows, by targeting M2 macrophages, S15-induced myeloid
cells and S15-positive tumors, NC318 is engineered to decrease inflammatory cytokines associated with enhanced tumor growth, promote T cell proliferation and restore T cell function, which we believe
will reduce and kill tumors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>96</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=99,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=169172,FOLIO='96',FILE='DISK125:[19ZCO1.19ZCO70301]DU70301A.;24',USER='VRIVERA',CD='12-NOV-2019;05:54' -->
<A NAME="page_du70301_1_97"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="du70301_nc318_is_designed_to_block_imm__nc302536"> </A>
<A NAME="toc_du70301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  NC318 is Designed to Block Immunosuppressive Activity Induced by S15    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g206014.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="378">
  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
preclinical studies, we have observed that S15 is highly expressed on both tumor cells and M2&nbsp;macrophages in the TME in multiple tumor types, including human lung cancer,
ovarian cancer, breast cancer and melanoma. In contrast, S15 expression on normal tissues is minimal. Our analysis shows that S15 exhibits&nbsp;a distinct expression pattern on tumors and functions
independently from the PD-L1 pathway. The left panel of the following figure illustrates the expression of S15 relative to PD-L1 among more than 200 NSCLC tumor samples across multiple microarrays.
Three distinct populations are identified: S15-positive and PD-L1-negative tumors; PD-L1-positive and S15-negative tumors; and tumors that express neither S15 nor PD-L1. This observation suggests that
the expression of S15 is generally non-overlapping from PD-L1 on tumors. As reflected in the right panel of the following figure, we believe NC318 may provide a therapeutic solution for patients who
have S15-positive and PD-L1-negative tumors, a patient population that is less likely to respond to a PD-1/PD-L1 directed therapy. This is consistent with our goal to develop immunomedicines that
restore normal immune function in ways that differ from existing immunotherapies in order to provide effective therapies for patients who are not adequately served by currently available therapies. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>97</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=100,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=913118,FOLIO='97',FILE='DISK125:[19ZCO1.19ZCO70301]DU70301A.;24',USER='VRIVERA',CD='12-NOV-2019;05:54' -->
<A NAME="page_du70301_1_98"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g770439.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="337">
  </B></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


S15 Target Validation  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe S15 represents a novel target for the treatment of cancer. We and others have conducted multiple preclinical studies in various
animal models evaluating the effect of inhibiting S15 by knocking out the gene responsible for producing S15 in mice. Across these studies, we observed that mice in which S15 is absent have generally
developed normally, suggesting that the inhibition of S15 is not associated with adverse effects on normal cells. In subsequent studies, we observed that S15 knockout mice mounted enhanced
antigen-specific T cell responses </FONT><FONT SIZE=2><I>in vivo</I></FONT><FONT SIZE=2> as compared with wild-type mice, as shown in the following figure. In addition, when S15 was knocked out in
myeloid-derived cells, reflected as conditional knockout in the figure below, the mice mounted an enhanced antigen-specific T cell response similar to that of the knockout mice, which suggests the key
role that macrophages play in S15-mediated immunosuppression. The data show a statistically significant increase in antigen-specific T cells in knockout and conditional knockout mice as compared to
wild-type mice, and the increase is prolonged and maintained over a longer period than in the wild-type mice. In addition, we observed a significant increase in antigen-specific T cells in the spleen,
as measured by the percentage of OVA+ CD8+ cells among CD8+ cells. The knockout mice showed an increase of nearly 20% as compared to less than 2% in wild-type mice. This suggests that S15 plays a key
role in mediating immune suppression and the absence or inhibition of S15 could restore normal immune function. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>98</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=101,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=250652,FOLIO='98',FILE='DISK125:[19ZCO1.19ZCO70301]DU70301A.;24',USER='VRIVERA',CD='12-NOV-2019;05:54' -->
<A NAME="page_du70301_1_99"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="du70301_increase_in_t_cells_observed_when_s15_is_absent"> </A>
<A NAME="toc_du70301_3"> </A>
<BR></FONT><FONT SIZE=2><B>  Increase in T Cells Observed When S15 is Absent    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g13934.jpg" ALT="GRAPHIC" WIDTH="465" HEIGHT="279">
  </B></FONT></P>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >


<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>The
p-value, or probability value, cited in figures in this prospectus as "p," is the likelihood that an observed result occurred by chance. The smaller the p-value,
the less likely that chance caused the result. A result that is sufficiently unlikely to have occurred by chance is referred to as being statistically significant. The FDA generally considers a
p-value of less than or equal to 0.05, meaning that there is a 5% or less chance that the results occurred by chance, to be statistically significant. </FONT></DD></DL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
also evaluated tumor progression in S15 knockout mice compared to wild-type mice in a glioma tumor model. As shown in the figures below, the knockout group showed delayed tumor
progression as well as a corresponding increase in survival as compared to the wild-type group. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="du70301_knocking_out_s15_delayed_tumor__kno03245"> </A>
<A NAME="toc_du70301_4"> </A>
<BR></FONT><FONT SIZE=2><B>  Knocking Out S15 Delayed Tumor Progression and Prolonged Survival in Glioma Model    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g185629.jpg" ALT="GRAPHIC" WIDTH="676" HEIGHT="244">
  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
order to study the potential benefit of S15 inhibition in non-responders to PD-1/PD-L1 therapies, we conducted a preclinical study evaluating S15 knockout mice in a frequently used
melanoma model, the B16.GMCSF tumor model, which has been demonstrated to be resistant to PD-1/PD-L1 therapy. We observed that S15 knockout mice demonstrated greater anti-tumor effect and, as shown in
the following figure, had better overall survival than wild-type mice. We believe that this study suggests NC318 may have therapeutic potential in patients who do not respond to checkpoint inhibitors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>99</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=102,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=508635,FOLIO='99',FILE='DISK125:[19ZCO1.19ZCO70301]DU70301A.;24',USER='VRIVERA',CD='12-NOV-2019;05:54' -->
<A NAME="page_du70301_1_100"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="du70301_knocking_out_s15_prolonged_sur__kno02582"> </A>
<A NAME="toc_du70301_5"> </A>
<BR></FONT><FONT SIZE=2><B>  Knocking Out S15 Prolonged Survival in PD-1/PD-L1 Resistant Tumor Model    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g29650.jpg" ALT="GRAPHIC" WIDTH="532" HEIGHT="318">
  </B></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


First in Human Phase&nbsp;1/2 Clinical Trial  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In October 2018, we initiated a Phase&nbsp;1/2 clinical trial to evaluate NC318 as a monotherapy in patients with advanced or metastatic solid
tumors. This ongoing first-in-human trial is an open-label Phase&nbsp;1/2 clinical trial designed to assess the safety and tolerability of NC318, to define the maximum tolerable dose and/or
pharmacologically active dose and to assess preliminary efficacy. Patients receive NC318 on day one of each cycle. We initiated the trial with 14-day cycles; however, we may explore alternate doses
and dose administration schedules. The trial is being conducted in two phases. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Phase&nbsp;1 portion was designed to determine the pharmacologically active dose, defined as the dose that provides a maximal biologic effect, such as an increase in biomarkers of
immune activation or a reduction of biomarkers associated with immune suppression, and/or the maximum tolerable dose of NC318, including defining the optimal dose administration schedule and the
maximum number of tolerated doses. We completed enrollment of the Phase&nbsp;1 portion of the trial in August 2019 and have dosed 49 patients across seven dose cohorts: 8 mg, 24 mg, 80 mg,
240&nbsp;mg, 400 mg, 800 mg and 1,600 mg, the last of which was added to the trial because a maximum tolerated dose had not been reached through 800 mg. The most common tumors in the trial were
NSCLC (13&nbsp;patients), ovarian (seven patients), melanoma (seven patients), breast (four patients) and colorectal (three patients). Enrolled
patients had all been subject to previous cancer treatments, with a median of three prior therapies, and all 13 NSCLC patients were PD-1 refractory and had been treated with a median of four prior
therapies. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preliminary
data from the Phase&nbsp;1 portion was presented in November 2019 at the SITC annual meeting. As of September 26, 2019, the cutoff date of the data presented by the NC318
trial investigator at SITC, tumor responses were evaluable in 45 patients, and four patients had not yet been assessed. Treatment-related adverse events experienced by more than 5% of patients as of
September 26, 2019 were diarrhea (16%), infusion reactions (8%), fatigue (6%), headaches (6%), pruritis (6%), elevated amylase (8%) and elevated lipase (6%). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>100</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=103,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=273328,FOLIO='100',FILE='DISK125:[19ZCO1.19ZCO70301]DU70301A.;24',USER='VRIVERA',CD='12-NOV-2019;05:54' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_dw70301_1_101"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of November&nbsp;9, 2019, NC318 has been well tolerated in the Phase&nbsp;1 portion of the trial and only one dose-limiting toxicity, a grade 3 pneumonitis
at the highest dose level, was observed. Treatment-related adverse events experienced by more than 5% of patients as of that date continued to be diarrhea, infusion reactions, fatigue, headaches,
pruritis, elevated amylase and elevated lipase. Most treatment-related adverse events have been easily manageable, asymptomatic or mild or moderate, with the exception of one case of grade 3
episcleritis/uveitis at the 400 mg dose level that resolved after steroid therapy and two cases of grade 3 pneumonitis (one at the 400 mg dose level and one at the 1,600 mg dose level). We also
observed two grade 1 cases of vitiligo (one at the 80 mg dose level and one at the 400 mg dose level) that, along with other immune-related adverse events including diarrhea, elevated amylase and
lipase, pruritis, episcleritis/uveitis and pneumonitis, indicate NC318's activity as a modulator of the immune system. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Data
from the trial indicate activity in multiple tumor types, including durable stable disease in patients with NSCLC, endometrial cell cancer, ovarian cancer, squamous cell carcinoma,
Merkel cell cancer, and head and neck cancer. As of November&nbsp;9, 2019, durable responses observed include one complete response, which remains ongoing at 55&nbsp;weeks, and one partial
response, which remains ongoing at 28&nbsp;weeks, both in NSCLC patients, as well as 14 patients with stable disease, which remain ongoing for between 16 and 42 weeks. The patient with the complete
response had multiple lesions prior to treatment with NC318, including two lesions that were at least 10&nbsp;mm. Among the 14 patients with stable disease, four patients have NSCLC, with stable
disease ongoing for between 16 and 40&nbsp;weeks. Three NSCLC patients (out of 13 NSCLC patients in total) have not been in the study long enough to confirm the status of their disease. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
began enrolling patients in the Phase&nbsp;2 portion of the Phase&nbsp;1/2 clinical trial of NC318 in October 2019. The Phase&nbsp;2 portion of the trial is an open-label trial
designed to detect a relevant efficacy signal, or response rate, for each tumor type at a 400 mg dose administered every two weeks. In this portion, we will enroll up to 100 patients with tumor types
that have been shown to have elevated S15 expression, including NSCLC, ovarian cancer, HNSCC and TNBC. The primary endpoints for the Phase&nbsp;2 portion of the trial are safety and tolerability,
and secondary endpoints include response rate, progression-free survival, duration of response and overall survival. We expect to announce initial data from this portion of the trial by the end of
2020. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
designed the clinical trial for NC318 with a robust biomarker strategy to help evaluate clinical activity throughout the trial by focusing on markers of pharmacodynamics. During the
trial, we are obtaining a series of blood samples from patients before and during treatment. These blood samples are being used for the analysis and characterization of the immune cell population.
T&nbsp;cell receptor clones are also being analyzed to detect evidence of therapy-induced clonal expansion of a subpopulation of antigen-specific T cells. Other assays relevant to the objectives of
the trial, such as flow cytometry analysis of intracellular cytokines, may be performed based upon emerging data. In the Phase&nbsp;2 portion of this trial, we will also obtain tumor biopsy samples
before the first dose of NC318 and at least once more after the third dose. The biopsy samples will be used to investigate molecular signatures associated with response or resistance to treatment with
NC318. We may also examine tissue by histology and immunohistochemistry or by exploratory methods to evaluate markers of inflammation and effector T&nbsp;cell populations, growth, signaling,
apoptosis and similar markers that may be associated with safety, response or resistance to treatment with NC318. We believe our biomarker strategy will allow us to better monitor the clinical trial
and could help shape the treatment strategy of NC318 in future clinical trials and, if approved, in clinical practice. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Phase 2 Combination Clinical Trial  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the first half of 2020, we intend to initiate a Phase 2 clinical trial to evaluate NC318 in combination with standard of care chemotherapies
in patients with advanced or metastatic
solid tumors. This trial will be an open-label trial designed to assess the safety and tolerability of NC318 in combination with at least </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>101</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=104,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=948986,FOLIO='101',FILE='DISK125:[19ZCO1.19ZCO70301]DW70301A.;27',USER='WWASSER',CD='12-NOV-2019;14:05' -->
<A NAME="page_dw70301_1_102"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>two
different chemotherapy regimens and to define the maximum tolerable dose of NC318 when administered with each chemotherapy. The trial will also be designed to assess preliminary efficacy of each
combination in specific tumor types in a manner that can potentially support the use of such combinations in first-line therapies of advanced or metastatic solid tumors. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Preclinical Data  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Most syngeneic mouse tumor cell lines, which are common mouse models used to test immunotherapies, do not express S15. In order to study the
effects of our S15-targeted antibody, we generated a tumor model where the mouse expresses S15. The model was initiated by differentiating mouse bone marrow cells into S15-positive M2 macrophages </FONT> <FONT SIZE=2><I>in vitro</I></FONT><FONT
SIZE=2>. These cells were then implanted into mice with an S15-negative mouse colon cancer cell line called CT26. The mice were then treated with
either the S15-targeted antibody 5G12, the murine parent antibody of NC318, which has similar overall functional properties to NC318, or a control antibody. Across multiple preclinical studies, we
evaluated the safety and efficacy of 5G12 and observed that blocking the effects of S15 with 5G12 restored immune function and anti-tumor immunity. For example, as the figure below shows, mice treated
with 5G12 every four days for seven doses had smaller tumors and increased survival when compared to the mice treated with a control antibody. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dw70301_treatment_with_5g12_reduced_tu__tre02451"> </A>
<A NAME="toc_dw70301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Treatment with 5G12 Reduced Tumor Growth and Increased Survival    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g680862.jpg" ALT="GRAPHIC" WIDTH="682" HEIGHT="207">
  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
also generated murine tumors expressing S15 on their surface. In our preclinical studies of an S15-positive murine colon cancer cell line, we observed that 5G12 delayed tumor growth
and tumor metastasis, which was demonstrated by fewer lung nodules measured 28&nbsp;days after treatment in the mice treated with 5G12 as compared to the mice treated with a control antibody, as
shown in the figure below. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>102</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=105,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=318514,FOLIO='102',FILE='DISK125:[19ZCO1.19ZCO70301]DW70301A.;27',USER='WWASSER',CD='12-NOV-2019;14:05' -->
<A NAME="page_dw70301_1_103"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dw70301_treatment_with_5g12_de__dw702277"> </A>
<A NAME="toc_dw70301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Treatment with 5G12 Delayed Tumor Metastasis in Lung Model    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g932267.jpg" ALT="GRAPHIC" WIDTH="312" HEIGHT="328">
  </B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> studies, we understand that S15 drives an increase in pro-inflammatory and pro-tumorigenic cytokines, such as
IL-1<FONT FACE="SYMBOL">b</FONT>, IL-6 and TNF-<FONT FACE="SYMBOL">a</FONT>. As indicated in the figure below, when human peripheral blood mononuclear cells, or PBMCs, which are
blood cells that are critical components in the immune system, were cultured in the presence of S15, the amount of pro-inflammatory and pro-tumorigenic cytokines increased, indicating an
immunosuppressive environment. However, when human PBMCs were cultured with S15 protein and 5G12 or NC318, the amount of pro-inflammatory and pro-tumorigenic cytokines was reduced relative to when
cultured with S15 and a control antibody. In addition, 5G12 and NC318 promoted the ability of human T cells to proliferate and produce interferon-gamma, or
IFN-<FONT FACE="SYMBOL">g</FONT>. These data, which are shown in the figures below, suggest that 5G12 and NC318 have the potential to block immune suppression mediated by S15. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dw70301_nc318_decreased_inflammatory_cytokines"> </A>
<A NAME="toc_dw70301_3"> </A>
<BR></FONT><FONT SIZE=2><B>  NC318&nbsp;Decreased Inflammatory Cytokines    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g547758.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="193">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>103</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=106,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=826899,FOLIO='103',FILE='DISK125:[19ZCO1.19ZCO70301]DW70301A.;27',USER='WWASSER',CD='12-NOV-2019;14:05' -->
<A NAME="page_dw70301_1_104"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g717089.jpg" ALT="GRAPHIC" WIDTH="495" HEIGHT="264">
  </B></FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


NC410  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NC410 is a fusion protein of LAIR-2, a naturally occurring soluble version of and decoy protein for LAIR-1, and is designed to block immune
suppression mediated by LAIR-1. Multiple preclinical studies support our understanding that eliminating or blocking the binding of LAIR-1 restores normal immune function in multiple immune cells. Our
translational work has shown that NC410 blocks the interaction of LAIR-1 with its binding partners, thereby promoting T cell function and dendritic cell activity to contribute to restoring anti-tumor
immune activity. Consistent with our strategy, we believe NC410 has the potential to address the needs of patients who are not adequately addressed by currently available therapies. We are currently
conducting IND-enabling studies and expect to file an IND and initiate a Phase 1/2 clinical trial in patients with advanced or metastatic solid tumors in the first quarter of 2020. We have exclusive
worldwide rights to NC410. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Background of LAIR Pathway in Cancer  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LAIR-1 is a co-inhibitory receptor expressed on T cells and several other immune cell subsets, including monocytes, macrophages and dendritic
cells. Its binding partners include certain types of collagen and complement component 1q, or C1q. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
normal conditions, collagen forms&nbsp;a scaffold to provide strength and structure to tissues. C1q is part of the innate immune system to protect the host from infection and
other foreign agents. Both collagen and C1q are highly upregulated and expressed under pathologic conditions, such as in the TME and in the immune organelles close to the tumor site known as lymph
nodes, which are important sites for mounting immune responses to the tumor. However, binding of LAIR-1 to collagen or C1q leads to immune suppression. Our preclinical studies have shown that LAIR-1
and LAIR-2 bind to similar ligands, including collagen and C1q. LAIR-2, which is a secreted protein as opposed to a membrane-bound protein like LAIR-1, binds to the same regions of these ligands with
stronger affinity than LAIR-1. However, because LAIR-2 does not induce immune suppression when binding to these ligands, LAIR-2 functions as an efficient decoy for LAIR-1. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the harsh conditions of the TME, collagen and C1q are overexpressed as a membrane protein on many types of tumor cells and in the ECM surrounding the tumor. This increased
expression of collagen and C1q, combined with insufficient levels of natural LAIR-2, leads to increased binding of LAIR-1, resulting in immune suppression, tumor immune evasion and tumor growth. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NC410
is a novel immunotherapeutic protein that was developed to block LAIR-1-mediated immune suppression by mimicking the natural decoy effects of LAIR-2. Our approach of using NC410 as
a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>104</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=107,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=562916,FOLIO='104',FILE='DISK125:[19ZCO1.19ZCO70301]DW70301A.;27',USER='WWASSER',CD='12-NOV-2019;14:05' -->
<A NAME="page_dw70301_1_105"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>therapeutic
is intended to take advantage of the natural LAIR-2 regulatory system in humans, which maintains human immune function under normal non-pathologic conditions. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
mechanism of action of NC410 prevents immune suppression caused by LAIR-1 binding to collagen or C1q and promotes anti-tumor immune activity. As the figure below shows, when LAIR-2
and NC410 are present in the TME, they bind to collagen or C1q preferentially compared to LAIR-1 given their higher binding affinity. This has the effect of blocking the collagen or C1q from binding
to
LAIR-1, which otherwise would have resulted in an immunosuppressive effect. By blocking this interaction with LAIR-1 and its binding partners, T cell function and dendritic cell activity is promoted
in order to restore anti-tumor immune activity. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dw70301_nc410_is_designed_to_prevent_i__nc402351"> </A>
<A NAME="toc_dw70301_4"> </A>
<BR></FONT><FONT SIZE=2><B>  NC410 is Designed to Prevent Immune Suppression Caused by LAIR-1    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g938650.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="333">
  </B></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Preclinical Data  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have conducted multiple preclinical studies to assess the activity of NC410 across a variety of preclinical models. These studies support our
understanding that eliminating or blocking the binding of LAIR-1 to collagen or C1q can restore normal immune function in multiple immune cells, including T cells and myeloid cells, resulting in
activation of T cells and anti-tumor immunity. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have observed </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> with human cells that using NC410 to block LAIR-1 from binding with collagen or C1q reverses immune suppression
and restores normal immune cell function for both peripheral blood monocytes, including T cells, and myeloid cells. In one study of peripheral blood monocytes, we added 0
&micro;g/mL, 10 &micro;g/mL and 100 &micro;g/mL of NC410 to 20 &micro;g/mL of collagen peptide </FONT><FONT SIZE=2><I>in
vitro</I></FONT><FONT SIZE=2>. Similarly, we also evaluated the addition of 0 &micro;g/mL, 2.5 &micro;g/mL and 10 &micro;g/mL of NC410 to 10
&micro;g/mL of C1q on human myeloid cells. As shown in the figures below, NC410 promoted the activation of immune cells in the presence of high levels of collagen in peripheral
blood monocytes and high levels of C1q in myeloid cells in a dose-dependent manner. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>105</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=108,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=703942,FOLIO='105',FILE='DISK125:[19ZCO1.19ZCO70301]DW70301A.;27',USER='WWASSER',CD='12-NOV-2019;14:05' -->
<A NAME="page_dw70301_1_106"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g89498.jpg" ALT="GRAPHIC" WIDTH="666" HEIGHT="388">
  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
another preclinical study with human cells, we observed that NC410 promoted increases in the cytokines IL-2 and TNF-<FONT FACE="SYMBOL">a</FONT>, as shown in the left-hand
panel of the following figure, which is indicative of increased immune function. In addition, simultaneous </FONT><FONT SIZE=2><I>in vivo</I></FONT><FONT SIZE=2> injections of NC410 and human T cells
in immune-deficient mice resulted in increased amounts of CD4+ and CD8+ T cells, as shown in the right-hand panel of the figure below. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g218389.jpg" ALT="GRAPHIC" WIDTH="660" HEIGHT="264">
  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Through
multiple preclinical studies in several additional tumor models, we observed that eliminating or blocking LAIR-1-mediated immune suppression prolonged survival. In addition,
anti-tumor activity of NC410 correlated with a local increase in antigen-specific T cells in the TME </FONT><FONT SIZE=2><I>in vivo</I></FONT><FONT SIZE=2> using an engineered mouse model to measure
localized antigen-specific responses. We used an antigen-specific tumor model of EL4, a murine lymphoma cell line. We measured the weight of the animals daily as a proxy for tumor growth. As shown in
the figure below, we observed that mice treated with NC410 had smaller tumors than mice treated with a control, suggesting that NC410 has potential anti-tumor activity. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>106</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=109,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=533820,FOLIO='106',FILE='DISK125:[19ZCO1.19ZCO70301]DW70301A.;27',USER='WWASSER',CD='12-NOV-2019;14:05' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_dy70301_1_107"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dy70301_nc410_showed_anti-tumor_activity"> </A>
<A NAME="toc_dy70301_1"> </A></FONT> <FONT SIZE=2><B>  NC410 Showed Anti-Tumor Activity    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g897145.jpg" ALT="GRAPHIC" WIDTH="411" HEIGHT="310">
  </B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
also measured T cells specific for ovalbumin, and as shown in the figures below, we observed systemic and local increases, as measured in the spleen and lymph node, respectively, in
mice treated with NC410 compared to those treated with control. We believe that these data support an immune response in and around the TME. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dy70301_nc410_increased_t_cell__dy702017"> </A>
<A NAME="toc_dy70301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  NC410 Increased T Cells Both Systemically and Locally    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g279714.jpg" ALT="GRAPHIC" WIDTH="552" HEIGHT="283">
  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, when human PBMCs were implanted into mice with mouse P815 mastocytoma tumor cells, we observed that NC410 mediated an increase in human T cells </FONT><FONT SIZE=2><I>in
vivo</I></FONT><FONT SIZE=2> and that the increase in human T cells correlated with a delay in tumor growth. As shown in the figures below, NC410 increased the number of CD8+ T cells on day 13 in a
dose-dependent manner and that increase corresponded to a decrease in tumor volume. To mimic human cancers, human PBMCs were also implanted into mice with human HT29 colon adenocarcinoma cells to test
efficacy in a human tumor model. NC410 promoted an anti-tumor response against the human HT29 tumor cell line in a dose-dependent manner, as shown in the figure below. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>107</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=110,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=933697,FOLIO='107',FILE='DISK125:[19ZCO1.19ZCO70301]DY70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:30' -->
<A NAME="page_dy70301_1_108"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dy70301_mouse_p815_mastocytoma_model"> </A>
<A NAME="toc_dy70301_3"> </A>
<BR></FONT><FONT SIZE=2><B>  Mouse P815 Mastocytoma Model    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g619902.jpg" ALT="GRAPHIC" WIDTH="666" HEIGHT="246">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dy70301_human_ht29_colon_adenocarcinoma_model"> </A>
<A NAME="toc_dy70301_4"> </A>
<BR></FONT><FONT SIZE=2><B>  Human HT29 Colon Adenocarcinoma Model    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="dy70301_nc410_decreased_tumor_volume"> </A>
<A NAME="toc_dy70301_5"> </A>
<BR></FONT><FONT SIZE=2><B>  NC410&nbsp;Decreased Tumor Volume    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g918369.jpg" ALT="GRAPHIC" WIDTH="367" HEIGHT="255">
  </B></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Clinical Development Plan for NC410  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We and others have analyzed genomic and protein databases and observed that LAIR-1 expression levels negatively correlate with survival rates
for several cancers, including brain, renal, colorectal, glioma, lung, urothelial and ovarian cancers. These analyses support possible targeting of these tumor types as primary indications for
therapeutic treatment with NC410. We are conducting expansive screening efforts on tumor samples from different solid tumor types to identify tumors that express LAIR-1 on the surface of either cancer
cells or infiltrating immune cells to guide our ultimate selection of patients for planned clinical trials of NC410 in humans. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are currently conducting IND-enabling studies for NC410 and plan to file an IND and initiate a Phase&nbsp;1/2 clinical trial in patients with advanced or metastatic solid tumors in
the first quarter of 2020. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Research Programs  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to NC318 and NC410, we are also pursuing preclinical evaluation of other potential novel immunomodulatory molecules. Among these is
an antibody that targets a novel member of the B7-family </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>108</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=111,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=453202,FOLIO='108',FILE='DISK125:[19ZCO1.19ZCO70301]DY70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:30' -->
<A NAME="page_dy70301_1_109"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>of
immunomodulatory proteins. In our preclinical studies, this antibody has shown highly reproducible and potent anti-tumor activity with </FONT><FONT SIZE=2><I>in vivo</I></FONT><FONT SIZE=2>
modeling and appears to involve an important immunomodulatory pathway in the TME that may complement the activity of NC318 and NC410. Consistent with our focus on patients who do not respond to
current therapies, patients whose cancer progresses despite treatment and patients with cancer types that are not adequately addressed by currently available therapies, the target of this antibody
appears to be non-overlapping with the expression of both S15 and PD-L1 on tumor cells. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
also have an antibody in preclinical development targeting an immune modulator that is highly expressed in inflamed tissue and the TME in multiple tumor types. In our preclinical
research, we
observed that disrupting inhibitory signaling by this molecule with our antibody increased T cell and NK cell effector functions. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on our understanding of the LAIR pathway, including through our development of NC410, we are also pursuing monoclonal antibodies that target LAIR-1 and directly block LAIR-1
binding and signaling to prevent tumor growth or to eliminate the tumor. These novel LAIR-1 antibodies have unique functional properties that may provide additional opportunities in both cancer and
autoimmune disorders. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our FIND-IO Discovery Engine  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our FIND-IO platform uses proprietary approaches to functionally assess immune pathways in both primary immune cells and established cell lines
from immune lineages, including T cell subsets, monocytes, macrophage subpopulations, dendritic cells, cancer cell lines, and cells isolated from diseased patients. This platform allows us to identify
proteins that can be targeted with novel immunomedicines to repair and maintain anti-tumor immunity. We have identified multiple novel targets using our FIND-IO platform, including those for which
certain of our research programs are being designed to target. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are three integrated components to our FIND-IO platform. The first component consists of gene libraries, also called target libraries, comprising genes that are expressed and
queried for immune or other functions. Our target libraries are composed of genes that encode a structurally diverse set of protein molecules and that are either inserted into the plasma membrane on
the host cell surface or secreted outside of the host cell. The second component encompasses a variety of immune and non-immune cell types, called responder cells, used to evaluate the functional
effects of the target libraries. The immune responder cell types include primarily immune cells obtained from human volunteers and multiple immune cell lines that have been grown in culture, and the
non-immune responder cell types include tumor cell lines. The third component utilizes a broad set of outputs indicative of whether a newly discovered target inhibits or stimulates functional immune
responses. We utilize a cube to illustrate these three components as shown in the figure below. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>109</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=3,SEQ=112,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=785817,FOLIO='109',FILE='DISK125:[19ZCO1.19ZCO70301]DY70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:30' -->
<A NAME="page_dy70301_1_110"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g979346.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="412">
  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unlike
other screening platforms that often focus on a single parameter or cell type, our approach uses a broad search across multiple cell types and multiple functions and is
purposefully designed to produce physiologically relevant results. Although the orchestration of an immune response is complex and dynamic within the TME, we have designed the FIND-IO platform to be
simple yet functional. The platform integrates multiple components to assess immune function resulting from cellular interactions in order to identify new immune modulators in an approach that mimics
physiological interactions. The goal is to identify proteins that can be targeted with immunomedicines, such as monoclonal antibodies or fusion proteins. Potential targets that are preliminarily
identified through the FIND-IO platform undergo reproducible, robust, relevant and comprehensive characterization resulting in functional readouts that improve the likelihood of developing
immunomedicines against novel immune modulatory molecules. This approach is intended to meet our goal of extending beyond the success of current immunotherapies to treat patients who are not
adequately addressed by currently available therapies and to enhance overall survival in these patients. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
first step in the application of our FIND-IO platform is to transfect the target library into a host cell on a gene-by-gene basis. The host cells then express the library genes and
the proteins are present on the cell surface or secreted into the surrounding space. In addition, the host cell has been engineered to express a reporter of transcriptional activity associated with a
cellular function. For example, we engineer the host cells to report transcription factor activity in a cellular pathway by linking a selected DNA with a different fluorescent reporter, such as red
fluorescent protein, or RFP. Thus, if the library gene expresses a protein that can signal via the applicable pathway, then the RFP gene is transcribed, expressed as a protein and the cell will glow
red. The immune or non-immune responder cells are also engineered to express a reporter of transcriptional activity associated with a cellular function. For example, we engineer the responder cells to
report transcription factor activity in a cellular pathway by linking a selected DNA with a fluorescent reporter such as green fluorescent protein, or GFP. Therefore, when transcription occurs in the
responder cell, the GFP gene is transcribed, expressed as a protein and the cell will glow green. The red and/or green glow of the cells can be measured quantitatively. This is called bi-directional
signaling as the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>110</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=113,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=842877,FOLIO='110',FILE='DISK125:[19ZCO1.19ZCO70301]DY70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:30' -->
<A NAME="page_dy70301_1_111"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>FIND-IO
platform was designed to look at signaling events in the host cells as well as the immune and non-immune responder cells. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g201142.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="373">
  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FIND-IO platform allows us to select and screen multiple immune and non-immune responder cell types, including T cells, myeloid cells, leukemia cells, epithelial cancer cells, plasma
B cells and multiple myeloma cells, as well as primary immune cells from healthy donors. For each of these cell types, we undertake functional screening, including activity of many reporter pathways,
effector function activity and effects on cell death, in order to identify novel immunomodulatory targets with common or differentiating effects across multiple cell types. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
with our FIND-IO technology we can test for combination screens to search for synergistic or additive combinations with certain pathways, including immune checkpoint
pathways, like the PD-1/PD-L1 pathway, that are currently approved for treating cancer patients. We expect that this screening will help with the identification of potential combination treatments to
enhance response rates. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
goal of our FIND-IO platform is to sustain a pipeline of novel immunomedicines that restore normal immune function to treat cancer and other immune-related diseases. While we are
primarily focused on cancer treatment, we believe that our proprietary technology, our approach, our understanding of biological pathways and the convergence of immunology and inflammation provide us
with opportunity to explore novel immunomedicines for other significant unmet medical needs. To maximize the full potential of our platform and expertise, we are expanding the functional screening
approach of our FIND-IO platform to the identification of novel targets in autoimmunity and inflammation, where we are using this approach to develop our FIND-AI platform, as well as in
neuro-inflammatory diseases. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Collaboration Agreements  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Agreements with Yale University  </I></B></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


License Agreement with Yale  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In December 2015, we entered into a license agreement with Yale, or the Yale Agreement, pursuant to which we obtained an exclusive,
royalty-bearing, sublicensable worldwide license to products that either </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>111</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=114,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=459544,FOLIO='111',FILE='DISK125:[19ZCO1.19ZCO70301]DY70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:30' -->
<A NAME="page_dy70301_1_112"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>incorporate
certain licensed patents used in the discovery of targets or arise out of research and development of Dr.&nbsp;Chen's laboratory at Yale, including S15. We are obligated to pay Yale low
single-digit royalties on sales of products, including NC318, that are either covered by the patents licensed to us under the Yale Agreement or arise out of Dr.&nbsp;Chen's laboratory, subject to
minimum annual royalty payments in the low to mid hundreds of thousands of dollars. Until we are required to pay royalties under the Yale Agreement, we must pay an annual license maintenance fee to
Yale in the mid to high tens of thousands of dollars. In addition, with respect to each product covered by licenses under the Yale Agreement, we are obligated to pay Yale milestone payments upon
(i)&nbsp;the initiation of each of a Phase&nbsp;1 clinical trial, Phase&nbsp;2 clinical trial and Phase&nbsp;3 clinical trial or a pivotal trial, (ii)&nbsp;first commercial sale in the
United States and (iii)&nbsp;first commercial sale in China, Japan or a major European country, in an aggregate amount of up to $2,975,000. The term of the license agreement with Yale runs, on a
country-by-country basis, until the later of the expiration of all licensed patents or 10&nbsp;years from the first commercial sale in such country, unless Yale has cause to terminate earlier for
our material breach of the license, bankruptcy or if we or any sublicensee bring a challenge against Yale in relation to the licensed patents. We have the right to terminate the Yale Agreement for
Yale's material breach or at any time during the term with six months' prior written notice to Yale. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sponsored Research Agreement with Yale  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with the Yale Agreement, we also entered into a corporate sponsored research agreement, or SRA, with Yale, in which we agreed to
provide an aggregate of up to $12.4&nbsp;million to fund a research program aimed at discovering new targets for immunomedicines. The research program is under the direction and supervision of
Dr.&nbsp;Chen. Pursuant to the SRA, we have the option to add any patents invented pursuant to the research program as a licensed patent under the Yale Agreement and the right to obtain a
royalty-bearing, exclusive, worldwide license to any such patents. If we do not exercise our option within the exercise period, Yale is permitted to license any such patents to any third party. The
SRA will expire on December&nbsp;31, 2020, and we have the option of extending the term upon mutual agreement with Yale. We can terminate the SRA at any time upon
90&nbsp;days' written notice to Yale. Yale can terminate for an uncured breach or with 90&nbsp;days' written notice for cause. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Collaboration with Lilly  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In November 2018, we entered into the Lilly Agreement, pursuant to which we will use our FIND-IO platform to identify novel oncology targets for
additional collaborative research and drug discovery by us and Lilly. Under this agreement, we granted Lilly the exclusive option to obtain worldwide exclusive licenses to research, develop,
manufacture and commercialize multiple compounds and products directed to oncology targets identified through our research collaboration. Lilly currently has all options remaining eligible for
exercise. In addition, Lilly granted us the exclusive option to obtain worldwide exclusive licenses to research, develop, manufacture and commercialize an equal number of compounds and products
directed to oncology targets for which Lilly does not exercise its option. We currently have all options remaining eligible for exercise. Under the Lilly Agreement, we retain all rights to our
intellectual property outside of oncology for any targets that are not actively being researched and developed pursuant to the Lilly Agreement. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the Lilly Agreement, we and Lilly have agreed to engage in a multi-year research collaboration, which will be managed by a joint steering committee formed by an equal number of
members from each party and expire upon the earlier of the exercise of all options granted to Lilly or four years from the date of the agreement, subject to certain extensions. We have granted Lilly
exclusivity with respect to targets identified through our FIND-IO platform that can be used in the oncology field during the research term or until Lilly has exercised all of its options. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the research term, as a part of target discovery, we will be responsible for providing Lilly with oncology targets identified using our FIND-IO platform. From the targets provided
by us, Lilly may select </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>112</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=115,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=583819,FOLIO='112',FILE='DISK125:[19ZCO1.19ZCO70301]DY70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:30' -->
<A NAME="page_dy70301_1_113"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>targets
to advance to target validation using criteria developed by both parties. Following completion of the agreed upon target validation plan with respect to a given target, either party may
propose to advance that target to compound discovery. For each target that has been advanced to compound discovery, Lilly will have the option to obtain an exclusive license in all fields of use with
respect to the compounds and products directed to the target. If Lilly does not exercise its option with respect to a given target that has advanced through compound discovery, or has previously
exercised all of its options, we have the option to obtain licenses with respect to compounds and products directed to the
target. Lilly and we may each exercise our respective options with respect to targets during the research term. Following option exercise by a party, the development and commercialization of any
compounds and products directed to the target will be conducted by the exercising party. The exercising party must use commercially reasonable efforts to develop, seek regulatory approval for and
commercialize any such products under mutually agreed work plans. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
received an upfront, non-refundable payment of $25.0&nbsp;million in cash and a $15.0&nbsp;million equity investment from Lilly upon entering into the agreement. Lilly is also
required to pay us quarterly research and development support payments in an aggregate in the mid single digit millions of dollars during a portion of the research term as well as option exercise fees
in an aggregate of up to the high single digit millions of dollars upon the exercise of options by Lilly. For the first product directed to each target optioned by Lilly, Lilly will pay development
and regulatory milestones. For the first additional indication in a different therapeutic area for such product, Lilly will pay regulatory milestones upon regulatory approval in each of the United
States, European Union and Japan. Additionally, regardless of indication, Lilly will pay sales milestones as well as mid to high single-digit royalties on net sales for all products directed to each
target optioned by Lilly. The milestone payments could amount to an aggregate of up to $1.4&nbsp;billion. This amount assumes that Lilly exercises all of the options available to it, as well as the
successful achievement of all development and regulatory milestones and sales milestones for each target optioned by Lilly. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
our exercise of an option with respect to a given target, we will owe Lilly option exercise, milestone and royalty payments in amounts equivalent to a portion of the amounts payable
by Lilly were Lilly to exercise an option, including an aggregate of up to $710&nbsp;million in development and regulatory milestones and sales milestones and low to mid single-digit royalties.
Unless terminated earlier, the term of the Lilly Agreement will continue in effect, on a product-by-product and country-by-country basis, until the expiration of the applicable royalty term. Either
party may terminate the agreement, in whole or in part, for the other's material breach that has not been cured within a certain period or general assignment for the benefit of creditors or in
connection with the other's bankruptcy or insolvency. In addition, Lilly has the right to terminate the agreement in its entirety or with respect to one or more specified products or targets at any
time with 60&nbsp;days prior notice. To the extent that we terminate for Lilly's material breach or insolvency or Lilly terminates for convenience, all licenses and rights granted by us to Lilly
will automatically terminate and the licenses and rights granted by Lilly to us will survive. Similarly, if Lilly terminates for our material breach or insolvency, all licenses and rights granted by
Lilly to us will automatically terminate, and the licenses and rights granted by us to Lilly will survive. In such cases, all future royalties and milestones will be reduced in an amount to be
reasonably agreed by the parties. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Manufacturing  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have a purpose-built, dedicated, state-of-the-art cGMP manufacturing facility that utilizes single-use technology to support our pipeline and
advance our product candidates into and through clinical development. The facility has an initial production capacity of 1,000 liters and was designed with additional room for expansion to support
multiple product candidates. The investment in our manufacturing facility is a critical element of our ability to quickly identify whether a candidate is
likely to be successful and to facilitate an efficient development path. While other companies may need to work with third parties for antibody production, we can do so in our own facility. Compared
to working with third-party </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>113</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=116,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=498912,FOLIO='113',FILE='DISK125:[19ZCO1.19ZCO70301]DY70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:30' -->
<A NAME="page_dy70301_1_114"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>manufacturers,
we believe our facility provides better quality assurance, greater control in scheduling and prioritizing manufacturing activities and enhanced capital efficiency. We are currently
manufacturing all of the drug supply for our preclinical studies and our Phase&nbsp;1/2 clinical trial of NC318 and intend to expand our cGMP manufacturing capacity, including to provide the drug
supply for future clinical trials of NC318. As we advance the development of our growing pipeline of product candidates, we will continue to evaluate the merits of further expanding our internal
manufacturing capabilities, including for the production of commercial drug supply, as compared to collaborating with third-party manufacturers. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Competition  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The biotechnology and pharmaceutical industries, and the immuno-oncology subsector, are characterized by rapid evolution of technologies, fierce
competition and strong defense of intellectual property. We believe that our programs, platforms, technology, knowledge, experience and scientific resources provide us with competitive advantages, but
we also face competition from pharmaceutical and biotechnology companies, academic institutions, governmental agencies and public and private research institutions, among others. Our competitors
include larger and better funded biopharmaceutical, biotechnology and therapeutics companies, including companies focused on cancer immunotherapies, such as Amgen,&nbsp;Inc., AstraZeneca&nbsp;plc,
Bristol-Myers Squibb Company, or BMS, Genentech,&nbsp;Inc., GlaxoSmithKline&nbsp;PLC, Merck&nbsp;&amp;&nbsp;Co.,&nbsp;Inc., Novartis AG, Pfizer&nbsp;Inc., Roche Holding&nbsp;Ltd and
Sanofi&nbsp;S.A. Moreover, we may also compete with smaller or earlier-stage companies, universities and other research institutions that have developed, are developing or may be developing current
and future cancer therapeutics. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Product
candidates that we successfully develop and commercialize will compete with a range of therapies that are currently approved and any new therapies that may become available in
the future. Key product features that would affect our ability to effectively compete with other therapeutics include the efficacy, safety and convenience of our products. Currently marketed oncology
drugs and therapeutics range from traditional cancer therapies, including chemotherapy, to antibody-drug conjugates, such as Genentech&nbsp;Inc.'s Kadcyla, to immune checkpoint inhibitors targeting
CTLA-4, such as BMS' Yervoy, and PD-1/PD-L1, such as BMS' Opdivo, Merck&nbsp;&amp;&nbsp;Co.'s Keytruda and Genentech's Tecentriq, to T cell-engager immunotherapies, such as Amgen's Blincyto. In
addition to these marketed therapies, numerous compounds are in clinical development for the potential treatment of cancer. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
availability of reimbursement from government and other third-party payors will also significantly affect the pricing and competitiveness of our products. Our competitors may also
obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are
able to enter the market. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Intellectual Property  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our commercial success depends in part on our ability to obtain and maintain proprietary protection for our products, methods and manufacturing
processes, to operate without infringing the proprietary rights of others and to prevent others from infringing our proprietary rights. We rely on a combination of patent applications and trade
secrets, as well as contractual protections, to establish and protect our intellectual property rights. We seek to protect our proprietary position by, among other things, filing patent applications
in the United States and internationally. Our patent estate includes patent applications with claims relating to our product candidates, methods of use and manufacturing processes, and claims for
potential future products and developments. As of October&nbsp;29, 2019, our intellectual property portfolio includes, on a worldwide basis, 18 pending foreign patent applications relating to NC318
and NC410, one pending U.S. patent application relating to NC318, one pending U.S. patent application relating to NC410 and additional pending patent applications for other discovery and research
programs. Patents resulting from our patent applications for NC318 and NC410, if issued, are expected to expire beginning in 2037 absent any patent term adjustments or extensions. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>114</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=117,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=114494,FOLIO='114',FILE='DISK125:[19ZCO1.19ZCO70301]DY70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:30' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_dz70301_1_115"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, as described above, under the Yale Agreement, we have an exclusive, royalty-bearing, sublicensable worldwide license from Yale for an intellectual
property portfolio, including patent applications, relating to methods of use for S15 that covers the use of NC318. Any patents from these patent applications, if issued, are expected to expire no
earlier than 2036 absent any patent term adjustments or extensions. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
all patent applications, we determine strategy for claim scope on a case-by-case basis, taking into account advice of counsel and our business model and needs. We file patents
containing claims for protection of all useful applications of our proprietary technologies and any products, as well as all new applications and/or uses we discover for existing technologies and
products, based on our assessment of
their strategic value. We continuously reassess the number and type of patent applications, as well as the pending and issued patent claims to ensure that maximum coverage and value are obtained for
our processes and compositions, given existing patent office rules and regulations. Further, claims may be modified during patent prosecution to meet our intellectual property and business needs. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
also rely upon trade secrets, know-how and continuing technological innovation to develop and maintain our competitive position, including with respect to our FIND-IO platform. We
seek to protect our proprietary technology and processes, in part, by confidentiality and invention assignment agreements with our employees, consultants, scientific advisors and other contractors. In
addition, in the ordinary course of our business, we enter into agreements with other third parties for non-exclusive rights to intellectual property directed to other technologies that are ancillary
to our business, including laboratory information management software and research and development tools. In addition, we have filed for trademark registration with the U.S. Patent and Trademark
Office, or the USPTO, for "NextCure," our logo and our FIND-IO platform. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Government Regulation  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Government Regulation and Product Approval  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The FDA and other regulatory authorities at federal, state and local levels, as well as in foreign countries, extensively regulate, among other
things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, recordkeeping, approval, advertising,
promotion, marketing, post-approval monitoring and post-approval reporting of biological products. Along with third-party contractors, we will be required to navigate the various preclinical, clinical
and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product candidates. The processes
for obtaining regulatory approvals in the United States and in foreign jurisdictions, along with subsequent compliance with applicable laws and regulations and other regulatory authorities, require
the expenditure of substantial time and financial resources. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Government
policies may change and additional government regulations may be enacted that could prevent or delay further development or regulatory approval of any product candidates,
product or manufacturing changes, additional disease indications, or label changes. We cannot predict the likelihood, nature or extent of government regulation that might arise from future legislative
or administrative action. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Review and Approval for Licensing Biologics in the United States  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the United States, the FDA regulates our current product candidates as biological products, or biologics, under the Federal Food, Drug, and
Cosmetic Act, or FDCA, the Public Health Service Act and associated implementing regulations. Biologics, like other drugs, are used for the treatment, prevention or cure of disease in humans. In
contrast to chemically synthesized small molecular weight drugs, which have a well-defined structure and can be thoroughly characterized, biologics are generally derived from living material (human,
animal, or microorganism) are complex in structure, and thus are usually not fully characterized. Biologics include immunomedicines for cancer and other diseases. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>115</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=118,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=323284,FOLIO='115',FILE='DISK125:[19ZCO1.19ZCO70301]DZ70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dz70301_1_116"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biologics
are also subject to other federal, state and local statutes and regulations. The failure to comply with applicable statutory and regulatory requirements at any time during the
product development process, approval process or after approval may subject a sponsor or applicant to administrative or judicial enforcement actions. These actions could include the suspension or
termination of clinical trials by the FDA, the FDA's refusal to approve pending applications or supplemental applications, withdrawal of an approval, Warning Letters or Untitled Letters, product
recalls, product seizures, total or partial suspension of production or distribution, import detention, injunctions, fines, refusals of government contracts, restitution, disgorgement of profits, or
civil or criminal investigations and penalties brought by the FDA, the Department of Justice, or the DOJ, or other governmental entities. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
applicant seeking approval to market and distribute a biologic in the United States must typically undertake the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> completion of non-clinical laboratory tests and animal studies performed in accordance with the FDA's good laboratory practice, or GLP,
regulations; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> manufacture, labeling and distribution of investigational drug in compliance with cGMP; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> submission to the FDA of an IND application, which must become effective before clinical trials may begin and must be updated annually or when
significant changes are made; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> approval by an independent institutional review board, or IRB, or ethics committee at each clinical site before each clinical trial may be
initiated; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> performance of adequate and well-controlled human clinical trials in accordance with the FDA's current Good Clinical Practices requirements, or
cGCP, to establish the safety, purity and potency of the proposed biological product candidate for its intended purpose; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> preparation of and submission to the FDA of a biologics license application, or BLA, after completion of all pivotal clinical trials requesting
marketing approval for one or more proposed indications; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> obtain satisfactory completion of an FDA Advisory Committee review, where appropriate, as may be requested by the FDA to assist with its
review; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> satisfactory completion of one or more FDA inspections of the manufacturing facility or facilities at which the proposed product, or certain
components thereof, are produced to assess compliance with cGMP and data integrity requirements to assure that the facilities, methods and controls are adequate to preserve the biologic's identity,
safety, quality, purity and potency; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> satisfactory completion of FDA audits of selected clinical investigation sites to assure compliance with cGCP requirements and the integrity of
the clinical data; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> payment of user fees under the Prescription Drug User Fee Act for the relevant year; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> obtain FDA review and approval of the BLA to permit commercial marketing of the licensed biologic for particular indications for use in the
United States; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> compliance with any post-approval requirements, including the potential requirements to implement a Risk Evaluation and Mitigation Strategy, or
REMS, and to complete post-approval studies. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From
time to time, legislation is drafted, introduced and passed in Congress that could significantly change the statutory provisions governing the testing, approval, manufacturing and
marketing of products regulated by the FDA. In addition to new legislation, FDA regulations and policies are often revised or interpreted by the agency in ways that may significantly affect our
business and our products. It is impossible to predict whether further legislative changes will be enacted or whether FDA regulations, guidance, policies or interpretations will be changed or what the
effect of such changes, if any, may be. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>116</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=119,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=790075,FOLIO='116',FILE='DISK125:[19ZCO1.19ZCO70301]DZ70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dz70301_1_117"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Preclinical and Clinical Development  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Before an applicant can begin testing the potential candidate in human subjects, the applicant must first conduct preclinical studies.
Preclinical studies include laboratory evaluations of product chemistry, toxicity and formulation, as well as </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> and animal studies to assess the
potential safety and activity of the drug for initial testing in humans and to establish a rationale for therapeutic use. Preclinical studies are subject to federal regulations and requirements,
including GLP regulations. The results of an applicant's preclinical studies are submitted to the FDA as part of an IND. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
IND is a request for authorization from the FDA to administer an investigational new drug product to humans. An IND is an exemption from the FDCA that allows an unapproved drug to be
shipped in interstate commerce for use in an investigational clinical trial. Such authorization must be secured prior to interstate shipment and administration of a biologic that is not subject of an
approved BLA. In support of a request for an IND, applicants must submit a protocol for each clinical trial. Any subsequent protocol amendments must be submitted to the FDA as part of the IND. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Human
clinical trials may not begin until an IND is effective. The IND automatically becomes effective 30&nbsp;days after receipt by the FDA, unless the FDA raises safety concerns or
questions about the proposed clinical trial within the 30-day time period. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns
or questions before the clinical trial can begin. Submission of an IND therefore may or may not result in FDA authorization to begin a clinical trial. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA may also place a clinical hold or partial clinical hold on such trial following commencement of a clinical trial under an IND. A clinical hold is an order issued by the FDA to
the sponsor to delay a proposed clinical investigation or to suspend an ongoing investigation. A partial clinical hold is a delay or suspension of only part of the clinical work requested under the
IND. For example, a specific protocol or part of a protocol is not allowed to proceed, while other protocols may do so. No more than 30&nbsp;days after imposition of a clinical hold or partial
clinical hold, the FDA will provide the sponsor a written explanation of the basis for the hold. Following issuance of a clinical hold or partial clinical hold, an investigation may only resume after
the FDA has notified the sponsor that the investigation may proceed. The FDA will base that determination on information provided by the sponsor correcting the deficiencies previously cited or
otherwise satisfying the FDA that the investigation can proceed. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clinical
trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with cGCP regulations, which
include the requirement that all research subjects provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other
things, the objectives of the trial, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. A separate submission to the existing IND must be made for each
successive clinical trial conducted during product development and for any subsequent protocol amendments. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
sponsor may choose, but is not required, to conduct a foreign clinical study under an IND. When a foreign clinical study is conducted under an IND, all FDA IND requirements must be met
unless waived. When the foreign clinical study is not conducted under an IND, the sponsor must ensure that the study complies with cGCP regulations in order to use the study as support for an IND or
application for marketing approval, including cGCP regulations, including review and approval by an independent ethics committee and informed consent from subjects. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Furthermore,
an independent IRB for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial and its informed consent form before the
clinical trial begins at that site, and must monitor the trial until completed. Regulatory authorities, the IRB or the sponsor may suspend a clinical trial at any time on various grounds, including a
finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>117</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=120,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=59468,FOLIO='117',FILE='DISK125:[19ZCO1.19ZCO70301]DZ70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dz70301_1_118"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Some
trials also include oversight by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board, or DSMB. DSMBs provide
authorization for whether or not a trial may move forward at designated check points based on access to certain data from the trial and may halt the clinical trial if it determines that there is an
unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy. Other grounds for suspension or termination may be made based on evolving business objectives and/or
competitive climate. There are also requirements governing the reporting of ongoing clinical trials and clinical trial results to public registries. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Clinical Trials  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of BLA approval, clinical trials are typically conducted in the following sequential
phases:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Phase&nbsp;1: The investigational product is initially introduced into healthy human subjects or patients with the target disease or
condition. These trials are designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans and the side effects associated with
increasing doses. These trials may also yield early evidence of effectiveness. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Phase&nbsp;2: The investigational product is administered to a limited patient population with a specified disease or condition to evaluate
the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. Multiple Phase&nbsp;2 clinical trials may be conducted to obtain
information prior to beginning larger and more expensive Phase&nbsp;3 clinical trials. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Phase&nbsp;3: The investigational product is administered to an expanded patient population to further evaluate dosage, to provide
statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to
generate sufficient data to statistically evaluate the efficacy and safety of the product for approval, to establish the overall risk/benefit ratio of the investigational product and to provide an
adequate basis for product approval by the FDA. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
phases may overlap or be combined. In some cases, the FDA may require, or companies may voluntarily pursue, additional clinical trials after a product is approved to gain more
information about the product, referred to as Phase&nbsp;4 trials. Such post-approval trials, when applicable, are conducted following initial approval, typically to develop additional data and
information relating to the biological characteristics of the product and treatment of patients in the intended therapeutic indication. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Progress
reports detailing the results of the clinical trials must be submitted at least annually to the FDA and more frequently if serious adverse events occur. In addition, IND safety
reports must be submitted to the FDA for any of the following: suspected serious and unexpected adverse reactions; findings from epidemiological studies, pooled analysis of multiple studies, animal or </FONT> <FONT SIZE=2><I>in vitro</I></FONT><FONT
SIZE=2> testing, or other clinical studies, whether or not conducted under an IND, and whether or not conducted by the sponsor, that suggest a
significant risk in humans exposed to the drug; and any clinically important increase in the rate of a serious suspected adverse reaction over such rate listed in the protocol or investigator
brochure. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
planned clinical trials may not be completed successfully within any specified period, or at all. Furthermore, the FDA or the sponsor may suspend or terminate a clinical trial at any
time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its
institution, or an institution it represents, if the clinical trial is not being conducted in accordance with the IRB's
requirements or if the drug has been associated with unexpected serious harm to patients. The FDA will typically inspect one or more clinical sites to assure compliance with cGCP and the integrity of
the clinical data submitted. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>118</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=121,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=90206,FOLIO='118',FILE='DISK125:[19ZCO1.19ZCO70301]DZ70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dz70301_1_119"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
clinical development, the sponsor often refines the indication and endpoints on which the BLA will be based. For endpoints based on patient-reported outcomes, or PROs, and outcome
reported outcomes, or OROs, the process typically is an iterative one. The FDA has issued guidance on the framework it uses to evaluate PRO instruments. Although the agency may offer advice on
optimizing PRO and ORO instruments during the clinical development process, the FDA usually reserves final judgment until it reviews the BLA. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrent
with clinical trials, companies often complete additional animal studies, and develop additional information about the chemistry and physical characteristics of the drug and
finalize a process for manufacturing the product in commercial quantities in accordance with cGMP. The manufacturing process must be capable of consistently producing quality batches of the drug
candidate and, among other things, must develop methods for testing the identity, strength, quality, purity and potency of the final drug. Additionally, appropriate packaging must be selected and
tested and stability studies must be conducted to demonstrate that the drug candidate does not undergo unacceptable deterioration over its shelf life. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


BLA Submission and Review  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assuming successful completion of all required clinical testing in accordance with all applicable regulatory requirements, an applicant may
submit a BLA requesting licensing to market the biologic for one or more indications in the United States. The BLA must include the results of product development, nonclinical studies and clinical
trials; detailed information on the product's chemistry, manufacture, controls; and proposed labeling. Under the Prescription Drug User Fee Amendments, a BLA submission is subject to an application
user fee, unless a waiver or exemption applies. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA will initially review the BLA for completeness before accepting it for filing. Under the FDA's procedures, the agency has 60&nbsp;days from its receipt of a BLA to determine
whether the application will be accepted for filing and substantive review. If the agency determines that the application does not meet this initial threshold standard, the FDA may refuse to file the
application and request additional
information, in which case the application must be resubmitted with the requested information and review of the application delayed. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
certain exceptions, BLAs must include a pediatric assessment, generally based on clinical trial data, of the safety and effectiveness of the biologic in relevant pediatric
populations. Under certain circumstances, the FDA may waive or defer the requirement for a pediatric assessment, either at the sponsor's request or by the agency's initiative. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
the BLA is accepted for filing, the FDA reviews the BLA to determine, among other things, whether a product is safe, pure and potent and if the facility in which it is
manufactured, processed, packed or held meets standards designed to assure the product's continued identity, strength, quality, safety, purity and potency. The FDA may convene an advisory committee to
provide clinical insight on application review questions. Before approving a BLA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA will not approve
an application unless it determines that the manufacturing processes and facilities comply with cGMP and are adequate to assure consistent production of the product within required specifications. In
addition, the FDA expects that all data be reliable and accurate, and requires sponsors to implement meaningful and effective strategies to manage data integrity risks. Data integrity is an important
component of the sponsor's responsibility to ensure the safety, efficacy and quality of its product or products. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA will typically inspect one or more clinical sites to assure compliance with cGCP regulations before approving a BLA. If the FDA determines that the application, manufacturing
process or manufacturing facilities are not acceptable, it will outline the deficiencies in the submission and often will request additional testing or information. Notwithstanding the submission of
any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>119</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=122,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=658025,FOLIO='119',FILE='DISK125:[19ZCO1.19ZCO70301]DZ70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dz70301_1_120"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FDA
performance goals generally provide for action on a BLA within 10&nbsp;months of filing, which (as discussed above) typically occurs within 60&nbsp;days of submission, but that
deadline is extended in certain circumstances. Furthermore, the review process is often significantly extended by FDA requests for additional information or clarification. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA may refer applications for novel products or products that present difficult questions of safety or efficacy to an advisory committee. Typically, an advisory committee consists
of a panel that includes clinicians and other experts who will review, evaluate and provide a recommendation as to whether the application should be approved and, if so, under what conditions. The FDA
is not bound
by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions and usually has followed such recommendations. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
the FDA evaluates a BLA and conducts inspections of manufacturing facilities where the investigational product and/or its components will be produced, the FDA may issue an approval
letter or a Complete Response Letter, or CRL. An approval letter authorizes commercial marketing of the biologic with specific prescribing information for specific indications. A CRL will describe all
of the deficiencies that the FDA has identified in the BLA, except that where the FDA determines that the data supporting the application are inadequate to support approval, the FDA may issue the CRL
without first conducting required inspections, testing submitted product lots and/or reviewing proposed labeling. If and when the deficiencies have been addressed to the FDA's satisfaction in a
resubmission of the BLA, the FDA will issue an approval letter. In issuing the CRL, the FDA may recommend actions that the applicant might take to place the BLA in condition for approval, including
requests for additional data, information or clarification. The FDA may delay or refuse approval of a BLA if applicable regulatory criteria are not satisfied, and may require additional testing or
information and/or require post-marketing studies and clinical trials. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the
regulatory criteria for approval. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the approval process, the FDA will determine whether a REMS is necessary to assure the safe use of the biologic. A REMS is a safety strategy to manage a known or potential serious
risk associated with a product and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans or
elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. If the FDA concludes that a REMS is needed, the BLA sponsor must submit a
proposed REMS and the FDA will not approve the BLA without a REMS that the agency has determined is acceptable. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the FDA approves a product, it may limit the approved indications for use for the product, or require that contraindications, warnings or precautions be included in the product
labeling. The FDA may also require that post-approval studies, including Phase&nbsp;4 clinical trials, be conducted to further assess the drug's safety after approval. The FDA may prevent or limit
further marketing of a product based on the results of post-market studies or surveillance programs. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA may also require testing and surveillance programs to monitor the product after commercialization. For biologics, such testing may include official lot release, which requires
the manufacturer to perform certain tests on each lot of the product before it is released for distribution. The manufacturer then typically must submit samples of each lot of product to the FDA,
together with a release protocol showing a summary of the history of manufacture of the lot and the results of all of the manufacturer's tests performed on the lot. The FDA may also perform certain
confirmatory tests on lots of some products itself, before releasing the lots for distribution by the manufacturer. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
approval, many types of changes to the approved product, such as adding new indications, manufacturing changes and additional labeling claims, are often subject to further testing
requirements and FDA review and approval, depending on the nature of the post-approval change. The FDA may
withdraw the product approval if compliance with pre- and post-marketing requirements is not maintained or if problems occur after the product reaches the marketplace. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>120</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=123,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=613050,FOLIO='120',FILE='DISK125:[19ZCO1.19ZCO70301]DZ70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dz70301_1_121"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pediatric Studies  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the Pediatric Research Equity Act, a BLA or BLA supplement thereto must contain data that are adequate to assess the safety and
effectiveness of the drug product for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the product
is safe and effective. Those plans must contain an outline of the proposed pediatric study or studies the applicant plans to conduct, including study objectives and design, any deferral or waiver
requests and any other information required by regulation. The applicant, the FDA and the FDA's internal review committee must then review the information submitted, consult with each other, and agree
upon a final plan. The FDA or the applicant may request an amendment to the plan at any time. In addition, the FDA Reauthorization Act of 2017 requires the FDA to meet early in the development process
to discuss pediatric study plans with drug sponsors. The law requires the FDA to meet with drug sponsors by no later than the end-of-Phase&nbsp;1 meeting for serious or life-threatening diseases and
by no later than 90&nbsp;days after the FDA's receipt of the study plan. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults,
or full or partial waivers from the pediatric data requirements. For example, the requirement for such studies or clinical trials may be waived if necessary studies or clinical trials in children are
impossible, there is strong evidence suggesting the drug will not be effective or safe in children, the drug does not represent a meaningful therapeutic benefit over existing therapies for children,
or the drug is not likely to be used in a substantial number of children. Such studies or clinical trials may also be deferred if the drug is ready for approval in adults before pediatric studies or
clinical trials are completed or due to concerns about the safety or effectiveness of the drugs in pediatric populations. When such studies or clinical trials are deferred, they will be reported as
post-marketing requirements. Pediatric data requirements do not apply to products with orphan designation. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Post-Approval Requirements  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any products manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including,
among other things, requirements relating to recordkeeping, periodic reporting, reporting of certain deviations and adverse experiences, product sampling and distribution and advertising and promotion
of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to FDA review and approval. There also are continuing user
fee requirements, under which FDA assesses an annual program fee for each product identified in an approved BLA. Biologic manufacturers and their third-party contractors are required to register their
establishments with the FDA and certain state agencies. These establishments are subject to routine and periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP
and data integrity requirements, which impose certain procedural and documentation requirements to assure quality of manufacturing and product. FDA has increasingly observed cGMP violations involving
data integrity during site inspections and is a significant focus of its oversight. Requirements with respect to data integrity include, among other things, controls to ensure data are complete and
secure; activities documented at the time of performance; audit trail functionality; authorized access and limitations; validated computer systems; and review of records for accuracy, completeness and
compliance with established standards. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Post-approval
changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require FDA approval before being implemented. FDA
regulations also require investigation and correction of any deviations from cGMP and impose reporting requirements upon us and any third-party manufacturers that we may decide to use. Accordingly,
manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP, data integrity, pharmacovigilance and other aspects of
regulatory compliance. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>121</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=124,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=371017,FOLIO='121',FILE='DISK125:[19ZCO1.19ZCO70301]DZ70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dz70301_1_122"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of
previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may
result in revisions to the approved labeling to add new safety information; imposition of post-approval studies or clinical trials to assess new safety risks; or imposition of distribution or other
restrictions under a REMS. Other potential consequences include, among other things:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> restrictions on the marketing or manufacturing of a product, complete withdrawal of the product from the market or product recalls; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> fines, Warning Letters, Untitled Letters or holds on post-approval clinical studies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of existing product
approvals; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> product seizure or detention, or refusal of the FDA to permit the import or export of products or Import Alert; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> permanent injunctions and consent decrees, including the imposition of civil or criminal penalties. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA strictly regulates the marketing, labeling, advertising and promotion of prescription drug products placed on the market. A company can make only those claims relating to safety
and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. The FDA's regulation includes, among other things, standards and regulations
for direct-to-consumer advertising, communications regarding unapproved uses, industry-sponsored scientific and educational activities and promotional activities involving the Internet and social
media. Promotional claims relating to a product's safety or effectiveness are prohibited before the drug is approved. After approval, a product generally may not be promoted for uses that are not
approved by the FDA, as reflected in the product's prescribing information. In the United States, healthcare professionals are generally permitted to prescribe drugs for such uses not described in the
drug's labeling, known as off-label uses, because the FDA does not regulate the practice of medicine. However, FDA regulations impose rigorous restrictions on manufacturers' communications,
prohibiting the promotion of off-label uses. It may be permissible, under very specific, narrow conditions, for a manufacturer to engage in non-promotional, non-misleading communication regarding
off-label information, such as distributing scientific or medical journal information. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a company is found to have promoted off-label uses, it may become subject to adverse public relations and administrative and judicial enforcement by the FDA, the DOJ or the Office of
the Inspector General of the Department of Health and Human Services, or HHS, as well as other federal and state authorities. This could subject a company to a range of penalties that could have a
significant commercial impact, including civil and criminal fines and agreements that materially restrict the manner in which a company promotes or distributes products. The federal government has
levied large civil and criminal fines against companies for alleged improper promotion, and has also requested that companies enter into consent decrees and permanent injunctions under which specified
promotional conduct is changed or curtailed. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
distribution of prescription drug and biologic are subject to the Drug Supply Chain Security Act, or DSCSA, which requires manufacturers and other stakeholders to comply with product
identification, tracing, verification, detection and response, notification and licensing requirements. In addition, the Prescription Drug Marketing Act, or PDMA, and its implementing regulations, and
state laws limit the distribution of prescription pharmaceutical product samples, and the DSCSA imposes requirements to ensure accountability in distribution and to identify and remove prescription
drug and biological products that may be counterfeit, stolen, contaminated, or otherwise harmful from the market. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>122</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=125,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=88819,FOLIO='122',FILE='DISK125:[19ZCO1.19ZCO70301]DZ70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dz70301_1_123"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Patent Term Restoration and Marketing Exclusivity  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After approval, owners of relevant drug or biological product patents may apply for up to a five year patent extension to restore a portion of
patent term lost during product development and FDA review of a BLA if approval of the application is the first permitted commercial marketing or use of a biologic containing the active ingredient
under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Act. The allowable patent term extension is calculated as one-half of the product's testing
phase, which is the time between IND and BLA submission, and all of the review phase, which is the time between BLA submission and approval, up to a maximum of five years. The time can be shortened if
the FDA determines that the applicant did not pursue approval with due diligence. The total patent term after the extension may not exceed more than 14&nbsp;years from the date of FDA approval of
the product. Only one patent claiming each approved product is eligible for restoration and the patent holder must apply for restoration within 60&nbsp;days of approval. The USPTO, in consultation
with the FDA, reviews and approves the application for patent term restoration. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
patents that might expire during the application phase, the patent owner may request an interim patent extension. An interim patent extension increases the patent term by one year
and may be
renewed up to four times. For each interim patent extension granted, the post-approval patent extension is reduced by one year. The director of the USPTO must determine that approval of the product
candidate covered by the patent for which a patent extension is being sought is likely. Interim patent extensions are not available for a product candidate for which a BLA has not been submitted. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Biosimilars and Marketing Exclusivities  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Biologics Price Competition and Innovation Act, or BPCIA, created an abbreviated approval pathway for biological product candidates shown to
be highly similar to or interchangeable with an FDA licensed reference biological product. Biosimilarity sufficient to reference a prior FDA-approved product requires that there be no differences in
conditions of use, route of administration, dosage form and strength, and no clinically meaningful differences between the biological product candidate and the reference product in terms of safety,
purity and potency. Biosimilarity must be shown through analytical trials, animal trials and at least one clinical trial, unless the Secretary of HHS waives a required element. A biosimilar product
candidate may be deemed interchangeable with a prior approved product if it meets the higher hurdle of demonstrating that it can be expected to produce the same clinical results as the reference
product and, for products administered multiple times, the biologic and the reference biologic may be switched after one has been previously administered without increasing safety risks or risks of
diminished efficacy relative to exclusive use of the reference biologic. To date, a handful of biosimilar products and no interchangeable products have been approved under the BPCIA. Complexities
associated with the larger, and often more complex, structures of biologics, as well as the process by which such products are manufactured, pose significant hurdles to implementation of the
abbreviated approval pathway that are still being worked out by the FDA. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
reference biologic is granted 12&nbsp;years of exclusivity from the time of first licensure of the reference product, and no application for a biosimilar can be submitted for four
years from the date of licensure of the reference product. The first biological product candidate submitted under the abbreviated approval pathway that is determined to be interchangeable with the
reference product has exclusivity against a finding of interchangeability for other biologics for the same condition of use for the lesser of (i)&nbsp;one year after first commercial marketing of
the first interchangeable biosimilar, (ii)&nbsp;18&nbsp;months after the first interchangeable biosimilar is approved if there is no patent challenge, (iii)&nbsp;18&nbsp;months after
resolution of a lawsuit over the patents of the reference biologic in favor of the first interchangeable biosimilar applicant, or (iv)&nbsp;42&nbsp;months after the first interchangeable
biosimilar's application has been approved if a patent lawsuit is ongoing within the 42&nbsp;month period. At this time, it is unclear whether products deemed "interchangeable" by the FDA will, in
fact, be readily substituted by pharmacies, which are governed by state pharmacy laws and regulations. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>123</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=126,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=369748,FOLIO='123',FILE='DISK125:[19ZCO1.19ZCO70301]DZ70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_dz70301_1_124"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a biologic is designated and approved for an orphan indication, it will be granted seven years of orphan drug exclusivity. An orphan indication is granted to biological products and
drugs designated and approved to treat diseases or conditions affecting fewer than 200,000 individuals in the United States, or if there is no reasonable expectation that the sponsor will be able to
recover the costs of developing and marketing the drug or biological product in the United States. A biosimilar may not be licensed by FDA for the protected orphan indication until after the
expiration of the seven year orphan drug exclusivity period or the 12&nbsp;year reference product exclusivity, whichever is later. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pediatric
exclusivity adds an additional six month exclusivity period to any marketing exclusivities and patents that a biological product has obtained. In order to obtain pediatric
exclusivity, a BLA sponsor must conduct pediatric studies as requested by the FDA in a Written Request. The data do not need to show the product to be effective in the pediatric population studied;
rather, if the clinical trial is deemed to fairly respond to the FDA's request, the additional protection is granted. If reports of requested pediatric studies are submitted to and accepted by the FDA
within the statutory time limits, whatever statutory or regulatory periods of exclusivity or patent protection cover the product are extended by six months. While pediatric exclusivity is not an
actual extension on a patent term, it effectively extends the preclusive effect of the patent on FDA's authority to approve another application that relies on the product with pediatric exclusivity. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
BPCIA is complex and continues to be interpreted and implemented by the FDA. The FDA has issued several guidance documents outlining an approach to review and approval of
biosimilars. In July 2018, the FDA released its Biosimilars Action Plan to improve the efficiency of the biosimilar and interchangeable product development and approval process. Other aspects of the
BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. As a result, the ultimate impact, implementation and impact of the BPCIA is subject
to significant uncertainty. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Regulation of Companion Diagnostics and Laboratory Developed Tests  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A companion diagnostic is an </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> diagnostic that can: identify the patients most likely to
benefit from a particular therapeutic product; identify those likely to be at an increased risk for serious side effects; or monitor responses to treatment with a particular therapeutic product for
the purpose of adjusting treatment to achieve improved safety or effectiveness. Under the FDCA, </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> companion diagnostics are generally regulated
as medical devices. The FDA has generally classified </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> companion diagnostics as high-risk, Class&nbsp;III devices, which require FDA approval
of a premarket approval application, or PMA, but recognizes the possibility of a moderate-risk IVD companion diagnostic (</FONT><FONT SIZE=2><I>i.e</I></FONT><FONT SIZE=2>.,&nbsp;Class&nbsp;II
device), which would require clearance of a 510(k) premarket notification or grant of a </FONT><FONT SIZE=2><I>de novo</I></FONT><FONT SIZE=2> request. Approval or clearance of the </FONT> <FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> companion
diagnostic device will ensure that the device has been adequately evaluated and has adequate performance characteristics in the
intended population. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
those </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> companion diagnostics that require PMA approval, the process involves gathering and submitting clinical and preclinical
data on the device for review by the FDA. It involves a rigorous premarket review, during which the applicant must provide the FDA with reasonable assurance of the device's safety and effectiveness,
as well as information regarding the device's design, manufacturing and labeling. In addition, the FDA will typically inspect the device manufacturer's facilities for compliance with the Quality
System Regulation, which imposes testing, control, documentation and other quality assurance requirements. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA has issued guidance on the approval of therapeutic products and </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> companion diagnostic devices. According to the FDA's
guidance, for novel therapeutic products including biologics, an </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> companion diagnostic device and its corresponding therapeutic should be
approved or cleared contemporaneously by the FDA for the use indicated in the therapeutic product's labeling. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>124</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=127,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=570273,FOLIO='124',FILE='DISK125:[19ZCO1.19ZCO70301]DZ70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_ea70301_1_125"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In some cases, information from a diagnostic test may be useful to a prescriber, but not necessary for the safe and effective administration of the therapeutic
product. In those cases, health care providers may employ information derived from a laboratory developed test, or LDT, when administering a therapeutic product. An LDT is a type of </FONT> <FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> diagnostic
test that is designed, manufactured and used within a single laboratory. LDTs can be used to measure or detect a wide variety of
analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Centers for Medicare and Medicaid Services, or CMS, regulates LDTs and the laboratories that develop them, and enforces the Clinical Laboratories Improvement Amendments, or CLIA. CMS
evaluates whether there is clinical utility for each specific test, and also performs postmarket oversight of laboratory operational processes. CMS's oversight through the CLIA program is designed to
confirm that a lab assesses analytical validity, but does not confirm whether it had results from an analytical validity assessment that were sufficient to support the claimed intended use of the
test. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Historically,
the FDA has generally not enforced premarket review and other FDA requirements on LDTs because LDTs were relatively simple lab tests and generally available on a limited
basis. Due to advances in technology, however, some LDTs are now much more complex, have a nationwide reach and present higher risks, such as detection of risk for breast cancer and Alzheimer's
disease, which are similar to those of other IV </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2> diagnostics that have undergone premarket review. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
FDA has announced that in the future it intends to assert jurisdiction over LDTs and proposed increasing regulatory requirements for LDTs through a risk-based framework. The FDA
received considerable resistance to its proposal, and to date generally exercises enforcement discretion with respect to LDTs, leaving responsibility to CMS. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New
laws, regulations or changes to existing laws, regulations and policies may result in changes to the requirements for LDTs or </FONT><FONT SIZE=2><I>in vitro</I></FONT><FONT SIZE=2>
diagnostic devices and to the FDA's compliance and enforcement policies. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Healthcare Regulation  </I></B></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pharmaceutical Coverage and Reimbursement  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our ability to successfully commercialize any of our product candidates for which we may receive regulatory approval will depend in significant
part on the availability of coverage and reimbursement from third-party payors, including governmental healthcare programs such as the Medicare and Medicaid programs in the U.S.; private health
insurers; managed care organizations; and other entities. Third-party payors establish the coverage and reimbursement policies for pharmaceutical products, and the marketability of any products for
which we may receive regulatory approval for commercial sale depends on those payors' coverage policies and reimbursement rates. Third-party payors may limit coverage to specific products on an
approved list, or formulary, which might not include one or more of our product candidates. Third-party payors, together with regulators and others,
are increasingly challenging the prices charged for pharmaceutical products and health services, in addition to their cost-effectiveness, safety and efficacy. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, no uniform policy for coverage and reimbursement exists in the United States. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting
their own coverage and reimbursement policies, but also have their own methods and approval process apart from Medicare determinations. Therefore, coverage and reimbursement rates can vary
significantly from payor to payor. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moreover,
obtaining coverage and adequate reimbursement is a time-consuming and costly process. We may be required to provide scientific and clinical support for the use of any product
to each third-party payor separately with no assurance that approval will be obtained, and we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the cost-effectiveness of
our products. We cannot be </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>125</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=128,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=847532,FOLIO='125',FILE='DISK125:[19ZCO1.19ZCO70301]EA70301A.;14',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_ea70301_1_126"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>certain
that our product candidates will be considered cost-effective by third-party payors. This process could delay the market acceptance of any product candidates for which we may receive approval
and could have a negative effect on our future revenues and operating results. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other U.S. Healthcare Laws and Compliance Requirements  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the United States, our business may be subject to healthcare fraud and abuse regulation and enforcement by both the federal government and
the states in which we conduct our business, particularly once third-party reimbursement becomes available for one or more of our products. The healthcare fraud and abuse laws and regulations that may
affect our ability to operate include but are not limited to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> The federal Anti-Kickback Statute, which prohibits, among other things, knowingly and willfully soliciting, receiving, offering or paying any
remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the
purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under the Medicare and Medicaid programs, or other federal
healthcare programs. A person or entity can be found guilty of violating the statute without actual knowledge of the statute or specific intent to violate it. The federal Anti-Kickback Statute has
been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, purchasers, and formulary managers on the other. Although there are a number of
statutory exceptions and regulatory safe harbors to the federal Anti-Kickback Law protecting certain common business arrangements and activities from prosecution or regulatory sanctions, the
exceptions and safe harbors are drawn narrowly, and practices that involve remuneration to those who prescribe, purchase, or recommend pharmaceutical and biological products, including certain
discounts, or engaging such individuals as speakers or consultants, may be subject to scrutiny if they do not fit squarely within an exception or safe harbor. Our practices may not in all cases meet
all of the criteria for safe harbor protection from anti-kickback liability. Moreover, there are no safe harbors for many common practices, such as educational and research grants or patient or
product assistance programs; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> The federal civil and criminal false claims laws and civil monetary penalty laws, including the civil False Claims Act, or FCA, which
prohibits, among other things, knowingly presenting, or causing to be presented, claims for payment of government funds that are false or fraudulent, or knowingly making, or using or causing to be
made or used, a false record or statement material to a false or fraudulent claim to avoid, decrease, or conceal an obligation to pay money to the federal government. Private individuals, commonly
known as "whistleblowers," can bring FCA </FONT><FONT SIZE=2><I>qui tam</I></FONT><FONT SIZE=2> actions, on behalf of the government and such individuals and may share in amounts paid by the entity
to the government in recovery or settlement. In addition, a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim
for purposes of the FCA. FCA liability is potentially significant in the healthcare industry because the statute provides for treble damages and significant mandatory penalties per false claim or
statement for violations. Criminal penalties, including imprisonment and criminal fines, are also possible for making or presenting a false, fictitious or fraudulent claim to the federal government; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> The federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which, among other things, prohibits executing a scheme to
defraud any healthcare benefit program, including private third-party payors, and prohibits (i)&nbsp;knowingly and willfully falsifying, concealing or covering up a material fact or making any
materially false, fictitious or fraudulent statement or representation and (ii)&nbsp;making or using any false writing or document knowing the same to contain any materially false, fictitious or
fraudulent statement or entry in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity can be found
guilty of violating the HIPAA fraud provisions without actual knowledge of the statute or specific intent to violate it; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>126</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=129,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=988238,FOLIO='126',FILE='DISK125:[19ZCO1.19ZCO70301]EA70301A.;14',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_ea70301_1_127"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective
implementing regulations, which impose requirements relating to the privacy, security and transmission of individually identifiable health information held by covered entities, including health plans,
healthcare clearinghouses and certain healthcare providers, and their business associates, individuals or entities that perform certain services on behalf of a covered entity that involve the use or
disclosure of individually identifiable health information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to
business associates and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorneys' fees and costs associated
with pursuing federal civil actions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> The federal Physician Payments Sunshine Act, being implemented as the Open Payments Program, which requires manufacturers of drugs, devices,
biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children's Health Insurance Program (with certain exceptions) to report annually to CMS information
related to direct or indirect payments and other transfers of value to physicians and teaching hospitals, as well as ownership and investment interests held in a company by physicians and their
immediate family members. Beginning in 2022, applicable manufacturers will also be required to report information regarding payments and transfers of value provided to physician assistants, nurse
practitioners, clinical nurse specialists, certified nurse anesthetists and certified nurse-midwives; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Analogous U.S. state and local laws and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing
arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers; state laws that require pharmaceutical companies to comply
with the pharmaceutical industry's voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to
healthcare providers; state laws that restrict the ability of manufacturers to offer co-pay support to patients for certain prescription drugs; state laws that require drug manufacturers to report
information related to clinical trials, or information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; state laws that require
drug manufacturers to report information on the pricing of certain drugs; state laws and local ordinances that require identification or licensing of sales representatives; and state laws governing
the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance
efforts. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
will be required to spend substantial time and money to ensure that our business arrangements with third parties comply with applicable healthcare laws and regulations. Even then,
governmental authorities may conclude that our business practices do not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws
and regulations. If governmental authorities find that our operations violate any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil,
criminal and administrative penalties, damages, fines, disgorgement, individual imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, and additional
reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, and we may be required to
curtail or restructure our operations. Moreover, we expect that there will continue to be federal and state laws and regulations, proposed and implemented, that could impact our operations and
business. In addition, the approval and commercialization of any product candidate we develop outside the United States will also likely subject us to foreign equivalents of the healthcare laws
mentioned above, among other foreign laws. The extent to which future legislation or regulations, if any, relating to health care fraud and abuse laws or enforcement, may be enacted or what effect
such legislation or regulation would have on our business remains uncertain. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>127</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=130,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=922182,FOLIO='127',FILE='DISK125:[19ZCO1.19ZCO70301]EA70301A.;14',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_ea70301_1_128"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Healthcare Reform  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the United States there have been, and continue to be, several legislative and regulatory changes and proposed reforms of the healthcare
system to contain costs, improve quality and
expand access to care. In the United States, there have been and continue to be a number of healthcare-related legislative initiatives that have significantly affected the pharmaceutical industry. For
example, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively, the ACA, was passed in March 2010, substantially
changing the way healthcare is financed by both governmental and private insurers and significantly impacting the U.S. pharmaceutical industry. Among other things, the ACA subjects biologics to
potential competition by lower-cost biosimilars; addresses a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled,
infused, instilled, implanted or injected; increases the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extends the rebate program to individuals enrolled in
Medicaid managed care organizations; establishes annual fees and taxes on manufacturers of certain branded prescription drugs; and creates a new Medicare Part&nbsp;D coverage gap discount program in
which, as a condition of coverage of its products under Medicare Part&nbsp;D, manufacturers must now agree to offer 70% point-of-sale discounts off negotiated prices of applicable brand drugs to
eligible beneficiaries during their coverage gap period. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Some
of the provisions of the ACA have yet to be fully implemented, while certain provisions have been subject to judicial and Congressional challenges. In addition, there have been
efforts by the Trump Administration to repeal or replace certain aspects of the ACA and to alter the implementation of the ACA and related laws. For example, Congress has considered legislation that
would repeal or repeal and replace all or part of the ACA. While Congress has not passed comprehensive repeal legislation, bills affecting the implementation of certain taxes under the ACA have been
signed into law. The Tax Cuts and Jobs Act of 2017, or the Tax Act, includes a provision repealing, effective January&nbsp;1, 2019, the tax-based shared responsibility payment imposed by the ACA on
certain individuals who fail to maintain qualifying health coverage for all or part of a year commonly referred to as the "individual mandate." On January&nbsp;22, 2018, President Trump signed a
continuing resolution on appropriations for fiscal year 2018 that delayed the implementation of certain ACA-mandated fees, including the so-called "Cadillac" tax on certain high cost
employer-sponsored insurance plans, the annual fee imposed on certain high cost employer-sponsored insurance plans, the annual fee imposed on certain health insurance providers based on market share
and the medical device excise tax on non-exempt medical devices. The Bipartisan Budget Act of 2018, or the BBA, among other things, amends the ACA, effective January&nbsp;1, 2019, to reduce the
coverage gap in most Medicare drug plans, commonly referred to as the "donut hole." Also, in 2018, CMS issued final rules permitting further collections and payments to and from certain ACA qualified
health plans and health insurance issuers under the ACA risk adjustment program in response to the outcome of federal district court litigation regarding the method CMS uses to determine this risk
adjustment. Additional legislative changes or regulatory changes related to the ACA remain possible. In December 2018, a United States District Court Judge for the Northern District of Texas ruled
that the entire ACA is invalid as a result of the tax penalty associated with the "individual mandate" being repealed by Congress as part of the Tax Act. This ruling is under appeal and stayed pending
appeal. It is unclear how this decision, subsequent appeals and other efforts to repeal, replace or invalidate the ACA, regulations promulgated under the ACA or portions thereof, will impact the ACA
and its implementation or our business. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several
recent U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing; reduce the cost of prescription
drugs under Medicare; review the relationship between pricing and manufacturer patient programs; and reform government program reimbursement methodologies for drugs. The Trump Administration's budget
proposals for fiscal 2019 and 2020 contain drug price control measures, including measures to permit Medicare Part&nbsp;D plans to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>128</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=131,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=866778,FOLIO='128',FILE='DISK125:[19ZCO1.19ZCO70301]EA70301A.;14',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_ea70301_1_129"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>negotiate
the price of certain drugs under Medicare Part&nbsp;B, to allow some states to negotiate drug prices under Medicaid and to eliminate cost sharing for generic drugs for low-income patients.
Further, the Trump Administration released a "Blueprint" to lower drug prices and reduce out of pocket costs of drugs that contains additional proposals to increase manufacturer competition, increase
the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out of pocket costs of drug products paid by consumers.
HHS has started soliciting feedback on some of these measures and, at the same, is implementing others under its existing authority. For example, in May 2019, CMS issued a final rule to allow Medicare
Advantage Plans the option of using step therapy for Part&nbsp;B drugs beginning January&nbsp;1, 2020. This final rule codified CMS's policy change that was effective January&nbsp;1, 2019.
Although a number of these and other proposed measures may require additional authorization to become effective, Congress and the Trump Administration have each indicated that they will continue to
seek new legislative and/or administrative measures to control drug costs. Individual states in the United States have also increasingly passed legislation and implemented regulations designed to
control pharmaceutical and biological product pricing, including price or patient reimbursement limitations, discounts, restrictions on certain product access and marketing cost disclosure and
transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional healthcare authorities and individual hospitals are
increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moreover,
on May&nbsp;30, 2018, the Right to Try Act was signed into law. The law, among other things, provides a federal framework for certain patients to access certain
investigational new drug products that have completed a Phase&nbsp;1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek
treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a pharmaceutical manufacturer to make its drug
products available to eligible patients as a result of the Right to Try Act. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employees  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of October&nbsp;23, 2019, we had 67 full-time employees, of which 52 were primarily engaged in research and development activities and 27
hold M.D. or Ph.D. degrees. None of our employees is represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Facilities  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our corporate headquarters are located in Beltsville, Maryland and consist of 11,329 square feet of office space, 13,579 square feet of
laboratory and manufacturing space and 10,209 square that we are in the process of converting into office space, or collectively the Current Space, under a lease that expires in August 2025, or the
Original Lease. In June 2019, we took possession of an additional 14,075 square feet of space to be used for future office, laboratory and manufacturing space under a new lease entered into in January
2019, or the New Lease. In August 2019, we entered into an amendment to the New Lease for an additional 14,446 square feet to be used for future office, laboratory and manufacturing space, which we
expect the landlord to deliver in April 2020. The New Lease expires in March 2030 and will also cover the Current Space upon expiration of the Original Lease. We believe that these facilities are
adequate for our current needs and that suitable additional or substitute space will be available in the future if needed. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Legal Proceedings  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From time to time, we may become involved in litigation or other legal proceedings as part of our ordinary course of business. We are not
currently a party to any litigation or legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>129</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=132,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=612930,FOLIO='129',FILE='DISK125:[19ZCO1.19ZCO70301]EA70301A.;14',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_ea70301_1_130"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ea70301_management"> </A>
<A NAME="toc_ea70301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  MANAGEMENT    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Officers and Directors  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth the name and position of each of our executive officers and directors, and their ages as of November&nbsp;12,
2019: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="45%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="45%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Age </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Position(s) </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Executive Officers and Employee Directors</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael Richman</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>58</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>President, Chief Executive Officer and Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Steven P. Cobourn, CPA</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>56</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Financial Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Kevin N. Heller, M.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>48</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Medical Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James B. Bingham, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Development Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sol Langermann, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Scientific Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Timothy Mayer, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Operating Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Linda Liu, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Senior Vice President, Research</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Non-Employee Directors</I></B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David Kabakoff, Ph.D.<SUP>(1)(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>71</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chair of our Board of Directors</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Elaine V. Jones, Ph.D.<SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>64</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chau Q. Khuong<SUP>(2)(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>43</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Judith J. Li<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Briggs Morrison, M.D.<SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Timothy M. Shannon, M.D.<SUP>(2)(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stephen W. Webster<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>58</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stella Xu, Ph.D.<SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Member
of the audit committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Member
of the compensation committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Member
of the nominating and corporate governance committee.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Officers  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B><I>Michael Richman</I></B></FONT><FONT SIZE=2> co-founded our company and has served as our President, Chief Executive Officer
and a member of our board of directors since October 2015. Mr.&nbsp;Richman served as President and Chief Executive Officer of Amplimmune,&nbsp;Inc. (now MedImmune,&nbsp;LLC), a
biopharmaceutical company focused on immuno-oncology, from 2007 to August 2015, including through Amplimmune's acquisition by AstraZeneca&nbsp;plc in October 2013. Before Amplimmune,
Mr.&nbsp;Richman served as Executive Vice President and Chief Operating Officer of MacroGenics,&nbsp;Inc., a biopharmaceutical company focused on the treatment of cancer, from 2002 to 2007.
Mr.&nbsp;Richman joined MacroGenics with approximately 20&nbsp;years' experience in corporate business development within the biotechnology industry. Mr.&nbsp;Richman has served as a director of
publicly traded Pieris Pharmaceuticals,&nbsp;Inc., a clinical-stage biotechnology company, since December 2014 and as a director of Madison Vaccines,&nbsp;Inc., a private company, since May 2014.
Mr.&nbsp;Richman was previously a member of the board of directors of GenVec,&nbsp;Inc. from April 2015 until its acquisition by Intrexon Corporation in June 2017 and Opexa
Therapeutics,&nbsp;Inc. from June 2006 until its acquisition by Acer Therapeutics in September 2017. Mr.&nbsp;Richman received a B.S. in genetics and molecular biology from the University of
California at Davis and an M.S.B.A. in international business from San Francisco State University. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that Mr.&nbsp;Richman is qualified to serve on our board of directors because of his service as our President and Chief Executive Officer, his service on the boards of other
private and public life </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>130</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=133,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=98196,FOLIO='130',FILE='DISK125:[19ZCO1.19ZCO70301]EA70301A.;14',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_ea70301_1_131"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>sciences
companies and his extensive knowledge of our company and industry, including comprehensive experience in financing, corporate management, research and business development. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Steven P. Cobourn, CPA</I></B></FONT><FONT SIZE=2> has served as our Chief Financial Officer since January 2018. Previously, he served as Chief Financial Officer of
Vaccinex,&nbsp;Inc., a biotechnology company, from May 2014 to January 2018. Prior to joining Vaccinex, Mr.&nbsp;Cobourn was the Vice President of Finance and Treasurer of Otsuka America
Pharmaceutical,&nbsp;Inc., a private pharmaceutical company, from 2003 to April 2014, and served in other roles at Otsuka America Pharmaceutical from 1993 to 2003. Prior to joining Otsuka America
Pharmaceutical, Mr.&nbsp;Cobourn was a Certified Public Accountant at Hass&nbsp;&amp; Company&nbsp;LLC, an accounting firm. Mr.&nbsp;Cobourn received a B.S. in business administration from Drexel
University and is a Certified Public Accountant. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Kevin N. Heller, M.D.</I></B></FONT><FONT SIZE=2> has served as our Chief Medical Officer since April 2018. He has also served as an Adjunct Professor at the Yale
University School of Medicine since October 2018. Dr.&nbsp;Heller served as head of antibody clinical development at Incyte Corporation, a biotechnology company, from May 2015 to April 2018 and as
Global Medical Lead for the vandetanib program at AstraZeneca&nbsp;plc from May 2013 to May 2015. Prior to joining AstraZeneca&nbsp;plc, Dr.&nbsp;Heller served as an early clinical development
lead for multiple programs, clinical strategy lead for ipilumumab and global lead for oncology search and evaluation in the business development group at Bristol-Meyers Squibb Company from 2007 to
2013. Dr.&nbsp;Heller received a B.S. in molecular biophysics and biochemistry from Yale University and an M.D. from George Washington University. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>James B. Bingham, Ph.D.</I></B></FONT><FONT SIZE=2> has served as our Chief Development Officer since December 2018 and previously served as our Senior Vice
President, Development and Manufacturing from October 2015 to December 2018. Dr.&nbsp;Bingham has also served as President of MMG Biopharmaceuticals Consulting,&nbsp;LLC since November 2008. Prior
to joining NextCure, Dr.&nbsp;Bingham held various positions at Amplimmune from 2007 to July 2015, including Senior Vice President of Development, Manufacturing and Quality from January 2013 to July
2015. Dr.&nbsp;Bingham served as Associate Director of Microbial Research&nbsp;&amp; Development at Cambrex Corporation and, after its acquisition of Cambrex, Lonza Group AG from 2006 to 2007.
Dr.&nbsp;Bingham also worked for Human Genome Sciences,&nbsp;Inc. (acquired by GlaxoSmithKline&nbsp;plc), or HGS, from 2000 to 2006. Prior to joining HGS, Dr.&nbsp;Bingham was also employed at
MedImmune and Integrated Genetics (now part of Laboratory Corporation of America Holdings). Dr.&nbsp;Bingham received a B.S. in biology from St.&nbsp;Michael's College and a Ph.D. in biological
chemistry from The Johns Hopkins University. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Sol Langermann, Ph.D.</I></B></FONT><FONT SIZE=2> has served as our Chief Scientific Officer since December 2018 and previously served as our Senior Vice President,
Research from October 2015 to December 2018. Prior to joining NextCure, Dr.&nbsp;Langermann served as Senior Vice President and Chief Scientific Officer of
Amplimmune from 2007 to July 2015. Dr.&nbsp;Langermann previously served as Chief Scientific Officer at PharmAthene,&nbsp;Inc., which was later acquired by Altimmune,&nbsp;Inc., from 2004 to
2007. Prior to PharmAthene, he held several positions at MedImmune,&nbsp;LLC, including Senior Director of Cell Biology, Director of Immunology and Molecular Genetics and Research Scientist in
Immunology. Dr.&nbsp;Langermann received a B.A. in philosophy of science from Columbia College, an M.L.A. in immunology from Harvard University and a Ph.D. in microbiology and molecular biology from
Tufts University. He completed his postdoctoral fellowship in mucosal immunology at Harvard University. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Timothy Mayer, Ph.D.</I></B></FONT><FONT SIZE=2> has served as our Chief Operating Officer since October 2019. He previously served as our Senior Vice President,
Corporate Development from December 2018 to October 2019 and our Vice President, Business Development from February 2016 to December 2018. Prior to joining NextCure, Dr.&nbsp;Mayer held several
positions at MacroGenics,&nbsp;Inc., a biopharmaceutical company focused on the treatment of cancer, from 2004 to February 2016, including Senior Director, Intellectual Property from 2009 to
February 2016. Prior to that, Dr.&nbsp;Mayer worked on biotechnology and pharmaceutical patent matters as a Technical Specialist at Banner&nbsp;&amp; Witcoff,&nbsp;Ltd., an intellectual property law
firm, from 2000 to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>131</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=134,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=830060,FOLIO='131',FILE='DISK125:[19ZCO1.19ZCO70301]EA70301A.;14',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<A NAME="page_ea70301_1_132"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>2004.
Dr.&nbsp;Mayer received a B.S. in microbiology and a B.S. in biochemistry from California Polytechnic State University and a Ph.D. in microbiology and immunology from the Pennsylvania State
University College of Medicine. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Linda N. Liu, Ph.D.</I></B></FONT><FONT SIZE=2> has served as our Senior Vice President, Research since December 2018 and previously served as our Vice President,
Translational Research from October 2015 to December 2018. Prior to joining NextCure, Dr.&nbsp;Liu held several positions at Amplimmune from 2007 to August 2015, including Executive Director of
Translational Science/Scientific Affairs and Vice President of New Product Development from January 2013 to August 2015. She served as a Senior Director of Biological Product Development at
MaxCyte,&nbsp;Inc., a clinical stage biotechnology company aimed at commercializing cell loading technology, from 2000 to 2007 and as a Senior Scientist at Osiris Therapeutics,&nbsp;Inc. from 1999
to 2000. Dr.&nbsp;Liu received a B.S. in virology and molecular biology from Wuhan University in China and a Ph.D. in virology and cell biology from the University of Texas at Austin. She conducted
her postdoctoral training in tumor cell biology at the St.&nbsp;Jude Children's Research Hospital. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Employee Directors  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B><I>David Kabakoff, Ph.D.</I></B></FONT><FONT SIZE=2> has served as Chair of our board of directors since December 2015.
Dr.&nbsp;Kabakoff has served as Executive Partner at Sofinnova Investments,&nbsp;Inc. since May 2007 and became a founding Partner of HealthQuest Capital in 2012. Dr.&nbsp;Kabakoff has served on
the board of directors of Castle Biosciences,&nbsp;Inc., a publicly traded company that develops and commercializes diagnostic and prognostic tests for dermatologic cancers, since September 2017,
and currently also serves on the board of directors of several privately held life sciences companies, including Lineagen,&nbsp;Inc., where he serves as chairman, Dauntless
Pharmaceuticals,&nbsp;Inc., Rainier Therapeutics, Neurana Pharmaceuticals, bioTheranostics,&nbsp;Inc. and Antiva Biosciences,&nbsp;Inc. Dr.&nbsp;Kabakoff previously served as a director of
several other publicly traded and privately held life sciences companies, including Principia Biopharma,&nbsp;Inc. from June 2016 to August 2018 in advance of Principia's September 2018 initial
public offering, publicly traded lnterMune,&nbsp;Inc. from November 2005 to September 2014 and Amplimmune. In 2001, Dr.&nbsp;Kabakoff co-founded Salmedix,&nbsp;Inc., a company that developed
cancer drug treatments, and served as the company's Chairman and Chief Executive Officer and led its acquisition in June 2005 by Cephalon,&nbsp;Inc. Previously, Dr.&nbsp;Kabakoff held the
positions of Executive Vice President of Dura Pharmaceuticals,&nbsp;Inc. and President and Chief Executive Officer of Spiros, both pharmaceutical companies, Chief Executive Officer of Corvas
International,&nbsp;Inc., a developer of biotherapeutics, and held senior executive positions with Hybritech, a biotechnology company. Dr.&nbsp;Kabakoff received a B.A. in chemistry from Case
Western Reserve University and a Ph.D. in chemistry from Yale University. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe Dr.&nbsp;Kabakoff is qualified to serve as a member of our board of directors due to his extensive experience in the biotechnology industry and his investing experience. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Elaine V. Jones, Ph.D.</I></B></FONT><FONT SIZE=2> has served as a member of our board of directors since December 2015. Dr.&nbsp;Jones served as Vice President,
Worldwide Business Development and Senior Partner at Pfizer Ventures, where she was responsible for making and managing venture investments of strategic interest to Pfizer&nbsp;Inc., from December
2008 to April 2019. Prior to joining Pfizer, Dr.&nbsp;Jones was a General Partner with EuclidSR Partners. She began her private equity career in 1999 at S.R. One, GlaxoSmithKline's venture fund.
Before that, she was Director of Scientific Licensing for SmithKline Beecham and a research scientist for SmithKline Beecham Pharmaceutical R&amp;D. Dr.&nbsp;Jones has served on the board of directors
of publicly traded CytomX Therapeutics,&nbsp;Inc., a clinical-stage biopharmaceutical company, since May 2019 (she also previously served on CytomX's board from December 2014 to June 2016) and
Gritstone Oncology,&nbsp;Inc., an immuno-oncology company, since September 2019 and currently serves on the board of directors for various privately held companies and as a trustee of Juniata
College. Dr.&nbsp;Jones previously served on the boards of directors of several publicly traded healthcare companies, including Mersana Therapeutics,&nbsp;Inc. from February 2015 to June 2018,
Mirna Therapeutics,&nbsp;Inc. from December 2012 to June 2016, Aquinox Pharmaceuticals,&nbsp;Inc. from June 2010 to February 2015 and Flexion Therapeutics,&nbsp;Inc. from December 2009 to June
2014. Dr.&nbsp;Jones received a B.S. in biology from Juniata College and a Ph.D. in microbiology from the University of Pittsburgh. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>132</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=135,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=746552,FOLIO='132',FILE='DISK125:[19ZCO1.19ZCO70301]EA70301A.;14',USER='JTAYLORA',CD='12-NOV-2019;10:14' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_ec70301_1_133"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that Dr.&nbsp;Jones is qualified to serve as a member of our board of directors due to her scientific and pharmaceutical industry background, as well
as her extensive experience in the venture capital industry. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Chau Q. Khuong</I></B></FONT><FONT SIZE=2> has served as a member of our board of directors since December 2015. Mr.&nbsp;Khuong has served as a Private Equity
Partner at OrbiMed Advisors&nbsp;LLC, a venture capital and asset management firm, since 2003. Mr.&nbsp;Khuong currently serves as a director of several publicly traded life sciences companies,
including BELLUS Health&nbsp;Inc. since December 2018, Synlogic,&nbsp;Inc. since February 2016, Inspire Medical Systems,&nbsp;Inc. since May 2014 and Aerpio Pharmaceuticals,&nbsp;Inc. since
April 2014, and previously served as a director of Nabriva Therapeutics&nbsp;plc (formerly Nabriva Therapeutics AG)
from April 2015 to August 2017, Otonomy,&nbsp;Inc. from August 2013 to July 2016 and as chairman of the board of directors of Pieris Pharmaceuticals,&nbsp;Inc. from December 2014 to November 2017.
Mr.&nbsp;Khuong has also served on the board of directors for several privately held companies. Mr.&nbsp;Khuong received a B.S. in molecular biology with concentration in biotechnology and a
M.P.H. with concentration in infectious diseases from Yale University. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that Mr.&nbsp;Khuong is qualified to serve as a member of our board of directors due to his extensive directorship and healthcare industry experience. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Judith J. Li</I></B></FONT><FONT SIZE=2> has served as a member of our board of directors since December 2015. Ms.&nbsp;Li has served as a Partner at Lilly Asia
Ventures, which focuses on early- and growth-stage life sciences investments, since April 2015 and prior to that served as Principal at Lilly Asia Ventures from November 2013 to April 2015.
Ms.&nbsp;Li has served as a director of Gritstone Oncology,&nbsp;Inc. since September 2017 and holds board appointments at a variety of Lilly Asia Ventures' private portfolio companies, including
Just Biotherapeutics,&nbsp;Inc. and Veritas Genetics&nbsp;Inc. From April 2014 to December 2017, she served on the board of Crown BioScience&nbsp;Inc., a biotechnology company that was publicly
listed on the Taiwan Stock Exchange until it was acquired in December 2017. Prior to joining Lilly Asia Ventures, Ms.&nbsp;Li served as a senior business analyst at McKinsey&nbsp;&amp; Company, worked
in hospital administration at Partners Healthcare, and co-founded an interventional nephrology medical device venture. Ms.&nbsp;Li received a B.A. in biology from Harvard University and an M.B.A.
from Harvard Business School. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that Ms.&nbsp;Li is qualified to serve on our board of directors due to her experience as a board member of biotechnology and pharmaceutical companies and her experience as
an investor in early-stage life sciences companies. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Briggs Morrison, M.D.</I></B></FONT><FONT SIZE=2> has served as a member of our board of directors since April 2019. Dr.&nbsp;Morrison has served as Executive
Partner at MPM Capital,&nbsp;Inc. since June 2015 and as Chief Executive Officer and a member of the board of directors of Syndax Pharmaceuticals,&nbsp;Inc., a publicly traded biopharmaceutical
company, since June 2015. Dr.&nbsp;Morrison has served as a member of the board of directors of Arvinas,&nbsp;Inc., a publicly traded biopharmaceutical company focused on therapies to degrade
disease-causing proteins, since June 2018 and prior to that as a member of its Scientific Advisory Board from August 2016 to June 2018. Before that, Dr.&nbsp;Morrison was the Chief Medical Officer
and Head of Global Medicines Development at AstraZeneca&nbsp;plc from January 2012 to June 2015. Before joining AstraZeneca, Dr.&nbsp;Morrison held several positions at Pfizer&nbsp;Inc.,
including Head, Medical Affairs, Safety and Regulatory Affairs for Pfizer's human health business. Dr.&nbsp;Morrison also previously held several positions at Merck Research Laboratories, a division
of Merck&nbsp;&amp;&nbsp;Co.,&nbsp;Inc., including Vice President, Clinical Sciences, Oncology. Dr.&nbsp;Morrison was a member of the executive committee of the Clinical Trials Transformation
Initiative sponsored by the FDA and is on the board of the Alliance for Clinical Research Excellence and Safety. Dr.&nbsp;Morrison also serves on the board of directors for multiple private
pharmaceutical companies. Dr.&nbsp;Morrison received a B.S. in biology from Georgetown University and an M.D. from the University of Connecticut Medical School. He completed residency training in
internal medicine at Massachusetts General Hospital and a fellowship in medical oncology at the Dana-Farber Cancer Institute. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>133</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=136,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=128431,FOLIO='133',FILE='DISK125:[19ZCO1.19ZCO70301]EC70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ec70301_1_134"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe Dr.&nbsp;Morrison is qualified to serve as a member of our board of directors due to his extensive executive leadership experience, his medical background and training and
his service on the boards of other public and private biopharmaceutical and biotechnology companies. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Timothy M. Shannon, M.D.</I></B></FONT><FONT SIZE=2> has served as a member of our board of directors since December 2015. Dr.&nbsp;Shannon has served as a General
Partner at Canaan Partners since November 2009. Dr.&nbsp;Shannon has also served as the chairman of the board of directors at publicly traded Arvinas,&nbsp;Inc. since July 2013, and on the board
of directors of IDEAYA Biosciences,&nbsp;Inc., a publicly traded oncology-focused precision medicine company, since March 2016. Dr.&nbsp;Shannon was the President and Chief Executive Officer of
Aldea Pharmaceuticals, a biopharmaceutical company focused on the treatment of toxic aldehyde-related diseases, from November 2010 to September 2013. Dr.&nbsp;Shannon also served as Chief Executive
Officer of CuraGen Corporation from 2007 to 2009 and as CuraGen's Chief Medical Officer from 2004 to 2007. From 1992 to 2002, Dr.&nbsp;Shannon served in various senior research and development roles
at Bayer Healthcare, including Senior Vice President of Worldwide Clinical Development. Dr.&nbsp;Shannon previously served as a member of the boards of directors of publicly traded CytomX
Therapeutics,&nbsp;Inc. from July 2012 to March 2017, Celldex Therapeutics,&nbsp;Inc. from October 2009 to December 2014 and CuraGen Corporation from September 2007 until its acquisition by
Celldex in October 2009. Dr.&nbsp;Shannon received a B.A. in chemistry from Amherst College and an M.D. from the University of Connecticut. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe Dr.&nbsp;Shannon is qualified to serve on our board of directors due to his extensive experience in the venture capital industry, his executive leadership experience, his
medical background and training and his service on the boards of other public and private biopharmaceutical companies. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Stephen W. Webster</I></B></FONT><FONT SIZE=2> has served as a member of our board of directors since April 2019. Mr.&nbsp;Webster has served as the Chief Financial
Officer of Spark Therapeutics,&nbsp;Inc., a publicly traded biotechnology company, since July 2014. He was previously Senior Vice President and Chief Financial Officer of Optimer
Pharmaceuticals,&nbsp;Inc., a publicly traded biotechnology company, from July 2012 until its acquisition by Cubist Pharmaceuticals,&nbsp;Inc. in October 2013. Prior to joining Optimer,
Mr.&nbsp;Webster served as SVP and Chief Financial Officer of Adolor Corporation, a biopharmaceutical company, from 2008 until its acquisition by Cubist Pharmaceuticals,&nbsp;Inc. in 2011. From
2007 until joining Adolor Corporation in 2008, Mr.&nbsp;Webster served as Managing Director, Investment Banking Division, Health Care Group for Broadpoint Capital&nbsp;Inc. (formerly First Albany
Capital). Mr.&nbsp;Webster served as co-founder, President and Chief Executive Officer for Neuronyx,&nbsp;Inc., a biopharmaceutical company, from 2000 to 2006. Mr.&nbsp;Webster previously served
in positions of increased responsibility, including as Director, Investment Banking Division, Health Care Group for PaineWebber Incorporated. Mr.&nbsp;Webster has served as a director of Nabriva
Therapeutics AG (formerly Nabriva Therapeutics&nbsp;plc), a publicly traded biopharmaceutical company, since August 2016 and Viking Therapeutics,&nbsp;Inc., a publicly traded biopharmaceutical
company, since May 2014. Mr.&nbsp;Webster received an A.B. in economics from
Dartmouth College and an M.B.A. in finance from The Wharton School of the University of Pennsylvania. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that Mr.&nbsp;Webster is qualified to serve as a member of our board of directors due to his extensive experience in the biopharmaceutical industry, particularly his service
as chief financial officer and on the boards of other public companies. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>Stella Xu, Ph.D.</I></B></FONT><FONT SIZE=2> has served as a member of our board of directors since November 2018. Dr.&nbsp;Xu has served as Managing Director of
Quan Capital, a life sciences venture fund with offices in China and the United States, since August 2017. Prior to joining Quan Capital, Dr.&nbsp;Xu served as Vice President and site head of Roche
Innovation Center Shanghai, and a member of the global management team for Roche's Immunology, Inflammation&nbsp;&amp; Infectious Diseases Discovery and Translation Area, from September 2012 to August
2017. Dr.&nbsp;Xu joined Roche from McKinsey&nbsp;&amp; Company. Dr.&nbsp;Xu has served as a director of Centrexion Therapeutics Corporation, a biopharmaceutical company focused on the treatment of
chronic pain, since January 2018 and previously served as a director of ARMO BioSciences,&nbsp;Inc., a publicly traded late-stage biopharmaceutical company focused on immuno-oncology, from August
2017 to July 2018 when </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>134</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=137,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=906504,FOLIO='134',FILE='DISK125:[19ZCO1.19ZCO70301]EC70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ec70301_1_135"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>it
was acquired by Eli Lilly and Company. Dr.&nbsp;Xu received a B.S. in biophysics from Peking University and a Ph.D. in immunology from Northwestern University. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that Dr.&nbsp;Xu is qualified to serve on our board of directors due to her extensive, global experience in the development and commercialization of innovative therapies. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Composition and Diversity  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors currently consists of nine members. Each of our current directors will continue to serve until the election and
qualification of his or her successor, or his or her earlier death, resignation or removal. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
nominating and corporate governance committee is responsible for reviewing with the board of directors, on an annual basis, the appropriate characteristics, skills and experience
required for the board of directors as a whole and its individual members. In evaluating the suitability of individual candidates (both new candidates and current members), the nominating and
corporate governance committee, in recommending candidates for election, and the board of directors, in approving (and, in the case of vacancies, appointing) such candidates, may take into account
many factors, including but not limited to the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> personal and professional integrity; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> ethics and values; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> experience in corporate management, such as serving as an officer or former officer of a publicly traded company; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> experience in the industries in which we compete; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> experience as a board member or executive officer of another publicly traded company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> diversity of expertise and experience in substantive matters pertaining to our business relative to other board members; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> diversity of background and perspective, including, but not limited to, with respect to race, gender or national origin; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> conflicts of interest; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> practical and mature business judgment. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have no formal policy regarding board diversity. Our board of directors evaluates each individual in the context of the board of directors as a whole, with the objective of assembling
a group that can best maximize the success of the business and represent stockholder interests through the exercise of sound judgment using its diversity of experience in these various areas. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Director Independence  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors has determined that none of our directors other than Mr.&nbsp;Richman has a relationship that would interfere with the
exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors is "independent" as that term is defined under Nasdaq rules. There are no family
relationships among any of our directors or executive officers. In making these determinations, our board of directors considered the current and prior relationships that each non-employee director
has with our company and all other facts and circumstances deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director and
the transactions involving them described in the section entitled "Certain Relationships and Related Party Transactions." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>135</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=138,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=393677,FOLIO='135',FILE='DISK125:[19ZCO1.19ZCO70301]EC70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ec70301_1_136"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Leadership Structure  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.&nbsp;Kabakoff currently serves as Chair of our board of directors. Our board of directors believes that separation of the positions of
Chair and Chief Executive Officer reinforces the independence of our board of directors from management, creates an environment that encourages objective oversight of management's performance and
enhances the effectiveness of our board of directors as a whole, and has concluded that our current board leadership structure is appropriate at this time. However, our amended and restated bylaws and
corporate governance guidelines provide our board of directors with flexibility to combine or separate the positions of Chair and Chief Executive Officer and to appoint a lead director in accordance
with its determination that utilizing one or the other structure would be in the best interests of our company. Our board of directors will continue to periodically review our leadership structure and
may make such changes in the future as it deems appropriate. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Classified Board of Directors  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In accordance with our amended and restated certificate of incorporation, our board of directors is divided into three classes with staggered,
three-year terms. At each annual meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of election and qualification until the third
annual meeting following election. Our directors are divided among the three classes as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the Class&nbsp;I directors are Ms.&nbsp;Li, Dr.&nbsp;Shannon and Dr.&nbsp;Xu, and their terms will expire at the annual meeting of
stockholders to be held in 2020; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the Class&nbsp;II directors are Dr.&nbsp;Jones, Mr.&nbsp;Khuong and Dr.&nbsp;Morrison, and their terms will expire at the annual
meeting of stockholders to be held in 2021; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the Class&nbsp;III directors are Dr.&nbsp;Kabakoff, Mr.&nbsp;Richman and Mr.&nbsp;Webster, and their terms will expire at the annual
meeting of stockholders to be held in 2022. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
amended and restated certificate of incorporation provides that the authorized number of directors may be changed only by resolution of the board of directors. Any additional
directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors.
The division of our board of directors into three classes with staggered three-year terms may delay or prevent a change of our management or a change in control of our company. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Role of the Board in Risk Oversight  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Risk assessment and oversight are an integral part of our governance and management processes. Our board of directors encourages management to
promote a culture that incorporates risk management into our corporate strategy and day-to-day business operations. Management discusses strategic and operational risks at regular management meetings
and conducts specific strategic planning and review sessions during the year that include a focused discussion and analysis of the risks facing us. Throughout the year, senior management reviews these
risks with the board of directors at regular board meetings as part of management presentations that focus on particular business functions, operations or strategies and presents the steps taken by
management to mitigate or eliminate such risks. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
board of directors does not have a standing risk management committee, but rather administers this oversight function directly through our board of directors as a whole, as well as
through various standing committees of our board of directors that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring
and assessing strategic risk exposure and our audit committee is responsible for overseeing our major financial risk exposures and the steps our management has taken to monitor and control these
exposures. The audit committee also monitors compliance with legal and regulatory requirements and considers and approves or disapproves </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>136</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=139,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=520351,FOLIO='136',FILE='DISK125:[19ZCO1.19ZCO70301]EC70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ec70301_1_137"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>any
related person transactions. Our nominating and corporate governance committee monitors the effectiveness of our corporate governance practices and of our board of directors. Our compensation
committee assesses and monitors whether any of our compensation policies and programs have the potential to encourage excessive risk-taking. While each committee is responsible for evaluating certain
risks and overseeing the management of such risks, our entire board of directors is regularly informed about such risks through committee reports. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Committees  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors has established an audit committee, a compensation committee and a nominating and corporate governance committee. Each of
these committees operates under a written charter approved by our board of directors that satisfies applicable SEC and Nasdaq standards. From time to time, our board of directors may establish other
committees to facilitate the management of our business. Each committee's charter is available under the Governance section of our website at </FONT> <FONT SIZE=2><I>www.nextcure.com</I></FONT><FONT SIZE=2>. The reference to our website address does
not constitute incorporation by reference of the information contained at or available
through our website. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Audit Committee  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The primary function of our audit committee is to oversee our corporate accounting and financial reporting process. Our audit committee's
responsibilities include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> appointing and retaining, approving the compensation of, overseeing and evaluating the independence, qualification and performance of our
independent registered public accounting firm; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> reviewing and discussing with management and the registered public accounting firm our annual and quarterly financial statements and related
disclosures; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> coordinating our board of directors' oversight of our internal control over financial reporting, disclosure controls and procedures and the
prompt reporting of violations of our code of business conduct and ethics </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> reviewing our critical accounting policies and estimates; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> discussing our risk management policies; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> reviewing and approving or ratifying any related person transaction; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> preparing the audit committee report required to be included in our annual proxy statement </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
members of our audit committee are Dr.&nbsp;Kabakoff, Ms.&nbsp;Li and Mr.&nbsp;Webster and Mr.&nbsp;Webster serves as the chair of the committee. Our board of directors has
determined that each of the members of our audit committee satisfies the financial literacy and sophistication requirements of the SEC and the Nasdaq listing rules. In addition, our board of directors
has determined that Mr.&nbsp;Webster qualifies as an audit committee financial expert under SEC rules. Under SEC rules, members of our audit committee must also meet heightened independence
standards. Our board of directors has determined that each of the members of our audit committee is independent under the applicable SEC and Nasdaq listing rules. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Committee  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our compensation committee oversees policies relating to compensation and benefits of our officers and employees. The compensation committee
reviews and approves or
recommends corporate goals and objectives relevant to compensation of our executive officers, evaluates the performance of these officers in light of those goals and objectives and approves the
compensation of these officers based on such evaluations. The compensation committee also reviews and approves or makes recommendations to our board of directors regarding the issuance of stock
options and other awards to our executive officers. The </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>137</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=140,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=103822,FOLIO='137',FILE='DISK125:[19ZCO1.19ZCO70301]EC70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ec70301_1_138"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>compensation
committee will review and evaluate, at least annually, the performance of the compensation committee and its members, including compliance by the compensation committee with its charter.
The members of our compensation committee are Dr.&nbsp;Shannon, Mr.&nbsp;Khuong, Dr.&nbsp;Kabakoff and Dr.&nbsp;Morrison and Dr.&nbsp;Shannon serves as chair of the committee. Each of the
members of our compensation committee is independent under the applicable Nasdaq listing rules and is a "non-employee director" as defined in Rule&nbsp;16b-3 promulgated under the Securities
Exchange Act of 1934, as amended, or the Exchange Act. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Nominating and Corporate Governance Committee  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our nominating and corporate governance committee is responsible for making recommendations to our board of directors regarding candidates for
directorships and the size and composition of our board of directors. In addition, our nominating and corporate governance committee is responsible for overseeing our corporate governance policies and
reporting and making recommendations to our board of directors concerning governance matters. The members of our nominating and corporate governance committee are Dr.&nbsp;Jones, Mr.&nbsp;Khuong,
Dr.&nbsp;Shannon and Dr.&nbsp;Xu and Dr.&nbsp;Jones serves as chair of the committee. Each of the members of our nominating and corporate governance committee is independent under the applicable
Nasdaq listing rules. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Committee Interlocks and Insider Participation  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of the members of our compensation committee has ever served as one of our officers or employees. None of our executive officers serves, or
has served during the last three fiscal years, as a member of the board of directors, compensation committee or other board committee performing equivalent functions of any entity that has one or more
executive officers serving as one of our directors or on our compensation committee. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Code of Business Conduct and Ethics  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We adopted a code of business conduct and ethics that applies to all of our directors, officers and employees, including those officers
responsible for financial reporting. A current copy of the code of business conduct and ethics is available under the Corporate Governance section of our website. We intend to disclose future
amendments to the code or any waivers of its requirements on our website. The reference to our website address does not constitute incorporation by reference of the information contained at or
available through our website. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Limitation on Liability and Indemnification Matters  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our amended and restated certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the
fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors,
except liability for:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> any breach of the duty of loyalty to us or our stockholders; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> any act or omission not in good faith that involves intentional misconduct or a knowing violation of law; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&nbsp;174 of the Delaware General
Corporation Law; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> any transaction from which the director derived an improper personal benefit. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
amended and restated bylaws provide that we are required to indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. Our amended and
restated bylaws also obligate us to advance expenses incurred by a director or officer in advance of the final disposition of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>138</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=141,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=471841,FOLIO='138',FILE='DISK125:[19ZCO1.19ZCO70301]EC70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ec70301_1_139"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>any
action or proceeding and permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of such person's actions in that capacity
regardless of whether we would otherwise be permitted to indemnify such person under Delaware law. We have entered and expect to continue to enter into agreements to indemnify our directors, executive
officers and other employees as determined by our board of directors. These indemnification agreements generally require us, among other things, to indemnify our directors, executive officers and
these employees against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct. These indemnification
agreements also generally require us to advance any expenses incurred by the directors, executive officers and employees as a result of any proceeding against them as to which they could be
indemnified. We believe that these provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. We also maintain directors' and officers'
liability insurance that insures our directors and officers against the cost of defense, settlement or payment of a judgment in some circumstances. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from
bringing a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our directors and officers, even though
an action, if successful, might benefit us and our stockholders. Further, a stockholder's investment may be adversely affected to the extent that we pay the costs of settlement and damage. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Employee Director Compensation  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the year ended December&nbsp;31, 2018, we did not pay any fees to, or make any equity or non-equity awards to, or pay any other
compensation to the non-employee members of our board of directors for their services as directors, except that we granted Dr.&nbsp;Kabakoff an option to purchase 37,342 shares of our common stock
at an exercise price of $7.63 per share. Prior to our IPO, we did not compensate any of our other non-employee directors for service on our board of directors. We did reimburse our non-employee
directors for travel and other necessary business expenses incurred in the performance of their service as directors. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with our IPO, our board of directors approved a compensation program for our non-employee directors, or the Non-Employee Director Compensation Program. Pursuant to this
program, our non-employee directors receive annual cash compensation as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the Chair of our board of directors receives a $65,000 annual retainer and each other non-employee director receives $35,000; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the chair of our audit committee receives a $15,000 annual retainer and each other member receives $7,500; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the chair of our compensation committee receives a $10,000 annual retainer and each other member receives $5,000; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the chair of our nominating and corporate governance committee receives a $8,000 annual retainer and each other member receives $4,000. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
fees under the Non-Employee Director Compensation Program are paid quarterly in arrears and are pro-rated for any partial quarters of service, and no per meeting fees are paid,
except that we reimburse non-employee directors for reasonable expenses incurred in connection with attending board and committee meetings. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the Non-Employee Director Compensation Program, each non-employee director is also entitled to receive an annual stock option award to purchase 11,000 shares of our common stock
that vests on the earlier of one year from the grant date of the award or the date of the next annual meeting of the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>139</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=142,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=377023,FOLIO='139',FILE='DISK125:[19ZCO1.19ZCO70301]EC70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ec70301_1_140"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>stockholders,
subject to continued service through the vesting date. Annual stock option grants for non-employee directors who were initially elected in the 12&nbsp;months preceding the annual grant
date will be pro-rated on a monthly basis for time in service. In addition, each non-employee director who is elected or appointed to our board of directors is entitled to receive an initial stock
option award to purchase 22,000 shares of our common stock that vests in three equal annual installments commencing on the grant date of the award, subject to continued service through the applicable
vesting date. All stock options granted pursuant to the Non-Employee Director Compensation Program are subject to the terms and provisions of the 2019 Plan. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Director Compensation Table  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As described above, we did not pay any cash or grant any stock awards or other compensation to our non-employee directors during 2018 for their
services as non-employee directors, except for the option granted to Dr.&nbsp;Kabakoff. Except as described below for Dr.&nbsp;Kabakoff, there were no outstanding stock awards or option awards
held by our non-employee directors as of December&nbsp;31, 2018. The table below sets forth information on the compensation of all our non-employee directors for the year ended December&nbsp;31,
2018. Michael Richman, our President and Chief Executive Officer, is also a member of our board of directors, but did not receive any additional compensation for his service as a director. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Awards<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Awards<BR>
($)<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David Kabakoff, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>182,888</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>182,888</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All other non-employee directors</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Amounts
in this column reflect the full grant date fair value of stock option awards granted during the year as measured pursuant to Financial Accounting Standards
Board Accounting Standards Codification Topic 718 and do not correspond to the actual value that may be recognized by the director in connection with the applicable awards. See Note&nbsp;11 to our
audited financial statements included elsewhere in this prospectus regarding assumptions underlying the valuation of equity awards.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>As
of December&nbsp;31, 2018, Dr.&nbsp;Kabakoff held 62,237 shares of restricted common stock that were purchased in May 2016 and are subject to repurchase
following termination, of which 10,372 shares were unvested and will vest in equal monthly installments through December&nbsp;29, 2019, subject to Dr.&nbsp;Kabakoff's continued service with us
through the applicable vesting date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>As
of December&nbsp;31, 2018, Dr.&nbsp;Kabakoff held an option to purchase 37,342 shares of our common stock. The option vests 25% on December&nbsp;21, 2019
and, thereafter, <SUP>1</SUP>/<SMALL>36</SMALL>th of the remaining option will vest on each monthly anniversary of the grant date.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>140</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=143,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=780830,FOLIO='140',FILE='DISK125:[19ZCO1.19ZCO70301]EC70301A.;11',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_ee70301_1_141"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ee70301_executive_compensation"> </A>
<A NAME="toc_ee70301_1"> </A></FONT> <FONT SIZE=2><B>  EXECUTIVE COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This section discusses the material components of the executive compensation program for our named executive officers, or NEOs, who are named in
the "Summary Compensation Table" below. As an "emerging growth company" as defined in the JOBS Act, we are not required to include a Compensation Discussion and Analysis section and have elected to
comply with the scaled
disclosure requirements applicable to emerging growth companies. In 2018, our NEOs and their positions were as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Michael Richman, President and Chief Executive Officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Steven P. Cobourn, Chief Financial Officer; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> Sol Langermann, Ph.D., Chief Scientific Officer. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Summary Compensation Table  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth information concerning the compensation of our NEOs for the year ended December&nbsp;31, 2018: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name and Principal Position

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Salary<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Bonus<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Awards<BR>
($)<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Non-Equity<BR>
Incentive Plan<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael Richman</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>383,400</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>1,963,224</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>154,480</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>493</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>2,501,597</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2><I>President and Chief Executive Officer</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Steven P. Cobourn, CPA</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
239,583</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR><SUP>(2)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
58,800</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
694,465</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
493</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
993,341</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Chief Financial Officer</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Sol Langermann, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2018</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
340,976</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
455,022</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
85,800</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
493</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
882,291</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2><I>Chief Scientific Officer</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Amounts
in this column reflect the full grant date fair value of stock option awards granted during the year as measured pursuant to Financial Accounting Standards
Board Accounting Standards Codification Topic 718 and do not correspond to the actual value that may be recognized by the director in connection with the applicable awards. See Note&nbsp;11 to our
audited financial statements included elsewhere in this prospectus regarding assumptions underlying the valuation of equity awards.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Mr.&nbsp;Cobourn's
employment commenced with us on January&nbsp;22, 2018. The 2018 salary reported reflects the pro rata portion of Mr.&nbsp;Cobourn's annual
salary of $250,000 earned during 2018 from commencement of his employment through December&nbsp;31, 2018.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Narrative to Summary Compensation Table  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Annual Base Salary  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have entered into employment agreements with each of our NEOs that establish annual base salaries, which are generally determined, approved
and reviewed periodically by our board of directors in order to compensate our NEOs for services rendered to our company. The base salary payable to each NEO is intended to provide a fixed component
of compensation reflecting the executive's skill set, experience, role and responsibilities. Base salaries for our NEOs have generally been set at levels deemed necessary to attract and retain
individuals with superior talent. In March 2018, the annual base salaries of Mr.&nbsp;Richman and Dr.&nbsp;Langermann were increased by 3% and 2.5% to $386,200 and $343,050, respectively.
Mr.&nbsp;Cobourn's annual base salary for 2018 was $250,000. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>141</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=144,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=715896,FOLIO='141',FILE='DISK125:[19ZCO1.19ZCO70301]EE70301A.;17',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ee70301_1_142"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Annual Bonus and Non-Equity Incentive Plan Compensation  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our NEOs are eligible to receive annual bonuses, which are determined at the discretion of our board of directors based upon, among other
things, the achievement of pre-determined performance milestones. For 2018, Mr.&nbsp;Richman and Dr.&nbsp;Langermann were each eligible to receive a target bonus of up to 35% and 25%,
respectively, of his base salary. Our board of directors reviewed performance for the fiscal year 2018 and based on the level of achievement of performance milestones determined to pay these bonuses
at target with the exception of Mr.&nbsp;Richman, who received a bonus of 40% of his base salary, which was above his target. At the time Mr.&nbsp;Cobourn joined our company in 2018, our board of
directors did not set a target bonus percentage for Mr.&nbsp;Cobourn. Mr.&nbsp;Cobourn's bonus was determined by our board of directors using the same pre-determined performance milestones used
for our other NEOs and represented 25% of his base salary pro-rated to reflect his start date of January&nbsp;22, 2018. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Awards  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although we do not have a formal policy with respect to the grant of equity incentive awards to our NEOs, we believe that equity grants provide
our NEOs with a strong link to our long-term performance, create an ownership culture and help to align the interests of our NEOs and our stockholders. Our board of directors and compensation
committee has historically been responsible for approving NEO equity grants, Our compensation committee is generally responsible for approving NEO equity grants. Vesting of equity awards is generally
tied to continuous service with us and serves as an additional retention measure. Our NEOs generally are awarded an initial new hire grant upon commencement of employment. Additional grants may occur
periodically in order to specifically incentivize executives with respect to achieving certain goals or to reward NEOs for exceptional performance. Prior to our IPO, we granted all awards pursuant to
our 2015 Omnibus Incentive Plan, or the 2015 Plan, the terms of which are described below under "&#151;Equity Compensation Plans&#151;2015 Omnibus Incentive Plan." </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
August 2018, our board of directors awarded Mr.&nbsp;Richman an option to purchase 118,249 shares of our common stock, Mr.&nbsp;Cobourn an option to purchase 74,684 shares of our
common stock and
Mr.&nbsp;Langermann an option to purchase 24,894 shares of our common stock, each at an exercise price of $1.77 per share. In December 2018, our board of directors awarded Mr.&nbsp;Richman an
option to purchase 373,422 shares of our common stock, Mr.&nbsp;Cobourn an option to purchase 124,474 shares of our common stock and Dr.&nbsp;Langermann an option to purchase 87,131 shares of our
common stock, each at an exercise price of $7.63 per share. With respect to each of the grants disclosed above, 25% vest on the one-year anniversary of the grant date, and, thereafter,
<SUP>1</SUP>/<SMALL>36</SMALL>th&nbsp;of the remaining options vest on each monthly anniversary of the grant date. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Outstanding Equity Awards at Fiscal Year-End  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table provides information regarding equity awards held by our NEOs that were outstanding as of December&nbsp;31, 2018. All of
the awards listed in this table were granted under the 2015 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>142</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=145,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=140376,FOLIO='142',FILE='DISK125:[19ZCO1.19ZCO70301]EE70301A.;17',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ee70301_1_143"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>Plan,
the terms of which are described below under "&#151;Equity Compensation Plans&#151;2015 Omnibus Incentive Plan." </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Unexercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Exercise<BR>
Price ($/sh) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Expiration<BR>
Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares of<BR>
Stock<BR>
That Have<BR>
Not Vested (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Market<BR>
Value of<BR>
Shares of<BR>
Stock<BR>
That Have<BR>
Not Vested ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael Richman</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3/15/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>43,565</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>56,014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3/15/2027</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8/27/2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>118,249</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.77</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8/27/2028</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/21/2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>373,422</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.63</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/21/2028</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>64,311</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>964,665</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(4)</SUP></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Steven P. Cobourn, CPA</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>8/27/2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
74,684</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR><SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
1.77</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
8/27/2028</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/21/2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>124,474</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.63</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/21/2028</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sol Langermann, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>9/1/2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
14,003</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
10,891</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR><SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
0.48</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
9/1/2026</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3/15/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,891</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,003</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3/15/2027</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8/27/2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>24,894</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1.77</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8/27/2028</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/21/2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>87,131</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.63</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12/21/2028</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>On
the one-year anniversary of the grant date, 25% of these options vest or vested and, thereafter, <SUP>1</SUP>/<SMALL>36</SMALL>th&nbsp;of the remaining options vest on
each monthly anniversary of the grant date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>On
March&nbsp;15, 2019, one quarter of the options vested and, thereafter, <SUP>1</SUP>/<SMALL>36</SMALL>th&nbsp;of the remaining options vest on each monthly anniversary
thereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Represents
unvested restricted common stock purchased by the NEO on October&nbsp;1, 2015 in connection with our founding. On December&nbsp;29, 2015, the NEO
entered into a stock restriction agreement pursuant to which 25% of the stock vested on the agreement date, 25% vested on the one-year anniversary of the agreement date and, thereafter,
<SUP>1</SUP>/<SMALL>36</SMALL>th&nbsp;of the remaining shares vest on each monthly anniversary of the agreement date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>The
market value of the stock award is based on our IPO price of $15.00 per share.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>On
January&nbsp;22, 2019, one quarter of the options vested and, thereafter, <SUP>1</SUP>/<SMALL>36</SMALL>th&nbsp;of the remaining options vest on each monthly anniversary
thereof.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employment Agreements with Named Executive Officers and Potential Payments Upon Termination or Change
in Control  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have entered into employment agreements with each of our NEOs, as described below. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
entered into a letter agreement with Michael Richman, our President and Chief Executive Officer, in August 2016 that governs the current terms of his employment with us. Pursuant to
that agreement, Mr.&nbsp;Richman (i)&nbsp;was entitled to an initial annual base salary of $375,000, which has since increased, (ii)&nbsp;is eligible to receive an annual bonus of up to 35% of
his base salary, (iii)&nbsp;in our board of directors' sole discretion, from time to time, is entitled to equity compensation awards under the 2015 Plan and (iv)&nbsp;receives health insurance
benefits and other benefits approved by our board of directors. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
entered into a letter agreement with Steven P. Cobourn, our Chief Financial Officer, in December 2017 that governs the current terms of his employment with us. Pursuant to that
agreement, Mr.&nbsp;Cobourn (i)&nbsp;was entitled to an initial annual base salary of $250,000, (ii)&nbsp;received an option to purchase 74,684 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>143</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=146,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=861084,FOLIO='143',FILE='DISK125:[19ZCO1.19ZCO70301]EE70301A.;17',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ee70301_1_144"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>shares
of our common stock under the 2015 Plan and (iii)&nbsp;receives health insurance benefits and other benefits approved by our board of directors. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
entered into a letter agreement with Sol Langermann, Ph.D., our Chief Scientific Officer, in August 2016 that governs the current terms of his employment with us. Pursuant to that
agreement, Dr.&nbsp;Langermann (i)&nbsp;was entitled to an initial annual base salary of $325,000, which has since increased, (ii)&nbsp;is eligible to receive an annual bonus of up to 25% of his
base salary, (iii)&nbsp;received an option to purchase 24,894 shares of our common stock under the 2015 Plan and (iv)&nbsp;receives health insurance benefits and other benefits approved by our
board of directors. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event Mr.&nbsp;Richman or Dr.&nbsp;Langermann's employment with us is terminated by us for any reason other than Cause (as defined in the employment agreements) or by the NEO
for Good Reason (as defined in the employment agreements), then he will be entitled to: (i)&nbsp;any unpaid salary for services rendered prior to the date of termination of employment;
(ii)&nbsp;any earned but unpaid annual bonus for any fiscal year prior to the year in which termination of employment occurs; (iii)&nbsp;reimbursement of any unreimbursed business expenses;
(iv)&nbsp;accrued but unused vacation; (v)&nbsp;any other payments, benefits or fringe benefits to which the NEO is entitled under the terms of any applicable compensation arrangement or benefit,
equity, program or grant; (vi)&nbsp;12&nbsp;months' base salary, in the case of Mr.&nbsp;Richman, and six months' base salary, in the case of Dr.&nbsp;Langermann, subject to certain conditions
and terms set forth in the employment agreement, including the execution of a release of claims; and (vii)&nbsp;health insurance coverage until the earlier of (a)&nbsp;six months following the
effective termination date or (b)&nbsp;the date upon which the NEO commences full-time employment. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Agreements  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have also entered into standard confidentiality and proprietary rights agreements with each of our NEOs pursuant to which each NEO has agreed
to protect our confidential, proprietary information and trade secret information indefinitely. Pursuant to these agreements, each NEO has agreed not to compete with us during his employment and for a
period of one year after the termination of his employment and not to solicit our employees during his
employment and for a period of one year after the termination of his employment. In addition, each NEO has agreed that there is a presumption that we own all inventions or works created by the NEO
(i)&nbsp;using our facilities, supplies, information, trade secrets or time, (ii)&nbsp;that are indirectly related to or arise out of our actual or proposed business, (iii)&nbsp;that relate to
any task assigned or performed by the NEO on our behalf or (iv)&nbsp;that are based on our confidential information. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Compensation Plans  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2015 Omnibus Incentive Plan  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors adopted, and our stockholders approved the 2015 Plan on December&nbsp;29, 2015, which was subsequently amended to
increase the number of shares issuable under the 2015 Plan. The 2015 Plan is intended to enhance our company's ability to attract and retain highly qualified officers, directors, key employees and
other persons, and to motivate such persons to serve us and our affiliates and to expend maximum effort to improve the business results and our earnings, by providing to such persons an opportunity to
acquire or increase a direct proprietary interest in our operations and our future success. The 2015 Plan provides for the grant of stock options, restricted stock and stock units. No further awards
will be made under the 2015 Plan; however, awards outstanding under the 2015 Plan will continue to be governed by their existing terms. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Outstanding Awards  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of September&nbsp;30, 2019, options to purchase 2,001,678 shares of our common stock and 2,593 unvested shares of restricted stock were
outstanding under the 2015 Plan. If any shares covered by an award granted under the 2015 Plan are not purchased or are forfeited, expire or otherwise terminate </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>144</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=147,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=846767,FOLIO='144',FILE='DISK125:[19ZCO1.19ZCO70301]EE70301A.;17',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ee70301_1_145"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>without
delivery of any shares subject to the award, or are settled in cash in lieu of shares, then the number of shares subject to such award will, to the extent of any such forfeiture, termination,
expiration or settlement, again be available for future issuance under the 2019 Plan. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Administration  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The compensation committee of our board of directors generally administers the 2015 Plan. The administrator has complete discretion to make all
decisions relating to the 2015 Plan and outstanding awards. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Changes in Capitalization  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of a recapitalization, reclassification, stock split, reverse stock split, spin-off, combination of shares, exchange of shares,
stock dividend or other distribution payable in capital stock, or other increase or decrease in our shares of common stock effected without the receipt of consideration by us, then the number and kind
of shares for which grants of options and other awards may be made under the 2015 Plan will be adjusted proportionately and accordingly by the administrator of the 2015 Plan. In addition, the number
and kind of shares for which awards are outstanding, as well as the exercise price of outstanding options will be adjusted proportionately and accordingly by the administrator of the 2015 Plan. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Transaction  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors has the discretion to determine the effect of a "corporate transaction" (as defined in the 2015 Plan) on any outstanding
awards. Without limiting the generality of the foregoing, in connection with a corporate transaction, our board of directors may elect, in its sole discretion,
to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> cancel any outstanding awards and pay or deliver, or cause to be paid or delivered, to the holder of the award an amount in cash or securities
having a value (as determined by our board of directors acting in good faith) equal to the product of the number of shares subject to the award, or the Grant Shares, multiplied by, (i)&nbsp;in the
case of options, the amount, if any, by which (a)&nbsp;the formula or fixed price per share paid to holders of shares of our common stock pursuant to such transaction exceeds (b)&nbsp;the exercise
price applicable to such Grant Shares and (ii)&nbsp;in the case of restricted stock and stock units, the formula or fixed price per share paid to holders of shares of our common stock pursuant to
the transaction; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> provide in connection with such corporate transaction for the assumption or continuation of the options previously granted, or for the
substitution for such awards for new common stock options relating to the stock of a successor entity, or a parent or subsidiary thereof, with appropriate adjustments as to the number of shares
(disregarding any consideration that is not common stock) and exercise prices, such that awards previously granted will continue in the manner and under the terms so provided; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> cancel any outstanding awards that are unvested (or any unvested portion thereof) without payment to the holders of such awards; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> cancel any outstanding awards to the extent the exercise price applicable to the Grant Shares issuable under such awards is greater than the
formula or fixed price per share paid to holders of shares of our common stock pursuant to such transaction, with or without any payment to the holders of such awards. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we establish an exercise window in connection with a scheduled consummation of a corporate transaction, any exercise of an option during such period will be conditioned upon the
consummation of the event and will be effective only immediately before the consummation of the event. Upon the consummation of any corporate transaction, the 2015 Plan and all outstanding but
unexercised options will terminate. Our board of directors will send written notice of an event that will result in such a termination </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>145</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=148,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=313466,FOLIO='145',FILE='DISK125:[19ZCO1.19ZCO70301]EE70301A.;17',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ee70301_1_146"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>to
all individuals who hold options not later than the time at which we give notice of the event to the holders of our common stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
board of directors may, in its sole discretion, provide for the accelerated vesting or lapse of restrictions of awards at any time. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Plan Amendment and Termination  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors may amend or terminate the 2015 Plan or any outstanding award under the 2015 Plan at any time; provided that no amendment
may adversely impair a participant's rights under outstanding awards without his or her consent. Our stockholders must approve any amendment if such approval is required under applicable law or Nasdaq
listing rules. Unless terminated sooner by our board of directors or extended with stockholder approval, the 2015 Plan will terminate on December&nbsp;29, 2025. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2019 Omnibus Incentive Plan  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors adopted our 2019 Omnibus Incentive Plan, or the 2019 Plan, in April 2019 and our stockholders approved the 2019 Plan in
May 2019. The 2019 Plan became effective on May&nbsp;8, 2019 upon the effectiveness of the registration statement for our IPO. The purpose of the 2019 Plan is to provide eligible individuals with an
incentive to contribute to our success and to operate and manage our business in a manner that will provide for our long-term growth and profitability and that will benefit our stockholders and other
important stakeholders, including our employees and customers. The 2019 Plan is also intended to provide a means of recruiting, rewarding and retaining key personnel. The 2019 Plan provides for the
grant of stock options, stock appreciation rights, restricted stock, restricted stock units, deferred stock units, unrestricted stock, dividend equivalent rights, other equity-based awards and cash
bonus awards. The 2019 Plan replaces the 2015 Plan; however, awards outstanding under the 2015 Plan will continue to be governed by their existing terms. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Share Reserve  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The number of shares of our common stock reserved for issuance under the 2019 Plan is equal to the sum of (i)&nbsp;2,900,000 shares plus
(ii)&nbsp;any shares related to awards outstanding under the 2015 Plan on May&nbsp;8, 2019 that subsequently terminate by expiration or forfeiture, cancellation, or otherwise without the issuance
of such shares. The number of shares reserved for issuance under the 2019 Plan will automatically increase on January&nbsp;1st&nbsp;of each year during the term of the 2019 Plan, by a number equal
to 4% of the shares of common stock outstanding on December&nbsp;31st&nbsp;of the prior calendar year; however, our board of directors may provide that there will be no increase, or a smaller
increase, in the share reserve for a given calendar year. As of September&nbsp;30, 2019, options to purchase 247,275 shares of our common stock were outstanding under the 2019 Plan and 2,653,969
additional shares of our common stock remained available for future issuance. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any shares covered by an award granted under the 2019 Plan are not purchased or are forfeited or expire or otherwise terminate without delivery of any shares subject to the award, or
are settled in cash in lieu of shares, then the number of shares subject to such award will, to the extent of any such forfeiture, termination, expiration or settlement, again be available for future
issuance under the 2019 Plan. In addition, if shares subject to an award are applied to the exercise price or tax withholding obligations related to the award, such shares will again be available for
future issuance under the 2019 Plan. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Administration  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The 2019 Plan is administered by our board of directors or a committee of our board of directors to which our board of directors delegates such
administration (as applicable, the administrator). Subject to the terms of the 2019 Plan, the administrator has the complete discretion to determine the eligible individuals who are to receive awards
under the 2019 Plan, to determine the terms and conditions of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>146</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=149,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=267687,FOLIO='146',FILE='DISK125:[19ZCO1.19ZCO70301]EE70301A.;17',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ee70301_1_147"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>awards
granted under the 2019 Plan and to make all decisions related to the 2019 Plan and awards granted thereunder. The administrator also interprets the provisions of the 2019 Plan. Our board of
directors has delegated full authority to administer the 2019 Plan to its compensation committee. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Eligibility  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All of our employees and the employees of our affiliates are eligible to receive awards under the 2019 Plan. In addition, our non-employee
directors and certain consultants and advisors who perform services for us and our affiliates may receive awards under the 2019 Plan. However, only our employees and our subsidiaries are eligible to
receive incentive stock options. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Options  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The 2019 Plan authorizes our compensation committee to grant incentive stock options (under Section&nbsp;422 of the Internal Revenue Code of
1986, as amended, or the Code) and stock options that do not qualify as incentive stock options, or non-qualified stock options. The maximum number of shares that may be issued under the 2019 Plan
pursuant to the exercise of incentive stock options is 8,700,000. The compensation committee will determine the exercise price of each stock option, provided that the price must be equal to at least
the fair market value of our shares of common stock on the date on which the stock option is granted. If we were to grant incentive stock options to any 10% stockholder, the exercise price may not be
less than 110% of the fair market value of our shares of common stock on the date of grant. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
term of a stock option cannot exceed 10&nbsp;years from the date of grant. If we were to grant incentive stock options to any 10% stockholder, the term cannot exceed five years
from the date of grant. The compensation committee will determine at what time or times each stock option may be exercised and the period of time, if any, after death, disability or termination of
employment during which stock options may be exercised. Stock options may be made exercisable in installments. The compensation committee may accelerate the exercisability of stock options. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
aggregate fair market value, determined at the time of grant, of our common stock with respect to incentive stock options that are exercisable for the first time by a grantee during
any calendar year under all of our stock plans may not exceed $100,000. We will generally treat stock options or portions thereof that exceed such limit as non-qualified stock options. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Appreciation Rights  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The 2019 Plan authorizes our compensation committee to grant stock appreciation rights that provide the recipient with the right to receive,
upon exercise of the stock appreciation right, cash, shares of our common stock or a combination of the two. The amount that the recipient will receive upon exercise of the stock appreciation right
generally will equal the excess of the fair market value of our common stock on the date of exercise over the shares' fair market value on the date of grant. Stock appreciation rights will become
exercisable in accordance with terms determined by our compensation committee. Stock appreciation rights may be granted in tandem with a stock option grant or independently from a stock option grant.
The term of a stock appreciation right cannot exceed 10&nbsp;years from the date of grant. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Restricted Stock, Restricted Stock Units and Deferred Stock Units  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The 2019 Plan authorizes our compensation committee to grant restricted stock, restricted stock units and deferred stock units. Restricted stock
is an award of our common stock on which vesting restrictions are imposed that subject such shares of our common stock to a substantial risk of forfeiture, as defined in Section&nbsp;83 of the Code.
A restricted stock unit is an award that represents the right to receive a compensation amount, based on the value of our shares of common stock, if vesting criteria established by the compensation
committee are met. If the vesting criteria are met, we will settle restricted stock units in </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>147</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=150,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=491105,FOLIO='147',FILE='DISK125:[19ZCO1.19ZCO70301]EE70301A.;17',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ee70301_1_148"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>cash,
shares of our common stock or a combination of the two. A deferred stock unit is a restricted stock unit that may be settled at some point in the future at a time or times consistent with the
requirements of Section&nbsp;409A of the Code. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the provisions of the 2019 Plan, our compensation committee will determine the terms and conditions of each award of restricted stock, restricted stock units and deferred
stock units, including the restricted period for all or a portion of the award, the restrictions applicable to the award and the purchase price, if any, for the shares of our common stock subject to
the award. A grantee of restricted stock will have all the rights of a stockholder, including the right to vote the shares and receive dividends, except to the extent limited by our compensation
committee. However, all cash dividends
declared or paid on shares of restricted stock will not vest or become payable unless and until the shares of restricted stock to which the dividends apply become vested and nonforfeitable. In
addition, all stock dividend payments or distributions, if any, received by a grantee with respect to shares of restricted stock as a result of any stock split, stock dividend, combination of stock or
other similar transaction will be subject to the same vesting conditions and restrictions as applicable to such underlying shares of restricted stock. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grantees
of restricted stock units and deferred stock units will have no voting or dividend rights or other rights associated with stock ownership, although our compensation committee
may award dividend equivalent rights on such units. Dividend equivalent rights granted as a component of another award will not vest or become payable unless and until the award to which the dividend
equivalent rights correspond becomes vested and settled. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Dividend Equivalent Rights  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The 2019 Plan authorizes our compensation committee to grant dividend equivalent rights in connection with the grant of any equity-based award
other than stock options and stock appreciation rights. Dividend equivalent rights entitle the grantee to receive, or to receive credits for the future payment of, cash, shares of our common stock or
other property equal in value to dividend payments or distributions declared or paid by us with respect to a number of shares of our common stock specified in such dividend equivalent right (or other
award to which such right relates), as if such shares had been issued to and held by the grantee as of the record date of such dividend or distribution. Dividend equivalent rights may be paid
currently or may be deemed to be reinvested in additional shares of stock, which may thereafter accrue additional dividend equivalent rights and may be payable in cash, shares of our common stock or a
combination of the two; however, dividend equivalent rights granted as a component of another award will not vest or become payable unless and until the award to which the dividend equivalent rights
correspond becomes vested and settled. Our compensation committee will determine the terms of any dividend equivalent rights. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Equity-Based Awards  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The 2019 Plan authorizes our compensation committee to grant other types of equity-based awards under the 2019 Plan. Other equity-based awards
may be granted with vesting, value and/or payment contingent upon the achievement of one or more performance goals or other vesting conditions, and may be payable in cash, shares of our common stock
or a combination thereof. The terms and conditions that apply to other equity-based awards will be determined by our compensation committee. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Employee Director Compensation Limitation  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The 2019 Plan provides that the aggregate value of all awards granted under the plan and all other cash compensation paid by us to any of our
non-employee directors in any calendar year may not exceed $750,000; however, such amount will be $1.0&nbsp;million for the calendar year in which the non-employee director is initially elected or
appointed to our board of directors. Our board of directors may make exceptions to these limitations for individual non-employee directors in extraordinary circumstances, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>148</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=151,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=440056,FOLIO='148',FILE='DISK125:[19ZCO1.19ZCO70301]EE70301A.;17',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ee70301_1_149"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>provided
that the non-employee director receiving such additional compensation may not participate in the decision to award such compensation or in other contemporaneous compensation decisions
involving non-employee directors. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Changes in Capitalization  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of a recapitalization, reclassification, stock split, reverse stock split, spin-off, combination of shares, exchange of shares,
stock dividend or other distribution payable in capital stock, or other increase or decrease in our shares of common stock effected without the receipt of consideration by us, then the number and kind
of shares for which grants of options and other awards may be made under the 2019 Plan, including the maximum number of shares that may be issued upon the exercise of incentive stock options, will be
adjusted proportionately and accordingly by our compensation committee. In addition, the number and kind of shares for which awards are outstanding, as well as the exercise price of outstanding
options and stock appreciation rights, will be adjusted proportionately and accordingly by our compensation committee. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Change in Control  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in the applicable award agreement, in another agreement with a grantee, or as otherwise set forth in writing, upon
the occurrence of a "change in control" (as defined in the 2019 Plan) in which outstanding awards are not being assumed, continued or substituted for, the following provisions will apply to the
awards: (i)&nbsp;except for performance-based awards, all shares of restricted stock, restricted stock units, deferred stock units and dividend equivalent rights will be deemed to have vested and
any underlying shares of our common stock will be deemed delivered immediately before the change in control; and (ii)&nbsp;at our compensation committee's discretion, either all options and stock
appreciation rights will become exercisable 15&nbsp;days before the change in control (with any exercise of an option or stock appreciation right during such 15&nbsp;day period to be contingent
upon the consummation of the change in control) and terminate upon the change in control to the extent not exercised, or all options, stock appreciation rights, shares of restricted stock, restricted
stock units, deferred stock units and/or dividend equivalent rights will be canceled and cashed out in connection with the change in control. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the case of performance-based awards, if less than half of the performance period has lapsed, the award will be treated as though target performance has been achieved. If at least
half of the performance period has lapsed, actual performance to date will be determined as of a date reasonably proximal to the date of the consummation of the change in control, as determined by our
compensation committee in its sole discretion, and that level of performance will be treated as achieved immediately prior to the occurrence of the change in control. If our compensation committee
determines that actual performance is not determinable, the award will be treated as though target performance has been achieved. Any awards that arise after performance is determined in accordance
with this paragraph will be treated as set forth in the preceding paragraph. Other equity-based awards will be governed by the terms of the applicable award agreement. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
we experience a change in control in which outstanding awards will be assumed, continued or substituted for by the surviving entity, then, except as otherwise provided in the
applicable award agreement, in another agreement with a grantee, or as otherwise set forth in writing, upon the occurrence of the change in control, the 2019 Plan and the awards granted under the 2019
Plan will continue in the manner and under the terms so provided in the event of the change in control to the extent that provision is made in writing in connection with such change in control for the
assumption or continuation of such awards, or for the substitution for such awards with new awards, with appropriate adjustments as to the number of shares (disregarding any consideration that is not
common stock) and exercise prices of options and stock appreciation rights. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>149</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=152,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=172513,FOLIO='149',FILE='DISK125:[19ZCO1.19ZCO70301]EE70301A.;17',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_eg70301_1_150"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in the applicable award agreement, in another agreement with a grantee, or as otherwise set forth in writing, in the event a
grantee's award is assumed, continued, or substituted upon the consummation of any change in control and the service of such grantee with us or an affiliate of ours is terminated without "cause" (as
defined in the 2019 Plan) within 12&nbsp;months following the consummation of such change in control, such award will become fully vested and may be exercised in full, to the extent applicable,
beginning on the date of such termination and for the one-year period, or such longer period as may be determined by our compensation committee, immediately following such termination. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Clawback; Transferability  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All awards will be subject to mandatory repayment to us by a grantee to the extent the grantee is, or in the future becomes, subject to
(i)&nbsp;any "clawback" or recoupment policy by us or any of our affiliates that is adopted to comply with the requirements of any applicable laws, or (ii)&nbsp;any applicable laws which impose
mandatory recoupment, under circumstances set forth in such applicable laws. Except in limited circumstances, awards granted under the 2019 Plan may generally not be transferred in any manner prior to
vesting other than by will or by the laws of descent and distribution. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Plan Amendment and Termination  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our compensation committee may amend or terminate the 2019 Plan at any time; provided that no amendment may materially impair a participant's
rights under outstanding awards without his or her consent. Our stockholders must approve any amendment if such approval is required under applicable law or Nasdaq listing rules. Unless terminated
sooner by our board of directors or extended with stockholder approval, the 2019 Plan will terminate on the day before the tenth anniversary of the effective date of the registration statement of
which this prospectus is a part. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


No Repricing without Stockholder Approval  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except in connection with certain corporate transactions, we may not, without obtaining stockholder approval: (i)&nbsp;amend the terms of
outstanding options or stock appreciation rights to reduce the applicable exercise price; (ii)&nbsp;cancel outstanding options or stock appreciation rights in exchange for or substitution of options
or stock appreciation rights with an exercise price that is less than the exercise price of the original options or stock appreciation rights; or (iii)&nbsp;cancel outstanding options or stock
appreciation rights with an exercise price above the current stock price in exchange for cash or other securities. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2019 Employee Stock Purchase Plan  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors adopted the ESPP in April 2019 and our stockholders approved the ESPP in May 2019. The ESPP became effective on
May&nbsp;8, 2019 upon the effectiveness of the registration statement for our IPO. The purpose of the ESPP is to encourage and to enable eligible employees to acquire proprietary interests in our
company through the purchase and ownership of shares of our common stock. The ESPP is intended to benefit us and our stockholders by incentivizing participants to contribute to our success and to
operate and manage our business in a manner that will provide for our long-term growth and profitability and that will benefit our stockholders and other important stakeholders. The ESPP is intended
to qualify as an "employee stock purchase plan" within the meaning of Section&nbsp;423 of the Code. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Share Reserve  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The ESPP authorizes the issuance of up to 240,000 shares of our common stock pursuant to purchase rights granted to our employees or to
employees of any of our participating affiliates. The number of shares of our common stock reserved for issuance will automatically increase on January&nbsp;1st&nbsp;of each year, commencing on
January&nbsp;1, 2020 and continuing until the expiration of the ESPP, in an amount equal to the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>150</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=153,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=429295,FOLIO='150',FILE='DISK125:[19ZCO1.19ZCO70301]EG70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_eg70301_1_151"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>least
of (i)&nbsp;1% of the total number of shares of our common stock outstanding on December&nbsp;31st&nbsp;of the preceding calendar year, (ii)&nbsp;480,000 shares of our common stock
(subject to adjustment as provided in the ESPP) and (iii)&nbsp;a number of shares of our common stock determined by our board of directors or our compensation committee, as applicable; however, our
board of directors or our compensation committee, as applicable, may act prior to the first day of any calendar year to provide that there will be no increase in the share reserve for such calendar
year. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Administration  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The ESPP is administered under the direction of our board of directors, our compensation committee, or any other committee designated by our
board of directors. Our board of directors has delegated full authority to administer the ESPP to its compensation committee. Among other things, the compensation committee has the authority to
determine eligibility for participation in the ESPP, designate separate offerings under the plan and construe, interpret and apply the terms of the plan. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Eligibility  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All of our employees who are employed by us or our participating affiliates may be eligible to participate in the ESPP, provided that the
following employees are among those that are ineligible under the ESPP: (i)&nbsp;employees whose customary employment is 20&nbsp;hours or less per week; (ii)&nbsp;employees whose customary
employment is for not more than five months in any calendar year; and (iii)&nbsp;employees who, after exercising their rights to purchase our common stock under the ESPP, would own 5% or more of our
total combined voting power. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
employee may purchase shares of our common stock in any calendar year under the ESPP and under all other employee stock purchase plans having an aggregate fair market value in excess
of $25,000, determined as of the first trading day of the offering period. In addition, unless otherwise determined by our compensation committee, no employee may purchase more than 5,000 shares of
our common stock in any one offering period. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Offering Periods  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The ESPP is being implemented through a series of offerings under which eligible employees are granted purchase rights to purchase our common
stock on specified dates during such offerings. Our compensation committee will determine offering periods of not more than 27&nbsp;months and may permit periodic purchases of our common stock
within a single offering period. Unless otherwise established by our compensation committee prior to the start of an offering period, the plan will have two offering periods (with concurrent purchase
periods) that commence each calendar year, and each offering period will be of approximately six months' duration, with the first such offering period beginning on the first trading day of April and
ending on the last trading day of the immediately
following September, and the second such offering period beginning on the first trading day of October and ending on the last trading day of the immediately following March. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Payroll Deductions and Purchase Price  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Generally, all employees, including executive officers, employed by us or by any of our participating affiliates, may participate in the ESPP
and may contribute, normally through payroll deductions, up to 15% of their eligible compensation for the purchase of our common stock under the ESPP. Unless otherwise determined by our compensation
committee, the purchase price per share of our common stock under the ESPP will be 85% of the lesser of the average of the high and low sales price of our common stock on (i)&nbsp;the first trading
day of the relevant offering period and (ii)&nbsp;the last trading day of the relevant offering period (or, if the relevant offering period has multiple purchase periods, the last trading day of the
relevant purchase period). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>151</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=154,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=110350,FOLIO='151',FILE='DISK125:[19ZCO1.19ZCO70301]EG70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_eg70301_1_152"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Limitations on the Sale of Shares  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our compensation committee has the right to (i)&nbsp;require that an employee not request that all or a part of the shares of our common stock
purchased by the employee be reissued in the employee's own name and shares be delivered to the employee until two years have elapsed since the offering date of the offering period in which the shares
of our common stock were purchased and one year has elapsed since the day the shares of our common stock were purchased, or the holding period, (ii)&nbsp;require that any sales of our common stock
during the holding period be performed through a licensed broker acceptable to us and (iii)&nbsp;limit sales or other transfers of shares of our common stock for up to two years from the date the
employee purchases shares of our common stock under the ESPP. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Transactions  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that there occurs a change in our capital structure through such actions as a recapitalization, stock split, reverse stock split,
spin-off, combination of shares, exchange of shares, stock dividend or other distribution payable in capital stock, our compensation committee will make appropriate adjustments to the number and kind
of shares that may be purchased, and the number and kind of shares for which options are outstanding, under the ESPP. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event of certain significant corporate transactions, including (i)&nbsp;a dissolution or liquidation, (ii)&nbsp;a merger, consolidation or reorganization where we are not the
surviving entity, (iii)&nbsp;a sale of all or substantially all of our assets, or (iv)&nbsp;a merger or consolidation resulting in any person or entity owning more than 50% of the combined voting
power of all classes of our capital stock, the ESPP and all elections outstanding under the ESPP will terminate, except for certain situations where, for instance, the parties make arrangements for
the continuation or assumption of the ESPP. In the event of any such termination of the ESPP, the offering period and the purchase period will be deemed to have ended on the last trading day prior to
such termination, and the options of each participant then outstanding will be deemed to be automatically exercised on such last trading day. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Amendment, Suspension, or Termination  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The ESPP will terminate on the day before the 10th&nbsp;anniversary of the date of adoption of the ESPP by our board of directors, unless
earlier terminated. Our compensation committee may amend, suspend, or terminate the ESPP; however, any such amendment, suspension, or termination may not impair any vested rights without the
employee's consent. Our compensation committee may not increase the number of shares reserved for issuance under the ESPP without stockholder approval. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>152</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=155,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=630465,FOLIO='152',FILE='DISK125:[19ZCO1.19ZCO70301]EG70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_eg70301_1_153"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="eg70301_certain_relationships_and_related_party_transactions"> </A>
<A NAME="toc_eg70301_1"> </A>
<BR></FONT><FONT SIZE=2><B>  CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a description of transactions since January&nbsp;1, 2016 to which we have been or are to be a participant, in which the
amount exceeds $120,000, and in which any of our directors, executive officers or beneficial owners of more than 5% of any class of our voting securities, or any immediate family member of or person
sharing a household with any of the foregoing persons, had or will have a direct or indirect material interest, other than employment relationships with our executive officers and compensation to our
directors. Employment relationships with and compensation paid to our NEOs are described under the section entitled "Executive Compensation" and compensation to our directors is described in
"Management&#151;Non-Employee Director Compensation." </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Relationships with Yale University and Dr.&nbsp;Lieping Chen  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Consulting Agreement with Lieping Chen, M.D., Ph.D.  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In December 2015, we entered into a consulting agreement for advisory services with our scientific founder, Dr.&nbsp;Lieping Chen, who
beneficially owned more than 5% of our outstanding common stock at the time of the transaction. The term of the consulting agreement expires December&nbsp;31, 2020. Under the agreement,
Dr.&nbsp;Chen receives $5,000 per month in consulting fees until the expiration of the agreement. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Yale License Agreement and Sponsored Research Agreement  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In December 2015, we entered into a license agreement with Yale University, which beneficially owned more than 5% of our outstanding common
stock at the time of the transaction. Under the Yale Agreement, we obtained a license to products that either incorporate
certain licensed patents used in the discovery of targets or arise out of research and development of Dr.&nbsp;Chen's laboratory at Yale, including S15. We are obligated to pay Yale low single-digit
royalties on sales of products, including NC318, that are either covered by the patents licensed to us under the Yale Agreement or arise out of Dr.&nbsp;Chen's laboratory, subject to minimum annual
royalty payments in the low to mid hundreds of thousands of dollars. Until we are required to pay royalties under the Yale Agreement, we must pay an annual license maintenance fee to Yale in the mid
to high tens of thousands of dollars. In addition, with respect to each product covered by licenses under the Yale Agreement, we are obligated to pay Yale milestone payments in an aggregate amount of
up to approximately $3.0&nbsp;million. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the Yale Agreement, we also entered into the SRA with Yale, in which we agreed to provide an aggregate of up to $12.4&nbsp;million to fund a research program aimed
at discovering new targets for immunomedicines. The research program is under the direction and supervision of Dr.&nbsp;Chen. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.&nbsp;Chen
is the United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology) at Yale, and the
Co-Director of the Cancer Immunology Program at the Yale Cancer Center. For more information about the Yale Agreement and the SRA, see "Business&#151;Our Collaboration
Agreements&#151;Agreements with Yale University." </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Gift to Yale University  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In March 2016, we made a charitable contribution to Dr.&nbsp;Chen at Yale University of $500,000 to be used at Dr.&nbsp;Chen's discretion to
support research activities. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Relationship with Eli Lilly  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In November 2018, we entered into the Lilly Agreement, which is focused on the discovery and development of immunomedicines for oncology using
our FIND-IO platform. At the time of the transaction, Lilly beneficially owned more than 5% of our outstanding common stock. We received an upfront payment of $25.0&nbsp;million in cash and an
equity investment of $15.0&nbsp;million from Lilly upon entering into the Lilly Agreement and are eligible for support, option exercise and milestone payments of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>153</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=156,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=544148,FOLIO='153',FILE='DISK125:[19ZCO1.19ZCO70301]EG70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_eg70301_1_154"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>an
aggregate of up to $1.4&nbsp;billion, as well as mid to high single-digit royalties under the Lilly Agreement. Upon our exercise of an option with respect to a given target, we will owe Lilly
option exercise, milestone and royalty payments in amounts equivalent to a portion of the amounts payable by Lilly were Lilly to exercise an option. For more information on the Lilly Agreement, see
"Business&#151;Our Collaboration Agreements&#151;Research and Development Collaboration with Lilly." </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sales and Purchases of Securities  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Series&nbsp;A-2 and Series&nbsp;A-3 Preferred Stock Financings  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In January 2017, we issued and sold an aggregate of 25,000,000 shares of our Series&nbsp;A-2 Preferred Stock, at a purchase price of $1.00 per
share, for aggregate proceeds to us of $25&nbsp;million. In April 2018, we issued and sold an aggregate of 28,181,819 shares of our Series&nbsp;A-3 Preferred Stock, at a purchase price of $1.10
per share, for aggregate proceeds to us of approximately $31&nbsp;million. Each share of Series&nbsp;A-2 and Series&nbsp;A-3 Preferred Stock was converted into 0.1245 shares of common stock upon
the closing of our IPO. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
owners of 5% or more of a class of our voting stock and entities that may have been deemed to beneficially own 5% or more of a class of our voting stock purchased shares of our
Series&nbsp;A-2 and Series&nbsp;A-3 Preferred Stock in these financings. The following table summarizes those purchases: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Participants

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares of<BR>
Series&nbsp;A-2<BR>
Preferred<BR>
Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares of<BR>
Series&nbsp;A-3<BR>
Preferred<BR>
Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Purchase<BR>
Price </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OrbiMed Private Investments VI,&nbsp;LP<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,970,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,861,455</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12,417,601</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Canaan X&nbsp;L.P.<SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.970,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,861,455</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12,417,601</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sofinnova Venture Partners IX,&nbsp;L.P.<SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,732,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,301,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,763,600</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Pfizer&nbsp;Inc.<SUP>(4)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,477,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,396,091</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,313,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Entities associated with Lilly Asia Ventures<SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,477,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,396,091</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,313,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Alexandria Venture Investments,&nbsp;LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>372,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>365,727</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>774,780</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Chau
Q. Khuong, a member of our board of directors, is a Partner at OrbiMed Advisors&nbsp;LLC, which is associated with OrbiMed Private Investments VI,&nbsp;LP.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Timothy
M. Shannon, M.D., a member of our board of directors, is a managing member of Canaan Partners X&nbsp;LLC, the general partner of Canaan X&nbsp;L.P.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>David
Kabakoff, Ph.D., the Chair of our board of directors, is an Executive Partner at Sofinnova Investments,&nbsp;Inc., the management company of Sofinnova
Venture Partners IX,&nbsp;L.P.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>These
shares are directly owned by Pfizer Ventures (US)&nbsp;LLC, or Pfizer Ventures. Pfizer&nbsp;Inc. is the parent company of Pfizer Ventures and may be deemed
to beneficially own the shares directly owned by Pfizer Ventures. Elaine V. Jones, a member of our board of directors, was Vice President, Worldwide Business Development and Senior Partner at Pfizer
Ventures, which is associated with Pfizer&nbsp;Inc., when these shares were issued.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Consists
of 1,492,500 shares of Series&nbsp;A-2 Preferred Stock and 1,465,364 shares of Series&nbsp;A-3 Preferred Stock purchased by Lilly Asia Ventures Fund
III,&nbsp;L.P. and 2,985,000 shares of Series&nbsp;A-2 Preferred Stock and 2,930,727 shares of Series&nbsp;A-3 Preferred Stock purchased by LAV Biosciences Fund III,&nbsp;L.P. Judith J. Li, a
member of our board of directors, is a Partner at Lilly Asia Ventures, which is associated with Lilly Asia Ventures Fund III,&nbsp;L.P. and LAV Biosciences Fund III.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>154</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=157,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=677712,FOLIO='154',FILE='DISK125:[19ZCO1.19ZCO70301]EG70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_eg70301_1_155"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Series&nbsp;B Preferred Stock Financing  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In November 2018, we issued and sold an aggregate of 15,052,117 shares of our Series&nbsp;B-1 Preferred Stock at a purchase price of $1.59 per
share, 34,276,734 shares of our Series&nbsp;B-2 Preferred Stock at a purchase price of $1.59 per share and 7,500,000 shares of our Series&nbsp;B-3 Preferred Stock at a purchase price of $2.00 per
share. We received aggregate gross proceeds of approximately $93.4&nbsp;million for the sale of our Series&nbsp;B Preferred Stock. Each share of Series&nbsp;B Preferred Stock was converted into
0.1245 shares of common stock upon the closing of our IPO. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
owners of 5% or more of a class of our voting stock and entities that may have been deemed to beneficially own 5% or more of a class of our voting stock purchased shares of our
Series&nbsp;B-1, B-2 and B-3 Preferred Stock in these financings. The following table summarizes that participation: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Participants

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares of<BR>
Series&nbsp;B-1<BR>
Preferred<BR>
Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares of<BR>
Series&nbsp;B-2<BR>
Preferred<BR>
Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares of<BR>
Series&nbsp;B-3<BR>
Preferred<BR>
Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Purchase<BR>
Price </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OrbiMed Private Investments VI,&nbsp;LP<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,554,466</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,651,601</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Canaan X&nbsp;L.P.<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,296,605</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,651,602</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sofinnova Venture Partners IX,&nbsp;L.P.<SUP>(3)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,773,585</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Pfizer&nbsp;Inc.<SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,665,850</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,238,702</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Entities associated with Lilly Asia Ventures<SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,132,680</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,390,961</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Alexandria Venture Investments,&nbsp;LLC</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>628,931</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>HH NCure Holdings&nbsp;LLC<SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,861,636</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,500,001</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Quan Venture Fund II,&nbsp;L.P.<SUP>(7)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,861,636</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,500,001</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bay City Capital GF Xinde International Life Sciences USD Fund,&nbsp;L.P.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,716,982</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,500,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Citadel Multi-Strategy Equities Master Fund&nbsp;Ltd.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,144,655</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,000,001</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Taiho Ventures,&nbsp;LLC</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,144,655</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,000,001</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Ling Tong Investment Limited</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,144,654</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Entities associated with ArrowMark Partners</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,515,723</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Entities associated with NS Investment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,886,793</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Eli Lilly and Company</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,500,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>15,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Chau
Q. Khuong, a member of our board of directors, is a Partner at OrbiMed Advisors&nbsp;LLC, which is associated with OrbiMed Private Investments VI,&nbsp;LP.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Timothy
M. Shannon, M.D., a member of our board of directors, is a managing member of Canaan Partners X&nbsp;LLC, the general partner of Canaan X&nbsp;L.P.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>David
Kabakoff, Ph.D., the Chair of our board of directors, is an Executive Partner at Sofinnova Investments,&nbsp;Inc., the management company of Sofinnova
Venture Partners IX,&nbsp;L.P.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Elaine
V. Jones, a member of our board of directors, was Vice President, Worldwide Business Development and Senior Partner at Pfizer Ventures, which is associated
with Pfizer&nbsp;Inc., when these shares were issued.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Consists
of 710,893 shares of Series&nbsp;B-1 Preferred Stock purchased by Lilly Asia Ventures Fund&nbsp;III,&nbsp;L.P. and 1,421,787 shares of
Series&nbsp;B-1 Preferred Stock purchased by LAV Biosciences Fund&nbsp;III,&nbsp;L.P. Judith&nbsp;J.&nbsp;Li, a member of our board of directors, is a Partner at Lilly Asia Ventures, which
is associated with Lilly Asia Ventures Fund&nbsp;III,&nbsp;L.P. and LAV Biosciences Fund III.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Qingqing
Yi, a former member of our board of directors, is a Partner at Hillhouse Capital Group, which is associated with HH NCure Holdings&nbsp;LLC.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Stella
Xu, a member of our board of directors, is a Managing Director at Quan Capital, which is associated with Quan Venture Fund II,&nbsp;L.P.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>155</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=158,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=779579,FOLIO='155',FILE='DISK125:[19ZCO1.19ZCO70301]EG70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_eg70301_1_156"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the Series&nbsp;B Preferred Stock financing, we reimbursed (i)&nbsp;counsel for HH NCure Holdings&nbsp;LLC in the amount of $150,000, (ii)&nbsp;counsel for
Quan Venture Fund II,&nbsp;L.P., in the amount of $10,000 and (iii)&nbsp;counsel for Pfizer&nbsp;Inc., OrbiMed Private Investments VI,&nbsp;LP, Lilly Asia Ventures and Sofinnova Venture
Partners IX,&nbsp;L.P., collectively, in an aggregate amount of $45,000 for legal fees incurred by them. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Amended and Restated Investors' Rights Agreement  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with our Series&nbsp;B Preferred Stock financing in November 2018, we entered into an amended and restated investors' rights
agreement with the holders of our preferred stock. One stockholders is entitled to rights with respect to the registration of its shares under the
Securities Act in certain circumstances. For a more detailed description of these registration rights, see the section entitled "Description of Capital Stock&#151;Registration Rights." </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Voting Agreement  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with our Series&nbsp;A Preferred Stock financing, we entered into a voting agreement with the holders of our preferred stock and
the holders of our common stock with respect to election of our directors and certain other matters, which voting agreement was amended and restated in connection with our Series&nbsp;B Preferred
Stock financing in November 2018. The agreement terminated upon the closing of our IPO. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Management Rights Letters  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with our preferred stock financings, we entered into management rights letters with purchasers of our preferred stock with which
certain of our directors are affiliated, pursuant to which such purchasers were granted certain management rights, including the right to consult with and advise our management on significant business
issues, review our operating plans, examine our books and records and inspect our facilities. These management rights terminated upon the closing of our IPO. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Participation in our Initial Public Offering  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with our IPO, certain of our 5% stockholders and funds associated with certain of our directors purchased shares of our common
stock from the underwriters at the IPO price of $15.00 per share, and on the same terms as other investors in our IPO. The following table summarizes those purchases: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Participants

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares of<BR>
Common<BR>
Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Purchase<BR>
Price </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sofinnova Ventures,&nbsp;Inc.<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>400,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,000,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OrbiMed Advisors, New York<SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>350,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,250,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Pfizer&nbsp;Inc.<SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>200,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,000,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Quan Venture Fund II,&nbsp;L.P.<SUP>(4)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>125,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,875,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Canaan X&nbsp;LP<SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>50,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>750,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>David
Kabakoff, Ph.D., the Chair of our board of directors, is an Executive Partner at Sofinnova Investments,&nbsp;Inc., which is associated with Sofinnova
Ventures,&nbsp;Inc.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Chau
Q. Khuong, a member of our board of directors, is a Partner at OrbiMed Advisors&nbsp;LLC, which is associated with OrbiMed Advisors, New York.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>These
shares are directly owned by Pfizer Ventures. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>156</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=159,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=46107,FOLIO='156',FILE='DISK125:[19ZCO1.19ZCO70301]EG70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_eg70301_1_157"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Stella
Xu, a member of our board of directors, is a Managing Director at Quan Capital, which is associated with Quan Venture Fund II,&nbsp;L.P.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Timothy
M. Shannon, M.D., a member of our board of directors, is a managing member of Canaan Partners X&nbsp;LLC, which is associated with Canaan X&nbsp;LP. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Indemnification Agreements  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have entered into indemnification agreements with each of our directors and executive officers. These indemnification agreements generally
require us, among other things, to indemnify our directors and executive officers against liabilities that may arise by reason of their status
or service as directors or officers, other than liabilities arising from willful misconduct. These indemnification agreements also generally require us to advance any expenses incurred by the
directors and executive officers as a result of any proceeding against them as to which they could be indemnified. For more information regarding these agreements, see
"Management&#151;Limitation on Liability and Indemnification Matters." </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Policies and Procedures Regarding Transactions with Related Persons  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors adopted a written related person transaction policy, effective upon the closing of the IPO, setting forth the policies
and procedures for the review and approval or ratification of related person transactions. This policy covers, with certain exceptions set forth in Item&nbsp;404 of Regulation&nbsp;S-K under the
Securities Act, any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships in which we were or are to be a participant, where the amount
involved exceeds $120,000 and a related person had or will have a direct or indirect material interest. Types of transactions covered by this policy include, without limitation, purchases of goods or
services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related person. In reviewing
and approving any such transactions, our audit committee is tasked to consider all relevant facts and circumstances, including but not limited to whether the transaction is on terms comparable to
those that could be obtained in an arm's length transaction with an unrelated third party and the extent of the related person's interest in the transaction. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>157</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=160,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=639885,FOLIO='157',FILE='DISK125:[19ZCO1.19ZCO70301]EG70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_ei70301_1_158"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ei70301_principal_stockholders"> </A>
<A NAME="toc_ei70301_1"> </A></FONT> <FONT SIZE=2><B>  PRINCIPAL STOCKHOLDERS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth information relating to the beneficial ownership of our common stock as of November&nbsp;11, 2019,
by:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> each person, or group of affiliated persons, known by us to beneficially own more than 5% of our outstanding shares of common stock; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> each of our directors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> each of our NEOs; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> all of our directors and executive officers as a group. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
number of shares beneficially owned prior to this offering by each entity, person, director or executive officer is determined in accordance with SEC rules, and the information is
not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares over which the individual has sole or shared voting power or
investment power as well as any shares that the individual has the right to acquire within 60&nbsp;days of November&nbsp;11, 2019 through the exercise of any stock option or other rights. Except
as otherwise indicated, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of common stock held by that
person. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
percentage of shares beneficially owned is computed on the basis of 22,753,960 shares of our common stock outstanding on November&nbsp;11, 2019. The percentage of beneficial
ownership after this offering in the table below is based on 25,953,960 shares of common stock assumed to be outstanding after the closing of this offering, assuming no exercise of the underwriters'
option to purchase additional shares. Shares of our common stock that a person has the right to acquire within 60&nbsp;days of November&nbsp;11, 2019 are deemed outstanding for purposes of
computing the percentage ownership of the person holding such rights, but not for purposes of computing the percentage ownership of any other person, except with respect to the percentage ownership of
all directors and executive officers as a group. Except as set forth </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>158</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=161,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=750815,FOLIO='158',FILE='DISK125:[19ZCO1.19ZCO70301]EI70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:05' -->
<A NAME="page_ei70301_1_159"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>below,
the address for each beneficial owner listed is c/o NextCure,&nbsp;Inc., 9000 Virginia Manor Road, Suite&nbsp;200, Beltsville, Maryland 20705. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percentage of<BR>
Shares Beneficially<BR>
Owned </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares<BR>
Beneficially<BR>
Owned </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name of Beneficial Owner

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Before<BR>
Offering </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>After<BR>
Offering </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>5% Stockholders:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OrbiMed Advisors&nbsp;LLC<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,711,013</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11.91</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10.45</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sofinnova Venture Partners IX,&nbsp;L.P.<SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,521,856</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11.08</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9.72</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Canaan X&nbsp;L.P.<SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,254,442</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9.91</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8.69</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Pfizer&nbsp;Inc.<SUP>(4)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,970,759</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8.66</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.59</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Entities associated with Lilly Asia Ventures<SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,704,391</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.49</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.57</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Named Executive Officers and Directors:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael Richman<SUP>(6)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>599,420</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2.61</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2.31</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Steven P. Cobourn, CPA<SUP>(7)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>66,905</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sol Langermann, Ph.D.<SUP>(8)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>107,876</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David Kabakoff, Ph.D.<SUP>(9)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>71,573</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Elaine V. Jones, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chau Q. Khuong</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Judith J. Li</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Briggs Morrison, M.D.<SUP>(10)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,290</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Timothy M. Shannon, M.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stephen W. Webster</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stella Xu, Ph.D.<SUP>(11)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,103,570</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4.85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4.25</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>All executive officers and directors as a group (15 persons)</B></FONT><FONT SIZE=2><SUP>(12)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,314,074</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9.90</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8.92</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Indicates
beneficial ownership of less than 1% of the total outstanding common stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Based
solely on a Schedule&nbsp;13D filed by OrbiMed Advisors&nbsp;LLC and OrbiMed Capital&nbsp;GP VI&nbsp;LLC on May&nbsp;21, 2019. OrbiMed
Advisors&nbsp;LLC is the general partner of OrbiMed Capital&nbsp;GP VI&nbsp;LLC, the general partner of OrbiMed Private Investments VI,&nbsp;LP, which directly owns the shares. OrbiMed
Advisors&nbsp;LLC and OrbiMed Capital&nbsp;GP VI&nbsp;LLC may be deemed to have shared voting and dispositive power over the shares. Carl L. Gordon, Sven H. Borho and Jonathan T. Silverstein as
members of OrbiMed Advisors&nbsp;LLC's management committee share voting and dispositive power over the shares. The address for OrbiMed Advisors&nbsp;LLC is 601 Lexington Ave, 54th&nbsp;Floor,
New York, NY 10022.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Based
solely on a Schedule&nbsp;13D filed by Sofinnova Venture Partners IX,&nbsp;L.P. and Sofinnova Management IX, L.L.C. on May&nbsp;17, 2019. Sofinnova
Management IX, L.L.C., or SM IX, the general partner of Sofinnova Venture Partners IX,&nbsp;L.P., may be deemed to have sole voting and dispositive power with respect to, and Dr.&nbsp;Michael F.
Powell, Dr.&nbsp;James I. Healy and Dr.&nbsp;Anand Mehra, the managing members of SM IX, may be deemed to have shared power to vote and dispose of, the shares owned by Sofinnova Venture Partners
IX,&nbsp;L.P. The address for Sofinnova Venture Partners IX,&nbsp;L.P. is 3000 Sand Hill Rd., Bldg. 4, Suite&nbsp;250, Menlo Park, CA 94025.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Canaan
Partners X&nbsp;LLC is the sole general partner of Canaan X&nbsp;L.P. and may be deemed to have sole voting and dispositive power over the shares held by
Canaan X&nbsp;L.P. Investment, voting and dispositive decisions with respect to the shares held by Canaan X&nbsp;L.P. are made by the managers of Canaan Partners X&nbsp;LLC, collectively. None
of the managers of Canaan Partners X&nbsp;LLC has beneficial ownership (within the meaning of Rule&nbsp;13d-3 promulgated under the Exchange Act) of any shares held by Canaan X&nbsp;L.P. The
address for Canaan X&nbsp;L.P. is 285 Riverside Ave., Suite&nbsp;250, Westport, CT&nbsp;06880. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>159</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=162,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=12116,FOLIO='159',FILE='DISK125:[19ZCO1.19ZCO70301]EI70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:05' -->
<A NAME="page_ei70301_1_160"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Based
solely on a Schedule&nbsp;13G filed by Pfizer&nbsp;Inc. and Pfizer Ventures (US)&nbsp;LLC on May&nbsp;22, 2019. Pfizer&nbsp;Inc. has sole voting and
dispositive power with respect to 331,829 shares and shared voting and dispositive power with respect to 1,638,930 shares. As of October&nbsp;28, 2019, the board of directors of Pfizer&nbsp;Inc.
was comprised of the following individuals: Ronald E. Blaylock, Albert Bourla, W. Don Cornwell, Joseph J. Echevarria, Scott Gottlieb, Helen H. Hobbs, James M. Kilts, Dan R. Littman, Shantanu Narayen,
Suzanne Nora Johnson, Ian C. Read and James C. Smith. Pfizer&nbsp;Inc. is a publicly traded company. The address for Pfizer&nbsp;Inc. is 235 East 42nd&nbsp;St., New York, NY 10017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>LAV&nbsp;GP
III,&nbsp;L.P. is the General Partner of LAV Biosciences Fund III,&nbsp;L.P. and Lilly Asia Ventures Fund III,&nbsp;L.P. The Managing Partner of
LAV&nbsp;GP III,&nbsp;L.P. is Yi Shi, Ph.D. Dr.&nbsp;Shi may be deemed to have voting and dispositive power over the shares owned by LAV Biosciences Fund III,&nbsp;L.P. and Lilly Asia Ventures
Fund III,&nbsp;L.P. The address for Lilly Asia Ventures is Unit 902-904, Two Chinachem Central, 26 Des Voeux Road Central, Hong Kong.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Consists
of (a)&nbsp;385,869 shares of common stock, including up to 10,718 shares of restricted common stock subject to repurchase by us upon certain
terminations, and (b)&nbsp;213,551 shares of common stock issuable upon the exercise of stock options within 60&nbsp;days of November&nbsp;11, 2019. Our right of repurchase lapses in equal
monthly installments through December&nbsp;29, 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Consists
of 66,905 shares of common stock issuable upon the exercise of stock options within 60&nbsp;days of November&nbsp;11, 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Consists
of (a)&nbsp;37,342 shares of common stock, including up to 1,555 shares of restricted common stock subject to repurchase by us upon certain terminations,
and (b)&nbsp;70,534 shares of common stock issuable upon the exercise of stock options within 60&nbsp;days of November&nbsp;11, 2019. Our right of repurchase lapses in equal monthly installments
through December&nbsp;29, 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(9)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Consists
of (a)&nbsp;62,237 shares of restricted common stock subject to repurchase following termination, 1,729 of which are unvested and subject to forfeiture
following termination for any reason other than death or disability prior to December&nbsp;29, 2019 and (b)&nbsp;9,336 shares of common stock issuable upon the exercise of stock options within
60&nbsp;days of November&nbsp;11, 2019. The unvested restricted common stock will vest in equal monthly installments through December&nbsp;29, 2019, subject to Dr.&nbsp;Kabakoff's continued
service with us.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(10)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Consists
of 5,290 shares of common stock issuable upon the exercise of stock options within 60&nbsp;days of November&nbsp;11, 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(11)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Consists
of 1,103,570 shares of common stock directly owned by Quan Venture Fund II,&nbsp;L.P. Dr.&nbsp;Xu is a Managing Director and has voting and dispositive
power over the shares directly owned by Quan Venture Fund II,&nbsp;L.P.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(12)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Consists
of (a)&nbsp;1,697,931 shares of common stock, including 78,140 shares subject to repurchase or forfeiture, and (b)&nbsp;616,143 shares of common stock
issuable upon the exercise of stock options within 60&nbsp;days of November&nbsp;11, 2019.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>160</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=163,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=565605,FOLIO='160',FILE='DISK125:[19ZCO1.19ZCO70301]EI70301A.;18',USER='VRIVERA',CD='11-NOV-2019;23:05' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_ek70301_1_161"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ek70301_description_of_capital_stock"> </A>
<A NAME="toc_ek70301_1"> </A></FONT> <FONT SIZE=2><B>  DESCRIPTION OF CAPITAL STOCK    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><I>The following summary describes our capital stock and the material provisions of our amended and restated certificate of
incorporation and our amended and restated bylaws and of the Delaware General Corporation Law. Because the following is only a summary, it does not contain all of the information that may be important
to you. For a complete description, you should refer to our amended and restated certificate of incorporation and amended and restated bylaws, copies of which have been filed as exhibits to the
registration statement of which this prospectus is part.</I></FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our amended and restated certificate of incorporation authorizes 100,000,000 shares of common stock, $0.001 par value per share, and 10,000,000
shares of preferred stock, $0.001 par value per share, all of which shares of preferred stock are undesignated. Our board of directors may establish the rights and preferences of the preferred stock
from time to time. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of September&nbsp;30, 2019, there were outstanding:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 22,739,345 shares of our common stock held by approximately 40 stockholders of record; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> 2,248,953 shares of our common stock issuable upon exercise of outstanding stock options. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Common Stock  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Voting Rights  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each holder of our common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the
election of directors. Our stockholders do not have cumulative voting rights in the election of directors. Accordingly, holders of a majority of the
voting shares are able to elect all of the directors. In addition, the affirmative vote of holders of 66 <SUP>2</SUP>/<SMALL>3</SMALL>% of the voting power of all of the then outstanding voting stock will be
required to take certain actions, including amending certain provisions of our amended and restated certificate of incorporation, such as the provisions relating to the classified board. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Dividends  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled to receive
dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Liquidation  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets
legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then
outstanding shares of preferred stock. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rights and Preferences  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders of our common stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions
applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to and may be adversely affected by the rights of the holders of shares of any
series of our preferred stock that we may designate in the future. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>161</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=164,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=695280,FOLIO='161',FILE='DISK125:[19ZCO1.19ZCO70301]EK70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ek70301_1_162"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fully Paid and Nonassessable  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All of our outstanding shares of common stock are, and the shares of common stock to be issued in this offering will be, fully paid and
nonassessable. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Options  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of September&nbsp;30, 2019, options to purchase 2,001,678 shares of our common stock were outstanding under the 2015 Plan, with a weighted
average exercise price of $4.83 per share. No further awards will be made under the 2015 Plan. For additional information regarding the terms of the 2015 Plan, see "Executive
Compensation&#151;Equity Incentive Plans&#151;2015 Omnibus Incentive Plan." As of September&nbsp;30, 2019, options to purchase 247,275 shares of our common stock were outstanding under
the 2019 Plan, with a weighted average exercise price of $18.18 per share, and 2,653,969 additional shares of our common stock remained available for future issuance thereunder. For additional
information regarding the terms of the 2019 Plan, see "Executive Compensation&#151;Equity Incentive Plans&#151;2019 Omnibus Incentive Plan." </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Preferred Stock  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the terms of our amended and restated certificate of incorporation, our board of directors has the authority, without further action by
our stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and
privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting, or the designation
of, such series, any or all of which may be greater than the rights of common stock. The issuance of our preferred stock could adversely affect the voting power of holders of common stock and the
likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of our preferred stock could have the effect of delaying, deferring or
preventing a change in control of our company or other corporate action. No shares of preferred stock are currently outstanding, and we have no present plan to issue any shares of preferred stock. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Registration Rights  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the terms of our amended and restated investors' rights agreement, the holders of 6,336,439 shares of common stock, or their transferees,
have the right to require us to register their shares, or the registrable shares, under the Securities Act so that those shares may be publicly resold, and the right to include their shares in any
registration statement we file, in each case as described below. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Demand Registration Rights  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The holders of the registrable shares are entitled to certain demand registration rights. Beginning on November&nbsp;8, 2019, the holders of
at least 20% of these shares can, on not more than two occasions, request that we register all or a portion of their shares if the aggregate offering price of the shares would exceed
$10&nbsp;million (after deductions of underwriters' commissions and expenses). </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Piggyback Registration Rights  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that we determine to register any of our securities under the Securities Act (subject to certain exceptions), either for our own
account or for the account of other security holders, the holders of the registrable shares will be entitled to certain "piggyback" registration rights allowing the holders to include their shares in
such registration, subject to certain marketing and other limitations. As a result, whenever we propose to file&nbsp;a registration statement under the Securities Act, other than with respect to a
registration related to employee benefit plans, registration on a form that does not include substantially the same information as would be required to be included in a registration statement covering
the registrable </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>162</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=165,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=20284,FOLIO='162',FILE='DISK125:[19ZCO1.19ZCO70301]EK70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ek70301_1_163"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>shares,
a registration in which the only common stock being registered is common stock issuable upon conversion of debt securities also being registered, or corporate reorganizations or certain other
transactions, the holders of these shares are entitled to notice of the registration and have the right, subject to limitations that the underwriters may impose on the number of shares included in the
registration, to include their shares in the registration. In an underwritten offering, the underwriters have the right, subject to specified conditions, to exclude or limit the number of shares such
holders may include. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Form&nbsp;S-3 Registration Rights  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If we become and are eligible to file&nbsp;a registration statement on Form&nbsp;S-3, the holders of the registrable shares can make a
written request that we register their shares on Form&nbsp;S-3 if we are eligible to file&nbsp;a registration statement on Form&nbsp;S-3 and if the aggregate offering price of the shares is at
least $1&nbsp;million (after deductions of underwriters' commissions and expenses). These stockholders may make an unlimited number of requests for registration on Form&nbsp;S-3, but in no event
shall we be required to file more than two registrations on Form&nbsp;S-3 in any given 12-month period. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Expenses of Registration  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will pay the registration expenses of the holders of the shares registered pursuant to the demand, piggyback and Form&nbsp;S-3 registration
rights described above, including the reasonable expenses of one counsel for the selling holders. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Expiration of Registration Rights  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The demand, piggyback and Form&nbsp;S-3 registration rights described above will expire, with respect to any particular stockholder, upon the
earlier of May&nbsp;13, 2024 and when that
stockholder can sell all of its shares under Rule&nbsp;144 under the Securities Act without limitation during any three-month period without registration. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation, Our
Amended and Restated Bylaws and Delaware Law  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain provisions of Delaware law and our amended and restated certificate of incorporation and our amended and restated bylaws could make the
following transactions more difficult: acquisition of us by means of a tender offer; acquisition of us by means of a proxy contest or otherwise; or removal of our incumbent officers and directors. It
is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests,
including transactions that might result in a premium over the market price for our shares. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking
to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of an unfriendly
or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Delaware Anti-Takeover Statute  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are subject to Section&nbsp;203 of the Delaware General Corporation Law, which prohibits persons deemed "interested stockholders" from
engaging in a "business combination" with a publicly traded Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or
the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>163</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=166,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=702206,FOLIO='163',FILE='DISK125:[19ZCO1.19ZCO70301]EK70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ek70301_1_164"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>"interested
stockholder" is a person who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a
corporation's voting stock. Generally, a "business combination" includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The
existence of this provision may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors, such as discouraging takeover attempts that might result in
a premium over the market price of our common stock. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Undesignated Preferred Stock  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The ability to authorize undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other
rights or preferences that could impede the success of any attempt to change control of us. These and other provisions may have the effect of deterring hostile takeovers or delaying changes in control
or management of our company. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Special Stockholder Meetings  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our amended and restated bylaws provide that a special meeting of stockholders may be called only by our board of directors, our Chair,
President or Chief Executive Officer. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Requirements for Advance Notification of Stockholder Nominations and Proposals  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our amended and restated bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for
election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Elimination of Stockholder Action by Written Consent  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our amended and restated certificate of incorporation and our amended and restated bylaws eliminate the right of stockholders to act by written
consent without a meeting. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Classified Board; Election and Removal of Directors; Filling Vacancies; Board Size  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors is divided into three classes. The directors in each class will serve for a three-year term, one class being elected each
year by our stockholders, with staggered three-year terms. Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder
of their respective three-year terms. Because our stockholders do not have cumulative voting rights, our stockholders holding a majority of the shares of common stock outstanding will be able to elect
all of our directors. Our amended and restated certificate of incorporation provides for the removal of any of our directors only for cause and requires a stockholder vote by the holders of at least a
66 <SUP>2</SUP>/<SMALL>3</SMALL>% of the voting power of the then outstanding voting stock. For more information on the classified board, see "Management&#151;Classified Board of Directors." Any vacancy
on our board of directors, however occurring, including a vacancy resulting from an increase in the size of the board, may only be filled by a resolution of the board of directors unless the board of
directors determines that such vacancies shall be filled by the stockholders. Furthermore, the authorized number of directors may be changed only by a resolution of the board of directors. This system
of electing and removing directors, filling vacancies and fixing the size of the board may tend to discourage a third party from making a tender offer or otherwise attempting to obtain control of us,
because it generally makes it more difficult for stockholders to replace a majority of the directors. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Choice of Forum  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our amended and restated bylaws provide that unless we consent in writing to an alternative forum, the Court of Chancery of the State of
Delaware or, if subject matter jurisdiction of such action is vested </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>164</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=167,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=997229,FOLIO='164',FILE='DISK125:[19ZCO1.19ZCO70301]EK70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<A NAME="page_ek70301_1_165"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>exclusively
in the federal courts, the United States District Court for the District of Delaware will, to the fullest extent permitted by law, be the sole and exclusive forum for (i)&nbsp;any
derivative action or proceeding brought on our behalf, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any of our current or former directors, officers and employees,
(iii)&nbsp;any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our certificate of incorporation or our bylaws, (iv)&nbsp;any action or
proceeding to interpret, apply, enforce or determine the validity of our certificate of incorporation or the bylaws or (v)&nbsp;any action asserting a claim that is governed by the internal affairs
doctrine, in each case subject to the Court of Chancery or the United States District Court for the District of Delaware, as applicable, having personal jurisdiction over the indispensable parties
named as defendants therein. In addition, any person holding, owning or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and to have consented to this
provision of our bylaws. The choice of forum provision does not apply to any actions arising under the Securities Act or the Exchange Act. Although our amended and restated bylaws contain the choice
of forum provision described above, it is possible that a court could find that such a provision is inapplicable for a particular claim or action or that such provision is unenforceable. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Amendment of Charter Provisions  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amendment of any of the above provisions that are in our amended and restated certificate of incorporation, except for the provision making
it possible for our board of directors to issue undesignated preferred stock, would require approval by a stockholder vote by the holders of at least a 66<SUP>2</SUP>/<SMALL>3</SMALL>% of the voting power of the
then outstanding voting stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
provisions of the Delaware General Corporation Law, our amended and restated certificate of incorporation and our amended and restated bylaws could have the effect of discouraging
others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile
takeover attempts. These provisions may also have the effect of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions that
stockholders may otherwise deem to be in their best interests. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Limitation of Liability and Indemnification Matters  </B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For a discussion of liability and indemnification, see "Management&#151;Limitation on Liability and Indemnification Matters." </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Listing  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our common stock is listed on the Nasdaq Global Select Market under the symbol "NXTC". </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Transfer Agent and Registrar  </B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The transfer agent and registrar for our common stock is American Stock Transfer&nbsp;&amp; Trust Company,&nbsp;LLC. The transfer agent and
registrar's address is 6201 15th&nbsp;Avenue, Brooklyn, New York&nbsp;11219. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>165</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=168,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=330378,FOLIO='165',FILE='DISK125:[19ZCO1.19ZCO70301]EK70301A.;14',USER='VRIVERA',CD='11-NOV-2019;23:27' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_em70301_1_166"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="em70301_material_u.s._federal_income_t__mat03024"> </A>
<A NAME="toc_em70301_1"> </A></FONT> <FONT SIZE=2><B>  MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS OF COMMON STOCK    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of the material U.S. federal income tax consequences of the ownership and disposition of our common stock acquired in
this offering by a Non-U.S. Holder (as defined below). For purposes of this discussion, a Non-U.S. Holder is a beneficial owner of our common stock that is not a "U.S. person" or partnership,
including any entity or arrangement treated as a partnership and the equity holders therein, for U.S. federal income tax purposes. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
U.S. person is any of the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> an individual citizen or resident of the United States; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized under the laws of the United
States, any state thereof or the District of Columbia; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> a trust (i)&nbsp;whose administration is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have
the authority to control all substantial decisions of the trust, or (ii)&nbsp;that has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you are an entity or arrangement that is classified as a partnership for U.S. federal income tax purposes, the U.S. federal income tax treatment of a partner will generally depend on
the status of the partner and your activities. Partnerships holding our common stock and the partners in such partnerships are urged to consult their tax advisors as to particular U.S. federal income
tax consequences to them of holding and disposing of our common stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
discussion is based on the Code, administrative pronouncements, judicial decisions and final, temporary and proposed Treasury regulations, changes to any of which subsequent to the
date of this prospectus supplement may affect the tax consequences described herein, possibly with retroactive effect. We have not sought and will not seek any rulings from the Internal Revenue
Service, or IRS, regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the
ownership and disposition of our common stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
discussion is limited to Non-U.S. Holders who hold our common stock as a "capital asset" within the meaning of Section&nbsp;1221 of the Code (generally, property held for
investment). This discussion does consider any specific facts or circumstances that may be relevant to holders subject to special rules under the U.S. federal income tax laws, including, without
limitation, certain former citizens or long-term residents of the United States, a person who holds or receives our common stock pursuant to the exercise of an employee stock option or otherwise as
compensation, partnerships (or arrangements classified as partnerships for U.S. federal income tax purposes) or other pass-through entities and the equity holders therein, "controlled foreign
corporations," "passive foreign investment companies," corporations that accumulate earnings to avoid U.S. federal income tax, banks, financial institutions, investment funds, insurance companies,
brokers, dealers or traders in securities, tax-exempt organizations, tax-qualified retirement plans or foreign pension funds, persons subject to the alternative minimum tax, persons subject to special
tax accounting rules under Section&nbsp;451(b) of the Code, persons that own, or have owned, actually or constructively, more than 5% of our common stock and persons holding our common stock as part
of a hedging or conversion transaction or straddle, or a constructive sale, or other risk reduction strategy. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
discussion does not describe all of the U.S. federal income tax consequences that may be relevant to you in light of your particular circumstances, and does not address the
potential application of the alternative minimum tax, Medicare contribution tax, estate or gift taxes and does not address any aspect of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>166</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=169,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=211941,FOLIO='166',FILE='DISK125:[19ZCO1.19ZCO70301]EM70301A.;7',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_em70301_1_167"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>state,
local or non-U.S. taxation, or any taxes other than income taxes. You should consult your tax adviser with regard to the application of the U.S. federal tax laws to your particular situation,
as well as any tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PROSPECTIVE
INVESTORS SHOULD CONSULT THEIR TAX ADVISORS REGARDING THE PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES TO THEM OF ACQUIRING, OWNING AND DISPOSING OF OUR COMMON STOCK, AS
WELL AS ANY TAX CONSEQUENCES ARISING UNDER ANY STATE, LOCAL OR NON-U.S. TAX LAWS AND ANY OTHER U.S. FEDERAL TAX LAWS. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Distributions  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distributions of cash or other property paid on our common stock will constitute dividends for U.S. federal income tax purposes to the extent
paid from our current or accumulated
earnings and profits, as determined under U.S. federal income tax principles. To the extent those distributions exceed our current and accumulated earnings and profits, they will constitute a return
of capital, which will first reduce your basis in our common stock, but not below zero, and any excess will be treated as gain from the sale or other disposition of our common stock, as described
below under "&#151;Gain on Disposition of Our Common Stock." </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends
paid to you generally will be subject to withholding tax at a 30% rate or a reduced rate specified by an applicable income tax treaty. In order to obtain a reduced rate of
withholding, subject to the discussion below under "&#151;FATCA," you will be required to provide to us or our paying agent a properly executed IRS Form&nbsp;W-8BEN or IRS
Form&nbsp;W-8BEN-E (or applicable successor form) certifying your entitlement to benefits under a treaty. This certification must be provided to us or our paying agent prior to the payment of
dividends and must be updated periodically. If you hold our common stock through a financial institution or other agent acting on your behalf, you will be required to provide appropriate documentation
to the agent, which then will be required to provide certification to us or our paying agent, either directly or through other intermediaries. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you do not timely provide the required certification, but qualify for a reduced treaty rate, you may obtain a refund of any excess amounts withheld by timely filing an appropriate
claim for refund with the IRS. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
dividends paid to you are effectively connected with your conduct of a trade or business in the United States (and, if required by an applicable income tax treaty, are attributable to
a permanent establishment or fixed base maintained by you in the United States), you will generally be taxed on the dividends on a net income basis in the same manner as a U.S. person. If you are a
foreign corporation you also may be subject to an additional branch profits tax equal to 30% (or such lower rate specified by an applicable income tax treaty) of your effectively connected earnings
and profits for the taxable year, as adjusted for certain items. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
dividends paid to you are effectively connected with your conduct of a trade or business in the United States (and, if required by an applicable income tax treaty, are attributable to
a permanent establishment or fixed base maintained by you in the United States), you will be exempt from the withholding tax discussed in the preceding paragraph, although you will be required to
provide a properly executed IRS Form&nbsp;W-8ECI in order to claim an exemption from withholding. You should consult your tax advisors regarding any applicable income tax treaties that may provide
for different rules. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>167</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=170,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=942919,FOLIO='167',FILE='DISK125:[19ZCO1.19ZCO70301]EM70301A.;7',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_em70301_1_168"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Gain on Disposition of Our Common Stock  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the discussions below under "&#151;Information Reporting and Backup Withholding" and "&#151;FATCA," you generally will
not be subject to U.S. federal income or withholding tax on gain realized on a sale or other taxable disposition of our common stock unless:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the gain is effectively connected with your conduct of a trade or business in the United States (and, if required by an applicable income tax
treaty, is attributable to a permanent establishment or fixed base maintained by you in the United States); </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> you are a nonresident alien individual present in the United States for 183&nbsp;days or more during the taxable year of the disposition, and
certain other requirements are met; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we are or have been a "United States real property holding corporation," as defined in the Code, or a USRPHC, at any time within the five-year
period ending on the date of the taxable disposition or your holding period for such common stock, whichever period is shorter, and our common stock is not regularly traded on an established
securities market or you hold more than 5% of our outstanding common stock, directly or indirectly, during the shorter of the five-year period ending on the date of the taxable disposition or the
holding period for such common stock. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
will generally be taxed on the gain described in the first bullet above in the same manner as a U.S. person. If you are a foreign corporation, you also may be subject to an
additional branch profits tax equal to 30% (or such lower rate specified by an applicable income tax treaty) of your effectively connected earnings and profits for the taxable year, as adjusted for
certain items. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
will generally be subject to U.S. federal income tax at a flat 30% rate (or such lower rate specified by an applicable income tax treaty) on gain described in the second bullet point
above; however, such gain may be offset by certain U.S.-source capital losses (even though you are not considered a resident
of the United States), provided that you have timely filed U.S. federal income tax returns with respect to such losses. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Generally,
a corporation is a USRPHC only if the fair market value of its U.S. real property interests equals or exceeds 50% of the sum of the fair market value of its worldwide real
property interests plus any of its assets used or held for use in a trade or business. Although there can be no assurance, we do not believe that we are, or have been, a UPRHC, or that we are likely
to become one in the future. Even if we are a USRPHC, for so long as our common stock is regularly traded on an established securities market, sales of our common stock generally will not be subject
to tax if you have not held more than 5% of our common stock, actually or constructively, during the five-year period preceding such sale or other disposition of our common stock (or your holding
period, if shorter). If we are a USRPHC and either our common stock is not regularly traded on an established securities market or you hold, or are treated as holding, more than 5% of our outstanding
common stock, directly or indirectly, during the applicable testing period, you will generally be taxed on any gain in the same manner as gain that is effectively connected with the conduct of a U.S.
trade or business, except that the branch profits tax generally will not apply. No assurance can be provided that our common stock will continue to be regularly traded on an established securities
market for purposes of the rules described above. You are encouraged to consult your own tax advisors regarding the possible consequences to you if we are, or were to become, a USRPHC. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Information Reporting and Backup Withholding  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Information returns are required to be filed with the IRS in connection with payments of dividends on our common stock. Unless you comply with
certification procedures to establish that you are not a U.S. person, information returns may also be filed with the IRS in connection with the proceeds from a sale or other disposition of our common
stock. You may be subject to backup withholding on payments on our common stock or on the proceeds from a sale or other disposition of our common stock unless the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>168</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=171,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=537413,FOLIO='168',FILE='DISK125:[19ZCO1.19ZCO70301]EM70301A.;7',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_em70301_1_169"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>applicable
withholding agent does not have actual knowledge or reason to know that you are a U.S. person and you comply with certification procedures to establish that you are not a U.S. person or
otherwise establish an exemption. Your provision of a properly executed applicable IRS Form&nbsp;W-8 certifying your non-U.S. status will permit you to avoid backup withholding, provided the
applicable withholding agent does not have actual knowledge or reason to know that you are a U.S. person. Amounts withheld under the backup withholding rules are not additional taxes and may be
refunded or credited against your U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


FATCA  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions of the Code commonly referred to as the Foreign Account Tax Compliance Act, or FATCA, require withholding of 30% on payments of
dividends on our common stock, and, subject to the discussion of certain proposed Treasury Regulations below, gross proceeds of dispositions of our common stock, to "foreign financial institutions"
(which is broadly defined for this purpose and in general includes investment vehicles) and certain other non-U.S. entities unless various U.S. information reporting and due diligence requirements
(generally relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfied, or an exemption applies. An intergovernmental agreement between the United States
and an applicable foreign country may modify these requirements. Under certain circumstances, you may be eligible for refunds or credits of such taxes. The U.S. Treasury recently released proposed
Treasury Regulations which, if finalized in their present form, would eliminate the federal withholding tax of 30% applicable to the gross proceeds of a sale or other disposition of our common stock.
In its preamble to such proposed Treasury Regulations, the U.S. Treasury stated that taxpayers may generally rely on the proposed regulations until final regulations are issued. You should consult
your tax adviser regarding the effects of FATCA on your investment in our common stock. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>169</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=172,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=904432,FOLIO='169',FILE='DISK125:[19ZCO1.19ZCO70301]EM70301A.;7',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_eo70301_1_170"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="eo70301_underwriters"> </A>
<A NAME="toc_eo70301_1"> </A></FONT> <FONT SIZE=2><B>  UNDERWRITERS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the terms and subject to the conditions in an underwriting agreement dated the date of this prospectus, the underwriters named below, for
whom Morgan Stanley&nbsp;&amp;&nbsp;Co.&nbsp;LLC, BofA Securities,&nbsp;Inc. and Piper Jaffray&nbsp;&amp;&nbsp;Co. are acting as representatives, have severally agreed to purchase, and we have
agreed to sell to them, severally, the number of shares indicated below: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Morgan Stanley&nbsp;&amp;&nbsp;Co.&nbsp;LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BofA Securities,&nbsp;Inc.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Piper Jaffray&nbsp;&amp;&nbsp;Co.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Needham&nbsp;&amp; Company,&nbsp;LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BTIG,&nbsp;LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,200,000 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters are offering the shares of common stock subject to their acceptance of the shares from us and subject to prior sale. The underwriting agreement provides that the
obligations of the
several underwriters to pay for and accept delivery of the shares of common stock offered by this prospectus are subject to the approval of certain legal matters by their counsel and to certain other
conditions. The underwriters are obligated to take and pay for all of the shares of common stock offered by this prospectus if any such shares are taken. However, the underwriters are not required to
take or pay for the shares covered by the underwriters' option to purchase additional shares described below. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters initially propose to offer part of the shares of common stock directly to the public at the offering price listed on the cover of this prospectus and part to certain
dealers at a price that represents a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share under the public offering price. After the initial offering of the shares of common stock, the
offering
price and other selling terms may from time to time be varied by the representatives. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have granted the underwriters an option for a period of 30&nbsp;days from the date of this prospectus to purchase up to an additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock. To
the extent the option is exercised, each underwriter will become obligated, subject to certain conditions, to purchase about the same percentage of the additional shares of common stock as the number
listed next to the underwriter's name in the preceding table bears to the total number of shares of common stock listed next to the names of all underwriters in the preceding table. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table shows the per share and total public offering price, underwriting discounts and commissions and proceeds before expenses to us. These amounts are shown assuming both
no exercise and full exercise of the underwriters' option to purchase up to an additional 480,000 shares of common stock. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Per Share </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>No Exercise </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Full Exercise </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Public offering price</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Underwriting discounts and commissions to be paid by us</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds, before expenses, to us</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
estimated offering expenses payable by us, exclusive of the underwriting discounts and commissions, are approximately $0.9&nbsp;million. We have agreed to reimburse the
underwriters for expenses relating to clearance of this offering with the Financial Industry Regulatory Authority of up to $35,000. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters have informed us that they do not intend sales to discretionary accounts to exceed 5% of the total number of shares of common stock offered by them. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
common stock is listed on the Nasdaq Global Select Market under the trading symbol "NXTC." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>170</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=173,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=115268,FOLIO='170',FILE='DISK125:[19ZCO1.19ZCO70301]EO70301A.;14',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_eo70301_1_171"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
and all directors and officers and certain stockholders have agreed that, without the prior written consent of the representatives, on behalf of the underwriters, we and they will
not, during the period ending 90&nbsp;days after the date of this prospectus, or the restricted period:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for shares
of common stock; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> file any registration statement with the SEC relating to the offering of any shares of common stock or any securities convertible into or
exercisable or exchangeable for shares of common stock; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the
common stock, </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>whether
any such transaction described above is to be settled by delivery of common stock or such other securities, in cash or otherwise. In addition, we and each such person agrees that, without the
prior written consent of the representatives, on behalf of the underwriters, we or such other person will not, during the restricted period, make any demand for, or exercise any right with respect to,
the registration of any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock. None of our other stockholders is subject to any such
restrictions and, accordingly, common stock or other securities held by these other stockholders may be transferred or disposed of, to or through any broker-dealer, at any time during or following
this offering, subject to such stockholder's compliance with applicable securities laws. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
restrictions described in the immediately preceding paragraph to do not apply to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the sale of shares to the underwriters; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the issuance by us of shares of common stock upon the exercise of an option or a warrant or the conversion of a security outstanding on the
date of this prospectus of which the underwriters have been advised in writing; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> transactions by any person other than us relating to shares of common stock or other securities acquired in open market transactions after the
closing of this offering; provided that no filing under Section&nbsp;16(a) of the Exchange Act is required or voluntarily made in connection with subsequent sales of the common stock or other
securities acquired in such open market transactions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> transfers of shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock (i)&nbsp;as
a bona fide gift or (ii)&nbsp;to any corporation, partnership, limited liability company, investment fund or other entity controlled or managed, or under common control or management by, the holder,
provided that, (a)&nbsp;each transferee shall sign and deliver a lock-up agreement and (b)&nbsp;no filing under Section&nbsp;16(a) of the Exchange Act reporting a reduction in the beneficial
ownership of shares of common stock shall be required or shall be voluntarily made during the restricted period; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the establishment of a trading plan pursuant to Rule&nbsp;10b5-1 under the Exchange Act for the transfer of shares of common stock, provided
that (i)&nbsp;such plan does not provide for the transfer of common stock during the restricted period and (ii)&nbsp;to the extent a public announcement or filing </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> under the Exchange Act, if any, is required or voluntarily made regarding the establishment of such plan, such announcement or filing shall
include a statement to the effect that no transfer of common stock may be made under such plan during the restricted period. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
representatives, in their joint discretion, may release the common stock and other securities subject to the lock-up agreements described above in whole or in part at any time. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>171</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=174,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=610933,FOLIO='171',FILE='DISK125:[19ZCO1.19ZCO70301]EO70301A.;14',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_eo70301_1_172"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
order to facilitate the offering of the common stock, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of the common stock.
Specifically, the underwriters may sell more shares than they are obligated to purchase under the underwriting agreement, creating a short position. A short sale is covered if the short position is no
greater than the number of shares available for purchase by the underwriters under the option. The underwriters can close out a covered short sale by exercising the option or purchasing shares in the
open market. In determining the source of shares to close out a covered short sale, the underwriters will consider, among other things, the open market price of shares compared to the price available
under the option. The underwriters may also sell shares in excess of the option, creating a naked short position. The underwriters must close out any naked short position by purchasing shares in the
open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market after pricing
that could adversely affect investors who purchase in this offering. As an additional means of facilitating this offering, the underwriters may bid for, and purchase, shares of common stock in the
open market to stabilize the price of the common stock. These activities may raise or maintain the market price of the common stock above independent market levels or prevent or retard a decline in
the market price of the common stock. The underwriters are not required to engage in these activities and may end any of these activities at any time. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
and the underwriters have agreed to indemnify each other against certain liabilities, including liabilities under the Securities Act. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
prospectus in electronic format may be made available on websites maintained by one or more underwriters, or selling group members, if any, participating in this offering. The
representatives may agree to allocate a number of shares of common stock to underwriters for sale to their online brokerage account holders. Internet distributions will be allocated by the
representatives to underwriters that may make Internet distributions on the same basis as other allocations. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment
banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters and their respective affiliates
have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for us, for which they received or will receive customary fees and
expenses. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition, in the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively
trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers and may at any time
hold long and short positions in such securities and instruments. Such investment and securities activities may involve our securities and instruments. The underwriters and their respective affiliates
may also make investment recommendations or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they
acquire, long or short positions in such securities and instruments. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Selling Restrictions  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Canada  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in
National Instrument&nbsp;45-106 </FONT><FONT SIZE=2><I>Prospectus Exemptions</I></FONT><FONT SIZE=2> or subsection&nbsp;73.3(1) of the </FONT><FONT SIZE=2><I>Securities
Act</I></FONT><FONT SIZE=2> (Ontario), and are permitted clients, as defined in National Instrument&nbsp;31-103 </FONT><FONT SIZE=2><I>Registration Requirements, Exemptions and Ongoing Registrant
Obligations</I></FONT><FONT SIZE=2>. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable
securities laws. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>172</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=175,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=86130,FOLIO='172',FILE='DISK125:[19ZCO1.19ZCO70301]EO70301A.;14',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_eo70301_1_173"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto)
contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser's
province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser's province or territory for particulars of these rights or consult with a
legal advisor. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to section&nbsp;3A.3 (or, in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section&nbsp;3A.4) of National
Instrument&nbsp;33-105 </FONT><FONT SIZE=2><I>Underwriting Conflicts</I></FONT><FONT SIZE=2> (NI&nbsp;33-105), the underwriters are not required to comply with the disclosure requirements of
NI&nbsp;33-105 regarding underwriter conflicts of interest in connection with this offering. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


European Economic Area  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive, or each, a Relevant Member State,
an offer to the public of any shares of our common stock may not be made in that Relevant Member State, except that an offer to the public in that Relevant Member State of any shares of our common
stock may be made at any time under the following exemptions under the Prospectus Directive, if they have been implemented in that Relevant Member State: </FONT></P>

<UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;to
any legal entity which is a qualified investor as defined in the Prospectus Directive; </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;to
fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject
to obtaining the prior consent of the representatives for any such offer; or </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;in
any other circumstances falling within Article&nbsp;3(2) of the Prospectus Directive, provided that no such offer of shares of our common stock shall result in a
requirement for the publication by us or any underwriter of a prospectus pursuant to Article&nbsp;3 of the Prospectus Directive. </FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the purposes of this provision, the expression an "offer to the public" in relation to any shares of our common stock in any Relevant Member State means the communication in any form
and by any means of sufficient information on the terms of the offer and any shares of our common stock to be offered so as to enable an investor to decide to purchase any shares of our common stock,
as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State, the expression "Prospectus Directive" means Directive 2003/71/EC (and
amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in the Relevant Member State, and
the expression "2010 PD Amending Directive" means Directive 2010/73/EU. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


United Kingdom  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each underwriter has represented and agreed that: </FONT></P>

<UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;it
has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity
within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000, or FSMA, received by it in connection with the issue or sale of the shares of our common stock in circumstances
in which Section&nbsp;21(1) of the FSMA does not apply to us; and </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;it
has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the shares of our common stock in, from or
otherwise involving the United Kingdom. </FONT></P>

</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>173</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=176,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=772193,FOLIO='173',FILE='DISK125:[19ZCO1.19ZCO70301]EO70301A.;14',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_eo70301_1_174"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Hong Kong  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares of our common stock may not be offered or sold by means of any document other than (i)&nbsp;in circumstances which do not constitute an
offer to the public within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong), (ii)&nbsp;to "professional investors" within the meaning of the Securities and Futures Ordinance
(Cap.571, Laws of Hong Kong) and any rules made thereunder or (iii)&nbsp;in other circumstances which do not result in the document being a "prospectus" within the meaning of the Companies Ordinance
(Cap.32, Laws of Hong Kong), and no advertisement, invitation or document relating to shares of our common stock may be issued or may be in the possession of any person for the purpose of issue (in
each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws
of Hong Kong) other than with respect to shares of our common stock which are or are intended to be disposed of only to persons outside Hong Kong or only to "professional investors" within the meaning
of the Securities and Futures Ordinance (Cap.571, Laws of Hong Kong) and any rules made thereunder. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Japan  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No registration pursuant to Article&nbsp;4, paragraph&nbsp;1 of the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25 of
1948, as amended), or the FIEL, has been made or will be
made with respect to the solicitation of the application for the acquisition of the shares of common stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accordingly,
the shares of common stock have not been, directly or indirectly, offered or sold and will not be, directly or indirectly, offered or sold in Japan or to, or for the benefit
of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan) or to others for re-offering or
re-sale, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan except pursuant to an exemption from the registration requirements, and otherwise in compliance with, the
FIEL and the other applicable laws and regulations of Japan. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


For Qualified Institutional Investors, or QII  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please note that the solicitation for newly issued or secondary securities (each as described in Paragraph&nbsp;2, Article&nbsp;4 of the
FIEL) in relation to the shares of common stock constitutes either a "QII only private placement" or a "QII only secondary distribution" (each as described in Paragraph&nbsp;1, Article&nbsp;23-13
of the FIEL). Disclosure regarding any such solicitation, as is otherwise prescribed in Paragraph&nbsp;1, Article&nbsp;4 of the FIEL, has not been made in relation to the shares of common stock.
The shares of common stock may only be transferred to QIIs. </FONT></P>

<UL>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


For Non-QII Investors  </I></FONT></P>

</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please note that the solicitation for newly issued or secondary securities (each as described in Paragraph&nbsp;2, Article&nbsp;4 of the
FIEL) in relation to the shares of common stock constitutes either a "small number private placement" or a "small number private secondary distribution" (each as is described in Paragraph&nbsp;4,
Article&nbsp;23-13 of the FIEL). Disclosure regarding any such solicitation, as is otherwise prescribed in Paragraph&nbsp;1, Article&nbsp;4 of the FIEL, has not been made in relation to the
shares of common stock. The shares of common stock may only be transferred en bloc without subdivision to a single investor. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Singapore  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other
document or material in connection with the offer or sale, or invitation for subscription or purchase, of shares of our common stock may not be circulated or distributed, nor may the shares of our
common stock be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>174</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=177,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=435548,FOLIO='174',FILE='DISK125:[19ZCO1.19ZCO70301]EO70301A.;14',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_eo70301_1_175"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>institutional
investor under Section&nbsp;274 of the Securities and Futures Act, Chapter&nbsp;289 of Singapore, or the SFA, (ii)&nbsp;to a relevant person, or any person pursuant to
Section&nbsp;275(1A), and in accordance with the conditions, specified in Section&nbsp;275 of the SFA or (iii)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other
applicable provision of the SFA. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Where
shares of our common stock are subscribed or purchased under Section&nbsp;275 by a relevant person which is: (i)&nbsp;a corporation (which is not an accredited investor) the
sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or (ii)&nbsp;a trust (where the
trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary is an accredited investor, shares, debentures and units of shares and debentures of that
corporation or the beneficiaries' rights and interest in that trust shall not be transferable for 6&nbsp;months after that corporation or that trust has acquired shares of our common stock under
Section&nbsp;275 except: (a)&nbsp;to an institutional investor under Section&nbsp;274 of the SFA or to a relevant person, or any person pursuant to Section&nbsp;275(1A), and in accordance with
the conditions, specified in Section&nbsp;275 of the SFA; (b)&nbsp;where no consideration is given for the transfer; or (c)&nbsp;by operation of law. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>175</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=178,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=854013,FOLIO='175',FILE='DISK125:[19ZCO1.19ZCO70301]EO70301A.;14',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<A NAME="page_eo70301_1_176"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="eo70301_legal_matters"> </A>
<A NAME="toc_eo70301_2"> </A>
<BR></FONT><FONT SIZE=2><B>  LEGAL MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the shares of our common stock to be issued in this offering will be passed upon for us by our counsel, Hogan Lovells
US&nbsp;LLP, Baltimore, Maryland. As of the date of this prospectus, a partner of Hogan Lovells US&nbsp;LLP owns 37,342 shares of our common stock. Cooley&nbsp;LLP, New York, New York, is acting
as counsel for the underwriters in connection with this offering. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="eo70301_experts"> </A>
<A NAME="toc_eo70301_3"> </A>
<BR></FONT><FONT SIZE=2><B>  EXPERTS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ernst&nbsp;&amp; Young&nbsp;LLP, independent registered public accounting firm, has audited our financial statements at December&nbsp;31, 2018
and 2017, and for each of the two years in the period ended December&nbsp;31, 2018, as set forth in their report. We have included our financial statements in this prospectus and elsewhere in the
registration statement in reliance on Ernst&nbsp;&amp; Young&nbsp;LLP's report, given on their authority as experts in accounting and auditing. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="eo70301_where_you_can_find_more_information"> </A>
<A NAME="toc_eo70301_4"> </A>
<BR></FONT><FONT SIZE=2><B>  WHERE YOU CAN FIND MORE INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have filed with the SEC a registration statement on Form&nbsp;S-1 under the Securities Act with respect to the shares of common stock
offered hereby. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits and schedules
filed therewith. For further information with respect to us and the common stock offered hereby, reference is made to the registration statement and the exhibits and schedules filed therewith.
Statements contained in this prospectus regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and each
such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit to the registration statement. The SEC maintains a website that
contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address is www.sec.gov. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are subject to the information and periodic reporting requirements of the Exchange Act and, in accordance therewith, file periodic reports, proxy statements and other information with
the SEC. Such periodic reports, proxy statements and other information are available for inspection and copying at the website of the SEC referred to above. We maintain a website at www.nextcure.com.
You may access our annual reports on Form&nbsp;10-K, quarterly reports on Form&nbsp;10-Q, current reports on Form&nbsp;8-K, and
amendments to those reports filed or furnished pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act with the SEC free of charge at our website as soon as reasonably practicable after such
material is electronically filed with, or furnished to, the SEC. The reference to our website address does not constitute incorporation by reference of the information contained at or available
through our website, and you should not consider the contents of our website in making an investment decision with respect to our common stock. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>176</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=179,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=770704,FOLIO='176',FILE='DISK125:[19ZCO1.19ZCO70301]EO70301A.;14',USER='DSLOAN',CD='12-NOV-2019;05:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fa70301_1_1"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fa70301_index_to_financial_statements___ind02746"> </A></FONT> <FONT SIZE=2><B>  INDEX TO FINANCIAL STATEMENTS    <BR>    <BR>    As of and for the Years Ended December&nbsp;31, 2017 and 2018    <BR>    </B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>
<A NAME="FA70301_TOC2"></A> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Page </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#fc70301_report_of_independent___fc702275"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Report of Independent Registered Public Accounting Firm</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#fc70301_report_of_independent___fc702275"><FONT SIZE=2>F-2</FONT></A></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#fe70301_nextcure,_inc._balance_sheets___nex02934"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Balance Sheets</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#fe70301_nextcure,_inc._balance_sheets___nex02934"><FONT SIZE=2>F-3</FONT></A></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#fg70301_nextcure,_inc._statements_of_o__nex04364"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Statements of Operations and Comprehensive Loss</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#fg70301_nextcure,_inc._statements_of_o__nex04364"><FONT SIZE=2>F-4</FONT></A></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#fi70301_nextcure,_inc._statements_of_p__nex03919"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Statements of Preferred Stock and Stockholders' Deficit</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#fi70301_nextcure,_inc._statements_of_p__nex03919"><FONT SIZE=2>F-5</FONT></A></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#page_fk70301_1_6"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Statements of Cash Flows</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#page_fk70301_1_6"><FONT SIZE=2>F-6</FONT></A></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#fm70301_nextcure,_inc._notes_to_financial_statements"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Notes to Financial Statements</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#fm70301_nextcure,_inc._notes_to_financial_statements"><FONT SIZE=2>F-7</FONT></A></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fa70301_as_of_and_for_the_nine_months___as_01852"> </A>
<BR></FONT><FONT SIZE=2><B>  As of and for the Nine Months Ended September&nbsp;30, 2018 and 2019    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
<A NAME="FA70301_TOC"></A> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="28pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Page </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#fs70301_nextcure,_inc._condensed_balan__nex03713"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Condensed Balance Sheets</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#fs70301_nextcure,_inc._condensed_balan__nex03713"><FONT SIZE=2>F-29</FONT></A></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#fu70301_nextcure,_inc._condensed_state__nex05143"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unaudited Condensed Statements of Operations and Comprehensive Loss</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#fu70301_nextcure,_inc._condensed_state__nex05143"><FONT SIZE=2>F-30</FONT></A></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#fw70301_nextcure,_inc._condensed_state__nex04962"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unaudited Condensed Statements of Preferred Stock and Stockholders' Deficit</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#fw70301_nextcure,_inc._condensed_state__nex04962"><FONT SIZE=2>F-31</FONT></A></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#fy70301_nextcure,_inc._condensed_state__nex02776"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unaudited Condensed Statements of Cash Flows</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#fy70301_nextcure,_inc._condensed_state__nex02776"><FONT SIZE=2>F-32</FONT></A></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><A HREF="#ga"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Notes to Unaudited Condensed Financial Statements</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><A HREF="#ga"><FONT SIZE=2>F-33</FONT></A></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=180,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=45680,FOLIO='F-1',FILE='DISK125:[19ZCO1.19ZCO70301]FA70301A.;8',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fc70301_1_2"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fc70301_report_of_independent___fc702275"> </A>
<A NAME="toc_fc70301_1"> </A></FONT> <FONT SIZE=2><B>  REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>To
the Stockholders and the Board of Directors of NextCure,&nbsp;Inc. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Opinion on the Financial Statements  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have audited the accompanying balance sheets of NextCure,&nbsp;Inc. (the "Company") as of December&nbsp;31, 2018 and 2017, the related
statements of operations and comprehensive loss, preferred stock and stockholders' equity and cash flows for the years then ended and the related notes (collectively referred to as the "financial
statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December&nbsp;31, 2018 and 2017, and the results of its
operations and its cash flows for the years then ended in conformity with U.S. generally accepted accounting principles. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Basis for Opinion  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with
respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness
of the Company's internal control over financial reporting. Accordingly, we express no such opinion. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our
opinion. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>/s/
Ernst&nbsp;&amp; Young&nbsp;LLP </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>We
have served as the Company's auditor since 2017. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>Tysons,
VA<BR>
March&nbsp;5, 2019, except as to the fourth paragraph of Note&nbsp;16, as to which the date is May&nbsp;3, 2019. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=181,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=910558,FOLIO='F-2',FILE='DISK125:[19ZCO1.19ZCO70301]FC70301A.;6',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fe70301_1_3"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fe70301_nextcure,_inc._balance_sheets___nex02934"> </A>
<A NAME="toc_fe70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.    <BR>    <BR>    BALANCE SHEETS    <BR>    <BR>    (in thousands, except share and per share amounts)    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Assets</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current assets:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>135,173</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,427</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Restricted cash</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>460</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>860</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Prepaid expenses and other current assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>152</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>133 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total current assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>135,785</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,420</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Property and equipment, net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,407</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,021</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>436</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>26 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>147,628</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,467 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Liabilities, Preferred Stock and Stockholders' Deficit</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current liabilities:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accounts payable</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,483</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,141</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,411</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,564</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred rent, current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>28</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Term loan, current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>387</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred revenue from related party, current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,989</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total current liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,298</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,124</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred rent, net of current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>242</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>295</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Term loan, net of current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>73</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>460</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred revenue from related party, net of current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21,736</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32,349</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,879 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Commitments and contingencies (Note&nbsp;7)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Preferred stock:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Series&nbsp;A Preferred Stock, par value of $0.001 per share; 68,181,819 and 64,545,455 shares authorized at December&nbsp;31, 2018 and 2017,
respectively, 68,181,819 and 40,000,000 shares issued and outstanding at December&nbsp;31, 2018 and 2017, respectively</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>71,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>40,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Series&nbsp;B Preferred Stock, par value $0.001 per share; 56,828,852 and 0 shares authorized at December&nbsp;31, 2018 and 2017, respectively,
56,828,851 and 0 shares issued and outstanding at December&nbsp;31, 2018 and 2017, respectively</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>91,223</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Preferred Stock</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>162,223</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>40,000 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stockholders' deficit:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Common stock, par value of $0.001 per share; 158,745,671 and 84,045,455 shares authorized as of December&nbsp;31, 2018 and 2017, respectively, 1,374,812
and 1,369,212 shares issued and outstanding at December&nbsp;31, 2018 and 2017, respectively</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Additional paid-in capital</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>75</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(47,297</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(24,498</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total stockholders' deficit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(46,944</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(24,412</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities, preferred stock and stockholders' deficit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>147,628</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,467 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=2>
The accompanying notes are an integral part of these financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=182,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=769649,FOLIO='F-3',FILE='DISK125:[19ZCO1.19ZCO70301]FE70301A.;7',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fg70301_1_4"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fg70301_nextcure,_inc._statements_of_o__nex04364"> </A>
<A NAME="toc_fg70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.    <BR>    <BR>    STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS    <BR>    <BR>    (in thousands, except share and per share amounts)    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>19,787</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,954</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,409</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,595 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,196</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>15,549 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loss from operations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(23,196</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,549</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income, net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>397</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>80 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,469</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other comprehensive income</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total comprehensive loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,469</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss per share attributable to common stockholders&#151;basic and diluted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(16.64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(11.30</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Weighted average common shares outstanding&#151;basic and diluted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,846</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,212 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=2>
The accompanying notes are an integral part of these financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=183,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=901076,FOLIO='F-4',FILE='DISK125:[19ZCO1.19ZCO70301]FG70301A.;6',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fi70301_1_5"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fi70301_nextcure,_inc._statements_of_p__nex03919"> </A>
<A NAME="toc_fi70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.    <BR>    <BR>    STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT    <BR>    <BR>    (in thousands, except share data)    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Preferred Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stockholders' Deficit </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Series&nbsp;A </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Series&nbsp;B </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Common Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Additional<BR>
Paid-in<BR>
Capital </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Accumulated<BR>
Deficit </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stockholders'<BR>
Deficit </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of December&nbsp;31, 2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>15,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>15,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,369,212</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(9,029</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(9,018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Stock-based compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>75</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>75</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issuance of Series&nbsp;A-2 preferred stock, net of issuance costs of $0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(15,469</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(15,469</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of December&nbsp;31, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,369,212</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>75</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(24,498</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(24,412</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Stock-based compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>263</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>263</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issuance of common stock</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,600</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issuance of Series&nbsp;A-3 preferred stock, net of issuance costs of $0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>28,181,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>31,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issuance of Series&nbsp;B preferred stock, net of issuance costs of $485</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>56,828,851</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>91,223</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(22,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(22,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of December&nbsp;31, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>68,181,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>71,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>56,828,851</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>91,223</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,374,812</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(47,297</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(46,944</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=2>
The accompanying notes are an integral part of these financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=184,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=242474,FOLIO='F-5',FILE='DISK125:[19ZCO1.19ZCO70301]FI70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:29' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fk70301_1_6"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fk70301_nextcure,_inc._stateme__fk702032"> </A>
<A NAME="toc_fk70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.    <BR>    <BR>    STATEMENTS OF CASH FLOWS    <BR>    <BR>    (in thousands)    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash flows from operating activities:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,469</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Adjustments to reconcile net loss to net cash provided by (used) in operating activities:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Depreciation and amortization</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,677</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>582</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stock-based compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>263</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>75</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Changes in operating assets and liabilities:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Prepaid expenses and other current assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(89</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accounts payable</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>767</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>847</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,557</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred rent</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(44</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>42</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred revenue from related party</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>26,725</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net cash provided by (used) in operating activities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,992</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(12,514</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash flows from investing activities:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Purchase of property and equipment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3,063</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8,652</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net cash used in investing activities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(3,063</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8,652</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash flows from financing activities:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from issuance of preferred stock, net of issuance costs</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>122,223</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>25,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from issuance of common stock</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Payments of the term loan</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(400</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(140</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred financing costs</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(410</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net cash provided by financing activities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>121,417</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24,860 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net increase in cash, cash equivalents and restricted cash</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>126,346</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,694</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash, cash equivalents and restricted cash&#151;beginning of year</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,287</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,593 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash, cash equivalents and restricted cash&#151;end of year</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>135,633</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,287 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Supplemental disclosures of cash flow information:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash paid for interest</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>30 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash paid for income taxes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Supplemental disclosures of noncash investing and financing activities:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Purchase of property and equipment included in accrued liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>515</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred financing costs in accrued liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>284</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=2>
The accompanying notes are an integral part of these financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=185,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=751424,FOLIO='F-6',FILE='DISK125:[19ZCO1.19ZCO70301]FK70301A.;7',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fm70301_1_7"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fm70301_nextcure,_inc._notes_to_financial_statements"> </A>
<A NAME="toc_fm70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.    <BR>    <BR>    NOTES TO FINANCIAL STATEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


1. Nature of the Business and Basis of Presentation  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Organization  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NextCure,&nbsp;Inc. ("NextCure" or the "Company") was incorporated in Delaware in September 2015 and is headquartered in Beltsville, Maryland.
The Company is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring
normal immune function. Through its proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology ("FIND-IO") platform, the Company studies various immune cells in order to discover and
understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Since inception, the Company has devoted substantially all of its efforts
and financial resources to organizing and staffing the Company, identifying business development opportunities, raising capital, securing intellectual property rights related to the Company's product
candidates, building and optimizing the Company's manufacturing capabilities and conducting discovery, research and development activities for the Company's product candidates, discovery programs and
its FIND-IO platform. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks and Uncertainties  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is subject to risks common to early-stage companies in the biotechnology industry including, but not limited to: having a limited
operating history and no products approved for commercial sale; having a history of significant losses; our need to obtain additional financing; dependence on its ability to advance its current and
future product candidates through clinical trials, marketing approval and commercialization; the unproven approach to the discovery and development of product candidates based on the Company's FIND-IO
platform; the lengthy and expensive nature and uncertain outcomes of the clinical development process; the lengthy, time-consuming and unpredictable nature of the regulatory approval process; the
results of preclinical studies and early-stage clinical trials that may not be predictive of future results; dependence on its key personnel; its limited manufacturing experience as an organization
and with its manufacturing facility; risks related to patent protection and our pending patent applications; dependence on third-party collaborators for the discovery, development and
commercialization of current and future product candidates; and significant competition from other biotechnology and pharmaceutical companies. Pursuit of the Company's business efforts will require
significant amounts of additional capital, adequate personnel, infrastructure and extensive compliance-reporting capabilities. Even if the Company's development efforts are successful, it is uncertain
when, if ever, the Company will realize significant revenue from product sales. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Liquidity  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company expects that its operating losses and negative cash flows will continue for the foreseeable future. As of the issuance date of the
financial statements for the year ended December&nbsp;31, 2018, the Company expects that its cash and cash equivalents will be sufficient to fund its operating expenses and capital expenditure
requirements through at least two years from the issuance date of the financial statements. The future viability of the Company beyond that date is dependent on its ability to raise additional capital
to finance its operations. On April&nbsp;5, 2018, the Company issued 28,181,819 shares of Series&nbsp;A-3 Preferred Stock at an issuance price of $1.10 per share for cash proceeds of
$31.0&nbsp;million (Note&nbsp;9). On November&nbsp;5, 2018, the Company entered into a Series&nbsp;B Preferred Stock Purchase Agreement and issued 15,052,117 shares of Series&nbsp;B-1
Preferred Stock at an issuance price of $1.59 per share, 34,276,734 shares of Series&nbsp;B-2 Preferred Stock at an issuance price of $1.59 per share and 7,500,000 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=186,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=504997,FOLIO='F-7',FILE='DISK125:[19ZCO1.19ZCO70301]FM70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fm70301_1_8"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


1. Nature of the Business and Basis of Presentation (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>shares
of Series&nbsp;B-3 Preferred Stock at an issuance price of $2.00 per share for aggregate cash proceeds of $93.4&nbsp;million (Note&nbsp;9). </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company plans to seek additional funding through public or private equity offerings, debt financings, marketing and distribution arrangements, other collaborations, strategic
alliances and licensing arrangements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into strategic alliances or other
arrangements on favorable terms, or at all. The terms of any financing may adversely affect the holdings or the rights of the Company's stockholders. If the Company is unable to obtain funding, the
Company could be required to delay, reduce or eliminate research and development programs, product portfolio expansion or future commercialization efforts, which could adversely affect its business
prospects. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
management continues to pursue these funding plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company,
if at all, to fund continuing operations past two years from the issuance date of these financial statements. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Basis of Presentation  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The accompanying financial statements include the accounts of the Company. The Company's financial statements have been prepared in accordance
with United States generally accepted accounting principles ("GAAP"). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting
Standards Codification ("ASC") and Accounting Standards Update ("ASU") of the Financial Accounting Standards Board ("FASB"). </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reverse Stock Split  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On May&nbsp;3, 2019, the Company effected a 1-for-8.0338 reverse stock split of its outstanding common stock. The par value and authorized
shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to
reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Use of Estimates  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts
reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to accrued expenses, revenue recognition, the valuation of
equity-based compensation, including incentive stock options, common stock and restricted common stock, as well as income taxes. The Company bases its estimates on various assumptions that the Company
believes to be reasonable under the circumstances. Actual results could differ from those estimates. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Segment and Geographic Information  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating segments are defined as components of an entity about which separate discrete information is available for evaluation by the chief
operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company views its operations as and manages its business in one operating
segment operating exclusively in the United States. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=187,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=280269,FOLIO='F-8',FILE='DISK125:[19ZCO1.19ZCO70301]FM70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fm70301_1_9"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash and Cash Equivalents  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash
equivalents. The Company deposits its cash primarily in checking, sweep account and money market accounts. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Restricted Cash  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is required to maintain cash collateral on deposit in a segregated money market bank account, as a condition of its Term Loan
(Note&nbsp;8) equal to the principal portion on a quarterly basis. The bank may restrict withdrawals or transfers by, or on behalf of, the Company. The required reserve totaled $460,000 as of
December&nbsp;31, 2018. This amount is presented as restricted cash on the accompanying balance sheet. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>135,173</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,427</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Restricted cash</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>460</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>860 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>135,633</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,287 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Concentration of Credit Risk  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial instruments that potentially expose the Company to concentrations of credit risk primarily consist of cash and cash equivalents. The
Company maintains its cash and cash equivalents at one accredited financial institution in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual
credit risk beyond the normal credit risk associated with commercial banking relationships. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fair Value of Financial Instruments  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ASC Topic 820, </FONT><FONT SIZE=2><I>Fair Value Measurement</I></FONT><FONT SIZE=2> ("ASC 820"), establishes a fair value hierarchy for
instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company's own assumptions (unobservable inputs). Observable inputs are inputs
that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's
assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. ASC 820 identifies
fair value as the exchange price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.
As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three-tier value hierarchy that distinguishes between the following: </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level&nbsp;1&#151;Quoted
market prices in active markets for identical assets or liabilities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=188,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=842647,FOLIO='F-9',FILE='DISK125:[19ZCO1.19ZCO70301]FM70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fm70301_1_10"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level&nbsp;2&#151;Inputs
other than Level&nbsp;1 inputs that are either directly or indirectly observable, such as quoted market prices, interest rates and yield curves. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level&nbsp;3&#151;Unobservable
inputs developed using estimates of assumptions developed by the Company, which reflect those that a market participant would use. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair values requires more judgment. Accordingly, the
degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized as Level&nbsp;3. A financial instrument's level within the fair value hierarchy is based
on the lowest level of any input that is significant to the fair value measurement. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Property and Equipment, Net  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment are recorded at cost. Depreciation is computed over the estimated useful lives of the related assets using the
straight-line method. Leasehold improvements are amortized on a straight-line basis over the shorter of the useful life or term of the lease. Upon retirement or disposal, the cost and related
accumulated depreciation are removed from the balance sheet and the resulting gain or loss is recorded to general and administrative expenses in the accompanying statement of operations and
comprehensive loss. Routine expenditures for maintenance and repairs are expensed as incurred. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estimated
useful lives for property and equipment are as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="308pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated Useful Life </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Computers and peripherals</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3&nbsp;years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5&nbsp;years</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Furniture and fixtures</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7&nbsp;years</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Leasehold improvements</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Lesser of estimated useful life or remaining lease term</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Construction in Progress  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Construction in progress (Note&nbsp;4) is carried at cost and consists of specifically identifiable direct and indirect development and
construction costs. While under construction, costs of the property are included in construction in progress until the property is placed in service, at which time costs are transferred to the
appropriate property and equipment account including, but not limited to, leasehold improvements or other such accounts. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Impairment of Long-Lived Assets  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company reviews the recoverability of its long-lived asset group when events or changes in circumstances occur that indicate that the
carrying value of the asset group may not be recoverable. The assessment of possible impairment is based on the ability to recover the carrying value of the asset group from the expected future cash
flows (undiscounted and without interest expense) of the related operations. If these cash flows are less than the carrying value of such asset group, an impairment loss for the difference between the
estimated fair value and carrying value is recorded. There was no impairment loss recognized during the years ended December&nbsp;31, 2018 or 2017. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=189,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=642131,FOLIO='F-10',FILE='DISK125:[19ZCO1.19ZCO70301]FM70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fm70301_1_11"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Preferred Stock  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company's preferred stock is classified outside of stockholders' deficit because the shares contain deemed liquidation rights that are a
contingent redemption feature not solely within the control of the Company. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Costs  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenditures, including payroll, contractor expenses and supplies, for research and development of products are expensed as incurred.
Development costs incurred by third parties are expensed as the contracted work is performed. Where contingent milestone payments are due to third parties under research and development arrangements,
the milestone payment obligations are expensed when the milestone results are probable of being achieved. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Patent Costs  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty
about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses in the accompanying statement of operations and comprehensive loss. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock-Based Compensation  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company accounts for its stock-based compensation in accordance with ASC Topic 718, </FONT><FONT SIZE=2><I>Compensation&#151;Stock
Compensation</I></FONT><FONT SIZE=2> ("ASC 718"). ASC 718 requires all share-based payments to employees, consultants and directors, including grants of incentive stock options, nonqualified stock
options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company, to be recognized as expense in the
statement of operations and comprehensive loss based on their grant date fair values. The Company estimates the fair value of options granted using the Black-Scholes option pricing model
("Black-Scholes") for stock option grants to both employees and non-employees and the fair value of common stock to determine the fair value of restricted stock. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company recognizes forfeitures as they occur as allowed by ASU No.&nbsp;2016-09, </FONT><FONT SIZE=2><I>Improvements to Employee Share-Based Payment
Accounting</I></FONT><FONT SIZE=2> ("ASU 2016-09"). </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Black-Scholes option pricing model requires inputs based on certain subjective assumptions, including (i)&nbsp;the expected stock price volatility, (ii)&nbsp;the expected term of
the award, (iii)&nbsp;the risk-free interest rate and (iv)&nbsp;expected dividends. Due to the lack of a public market for the Company's common stock and lack of company-specific historical and
implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the
Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with expected term assumption. The
Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No.&nbsp;107, Share-Based Payment, to calculate the expected term for options granted to employees as it does
not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the
Company does not expect substantially different exercise or post-vesting termination behavior among its employee </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=190,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=718023,FOLIO='F-11',FILE='DISK125:[19ZCO1.19ZCO70301]FM70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fm70301_1_12"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>population.
For options granted to non-employees, the Company utilizes the simplified method also as the basis for the expected term assumption. The risk-free interest rate is based on a treasury
instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to
pay any dividends on its common stock. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are significant judgments and estimates inherent in the determination of the fair value of the Company's common stock. These estimates and assumptions include a number of objective
and subjective factors, including external market conditions, the prices at which the Company sold shares of preferred stock, the superior rights and preferences of securities senior to its common
stock at the time of, and the likelihood of, achieving a liquidity event, such as an initial public offering or sale. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company expenses the fair value of its share-based compensation awards on a straight-line basis over the requisite service period, which is generally the vesting period. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Income Taxes  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the
estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax
assets and liabilities, which relate primarily to the carrying amount of the Company's property and equipment and its net operating loss carryforwards, are measured using enacted tax rates expected to
apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets
and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, the Company concludes that it is more-likely-than-not that
the deferred tax assets will not be realized. In evaluating its ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including its operating
results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. Because of the uncertainty of the realization of deferred tax assets, the Company has
recorded a full valuation allowance against its deferred tax assets. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reserves
are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more-likely-than-not to be
sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the
provision of income taxes; however, the Company currently has no interest or penalties related to uncertain income tax benefits. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenue Recognition  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has adopted ASC Topic 606, </FONT><FONT SIZE=2><I>Revenue from Contracts with Customers</I></FONT><FONT SIZE=2> ("ASC 606"). Under
ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for
those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps:
(i)&nbsp;identification of the promised goods or services in the contract; (ii)&nbsp;determination of whether the promised goods or services are performance obligations including whether they are
distinct in the context of the contract; (iii)&nbsp;measurement of the transaction price, including the constraint on variable </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=191,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=713276,FOLIO='F-12',FILE='DISK125:[19ZCO1.19ZCO70301]FM70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fm70301_1_13"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>consideration;
(iv)&nbsp;allocation of the transaction price to the performance obligations; and (v)&nbsp;recognition of revenue when (or as) the Company satisfies each performance obligation. The
Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the
customer. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to
represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performance
obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i)&nbsp;the customer can
benefit from the good or service on its own or together with other readily available resources and (ii)&nbsp;the promised good or service is separately identifiable from other promises in the
contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the
customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral or dependent to other goods or services
in the contract. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may
include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the
payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts
the amount expected to be received. The amount of variable consideration which is included in the transaction price may be constrained and will be included in the transaction price only to the extent
that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company's contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a
significant revenue reversal would occur. Milestone payments that are not within the Company's control or the licensee's control, such as regulatory approvals, will not be considered probable of being
achieved until those approvals are received. At the end of each reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint,
and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period
of adjustment. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties
relate, the Company will recognize revenue at the later of (i)&nbsp;when the related sales occur or (ii)&nbsp;when the performance obligation to which some or all of the royalty has been allocated
has been satisfied (or partially satisfied). </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require
judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for
service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling
price for material rights, the Company </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=192,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=53429,FOLIO='F-13',FILE='DISK125:[19ZCO1.19ZCO70301]FM70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fm70301_1_14"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>may
reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more
performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the
amounts the Company would expect to receive for the satisfaction of each performance obligation. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which
consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied
over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the
measure of performance and related revenue recognition. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upfront
payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized
as revenue within the 12&nbsp;months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to
be recognized as revenue within the 12&nbsp;months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the
Company's right to consideration is unconditional. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comprehensive Loss  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company did not have any other comprehensive income or loss for any of the periods presented and, therefore, comprehensive loss did not
differ from net loss. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Net Loss per Share  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required
for participating securities. The Company considers its Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock to be participating securities because in the event a dividend is paid on
common stock, the holders of Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock would be entitled to receive dividends on a basis consistent with the common stockholders. Under the
two-class method, the net loss attributable to common stockholders is not allocated to the preferred stock as the holders of the preferred stock do not have a contractual obligation to share in
losses. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the two-class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average
number of shares of common stock. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recently Adopted Accounting Pronouncements  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In March 2016, the FASB issued ASU No.&nbsp;2016-08, </FONT><FONT SIZE=2><I>Revenue from Contracts with Customers (Topic&nbsp;606):
Principal versus Agent Considerations (Reporting Revenue Gross versus Net)</I></FONT><FONT SIZE=2> ("ASU&nbsp;2016-08"), which clarified the revenue recognition implementation guidance on principal
versus agent considerations. In April 2016, the FASB issued ASU No.&nbsp;2016-10, </FONT><FONT SIZE=2><I>Revenue from Contracts with Customers (Topic&nbsp;606): Identifying Performance
Obligations and Licensing</I></FONT><FONT SIZE=2> ("ASU&nbsp;2016-10"), which clarified the revenue recognition </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=193,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=982657,FOLIO='F-14',FILE='DISK125:[19ZCO1.19ZCO70301]FM70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fm70301_1_15"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>guidance
regarding the identification of performance obligations and the licensing implementation. In May 2016, the FASB issued ASU No.&nbsp;2016-12, </FONT><FONT SIZE=2><I>Revenue from Contracts
with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients</I></FONT><FONT SIZE=2> ("ASU 2016-12"), which narrowly amended the revenue recognition guidance regarding
collectability, noncash consideration, presentation of sales tax and transition. ASU No.&nbsp;2016-08, ASU No.&nbsp;2016-10 and ASU 2016-12 are effective during the same period as ASU
No.&nbsp;2014-09, </FONT><FONT SIZE=2><I>Revenue from Contracts with Customers</I></FONT><FONT SIZE=2> ("ASU 2014-09"), which is effective for the Company for fiscal years beginning after
December&nbsp;15, 2018 and interim periods within fiscal years beginning after December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU&nbsp;2016-08, ASU 2016-10, ASU 2016-12
and ASU 2014-09 as of January&nbsp;1, 2018 on a retrospective basis. There was no revenue in previous years and the adoption of ASC 606 did not have any impact on prior year financial statements. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
August 2016, the FASB issued ASU No.&nbsp;2016-15, </FONT><FONT SIZE=2><I>Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash
Payments</I></FONT><FONT SIZE=2> ("ASU 2016-15"). ASU 2016-15 eliminates the diversity in practice related to the classification of certain cash receipts and payments for debt prepayment or
extinguishment costs, the maturing of a zero-coupon bond, the settlement of contingent liabilities arising from a business combination, proceeds from insurance settlements, distributions from certain
equity method investees and beneficial interests obtained in a financial asset securitization. ASU 2016-15 designates the appropriate cash flow classification, including requirements to allocate
certain components of these cash receipts and payments among operating, investing and financing activities. The retrospective transition method, requiring adjustment to all comparative periods
presented, is required unless it is impracticable for some of the amendments, in which case those amendments would be prospectively applied as of the earliest date practicable. ASU 2016-15 is
effective for the Company for fiscal years beginning after December&nbsp;15, 2018 and interim periods within fiscal years beginning after December&nbsp;15, 2019. Early adoption is permitted. The
Company adopted ASU 2016-15 as of January&nbsp;1, 2018. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2016, the FASB issued ASU No.&nbsp;2016-18, </FONT><FONT SIZE=2><I>Statement of Cash Flows (Topic 230): Restricted Cash</I></FONT><FONT SIZE=2> ("ASU 2016-18'), which
requires that a statement of cash flows explain the change during the period in the total cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents.
Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning and ending balances shown on
the statement of cash flows. The guidance is effective for the Company for fiscal years beginning after December&nbsp;15, 2018 and interim periods within fiscal years beginning after
December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016-18 as of January&nbsp;1, 2017. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
May 2017, the FASB issued ASU No.&nbsp;2017-09, </FONT><FONT SIZE=2><I>Compensation&#151;Stock Compensation (Topic 718): Scope of Modification
Accounting</I></FONT><FONT SIZE=2> ("ASU 2017-09"), which clarifies when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance,
modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions
of the agreement. The standard is effective for fiscal years, and interim periods within those
years, beginning after December&nbsp;15, 2017. The Company adopted ASU 2017-09 as of the required effective date of January&nbsp;1, 2018. In June 2018, the FASB issued ASU No.&nbsp;2018-07 </FONT> <FONT SIZE=2><I>Compensation&#151;Stock Compensation
(Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</I></FONT><FONT SIZE=2> ("ASU No.&nbsp;2018-07"). ASU
No.&nbsp;2018-07 expands the guidance in ASC718 to include share-based payments for goods and services to non-employees and generally aligns it with the guidance for share-based payments to
employees. The amendments are effective for the Company for fiscal years beginning after December&nbsp;15, 2019 and interim periods within </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=194,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=608016,FOLIO='F-15',FILE='DISK125:[19ZCO1.19ZCO70301]FM70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fm70301_1_16"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>fiscal
years beginning after December&nbsp;15, 2020, with early adoption permitted for entities that have adopted ASC 606. The Company adopted this new standard on January&nbsp;1, 2018. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recently Issued Accounting Pronouncements  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In February 2016, the FASB issued ASU No.&nbsp;2016-02, </FONT><FONT SIZE=2><I>Leases</I></FONT><FONT SIZE=2> ("ASU 2016-02"). The new
guidance requires lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016-02 states that a
lessee would recognize a lease liability for the obligation to make lease payments and a right-to-use asset for the right to use the underlying asset for the lease term. The standard is effective for
the Company for fiscal years beginning after December&nbsp;15, 2019 and interim periods fiscal years beginning after December&nbsp;15, 2020. Early adoption is permitted. The Company is currently
evaluating the effect of this standard on its financial statements. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. Fair Value of Financial Instruments  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth the fair value of the Company's financial assets by level within the fair value hierarchy (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December&nbsp;31, 2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fair Value Measurement Based on </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Assets

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Carrying<BR>
Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fair<BR>
Value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Quoted Prices<BR>
in Active<BR>
Markets<BR>
(Level&nbsp;1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Significant<BR>
Other<BR>
Observable<BR>
Inputs<BR>
(Level&nbsp;2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Significant<BR>
Unobservable<BR>
Inputs<BR>
(Level&nbsp;3) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Money market funds (cash equivalents)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>As of December&nbsp;31, 2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fair Value Measurement Based on </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Assets

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Carrying<BR>
Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fair<BR>
Value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Quoted Prices<BR>
in Active<BR>
Markets<BR>
(Level&nbsp;1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Significant<BR>
Other<BR>
Observable<BR>
Inputs<BR>
(Level&nbsp;2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Significant<BR>
Unobservable<BR>
Inputs<BR>
(Level&nbsp;3) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Money market funds (cash equivalents)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company did not transfer any assets measured at fair value on a recurring basis to or from Level&nbsp;1 during the years ended December&nbsp;31, 2018 and 2017. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=195,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=562216,FOLIO='F-16',FILE='DISK125:[19ZCO1.19ZCO70301]FM70301A.;10',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fo70301_1_17"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


4. Property and Equipment, Net  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment consist of the following (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,787</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,213</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Leasehold improvements</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,825</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>564</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Computer equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>167</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>111</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Furniture and fixtures</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Construction in progress</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,027</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,892 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Property and equipment, gross</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13,876</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,813</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Less: accumulated depreciation and amortization</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2,469</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(792</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Property and equipment, net</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,407</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,021 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Construction
in progress at December&nbsp;31, 2018 consists of the costs incurred for research equipment. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation
and amortization expense was $1.7&nbsp;million and $582,000 for the years ended December&nbsp;31, 2018 and 2017, respectively. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


5. Accrued Liabilities  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities consist of the following (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued construction in progress</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>515</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued payroll and related benefits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,008</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>493</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued clinical trial costs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>271</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued operating expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>719</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>450</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued financing costs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>284</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued office lease</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>127</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>104</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued interest</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total accrued liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,411</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,564 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


6. Agreement with Eli Lilly and Company  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On November&nbsp;2, 2018, the Company entered into a multi-year research and development collaboration agreement (the "Lilly Agreement") with Eli Lilly and Company ("Lilly"), pursuant
to which the Company will use its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Under the Lilly
Agreement, Lilly and the Company have granted one another an equal number of exclusive options to research, develop, manufacture and commercialize compounds and products directed to oncology targets
identified through the Lilly Agreement. Both Lilly and the Company each have all options remaining eligible for exercise. The research collaboration with Lilly will be managed by a joint steering
committee formed by an equal number of members from the Company and Lilly and will expire upon the earlier of the exercise of all options granted to Lilly or four years from the date of the agreement,
subject to certain extensions. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=196,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=760004,FOLIO='F-17',FILE='DISK125:[19ZCO1.19ZCO70301]FO70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fo70301_1_18"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


6. Agreement with Eli Lilly and Company (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the research term under the Lilly Agreement, as a part of target discovery, the Company will be responsible for providing Lilly with oncology targets identified using the
Company's FIND-IO platform. From the targets provided by the Company, Lilly may select targets to advance to target validation using criteria developed by both parties. Following completion of the
agreed upon target validation plan with respect to a given target, either party may propose to advance that target to compound discovery. For each target that has been advanced to compound discovery,
Lilly will have the option to obtain an exclusive license with respect to the compounds and products directed to the target. If Lilly does not exercise its option with respect to a given target or has
previously exercised all of its options, the Company will have the option to obtain licenses with respect to compounds and products directed to that target. Following option exercise by a party, the
development and commercialization of any products directed to the target will be conducted by the exercising party. The exercising party must use commercially reasonable efforts to develop, seek
regulatory approval for and commercialize any such products under mutually agreed upon work plans. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company received an upfront, non-refundable payment of $25.0&nbsp;million under the Lilly Agreement and a concurrent $15.0&nbsp;million equity investment (Note&nbsp;9). In
addition, the Company will receive quarterly research and development support payments during a portion of the research term as well as option exercise fees upon option exercises by Lilly. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the Lilly Agreement, Lilly will owe an aggregate of up to $1.4&nbsp;billion in development and regulatory milestones and sales milestones. Additionally, Lilly will pay mid
to high single-digit royalties on net sales for all products directed to each target optioned by Lilly. Upon the Company's exercise of an option with respect to a given target, the Company will pay
Lilly option exercise, milestone and royalty payments. The company will owe an aggregate of up to $710.0&nbsp;million in development and regulatory milestones and sales milestones. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
company has evaluated the Lilly Agreement under ASC 606. Two performance obligations were identified as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> research and development services; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> material right related to an optional term extension by Lilly. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Lilly Agreement was executed in November 2018, however, the performance obligations were initiated in January 2019; accordingly no revenue was recorded under the Lilly Agreement in
2018. As of December&nbsp;31, 2018, deferred revenue included in the Company's balance sheets in connection with the Lilly Agreement was $26.7&nbsp;million, which consisted of the
$25.0&nbsp;million upfront payment plus $1.7&nbsp;million attributed as a premium on the proceeds from Lilly's equity investment in the Company (Note&nbsp;9). </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


7. Commitments and Contingencies  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Operating Leases  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company subleases its facilities under a non-cancelable operating sublease agreement. The sublease commenced on February&nbsp;9, 2016 and
expires on August&nbsp;31, 2025. The Company is also responsible for its prorated share of the sublandlord's operating expense. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=197,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=809351,FOLIO='F-18',FILE='DISK125:[19ZCO1.19ZCO70301]FO70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fo70301_1_19"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


7. Commitments and Contingencies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
future minimum payments for the operating leases are as follows (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Year Ending December&nbsp;31,

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2019</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>325</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>308</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2021</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>317</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2022</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>355</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2023</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>335</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thereafter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>635 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total future minimum payments</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,275 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rent
expense incurred under operating leases was approximately $420,000 and $376,000 for the years ended December&nbsp;31, 2018 and 2017, respectively. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Contingencies  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is subject to claims and assessments from time to time in the ordinary course of business. The Company records a provision for a
liability when it believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. Significant judgment is required to determine both probability and
the estimated amount. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the normal course of business, the Company may become involved in legal proceedings. The Company will accrue a liability for such matters when it is probable that a liability has been
incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better
estimate than any other amount within the range, the minimum amount in the range is accrued. As of December&nbsp;31, 2018 and 2017, the Company was not involved in any material legal proceedings. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


8. Term Loan  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In April 2016, the Company entered into a $1.0&nbsp;million term loan (the "Term Loan"). The Term Loan bears interest at the prime rate less 1%. The interest rate in effect was 4.5%
and 3.5% for the years ended December&nbsp;31, 2018 and 2017, respectively. The Term Loan is secured by all certificates of
deposit, money market accounts, cash, securities, investment property and deposit or investment accounts. The Term Loan requires monthly payments of interest only before May 2017, and equal monthly
payments of principal and interest thereafter, as defined in the agreement. Interest expense under the Term Loan was approximately $25,000 and $30,000 for the years ended December&nbsp;31, 2018 and
2017, respectively. The outstanding balance on the Term Loan totaled $460,000 as of December&nbsp;31, 2018. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Future
maturities of the Term Loan as of December&nbsp;31, 2018 are as follows (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>387</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>73 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>460</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Less: current portion of term loan</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>387 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Term loan, net of current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>73 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=198,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=496176,FOLIO='F-19',FILE='DISK125:[19ZCO1.19ZCO70301]FO70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fo70301_1_20"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


9. Preferred Stock  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December&nbsp;31, 2018, the Company's certificate of incorporation, as amended and restated, authorized the Company to issue 125,010,671 shares of $0.001 par value preferred
stock. The Company's preferred stock is classified outside of stockholders' deficit because the shares contain deemed liquidation rights that are a contingent redemption feature not solely within the
control of the Company. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Series&nbsp;A Preferred Stock  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December&nbsp;31, 2018, the Company has issued 68,181,819 shares of Series&nbsp;A Preferred Stock as follows: </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
December 2015, the Company issued 15,000,000 shares of Series&nbsp;A-1 Preferred Stock at an issuance price of $1.00 per share for cash proceeds of $15.0&nbsp;million. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
January 2017, the Company issued 25,000,000 shares of Series&nbsp;A-2 Preferred Stock at an issuance price of $1.00 per share for cash proceeds of $25.0&nbsp;million. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
April 2018, the Company issued 28,181,819 shares of Series&nbsp;A-3 Preferred Stock at an issuance price of $1.10 per share for cash proceeds of approximately $31.0&nbsp;million. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Series&nbsp;B Preferred Stock  </I></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December&nbsp;31, 2018, the Company has issued 56,828,851 shares of Series&nbsp;B Preferred Stock as follows: </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2018, the Company issued 15,052,117 and 34,276,734 shares of Series&nbsp;B-1 Preferred Stock and Series&nbsp;B-2 Preferred Stock, respectively, at an issuance price of
$1.59 per share for aggregate cash proceeds of approximately $78.4&nbsp;million. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Concurrent
with the issuance of the Series&nbsp;B-1 Preferred Stock and Series&nbsp;B-2 Preferred Stock, in November 2018, the Company issued 7,500,000 shares of Series&nbsp;B-3
Preferred Stock at an issuance price of $2.00 per share for cash proceeds of $15.0&nbsp;million in connection with the execution of the Collaboration Agreement with Lilly. The Company allocated
$13.3&nbsp;million of the proceeds to Series&nbsp;B-3 Preferred Stock and $1.7&nbsp;million to deferred revenue. The $1.7&nbsp;million was determined to be a premium over the fair value of the
Series&nbsp;B-3 Preferred Stock and attributed as additional consideration of the Collaboration Agreement (Note&nbsp;6). </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company estimated the premium of the Series&nbsp;B-3 Preferred Stock based on a valuation of the Company's preferred stock prepared by an unrelated third-party valuation firm in
accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. The
$1.7&nbsp;million premium on the Series&nbsp;B-3 Preferred Stock will be recognized as revenue on a proportional performance basis over the term of the Collaboration Agreement. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company's Preferred Stock has the following rights and preferences, privileges and restrictions: </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Dividends  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The holders of Preferred Stock are entitled to receive annual noncumulative dividends at an annual rate of 8% in preference to any declaration
or payment of any dividend on the common stock, on an </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=199,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=117058,FOLIO='F-20',FILE='DISK125:[19ZCO1.19ZCO70301]FO70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fo70301_1_21"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


9. Preferred Stock (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>as-converted
basis when, as and if declared by the Board of Directors. As of December&nbsp;31, 2018, no dividends have been declared. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Voting Rights  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each share of Preferred Stock represents such number of votes as is equal to the number of shares of common stock into which such share is
convertible. The holders of Preferred Stock vote together with the holders of common stock on an as-converted basis on all matters in which stockholders are entitled to vote. The holders of
Series&nbsp;A Preferred Stock, exclusively and as a separate class, are entitled to elect five directors, the holders of the Series&nbsp;B Preferred Stock, exclusively and as a separate class, are
entitled to elect two directors of the Company as of December&nbsp;31, 2018. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Conversion Rights  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The holders of the Preferred Stock are entitled to convert each share into 0.1245 shares of common stock on demand. The Preferred Stock is
mandatorily convertible upon the closing of a qualified public offering in which gross proceeds to the Company of not less than $75.0&nbsp;million or on the date specified by a majority vote of the
outstanding shares of Preferred Stock voting on an as-converted basis. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Liquidation Preference  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of the Company's Series&nbsp;B
Preferred Stock are entitled to receive, before any payment of any of the assets of the Company to the holders of the Series&nbsp;A Preferred Stock and holders of common stock, $12.77 per share with
respect to shares of Series&nbsp;B-1 Preferred Stock and Series&nbsp;B-2 Preferred Stock and $16.07 per share with respect to shares of Series&nbsp;B-3 Preferred Stock (as adjusted for any stock
dividend, stock split, combination or other similar transactions, plus any declared but unpaid dividends). After payment of the above but before any payment of any of the assets of the Company to the
holders of common stock, the holders of Series&nbsp;A Preferred Stock are entitled to receive $8.03 per share with respect to shares of Series&nbsp;A-1 Preferred Stock and Series&nbsp;A-2
Preferred Stock and $8.84 per share with respect to shares of Series&nbsp;A-3 Preferred Stock (as adjusted for any stock dividend, stock split, combination or other similar transactions, plus any
declared but unpaid dividends). </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


10. Common Stock  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December&nbsp;31, 2018, the Company's Certificate of Incorporation, as amended and restated, authorized the Company to issue 158,745,671 shares of $0.001 par value common stock,
of which 1,374,812 were issued and outstanding. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company's stockholders. Common stockholders are entitled to receive dividends, as may
be declared by the board of directors, if any, subject to the preferential dividend rights of the preferred stock. When dividends are declared on shares of common stock, the Company must declare at
the same time a dividend payable to the holders of preferred stock equivalent to the dividend amount they would receive if each share of preferred stock was converted into common stock. The Company
may not pay dividends to common stockholders until all dividends accrued or declared but unpaid on the preferred
stock have been paid in full. No dividends have been declared or paid by the Company through December&nbsp;31, 2018. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=200,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=792947,FOLIO='F-21',FILE='DISK125:[19ZCO1.19ZCO70301]FO70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fq70301_1_22"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


10. Common Stock (Continued)  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of any liquidation or dissolution of the Company, the holders of common stock are entitled to the remaining assets of the Company legally available for distribution after
the payment of the full liquidation preference for the preferred stock. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


11. Stock-Based Compensation  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2015 Omnibus Incentive Plan  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The NextCure,&nbsp;Inc. 2015 Omnibus Incentive Plan (the "2015 Plan") provides for the Company to grant incentive stock options or
nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company. The 2015 Plan is administered by the
board of directors, or at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of
the board of directors or its committee if so delegated, except that the exercise price per share of the stock options may not be less than 100% of the fair market value of a share of the Company's
common stock on the date of grant and the term of the stock options may not be greater than 10&nbsp;years. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the 2015 Plan, the Company had initially reserved on December&nbsp;29, 2015, 311,185 shares of common stock, which number of shares was automatically increased pursuant to the
terms of the 2015 Plan by 373,422 as of the second closing of the Series&nbsp;A Preferred Stock financing on January&nbsp;24, 2017. The total number of shares of common stock that may be issued
under the 2015 Plan was 2,824,317 as of December&nbsp;31, 2018. As of December&nbsp;31, 2018, there were 2,056,891 stock options and 62,237 shares of registered stock outstanding and 699,590
shares of common stock available for future issuance under the 2015 Plan. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock
options granted under the 2015 Plan generally vest over four years and expire after 10&nbsp;years. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
exercise price for stock options granted is not less than the fair value of common shares as determined by the board of directors as of the date of grant. The board of directors
determines the value the Company's common stock taking into consideration the most recently available third-party valuation of common shares, as well as additional factors, which may have changed
since the date of the most recent contemporaneous valuation through the date of grant. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=201,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=550065,FOLIO='F-22',FILE='DISK125:[19ZCO1.19ZCO70301]FQ70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fq70301_1_23"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


11. Stock-Based Compensation (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
summary of stock option activity for awards under the 2015 Plan is presented below: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Options Outstanding and Exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted<BR>
Average<BR>
Exercise<BR>
Price </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted<BR>
Average<BR>
Remaining<BR>
Contractual<BR>
Life (Years) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Aggregate<BR>
Intrinsic<BR>
Value<SUP>(1)</SUP><BR>
(in thousands) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Outstanding as of January&nbsp;1, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>189,189</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.48</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8.6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>137</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>317,397</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Outstanding as of December&nbsp;31, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>506,586</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.94</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9.0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>137</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,570,136</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5.92</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9.9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,684</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,599</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.84</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Forfeitures</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(14,232</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Outstanding as of December&nbsp;31, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,056,891</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4.74</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,946 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vested and expected to vest as of December&nbsp;31, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,056,891</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4.74</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,946</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercisable as of December&nbsp;31, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>242,079</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.88</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7.9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,634</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock
for the options that were in the money at December&nbsp;31, 2018 and 2017.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
weighted average grant date fair value per share of stock options granted during the years ended December&nbsp;31, 2018 and 2017 was $3.80 and $0.80, respectively. The aggregate
intrinsic value of stock options exercised during the years ended December&nbsp;31, 2018 and 2017 was $38,000 and $0, respectively. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
aggregate grant date fair value of stock options and restricted stock vested during the year ended December&nbsp;31, 2018 and 2017 was approximately $157,000 and $29,000,
respectively. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock-Based Compensation  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company recorded stock-based compensation expense of $263,000 and $75,000 during the years ended December&nbsp;31, 2018 and 2017,
respectively. As of December&nbsp;31, 2018, there was $6.0&nbsp;million of unrecognized compensation cost related to unvested stock-based compensation arrangements granted under the 2015 Plan.
This remaining compensation expense is expected to be recognized over a weighted average period of three years as of December&nbsp;31, 2018. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based
compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>178</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>40 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total stock-based compensation expense</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>263</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>75 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=202,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=13781,FOLIO='F-23',FILE='DISK125:[19ZCO1.19ZCO70301]FQ70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fq70301_1_24"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


11. Stock-Based Compensation (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
assumptions used in the Black-Scholes option-pricing model for stock options granted were as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year Ended<BR>
December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected term</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.1&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected volatility</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>69.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Risk free interest rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2.77</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected dividend yield</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Restricted Common Stock  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In May 2016, the Company issued 62,237 shares of restricted common stock from the 2015 Plan, which are restricted as to sale or transferability.
These restrictions lapse over a four-year period. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


12. Net Loss Per Share Attributable to Common Stockholders  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share
amounts): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Numerator:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,799</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,469</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Denominator:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Weighted average number of common shares, basic and diluted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,846</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,212 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss per common share attributable to common stockholders, basic and diluted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(16.64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(11.30</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company's potential dilutive securities, which include preferred stock and common stock options, have been excluded from the computation of diluted net loss per share as the effect
would be anti-dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same.
The Company excluded the following potential common shares, presented based on amounts outstanding at period end, from the computation of diluted net loss per share attributable to common stockholders
for the period indicated because including them would have had an anti-dilutive effect: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Preferred stock</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15,560,569</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,978,957</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Options to purchase common stock</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>242,079</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>64,783 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15,802,648</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,043,746 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=203,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=18684,FOLIO='F-24',FILE='DISK125:[19ZCO1.19ZCO70301]FQ70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fq70301_1_25"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


13. Income Taxes  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 U.S. Tax Reform  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On December&nbsp;22, 2017, the U.S. government signed into law the Tax Cuts and Jobs Act (the "Tax Act") that significantly reforms the
Internal Revenue Code of 1986, as amended. The Tax Act, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate
of 35% to a flat rate of 21%, effective as of January&nbsp;1, 2018; limitation of the tax deduction for interest expense; limitation of the deduction for net operating losses to 80% of annual
taxable income and elimination of net operating loss carrybacks, in each case, for losses arising in taxable years beginning after December&nbsp;31, 2017 (though any such tax losses may be carried
forward indefinitely); and modifying or repealing many business deductions and credits, including reducing the business tax credit for certain clinical testing expenses incurred in the testing of
certain drugs for rare diseases or conditions generally referred to as "orphan drugs". </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2018, the Company finished its analysis of the impact of the Tax Act. Where the Company made reasonable estimates in 2017 of the effects related to the Tax Act, the Company recorded
provisional amounts. After the completed analysis, the resulting impact to the Company's financial statements did not differ from the recorded provisional amounts. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Income Taxes  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The reconciliation of federal statutory income tax rate to the Company's effective income tax rate is as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="31pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Expected income tax benefit at the federal statutory rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>34.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>State taxes, net of federal benefit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development credit, net</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-deductible items</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(5.3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Prior year provision to return adjustments</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(7.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4.1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tax rate reduction due to the Tax Act</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(15.6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2.9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Change in valuation allowance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(25.1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(25.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>% </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred
income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for
income tax purposes. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=204,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=645181,FOLIO='F-25',FILE='DISK125:[19ZCO1.19ZCO70301]FQ70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fq70301_1_26"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


13. Income Taxes (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
principal components of the Company's deferred tax assets consisted of the following as of December&nbsp;31, 2018 and 2017 (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred tax assets:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Federal and state net operating loss carryforwards</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,946</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,176</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development tax credits</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,393</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,283</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Charitable contribution carryforwards</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>165</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>153</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accruals</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>290</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>135</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gross deferred tax assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15,817</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,751</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Less: valuation allowance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(15,525</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(7,491</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total deferred tax assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>292</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>260 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred tax liabilities:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Depreciation and amortization</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(292</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(260</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gross deferred tax liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(292</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(260</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net deferred tax assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on the Company's history of losses, the Company recorded a full valuation allowance against its deferred tax assets as of December&nbsp;31, 2018. The Company increased its
valuation allowance by approximately $8.0&nbsp;million for the year ended December&nbsp;31, 2018. The Company intends to maintain a valuation allowance until sufficient positive evidence exists to
support a reversal of the allowance. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of December&nbsp;31, 2018, the Company had federal and state net operating loss carryforwards of $43.5&nbsp;million and $43.0&nbsp;million, respectively, some of which begin to
expire in the year ending December&nbsp;31, 2036. Approximately $20.8&nbsp;million of the federal and state net operating loss carryforwards do not expire. The Company had federal and state
research and development tax credit carryforwards of approximately $2.5&nbsp;million and $1.1&nbsp;million, respectively, as of December&nbsp;31, 2018. The federal credits begin to expire in the
year ending December&nbsp;31, 2036 and the state credits begin to expire in the year ending December&nbsp;31, 2024. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the provisions of Sections&nbsp;382 and 383 of the Internal Revenue Code (the "IRC"), net operating loss and credit carryforwards and other tax attributes may be subject to
limitation if there has been a significant change in ownership of the Company, as defined by the IRC. Future owner or equity shifts, including an initial public offering, could result in limitations
on net operating loss and credit carryforwards. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company files income tax returns in the U.S. federal jurisdiction as well as in Maryland. The tax years 2015 to 2017 remain open to examination by the major jurisdictions in which
the Company are subject to tax. Fiscal years outside the normal statute of limitation remain open to audit by tax authorities due to tax attributes generated in those early years, which have been
carried forward and may be audited in subsequent years when utilized. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=205,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=111276,FOLIO='F-26',FILE='DISK125:[19ZCO1.19ZCO70301]FQ70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fq70301_1_27"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


13. Income Taxes (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company evaluates tax positions for recognition using a more-likely-than-not recognition threshold, and those tax positions eligible for recognition are measured as the largest
amount of tax benefit that is greater than 50% likely of being realized upon the effective settlement with a taxing authority that has full knowledge of all relevant information. As of
December&nbsp;31, 2018, the Company had no unrecognized income tax benefits that would affect the Company's effective tax rate if recognized. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


14. Employee Benefit Plan  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company sponsors a 401(k) plan that stipulates that eligible employees can elect to contribute to the 401(k) plan, subject to certain limitations, up to the lesser of the statutory
maximum or 100% of eligible compensation on a pre-tax basis. Through December&nbsp;31, 2018, the Company has not provided any contributions to this plan. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


15. Related Party Transactions  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Lilly Agreement  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In November 2018, the Company entered into the Lilly Agreement with a stockholder of the Company, Lilly, pursuant to which the Company will use
its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Lilly provided to the Company a cash upfront
payment of $25.0&nbsp;million upon entering into the Collaboration Agreement and made a concurrent $15.0&nbsp;million equity investment in the Company (Note&nbsp;6 and Note&nbsp;9). </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Consulting Agreement with Scientific Founder  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In December 2015, the Company entered into a consulting agreement for scientific advisory services with a founder of the Company (the
"Scientific Founder"), who is also a stockholder of the Company. The term of the consulting agreement expires December&nbsp;31, 2020. Under the agreement, the Scientific Founder is entitled to
receive $5,000 per month in consulting fees until the expiration of the agreement. As of December&nbsp;31, 2018, the amount due under this agreement is $120,000. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Yale License Agreement and Sponsored Research Agreement  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In December 2015, the Company entered into a license agreement with Yale University (the "Yale Agreement"), which is also a stockholder of the
Company. Under the Yale Agreement, the Company obtained a license to products that either incorporate certain licensed patents used in the discovery of targets or arise out of research and development
of the Scientific Founder's laboratory at Yale, including a proprietary target. The Company is obligated to pay Yale low single-digit royalties on sales of products that are either covered by the
patents licensed to the Company under the Yale Agreement or arise out of the Scientific Founder's laboratory, subject to minimum annual royalty payments in the low to mid hundreds of thousands of
dollars, an annual license maintenance fee in the mid to high tens of thousands of dollars and milestone payments of up to $3.0&nbsp;million per product. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the Yale Agreement, the Company also entered into the Corporate Sponsored Research Agreement with Yale (the "SRA"), in which the Company agreed to provide an aggregate
of up to $12.4&nbsp;million to fund a research program aimed at discovering new targets for immunomedicines.
The research program is under the direction and supervision of the Scientific Founder. As of December&nbsp;31, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=206,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=883321,FOLIO='F-27',FILE='DISK125:[19ZCO1.19ZCO70301]FQ70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_fq70301_1_28"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NOTES TO FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


15. Related Party Transactions (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>2018,
the Company has made payments in an aggregate of $7.4&nbsp;million under the SRA, including $2.5&nbsp;million and $2.1&nbsp;million in the years ended December&nbsp;31, 2018 and 2017,
respectively. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


16. Subsequent Events  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On January&nbsp;25, 2019, the Company amended its Term Loan to an aggregate principal amount of $5.0&nbsp;million, which remains secured by the Company's certificates of deposit,
money market account, investment property and deposit or investment accounts. As amended, the Term Loan bears interest at the greater of the prime rate less 1% and 4.25%. Under the agreement, the
Company is required to make monthly interest-only payments through January 2020 and is required to make 36 equal monthly payments of principal plus accrued interest thereafter through January 2023. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
January&nbsp;30, 2019, the Company entered into a new lease for 14,075 square feet to be used for office, manufacturing and laboratory space, which the Company expects to take
possession of in June 2019. The new lease is expected to expire in March 2030 and will also cover the Company's existing space after expiration of the Company's current lease. Base rent for the first
10&nbsp;months is abated, after which the base rent of the lease is $19,650 per month, with an increase in annual rent of 3.0% in each subsequent year of the lease term. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
March&nbsp;15, 2019, the Company entered into an amended and restated lease that covers the Company's existing space plus additional square footage to be used as office space, which
the Company took possession of upon entering into the amended and restated lease. The amended and restated lease expires in August 2025. The total remaining commitment under the amended and restated
lease is approximately $3.0&nbsp;million. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
May&nbsp;3, 2019, the Company effected a 1-for-8.0338 reverse stock split of its outstanding common stock. The par value and authorized shares of common stock were not adjusted as a
result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to reflect the reverse common stock split on a
retroactive basis for all periods and as of all dates presented. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=207,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=933581,FOLIO='F-28',FILE='DISK125:[19ZCO1.19ZCO70301]FQ70301A.;9',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fs70301_1_29"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fs70301_nextcure,_inc._condensed_balan__nex03713"> </A>
<A NAME="toc_fs70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.    <BR>    <BR>    CONDENSED BALANCE SHEETS    <BR>    <BR>    (unaudited, in thousands, except share and per share amounts)    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>September&nbsp;30,<BR>
2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Assets</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current assets:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9,935</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>135,173</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Marketable securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>174,147</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Restricted cash</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,289</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>460</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Prepaid expenses and other current assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,777</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>152 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total current assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>189,148</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>135,785</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Property and equipment, net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,031</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,407</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,945</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>436 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total assets</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>205,124</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>147,628 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Liabilities, Preferred Stock and Stockholders' Equity (Deficit)</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Current liabilities:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accounts payable</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,576</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,483</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,582</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,411</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred rent, current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>28</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Term loan, current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>387</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred revenue, current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,199</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,989 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total current liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,607</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10,298</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred rent, net of current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>434</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>242</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Term loan, net of current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,750</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>73</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred revenue, net of current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,684</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21,736 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>34,475</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>32,349 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Commitments and contingencies (Note&nbsp;7)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Redeemable preferred stock:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Series&nbsp;A Preferred Stock, par value of $0.001 per share; 0 and 68,181,819 shares authorized, issued and outstanding at September&nbsp;30, 2019 and
December&nbsp;31, 2018, respectively</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>71,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Series&nbsp;B Preferred Stock, par value $0.001 per share; 0 and 56,828,852 shares authorized at September&nbsp;30, 2019 and December&nbsp;31, 2018,
respectively, 0 and 56,828,851 shares issued and outstanding at September&nbsp;30, 2019 and December&nbsp;31, 2018, respectively</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>91,223 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total redeemable preferred stock</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>162,223 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stockholders' equity (deficit):</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Preferred stock, par value of $0.001 per share; 10,000,000 and 0 shares authorized at September&nbsp;30, 2019 and December&nbsp;31, 2018. No shares issued
and outstanding at September&nbsp;30, 2019 and December&nbsp;31, 2018, respectively</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Common stock, par value of $0.001 per share; 100,000,000 and 158,745,671 shares authorized at September&nbsp;30, 2019 and December&nbsp;31, 2018,
respectively, 22,739,345, and 1,374,812 shares issued and outstanding at September&nbsp;30, 2019 and December&nbsp;31, 2018, respectively</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Additional paid-in capital</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>240,791</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>352</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated other comprehensive loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(70,107</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(47,297</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total stockholders' equity (deficit)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>170,649</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(46,944</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total liabilities, preferred stock and stockholders' equity (deficit)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>205,124</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>147,628 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=2>
The accompanying notes are an integral part of these unaudited condensed financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=208,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=8817,FOLIO='F-29',FILE='DISK125:[19ZCO1.19ZCO70301]FS70301A.;5',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fu70301_1_30"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fu70301_nextcure,_inc._condensed_state__nex05143"> </A>
<A NAME="toc_fu70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.    <BR>    <BR>    CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS    <BR>    <BR>    (unaudited, in thousands, except share and per share amounts)    <BR>
</B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Three Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue from research and development arrangement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,583</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,663</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4,895</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>13,539</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,622</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>925</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,995</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,590 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>11,285</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,820</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>29,814</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>16,129 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Loss from operations</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(9,702</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,820</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(25,472</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(16,129</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other income, net</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,268</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>110</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,662</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>192 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8,434</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,810</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,937</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Comprehensive loss:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Unrealized loss on marketable securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total comprehensive loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(8,492</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(5,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(22,868</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(15,937</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss per common share&#151;basic and diluted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.37</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4.17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1.81</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(11.64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Weighted average number of common shares&#151;basic and diluted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>22,715,567</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,212</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,609,219</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,369,212 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=2>
The accompanying notes are an integral part of these unaudited condensed financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=209,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=602680,FOLIO='F-30',FILE='DISK125:[19ZCO1.19ZCO70301]FU70301A.;6',USER='VRIVERA',CD='11-NOV-2019;23:06' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fw70301_1_31"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fw70301_nextcure,_inc._condensed_state__nex04962"> </A>
<A NAME="toc_fw70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.    <BR>    <BR>    CONDENSED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)    <BR>    <BR>    (unaudited, in thousands, except share data)    <BR>
</B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="34pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="34pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=31 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nine Months Ended September&nbsp;30, 2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Preferred Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=17 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stockholders' Equity (Deficit) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Series&nbsp;A </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Series&nbsp;B </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Common Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=4 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=4 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Accumulated<BR>
Other<BR>
Comprehensive<BR>
Loss </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Additional<BR>
Paid-in<BR>
Capital </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Accumulated<BR>
Deficit </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stockholders'<BR>
Equity<BR>
(Deficit) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR style="font-size:1.5pt;" VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;">&nbsp;<BR></TH>
<TH style="font-family:times;">&nbsp;</TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B><BR></TH>
<TH style="font-family:times;">&nbsp;</TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:6pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of December&nbsp;31, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>68,181,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>71,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>56,828,851</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>91,223</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>



<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,374,812</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>352</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(47,297</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(46,944</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Stock-based compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>383</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>383</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issuance of common stock</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4,697</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(6,155</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(6,155</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:6pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of March&nbsp;31, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>68,181,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>71,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>56,828,851</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>91,223</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,379,509</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>739</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(53,452</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(52,712</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Initial public offering, net of issuance costs of
$9.4M&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,750,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>76,848</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>76,854</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Conversion of preferred stock to common stock</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(68,181,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(71,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(56,828,851</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(91,223</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>15,560,569</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>15</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>162,208</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>162,223</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Stock-based compensation expense</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>412</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>412</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issuance of common stock upon exercise of vested options, $0.001 par value</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>24,687</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>38</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>39</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(8,221</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(8,221</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:6pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of June&nbsp;30, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>22,714,765</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>240,245</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(61,673</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>178,595 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Stock-based compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>524</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>524</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issuance of common stock</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>24,580</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>22</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Unrealized loss on marketable securities</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:12pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(8,434</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(8,434</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:6pt;text-indent:-6pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of September&nbsp;30, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>22,739,345</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>23</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>240,791</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(70,107</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>170,649 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0.75pt;font-size:0.75pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="35pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="35pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="35pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=31 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nine Months Ended September&nbsp;30, 2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Preferred Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=17 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stockholders' Deficit </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Series&nbsp;A </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Series&nbsp;B </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Common Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=4 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=4 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Accumulated<BR>
Other<BR>
Comprehensive<BR>
Loss </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Additional<BR>
Paid-in<BR>
Capital </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Accumulated<BR>
Deficit </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stockholders'<BR>
Deficit </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Shares </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR style="font-size:1.5pt;" VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;">&nbsp;<BR></TH>
<TH style="font-family:times;">&nbsp;</TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B><BR></TH>
<TH style="font-family:times;">&nbsp;</TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of December&nbsp;31, 2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>



<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,369,212</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>84</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(24,498</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(24,413</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Stock-based compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(4,996</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(4,996</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of March&nbsp;31, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,369,212</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>108</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(29,494</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(29,385</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issuance of Series&nbsp;A-3 preferred stock, net of issuance costs of $0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>28,181,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>31,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Stock-based compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>24</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(5,231</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(5,231</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of June&nbsp;30, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>68,181,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>71,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,369,212</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>132</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(34,725</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(34,592</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Stock-based compensation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>90</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>90</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Issuance of common stock</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Net loss</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(5,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(5,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Balance as of September&nbsp;30, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>68,181,819</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>71,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1>



<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,369,212</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>222</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(40,435</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>(40,212</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0.75pt;font-size:0.75pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="TOP" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=2>
The accompanying notes are an integral part of these unaudited condensed financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=210,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=598212,FOLIO='F-31',FILE='DISK125:[19ZCO1.19ZCO70301]FW70301A.;22',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_fy70301_1_32"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="fy70301_nextcure,_inc._condensed_state__nex02776"> </A>
<A NAME="toc_fy70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.    <BR>    <BR>    CONDENSED STATEMENTS OF CASH FLOWS    <BR>    <BR>    (unaudited, in thousands)    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nine Months Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash flows from operating activities:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(22,810</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(15,937</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Adjustments to reconcile net loss to net cash used in operating activities:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Depreciation and amortization</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,933</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,159</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stock-based compensation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,319</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>138</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Changes in operating assets and liabilities:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Prepaid expenses and other assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(3,660</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(89</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accounts payable</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>93</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>776</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accrued liabilities and other current liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>335</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(526</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred revenue</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2,842</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net cash used in operating activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(25,632</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(14,479</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash flows from investing activities:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Purchase of property and equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2,557</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1,159</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Purchase of marketable securities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(174,205</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net cash used in investing activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(176,762</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1,159</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash flows from financing activities:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from initial public offering, net of issuance costs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>77,264</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from issuance of preferred stock, net of issuance costs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>31,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from issuance of common stock</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>65</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Proceeds from the term loan</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,540</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred financing costs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(134</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Payments of the term loan</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(300</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net cash provided by financing activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>81,735</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>30,686 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Net (decrease) increase in cash, cash equivalents and restricted cash</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(120,659</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15,048</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash, cash equivalents and restricted cash&#151;beginning of year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>135,633</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,287 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash, cash equivalents and restricted cash&#151;end of period</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,974</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>24,335 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Supplemental disclosures of cash flow information:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash paid for interest</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>137</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Supplemental disclosures of noncash investing and financing activities:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Purchase of property and equipment included in accrued liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>76 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred financing costs included in accrued liabilities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>134</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Conversion of convertible preferred stock into common stock</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>162,223</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT SIZE=2>
The accompanying notes are an integral part of these unaudited condensed financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=211,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=941041,FOLIO='F-32',FILE='DISK125:[19ZCO1.19ZCO70301]FY70301A.;6',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_ga70301_1_33"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="ga"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ga70301_nextcure,_inc._notes_to_conden__nex02457"> </A>
<A NAME="toc_ga70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.<BR>  NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>  (unaudited)    <BR>        <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


1. Nature of the Business  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Organization  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NextCure,&nbsp;Inc. ("NextCure" or the "Company") was incorporated in Delaware in September 2015 and is headquartered in Beltsville, Maryland.
The Company is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring
normal immune function. Through its proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology ("FIND-IO") platform, the Company studies various immune cells in order to discover and
understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Since inception, the Company has devoted substantially all of its efforts
and financial resources to organizing and staffing the Company, identifying business development opportunities, raising capital, securing intellectual property rights related to the Company's product
candidates, building and optimizing the Company's manufacturing capabilities and conducting discovery, research and development activities for the Company's product candidates, discovery programs and
its FIND-IO platform. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Initial Public Offering  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On May&nbsp;13, 2019, the Company closed its initial public offering ("IPO"), in which the Company issued and sold 5,750,000 shares of common
stock at a public offering price of $15.00 per share, for net proceeds to the Company of approximately $77.0&nbsp;million after deducting underwriting discounts and commissions of
$6.0&nbsp;million and offering expenses of approximately $3.4&nbsp;million. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
preparation for the IPO, on May&nbsp;3, 2019, the Company effected a one-for-8.0338 reverse stock split of its issued and outstanding common stock. The par value and authorized
shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to
reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the closing of the IPO, on May&nbsp;13, 2019, all of the outstanding shares of the Company's convertible preferred stock automatically converted into 15,560,569 shares of common
stock at the applicable conversion ratio then in effect. Subsequent to the closing of the IPO, there were no shares of preferred stock outstanding. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the closing of the IPO, on May&nbsp;13, 2019, the Company's certificate of incorporation was amended and restated to provide for 100,000,000 authorized shares of common stock with
a par value of $0.001 per share and 10,000,000 authorized shares of preferred stock with a par value of $0.001 per share. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Liquidity  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has not generated any revenue to date from product sales and does not expect to generate any revenues from product sales in the
foreseeable future. Through September 2019, the Company has funded its operations primarily with proceeds from the sale of preferred stock and proceeds from the Company's agreement with Eli Lilly and
Company (Note&nbsp;6) and proceeds from the IPO. The Company expects to incur additional operating losses and negative operating cash flows for the foreseeable future. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=212,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=80273,FOLIO='F-33',FILE='DISK125:[19ZCO1.19ZCO70301]GA70301A.;8',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_ga70301_1_34"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Basis of Presentation  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The accompanying unaudited condensed financial statements as of September&nbsp;30, 2019 and for the three and nine months ended
September&nbsp;30, 2019 and 2018 have been prepared by the
Company in conformity with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC")
for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to
such rules and regulations. Accordingly, these condensed financial statements should be read in conjunction with the Company's audited financial statements and the notes thereto as of and for the year
ended December&nbsp;31, 2018, which are included in the Company's final prospectus that forms&nbsp;a part of the Company's Registration Statement on Form&nbsp;S-1 (Reg. No.&nbsp;333-230837)
(the "Registration Statement"), as filed with the SEC pursuant to Rule&nbsp;424(b)(4) under the Securities Act of 1933, as amended, on May&nbsp;9, 2019. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
unaudited interim condensed financial statements have been prepared on the same basis as the audited financial statements. In the opinion of management, the accompanying unaudited
interim condensed financial statements contain all adjustments necessary for a fair statement of the Company's financial position as of September&nbsp;30, 2019 and condensed results of operations
and cash flows for the three and nine months ended September&nbsp;30, 2019 and 2018. Such adjustments are of a normal and recurring nature. The results of operations for the three and nine months
ended September&nbsp;30, 2019 are not necessarily indicative of the results of operations that may be expected for the year ending December&nbsp;31, 2019. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Use of Estimates  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts
reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to accrued expenses, revenue recognition, the valuation of
equity-based compensation, including incentive stock options, common stock and restricted common stock, as well as income taxes. The Company bases its estimates on various assumptions that the Company
believes to be reasonable under the circumstances. Although actual results could differ from those estimates, management does not believe that such differences would be material. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Restricted Cash  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is required, as a condition of its Term Loan (Note&nbsp;8), to maintain cash collateral on deposit in a segregated money market
bank account equal to the principal portion of the Term Loan, as determined on a quarterly basis. The bank may restrict withdrawals or transfers by or on behalf of the Company that would violate this
requirement. The required reserve totaled
$5.0&nbsp;million as of September&nbsp;30, 2019. This amount is presented in part as restricted cash and in part as other assets on the accompanying balance sheet. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=213,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=89079,FOLIO='F-34',FILE='DISK125:[19ZCO1.19ZCO70301]GA70301A.;8',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_ga70301_1_35"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>September&nbsp;30,<BR>
2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,935</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>135,173</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Restricted cash (including $3,750 in other assets)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,039</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>460 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,974</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>135,633 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Marketable Securities  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our investments primarily consist of government debt securities, corporate bonds and agency bonds. These marketable securities are classified as
available-for-sale, and as such, are reported at fair value on our condensed balance sheets. Unrealized holding gains and losses are reported within accumulated other comprehensive income (loss) as a
separate component of stockholders' equity. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization, together with
interest on securities, are included in other income, net, on our condensed statements of operations. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a decline in the fair value of a marketable security below our cost basis is determined to be other than temporary, such marketable security is written down to its estimated fair
value as a new cost basis and the amount of the write-down is included in earnings as an impairment charge. The cost of securities sold is based on the specific identification method. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenue Recognition  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has adopted Accounting Standards Codification Topic 606, Revenue from Contracts with Customers ("ASC 606"). Under ASC 606, an entity
recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or
services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps:
(i)&nbsp;identification of the promised goods or services in the contract; (ii)&nbsp;determination of whether the promised goods or services are performance obligations, including whether they are
distinct in the context of the contract; (iii)&nbsp;measurement of the transaction price, including the constraint on variable consideration; (iv)&nbsp;allocation of the transaction price to the
performance obligations; and (v)&nbsp;recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is
probable that the Company will collect consideration to which it is entitled in exchange for the goods or services it transfers to the customer. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to
represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performance
obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i)&nbsp;the customer can
benefit from the good or service on its own or together with other readily available resources and (ii)&nbsp;the promised good or service is separately identifiable from other promises in the
contract. In assessing whether promised goods or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=214,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=123820,FOLIO='F-35',FILE='DISK125:[19ZCO1.19ZCO70301]GA70301A.;8',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_ga70301_1_36"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>services
are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on
its own or whether the required expertise is readily available and whether the goods or services are integral to or dependent on other goods or services in the contract. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may
include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the
payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts
the amount expected to be received. The amount of variable consideration that is included in the transaction price may be constrained and will be included in the transaction price only to the extent
that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company's contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a
significant revenue reversal would occur. Milestone payments that are not within the Company's control or the licensee's control, such as regulatory approvals, will not be considered probable of being
achieved until those approvals are received. At the end of each reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and
if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of
adjustment. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties
relate, the Company will recognize revenue at the later of (i)&nbsp;when the related sales occur and (ii)&nbsp;when the performance obligation to which some or all of the royalty has been
allocated has been satisfied (or partially satisfied). </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require
judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for
service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling
price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated
specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts
allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which
consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied
over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=215,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=562133,FOLIO='F-36',FILE='DISK125:[19ZCO1.19ZCO70301]GA70301A.;8',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_ga70301_1_37"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>measure
of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upfront
payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized
as revenue within the 12&nbsp;months following the balance sheet date are classified as current portion of deferred revenue in the accompanying condensed balance sheets. Amounts not expected to be
recognized as revenue within the 12&nbsp;months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the
Company's right to consideration is unconditional. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recently Issued Accounting Pronouncements  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company qualifies as an emerging growth company ("EGC") as defined under the Jumpstart Our Business Startups Act (the "JOBS Act"). Using
exemptions provided under
the JOBS Act provided to EGCs, the Company has elected to defer compliance with new or revised financial accounting standards until it is required to comply with such standards. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
February 2016, the FASB issued ASU No.&nbsp;2016-02, Leases ("ASU 2016-02"). The new guidance will require lessees to record most leases on their balance sheets and recognize the
related expenses on their income statements in a manner similar to current practice. ASU 2016-02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a
right-to-use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company January&nbsp;1, 2020. The Company continues to determine if it will elect
to use the practical expedients permitted by the guidance and continues to gather data required to comply with the guidance. Based on the work completed to date, the Company is considering the
implications of adopting the new standard, including the discount rate to be used in valuing new and existing leases and all applicable financial statement disclosures required by the new guidance.
The Company is continuing to evaluate the effect of adoption and anticipates that it will result in the recognition of additional assets and corresponding liabilities related to the existing leases on
its balance sheet. The Company is assessing any potential impacts on its internal controls, business processes, and accounting policies related to both the implementation of, and ongoing compliance
with, the new guidance. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
June 2016, the FASB issued ASU No.&nbsp;2016-13, Financial Instruments&#151;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13").
ASU 2016-13 will require credit losses to be reported using an expected losses model rather than the incurred losses model that is currently used, and will require additional disclosures related to
credit risks. For available-for-sale debt securities with unrealized losses, this standard will require allowances to be recorded instead of reducing the amortized cost of the investment. ASU 2016-13
will be effective for non-emerging growth companies for fiscal years beginning December&nbsp;15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal
years beginning after December&nbsp;15, 2020, and interim periods within fiscal years beginning after December&nbsp;15, 2021, assuming the Company remains an emerging growth company. Early
adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2016-13 will have on its financial statements. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
August 2018, the FASB issued ASU No.&nbsp;2018-13, Fair Value Measurement&#151;Disclosure Framework-Changes to the Disclosure Requirement for Fair Value Measurement ("ASU
2018-13"). The </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=216,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=869291,FOLIO='F-37',FILE='DISK125:[19ZCO1.19ZCO70301]GA70301A.;8',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_ga70301_1_38"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


2. Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>amendments
in ASU 2018-13 modify the disclosure requirements on fair value measurements in ASC 820, Fair Value Measurement, based on the concepts in the FASB Concepts Statement, including the
consideration of costs and benefits. ASU 2018-13 will be effective for all companies for fiscal periods beginning after December&nbsp;15, 2019 and interim periods within those fiscal years. Early
adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2018-13 will have on its financial statements. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2018, the FASB issued ASU No.&nbsp;2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 ("ASU 2018-18"). ASU 2018-18
clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in
the context of a unit of account. In those situations, all the guidance in Topic 606 should be applied, including recognition, measurement, presentation and disclosure requirements. The amendment also
adds unit of account guidance in Topic 808 to align with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of
the arrangement is within the scope of Topic 606. Lastly, ASU 2018-18 provides that in a transaction with a collaborative arrangement participant that is not directly related to sales to third
parties, presenting the transaction together with revenue recognized under Topic 606 will be precluded if the collaborative arrangement participant is not a customer. ASU 2018-18 will be effective for
non-emerging growth companies for fiscal years beginning after December&nbsp;15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning
after December&nbsp;15, 2020 and interim periods within fiscal years beginning after December&nbsp;15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted.
The Company is currently evaluating these clarifications for the accounting and presentation for its collaborative arrangements within the scope of Topic 808, but does not expect that the adoption of
ASU 2018-18 will have any impact. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


3. Investments  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investments consist of the following (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>September&nbsp;30, 2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amortized<BR>
Cost </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Gross<BR>
Unrealized<BR>
Gain </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Gross<BR>
Unrealized<BR>
Loss </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated<BR>
Fair Value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>U.S. treasury securities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19,982</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19,983</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Agency bonds</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>47,178</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(17</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>47,161</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Corporate bonds</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>107,045</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(62</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>107,003 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>174,205</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(79</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>174,147 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of September&nbsp;30, 2019, no investments are considered to be other-than-temporarily impaired. The Company uses the specific identification method when calculating realized gains
and losses. For the three and nine months ended September&nbsp;30, 2019, the Company recorded no realized gains and losses on available-for-sale securities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=217,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=890336,FOLIO='F-38',FILE='DISK125:[19ZCO1.19ZCO70301]GA70301A.;8',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_ga70301_1_39"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


4. Fair Value of Financial Instruments  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has certain financial assets recorded at fair value, which have been classified as Level&nbsp;1, 2 or 3 within the fair value hierarchy as described in the accounting
standards for fair value measurements. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level&nbsp;1&#151;Quoted
market prices in active markets for identical assets or liabilities. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level&nbsp;2&#151;Inputs
other than Level&nbsp;1 inputs that are either directly or indirectly observable, such as quoted market prices, interest rates and yield curves. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level&nbsp;3&#151;Unobservable
inputs developed using estimates of assumptions developed by the Company, which reflect those that a market participant would use. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair values requires more judgment. Accordingly, the
degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized as Level&nbsp;3. A financial instrument's level within the fair value hierarchy is based
on the lowest level of any input that is significant to the fair value measurement. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following tables set forth the fair value of the Company's financial assets by level within the fair value hierarchy (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>September&nbsp;30, 2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Carrying<BR>
Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fair Value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;3 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash equivalents:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Money market</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,465</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,465</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,465</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Marketable securities:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>U.S. treasury securities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19,982</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19,983</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19,983</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Agency bonds</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>47,178</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>47,161</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>47,161</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Corporate bonds</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>107,045</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>107,003</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>107,003</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>179,670</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>179,612</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,465</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>174,147</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31, 2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Carrying<BR>
Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fair Value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;1 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;2 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Level&nbsp;3 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cash equivalents:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Money market</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company did not transfer any assets measured at fair value on a recurring basis between levels during the three and nine months ended September&nbsp;30, 2019. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=218,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=89031,FOLIO='F-39',FILE='DISK125:[19ZCO1.19ZCO70301]GA70301A.;8',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_gc70301_1_40"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="gc70301_nextcure,_inc._notes_to_conden__nex02457"> </A>
<A NAME="toc_gc70301_1"> </A></FONT> <FONT SIZE=2><B><BR>  NEXTCURE,&nbsp;INC.<BR>  NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>  (unaudited)    <BR>        <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


5. Property and Equipment, Net  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment consist of the following (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>September&nbsp;30,<BR>
2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,746</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,787</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Leasehold improvements</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,365</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,825</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Computer equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>441</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>167</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Furniture and fixtures</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>94</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Construction in progress</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>787</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,027 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Property and equipment, gross</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16,433</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>13,876</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Less: accumulated depreciation and amortization</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(4,402</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2,469</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Property and equipment, net</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12,031</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>11,407 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Construction
in progress at September&nbsp;30, 2019 consists of the costs incurred for research equipment and for the build-out of additional lab and office space and at
December&nbsp;31, 2018 consists of the costs incurred for the build-out of a manufacturing suite at the Company's headquarters in Beltsville, Maryland. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation
and amortization expense was $788,000 and $1,933,000 for the three and nine months ended September&nbsp;30, 2019, respectively, and $396,000 and $1,159,000 for the three
and nine months ended September&nbsp;30, 2018, respectively. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


6. Agreement with Eli Lilly and Company  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On November&nbsp;2, 2018, the Company entered into a multi-year research and development collaboration agreement (the "Lilly Agreement") with Eli Lilly and Company ("Lilly"), pursuant
to which the Company will use its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Under the Lilly
Agreement, Lilly and the Company have granted one another an equal number of exclusive options to research, develop, manufacture and commercialize compounds and products directed to oncology targets
identified through the Lilly Agreement. Both Lilly and the Company have all options remaining eligible for exercise. The research collaboration with Lilly will be managed by a joint steering committee
formed by an equal number of members from the Company and Lilly and will expire upon the earlier of the exercise of all options granted to Lilly or four years from the date of the agreement, subject
to certain extensions. The Company considers Lilly to be a related party based on Lilly's equity investment in the Company as discussed below. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the research term under the Lilly Agreement, as a part of target discovery, the Company will be responsible for providing Lilly with oncology targets identified using the
Company's FIND-IO platform. From the targets provided by the Company, Lilly may select targets to advance to target validation using criteria developed by both parties. Following completion of the
agreed upon target validation plan with respect to a given target, either party may propose to advance that target to compound discovery. For each target that has been advanced to compound discovery,
Lilly will have the option to obtain an exclusive license with respect to the compounds and products directed to the target. If Lilly does not exercise its option with respect to a given target or has
previously exercised all of its options, the Company will have the option to obtain licenses with respect to compounds and products directed to that target. Following option exercise by a party, the
development and commercialization of any products directed to the target </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=219,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=43325,FOLIO='F-40',FILE='DISK125:[19ZCO1.19ZCO70301]GC70301A.;12',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_gc70301_1_41"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


6. Agreement with Eli Lilly and Company (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>will
be conducted by the exercising party. The exercising party must use commercially reasonable efforts to develop, seek regulatory approval for and commercialize any such products under mutually
agreed upon work plans. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
November 2018, the Company received an upfront, non-refundable payment of $25.0&nbsp;million under the Lilly Agreement and a concurrent $15.0&nbsp;million equity investment. In
addition, the Company will receive quarterly research and development support payments during a portion of the research term as well as option exercise fees upon option exercises by Lilly. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the Lilly Agreement, Lilly may owe an aggregate of up to $1.4&nbsp;billion in development and regulatory milestones and sales milestones. Additionally, Lilly will pay mid
to high single-digit royalties on net sales for all products directed to each target optioned by Lilly. Upon the Company's exercise of an option with respect to a given target, the Company will pay
Lilly an option exercise payment and may become obligated to milestone and royalty payments. The company may owe an aggregate of up to $710.0&nbsp;million in development and regulatory milestones
and sales milestones. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the adoption of ASC 606, the Company evaluated the Lilly Agreement under the provisions of ASC 606 and concluded that Lilly is a customer prior to the exercise of its option to
obtain an exclusive license with respect to the compounds and products directed to a target that has been advanced to compound discovery. The Company identified the following material promises under
the Lilly Agreement: (i)&nbsp;a limited research license to conduct activities under the research collaboration; (ii)&nbsp;research and development services together with the provision of a data
package in connection with Lilly's option; (iii)&nbsp;various governance obligations, most notably participation on the joint steering committee; and (iv)&nbsp;rights related to an optional term
extension by Lilly. The Company evaluated Lilly's option to obtain an exclusive license with respect to the compounds and products directed to a target that has been advanced to compound discovery and
concluded that the option was not issued at a significant and incremental discount, and therefore does not provide material rights. As such, they are excluded as performance obligations at the outset
of the arrangement. The Company determined that the research license was not capable of being distinct and the related research and development services and governance activities are not distinct in
the context of the contract and, as such, the Company determined that these promises should be combined into a single performance obligation, resulting in a total of two performance obligations under
the Lilly Agreement; one for research and development services and one for the right related to an optional term extension by Lilly. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
transaction price at the outset of the arrangement was determined to be $32.7&nbsp;million, comprised of the upfront fee received from Lilly, quarterly research and development
support payments to be received from Lilly during a portion of the research term and an equity investment premium as determined by the Company with reference to a valuation of the Company's preferred
stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, </FONT> <FONT SIZE=2><I>Valuation of Privately-Held-Company Equity Securities
Issued as Compensation.</I></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
transaction price was allocated to the two performance obligations based on their relative standalone selling price determined with reference to the Company's estimated costs
attendant to the obligations. Revenue allocated to the research and development performance obligation is being recognized as the research and development services are provided using an input method
according to research and development costs incurred to date compared to estimated total research and development </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=220,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=187813,FOLIO='F-41',FILE='DISK125:[19ZCO1.19ZCO70301]GC70301A.;12',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_gc70301_1_42"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


6. Agreement with Eli Lilly and Company (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>costs.
The transfer of control occurs over this time period and, in management's judgment, is the best measure of progress towards satisfying the performance obligation. Revenue allocated to Lilly's
right related to an optional term extension is deferred until the right is exercised or lapses, and will subsequently be recognized accordingly. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
the Lilly Agreement was executed in November 2018, the Company's performance initiated in January 2019. Under the Lilly Agreement, the Company recognized revenue of
$1.6&nbsp;million and $4.3&nbsp;million for the three and nine months ended September&nbsp;30, 2019, respectively. As of September&nbsp;30, 2019, deferred revenue included in the Company's
balance sheets comprised the following (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>September&nbsp;30,<BR>
2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>December&nbsp;31,<BR>
2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred revenue, beginning of period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>26,725</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Up-front payment</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>25,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Attributed premium on the proceeds from Lilly's investment in the Company</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,725</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development support billing</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Revenue from research and development arrangement recognized</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total deferred revenue, end of period</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23,883</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>26,725</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Less: Deferred revenue, current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(6,199</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(4,989</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Deferred revenue, non-current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>17,684</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>21,736 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


7. Commitments and Contingencies  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Operating Leases  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On February&nbsp;9, 2016, the Company entered into a non-cancelable facilities operating sublease (the "2016 Sublease"). On March&nbsp;15,
2019, the Company amended and restated the 2016 Sublease (as amended, the "Amended 2016 Sublease") to include additional square footage to be used for office space, which the Company took possession
of upon entering into the Amended 2016 Sublease. The Amended 2016 Sublease expires in August 2025. The base rent under the Amended 2016 Sublease is currently $32,254 per month plus the Company's
prorated share of the sublandlord's operating expense and is subject to annual rent increases of 3%. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
January&nbsp;30, 2019, the Company entered into a new lease to be used for office and laboratory space (the "New Premises"), which the Company took possession of on June&nbsp;1,
2019 (the "2019 Lease"). On August&nbsp;2, 2019, the Company amended the 2019 Lease (as, the "Amended 2019 Lease") to include additional space to be used for office and laboratory space (the
"Expansion Premises"), which the Company expects to take possession of on April&nbsp;1, 2020. The Amended 2019 Lease expires in March 2030. Upon expiration of the Amended 2016 Sublease, the Amended
2019 Lease will also cover the space the Company is currently subleasing under the Amended 2016 Sublease. Base rent is abated until April&nbsp;1, 2020 for the New Premises and until seven months
after delivery of the Expansion Premises for the Expansion Premises, after which the base rent will be $19,646 per month for the New Premises and $18,178 per month for the Expansion Premises, each
subject to annual rent increases of 3%. In connection with this lease, the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-42</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=221,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=544365,FOLIO='F-42',FILE='DISK125:[19ZCO1.19ZCO70301]GC70301A.;12',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_gc70301_1_43"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


7. Commitments and Contingencies (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>Company
executed a $39,000 letter of credit, which has not been drawn down on. Additionally, there is a base rate adjustment of 8.5% per annum multiplied by the outstanding balance of amounts paid for
tenant improvements. The budgeted amounts of tenant improvements are approximately $1,477,000 for the New Premises and $1,517,000 for the Expansion Premises, which are to be fully reimbursed by the
landlord. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
future minimum payments for the operating leases are as follows (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Remainder of the year</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>97</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>566</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2021</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>692</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>742</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2023</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>733</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Thereafter</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6,088 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total future minimum payments</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8,918 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rent
expense incurred under operating leases was approximately $252,000 and $442,000 for the three and nine months ended September&nbsp;30, 2019, respectively, and $107,000 and
$308,000 for the three and nine months ended September&nbsp;30, 2018, respectively. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Legal Proceedings  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company, from time to time, may be party to litigation arising in the ordinary course of business. The Company is not a party to any
litigation or legal proceedings, nor is management aware of any pending or threatened litigation that, in the opinion of the Company's management, are likely to have a material adverse effect on the
Company's business. At each reporting date, the Company evaluates whether a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the
authoritative guidance that addresses accounting for contingencies. The Company expenses the costs related to its legal proceedings as incurred. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


8. Term Loan  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In April 2016, the Company entered into a $1.0&nbsp;million term loan with a commercial bank (the "Term Loan"). On January&nbsp;25, 2019, the Company amended the Term Loan to
increase the Company's borrowing capacity to $5.0&nbsp;million, which amount remains secured by the Company's certificates of deposit, money market account, investment property and deposit or
investment accounts. As amended, the Term Loan bears interest at the greater of the prime rate less 1% and 4.25%. The effective interest rate was 4.33% and 4.44% for the three and nine months ended
September&nbsp;30, 2019, respectively. The effective interest rate was 4.18% and 3.84% for the three and nine months ended September&nbsp;30, 2018, respectively. Under the Term Loan, the Company
is required to make monthly interest-only payments through January 2020 and is required to make 36 equal monthly payments of principal plus accrued interest thereafter through January 2023. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-43</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=222,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=286680,FOLIO='F-43',FILE='DISK125:[19ZCO1.19ZCO70301]GC70301A.;12',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_gc70301_1_44"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


8. Term Loan (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Future
maturities of the Term Loan as of September&nbsp;30, 2019 are as follows (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Remainder of the year</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,528</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2021</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,667</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,667</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>2023</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>138 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Less: current portion of term loan</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Term loan, net of current portion</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,750 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest
expense under the Term Loan was approximately $56,000 and $155,000 for the three and nine months ended September&nbsp;30, 2019, respectively, and $7,000 and $20,000 for the
three and nine months ended September&nbsp;30, 2018, respectively. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


9. Stock-Based Compensation  </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employee Equity Plans  </I></B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The NextCure,&nbsp;Inc. 2015 Omnibus Incentive Plan (the "2015 Plan") provides for the Company to grant incentive stock options or
nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company. The 2015 Plan is administered by the
board of directors, or at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of
the board of directors or its committee if so delegated, except that the exercise price per share of the stock options may not be less than 100% of the fair market value of a share of the Company's
common stock on the date of grant and the term of the stock options may not be greater than 10&nbsp;years. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
May&nbsp;3, 2019, the Company's stockholders approved the NextCure,&nbsp;Inc. 2019 Omnibus Incentive Plan (the "2019 Plan"), which became effective on May&nbsp;8, 2019, the date
on which the Registration Statement was declared effective (the "Effective Date"). The 2019 Plan replaces the 2015 Plan as the Company's board of directors (the "Board") determined not to make
additional awards under the 2015 Plan following the effectiveness of the 2019 Plan. The 2019 Plan provides for the grant of awards of options, stock appreciation rights, restricted stock, restricted
stock units, deferred stock units, unrestricted stock, dividend equivalent rights, other equity-based awards and cash bonus awards to the Company's officers, employees, non-employee directors and
other key persons (including consultants). The number of shares of common stock reserved for issuance under the 2019 Plan is 2,900,000 plus the number of shares of stock related to awards outstanding
under the 2015 Plan that subsequently terminate by expiration or forfeiture, cancellation or otherwise without the issuance of such shares. The number of shares reserved for issuance under the 2019
Plan will automatically increase on January&nbsp;1, 2020 and each January&nbsp;1st&nbsp;thereafter during the term of the 2019 Plan by 4% of the number of shares of the Company's common stock
outstanding on December&nbsp;31st&nbsp;of the preceding calendar year or such lesser number of shares determined by the Board. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of September&nbsp;30, 2019, 2,653,969 shares were reserved for future grant under the 2019 Plan. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-44</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=223,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=814748,FOLIO='F-44',FILE='DISK125:[19ZCO1.19ZCO70301]GC70301A.;12',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_gc70301_1_45"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


9. Stock-Based Compensation (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock
options granted under the 2015 Plan and 2019 Plan (together, the "Plans") to employees generally vest over four years and expire after ten years. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
summary of stock option activity for awards under the Plans is presented below: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Options Outstanding and Exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted<BR>
Average<BR>
Exercise<BR>
Price </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted<BR>
Average<BR>
Remaining<BR>
Contractual<BR>
Life (Years) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Aggregate<BR>
Intrinsic<BR>
Value<SUP>(1)</SUP><BR>
(in thousands) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Outstanding as of December&nbsp;31, 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,056,891</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>4.74</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>5,946</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Granted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>247,275</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>18.18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercised</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(53,963</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.20</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Forfeitures</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(1,250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7.63</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Outstanding as of September&nbsp;30, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,248,953</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6.30</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>9.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>55,305 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Vested and expected to vest as of September&nbsp;30, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,248,953</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>6.30</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>55,305</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Exercisable as of September&nbsp;30, 2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>450,866</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.15</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>12,335</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock
for the options that were in the money at September&nbsp;30, 2019 and December&nbsp;31, 2018.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
weighted-average grant date fair value of stock options granted to employees for the nine months ended September&nbsp;30, 2019 was $11.48. The aggregate intrinsic value of stock
options exercised during the nine months ended September&nbsp;30, 2019 was $1,600,000. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company's potential dilutive securities, which as of September&nbsp;30, 2019 include common stock options, have been excluded from the computation of diluted net loss per share as
the effect would be anti-dilutive. Therefore, the weighted average number of common shares used to calculate both basic and diluted net loss per common share is the same. The Company excluded
2,248,953 potential shares of common stock, presented based on amounts outstanding at three and nine periods ended September&nbsp;30, 2019, from the computation of diluted net loss per common share
for the period indicated because including them would have had an anti-dilutive effect. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
May&nbsp;3, 2019, the Company's stockholders approved the NextCure,&nbsp;Inc. 2019 Employee Stock Purchase Plan (the "ESPP"), which became effective on the Effective Date. The
ESPP is intended to qualify as an "employee stock purchase plan" within the meaning of Section&nbsp;423(b) of the Internal Revenue Code. A total of 240,000 shares of common stock were reserved for
issuance under this plan. In addition, the number of shares of common stock that may be issued under the ESPP will automatically increase on January&nbsp;1, 2020 and each
January&nbsp;1st&nbsp;thereafter until expiration of the ESPP, in an amount equal to the lesser of (i)&nbsp;1% of the number of shares of the Company's common stock outstanding on
December&nbsp;31st&nbsp;of the preceding calendar year, (ii)&nbsp;480,000 shares of common stock and (iii)&nbsp;a number of shares of common stock determined by the administrator of the ESPP. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-45</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=224,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=1030747,FOLIO='F-45',FILE='DISK125:[19ZCO1.19ZCO70301]GC70301A.;12',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<A NAME="page_gc70301_1_46"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B><BR>
NEXTCURE,&nbsp;INC.<BR>
NOTES TO CONDENSED FINANCIAL STATEMENTS<BR>
(unaudited) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


9. Stock-Based Compensation (Continued) </B></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock-Based Compensation  </I></B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company recorded stock-based compensation expense of $524,000 and $1,319,000 for the three and nine months ended September&nbsp;30, 2019,
respectively, and $90,000 and $138,000 for the three and nine months ended September&nbsp;30, 2018, respectively. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based
compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands): </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="15pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Three<BR>
Months<BR>
Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nine Months<BR>
Ended<BR>
September&nbsp;30, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2019 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2018 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Research and development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>182</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>41</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>482</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>62</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General and administrative</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>342</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>49</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>837</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>76 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total stock-based compensation expense</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>524</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>90</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,319</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>138 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


10. Income Taxes  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company did not record a provision or benefit for income taxes during the nine months ended
September&nbsp;30, 2019. The Company continues to maintain a full valuation allowance against its deferred tax assets. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has evaluated the positive and negative evidence involving its ability to realize its deferred tax assets. Management has considered the Company's history of cumulative net
losses incurred since inception and its lack of any commercially ready products. It has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax
assets. Management reevaluates the positive and negative evidence at each reporting period. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the provisions of Sections&nbsp;382 and 383 of the Internal Revenue Code, certain substantial changes in the Company's ownership may have limited, or may limit in the future, the
amount of net operating loss and research and development credit carryforwards that can be used to reduce future income taxes. </FONT></P>


<P style="font-family:times;text-align:justify;margin-left:0pt;text-indent:-0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


11. Subsequent Events  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has evaluated subsequent events through the issuance date of these interim condensed financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>F-46</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=225,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=914131,FOLIO='F-46',FILE='DISK125:[19ZCO1.19ZCO70301]GC70301A.;12',USER='VRIVERA',CD='11-NOV-2019;23:28' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->



<!-- PARA=JUSTIFY -->
</FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=5><I>3,200,000 Shares  </I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=5><B>
<IMG SRC="g235912.jpg" ALT="LOGO" WIDTH="324" HEIGHT="57">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><I>Common Stock  </I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><I>PROSPECTUS  </I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><I>Joint Book-Running Managers  </I></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="172pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="172pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=3><I>MORGAN STANLEY</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=3>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><I>BofA SECURITIES</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=3>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=3><I>PIPER JAFFRAY</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><I>Co-Managers  </I></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><I>NEEDHAM &amp; COMPANY</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=3>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><I>BTIG</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2><I>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</i></font></p><p align=left style="font-family:times;"><font></FONT><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019</I></FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=226,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=222785,FOLIO='blank',FILE='DISK125:[19ZCO1.19ZCO70301]HO70301A.;16',USER='VRIVERA',CD='11-NOV-2019;23:09' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_ja70301_1_1"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="ja70301_part_ii_information_not_required_in_prospectus"> </A>
<A NAME="toc_ja70301_1"> </A></FONT> <FONT SIZE=2><B>  PART II    <BR>    <BR>    INFORMATION NOT REQUIRED IN PROSPECTUS    <BR>    </B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="ja70301_item_13._other_expense__ja701984"> </A>
<A NAME="toc_ja70301_2"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;13.&nbsp;&nbsp;&nbsp;&nbsp;Other Expenses of Issuance and Distribution.    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth the costs and expenses, other than the underwriting discounts and commissions, payable by us in connection with
the sale of common stock being registered. All amounts are estimates except for the SEC registration fee and the Financial Industry Regulatory Authority,&nbsp;Inc., or FINRA, filing fee. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount to<BR>
be Paid </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SEC registration fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18,638.45</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>FINRA filing fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22,039.04</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Printing and engraving expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>120,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Legal fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>475,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Accounting fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>225,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Transfer agent and registrar fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Miscellaneous expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>34,322.51 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>900,000.00 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->

 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="ja70301_item_14._indemnification_of_directors_and_officers."> </A>
<A NAME="toc_ja70301_3"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;14.&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers.    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are incorporated under the laws of the State of Delaware. As permitted by Section&nbsp;102 of the Delaware General Corporation Law, we have
adopted provisions in our amended and restated certificate of incorporation and bylaws that limit or eliminate the personal liability of our directors for a breach of their fiduciary duty of care as a
director. The duty of care generally requires that, when acting on behalf of the corporation, directors exercise an informed business judgment based on all material information reasonably available to
them. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability
for:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> any breach of the duty of loyalty to us or our stockholders; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> any act or omission not in good faith that involves intentional misconduct or a knowing violation of law; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&nbsp;174 of the Delaware General
Corporation Law; or </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> any transaction from which the director derived an improper personal benefit. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
limitations of liability do not affect the availability of equitable remedies such as injunctive relief or rescission. Our amended and restated certificate of incorporation also
authorizes us to indemnify our officers, directors and other agents to the fullest extent permitted under Delaware law. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
permitted by Section&nbsp;145 of the Delaware General Corporation Law, our amended and restated bylaws provide that:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we will indemnify our directors and officers to the fullest extent permitted by the Delaware General Corporation Law, subject to limited
exceptions; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> we will advance expenses to our directors in connection with legal proceedings to the fullest extent permitted by the Delaware General
Corporation Law, subject to limited exceptions; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2> the rights provided in our amended and restated bylaws are not exclusive. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=227,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=401185,FOLIO='II-1',FILE='DISK125:[19ZCO1.19ZCO70301]JA70301A.;14',USER='WWASSER',CD='12-NOV-2019;13:21' -->
<A NAME="page_ja70301_1_2"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
amended and restated certificate of incorporation, attached as Exhibit&nbsp;3.1 hereto, and our amended and restated bylaws, attached as Exhibit&nbsp;3.2 hereto, provide for the
indemnification provisions described above and elsewhere herein. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have entered and expect to continue to enter into agreements to indemnify our directors, executive officers and other employees as determined by our board of directors. These
indemnification agreements generally require us, among other things, to indemnify our directors, executive officers and these employees against liabilities that may arise by reason of their status or
service as directors or officers, other than liabilities arising from willful misconduct. These indemnification agreements also generally require us to advance any expenses incurred by the directors,
executive officers and employees as a result of any proceeding against them as to which they could be indemnified. We also maintain directors' and officers' liability insurance that insures our
directors and officers against the cost of defense, settlement or payment of a judgment in some circumstances. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
form of Underwriting Agreement, attached as Exhibit&nbsp;1.1 hereto, provides for indemnification by the underwriters named in this registration statement of our executive
officers, directors and us, and by us of the underwriters named in this registration statement, for specified liabilities, including liabilities arising under the Securities Act. Our amended and
restated investors' rights agreement with certain stockholders, attached as Exhibit&nbsp;4.2 hereto, also provides for cross-indemnification in connection with the registration of our common stock
on behalf of such investors. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See
the undertakings set forth in response to Item&nbsp;17 herein.  </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="ja70301_item_15._recent_sales_of_unregistered_securities."> </A>
<A NAME="toc_ja70301_4"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;15.&nbsp;&nbsp;&nbsp;&nbsp;Recent Sales of Unregistered Securities.    <BR>    </B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following list sets forth information regarding all securities sold or granted by us within the last three years that were not registered
under the Securities Act and the consideration, if any, received by us for such securities. </FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Issuances of Capital Stock  </I></B></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>In
January 2017, we issued an aggregate of 25,000,000 shares of our Series&nbsp;A-2 Preferred Stock to seven accredited investors at a price per share of $1.00 for
aggregate proceeds of $25&nbsp;million. Upon the closing of our IPO, each share of Series&nbsp;A-2 Preferred Stock converted into 0.1245&nbsp;shares of our common stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>In
April 2018, we issued an aggregate of 28,181,819 shares of our Series&nbsp;A-3 Preferred Stock to seven accredited investors at a price per share of $1.10 for
aggregate proceeds of $31&nbsp;million. Upon the closing of our IPO, each share of Series&nbsp;A-3 Preferred Stock converted into 0.1245&nbsp;shares of our common stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>In
November 2018, we issued an aggregate of 15,052,117 shares of our Series&nbsp;B-1 Preferred Stock to seven accredited investors at a price per share of $1.59
for aggregate proceeds of approximately $23.9&nbsp;million. Upon the closing of our IPO, each share of Series&nbsp;B-1 Preferred Stock converted into 0.1245&nbsp;shares of our common stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>In
November 2018, we issued an aggregate of 34,276,734 shares of our Series&nbsp;B-2 Preferred Stock to 14 accredited investors at a price per share of $1.59 for
aggregate proceeds of approximately $54.5&nbsp;million. Upon the closing of our IPO, each share of Series&nbsp;B-2 Preferred Stock converted into 0.1245&nbsp;shares of our common stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>In
November 2018, we issued an aggregate of 7,500,000 shares of our Series&nbsp;B-3 Preferred Stock to Eli Lilly and Company at a price per share of $2.00 for
aggregate proceeds of $15&nbsp;million. Upon the closing of our IPO, each share of Series&nbsp;B-3 Preferred Stock converted into 0.1245 shares of our common stock. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=228,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=484606,FOLIO='II-2',FILE='DISK125:[19ZCO1.19ZCO70301]JA70301A.;14',USER='WWASSER',CD='12-NOV-2019;13:21' -->
<A NAME="page_ja70301_1_3"> </A>


<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Grants of Stock Options and Restricted Stock  </I></B></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Since
November&nbsp;12, 2016, we have granted to our directors, officers, employees, consultants and other service providers stock options to purchase an aggregate
of 2,139,164 shares of our common stock under the 2015 Plan or the 2019 Plan at exercise prices ranging from $0.48 to $15.57 per share. Of these, stock options covering an aggregate of 15,476 shares
were cancelled without being exercised.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>From
November&nbsp;12, 2016 through the filing of our registration statement on Form&nbsp;S-8 on May&nbsp;13, 2019, we issued an aggregate of 34,984 shares of
our common stock to our directors, officers and employees pursuant to the exercise of stock options under the 2015 Plan at exercise prices ranging from $0.48 to $1.76 per share for aggregate proceeds
of approximately $48,431. </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
deemed the offers, sales and issuances of the securities described in paragraphs&nbsp;(1) through (5)&nbsp;above to be exempt from registration under the Securities Act, in
reliance on Section&nbsp;4(a)(2) of the Securities Act, including Regulation&nbsp;D and Rules&nbsp;504 and 506 promulgated thereunder, relative to transactions by an issuer not involving a
public offering. All purchasers of securities in transactions exempt from registration pursuant to Regulation&nbsp;D represented to us that they were accredited investors and were acquiring the
shares for investment purposes only and not with a view to, or for sale in connection with, any distribution thereof and that they could bear the risks of the investment and could hold the securities
for an indefinite period of time. The purchasers received written disclosures that the securities had not been registered under the Securities Act and that any resale must be made pursuant to a
registration statement or an available exemption from such registration. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
deemed the issuance of restricted common stock and grants and exercises of stock options described in paragraphs&nbsp;(6) and (7)&nbsp;above to be exempt from registration under
the Securities Act in reliance on Rule&nbsp;701 of the Securities Act as offers and sales of securities under compensatory benefit plans and contracts relating to compensation in compliance with
Rule&nbsp;701. Each of the recipients of
securities in any transaction exempt from registration either received or had adequate access, through employment, business or other relationships, to information about us. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
of the foregoing securities are deemed restricted securities for purposes of the Securities Act. All certificates representing securities issued in the transactions described in this
Item&nbsp;15 included appropriate legends setting forth that the securities had not been offered or sold pursuant to a registration statement and describing the applicable restrictions on transfer
of the securities. There were no underwriters employed in connection with any of the transactions set forth in this Item&nbsp;15.  </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="ja70301_item_16._exhibits_and_financial_statement_schedules."> </A>
<A NAME="toc_ja70301_5"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;16.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits and Financial Statement Schedules.    <BR>    </B></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Exhibits
</FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See
the Index to Exhibits attached to this registration statement, which is incorporated by reference herein.  </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Financial
Statement Schedules </FONT></DD></DL>
</UL>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
financial statement schedules are provided, because the information called for is not required or is shown either in the financial statements or the notes thereto.  </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="ja70301_item_17._undertakings."> </A>
<A NAME="toc_ja70301_6"> </A></FONT> <FONT SIZE=2><B>  Item&nbsp;17.&nbsp;&nbsp;&nbsp;&nbsp;Undertakings.    <BR>    </B></FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=229,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=873586,FOLIO='II-3',FILE='DISK125:[19ZCO1.19ZCO70301]JA70301A.;14',USER='WWASSER',CD='12-NOV-2019;13:21' -->
<A NAME="page_ja70301_1_4"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>registrant
of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit
to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of
such issue. </FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned registrant hereby undertakes that: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>For
purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement
in reliance upon Rule&nbsp;430A and contained in the form of prospectus filed by the registrant pursuant to Rule&nbsp;424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be deemed to
be part of this registration statement as of the time it was declared effective.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>For
the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </FONT><FONT SIZE=2><I>bona
fide</I></FONT><FONT SIZE=2> offering thereof. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=230,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=472996,FOLIO='II-4',FILE='DISK125:[19ZCO1.19ZCO70301]JA70301A.;14',USER='WWASSER',CD='12-NOV-2019;13:21' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_jb70301_1_5"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="jb70301_index_to_exhibits"> </A>
<A NAME="toc_jb70301_1"> </A></FONT> <FONT SIZE=2><B>  INDEX TO EXHIBITS    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="75pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit<BR>
Number </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit Description </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="a2240001zex-1_1.htm">Form of Underwriting Agreement.</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>3.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919003060/a2238817zex-3_1.htm">Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit&nbsp;3.1 filed with Registrant's Current Report on 8-K filed with
 the Commission on May&nbsp;13, 2019 (File No.&nbsp;001-38905)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>3.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919003060/a2238817zex-3_2.htm">Amended and Restated Bylaws (incorporated by reference to Exhibit&nbsp;3.2 filed with Registrant's Current Report on 8-K filed with the Commission on
 May&nbsp;13, 2019 (File No.&nbsp;001-38905)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>4.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-4_1.htm">Amended and Restated Investors' Rights Agreement, dated as of November&nbsp;5, 2018, by and among the Company and the investors party thereto
 (incorporated by reference to Exhibit&nbsp;4.1 filed with Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>5.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="a2240001zex-5_1.htm">Opinion of Hogan Lovells US&nbsp;LLP.</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&#134;*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_1.htm">License Agreement, dated as of December&nbsp;29, 2015, by and between the Company and Yale University (incorporated by reference to Exhibit&nbsp;10.1
 filed with Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&#134;*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_2.htm">Corporate Sponsored Research Agreement, dated as of December&nbsp;29, 2015, by and between the Company and Yale University (incorporated by reference to
 Exhibit&nbsp;10.2 filed with Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&#134;*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_3.htm">Research and Development Collaboration Agreement, dated as of November&nbsp;2, 2018, by and between the Company and Eli Lilly and Company (incorporated
 by reference to Exhibit&nbsp;10.3 filed with Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&#134;*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_4.htm">Amended and Restated Sublease Agreement, dated as of March&nbsp;15, 2019, by and between the Company and Lupin,&nbsp;Inc. (incorporated by reference to
 Exhibit&nbsp;10.4 filed with Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_5.htm">Form of Indemnification Agreement by and between the Company and each of its directors and executive officers (incorporated by reference to
 Exhibit&nbsp;10.5 filed with Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_6.htm">NextCure,&nbsp;Inc. 2015 Omnibus Incentive Plan, as amended (incorporated by reference to Exhibit&nbsp;10.6 filed with Registrant's Registration
 Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_7.htm">Form of Stock Option Agreement under the NextCure,&nbsp;Inc. 2015 Omnibus Incentive Plan (incorporated by reference to Exhibit&nbsp;10.7 filed with
 Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=231,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=866024,FOLIO='II-5',FILE='DISK125:[19ZCO1.19ZCO70301]JB70301A.;23',USER='JTAYLORA',CD='12-NOV-2019;09:58' -->
<A NAME="page_jb70301_1_6"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="75pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit<BR>
Number </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit Description </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002652/a2238596zex-10_8.htm">NextCure,&nbsp;Inc. 2019 Omnibus Incentive Plan (incorporated by reference to Exhibit&nbsp;10.8 filed with Registration Statement on Form&nbsp;S-1/A
 filed with the Commission on April&nbsp;29, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002652/a2238596zex-10_9.htm">Forms of Stock Option Agreement under the NextCure,&nbsp;Inc. 2019 Omnibus Incentive Plan (incorporated by reference to Exhibit&nbsp;10.9 filed with
 Registrant's Registration Statement on Form&nbsp;S-1/A filed with the Commission on April&nbsp;29, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.10</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002652/a2238596zex-10_10.htm">Form of Restricted Stock Agreement under the NextCure,&nbsp;Inc. 2019 Omnibus Incentive Plan (incorporated by reference to Exhibit&nbsp;10.10 filed
 with Registrant's Registration Statement on Form&nbsp;S-1/A filed with the Commission on April&nbsp;29, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002652/a2238596zex-10_11.htm">Form of Restricted Stock Unit Agreement under the NextCure,&nbsp;Inc. 2019 Omnibus Incentive Plan (incorporated by reference to Exhibit&nbsp;10.11
 filed with Registrant's Registration Statement on Form&nbsp;S-1/A filed with the Commission on April&nbsp;29, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.12</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002652/a2238596zex-10_12.htm">NextCure,&nbsp;Inc. 2019 Employee Stock Purchase Plan (incorporated by reference to Exhibit&nbsp;10.12 filed with Registrant's Registration Statement
 on Form&nbsp;S-1/A filed with the Commission on April&nbsp;29, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002652/a2238596zex-10_13.htm">Non-Employee Director Compensation Program (incorporated by reference to Exhibit&nbsp;10.13 filed with Registrant's Registration Statement on
 Form&nbsp;S-1/A filed with the Commission on April&nbsp;29, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.14</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&#134;*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_14.htm">Lease Agreement, dated as of January&nbsp;30, 2019, by and between the Company and ARE-8000/9000/10000 Virginia Manor,&nbsp;LLC (incorporated by
 reference to Exhibit&nbsp;10.14 filed with Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.15</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&#134;*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000155837019010701/nxtc-20190930ex101b27cfe.htm">First Amendment to Lease Agreement, dated August&nbsp;2, 2019, by and between the Company and ARE-8000/9000/10000 Virginia Manor,&nbsp;LLC
 (incorporated by reference to Exhibit&nbsp;10.1 filed with Registrant's Quarterly Report on Form 10-Q filed on November&nbsp;12, 2019 (File No.&nbsp;001-38905)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.16</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_15.htm">Employment Letter, dated as of September&nbsp;12, 2016, by and between the Company and Michael Richman (incorporated by reference to Exhibit&nbsp;10.15
 filed with Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.17</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_16.htm">Employment Letter, dated as of December&nbsp;18, 2017, by and between the Company and Steven&nbsp;P. Cobourn (incorporated by reference to
 Exhibit&nbsp;10.16 filed with Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>10.18</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>+*</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="http://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/a2238441zex-10_17.htm">Employment Letter, dated as of September&nbsp;12, 2016, by and between the Company and Sol Langermann, Ph.D. (incorporated by reference to
 Exhibit&nbsp;10.17 filed with Registrant's Registration Statement on Form&nbsp;S-1 filed with the Commission on April&nbsp;12, 2019 (File No.&nbsp;333-230837)).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>23.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="a2240001zex-23_1.htm">Consent of Ernst&nbsp;&amp; Young&nbsp;LLP, independent registered public accounting firm.</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>23.2</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="a2240001zex-5_1.htm">Consent of Hogan Lovells US&nbsp;LLP (included in Exhibit&nbsp;5.1).</A></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=232,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=815822,FOLIO='II-6',FILE='DISK125:[19ZCO1.19ZCO70301]JB70301A.;23',USER='JTAYLORA',CD='12-NOV-2019;09:58' -->
<A NAME="page_jb70301_1_7"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="75pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit<BR>
Number </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exhibit Description </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24.1</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 <A HREF="#sig">Power of Attorney (included on signature page of Registration Statement).</A></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>EX-101.INS</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 XBRL Instance Document</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>EX-101.SCH</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 XBRL Taxonomy Extension Schema Document</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>EX-101.CAL</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 XBRL Taxonomy Extension Calculation Linkbase Document</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>EX-101.DEF</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 XBRL Taxonomy Extension Definition Linkbase Document</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>EX-101.LAB</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 XBRL Taxonomy Extension Label Linkbase Document</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>EX-101.PRE</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:justify;"><BR><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:justify;" -->


 XBRL Taxonomy Extension Presentation Linkbase Document</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="10%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Previously
filed.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>+</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Indicates
a management contract or compensatory plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#134;</FONT></DT><DD style="font-family:times;text-align:justify"><FONT SIZE=2>Portions
of this exhibit have been omitted in compliance with Item&nbsp;601 of Regulation&nbsp;S-K.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=233,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=769564,FOLIO='II-7',FILE='DISK125:[19ZCO1.19ZCO70301]JB70301A.;23',USER='JTAYLORA',CD='12-NOV-2019;09:58' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A NAME="page_jc70301_1_8"> </A>
 </FONT> <FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->





<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


<!-- PARA=JUSTIFY -->
 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A NAME="jc70301_signatures"> </A>
<A NAME="toc_jc70301_1"> </A></FONT> <FONT SIZE=2><B>  SIGNATURES    <BR>    </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in Beltsville, Maryland, on this 12th day of November 2019. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="47%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="22pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="47%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><B> NEXTCURE,&nbsp;INC.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>By:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;MICHAEL RICHMAN<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Michael Richman<BR></FONT> <FONT SIZE=2><I>President and Chief Executive Officer</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="sig"></A>POWER OF ATTORNEY  </B></FONT></P>

<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each person whose individual signature appears below hereby authorizes and appoints Michael Richman and Steven P. Cobourn and each of them, with
full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to
execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this registration statement, including any and all
post-effective amendments and amendments thereto, and any subsequent registration statement relating to the same offering as this registration statement that is to be effective upon filing pursuant to
Rule&nbsp;462(b) under the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection
therewith, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof. </FONT></P>


<P style="font-family:times;text-align:justify"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="38%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="38%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="111pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Signature

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Title

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Date

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>/s/&nbsp;MICHAEL RICHMAN<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Michael Richman</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>President, Chief Executive Officer and Director </FONT><FONT SIZE=2><I>(Principal Executive Officer)</I></FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>November&nbsp;12, 2019</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;STEVEN P. COBOURN<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Steven P. Cobourn</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Chief Financial Officer </FONT><FONT SIZE=2><I>(Principal Financial and Accounting Officer)</I></FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>November&nbsp;12, 2019</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;DAVID KABAKOFF, PH.D.<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> David Kabakoff, Ph.D.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Chair of the Board</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>November&nbsp;12, 2019</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;ELAINE V. JONES, PH.D.<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Elaine V. Jones, Ph.D.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>November&nbsp;12, 2019</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=234,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=269239,FOLIO='II-8',FILE='DISK125:[19ZCO1.19ZCO70301]JC70301A.;16',USER='LGADISH',CD='11-NOV-2019;23:14' -->
<A NAME="page_jc70301_1_9"> </A>

<P style="font-family:times;text-align:justify"><FONT SIZE=2><A HREF="#bg70301a_main_toc">Table of Contents</A></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="38%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="38%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="111pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Signature

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Title

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Date

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>/s/&nbsp;CHAU Q. KHUONG<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Chau Q. Khuong</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2>November&nbsp;12, 2019</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;JUDITH J. LI<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Judith J. Li</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>November&nbsp;12, 2019</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;BRIGGS MORRISON, M.D.<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Briggs Morrison, M.D.</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>November&nbsp;12, 2019</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;TIM SHANNON, M.D.<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Tim Shannon, M.D.</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>November&nbsp;12, 2019</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;STEPHEN WEBSTER<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Stephen Webster</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>November&nbsp;12, 2019</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2>/s/&nbsp;STELLA XU<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> Stella Xu</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>Director</FONT></TD>
<TD VALIGN="MIDDLE" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" style="font-family:times;"><BR><FONT SIZE=2>November&nbsp;12, 2019</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>II-9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=235,EFW="2240001",CP="NEXTCURE, INC.",DN="1",CHK=1036911,FOLIO='II-9',FILE='DISK125:[19ZCO1.19ZCO70301]JC70301A.;16',USER='LGADISH',CD='11-NOV-2019;23:14' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>a2240001zex-1_1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;1.1</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">[&#149;] Shares</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NEXTCURE,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">COMMON STOCK, PAR VALUE $0.001 PER SHARE</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">UNDERWRITING AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;text-indent:35.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>, 2019</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=725024,FOLIO='',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-01_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:17 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">, 2019</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Morgan Stanley&nbsp;&amp; Co. LLC<br>  </font>BofA Securities,&nbsp;Inc.</p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Piper Jaffray&nbsp;&amp; Co.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c/o Morgan Stanley&nbsp;&amp; Co. LLC</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1585 Broadway<br> New York, New York 10036</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c/o BofA Securities,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">One Bryant Park</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">New York, New York 10036</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c/o Piper Jaffray&nbsp;&amp; Co.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">800 Nicollet Mall</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, Minnesota 55402</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NextCure,&nbsp;Inc., a Delaware corporation (the &#147;<b>Company</b>&#148;), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the &#147;<b>Underwriters</b>&#148;) [&#149;] shares of its common stock, par value $0.001 per share (the &#147;<b>Firm Shares</b>&#148;).&#160; The Company also proposes to issue and sell to the several Underwriters not more than an additional [&#149;] shares of its common stock, par value $0.001 per share (the &#147;<b>Additional Shares</b>&#148;) if and to the extent that you, as representatives of the several Underwriters (the &#147;<b>Representatives</b>&#148;) of the offering, shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section&nbsp;2 hereof.&#160; The Firm Shares and the Additional Shares are hereinafter collectively referred to as the &#147;<b>Shares.</b>&#148; The shares of common stock, par value $0.001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the &#147;<b>Common Stock.</b>&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company has filed with the Securities and Exchange Commission (the &#147;<b>Commission</b>&#148;) a registration statement on Form&nbsp;S-1 (File No.&nbsp;333-[&#149;]) including a prospectus, relating to the Shares.&#160; The registration statement as amended at the time it becomes effective, including the information (if any) deemed to be part of the registration statement at the time of effectiveness pursuant to Rule&nbsp;430A under the Securities Act of 1933, as amended (the &#147;<b>Securities Act</b>&#148;), is hereinafter referred to as the &#147;<b>Registration Statement</b>&#148;; the prospectus in the form first used to confirm sales of Shares (or in the form first made available to the Underwriters by the Company to meet requests of purchasers pursuant to Rule&nbsp;173 under the Securities Act) is hereinafter referred to as the &#147;<b>Prospectus.</b>&#148;&#160; If the Company has filed an abbreviated registration statement to register</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">1<a name="21003-2-KA-01_PB_1_004726_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=373139,FOLIO='1',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-01_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:17 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">additional shares of Common Stock pursuant to Rule&nbsp;462(b)&nbsp;under the Securities Act (a &#147;<b>Rule&nbsp;462 Registration Statement</b>&#148;), then any reference herein to the term &#147;<b>Registration Statement</b>&#148; shall be deemed to include such Rule&nbsp;462 Registration Statement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For purposes of this Agreement, &#147;<b>free writing prospectus</b>&#148; has the meaning set forth in Rule&nbsp;405 under the Securities Act, &#147;<b>Time of Sale Prospectus</b>&#148; means the preliminary prospectus contained in the Registration Statement at the time of its effectiveness together with the documents and pricing information set forth in Schedule II hereto, and &#147;<b>broadly available road show</b>&#148; means a &#147;bona fide electronic road show&#148; as defined in Rule&nbsp;433(h)(5)&nbsp;under the Securities Act that has been made available without restriction to any person.&#160; As used herein, the terms &#147;Registration Statement,&#148; &#147;preliminary prospectus,&#148; &#147;Time of Sale Prospectus&#148; and &#147;Prospectus&#148; shall include the documents, if any, incorporated by reference therein as of the date hereof.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.65in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Representations and Warranties</i>.&#160; The Company represents and warrants to and agrees with each of the Underwriters that:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Registration Statement has become effective; no stop order suspending the effectiveness of the Registration Statement is in effect, and no proceedings for such purpose are pending before or, to the Company&#146;s knowledge, threatened by the Commission.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;The Registration Statement, when it became effective, did not contain and, as amended or supplemented, if applicable, will not contain, as of the date of such amendment or supplement, any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii)&nbsp;the Registration Statement and the Prospectus comply and, as amended or supplemented, if applicable, will comply, as of the date of such amendment or supplement, in all material respects with the applicable requirements of the Securities Act and the applicable rules&nbsp;and regulations of the Commission thereunder, (iii)&nbsp;the Time of Sale Prospectus does not, and at the time of each sale of the Shares in connection with the offering when the Prospectus is not yet available to prospective purchasers and at the Closing Date (as defined in Section&nbsp;4), the Time of Sale Prospectus, as then amended or supplemented by the Company, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, (iv)&nbsp;each broadly available road show, if any, when considered together with the Time of Sale Prospectus, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading and (v)&nbsp;the Prospectus, as of its date, does not contain and, as amended or supplemented, if applicable, will not contain, as of the date of such amendment or supplement, any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, except that the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="21003-2-KA-01_PB_2_004739_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=78117,FOLIO='2',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-01_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:17 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .65in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">representations and warranties set forth in this paragraph do not apply to statements or omissions in the Registration Statement, the Time of Sale Prospectus or the Prospectus based upon information relating to any Underwriter furnished to the Company in writing by such Underwriter through you expressly for use therein.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company is not an &#147;ineligible issuer&#148; in connection with the offering pursuant to Rules&nbsp;164, 405 and 433 under the Securities Act.&#160; Any free writing prospectus that the Company is required to file pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act has been, or will be, filed with the Commission in accordance with the applicable requirements of the Securities Act and the applicable rules&nbsp;and regulations of the Commission thereunder.&#160; Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act or that was prepared by or on behalf of or used or referred to by the Company complies or, if filed after the date of this Agreement, will comply, when filed, in all material respects with the requirements of the Securities Act and the applicable rules&nbsp;and regulations of the Commission thereunder.&#160; Except for the free writing prospectuses, if any, identified in Schedule II hereto, and electronic road shows, if any, each furnished to you before first use, the Company has not prepared, used or referred to, and will not, without your prior consent, prepare, use or refer to, any free writing prospectus.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company has been duly incorporated, is validly existing as a corporation and in good standing under the laws of the jurisdiction of its incorporation, has the corporate power and authority to own or lease its property and to conduct its business as described in the Time of Sale Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good standing would not reasonably be expected to have a material adverse effect on the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company does not have any subsidiaries.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Agreement has been duly authorized, executed and delivered by the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The authorized capital stock of the Company conforms as to legal matters to the description thereof contained in the sections entitled &#147;Capitalization&#148; and &#147;Description of Capital Stock&#148; in each of the Time of Sale Prospectus and the Prospectus.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The shares of Common Stock outstanding prior to the issuance of the Shares have been duly authorized and are validly issued, fully paid and non-assessable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="21003-2-KA-01_PB_3_004757_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=958606,FOLIO='3',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-01_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:17 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Shares have been duly authorized and, when issued, delivered and paid for in accordance with the terms of this Agreement, will be validly issued, fully paid and non-assessable, and the issuance of such Shares will not be subject to any preemptive or similar rights that have not been validly waived.</p>
<p style="margin:0in 0in .0001pt .65in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The execution and delivery by the Company of, and the performance by the Company of its obligations under, this Agreement will not contravene (i)&nbsp;any provision of applicable law, (ii)&nbsp;the certificate of incorporation or by-laws of the Company, (iii)&nbsp;any agreement or other instrument binding upon the Company that is material to the Company, or (iv)&nbsp;any judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company, except in the case of clauses (i), (iii)&nbsp;and (iv)&nbsp;as would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the Company, and no consent, approval, authorization or order of, or qualification with, any governmental body or agency is required for the performance by the Company of its obligations under this Agreement, except such as have been obtained or waived or as may be required by the securities or blue sky laws of the various states in connection with the offer and sale of the Shares.</p>
<p style="margin:0in 0in .0001pt .65in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>There has not occurred any material adverse change, or any development that would reasonably be expected to result in a material adverse change, in the condition, financial or otherwise, or in the earnings, business, management or operations of the Company from that set forth in the Time of Sale Prospectus.</p>
<p style="margin:0in 0in .0001pt .65in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(l)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>There are no legal or governmental proceedings pending or, to the Company&#146;s knowledge, threatened to which the Company is a party or to which any of the properties of the Company is subject (i)&nbsp;other than (A)&nbsp;proceedings accurately described in all material respects in the Time of Sale Prospectus and (B)&nbsp;proceedings that would not reasonably, individually or in the aggregate, be expected to have a material adverse effect on the Company or on the power or ability of the Company to perform its obligations under this Agreement or to consummate the transactions contemplated by the Time of Sale Prospectus or (ii)&nbsp;that are required to be described in the Registration Statement or the Prospectus and are not so described in all material respects; and there are no statutes, regulations, contracts or other documents to which the Company or its property are subject or bound that are required to be described in the Registration Statement or the Prospectus or to be filed or incorporated by reference as exhibits to the Registration Statement that are not described in all material respects or filed or incorporated by reference as required.</p>
<p style="margin:0in 0in .0001pt .65in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(m)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each preliminary prospectus filed as part of the Registration Statement as originally filed or as part of any amendment thereto, or filed pursuant to Rule&nbsp;424 under the Securities Act, complied when so filed in all material respects with the applicable requirements of the Securities Act and the applicable rules&nbsp;and regulations of the Commission thereunder.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="21003-2-KA-01_PB_4_004809_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=51029,FOLIO='4',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-01_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:17 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(n)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company is not, and after giving effect to the offering and sale of the Shares and the application of the proceeds thereof as described in the Prospectus will not be, required to register as an &#147;investment company&#148; as such term is defined in the Investment Company Act of 1940, as amended.</p>
<p style="margin:0in 0in .0001pt .65in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(o)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company (i)&nbsp;is in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#147;<b>Environmental Laws</b>&#148;), (ii)&nbsp;has received all permits, licenses or other approvals required of it under applicable Environmental Laws to conduct its business and (iii)&nbsp;is in compliance with all terms and conditions of any such permit, license or approval, except where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would not, singly or in the aggregate, reasonably be expected to have a material adverse effect on the Company.</p>
<p style="margin:0in 0in .0001pt .65in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(p)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>There are no costs or liabilities associated with Environmental Laws (including, without limitation, any capital or operating expenditures required for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties) that would, singly or in the aggregate, reasonably be expected to have a material adverse effect on the Company.</p>
<p style="margin:0in 0in .0001pt .65in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(q)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>There are no contracts, agreements or understandings between the Company and any person granting such person the right to require the Company to file a registration statement under the Securities Act with respect to any securities of the Company or to require the Company to include such securities with the Shares registered pursuant to the Registration Statement, except those contracts, agreements and understandings described in the Time of Sale Prospectus and the Prospectus (i)&nbsp;as have been validly waived in connection with the issuance and sale of the Shares or (ii)&nbsp;pursuant to which such right has lapsed in accordance with its terms.</p>
<p style="margin:0in 0in .0001pt .65in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(r)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;None of the Company or its controlled affiliates, any director or officer, thereof, or, to the Company&#146;s knowledge, any employee, agent or representative of the Company or of any of its controlled affiliates, has taken or will take any action in furtherance of an offer, payment, promise to pay, or authorization or approval of the payment, giving or receipt of money, property, gifts or anything else of value, directly or indirectly, to any government official (including any officer or employee of a government or government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office) in order to improperly influence official action, or to any person in violation of any applicable anti-corruption laws; (ii)&nbsp;the Company and its controlled affiliates have conducted their</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="21003-2-KA-01_PB_5_004820_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=305449,FOLIO='5',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-01_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:17 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .65in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">businesses in compliance with applicable anti-corruption laws and have instituted and maintained and will continue to maintain policies and procedures reasonably designed to promote and achieve compliance with such laws and with the representations and warranties contained herein; and (iii)&nbsp;the Company will not use, directly or indirectly, the proceeds of the offering in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of any applicable anti-corruption laws.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(s)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The operations of the Company are and have been conducted at all times in material compliance with all applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of jurisdictions where the Company conducts business, the rules&nbsp;and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#147;<b>Anti-Money Laundering Laws</b>&#148;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</p>
<p style="margin:0in 0in .0001pt .65in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(t)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;None of the Company or any director or officer thereof, or, to the Company&#146;s knowledge, any employee, agent, affiliate or representative of the Company, is an individual or entity (&#147;<b>Person</b>&#148;) that is, or is owned or controlled by one or more Persons that are:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(A)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the subject of any sanctions administered or enforced by the U.S. Department of Treasury&#146;s Office of Foreign Assets Control, the United Nations Security Council, the European Union, Her Majesty&#146;s Treasury, or other relevant sanctions authority (collectively, &#147;<b>Sanctions</b>&#148;), or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(B)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation, Crimea, Cuba,&nbsp;Iran, North Korea and Syria).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.1in;text-indent:.4in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(A)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="21003-2-KA-01_PB_6_004834_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=305171,FOLIO='6',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-01_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:17 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(B)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.1in;text-indent:.4in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For the past five years, the Company has not knowingly engaged in, is not now knowingly engaged in, and will not engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(u)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subsequent to the respective dates as of which information is given in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus, (i)&nbsp;the Company has not incurred any material liability or obligation, direct or contingent, nor entered into any material transaction; (ii)&nbsp;the Company has not purchased any of its outstanding capital stock, other than in connection with the termination of service of employees, directors or other service providers pursuant to equity compensation plans described in the Time of Sale Prospectus or existing agreements or in connection with the exercise of the Company&#146;s right of first refusal upon a proposed transfer, nor declared, paid or otherwise made any dividend or distribution of any kind on its capital stock other than ordinary and customary dividends; and (iii)&nbsp;there has not been any material change in the capital stock (other than the exercise of equity awards or grants of equity awards or repurchase or forfeiture of equity awards or restricted stock outstanding as of such respective dates as of which information is given in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus, in each case granted pursuant to the equity compensation plans described in the Time of Sale Prospectus or subject to an existing agreement), short-term debt or long-term debt of the Company, except in each case as described in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus, respectively.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company does not own any real property.&#160; The Company has good and marketable title to all personal property owned by it that is material to the business of the Company, in each case free and clear of all liens, encumbrances and defects except such as are described in the Time of Sale Prospectus or such as do not materially diminish the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company; and any real property and buildings held under lease by the Company is held by the Company under valid, subsisting and enforceable leases with such exceptions as are not material and do not materially interfere with the use made and proposed to be made of such property and buildings by the Company, in each case except as described in the Time of Sale Prospectus.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(w)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company owns, has obtained licenses or can acquire on reasonable terms all material patent rights, inventions, trademarks, trade names, service marks, logos, trade dress, designs, data, database rights,&nbsp;Internet domain names, copyrights, works of authorship, trade secrets, know-how and proprietary</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="21003-2-KA-01_PB_7_005028_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=281109,FOLIO='7',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-01_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:17 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .65in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">information (including unpatented and unpatentable proprietary or confidential information, systems or procedures) and other intellectual property rights (collectively, &#147;<b>Intellectual Property Rights</b>&#148;) necessary to the current conduct of the business as described in the Registration Statement, the Time of Sale Prospectus, and the Prospectus, except where any failure to own, possess or acquire such Intellectual Property Rights would not reasonably be expected to have a material adverse effect on the Company.&#160; Such Intellectual Property Rights owned by or licensed to the Company have not been adjudged by a court of competent jurisdiction to be invalid or unenforceable, in whole or in part.&#160; To the Company&#146;s knowledge: (i)&nbsp;there are no third parties that have rights to any Intellectual Property Rights of the Company except for (a)&nbsp;customary retained and reversionary rights of third-party licensors with respect to Intellectual Property Rights licensed to the Company, (b)&nbsp;non-exclusively licensed Intellectual Property Rights, where the licensor may provide licenses to a third party and (c)&nbsp;third parties that have been explicitly granted licenses by the Company; and (ii)&nbsp;there is no infringement by third parties of any Intellectual Property Rights of the Company.&#160; Except as disclosed in the Registration Statement, the Time of Sale Prospectus and the Prospectus, there is no pending or, to the Company&#146;s knowledge, threatened action, suit, proceeding or claim by any third party: (A)&nbsp;challenging the Company&#146;s rights in or to any of their Intellectual Property Rights; (B)&nbsp;challenging the validity, enforceability or scope of any Intellectual Property Rights of the Company; or (C)&nbsp;asserting that the Company infringes, misappropriates, or otherwise violates, or would, upon the commercialization of any product or service described in the Registration Statement, the Time of Sale Prospectus or the Prospectus as under development, infringe, misappropriate, or violate, any patent, trademark, trade name, service name, copyright, trade secret or other proprietary rights of others.&#160; The Company has complied in all material respects with the terms of each agreement pursuant to which Intellectual Property Rights have been licensed to the Company, and all such agreements are in full force and effect.&#160; The Company has taken all reasonable steps necessary to secure its interests in the Company-owned Intellectual Property Rights from its employees and contractors and to protect the confidentiality of all of its confidential information and trade secrets, including the execution of appropriate nondisclosure, confidentiality agreements, invention assignment agreements and invention assignments with its employees, and to the Company&#146;s knowledge, no employee of the Company is in or has been in violation of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement, or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&#146;s employment with the Company.&#160; The product candidates described in the Registration Statement, the Time of Sale Prospectus and the Prospectus as under development by the Company fall within the scope of one or more claim of one or more patents or patent applications owned by, or exclusively licensed to, the Company.&#160; To the Company&#146;s knowledge, the duties of candor and good faith required by the United States Patent and Trademark Office, including citation of material prior art that the</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="21003-2-KA-01_PB_8_005037_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=475425,FOLIO='8',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-01_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:17 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .65in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company is aware of, during the prosecution of Company-owned United States patents and patent applications included in the Intellectual Property Rights have been complied with.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(x)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the Company&#146;s knowledge, none of the Company-owned Intellectual Property Rights or technology (including information technology and outsourced arrangements) employed by the Company in the conduct of the business in the manner described in the Registration Statement, the Time of Sale Prospectus or the Prospectus has been obtained or is being used by the Company in violation of any contractual obligation binding on the Company or any of its officers, directors or employees or otherwise in violation of the rights of any persons.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(y)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as would not reasonably be expected to result in a material adverse effect on the Company, (A)&nbsp;each Plan (as defined below) has been maintained in compliance with its terms and in all material respects with the requirements of any applicable statutes, orders, rules&nbsp;and regulations, including but not limited to the Employee Retirement Income Security Act of 1974, as amended (&#147;<b>ERISA</b>&#148;) and the Internal Revenue Code of 1986, as amended (the &#147;<b>Code</b>&#148;); (B)&nbsp;no non-exempt prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, has occurred with respect to any Plan; (C)&nbsp;for each Plan, no failure to satisfy the minimum funding standards (within the meaning of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA), whether or not waived, has occurred or is reasonably expected to occur; (D)&nbsp;no &#147;reportable event&#148; (within the meaning of Section&nbsp;4043(c)&nbsp;of ERISA, other than those events as to which notice is waived) has occurred or is reasonably expected to occur; and (E)&nbsp;neither the Company nor any member of its &#147;Controlled Group&#148; (defined as any organization that is a member of a controlled group of corporations within the meaning of Section&nbsp;414 of the Code) has incurred, nor is reasonably expected to incur, any liability under Title IV of ERISA (other than contributions to any Plan or any Multiemployer Plan or premiums to the PBGC, in the ordinary course and without default) in respect of a Plan or a Multiemployer Plan. For purposes of this paragraph, (x)&nbsp;the term &#147;<b>Plan</b>&#148; means an employee benefit plan, within the meaning of Section&nbsp;3(3)&nbsp;of ERISA, subject to Title IV of ERISA, but excluding any Multiemployer Plan, for which the Company or any member of its &#147;Controlled Group&#148; has any liability and (y)&nbsp;the term &#147;Multiemployer Plan&#148; means a multiemployer plan within the meaning of Section&nbsp;4001(a)(3)&nbsp;of ERISA.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .65in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(z)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No material labor dispute with the employees of the Company exists, except as described in the Time of Sale Prospectus, or, to the knowledge of the Company, is imminent; and the Company is not aware of any existing, threatened or imminent labor disturbance by the employees of any of its principal suppliers, manufacturers or contractors that would reasonably be expected to have a material adverse effect on the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="21003-2-KA-01_PB_9_005051_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=40233,FOLIO='9',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-01_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:17 2019' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(aa)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company is insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are, in the reasonable judgment of the Company, prudent and customary in the businesses in which it is engaged; the Company has not been refused any insurance coverage sought or applied for; and the Company does not have any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a material adverse effect on the Company, except as described in the Time of Sale Prospectus.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(bb)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company possesses all certificates, authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct its business, except where failure to obtain such certificates, authorizations and permits would not, singly or in the aggregate, reasonably by expected to have a material adverse effect on the Company, and the Company has not received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit that, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a material adverse effect on the Company, except as described in the Time of Sale Prospectus.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(cc)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles in the United States (&#147;<b>U.S. GAAP</b>&#148;) and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v)&nbsp;the interactive data in eXtensible Business Reporting Language included in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#146;s rules&nbsp;and guidelines applicable thereto.&#160; Except as described in the Time of Sale Prospectus, since the end of the Company&#146;s most recent audited fiscal year, there has been (i)&nbsp;no material weakness in the Company&#146;s internal control over financial reporting (whether or not remediated) and (ii)&nbsp;no change in the Company&#146;s internal control over financial reporting that has materially and adversely affected, or is reasonably likely to materially and adversely affect, the Company&#146;s internal control over financial reporting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(dd)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The financial statements (including the related notes thereto) of the Company included in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and present fairly in all material respects the consolidated financial position of the Company as of the dates indicated and the results of its operations and cash flows for the periods specified.&#160; Such financial</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="21003-2-KA-03_PB_10_005207_1912"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=735965,FOLIO='10',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-03_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:22 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">statements have been prepared in conformity with U.S. GAAP applied on a consistent basis throughout the periods involved.&#160; The other financial information of the Company included in the Registration Statement, the Time of Sale Prospectus and the Prospectus has been derived from the accounting or other records of the Company and presents fairly in all material respects the information shown thereby.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ee)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Ernst&nbsp;&amp; Young LLP, independent public accountants, who have expressed their opinion with respect to certain financial statements (which term as used in this Agreement includes the related notes thereto) of the Company included in the Registration Statement, are independent with respect to the Company within the applicable rules&nbsp;and regulations of the Commission and as required by the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ff)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company maintains disclosure controls and procedures that comply with the requirements of the Securities Exchange Act of 1934, as amended (the &#147;<b>Exchange Act</b>&#148;); such disclosure controls and procedures have been designed to ensure that material information relating to the Company is made known to the Company&#146;s principal executive officer and principal financial officer by others within the Company; such disclosure controls and procedures are effective at the reasonable assurance level; and the Company has carried out evaluations of the effectiveness of its disclosure controls and procedures as required by Rule&nbsp;13a-15 of the Exchange Act through September&nbsp;30, 2019.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(gg)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as described in the Time of Sale Prospectus, the Company has not sold, issued or distributed any shares of Common Stock during the six-month period preceding the date hereof, including any sales pursuant to Rule&nbsp;144A under, or Regulation&nbsp;D or S of, the Securities Act, other than shares issued pursuant to employee benefit plans, qualified stock option plans or other employee compensation plans or pursuant to outstanding options, rights or warrants.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(hh)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company is in compliance, to the extent required, with all provisions of the Sarbanes-Oxley Act of 2002, as amended (the &#147;<b>Sarbanes-Oxley Act</b>&#148;), and all rules&nbsp;and regulations promulgated thereunder applicable to the Company as of the date hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company has filed all federal, state, local and foreign tax returns required to be filed through the date of this Agreement or has requested extensions thereof, except where the failure to file would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the Company, and has paid all taxes required to be paid thereon, except for cases in which the failure to file or pay would not reasonably be expected to have a material adverse effect on the Company, or, except as currently being contested in good faith and for which reserves required by U.S. GAAP have been created in the financial statements of the Company, and no tax deficiency has been determined adversely to the Company that has had (nor does the Company have</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">11<a name="21003-2-KA-03_PB_11_005221_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=992328,FOLIO='11',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-03_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:22 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">any notice or knowledge of any tax deficiency that would reasonably be expected to be determined adversely to the Company and that would reasonably be expected to have) a material adverse effect on the Company.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(jj)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>From the time of initial confidential submission of the Registration Statement to the Commission (or, if earlier, the first date on which the Company engaged directly or through any person authorized to act on its behalf in any Testing-the-Waters Communication) through the date hereof, the Company has been and is an &#147;emerging growth company,&#148; as defined in Section&nbsp;2(a)&nbsp;of the Securities Act (an &#147;<b>Emerging Growth Company</b>&#148;).&#160; &#147;<b>Testing-the-Waters Communication</b>&#148; means any oral or written communication with potential investors undertaken in reliance on Section&nbsp;5(d)&nbsp;of the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(kk)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company (i)&nbsp;has not alone engaged in any Testing-the-Waters Communication other than Testing-the-Waters Communications with the consent of the Representatives with entities that are qualified institutional buyers within the meaning of Rule&nbsp;144A under the Securities Act or institutions that are accredited investors within the meaning of Rule&nbsp;501 under the Securities Act and (ii)&nbsp;has not authorized anyone other than the Representatives to engage in Testing-the-Waters Communications.&#160; The Company reconfirms that the Representatives have been authorized to act on its behalf in undertaking Testing-the-Waters Communications.&#160; The Company has not distributed any Written Testing-the-Waters Communications other than those listed on Schedule III hereto.&#160; &#147;<b>Written Testing-the-Waters Communication</b>&#148; means any Testing-the-Waters Communication that is a written communication within the meaning of Rule&nbsp;405 under the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ll)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As of the time of each sale of the Shares in connection with the offering when the Prospectus is not yet available to prospective purchasers, none of (A)&nbsp;the Time of Sale Prospectus, (B)&nbsp;any free writing prospectus, when considered together with the Time of Sale Prospectus, and (C)&nbsp;any individual Written Testing-the-Waters Communication, when considered together with the Time of Sale Prospectus, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(mm)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company has complied, and is presently in compliance, in all material respects with its privacy and security policies, and with all obligations, laws and regulations regarding the collection, use, transfer, storage, protection, disposal or disclosure of personally identifiable information or any other information collected from or provided by third parties.&#160; The Company has taken commercially reasonable steps to protect the information technology systems and data used in connection with the operation of the Company.&#160; The Company has used reasonable efforts to establish, and has established, commercially reasonable disaster recovery and security plans, procedures and facilities for the business, including, without limitation, for the information technology systems and data</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">12<a name="21003-2-KA-03_PB_12_005232_455"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=13,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=129609,FOLIO='12',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-03_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:22 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">held or used by or for the Company.&#160; To its knowledge, there has been no material security breach or attack or other compromise of or relating to any such information technology system or data.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(nn)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The statistical, industry and market-related data included in the Registration Statement, the Time of Sale Prospectus and the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate.&#160; To the Company&#146;s knowledge, it does not require the consent of any third party for the use of any such data except as already obtained.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(oo)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company has not taken, directly or indirectly, any action designed to or that would reasonably be expected to cause or result in any stabilization or manipulation of the price of the Shares to facilitate the sale or resale thereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(pp)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The preclinical tests and clinical trials, and other studies (collectively, &#147;studies&#148;) that are described in, or the results of which are referred to in, the Registration Statement, the Time of Sale Prospectus or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company has no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Time of Sale Prospectus or the Prospectus; the Company has made all such filings and obtained all such approvals or authorizations as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or from any other U.S. or foreign government or drug regulatory agency, or health care facility Institutional Review Board (collectively, the &#147;<b>Regulatory Agencies</b>&#148;), except where the failure to make such filing or obtain such approval would not reasonably be expected to result in a material adverse effect on the Company; except as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, the Company has not received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement, the Time of Sale Prospectus; and the Company has operated and currently is in compliance in all material respects with all applicable rules&nbsp;and regulations of the Regulatory Agencies.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(qq)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company is, and at all times has been, in compliance with all applicable Health Care Laws except where failure to be in compliance would not be reasonably expected to have a material adverse effect on the Company.&#160; For purposes of this Agreement, &#147;<b>Health Care Laws</b>&#148; means: (i)&nbsp;the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &#167;&#167; 301 et seq.), the Public Health Service Act (42 U.S.C. &#167;&#167; 201 et seq.) and the regulations promulgated thereunder; (ii)&nbsp;all</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">13<a name="21003-2-KA-03_PB_13_005311_4141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=14,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=526854,FOLIO='13',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-03_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:22 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">applicable federal, state, local and foreign health care related fraud and abuse laws, including, without limitation, the U.S. Anti-Kickback Statute (42 U.S.C. &#167; 1320a-7b(b)), the U.S. False Statements Law (42 U.S.C. &#167; 1320a-7b(a)), the Civil Monetary Penalties Law (42 U.S.C. &#167;1320a-7a), the U.S. Civil False Claims Act (31 U.S.C. &#167; 3729 et seq.), all applicable federal, state, local and foreign criminal laws relating to health care fraud and abuse, including but not limited to 18 U.S.C. &#167;&#167; 286 and 287, and the health care fraud criminal provisions under the U.S. Health Insurance Portability and Accountability Act of 1996 (&#147;<b>HIPAA</b>&#148;) (42 U.S.C. &#167;&#167; 1320d et seq.), the Physician Payments Sunshine Act (42 U.S.C. &#167; 1320a-7h), the exclusion law (42 U.S.C. &#167;1320a-7), the statutes, regulations and directives of applicable federal healthcare programs (as defined in 42 U.S.C. &#167; 1320a-7b(f)), and the regulations promulgated pursuant to such statutes, including but not limited to Medicare (Title XVIII of the Social Security Act) and Medicaid (Title XIX of the Social Security Act); (iii)&nbsp;HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. &#167;&#167; 17921 et seq.), and the regulations promulgated thereunder, including without limitation, the Standards for Privacy of Individually Identifiable Health Information, the Security Standards, and the Standards for Electronic Transactions and Code Sets, and any state or non-U.S. counterpart thereof or other law or regulation the purpose of which is to protect the privacy of individuals or prescribers; (iv)&nbsp;the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, the regulations promulgated thereunder; and (v)&nbsp;any and all other applicable health care laws and regulation applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, advertising, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed by the Company.&#160; The Company has not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or governmental or regulatory authority or third party alleging that it is in violation of any Health Care Laws, and, to the Company&#146;s knowledge, no such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action is threatened.&#160; Neither the Company nor its officers, directors, or, to the Company&#146;s knowledge, its employees, contractors or agents, is a party to any corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory authority.&#160; Additionally, neither the Company nor any of its officers, directors, or to the Company&#146;s knowledge, its employees, contractors or agents has been excluded, suspended or debarred from participation in any federal health care program (as defined in 42 U.S.C. &#167; 1320a-7b(f)) or human clinical research or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in such debarment, suspension, or exclusion.&#160; The Company has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by the Health Care Laws, and all such reports,</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">14<a name="21003-2-KA-03_PB_14_005321_8627"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=15,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=921322,FOLIO='14',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-03_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:22 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">documents, forms, notices, applications, records, claims, submissions and supplements or amendments were timely, complete, accurate and not misleading on the date filed (or were corrected or supplemented by a subsequent submission), except as would not reasonably be expected to have a material adverse effect on the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(rr)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The interactive data in eXtensible Business Reporting Language included in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#146;s rules&nbsp;and guidelines applicable thereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Agreements to Sell and Purchase.&#160; </i>The Company hereby agrees to sell to the several Underwriters, and each Underwriter, upon the basis of the representations and warranties herein contained, but subject to the conditions hereinafter stated, agrees, severally and not jointly, to purchase from the Company the respective number of Firm Shares set forth in Schedule&nbsp;I hereto opposite its name at $[&#149;] a share (the &#147;<b>Purchase Price</b>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On the basis of the representations and warranties contained in this Agreement, and subject to its terms and conditions, the Company agrees to sell to the Underwriters the Additional Shares, and the Underwriters shall have the right to purchase, severally and not jointly, up to [&#149;] Additional Shares at the Purchase Price, provided, however, that the amount paid by the Underwriters for any Additional Shares shall be reduced by an amount per share equal to any dividends declared by the Company and payable on the Firm Shares but not payable on such Additional Shares.&#160; You may exercise this right on behalf of the Underwriters in whole or from time to time in part by giving written notice to the Company not later than 30 days after the date of this Agreement.&#160; Any exercise notice shall specify the number of Additional Shares to be purchased by the Underwriters and the date on which such shares are to be purchased.&#160; Each purchase date must be at least one business day after the written notice is given and may not be earlier than the Closing Date nor later than ten business days after the date of such notice.&#160; Additional Shares may be purchased as provided in Section&nbsp;4 hereof solely for the purpose of covering over-allotments made in connection with the offering of the Firm Shares.&#160; On each day, if any, that Additional Shares are to be purchased (an &#147;<b>Option Closing Date</b>&#148;), each Underwriter agrees, severally and not jointly, to purchase the number of Additional Shares (subject to such adjustments to eliminate fractional shares as you may determine) that bears the same proportion to the total number of Additional Shares to be purchased on such Option Closing Date as the number of Firm Shares set forth in Schedule&nbsp;I hereto opposite the name of such Underwriter bears to the total number of Firm Shares.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Terms of Public Offering</i>.&#160; The Company is advised by you that the Underwriters propose to make a public offering of their respective portions of the Shares as soon after the Registration Statement and this Agreement have become effective as in your judgment is advisable.&#160; The Company is further advised by you that the Shares are to be offered to the public initially at $[&#149;] a share (the &#147;<b>Public Offering Price</b>&#148;) and to certain dealers selected by you at a price that represents a concession not in excess of $[&#149;] a share under the Public Offering Price, and that any Underwriter may allow, and such</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">15<a name="21003-2-KA-03_PB_15_005400_7906"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=16,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=646130,FOLIO='15',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-03_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:22 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dealers may reallow, a concession, not in excess of $[&#149;] a share, to any Underwriter or to certain other dealers.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Payment and Delivery.&#160; </i>Payment for the Firm Shares shall be made to the Company in Federal or other funds immediately available in New York City against delivery of such Firm Shares for the respective accounts of the several Underwriters at 10:00 a.m., New York City time, on [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2019, or at such other time on the same or such other date, not later than [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2019, as shall be designated in writing by you.&#160; The time and date of such payment are hereinafter referred to as the &#147;<b>Closing Date</b>&#148;.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Payment for any Additional Shares shall be made to the Company in Federal or other funds immediately available in New York City against delivery of such Additional Shares for the respective accounts of the several Underwriters at 10:00 a.m., New York City time, on the date specified in the corresponding notice described in Section&nbsp;2 or at such other time on the same or on such other date, in any event not later than [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2019, as shall be designated in writing by you.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Firm Shares and Additional Shares shall be registered in such names and in such denominations as you shall request in writing not later than one full business day prior to the Closing Date or the applicable Option Closing Date, as the case may be.&#160; The Firm Shares and Additional Shares shall be delivered to you on the Closing Date or an Option Closing Date, as the case may be, for the respective accounts of the several Underwriters designated by you through the facilities of the Depository Trust Company, with any transfer taxes payable in connection with the transfer of the Shares to the Underwriters duly paid, against payment of the Purchase Price therefor.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Conditions to the Underwriters&#146; Obligations</i>.&#160; The obligations of the Company to sell the Shares to the Underwriters and the several obligations of the Underwriters to purchase and pay for the Shares on the Closing Date are subject to the condition that the Registration Statement shall have become effective not later than 4:00pm (New York City time) on the date hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The several obligations of the Underwriters are subject to the following further conditions:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subsequent to the execution and delivery of this Agreement and prior to the Closing Date:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>no order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding for such purpose or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>there shall not have occurred any downgrading, nor shall any notice have been given of any intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any of the securities of the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">16<a name="21003-2-KA-03_PB_16_005559_3736"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=17,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=460456,FOLIO='16',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-03_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:22 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company by any &#147;nationally recognized statistical rating organization,&#148; as such term is defined in Section&nbsp;3(a)(62) of the Exchange Act; and</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>there shall not have occurred any change, or any development involving a prospective change, in the condition, financial or otherwise, or in the earnings, business, management or operations of the Company from that set forth in the Time of Sale Prospectus that, in your judgment, is material and adverse and that makes it, in your judgment, impracticable to market the Shares on the terms and in the manner contemplated in the Time of Sale Prospectus.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Underwriters shall have received on the Closing Date a certificate, dated the Closing Date and signed on behalf of the Company by an executive officer of the Company, to the effect set forth in Section&nbsp;5(a)(i)&nbsp;above and to the effect that the representations and warranties of the Company contained in this Agreement are true and correct as of the Closing Date and that the Company has complied with all of the agreements and satisfied all of the conditions on its part to be performed or satisfied hereunder on or before the Closing Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The officer signing and delivering such certificate may rely upon the best of his or her knowledge as to proceedings threatened.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Underwriters shall have received on the Closing Date an opinion and negative assurance letter of Hogan Lovells US LLP, outside counsel for the Company, dated the Closing Date, in form and substance reasonably satisfactory to the Underwriters.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Underwriters shall have received on the Closing Date an opinion and negative assurance letter of Smith, Gambrell&nbsp;&amp; Russell, LLP, intellectual property counsel for the Company, dated the Closing Date, in form and substance reasonably satisfactory to the Underwriters.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Underwriters shall have received on the Closing Date an opinion and negative assurance letter of Cooley LLP, counsel for the Underwriters, dated the Closing Date, in form and substance reasonably satisfactory to the Underwriters.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">With respect to the opinion and negative assurance letters to be delivered pursuant to Sections 5(c)&nbsp;and 5(e)&nbsp;above, Hogan Lovells US LLP and Cooley LLP, respectively, may state that their opinions and beliefs are based upon their participation in the preparation of the Registration Statement, the Time of Sale Prospectus and the Prospectus and any amendments or supplements thereto and review and discussion of the contents thereof, but are without independent check or verification, except as specified.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The opinion of Hogan Lovells US LLP described in Section&nbsp;5(c)&nbsp;above shall be rendered to the Underwriters at the request of the Company and shall so state therein.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">17<a name="21003-2-KA-03_PB_17_005619_9621"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=18,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=130270,FOLIO='17',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-03_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:22 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Underwriters shall have received, on each of the date hereof and the Closing Date, a letter dated the date hereof or the Closing Date, as the case may be, in form and substance reasonably satisfactory to the Underwriters, from Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, containing statements and information of the type ordinarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements and certain financial information contained in the Registration Statement, the Time of Sale Prospectus and the Prospectus; <i>provided</i> that the letter delivered on the Closing Date shall use a &#147;cut-off date&#148; not earlier than the date hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The &#147;lock-up&#148; agreements, each substantially in the form of Exhibit&nbsp;A hereto, between you and the officers, directors and certain stockholders of the Company relating to sales and certain other dispositions of shares of Common Stock or certain other securities, delivered to you on or before the date hereof, shall be in full force and effect on the Closing Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>[The Underwriters shall have received, on each of the date hereof and the Closing Date, a certificate of the accuracy of certain financial information included in the Time of Sale Prospectus and the Prospectus, in form and substance reasonably satisfactory to the Underwriters, signed by the Chief Financial Officer of the Company.]</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The several obligations of the Underwriters to purchase Additional Shares hereunder are subject to the delivery to you on the applicable Option Closing Date of the following:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a certificate, dated the Option Closing Date and signed on behalf of the Company by an executive officer of the Company, confirming that the certificate delivered on the Closing Date pursuant to Section&nbsp;5(b)&nbsp;hereof remains true and correct as of such Option Closing Date;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an opinion of Hogan Lovells US LLP, outside counsel for the Company, dated the Option Closing Date, relating to the Additional Shares to be purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section&nbsp;5(c)&nbsp;hereof;</p>
<p style="margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an opinion of Smith, Gambrell&nbsp;&amp; Russell, LLP, intellectual property counsel for the Company, dated the Option Closing Date, relating to the Additional Shares to be purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section&nbsp;5(d)&nbsp;hereof;</p>
<p style="margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an opinion of Cooley LLP, counsel for the Underwriters, dated the Option Closing Date, relating to the Additional Shares to be</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">18<a name="21003-2-KA-03_PB_18_005701_8715"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=19,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=65760,FOLIO='18',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-03_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:22 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section&nbsp;5(e)&nbsp;hereof;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a letter dated the Option Closing Date, in form and substance reasonably satisfactory to the Underwriters, from Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, substantially in the same form and substance as the letter furnished to the Underwriters pursuant to Section&nbsp;5(e)&nbsp;hereof; <i>provided</i> that the letter delivered on the Option Closing Date shall use a &#147;cut-off date&#148; not earlier than three business days prior to such Option Closing Date; and</p>
<p style="margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>such other documents as you may reasonably request with respect to the good standing of the Company, the due authorization and issuance of the Additional Shares to be sold on such Option Closing Date and other matters related to the issuance of such Additional Shares.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.65in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Covenants of the Company</i>.&#160; The Company covenants with each Underwriter as follows:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To furnish to you, without charge and upon request, four conformed copies of the Registration Statement (including exhibits thereto) and for delivery to each other Underwriter a conformed copy of the Registration Statement (without exhibits thereto) and to furnish to you in New York City, without charge, prior to 10:00&nbsp;a.m.&nbsp;New York City time on the business day next succeeding the date of this Agreement and during the period mentioned in Section&nbsp;6(e)&nbsp;or 6(f)&nbsp;below, as many copies of the Time of Sale Prospectus, the Prospectus and any supplements and amendments thereto or to the Registration Statement as you may reasonably request.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Before amending or supplementing the Registration Statement, the Time of Sale Prospectus or the Prospectus, to furnish to you a copy of each such proposed amendment or supplement and not to file any such proposed amendment or supplement to which you reasonably object in writing, and to file with the Commission within the applicable period specified in Rule&nbsp;424(b)&nbsp;under the Securities Act any prospectus required to be filed pursuant to such Rule.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To furnish to you a copy of each proposed free writing prospectus to be prepared by or on behalf of, used by, or referred to by the Company and not to use or refer to any proposed free writing prospectus to which you reasonably object.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Not to take any action that would result in an Underwriter or the Company being required to file with the Commission pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act a free writing prospectus prepared by or on behalf of the Underwriter that the Underwriter otherwise would not have been required to file thereunder.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">19<a name="21003-2-KA-03_PB_19_005720_563"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=20,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=234965,FOLIO='19',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-03_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:22 2019' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160;&#160;&#160; If the Time of Sale Prospectus is being used to solicit offers to buy the Shares at a time when the Prospectus is not yet available to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Time of Sale Prospectus in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if any event shall occur or condition exist as a result of which the Time of Sale Prospectus conflicts with the information contained in the Registration Statement then on file, or if, in the reasonable opinion of counsel for the Underwriters, it is necessary to amend or supplement the Time of Sale Prospectus to comply with applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, either amendments or supplements to the Time of Sale Prospectus so that the statements in the Time of Sale Prospectus as so amended or supplemented will not, in the light of the circumstances when the Time of Sale Prospectus is delivered to a prospective purchaser, be misleading or so that the Time of Sale Prospectus, as amended or supplemented, will no longer conflict with the Registration Statement, or so that the Time of Sale Prospectus, as amended or supplemented, will comply with applicable law.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;&#160;&#160;&#160;&#160; If, during such period after the first date of the public offering of the Shares as in the reasonable opinion of counsel for the Underwriters the Prospectus (or in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;of the Securities Act) is required by law to be delivered in connection with sales by an Underwriter or dealer, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein, in the light of the circumstances when the Prospectus (or in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;of the Securities Act) is delivered to a purchaser, not misleading, or if, in the reasonable opinion of counsel for the Underwriters, it is necessary to amend or supplement the Prospectus to comply with applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to the dealers (whose names and addresses you will furnish to the Company) to which Shares may have been sold by you on behalf of the Underwriters and to any other dealers upon request, either amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances when the Prospectus (or in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;of the Securities Act) is delivered to a purchaser, be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&#160;&#160;&#160;&#160;&#160; To endeavor to qualify the Shares for offer and sale under the securities or blue sky laws of such jurisdictions as you shall reasonably request, provided, however, that nothing contained herein shall require the Company to qualify to do business in any jurisdiction, to execute a general consent to service of process in any jurisdiction, or to subject itself to taxation in any jurisdiction in which it is not otherwise subject.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">20<a name="21003-2-KA-05_PB_20_013056_8145"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=21,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=528470,FOLIO='20',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-05_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:54 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)&#160;&#160;&#160;&#160;&#160; To make generally available (which may be satisfied by filing with the Commission on its Electronic Data Gathering, Analysis, and Retrieval system) to the Company&#146;s security holders and to you as soon as practicable an earnings statement covering a period of at least 12 months beginning with the first fiscal quarter of the Company occurring after the date of this Agreement that shall satisfy the provisions of Section&nbsp;11(a)&nbsp;of the Securities Act and the rules&nbsp;and regulations of the Commission thereunder.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; Whether or not the transactions contemplated in this Agreement are consummated or this Agreement is terminated, to pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including: (i) the fees, disbursements and expenses of the Company&#146;s counsel and the Company&#146;s accountants in connection with the registration and delivery of the Shares under the Securities Act and all other fees or expenses in connection with the preparation and filing of the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, the Prospectus, any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company and amendments and supplements to any of the foregoing, including all printing costs associated therewith, and the mailing and delivering of copies thereof to the Underwriters and dealers, in the quantities hereinabove specified, (ii) all costs and expenses related to the transfer and delivery of the Shares to the Underwriters, including any transfer or other taxes payable thereon, (iii) the reasonable cost of printing or producing any blue sky or legal investment memorandum in connection with the offer and sale of the Shares under state securities laws and all expenses incurred in connection with the qualification of the Shares for offer and sale under state securities laws as provided in Section 6(g) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Underwriters in connection with such qualification and in connection with the blue sky or legal investment memorandum, (iv) all filing fees and the reasonable fees and disbursements of counsel to the Underwriters incurred in connection with the review and qualification of the offering of the Shares by the Financial Industry Regulatory Authority, Inc. provided that the amount payable by the Company with respect to fees and disbursements of the Underwriters and counsel for the Underwriters pursuant to subsections (iii) and (iv) shall not exceed $35,000 in the aggregate, (v) all costs and expenses incident to listing the Shares on the Nasdaq Global Select Market, (vi) the cost of printing certificates representing the Shares, (vii) the costs and charges of any transfer agent, registrar or depositary, (viii) the costs and expenses of the Company relating to investor presentations on any &#147;road show&#148; undertaken in connection with the marketing of the offering of the Shares, including, without limitation, expenses associated with the preparation or dissemination of any electronic road show, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations with the prior approval of the Company, travel and lodging expenses of the representatives and officers of the Company and any such consultants, and 50% of the cost of any aircraft chartered in connection with the road show (the remaining 50% of the cost of such aircraft to be paid by the Underwriters), (ix) the document production</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">21<a name="21003-2-KA-05_PB_21_013108_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=22,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=295480,FOLIO='21',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-05_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:54 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">charges and expenses associated with printing this Agreement and (x) all other costs and expenses incident to the performance of the obligations of the Company hereunder for which provision is not otherwise made in this Section.&#160; It is understood, however, that except as provided in this Section, Section 8(a) entitled &#147;Indemnity and Contribution&#148; and the last paragraph of Section 10 below, the Underwriters will pay all of their costs and expenses, including fees and disbursements of their counsel, stock transfer taxes payable on resale of any of the Shares by them and any advertising expenses connected with any offers they may make and all travel and other expenses of the Underwriters, their representatives, their counsel or any of their employees incurred by them in connection with their participation in investor presentations on any &#147;road show&#148; undertaken in connection with the marketing of the offering of the Shares.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160; To promptly notify the Representatives if the Company ceases to be an Emerging Growth Company at any time prior to the later of (a)&nbsp;completion of the distribution of the Shares within the meaning of the Securities Act and (b)&nbsp;completion of the Restricted Period (as defined in this Section&nbsp;6).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)&#160;&#160;&#160;&#160;&#160; If at any time during the period in which delivery of a prospectus is required by the Securities Act following the distribution of any Written Testing-the-Waters Communication there occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication, as then amended or supplemented, included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, to promptly notify the Representatives and will promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such untrue statement or omission.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company also covenants with each Underwriter that, without the prior written consent of the Representatives, on behalf of the Underwriters, it will not, during the period ending 90 days after the date of the Prospectus (the &#147;<b>Restricted Period</b>&#148;), (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or (2)&nbsp;enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause&nbsp;(1)&nbsp;or (2)&nbsp;above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise or (3)&nbsp;file any registration statement with the Commission relating to the offering of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The restrictions contained in the preceding paragraph shall not apply to (a)&nbsp;the Shares to be sold hereunder, (b)&nbsp;the issuance by the Company of shares of Common Stock upon the exercise of an option or warrant or the conversion of a security outstanding on the date hereof, as described in the Time of Sale Prospectus and the</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">22<a name="21003-2-KA-05_PB_22_013138_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=23,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=111448,FOLIO='22',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-05_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:54 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prospectus or of which the Underwriters have been advised in writing, (c)&nbsp;the establishment of a trading plan pursuant to Rule&nbsp;10b5-1 under the Exchange Act for the transfer of shares of Common Stock, <i>provided</i> that (i)&nbsp;such plan does not provide for the transfer of Common Stock during the Restricted Period and (ii)&nbsp;to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by the Company regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer of Common Stock may be made under such plan during the Restricted Period, (d)&nbsp;the grant or issuance by the Company of options, restricted stock awards, restricted stock units or any other type of equity award to employees, officers, directors, advisors or consultants of the Company pursuant to employee benefit plans described in the Time of Sale Prospectus, (e)&nbsp;the filing by the Company of one or more registration statements with the Commission on Form&nbsp;S-8 with respect to employee benefit plans in described in the Time of Sale Prospectus and the Prospectus, or (f)&nbsp;the sale or issuance of or entry into an agreement to sell or issue shares of Common Stock or securities convertible into or exercisable for Common Stock in connection with any (i)&nbsp;merger, (ii)&nbsp;acquisition of securities, businesses, technology, property or any other assets, (iii)&nbsp;joint venture, (iv)&nbsp;strategic alliance or (v)&nbsp;equipment leasing arrangement, provided that the aggregate number of shares of Common Stock or securities convertible into or exercisable for Common Stock (on an as-converted or as exercised basis, as the case may be) that the Company may sell or issue or agree to sell or issue pursuant to this clause (f)&nbsp;shall not exceed 5% of the total number of shares of the Company&#146;s Common Stock issued and outstanding immediately following the completion of the transactions contemplated by this Agreement, and provided further, that each recipient of shares of Common Stock or securities convertible into or exercisable for Common Stock pursuant to clauses (d)&nbsp;and (f)&nbsp;shall execute a lock-up letter substantially in the form of Exhibit&nbsp;A hereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <i>Covenants of the Underwriters</i>.&#160; Each Underwriter severally covenants with the Company not to take any action that would result in the Company being required to file with the Commission under Rule&nbsp;433(d)&nbsp;a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <i>Indemnity and Contribution.</i>&#160; (a)&nbsp;The Company agrees to indemnify and hold harmless each Underwriter, each person, if any, who controls any Underwriter within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act and each affiliate of any Underwriter within the meaning of Rule&nbsp;405 under the Securities Act from and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other reasonable expenses incurred in connection with defending or investigating any such action or claim) arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any amendment thereof, any preliminary prospectus, the Time of Sale Prospectus or any amendment or supplement thereto, any issuer free writing prospectus as defined in Rule&nbsp;433(h)&nbsp;under the Securities Act, any Company information that the Company has filed, or is required to file, pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act, any road show as defined in Rule&nbsp;433(h)&nbsp;under the Securities Act (a &#147;road show&#148;), or the Prospectus or any amendment or supplement thereto, or any Written</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">23<a name="21003-2-KA-05_PB_23_014159_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=24,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=43646,FOLIO='23',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-05_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:54 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Testing-the-Waters Communication arising out of or based upon any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as such losses, claims, damages or liabilities arising out of or based upon such untrue statement or omission or alleged untrue statement or omission based upon information relating to any Underwriter furnished to the Company in writing by such Underwriter through you expressly for use therein.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160; Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers who sign the Registration Statement and each person, if any, who controls the Company within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the foregoing indemnity from the Company to such Underwriter, but only with reference to information relating to such Underwriter furnished to the Company in writing by such Underwriter through you expressly for use in the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, any issuer free writing prospectus, road show or the Prospectus or any amendment or supplement thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160; In case any proceeding (including any governmental investigation) shall be instituted involving any person in respect of which indemnity may be sought pursuant to Section 8(a) or 8(b), such person (the &#147;indemnified party&#148;) shall promptly notify the person against whom such indemnity may be sought (the &#147;indemnifying party&#148;) in writing and the indemnifying party, upon request of the indemnified party, shall retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and any others the indemnifying party may designate in such proceeding and shall pay the reasonably incurred fees and disbursements of such counsel related to such proceeding.&#160; In any such proceeding, any indemnified party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i) the indemnifying party and the indemnified party shall have mutually agreed in writing to the retention of such counsel, (ii) the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them (iii) the indemnified party shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the indemnifying party, or (iv) the indemnifying party has failed within a reasonable time to retain counsel reasonably satisfactory to the indemnified party.&#160; It is understood that the indemnifying party shall not, in respect of the legal expenses of any indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all such indemnified parties and that all such fees and expenses shall be reimbursed as they are incurred.&#160; Such firm shall be designated in writing by the Representatives, in the case of parties indemnified pursuant to Section 8(a), and by the Company, in the case of parties indemnified</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">24<a name="21003-2-KA-05_PB_24_014424_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=25,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=123629,FOLIO='24',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-05_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:54 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">pursuant to Section 8(b).&#160; The indemnifying party shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against any loss or liability by reason of such settlement or judgment.&#160; Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by the second and third sentences of this paragraph, the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement.&#160; No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such proceeding.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160; To the extent the indemnification provided for in Section 8(a) or 8(b) is unavailable to an indemnified party or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the indemnifying party or parties on the one hand and the indemnified party or parties on the other hand from the offering of the Shares or (ii) if the allocation provided by clause 8(d)(i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause 8(d)(i) above but also the relative fault of the indemnifying party or parties on the one hand and of the indemnified party or parties on the other hand in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations.&#160; The relative benefits received by the Company on the one hand and the Underwriters on the other hand in connection with the offering of the Shares shall be deemed to be in the same respective proportions as the net proceeds from the offering of the Shares (before deducting expenses) received by the Company and the total underwriting discounts and commissions received by the Underwriters, in each case as set forth in the table on the cover of the Prospectus, bear to the aggregate Public Offering Price of the Shares.&#160; The relative fault of the Company on the one hand and the Underwriters on the other hand shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">25<a name="21003-2-KA-05_PB_25_014509_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=26,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=119912,FOLIO='25',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-05_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:54 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .5in;text-indent:.75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">omission.&#160; The Underwriters&#146; respective obligations to contribute pursuant to this Section 8(a) are several in proportion to the respective number of Shares they have purchased hereunder, and not joint.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160;&#160;&#160; The Company and the Underwriters agree that it would not be just or equitable if contribution pursuant to this Section&nbsp;8(a)&nbsp;were determined by <i>pro rata</i> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in Section&nbsp;8(d)(i).&#160; The amount paid or payable by an indemnified party as a result of the losses, claims, damages and liabilities referred to in Section&nbsp;8(d)(i)&nbsp;shall be deemed to include, subject to the limitations set forth above, any legal or other reasonable expenses incurred by such indemnified party in connection with investigating or defending any such action or claim.&#160; Notwithstanding the provisions of this Section&nbsp;8(a), no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Shares underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.&#160; No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.&#160; The remedies provided for in this Section&nbsp;8(a)&nbsp;are not exclusive and shall not limit any rights or remedies that may otherwise be available to any indemnified party at law or in equity.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;&#160;&#160;&#160;&#160; The indemnity and contribution provisions contained in this Section 8(a) and the representations, warranties and other statements of the Company contained in this Agreement shall remain operative and in full force and effect regardless of (i) any termination of this Agreement, (ii) any investigation made by or on behalf of any Underwriter, any person controlling any Underwriter or any affiliate of any Underwriter or by or on behalf of the Company, its officers or directors or any person controlling the Company and (iii) acceptance of and payment for any of the Shares.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <i>Termination</i>.&#160; The Underwriters may terminate this Agreement by notice given by you to the Company, if after the execution and delivery of this Agreement and prior to the Closing Date (i)&nbsp;trading generally shall have been suspended or materially limited on, or by, as the case may be, any of the New York Stock Exchange, NYSE American, the Nasdaq Global Market, the Chicago Board of Options Exchange, the Chicago Mercantile Exchange or the Chicago Board of Trade or other relevant exchanges, (ii)&nbsp;trading of any securities of the Company shall have been suspended on any exchange or in any over-the-counter market, (iii)&nbsp;a material disruption in securities settlement, payment or clearance services in the United States or other relevant jurisdiction shall have occurred, (iv)&nbsp;any moratorium on commercial banking activities shall have been declared by Federal or New York State authorities or (v)&nbsp;there shall have occurred any outbreak or escalation of hostilities, or any change in financial markets or any calamity or crisis that, in your judgment, is material and adverse and which, singly or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">26<a name="21003-2-KA-05_PB_26_014810_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=27,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=530930,FOLIO='26',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-05_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:54 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">together with any other event specified in this clause&nbsp;(v), makes it, in your judgment, impracticable or inadvisable to proceed with the offer, sale or delivery of the Shares on the terms and in the manner contemplated in the Time of Sale Prospectus or the Prospectus.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.&#160;&#160;&#160;&#160;&#160;&#160; <i>Effectiveness; Defaulting Underwriters</i>.&#160; This Agreement shall become effective upon the execution and delivery hereof by the parties hereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If, on the Closing Date or an Option Closing Date, as the case may be, any one or more of the Underwriters shall fail or refuse to purchase Shares that it has or they have agreed to purchase hereunder on such date, and the aggregate number of Shares that such defaulting Underwriter or Underwriters agreed but failed or refused to purchase is not more than one-tenth of the aggregate number of the Shares to be purchased on such date, the other Underwriters shall be obligated severally in the proportions that the number of Firm Shares set forth opposite their respective names in Schedule&nbsp;I bears to the aggregate number of Firm Shares set forth opposite the names of all such non-defaulting Underwriters, or in such other proportions as you may specify, to purchase the Shares that such defaulting Underwriter or Underwriters agreed but failed or refused to purchase on such date; <i>provided</i> that in no event shall the number of Shares that any Underwriter has agreed to purchase pursuant to this Agreement be increased pursuant to this Section&nbsp;10 by an amount in excess of one-ninth of such number of Shares without the written consent of such Underwriter.&#160; If, on the Closing Date, any Underwriter or Underwriters shall fail or refuse to purchase Firm Shares and the aggregate number of Firm Shares with respect to which such default occurs is more than one-tenth of the aggregate number of Firm Shares to be purchased on such date, and arrangements satisfactory to you and the Company for the purchase of such Firm Shares are not made within 36 hours after such default, this Agreement shall terminate without liability on the part of any non-defaulting Underwriter or the Company.&#160; In any such case either you or the Company shall have the right to postpone the Closing Date, but in no event for longer than seven days, in order that the required changes, if any, in the Registration Statement, in the Time of Sale Prospectus, in the Prospectus or in any other documents or arrangements may be effected.&#160; If, on an Option Closing Date, any Underwriter or Underwriters shall fail or refuse to purchase Additional Shares and the aggregate number of Additional Shares with respect to which such default occurs is more than one-tenth of the aggregate number of Additional Shares to be purchased on such Option Closing Date, the non-defaulting Underwriters shall have the option to (i)&nbsp;terminate their obligation hereunder to purchase the Additional Shares to be sold on such Option Closing Date or (ii)&nbsp;purchase not less than the number of Additional Shares that such non-defaulting Underwriters would have been obligated to purchase in the absence of such default.&#160; Any action taken under this paragraph shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If this Agreement shall be terminated by the Underwriters, or any of them, because of any failure or refusal on the part of the Company to comply with the terms or to fulfill any of the conditions of this Agreement required to be complied with or fulfilled by the Company, or if for any reason the Company shall be unable to perform its obligations under this Agreement (other than by reason of a default by the Underwriters</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">27<a name="21003-2-KA-05_PB_27_014825_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=28,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=916204,FOLIO='27',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-05_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:54 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">or the occurrence of any of the events described in clauses (i), (iii), (iv)&nbsp;or (v)&nbsp;of Section&nbsp;10), the Company will reimburse the Underwriters or such Underwriters as have so terminated this Agreement with respect to themselves, severally, for all reasonable and documented out-of-pocket expenses (including the reasonable and documented fees and disbursements of their counsel) incurred by such Underwriters in connection with this Agreement or the offering contemplated hereunder.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.&#160;&#160;&#160;&#160;&#160;&#160; <i>Entire Agreement</i>.&#160; (a)&nbsp;This Agreement together with any contemporaneous written agreements and any prior written agreements (to the extent not superseded by this Agreement) that relate to the offering of the Shares represents the entire agreement between the Company and the Underwriters with respect to the preparation of any preliminary prospectus, the Time of Sale Prospectus, the Prospectus, the conduct of the offering, and the purchase and sale of the Shares.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160; The Company acknowledges that in connection with the offering of the Shares: (i)&nbsp;the Underwriters have acted at arm&#146;s length, are not agents of, and owe no fiduciary duties to, the Company or any other person; (ii)&nbsp;the Underwriters owe the Company only those duties and obligations set forth in this Agreement and prior written agreements (to the extent not superseded by this Agreement), if any; and (iii)&nbsp;the Underwriters may have interests that differ from those of the Company.&#160; The Company waives to the full extent permitted by applicable law any claims it may have against the Underwriters arising from an alleged breach of fiduciary duty in connection with the offering of the Shares.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.&#160;&#160;&#160;&#160;&#160;&#160; <i>Recognition of the U.S. Special Resolution Regimes</i>.&#160; (a)&nbsp;In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:30.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160; In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For purposes of this Section: (i)&nbsp;a &#147;<b>BHC Act Affiliate</b>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k); (ii)&nbsp;&#147;<b>Covered Entity</b>&#148; means any of the following: (A)&nbsp;a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (B)&nbsp;a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or (C)&nbsp;a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b); (iii)&nbsp;&#147;<b>Default Right</b>&#148; has the meaning assigned to that term</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">28<a name="21003-2-KA-05_PB_28_014838_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=29,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=425408,FOLIO='28',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-05_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:54 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable; and (iv)&nbsp;&#147;<b>U.S. Special Resolution Regime</b>&#148; means each of (A)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (B)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.&#160;&#160;&#160;&#160;&#160;&#160; <i>Counterparts</i>.&#160; This Agreement may be signed in two or more counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.&#160;&#160;&#160;&#160;&#160;&#160; <i>Applicable Law</i>.&#160; This Agreement and any claim, controversy or dispute arising out of this Agreement shall be governed by and construed in accordance with the internal laws of the State of New York.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.&#160;&#160;&#160;&#160;&#160;&#160; <i>Headings</i>.&#160; The headings of the sections of this Agreement have been inserted for convenience of reference only and shall not be deemed a part of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.&#160;&#160;&#160;&#160;&#160;&#160; <i>Notices</i>.&#160; All communications hereunder shall be in writing and effective only upon receipt and if to the Underwriters shall be delivered, mailed or sent to you in care of Morgan Stanley&nbsp;&amp;&nbsp;Co. LLC, 1585&nbsp;Broadway, New York, New York&nbsp;10036, Attention: Equity Syndicate Desk, with a copy to the Legal Department; BofA Securities,&nbsp;Inc., One Bryant Park, New York, New York 10036, Attention: Equity Syndicate Desk, with a copy to the Legal Department; Piper Jaffray&nbsp;&amp; Co., 800 Nicollet Mall, Minneapolis, Minnesota 55402, Attention: Equity Syndicate Desk, with a copy to the Legal Department, and in each case with a copy (which shall not constitute notice) to Cooley LLP, 55 Hudson Yards, New York, New York 10001, Attention: Div Gupta, Brent Siler and Josh Kaufman; and if to the Company shall be delivered, mailed or sent to 9000 Virginia Manor Road, Suite&nbsp;200, Beltsville, Maryland 20705, with a copy (which shall not constitute notice) to Hogan Lovells US LLP, 100 International Drive, Suite&nbsp;2000, Baltimore, Maryland 21202, Attention: William I. Intner.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">29<a name="21003-2-KA-05_PB_29_014848_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=30,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=380107,FOLIO='29',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-05_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 01:54 2019' -->

<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NextCure,&nbsp;Inc.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">30<a name="21003-2-KA-07_PB_30_014451_9480"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=31,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=988247,FOLIO='30',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accepted as of the date   hereof</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Morgan Stanley&nbsp;&amp;   Co. LLC</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BofA   Securities,&nbsp;Inc.</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Piper   Jaffray&nbsp;&amp; Co.</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Acting severally on behalf of themselves and the several Underwriters   named in Schedule I hereto.</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Morgan Stanley&nbsp;&amp; Co. LLC</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BofA Securities,&nbsp;Inc.</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Piper   Jaffray&nbsp;&amp; Co.</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt 23.05pt;text-indent:-23.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">31<a name="21003-2-KA-07_PB_31_014836_9497"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=32,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=511075,FOLIO='31',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SCHEDULE I</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="79%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:79.06%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Underwriter</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="19%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:19.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number&nbsp;of&nbsp;Firm&nbsp;Shares&nbsp;To<br>   Be&nbsp;Purchased</font></b></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:79.06%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Morgan Stanley&nbsp;&amp; Co. LLC</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="19%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.06%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BofA Securities,&nbsp;Inc.</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="19%" valign="top" style="padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:79.06%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Piper Jaffray&nbsp;&amp; Co.</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="19%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.06%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="19%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:79.06%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total:</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="19%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I-</font>1<a name="21003-2-KA-07_PB_1_015033_7729"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=33,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=908522,FOLIO='I-1',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SCHEDULE II</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Time of Sale Prospectus</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Preliminary Prospectus issued [date]</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Price per share to the public: [<font face="Symbol">&#183;</font>]</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Number of shares offered: [</font><font face="Symbol">&#183;</font>]</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Underwriters&#146; option to purchase additional shares: [</font><font face="Symbol">&#183;</font>]</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">II-</font>1<a name="21003-2-KA-07_PB_1_015013_2451"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=34,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=1017607,FOLIO='II-1',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SCHEDULE III</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Written Testing-the-Waters Communication</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">III-</font>1<a name="21003-2-KA-07_PB_1_015050_1388"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=35,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=998612,FOLIO='III-1',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;A</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FORM&nbsp;OF LOCK-UP LETTER</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>1<a name="21003-2-KA-07_PB_1_015102_4328"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=36,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=652930,FOLIO='A-1',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">LOCK-UP LETTER</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">, 2019</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Morgan Stanley&nbsp;&amp; Co. LLC</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BofA Securities,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Piper Jaffray&nbsp;&amp; Co.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c/o Morgan Stanley&nbsp;&amp; Co. LLC</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1585 Broadway</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">New York, New York 10036</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c/o BofA Securities,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">One Bryant Park</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">New York, New York 10036</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c/o Piper Jaffray&nbsp;&amp; Co.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">800 Nicollet Mall</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, Minnesota 55402</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The undersigned understands that Morgan Stanley&nbsp;&amp; Co. LLC (&#147;<b>Morgan Stanley</b>&#148;), Bof A Securities,&nbsp;Inc. (&#147;<b>BofAS</b>&#148;) and Piper Jaffray and Co. (together with Morgan Stanley and BofAS, the &#147;<b>Representatives</b>&#148;), propose to enter into an Underwriting Agreement (the &#147;<b>Underwriting Agreement</b>&#148;) with NextCure,&nbsp;Inc., a Delaware corporation (the &#147;<b>Company</b>&#148;), providing for the public offering (the &#147;<b>Public Offering</b>&#148;) by the several Underwriters, including the Representatives (the &#147;<b>Underwriters</b>&#148;), of a number of&#160; shares (the &#147;<b>Shares</b>&#148;) of the common stock, par value $0.001 per share, of the Company (the &#147;<b>Common Stock</b>&#148;) in an amount to be determined.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To induce the Underwriters that may participate in the Public Offering to continue their efforts in connection with the Public Offering, the undersigned hereby agrees that, without the prior written consent of the Representatives, on behalf of the Underwriters, it will not, during the period commencing on the date hereof and ending 90 days after the date of the final prospectus (the &#147;<b>Restricted Period</b>&#148;) relating to the Public Offering (the &#147;<b>Prospectus</b>&#148;), (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock beneficially owned (as such term is used in Rule&nbsp;13d-3 of the Securities Exchange Act of 1934, as amended (the &#147;<b>Exchange Act</b>&#148;)), by the undersigned or any other securities so owned convertible into or exercisable or exchangeable for Common Stock (together, with Common Stock, &#147;<b>Securities</b>&#148;) or make any public announcement of its intention to enter into any of the foregoing or (2)&nbsp;enter into any swap or other</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>2<a name="21003-2-KA-07_PB_2_015138_5250"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=37,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=216640,FOLIO='A-2',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause (1)&nbsp;or (2)&nbsp;above is to be settled by delivery of Securities, in cash or otherwise.&#160; The foregoing sentence shall not apply to:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>transactions relating to Securities acquired in the Public Offering or in open market transactions after the completion of the Public Offering; <i>provided</i> that no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act shall be required, or shall be voluntarily made during the Restricted Period, in connection with subsequent sales of Securities acquired in such open market transactions;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>transfers of Securities</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as a bona fide gift or charitable contribution;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>upon death or by will, testamentary document or intestate succession to the legal representative, heir, beneficiary or an immediate family member (as defined below) of the undersigned;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>to an immediate family member of the undersigned or to any trust, partnership or limited liability company for the direct or indirect benefit of the undersigned or the immediate family of the undersigned (for purposes of this agreement, &#147;immediate family&#148; shall mean any relationship by blood, current or former marriage or adoption, not more remote than first cousin);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>not involving a change in beneficial ownership;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if the undersigned is a trust, to any beneficiary of the undersigned or the estate of any such beneficiary;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as forfeitures to satisfy tax withholding obligations of or pursuant to a net or cashless exercise by the undersigned in connection with the vesting or exercise of equity awards by the undersigned to the extent such equity awards are outstanding as of the date of the Prospectus and granted pursuant to any equity incentive plan of the Company existing as of the date of the Prospectus and described in the Prospectus and so long as such net or cashless exercise is effected solely by the surrender of outstanding equity awards and the Company&#146;s cancellation of all or a portion thereof to pay the exercise price (including the payment of taxes due as a result of such vesting event or exercise) and/or withholding tax obligations, but for the avoidance of doubt, excluding all methods of exercise that would involve a sale of any Securities related to such equity awards, whether to cover the applicable exercise price, withholding tax obligations or otherwise; <i>provided</i> that no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act or any other public filing or disclosure of such receipt or transfer by or on</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>3<a name="21003-2-KA-07_PB_3_015206_7672"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=38,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=449606,FOLIO='A-3',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">behalf of the undersigned shall be required or shall be voluntarily made within 30 days after the date of the Prospectus, and after such 30th day, any filing under Section&nbsp;16(a)&nbsp;of the Exchange Act shall clearly indicate in the footnotes thereto that no shares were sold by the undersigned and the purpose of such transfer was to cover tax obligations of the undersigned or to pay the exercise price in connection with such exercise;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>pursuant to a bona fide third-party tender offer for all outstanding shares of the Company, merger, consolidation or other similar transaction made to all holders of the Company&#146;s Securities involving a Change of Control (as defined below) of the Company (including, without limitation, the entering into any lock-up, voting or similar agreement pursuant to which the undersigned may agree to transfer, sell, tender or otherwise dispose of Securities in connection with such transaction, or vote any Securities in favor of any transaction), <i>provided</i> that in the event that such tender offer, merger, consolidation or other such transaction is not completed, such Securities held by the undersigned shall remain subject to the provisions of this letter agreement, <i>provided further</i> that if the undersigned is required to make a filing under Section&nbsp;16(a)&nbsp;of the Exchange Act reporting a reduction in beneficial ownership of shares of Common Stock during the Restricted Period, the undersigned shall include a statement that such transfer is being made pursuant to the circumstances described in this clause (b)(vii)&nbsp;(as used herein, &#147;<b>Change of Control</b>&#148; shall mean the transfer (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons (other than any Underwriters pursuant to the Public Offering), of the Company&#146;s voting securities if, after such transfer, such person or group of affiliated persons would hold more than 50% of the outstanding voting securities of the Company (or the surviving entity));</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(viii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by operation of law pursuant to an order of a court or regulatory agency, <i>provided</i> that if the undersigned is required to make a filing under Section&nbsp;16(a)&nbsp;of the Exchange Act reporting a reduction in beneficial ownership of shares of Common Stock during the Restricted Period, the undersigned shall include a statement that such transfer is being made pursuant to the circumstances described in this clause (b)(viii);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ix)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if the undersigned is a corporation, partnership, limited liability company or other entity, (A)&nbsp;distributions of Securities to stockholders, direct or indirect affiliates (within the meaning set forth in Rule&nbsp;405 under the Securities Act of 1933, as amended), current or former partners (general or limited), members, directors, officers or managers of the undersigned, as applicable, or to the estates of any such stockholders, affiliates, partners, members, directors, officers or managers or (B)&nbsp;sales or transfers of any Securities to another such entity that is a direct or indirect affiliate of the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>4<a name="21003-2-KA-07_PB_4_015234_536"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=39,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=244268,FOLIO='A-4',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">undersigned, or to any investment fund or other entity that is, directly or indirectly, controlling or managing, controlled or managed by, or under common control or management with, the undersigned or affiliates of the undersigned; or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(x)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>to the Company pursuant to any contractual arrangement that provides for the repurchase by the Company or forfeiture to the Company of the undersigned&#146;s Securities upon termination of the undersigned&#146;s employment or service with the Company, <i>provided</i> that if the undersigned is required to make a filing under the Exchange Act reporting a reduction in beneficial ownership of shares of Common Stock during the Restricted Period, the undersigned shall include a statement that such transfer is being made pursuant to the circumstances described in this clause (b)(x);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the establishment of a trading plan pursuant to Rule&nbsp;10b5-1 under the Exchange Act for the transfer of shares of Common Stock, <i>provided</i> that (i)&nbsp;such plan does not provide for the transfer of Common Stock during the Restricted Period and (ii)&nbsp;to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of the undersigned or the Company regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer of Common Stock may be made under such plan during the Restricted Period;&#160; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>dispositions or transfers to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (a)&nbsp;and (b)&nbsp;above;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">provided</font></i> that in the case of any transfer or distribution pursuant to clause&nbsp;(b), (i)&nbsp;each transferee, recipient, donee, distributee, trustee or beneficiary shall sign and deliver a lock-up letter substantially in the form of this letter and (ii)&nbsp;no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act, reporting a reduction in beneficial ownership of shares of Common Stock, shall be required or shall be voluntarily made during the Restricted Period except as otherwise provided in clauses (b)(vi), (b)(vii), (b)(viii)&nbsp;and (b)(x).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, the undersigned agrees that, without the prior written consent of the Representatives, on behalf of the Underwriters, it will not, during the Restricted Period, make any demand for or exercise any right with respect to, the registration of any Securities.&#160; The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&#146;s transfer agent and registrar against the transfer of the undersigned&#146;s shares of Common Stock except in compliance with the foregoing restrictions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The undersigned understands that, if (a)&nbsp;the Underwriting Agreement does not become effective by December&nbsp;31, 2019, (b)&nbsp;the Company informs the undersigned that the Board of Directors has determined not to proceed with the Public Offering prior to the execution of the Underwriting Agreement or the registration statement filed with the U.S.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>5<a name="21003-2-KA-07_PB_5_015304_5926"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=40,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=598026,FOLIO='A-5',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Securities and Exchange Commission in connection with the Public Offering is withdrawn, (c)&nbsp;a Representative informs the Company that the Representatives have determined not to proceed with the Public Offering prior to the execution of the Underwriting Agreement, or if (d)&nbsp;the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Securities, this agreement shall terminate and the undersigned shall be released from all obligations hereunder.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The undersigned understands that the Company and the Underwriters are relying upon this agreement in proceeding toward consummation of the Public Offering.&#160; The undersigned further understands that this agreement is irrevocable and shall be binding upon the undersigned&#146;s heirs, legal representatives, successors and assigns. This letter agreement and any claim, controversy or dispute arising under or related to this letter agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature Page&nbsp;Follows]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>6<a name="21003-2-KA-07_PB_6_015321_4688"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=41,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=1009174,FOLIO='A-6',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Whether or not the Public Offering actually occurs depends on a number of factors, including market conditions.&#160; Any Public Offering will only be made pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Underwriters.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name)</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address)</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A-</font>7<a name="21003-2-KA-07_PB_7_015409_2983"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=42,EFW="2240001",CP="NEXTCURE, INC.",DN="2",CHK=636042,FOLIO='A-7',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KA-07_ZCO70302.CHC",USER="JTAYLORA",CD='Nov  9 02:24 2019' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>a2240001zex-5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;"><font style="font-weight:bold;">Exhibit&nbsp;5.1</font><a name="21003-2-KI_Exhibit5_1_070230"></a></font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="95" height="95" src="g210032kii001.jpg"></font></p>    </td>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Hogan Lovells US LLP</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Harbor East</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100 International Drive</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Suite&nbsp;2000</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Baltimore, MD 21202</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">T +1 410 659 2700</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">F +1 410 659 2701</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">www.hoganlovells.com</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">November&nbsp;12, 2019</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Board of Directors</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NextCure,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9000 Virginia Manor Road</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Suite&nbsp;200</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Beltsville, Maryland 20705</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We are acting as counsel to NextCure,&nbsp;Inc., a Delaware corporation (the &#147;<b>Company</b>&#148;), in connection with its registration statement on Form&nbsp;S-1, as amended, and any Rule&nbsp;462(b)&nbsp;registration statement (collectively, the &#147;<b>Registration Statement</b>&#148;), filed with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the &#147;<b>Act</b>&#148;) relating to the proposed public offering of up to 3,680,000 shares of the common stock, par value $0.001 per share (the &#147;<b>Common Stock</b>&#148;) of the Company (such shares together with any additional shares of Common Stock that may be sold pursuant to Rule&nbsp;462(b)&nbsp;under the Act, the &#147;<b>Shares</b>&#148;), all of which shares are to be sold by the Company. This opinion letter is furnished to you at your request to enable you to fulfill the requirements of Item&nbsp;601(b)(5)&nbsp;of Regulation S-K, 17&nbsp;C.F.R. &#167;&nbsp;229.601(b)(5), in connection with the Registration Statement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For purposes of this opinion letter, we have examined copies of such agreements, instruments and documents as we have deemed an appropriate basis on which to render the opinions hereinafter expressed. In our examination of the aforesaid documents, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the accuracy and completeness of all documents submitted to us, the authenticity of all original documents, and the conformity to authentic original documents of all documents submitted to us as copies (including pdfs). As to all matters of fact, we have relied on the representations and statements of fact made in the documents so reviewed, and we have not independently established the facts so relied on. This opinion letter is given, and all statements herein are made, in the context of the foregoing.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This opinion letter is based as to matters of law solely on the Delaware General Corporation Law, as amended. We express no opinion herein as to any other statutes, rules&nbsp;or regulations.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Based upon, subject to and limited by the foregoing, we are of the opinion that following (i)&nbsp;execution and delivery by the Company of the Underwriting Agreement, (ii)&nbsp;effectiveness of the Registration Statement, (iii)&nbsp;issuance of the Shares pursuant to the terms of the Underwriting Agreement, and (iv)&nbsp;receipt by the Company of the consideration for the Shares specified in the resolutions of the Board of Directors and the Pricing Committee of the Board of Directors, the Shares will be validly issued, fully paid, and nonassessable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">Hogan Lovells US LLP is a limited liability partnership registered in the District of Columbia.&#160; &#147;Hogan Lovells&#148; is an international legal practice that includes Hogan Lovells US LLP and Hogan Lovells International LLP, with offices in:&#160; Alicante&#160; Amsterdam&#160; Baltimore&#160; Beijing&#160; Birmingham&#160; Boston&#160; Brussels&#160; Colorado Springs&#160; Denver&#160; Dubai&#160; Dusseldorf&#160; Frankfurt&#160; Hamburg&#160; Hanoi&#160; Ho Chi Minh City&#160; Hong Kong&#160; Houston&#160; Johannesburg&#160; London&#160; Los Angeles&#160; Luxembourg&#160; Madrid&#160; Mexico City&#160; Miami&#160; Milan&#160; Minneapolis&#160; Monterrey&#160; Moscow&#160; Munich&#160; New York&#160; Northern Virginia&#160; Paris&#160; Perth&#160; Philadelphia&#160; Rome&#160; San Francisco&#160; S&#227;o Paulo&#160; Shanghai&#160; Silicon Valley&#160; Singapore&#160; Sydney&#160; Tokyo&#160; Warsaw&#160; Washington, D.C.&#160;&#160; Associated Offices:&#160; Budapest&#160; Jakarta&#160; Riyadh&#160; Shanghai FTZ&#160; Ulaanbaatar&#160; Zagreb.&#160;&#160; Business Service Centers:&#160; Johannesburg&#160; Louisville.&#160;&#160; Legal Services Center:&#160; Berlin.&#160; For more information see www.hoganlovells.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2240001",CP="NEXTCURE, INC.",DN="3",CHK=102089,FOLIO='',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KI_ZCO70302.CHC",USER="JTAYLORA",CD='Nov 12 21:43 2019' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This opinion letter has been prepared for use in connection with the Registration Statement. We assume no obligation to advise of any changes in the foregoing subsequent to the effective date of the Registration Statement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We hereby consent to the filing of this opinion letter as Exhibit&nbsp;5.1 to the Registration Statement and to the reference to this firm under the caption &#147;Legal Matters&#148; in the prospectus constituting a part of the Registration Statement. In giving this consent, we do not thereby admit that we are an &#147;expert&#148; within the meaning of the Act.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very   truly yours,</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   HOGAN LOVELLS US LLP</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">HOGAN LOVELLS US LLP</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="21003-2-KI_PB_2_070658_3040"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2240001",CP="NEXTCURE, INC.",DN="3",CHK=795483,FOLIO='2',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KI_ZCO70302.CHC",USER="JTAYLORA",CD='Nov 12 21:43 2019' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>a2240001zex-23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 23.1<a name="21003-2-KU_Exhibit23_1_064941"></a></font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Consent of Independent Registered Public Accounting Firm</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We consent to the reference to our firm under the caption &#147;Experts&#148; and to the use of our report dated March&nbsp;5, 2019 (except for the fourth paragraph of Note 16, as to which the date is May&nbsp;3, 2019) in the Registration Statement (Form&nbsp;S-1) and related Prospectus of NextCure,&nbsp;Inc. for the registration of 3,680,000 shares of its common stock.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Ernst&nbsp;&amp; Young LLP</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tysons, VA</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">November&nbsp;12, 2019</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2240001",CP="NEXTCURE, INC.",DN="4",CHK=439855,FOLIO='',FILE="DISK126:[19ZCO2.19ZCO70302]21003-2-KU_ZCO70302.CHC",USER="JTAYLORA",CD='Nov 13 01:13 2019' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>nxtc-20191112.xml
<DESCRIPTION>EX-101.INS
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Toppan Merrill -->
<!-- Generated by Fujitsu Interstage XWand B0189 -->
<xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nxtc="http://www.nextcure.com/20191112" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:schemaRef xlink:type="simple" xlink:href="nxtc-20191112.xsd" />
  <xbrli:context id="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2016-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-12-31_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-12-31</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-12-31_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-12-31</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-05_2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB2PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB2PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-05</xbrli:startDate>
      <xbrli:endDate>2018-11-05</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-05_2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB1PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-05</xbrli:startDate>
      <xbrli:endDate>2018-11-05</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-01_2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB2PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB2PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-01</xbrli:startDate>
      <xbrli:endDate>2018-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-01_2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB1PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-01</xbrli:startDate>
      <xbrli:endDate>2018-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series3PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series2PreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series2PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-05-03_2019-05-03_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-05-03</xbrli:startDate>
      <xbrli:endDate>2019-05-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-05-03_2019-05-03">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-05-03</xbrli:startDate>
      <xbrli:endDate>2019-05-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2016-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1AndB2PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB1AndB2PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-11-05</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB2PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB2PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-11-05</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB1PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-11-05</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-04-30_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-04-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-04-05_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-04-05</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-01-31_us-gaap-StatementClassOfStockAxis_nxtc-Series2PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series2PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2015-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series1PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series1PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-AwardTypeAxis_us-gaap-RestrictedStockMember_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-AwardTypeAxis_us-gaap-EmployeeStockOptionMember_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-AwardTypeAxis_us-gaap-RestrictedStockMember_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2016-01-01_2016-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2016-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2016-05-01_2016-05-31_us-gaap-AwardTypeAxis_us-gaap-RestrictedStockMember_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-05-01</xbrli:startDate>
      <xbrli:endDate>2016-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ResearchAndDevelopmentCollaborativeAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ComputerEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_nxtc-ResearchEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nxtc:ResearchEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ComputerEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_nxtc-ResearchEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nxtc:ResearchEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-EquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ComputerEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-05_2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-05</xbrli:startDate>
      <xbrli:endDate>2018-11-05</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-02_2018-11-02">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-02</xbrli:startDate>
      <xbrli:endDate>2018-11-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-01_2018-11-30_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-EliLillyAndCompanyMember_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nxtc:EliLillyAndCompanyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB3PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ResearchAndDevelopmentCollaborativeAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-01</xbrli:startDate>
      <xbrli:endDate>2018-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-01_2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-01</xbrli:startDate>
      <xbrli:endDate>2018-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-01_2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1AndB2PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB1AndB2PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-01</xbrli:startDate>
      <xbrli:endDate>2018-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-04-05_2018-04-05_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-04-05</xbrli:startDate>
      <xbrli:endDate>2018-04-05</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-04-01_2018-04-30_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-04-01</xbrli:startDate>
      <xbrli:endDate>2018-04-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-01-31_us-gaap-StatementClassOfStockAxis_nxtc-Series2PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series2PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2015-12-01_2015-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series1PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series1PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-12-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1AndB2PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB1AndB2PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series1PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series1PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-03-15_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-15</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_srt-RangeAxis_srt-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-ScientificFounderMember_us-gaap-TypeOfArrangementAxis_nxtc-ConsultingAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nxtc:ScientificFounderMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ConsultingAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-01-25_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-25</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2016-04-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-04-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-25_2019-01-25_srt-RangeAxis_srt-MaximumMember_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember_us-gaap-VariableRateAxis_us-gaap-PrimeRateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-25</xbrli:startDate>
      <xbrli:endDate>2019-01-25</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2016-04-01_2016-04-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-04-01</xbrli:startDate>
      <xbrli:endDate>2016-04-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ResearchAndDevelopmentCollaborativeAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2016-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-01-24_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-24</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2015-12-29_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-29</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2016-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel1Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel1Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-01-30_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series2PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series2PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:SeriesB3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember_srt-RangeAxis_srt-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-YaleUniversityMember_us-gaap-TypeOfArrangementAxis_nxtc-SponsoredResearchAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nxtc:YaleUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:SponsoredResearchAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-YaleUniversityMember_us-gaap-TypeOfArrangementAxis_nxtc-SponsoredResearchAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nxtc:YaleUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:SponsoredResearchAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2015-12-01_2015-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-ScientificFounderMember_us-gaap-TypeOfArrangementAxis_nxtc-ConsultingAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nxtc:ScientificFounderMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ConsultingAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-12-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2015-12-01_2015-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-YaleUniversityMember_us-gaap-TypeOfArrangementAxis_nxtc-YaleLicenseAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nxtc:YaleUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:YaleLicenseAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-12-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2015-12-01_2015-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-YaleUniversityMember_us-gaap-TypeOfArrangementAxis_nxtc-SponsoredResearchAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nxtc:YaleUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:SponsoredResearchAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-12-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-YaleUniversityMember_us-gaap-TypeOfArrangementAxis_nxtc-SponsoredResearchAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nxtc:YaleUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:SponsoredResearchAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_srt-CounterpartyNameAxis_nxtc-EliLillyAndCompanyMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nxtc:EliLillyAndCompanyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ResearchAndDevelopmentCollaborativeAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2017-01-01_2017-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-25_2019-01-25_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-25</xbrli:startDate>
      <xbrli:endDate>2019-01-25</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-01_2018-11-30_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-EliLillyAndCompanyMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">nxtc:EliLillyAndCompanyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ResearchAndDevelopmentCollaborativeAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-01</xbrli:startDate>
      <xbrli:endDate>2018-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-02_2018-11-02_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ResearchAndDevelopmentCollaborativeAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-02</xbrli:startDate>
      <xbrli:endDate>2018-11-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-11-02_srt-CounterpartyNameAxis_nxtc-EliLillyAndCompanyMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nxtc:EliLillyAndCompanyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ResearchAndDevelopmentCollaborativeAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-11-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-30_2019-01-30_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-30</xbrli:startDate>
      <xbrli:endDate>2019-01-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2017-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-03-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-03-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-06-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-03-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-07-01_2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-04-01_2019-06-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-04-01_2019-06-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-03-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-06-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-03-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-05-13_us-gaap-SubsidiarySaleOfStockAxis_us-gaap-IPOMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-05-13</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-12-31_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-12-31</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-07-01_2019-09-30_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ResearchAndDevelopmentCollaborativeAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-FurnitureAndFixturesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ComputerEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-PropertyPlantAndEquipmentByTypeAxis_nxtc-ResearchEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nxtc:ResearchEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-07-01_2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-07-01_2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-07-01_2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-07-01</xbrli:startDate>
      <xbrli:endDate>2018-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-04-01_2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-04-01</xbrli:startDate>
      <xbrli:endDate>2018-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-01-25">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-25</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-25_2019-01-25_srt-RangeAxis_srt-MaximumMember_us-gaap-VariableRateAxis_us-gaap-PrimeRateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-25</xbrli:startDate>
      <xbrli:endDate>2019-01-25</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-06-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-05-13">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-05-13</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-PlanNameAxis_nxtc-EmployeeStockPurchase2019PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:EmployeeStockPurchase2019PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-05-03_us-gaap-PlanNameAxis_nxtc-OmnibusIncentive2019PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:OmnibusIncentive2019PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-05-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-05-03_us-gaap-PlanNameAxis_nxtc-EmployeeStockPurchase2019PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:EmployeeStockPurchase2019PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-05-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-09-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel1Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel1Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2018-12-31_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USTreasurySecuritiesMember_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel2Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USGovernmentAgenciesDebtSecuritiesMember_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel2Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-CorporateDebtSecuritiesMember_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel2Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USTreasurySecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USTreasurySecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USGovernmentAgenciesDebtSecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USGovernmentAgenciesDebtSecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-CorporateDebtSecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-CorporateDebtSecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-USGovernmentAgenciesDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-USTreasurySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-CorporateDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-07-01_2019-09-30_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-09-30_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-07-01_2019-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-07-01_2019-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-07-01_2018-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-07-01</xbrli:startDate>
      <xbrli:endDate>2018-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-07-01_2018-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-07-01</xbrli:startDate>
      <xbrli:endDate>2018-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-09-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-04-01_2018-06-30_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series3PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-04-01</xbrli:startDate>
      <xbrli:endDate>2018-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-07-01_2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-07-01_2019-09-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-07-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-03-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-07-01_2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-07-01</xbrli:startDate>
      <xbrli:endDate>2018-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-07-01_2018-09-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-07-01</xbrli:startDate>
      <xbrli:endDate>2018-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-04-01_2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-04-01</xbrli:startDate>
      <xbrli:endDate>2018-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-04-01_2018-06-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-04-01</xbrli:startDate>
      <xbrli:endDate>2018-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-01-01_2018-03-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-04-01_2019-06-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-04-01_2018-06-30_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nxtc:Series3PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-04-01</xbrli:startDate>
      <xbrli:endDate>2018-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember_srt-RangeAxis_srt-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-05-03_2019-05-03_us-gaap-PlanNameAxis_nxtc-OmnibusIncentive2019PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:OmnibusIncentive2019PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-05-03</xbrli:startDate>
      <xbrli:endDate>2019-05-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-05-03_2019-05-03_us-gaap-PlanNameAxis_nxtc-EmployeeStockPurchase2019PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:EmployeeStockPurchase2019PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-05-03</xbrli:startDate>
      <xbrli:endDate>2019-05-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember_srt-RangeAxis_srt-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:A2015OmnibusIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nxtc:OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-09-30_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ResearchAndDevelopmentCollaborativeAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-05-13_2019-05-13_us-gaap-SubsidiarySaleOfStockAxis_us-gaap-IPOMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-05-13</xbrli:startDate>
      <xbrli:endDate>2019-05-13</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel2Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel1Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-09-30_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-25_2019-01-25">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-25</xbrli:startDate>
      <xbrli:endDate>2019-01-25</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2018-11-02_2018-11-02_srt-CounterpartyNameAxis_nxtc-EliLillyAndCompanyMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nxtc:EliLillyAndCompanyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nxtc:ResearchAndDevelopmentCollaborativeAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-11-02</xbrli:startDate>
      <xbrli:endDate>2018-11-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-08-02">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-08-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="I2019-01-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-08-02_2019-08-02">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-08-02</xbrli:startDate>
      <xbrli:endDate>2019-08-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-30_2019-01-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-30</xbrli:startDate>
      <xbrli:endDate>2019-01-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2016-02-09_2016-02-09">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-02-09</xbrli:startDate>
      <xbrli:endDate>2016-02-09</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="D2019-01-01_2019-09-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001661059</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="nxtc-segment">
    <xbrli:measure>nxtc:segment</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="iso4217-USD_xbrli-shares">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="utr-sqft">
    <xbrli:measure>utr:sqft</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="xbrli-shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="nxtc-Vote">
    <xbrli:measure>nxtc:Vote</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="xbrli-pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="nxtc-item">
    <xbrli:measure>nxtc:item</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="iso4217-USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-e2c1ffde-badb-45ba-a86c-fb7ab6d50587_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">91223000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesOutstanding id="Fact-095b89f4-c021-4703-aa6e-4fd16a74fbf2_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">56828851</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-7fab3f3c-6b34-48c4-856c-e7d98fd09dba_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">71000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesOutstanding id="Fact-0fac93f8-c354-4a0b-9362-2d929a8b4a0c_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">68181819</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-b2d90668-1fab-4edd-a7f4-e68eea16e4ec_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">40000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesOutstanding id="Fact-f63410d4-4300-408d-b1d5-ba9d1c8bf38a_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">40000000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-6118ff6e-a9d6-43c0-b3e5-b73b094d237a_20181231" decimals="-3" contextRef="I2016-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">15000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesOutstanding id="Fact-e97cabae-1e48-4e02-a37b-6606275fb76a_20181231" decimals="INF" contextRef="I2016-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">15000000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-018c93bf-825b-442b-900b-c80056c24a4e_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">5600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-2eab55b9-36e9-4053-bcf7-7458673d308f_20181231" decimals="INF" contextRef="D2018-12-31_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="xbrli-shares">56828851</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-fbb54b98-5c09-4c98-8c61-0314ac242466_20181231" decimals="INF" contextRef="D2018-12-31_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="xbrli-shares">68181819</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-0a0140d9-659d-405e-9744-78bf10cb5394_20181231" decimals="INF" contextRef="D2018-11-05_2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB2PreferredStockMember" unitRef="xbrli-shares">34276734</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-1e9374d3-0572-405c-b6ee-18a3fffbfd36_20181231" decimals="INF" contextRef="D2018-11-05_2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1PreferredStockMember" unitRef="xbrli-shares">15052117</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-ec6fbea5-7af8-407e-8ed6-273e1e176b6e_20181231" decimals="INF" contextRef="D2018-11-01_2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB2PreferredStockMember" unitRef="xbrli-shares">34276734</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-1f04529a-1de6-4f6c-b3e1-ffd59f48ee0c_20181231" decimals="INF" contextRef="D2018-11-01_2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1PreferredStockMember" unitRef="xbrli-shares">15052117</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-cf133d8e-14da-40e7-a918-0dcec4ae3b87_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">56828851</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-997a4f3f-2d3d-4be4-a539-e15e941a0266_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">91223000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-61bb762d-ed35-403a-8273-d1cd76d72a76_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">28181819</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-b1964cda-49cf-4955-ac4e-65e10768995a_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">31000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-e5c2f205-f5ef-408a-8909-fa83010da6ed_20181231" decimals="INF" contextRef="D2017-01-01_2017-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series2PreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">25000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-00881fad-d44f-46e6-acfb-501d12b443de_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series2PreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">25000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 id="Fact-0cb35262-1d74-444e-b72c-04b4b6b16948_20181231" decimals="4" contextRef="D2019-05-03_2019-05-03_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember" unitRef="xbrli-pure">0.1245</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
  <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 id="Fact-ea278321-67bd-4a78-98f4-ac5459de10ca_20181231" decimals="4" contextRef="D2019-05-03_2019-05-03" unitRef="xbrli-pure">0.1245</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
  <us-gaap:StockholdersEquity id="Fact-2ea0eef5-3424-4d15-b38e-0ba52c7ae4d0_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-47297000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-8ee2f57c-91da-434d-b44a-2b780b22b14d_20190630" decimals="-3" contextRef="I2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">352000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-a608deee-f32f-40d8-aca2-5553c1122759_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-24498000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-57c127e5-fe8b-426e-8c2e-6d784eb4e525_20190630" decimals="-3" contextRef="I2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">84000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-2a5cdd88-2e91-4318-806e-f91fe162368c_20181231" decimals="-3" contextRef="I2016-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-9029000</us-gaap:StockholdersEquity>
  <us-gaap:SharePrice id="Fact-09c513fc-b348-49df-892c-ded677a1ecab_20181231" decimals="INF" contextRef="I2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1AndB2PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">1.59</us-gaap:SharePrice>
  <us-gaap:SharePrice id="Fact-13ac8622-87bc-49e5-b8d8-c3e00780d79f_20181231" decimals="INF" contextRef="I2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">2.00</us-gaap:SharePrice>
  <us-gaap:SharePrice id="Fact-a1bc7b83-a355-4df8-8056-c6a0b3ca17a8_20181231" decimals="INF" contextRef="I2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB2PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">1.59</us-gaap:SharePrice>
  <us-gaap:SharePrice id="Fact-55a8ae6e-ada9-49c5-9177-21f799bac975_20181231" decimals="INF" contextRef="I2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">1.59</us-gaap:SharePrice>
  <us-gaap:SharePrice id="Fact-43c297b0-e5bb-4944-b975-d289b33f145f_20181231" decimals="INF" contextRef="I2018-04-30_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">1.10</us-gaap:SharePrice>
  <us-gaap:SharePrice id="Fact-3367a8fe-c919-4e15-af69-36cdcd05dff0_20181231" decimals="INF" contextRef="I2018-04-05_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">1.10</us-gaap:SharePrice>
  <us-gaap:SharePrice id="Fact-f39361c1-fe9a-49ed-ae21-5a819315c025_20181231" decimals="INF" contextRef="I2017-01-31_us-gaap-StatementClassOfStockAxis_nxtc-Series2PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">1.00</us-gaap:SharePrice>
  <us-gaap:SharePrice id="Fact-dcdb538e-9662-4c35-ae9c-27fa16e85a55_20181231" decimals="INF" contextRef="I2015-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series1PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">1.00</us-gaap:SharePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod id="Fact-eff863cf-a439-461a-b635-9314453d65bc_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31_us-gaap-AwardTypeAxis_us-gaap-RestrictedStockMember_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">62237</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 id="Fact-a9979895-8b51-4139-b422-2fa8349e897c_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31_us-gaap-AwardTypeAxis_us-gaap-EmployeeStockOptionMember_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">157000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod id="Fact-46eb42c3-8f71-4ec1-b6a6-f6ab0dc8c661_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31_us-gaap-AwardTypeAxis_us-gaap-EmployeeStockOptionMember_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">2056891</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 id="Fact-6944cbf3-1c7f-4f56-88db-fb6004314635_20181231" decimals="0" contextRef="D2017-01-01_2017-12-31_us-gaap-AwardTypeAxis_us-gaap-RestrictedStockMember_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">29000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Fact-14b232ce-ef46-4371-bb48-a257d9a88efa_20181231" contextRef="D2016-01-01_2016-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P8Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="Fact-53f6c61b-2e03-4d47-a7cc-ec4a31d5e9b8_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">137000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Fact-b29b8fc0-daec-4a1f-a70e-ca850fa7e96c_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">506586</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Fact-aba48cfa-dd6a-4e60-b2e9-3b89b46930d8_20181231" decimals="2" contextRef="I2017-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">0.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="Fact-16cadb28-b56d-4ae2-8c28-0a823ee55de2_20181231" decimals="-3" contextRef="I2016-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">137000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Fact-5f63841a-52b1-4155-b4a5-8c8b697e04c8_20181231" decimals="INF" contextRef="I2016-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">189189</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Fact-f024995b-58a3-4a6f-9697-3c5661cf3577_20181231" decimals="2" contextRef="I2016-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">0.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="Fact-ec99215b-19aa-4a63-ae30-a6d301c213bb_20181231" decimals="0" contextRef="D2017-01-01_2017-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="Fact-7b01ce58-26c4-4809-8f0d-38b2c54855e3_20181231" decimals="INF" contextRef="D2017-01-01_2017-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">317397</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Fact-b6e59390-925b-400d-b4f1-8f9f0b493e95_20181231" decimals="2" contextRef="D2017-01-01_2017-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">0.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Fact-0a62693b-98d1-4ebe-82ae-061056e72de9_20181231" contextRef="D2017-01-01_2017-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P9Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Fact-dc269d2a-321c-48ae-94c7-2fd6d430ead5_20181231" decimals="2" contextRef="D2017-01-01_2017-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">1.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="Fact-7647f81c-378e-4ab2-b8da-c7ebc8d2a061_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">2824317</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="Fact-b3d5a08f-a875-4da6-ae72-4221f764f214_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">699590</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue id="Fact-fb4d7705-2297-4bcb-8e6b-32d1cbc4a34c_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">1634000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber id="Fact-0427ca84-a24a-4b02-893f-5cc5c21a831c_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">242079</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice id="Fact-c6481c5d-1d12-4bb2-ad36-921706a4f41c_20181231" decimals="2" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">0.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue id="Fact-144f568b-312c-48db-aef1-e7986ead8aa5_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">5946000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber id="Fact-9931f79c-b746-4191-8b5d-ab61f4a85333_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">2056891</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice id="Fact-007b8d3e-302c-4cda-95c4-2057ffc9c932_20181231" decimals="2" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">4.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="Fact-31973d2d-fa94-425a-bb8d-4a4f4ed3ab12_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">5946000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Fact-19e8ef99-5170-4f88-9836-29c9f95427c2_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">2056891</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Fact-beccdefe-5415-4145-b4d8-13ad3c09dfa0_20181231" decimals="2" contextRef="I2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">4.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 id="Fact-74d0bf54-6e58-4940-94ca-2cb95ded92c1_20181231" contextRef="D2016-05-01_2016-05-31_us-gaap-AwardTypeAxis_us-gaap-RestrictedStockMember_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod id="Fact-d2259cce-7578-470c-bd85-a77b387aff34_20181231" decimals="INF" contextRef="D2016-05-01_2016-05-31_us-gaap-AwardTypeAxis_us-gaap-RestrictedStockMember_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">62237</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact-f266b203-3924-4b00-97f0-6408c2a71f5e_20181231" decimals="-5" contextRef="D2018-01-01_2018-12-31_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-8d503c11-c02c-4951-8543-d2c683e3acd0_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-LeaseholdImprovementsMember" unitRef="iso4217-USD">4825000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-0787d117-aef6-445e-b005-4f8ca217ab35_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-FurnitureAndFixturesMember" unitRef="iso4217-USD">70000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-9d5b33ef-eeb0-46f4-95fe-e0533d0b56ed_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ConstructionInProgressMember" unitRef="iso4217-USD">1027000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-d9d1f00d-c379-46b4-b97c-3f0478a12d9a_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ComputerEquipmentMember" unitRef="iso4217-USD">167000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-a37e86b8-8f64-4872-b197-6b4ca14b5840_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_nxtc-ResearchEquipmentMember" unitRef="iso4217-USD">7787000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-543fabe9-3af1-4074-9077-3ee042c61d47_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-LeaseholdImprovementsMember" unitRef="iso4217-USD">564000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-d58de68a-1cd8-433f-ab0d-4656ef1f321b_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-FurnitureAndFixturesMember" unitRef="iso4217-USD">33000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-827796be-22ef-40fb-ad1f-f16286b2e0c9_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ConstructionInProgressMember" unitRef="iso4217-USD">3892000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-f74fd4bd-7b11-4ece-8411-88d5bbfb8fa6_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ComputerEquipmentMember" unitRef="iso4217-USD">111000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-cf993d0e-7c5f-4bcf-89c8-64a5eabad3b0_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_nxtc-ResearchEquipmentMember" unitRef="iso4217-USD">6213000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives id="Fact-f6552cf3-8625-4a84-bfe0-45e864f6133c_20181231" contextRef="D2018-01-01_2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-FurnitureAndFixturesMember">P7Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
  <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives id="Fact-6c7d3b19-d2ad-49f2-9b26-4692f21c0fbf_20181231" contextRef="D2018-01-01_2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-EquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
  <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives id="Fact-42561246-5ecb-4a41-b13f-d7a3f56bccff_20181231" contextRef="D2018-01-01_2018-12-31_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ComputerEquipmentMember">P3Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-57dcbae7-0b88-450d-b064-c43b96aeed99_20181231" decimals="-5" contextRef="D2018-11-05_2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember" unitRef="iso4217-USD">93400000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-048afa2b-dabd-46e4-adb4-6a80dcdaf37a_20181231" decimals="INF" contextRef="D2018-11-05_2018-11-05_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember" unitRef="xbrli-shares">7500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-d1f1cd91-f752-4015-bc68-302a9cbdd050_20181231" decimals="-5" contextRef="D2018-11-02_2018-11-02" unitRef="iso4217-USD">15000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-0fe1c3f3-a527-4957-bd68-e062a1c75d2d_20181231" decimals="-5" contextRef="D2018-11-01_2018-11-30_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-EliLillyAndCompanyMember_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">15000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-cbae1b98-484f-4898-9726-21713b191fbf_20181231" decimals="-5" contextRef="D2018-11-01_2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember" unitRef="iso4217-USD">15000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-64b58d51-bb57-4bfd-925e-c4ac23274f87_20181231" decimals="INF" contextRef="D2018-11-01_2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember" unitRef="xbrli-shares">7500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-9acb06e7-12e7-4d51-a17f-d9917febe5ea_20181231" decimals="-5" contextRef="D2018-11-01_2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1AndB2PreferredStockMember" unitRef="iso4217-USD">78400000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-bd364761-3408-4f51-8175-28bbed056abd_20181231" decimals="-5" contextRef="D2018-04-05_2018-04-05_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember" unitRef="iso4217-USD">31000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-4cd5d0b9-8e28-48ff-83b7-3664bbb4bb86_20181231" decimals="INF" contextRef="D2018-04-05_2018-04-05_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember" unitRef="xbrli-shares">28181819</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-6799371f-6b55-46c5-9bdd-d0ca5d86ac9a_20181231" decimals="-5" contextRef="D2018-04-01_2018-04-30_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember" unitRef="iso4217-USD">31000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-216a0a7f-eb48-43bd-866e-020e6c127446_20181231" decimals="INF" contextRef="D2018-04-01_2018-04-30_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember" unitRef="xbrli-shares">28181819</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-4f8baf72-15e3-4c9b-9c55-2cb5d8f652bd_20181231" decimals="-5" contextRef="D2017-01-01_2017-01-31_us-gaap-StatementClassOfStockAxis_nxtc-Series2PreferredStockMember" unitRef="iso4217-USD">25000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-2f45783c-e28b-47bd-af8d-75ff594ae17f_20181231" decimals="INF" contextRef="D2017-01-01_2017-01-31_us-gaap-StatementClassOfStockAxis_nxtc-Series2PreferredStockMember" unitRef="xbrli-shares">25000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-e1792ba7-0e96-43f6-b44b-c7b5353f7a1e_20181231" decimals="-5" contextRef="D2015-12-01_2015-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series1PreferredStockMember" unitRef="iso4217-USD">15000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-275b2ee8-f2bb-49ec-9421-393d98a1f51e_20181231" decimals="INF" contextRef="D2015-12-01_2015-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series1PreferredStockMember" unitRef="xbrli-shares">15000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Fact-6d212943-a63d-47a5-86d2-3b7c837e787d_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Fact-fe61c0a5-95f3-4d60-97e0-1c826c0f70a5_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="xbrli-shares">56828852</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="Fact-35afff08-e7d8-4a63-8a47-b054156e3e46_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="xbrli-shares">56828851</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="Fact-c63b4907-1ae1-4d73-bd2a-ddfb52d52ec9_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="xbrli-shares">56828851</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-ea2fdec1-7caa-47ee-9572-492364594f8c_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="iso4217-USD">91223000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Fact-9a80ce57-dbdf-49ce-ba6d-a158ea731a8c_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Fact-210c8186-d032-428b-bb92-ed98f555407e_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="xbrli-shares">68181819</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="Fact-209bb002-d705-4808-8615-198635f673e8_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="xbrli-shares">68181819</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="Fact-2c5bae1a-1ec7-4b1d-874a-ec5b75b80356_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="xbrli-shares">68181819</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-6b2efeae-5f71-4945-9172-3a6947fd1f2b_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="iso4217-USD">71000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Fact-ac32f80e-71e6-41bc-9c47-d6c45be88300_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Fact-1c5b610f-d790-4a76-ae37-1a06ae44e85f_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="Fact-0ce8cf4a-5bc1-4b5f-9321-5adaaeac82e4_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="Fact-b7af4297-507a-4739-b336-b987dd63f235_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Fact-ea4b20a5-fac1-4784-a835-2768dd5b5e80_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Fact-35106826-dbf7-4688-9e8b-83f6f43eccc9_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="xbrli-shares">64545455</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="Fact-a0769e96-f236-4fda-b9b3-c9821270a55b_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="xbrli-shares">40000000</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="Fact-be3dc613-660e-465a-a4a3-d43f281a72e5_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="xbrli-shares">40000000</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-f079f360-79a1-434c-b628-6eb048591785_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="iso4217-USD">40000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:PreferredStockLiquidationPreference id="Fact-e214de77-fafd-4ec0-8639-297ed8982b89_20181231" decimals="2" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">16.07</us-gaap:PreferredStockLiquidationPreference>
  <us-gaap:PreferredStockLiquidationPreference id="Fact-b20aea84-0dc3-4b97-8340-c920e958d4cb_20181231" decimals="2" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB1AndB2PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">12.77</us-gaap:PreferredStockLiquidationPreference>
  <us-gaap:PreferredStockLiquidationPreference id="Fact-5e35c9a0-befb-4012-97a0-d2d032fb680a_20181231" decimals="2" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">8.84</us-gaap:PreferredStockLiquidationPreference>
  <us-gaap:PreferredStockLiquidationPreference id="Fact-4ab7eff1-ca9d-4449-a937-32cc65f4fa52_20181231" decimals="2" contextRef="I2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series1PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">8.03</us-gaap:PreferredStockLiquidationPreference>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="Fact-3e1786cc-f403-4461-8522-db8c516153b3_20181231" decimals="-5" contextRef="I2019-03-15_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember" unitRef="iso4217-USD">3000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:NetIncomeLoss id="Fact-a03a47c1-0e24-4ac6-8688-61c95291455d_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-22799000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Fact-78d29731-0d3b-4da2-b194-7d2d61aa4b1f_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-15469000</us-gaap:NetIncomeLoss>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Fact-94f0e6bb-335d-4f7b-98a7-6640d642c0ef_20181231" decimals="2" contextRef="D2017-01-01_2017-12-31_srt-RangeAxis_srt-MaximumMember" unitRef="xbrli-pure">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent id="Fact-24c1e9bc-3752-42b2-8594-9cfd21b2943e_20181231" decimals="0" contextRef="I2018-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-ScientificFounderMember_us-gaap-TypeOfArrangementAxis_nxtc-ConsultingAgreementMember" unitRef="iso4217-USD">120000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
  <us-gaap:DebtInstrumentFaceAmount id="Fact-1489fb67-0484-4f03-a4b4-5b09884eea29_20181231" decimals="-5" contextRef="I2019-01-25_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember" unitRef="iso4217-USD">5000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentFaceAmount id="Fact-cc6aeb36-1028-4532-8747-abb1ac133cf4_20181231" decimals="-5" contextRef="I2016-04-30" unitRef="iso4217-USD">1000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Fact-98434989-347c-472e-a9eb-f498f9a5272e_20181231" decimals="2" contextRef="D2019-01-25_2019-01-25_srt-RangeAxis_srt-MaximumMember_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember_us-gaap-VariableRateAxis_us-gaap-PrimeRateMember" unitRef="xbrli-pure">-0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Fact-27cd4614-c9c1-44f0-afd5-70eaa6925fb2_20181231" decimals="2" contextRef="D2016-04-01_2016-04-30" unitRef="xbrli-pure">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:ContractWithCustomerLiability id="Fact-5cf62baf-8f0d-4669-8bdb-fc4d497a828d_20181231" decimals="-5" contextRef="I2018-12-31_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">26700000</us-gaap:ContractWithCustomerLiability>
  <us-gaap:CommonStockSharesOutstanding id="Fact-416d4427-f704-4c92-a075-c041e6c78a6d_20181231" decimals="INF" contextRef="I2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">1374812</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity id="Fact-0243e5f9-568f-44a8-99ff-af124e50a245_20190630" decimals="-3" contextRef="I2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">1000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding id="Fact-41b660d9-4286-456c-97a7-181449fd0e8a_20181231" decimals="INF" contextRef="I2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">1369212</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity id="Fact-c1b8bceb-ccaf-4076-994b-73b369159855_20190630" decimals="-3" contextRef="I2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">1000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding id="Fact-eca5da9b-dc23-43fa-8c0a-dabcf386c88f_20181231" decimals="INF" contextRef="I2016-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">1369212</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity id="Fact-a4a0175d-0f96-4c92-a67c-ef0b97b6bd3a_20181231" decimals="-3" contextRef="I2016-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">11000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="Fact-c68cb2be-9df3-477c-8c2e-fe3364f5cf78_20181231" decimals="INF" contextRef="I2017-01-24_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">373422</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="Fact-81b32c6a-c701-4607-8676-33a61ee3eee2_20181231" decimals="INF" contextRef="I2015-12-29_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">311185</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Fact-8a9de5df-60ca-4fab-8ee4-513543c502f0_20181231" decimals="-3" contextRef="I2016-12-31" unitRef="iso4217-USD">5593000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:StockholdersEquity id="Fact-6fb62600-815a-41bf-abca-8552e3394ee0_20181231" decimals="-3" contextRef="I2016-12-31" unitRef="iso4217-USD">-9018000</us-gaap:StockholdersEquity>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-59fbafac-c9cc-4ce3-bfac-96d2b37638f6_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel1Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">5000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-686bc41c-f575-4170-bc62-8e8a1cc21e38_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">5000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-adf98218-ec5b-4ece-95f3-d27381de466d_20181231" decimals="-3" contextRef="I2018-12-31_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember" unitRef="iso4217-USD">5000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-f906bb63-8266-41ee-9c1d-27ca7fb17d8a_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel1Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">1000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-5334b138-b265-40f2-94fc-927a959cc57b_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">1000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-f3a0ad1f-02f8-4edb-9393-910d02f9d52a_20181231" decimals="-3" contextRef="I2017-12-31_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember" unitRef="iso4217-USD">1000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:AreaOfRealEstateProperty id="Fact-3a75e186-e43f-4a01-ba4b-4089794496e2_20181231" decimals="INF" contextRef="I2019-01-30_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember" unitRef="utr-sqft">14075</us-gaap:AreaOfRealEstateProperty>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact-3a86dfd3-a00d-4362-a923-f30497cb3f44_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">15560569</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact-c3f2aed9-59b0-4cf2-8382-091b0f6cd0cf_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-EmployeeStockOptionMember" unitRef="xbrli-shares">242079</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact-dccda494-3c0f-4109-a5cd-ffeea7bb18ad_20181231" decimals="0" contextRef="D2017-01-01_2017-12-31_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">4978957</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact-57661b9e-fd61-41e4-83f7-87c7897df31c_20181231" decimals="0" contextRef="D2017-01-01_2017-12-31_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-EmployeeStockOptionMember" unitRef="xbrli-shares">64783</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-781f9b68-5a6d-4a2c-ab96-092b4fd8332a_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember" unitRef="iso4217-USD">85000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-d59bb1d1-5e7a-4d20-ba23-53a09bb87557_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember" unitRef="iso4217-USD">178000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-248bc749-1580-41d9-871b-41601ae7fec1_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember" unitRef="iso4217-USD">35000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-af7e46b6-a7eb-4630-b615-e8c991f1b37c_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember" unitRef="iso4217-USD">40000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="Fact-29b8497f-3fa6-4252-a58b-a98f1a413d75_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember" unitRef="iso4217-USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="Fact-9a8c4a82-289c-4e4b-a0ea-c6dd535dd137_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31_us-gaap-StatementClassOfStockAxis_nxtc-Series2PreferredStockMember" unitRef="iso4217-USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-ca20c715-d49f-4159-87a7-4f1b66ccc11b_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">263000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-59828fcb-847f-4f31-aaa5-993c6cfc35f9_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">4000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-5201ba06-4b09-48f4-abfa-98344c9bfbe1_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">75000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdditionalPaidInCapitalPreferredStock id="Fact-0f5e570f-bc91-4c6a-a4f6-80ab6d68ccf5_20181231" decimals="-5" contextRef="I2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember" unitRef="iso4217-USD">1700000</us-gaap:AdditionalPaidInCapitalPreferredStock>
  <us-gaap:PreferredStockValue id="Fact-708d1d9f-ae5f-40a9-9f31-bbe40d34f3de_20181231" decimals="-5" contextRef="I2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember" unitRef="iso4217-USD">13300000</us-gaap:PreferredStockValue>
  <us-gaap:SharePrice id="Fact-47f88f07-2578-4fc0-b907-d7e990095cf1_20181231" decimals="INF" contextRef="I2018-11-30_us-gaap-StatementClassOfStockAxis_nxtc-SeriesB3PreferredStockMember" unitRef="iso4217-USD_xbrli-shares">2.00</us-gaap:SharePrice>
  <nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward id="Fact-0c06db3a-1c36-403c-86f7-5f1731681366_20181231" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember_srt-RangeAxis_srt-MaximumMember">P10Y</nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward>
  <nxtc:RelatedPartyTransactionPaymentsMade id="Fact-02d712e9-4c2e-4d84-8336-cab59c2e5b07_20181231" decimals="-5" contextRef="D2018-01-01_2018-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-YaleUniversityMember_us-gaap-TypeOfArrangementAxis_nxtc-SponsoredResearchAgreementMember" unitRef="iso4217-USD">2500000</nxtc:RelatedPartyTransactionPaymentsMade>
  <nxtc:RelatedPartyTransactionPaymentsMade id="Fact-0e7b5b38-757f-4ccd-a6a0-0c73e3f501a9_20181231" decimals="-5" contextRef="D2017-01-01_2017-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-YaleUniversityMember_us-gaap-TypeOfArrangementAxis_nxtc-SponsoredResearchAgreementMember" unitRef="iso4217-USD">2100000</nxtc:RelatedPartyTransactionPaymentsMade>
  <nxtc:RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty id="Fact-249f425e-c110-4d14-b097-478093307fad_20181231" decimals="0" contextRef="D2015-12-01_2015-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-ScientificFounderMember_us-gaap-TypeOfArrangementAxis_nxtc-ConsultingAgreementMember" unitRef="iso4217-USD">5000</nxtc:RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty>
  <nxtc:RelatedPartyTransactionMilestonePaymentsPerProduct id="Fact-5fdf782c-764c-4f4c-af1c-a051c0762589_20181231" decimals="-5" contextRef="D2015-12-01_2015-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-YaleUniversityMember_us-gaap-TypeOfArrangementAxis_nxtc-YaleLicenseAgreementMember" unitRef="iso4217-USD">3000000</nxtc:RelatedPartyTransactionMilestonePaymentsPerProduct>
  <nxtc:RelatedPartyTransactionAmountProvidedToFundResearchProgram id="Fact-1f5c7ac2-21a4-4894-b46c-d0faa1385495_20181231" decimals="-5" contextRef="D2015-12-01_2015-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-YaleUniversityMember_us-gaap-TypeOfArrangementAxis_nxtc-SponsoredResearchAgreementMember" unitRef="iso4217-USD">12400000</nxtc:RelatedPartyTransactionAmountProvidedToFundResearchProgram>
  <nxtc:RelatedPartyTransactionAggregatePaymentsMade id="Fact-2caf0d91-036b-4fc7-a27c-d12e8cb5af25_20181231" decimals="-5" contextRef="I2018-12-31_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-YaleUniversityMember_us-gaap-TypeOfArrangementAxis_nxtc-SponsoredResearchAgreementMember" unitRef="iso4217-USD">7400000</nxtc:RelatedPartyTransactionAggregatePaymentsMade>
  <nxtc:PremiumFromIssuanceOfPreferredStock id="Fact-3ea69434-9422-42c1-b7cd-e5e692f40513_20181231" decimals="-5" contextRef="D2018-01-01_2018-12-31_srt-CounterpartyNameAxis_nxtc-EliLillyAndCompanyMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">1700000</nxtc:PremiumFromIssuanceOfPreferredStock>
  <nxtc:NumberOfDirectorsStockHoldersAreEntitledToElect id="Fact-74d82bd3-629c-45f8-b64a-fc3679004dc4_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="nxtc-item">2</nxtc:NumberOfDirectorsStockHoldersAreEntitledToElect>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="Fact-e7b0d2ea-859a-4daa-a6df-8fdab71609c2_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="iso4217-USD">485000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <nxtc:NumberOfDirectorsStockHoldersAreEntitledToElect id="Fact-d8e169a1-fc8f-418e-8ef4-4812f7fc8eae_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="nxtc-item">5</nxtc:NumberOfDirectorsStockHoldersAreEntitledToElect>
  <nxtc:MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare id="Fact-c4d8e7c8-030e-4f0b-b0d0-5db52618f0a9_20181231" decimals="2" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-pure">1.00</nxtc:MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare>
  <nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue id="Fact-1e3bc6aa-dd46-4d31-b0ff-14d7e49eaa32_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">2684000</nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue>
  <nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm id="Fact-ad83b76e-0aef-4de1-b0b3-af0067f0f60e_20181231" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P9Y10M24D</nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 id="Fact-2469282a-8c13-46ea-91ee-c8385a4d537c_20181231" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="Fact-608f669c-15aa-4b06-8074-d4e9ff4f5783_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">38000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="Fact-980777b2-b860-4b74-9679-05cf03d78276_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">14232</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="Fact-80f31770-328e-40f6-817c-e7d2f9e80002_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">1570136</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Fact-b918f367-fd02-4259-ae3a-91ff0047c855_20181231" decimals="2" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">3.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Fact-b3b69762-ab7e-4de5-9dbc-567c50415069_20181231" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P9Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 id="Fact-eecb40bf-cd68-4b34-80d9-6cba1d981657_20181231" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P7Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 id="Fact-19fb9131-ce02-45b9-8b7f-565c54d5b813_20181231" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P9Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="Fact-1d3b2a3d-78a4-488e-8ff6-beb52370ef4c_20181231" decimals="2" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">0.84</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice id="Fact-b5414b4d-922f-4a6e-9a5f-7b660a2f3e6b_20181231" decimals="2" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">1.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Fact-b4349a44-a092-4e06-827e-f05698980dbe_20181231" decimals="2" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">5.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Fact-504fa9e6-57e7-46aa-9c15-72a24cd4c3f7_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">5599</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <nxtc:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent id="Fact-4880c7ad-9f20-47ed-b0ae-44d65a696f91_20181231" decimals="1" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-pure">-15.6</nxtc:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-66c3e981-3ea6-41fc-be17-eebc911e1b95_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">75000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-87a929e0-4bde-48c3-856f-26ca4a80e7f8_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">75000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact-2d6bdab1-e7b7-4ae8-8156-8f8de1499de8_20181231" decimals="0" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-shares">5043746</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid id="Fact-5b6354f4-a865-409a-b63c-29b5caf77d32_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">515000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect id="Fact-c246deb7-7084-41fa-af14-8513da063443_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">3694000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Fact-1bc7e2c2-9de0-49eb-ae0d-3097826a43fd_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">-15469000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="Fact-a7d75a2c-1e7a-4533-a4e4-7cdf81cb69e9_20181231" decimals="3" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-pure">0.035</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <us-gaap:DepreciationDepletionAndAmortization id="Fact-70990c57-6705-4fe4-b520-f00e077dbadf_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">582000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="Fact-d58298d7-de18-4b5c-90a9-08afac229636_20181231" decimals="0" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">582000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact-7332e9f6-abd1-47f2-94b5-90d94012055e_20181231" decimals="2" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD_xbrli-shares">-11.30</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact-905a4801-7a81-48d8-9c9d-68bcc9f12941_20181231" decimals="2" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD_xbrli-shares">-11.30</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Fact-59f91702-3a27-41b1-81cd-5edd93709b5b_20181231" decimals="3" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-pure">0.340</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance id="Fact-06c8b001-f6df-43ac-b5f6-acd9f74bfba5_20181231" decimals="3" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-pure">-0.255</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense id="Fact-062911c2-ad87-4939-88ca-8e05e6206467_20181231" decimals="3" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-pure">-0.053</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments id="Fact-6ed8926f-40d0-4700-9341-2e1ff2412e0b_20181231" decimals="3" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-pure">-0.029</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes id="Fact-1ae41c54-8c1d-48d9-9370-d229c98a86a5_20181231" decimals="3" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-pure">0.041</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes id="Fact-7d7643b9-046b-421f-a84e-07ec0651cce8_20181231" decimals="3" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-pure">0.065</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch id="Fact-34bc52e7-9a41-48fb-a63d-b293ea7485a7_20181231" decimals="3" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-pure">0.047</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
  <us-gaap:GeneralAndAdministrativeExpense id="Fact-bd294010-e7e5-4ab3-87fc-44c2cdc240d1_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">2595000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf id="Fact-8d38c300-90ff-4ba5-8128-699de180ed15_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="Fact-b3cab6b0-29d2-47ba-ae65-120314bfc467_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">767000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="Fact-0a762d66-a717-4a9e-9bfb-03747bf84312_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">1557000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="Fact-ba8b876a-bdc4-465d-81eb-8705f971d2f4_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">42000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets id="Fact-0bbb107a-39e4-41d5-8626-df91ee0f498e_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">-21000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Fact-6d47dfe8-92ba-4531-98e1-5822969d32a1_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">89000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:InterestExpense id="Fact-71abfe11-ffb6-41e9-97f4-017d93ef71f1_20181231" decimals="0" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">30000</us-gaap:InterestExpense>
  <us-gaap:InterestPaidNet id="Fact-ac65551c-69e2-4b97-b56c-24c5cad4c020_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">30000</us-gaap:InterestPaidNet>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="Fact-680bfc51-522c-48d7-8484-b418ded35e33_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">24860000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="Fact-110d5cc5-3413-4855-9acc-82dec79244f8_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">-8652000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Fact-9ebd4f1d-7c9a-43b9-8473-8b82e6b7dc74_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">-12514000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLoss id="Fact-96a306e2-199d-4282-8434-fbc507efc6ac_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">-15469000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Fact-10aa7c15-1963-4be7-b1f5-9d5ccd3a5baf_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">-15469000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Fact-befe8122-a304-4572-b4aa-bd3fff87ae60_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">-15469000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:OperatingExpenses id="Fact-3bafb70f-2159-4f26-8798-f45dee477c6f_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">15549000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="Fact-53947d60-62b5-4418-9203-b9bfae1ba7dd_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">-15549000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingLeasesRentExpenseNet id="Fact-14a6916b-126d-4fa7-b575-fc513c679ab5_20181231" decimals="0" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">376000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OtherNonoperatingIncomeExpense id="Fact-3460a933-f5b6-45f7-89e3-d6f053e666fd_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">80000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Fact-ae2bf10f-bf0a-49bc-9ed6-bbb90d44c8d0_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">8652000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-74223ba6-8bac-456e-9919-6e7b746120a3_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">25000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProfitLoss id="Fact-ff458fa4-fdec-4b8a-bda8-c3ad70e7f6b2_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">-15469000</us-gaap:ProfitLoss>
  <us-gaap:RepaymentsOfDebt id="Fact-253ed86a-4618-41b6-96d1-1346a98d1a51_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">140000</us-gaap:RepaymentsOfDebt>
  <us-gaap:ResearchAndDevelopmentExpense id="Fact-03b477b5-6880-4174-9186-5194bd3f727a_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">12954000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ShareBasedCompensation id="Fact-9106ed72-08f9-42ad-a976-ef3ca0a44a63_20181231" decimals="-3" contextRef="D2017-01-01_2017-12-31" unitRef="iso4217-USD">75000</us-gaap:ShareBasedCompensation>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact-8498187c-bfef-4d0d-85ab-519c9ac08173_20181231" decimals="0" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-shares">1369212</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact-2ec4ac6e-04c9-46bd-a729-00c19eb1f423_20181231" decimals="0" contextRef="D2017-01-01_2017-12-31" unitRef="xbrli-shares">1369212</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <nxtc:DebtInstrumentMonthlyPaymentsNumber id="Fact-05667742-43b2-47d3-bada-3b110477daeb_20181231" decimals="INF" contextRef="D2019-01-25_2019-01-25_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember" unitRef="nxtc-item">36</nxtc:DebtInstrumentMonthlyPaymentsNumber>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="Fact-d8f4091d-2696-4e9a-af0a-b1b0e197265f_20181231" decimals="4" contextRef="D2019-01-25_2019-01-25_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember" unitRef="xbrli-pure">0.0425</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <nxtc:RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment id="Fact-5cff1823-38ba-4991-9d51-fa55bbb66360_20190630" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">1725000</nxtc:RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment>
  <nxtc:RelatedPartyTransactionsDeferredRevenueUpFrontPayment id="Fact-fcc1e863-e5be-4b16-9871-e657bca68c69_20190630" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">25000000</nxtc:RelatedPartyTransactionsDeferredRevenueUpFrontPayment>
  <nxtc:CommonStockTextBlock id="Fact-d0669fb7-dcad-43c1-9839-baff34ba070d_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;10. Common Stock&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;As of December&amp;nbsp;31, 2018, the Company&amp;#x2019;s Certificate of Incorporation, as amended and restated, authorized the Company to issue 158,745,671 shares of $0.001 par value common stock, of which 1,374,812 were issued and outstanding.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&amp;#x2019;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the board of directors, if any, subject to the preferential dividend rights of the preferred stock. When dividends are declared on shares of common stock, the Company must declare at the same time a dividend payable to the holders of preferred stock equivalent to the dividend amount they would receive if each share of preferred stock was converted into common stock. The Company may not pay dividends to common stockholders until all dividends accrued or declared but unpaid on the preferred stock have been paid in full. No dividends have been declared or paid by the Company through December&amp;nbsp;31, 2018.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In the event of any liquidation or dissolution of the Company, the holders of common stock are entitled to the remaining assets of the Company legally available for distribution after the payment of the full liquidation preference for the preferred stock.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</nxtc:CommonStockTextBlock>
  <nxtc:DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock id="Fact-0b9ef959-9d6d-449d-9bd6-0903dd9b8121_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Recently Issued Accounting Pronouncements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In February&amp;nbsp;2016, the FASB issued ASU No.&amp;nbsp;2016&amp;#8209;02, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Leases&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;02&amp;#x201D;). The new guidance requires lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016&amp;#8209;02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right&amp;#8209;to&amp;#8209;use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company for fiscal&amp;nbsp;years beginning after December 15, 2019 and interim periods fiscal&amp;nbsp;years beginning after December&amp;nbsp;15, 2020. Early adoption &lt;/font&gt;&lt;font style="display:inline;"&gt;is permitted. The Company is currently evaluating the effect of this standard on its financial statements.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</nxtc:DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock>
  <nxtc:IncreaseDecreaseInDeferredRevenueFromRelatedParty id="Fact-11d39ae3-ec6f-44a6-ba2c-916343f9e8ed_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">26725000</nxtc:IncreaseDecreaseInDeferredRevenueFromRelatedParty>
  <nxtc:MinimumGrossProceedsForMandatorilyRedeemablePreferredStock id="Fact-85495d88-fc79-403a-b13c-960c2b3e69be_20181231" decimals="-5" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">75000000</nxtc:MinimumGrossProceedsForMandatorilyRedeemablePreferredStock>
  <nxtc:NumberOfVotesPerShare id="Fact-b9cc9edf-1940-4f10-b834-4ecc1090431c_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31" unitRef="nxtc-Vote">1</nxtc:NumberOfVotesPerShare>
  <nxtc:PreferredStockConvertibleConversionRatio id="Fact-e6fc66b9-0261-4058-bb0b-c887bc1c67d8_20181231" decimals="4" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">0.1245</nxtc:PreferredStockConvertibleConversionRatio>
  <nxtc:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock id="Fact-2909223e-1c12-4fd3-9bce-2ca79153758b_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Estimated&amp;nbsp;Useful&amp;nbsp;Life&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Computers and peripherals&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;3&amp;nbsp;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;5&amp;nbsp;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;7&amp;nbsp;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Lesser of estimated useful life or remaining lease term&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</nxtc:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock id="Fact-cc51f11f-f433-4f30-a7c0-6e27c0a52d32_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;5. Accrued Liabilities&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Accrued liabilities consist of the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued construction in progress&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 515&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued payroll and related benefits&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,008&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 493&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued clinical trial costs&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 271&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued operating expenses&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 719&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 450&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued financing costs &lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 284&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued office lease&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 127&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 104&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued interest&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total accrued liabilities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,411&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,564&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
			&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-d7e672c0-98c2-4c00-b78f-df20d4dfc44d_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">263000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-cd77cb2c-996e-476d-a86d-ccabe083d9ff_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">263000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact-14c4df42-7943-4410-9729-5ae10b8377c4_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-shares">15802648</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock id="Fact-023a1aaf-5b80-4676-9c5e-166ccf2b5f7e_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Cash and Cash Equivalents&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company considers all highly liquid investments with an original maturity of three&amp;nbsp;months or less at the date of purchase to be cash equivalents. The Company deposits its cash primarily in checking, sweep account and money market accounts.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy id="Fact-234a3158-871b-472f-8556-5c70287ade0b_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Restricted Cash&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company is required to maintain cash collateral on deposit in a segregated money market bank account, as a condition of its Term Loan (Note&amp;nbsp;8) equal to the principal portion on a quarterly basis. The bank may restrict withdrawals or transfers by, or on behalf of, the Company. The required reserve totaled $460,000 as of December&amp;nbsp;31, 2018. This amount is presented as restricted cash on the accompanying balance sheet.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,173&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 8,427&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Restricted cash&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 460&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 860&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,633&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9,287&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect id="Fact-df61b71e-7ff4-4682-b2f1-d595f34cdd97_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">126346000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
  <us-gaap:CollaborativeArrangementDisclosureTextBlock id="Fact-8618d46a-1a9b-4a38-a07b-888225439611_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;6. Agreement with Eli Lilly and Company&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On November 2, 2018, the Company entered into a multi-year research and development collaboration agreement (the &amp;#x201C;Lilly Agreement&amp;#x201D;) with Eli Lilly and Company (&amp;#x201C;Lilly&amp;#x201D;), pursuant to which the Company will use its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Under the Lilly Agreement, Lilly and the Company have granted one another an equal number of exclusive options to &lt;a name="_cp_text_1_8"&gt;&lt;/a&gt;research, develop, manufacture and commercialize compounds and products directed to oncology targets identified through the Lilly Agreement. &lt;a name="_cp_text_1_9"&gt;&lt;/a&gt;Both Lilly and the Company each have all options remaining eligible for exercise. The research collaboration with Lilly will be managed by a joint steering committee formed by an equal number of members from the Company and Lilly and will expire upon the earlier of the exercise of all options granted to Lilly or four years from the date of the agreement, subject to certain extensions.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;During the research term under the Lilly Agreement, as a part of target discovery, the Company will be responsible for providing Lilly with oncology targets identified using the Company&amp;#x2019;s FIND-IO platform. From the targets provided by the Company, Lilly may select targets to advance to target validation using criteria developed by both parties. Following completion of the agreed upon target validation plan with respect to a given target, either party may propose to advance that target to compound discovery. &lt;a name="_cp_text_1_10"&gt;&lt;/a&gt;For each target that has been advanced to compound discovery, Lilly will have the option to obtain an exclusive license with respect to the compounds and products directed to the target. If Lilly does not exercise its option with respect to a given target or has previously exercised all of its options, the Company will have the option to obtain licenses with respect to compounds and products directed to that target. Following option exercise by a party, the development and commercialization of any products directed to the target will be conducted by the exercising party. The exercising party must use commercially reasonable efforts to develop, seek regulatory approval for and commercialize any such products under mutually agreed upon work plans.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company received an upfront, non-refundable payment of $25.0 million under the Lilly Agreement and a concurrent $15.0 million equity investment (Note 9). In addition, the Company will receive quarterly research and development support payments during a portion of the research term as well as option exercise fees upon option exercises by Lilly.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Pursuant to the Lilly Agreement, Lilly will owe an aggregate of up to $&lt;a name="_cp_text_1_14"&gt;&lt;/a&gt;1.4 billion in development and regulatory milestones&amp;nbsp;&lt;a name="_cp_text_1_15"&gt;&lt;/a&gt;and sales milestones. Additionally, Lilly will pay mid to high single-digit royalties&lt;a name="_cp_text_1_18"&gt;&lt;/a&gt; on net sales for all products directed to each target optioned by Lilly. Upon the Company&amp;#x2019;s exercise of an option with respect to a given target, the Company will &lt;a name="_cp_text_1_20"&gt;&lt;/a&gt;pay Lilly option exercise, milestone and royalty payments. The company will owe an aggregate of up to $&lt;a name="_cp_text_1_22"&gt;&lt;/a&gt;710.0&amp;nbsp;million in development and regulatory milestones&amp;nbsp;&lt;a name="_cp_text_1_24"&gt;&lt;/a&gt;and sales milestones.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The company has evaluated the Lilly Agreement under ASC 606. Two performance obligations were identified as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%"&gt;&lt;table style="width:100%;" cellpadding="0" cellspacing="0"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;p style="width:36pt;font-size:0pt;"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" align="left" style="width: 17.00pt;"&gt;
			&lt;p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;"&gt;
				&lt;font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"&gt; &amp;#xB7;&lt;/font&gt;
			&lt;/p&gt;
		&lt;/td&gt;&lt;td style="width:1pt;"&gt;&lt;p style="width:1pt;width:1pt;font-size:0pt;"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td align="left" valign="top"&gt;
			&lt;p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;"&gt;
			&lt;font style="display:inline;"&gt;research and development services; and&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
		&lt;div style="width:100%"&gt;&lt;table style="width:100%;" cellpadding="0" cellspacing="0"&gt;&lt;tr&gt;&lt;td style="width:36pt;"&gt;&lt;p style="width:36pt;font-size:0pt;"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" align="left" style="width: 17.00pt;"&gt;
			&lt;p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;"&gt;
				&lt;font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"&gt; &amp;#xB7;&lt;/font&gt;
			&lt;/p&gt;
		&lt;/td&gt;&lt;td style="width:1pt;"&gt;&lt;p style="width:1pt;width:1pt;font-size:0pt;"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td align="left" valign="top"&gt;
			&lt;p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;"&gt;
			&lt;font style="display:inline;"&gt;material right related to an optional term extension by Lilly.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Lilly Agreement was executed in November 2018, however, the performance obligations were initiated in January 2019; accordingly no revenue was recorded under the Lilly Agreement in 2018. As of December 31, 2018, deferred revenue included in the Company&amp;#x2019;s balance sheets in connection with the Lilly Agreement was $26.7 million, which consisted of the $25.0 million upfront payment plus $1.7 million attributed as a premium on the proceeds from Lilly&amp;#x2019;s equity investment in the Company (Note 9).&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="Fact-015bf9aa-a126-40fb-bab1-053acbf13a38_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;7. Commitments and Contingencies&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Operating Leases&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company subleases its facilities under a non&amp;#8209;cancelable operating sublease agreement. The sublease commenced on February&amp;nbsp;9, 2016 and expires on August&amp;nbsp;31, 2025. The Company is also responsible for its prorated share of the sublandlord&amp;#x2019;s operating expense.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The future minimum payments for the operating leases are as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Year Ending December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 325&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2020&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 308&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2021&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 317&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2022&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 355&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2023&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 335&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Thereafter&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 635&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total future minimum payments&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,275&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Rent expense incurred under operating leases was approximately $420,000 and $376,000 for the&amp;nbsp;years ended December&amp;nbsp;31, 2018 and 2017, respectively.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Contingencies&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company is subject to claims and assessments from time to time in the ordinary course of business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In the normal course of business, the Company may become involved in legal proceedings. The Company will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. As of December&amp;nbsp;31, 2018 and 2017, the Company was not involved in any material legal proceedings.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:CommonStockDividendsPerShareCashPaid id="Fact-b0890440-1d40-47a0-8989-bd8ccdd1dcfc_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD_xbrli-shares">0</us-gaap:CommonStockDividendsPerShareCashPaid>
  <us-gaap:CommonStockDividendsPerShareDeclared id="Fact-651df2da-35b1-44d2-a20d-77caf16e704d_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD_xbrli-shares">0</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Fact-07414740-5cdf-48c1-86b6-cab100bac594_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">-22799000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock id="Fact-c685fccf-c071-4fdd-bdec-c33748b86795_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Comprehensive Loss&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company did not have any other comprehensive income or loss for any of the periods presented and, therefore, comprehensive loss did not differ from net loss.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk id="Fact-db5ec44e-8392-4c59-9421-de653db0d1ee_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Concentration of Credit Risk&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk primarily consist of cash and cash equivalents. The Company maintains its cash and cash equivalents at one accredited financial institution in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:ConstructionContractorsPolicyPolicyTextBlock id="Fact-286794ee-f076-4da4-a3f3-39aaf10e0f67_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Construction in Progress&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Construction in progress (Note&amp;nbsp;4) is carried at cost and consists of specifically identifiable direct and indirect development and construction costs. While under construction, costs of the property are included in construction in progress until the property is placed in service, at which time costs are transferred to the appropriate property and equipment account including, but not limited to, leasehold improvements or other such accounts.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ConstructionContractorsPolicyPolicyTextBlock>
  <us-gaap:DebtDisclosureTextBlock id="Fact-52fa908f-3499-47e1-8fea-e808c87de853_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;8. Term Loan&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In April&amp;nbsp;2016, the Company entered into a $1.0&amp;nbsp;million term loan (the &amp;#x201C;Term Loan&amp;#x201D;). The Term Loan bears interest at the prime rate less 1%. The interest rate in effect was &lt;/font&gt;&lt;font style="display:inline;font-family:Symbol;"&gt;4.5&lt;/font&gt;&lt;font style="display:inline;"&gt;% and 3.5% for the years ended December 31, 2018 and 2017, respectively. The Term Loan is secured by all certificates of deposit, money market accounts, cash, securities, investment property and deposit or investment accounts. The Term Loan requires&amp;nbsp;monthly payments of interest only before May&amp;nbsp;2017, and equal&amp;nbsp;monthly payments of principal and interest thereafter, as defined in the agreement. Interest expense under the Term Loan was approximately $25,000 and $30,000 for the&amp;nbsp;years ended December&amp;nbsp;31, 2018 and 2017, respectively. The outstanding balance on the Term Loan totaled $460,000 as of December&amp;nbsp;31, 2018.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Future maturities of the Term Loan as of December&amp;nbsp;31, 2018 are as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 387&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2020&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 73&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 460&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: current portion of term loan&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 387&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Term loan, net of current portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 73&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
			&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="Fact-8b8aeee7-844a-40ba-bd46-d036caeb7896_20181231" decimals="3" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">0.045</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction id="Fact-89493cb6-1e77-443b-abfe-983a204a2504_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">284000</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
  <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch id="Fact-cbb1acbb-2641-444b-959e-1af62b4cf528_20181231" decimals="2" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">1.00</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
  <us-gaap:DepreciationDepletionAndAmortization id="Fact-5ba05ef6-da83-4320-a0ef-18f65eacab78_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">1677000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="Fact-7b81f516-4053-48a0-92c3-ae3ee41475ec_20181231" decimals="-5" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">1700000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="Fact-a1f57707-d349-4a4b-ba0e-16f64f7049bb_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;11. Stock&amp;#8209;Based Compensation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;2015 Omnibus Incentive Plan&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The NextCure,&amp;nbsp;Inc. 2015 Omnibus Incentive Plan (the &amp;#x201C;2015 Plan&amp;#x201D;) provides for the Company to grant incentive stock options or nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company. The 2015&amp;nbsp;Plan is administered by the board of directors, or at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors or its committee if so delegated, except that the exercise price per share of the stock options may not be less than 100% of the fair market value of a share of the Company&amp;#x2019;s common stock on the date of grant and the term of the stock options may not be greater than 10 years.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Under the 2015 Plan, the Company had initially reserved on December&amp;nbsp;29, 2015, 311,185 shares of common stock, which number of shares was automatically increased pursuant to the terms of the 2015&amp;nbsp;Plan by 373,422 as of the second closing of the Series&amp;nbsp;A Preferred Stock financing on January&amp;nbsp;24, 2017. The total number of shares of common stock that may be issued under the 2015 Plan was 2,824,317 as of December&amp;nbsp;31, 2018. As of December&amp;nbsp;31, 2018, there were &lt;/font&gt;&lt;font style="display:inline;font-family:Symbol;"&gt;2,056,891&lt;/font&gt;&lt;font style="display:inline;"&gt;&amp;nbsp;stock options and 62,237&amp;nbsp;shares of registered stock outstanding and &lt;/font&gt;&lt;font style="display:inline;font-family:Symbol;"&gt;699,590&lt;/font&gt;&lt;font style="display:inline;"&gt;&amp;nbsp;shares of common stock available for future issuance under the 2015 Plan.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Stock options granted under the 2015 Plan generally vest over four years and expire after 10&amp;nbsp;years.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The exercise price for stock options granted is not less than the fair value of common shares as determined by the board of directors as of the date of grant. The board of directors determines the value the Company&amp;#x2019;s common stock taking into consideration the most recently available third&amp;#8209;party valuation of common shares, as well as additional factors, which may have changed since the date of the most recent contemporaneous valuation through the date of grant.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;A summary of stock option activity for awards under the 2015 Plan is presented below:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="9" valign="bottom" style="width:40.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Options&amp;nbsp;Outstanding&amp;nbsp;and&amp;nbsp;Exercisable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Weighted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Weighted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Average&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Average&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Remaining&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Number&amp;nbsp;of&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Exercise&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Contractual&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%"&gt;(1)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Shares&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Price&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Life&amp;nbsp;(Years)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;(in&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Outstanding as of January&amp;nbsp;1, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 189,189&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 0.48&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 8.6&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 137&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Granted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 317,397&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1.21&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Outstanding as of December&amp;nbsp;31,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 506,586&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 0.94&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.0&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 137&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Granted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,570,136&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5.92&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.9&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,684&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (5,599)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 0.84&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Forfeitures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (14,232)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1.11&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Outstanding as of December&amp;nbsp;31,&amp;nbsp;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,056,891&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4.74&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.4&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,946&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Vested and expected to vest as of December&amp;nbsp;31,&amp;nbsp;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,056,891&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4.74&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.4&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,946&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Exercisable as of December&amp;nbsp;31,&amp;nbsp;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 242,079&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 0.88&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7.9&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,634&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;div&gt;&lt;hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"&gt;&lt;/hr&gt;&lt;/div&gt;
		&lt;div style="width:100%"&gt;&lt;table style="width:100%;" cellpadding="0" cellspacing="0"&gt;&lt;tr&gt;&lt;td style="width:0pt;"&gt;&lt;p style="width:0pt;font-size:0pt;"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" align="left" style="width: 18.00pt;"&gt;
			&lt;p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;"&gt;
				&lt;font style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"&gt; (1)&lt;/font&gt;
			&lt;/p&gt;
		&lt;/td&gt;&lt;td style="width:0pt;"&gt;&lt;p style="width:0pt;width:0pt;font-size:0pt;"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td align="left" valign="top"&gt;
			&lt;p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at December&amp;nbsp;31, 2018 and 2017.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The weighted average grant date fair value per share of stock options granted during the&amp;nbsp;years ended December&amp;nbsp;31, 2018 and 2017 was $3.80 and $0.80, respectively. The aggregate intrinsic value of stock options exercised during the&amp;nbsp;years ended December&amp;nbsp;31, 2018 and 2017 was $38,000 and $0, respectively.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The aggregate grant date fair value of stock options and restricted stock vested during the&amp;nbsp;year ended December&amp;nbsp;31, 2018 and 2017 was approximately $157,000 and $29,000, respectively.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Stock&amp;#8209;Based Compensation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company recorded stock&amp;#8209;based compensation expense of $263,000 and $75,000 during the&amp;nbsp;years ended December&amp;nbsp;31, 2018 and 2017, respectively. As of December&amp;nbsp;31, 2018, there was $6.0 million of unrecognized compensation cost related to unvested stock&amp;#8209;based compensation arrangements granted under the 2015 Plan. This remaining compensation expense is expected to be recognized over a weighted average period of three years as of December&amp;nbsp;31, 2018.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Stock&amp;#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research and development&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 85&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 35&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;General and administrative&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 178&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 40&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total stock-based compensation expense&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 263&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 75&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The assumptions used in the Black&amp;#8209;Scholes option&amp;#8209;pricing model for stock options granted were as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Year Ended &lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Expected term&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6.1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 69.7&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2.77&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Restricted Common Stock&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In May&amp;nbsp;2016, the Company issued 62,237 shares of restricted common stock from the 2015 Plan, which are restricted as to sale or transferability. These restrictions lapse over a four&amp;#8209;year period.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact-b92bc031-940f-42f0-8c56-7de7edb4596c_20181231" decimals="2" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD_xbrli-shares">-16.64</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact-df17b617-f49e-4a1b-a7a1-0cf87542bdb3_20181231" decimals="2" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD_xbrli-shares">-16.64</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerSharePolicyTextBlock id="Fact-31ecc00c-9713-4a4e-956d-a999aac0fb84_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Net Loss per Share&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two&amp;#8209;class method required for participating securities. The Company considers its Series&amp;nbsp;A Preferred Stock and Series&amp;nbsp;B Preferred Stock to be participating securities because in the event a dividend is paid on common stock, the holders of Series&amp;nbsp;A Preferred Stock and Series&amp;nbsp;B Preferred Stock would be entitled to receive dividends on a basis consistent with the common stockholders. Under the two&amp;#8209;class method, the net loss attributable to common stockholders is not allocated to the preferred stock as the holders of the preferred stock do not have a contractual obligation to share in losses.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Under the two&amp;#8209;class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:EarningsPerShareTextBlock id="Fact-38a99e84-e622-454f-8cc6-79cfb7710bf5_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;12. Net Loss Per Share Attributable to Common Stockholders&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share amounts):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:30.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:14.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Numerator:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (22,799)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (15,469)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Denominator:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Weighted average number of common shares, basic and diluted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,369,846&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,369,212&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Net loss per common share attributable to common stockholders, basic and diluted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;(16.64)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (11.30)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company&amp;#x2019;s potential dilutive securities, which include preferred stock and common stock options, have been excluded from the computation of diluted net loss per share as the effect would be anti&amp;#8209;dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at period end, from the computation of diluted net loss per share attributable to common stockholders for the period indicated because including them would have had an anti&amp;#8209;dilutive effect:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="3" valign="bottom" style="width:29.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Preferred stock&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 15,560,569&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4,978,957&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Options to purchase common stock&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;242,079&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;64,783&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;15,802,648&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;5,043,746&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
			&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Fact-bdd4f369-a4ea-4039-8a88-71dfdd689bb0_20181231" decimals="2" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Fact-4e768e16-2f06-41ab-a7ec-8b7adce17c6f_20181231" decimals="3" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance id="Fact-7150a1a1-8ed3-4d86-a8c6-77f2cf2d1093_20181231" decimals="3" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">-0.251</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense id="Fact-cdf1cd0d-d17c-4a92-867f-d956fa9bbbe3_20181231" decimals="3" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">-0.022</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments id="Fact-d7a9822a-c4ab-4a03-8a43-1898998a3506_20181231" decimals="3" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes id="Fact-15bfef63-64d4-4483-84d2-4a3260175b2b_20181231" decimals="3" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">-0.077</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes id="Fact-517b2dbd-4a97-4297-9ab6-8a53008882cc_20181231" decimals="3" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">0.065</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch id="Fact-73e48e23-9af5-478f-919a-94d8d00d7c17_20181231" decimals="3" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">0.072</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="Fact-b5645ff3-46ff-4b00-88b8-af5d16d88f47_20181231" contextRef="D2018-01-01_2018-12-31">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:FairValueByBalanceSheetGroupingTextBlock id="Fact-0ae0391c-fec2-43b3-8f10-6f8f9af82eb0_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table sets forth the fair value of the Company&amp;#x2019;s financial assets by level within the fair value hierarchy (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;As&amp;nbsp;of&amp;nbsp;December&amp;nbsp;31,&amp;nbsp;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair&amp;nbsp;Value&amp;nbsp;Measurement&amp;nbsp;Based&amp;nbsp;on&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Significant&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Quoted&amp;nbsp;Prices&amp;nbsp;in&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Other&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Significant&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Carrying&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Active&amp;nbsp;Markets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Observable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Unobservable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Amount&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;(Level&amp;nbsp;1)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Inputs&amp;nbsp;(Level&amp;nbsp;2)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Inputs&amp;nbsp;(Level&amp;nbsp;3)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Money market funds (cash equivalents)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;As&amp;nbsp;of&amp;nbsp;December&amp;nbsp;31,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair&amp;nbsp;Value&amp;nbsp;Measurement&amp;nbsp;Based&amp;nbsp;on&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Significant&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Quoted&amp;nbsp;Prices&amp;nbsp;in&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Other&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Significant&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Carrying&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Active&amp;nbsp;Markets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Observable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Unobservable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Amount&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;(Level&amp;nbsp;1)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Inputs&amp;nbsp;(Level&amp;nbsp;2)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Inputs&amp;nbsp;(Level&amp;nbsp;3)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Money market funds (cash equivalents)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock id="Fact-8045dbdf-2351-4cfd-90a0-4351aed73d9d_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;3. Fair Value of Financial Instruments&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table sets forth the fair value of the Company&amp;#x2019;s financial assets by level within the fair value hierarchy (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;As&amp;nbsp;of&amp;nbsp;December&amp;nbsp;31,&amp;nbsp;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair&amp;nbsp;Value&amp;nbsp;Measurement&amp;nbsp;Based&amp;nbsp;on&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Significant&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Quoted&amp;nbsp;Prices&amp;nbsp;in&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Other&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Significant&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Carrying&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Active&amp;nbsp;Markets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Observable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Unobservable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Amount&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;(Level&amp;nbsp;1)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Inputs&amp;nbsp;(Level&amp;nbsp;2)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Inputs&amp;nbsp;(Level&amp;nbsp;3)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Money market funds (cash equivalents)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;As&amp;nbsp;of&amp;nbsp;December&amp;nbsp;31,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair&amp;nbsp;Value&amp;nbsp;Measurement&amp;nbsp;Based&amp;nbsp;on&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Significant&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Quoted&amp;nbsp;Prices&amp;nbsp;in&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Other&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Significant&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Carrying&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Active&amp;nbsp;Markets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Observable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Unobservable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Amount&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;(Level&amp;nbsp;1)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Inputs&amp;nbsp;(Level&amp;nbsp;2)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Inputs&amp;nbsp;(Level&amp;nbsp;3)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Money market funds (cash equivalents)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company did&amp;nbsp;not transfer any assets measured at fair value on a recurring basis to or from Level&amp;nbsp;1 during the&amp;nbsp;years ended December&amp;nbsp;31, 2018 and 2017.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy id="Fact-f2e1089a-4af9-4b3f-b9e4-254635111143_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Fair Value of Financial Instruments&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;ASC Topic 820, &lt;/font&gt;&lt;font style="display:inline;font-style:italic;"&gt;Fair Value Measurement&lt;/font&gt;&lt;font style="display:inline;"&gt; (&amp;#x201C;ASC 820&amp;#x201D;), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company&amp;#x2019;s own assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&amp;#x2019;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. ASC 820 identifies fair value as the exchange price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three&amp;#8209;tier value hierarchy that distinguishes between the following:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Level&amp;nbsp;1&amp;#x2014;Quoted market prices in active markets for identical assets or liabilities.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Level&amp;nbsp;2&amp;#x2014;Inputs other than Level&amp;nbsp;1 inputs that are either directly or indirectly observable, such as quoted market prices, interest rates and yield curves.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Level&amp;nbsp;3&amp;#x2014;Unobservable inputs developed using estimates of assumptions developed by the Company, which reflect those that a market participant would use.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;To the extent the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair values requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized as Level&amp;nbsp;3. A financial instrument&amp;#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:GeneralAndAdministrativeExpense id="Fact-2b749aff-779d-44fa-a2bd-7e37e3f7f595_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">3409000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy id="Fact-e1f46f93-2340-4c53-b76a-9861af7c5b94_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Patent Costs&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;All patent&amp;#8209;related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses in the accompanying statement of operations and comprehensive loss.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
  <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf id="Fact-62f61d1e-7681-4992-b93f-db31cc6de6a4_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock id="Fact-c8e37da8-eac9-49b2-bc3e-4837865a62f4_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Impairment of Long&amp;#8209;Lived Assets&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company reviews the recoverability of its long&amp;#8209;lived asset group when events or changes in circumstances occur that indicate that the carrying value of the asset group may not be recoverable. The assessment of possible impairment is based on the ability to recover the carrying value of the asset group from the expected future cash flows (undiscounted and without interest expense) of the related operations. If these cash flows are less than the carrying value of such asset group, an impairment loss for the difference between the estimated fair value and carrying value is recorded. There was no impairment loss recognized during the&amp;nbsp;years ended December&amp;nbsp;31, 2018 or 2017.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock id="Fact-dd2c3bf9-c760-4d5a-ac2a-b660193da464_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;13. Income Taxes&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;2017 U.S. Tax Reform&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On December&amp;nbsp;22, 2017, the U.S. government signed into law the Tax Cuts and Jobs Act (the &amp;#x201C;Tax Act&amp;#x201D;) that significantly reforms the Internal Revenue Code of 1986, as amended. The Tax Act, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%, effective as of January&amp;nbsp;1, 2018; limitation of the tax deduction for interest expense; limitation of the deduction for net operating losses to 80% of annual taxable income and elimination of net operating loss carrybacks, in each case, for losses arising in taxable years beginning after December&amp;nbsp;31, 2017 (though any such tax losses may be carried forward indefinitely); and modifying or repealing many business deductions and credits, including reducing the business tax credit for certain clinical testing expenses incurred in the testing of certain drugs for rare diseases or conditions generally referred to as &amp;#x201C;orphan drugs&amp;#x201D;.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In 2018, the Company finished its analysis of the impact of the Tax Act. Where the Company made reasonable estimates in 2017 of the effects related to the Tax Act, the Company recorded provisional amounts. After the completed analysis, the resulting impact to the Company&amp;#x2019;s financial statements did not differ from the recorded provisional amounts.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;font-style:italic;"&gt;Income Taxes&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The reconciliation of federal statutory income tax rate to the Company&amp;#x2019;s effective income tax rate is as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="3" valign="bottom" style="width:21.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Expected income tax benefit at the federal statutory rate&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 21.0&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 34.0&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;State taxes, net of federal benefit&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6.5&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6.5&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research and development credit, net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7.2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4.7&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Non-deductible items&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (2.2)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (5.3)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Prior year provision to return adjustments&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (7.7)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4.1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Tax rate reduction due to the Tax Act&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (15.6)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Other&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 0.3&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (2.9)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Change in valuation allowance&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (25.1)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (25.5)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The principal components of the Company&amp;#x2019;s deferred tax assets consisted of the following as of December&amp;nbsp;31, 2018 and 2017 (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Deferred tax assets:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Federal and state net operating loss carryforwards&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 11,946&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6,176&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research and development tax credits&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 3,393&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,283&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Charitable contribution carryforwards&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 165&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 153&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accruals&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 290&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Other&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 23&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;4&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Gross deferred tax assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 15,817&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7,751&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: valuation allowance&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (15,525)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (7,491)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total deferred tax assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 292&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 260&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Deferred tax liabilities:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Depreciation and amortization&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (292)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (260)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Gross deferred tax liabilities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (292)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (260)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Net deferred tax assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Based on the Company&amp;#x2019;s history of losses, the Company recorded a full valuation allowance against its deferred tax assets as of December&amp;nbsp;31, 2018. The Company increased its valuation allowance by approximately $8.0&amp;nbsp;million for the&amp;nbsp;year ended December&amp;nbsp;31, 2018. The Company intends to maintain a valuation allowance until sufficient positive evidence exists to support a reversal of the allowance.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;As of December&amp;nbsp;31, 2018, the Company had federal and state net operating loss carryforwards of $43.5&amp;nbsp;million and $43.0&amp;nbsp;million, respectively, some of which begin to expire in the&amp;nbsp;year ending December&amp;nbsp;31, 2036. Approximately $20.8 million of the federal and state net operating loss carryforwards do not expire. The Company had federal and state research and development tax credit carryforwards of approximately $2.5 million and $1.1&amp;nbsp;million, respectively, as of December&amp;nbsp;31, 2018. The federal credits begin to expire in the&amp;nbsp;year ending December&amp;nbsp;31, 2036 and the state credits begin to expire in the&amp;nbsp;year ending December&amp;nbsp;31, 2024.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Under the provisions of Sections&amp;nbsp;382 and 383 of the Internal Revenue Code (the &amp;#x201C;IRC&amp;#x201D;), net operating loss and credit carryforwards and other tax attributes may be subject to limitation if there has been a significant change in ownership of the Company, as defined by the IRC. Future owner or equity shifts, including an initial public offering, could result in limitations on net operating loss and credit carryforwards.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company files income tax returns in the U.S. federal jurisdiction as well as in Maryland. The tax&amp;nbsp;years 2015 to 2017 remain open to examination by the major jurisdictions in which the Company are subject to tax. Fiscal&amp;nbsp;years outside the normal statute of limitation remain open to audit by tax authorities due to tax attributes generated in those early&amp;nbsp;years, which have been carried forward and may be audited in subsequent&amp;nbsp;years when utilized.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company evaluates tax positions for recognition using a more&amp;#8209;likely&amp;#8209;than&amp;#8209;not recognition threshold, and those tax positions eligible for recognition are measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon the effective settlement with a taxing authority that has full knowledge of all relevant information. As of December&amp;nbsp;31, 2018, the Company had no unrecognized income tax benefits that would affect the Company&amp;#x2019;s effective tax rate if recognized.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock id="Fact-d3f68835-947b-4182-9e6c-41e628094e75_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Income Taxes&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities, which relate primarily to the carrying amount of the Company&amp;#x2019;s property and equipment and its net operating loss carryforwards, are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, the Company concludes that it is more&amp;#8209;likely&amp;#8209;than&amp;#8209;not that the deferred tax assets will not be realized. In evaluating its ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction&amp;#8209;by&amp;#8209;jurisdiction basis. Because of the uncertainty of the realization of deferred tax assets, the Company has recorded a full valuation allowance against its deferred tax assets.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Reserves are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more&amp;#8209;likely&amp;#8209;than&amp;#8209;not to be sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the provision of income taxes; however, the Company currently has no interest or penalties related to uncertain income tax benefits.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="Fact-fab77ea7-a523-4713-b649-1c23dd3bdb3f_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">1342000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="Fact-82f8570d-4560-42a7-9e5a-a4f6a4e3af0b_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">847000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="Fact-bdcc41e5-1774-486d-8546-d01ecac8008f_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">-44000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Fact-fdfcc132-274d-4a6a-8c80-63e3da3e5d85_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">19000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:InterestExpense id="Fact-fea302a2-7f1b-4c17-b903-cf6d03482f0a_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">25000</us-gaap:InterestExpense>
  <us-gaap:InterestPaidNet id="Fact-f6c7578e-858a-416f-a7c1-950a064cca38_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">25000</us-gaap:InterestPaidNet>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="Fact-8338c632-38af-4c4c-a13d-798d7feb4c01_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">121417000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="Fact-86271a2a-4e0c-46a8-8658-6f8eefb5e110_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">-3063000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Fact-165904ae-c160-428a-a4a3-77d4010520d1_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">7992000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLoss id="Fact-1b6bf5e1-f9c9-4a42-bec1-885df2a8b4fe_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">-22799000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Fact-8a44280a-0231-4797-b4b2-1964e454946c_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">-22799000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="Fact-ee0ed1c8-35ff-4730-86e9-527997d66387_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">-22799000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="Fact-e62cc9bd-b2bb-4aaa-a597-ab6c75e31e8c_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In March&amp;nbsp;2016, the FASB issued ASU&amp;nbsp;No.&amp;nbsp;2016&amp;#8209;08, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic&amp;nbsp;606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;08&amp;#x201D;), which clarified the revenue recognition implementation guidance on principal versus agent considerations. In April&amp;nbsp;2016, the FASB issued ASU No.&amp;nbsp;2016&amp;#8209;10, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;10&amp;#x201D;), which clarified the revenue recognition guidance regarding the identification of performance obligations and the licensing implementation. In May&amp;nbsp;2016, the FASB issued ASU No.&amp;nbsp;2016&amp;#8209;12, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606): Narrow&amp;#8209;Scope Improvements and Practical Expedients&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;12&amp;#x201D;), which narrowly amended the revenue recognition guidance regarding collectability, noncash consideration, presentation of sales tax and transition. ASU No.&amp;nbsp;2016&amp;#8209;08, ASU No.&amp;nbsp;2016&amp;#8209;10 and ASU 2016&amp;#8209;12 are effective during the same period as ASU No.&amp;nbsp;2014&amp;#8209;09, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2014&amp;#8209;09&amp;#x201D;), which is effective for the Company for fiscal&amp;nbsp;years beginning after December 15, 2018 and interim periods within fiscal&amp;nbsp;years beginning after December&amp;nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016&amp;#8209;08, ASU 2016&amp;#8209;10, ASU&amp;nbsp;2016&amp;#8209;12 and ASU&amp;nbsp;2014&amp;#8209;09 as of January 1, 2018 on a retrospective basis. There was no revenue in previous years and the adoption of ASC 606 did not have any impact on prior year financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In August&amp;nbsp;2016, the FASB issued ASU No.&amp;nbsp;2016&amp;#8209;15, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;15&amp;#x201D;). ASU 2016&amp;#8209;15 eliminates the diversity in practice related to the classification of certain cash receipts and payments for debt prepayment or extinguishment costs, the maturing of a zero-coupon bond, the settlement of contingent liabilities arising from a business combination, proceeds from insurance settlements, distributions from certain equity method investees and beneficial interests obtained in a financial asset securitization. ASU 2016&amp;#8209;15 designates the appropriate cash flow classification, including requirements to allocate certain components of these cash receipts and payments among operating, investing and financing activities. The retrospective transition method, requiring adjustment to all comparative periods presented, is required unless it is impracticable for some of the amendments, in which case those amendments would be prospectively applied as of the earliest date practicable. ASU 2016&amp;#8209;15 is effective for the Company for fiscal&amp;nbsp;years beginning after December 15, 2018 and interim periods within fiscal&amp;nbsp;years beginning after December&amp;nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016-15 as of January 1, 2018.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In November&amp;nbsp;2016, the FASB issued ASU No.&amp;nbsp;2016&amp;#8209;18, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Statement of Cash Flows (Topic 230): Restricted Cash&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;18&amp;#x201D;), which requires that a statement of cash flows explain the change during the period in the total cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning and ending balances shown on the statement of cash flows. The guidance is effective for the Company for fiscal&amp;nbsp;years beginning after December 15, 2018 and interim periods within fiscal years beginning after December&amp;nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU&amp;nbsp;2016&amp;#8209;18 as of January&amp;nbsp;1, 2017.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In May&amp;nbsp;2017, the FASB issued ASU No.&amp;nbsp;2017&amp;#8209;09, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Compensation&amp;#x2014;Stock Compensation (Topic 718): Scope of Modification Accounting&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2017&amp;#8209;09&amp;#x201D;), which clarifies when to account for a change to the terms or conditions of a share&amp;#8209;based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions of the agreement. The standard is effective for fiscal&amp;nbsp;years, and interim periods within those&amp;nbsp;years, beginning after December&amp;nbsp;15, 2017. The Company adopted ASU 2017&amp;#8209;09 as of the required effective date of January&amp;nbsp;1, 2018. In June&amp;nbsp;2018, the FASB issued ASU No.&amp;nbsp;2018&amp;#8209;07&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt; Compensation&amp;#x2014;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU No.&amp;nbsp;2018&amp;#8209;07&amp;#x201D;). ASU No.&amp;nbsp;2018&amp;#8209;07 expands the guidance in ASC718 to include share-based payments for goods and services to non-employees and generally aligns it with the guidance for share-based payments to employees. The amendments are effective for the Company for fiscal&amp;nbsp;years beginning after December&amp;nbsp;15, 2019 and interim periods within fiscal years beginning after December 15, 2020, with early adoption permitted for entities that have adopted ASC 606. The Company adopted this new standard on January&amp;nbsp;1, 2018.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:NumberOfOperatingSegments id="Fact-34296dd5-bc06-4007-a12c-f4fadf6f3e96_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31" unitRef="nxtc-segment">1</us-gaap:NumberOfOperatingSegments>
  <us-gaap:OperatingExpenses id="Fact-d9b7aa45-77f5-401f-988f-651137a0f01a_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">23196000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="Fact-bb19ca9d-299a-4381-9a87-da76df2e8b58_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">-23196000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingLeasesRentExpenseNet id="Fact-579aa581-0f42-492f-a9a1-85b3b5e62c9e_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">420000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock id="Fact-9150180d-79d2-475f-b3ae-0b5bf9e740be_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;NEXTCURE,&amp;nbsp;INC.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;NOTES&amp;nbsp;TO FINANCIAL STATEMENTS&lt;a name="NOTESTOFINANCIALSTATEMENTS_913411"&gt;&lt;/a&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;1. Nature of the Business and Basis of Presentation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Organization&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;NextCure,&amp;nbsp;Inc. (&amp;#x201C;NextCure&amp;#x201D; or the &amp;#x201C;Company&amp;#x201D;) was incorporated in Delaware in September&amp;nbsp;2015 and is headquartered in Beltsville, Maryland. The Company is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first&amp;#8209;in&amp;#8209;class immunomedicines to treat cancer and other immune&amp;#8209;related diseases by restoring normal immune function. Through its proprietary Functional, Integrated, NextCure Discovery in Immuno&amp;#8209;Oncology (&amp;#x201C;FIND&amp;#8209;IO&amp;#x201D;) platform, the Company studies various immune cells in order to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Since inception, the Company has devoted substantially all of its efforts and financial resources to organizing and staffing the Company, identifying business development opportunities, raising capital, securing intellectual property rights related to the Company&amp;#x2019;s product candidates, building and optimizing the Company&amp;#x2019;s manufacturing capabilities and conducting discovery, research and development activities for the Company&amp;#x2019;s product candidates, discovery programs and its FIND&amp;#8209;IO platform.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Risks and Uncertainties&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company is subject to risks common to early&amp;#8209;stage companies in the biotechnology industry including, but not limited to: having a limited operating history and no products approved for commercial sale; having a history of significant losses; our need to obtain additional financing; dependence on its ability to advance its current and future product candidates through clinical trials, marketing approval and commercialization; the unproven approach to the discovery and development of product candidates based on the Company&amp;#x2019;s FIND&amp;#8209;IO platform; the lengthy and expensive nature and uncertain outcomes of the clinical development process; the lengthy, time&amp;#8209;consuming and unpredictable nature of the regulatory approval process; the results of preclinical studies and early&amp;#8209;stage clinical trials that may not be predictive of future results; dependence on its key personnel; its limited manufacturing experience as an organization and with its manufacturing facility; risks related to patent protection and our pending patent applications; dependence on third&amp;#8209;party collaborators for the discovery, development and commercialization of current and future product candidates; and significant competition from other biotechnology and pharmaceutical companies. Pursuit of the Company&amp;#x2019;s business efforts will require significant amounts of additional capital, adequate personnel, infrastructure and extensive compliance&amp;#8209;reporting capabilities. Even if the Company&amp;#x2019;s development efforts are successful, it is uncertain when, if ever, the Company will realize significant revenue from product sales.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Liquidity&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company expects that its operating losses and negative cash flows will continue for the foreseeable future. As of the issuance date of the financial statements for the&amp;nbsp;year ended December&amp;nbsp;31, 2018, the Company expects that its cash and cash equivalents will be sufficient to fund its operating expenses and capital expenditure requirements through at least two years from the issuance date of the financial statements. The future viability of the Company beyond that date is dependent on its ability to raise additional capital to finance its operations. On April&amp;nbsp;5, 2018, the Company issued 28,181,819 shares of Series&amp;nbsp;A&amp;#8209;3 Preferred Stock at an issuance price of $1.10 per share for cash proceeds of $31.0&amp;nbsp;million (Note&amp;nbsp;9). On November&amp;nbsp;5, 2018, the Company entered into a Series&amp;nbsp;B Preferred Stock Purchase Agreement and issued 15,052,117 shares of Series&amp;nbsp;B&amp;#8209;1 Preferred Stock at an issuance price of $1.59 per share, 34,276,734 shares of Series&amp;nbsp;B&amp;#8209;2 Preferred Stock at an issuance price of $1.59 per share and 7,500,000 shares of Series&amp;nbsp;B&amp;#8209;3 Preferred Stock at an issuance price of $2.00 per share for aggregate cash proceeds of $93.4&amp;nbsp;million (Note&amp;nbsp;9).&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company plans to seek additional funding through public or private equity offerings, debt financings, marketing and distribution arrangements, other collaborations, strategic alliances and licensing arrangements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into strategic alliances or other arrangements on favorable terms, or at all. The terms of any financing may adversely affect the holdings or the rights of the Company&amp;#x2019;s stockholders. If the Company is unable to obtain funding, the Company could be required to delay, reduce or eliminate research and development programs, product portfolio expansion or future commercialization efforts, which could adversely affect its business prospects.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Although management continues to pursue these funding plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company, if at all, to fund continuing operations past two years from the issuance date of these financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Basis of Presentation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The accompanying financial statements include the accounts of the Company. The Company&amp;#x2019;s financial statements have been prepared in accordance with United States generally accepted accounting principles (&amp;#x201C;GAAP&amp;#x201D;). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&amp;#x201C;ASC&amp;#x201D;) and Accounting Standards Update (&amp;#x201C;ASU&amp;#x201D;) of the Financial Accounting Standards Board (&amp;#x201C;FASB&amp;#x201D;).&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;font-style:italic;"&gt;Reverse Stock Split&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On May&amp;nbsp;3, 2019, the Company effected a 1&amp;#8209;for&amp;#8209;8.0338 reverse stock split of its outstanding common stock. The par value and authorized shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Use of Estimates&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to accrued expenses, revenue recognition, the valuation of equity&amp;#8209;based compensation, including incentive stock options, common stock and restricted common stock, as well as income taxes. The Company bases its estimates on various assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Segment and Geographic Information&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Operating segments are defined as components of an entity about which separate discrete information is available for evaluation by the chief operating decision maker, or decision&amp;#8209;making group, in deciding how to allocate resources and in assessing performance. The Company views its operations as and manages its business in one operating segment operating exclusively in the United States.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:OtherNonoperatingIncomeExpense id="Fact-8b840cbb-ddd3-44e1-af6d-565e4ae4ceac_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">397000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:PaymentsOfFinancingCosts id="Fact-4b206b70-5b41-49c1-aba6-c9814763a5c1_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">410000</us-gaap:PaymentsOfFinancingCosts>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Fact-ae110d90-cdf6-4042-9394-cfd0a7bfd25e_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">3063000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock id="Fact-85b33f9d-6a73-407e-994d-c54595cfe0e1_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;14. Employee Benefit Plan&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company sponsors a 401(k)&amp;nbsp;plan that stipulates that eligible employees can elect to contribute to the 401(k)&amp;nbsp;plan, subject to certain limitations, up to the lesser of the statutory maximum or 100% of eligible compensation on a pre&amp;#8209;tax basis. Through December&amp;nbsp;31, 2018, the Company has not provided any contributions to this plan.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:PreferredStockDividendRatePercentage id="Fact-6e35f595-b720-4e0a-95a9-0cf39b709357_20181231" decimals="2" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
  <us-gaap:PreferredStockDividendsPerShareDeclared id="Fact-f9705bf0-ca82-4d6b-9d76-271b0eef1379_20181231" decimals="INF" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD_xbrli-shares">0</us-gaap:PreferredStockDividendsPerShareDeclared>
  <us-gaap:PreferredStockTextBlock id="Fact-7c2c781e-1fd5-493c-99a2-ef1ff9276a89_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;9. Preferred Stock&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;As of December&amp;nbsp;31, 2018, the Company&amp;#x2019;s certificate of incorporation, as amended and restated, authorized the Company to issue 125,010,671 shares of $0.001 par value preferred stock. The Company&amp;#x2019;s preferred stock is classified outside of stockholders&amp;#x2019; deficit because the shares contain deemed liquidation rights that are a contingent redemption feature not solely within the control of the Company.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Series&amp;nbsp;A Preferred Stock&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;As of December&amp;nbsp;31, 2018, the Company has issued 68,181,819 shares of Series&amp;nbsp;A Preferred Stock as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In December&amp;nbsp;2015, the Company issued 15,000,000 shares of Series&amp;nbsp;A&amp;#8209;1 Preferred Stock at an issuance price of $1.00 per share for cash proceeds of $15.0&amp;nbsp;million.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In January&amp;nbsp;2017, the Company issued 25,000,000 shares of Series&amp;nbsp;A&amp;#8209;2 Preferred Stock at an issuance price of $1.00 per share for cash proceeds of $25.0&amp;nbsp;million.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In April&amp;nbsp;2018, the Company issued 28,181,819 shares of Series&amp;nbsp;A&amp;#8209;3 Preferred Stock at an issuance price of $1.10 per share for cash proceeds of approximately $31.0 million.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Series&amp;nbsp;B Preferred Stock&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;As of December 31, 2018, the Company has issued 56,828,851 shares of Series B Preferred Stock as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In November 2018, the Company issued 15,052,117 and 34,276,734 shares of Series B-1 Preferred Stock and Series B-2 Preferred Stock, respectively, at an issuance price of $1.59 per share for aggregate cash proceeds of approximately $78.4 million.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Concurrent with the issuance of the Series B-1 Preferred Stock and Series B-2 Preferred Stock, in November 2018, the Company issued 7,500,000 shares of Series B-3 Preferred Stock at an issuance price of $2.00 per share for cash proceeds of $15.0 million in connection with the execution of the Collaboration Agreement with Lilly. The Company allocated $13.3 million of the proceeds to Series B-3 Preferred Stock and $1.7 million to deferred revenue. The $1.7 million was determined to be a premium over the fair value of the Series B-3 Preferred Stock and attributed as additional consideration of the Collaboration Agreement (Note 6).&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;The Company estimated the premium of the Series B-3 Preferred Stock based on a valuation of the Company&amp;#x2019;s preferred stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. The $1.7 million premium on the Series B-3 Preferred Stock will be recognized as revenue on a proportional performance basis over the term of the Collaboration Agreement.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company&amp;#x2019;s Preferred Stock has the following rights and preferences, privileges and restrictions:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Dividends&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The holders of Preferred Stock are entitled to receive annual noncumulative dividends at an annual rate of 8% in preference to any declaration or payment of any dividend on the common stock, on an as&amp;#8209;converted basis when, as and if declared by the Board of Directors. As of December&amp;nbsp;31, 2018, no dividends have been declared.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Voting Rights&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Each share of Preferred Stock represents such number of votes as is equal to the number of shares of common stock into which such share is convertible. The holders of Preferred Stock vote together with the holders of common stock on an as&amp;#8209;converted basis on all matters in which stockholders are entitled to vote. The holders of Series&amp;nbsp;A Preferred Stock, exclusively and as a separate class, are entitled to elect five directors, the holders of the Series&amp;nbsp;B Preferred Stock, exclusively and as a separate class, are entitled to elect two directors of the Company as of December&amp;nbsp;31, 2018.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Conversion Rights&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The holders of the Preferred Stock are entitled to convert each share into 0.1245 shares of common stock on demand. The Preferred Stock is mandatorily convertible upon the closing of a qualified public offering in which gross proceeds to the Company of not less than $75.0 million or on the date specified by a majority vote of the outstanding shares of Preferred Stock voting on an as&amp;#8209;converted basis.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Liquidation Preference&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In the event of any &lt;a name="_cp_text_1_29"&gt;&lt;/a&gt;voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of the Company&amp;#x2019;s &lt;a name="_cp_text_1_30"&gt;&lt;/a&gt;Series B Preferred Stock are entitled to &lt;a name="_cp_text_1_32"&gt;&lt;/a&gt;receive, before any payment of any of the assets of the Company to the holders of the Series A Preferred Stock and holders of common stock, $12.77 per share with respect to shares of Series B-1 Preferred Stock and Series B-2 Preferred Stock and $16.07 per share with respect to shares of Series B-3 Preferred Stock (as adjusted for any stock dividend, stock split, combination or other similar transactions, plus any declared but unpaid dividends). After payment of the above but before any payment of any of the assets of the Company to the holders of common stock, the holders of Series A Preferred Stock are entitled to receive $8.03 per share with respect to shares of Series A-1 Preferred Stock and Series A-2 Preferred Stock and $8.84 per share with respect to shares of Series A-3 Preferred Stock (as adjusted for any stock dividend, stock split, combination or other similar transactions, plus any declared but unpaid dividends).&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PreferredStockTextBlock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Fact-c181668a-e394-4da7-97fd-ed94526786da_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">4000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-1bbfb3ae-d191-4eab-aea3-855888cbf740_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">122223000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProfitLoss id="Fact-b310ff50-ddf0-4e12-9560-990c756cebfc_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">-22799000</us-gaap:ProfitLoss>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="Fact-2cb981d1-f2fc-49e7-80d8-d1c5748690c4_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;4. Property and Equipment, Net&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Property and equipment consist of the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7,787&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6,213&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4,825&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 564&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Computer equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 167&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 111&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 70&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 33&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Construction in progress&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,027&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 3,892&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Property and equipment, gross&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 13,876&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 10,813&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (2,469)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (792)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Property and equipment, net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 11,407&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 10,021&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Construction in progress at December&amp;nbsp;31, 2018 consists of the costs incurred for research equipment.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Depreciation and amortization expense was $1.7&amp;nbsp;million and $582,000 for the&amp;nbsp;years ended December&amp;nbsp;31, 2018 and 2017, respectively.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="Fact-7bbb375f-f7d1-4839-bc70-f152aac9130d_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Property and Equipment, Net&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Property and equipment are recorded at cost. Depreciation is computed over the estimated useful lives of the related assets using the straight&amp;#8209;line method. Leasehold improvements are amortized on a straight&amp;#8209;line basis over the shorter of the useful life or term of the lease. Upon retirement or disposal, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is recorded to general and administrative expenses in the accompanying statement of operations and comprehensive loss. Routine expenditures for maintenance and repairs are expensed as incurred.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Estimated useful lives for property and equipment are as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Estimated&amp;nbsp;Useful&amp;nbsp;Life&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Computers and peripherals&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;3&amp;nbsp;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;5&amp;nbsp;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;7&amp;nbsp;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Lesser of estimated useful life or remaining lease term&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="Fact-5da7ff41-b9ed-48a9-adfd-319818c7caf2_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Property and equipment consist of the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7,787&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6,213&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4,825&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 564&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Computer equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 167&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 111&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 70&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 33&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Construction in progress&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,027&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 3,892&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Property and equipment, gross&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 13,876&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 10,813&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (2,469)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (792)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Property and equipment, net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 11,407&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 10,021&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock id="Fact-ad639e92-fe48-4562-a4e3-36ac2be114d3_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;15. Related Party Transactions&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;"&gt;Lilly Agreement&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In November 2018, the Company entered into the Lilly Agreement with a stockholder of the Company, Lilly, pursuant to which the Company will use its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Lilly provided to the Company a cash upfront payment of $25.0 million upon entering into the Collaboration Agreement and made a concurrent $15.0 million equity investment in the Company (Note 6 and Note 9).&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Consulting Agreement with Scientific Founder&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;a name="_cp_text_2_45"&gt;&lt;/a&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In December 2015&lt;a name="_cp_text_5_46"&gt;&lt;/a&gt;&lt;/font&gt;&lt;font style="display:inline;"&gt;, the Company entered into a &lt;a name="_cp_text_2_47"&gt;&lt;/a&gt;consulting agreement for scientific advisory services with a founder of the Company (the &amp;#x201C;Scientific Founder&amp;#x201D;), who is also a stockholder of the Company. The term of the consulting agreement expires December 31, 2020. Under the agreement, the Scientific Founder is entitled to receive $5,000 per month in consulting fees until the expiration of the agreement. As of December 31, 2018, the amount due under this agreement is $120,000.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Yale License Agreement and Sponsored Research Agreement&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In December&amp;nbsp;2015, the Company entered into a license agreement with Yale University (the &amp;#x201C;Yale Agreement&amp;#x201D;), which is also a stockholder of the Company. Under the Yale Agreement, the Company obtained a license to products that either incorporate certain licensed patents used in the discovery of targets or arise out of research and development of the Scientific Founder&amp;#x2019;s laboratory at Yale, including a proprietary target. The Company is obligated to pay Yale low single&amp;#8209;digit royalties on sales of products that are either covered by the patents licensed to the Company under the Yale Agreement or arise out of the Scientific Founder&amp;#x2019;s laboratory, subject to minimum annual royalty payments in the low to mid hundreds of thousands of dollars, an annual license maintenance fee in the mid to high tens of thousands of dollars and milestone payments of up to $3.0&amp;nbsp;million per product.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In connection with the Yale Agreement, the Company also entered into the Corporate Sponsored Research Agreement with Yale (the &amp;#x201C;SRA&amp;#x201D;), in which the Company agreed to provide an aggregate of up to $12.4&amp;nbsp;million to fund a research program aimed at discovering new targets for immunomedicines. The research program is under the direction and supervision of the Scientific Founder. As of December&amp;nbsp;31, 2018, the Company has made payments in an aggregate of &lt;/font&gt;&lt;font style="display:inline;font-family:Symbol;"&gt;$7.4&lt;/font&gt;&lt;font style="display:inline;"&gt;&amp;nbsp;million under the SRA, including $&lt;/font&gt;&lt;font style="display:inline;font-family:Symbol;"&gt;2.5&lt;/font&gt;&lt;font style="display:inline;"&gt;&amp;nbsp;million and $2.1 million in the&amp;nbsp;years ended December&amp;nbsp;31, 2018 and 2017, respectively.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:RepaymentsOfDebt id="Fact-e0ad7660-da91-429c-873d-94ed0427c578_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">400000</us-gaap:RepaymentsOfDebt>
  <us-gaap:ResearchAndDevelopmentExpense id="Fact-3e9c349b-ce8b-4e14-ad7d-174e7f7af54c_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">19787000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpensePolicy id="Fact-7b7ee6a5-d27a-49e3-97c6-9d2b254b4cd7_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Research and Development Costs&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Expenditures, including payroll, contractor expenses and supplies, for research and development of products are expensed as incurred. Development costs incurred by third parties are expensed as the contracted work is performed. Where contingent milestone payments are due to third parties under research and development arrangements, the milestone payment obligations are expensed when the milestone results are probable of being achieved.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock id="Fact-fd280938-b088-48c7-8ae9-029669d5fa27_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Revenue Recognition&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company has adopted ASC Topic 606, Revenue from Contracts with Customers (&amp;#x201C;ASC 606&amp;#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral or dependent to other goods or services in the contract.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration which is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company&amp;#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&amp;#x2019;s control or the licensee&amp;#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related&amp;nbsp;revenue recognition.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&amp;#x2019;s right to consideration is unconditional.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock id="Fact-78ad3218-a3e8-49ba-b767-a4ba28a42908_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Accrued liabilities consist of the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued construction in progress&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 515&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued payroll and related benefits&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,008&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 493&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued clinical trial costs&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 271&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued operating expenses&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 719&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 450&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued financing costs &lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 284&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued office lease&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 127&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 104&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accrued interest&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total accrued liabilities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,411&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,564&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock id="Fact-b116f137-2bf6-44f9-bd09-ca78a43bfa87_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="3" valign="bottom" style="width:29.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Preferred stock&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 15,560,569&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4,978,957&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Options to purchase common stock&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;242,079&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;64,783&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;15,802,648&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;5,043,746&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock id="Fact-986ecdeb-4082-4721-a326-8544776a8563_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,173&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 8,427&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Restricted cash&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 460&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 860&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,633&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9,287&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock id="Fact-296acc1d-37d9-46f4-bfcd-3625d1fdabf8_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The principal components of the Company&amp;#x2019;s deferred tax assets consisted of the following as of December&amp;nbsp;31, 2018 and 2017 (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Deferred tax assets:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Federal and state net operating loss carryforwards&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 11,946&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6,176&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research and development tax credits&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 3,393&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,283&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Charitable contribution carryforwards&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 165&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 153&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Accruals&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 290&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Other&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 23&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;4&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Gross deferred tax assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 15,817&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7,751&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: valuation allowance&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (15,525)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (7,491)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total deferred tax assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 292&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 260&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Deferred tax liabilities:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Depreciation and amortization&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (292)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (260)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Gross deferred tax liabilities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (292)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (260)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Net deferred tax assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock id="Fact-70c45d42-0d76-463c-b0af-66e8c8d8ed7f_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share amounts):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:30.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:14.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Numerator:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (22,799)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (15,469)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Denominator:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Weighted average number of common shares, basic and diluted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,369,846&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,369,212&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Net loss per common share attributable to common stockholders, basic and diluted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;(16.64)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (11.30)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock id="Fact-61c3f229-ac9c-4119-9625-8c193464caab_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="3" valign="bottom" style="width:21.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Expected income tax benefit at the federal statutory rate&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 21.0&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 34.0&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;State taxes, net of federal benefit&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6.5&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6.5&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research and development credit, net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7.2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4.7&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Non-deductible items&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (2.2)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (5.3)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Prior year provision to return adjustments&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (7.7)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4.1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Tax rate reduction due to the Tax Act&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (15.6)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Other&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 0.3&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (2.9)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Change in valuation allowance&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (25.1)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (25.5)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="Fact-f114fb9a-9c64-4cf1-a296-d05d621b6868_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Stock&amp;#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research and development&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 85&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 35&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;General and administrative&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 178&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 40&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total stock-based compensation expense&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 263&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 75&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="Fact-9d955da0-7a99-401a-b729-9e8cf2a046c2_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The future minimum payments for the operating leases are as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Year Ending December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 325&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2020&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 308&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2021&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 317&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2022&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 355&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2023&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 335&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Thereafter&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 635&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total future minimum payments&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,275&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock id="Fact-00083a92-7e72-4cde-b82b-1cd5f2a5dc55_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Future maturities of the Term Loan as of December&amp;nbsp;31, 2018 are as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 387&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2020&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 73&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 460&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: current portion of term loan&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 387&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Term loan, net of current portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 73&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="Fact-5c40d53b-f673-4643-8889-90920da48752_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;A summary of stock option activity for awards under the 2015 Plan is presented below:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="9" valign="bottom" style="width:40.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Options&amp;nbsp;Outstanding&amp;nbsp;and&amp;nbsp;Exercisable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Weighted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Weighted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Average&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Average&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Remaining&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Number&amp;nbsp;of&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Exercise&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Contractual&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%"&gt;(1)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Shares&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Price&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Life&amp;nbsp;(Years)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;(in&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Outstanding as of January&amp;nbsp;1, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 189,189&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 0.48&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 8.6&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 137&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Granted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 317,397&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1.21&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Outstanding as of December&amp;nbsp;31,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 506,586&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 0.94&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.0&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 137&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Granted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,570,136&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5.92&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.9&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,684&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (5,599)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 0.84&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Forfeitures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (14,232)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1.11&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Outstanding as of December&amp;nbsp;31,&amp;nbsp;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,056,891&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4.74&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.4&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,946&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Vested and expected to vest as of December&amp;nbsp;31,&amp;nbsp;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,056,891&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4.74&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.4&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,946&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Exercisable as of December&amp;nbsp;31,&amp;nbsp;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 242,079&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 0.88&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7.9&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,634&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;div&gt;&lt;hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"&gt;&lt;/hr&gt;&lt;/div&gt;
		&lt;div style="width:100%"&gt;&lt;table style="width:100%;" cellpadding="0" cellspacing="0"&gt;&lt;tr&gt;&lt;td style="width:0pt;"&gt;&lt;p style="width:0pt;font-size:0pt;"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" align="left" style="width: 18.00pt;"&gt;
			&lt;p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;"&gt;
				&lt;font style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"&gt; (1)&lt;/font&gt;
			&lt;/p&gt;
		&lt;/td&gt;&lt;td style="width:0pt;"&gt;&lt;p style="width:0pt;width:0pt;font-size:0pt;"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td align="left" valign="top"&gt;
			&lt;p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at December&amp;nbsp;31, 2018 and 2017.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock id="Fact-758f5714-4ff8-4a66-a6cc-cde907a73ffd_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Year Ended &lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Expected term&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6.1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 69.7&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2.77&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedCompensation id="Fact-d962a873-28fd-4578-a69e-5f9d87102788_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">263000</us-gaap:ShareBasedCompensation>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="Fact-3ff462be-6adf-4d06-a7d0-03a1ebd5c6fb_20181231" contextRef="D2018-01-01_2018-12-31">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="Fact-f6e66f8c-fea9-4576-b0ee-015d223c32a2_20181231" decimals="4" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">0.0277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate id="Fact-6a409f94-51ba-424c-9eba-808b47390233_20181231" decimals="3" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-pure">0.697</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="Fact-1e7f9290-0ac3-48bc-a0c4-5edb7a7cd169_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Stock&amp;#8209;Based Compensation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company accounts for its stock&amp;#8209;based compensation in accordance with ASC Topic 718, &lt;/font&gt;&lt;font style="display:inline;font-style:italic;"&gt;Compensation&amp;#8209;Stock Compensation&lt;/font&gt;&lt;font style="display:inline;"&gt; (&amp;#x201C;ASC 718&amp;#x201D;). ASC 718 requires all share&amp;#8209;based payments to employees, consultants and directors, including grants of incentive stock options, nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company, to be recognized as expense in the statement of operations and comprehensive loss based on their grant date fair values. The Company estimates the fair value of options granted using the Black&amp;#8209;Scholes option pricing model (&amp;#x201C;Black&amp;#8209;Scholes&amp;#x201D;) for stock option grants to both employees and non&amp;#8209;employees and the fair value of common stock to determine the fair value of restricted stock.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company recognizes forfeitures as they occur as allowed by ASU No.&amp;nbsp;2016&amp;#8209;09, &lt;/font&gt;&lt;font style="display:inline;font-style:italic;"&gt;Improvements to Employee Share&amp;#8209;Based Payment Accounting&lt;/font&gt;&lt;font style="display:inline;"&gt; (&amp;#x201C;ASU&amp;nbsp;2016&amp;#8209;09&amp;#x201D;).&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Black&amp;#8209;Scholes option pricing model requires inputs based on certain subjective assumptions, including (i)&amp;nbsp;the expected stock price volatility, (ii)&amp;nbsp;the expected term of the award, (iii)&amp;nbsp;the risk&amp;#8209;free interest rate and (iv)&amp;nbsp;expected dividends. Due to the lack of a public market for the Company&amp;#x2019;s common stock and lack of company&amp;#8209;specific historical and implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with expected term assumption. The Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No.&amp;nbsp;107, Share&amp;#8209;Based Payment, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the Company does not expect substantially different exercise or post&amp;#8209;vesting termination behavior among its employee population. For options granted to non&amp;#8209;employees, the Company utilizes the simplified method also as the basis for the expected term assumption. The risk&amp;#8209;free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;There are significant judgments and estimates inherent in the determination of the fair value of the Company&amp;#x2019;s common stock. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of preferred stock, the superior rights and preferences of securities senior to its common stock at the time of, and the likelihood of, achieving a liquidity event, such as an initial public offering or sale.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company expenses the fair value of its share&amp;#8209;based compensation awards on a straight&amp;#8209;line basis over the requisite service period, which is generally the vesting period.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="Fact-f9aa5e5f-abc4-488c-87e5-4576ff59bfca_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;2. Summary of Significant Accounting Policies&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Cash and Cash Equivalents&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company considers all highly liquid investments with an original maturity of three&amp;nbsp;months or less at the date of purchase to be cash equivalents. The Company deposits its cash primarily in checking, sweep account and money market accounts.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Restricted Cash&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company is required to maintain cash collateral on deposit in a segregated money market bank account, as a condition of its Term Loan (Note&amp;nbsp;8) equal to the principal portion on a quarterly basis. The bank may restrict withdrawals or transfers by, or on behalf of, the Company. The required reserve totaled $460,000 as of December&amp;nbsp;31, 2018. This amount is presented as restricted cash on the accompanying balance sheet.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:23.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,173&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 8,427&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Restricted cash&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 460&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 860&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,633&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9,287&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Concentration of Credit Risk&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk primarily consist of cash and cash equivalents. The Company maintains its cash and cash equivalents at one accredited financial institution in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Fair Value of Financial Instruments&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;ASC Topic 820, &lt;/font&gt;&lt;font style="display:inline;font-style:italic;"&gt;Fair Value Measurement&lt;/font&gt;&lt;font style="display:inline;"&gt; (&amp;#x201C;ASC 820&amp;#x201D;), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company&amp;#x2019;s own assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&amp;#x2019;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. ASC 820 identifies fair value as the exchange price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three&amp;#8209;tier value hierarchy that distinguishes between the following:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Level&amp;nbsp;1&amp;#x2014;Quoted market prices in active markets for identical assets or liabilities.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Level&amp;nbsp;2&amp;#x2014;Inputs other than Level&amp;nbsp;1 inputs that are either directly or indirectly observable, such as quoted market prices, interest rates and yield curves.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Level&amp;nbsp;3&amp;#x2014;Unobservable inputs developed using estimates of assumptions developed by the Company, which reflect those that a market participant would use.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;To the extent the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair values requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized as Level&amp;nbsp;3. A financial instrument&amp;#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Property and Equipment, Net&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Property and equipment are recorded at cost. Depreciation is computed over the estimated useful lives of the related assets using the straight&amp;#8209;line method. Leasehold improvements are amortized on a straight&amp;#8209;line basis over the shorter of the useful life or term of the lease. Upon retirement or disposal, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is recorded to general and administrative expenses in the accompanying statement of operations and comprehensive loss. Routine expenditures for maintenance and repairs are expensed as incurred.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Estimated useful lives for property and equipment are as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Estimated&amp;nbsp;Useful&amp;nbsp;Life&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Computers and peripherals&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;3&amp;nbsp;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;5&amp;nbsp;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;7&amp;nbsp;years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Lesser of estimated useful life or remaining lease term&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Construction in Progress&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Construction in progress (Note&amp;nbsp;4) is carried at cost and consists of specifically identifiable direct and indirect development and construction costs. While under construction, costs of the property are included in construction in progress until the property is placed in service, at which time costs are transferred to the appropriate property and equipment account including, but not limited to, leasehold improvements or other such accounts.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Impairment of Long&amp;#8209;Lived Assets&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company reviews the recoverability of its long&amp;#8209;lived asset group when events or changes in circumstances occur that indicate that the carrying value of the asset group may not be recoverable. The assessment of possible impairment is based on the ability to recover the carrying value of the asset group from the expected future cash flows (undiscounted and without interest expense) of the related operations. If these cash flows are less than the carrying value of such asset group, an impairment loss for the difference between the estimated fair value and carrying value is recorded. There was no impairment loss recognized during the&amp;nbsp;years ended December&amp;nbsp;31, 2018 or 2017.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Preferred Stock&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company&amp;#x2019;s preferred stock is classified outside of stockholders&amp;#x2019; deficit because the shares contain deemed liquidation rights that are a contingent redemption feature not solely within the control of the Company.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Research and Development Costs&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Expenditures, including payroll, contractor expenses and supplies, for research and development of products are expensed as incurred. Development costs incurred by third parties are expensed as the contracted work is performed. Where contingent milestone payments are due to third parties under research and development arrangements, the milestone payment obligations are expensed when the milestone results are probable of being achieved.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Patent Costs&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;All patent&amp;#8209;related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses in the accompanying statement of operations and comprehensive loss.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Stock&amp;#8209;Based Compensation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company accounts for its stock&amp;#8209;based compensation in accordance with ASC Topic 718, &lt;/font&gt;&lt;font style="display:inline;font-style:italic;"&gt;Compensation&amp;#8209;Stock Compensation&lt;/font&gt;&lt;font style="display:inline;"&gt; (&amp;#x201C;ASC 718&amp;#x201D;). ASC 718 requires all share&amp;#8209;based payments to employees, consultants and directors, including grants of incentive stock options, nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company, to be recognized as expense in the statement of operations and comprehensive loss based on their grant date fair values. The Company estimates the fair value of options granted using the Black&amp;#8209;Scholes option pricing model (&amp;#x201C;Black&amp;#8209;Scholes&amp;#x201D;) for stock option grants to both employees and non&amp;#8209;employees and the fair value of common stock to determine the fair value of restricted stock.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company recognizes forfeitures as they occur as allowed by ASU No.&amp;nbsp;2016&amp;#8209;09, &lt;/font&gt;&lt;font style="display:inline;font-style:italic;"&gt;Improvements to Employee Share&amp;#8209;Based Payment Accounting&lt;/font&gt;&lt;font style="display:inline;"&gt; (&amp;#x201C;ASU&amp;nbsp;2016&amp;#8209;09&amp;#x201D;).&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Black&amp;#8209;Scholes option pricing model requires inputs based on certain subjective assumptions, including (i)&amp;nbsp;the expected stock price volatility, (ii)&amp;nbsp;the expected term of the award, (iii)&amp;nbsp;the risk&amp;#8209;free interest rate and (iv)&amp;nbsp;expected dividends. Due to the lack of a public market for the Company&amp;#x2019;s common stock and lack of company&amp;#8209;specific historical and implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with expected term assumption. The Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No.&amp;nbsp;107, Share&amp;#8209;Based Payment, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the Company does not expect substantially different exercise or post&amp;#8209;vesting termination behavior among its employee population. For options granted to non&amp;#8209;employees, the Company utilizes the simplified method also as the basis for the expected term assumption. The risk&amp;#8209;free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;There are significant judgments and estimates inherent in the determination of the fair value of the Company&amp;#x2019;s common stock. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of preferred stock, the superior rights and preferences of securities senior to its common stock at the time of, and the likelihood of, achieving a liquidity event, such as an initial public offering or sale.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company expenses the fair value of its share&amp;#8209;based compensation awards on a straight&amp;#8209;line basis over the requisite service period, which is generally the vesting period.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Income Taxes&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities, which relate primarily to the carrying amount of the Company&amp;#x2019;s property and equipment and its net operating loss carryforwards, are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, the Company concludes that it is more&amp;#8209;likely&amp;#8209;than&amp;#8209;not that the deferred tax assets will not be realized. In evaluating its ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction&amp;#8209;by&amp;#8209;jurisdiction basis. Because of the uncertainty of the realization of deferred tax assets, the Company has recorded a full valuation allowance against its deferred tax assets.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Reserves are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more&amp;#8209;likely&amp;#8209;than&amp;#8209;not to be sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the provision of income taxes; however, the Company currently has no interest or penalties related to uncertain income tax benefits.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Revenue Recognition&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company has adopted ASC Topic 606, Revenue from Contracts with Customers (&amp;#x201C;ASC 606&amp;#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral or dependent to other goods or services in the contract.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration which is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company&amp;#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&amp;#x2019;s control or the licensee&amp;#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related&amp;nbsp;revenue recognition.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&amp;#x2019;s right to consideration is unconditional.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Comprehensive Loss&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company did not have any other comprehensive income or loss for any of the periods presented and, therefore, comprehensive loss did not differ from net loss.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Net Loss per Share&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two&amp;#8209;class method required for participating securities. The Company considers its Series&amp;nbsp;A Preferred Stock and Series&amp;nbsp;B Preferred Stock to be participating securities because in the event a dividend is paid on common stock, the holders of Series&amp;nbsp;A Preferred Stock and Series&amp;nbsp;B Preferred Stock would be entitled to receive dividends on a basis consistent with the common stockholders. Under the two&amp;#8209;class method, the net loss attributable to common stockholders is not allocated to the preferred stock as the holders of the preferred stock do not have a contractual obligation to share in losses.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Under the two&amp;#8209;class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In March&amp;nbsp;2016, the FASB issued ASU&amp;nbsp;No.&amp;nbsp;2016&amp;#8209;08, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic&amp;nbsp;606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;08&amp;#x201D;), which clarified the revenue recognition implementation guidance on principal versus agent considerations. In April&amp;nbsp;2016, the FASB issued ASU No.&amp;nbsp;2016&amp;#8209;10, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;10&amp;#x201D;), which clarified the revenue recognition guidance regarding the identification of performance obligations and the licensing implementation. In May&amp;nbsp;2016, the FASB issued ASU No.&amp;nbsp;2016&amp;#8209;12, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606): Narrow&amp;#8209;Scope Improvements and Practical Expedients&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;12&amp;#x201D;), which narrowly amended the revenue recognition guidance regarding collectability, noncash consideration, presentation of sales tax and transition. ASU No.&amp;nbsp;2016&amp;#8209;08, ASU No.&amp;nbsp;2016&amp;#8209;10 and ASU 2016&amp;#8209;12 are effective during the same period as ASU No.&amp;nbsp;2014&amp;#8209;09, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2014&amp;#8209;09&amp;#x201D;), which is effective for the Company for fiscal&amp;nbsp;years beginning after December 15, 2018 and interim periods within fiscal&amp;nbsp;years beginning after December&amp;nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016&amp;#8209;08, ASU 2016&amp;#8209;10, ASU&amp;nbsp;2016&amp;#8209;12 and ASU&amp;nbsp;2014&amp;#8209;09 as of January 1, 2018 on a retrospective basis. There was no revenue in previous years and the adoption of ASC 606 did not have any impact on prior year financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In August&amp;nbsp;2016, the FASB issued ASU No.&amp;nbsp;2016&amp;#8209;15, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;15&amp;#x201D;). ASU 2016&amp;#8209;15 eliminates the diversity in practice related to the classification of certain cash receipts and payments for debt prepayment or extinguishment costs, the maturing of a zero-coupon bond, the settlement of contingent liabilities arising from a business combination, proceeds from insurance settlements, distributions from certain equity method investees and beneficial interests obtained in a financial asset securitization. ASU 2016&amp;#8209;15 designates the appropriate cash flow classification, including requirements to allocate certain components of these cash receipts and payments among operating, investing and financing activities. The retrospective transition method, requiring adjustment to all comparative periods presented, is required unless it is impracticable for some of the amendments, in which case those amendments would be prospectively applied as of the earliest date practicable. ASU 2016&amp;#8209;15 is effective for the Company for fiscal&amp;nbsp;years beginning after December 15, 2018 and interim periods within fiscal&amp;nbsp;years beginning after December&amp;nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016-15 as of January 1, 2018.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In November&amp;nbsp;2016, the FASB issued ASU No.&amp;nbsp;2016&amp;#8209;18, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Statement of Cash Flows (Topic 230): Restricted Cash&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;18&amp;#x201D;), which requires that a statement of cash flows explain the change during the period in the total cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning and ending balances shown on the statement of cash flows. The guidance is effective for the Company for fiscal&amp;nbsp;years beginning after December 15, 2018 and interim periods within fiscal years beginning after December&amp;nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU&amp;nbsp;2016&amp;#8209;18 as of January&amp;nbsp;1, 2017.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In May&amp;nbsp;2017, the FASB issued ASU No.&amp;nbsp;2017&amp;#8209;09, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Compensation&amp;#x2014;Stock Compensation (Topic 718): Scope of Modification Accounting&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2017&amp;#8209;09&amp;#x201D;), which clarifies when to account for a change to the terms or conditions of a share&amp;#8209;based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions of the agreement. The standard is effective for fiscal&amp;nbsp;years, and interim periods within those&amp;nbsp;years, beginning after December&amp;nbsp;15, 2017. The Company adopted ASU 2017&amp;#8209;09 as of the required effective date of January&amp;nbsp;1, 2018. In June&amp;nbsp;2018, the FASB issued ASU No.&amp;nbsp;2018&amp;#8209;07&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt; Compensation&amp;#x2014;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU No.&amp;nbsp;2018&amp;#8209;07&amp;#x201D;). ASU No.&amp;nbsp;2018&amp;#8209;07 expands the guidance in ASC718 to include share-based payments for goods and services to non-employees and generally aligns it with the guidance for share-based payments to employees. The amendments are effective for the Company for fiscal&amp;nbsp;years beginning after December&amp;nbsp;15, 2019 and interim periods within fiscal years beginning after December 15, 2020, with early adoption permitted for entities that have adopted ASC 606. The Company adopted this new standard on January&amp;nbsp;1, 2018.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Recently Issued Accounting Pronouncements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In February&amp;nbsp;2016, the FASB issued ASU No.&amp;nbsp;2016&amp;#8209;02, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"&gt;Leases&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt; (&amp;#x201C;ASU 2016&amp;#8209;02&amp;#x201D;). The new guidance requires lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016&amp;#8209;02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right&amp;#8209;to&amp;#8209;use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company for fiscal&amp;nbsp;years beginning after December 15, 2019 and interim periods fiscal&amp;nbsp;years beginning after December&amp;nbsp;15, 2020. Early adoption &lt;/font&gt;&lt;font style="display:inline;"&gt;is permitted. The Company is currently evaluating the effect of this standard on its financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;a name="_cp_text_4_25"&gt;&lt;/a&gt;&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy id="Fact-fb067c99-8a6e-4f11-b2f0-0c8a9fda6647_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Preferred Stock&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company&amp;#x2019;s preferred stock is classified outside of stockholders&amp;#x2019; deficit because the shares contain deemed liquidation rights that are a contingent redemption feature not solely within the control of the Company.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-89535102-d6a8-4716-b4be-672c473a2908_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">4000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:SubsequentEventsTextBlock id="Fact-d380dfe9-1b05-4c9f-acf2-1174bc7e8dde_20181231" contextRef="D2018-01-01_2018-12-31">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;16. Subsequent Events&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On January&amp;nbsp;25, 2019, the Company amended its Term Loan to an aggregate principal amount of $5.0&amp;nbsp;million, which remains secured by the Company&amp;#x2019;s certificates of deposit, money market account, investment property and deposit or investment accounts. As amended, the Term Loan bears interest at the greater of the prime rate less 1% and 4.25%. Under the agreement, the Company is required to make&amp;nbsp;monthly interest&amp;#8209;only payments through January&amp;nbsp;2020 and is required to make 36 equal&amp;nbsp;monthly payments of principal plus accrued interest thereafter through January&amp;nbsp;2023.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On January&amp;nbsp;30, 2019, the Company entered into a new lease for 14,075 square feet to be used for office, manufacturing and laboratory space, which the Company expects to take possession of in June&amp;nbsp;2019. The new lease is expected to expire in March&amp;nbsp;2030 and will also cover the Company&amp;#x2019;s existing space after expiration of the Company&amp;#x2019;s current lease. Base rent for the first 10 months is abated, after which the base rent of the lease is $19,650 per&amp;nbsp;month, with an increase in annual rent of 3.0% in each subsequent&amp;nbsp;year of the lease term.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On March&amp;nbsp;15, 2019, the Company entered into an amended and restated lease that covers the Company&amp;#x2019;s existing space plus additional square footage to be used as office space, which the Company took possession of upon entering into the amended and restated lease. The amended and restated lease expires in August 2025. The total remaining commitment under the amended and restated lease is approximately $3.0&amp;nbsp;million.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On May&amp;nbsp;3, 2019, the Company effected a 1&amp;#8209;for&amp;#8209;8.0338 reverse stock split of its outstanding common stock. The par value and authorized shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense id="Fact-dee663a1-5d49-4b53-9750-0c93bdd4d562_20181231" decimals="-3" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount id="Fact-529cfc03-7a62-45f9-a690-11dca843f8f8_20181231" decimals="-5" contextRef="D2018-01-01_2018-12-31" unitRef="iso4217-USD">8000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact-2c507ed5-3921-47ab-95d6-bd328b255887_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-shares">1369846</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact-f53a78f6-9135-4125-962a-2060ba60cb43_20181231" decimals="0" contextRef="D2018-01-01_2018-12-31" unitRef="xbrli-shares">1369846</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <nxtc:CollaborativeArrangementUpfrontNonRefundablePaymentReceived id="Fact-fd8137e7-da82-414d-8c89-29f156dc9d5c_20181231" decimals="-5" contextRef="D2018-11-01_2018-11-30_us-gaap-RelatedPartyTransactionsByRelatedPartyAxis_nxtc-EliLillyAndCompanyMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">25000000</nxtc:CollaborativeArrangementUpfrontNonRefundablePaymentReceived>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-9e33d166-a1b4-45fa-8323-0b5aafbbd9a0_20190630" decimals="-5" contextRef="D2018-11-02_2018-11-02_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">15000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <nxtc:RevenueRecognitionNumberOfPerformanceObligations id="Fact-5f822b62-f5dd-494f-a20b-3bc3fcfbbda6_20181231" decimals="0" contextRef="D2018-11-02_2018-11-02_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="nxtc-item">2</nxtc:RevenueRecognitionNumberOfPerformanceObligations>
  <nxtc:CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement id="Fact-aaf17186-770e-4a85-b239-ac8317cc75b8_20181231" contextRef="D2018-11-02_2018-11-02_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember">P4Y</nxtc:CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement>
  <nxtc:CollaborativeArrangementUpfrontNonRefundablePaymentReceived id="Fact-58d099d9-2670-4f09-b55e-ab7b27370f75_20181231" decimals="-5" contextRef="D2018-11-02_2018-11-02_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">25000000</nxtc:CollaborativeArrangementUpfrontNonRefundablePaymentReceived>
  <nxtc:CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise id="Fact-f6bba081-0ea5-4b87-b6ad-9b52f67b19a4_20181231" decimals="-5" contextRef="I2018-11-02_srt-CounterpartyNameAxis_nxtc-EliLillyAndCompanyMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">710000000</nxtc:CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise>
  <nxtc:CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable id="Fact-032593a7-eef9-4bc8-aa0e-716361b3b455_20181231" decimals="-8" contextRef="I2018-11-02_srt-CounterpartyNameAxis_nxtc-EliLillyAndCompanyMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">1400000000</nxtc:CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable>
  <nxtc:AnnualBaseRentPerMonthAfterAbatement id="Fact-08c27896-652c-4e5d-af68-f38af6ad8bd2_20181231" decimals="0" contextRef="D2019-01-30_2019-01-30_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember" unitRef="iso4217-USD">19650</nxtc:AnnualBaseRentPerMonthAfterAbatement>
  <nxtc:PercentageOfAnnualIncreaseInLeaseRent id="Fact-78c174c8-00f8-4c70-9061-c21c2f350dc0_20181231" decimals="3" contextRef="D2019-01-30_2019-01-30_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember" unitRef="xbrli-pure">0.030</nxtc:PercentageOfAnnualIncreaseInLeaseRent>
  <nxtc:PeriodForWhichBaseRentIsAbated id="Fact-189f1a07-1916-4378-9a2d-4295f1ff6ecb_20181231" contextRef="D2019-01-30_2019-01-30_us-gaap-SubsequentEventTypeAxis_us-gaap-SubsequentEventMember">P10M</nxtc:PeriodForWhichBaseRentIsAbated>
  <nxtc:AccruedConstructionInProgressCurrent id="Fact-3d305989-fe18-4ebd-9555-08833f9e058d_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">515000</nxtc:AccruedConstructionInProgressCurrent>
  <nxtc:AccruedOperatingExpensesCurrent id="Fact-93ae229e-fa18-4061-b3da-6b51fea2310f_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">450000</nxtc:AccruedOperatingExpensesCurrent>
  <nxtc:DeferredTaxLiabilitiesDepreciationAndAmortization id="Fact-df4cf945-bc31-4d2b-a4b4-6bba2ba96b9a_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">260000</nxtc:DeferredTaxLiabilitiesDepreciationAndAmortization>
  <us-gaap:AccountsPayableCurrent id="Fact-71e6d7ea-0e16-4afc-a82d-a5f66f9af3c9_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">1141000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="Fact-e861df31-116b-4ae3-be32-85be6ea2a272_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">1564000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="Fact-27708515-6b2e-4662-9693-48662e258f6e_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">1564000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedRentCurrent id="Fact-3fd758f1-8b76-479f-85ac-413db3432254_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">104000</us-gaap:AccruedRentCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Fact-d5fbea4b-c73b-474c-99f4-1b85d55c19da_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">792000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AdditionalPaidInCapital id="Fact-df6fd6c3-bd53-4115-b63c-a046573393e6_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">75000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:Assets id="Fact-a8ca8b3e-5751-4454-8e7d-b2b335146a17_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">19467000</us-gaap:Assets>
  <us-gaap:AssetsCurrent id="Fact-69ab6d03-8730-4f56-8b1d-dd44cb01c50d_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">9420000</us-gaap:AssetsCurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Fact-108d50ab-dfb2-45f1-9f1e-c04ce41406b0_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">8427000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Fact-1b86f5ec-8aa2-4f97-befa-711b9f1c3797_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">8427000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommitmentsAndContingencies id="Fact-bf6788db-3e90-4cd8-9e54-193c3a0a5587_20181231" xsi:nil="true" contextRef="I2017-12-31" unitRef="iso4217-USD" />
  <us-gaap:CommonStockParOrStatedValuePerShare id="Fact-47ff4312-7abf-4208-a111-86e40a2096f1_20181231" decimals="INF" contextRef="I2017-12-31" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="Fact-0bd3cfaa-5028-4315-8927-0e5c610701e6_20181231" decimals="INF" contextRef="I2017-12-31" unitRef="xbrli-shares">84045455</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="Fact-54fba797-1528-4550-b3a5-a17d7a371e61_20181231" decimals="INF" contextRef="I2017-12-31" unitRef="xbrli-shares">1369212</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="Fact-60fd900d-1227-4e03-830b-32c3375c469f_20181231" decimals="INF" contextRef="I2017-12-31" unitRef="xbrli-shares">1369212</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue id="Fact-6a796f82-873e-4194-b255-89d1c1d2f9cf_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">11000</us-gaap:CommonStockValue>
  <us-gaap:DeferredIncomeTaxLiabilities id="Fact-a0217b84-9cad-45bd-8f9d-6edc57613e9f_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">260000</us-gaap:DeferredIncomeTaxLiabilities>
  <us-gaap:DeferredRentCreditCurrent id="Fact-889ca15a-2fe0-4644-b742-f9703f24380c_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">19000</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRentCreditNoncurrent id="Fact-92ca4ca9-ec4a-442e-a930-170ab1996c62_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">295000</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards id="Fact-71234e11-25f0-4e81-b760-35bbae04faf9_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">153000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
  <us-gaap:DeferredTaxAssetsGross id="Fact-974a7cba-8aec-42e9-bb08-b63aad7c3f8a_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">7751000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsNet id="Fact-6654734c-227d-4ce1-88a9-ca0fdbd333e0_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">260000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards id="Fact-ae6a6037-f1c3-4627-8da6-cd4703637f7b_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">6176000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsOther id="Fact-1f23f14f-de18-4cc9-9a1a-da13a15f873f_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">4000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch id="Fact-696dcdb9-be07-4a14-8d46-17fa91c1cadf_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">1283000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals id="Fact-90e30608-2fb9-4947-b916-0775c4103958_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">135000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
  <us-gaap:DeferredTaxAssetsValuationAllowance id="Fact-67b2e926-3b68-4420-9101-0141ef9db683_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">7491000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="Fact-3a157334-9e0e-45f6-9c99-70a3857591d4_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">493000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount id="Fact-1a4864fe-5dcc-49bf-bdd5-29bd7434a62a_20181231" decimals="0" contextRef="I2017-12-31" unitRef="iso4217-USD">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
  <us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount id="Fact-b9074595-7f51-4118-8954-d099b7aef128_20181231" decimals="0" contextRef="I2017-12-31" unitRef="iso4217-USD">0</us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount>
  <us-gaap:InterestPayableCurrent id="Fact-a212bfef-a529-4734-8e55-59658532bc28_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">2000</us-gaap:InterestPayableCurrent>
  <us-gaap:Liabilities id="Fact-2d9acfd1-ecb3-4c38-8b81-27b4f81b46d5_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">3879000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Fact-2508bbe1-5215-432c-9911-e4eca369fddb_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">19467000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent id="Fact-660db455-0890-4136-9d9a-7c7b3255dc3c_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">3124000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermDebtCurrent id="Fact-c0ec330c-8a74-4793-a14a-7369f34b5546_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">400000</us-gaap:LongTermDebtCurrent>
  <us-gaap:LongTermDebtNoncurrent id="Fact-5b5d69fc-81cd-4e2b-8c5e-b9cfead8fe6c_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">460000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:OtherAssetsNoncurrent id="Fact-8c5f5c7f-f9ea-4160-93a6-aa99f39da4e7_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">26000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Fact-4daf4d14-13a5-4b93-bd2e-463791bcfa7b_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">133000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-507ed6bb-6d84-4bad-a5bc-221c41cbe522_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">10813000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentNet id="Fact-53abfa11-55cf-467c-bd10-ba72af15213d_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">10021000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="Fact-ea84abb6-e422-427e-abe0-6b42fe36807e_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">10021000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:RestrictedCashCurrent id="Fact-109131ca-c89a-4d0b-81c4-0398d18c20ad_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">860000</us-gaap:RestrictedCashCurrent>
  <us-gaap:RestrictedCashCurrent id="Fact-672d75fa-8e7a-4970-bdcf-76a9b97c563b_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">860000</us-gaap:RestrictedCashCurrent>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Fact-f1bcea32-09b6-47e6-afc2-3720d900554c_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">-24498000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-e06aea60-1f9f-4141-9aef-6e70377ae477_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">40000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Fact-5dccb6f0-700e-4b73-bc6a-b1e05cc726d1_20181231" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">9287000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:StockholdersEquity id="Fact-e8d8850d-3ec4-49dc-89ef-3c628e62c04c_20190630" decimals="-3" contextRef="I2017-12-31" unitRef="iso4217-USD">-24413000</us-gaap:StockholdersEquity>
  <nxtc:RelatedPartyTransactionsDeferredRevenue id="Fact-f0de0068-8572-41d6-8329-1ca5accd9988_20190630" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">26725000</nxtc:RelatedPartyTransactionsDeferredRevenue>
  <nxtc:RelatedPartyTransactionsDeferredRevenue id="Fact-90e637b7-a94a-4eec-af98-4a5d6fdbac0a_20190630" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">26725000</nxtc:RelatedPartyTransactionsDeferredRevenue>
  <nxtc:RestrictedCashAndOtherAssetsCurrent id="Fact-1ef15b2d-89e5-4040-ad55-e405ee3cacbc_20190630" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">460000</nxtc:RestrictedCashAndOtherAssetsCurrent>
  <us-gaap:PreferredStockSharesIssued id="Fact-16b5b327-b3f4-4a7e-a0fd-c51edf5ea341_20190630" decimals="0" contextRef="I2018-12-31" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="Fact-762e45f9-8654-4883-a228-a686ae454b9e_20190630" decimals="0" contextRef="I2018-12-31" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue id="Fact-ae58dc64-2596-46b2-99d1-f69a59948917_20190630" xsi:nil="true" contextRef="I2018-12-31" unitRef="iso4217-USD" />
  <nxtc:AccruedClinicalTrialCostsCurrent id="Fact-433232ca-daf5-4005-8e83-8944cab8b5d9_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">271000</nxtc:AccruedClinicalTrialCostsCurrent>
  <nxtc:AccruedFinancingCostsCurrent id="Fact-46feb7e5-273e-45b4-a5aa-34ca1db9e08c_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">284000</nxtc:AccruedFinancingCostsCurrent>
  <nxtc:AccruedOperatingExpensesCurrent id="Fact-30aa667e-5635-45f0-957a-e8a66bb33949_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">719000</nxtc:AccruedOperatingExpensesCurrent>
  <nxtc:DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal id="Fact-29c5e13c-27e6-437f-a9e5-949aa2d3fd66_20181231" decimals="-5" contextRef="I2018-12-31" unitRef="iso4217-USD">2500000</nxtc:DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal>
  <nxtc:DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState id="Fact-4aeaacf1-7cb2-487c-b966-e829a412f655_20181231" decimals="-5" contextRef="I2018-12-31" unitRef="iso4217-USD">1100000</nxtc:DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState>
  <nxtc:DeferredTaxLiabilitiesDepreciationAndAmortization id="Fact-579329a9-710f-40af-875c-6f74a94ab813_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">292000</nxtc:DeferredTaxLiabilitiesDepreciationAndAmortization>
  <us-gaap:AccruedRentCurrent id="Fact-2c90a798-b5df-4104-9cbd-c1ac07ab1926_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">127000</us-gaap:AccruedRentCurrent>
  <us-gaap:DeferredIncomeTaxLiabilities id="Fact-0b4e1937-d4d9-46de-896e-5b91cd3e72e0_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">292000</us-gaap:DeferredIncomeTaxLiabilities>
  <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards id="Fact-516609b5-fd6b-4db8-b5ed-d1d2b9a9cbb6_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">165000</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
  <us-gaap:DeferredTaxAssetsGross id="Fact-ad9d48a0-0056-4f99-a542-e7e9c557dc1b_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">15817000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsNet id="Fact-d4a700a2-e811-4f64-abd0-d2213bdb5b8a_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">292000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards id="Fact-cbdb1cda-5ba0-4758-937c-945b3034d5df_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">11946000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic id="Fact-b3366bd2-60cd-466f-b573-497fdabb9732_20181231" decimals="-5" contextRef="I2018-12-31" unitRef="iso4217-USD">43500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration id="Fact-e4c409bc-2278-40f0-ab3c-4e570d76570d_20181231" decimals="-5" contextRef="I2018-12-31" unitRef="iso4217-USD">20800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal id="Fact-0ecb63b3-ed34-4bb5-a426-8122784d05ed_20181231" decimals="-5" contextRef="I2018-12-31" unitRef="iso4217-USD">43000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
  <us-gaap:DeferredTaxAssetsOther id="Fact-9d098f2e-c049-44b4-b121-fe7ea01aba7c_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">23000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch id="Fact-e0868c3b-f364-4072-8d18-2fc28849eaa2_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">3393000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals id="Fact-90e5c528-2bbd-4e9f-b993-2e8df0bcf561_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">290000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
  <us-gaap:DeferredTaxAssetsValuationAllowance id="Fact-f9843d2e-a330-43c3-ace9-01e0bfc8bc54_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">15525000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="Fact-67ee533d-be04-43a3-ae55-ada463dd497b_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">1008000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="Fact-144e4fbb-3d79-4484-9d45-490a1530d727_20181231" decimals="-5" contextRef="I2018-12-31" unitRef="iso4217-USD">6000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount id="Fact-602e73a8-9a50-42f0-9c11-4f66548fdf11_20181231" decimals="0" contextRef="I2018-12-31" unitRef="iso4217-USD">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
  <us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount id="Fact-98473e75-4a8f-4135-813b-2f29193d3d0f_20181231" decimals="0" contextRef="I2018-12-31" unitRef="iso4217-USD">0</us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount>
  <us-gaap:InterestPayableCurrent id="Fact-cff33c79-9de5-409d-addb-0c081ff6b808_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">2000</us-gaap:InterestPayableCurrent>
  <us-gaap:LongTermDebt id="Fact-bfa6920a-ce1f-4e94-9b41-b44a94ddee42_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">460000</us-gaap:LongTermDebt>
  <us-gaap:LongTermDebt id="Fact-302fbc25-196f-4ce2-84d7-8a33d67ff834_20181231" decimals="0" contextRef="I2018-12-31" unitRef="iso4217-USD">460000</us-gaap:LongTermDebt>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths id="Fact-2e687b65-d414-47d5-9f0d-6638f19e80cf_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">387000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo id="Fact-6c99711f-0ab3-4232-b7e6-2aa88825ca88_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">73000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="Fact-4378a7d7-5691-4aa2-94ae-867597848430_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">2275000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="Fact-034a4f49-78b2-4a35-9ffc-1736fef9b05a_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">325000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears id="Fact-76d176bb-f62b-4bb1-a9ea-b0b8743bb66e_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">335000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears id="Fact-a6256597-7122-47b7-b52e-2ada0b9335bd_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">355000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="Fact-27236252-eaf9-4a87-85fb-9b6e378f143f_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">317000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="Fact-d28f44bb-feea-4da8-bb62-016c8d8cff4e_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">308000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter id="Fact-7a110803-d8d9-4948-8157-6dd5cb711bb8_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">635000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:UnrecognizedTaxBenefits id="Fact-4f3d8d6d-cf23-4c31-8c81-a6090dc41e4a_20181231" decimals="-5" contextRef="I2018-12-31" unitRef="iso4217-USD">0</us-gaap:UnrecognizedTaxBenefits>
  <nxtc:RelatedPartyTransactionsDeferredRevenueCurrent id="Fact-0e5a6e3d-2cb1-42e0-bdd8-fe7451548d55_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">4989000</nxtc:RelatedPartyTransactionsDeferredRevenueCurrent>
  <nxtc:RelatedPartyTransactionsDeferredRevenueNoncurrent id="Fact-43f59b0e-44b0-4c64-bb66-2d2fd80d2374_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">21736000</nxtc:RelatedPartyTransactionsDeferredRevenueNoncurrent>
  <us-gaap:AccountsPayableCurrent id="Fact-85f97feb-2dc8-44a0-a32e-b7e30737854e_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">2483000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="Fact-e69d444c-85bc-48f7-a421-008ce60df2bd_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">2411000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Fact-2ee9cb3c-1cff-44f3-a886-8041a48c4f7a_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">2469000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AdditionalPaidInCapital id="Fact-8d438d3a-2d38-490e-9c2a-f16dfc0e2162_20190630" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">352000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:Assets id="Fact-fa4d6e5b-3ca0-42c3-a99b-638069284607_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">147628000</us-gaap:Assets>
  <us-gaap:AssetsCurrent id="Fact-f4ff6724-3bad-4cb7-bb10-51cfd3f7e66f_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">135785000</us-gaap:AssetsCurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Fact-632b8319-29e1-40e4-a289-b8a825abf8d5_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">135173000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Fact-9c1b72b2-7c4f-4c72-ae45-6171f39a29a5_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">135633000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:CommitmentsAndContingencies id="Fact-3ede7b50-85fb-4faf-8108-62e0cf0272c0_20181231" xsi:nil="true" contextRef="I2018-12-31" unitRef="iso4217-USD" />
  <us-gaap:CommonStockParOrStatedValuePerShare id="Fact-8418d412-6494-4fed-a91f-0892d8583387_20181231" decimals="INF" contextRef="I2018-12-31" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="Fact-2562f422-f95c-46e4-954b-12d93a743f43_20190630" decimals="INF" contextRef="I2018-12-31" unitRef="xbrli-shares">158745671</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="Fact-812f7458-a3df-4d30-9e11-6517c092f011_20190630" decimals="INF" contextRef="I2018-12-31" unitRef="xbrli-shares">1374812</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="Fact-852318ee-3235-419f-a5fe-c8480ae35da3_20190630" decimals="INF" contextRef="I2018-12-31" unitRef="xbrli-shares">1374812</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue id="Fact-4d179c7d-9961-4530-afe9-3ca0d8909158_20190630" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">1000</us-gaap:CommonStockValue>
  <us-gaap:DeferredRentCreditCurrent id="Fact-04e6b95a-d28b-49ad-953b-cbf25b9aa023_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">28000</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRentCreditNoncurrent id="Fact-c0825783-4978-43df-8f5a-dd54f93b6138_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">242000</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:Liabilities id="Fact-903d01ee-1266-4e5a-82ac-910028603ed2_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">32349000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Fact-311d5868-97a6-4d40-bfbf-cf5be0a2f910_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">147628000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent id="Fact-a6dd793f-9b4a-4860-9b36-311343aad6db_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">10298000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermDebtCurrent id="Fact-67963fec-f865-47cc-9704-373dd1404476_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">387000</us-gaap:LongTermDebtCurrent>
  <us-gaap:LongTermDebtNoncurrent id="Fact-7b83c338-a952-4577-8723-f6173d2aa1df_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">73000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:OtherAssetsNoncurrent id="Fact-58caacba-f9d3-4215-906b-213db2bef7cd_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">436000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Fact-9bee20af-9140-459f-96ca-e8ff1f154062_20181231" decimals="INF" contextRef="I2018-12-31" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Fact-c3b1bf35-0bb3-4b19-aac2-4ea6c43ce507_20190630" decimals="0" contextRef="I2018-12-31" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Fact-4f0aee3e-9239-4b11-859f-06bf58fc9be6_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">152000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-7007374a-1428-422a-b635-ed86176819d0_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">13876000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentNet id="Fact-e650c1ed-13d8-4a70-8495-702447bed2fb_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">11407000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:RestrictedCashCurrent id="Fact-482776ee-7bba-4146-9e69-d48ecd9ce5c8_20181231" decimals="0" contextRef="I2018-12-31" unitRef="iso4217-USD">460000</us-gaap:RestrictedCashCurrent>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Fact-d4f516bd-2bb3-4c44-93d9-ffe24918e63a_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">-47297000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity id="Fact-b51036ab-9e0c-416e-baff-8059ac5f1abe_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">-46944000</us-gaap:StockholdersEquity>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-98dba667-426e-43d5-b528-2c916b3b414a_20181231" decimals="-3" contextRef="I2018-12-31" unitRef="iso4217-USD">162223000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-6076dd12-6cf3-4d68-bb39-4fcd5d1b39d3_20190630" decimals="-3" contextRef="I2019-03-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">91223000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesOutstanding id="Fact-1f3e929c-0a89-4850-95a6-740d3225d106_20190630" decimals="0" contextRef="I2019-03-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">56828851</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-51cccdb4-c348-44df-97b8-c4aaf55c3d2a_20190630" decimals="-3" contextRef="I2019-03-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">71000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesOutstanding id="Fact-cb2237c7-7deb-4b48-9f0a-10f515e9b20e_20190630" decimals="0" contextRef="I2019-03-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">68181819</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-6ec4c6a3-a542-4e86-ab3d-819b81758ea4_20190630" decimals="-3" contextRef="I2018-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">71000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesOutstanding id="Fact-ba816a1e-e459-4288-a363-60a0a92cb924_20190630" decimals="0" contextRef="I2018-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">68181819</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-3bf27c0d-2225-49da-91d5-52efe7bf40e6_20190630" decimals="-3" contextRef="I2018-06-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">71000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesOutstanding id="Fact-1d45bf3b-0e4f-411f-9c46-6b7e596399db_20190630" decimals="0" contextRef="I2018-06-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">68181819</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Fact-e8bdde5f-2c22-46cf-a22b-d51214af47cd_20190630" decimals="-3" contextRef="I2018-03-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">40000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesOutstanding id="Fact-e1b25275-7323-47b4-8db4-3e060fc94e67_20190630" decimals="0" contextRef="I2018-03-31_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">40000000</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-3cf16b29-63a7-44ff-aa6a-4b69a2ca2819_20190630" decimals="0" contextRef="D2019-07-01_2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">24580</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-b1612be9-dc9a-4414-8d96-cea8a999bf95_20190630" decimals="0" contextRef="D2019-01-01_2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">4697</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits id="Fact-dd0cbe04-5dce-484c-935f-2c108c73e7e8_20190630" decimals="0" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">-56828851</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="Fact-b0575e80-60b1-4807-b708-bce7100055be_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">-91223000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits id="Fact-517c0506-2c66-4961-8fab-5305a79b390c_20190630" decimals="0" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">-68181819</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="Fact-58bbf6ef-2cf9-4d19-89d9-c5ecfbc92dc1_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">-71000000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockholdersEquity id="Fact-b2349575-c6e4-4426-8d9c-e9fd98f0ee4b_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-70107000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-64c536e6-06e1-4b7b-8ea0-43c7030e586d_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">240791000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-876b7568-bff7-4fb2-9aec-58609a9a27ef_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AccumulatedOtherComprehensiveIncomeMember" unitRef="iso4217-USD">-58000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-9162c02c-cf51-4b21-ac9f-969b76154f14_20190630" decimals="-3" contextRef="I2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-61673000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-031cbf75-dd6d-4835-979c-a8733ae51644_20190630" decimals="-3" contextRef="I2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">240245000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-d0276b25-d803-4490-8107-7d4693fa6b57_20190630" decimals="-3" contextRef="I2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-53452000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-fb760dc6-260b-4042-955e-8b0f4d27456e_20190630" decimals="-3" contextRef="I2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">739000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-4d84cded-9560-4422-ae1c-ad2463a6fd59_20190630" decimals="-3" contextRef="I2019-03-31" unitRef="iso4217-USD">-52712000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-a6c1b729-7d5c-4426-8099-5487ccb060ea_20190630" decimals="-3" contextRef="I2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-40435000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-ea4d3591-4181-44f8-9149-ae9ef51e82e4_20190630" decimals="-3" contextRef="I2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">222000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-fc9f61f9-b95a-4cca-913a-6de7a1e782f2_20190630" decimals="-3" contextRef="I2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-34725000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-28df9231-4b43-43fa-af12-615986bf5a26_20190630" decimals="-3" contextRef="I2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">132000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-2492bb4f-9169-4586-a498-1c22772d221d_20190630" decimals="-3" contextRef="I2018-06-30" unitRef="iso4217-USD">-34592000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-b36e9242-f00c-4cb1-973a-c25969bcfd3a_20190630" decimals="-3" contextRef="I2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-29494000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-8cc54ac7-e4ba-46ad-8433-3801c93dd1b6_20190630" decimals="-3" contextRef="I2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">108000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-9245c862-1bd5-4c3b-8b4b-e26b11085574_20190630" decimals="-3" contextRef="I2018-03-31" unitRef="iso4217-USD">-29385000</us-gaap:StockholdersEquity>
  <us-gaap:SharePrice id="Fact-8c2cb679-7475-4fe4-88b4-63de80c791a1_20190630" decimals="INF" contextRef="I2019-05-13_us-gaap-SubsidiarySaleOfStockAxis_us-gaap-IPOMember" unitRef="iso4217-USD_xbrli-shares">15.00</us-gaap:SharePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Fact-35edda29-3dd2-4157-989d-ea8f070b2a72_20190630" contextRef="D2018-12-31_2018-12-31_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P9Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="Fact-3ef1ca78-a449-4e6c-a925-e88682e0ad63_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">55305000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Fact-b6095a8e-d821-4626-8bd3-e0832d032086_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">2248953</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Fact-f2ab5a11-2ed9-4c49-81e8-b59123f8ce31_20190630" decimals="2" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">6.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue id="Fact-85e4399b-9670-4fa6-9d91-ed309dfebd87_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">12335000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber id="Fact-bc4e6c2b-a700-402e-9403-fb5c79c102ce_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">450866</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice id="Fact-f8b5b0ac-5d26-46b2-a81b-e8c0cf3af84a_20190630" decimals="2" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">1.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue id="Fact-df60dedb-8dc0-4d42-900e-f793ada851d7_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">55305000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber id="Fact-55b26784-b341-4b50-ad6b-4409f9b9fa12_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">2248953</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice id="Fact-25f79e23-060a-4822-949d-90c0e823ae83_20190630" decimals="2" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">6.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact-84118d41-a833-4e3b-b7b7-8dd2867dbdfb_20190630" decimals="-5" contextRef="D2019-07-01_2019-09-30_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">1600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-1fe10f62-cc7a-4a69-9e90-ece073d652a0_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-LeaseholdImprovementsMember" unitRef="iso4217-USD">5365000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-78bb5d0f-3ae3-4d86-a242-8bf9f85469a5_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-FurnitureAndFixturesMember" unitRef="iso4217-USD">94000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-80920f28-7f09-418b-9732-2c14fd591670_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ConstructionInProgressMember" unitRef="iso4217-USD">787000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-f3fa20a4-d76e-4c29-b16f-fd28a135dcf5_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-PropertyPlantAndEquipmentByTypeAxis_us-gaap-ComputerEquipmentMember" unitRef="iso4217-USD">441000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-f628b1cd-dc3a-42da-958d-ab9484e1a766_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-PropertyPlantAndEquipmentByTypeAxis_nxtc-ResearchEquipmentMember" unitRef="iso4217-USD">9746000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Fact-d87bd325-ae91-4c6a-9024-00c70c00ca6e_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Fact-38ca342f-e567-44d4-9f0d-0a0395a2a45b_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="Fact-8e677b01-b836-425d-bfda-0ae4182b415c_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="Fact-528e1888-40d7-449d-91fc-f869f7129406_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesBPreferredStockMember" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Fact-1a684f0b-4194-46a9-991c-5c6f9ef6d0b4_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Fact-dd732c9f-d797-42c8-aca4-638ad28a2337_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="Fact-0fad6fb0-8e08-4776-a820-3bcac936160a_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="Fact-d00b15b3-04f6-4304-be32-a65ecabbaa47_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="Fact-a396b797-f335-4320-8429-49ec3aa8b556_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AccumulatedOtherComprehensiveIncomeMember" unitRef="iso4217-USD">-58000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss id="Fact-9ba47bb6-7062-41ec-a083-6499b1eb051a_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-8434000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Fact-30ed40a0-817c-4754-b3dd-ba4878f5d752_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-8221000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Fact-49c9a28f-ef65-4075-a438-38e5543b1693_20190630" decimals="-3" contextRef="D2019-01-01_2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-6155000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Fact-116d770d-2966-429a-9a30-b024d24c1689_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-5710000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Fact-a3d27124-5030-4915-9f7b-bb77562469c3_20190630" decimals="-3" contextRef="D2018-04-01_2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-5231000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Fact-9bbaeae0-4fd5-4974-a031-ec92c6ad78d8_20190630" decimals="-3" contextRef="D2018-01-01_2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-RetainedEarningsMember" unitRef="iso4217-USD">-4996000</us-gaap:NetIncomeLoss>
  <us-gaap:DebtInstrumentFaceAmount id="Fact-f99c3276-1596-407e-b895-cc22b555baec_20190630" decimals="-5" contextRef="I2019-01-25" unitRef="iso4217-USD">5000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Fact-dfc0c50d-d28f-407f-921d-9bac6a371273_20190630" decimals="2" contextRef="D2019-01-25_2019-01-25_srt-RangeAxis_srt-MaximumMember_us-gaap-VariableRateAxis_us-gaap-PrimeRateMember" unitRef="xbrli-pure">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:CommonStockSharesOutstanding id="Fact-9081cc9c-d525-4c54-8a8a-0c955c178e01_20190630" decimals="0" contextRef="I2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">22739345</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity id="Fact-dbaeb938-2ff6-45a2-afce-fe76815e7192_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">23000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding id="Fact-e5968771-0b5c-43a0-ab3b-1a0ac22f2086_20190630" decimals="0" contextRef="I2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">22714765</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity id="Fact-191e38e3-09e6-4205-b5cc-d771597e89b4_20190630" decimals="-3" contextRef="I2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">23000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding id="Fact-850e9736-9a23-41d5-a09d-7238d6d73092_20190630" decimals="0" contextRef="I2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">1379509</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity id="Fact-496d565c-b3a4-42ea-bffd-5e052aad63d1_20190630" decimals="-3" contextRef="I2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">1000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding id="Fact-63e962f5-c839-4a37-b1c0-2703af02a86a_20190630" decimals="0" contextRef="I2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">1369212</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity id="Fact-e501fcc7-981d-4feb-8694-65f040c31e78_20190630" decimals="-3" contextRef="I2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">1000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding id="Fact-0f33073a-b118-4b1d-affd-9c6a49d09978_20190630" decimals="0" contextRef="I2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">1369212</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity id="Fact-4286ada0-cebb-4e67-a106-1991e18524c2_20190630" decimals="-3" contextRef="I2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">1000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding id="Fact-12b0a46f-fe90-42ca-83e2-4e68a65a47b5_20190630" decimals="0" contextRef="I2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">1369212</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity id="Fact-a93475ab-9a4b-4e9a-bb37-e07fb3062bb3_20190630" decimals="-3" contextRef="I2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">1000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Fact-cf1a66a0-ef9a-4df6-a802-ae6e14eaf6d6_20190630" decimals="INF" contextRef="I2019-06-30" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:StockholdersEquity id="Fact-3fe6e026-17ca-48fd-bab0-359dfdd9336d_20190630" decimals="-3" contextRef="I2019-06-30" unitRef="iso4217-USD">178595000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Fact-59274f08-4969-4ae9-b46c-d3b493847c94_20190630" decimals="INF" contextRef="I2019-05-13" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="Fact-a559373d-1103-4499-8c97-738945aa34be_20190630" decimals="INF" contextRef="I2019-05-13" unitRef="xbrli-shares">100000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesOutstanding id="Fact-9e60cb30-4050-4103-9f09-0555e691cd42_20190630" decimals="0" contextRef="I2019-05-13" unitRef="xbrli-shares">15560569</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Fact-283962fa-400a-465d-a3e9-49c489427659_20190630" decimals="INF" contextRef="I2019-05-13" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Fact-52a8c455-12d2-487a-8505-2985544a70ed_20190630" decimals="INF" contextRef="I2019-05-13" unitRef="xbrli-shares">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesOutstanding id="Fact-1dc840c0-ffa4-4227-8dcb-a6bb7d3dab7b_20190630" decimals="0" contextRef="I2019-05-13" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="Fact-fe57337f-3a53-4de2-99ca-404533f012b1_20190630" decimals="0" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-EmployeeStockPurchase2019PlanMember" unitRef="xbrli-shares">2653969</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="Fact-af0be8f0-35cf-421c-a13f-367669ee4e5a_20190630" decimals="0" contextRef="I2019-05-03_us-gaap-PlanNameAxis_nxtc-OmnibusIncentive2019PlanMember" unitRef="xbrli-shares">2900000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="Fact-5cc13cb4-8918-49b0-af44-2c04d80d9cbf_20190630" decimals="0" contextRef="I2019-05-03_us-gaap-PlanNameAxis_nxtc-EmployeeStockPurchase2019PlanMember" unitRef="xbrli-shares">240000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Fact-332470c5-29be-4324-907d-4b769ae40ace_20190630" decimals="-3" contextRef="I2018-09-30" unitRef="iso4217-USD">24335000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:StockholdersEquity id="Fact-d69a938f-e12f-4c50-993b-ffcafc86288a_20190630" decimals="-3" contextRef="I2018-09-30" unitRef="iso4217-USD">-40212000</us-gaap:StockholdersEquity>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-f0c6a24c-3c6b-4e69-a004-9a45680e74a6_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel1Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">5465000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-e0873847-5a95-42da-a4a8-1afb24375672_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">5465000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-bb6e52d9-f766-40e6-b33e-ae80bc087628_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember" unitRef="iso4217-USD">5465000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-e859e3a2-1ed2-42c3-af95-882ac470dd4d_20190630" decimals="-3" contextRef="I2018-12-31_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel1Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">5000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-e1780daf-378a-4b53-9cb0-0c7d1f768f8d_20190630" decimals="-3" contextRef="I2018-12-31_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">5000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Fact-55816e5f-1b7e-4232-bfcc-d89f917fbd6f_20190630" decimals="-3" contextRef="I2018-12-31_us-gaap-CashAndCashEquivalentsAxis_us-gaap-MoneyMarketFundsMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember" unitRef="iso4217-USD">5000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-141a6eda-2d87-4899-84fc-1d3dde9ca13d_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USTreasurySecuritiesMember_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel2Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">19983000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-a5d631d7-8d8f-44c9-90d4-85c1519bd309_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USGovernmentAgenciesDebtSecuritiesMember_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel2Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">47161000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-10220cf1-954e-4698-a3be-397b24f549c8_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-CorporateDebtSecuritiesMember_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel2Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">107003000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-26feeb92-043f-44ac-89cd-e93b534e42c5_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USTreasurySecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">19983000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-f299e12d-71df-4857-bd64-e82e1437926e_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USTreasurySecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember" unitRef="iso4217-USD">19982000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-436fa28b-3ff9-40d1-a37f-0a3da5938649_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USGovernmentAgenciesDebtSecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">47161000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-e8f9aa47-0a1e-4afe-935d-821939049ccb_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-USGovernmentAgenciesDebtSecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember" unitRef="iso4217-USD">47178000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-9c6a9faf-845a-4ce8-9b1c-676ee945f60e_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-CorporateDebtSecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">107003000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-7dde12d3-b3ec-4016-a6a6-319d239989e8_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-CashAndCashEquivalentsAxis_us-gaap-CorporateDebtSecuritiesMember_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember" unitRef="iso4217-USD">107045000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="Fact-d01b2f82-8d77-4c2a-a194-b3ea21a56af6_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-USGovernmentAgenciesDebtSecuritiesMember" unitRef="iso4217-USD">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis id="Fact-5e1e2e34-a1d8-4165-a9ce-cef427317412_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-USGovernmentAgenciesDebtSecuritiesMember" unitRef="iso4217-USD">47178000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-058fa2de-406b-4233-b002-e88ec8f7c513_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-USGovernmentAgenciesDebtSecuritiesMember" unitRef="iso4217-USD">47161000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="Fact-caeeea1e-8bb1-4baa-9e62-f67bfa4ea46a_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-USTreasurySecuritiesMember" unitRef="iso4217-USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis id="Fact-89d235fe-16e1-4afd-9afd-4dc3fe20ed00_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-USTreasurySecuritiesMember" unitRef="iso4217-USD">19982000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-bcb90190-02ef-407c-8af1-85ba149c42bb_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-USTreasurySecuritiesMember" unitRef="iso4217-USD">19983000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="Fact-cd1e5746-5b25-4e54-a78e-35f5d22692bd_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-CorporateDebtSecuritiesMember" unitRef="iso4217-USD">20000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="Fact-3e105ec1-7ee6-4da9-ba44-ed433f9d6e46_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-CorporateDebtSecuritiesMember" unitRef="iso4217-USD">62000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis id="Fact-44a2e317-a7b5-4c5e-b130-ecb3e1c7b449_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-CorporateDebtSecuritiesMember" unitRef="iso4217-USD">107045000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-14f93376-aba9-40ed-94cf-4b35762b61e3_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FinancialInstrumentAxis_us-gaap-CorporateDebtSecuritiesMember" unitRef="iso4217-USD">107003000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact-8537cab8-3d8c-4c07-a2c9-2c9582fba88e_20190630" decimals="0" contextRef="D2019-07-01_2019-09-30_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-EmployeeStockOptionMember" unitRef="xbrli-shares">2248953</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Fact-c91d8ac3-587b-426f-aef6-dc7fb98d92c2_20190630" decimals="0" contextRef="D2019-01-01_2019-09-30_us-gaap-AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap-EmployeeStockOptionMember" unitRef="xbrli-shares">2248953</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-eda021a9-d53f-4b54-bb5c-d440c47921e9_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember" unitRef="iso4217-USD">182000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-aa8aecd9-1a18-46ca-9260-ee9e1973da4f_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember" unitRef="iso4217-USD">342000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-e109a21a-75c4-41cb-8246-b33b55814233_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember" unitRef="iso4217-USD">482000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-04f33c27-6717-47ce-beff-0a6a77ece315_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember" unitRef="iso4217-USD">837000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-62003926-3c0e-4833-9e0e-cfba7ea0b159_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember" unitRef="iso4217-USD">41000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-789ae026-13c7-4af2-aa52-4e1430901e27_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember" unitRef="iso4217-USD">49000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-ef700611-0d82-4f9b-a568-9ae438add1cb_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-ResearchAndDevelopmentExpenseMember" unitRef="iso4217-USD">62000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-5bc22875-039c-486d-b580-fda8043566ad_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30_us-gaap-IncomeStatementLocationAxis_us-gaap-GeneralAndAdministrativeExpenseMember" unitRef="iso4217-USD">76000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-d145087e-8064-4ce5-acf4-cae15e76042d_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">138000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-d71c9f93-27df-4597-97b8-be6148a3e1c5_20190630" decimals="0" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">138000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid id="Fact-08e3140a-a61d-4452-89bd-6566c78802f3_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">76000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect id="Fact-e028ab3f-10da-4618-9a6d-8853b43278a0_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">15048000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Fact-e55ec176-c3c3-46a7-aaf0-e528f389558e_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">-15937000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="Fact-85410413-972d-429d-9063-1b1e2737aef1_20190630" decimals="4" contextRef="D2018-01-01_2018-09-30" unitRef="xbrli-pure">0.0384</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <us-gaap:DepreciationDepletionAndAmortization id="Fact-3a4e4477-42e7-4833-b429-2085ffa17b2e_20190630" decimals="0" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">1159000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="Fact-17dfa8ad-db39-4585-9d97-271c85be9a44_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">1159000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact-21df21be-da2e-452d-8330-e714ad3d9d63_20190630" decimals="2" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD_xbrli-shares">-11.64</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:GeneralAndAdministrativeExpense id="Fact-b71fde06-ed6b-4197-8278-ff8731dbf133_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">2590000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="Fact-af534a89-bd5e-4633-abe0-2bd87c4d1d30_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">776000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="Fact-0f7ad193-3d5c-4ae8-bef5-f0b2be361e44_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">-526000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Fact-538a78f9-0b57-433b-a689-b425e4546478_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">89000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:InterestExpense id="Fact-7eb1f90e-85aa-46a3-a6bf-124d8bf84a7a_20190630" decimals="0" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">20000</us-gaap:InterestExpense>
  <us-gaap:InterestPaidNet id="Fact-0b7e7809-d47c-4406-819c-10ba272f1b14_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">18000</us-gaap:InterestPaidNet>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="Fact-1d557368-fc3c-4782-9187-2f5c37c02aae_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">30686000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="Fact-cb71cef8-56d6-4e9a-ace8-a15597afffc1_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">-1159000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Fact-884c7441-38fb-446f-b455-34c2c977b863_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">-14479000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLoss id="Fact-2c7a6cba-f1b7-461f-97cc-05160f5bed7e_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">-15937000</us-gaap:NetIncomeLoss>
  <us-gaap:OperatingExpenses id="Fact-de00694e-88a2-4f0a-86e6-893cdc61407a_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">16129000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="Fact-4f600941-3823-472e-b7f6-5c6aef283563_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">-16129000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingLeasesRentExpenseNet id="Fact-2f4208c7-b08f-4b19-8a1a-f1de43c54daf_20190630" decimals="0" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">308000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OtherNonoperatingIncomeExpense id="Fact-e7f0b842-e29c-4079-bcb7-5ec0c3f64d88_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">192000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:PaymentsOfFinancingCosts id="Fact-39d37c5f-9abf-4614-8f1a-97a7ddcbe662_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">14000</us-gaap:PaymentsOfFinancingCosts>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Fact-2f246abf-1913-4843-b177-65a2cee6c65b_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">1159000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="Fact-76205c6e-6baa-408b-a910-46c173c323c9_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">31000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProfitLoss id="Fact-873542d1-5649-44cd-914b-ea9cb93e8c11_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">-15937000</us-gaap:ProfitLoss>
  <us-gaap:RepaymentsOfDebt id="Fact-a007c98e-8c06-479b-88f8-e12f59558a09_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">300000</us-gaap:RepaymentsOfDebt>
  <us-gaap:ResearchAndDevelopmentExpense id="Fact-6e2b6e7c-876a-42c9-a557-37bdb7895dbf_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">13539000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ShareBasedCompensation id="Fact-ffc9f19b-be62-4685-ad6f-3b3cd68f998c_20190630" decimals="-3" contextRef="D2018-01-01_2018-09-30" unitRef="iso4217-USD">138000</us-gaap:ShareBasedCompensation>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact-efed9170-c8e2-4c2c-8379-7bdf0bb6aa33_20190630" decimals="0" contextRef="D2018-01-01_2018-09-30" unitRef="xbrli-shares">1369212</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="Fact-de0f087f-7582-4ccb-9d93-6e3d05d06d66_20190630" decimals="-3" contextRef="D2018-04-01_2018-06-30_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember" unitRef="iso4217-USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-45954d7f-d1e1-4949-b14b-f2c001eacc56_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">524000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-dc1aff01-9333-4547-af39-95c96de7a20b_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">22000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-8f8f0acb-d5f9-4288-92b2-1ce2715d1869_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">524000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-7b50eb7b-432d-4671-bb01-f145e2f8ed3a_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">524000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-b0880841-074a-47de-8de1-efff857c77e4_20190630" decimals="0" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">524000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Fact-e4078406-bba3-48b0-8ec4-81b3b0d7fef1_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">-8492000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="Fact-fd7f4840-b4ff-498b-915e-61f48485c887_20190630" decimals="4" contextRef="D2019-07-01_2019-09-30" unitRef="xbrli-pure">0.0433</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <us-gaap:DepreciationDepletionAndAmortization id="Fact-452af67d-ca78-4c98-a9b5-ba3c8b68acf1_20190630" decimals="0" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">788000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact-8e6e36ea-7d2c-4bec-bd89-9777f52027d4_20190630" decimals="2" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD_xbrli-shares">-0.37</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:GeneralAndAdministrativeExpense id="Fact-73c6b7ad-1a68-44fc-97d5-bb0784ca6ba4_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">2622000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:InterestExpense id="Fact-a0110a36-3407-4c6e-8028-7227b87d95ff_20190630" decimals="0" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">56000</us-gaap:InterestExpense>
  <us-gaap:NetIncomeLoss id="Fact-32229ed7-7230-4474-aeae-2723202bee28_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">-8434000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Fact-9b3528c8-dd8c-4313-8439-e52ccd0d7653_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">-8434000</us-gaap:NetIncomeLoss>
  <us-gaap:OperatingExpenses id="Fact-2612f24c-bd14-4afa-9446-9696cd8b939e_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">11285000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="Fact-acd7b721-cda8-410a-abee-8fea90f29a30_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">-9702000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingLeasesRentExpenseNet id="Fact-39f46605-1378-44b1-89ce-3b07b8227f14_20190630" decimals="0" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">252000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="Fact-be43875d-f009-482c-944d-f6120c6b4477_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">-58000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="Fact-9fd1210c-c338-4a7c-81bb-9d6c9f0a3f8f_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">-58000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherNonoperatingIncomeExpense id="Fact-79090da9-6330-416e-b1e6-1f5628601d07_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">1268000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="Fact-8d29e5a7-d925-47f9-83f9-a69ec4944fd1_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">8663000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact-5c3c2e54-04b9-4fd7-8b99-9240af62d997_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">1583000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-432b1631-afec-44c3-8f59-8f69c4c78ee5_20190630" decimals="-3" contextRef="D2019-07-01_2019-09-30" unitRef="iso4217-USD">22000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact-19c5c19e-9a9a-4492-a647-89389bfefb63_20190630" decimals="0" contextRef="D2019-07-01_2019-09-30" unitRef="xbrli-shares">22715567</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-50b4acc3-1d5b-4849-b805-96749633458c_20190630" decimals="-3" contextRef="D2019-01-01_2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">383000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-6a413b28-3bd2-44ba-a6c1-2d0dfd0e0f9a_20190630" decimals="-3" contextRef="D2019-01-01_2019-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">4000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-50b22522-e9d1-49e6-ab26-29e3f21f0357_20190630" decimals="-3" contextRef="D2019-01-01_2019-03-31" unitRef="iso4217-USD">383000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="Fact-80a1c63a-3e07-47b8-b4f2-065fd5490cd1_20190630" decimals="-3" contextRef="D2019-01-01_2019-03-31" unitRef="iso4217-USD">-6155000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-fb92bdea-68f4-4b88-a29e-1d53f57a9a42_20190630" decimals="-3" contextRef="D2019-01-01_2019-03-31" unitRef="iso4217-USD">4000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-2891bffd-b40d-4acd-a3f7-bf8753a96419_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">90000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-0d40bd0b-0b6f-4974-95a9-09cc47997756_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">90000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-76f2f999-82c9-428f-ac84-a6cf106258ff_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">90000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-5986d208-66ef-4967-9224-67c5cd26452d_20190630" decimals="0" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">90000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Fact-56103146-1fe1-46c2-94b6-ae2694080f69_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">-5710000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="Fact-3c703a12-9d04-406e-8326-b3e92df966fd_20190630" decimals="4" contextRef="D2018-07-01_2018-09-30" unitRef="xbrli-pure">0.0418</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <us-gaap:DepreciationDepletionAndAmortization id="Fact-460be11b-2aed-40dd-81e0-6843d319493f_20190630" decimals="0" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">396000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact-857bc037-0b11-4560-b28d-0b1054b8c01e_20190630" decimals="2" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD_xbrli-shares">-4.17</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:GeneralAndAdministrativeExpense id="Fact-98e651de-4161-4dba-bc4a-2bbd6d70dafb_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">925000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:InterestExpense id="Fact-0cd223ea-1620-4d51-9ea7-e1da018f4d45_20190630" decimals="0" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">7000</us-gaap:InterestExpense>
  <us-gaap:NetIncomeLoss id="Fact-bf9ccae8-8d17-4efd-8e19-30e2fb64266d_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">-5710000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Fact-3537324e-9b9c-4c6c-940e-cb7e6073503a_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">-5710000</us-gaap:NetIncomeLoss>
  <us-gaap:OperatingExpenses id="Fact-9f40c555-a7fe-43fa-bf1a-b64d6968ba7c_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">5820000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="Fact-7a4e883f-efd8-4129-976c-746a075a43c5_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">-5820000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingLeasesRentExpenseNet id="Fact-90899651-aec3-492f-942f-d471ab40d498_20190630" decimals="0" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">107000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OtherNonoperatingIncomeExpense id="Fact-45fa4766-94eb-42d2-9788-ee288838bee3_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">110000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="Fact-1bc01f29-8722-4b78-b169-e11ac3055bfb_20190630" decimals="-3" contextRef="D2018-07-01_2018-09-30" unitRef="iso4217-USD">4895000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact-c857fef5-41df-40a3-a48f-34c1f94093ca_20190630" decimals="0" contextRef="D2018-07-01_2018-09-30" unitRef="xbrli-shares">1369212</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-dfdfe487-a3e0-4757-90d2-b721f04da18c_20190630" decimals="-3" contextRef="D2018-04-01_2018-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">24000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-7b672da2-9e2d-4fe2-acdb-f1f8036785ee_20190630" decimals="-3" contextRef="D2018-04-01_2018-06-30" unitRef="iso4217-USD">24000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="Fact-87d089b4-6c3f-49bf-903d-83c47dbd26be_20190630" decimals="-3" contextRef="D2018-04-01_2018-06-30" unitRef="iso4217-USD">-5231000</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-c4d3c696-cb73-40cd-bb46-14e4469125d0_20190630" decimals="-3" contextRef="D2018-01-01_2018-03-31_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">24000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-5b38732e-9c3a-4f80-832d-e232e8fdb9b7_20190630" decimals="-3" contextRef="D2018-01-01_2018-03-31" unitRef="iso4217-USD">24000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:NetIncomeLoss id="Fact-bc7f7048-d380-4c47-818a-5d132143077f_20190630" decimals="-3" contextRef="D2018-01-01_2018-03-31" unitRef="iso4217-USD">-4996000</us-gaap:NetIncomeLoss>
  <nxtc:StockIssuedDuringPeriodValueInitialPublicOffering id="Fact-95926002-0d99-4502-a82f-9b3b44d963c9_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">76848000</nxtc:StockIssuedDuringPeriodValueInitialPublicOffering>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-70a97f47-8f0d-4267-9ae5-18aca10c5d24_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">412000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="Fact-cac7e20e-134d-4d51-891a-1beb1270b660_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">162208000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-eac1e09a-d8c8-4310-9ca3-dafa25aa15ac_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-AdditionalPaidInCapitalMember" unitRef="iso4217-USD">38000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <nxtc:StockIssuedDuringPeriodValueInitialPublicOffering id="Fact-6c851cc9-2cd4-4abc-b846-5eba369aaaaf_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30" unitRef="iso4217-USD">76854000</nxtc:StockIssuedDuringPeriodValueInitialPublicOffering>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Fact-b27dd787-f406-4e77-82f7-965077a0f907_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30" unitRef="iso4217-USD">412000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="Fact-cf9856c7-5a5b-4497-a440-f475313699cf_20190630" decimals="-5" contextRef="D2019-04-01_2019-06-30" unitRef="iso4217-USD">9400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:NetIncomeLoss id="Fact-ea3a29cc-1aac-406d-98d7-f84020e93e7a_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30" unitRef="iso4217-USD">-8221000</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="Fact-5cc6c57a-035a-4aed-a697-927f00b1692c_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30" unitRef="iso4217-USD">162223000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-a192bada-5ab9-41b4-9312-e75d829f3e66_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30" unitRef="iso4217-USD">39000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <nxtc:StockIssuedDuringPeriodSharesInitialPublicOffering id="Fact-a23d0758-e8f2-4a1f-a33d-e66fe0b490de_20190630" decimals="0" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">5750000</nxtc:StockIssuedDuringPeriodSharesInitialPublicOffering>
  <nxtc:StockIssuedDuringPeriodValueInitialPublicOffering id="Fact-725cda08-2c32-48af-8f45-b3131af1a08d_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">6000</nxtc:StockIssuedDuringPeriodValueInitialPublicOffering>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits id="Fact-10eaf3a2-39ff-4a65-8267-8f37d7abeae2_20190630" decimals="0" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">15560569</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-159084e5-edfb-420c-ba59-c23aada28ae2_20190630" decimals="0" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="xbrli-shares">24687</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="Fact-7cbc8e8e-2379-4473-be07-e51ed465b01a_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">15000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Fact-2bc572ba-0037-4eae-a908-80afd6e9305c_20190630" decimals="-3" contextRef="D2019-04-01_2019-06-30_us-gaap-StatementEquityComponentsAxis_us-gaap-CommonStockMember" unitRef="iso4217-USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <nxtc:StockIssuedDuringPeriodSharesInitialPublicOffering id="Fact-6a78fca1-0600-47f0-8dd7-f3ebf2ff4d88_20190630" decimals="0" contextRef="D2018-04-01_2018-06-30_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="xbrli-shares">28181819</nxtc:StockIssuedDuringPeriodSharesInitialPublicOffering>
  <nxtc:StockIssuedDuringPeriodValueInitialPublicOffering id="Fact-66480a24-9f36-41d6-ba50-f4e5eec24973_20190630" decimals="-3" contextRef="D2018-04-01_2018-06-30_us-gaap-StatementClassOfStockAxis_nxtc-Series3PreferredStockMember_us-gaap-StatementEquityComponentsAxis_us-gaap-PreferredStockMember" unitRef="iso4217-USD">31000000</nxtc:StockIssuedDuringPeriodValueInitialPublicOffering>
  <nxtc:SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock id="Fact-95ae2a92-6089-4206-999f-ede91d08f0fa_20190630" decimals="INF" contextRef="I2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember_srt-RangeAxis_srt-MinimumMember" unitRef="xbrli-pure">1</nxtc:SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock>
  <nxtc:ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding id="Fact-9cd47534-200f-45b5-b012-beacc9b707b4_20190630" decimals="2" contextRef="D2019-05-03_2019-05-03_us-gaap-PlanNameAxis_nxtc-OmnibusIncentive2019PlanMember" unitRef="xbrli-pure">0.04</nxtc:ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding>
  <nxtc:ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding id="Fact-e258a4d4-d238-449a-9fb7-310c17ded246_20190630" decimals="2" contextRef="D2019-05-03_2019-05-03_us-gaap-PlanNameAxis_nxtc-EmployeeStockPurchase2019PlanMember" unitRef="xbrli-pure">0.01</nxtc:ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding>
  <nxtc:ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan id="Fact-04718baa-d294-4892-bfe9-dd21ff74f854_20190630" decimals="0" contextRef="D2019-05-03_2019-05-03_us-gaap-PlanNameAxis_nxtc-EmployeeStockPurchase2019PlanMember" unitRef="xbrli-shares">480000</nxtc:ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan>
  <nxtc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm id="Fact-dd6ee7ca-b9aa-4420-b824-91cdb0d3a3a4_20190630" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember_srt-RangeAxis_srt-MaximumMember">P10Y</nxtc:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm>
  <nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm id="Fact-a0a7bfc8-64db-4e98-a34d-0fdb8862cb10_20190630" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P8Y1M6D</nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm>
  <nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm id="Fact-337bdd1f-1b38-4769-9cb6-f09dbfd45cac_20190630" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P9Y6M</nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm>
  <nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm id="Fact-9902308d-f031-4bd1-bd41-d106028b5cd0_20190630" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P10Y</nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="Fact-1f2d19e9-bb80-464e-8db4-dc97be2827fc_20190630" decimals="0" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="Fact-da0cb079-ef1d-4cb8-98fc-9526a854520f_20190630" decimals="INF" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">1250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="Fact-653fcc30-6d1c-4794-9def-f1b785cb1d04_20190630" decimals="INF" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">247275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Fact-ca152f43-2c2b-4d9b-8b50-d304c5e47690_20190630" decimals="2" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">11.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Fact-d11803e8-91f9-440e-b826-ed74a395bc95_20190630" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember">P9Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="Fact-329464f8-9682-454a-bfe3-35d0cc6baf84_20190630" decimals="2" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">1.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice id="Fact-18176349-a878-465f-b653-8e83f1ecb2aa_20190630" decimals="2" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">7.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Fact-a2bdf75f-e7c2-4916-8ae1-ad46d3bd13f7_20190630" decimals="2" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="iso4217-USD_xbrli-shares">18.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Fact-54bb6203-32da-49fb-adbd-d31dab593489_20190630" decimals="INF" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-A2015OmnibusIncentivePlanMember" unitRef="xbrli-shares">53963</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod id="Fact-08fe387a-b4c6-4591-b48f-590610971f7f_20190630" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember">P10Y</nxtc:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 id="Fact-b650f094-20d6-4a49-9dcb-1ebecee2b17c_20190630" contextRef="D2019-01-01_2019-09-30_us-gaap-PlanNameAxis_nxtc-OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <nxtc:RevenueRecognitionNumberOfPerformanceObligations id="Fact-ea0aea4f-df4f-425d-9901-bdff13cfa6f8_20190630" decimals="INF" contextRef="D2019-01-01_2019-09-30_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="nxtc-item">2</nxtc:RevenueRecognitionNumberOfPerformanceObligations>
  <nxtc:RevenueRecognitionNumberOfPerformanceObligations id="Fact-35c1b01f-f0b8-409a-b77b-4096283d8eb9_20190630" decimals="INF" contextRef="D2019-01-01_2019-09-30_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="nxtc-item">2</nxtc:RevenueRecognitionNumberOfPerformanceObligations>
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact-ef5c0428-1316-4f5a-97e4-24f632d41eaa_20190630" decimals="-5" contextRef="D2019-01-01_2019-09-30_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">4300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <nxtc:RelatedPartyTransactionsDeferredRevenue id="Fact-68ed804c-0caf-4d67-9eea-cdad51bb474c_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">23883000</nxtc:RelatedPartyTransactionsDeferredRevenue>
  <nxtc:RelatedPartyTransactionsDeferredRevenueCurrent id="Fact-6bf3678d-0c5e-4059-acef-e1a963b55934_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">6199000</nxtc:RelatedPartyTransactionsDeferredRevenueCurrent>
  <nxtc:RelatedPartyTransactionsDeferredRevenueCurrent id="Fact-cf867e0d-a4c2-469a-9a7f-f563aa153f5c_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">6199000</nxtc:RelatedPartyTransactionsDeferredRevenueCurrent>
  <nxtc:RelatedPartyTransactionsDeferredRevenueNoncurrent id="Fact-1d20f908-bda7-483f-b67b-9372c9d25b9b_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">17684000</nxtc:RelatedPartyTransactionsDeferredRevenueNoncurrent>
  <nxtc:RelatedPartyTransactionsDeferredRevenueNoncurrent id="Fact-8490d338-d051-482d-b3b9-26e363151517_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">17684000</nxtc:RelatedPartyTransactionsDeferredRevenueNoncurrent>
  <nxtc:RequiredReserveRestrictedCashCurrent id="Fact-9a60f026-ea41-4864-87fc-d31f599f80eb_20190630" decimals="-5" contextRef="I2019-09-30" unitRef="iso4217-USD">5000000</nxtc:RequiredReserveRestrictedCashCurrent>
  <nxtc:RestrictedCashAndOtherAssetsCurrent id="Fact-82f47952-4919-4c63-869b-fcf9444014bb_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">5039000</nxtc:RestrictedCashAndOtherAssetsCurrent>
  <nxtc:RestrictedCashOtherAssetsNonCurrent id="Fact-fa3428c5-f7a7-4609-8b0a-9898790cf8e8_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">3750000</nxtc:RestrictedCashOtherAssetsNonCurrent>
  <us-gaap:AccountsPayableCurrent id="Fact-f1a0fa0d-bd90-41cb-9106-ae8e5832b704_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">2576000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="Fact-afcac885-29ba-4296-a292-91ec72bfc5f1_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">2582000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Fact-d819c138-7def-46f8-86fd-e8e31c0432b1_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">4402000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="Fact-cea26b97-5dcc-49bc-9e94-11bfcb1b0307_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">-58000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AdditionalPaidInCapital id="Fact-8397fb5d-e988-4887-a89e-55220cdd1adc_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">240791000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:Assets id="Fact-5a3b8488-d1bc-440a-b56d-33234973f56e_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">205124000</us-gaap:Assets>
  <us-gaap:AssetsCurrent id="Fact-c27072ba-8519-4e6e-a416-5f550997f3f9_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">189148000</us-gaap:AssetsCurrent>
  <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="Fact-538c6422-44eb-4dd4-be10-3e6b74f14514_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="Fact-e9cf72fd-ad7e-4ce8-a7ec-b7ec2ed6602a_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">79000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis id="Fact-24db3685-ac01-49e2-af58-08a075f6ffd4_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">174205000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Fact-e865fc0f-ed5e-488f-9707-599b568456c1_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">174147000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent id="Fact-9c492cc6-1a62-48f2-a632-a5619d74e48e_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">174147000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Fact-a1e4939f-cd34-4771-9672-c65f028763ca_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">9935000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Fact-f1147301-8420-44d9-b560-0d84d07df228_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">9935000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Fact-4f572554-4db4-41b6-b27b-57f5ec8fe755_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">14974000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Fact-e65a622e-1650-4a84-b49a-1071383b57c3_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">14974000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:CommitmentsAndContingencies id="Fact-b9722fee-7e01-4f54-9144-31e49aa6c855_20190630" xsi:nil="true" contextRef="I2019-09-30" unitRef="iso4217-USD" />
  <us-gaap:CommonStockParOrStatedValuePerShare id="Fact-3a3286f6-ef2a-4b8d-9011-c12452a41ca8_20190630" decimals="INF" contextRef="I2019-09-30" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="Fact-2d26bbae-2f0e-4576-95ab-c1aaa720a31f_20190630" decimals="INF" contextRef="I2019-09-30" unitRef="xbrli-shares">100000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="Fact-098b9d06-8863-43fb-8388-ee89c63c1599_20190630" decimals="INF" contextRef="I2019-09-30" unitRef="xbrli-shares">22739345</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="Fact-3529abbd-b90a-40e3-add7-cf062ee464af_20190630" decimals="INF" contextRef="I2019-09-30" unitRef="xbrli-shares">22739345</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue id="Fact-e6edec71-48df-4413-a332-1db63b32138f_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">23000</us-gaap:CommonStockValue>
  <us-gaap:DeferredRentCreditNoncurrent id="Fact-5c7b58e1-7465-4341-839b-117826f685e6_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">434000</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount id="Fact-58898cf7-96a3-47b0-85b0-e07363ea5d5e_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
  <us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount id="Fact-c4fbcb1f-8dbf-4116-b043-afa90e87ac55_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">0</us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount>
  <us-gaap:Liabilities id="Fact-94071abb-b595-419e-a3d4-af661e9e533e_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">34475000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Fact-752a680b-1717-4bcc-9421-1a5eb792ca7a_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">205124000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent id="Fact-cdade8a7-f306-4f52-8a2b-6f9b3ab6fa77_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">12607000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermDebt id="Fact-8174e106-a9f8-487d-a1b2-0922dedef1ca_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">5000000</us-gaap:LongTermDebt>
  <us-gaap:LongTermDebtCurrent id="Fact-366b6b3f-72b4-42b1-ad8f-acc8dd199d4c_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">1250000</us-gaap:LongTermDebtCurrent>
  <us-gaap:LongTermDebtCurrent id="Fact-a07558c4-ea55-4a05-9565-aa16d963a69e_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">1250000</us-gaap:LongTermDebtCurrent>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive id="Fact-26ba1e68-adce-4550-a573-0332c35d16b5_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">138000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour id="Fact-11b9da67-9e03-4ac2-8567-95d9d8184c2b_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">1667000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree id="Fact-9597f8cf-1f8d-4c3a-b781-7a4c1768ca90_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">1667000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo id="Fact-00875e56-8fb5-465b-b0e3-e4816eab24ab_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">1528000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <us-gaap:LongTermDebtNoncurrent id="Fact-d144d053-bd2b-4319-ad41-61d406549ed0_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">3750000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent id="Fact-d8a121fc-babd-443f-80e0-de4c0857701a_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">3750000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="Fact-b31722da-fe09-4066-a7c4-b6dd5bebd056_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">8918000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears id="Fact-20571b0d-9660-4d47-93fa-e08cf7fe9787_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">733000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears id="Fact-4004645e-49f1-4365-9084-f95268073a4c_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">742000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="Fact-541e07c2-ffad-425e-b45c-40f5cb66c14d_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">692000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="Fact-6009a5b6-a8ce-45a4-aa55-bbf31ba97a5a_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">566000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter id="Fact-03232c05-2926-4b38-a496-85c9420866f2_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">6088000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear id="Fact-308adcc5-36e7-4352-a82a-24565d129da8_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">97000</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
  <us-gaap:OtherAssetsNoncurrent id="Fact-5a866f71-5e15-481d-a120-80c2920d3a74_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">3945000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Fact-d55ebb09-b45f-433b-99d4-3cc05a533fa2_20190630" decimals="INF" contextRef="I2019-09-30" unitRef="iso4217-USD_xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Fact-b1004b4a-52c0-4386-a3c7-d18b0ff9da84_20190630" decimals="0" contextRef="I2019-09-30" unitRef="xbrli-shares">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="Fact-62615bc9-01a4-4bf1-bd13-0d0118885120_20190630" decimals="0" contextRef="I2019-09-30" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="Fact-ef6a1e4b-d5a6-44f3-aff1-2d4765adafd5_20190630" decimals="0" contextRef="I2019-09-30" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue id="Fact-e0639447-b5b0-46e6-9708-321f0c1c26ed_20190630" xsi:nil="true" contextRef="I2019-09-30" unitRef="iso4217-USD" />
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Fact-c52bffa4-ca9a-442a-8e03-b691e787f4c7_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">3777000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentGross id="Fact-09a09fd0-3a08-4650-bb3e-5a4fd6fe9236_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">16433000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentNet id="Fact-4d75ed3d-7765-4b43-97f5-f0795998e4d4_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">12031000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="Fact-e9d2f342-a605-455d-88b0-fe801d8b5211_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">12031000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:RestrictedCashCurrent id="Fact-46d04101-8419-4ad3-8fdb-e4ce46375453_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">1289000</us-gaap:RestrictedCashCurrent>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Fact-26198634-e319-4697-bb79-d3352968244c_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">-70107000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity id="Fact-e4827cb1-7a5b-495b-8417-5a9ce047b0ab_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">170649000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Fact-be4568c9-c88b-42f3-bfca-5588315df83d_20190630" decimals="-3" contextRef="I2019-09-30" unitRef="iso4217-USD">170649000</us-gaap:StockholdersEquity>
  <nxtc:PaymentsOfUnderwritingDiscountsAndCommissions id="Fact-f8e27709-4040-499e-8ed4-235b202c3f12_20190630" decimals="-5" contextRef="D2019-05-13_2019-05-13_us-gaap-SubsidiarySaleOfStockAxis_us-gaap-IPOMember" unitRef="iso4217-USD">6000000</nxtc:PaymentsOfUnderwritingDiscountsAndCommissions>
  <us-gaap:PaymentsOfStockIssuanceCosts id="Fact-4870549b-cc2f-431b-bfc3-caca6224eac5_20190630" decimals="-5" contextRef="D2019-05-13_2019-05-13_us-gaap-SubsidiarySaleOfStockAxis_us-gaap-IPOMember" unitRef="iso4217-USD">3400000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering id="Fact-e8286df2-8f00-420a-8198-e72d91ede7f7_20190630" decimals="-5" contextRef="D2019-05-13_2019-05-13_us-gaap-SubsidiarySaleOfStockAxis_us-gaap-IPOMember" unitRef="iso4217-USD">77000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Fact-2c81915d-c7d9-411e-828c-56caf4a345e3_20190630" decimals="INF" contextRef="D2019-05-13_2019-05-13_us-gaap-SubsidiarySaleOfStockAxis_us-gaap-IPOMember" unitRef="xbrli-shares">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <nxtc:MarketableSecuritiesAndCashEquivalents id="Fact-ee722f7b-eef1-4ba6-a6a2-c06155c91773_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel2Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">174147000</nxtc:MarketableSecuritiesAndCashEquivalents>
  <nxtc:MarketableSecuritiesAndCashEquivalents id="Fact-a7717a9a-f55b-4319-aa92-acf8952327b3_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FairValueByFairValueHierarchyLevelAxis_us-gaap-FairValueInputsLevel1Member_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">5465000</nxtc:MarketableSecuritiesAndCashEquivalents>
  <nxtc:MarketableSecuritiesAndCashEquivalents id="Fact-f839cb1d-e184-489a-849c-104690c70831_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-EstimateOfFairValueFairValueDisclosureMember" unitRef="iso4217-USD">179612000</nxtc:MarketableSecuritiesAndCashEquivalents>
  <nxtc:MarketableSecuritiesAndCashEquivalents id="Fact-47ed1ce3-d0a9-4747-876e-5bed11e46d79_20190630" decimals="-3" contextRef="I2019-09-30_us-gaap-FairValueByMeasurementBasisAxis_us-gaap-CarryingReportedAmountFairValueDisclosureMember" unitRef="iso4217-USD">179670000</nxtc:MarketableSecuritiesAndCashEquivalents>
  <nxtc:DebtInstrumentMonthlyPaymentsNumber id="Fact-eb5d678d-27bf-4c1a-9f95-78695dc5bcc8_20190630" decimals="INF" contextRef="D2019-01-25_2019-01-25" unitRef="nxtc-item">36</nxtc:DebtInstrumentMonthlyPaymentsNumber>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="Fact-28c81478-f063-4758-8856-edd5dfd678db_20190630" decimals="4" contextRef="D2019-01-25_2019-01-25" unitRef="xbrli-pure">0.0425</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <nxtc:CollaborationAgreementTransactionPrice id="Fact-35287cb6-3087-4d95-8628-b57c725096a8_20190630" decimals="-5" contextRef="D2018-11-02_2018-11-02_srt-CounterpartyNameAxis_nxtc-EliLillyAndCompanyMember_us-gaap-TypeOfArrangementAxis_nxtc-ResearchAndDevelopmentCollaborativeAgreementMember" unitRef="iso4217-USD">32700000</nxtc:CollaborationAgreementTransactionPrice>
  <nxtc:BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements id="Fact-ceb16efc-23f1-4595-ace8-21cb10b6ceb8_20190630" decimals="3" contextRef="I2019-08-02" unitRef="xbrli-pure">0.085</nxtc:BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements>
  <nxtc:BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements id="Fact-137dcd36-c357-4fdf-b7f1-636209f79a73_20190630" decimals="3" contextRef="I2019-01-30" unitRef="xbrli-pure">0.085</nxtc:BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements>
  <nxtc:LetterOfCredit id="Fact-a9c61322-7fef-4146-8942-fd25fe0e442c_20190630" decimals="0" contextRef="I2019-01-30" unitRef="iso4217-USD">39000</nxtc:LetterOfCredit>
  <nxtc:AnnualBaseRentPerMonthAfterAbatement id="Fact-f4c02bef-f0a0-4318-a468-ba28687f31f1_20190630" decimals="0" contextRef="D2019-08-02_2019-08-02" unitRef="iso4217-USD">18178</nxtc:AnnualBaseRentPerMonthAfterAbatement>
  <nxtc:PercentageOfAnnualIncreaseInLeaseRent id="Fact-60a664b5-3ed2-470d-a25e-27a6ef77fc46_20190630" decimals="2" contextRef="D2019-08-02_2019-08-02" unitRef="xbrli-pure">0.03</nxtc:PercentageOfAnnualIncreaseInLeaseRent>
  <nxtc:PeriodForWhichBaseRentIsAbated id="Fact-630b8c3e-876f-458a-81cd-dd1ec909fd38_20190630" contextRef="D2019-08-02_2019-08-02">P7M</nxtc:PeriodForWhichBaseRentIsAbated>
  <nxtc:TenantImprovementsReimbursement id="Fact-d6ab7e7f-eac4-44f5-8908-af2183fbb55c_20190630" decimals="0" contextRef="D2019-08-02_2019-08-02" unitRef="iso4217-USD">1517000</nxtc:TenantImprovementsReimbursement>
  <nxtc:AnnualBaseRentPerMonthAfterAbatement id="Fact-6491d209-dfef-47e2-ba04-7f864358a3ff_20190630" decimals="0" contextRef="D2019-01-30_2019-01-30" unitRef="iso4217-USD">19646</nxtc:AnnualBaseRentPerMonthAfterAbatement>
  <nxtc:PercentageOfAnnualIncreaseInLeaseRent id="Fact-f8c0d848-1b70-448b-9cd2-51058716305e_20190630" decimals="2" contextRef="D2019-01-30_2019-01-30" unitRef="xbrli-pure">0.03</nxtc:PercentageOfAnnualIncreaseInLeaseRent>
  <nxtc:PeriodForWhichBaseRentIsAbated id="Fact-fda9b2de-13e1-4cb4-ba88-42e6cd6ecc77_20190630" contextRef="D2019-01-30_2019-01-30">P7M</nxtc:PeriodForWhichBaseRentIsAbated>
  <nxtc:TenantImprovementsReimbursement id="Fact-ec1d88ec-7765-4229-a494-c5e026d94674_20190630" decimals="0" contextRef="D2019-01-30_2019-01-30" unitRef="iso4217-USD">1477000</nxtc:TenantImprovementsReimbursement>
  <nxtc:AnnualBaseRentPerMonth id="Fact-e445c23f-8120-468e-835c-3d725a546e4f_20190630" decimals="0" contextRef="D2016-02-09_2016-02-09" unitRef="iso4217-USD">32254</nxtc:AnnualBaseRentPerMonth>
  <nxtc:PercentageOfAnnualIncreaseInLeaseRent id="Fact-a7beb55b-4d7d-4aed-9a76-9cdcdbb5fe09_20190630" decimals="2" contextRef="D2016-02-09_2016-02-09" unitRef="xbrli-pure">0.03</nxtc:PercentageOfAnnualIncreaseInLeaseRent>
  <nxtc:DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock id="Fact-7439499e-0af4-4e79-b3c2-66b5d3ee345d_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Recently Issued Accounting Pronouncements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;"&gt;The Company qualifies as an emerging growth company (&amp;#x201C;EGC&amp;#x201D;) as defined under the Jumpstart Our Business Startups Act (the &amp;#x201C;JOBS Act&amp;#x201D;). Using exemptions provided under the JOBS Act provided to EGCs, the Company has elected to defer compliance with new or revised financial accounting standards until it is required to comply with such standards. &lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (&amp;#x201C;ASU 2016-02&amp;#x201D;). The new guidance will require lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016-02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right-to-use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company January 1, 2020.The Company continues to determine if it will elect to use the practical expedients permitted by the guidance and continues to gather data required to comply with the guidance. Based on the work completed to date, the Company is considering the implications of adopting the new standard, including the discount rate to be used in valuing new and existing leases and all applicable financial statement disclosures required by the new guidance. The Company is continuing to evaluate the effect of adoption and anticipates that it will result in the recognition of additional assets and corresponding liabilities related to the existing leases on its balance sheet. The Company is assessing any potential impacts on its internal controls, business processes, and accounting policies related to both the implementation of, and ongoing compliance with, the new guidance.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&amp;#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (&amp;#x201C;ASU 2016-13&amp;#x201D;). ASU 2016-13 will require credit losses to be reported using an expected losses model rather than the incurred losses model that is currently used, and will require additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard will require allowances to be recorded instead of reducing the amortized cost of the investment. ASU 2016-13 will be effective for non-emerging growth companies for fiscal years beginning December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2016-13 will have on its financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement&amp;#x2014;Disclosure Framework-Changes to the Disclosure Requirement for Fair Value Measurement (&amp;#x201C;ASU 2018-13&amp;#x201D;). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements in ASC 820, Fair Value Measurement, based on the concepts in the FASB Concepts Statement, including the consideration of costs and benefits. ASU 2018-13 will be effective for all companies for fiscal periods beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2018-13 will have on its financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In November 2018, the FASB issued ASU No. 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 (&amp;#x201C;ASU 2018-18&amp;#x201D;). ASU 2018-18 clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, all the guidance in Topic 606 should be applied, including recognition, measurement, presentation and disclosure requirements. The amendment also adds unit of account guidance in Topic 808 to align with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of the arrangement is within the scope of Topic 606. Lastly, ASU 2018-18 provides that in a transaction with a collaborative arrangement participant that is not directly related to sales to third parties, presenting the transaction together with revenue recognized under Topic 606 will be precluded if the collaborative arrangement participant is not a customer. ASU 2018-18 will be effective for non-emerging growth companies for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020 and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating these clarifications for the accounting and presentation for its collaborative arrangements within the scope of Topic 808, but does not expect that the adoption of ASU 2018-18 will have any impact.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</nxtc:DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock>
  <nxtc:IncreaseDecreaseInDeferredRevenueFromRelatedParty id="Fact-42504e53-0a0d-4d7e-b09c-6baad5d682e3_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">-2842000</nxtc:IncreaseDecreaseInDeferredRevenueFromRelatedParty>
  <nxtc:NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock id="Fact-f81879f5-6210-479a-b5e3-dd6a28463d71_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">162223000</nxtc:NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock>
  <nxtc:RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized id="Fact-d77c7841-d13d-4a8b-a65a-98293df50a80_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">4342000</nxtc:RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized>
  <nxtc:RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment id="Fact-7a10ad0f-e49f-4b76-9378-0888f713f11e_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">1500000</nxtc:RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment>
  <nxtc:ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock id="Fact-2f27ecfb-f90d-496a-b0c8-e49117fe2c89_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;As of September&amp;nbsp;30, 2019, deferred revenue included in the Company&amp;#x2019;s balance sheets comprised the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="middle" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="middle" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="middle" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="middle" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Deferred revenue, beginning of period&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 26,725&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Up-front payment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 25,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Attributed premium on the proceeds from Lilly&amp;#x2019;s investment in the Company&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,725&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research and development support billing&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,500&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Revenue from research and development arrangement recognized&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (4,342)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total deferred revenue, end of period&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 23,883&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 26,725&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: Deferred revenue, current portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (6,199)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (4,989)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Deferred revenue, non-current portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 17,684&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 21,736&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</nxtc:ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-397a4e6e-8fe5-4367-8958-61220eb25784_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">1319000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Fact-8462dff8-2269-4e10-a302-574e1546209d_20190630" decimals="0" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">1319000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock id="Fact-9eb1d8c3-ec3d-44d6-92be-1a90c191a2bd_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Basis of Presentation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The accompanying unaudited condensed financial statements as of September 30, 2019 and for the three and nine months ended September 30, 2019 and 2018 have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (&amp;#x201C;GAAP&amp;#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&amp;#x201C;SEC&amp;#x201D;) for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed financial statements should be read in conjunction with the Company&amp;#x2019;s audited financial statements and the notes thereto as of and for the year ended December 31, 2018, which are included in the Company&amp;#x2019;s final prospectus that forms a part of the Company&amp;#x2019;s Registration Statement on Form S-1 (Reg. No. 333-230837) (the &amp;#x201C;Registration Statement&amp;#x201D;), as filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended, on May 9, 2019.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The unaudited interim condensed financial statements have been prepared on the same basis as the audited financial statements. In the opinion of management, the accompanying unaudited interim condensed financial statements contain all adjustments necessary for a fair statement of the Company&amp;#x2019;s financial position as of September 30, 2019 and condensed results of operations and cash flows for the three and nine months ended September 30, 2019 and 2018. Such adjustments are of a normal and recurring nature. The results of operations for the three and nine months ended September 30, 2019 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2019.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid id="Fact-953a4139-64cb-43f6-bad4-a165c69e682f_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">73000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy id="Fact-77f5383e-179d-46cd-ae50-6f52c894d314_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Restricted Cash&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;The Company is required, as a condition of its Term Loan (Note 8), to maintain cash collateral on deposit in a segregated money market bank account equal to the principal portion of the Term Loan, as determined on a quarterly basis. The bank may restrict withdrawals or transfers by or on behalf of the Company that would violate this requirement. The required reserve totaled $5.0 million as of September 30, 2019. This amount is presented in part as restricted cash and in part as other assets on the accompanying balance sheet.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9,935&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,173&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Restricted cash (including $3,750 in other assets)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,039&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 460&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 14,974&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,633&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect id="Fact-c5778e90-0e48-41ab-b00b-9701f0588f5e_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">-120659000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
  <us-gaap:CollaborativeArrangementDisclosureTextBlock id="Fact-6db6beaf-05f6-4824-9de5-62e4b9d758df_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;6. &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Agreement with Eli Lilly and Company&lt;a name="a6AgreementwithEliLillyandCompany_802770"&gt;&lt;/a&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On November 2, 2018, the Company entered into a multi-year research and development collaboration agreement (the &amp;#x201C;Lilly Agreement&amp;#x201D;) with Eli Lilly and Company (&amp;#x201C;Lilly&amp;#x201D;), pursuant to which the Company will use its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Under the Lilly Agreement, Lilly and the Company have granted one another an equal number of exclusive options to research, develop, manufacture and commercialize compounds and products directed to oncology targets identified through the Lilly Agreement. Both Lilly and the Company have all options remaining eligible for exercise. The research collaboration with Lilly will be managed by a joint steering committee formed by an equal number of members from the Company and Lilly and will expire upon the earlier of the exercise of all options granted to Lilly or four years from the date of the agreement, subject to certain extensions. The Company considers Lilly to be a related party based on Lilly&amp;#x2019;s equity investment in the Company as discussed below.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;During the research term under the Lilly Agreement, as a part of target discovery, the Company will be responsible for providing Lilly with oncology targets identified using the Company&amp;#x2019;s FIND-IO platform. From the targets provided by the Company, Lilly may select targets to advance to target validation using criteria developed by both parties. Following completion of the agreed upon target validation plan with respect to a given target, either party may propose to advance that target to compound discovery. For each target that has been advanced to compound discovery, Lilly will have the option to obtain an exclusive license with respect to the compounds and products directed to the target. If Lilly does not exercise its option with respect to a given target or has previously exercised all of its options, the Company will have the option to obtain licenses with respect to compounds and products directed to that target. Following option exercise by a party, the development and commercialization of any products directed to the target will be conducted by the exercising party. The exercising party must use commercially reasonable efforts to develop, seek regulatory approval for and commercialize any such products under mutually agreed upon work plans.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In November 2018, the Company received an upfront, non-refundable payment of $25.0 million under the Lilly Agreement and a concurrent $15.0 million equity investment. In addition, the Company will receive quarterly research and development support payments during a portion of the research term as well as option exercise fees upon option exercises by Lilly.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Pursuant to the Lilly Agreement, Lilly may owe an aggregate of up to $1.4 billion in development and regulatory milestones and sales milestones. Additionally, Lilly will pay mid to high single-digit royalties on net sales for all products directed to each target optioned by Lilly. Upon the Company&amp;#x2019;s exercise of an option with respect to a given target, the Company will pay Lilly an option exercise payment and may become obligated to milestone and royalty payments. The company may owe an aggregate of up to $710.0 million in development and regulatory milestones and sales milestones.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Upon the adoption of ASC 606, the Company evaluated the Lilly Agreement under the provisions of ASC 606 and concluded that Lilly is a customer prior to the exercise of its option to obtain an exclusive license with respect to the compounds and products directed to a target that has been advanced to compound discovery. The Company identified the following material promises under the Lilly Agreement: (i) a limited research license to conduct activities under the research collaboration; (ii) research and development services together with the provision of a data package in connection with Lilly&amp;#x2019;s option; (iii) various governance obligations, most notably participation on the joint steering committee; and (iv) rights related to an optional term extension by Lilly. The Company evaluated Lilly&amp;#x2019;s option to obtain an exclusive license with respect to the compounds and products directed to a target that has been advanced to compound discovery and concluded that the option was not issued at a significant and incremental discount, and therefore does not provide material rights. As such, they are excluded as performance obligations at the outset of the arrangement. The Company determined that the research license was not capable of being distinct and the related research and development services and governance activities are not distinct in the context of the contract and, as such, the Company determined that these promises should be combined into a single performance obligation, resulting in a total of two performance obligations under the Lilly Agreement; one for research and development services and one for the right related to an optional term extension by Lilly.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The transaction price at the outset of the arrangement was determined to be $32.7 million, comprised of the upfront fee received from Lilly, quarterly research and development support payments to be received from Lilly during a portion of the research term and an equity investment premium as determined by the Company with reference to a valuation of the Company&amp;#x2019;s preferred stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, &lt;/font&gt;&lt;font style="display:inline;font-style:italic;"&gt;Valuation of Privately-Held-Company Equity Securities Issued as Compensation.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The transaction price was allocated to the two performance obligations based on their relative standalone selling price determined with reference to the Company&amp;#x2019;s estimated costs attendant to the obligations. Revenue allocated to the research and development performance obligation is being recognized as the research and development services are provided using an input method according to research and development costs incurred to date compared to estimated total research and development costs. The transfer of control occurs over this time period and, in management&amp;#x2019;s judgment, is the best measure of progress towards satisfying the performance obligation. Revenue allocated to Lilly&amp;#x2019;s right related to an optional term extension is deferred until the right is exercised or lapses, and will subsequently be recognized accordingly.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;While the Lilly Agreement was executed in November 2018, the Company&amp;#x2019;s performance initiated in January 2019. Under the Lilly Agreement, the Company recognized revenue of $1.6 million and $4.3 million for the three and nine months ended September&amp;nbsp;30, 2019, respectively. As of September&amp;nbsp;30, 2019, deferred revenue included in the Company&amp;#x2019;s balance sheets comprised the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="middle" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="middle" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="middle" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="middle" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Deferred revenue, beginning of period&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 26,725&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Up-front payment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 25,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Attributed premium on the proceeds from Lilly&amp;#x2019;s investment in the Company&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,725&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research and development support billing&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,500&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Revenue from research and development arrangement recognized&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (4,342)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total deferred revenue, end of period&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 23,883&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 26,725&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: Deferred revenue, current portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (6,199)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (4,989)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Deferred revenue, non-current portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 17,684&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 21,736&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
			&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="Fact-3218162a-ecee-4834-bd5f-a5ff44a94887_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;7. Commitments and Contingencies&lt;a name="a7CommitmentsandContingencies_104288"&gt;&lt;/a&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Operating Leases&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;On February 9, 2016, the Company entered into a non-cancelable facilities operating sublease (the &amp;#x201C;2016 Sublease&amp;#x201D;). On March 15, 2019, the Company amended and restated the 2016 Sublease (as amended, the &amp;#x201C;Amended 2016 Sublease&amp;#x201D;) to include additional square footage to be used for office space, which the Company took possession of upon entering into the Amended 2016 Sublease. The Amended 2016 Sublease expires in August 2025. The base rent under the Amended 2016 Sublease is currently $32,254 per month plus the Company&amp;#x2019;s prorated share of the sublandlord&amp;#x2019;s operating expense and is subject to annual rent increases of 3%. &amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;On January 30, 2019, the Company entered into a new lease to be used for office and laboratory space (the &amp;#x201C;New Premises&amp;#x201D;), which the Company took possession of on June 1, 2019 (the &amp;#x201C;2019 Lease&amp;#x201D;). On August 2, 2019, the Company amended the 2019 Lease (as, the &amp;#x201C;Amended 2019 Lease&amp;#x201D;) to include additional space to be used for office and laboratory space (the &amp;#x201C;Expansion Premises&amp;#x201D;), which the Company expects to take possession of on April 1, 2020. The Amended 2019 Lease expires in March 2030. Upon expiration of the Amended 2016 Sublease, the Amended 2019 Lease will also cover the space the Company is currently subleasing under the Amended 2016 Sublease. Base rent is abated until April 1, 2020 for the New Premises and until seven months after delivery of the Expansion Premises for the Expansion Premises, after which the base rent will be $19,646 per month for the New Premises and $18,178 per month for the Expansion Premises, each subject to annual rent increases of 3%. In connection with this lease, the Company executed a $39,000 letter of credit, which has not been drawn down on. Additionally, there is a base rate adjustment of 8.5% per annum multiplied by the outstanding balance of amounts paid for tenant improvements. The budgeted amounts of tenant improvements are approximately $1,477,000 for the New Premises and $1,517,000 for the Expansion Premises, which are to be fully reimbursed by the landlord.&amp;nbsp; &lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The future minimum payments for the operating leases are as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Remainder of the year&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 97&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2020&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 566&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2021&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 692&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2022&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 742&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2023&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 733&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Thereafter&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6,088&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total future minimum payments&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 8,918&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Rent expense incurred under operating leases was approximately&amp;nbsp;$252,000&amp;nbsp;and $442,000&amp;nbsp;for the three and nine months ended September&amp;nbsp;30, 2019, respectively, and $107,000 and $308,000 for the three and nine months ended September 30, 2018, respectively.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Legal Proceedings&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company, from time to time, may be party to litigation arising in the ordinary course of business. The Company is not a party to any litigation or legal proceedings, nor is management aware of any pending or threatened litigation that, in the opinion of the Company&amp;#x2019;s management, are likely to have a material adverse effect on the Company&amp;#x2019;s business. At each reporting date, the Company evaluates whether a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses the costs related to its legal proceedings as incurred.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Fact-d176a6b9-8715-4409-a85e-920b02c0916e_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">-22868000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:DebtDisclosureTextBlock id="Fact-9d90d125-b8c9-4d8e-9446-f4d8fc5c72e7_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;8. Term Loan&lt;a name="a8TermLoan_295864"&gt;&lt;/a&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In April 2016, the Company entered into a $1.0 million term loan with a commercial bank (the &amp;#x201C;Term Loan&amp;#x201D;). On January 25, 2019, the Company amended the Term Loan to increase the Company&amp;#x2019;s borrowing capacity to $5.0 million, which amount remains secured by the Company&amp;#x2019;s certificates of deposit, money market account, investment property and deposit or investment accounts. As amended, the Term Loan bears interest at the greater of the prime rate less 1% and 4.25%. The effective interest rate was 4.33% and 4.44% for the three and nine months ended September 30, 2019, respectively. The effective interest rate was 4.18% and 3.84% for the three and nine months ended September 30, 2018, respectively. Under the Term Loan, the Company is required to make monthly interest-only payments through January 2020 and is required to make 36 equal monthly payments of principal plus accrued interest thereafter through January 2023.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Future maturities of the Term Loan as of September 30, 2019 are as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Remainder of the year&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2020&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,528&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2021&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,667&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2022&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,667&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2023&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 138&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: current portion of term loan&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (1,250)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Term loan, net of current portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 3,750&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Interest expense under the Term Loan was approximately&amp;nbsp;$56,000 and $155,000 for the three and nine months ended September&amp;nbsp;30, 2019, respectively, and $7,000 and $20,000 for the three and nine months ended September 30, 2018, respectively.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:DebtInstrumentInterestRateDuringPeriod id="Fact-1a285c53-9788-4732-8401-853af8d10d10_20190630" decimals="4" contextRef="D2019-01-01_2019-09-30" unitRef="xbrli-pure">0.0444</us-gaap:DebtInstrumentInterestRateDuringPeriod>
  <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction id="Fact-b1430f7c-dc21-4fea-b97c-dcb6f52fbc3c_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">134000</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
  <us-gaap:DepreciationDepletionAndAmortization id="Fact-b9d63ce3-53d1-4c6f-b724-a7a0d61e6df4_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">1933000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="Fact-245220e3-daad-4f98-b632-33dc3b576e17_20190630" decimals="0" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">1933000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="Fact-8ef5ef5d-4c8c-4033-b56a-0b7c57ecbc80_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;9. Stock&amp;#8209;Based Compensation&lt;a name="a11StockBasedCompensation_727125"&gt;&lt;/a&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;font-style:italic;"&gt;Employee Equity Plans&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The NextCure, Inc. 2015 Omnibus Incentive Plan (the "2015 Plan") provides for the Company to grant incentive stock options or nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company. The 2015 Plan is administered by the board of directors, or at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors or its committee if so delegated, except that the exercise price per share of the stock options may not be less than 100% of the fair market value of a share of the Company's common stock on the date of grant and the term of the stock options may not be greater than 10 years.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On May 3, 2019, the Company&amp;#x2019;s stockholders approved the NextCure, Inc. 2019 Omnibus Incentive Plan (the &amp;#x2018;&amp;#x2018;2019 Plan&amp;#x2019;&amp;#x2019;), which became effective on May 8, 2019, the date on which the Registration Statement was declared effective (the &amp;#x201C;Effective Date&amp;#x201D;). The 2019 Plan replaces the 2015 Plan as the Company&amp;#x2019;s board of directors (the &amp;#x201C;Board&amp;#x201D;) determined not to make additional awards under the 2015 Plan following the effectiveness of the 2019 Plan. The 2019 Plan provides for the grant of awards of options, stock appreciation rights, restricted stock, restricted stock units, deferred stock units, unrestricted stock, dividend equivalent rights, other equity-based awards and cash bonus awards to the Company&amp;#x2019;s officers, employees, non-employee directors and other key persons (including consultants). The number of shares of common stock reserved for issuance under the 2019 Plan is 2,900,000 plus the number of shares of stock related to awards outstanding under the 2015 Plan that subsequently terminate by expiration or forfeiture, cancellation or otherwise without the issuance of such shares. The number of shares reserved for issuance under the 2019 Plan will automatically increase on January 1, 2020 and each January 1st thereafter during the term of the 2019 Plan by 4% of the number of shares of the Company&amp;#x2019;s common stock outstanding on December 31st of the preceding calendar year or such lesser number of shares determined by the Board.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;As of September 30, 2019, &lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;2,653,969&lt;/font&gt;&lt;font style="display:inline;"&gt; &amp;nbsp;shares were reserved for future grant under the 2019 Plan.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Stock options granted under the 2015 Plan and 2019 Plan (together, the &amp;#x201C;Plans&amp;#x201D;) to employees generally vest over four years and expire after ten years. &lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;A summary of stock option activity for awards under the Plans is presented below: &lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="9" valign="bottom" style="width:39.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Options&amp;nbsp;Outstanding&amp;nbsp;and&amp;nbsp;Exercisable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Weighted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Weighted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Average&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Average&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Remaining&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Number&amp;nbsp;of&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Exercise&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Contractual&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%"&gt;(1)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Shares&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Price&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Life&amp;nbsp;(Years)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;(in&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Outstanding as of December&amp;nbsp;31,&amp;nbsp;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,056,891&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4.74&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.4&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,946&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Granted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 247,275&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 18.18&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 10.0&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (53,963)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1.20&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 8.1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Forfeitures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (1,250)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7.63&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.5&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Outstanding as of September&amp;nbsp;30,&amp;nbsp;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,248,953&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6.30&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 55,305&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Vested and expected to vest as of September&amp;nbsp;30,&amp;nbsp;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,248,953&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6.30&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 55,305&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Exercisable as of September&amp;nbsp;30,&amp;nbsp;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 450,866&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1.15&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 12,335&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;div&gt;&lt;hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"&gt;&lt;/hr&gt;&lt;/div&gt;
		&lt;div style="width:100%"&gt;&lt;table style="width:100%;" cellpadding="0" cellspacing="0"&gt;&lt;tr&gt;&lt;td style="width:0pt;"&gt;&lt;p style="width:0pt;font-size:0pt;"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" align="left" style="width: 18.00pt;"&gt;
			&lt;p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;"&gt;
				&lt;font style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"&gt; (1)&lt;/font&gt;
			&lt;/p&gt;
		&lt;/td&gt;&lt;td style="width:0pt;"&gt;&lt;p style="width:0pt;width:0pt;font-size:0pt;"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td align="left" valign="top"&gt;
			&lt;p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;"&gt;
			&lt;font style="display:inline;color:#000000;"&gt;The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at September 30, 2019 and December&amp;nbsp;31, 2018.&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The weighted-average grant date fair value of stock options granted to employees for the nine months ended September 30, 2019 was $11.48. The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2019 was $1,600,000.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;The Company&amp;#x2019;s potential dilutive securities, which as of September 30, 2019 include common stock options, have been excluded from the computation of diluted net loss per share as the effect would be anti&amp;#8209;dilutive. Therefore, the weighted average number of common shares used to calculate both basic and diluted net loss per common share is the same. The Company excluded 2,248,953 potential shares of common stock, presented based on amounts outstanding at three and nine periods ended September 30, 2019, from the computation of diluted net loss per common share for the period indicated because including them would have had an anti&amp;#8209;dilutive effect. &lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On May 3, 2019,&amp;nbsp;the Company&amp;#x2019;s stockholders approved the NextCure, Inc. 2019 Employee Stock Purchase Plan (the &amp;#x201C;ESPP&amp;#x201D;), which became effective on the Effective Date. The ESPP is intended to qualify as an &amp;#x201C;employee stock purchase plan&amp;#x201D; within the meaning of Section 423(b) of the Internal Revenue Code. A total of 240,000&amp;nbsp;shares of common stock were reserved for issuance under this plan. In addition, the number of shares of common stock that may be issued under the ESPP will automatically increase on January&amp;nbsp;1, 2020 and each January 1st thereafter until expiration of the ESPP, in an amount equal to the lesser of (i)&amp;nbsp;1% of the number of shares of the Company&amp;#x2019;s common stock outstanding on&amp;nbsp;December 31st of the preceding calendar year, (ii) 480,000 shares of common stock and (iii)&amp;nbsp;a number of shares of common stock determined by the administrator of the ESPP.&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Stock&amp;#8209;Based Compensation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company recorded stock-based compensation expense of&amp;nbsp;$524,000 and $1,319,000&amp;nbsp;for the three and nine months ended September&amp;nbsp;30, 2019, respectively, and $90,000 and $138,000 for the three and nine months ended September&amp;nbsp;30, 2018, respectively.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Stock&amp;#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.42%;"&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Three Months Ended &lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Nine Months Ended &lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research and development&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 182&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 41&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 482&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 62&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;General and administrative&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 342&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 49&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 837&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 76&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total stock-based compensation expense&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 524&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 90&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,319&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 138&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
			&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Fact-ef3f218d-0f81-4ad8-be05-3b66c746e9a2_20190630" decimals="2" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD_xbrli-shares">-1.81</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:FairValueByBalanceSheetGroupingTextBlock id="Fact-9068dfa7-26a5-48e3-b046-a6a83588de71_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following tables set forth the fair value of the Company&amp;#x2019;s financial assets by level within the fair value hierarchy (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="14" valign="bottom" style="width:47.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September 30, 2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Carrying&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Amount&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 3&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Cash equivalents:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Money market&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,465&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,465&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,465&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Marketable securities:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;U.S. treasury securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 19,982&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 19,983&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 19,983&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Agency bonds&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 47,178&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 47,161&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 47,161&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Corporate bonds&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 107,045&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 107,003&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 107,003&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 179,670&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 179,612&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,465&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 174,147&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="14" valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December 31, 2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Carrying&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Amount&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 3&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Cash equivalents:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Money market&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock id="Fact-ab6591d3-3677-4a12-ab04-9ac9a27911bf_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;4. Fair Value of Financial Instruments&lt;a name="a3FairValueofFinancialInstruments_290669"&gt;&lt;/a&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company has certain financial assets recorded at fair value, which have been classified as Level 1, 2 or 3 within the fair value hierarchy as described in the accounting standards for fair value measurements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Level 1&amp;#x2014;Quoted market prices in active markets for identical assets or liabilities. &lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Level 2&amp;#x2014;Inputs other than Level 1 inputs that are either directly or indirectly observable, such as quoted market prices, interest rates and yield curves. &lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Level 3&amp;#x2014;Unobservable inputs developed using estimates of assumptions developed by the Company, which reflect those that a market participant would use.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;To the extent the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair values requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized as Level 3. A financial instrument&amp;#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following tables set forth the fair value of the Company&amp;#x2019;s financial assets by level within the fair value hierarchy (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="14" valign="bottom" style="width:47.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September 30, 2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Carrying&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Amount&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 3&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Cash equivalents:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Money market&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,465&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,465&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,465&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Marketable securities:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;U.S. treasury securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 19,982&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 19,983&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 19,983&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Agency bonds&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 47,178&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 47,161&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 47,161&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Corporate bonds&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 107,045&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 107,003&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 107,003&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 179,670&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 179,612&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,465&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 174,147&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="14" valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December 31, 2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Carrying&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Amount&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Level 3&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Cash equivalents:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Money market&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company did&amp;nbsp;not transfer any assets measured at fair value on a recurring basis between levels during the&amp;nbsp;three and nine months ended September 30, 2019. &lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:GeneralAndAdministrativeExpense id="Fact-2287bd0a-3247-47e6-b6a6-2bf3c6e449d1_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">6995000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncomeTaxDisclosureTextBlock id="Fact-234464b2-bd68-47a7-af6a-62a7aad77bc1_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;10. Income Taxes&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;color:#000000;"&gt;The Company did not record a provision or benefit for income taxes during the nine months ended September 30, 2019.&amp;nbsp;&amp;nbsp;The Company continues to maintain a full valuation allowance against its deferred tax assets.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;color:#000000;"&gt;The Company has evaluated the positive and negative evidence involving its ability to realize its deferred tax assets.&amp;nbsp;&amp;nbsp;Management has considered the Company&amp;#x2019;s history of cumulative net losses incurred since inception and its lack of any commercially ready products.&amp;nbsp;&amp;nbsp;It has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Management reevaluates the positive and negative evidence at each reporting period.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;color:#000000;"&gt;Under the provisions of Sections&amp;nbsp;382 and 383 of the Internal Revenue Code, certain substantial changes in the Company&amp;#x2019;s ownership may have limited, or may limit in the future, the amount of net operating loss and research and development credit carryforwards that can be used to reduce future income taxes. &lt;a name="_Hlk512945225"&gt;&lt;/a&gt;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:IncomeTaxExpenseBenefit id="Fact-0b768ffd-53fa-4712-a079-9cbc7765ef19_20190630" decimals="0" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="Fact-b82c6f2f-5086-4bf9-b98a-0b87e220848f_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">93000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="Fact-56bc65fc-7ed4-42c9-ad05-963a47237cca_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">335000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Fact-7de2156f-30d1-4f21-8b59-2cbfeba1e06e_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">3660000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:InterestExpense id="Fact-3225758b-d247-4373-a682-dba3f2456c5a_20190630" decimals="0" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">155000</us-gaap:InterestExpense>
  <us-gaap:InterestPaidNet id="Fact-29d2fcd5-f8a7-4b77-beb9-b916aa1f3483_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">137000</us-gaap:InterestPaidNet>
  <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock id="Fact-3001c045-1045-4521-94d8-0b6216b48733_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;color:#000000;"&gt;3. Investments&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;color:#000000;"&gt;Investments consist of the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="11" valign="bottom" style="width:41.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September 30, 2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Amortized&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Estimated&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Gain&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Loss&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;U.S. treasury securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 19,982&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 19,983&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Agency bonds&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 47,178&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (17)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 47,161&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Corporate bonds&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 107,045&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 20&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (62)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 107,003&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 174,205&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 21&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (79)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 174,147&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;background-color: #FFFFFF;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;background-color: #FFFFFF;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;As of September 30, 2019, no investments &lt;/font&gt;&lt;font style="display:inline;color:#000000;"&gt;are considered to be other-than-temporarily impaired. The Company uses the specific identification method when calculating realized gains and losses. For the three and nine months ended September 30, 2019, the Company recorded no realized gains and losses on available-for-sale securities.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
  <us-gaap:MarketableSecuritiesPolicy id="Fact-f3f1e55a-c32b-4a98-9e59-c480234a7dc6_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Marketable Securities&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:normal;"&gt;Our investments primarily consist of government debt securities, corporate bonds and agency bonds. These marketable securities are classified as available-for-sale, and as such, are reported at fair value on our condensed balance sheets. Unrealized holding gains and losses are reported within accumulated other comprehensive income (loss) as a separate component of stockholders&amp;#x2019; equity. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization, together with interest on securities, are included in other income, net, on our condensed statements of operations.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:normal;"&gt;If a decline in the fair value of a marketable security below our cost basis is determined to be other than temporary, such marketable security is written down to its estimated fair value as a new cost basis and the amount of the write-down is included in earnings as an impairment charge. The cost of securities sold is based on the specific identification method.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="Fact-a73c5fc0-87a6-4b0c-bf8a-7a9f7404d29e_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">81735000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="Fact-9dcea3b2-a8f3-4183-8795-80a29b2ab7d6_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">-176762000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Fact-1b5c0cb0-abdc-4045-9bff-6383b0c694fc_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">-25632000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLoss id="Fact-3c54eadf-7226-4284-b30e-077a00ee4f45_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">-22810000</us-gaap:NetIncomeLoss>
  <us-gaap:OperatingExpenses id="Fact-b0a7e45c-864d-4ecb-a698-e0fe99d3f2a4_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">29814000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="Fact-04757d80-7f5a-4177-a0cb-b265f4441b45_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">-25472000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingLeasesRentExpenseNet id="Fact-d0a065de-dd4a-42cf-9bf7-38e5f988eaab_20190630" decimals="0" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">442000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock id="Fact-63c9e4ef-e16f-4e16-ae99-8f0c8465d10c_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-align:left;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;1. Nature of the Business&lt;a name="a1NatureoftheBusinessandBasisofPresentat"&gt;&lt;/a&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;font-style:italic;"&gt;Organization&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;NextCure,&amp;nbsp;Inc. (&amp;#x201C;NextCure&amp;#x201D; or the &amp;#x201C;Company&amp;#x201D;) was incorporated in Delaware in September&amp;nbsp;2015 and is headquartered in Beltsville, Maryland. The Company is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first&amp;#8209;in&amp;#8209;class immunomedicines to treat cancer and other immune&amp;#8209;related diseases by restoring normal immune function. Through its proprietary Functional, Integrated, NextCure Discovery in Immuno&amp;#8209;Oncology (&amp;#x201C;FIND&amp;#8209;IO&amp;#x201D;) platform, the Company studies various immune cells in order to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Since inception, the Company has devoted substantially all of its efforts and financial resources to organizing and staffing the Company, identifying business development opportunities, raising capital, securing intellectual property rights related to the Company&amp;#x2019;s product candidates, building and optimizing the Company&amp;#x2019;s manufacturing capabilities and conducting discovery, research and development activities for the Company&amp;#x2019;s product candidates, discovery programs and its FIND&amp;#8209;IO platform.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;font-style:italic;"&gt;Initial Public Offering&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On May 13, 2019, the Company closed its initial public offering (&amp;#x201C;IPO&amp;#x201D;), in which the Company issued and sold 5,750,000 shares of common stock at a public offering price of $15.00 per share, for net proceeds to the Company of approximately $77.0 million after deducting underwriting discounts and commissions of $6.0 million and offering expenses of approximately $3.4 million.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In preparation for the IPO, on May 3, 2019, the Company effected&amp;nbsp;a &amp;nbsp;one-for-8.0338 reverse stock split of its issued and outstanding common stock. The par value and authorized shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Upon the closing of the IPO, on May 13, 2019, all of the outstanding shares of the Company&amp;#x2019;s convertible preferred stock automatically converted into 15,560,569 shares of common stock at the applicable conversion ratio then in effect. Subsequent to the closing of the IPO, there were no shares of preferred stock outstanding. &lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Upon the closing of the IPO, on May 13, 2019, the Company&amp;#x2019;s certificate of incorporation was amended and restated to provide for 100,000,000 authorized shares of common stock with a par value of $0.001 per share and 10,000,000 authorized shares of preferred stock with a par value of $0.001 per share.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;font-style:italic;"&gt;Liquidity&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company has not generated any revenue to date from product sales and does not expect to generate any revenues from product sales in the foreseeable future. Through September 2019, the Company has funded its operations primarily with proceeds from the sale of preferred stock and proceeds from the Company&amp;#x2019;s agreement with Eli Lilly and Company &amp;nbsp;(Note 6)&amp;nbsp;and proceeds from the IPO. The Company expects to incur additional operating losses and negative operating cash flows for the foreseeable future.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="Fact-b70ac733-5950-4b03-ad8c-0687438f27e5_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">-58000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherNonoperatingIncomeExpense id="Fact-9218cff0-4046-479d-8182-8ca83413101f_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">2662000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:PaymentsOfFinancingCosts id="Fact-9cb236ff-be2f-403e-b482-0744094b575f_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">134000</us-gaap:PaymentsOfFinancingCosts>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="Fact-580d1e5a-d124-4405-8425-e9a4d432d4d4_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">174205000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Fact-79212397-f921-4a73-9eb1-609f2d075dc0_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">2557000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering id="Fact-244d55ba-f616-49d3-b131-ac3a6c615031_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">77264000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Fact-5a70879b-46de-461a-8588-532e61eaff0c_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">65000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfDebt id="Fact-eb6a4302-528c-4559-861b-14c262fdddfb_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">4540000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:ProfitLoss id="Fact-ff44e93a-4bf2-473e-a914-71b2b4d17131_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">-22810000</us-gaap:ProfitLoss>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="Fact-025a40a1-adfd-4346-a7f9-be6e6691b7e8_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;5. Property and Equipment, Net&lt;a name="a4PropertyandEquipmentNet_509472"&gt;&lt;/a&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Property and equipment consist of the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9,746&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7,787&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,365&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4,825&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Computer equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 441&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 167&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 94&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 70&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Construction in progress&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 787&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,027&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Property and equipment, gross&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 16,433&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 13,876&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (4,402)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (2,469)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Property and equipment, net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 12,031&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 11,407&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Construction in progress at September 30, 2019 consists of the costs incurred for research equipment and for the build-out of additional lab and office space and at December&amp;nbsp;31, 2018 consists of the costs incurred for the build-out of a manufacturing suite at the Company&amp;#x2019;s headquarters in Beltsville, Maryland. &lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Depreciation and amortization expense was $788,000 and $1,933,000 for the&amp;nbsp;three and nine months ended September&amp;nbsp;30, 2019, respectively, and $396,000 and $1,159,000 for the three and nine months ended September 30, 2018, respectively.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="Fact-a0072029-4ff0-45be-8b08-cf1dc3c288e6_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Property and equipment consist of the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9,746&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7,787&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,365&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4,825&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Computer equipment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 441&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 167&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 94&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 70&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Construction in progress&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 787&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,027&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Property and equipment, gross&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 16,433&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 13,876&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (4,402)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (2,469)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Property and equipment, net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 12,031&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 11,407&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:ResearchAndDevelopmentExpense id="Fact-40a1fd0e-3591-4b05-bd75-4d6d80c4a32f_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">22819000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Fact-e71576e4-0efd-4603-9b1f-1bd35b462bd1_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">4342000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
  <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock id="Fact-2455d8dc-c269-4628-9b51-2644bf365a03_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Revenue Recognition&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company has adopted Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (&amp;#x201C;ASC 606&amp;#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect consideration to which it is entitled in exchange for the goods or services it transfers to the customer.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral to or dependent on other goods or services in the contract.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration that is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company&amp;#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&amp;#x2019;s control or the licensee&amp;#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur and (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying condensed balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&amp;#x2019;s right to consideration is unconditional.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
  <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock id="Fact-7db0c4a1-788b-409d-a5ea-8640ca385a64_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="11" valign="bottom" style="width:41.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September 30, 2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Amortized&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Estimated&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Gain&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Loss&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;U.S. treasury securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 19,982&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 19,983&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Agency bonds&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 47,178&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (17)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 47,161&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Corporate bonds&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 107,045&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 20&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (62)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 107,003&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 174,205&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 21&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (79)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 174,147&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
  <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock id="Fact-4006c60b-e8bc-4249-aa79-869dd28c2d73_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9,935&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,173&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Restricted cash (including $3,750 in other assets)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,039&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 460&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 14,974&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,633&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="Fact-2c552817-dbb5-4af3-b87b-cef4e1455a81_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Stock&amp;#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.42%;"&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Three Months Ended &lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Nine Months Ended &lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Research and development&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 182&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 41&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 482&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 62&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;General and administrative&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 342&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 49&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 837&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 76&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total stock-based compensation expense&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 524&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 90&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,319&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 138&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="Fact-a28302c9-f3b7-4df1-9425-ee5766140c96_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The future minimum payments for the operating leases are as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Remainder of the year&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 97&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2020&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 566&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2021&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 692&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2022&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 742&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2023&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 733&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Thereafter&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6,088&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total future minimum payments&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 8,918&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock id="Fact-8bd162b1-1042-4b15-ace6-e6363ba8e6bb_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Future maturities of the Term Loan as of September 30, 2019 are as follows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Remainder of the year&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; &amp;nbsp;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2020&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,528&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2021&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,667&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2022&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1,667&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;2023&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 138&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,000&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Less: current portion of term loan&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (1,250)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Term loan, net of current portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 3,750&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="Fact-a1ce1b39-4ecd-40aa-a60c-8a25630123f0_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="9" valign="bottom" style="width:39.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Options&amp;nbsp;Outstanding&amp;nbsp;and&amp;nbsp;Exercisable&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Weighted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Weighted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Average&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Average&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Remaining&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Number&amp;nbsp;of&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Exercise&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Contractual&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%"&gt;(1)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Shares&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Price&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;Life&amp;nbsp;(Years)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;(in&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Outstanding as of December&amp;nbsp;31,&amp;nbsp;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,056,891&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 4.74&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.4&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,946&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Granted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 247,275&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 18.18&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 10.0&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (53,963)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1.20&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 8.1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Forfeitures&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; (1,250)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 7.63&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.5&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Outstanding as of September&amp;nbsp;30,&amp;nbsp;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,248,953&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6.30&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9.1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 55,305&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Vested and expected to vest as of September&amp;nbsp;30,&amp;nbsp;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 2,248,953&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 6.30&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 55,305&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Exercisable as of September&amp;nbsp;30,&amp;nbsp;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 450,866&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 1.15&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 12,335&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;div&gt;&lt;hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"&gt;&lt;/hr&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at September 30, 2019 and December&amp;nbsp;31, 2018.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensation id="Fact-6373130c-62d0-4732-9d31-101045e47fa6_20190630" decimals="-3" contextRef="D2019-01-01_2019-09-30" unitRef="iso4217-USD">1319000</us-gaap:ShareBasedCompensation>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="Fact-db87417a-6779-47d0-9721-f7930e23ed8c_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;"&gt;2. Summary of Significant Accounting Policies&lt;a name="a2SummaryofSignificantAccountingPolicies"&gt;&lt;/a&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Basis of Presentation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The accompanying unaudited condensed financial statements as of September 30, 2019 and for the three and nine months ended September 30, 2019 and 2018 have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (&amp;#x201C;GAAP&amp;#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&amp;#x201C;SEC&amp;#x201D;) for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed financial statements should be read in conjunction with the Company&amp;#x2019;s audited financial statements and the notes thereto as of and for the year ended December 31, 2018, which are included in the Company&amp;#x2019;s final prospectus that forms a part of the Company&amp;#x2019;s Registration Statement on Form S-1 (Reg. No. 333-230837) (the &amp;#x201C;Registration Statement&amp;#x201D;), as filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended, on May 9, 2019.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The unaudited interim condensed financial statements have been prepared on the same basis as the audited financial statements. In the opinion of management, the accompanying unaudited interim condensed financial statements contain all adjustments necessary for a fair statement of the Company&amp;#x2019;s financial position as of September 30, 2019 and condensed results of operations and cash flows for the three and nine months ended September 30, 2019 and 2018. Such adjustments are of a normal and recurring nature. The results of operations for the three and nine months ended September 30, 2019 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2019.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Use of Estimates&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to accrued expenses, revenue recognition, the valuation of equity&amp;#8209;based compensation, including incentive stock options, common stock and restricted common stock, as well as income taxes. The Company bases its estimates on various assumptions that the Company believes to be reasonable under the circumstances. A&lt;/font&gt;&lt;font style="display:inline;"&gt;lthough actual results could differ from those estimates, management does not believe that such differences would be material.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Restricted Cash&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;The Company is required, as a condition of its Term Loan (Note 8), to maintain cash collateral on deposit in a segregated money market bank account equal to the principal portion of the Term Loan, as determined on a quarterly basis. The bank may restrict withdrawals or transfers by or on behalf of the Company that would violate this requirement. The required reserve totaled $5.0 million as of September 30, 2019. This amount is presented in part as restricted cash and in part as other assets on the accompanying balance sheet.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;September&amp;nbsp;30,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 9,935&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,173&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Restricted cash (including $3,750 in other assets)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 5,039&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 460&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 14,974&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"&gt; 135,633&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Marketable Securities&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:normal;"&gt;Our investments primarily consist of government debt securities, corporate bonds and agency bonds. These marketable securities are classified as available-for-sale, and as such, are reported at fair value on our condensed balance sheets. Unrealized holding gains and losses are reported within accumulated other comprehensive income (loss) as a separate component of stockholders&amp;#x2019; equity. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization, together with interest on securities, are included in other income, net, on our condensed statements of operations.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:normal;"&gt;If a decline in the fair value of a marketable security below our cost basis is determined to be other than temporary, such marketable security is written down to its estimated fair value as a new cost basis and the amount of the write-down is included in earnings as an impairment charge. The cost of securities sold is based on the specific identification method.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Revenue Recognition&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company has adopted Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (&amp;#x201C;ASC 606&amp;#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect consideration to which it is entitled in exchange for the goods or services it transfers to the customer.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral to or dependent on other goods or services in the contract.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration that is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company&amp;#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&amp;#x2019;s control or the licensee&amp;#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur and (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying condensed balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&amp;#x2019;s right to consideration is unconditional.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Recently Issued Accounting Pronouncements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;"&gt;The Company qualifies as an emerging growth company (&amp;#x201C;EGC&amp;#x201D;) as defined under the Jumpstart Our Business Startups Act (the &amp;#x201C;JOBS Act&amp;#x201D;). Using exemptions provided under the JOBS Act provided to EGCs, the Company has elected to defer compliance with new or revised financial accounting standards until it is required to comply with such standards. &lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (&amp;#x201C;ASU 2016-02&amp;#x201D;). The new guidance will require lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016-02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right-to-use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company January 1, 2020.The Company continues to determine if it will elect to use the practical expedients permitted by the guidance and continues to gather data required to comply with the guidance. Based on the work completed to date, the Company is considering the implications of adopting the new standard, including the discount rate to be used in valuing new and existing leases and all applicable financial statement disclosures required by the new guidance. The Company is continuing to evaluate the effect of adoption and anticipates that it will result in the recognition of additional assets and corresponding liabilities related to the existing leases on its balance sheet. The Company is assessing any potential impacts on its internal controls, business processes, and accounting policies related to both the implementation of, and ongoing compliance with, the new guidance.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&amp;#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (&amp;#x201C;ASU 2016-13&amp;#x201D;). ASU 2016-13 will require credit losses to be reported using an expected losses model rather than the incurred losses model that is currently used, and will require additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard will require allowances to be recorded instead of reducing the amortized cost of the investment. ASU 2016-13 will be effective for non-emerging growth companies for fiscal years beginning December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2016-13 will have on its financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement&amp;#x2014;Disclosure Framework-Changes to the Disclosure Requirement for Fair Value Measurement (&amp;#x201C;ASU 2018-13&amp;#x201D;). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements in ASC 820, Fair Value Measurement, based on the concepts in the FASB Concepts Statement, including the consideration of costs and benefits. ASU 2018-13 will be effective for all companies for fiscal periods beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2018-13 will have on its financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;background-color: #FFFFFF;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In November 2018, the FASB issued ASU No. 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 (&amp;#x201C;ASU 2018-18&amp;#x201D;). ASU 2018-18 clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, all the guidance in Topic 606 should be applied, including recognition, measurement, presentation and disclosure requirements. The amendment also adds unit of account guidance in Topic 808 to align with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of the arrangement is within the scope of Topic 606. Lastly, ASU 2018-18 provides that in a transaction with a collaborative arrangement participant that is not directly related to sales to third parties, presenting the transaction together with revenue recognized under Topic 606 will be precluded if the collaborative arrangement participant is not a customer. ASU 2018-18 will be effective for non-emerging growth companies for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020 and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating these clarifications for the accounting and presentation for its collaborative arrangements within the scope of Topic 808, but does not expect that the adoption of ASU 2018-18 will have any impact.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:SubsequentEventsTextBlock id="Fact-5d46cdf8-12e2-4b41-9af0-b6ead655abfa_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;11. Subsequent Events&lt;a name="a16SubsequentEvents_824036"&gt;&lt;/a&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company has evaluated subsequent events through the issuance date of these interim condensed financial statements.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:TypeOfRevenueExtensibleList id="Fact-3ac15084-ac3f-41fa-828a-72d8f191e0dd_20190630" contextRef="D2019-01-01_2019-09-30">nxtc:RelatedPartyMember</us-gaap:TypeOfRevenueExtensibleList>
  <us-gaap:UseOfEstimates id="Fact-506cd0c3-6fb0-4715-bb4c-661b34ef50f5_20190630" contextRef="D2019-01-01_2019-09-30">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;Use of Estimates&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-family:Times New Roman,Times,serif;"&gt;The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to accrued expenses, revenue recognition, the valuation of equity&amp;#8209;based compensation, including incentive stock options, common stock and restricted common stock, as well as income taxes. The Company bases its estimates on various assumptions that the Company believes to be reasonable under the circumstances. A&lt;/font&gt;&lt;font style="display:inline;"&gt;lthough actual results could differ from those estimates, management does not believe that such differences would be material.&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Fact-41699b45-f208-4cde-91b9-759453df1faf_20190630" decimals="0" contextRef="D2019-01-01_2019-09-30" unitRef="xbrli-shares">12609219</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <dei:EntityRegistrantName contextRef="D2019-01-01_2019-09-30">NextCure, Inc.</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey contextRef="D2019-01-01_2019-09-30">0001661059</dei:EntityCentralIndexKey>
  <dei:DocumentType contextRef="D2019-01-01_2019-09-30">S-1</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="D2019-01-01_2019-09-30">2019-09-30</dei:DocumentPeriodEndDate>
  <dei:AmendmentFlag contextRef="D2019-01-01_2019-09-30">false</dei:AmendmentFlag>
  <dei:EntityFilerCategory contextRef="D2019-01-01_2019-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
  <dei:EntitySmallBusiness contextRef="D2019-01-01_2019-09-30">true</dei:EntitySmallBusiness>
  <dei:EntityEmergingGrowthCompany contextRef="D2019-01-01_2019-09-30">true</dei:EntityEmergingGrowthCompany>
  <dei:EntityExTransitionPeriod contextRef="D2019-01-01_2019-09-30">false</dei:EntityExTransitionPeriod>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>nxtc-20191112.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Toppan Merrill -->
<!-- Generated by Fujitsu Interstage XWand B0189 -->
<xsd:schema targetNamespace="http://www.nextcure.com/20191112" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:nxtc="http://www.nextcure.com/20191112" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:us-gaap-att="http://xbrl.us/us-gaap/attributes" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:attributeFormDefault="unqualified" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="nxtc-20191112_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="nxtc-20191112_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="nxtc-20191112_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="nxtc-20191112_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://www.nextcure.com/role/StatementBalanceSheets" id="StatementBalanceSheets">
        <link:definition>100100 - Statement - BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementStatementsOfOperationsAndComprehensiveLoss" id="StatementStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100200 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementStatementsOfCashFlows" id="StatementStatementsOfCashFlows">
        <link:definition>100400 - Statement - STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetails">
        <link:definition>140201 - Disclosure - Summary of Significant Accounting Policies - Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetails" id="DisclosurePropertyAndEquipmentNetDetails">
        <link:definition>140401 - Disclosure - Property and Equipment, Net - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureAccruedLiabilitiesDetails" id="DisclosureAccruedLiabilitiesDetails">
        <link:definition>140501 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetails" id="DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetails">
        <link:definition>140702 - Disclosure - Commitments and Contingencies - Future Minimum Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetails" id="DisclosureTermLoanMaturitiesDetails">
        <link:definition>140802 - Disclosure - Term Loan - Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetailscalc2" id="DisclosureTermLoanMaturitiesDetailscalc2">
        <link:definition>140802 - Disclosure - Term Loan - Maturities (Details)_Calc2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesReconciliationDetails" id="DisclosureIncomeTaxesReconciliationDetails">
        <link:definition>141301 - Disclosure - Income Taxes - Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesDeferredTaxAssetsDetails" id="DisclosureIncomeTaxesDeferredTaxAssetsDetails">
        <link:definition>141302 - Disclosure - Income Taxes - Deferred tax assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementBalanceSheetsParenthetical" id="StatementBalanceSheetsParenthetical">
        <link:definition>100105 - Statement - BALANCE SHEETS - (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficit" id="StatementStatementsOfPreferredStockAndStockholdersDeficit">
        <link:definition>100300 - Statement - STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficitParenthetical" id="StatementStatementsOfPreferredStockAndStockholdersDeficitParenthetical">
        <link:definition>100305 - Statement - STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureTermLoan" id="DisclosureTermLoan">
        <link:definition>110801 - Disclosure - Term Loan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosurePreferredStock" id="DisclosurePreferredStock">
        <link:definition>110901 - Disclosure - Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureCommonStock" id="DisclosureCommonStock">
        <link:definition>111001 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensation" id="DisclosureStockBasedCompensation">
        <link:definition>111101 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholders" id="DisclosureNetLossPerShareAttributableToCommonStockholders">
        <link:definition>111201 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>111301 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureEmployeeBenefitPlan" id="DisclosureEmployeeBenefitPlan">
        <link:definition>111401 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureRelatedPartyTransactions" id="DisclosureRelatedPartyTransactions">
        <link:definition>111501 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>111601 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureTermLoanTables" id="DisclosureTermLoanTables">
        <link:definition>130803 - Disclosure - Term Loan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationTables" id="DisclosureStockBasedCompensationTables">
        <link:definition>131103 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersTables" id="DisclosureNetLossPerShareAttributableToCommonStockholdersTables">
        <link:definition>131203 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>131303 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationDetails" id="DisclosureNatureOfBusinessAndBasisOfPresentationDetails">
        <link:definition>140101 - Disclosure - Nature of the Business and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
        <link:definition>140202 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetails" id="DisclosureFairValueOfFinancialInstrumentsDetails">
        <link:definition>140301 - Disclosure - Fair Value of Financial Instruments - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDetails" id="DisclosureAgreementWithEliLillyAndCompanyDetails">
        <link:definition>140601 - Disclosure - Agreement with Eli Lilly and Company (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureTermLoanOtherDetails" id="DisclosureTermLoanOtherDetails">
        <link:definition>140801 - Disclosure - Term Loan - Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosurePreferredStockDetails" id="DisclosurePreferredStockDetails">
        <link:definition>140901 - Disclosure - Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureCommonStockDetails" id="DisclosureCommonStockDetails">
        <link:definition>141001 - Disclosure - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensation2015OmnibusIncentivePlanDetails" id="DisclosureStockBasedCompensation2015OmnibusIncentivePlanDetails">
        <link:definition>141101 - Disclosure - Stock Based Compensation - 2015 Omnibus Incentive Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetails" id="DisclosureStockBasedCompensationStockOptionsDetails">
        <link:definition>141102 - Disclosure - Stock-Based Compensation - Stock options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails" id="DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails">
        <link:definition>141103 - Disclosure - Stock-Based Compensation - Stock based compensation expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationAssumptionsDetails" id="DisclosureStockBasedCompensationAssumptionsDetails">
        <link:definition>141104 - Disclosure - Stock-Based Compensation - Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationRestrictedCommonStockDetails" id="DisclosureStockBasedCompensationRestrictedCommonStockDetails">
        <link:definition>141105 - Disclosure - Stock-Based Compensation - Restricted Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersOtherDetails" id="DisclosureNetLossPerShareAttributableToCommonStockholdersOtherDetails">
        <link:definition>141201 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAntiDilutiveEffectDetails" id="DisclosureNetLossPerShareAttributableToCommonStockholdersAntiDilutiveEffectDetails">
        <link:definition>141202 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Anti-dilutive effect (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureEmployeeBenefitPlanDetails" id="DisclosureEmployeeBenefitPlanDetails">
        <link:definition>141401 - Disclosure - Employee Benefit Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureRelatedPartyTransactionsDetails" id="DisclosureRelatedPartyTransactionsDetails">
        <link:definition>141501 - Disclosure - Related Party Transactions - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSubsequentEventsDetails" id="DisclosureSubsequentEventsDetails">
        <link:definition>141601 - Disclosure - Subsequent Events - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation" id="DisclosureNatureOfBusinessAndBasisOfPresentation">
        <link:definition>110101 - Disclosure - Nature of the Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPolicies" id="DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>110201 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstruments" id="DisclosureFairValueOfFinancialInstruments">
        <link:definition>110301 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNet" id="DisclosurePropertyAndEquipmentNet">
        <link:definition>110401 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureAccruedLiabilities" id="DisclosureAccruedLiabilities">
        <link:definition>110501 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompany" id="DisclosureAgreementWithEliLillyAndCompany">
        <link:definition>110601 - Disclosure - Agreement with Eli Lilly and Company</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>110701 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>120202 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>130203 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsTables" id="DisclosureFairValueOfFinancialInstrumentsTables">
        <link:definition>130303 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetTables" id="DisclosurePropertyAndEquipmentNetTables">
        <link:definition>130403 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureAccruedLiabilitiesTables" id="DisclosureAccruedLiabilitiesTables">
        <link:definition>130503 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesTables" id="DisclosureCommitmentsAndContingenciesTables">
        <link:definition>130703 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>140203 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesOtherDetails" id="DisclosureCommitmentsAndContingenciesOtherDetails">
        <link:definition>140701 - Disclosure - Commitments and Contingencies - Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementCondensedBalanceSheetsQuarterEnd" id="StatementCondensedBalanceSheetsQuarterEnd">
        <link:definition>200100 - Statement - CONDENSED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfOperationsAndComprehensiveLossQuarterEnd" id="StatementCondensedStatementsOfOperationsAndComprehensiveLossQuarterEnd">
        <link:definition>200200 - Statement - CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfCashFlowsQuarterEnd" id="StatementCondensedStatementsOfCashFlowsQuarterEnd">
        <link:definition>200400 - Statement - CONDENSED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetailsQuarterEnd" id="DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetailsQuarterEnd">
        <link:definition>240201 - Disclosure - Summary of Significant Accounting Policies - Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureInvestmentsDetailsQuarterEnd" id="DisclosureInvestmentsDetailsQuarterEnd">
        <link:definition>240301 - Disclosure - Investments - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd" id="DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd">
        <link:definition>240401 - Disclosure - Fair Value of Financial Instruments - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetailsQuarterEnd" id="DisclosurePropertyAndEquipmentNetDetailsQuarterEnd">
        <link:definition>240501 - Disclosure - Property and Equipment, Net - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDeferredRevenueIncludedInBalanceSheetsDetailsQuarterEnd" id="DisclosureAgreementWithEliLillyAndCompanyDeferredRevenueIncludedInBalanceSheetsDetailsQuarterEnd">
        <link:definition>240602 - Disclosure - Agreement with Eli Lilly and Company - Deferred revenue included in balance sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetailsQuarterEnd" id="DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetailsQuarterEnd">
        <link:definition>240702 - Disclosure - Commitments and Contingencies - Future Minimum Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetailsQuarterEnd" id="DisclosureTermLoanMaturitiesDetailsQuarterEnd">
        <link:definition>240802 - Disclosure - Term Loan - Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetailscalc2QuarterEnd" id="DisclosureTermLoanMaturitiesDetailscalc2QuarterEnd">
        <link:definition>240802 - Disclosure - Term Loan - Maturities (Details)_Calc2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementCondensedBalanceSheetsParentheticalQuarterEnd" id="StatementCondensedBalanceSheetsParentheticalQuarterEnd">
        <link:definition>200105 - Statement - CONDENSED BALANCE SHEETS - (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitQuarterEnd" id="StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitQuarterEnd">
        <link:definition>200300 - Statement - CONDENSED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitParentheticalQuarterEnd" id="StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitParentheticalQuarterEnd">
        <link:definition>200305 - Statement - CONDENSED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureInvestmentsQuarterEnd" id="DisclosureInvestmentsQuarterEnd">
        <link:definition>210301 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureTermLoanQuarterEnd" id="DisclosureTermLoanQuarterEnd">
        <link:definition>210801 - Disclosure - Term Loan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationQuarterEnd" id="DisclosureStockBasedCompensationQuarterEnd">
        <link:definition>210901 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesQuarterEnd" id="DisclosureIncomeTaxesQuarterEnd">
        <link:definition>211001 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSubsequentEventsQuarterEnd" id="DisclosureSubsequentEventsQuarterEnd">
        <link:definition>211101 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureInvestmentsTablesQuarterEnd" id="DisclosureInvestmentsTablesQuarterEnd">
        <link:definition>230303 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureTermLoanTablesQuarterEnd" id="DisclosureTermLoanTablesQuarterEnd">
        <link:definition>230803 - Disclosure - Term Loan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationTablesQuarterEnd" id="DisclosureStockBasedCompensationTablesQuarterEnd">
        <link:definition>230903 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureNatureOfBusinessDetailsQuarterEnd" id="DisclosureNatureOfBusinessDetailsQuarterEnd">
        <link:definition>240101 - Disclosure - Nature of the Business - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyOtherDetailsQuarterEnd" id="DisclosureAgreementWithEliLillyAndCompanyOtherDetailsQuarterEnd">
        <link:definition>240601 - Disclosure - Agreement with Eli Lilly and Company - Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureTermLoanOtherDetailsQuarterEnd" id="DisclosureTermLoanOtherDetailsQuarterEnd">
        <link:definition>240801 - Disclosure - Term Loan - Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetailsQuarterEnd" id="DisclosureStockBasedCompensationStockOptionsDetailsQuarterEnd">
        <link:definition>240901 - Disclosure - Stock-Based Compensation - Stock options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetailsQuarterEnd" id="DisclosureStockBasedCompensationStockBasedCompensationExpenseDetailsQuarterEnd">
        <link:definition>240902 - Disclosure - Stock-Based Compensation - Stock based compensation expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesDetailsQuarterEnd" id="DisclosureIncomeTaxesDetailsQuarterEnd">
        <link:definition>241001 - Disclosure - Income Taxes - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSubsequentEventsDetailsQuarterEnd" id="DisclosureSubsequentEventsDetailsQuarterEnd">
        <link:definition>241101 - Disclosure - Subsequent Events - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureNatureOfBusinessQuarterEnd" id="DisclosureNatureOfBusinessQuarterEnd">
        <link:definition>210101 - Disclosure - Nature of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesQuarterEnd" id="DisclosureSummaryOfSignificantAccountingPoliciesQuarterEnd">
        <link:definition>210201 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsQuarterEnd" id="DisclosureFairValueOfFinancialInstrumentsQuarterEnd">
        <link:definition>210401 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetQuarterEnd" id="DisclosurePropertyAndEquipmentNetQuarterEnd">
        <link:definition>210501 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyQuarterEnd" id="DisclosureAgreementWithEliLillyAndCompanyQuarterEnd">
        <link:definition>210601 - Disclosure - Agreement with Eli Lilly and Company</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesQuarterEnd" id="DisclosureCommitmentsAndContingenciesQuarterEnd">
        <link:definition>210701 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciesQuarterEnd" id="DisclosureSummaryOfSignificantAccountingPoliciesPoliciesQuarterEnd">
        <link:definition>220202 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTablesQuarterEnd" id="DisclosureSummaryOfSignificantAccountingPoliciesTablesQuarterEnd">
        <link:definition>230203 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsTablesQuarterEnd" id="DisclosureFairValueOfFinancialInstrumentsTablesQuarterEnd">
        <link:definition>230403 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetTablesQuarterEnd" id="DisclosurePropertyAndEquipmentNetTablesQuarterEnd">
        <link:definition>230503 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyTablesQuarterEnd" id="DisclosureAgreementWithEliLillyAndCompanyTablesQuarterEnd">
        <link:definition>230603 - Disclosure - Agreement with Eli Lilly and Company (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesTablesQuarterEnd" id="DisclosureCommitmentsAndContingenciesTablesQuarterEnd">
        <link:definition>230703 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesOtherDetailsQuarterEnd" id="DisclosureCommitmentsAndContingenciesOtherDetailsQuarterEnd">
        <link:definition>240701 - Disclosure - Commitments and Contingencies - Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nextcure.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>000090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
  <xsd:element name="RelatedPartyTransactionsDeferredRevenueCurrent" id="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="RelatedPartyTransactionsDeferredRevenueNoncurrent" id="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="Series2PreferredStockMember" id="nxtc_Series2PreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Series3PreferredStockMember" id="nxtc_Series3PreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseInDeferredRevenueFromRelatedParty" id="nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="SeriesB1PreferredStockMember" id="nxtc_SeriesB1PreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SeriesB2PreferredStockMember" id="nxtc_SeriesB2PreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SeriesB3PreferredStockMember" id="nxtc_SeriesB3PreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" id="nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" id="nxtc_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ResearchEquipmentMember" id="nxtc_ResearchEquipmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AccruedConstructionInProgressCurrent" id="nxtc_AccruedConstructionInProgressCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="AccruedClinicalTrialCostsCurrent" id="nxtc_AccruedClinicalTrialCostsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="AccruedOperatingExpensesCurrent" id="nxtc_AccruedOperatingExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="AccruedFinancingCostsCurrent" id="nxtc_AccruedFinancingCostsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="CollaborativeArrangementDisclosureAbstract" id="nxtc_CollaborativeArrangementDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ResearchAndDevelopmentCollaborativeAgreementMember" id="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EliLillyAndCompanyMember" id="nxtc_EliLillyAndCompanyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" id="nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementUpfrontNonRefundablePaymentReceived" id="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="PremiumFromIssuanceOfPreferredStock" id="nxtc_PremiumFromIssuanceOfPreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="Series1PreferredStockMember" id="nxtc_Series1PreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SeriesB1AndB2PreferredStockMember" id="nxtc_SeriesB1AndB2PreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfDirectorsStockHoldersAreEntitledToElect" id="nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PreferredStockConvertibleConversionRatio" id="nxtc_PreferredStockConvertibleConversionRatio" type="xbrli:pureItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="nxtc_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" id="nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CommonStockTextBlock" id="nxtc_CommonStockTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfVotesPerShare" id="nxtc_NumberOfVotesPerShare" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="A2015OmnibusIncentivePlanMember" id="nxtc_A2015OmnibusIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" id="nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" id="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" id="nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" type="xbrli:pureItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DeferredTaxLiabilitiesDepreciationAndAmortization" id="nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" id="nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" id="nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="ConsultingAgreementMember" id="nxtc_ConsultingAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="YaleLicenseAgreementMember" id="nxtc_YaleLicenseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SponsoredResearchAgreementMember" id="nxtc_SponsoredResearchAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScientificFounderMember" id="nxtc_ScientificFounderMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="YaleUniversityMember" id="nxtc_YaleUniversityMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RelatedPartyTransactionMilestonePaymentsPerProduct" id="nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RelatedPartyTransactionAmountProvidedToFundResearchProgram" id="nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RelatedPartyTransactionAggregatePaymentsMade" id="nxtc_RelatedPartyTransactionAggregatePaymentsMade" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="RelatedPartyTransactionPaymentsMade" id="nxtc_RelatedPartyTransactionPaymentsMade" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="DebtInstrumentMonthlyPaymentsNumber" id="nxtc_DebtInstrumentMonthlyPaymentsNumber" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PeriodForWhichBaseRentIsAbated" id="nxtc_PeriodForWhichBaseRentIsAbated" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AnnualBaseRentPerMonthAfterAbatement" id="nxtc_AnnualBaseRentPerMonthAfterAbatement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfAnnualIncreaseInLeaseRent" id="nxtc_PercentageOfAnnualIncreaseInLeaseRent" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" id="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" id="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" id="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" id="nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RevenueRecognitionNumberOfPerformanceObligations" id="nxtc_RevenueRecognitionNumberOfPerformanceObligations" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PreferredStockAbstract" id="nxtc_PreferredStockAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" id="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PaymentsOfUnderwritingDiscountsAndCommissions" id="nxtc_PaymentsOfUnderwritingDiscountsAndCommissions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementTransactionPrice" id="nxtc_CollaborationAgreementTransactionPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="RelatedPartyTransactionsDeferredRevenue" id="nxtc_RelatedPartyTransactionsDeferredRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="RelatedPartyTransactionsDeferredRevenueUpFrontPayment" id="nxtc_RelatedPartyTransactionsDeferredRevenueUpFrontPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" id="nxtc_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" id="nxtc_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" id="nxtc_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" id="nxtc_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" id="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LetterOfCredit" id="nxtc_LetterOfCredit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="OmnibusIncentive2019PlanMember" id="nxtc_OmnibusIncentive2019PlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeeStockPurchase2019PlanMember" id="nxtc_EmployeeStockPurchase2019PlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" id="nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" id="nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" id="nxtc_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodValueInitialPublicOffering" id="nxtc_StockIssuedDuringPeriodValueInitialPublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodSharesInitialPublicOffering" id="nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RequiredReserveRestrictedCashCurrent" id="nxtc_RequiredReserveRestrictedCashCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" id="nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" id="nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" id="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" id="nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RestrictedCashAndOtherAssetsCurrent" id="nxtc_RestrictedCashAndOtherAssetsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" id="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MarketableSecuritiesAndCashEquivalents" id="nxtc_MarketableSecuritiesAndCashEquivalents" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="AnnualBaseRentPerMonth" id="nxtc_AnnualBaseRentPerMonth" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" id="nxtc_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="TenantImprovementsReimbursement" id="nxtc_TenantImprovementsReimbursement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RestrictedCashOtherAssetsNonCurrent" id="nxtc_RestrictedCashOtherAssetsNonCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>nxtc-20191112_cal.xml
<DESCRIPTION>EX-101.CAL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Toppan Merrill -->
<!-- Generated by Fujitsu Interstage XWand B0189 -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementStatementsOfCashFlows" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementStatementsOfCashFlows" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAccruedLiabilitiesDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanMaturitiesDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureIncomeTaxesReconciliationDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureIncomeTaxesDeferredTaxAssetsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedBalanceSheetsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedBalanceSheetsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfOperationsAndComprehensiveLossQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedStatementsOfOperationsAndComprehensiveLossQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfCashFlowsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedStatementsOfCashFlowsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureInvestmentsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureInvestmentsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePropertyAndEquipmentNetDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDeferredRevenueIncludedInBalanceSheetsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAgreementWithEliLillyAndCompanyDeferredRevenueIncludedInBalanceSheetsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanMaturitiesDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetailscalc2QuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanMaturitiesDetailscalc2QuarterEnd" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324805284699" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637091324805284699" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324805284699" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637091324805284699" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_637091324805284699" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324805284699" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_637091324805284699" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_637091324805284699" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324805284699" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_637091324805284699" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_637091324805284699" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324805284699" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_637091324805284699" use="optional" priority="2" order="4.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:label="nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty_637091324805284699" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324805284699" xlink:to="nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty_637091324805284699" use="optional" priority="2" order="5.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_637091324805284699" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324805284699" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_637091324805284699" use="optional" priority="3" order="6.0" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637091324805284699" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324805284699" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637091324805284699" use="optional" priority="3" order="7.0" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_637091324805284699" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324805284699" xlink:to="us-gaap_ProfitLoss_637091324805284699" use="optional" priority="2" order="8.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_637091324805284699" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324805284699" xlink:to="us-gaap_ShareBasedCompensation_637091324805284699" use="optional" priority="2" order="9.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091324805294803" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_RestrictedCashCurrent_637091324805294803" use="optional" priority="2" order="2.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAccruedLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedClinicalTrialCostsCurrent" xlink:label="nxtc_AccruedClinicalTrialCostsCurrent_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="nxtc_AccruedClinicalTrialCostsCurrent_637091324805294803" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedConstructionInProgressCurrent" xlink:label="nxtc_AccruedConstructionInProgressCurrent_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="nxtc_AccruedConstructionInProgressCurrent_637091324805294803" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedFinancingCostsCurrent" xlink:label="nxtc_AccruedFinancingCostsCurrent_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="nxtc_AccruedFinancingCostsCurrent_637091324805294803" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedOperatingExpensesCurrent" xlink:label="nxtc_AccruedOperatingExpensesCurrent_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="nxtc_AccruedOperatingExpensesCurrent_637091324805294803" use="optional" priority="2" order="4.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRentCurrent" xlink:label="us-gaap_AccruedRentCurrent_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedRentCurrent_637091324805294803" use="optional" priority="2" order="5.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_637091324805294803" use="optional" priority="2" order="6.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_InterestPayableCurrent_637091324805294803" use="optional" priority="2" order="7.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_637091324805294803" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_637091324805294803" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_637091324805294803" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_637091324805304833" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_637091324805304833" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_637091324805304833" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_637091324805304833" use="optional" priority="2" order="4.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_637091324805304833" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_637091324805304833" use="optional" priority="2" order="5.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_637091324805304833" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_637091324805304833" use="optional" priority="2" order="6.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_637091324805304833" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_637091324805304833" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637091324805304833" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637091324805304833" use="optional" priority="2" order="2.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureIncomeTaxesReconciliationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_637091324805334736" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_637091324805334736" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_637091324805334736" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_637091324805334736" use="optional" priority="2" order="4.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_637091324805334736" use="optional" priority="2" order="5.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_637091324805334736" use="optional" priority="2" order="6.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_637091324805334736" use="optional" priority="2" order="7.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:label="nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_637091324805334736" use="optional" priority="2" order="8.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureIncomeTaxesDeferredTaxAssetsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet_637091324805334736" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet_637091324805334736" xlink:to="us-gaap_DeferredTaxAssetsGross_637091324805334736" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_637091324805334736" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_637091324805334736" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_637091324805334736" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_637091324805334736" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_637091324805334736" xlink:to="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_637091324805334736" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_637091324805334736" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_637091324805334736" use="optional" priority="2" order="4.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross_637091324805334736" xlink:to="us-gaap_DeferredTaxAssetsOther_637091324805334736" use="optional" priority="2" order="5.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet_637091324805334736" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_637091324805334736" use="optional" priority="2" order="2.0" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_637091324805334736" use="optional" priority="2" order="2.0" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:label="nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization_637091324805334736" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities_637091324805334736" xlink:to="nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization_637091324805334736" use="optional" priority="2" order="1.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedBalanceSheetsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_637091327025074477" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent_637091327025074477" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091327025084455" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637091327025074477" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091327025084455" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_637091327025084455" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637091327025074477" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_637091327025084455" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent_637091327025084455" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637091327025074477" xlink:to="us-gaap_RestrictedCashCurrent_637091327025084455" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637091327025084455" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637091327025074477" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637091327025084455" use="optional" priority="2" order="4.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637091327025084455" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637091327025084455" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_637091327025084455" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent_637091327025084455" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637091327025164277" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity_637091327025164277" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_637091327025164277" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637091327025164277" xlink:to="us-gaap_CommonStockValue_637091327025164277" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_637091327025164277" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637091327025164277" xlink:to="us-gaap_AdditionalPaidInCapital_637091327025164277" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_637091327025164277" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637091327025164277" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_637091327025164277" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_637091327025164277" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637091327025164277" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_637091327025164277" use="optional" priority="2" order="4.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091327025164277" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091327025164277" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_637091327025164277" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities_637091327025164277" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637091327025164277" xlink:to="us-gaap_LiabilitiesCurrent_637091327025174218" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637091327025174218" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent_637091327025174218" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637091327025174218" xlink:to="us-gaap_AccountsPayableCurrent_637091327025174218" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637091327025174218" xlink:to="us-gaap_AccruedLiabilitiesCurrent_637091327025174218" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637091327025174218" xlink:to="us-gaap_DeferredRentCreditCurrent_637091327025174218" use="optional" priority="2" order="4.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637091327025174218" xlink:to="us-gaap_LongTermDebtCurrent_637091327025174218" use="optional" priority="2" order="5.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637091327025164277" xlink:to="us-gaap_DeferredRentCreditNoncurrent_637091327025174218" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637091327025164277" xlink:to="us-gaap_LongTermDebtNoncurrent_637091327025174218" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637091327025164277" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent_637091327025174218" use="optional" priority="2" order="4.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedStatementsOfOperationsAndComprehensiveLossQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_637091327025174218" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss_637091327025174218" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss_637091327025174218" xlink:to="us-gaap_OperatingIncomeLoss_637091327025174218" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_637091327025174218" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637091327025174218" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_637091327025174218" xlink:to="us-gaap_OperatingExpenses_637091327025174218" use="optional" priority="2" order="2.0" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_637091327025174218" xlink:to="us-gaap_ResearchAndDevelopmentExpense_637091327025174218" use="optional" priority="4" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_637091327025174218" xlink:to="us-gaap_GeneralAndAdministrativeExpense_637091327025174218" use="optional" priority="4" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_637091327025174218" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss_637091327025174218" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_637091327025174218" use="optional" priority="2" order="2.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedStatementsOfCashFlowsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091327025184189" use="optional" priority="3" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_637091327025184189" use="optional" priority="3" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637091327025184189" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_637091327025184189" use="optional" priority="2" order="1.0" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637091327025184189" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_637091327025184189" use="optional" priority="2" order="2.0" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091327025184189" use="optional" priority="3" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091327025184189" xlink:to="us-gaap_PaymentsOfFinancingCosts_637091327025184189" use="optional" priority="2" order="1.0" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091327025184189" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_637091327025184189" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091327025184189" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_637091327025184189" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091327025184189" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091327025184189" use="optional" priority="2" order="4.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091327025184189" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_637091327025184189" use="optional" priority="2" order="5.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt_637091327025184189" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091327025184189" xlink:to="us-gaap_RepaymentsOfDebt_637091327025184189" use="optional" priority="2" order="6.0" weight="-1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091327025194162" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RestrictedCashAndOtherAssetsCurrent" xlink:label="nxtc_RestrictedCashAndOtherAssetsCurrent_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="nxtc_RestrictedCashAndOtherAssetsCurrent_637091327025194162" use="optional" priority="2" order="2.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureInvestmentsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_637091327025194162" use="optional" priority="2" order="1.0" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_637091327025194162" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637091327025194162" use="optional" priority="2" order="3.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_MarketableSecuritiesAndCashEquivalents" xlink:label="nxtc_MarketableSecuritiesAndCashEquivalents" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="nxtc_MarketableSecuritiesAndCashEquivalents" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_637091327025194162" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="nxtc_MarketableSecuritiesAndCashEquivalents" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637091327025194162" use="optional" priority="2" order="2.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637091327025194162" use="optional" priority="2" order="1.0" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_637091327025194162" use="optional" priority="2" order="2.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDeferredRevenueIncludedInBalanceSheetsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenue" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenue" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="nxtc_RelatedPartyTransactionsDeferredRevenue" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent_637091327025194162" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="nxtc_RelatedPartyTransactionsDeferredRevenue" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent_637091327025194162" use="optional" priority="2" order="2.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_637091327025204308" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_637091327025204308" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_637091327025204308" use="optional" priority="2" order="4.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_637091327025204308" use="optional" priority="2" order="5.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_637091327025204308" use="optional" priority="2" order="6.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_637091327025194162" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_637091327025194162" use="optional" priority="2" order="1.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637091327025204308" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_637091327025204308" use="optional" priority="2" order="2.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_637091327025204308" use="optional" priority="2" order="3.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_637091327025204308" use="optional" priority="2" order="4.0" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetailscalc2QuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtCurrent_637091327025204308" use="optional" priority="2" order="1.0" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_637091327025204308" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtNoncurrent_637091327025204308" use="optional" priority="2" order="2.0" weight="1" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>nxtc-20191112_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Toppan Merrill -->
<!-- Generated by Fujitsu Interstage XWand B0189 -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementBalanceSheets" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementBalanceSheets" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementBalanceSheetsParenthetical" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficit" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementStatementsOfPreferredStockAndStockholdersDeficit" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficitParenthetical" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementStatementsOfPreferredStockAndStockholdersDeficitParenthetical" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNatureOfBusinessAndBasisOfPresentationDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureFairValueOfFinancialInstrumentsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePropertyAndEquipmentNetDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAgreementWithEliLillyAndCompanyDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanOtherDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanOtherDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePreferredStockDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePreferredStockDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensation2015OmnibusIncentivePlanDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensation2015OmnibusIncentivePlanDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationStockOptionsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationRestrictedCommonStockDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationRestrictedCommonStockDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAntiDilutiveEffectDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNetLossPerShareAttributableToCommonStockholdersAntiDilutiveEffectDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureIncomeTaxesReconciliationDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureRelatedPartyTransactionsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSubsequentEventsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSubsequentEventsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedBalanceSheetsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedBalanceSheetsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedBalanceSheetsParentheticalQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedBalanceSheetsParentheticalQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitParentheticalQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitParentheticalQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNatureOfBusinessDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNatureOfBusinessDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureInvestmentsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureInvestmentsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePropertyAndEquipmentNetDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyOtherDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAgreementWithEliLillyAndCompanyOtherDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanOtherDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanOtherDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationStockOptionsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationStockBasedCompensationExpenseDetailsQuarterEnd" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091324805613893" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_637091324805613893" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditCurrent" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtCurrent" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRentCreditNoncurrent" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PreferredStockAbstract" xlink:label="nxtc_PreferredStockAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="nxtc_PreferredStockAbstract" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nxtc_PreferredStockAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" use="optional" priority="1" order="5.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" use="optional" priority="1" order="9.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficit">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" use="optional" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series2PreferredStockMember" xlink:label="nxtc_Series2PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_Series2PreferredStockMember" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_Series3PreferredStockMember" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637091324805683979" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_637091324805683979" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" use="optional" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquity" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_CommonStockSharesOutstanding" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NetIncomeLoss" use="optional" priority="1" order="7.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficitParenthetical">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series2PreferredStockMember" xlink:label="nxtc_Series2PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_Series2PreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_Series3PreferredStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" use="optional" priority="1" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_Series3PreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB1PreferredStockMember" xlink:label="nxtc_SeriesB1PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_SeriesB1PreferredStockMember" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB2PreferredStockMember" xlink:label="nxtc_SeriesB2PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_SeriesB2PreferredStockMember" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB3PreferredStockMember" xlink:label="nxtc_SeriesB3PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_SeriesB3PreferredStockMember" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharePrice" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" use="optional" priority="1" order="6.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324805723938" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324805723938" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" use="optional" priority="1" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091324805723938" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091324805723938" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091324805734116" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091324805734116" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" use="optional" priority="1" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" use="optional" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchEquipmentMember" xlink:label="nxtc_ResearchEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="nxtc_ResearchEquipmentMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" use="optional" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" use="optional" priority="1" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324805743934" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324805743934" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" xlink:label="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_637091324805753917" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_637091324805753917" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EliLillyAndCompanyMember" xlink:label="nxtc_EliLillyAndCompanyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="nxtc_EliLillyAndCompanyMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:label="nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:label="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:label="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:label="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RevenueRecognitionNumberOfPerformanceObligations" xlink:label="nxtc_RevenueRecognitionNumberOfPerformanceObligations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_RevenueRecognitionNumberOfPerformanceObligations" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" use="optional" priority="1" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PremiumFromIssuanceOfPreferredStock" xlink:label="nxtc_PremiumFromIssuanceOfPreferredStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_PremiumFromIssuanceOfPreferredStock" use="optional" priority="1" order="10.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanOtherDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_VariableRateAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_637091324805763863" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_637091324805763863" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637091324805763863" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_637091324805763863" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DebtInstrumentMonthlyPaymentsNumber" xlink:label="nxtc_DebtInstrumentMonthlyPaymentsNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="nxtc_DebtInstrumentMonthlyPaymentsNumber" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpense" use="optional" priority="1" order="6.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series1PreferredStockMember" xlink:label="nxtc_Series1PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="nxtc_Series1PreferredStockMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series2PreferredStockMember" xlink:label="nxtc_Series2PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="nxtc_Series2PreferredStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="nxtc_Series3PreferredStockMember" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB1PreferredStockMember" xlink:label="nxtc_SeriesB1PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="nxtc_SeriesB1PreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB2PreferredStockMember" xlink:label="nxtc_SeriesB2PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="nxtc_SeriesB2PreferredStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB1AndB2PreferredStockMember" xlink:label="nxtc_SeriesB1AndB2PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="nxtc_SeriesB1AndB2PreferredStockMember" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB3PreferredStockMember" xlink:label="nxtc_SeriesB3PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="nxtc_SeriesB3PreferredStockMember" use="optional" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharePrice" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" use="optional" priority="1" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockValue" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalPreferredStock" xlink:label="us-gaap_AdditionalPaidInCapitalPreferredStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_AdditionalPaidInCapitalPreferredStock" use="optional" priority="1" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage" use="optional" priority="1" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockDividendsPerShareDeclared" use="optional" priority="1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect" xlink:label="nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect" use="optional" priority="1" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PreferredStockConvertibleConversionRatio" xlink:label="nxtc_PreferredStockConvertibleConversionRatio" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="nxtc_PreferredStockConvertibleConversionRatio" use="optional" priority="1" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" xlink:label="nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" use="optional" priority="1" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="us-gaap_PreferredStockLiquidationPreference" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockLiquidationPreference" use="optional" priority="1" order="15.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensation2015OmnibusIncentivePlanDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_637091324805793855" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_637091324805793855" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_A2015OmnibusIncentivePlanMember" xlink:label="nxtc_A2015OmnibusIncentivePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nxtc_A2015OmnibusIncentivePlanMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324805813746" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324805813746" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" xlink:label="nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" use="optional" priority="1" order="7.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_A2015OmnibusIncentivePlanMember" xlink:label="nxtc_A2015OmnibusIncentivePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nxtc_A2015OmnibusIncentivePlanMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" priority="1" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" use="optional" priority="1" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" use="optional" priority="1" order="11.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_637091324805853633" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_637091324805853633" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" use="optional" priority="1" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationRestrictedCommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_A2015OmnibusIncentivePlanMember" xlink:label="nxtc_A2015OmnibusIncentivePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nxtc_A2015OmnibusIncentivePlanMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" use="optional" priority="1" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAntiDilutiveEffectDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_637091324805863605" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_637091324805863605" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_PreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" use="optional" priority="1" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureIncomeTaxesReconciliationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:label="nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" use="optional" priority="1" order="9.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureRelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB3PreferredStockMember" xlink:label="nxtc_SeriesB3PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_SeriesB3PreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" xlink:label="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ConsultingAgreementMember" xlink:label="nxtc_ConsultingAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nxtc_ConsultingAgreementMember" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_YaleLicenseAgreementMember" xlink:label="nxtc_YaleLicenseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nxtc_YaleLicenseAgreementMember" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SponsoredResearchAgreementMember" xlink:label="nxtc_SponsoredResearchAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nxtc_SponsoredResearchAgreementMember" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_637091324805883548" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_637091324805883548" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EliLillyAndCompanyMember" xlink:label="nxtc_EliLillyAndCompanyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="nxtc_EliLillyAndCompanyMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ScientificFounderMember" xlink:label="nxtc_ScientificFounderMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="nxtc_ScientificFounderMember" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_YaleUniversityMember" xlink:label="nxtc_YaleUniversityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="nxtc_YaleUniversityMember" use="optional" priority="1" order="3.0" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:label="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" xlink:label="nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct" xlink:label="nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram" xlink:label="nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionAggregatePaymentsMade" xlink:label="nxtc_RelatedPartyTransactionAggregatePaymentsMade" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nxtc_RelatedPartyTransactionAggregatePaymentsMade" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionPaymentsMade" xlink:label="nxtc_RelatedPartyTransactionPaymentsMade" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="nxtc_RelatedPartyTransactionPaymentsMade" use="optional" priority="1" order="9.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_637091324805903169" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_637091324805903169" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" use="optional" order="1.0" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" use="optional" order="2.0" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_VariableRateAxis" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DebtInstrumentMonthlyPaymentsNumber" xlink:label="nxtc_DebtInstrumentMonthlyPaymentsNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nxtc_DebtInstrumentMonthlyPaymentsNumber" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PeriodForWhichBaseRentIsAbated" xlink:label="nxtc_PeriodForWhichBaseRentIsAbated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nxtc_PeriodForWhichBaseRentIsAbated" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AnnualBaseRentPerMonthAfterAbatement" xlink:label="nxtc_AnnualBaseRentPerMonthAfterAbatement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nxtc_AnnualBaseRentPerMonthAfterAbatement" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PercentageOfAnnualIncreaseInLeaseRent" xlink:label="nxtc_PercentageOfAnnualIncreaseInLeaseRent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nxtc_PercentageOfAnnualIncreaseInLeaseRent" use="optional" priority="1" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" use="optional" priority="1" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" use="optional" priority="1" order="11.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedBalanceSheetsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091327025463439" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_637091327025463439" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditCurrent" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtCurrent" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRentCreditNoncurrent" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PreferredStockAbstract" xlink:label="nxtc_PreferredStockAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="nxtc_PreferredStockAbstract" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nxtc_PreferredStockAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" priority="1" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedBalanceSheetsParentheticalQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" use="optional" priority="1" order="9.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_Series3PreferredStockMember" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637091327025533253" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_637091327025533253" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" use="optional" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" use="optional" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquity" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_CommonStockSharesOutstanding" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NetIncomeLoss" use="optional" priority="1" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:label="nxtc_StockIssuedDuringPeriodValueInitialPublicOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="nxtc_StockIssuedDuringPeriodValueInitialPublicOffering" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nxtc_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:to="nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" use="optional" priority="1" order="9.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitParentheticalQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="nxtc_Series3PreferredStockMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" use="optional" priority="1" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNatureOfBusinessDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_637091327025603067" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_637091327025603067" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SharePrice" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:label="nxtc_PaymentsOfUnderwritingDiscountsAndCommissions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="nxtc_PaymentsOfUnderwritingDiscountsAndCommissions" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" use="optional" priority="1" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" use="optional" priority="1" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" use="optional" priority="1" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" priority="1" order="13.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureInvestmentsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637091327025613040" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637091327025613040" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" use="optional" priority="1" order="5.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091327025623013" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091327025623013" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091327025623013" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091327025623013" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_637091327025623013" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_637091327025623013" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USTreasurySecuritiesMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember" use="optional" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_MarketableSecuritiesAndCashEquivalents" xlink:label="nxtc_MarketableSecuritiesAndCashEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="nxtc_MarketableSecuritiesAndCashEquivalents" use="optional" priority="1" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091327025632987" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091327025632987" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" use="optional" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchEquipmentMember" xlink:label="nxtc_ResearchEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="nxtc_ResearchEquipmentMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" use="optional" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" use="optional" priority="1" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyOtherDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091327025643068" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091327025643068" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" xlink:label="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_637091327025643068" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_637091327025643068" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EliLillyAndCompanyMember" xlink:label="nxtc_EliLillyAndCompanyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="nxtc_EliLillyAndCompanyMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:label="nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:label="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:label="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:label="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RevenueRecognitionNumberOfPerformanceObligations" xlink:label="nxtc_RevenueRecognitionNumberOfPerformanceObligations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_RevenueRecognitionNumberOfPerformanceObligations" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborationAgreementTransactionPrice" xlink:label="nxtc_CollaborationAgreementTransactionPrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="nxtc_CollaborationAgreementTransactionPrice" use="optional" priority="1" order="9.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanOtherDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_VariableRateAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_637091327025652934" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_637091327025652934" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637091327025652934" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_637091327025652934" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DebtInstrumentMonthlyPaymentsNumber" xlink:label="nxtc_DebtInstrumentMonthlyPaymentsNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="nxtc_DebtInstrumentMonthlyPaymentsNumber" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpense" use="optional" priority="1" order="6.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_637091327025662906" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_637091327025662906" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_A2015OmnibusIncentivePlanMember" xlink:label="nxtc_A2015OmnibusIncentivePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nxtc_A2015OmnibusIncentivePlanMember" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_OmnibusIncentive2019PlanMember" xlink:label="nxtc_OmnibusIncentive2019PlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nxtc_OmnibusIncentive2019PlanMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" xlink:label="nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EmployeeStockPurchase2019PlanMember" xlink:label="nxtc_EmployeeStockPurchase2019PlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nxtc_EmployeeStockPurchase2019PlanMember" use="optional" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_637091327025662906" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_637091327025662906" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" use="optional" priority="1" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" use="optional" priority="1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" use="optional" priority="1" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" use="optional" priority="1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" use="optional" priority="1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" use="optional" priority="1" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" use="optional" priority="1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" xlink:label="nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" use="optional" priority="1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:label="nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" use="optional" priority="1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" use="optional" priority="1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" use="optional" priority="1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" xlink:label="nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" use="optional" priority="1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" xlink:label="nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" use="optional" priority="1" order="9.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" use="optional" order="1.0" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_637091327025712772" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_637091327025712772" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" use="optional" priority="1" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>nxtc-20191112_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Toppan Merrill -->
<!-- Generated by Fujitsu Interstage XWand B0189 -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:label xlink:type="resource" xlink:label="label_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CounterpartyNameAxis" xml:lang="en-US" id="label_CounterpartyNameAxis">Counterparty Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CounterpartyNameAxis" xlink:to="label_CounterpartyNameAxis" xlink:title="label_CounterpartyNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="label_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_MaximumMember" xml:lang="en-US" id="label_MaximumMember">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="label_MaximumMember" xlink:title="label_MaximumMember" />
    <link:label xlink:type="resource" xlink:label="label_MaximumMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_MaximumMember_1" xml:lang="en-US" id="label_MaximumMember_1">Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="label_MaximumMember_1" xlink:title="label_MaximumMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="label_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_MinimumMember" xml:lang="en-US" id="label_MinimumMember">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="label_MinimumMember" xlink:title="label_MinimumMember" />
    <link:label xlink:type="resource" xlink:label="label_MinimumMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_MinimumMember_1" xml:lang="en-US" id="label_MinimumMember_1">Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="label_MinimumMember_1" xlink:title="label_MinimumMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="label_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RangeAxis" xml:lang="en-US" id="label_RangeAxis">Range [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="label_RangeAxis" xlink:title="label_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="label_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RangeMember" xml:lang="en-US" id="label_RangeMember">Range [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="label_RangeMember" xlink:title="label_RangeMember" />
    <link:label xlink:type="resource" xlink:label="label_RangeMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RangeMember_1" xml:lang="en-US" id="label_RangeMember_1">Range [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="label_RangeMember_1" xlink:title="label_RangeMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RepurchaseAgreementCounterpartyNameDomain" xml:lang="en-US" id="label_RepurchaseAgreementCounterpartyNameDomain">Repurchase Agreement Counterparty Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepurchaseAgreementCounterpartyNameDomain" xlink:to="label_RepurchaseAgreementCounterpartyNameDomain" xlink:title="label_RepurchaseAgreementCounterpartyNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_RepurchaseAgreementCounterpartyNameDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RepurchaseAgreementCounterpartyNameDomain_1" xml:lang="en-US" id="label_RepurchaseAgreementCounterpartyNameDomain_1">Counterparty Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepurchaseAgreementCounterpartyNameDomain" xlink:to="label_RepurchaseAgreementCounterpartyNameDomain_1" xlink:title="label_RepurchaseAgreementCounterpartyNameDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccountingPoliciesAbstract" xml:lang="en-US" id="label_AccountingPoliciesAbstract">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingPoliciesAbstract" xlink:to="label_AccountingPoliciesAbstract" xlink:title="label_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xml:lang="en-US" id="label_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="label_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="label_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_1" xml:lang="en-US" id="label_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_1">Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="label_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_1" xlink:title="label_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccountsPayableCurrent" xml:lang="en-US" id="label_AccountsPayableCurrent">Accounts Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="label_AccountsPayableCurrent" xlink:title="label_AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccountsPayableCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AccountsPayableCurrent_1" xml:lang="en-US" id="label_AccountsPayableCurrent_1">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="label_AccountsPayableCurrent_1" xlink:title="label_AccountsPayableCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccruedLiabilitiesCurrent" xml:lang="en-US" id="label_AccruedLiabilitiesCurrent">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="label_AccruedLiabilitiesCurrent" xlink:title="label_AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedLiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AccruedLiabilitiesCurrent_1" xml:lang="en-US" id="label_AccruedLiabilitiesCurrent_1">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="label_AccruedLiabilitiesCurrent_1" xlink:title="label_AccruedLiabilitiesCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_AccruedLiabilitiesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_AccruedLiabilitiesCurrent_2" xml:lang="en-US" id="label_AccruedLiabilitiesCurrent_2">Total accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="label_AccruedLiabilitiesCurrent_2" xlink:title="label_AccruedLiabilitiesCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccruedLiabilitiesCurrentAbstract" xml:lang="en-US" id="label_AccruedLiabilitiesCurrentAbstract">Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrentAbstract" xlink:to="label_AccruedLiabilitiesCurrentAbstract" xlink:title="label_AccruedLiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRentCurrent" xlink:label="AccruedRentCurrent" xlink:title="AccruedRentCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedRentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccruedRentCurrent" xml:lang="en-US" id="label_AccruedRentCurrent">Accrued Rent, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedRentCurrent" xlink:to="label_AccruedRentCurrent" xlink:title="label_AccruedRentCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedRentCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AccruedRentCurrent_1" xml:lang="en-US" id="label_AccruedRentCurrent_1">Accrued office lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedRentCurrent" xlink:to="label_AccruedRentCurrent_1" xlink:title="label_AccruedRentCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US" id="label_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="label_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="label_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xml:lang="en-US" id="label_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1">Less: accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="label_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xlink:title="label_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US" id="label_AccumulatedOtherComprehensiveIncomeLossNetOfTax">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="label_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="label_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xml:lang="en-US" id="label_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1">Accumulated other comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="label_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xlink:title="label_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="AccumulatedOtherComprehensiveIncomeMember" xlink:title="AccumulatedOtherComprehensiveIncomeMember" />
    <link:label xlink:type="resource" xlink:label="label_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US" id="label_AccumulatedOtherComprehensiveIncomeMember">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedOtherComprehensiveIncomeMember" xlink:to="label_AccumulatedOtherComprehensiveIncomeMember" xlink:title="label_AccumulatedOtherComprehensiveIncomeMember" />
    <link:label xlink:type="resource" xlink:label="label_AccumulatedOtherComprehensiveIncomeMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AccumulatedOtherComprehensiveIncomeMember_1" xml:lang="en-US" id="label_AccumulatedOtherComprehensiveIncomeMember_1">Accumulated Other Comprehensive Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedOtherComprehensiveIncomeMember" xlink:to="label_AccumulatedOtherComprehensiveIncomeMember_1" xlink:title="label_AccumulatedOtherComprehensiveIncomeMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="label_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AdditionalPaidInCapital" xml:lang="en-US" id="label_AdditionalPaidInCapital">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="label_AdditionalPaidInCapital" xlink:title="label_AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="label_AdditionalPaidInCapital_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AdditionalPaidInCapital_1" xml:lang="en-US" id="label_AdditionalPaidInCapital_1">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="label_AdditionalPaidInCapital_1" xlink:title="label_AdditionalPaidInCapital_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="label_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AdditionalPaidInCapitalMember" xml:lang="en-US" id="label_AdditionalPaidInCapitalMember">Additional Paid In Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="label_AdditionalPaidInCapitalMember" xlink:title="label_AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="label_AdditionalPaidInCapitalMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AdditionalPaidInCapitalMember_1" xml:lang="en-US" id="label_AdditionalPaidInCapitalMember_1">Additional Paid-in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="label_AdditionalPaidInCapitalMember_1" xlink:title="label_AdditionalPaidInCapitalMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalPreferredStock" xlink:label="AdditionalPaidInCapitalPreferredStock" xlink:title="AdditionalPaidInCapitalPreferredStock" />
    <link:label xlink:type="resource" xlink:label="label_AdditionalPaidInCapitalPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AdditionalPaidInCapitalPreferredStock" xml:lang="en-US" id="label_AdditionalPaidInCapitalPreferredStock">Additional Paid in Capital, Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalPreferredStock" xlink:to="label_AdditionalPaidInCapitalPreferredStock" xlink:title="label_AdditionalPaidInCapitalPreferredStock" />
    <link:label xlink:type="resource" xlink:label="label_AdditionalPaidInCapitalPreferredStock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AdditionalPaidInCapitalPreferredStock_1" xml:lang="en-US" id="label_AdditionalPaidInCapitalPreferredStock_1">Premium over the fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalPreferredStock" xlink:to="label_AdditionalPaidInCapitalPreferredStock_1" xlink:title="label_AdditionalPaidInCapitalPreferredStock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="label_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xml:lang="en-US" id="label_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="label_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="label_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="label_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" xml:lang="en-US" id="label_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1">Stock based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="label_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" xlink:title="label_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:title="AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="label_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xml:lang="en-US" id="label_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="label_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:title="label_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="label_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1" xml:lang="en-US" id="label_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1">Initial public offering issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="label_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1" xlink:title="label_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">Adjustments to reconcile net loss to net cash provided by (used) in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xml:lang="en-US" id="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:title="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" />
    <link:label xlink:type="resource" xlink:label="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xml:lang="en-US" id="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:title="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="label_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AllocatedShareBasedCompensationExpense" xml:lang="en-US" id="label_AllocatedShareBasedCompensationExpense">Allocated Share-based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="label_AllocatedShareBasedCompensationExpense" xlink:title="label_AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="label_AllocatedShareBasedCompensationExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AllocatedShareBasedCompensationExpense_1" xml:lang="en-US" id="label_AllocatedShareBasedCompensationExpense_1">Total stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="label_AllocatedShareBasedCompensationExpense_1" xlink:title="label_AllocatedShareBasedCompensationExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US" id="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" xml:lang="en-US" id="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1">Antidilutive securities excluded from computation of diluted net loss per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" xlink:title="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US" id="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xml:lang="en-US" id="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1" xml:lang="en-US" id="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1">Antidilutive Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1" xlink:title="label_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AntidilutiveSecuritiesNameDomain" xml:lang="en-US" id="label_AntidilutiveSecuritiesNameDomain">Antidilutive Securities Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="label_AntidilutiveSecuritiesNameDomain" xlink:title="label_AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_AntidilutiveSecuritiesNameDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AntidilutiveSecuritiesNameDomain_1" xml:lang="en-US" id="label_AntidilutiveSecuritiesNameDomain_1">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="label_AntidilutiveSecuritiesNameDomain_1" xlink:title="label_AntidilutiveSecuritiesNameDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:label xlink:type="resource" xlink:label="label_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AreaOfRealEstateProperty" xml:lang="en-US" id="label_AreaOfRealEstateProperty">Area of Real Estate Property</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfRealEstateProperty" xlink:to="label_AreaOfRealEstateProperty" xlink:title="label_AreaOfRealEstateProperty" />
    <link:label xlink:type="resource" xlink:label="label_AreaOfRealEstateProperty_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AreaOfRealEstateProperty_1" xml:lang="en-US" id="label_AreaOfRealEstateProperty_1">Area of office space (in square feet)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfRealEstateProperty" xlink:to="label_AreaOfRealEstateProperty_1" xlink:title="label_AreaOfRealEstateProperty_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xlink:type="resource" xlink:label="label_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US" id="label_ArrangementsAndNonarrangementTransactionsMember">Arrangements And Nonarrangement Transactions [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="label_ArrangementsAndNonarrangementTransactionsMember" xlink:title="label_ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xlink:type="resource" xlink:label="label_ArrangementsAndNonarrangementTransactionsMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ArrangementsAndNonarrangementTransactionsMember_1" xml:lang="en-US" id="label_ArrangementsAndNonarrangementTransactionsMember_1">Arrangements and Non-arrangement Transactions [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="label_ArrangementsAndNonarrangementTransactionsMember_1" xlink:title="label_ArrangementsAndNonarrangementTransactionsMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentChargesAbstract" xlink:label="AssetImpairmentChargesAbstract" xlink:title="AssetImpairmentChargesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_AssetImpairmentChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AssetImpairmentChargesAbstract" xml:lang="en-US" id="label_AssetImpairmentChargesAbstract">Impairment of Long Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetImpairmentChargesAbstract" xlink:to="label_AssetImpairmentChargesAbstract" xlink:title="label_AssetImpairmentChargesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="label_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_Assets" xml:lang="en-US" id="label_Assets">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="label_Assets" xlink:title="label_Assets" />
    <link:label xlink:type="resource" xlink:label="label_Assets_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_Assets_1" xml:lang="en-US" id="label_Assets_1">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="label_Assets_1" xlink:title="label_Assets_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AssetsAbstract" xml:lang="en-US" id="label_AssetsAbstract">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="label_AssetsAbstract" xlink:title="label_AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_AssetsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AssetsAbstract_1" xml:lang="en-US" id="label_AssetsAbstract_1">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="label_AssetsAbstract_1" xlink:title="label_AssetsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AssetsCurrent" xml:lang="en-US" id="label_AssetsCurrent">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="label_AssetsCurrent" xlink:title="label_AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AssetsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_AssetsCurrent_1" xml:lang="en-US" id="label_AssetsCurrent_1">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="label_AssetsCurrent_1" xlink:title="label_AssetsCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AssetsCurrentAbstract" xml:lang="en-US" id="label_AssetsCurrentAbstract">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="label_AssetsCurrentAbstract" xlink:title="label_AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_AssetsCurrentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AssetsCurrentAbstract_1" xml:lang="en-US" id="label_AssetsCurrentAbstract_1">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="label_AssetsCurrentAbstract_1" xlink:title="label_AssetsCurrentAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xml:lang="en-US" id="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1" xml:lang="en-US" id="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1">Gross Unrealized Gain</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1" xlink:title="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xml:lang="en-US" id="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1" xml:lang="en-US" id="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1">Gross Unrealized Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1" xlink:title="label_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xml:lang="en-US" id="label_AvailableForSaleDebtSecuritiesAmortizedCostBasis">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="label_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="label_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1" xml:lang="en-US" id="label_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1">Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="label_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1" xlink:title="label_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AvailableForSaleSecuritiesDebtSecurities" xml:lang="en-US" id="label_AvailableForSaleSecuritiesDebtSecurities">Debt Securities, Available-for-sale</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="label_AvailableForSaleSecuritiesDebtSecurities" xlink:title="label_AvailableForSaleSecuritiesDebtSecurities" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleSecuritiesDebtSecurities_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AvailableForSaleSecuritiesDebtSecurities_1" xml:lang="en-US" id="label_AvailableForSaleSecuritiesDebtSecurities_1">Marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="label_AvailableForSaleSecuritiesDebtSecurities_1" xlink:title="label_AvailableForSaleSecuritiesDebtSecurities_1" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleSecuritiesDebtSecurities_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_AvailableForSaleSecuritiesDebtSecurities_2" xml:lang="en-US" id="label_AvailableForSaleSecuritiesDebtSecurities_2">Estimated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="label_AvailableForSaleSecuritiesDebtSecurities_2" xlink:title="label_AvailableForSaleSecuritiesDebtSecurities_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xml:lang="en-US" id="label_AvailableForSaleSecuritiesDebtSecuritiesCurrent">Debt Securities, Available-for-sale, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="label_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:title="label_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1" xml:lang="en-US" id="label_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1">Marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="label_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1" xlink:title="label_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AwardTypeAxis" xml:lang="en-US" id="label_AwardTypeAxis">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="label_AwardTypeAxis" xlink:title="label_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US" id="label_BasisOfAccountingPolicyPolicyTextBlock">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="label_BasisOfAccountingPolicyPolicyTextBlock" xlink:title="label_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_BasisOfAccountingPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_BasisOfAccountingPolicyPolicyTextBlock_1" xml:lang="en-US" id="label_BasisOfAccountingPolicyPolicyTextBlock_1">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="label_BasisOfAccountingPolicyPolicyTextBlock_1" xlink:title="label_BasisOfAccountingPolicyPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="CapitalExpendituresIncurredButNotYetPaid" xlink:title="CapitalExpendituresIncurredButNotYetPaid" />
    <link:label xlink:type="resource" xlink:label="label_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CapitalExpendituresIncurredButNotYetPaid" xml:lang="en-US" id="label_CapitalExpendituresIncurredButNotYetPaid">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CapitalExpendituresIncurredButNotYetPaid" xlink:to="label_CapitalExpendituresIncurredButNotYetPaid" xlink:title="label_CapitalExpendituresIncurredButNotYetPaid" />
    <link:label xlink:type="resource" xlink:label="label_CapitalExpendituresIncurredButNotYetPaid_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CapitalExpendituresIncurredButNotYetPaid_1" xml:lang="en-US" id="label_CapitalExpendituresIncurredButNotYetPaid_1">Purchase of property and equipment included in accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CapitalExpendituresIncurredButNotYetPaid" xlink:to="label_CapitalExpendituresIncurredButNotYetPaid_1" xlink:title="label_CapitalExpendituresIncurredButNotYetPaid_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="CarryingReportedAmountFairValueDisclosureMember" xlink:title="CarryingReportedAmountFairValueDisclosureMember" />
    <link:label xlink:type="resource" xlink:label="label_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CarryingReportedAmountFairValueDisclosureMember" xml:lang="en-US" id="label_CarryingReportedAmountFairValueDisclosureMember">Carrying Reported Amount Fair Value Disclosure [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingReportedAmountFairValueDisclosureMember" xlink:to="label_CarryingReportedAmountFairValueDisclosureMember" xlink:title="label_CarryingReportedAmountFairValueDisclosureMember" />
    <link:label xlink:type="resource" xlink:label="label_CarryingReportedAmountFairValueDisclosureMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CarryingReportedAmountFairValueDisclosureMember_1" xml:lang="en-US" id="label_CarryingReportedAmountFairValueDisclosureMember_1">Carrying Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingReportedAmountFairValueDisclosureMember" xlink:to="label_CarryingReportedAmountFairValueDisclosureMember_1" xlink:title="label_CarryingReportedAmountFairValueDisclosureMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="label_CashAndCashEquivalentsAtCarryingValue">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="label_CashAndCashEquivalentsAtCarryingValue" xlink:title="label_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsAtCarryingValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US" id="label_CashAndCashEquivalentsAtCarryingValue_1">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="label_CashAndCashEquivalentsAtCarryingValue_1" xlink:title="label_CashAndCashEquivalentsAtCarryingValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="CashAndCashEquivalentsAxis" xlink:title="CashAndCashEquivalentsAxis" />
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CashAndCashEquivalentsAxis" xml:lang="en-US" id="label_CashAndCashEquivalentsAxis">Cash and Cash Equivalents [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAxis" xlink:to="label_CashAndCashEquivalentsAxis" xlink:title="label_CashAndCashEquivalentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="CashAndCashEquivalentsFairValueDisclosure" xlink:title="CashAndCashEquivalentsFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CashAndCashEquivalentsFairValueDisclosure" xml:lang="en-US" id="label_CashAndCashEquivalentsFairValueDisclosure">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsFairValueDisclosure" xlink:to="label_CashAndCashEquivalentsFairValueDisclosure" xlink:title="label_CashAndCashEquivalentsFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsFairValueDisclosure_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CashAndCashEquivalentsFairValueDisclosure_1" xml:lang="en-US" id="label_CashAndCashEquivalentsFairValueDisclosure_1">Money market funds (cash equivalents)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsFairValueDisclosure" xlink:to="label_CashAndCashEquivalentsFairValueDisclosure_1" xlink:title="label_CashAndCashEquivalentsFairValueDisclosure_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US" id="label_CashAndCashEquivalentsPolicyTextBlock">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPolicyTextBlock" xlink:to="label_CashAndCashEquivalentsPolicyTextBlock" xlink:title="label_CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CashAndCashEquivalentsPolicyTextBlock_1" xml:lang="en-US" id="label_CashAndCashEquivalentsPolicyTextBlock_1">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPolicyTextBlock" xlink:to="label_CashAndCashEquivalentsPolicyTextBlock_1" xlink:title="label_CashAndCashEquivalentsPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:title="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xml:lang="en-US" id="label_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="label_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:title="label_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1" xml:lang="en-US" id="label_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1">Restricted Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="label_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1" xlink:title="label_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US" id="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xml:lang="en-US" id="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1">Cash, cash equivalents and restricted cash-end of period (includes $3,750 of restricted cash in other assets)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" />
    <link:label xlink:type="resource" xlink:label="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xml:lang="en-US" id="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2">Cash, cash equivalents and restricted cash-beginning of year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
    <link:label xlink:type="resource" xlink:label="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3" xml:lang="en-US" id="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xml:lang="en-US" id="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1" xml:lang="en-US" id="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1">Reconciliation of cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US" id="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xml:lang="en-US" id="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1">Net (decrease) increase in cash, cash equivalents and restricted cash (includes $3,750 of restricted cash in other assets)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xlink:title="label_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:label="ChangeInContractWithCustomerLiabilityAbstract" xlink:title="ChangeInContractWithCustomerLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ChangeInContractWithCustomerLiabilityAbstract" xml:lang="en-US" id="label_ChangeInContractWithCustomerLiabilityAbstract">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChangeInContractWithCustomerLiabilityAbstract" xlink:to="label_ChangeInContractWithCustomerLiabilityAbstract" xlink:title="label_ChangeInContractWithCustomerLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ChangeInContractWithCustomerLiabilityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ChangeInContractWithCustomerLiabilityAbstract_1" xml:lang="en-US" id="label_ChangeInContractWithCustomerLiabilityAbstract_1">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChangeInContractWithCustomerLiabilityAbstract" xlink:to="label_ChangeInContractWithCustomerLiabilityAbstract_1" xlink:title="label_ChangeInContractWithCustomerLiabilityAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="label_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ClassOfStockDomain" xml:lang="en-US" id="label_ClassOfStockDomain">Class Of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="label_ClassOfStockDomain" xlink:title="label_ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="label_ClassOfStockDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ClassOfStockDomain_1" xml:lang="en-US" id="label_ClassOfStockDomain_1">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="label_ClassOfStockDomain_1" xlink:title="label_ClassOfStockDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ClassOfStockLineItems" xml:lang="en-US" id="label_ClassOfStockLineItems">Class of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockLineItems" xlink:to="label_ClassOfStockLineItems" xlink:title="label_ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="CollaborativeArrangementDisclosureTextBlock" xlink:title="CollaborativeArrangementDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CollaborativeArrangementDisclosureTextBlock" xml:lang="en-US" id="label_CollaborativeArrangementDisclosureTextBlock">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementDisclosureTextBlock" xlink:to="label_CollaborativeArrangementDisclosureTextBlock" xlink:title="label_CollaborativeArrangementDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CollaborativeArrangementDisclosureTextBlock_1" xml:lang="en-US" id="label_CollaborativeArrangementDisclosureTextBlock_1">Agreement with Eli Lilly and Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementDisclosureTextBlock" xlink:to="label_CollaborativeArrangementDisclosureTextBlock_1" xlink:title="label_CollaborativeArrangementDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xml:lang="en-US" id="label_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="label_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="label_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1" xml:lang="en-US" id="label_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1">Collaborative Arrangements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="label_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1" xlink:title="label_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="label_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommitmentsAndContingencies" xml:lang="en-US" id="label_CommitmentsAndContingencies">Commitments and Contingencies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="label_CommitmentsAndContingencies" xlink:title="label_CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="label_CommitmentsAndContingencies_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommitmentsAndContingencies_1" xml:lang="en-US" id="label_CommitmentsAndContingencies_1">Commitments and contingencies (Note 7)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="label_CommitmentsAndContingencies_1" xlink:title="label_CommitmentsAndContingencies_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US" id="label_CommitmentsAndContingenciesDisclosureAbstract">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="label_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="label_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US" id="label_CommitmentsAndContingenciesDisclosureTextBlock">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="label_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="label_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_CommitmentsAndContingenciesDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommitmentsAndContingenciesDisclosureTextBlock_1" xml:lang="en-US" id="label_CommitmentsAndContingenciesDisclosureTextBlock_1">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="label_CommitmentsAndContingenciesDisclosureTextBlock_1" xlink:title="label_CommitmentsAndContingenciesDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="CommonStockCapitalSharesReservedForFutureIssuance" xlink:title="CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockCapitalSharesReservedForFutureIssuance" xml:lang="en-US" id="label_CommonStockCapitalSharesReservedForFutureIssuance">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="label_CommonStockCapitalSharesReservedForFutureIssuance" xlink:title="label_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockCapitalSharesReservedForFutureIssuance_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommonStockCapitalSharesReservedForFutureIssuance_1" xml:lang="en-US" id="label_CommonStockCapitalSharesReservedForFutureIssuance_1">Number of shares reserved for issuance under the plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="label_CommonStockCapitalSharesReservedForFutureIssuance_1" xlink:title="label_CommonStockCapitalSharesReservedForFutureIssuance_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid" xlink:label="CommonStockDividendsPerShareCashPaid" xlink:title="CommonStockDividendsPerShareCashPaid" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockDividendsPerShareCashPaid" xml:lang="en-US" id="label_CommonStockDividendsPerShareCashPaid">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareCashPaid" xlink:to="label_CommonStockDividendsPerShareCashPaid" xlink:title="label_CommonStockDividendsPerShareCashPaid" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockDividendsPerShareCashPaid_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommonStockDividendsPerShareCashPaid_1" xml:lang="en-US" id="label_CommonStockDividendsPerShareCashPaid_1">Dividend paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareCashPaid" xlink:to="label_CommonStockDividendsPerShareCashPaid_1" xlink:title="label_CommonStockDividendsPerShareCashPaid_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockDividendsPerShareDeclared" xml:lang="en-US" id="label_CommonStockDividendsPerShareDeclared">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareDeclared" xlink:to="label_CommonStockDividendsPerShareDeclared" xlink:title="label_CommonStockDividendsPerShareDeclared" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockDividendsPerShareDeclared_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommonStockDividendsPerShareDeclared_1" xml:lang="en-US" id="label_CommonStockDividendsPerShareDeclared_1">Dividends declared</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareDeclared" xlink:to="label_CommonStockDividendsPerShareDeclared_1" xlink:title="label_CommonStockDividendsPerShareDeclared_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockMember" xml:lang="en-US" id="label_CommonStockMember">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="label_CommonStockMember" xlink:title="label_CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommonStockMember_1" xml:lang="en-US" id="label_CommonStockMember_1">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="label_CommonStockMember_1" xlink:title="label_CommonStockMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:title="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xml:lang="en-US" id="label_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">Common Stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="label_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:title="label_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockParOrStatedValuePerShare" xml:lang="en-US" id="label_CommonStockParOrStatedValuePerShare">Common Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="label_CommonStockParOrStatedValuePerShare" xlink:title="label_CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockParOrStatedValuePerShare_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommonStockParOrStatedValuePerShare_1" xml:lang="en-US" id="label_CommonStockParOrStatedValuePerShare_1">Common stock, par value per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="label_CommonStockParOrStatedValuePerShare_1" xlink:title="label_CommonStockParOrStatedValuePerShare_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockSharesAuthorized" xml:lang="en-US" id="label_CommonStockSharesAuthorized">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="label_CommonStockSharesAuthorized" xlink:title="label_CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommonStockSharesAuthorized_1" xml:lang="en-US" id="label_CommonStockSharesAuthorized_1">Common stock, number of shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="label_CommonStockSharesAuthorized_1" xlink:title="label_CommonStockSharesAuthorized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockSharesIssued" xml:lang="en-US" id="label_CommonStockSharesIssued">Common Stock, Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="label_CommonStockSharesIssued" xlink:title="label_CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesIssued_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommonStockSharesIssued_1" xml:lang="en-US" id="label_CommonStockSharesIssued_1">Common stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="label_CommonStockSharesIssued_1" xlink:title="label_CommonStockSharesIssued_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockSharesOutstanding" xml:lang="en-US" id="label_CommonStockSharesOutstanding">Common Stock, Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="label_CommonStockSharesOutstanding" xlink:title="label_CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_CommonStockSharesOutstanding_1" xml:lang="en-US" id="label_CommonStockSharesOutstanding_1">Balance at the end (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="label_CommonStockSharesOutstanding_1" xlink:title="label_CommonStockSharesOutstanding_1" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesOutstanding_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_CommonStockSharesOutstanding_2" xml:lang="en-US" id="label_CommonStockSharesOutstanding_2">Balance at the beginning (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="label_CommonStockSharesOutstanding_2" xlink:title="label_CommonStockSharesOutstanding_2" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesOutstanding_3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommonStockSharesOutstanding_3" xml:lang="en-US" id="label_CommonStockSharesOutstanding_3">Common stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="label_CommonStockSharesOutstanding_3" xlink:title="label_CommonStockSharesOutstanding_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_CommonStockValue" xml:lang="en-US" id="label_CommonStockValue">Common stock, par value of $0.001 per share; 158,745,671 and 84,045,455 shares authorized at December 31, 2018 and 2017, respectively, 1,374,812 and 1,369,212 shares issued and outstanding at December 31, 2018 and 2017, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="label_CommonStockValue" xlink:title="label_CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockValue_1" xml:lang="en-US" id="label_CommonStockValue_1">Common Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="label_CommonStockValue_1" xlink:title="label_CommonStockValue_1" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockValue_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommonStockValue_2" xml:lang="en-US" id="label_CommonStockValue_2">Common stock, par value of $0.001 per share; 100,000,000 and 158,745,671 shares authorized at September 30, 2019 and December 31, 2018, respectively, 22,739,345 and 1,374,812 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="label_CommonStockValue_2" xlink:title="label_CommonStockValue_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="CompensationAndRetirementDisclosureAbstract" xlink:title="CompensationAndRetirementDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CompensationAndRetirementDisclosureAbstract" xml:lang="en-US" id="label_CompensationAndRetirementDisclosureAbstract">Employee Benefit Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="label_CompensationAndRetirementDisclosureAbstract" xlink:title="label_CompensationAndRetirementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xml:lang="en-US" id="label_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="label_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="label_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1" xml:lang="en-US" id="label_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1">Principal components of the Company's deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="label_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1" xlink:title="label_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ComprehensiveIncomeNetOfTax" xml:lang="en-US" id="label_ComprehensiveIncomeNetOfTax">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="label_ComprehensiveIncomeNetOfTax" xlink:title="label_ComprehensiveIncomeNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_ComprehensiveIncomeNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_ComprehensiveIncomeNetOfTax_1" xml:lang="en-US" id="label_ComprehensiveIncomeNetOfTax_1">Total comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="label_ComprehensiveIncomeNetOfTax_1" xlink:title="label_ComprehensiveIncomeNetOfTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="ComprehensiveIncomePolicyPolicyTextBlock" xlink:title="ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ComprehensiveIncomePolicyPolicyTextBlock" xml:lang="en-US" id="label_ComprehensiveIncomePolicyPolicyTextBlock">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="label_ComprehensiveIncomePolicyPolicyTextBlock" xlink:title="label_ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ComprehensiveIncomePolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ComprehensiveIncomePolicyPolicyTextBlock_1" xml:lang="en-US" id="label_ComprehensiveIncomePolicyPolicyTextBlock_1">Comprehensive Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="label_ComprehensiveIncomePolicyPolicyTextBlock_1" xlink:title="label_ComprehensiveIncomePolicyPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ComputerEquipmentMember" xml:lang="en-US" id="label_ComputerEquipmentMember">Computer Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerEquipmentMember" xlink:to="label_ComputerEquipmentMember" xlink:title="label_ComputerEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_ComputerEquipmentMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ComputerEquipmentMember_1" xml:lang="en-US" id="label_ComputerEquipmentMember_1">Computer equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerEquipmentMember" xlink:to="label_ComputerEquipmentMember_1" xlink:title="label_ComputerEquipmentMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="ConcentrationRiskCreditRisk" xlink:title="ConcentrationRiskCreditRisk" />
    <link:label xlink:type="resource" xlink:label="label_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ConcentrationRiskCreditRisk" xml:lang="en-US" id="label_ConcentrationRiskCreditRisk">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskCreditRisk" xlink:to="label_ConcentrationRiskCreditRisk" xlink:title="label_ConcentrationRiskCreditRisk" />
    <link:label xlink:type="resource" xlink:label="label_ConcentrationRiskCreditRisk_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ConcentrationRiskCreditRisk_1" xml:lang="en-US" id="label_ConcentrationRiskCreditRisk_1">Concentration of Credit Risk</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskCreditRisk" xlink:to="label_ConcentrationRiskCreditRisk_1" xlink:title="label_ConcentrationRiskCreditRisk_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionContractorsPolicyPolicyTextBlock" xlink:label="ConstructionContractorsPolicyPolicyTextBlock" xlink:title="ConstructionContractorsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ConstructionContractorsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ConstructionContractorsPolicyPolicyTextBlock" xml:lang="en-US" id="label_ConstructionContractorsPolicyPolicyTextBlock">Construction Contractors, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConstructionContractorsPolicyPolicyTextBlock" xlink:to="label_ConstructionContractorsPolicyPolicyTextBlock" xlink:title="label_ConstructionContractorsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ConstructionContractorsPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ConstructionContractorsPolicyPolicyTextBlock_1" xml:lang="en-US" id="label_ConstructionContractorsPolicyPolicyTextBlock_1">Construction in Progress</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConstructionContractorsPolicyPolicyTextBlock" xlink:to="label_ConstructionContractorsPolicyPolicyTextBlock_1" xlink:title="label_ConstructionContractorsPolicyPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="ConstructionInProgressMember" xlink:title="ConstructionInProgressMember" />
    <link:label xlink:type="resource" xlink:label="label_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ConstructionInProgressMember" xml:lang="en-US" id="label_ConstructionInProgressMember">Construction In Progress [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConstructionInProgressMember" xlink:to="label_ConstructionInProgressMember" xlink:title="label_ConstructionInProgressMember" />
    <link:label xlink:type="resource" xlink:label="label_ConstructionInProgressMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ConstructionInProgressMember_1" xml:lang="en-US" id="label_ConstructionInProgressMember_1">Construction in progress</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConstructionInProgressMember" xlink:to="label_ConstructionInProgressMember_1" xlink:title="label_ConstructionInProgressMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="ContractWithCustomerLiability" xlink:title="ContractWithCustomerLiability" />
    <link:label xlink:type="resource" xlink:label="label_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ContractWithCustomerLiability" xml:lang="en-US" id="label_ContractWithCustomerLiability">Contract with Customer, Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerLiability" xlink:to="label_ContractWithCustomerLiability" xlink:title="label_ContractWithCustomerLiability" />
    <link:label xlink:type="resource" xlink:label="label_ContractWithCustomerLiability_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ContractWithCustomerLiability_1" xml:lang="en-US" id="label_ContractWithCustomerLiability_1">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerLiability" xlink:to="label_ContractWithCustomerLiability_1" xlink:title="label_ContractWithCustomerLiability_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="CorporateDebtSecuritiesMember" xlink:title="CorporateDebtSecuritiesMember" />
    <link:label xlink:type="resource" xlink:label="label_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CorporateDebtSecuritiesMember" xml:lang="en-US" id="label_CorporateDebtSecuritiesMember">Corporate Debt Securities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CorporateDebtSecuritiesMember" xlink:to="label_CorporateDebtSecuritiesMember" xlink:title="label_CorporateDebtSecuritiesMember" />
    <link:label xlink:type="resource" xlink:label="label_CorporateDebtSecuritiesMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CorporateDebtSecuritiesMember_1" xml:lang="en-US" id="label_CorporateDebtSecuritiesMember_1">Corporate bonds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CorporateDebtSecuritiesMember" xlink:to="label_CorporateDebtSecuritiesMember_1" xlink:title="label_CorporateDebtSecuritiesMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DebtDisclosureAbstract" xml:lang="en-US" id="label_DebtDisclosureAbstract">Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureAbstract" xlink:to="label_DebtDisclosureAbstract" xlink:title="label_DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DebtDisclosureTextBlock" xml:lang="en-US" id="label_DebtDisclosureTextBlock">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="label_DebtDisclosureTextBlock" xlink:title="label_DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_DebtDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DebtDisclosureTextBlock_1" xml:lang="en-US" id="label_DebtDisclosureTextBlock_1">Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="label_DebtDisclosureTextBlock_1" xlink:title="label_DebtDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:label xlink:type="resource" xlink:label="label_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DebtInstrumentBasisSpreadOnVariableRate1" xml:lang="en-US" id="label_DebtInstrumentBasisSpreadOnVariableRate1">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="label_DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="label_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:label xlink:type="resource" xlink:label="label_DebtInstrumentBasisSpreadOnVariableRate1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DebtInstrumentBasisSpreadOnVariableRate1_1" xml:lang="en-US" id="label_DebtInstrumentBasisSpreadOnVariableRate1_1">Spread (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="label_DebtInstrumentBasisSpreadOnVariableRate1_1" xlink:title="label_DebtInstrumentBasisSpreadOnVariableRate1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="label_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DebtInstrumentFaceAmount" xml:lang="en-US" id="label_DebtInstrumentFaceAmount">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="label_DebtInstrumentFaceAmount" xlink:title="label_DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="label_DebtInstrumentFaceAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DebtInstrumentFaceAmount_1" xml:lang="en-US" id="label_DebtInstrumentFaceAmount_1">Face amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="label_DebtInstrumentFaceAmount_1" xlink:title="label_DebtInstrumentFaceAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="DebtInstrumentInterestRateDuringPeriod" xlink:title="DebtInstrumentInterestRateDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="label_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DebtInstrumentInterestRateDuringPeriod" xml:lang="en-US" id="label_DebtInstrumentInterestRateDuringPeriod">Debt Instrument, Interest Rate During Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateDuringPeriod" xlink:to="label_DebtInstrumentInterestRateDuringPeriod" xlink:title="label_DebtInstrumentInterestRateDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="label_DebtInstrumentInterestRateDuringPeriod_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DebtInstrumentInterestRateDuringPeriod_1" xml:lang="en-US" id="label_DebtInstrumentInterestRateDuringPeriod_1">Interest rate (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateDuringPeriod" xlink:to="label_DebtInstrumentInterestRateDuringPeriod_1" xlink:title="label_DebtInstrumentInterestRateDuringPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:title="DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" />
    <link:label xlink:type="resource" xlink:label="label_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xml:lang="en-US" id="label_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="label_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:title="label_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" />
    <link:label xlink:type="resource" xlink:label="label_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1" xml:lang="en-US" id="label_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1">Deferred financing costs included in accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="label_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1" xlink:title="label_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="DebtSecuritiesAvailableForSaleTable" xlink:title="DebtSecuritiesAvailableForSaleTable" />
    <link:label xlink:type="resource" xlink:label="label_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DebtSecuritiesAvailableForSaleTable" xml:lang="en-US" id="label_DebtSecuritiesAvailableForSaleTable">Debt Securities, Available-for-sale [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtSecuritiesAvailableForSaleTable" xlink:to="label_DebtSecuritiesAvailableForSaleTable" xlink:title="label_DebtSecuritiesAvailableForSaleTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredIncomeTaxLiabilities" xml:lang="en-US" id="label_DeferredIncomeTaxLiabilities">Deferred Tax Liabilities, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="label_DeferredIncomeTaxLiabilities" xlink:title="label_DeferredIncomeTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_DeferredIncomeTaxLiabilities_1" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="label_DeferredIncomeTaxLiabilities_1" xml:lang="en-US" id="label_DeferredIncomeTaxLiabilities_1">Gross deferred tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="label_DeferredIncomeTaxLiabilities_1" xlink:title="label_DeferredIncomeTaxLiabilities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="DeferredRentCreditCurrent" xlink:title="DeferredRentCreditCurrent" />
    <link:label xlink:type="resource" xlink:label="label_DeferredRentCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredRentCreditCurrent" xml:lang="en-US" id="label_DeferredRentCreditCurrent">Deferred Rent Credit, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRentCreditCurrent" xlink:to="label_DeferredRentCreditCurrent" xlink:title="label_DeferredRentCreditCurrent" />
    <link:label xlink:type="resource" xlink:label="label_DeferredRentCreditCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredRentCreditCurrent_1" xml:lang="en-US" id="label_DeferredRentCreditCurrent_1">Deferred rent, current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRentCreditCurrent" xlink:to="label_DeferredRentCreditCurrent_1" xlink:title="label_DeferredRentCreditCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="DeferredRentCreditNoncurrent" xlink:title="DeferredRentCreditNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_DeferredRentCreditNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredRentCreditNoncurrent" xml:lang="en-US" id="label_DeferredRentCreditNoncurrent">Deferred Rent Credit, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRentCreditNoncurrent" xlink:to="label_DeferredRentCreditNoncurrent" xlink:title="label_DeferredRentCreditNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_DeferredRentCreditNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredRentCreditNoncurrent_1" xml:lang="en-US" id="label_DeferredRentCreditNoncurrent_1">Deferred rent, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRentCreditNoncurrent" xlink:to="label_DeferredRentCreditNoncurrent_1" xlink:title="label_DeferredRentCreditNoncurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="DeferredTaxAssetsCharitableContributionCarryforwards" xlink:title="DeferredTaxAssetsCharitableContributionCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsCharitableContributionCarryforwards" xml:lang="en-US" id="label_DeferredTaxAssetsCharitableContributionCarryforwards">Deferred Tax Assets, Charitable Contribution Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsCharitableContributionCarryforwards" xlink:to="label_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:title="label_DeferredTaxAssetsCharitableContributionCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsCharitableContributionCarryforwards_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsCharitableContributionCarryforwards_1" xml:lang="en-US" id="label_DeferredTaxAssetsCharitableContributionCarryforwards_1">Charitable contribution carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsCharitableContributionCarryforwards" xlink:to="label_DeferredTaxAssetsCharitableContributionCarryforwards_1" xlink:title="label_DeferredTaxAssetsCharitableContributionCarryforwards_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsGross" xml:lang="en-US" id="label_DeferredTaxAssetsGross">Deferred Tax Assets, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="label_DeferredTaxAssetsGross" xlink:title="label_DeferredTaxAssetsGross" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsGross_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_DeferredTaxAssetsGross_1" xml:lang="en-US" id="label_DeferredTaxAssetsGross_1">Gross deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="label_DeferredTaxAssetsGross_1" xlink:title="label_DeferredTaxAssetsGross_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="DeferredTaxAssetsLiabilitiesNet" xlink:title="DeferredTaxAssetsLiabilitiesNet" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsLiabilitiesNet" xml:lang="en-US" id="label_DeferredTaxAssetsLiabilitiesNet">Deferred Tax Assets, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsLiabilitiesNet" xlink:to="label_DeferredTaxAssetsLiabilitiesNet" xlink:title="label_DeferredTaxAssetsLiabilitiesNet" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsLiabilitiesNet_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_DeferredTaxAssetsLiabilitiesNet_1" xml:lang="en-US" id="label_DeferredTaxAssetsLiabilitiesNet_1">Net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsLiabilitiesNet" xlink:to="label_DeferredTaxAssetsLiabilitiesNet_1" xlink:title="label_DeferredTaxAssetsLiabilitiesNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="DeferredTaxAssetsNet" xlink:title="DeferredTaxAssetsNet" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsNet" xml:lang="en-US" id="label_DeferredTaxAssetsNet">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNet" xlink:to="label_DeferredTaxAssetsNet" xlink:title="label_DeferredTaxAssetsNet" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsNet_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_DeferredTaxAssetsNet_1" xml:lang="en-US" id="label_DeferredTaxAssetsNet_1">Total deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNet" xlink:to="label_DeferredTaxAssetsNet_1" xlink:title="label_DeferredTaxAssetsNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="DeferredTaxAssetsNetAbstract" xlink:title="DeferredTaxAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsNetAbstract" xml:lang="en-US" id="label_DeferredTaxAssetsNetAbstract">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="label_DeferredTaxAssetsNetAbstract" xlink:title="label_DeferredTaxAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsNetAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsNetAbstract_1" xml:lang="en-US" id="label_DeferredTaxAssetsNetAbstract_1">Deferred tax assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="label_DeferredTaxAssetsNetAbstract_1" xlink:title="label_DeferredTaxAssetsNetAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US" id="label_DeferredTaxAssetsOperatingLossCarryforwards">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="label_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsOperatingLossCarryforwards_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwards_1" xml:lang="en-US" id="label_DeferredTaxAssetsOperatingLossCarryforwards_1">Federal and state net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="label_DeferredTaxAssetsOperatingLossCarryforwards_1" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwards_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xml:lang="en-US" id="label_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="label_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1" xml:lang="en-US" id="label_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1">Federal net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="label_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xml:lang="en-US" id="label_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="label_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_1" xml:lang="en-US" id="label_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_1">Federal and state net operating loss carryforwards that do not expire</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="label_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_1" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xml:lang="en-US" id="label_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="label_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_1" xml:lang="en-US" id="label_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_1">State net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="label_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_1" xlink:title="label_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="DeferredTaxAssetsOther" xlink:title="DeferredTaxAssetsOther" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsOther" xml:lang="en-US" id="label_DeferredTaxAssetsOther">Deferred Tax Assets, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOther" xlink:to="label_DeferredTaxAssetsOther" xlink:title="label_DeferredTaxAssetsOther" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsOther_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsOther_1" xml:lang="en-US" id="label_DeferredTaxAssetsOther_1">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOther" xlink:to="label_DeferredTaxAssetsOther_1" xlink:title="label_DeferredTaxAssetsOther_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xml:lang="en-US" id="label_DeferredTaxAssetsTaxCreditCarryforwardsResearch">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="label_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1" xml:lang="en-US" id="label_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1">Research and development tax credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="label_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:title="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xml:lang="en-US" id="label_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="label_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:title="label_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1" xml:lang="en-US" id="label_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1">Accruals</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="label_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1" xlink:title="label_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="label_DeferredTaxAssetsValuationAllowance">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsValuationAllowance" xlink:to="label_DeferredTaxAssetsValuationAllowance" xlink:title="label_DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsValuationAllowance_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_DeferredTaxAssetsValuationAllowance_1" xml:lang="en-US" id="label_DeferredTaxAssetsValuationAllowance_1">Less: valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsValuationAllowance" xlink:to="label_DeferredTaxAssetsValuationAllowance_1" xlink:title="label_DeferredTaxAssetsValuationAllowance_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="DeferredTaxLiabilitiesNetAbstract" xlink:title="DeferredTaxLiabilitiesNetAbstract" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxLiabilitiesNetAbstract" xml:lang="en-US" id="label_DeferredTaxLiabilitiesNetAbstract">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="label_DeferredTaxLiabilitiesNetAbstract" xlink:title="label_DeferredTaxLiabilitiesNetAbstract" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxLiabilitiesNetAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxLiabilitiesNetAbstract_1" xml:lang="en-US" id="label_DeferredTaxLiabilitiesNetAbstract_1">Deferred tax liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="label_DeferredTaxLiabilitiesNetAbstract_1" xlink:title="label_DeferredTaxLiabilitiesNetAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:label xlink:type="resource" xlink:label="label_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xml:lang="en-US" id="label_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="label_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="label_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:label xlink:type="resource" xlink:label="label_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1" xml:lang="en-US" id="label_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1">Percentage of eligible compensation on a pre tax basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="label_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1" xlink:title="label_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="label_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DepreciationDepletionAndAmortization" xml:lang="en-US" id="label_DepreciationDepletionAndAmortization">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="label_DepreciationDepletionAndAmortization" xlink:title="label_DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="label_DepreciationDepletionAndAmortization_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DepreciationDepletionAndAmortization_1" xml:lang="en-US" id="label_DepreciationDepletionAndAmortization_1">Depreciation and amortization expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="label_DepreciationDepletionAndAmortization_1" xlink:title="label_DepreciationDepletionAndAmortization_1" />
    <link:label xlink:type="resource" xlink:label="label_DepreciationDepletionAndAmortization_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_DepreciationDepletionAndAmortization_2" xml:lang="en-US" id="label_DepreciationDepletionAndAmortization_2">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="label_DepreciationDepletionAndAmortization_2" xlink:title="label_DepreciationDepletionAndAmortization_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US" id="label_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="label_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="label_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US" id="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xml:lang="en-US" id="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xlink:title="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="DueToRelatedPartiesCurrentAndNoncurrent" xlink:title="DueToRelatedPartiesCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DueToRelatedPartiesCurrentAndNoncurrent" xml:lang="en-US" id="label_DueToRelatedPartiesCurrentAndNoncurrent">Due to Related Parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="label_DueToRelatedPartiesCurrentAndNoncurrent" xlink:title="label_DueToRelatedPartiesCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_DueToRelatedPartiesCurrentAndNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DueToRelatedPartiesCurrentAndNoncurrent_1" xml:lang="en-US" id="label_DueToRelatedPartiesCurrentAndNoncurrent_1">Amount due to related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="label_DueToRelatedPartiesCurrentAndNoncurrent_1" xlink:title="label_DueToRelatedPartiesCurrentAndNoncurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="label_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EarningsPerShareAbstract" xml:lang="en-US" id="label_EarningsPerShareAbstract">Net Loss Per Share Attributable to Common Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareAbstract" xlink:to="label_EarningsPerShareAbstract" xlink:title="label_EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_EarningsPerShareBasicAndDiluted" xml:lang="en-US" id="label_EarningsPerShareBasicAndDiluted">Net loss per share attributable to common stockholders-basic and diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDiluted" xlink:to="label_EarningsPerShareBasicAndDiluted" xlink:title="label_EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_EarningsPerShareBasicAndDiluted_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EarningsPerShareBasicAndDiluted_1" xml:lang="en-US" id="label_EarningsPerShareBasicAndDiluted_1">Earnings Per Share, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDiluted" xlink:to="label_EarningsPerShareBasicAndDiluted_1" xlink:title="label_EarningsPerShareBasicAndDiluted_1" />
    <link:label xlink:type="resource" xlink:label="label_EarningsPerShareBasicAndDiluted_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EarningsPerShareBasicAndDiluted_2" xml:lang="en-US" id="label_EarningsPerShareBasicAndDiluted_2">Net loss per common share-basic and diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDiluted" xlink:to="label_EarningsPerShareBasicAndDiluted_2" xlink:title="label_EarningsPerShareBasicAndDiluted_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="EarningsPerSharePolicyTextBlock" xlink:title="EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EarningsPerSharePolicyTextBlock" xml:lang="en-US" id="label_EarningsPerSharePolicyTextBlock">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerSharePolicyTextBlock" xlink:to="label_EarningsPerSharePolicyTextBlock" xlink:title="label_EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_EarningsPerSharePolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EarningsPerSharePolicyTextBlock_1" xml:lang="en-US" id="label_EarningsPerSharePolicyTextBlock_1">Net Loss per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerSharePolicyTextBlock" xlink:to="label_EarningsPerSharePolicyTextBlock_1" xlink:title="label_EarningsPerSharePolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="EarningsPerShareReconciliationAbstract" xlink:title="EarningsPerShareReconciliationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EarningsPerShareReconciliationAbstract" xml:lang="en-US" id="label_EarningsPerShareReconciliationAbstract">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareReconciliationAbstract" xlink:to="label_EarningsPerShareReconciliationAbstract" xlink:title="label_EarningsPerShareReconciliationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_EarningsPerShareReconciliationAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EarningsPerShareReconciliationAbstract_1" xml:lang="en-US" id="label_EarningsPerShareReconciliationAbstract_1">Numerator:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareReconciliationAbstract" xlink:to="label_EarningsPerShareReconciliationAbstract_1" xlink:title="label_EarningsPerShareReconciliationAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EarningsPerShareTextBlock" xml:lang="en-US" id="label_EarningsPerShareTextBlock">Earnings Per Share [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="label_EarningsPerShareTextBlock" xlink:title="label_EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_EarningsPerShareTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EarningsPerShareTextBlock_1" xml:lang="en-US" id="label_EarningsPerShareTextBlock_1">Net Loss Per Share Attributable to Common Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="label_EarningsPerShareTextBlock_1" xlink:title="label_EarningsPerShareTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US" id="label_EffectiveIncomeTaxRateContinuingOperations">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="label_EffectiveIncomeTaxRateContinuingOperations" xlink:title="label_EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_EffectiveIncomeTaxRateContinuingOperations_1" xml:lang="en-US" id="label_EffectiveIncomeTaxRateContinuingOperations_1">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="label_EffectiveIncomeTaxRateContinuingOperations_1" xlink:title="label_EffectiveIncomeTaxRateContinuingOperations_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:title="EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xml:lang="en-US" id="label_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">Reconciliation of federal statutory income tax rate to the Company's effective income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="label_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:title="label_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1" xml:lang="en-US" id="label_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1">Reconciliation of federal statutory income tax rate to the Company's effective income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="label_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1" xlink:title="label_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="label_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="label_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1">Expected income tax benefit at the federal statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="label_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xlink:title="label_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="label_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="label_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1">Change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="label_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xlink:title="label_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="label_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="label_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1">Non-deductible items</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="label_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1" xlink:title="label_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:title="EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationOtherAdjustments">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="label_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:title="label_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="label_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1" xlink:title="label_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="label_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:title="label_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1">Prior year provision to return adjustments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="label_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1" xlink:title="label_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="label_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="label_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1">State taxes, net of federal benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="label_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1" xlink:title="label_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:title="EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="label_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:title="label_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1">Research and development credit, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="label_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1" xlink:title="label_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EmployeeRelatedLiabilitiesCurrent" xml:lang="en-US" id="label_EmployeeRelatedLiabilitiesCurrent">Employee-related Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="label_EmployeeRelatedLiabilitiesCurrent" xlink:title="label_EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeRelatedLiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EmployeeRelatedLiabilitiesCurrent_1" xml:lang="en-US" id="label_EmployeeRelatedLiabilitiesCurrent_1">Accrued payroll and related benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="label_EmployeeRelatedLiabilitiesCurrent_1" xlink:title="label_EmployeeRelatedLiabilitiesCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xml:lang="en-US" id="label_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="label_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="label_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1" xml:lang="en-US" id="label_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1">Stock based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="label_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1" xlink:title="label_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US" id="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" xml:lang="en-US" id="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1">Unrecognized compensation cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" xlink:title="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US" id="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xml:lang="en-US" id="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1">Compensation expense recognition period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xlink:title="label_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EmployeeStockOptionMember" xml:lang="en-US" id="label_EmployeeStockOptionMember">Employee Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="label_EmployeeStockOptionMember" xlink:title="label_EmployeeStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeStockOptionMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EmployeeStockOptionMember_1" xml:lang="en-US" id="label_EmployeeStockOptionMember_1">Option to purchase common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="label_EmployeeStockOptionMember_1" xlink:title="label_EmployeeStockOptionMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquipmentMember" xlink:label="EquipmentMember" xlink:title="EquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EquipmentMember" xml:lang="en-US" id="label_EquipmentMember">Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquipmentMember" xlink:to="label_EquipmentMember" xlink:title="label_EquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_EquipmentMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EquipmentMember_1" xml:lang="en-US" id="label_EquipmentMember_1">Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquipmentMember" xlink:to="label_EquipmentMember_1" xlink:title="label_EquipmentMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="label_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EquityComponentDomain" xml:lang="en-US" id="label_EquityComponentDomain">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="label_EquityComponentDomain" xlink:title="label_EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="label_EquityComponentDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EquityComponentDomain_1" xml:lang="en-US" id="label_EquityComponentDomain_1">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="label_EquityComponentDomain_1" xlink:title="label_EquityComponentDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="EstimateOfFairValueFairValueDisclosureMember" xlink:title="EstimateOfFairValueFairValueDisclosureMember" />
    <link:label xlink:type="resource" xlink:label="label_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EstimateOfFairValueFairValueDisclosureMember" xml:lang="en-US" id="label_EstimateOfFairValueFairValueDisclosureMember">Estimate Of Fair Value Fair Value Disclosure [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimateOfFairValueFairValueDisclosureMember" xlink:to="label_EstimateOfFairValueFairValueDisclosureMember" xlink:title="label_EstimateOfFairValueFairValueDisclosureMember" />
    <link:label xlink:type="resource" xlink:label="label_EstimateOfFairValueFairValueDisclosureMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EstimateOfFairValueFairValueDisclosureMember_1" xml:lang="en-US" id="label_EstimateOfFairValueFairValueDisclosureMember_1">Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimateOfFairValueFairValueDisclosureMember" xlink:to="label_EstimateOfFairValueFairValueDisclosureMember_1" xlink:title="label_EstimateOfFairValueFairValueDisclosureMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:title="FairValueAssetsLevel1ToLevel2TransfersAmount" />
    <link:label xlink:type="resource" xlink:label="label_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueAssetsLevel1ToLevel2TransfersAmount" xml:lang="en-US" id="label_FairValueAssetsLevel1ToLevel2TransfersAmount">Fair Value, Assets, Level 1 to Level 2 Transfers, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:to="label_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:title="label_FairValueAssetsLevel1ToLevel2TransfersAmount" />
    <link:label xlink:type="resource" xlink:label="label_FairValueAssetsLevel1ToLevel2TransfersAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FairValueAssetsLevel1ToLevel2TransfersAmount_1" xml:lang="en-US" id="label_FairValueAssetsLevel1ToLevel2TransfersAmount_1">Assets transferred from level 1 to level 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:to="label_FairValueAssetsLevel1ToLevel2TransfersAmount_1" xlink:title="label_FairValueAssetsLevel1ToLevel2TransfersAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:title="FairValueAssetsLevel2ToLevel1TransfersAmount" />
    <link:label xlink:type="resource" xlink:label="label_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueAssetsLevel2ToLevel1TransfersAmount" xml:lang="en-US" id="label_FairValueAssetsLevel2ToLevel1TransfersAmount">Fair Value, Assets, Level 2 to Level 1 Transfers, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:to="label_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:title="label_FairValueAssetsLevel2ToLevel1TransfersAmount" />
    <link:label xlink:type="resource" xlink:label="label_FairValueAssetsLevel2ToLevel1TransfersAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FairValueAssetsLevel2ToLevel1TransfersAmount_1" xml:lang="en-US" id="label_FairValueAssetsLevel2ToLevel1TransfersAmount_1">Assets transferred from level 2 to level 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:to="label_FairValueAssetsLevel2ToLevel1TransfersAmount_1" xlink:title="label_FairValueAssetsLevel2ToLevel1TransfersAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:title="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xml:lang="en-US" id="label_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="label_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:title="label_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="FairValueByBalanceSheetGroupingTable" xlink:title="FairValueByBalanceSheetGroupingTable" />
    <link:label xlink:type="resource" xlink:label="label_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueByBalanceSheetGroupingTable" xml:lang="en-US" id="label_FairValueByBalanceSheetGroupingTable">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByBalanceSheetGroupingTable" xlink:to="label_FairValueByBalanceSheetGroupingTable" xlink:title="label_FairValueByBalanceSheetGroupingTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="FairValueByBalanceSheetGroupingTextBlock" xlink:title="FairValueByBalanceSheetGroupingTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueByBalanceSheetGroupingTextBlock" xml:lang="en-US" id="label_FairValueByBalanceSheetGroupingTextBlock">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByBalanceSheetGroupingTextBlock" xlink:to="label_FairValueByBalanceSheetGroupingTextBlock" xlink:title="label_FairValueByBalanceSheetGroupingTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_FairValueByBalanceSheetGroupingTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FairValueByBalanceSheetGroupingTextBlock_1" xml:lang="en-US" id="label_FairValueByBalanceSheetGroupingTextBlock_1">Summary of fair value of the Company's financial assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByBalanceSheetGroupingTextBlock" xlink:to="label_FairValueByBalanceSheetGroupingTextBlock_1" xlink:title="label_FairValueByBalanceSheetGroupingTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:label xlink:type="resource" xlink:label="label_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US" id="label_FairValueByFairValueHierarchyLevelAxis">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="label_FairValueByFairValueHierarchyLevelAxis" xlink:title="label_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="FairValueByMeasurementBasisAxis" xlink:title="FairValueByMeasurementBasisAxis" />
    <link:label xlink:type="resource" xlink:label="label_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueByMeasurementBasisAxis" xml:lang="en-US" id="label_FairValueByMeasurementBasisAxis">Measurement Basis [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByMeasurementBasisAxis" xlink:to="label_FairValueByMeasurementBasisAxis" xlink:title="label_FairValueByMeasurementBasisAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueDisclosuresAbstract" xml:lang="en-US" id="label_FairValueDisclosuresAbstract">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresAbstract" xlink:to="label_FairValueDisclosuresAbstract" xlink:title="label_FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueDisclosuresTextBlock" xml:lang="en-US" id="label_FairValueDisclosuresTextBlock">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="label_FairValueDisclosuresTextBlock" xlink:title="label_FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_FairValueDisclosuresTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FairValueDisclosuresTextBlock_1" xml:lang="en-US" id="label_FairValueDisclosuresTextBlock_1">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="label_FairValueDisclosuresTextBlock_1" xlink:title="label_FairValueDisclosuresTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:label xlink:type="resource" xlink:label="label_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueInputsLevel1Member" xml:lang="en-US" id="label_FairValueInputsLevel1Member">Fair Value Inputs Level1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel1Member" xlink:to="label_FairValueInputsLevel1Member" xlink:title="label_FairValueInputsLevel1Member" />
    <link:label xlink:type="resource" xlink:label="label_FairValueInputsLevel1Member_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FairValueInputsLevel1Member_1" xml:lang="en-US" id="label_FairValueInputsLevel1Member_1">Quoted Prices in Active Markets (Level 1)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel1Member" xlink:to="label_FairValueInputsLevel1Member_1" xlink:title="label_FairValueInputsLevel1Member_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:label xlink:type="resource" xlink:label="label_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueInputsLevel2Member" xml:lang="en-US" id="label_FairValueInputsLevel2Member">Fair Value Inputs Level2 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel2Member" xlink:to="label_FairValueInputsLevel2Member" xlink:title="label_FairValueInputsLevel2Member" />
    <link:label xlink:type="resource" xlink:label="label_FairValueInputsLevel2Member_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FairValueInputsLevel2Member_1" xml:lang="en-US" id="label_FairValueInputsLevel2Member_1">Significant Other Observable Inputs (Level 2)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel2Member" xlink:to="label_FairValueInputsLevel2Member_1" xlink:title="label_FairValueInputsLevel2Member_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xlink:type="resource" xlink:label="label_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US" id="label_FairValueMeasurementsFairValueHierarchyDomain">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="label_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="label_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xlink:type="resource" xlink:label="label_FairValueMeasurementsFairValueHierarchyDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FairValueMeasurementsFairValueHierarchyDomain_1" xml:lang="en-US" id="label_FairValueMeasurementsFairValueHierarchyDomain_1">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="label_FairValueMeasurementsFairValueHierarchyDomain_1" xlink:title="label_FairValueMeasurementsFairValueHierarchyDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="label_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US" id="label_FairValueOfFinancialInstrumentsPolicy">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="label_FairValueOfFinancialInstrumentsPolicy" xlink:title="label_FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="label_FairValueOfFinancialInstrumentsPolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FairValueOfFinancialInstrumentsPolicy_1" xml:lang="en-US" id="label_FairValueOfFinancialInstrumentsPolicy_1">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="label_FairValueOfFinancialInstrumentsPolicy_1" xlink:title="label_FairValueOfFinancialInstrumentsPolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="FinancialInstrumentAxis" xlink:title="FinancialInstrumentAxis" />
    <link:label xlink:type="resource" xlink:label="label_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FinancialInstrumentAxis" xml:lang="en-US" id="label_FinancialInstrumentAxis">Financial Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinancialInstrumentAxis" xlink:to="label_FinancialInstrumentAxis" xlink:title="label_FinancialInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:title="FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xml:lang="en-US" id="label_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="label_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:title="label_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1" xml:lang="en-US" id="label_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1">Fair value of the Company's financial assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="label_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1" xlink:title="label_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:label xlink:type="resource" xlink:label="label_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FurnitureAndFixturesMember" xml:lang="en-US" id="label_FurnitureAndFixturesMember">Furniture And Fixtures [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="label_FurnitureAndFixturesMember" xlink:title="label_FurnitureAndFixturesMember" />
    <link:label xlink:type="resource" xlink:label="label_FurnitureAndFixturesMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FurnitureAndFixturesMember_1" xml:lang="en-US" id="label_FurnitureAndFixturesMember_1">Furniture and fixtures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="label_FurnitureAndFixturesMember_1" xlink:title="label_FurnitureAndFixturesMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="label_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_GeneralAndAdministrativeExpense" xml:lang="en-US" id="label_GeneralAndAdministrativeExpense">General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpense" xlink:to="label_GeneralAndAdministrativeExpense" xlink:title="label_GeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="label_GeneralAndAdministrativeExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_GeneralAndAdministrativeExpense_1" xml:lang="en-US" id="label_GeneralAndAdministrativeExpense_1">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpense" xlink:to="label_GeneralAndAdministrativeExpense_1" xlink:title="label_GeneralAndAdministrativeExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:label xlink:type="resource" xlink:label="label_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_GeneralAndAdministrativeExpenseMember" xml:lang="en-US" id="label_GeneralAndAdministrativeExpenseMember">General And Administrative Expense [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpenseMember" xlink:to="label_GeneralAndAdministrativeExpenseMember" xlink:title="label_GeneralAndAdministrativeExpenseMember" />
    <link:label xlink:type="resource" xlink:label="label_GeneralAndAdministrativeExpenseMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_GeneralAndAdministrativeExpenseMember_1" xml:lang="en-US" id="label_GeneralAndAdministrativeExpenseMember_1">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpenseMember" xlink:to="label_GeneralAndAdministrativeExpenseMember_1" xlink:title="label_GeneralAndAdministrativeExpenseMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:title="GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
    <link:label xlink:type="resource" xlink:label="label_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xml:lang="en-US" id="label_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="label_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:title="label_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
    <link:label xlink:type="resource" xlink:label="label_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_1" xml:lang="en-US" id="label_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_1">Patent Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="label_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_1" xlink:title="label_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:title="ImpairmentOfLongLivedAssetsToBeDisposedOf" />
    <link:label xlink:type="resource" xlink:label="label_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ImpairmentOfLongLivedAssetsToBeDisposedOf" xml:lang="en-US" id="label_ImpairmentOfLongLivedAssetsToBeDisposedOf">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="label_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:title="label_ImpairmentOfLongLivedAssetsToBeDisposedOf" />
    <link:label xlink:type="resource" xlink:label="label_ImpairmentOfLongLivedAssetsToBeDisposedOf_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ImpairmentOfLongLivedAssetsToBeDisposedOf_1" xml:lang="en-US" id="label_ImpairmentOfLongLivedAssetsToBeDisposedOf_1">Impairment loss recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="label_ImpairmentOfLongLivedAssetsToBeDisposedOf_1" xlink:title="label_ImpairmentOfLongLivedAssetsToBeDisposedOf_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xml:lang="en-US" id="label_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="label_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="label_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_1" xml:lang="en-US" id="label_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_1">Impairment of Long Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="label_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_1" xlink:title="label_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="label_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeStatementAbstract" xml:lang="en-US" id="label_IncomeStatementAbstract">CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="label_IncomeStatementAbstract" xlink:title="label_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:label xlink:type="resource" xlink:label="label_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeStatementLocationAxis" xml:lang="en-US" id="label_IncomeStatementLocationAxis">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationAxis" xlink:to="label_IncomeStatementLocationAxis" xlink:title="label_IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:label xlink:type="resource" xlink:label="label_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeStatementLocationDomain" xml:lang="en-US" id="label_IncomeStatementLocationDomain">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationDomain" xlink:to="label_IncomeStatementLocationDomain" xlink:title="label_IncomeStatementLocationDomain" />
    <link:label xlink:type="resource" xlink:label="label_IncomeStatementLocationDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncomeStatementLocationDomain_1" xml:lang="en-US" id="label_IncomeStatementLocationDomain_1">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationDomain" xlink:to="label_IncomeStatementLocationDomain_1" xlink:title="label_IncomeStatementLocationDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeTaxDisclosureAbstract" xml:lang="en-US" id="label_IncomeTaxDisclosureAbstract">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="label_IncomeTaxDisclosureAbstract" xlink:title="label_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeTaxDisclosureTextBlock" xml:lang="en-US" id="label_IncomeTaxDisclosureTextBlock">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="label_IncomeTaxDisclosureTextBlock" xlink:title="label_IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncomeTaxDisclosureTextBlock_1" xml:lang="en-US" id="label_IncomeTaxDisclosureTextBlock_1">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="label_IncomeTaxDisclosureTextBlock_1" xlink:title="label_IncomeTaxDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeTaxExpenseBenefit" xml:lang="en-US" id="label_IncomeTaxExpenseBenefit">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="label_IncomeTaxExpenseBenefit" xlink:title="label_IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxExpenseBenefit_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_IncomeTaxExpenseBenefit_1" xml:lang="en-US" id="label_IncomeTaxExpenseBenefit_1">Provision or benefit from income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="label_IncomeTaxExpenseBenefit_1" xlink:title="label_IncomeTaxExpenseBenefit_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeTaxPolicyTextBlock" xml:lang="en-US" id="label_IncomeTaxPolicyTextBlock">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="label_IncomeTaxPolicyTextBlock" xlink:title="label_IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncomeTaxPolicyTextBlock_1" xml:lang="en-US" id="label_IncomeTaxPolicyTextBlock_1">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="label_IncomeTaxPolicyTextBlock_1" xlink:title="label_IncomeTaxPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxUncertaintiesAbstract" xlink:label="IncomeTaxUncertaintiesAbstract" xlink:title="IncomeTaxUncertaintiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeTaxUncertaintiesAbstract" xml:lang="en-US" id="label_IncomeTaxUncertaintiesAbstract">Income Tax Uncertainties [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxUncertaintiesAbstract" xlink:to="label_IncomeTaxUncertaintiesAbstract" xlink:title="label_IncomeTaxUncertaintiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxUncertaintiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncomeTaxUncertaintiesAbstract_1" xml:lang="en-US" id="label_IncomeTaxUncertaintiesAbstract_1">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxUncertaintiesAbstract" xlink:to="label_IncomeTaxUncertaintiesAbstract_1" xlink:title="label_IncomeTaxUncertaintiesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="IncreaseDecreaseInAccountsPayable" xlink:title="IncreaseDecreaseInAccountsPayable" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInAccountsPayable" xml:lang="en-US" id="label_IncreaseDecreaseInAccountsPayable">Increase (Decrease) in Accounts Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayable" xlink:to="label_IncreaseDecreaseInAccountsPayable" xlink:title="label_IncreaseDecreaseInAccountsPayable" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInAccountsPayable_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncreaseDecreaseInAccountsPayable_1" xml:lang="en-US" id="label_IncreaseDecreaseInAccountsPayable_1">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayable" xlink:to="label_IncreaseDecreaseInAccountsPayable_1" xlink:title="label_IncreaseDecreaseInAccountsPayable_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="IncreaseDecreaseInAccruedLiabilities" xlink:title="IncreaseDecreaseInAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInAccruedLiabilities" xml:lang="en-US" id="label_IncreaseDecreaseInAccruedLiabilities">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccruedLiabilities" xlink:to="label_IncreaseDecreaseInAccruedLiabilities" xlink:title="label_IncreaseDecreaseInAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInAccruedLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncreaseDecreaseInAccruedLiabilities_1" xml:lang="en-US" id="label_IncreaseDecreaseInAccruedLiabilities_1">Accrued liabilities and other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccruedLiabilities" xlink:to="label_IncreaseDecreaseInAccruedLiabilities_1" xlink:title="label_IncreaseDecreaseInAccruedLiabilities_1" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInAccruedLiabilities_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_IncreaseDecreaseInAccruedLiabilities_2" xml:lang="en-US" id="label_IncreaseDecreaseInAccruedLiabilities_2">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccruedLiabilities" xlink:to="label_IncreaseDecreaseInAccruedLiabilities_2" xlink:title="label_IncreaseDecreaseInAccruedLiabilities_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="IncreaseDecreaseInDeferredRevenue" xlink:title="IncreaseDecreaseInDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInDeferredRevenue" xml:lang="en-US" id="label_IncreaseDecreaseInDeferredRevenue">Increase (Decrease) in Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDeferredRevenue" xlink:to="label_IncreaseDecreaseInDeferredRevenue" xlink:title="label_IncreaseDecreaseInDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInDeferredRevenue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncreaseDecreaseInDeferredRevenue_1" xml:lang="en-US" id="label_IncreaseDecreaseInDeferredRevenue_1">Deferred rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDeferredRevenue" xlink:to="label_IncreaseDecreaseInDeferredRevenue_1" xlink:title="label_IncreaseDecreaseInDeferredRevenue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US" id="label_IncreaseDecreaseInOperatingCapitalAbstract">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="label_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInOperatingCapitalAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncreaseDecreaseInOperatingCapitalAbstract_1" xml:lang="en-US" id="label_IncreaseDecreaseInOperatingCapitalAbstract_1">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_IncreaseDecreaseInOperatingCapitalAbstract_1" xlink:title="label_IncreaseDecreaseInOperatingCapitalAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_IncreaseDecreaseInOtherNoncurrentAssets" xml:lang="en-US" id="label_IncreaseDecreaseInOtherNoncurrentAssets">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="label_IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="label_IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInOtherNoncurrentAssets_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInOtherNoncurrentAssets_1" xml:lang="en-US" id="label_IncreaseDecreaseInOtherNoncurrentAssets_1">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="label_IncreaseDecreaseInOtherNoncurrentAssets_1" xlink:title="label_IncreaseDecreaseInOtherNoncurrentAssets_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US" id="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xml:lang="en-US" id="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xlink:title="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2" xml:lang="en-US" id="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2">Prepaid expenses and other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2" xlink:title="label_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInStockholdersEquityRollForward" xml:lang="en-US" id="label_IncreaseDecreaseInStockholdersEquityRollForward">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="label_IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="label_IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInStockholdersEquityRollForward_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncreaseDecreaseInStockholdersEquityRollForward_1" xml:lang="en-US" id="label_IncreaseDecreaseInStockholdersEquityRollForward_1">Increase (Decrease) in Stockholders' Deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="label_IncreaseDecreaseInStockholdersEquityRollForward_1" xlink:title="label_IncreaseDecreaseInStockholdersEquityRollForward_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense" />
    <link:label xlink:type="resource" xlink:label="label_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_InterestExpense" xml:lang="en-US" id="label_InterestExpense">Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpense" xlink:to="label_InterestExpense" xlink:title="label_InterestExpense" />
    <link:label xlink:type="resource" xlink:label="label_InterestExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_InterestExpense_1" xml:lang="en-US" id="label_InterestExpense_1">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpense" xlink:to="label_InterestExpense_1" xlink:title="label_InterestExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="label_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_InterestPaidNet" xml:lang="en-US" id="label_InterestPaidNet">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="label_InterestPaidNet" xlink:title="label_InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="label_InterestPaidNet_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_InterestPaidNet_1" xml:lang="en-US" id="label_InterestPaidNet_1">Cash paid for interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="label_InterestPaidNet_1" xlink:title="label_InterestPaidNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="InterestPayableCurrent" xlink:title="InterestPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="label_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_InterestPayableCurrent" xml:lang="en-US" id="label_InterestPayableCurrent">Interest Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPayableCurrent" xlink:to="label_InterestPayableCurrent" xlink:title="label_InterestPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="label_InterestPayableCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_InterestPayableCurrent_1" xml:lang="en-US" id="label_InterestPayableCurrent_1">Accrued interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPayableCurrent" xlink:to="label_InterestPayableCurrent_1" xlink:title="label_InterestPayableCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_InvestmentsDebtAndEquitySecuritiesAbstract" xml:lang="en-US" id="label_InvestmentsDebtAndEquitySecuritiesAbstract">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="label_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="label_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xml:lang="en-US" id="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" xml:lang="en-US" id="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" xlink:title="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember" xlink:label="IPOMember" xlink:title="IPOMember" />
    <link:label xlink:type="resource" xlink:label="label_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IPOMember" xml:lang="en-US" id="label_IPOMember">I P O [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IPOMember" xlink:to="label_IPOMember" xlink:title="label_IPOMember" />
    <link:label xlink:type="resource" xlink:label="label_IPOMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IPOMember_1" xml:lang="en-US" id="label_IPOMember_1">IPO</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IPOMember" xlink:to="label_IPOMember_1" xlink:title="label_IPOMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="label_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LeaseholdImprovementsMember" xml:lang="en-US" id="label_LeaseholdImprovementsMember">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="label_LeaseholdImprovementsMember" xlink:title="label_LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="label_LeaseholdImprovementsMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LeaseholdImprovementsMember_1" xml:lang="en-US" id="label_LeaseholdImprovementsMember_1">Leasehold improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="label_LeaseholdImprovementsMember_1" xlink:title="label_LeaseholdImprovementsMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="label_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_Liabilities" xml:lang="en-US" id="label_Liabilities">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="label_Liabilities" xlink:title="label_Liabilities" />
    <link:label xlink:type="resource" xlink:label="label_Liabilities_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_Liabilities_1" xml:lang="en-US" id="label_Liabilities_1">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="label_Liabilities_1" xlink:title="label_Liabilities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LiabilitiesAndStockholdersEquity" xml:lang="en-US" id="label_LiabilitiesAndStockholdersEquity">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="label_LiabilitiesAndStockholdersEquity" xlink:title="label_LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_LiabilitiesAndStockholdersEquity_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US" id="label_LiabilitiesAndStockholdersEquity_1">Total liabilities, preferred stock and stockholders' equity (deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="label_LiabilitiesAndStockholdersEquity_1" xlink:title="label_LiabilitiesAndStockholdersEquity_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US" id="label_LiabilitiesAndStockholdersEquityAbstract">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_LiabilitiesAndStockholdersEquityAbstract" xlink:title="label_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_LiabilitiesAndStockholdersEquityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LiabilitiesAndStockholdersEquityAbstract_1" xml:lang="en-US" id="label_LiabilitiesAndStockholdersEquityAbstract_1">Liabilities, Preferred Stock and Stockholders' Equity (Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_LiabilitiesAndStockholdersEquityAbstract_1" xlink:title="label_LiabilitiesAndStockholdersEquityAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LiabilitiesCurrent" xml:lang="en-US" id="label_LiabilitiesCurrent">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="label_LiabilitiesCurrent" xlink:title="label_LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_LiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_LiabilitiesCurrent_1" xml:lang="en-US" id="label_LiabilitiesCurrent_1">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="label_LiabilitiesCurrent_1" xlink:title="label_LiabilitiesCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LiabilitiesCurrentAbstract" xml:lang="en-US" id="label_LiabilitiesCurrentAbstract">Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="label_LiabilitiesCurrentAbstract" xlink:title="label_LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_LiabilitiesCurrentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LiabilitiesCurrentAbstract_1" xml:lang="en-US" id="label_LiabilitiesCurrentAbstract_1">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="label_LiabilitiesCurrentAbstract_1" xlink:title="label_LiabilitiesCurrentAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LongTermDebt" xml:lang="en-US" id="label_LongTermDebt">Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="label_LongTermDebt" xlink:title="label_LongTermDebt" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebt_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_LongTermDebt_1" xml:lang="en-US" id="label_LongTermDebt_1">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="label_LongTermDebt_1" xlink:title="label_LongTermDebt_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LongTermDebtByMaturityAbstract" xml:lang="en-US" id="label_LongTermDebtByMaturityAbstract">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="label_LongTermDebtByMaturityAbstract" xlink:title="label_LongTermDebtByMaturityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtByMaturityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LongTermDebtByMaturityAbstract_1" xml:lang="en-US" id="label_LongTermDebtByMaturityAbstract_1">Future maturities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="label_LongTermDebtByMaturityAbstract_1" xlink:title="label_LongTermDebtByMaturityAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LongTermDebtCurrent" xml:lang="en-US" id="label_LongTermDebtCurrent">Long-term Debt, Current Maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="label_LongTermDebtCurrent" xlink:title="label_LongTermDebtCurrent" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtCurrent_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_LongTermDebtCurrent_1" xml:lang="en-US" id="label_LongTermDebtCurrent_1">Less: current portion of term loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="label_LongTermDebtCurrent_1" xlink:title="label_LongTermDebtCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtCurrent_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_LongTermDebtCurrent_2" xml:lang="en-US" id="label_LongTermDebtCurrent_2">Term loan, current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="label_LongTermDebtCurrent_2" xlink:title="label_LongTermDebtCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xml:lang="en-US" id="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1" xml:lang="en-US" id="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1">2019</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xml:lang="en-US" id="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">Long-term Debt, Maturities, Repayments of Principal in Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1" xml:lang="en-US" id="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xml:lang="en-US" id="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1" xml:lang="en-US" id="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xml:lang="en-US" id="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1" xml:lang="en-US" id="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xml:lang="en-US" id="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1" xml:lang="en-US" id="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1">2020</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1" xlink:title="label_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LongTermDebtNoncurrent" xml:lang="en-US" id="label_LongTermDebtNoncurrent">Long-term Debt, Excluding Current Maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtNoncurrent" xlink:to="label_LongTermDebtNoncurrent" xlink:title="label_LongTermDebtNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LongTermDebtNoncurrent_1" xml:lang="en-US" id="label_LongTermDebtNoncurrent_1">Term loan, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtNoncurrent" xlink:to="label_LongTermDebtNoncurrent_1" xlink:title="label_LongTermDebtNoncurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="MarketableSecuritiesPolicy" xlink:title="MarketableSecuritiesPolicy" />
    <link:label xlink:type="resource" xlink:label="label_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_MarketableSecuritiesPolicy" xml:lang="en-US" id="label_MarketableSecuritiesPolicy">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesPolicy" xlink:to="label_MarketableSecuritiesPolicy" xlink:title="label_MarketableSecuritiesPolicy" />
    <link:label xlink:type="resource" xlink:label="label_MarketableSecuritiesPolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_MarketableSecuritiesPolicy_1" xml:lang="en-US" id="label_MarketableSecuritiesPolicy_1">Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesPolicy" xlink:to="label_MarketableSecuritiesPolicy_1" xlink:title="label_MarketableSecuritiesPolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="MoneyMarketFundsMember" xlink:title="MoneyMarketFundsMember" />
    <link:label xlink:type="resource" xlink:label="label_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_MoneyMarketFundsMember" xml:lang="en-US" id="label_MoneyMarketFundsMember">Money Market Funds [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MoneyMarketFundsMember" xlink:to="label_MoneyMarketFundsMember" xlink:title="label_MoneyMarketFundsMember" />
    <link:label xlink:type="resource" xlink:label="label_MoneyMarketFundsMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_MoneyMarketFundsMember_1" xml:lang="en-US" id="label_MoneyMarketFundsMember_1">Money market funds (cash equivalents)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MoneyMarketFundsMember" xlink:to="label_MoneyMarketFundsMember_1" xlink:title="label_MoneyMarketFundsMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US" id="label_NetCashProvidedByUsedInFinancingActivities">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="label_NetCashProvidedByUsedInFinancingActivities" xlink:title="label_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInFinancingActivities_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_NetCashProvidedByUsedInFinancingActivities_1" xml:lang="en-US" id="label_NetCashProvidedByUsedInFinancingActivities_1">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="label_NetCashProvidedByUsedInFinancingActivities_1" xlink:title="label_NetCashProvidedByUsedInFinancingActivities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US" id="label_NetCashProvidedByUsedInFinancingActivitiesAbstract">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="label_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="label_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInFinancingActivitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NetCashProvidedByUsedInFinancingActivitiesAbstract_1" xml:lang="en-US" id="label_NetCashProvidedByUsedInFinancingActivitiesAbstract_1">Cash flows from financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="label_NetCashProvidedByUsedInFinancingActivitiesAbstract_1" xlink:title="label_NetCashProvidedByUsedInFinancingActivitiesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US" id="label_NetCashProvidedByUsedInInvestingActivities">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="label_NetCashProvidedByUsedInInvestingActivities" xlink:title="label_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInInvestingActivities_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_NetCashProvidedByUsedInInvestingActivities_1" xml:lang="en-US" id="label_NetCashProvidedByUsedInInvestingActivities_1">Net cash used in investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="label_NetCashProvidedByUsedInInvestingActivities_1" xlink:title="label_NetCashProvidedByUsedInInvestingActivities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US" id="label_NetCashProvidedByUsedInInvestingActivitiesAbstract">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="label_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="label_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInInvestingActivitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NetCashProvidedByUsedInInvestingActivitiesAbstract_1" xml:lang="en-US" id="label_NetCashProvidedByUsedInInvestingActivitiesAbstract_1">Cash flows from investing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="label_NetCashProvidedByUsedInInvestingActivitiesAbstract_1" xlink:title="label_NetCashProvidedByUsedInInvestingActivitiesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US" id="label_NetCashProvidedByUsedInOperatingActivities">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="label_NetCashProvidedByUsedInOperatingActivities" xlink:title="label_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInOperatingActivities_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_NetCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US" id="label_NetCashProvidedByUsedInOperatingActivities_1">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="label_NetCashProvidedByUsedInOperatingActivities_1" xlink:title="label_NetCashProvidedByUsedInOperatingActivities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="label_NetCashProvidedByUsedInOperatingActivitiesAbstract">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="label_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xml:lang="en-US" id="label_NetCashProvidedByUsedInOperatingActivitiesAbstract_1">Cash flows from operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:title="label_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetIncomeLoss" xml:lang="en-US" id="label_NetIncomeLoss">Net Income (Loss) Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="label_NetIncomeLoss" xlink:title="label_NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_NetIncomeLoss_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NetIncomeLoss_1" xml:lang="en-US" id="label_NetIncomeLoss_1">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="label_NetIncomeLoss_1" xlink:title="label_NetIncomeLoss_1" />
    <link:label xlink:type="resource" xlink:label="label_NetIncomeLoss_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_NetIncomeLoss_2" xml:lang="en-US" id="label_NetIncomeLoss_2">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="label_NetIncomeLoss_2" xlink:title="label_NetIncomeLoss_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xlink:type="resource" xlink:label="label_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US" id="label_NetIncomeLossAvailableToCommonStockholdersBasic">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="label_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="label_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xlink:type="resource" xlink:label="label_NetIncomeLossAvailableToCommonStockholdersBasic_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NetIncomeLossAvailableToCommonStockholdersBasic_1" xml:lang="en-US" id="label_NetIncomeLossAvailableToCommonStockholdersBasic_1">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="label_NetIncomeLossAvailableToCommonStockholdersBasic_1" xlink:title="label_NetIncomeLossAvailableToCommonStockholdersBasic_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US" id="label_NewAccountingPronouncementsPolicyPolicyTextBlock">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="label_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="label_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xml:lang="en-US" id="label_NewAccountingPronouncementsPolicyPolicyTextBlock_1">Recently Adopted Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="label_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xlink:title="label_NewAccountingPronouncementsPolicyPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="NoncashInvestingAndFinancingItemsAbstract" xlink:title="NoncashInvestingAndFinancingItemsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NoncashInvestingAndFinancingItemsAbstract" xml:lang="en-US" id="label_NoncashInvestingAndFinancingItemsAbstract">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashInvestingAndFinancingItemsAbstract" xlink:to="label_NoncashInvestingAndFinancingItemsAbstract" xlink:title="label_NoncashInvestingAndFinancingItemsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_NoncashInvestingAndFinancingItemsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NoncashInvestingAndFinancingItemsAbstract_1" xml:lang="en-US" id="label_NoncashInvestingAndFinancingItemsAbstract_1">Supplemental disclosures of noncash investing and financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashInvestingAndFinancingItemsAbstract" xlink:to="label_NoncashInvestingAndFinancingItemsAbstract_1" xlink:title="label_NoncashInvestingAndFinancingItemsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:label xlink:type="resource" xlink:label="label_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NumberOfOperatingSegments" xml:lang="en-US" id="label_NumberOfOperatingSegments">Number of Operating Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingSegments" xlink:to="label_NumberOfOperatingSegments" xlink:title="label_NumberOfOperatingSegments" />
    <link:label xlink:type="resource" xlink:label="label_NumberOfOperatingSegments_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NumberOfOperatingSegments_1" xml:lang="en-US" id="label_NumberOfOperatingSegments_1">Number of operating segment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingSegments" xlink:to="label_NumberOfOperatingSegments_1" xlink:title="label_NumberOfOperatingSegments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:label xlink:type="resource" xlink:label="label_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingExpenses" xml:lang="en-US" id="label_OperatingExpenses">Operating Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="label_OperatingExpenses" xlink:title="label_OperatingExpenses" />
    <link:label xlink:type="resource" xlink:label="label_OperatingExpenses_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_OperatingExpenses_1" xml:lang="en-US" id="label_OperatingExpenses_1">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="label_OperatingExpenses_1" xlink:title="label_OperatingExpenses_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingExpensesAbstract" xml:lang="en-US" id="label_OperatingExpensesAbstract">Operating Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="label_OperatingExpensesAbstract" xlink:title="label_OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_OperatingExpensesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OperatingExpensesAbstract_1" xml:lang="en-US" id="label_OperatingExpensesAbstract_1">Operating expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="label_OperatingExpensesAbstract_1" xlink:title="label_OperatingExpensesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingIncomeLoss" xml:lang="en-US" id="label_OperatingIncomeLoss">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="label_OperatingIncomeLoss" xlink:title="label_OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_OperatingIncomeLoss_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_OperatingIncomeLoss_1" xml:lang="en-US" id="label_OperatingIncomeLoss_1">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="label_OperatingIncomeLoss_1" xlink:title="label_OperatingIncomeLoss_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="OperatingLeasesFutureMinimumPaymentsDue" xlink:title="OperatingLeasesFutureMinimumPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDue" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDue">Operating Leases, Future Minimum Payments Due</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDue" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDue" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDue_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDue_1" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDue_1">Total future minimum payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDue" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDue_1" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDue_1" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDue_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDue_2" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDue_2">Future minimum payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDue" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDue_2" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDue_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="OperatingLeasesFutureMinimumPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueAbstract" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueAbstract">Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueAbstract_1" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueAbstract_1">Future minimum payments:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueAbstract_1" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueCurrent" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueCurrent">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueCurrent_1">2019</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueInFourYears">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1">2020</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:title="OperatingLeasesFutureMinimumPaymentsDueThereafter" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueThereafter" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueThereafter">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueThereafter" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsDueThereafter_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueThereafter_1" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsDueThereafter_1">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="label_OperatingLeasesFutureMinimumPaymentsDueThereafter_1" xlink:title="label_OperatingLeasesFutureMinimumPaymentsDueThereafter_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:title="OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">Operating Leases, Future Minimum Payments, Remainder of Fiscal Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="label_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:title="label_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_1" xml:lang="en-US" id="label_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_1">Remainder of the year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="label_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_1" xlink:title="label_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="OperatingLeasesRentExpenseNet" xlink:title="OperatingLeasesRentExpenseNet" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingLeasesRentExpenseNet" xml:lang="en-US" id="label_OperatingLeasesRentExpenseNet">Operating Leases, Rent Expense, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesRentExpenseNet" xlink:to="label_OperatingLeasesRentExpenseNet" xlink:title="label_OperatingLeasesRentExpenseNet" />
    <link:label xlink:type="resource" xlink:label="label_OperatingLeasesRentExpenseNet_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OperatingLeasesRentExpenseNet_1" xml:lang="en-US" id="label_OperatingLeasesRentExpenseNet_1">Rent expenses operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesRentExpenseNet" xlink:to="label_OperatingLeasesRentExpenseNet_1" xlink:title="label_OperatingLeasesRentExpenseNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US" id="label_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">Nature of the Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="label_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="label_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xml:lang="en-US" id="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1" xml:lang="en-US" id="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1">Nature of the Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1" xlink:title="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2" xml:lang="en-US" id="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2">Nature of the Business and Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2" xlink:title="label_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OtherAssetsNoncurrent" xml:lang="en-US" id="label_OtherAssetsNoncurrent">Other Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="label_OtherAssetsNoncurrent" xlink:title="label_OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_OtherAssetsNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OtherAssetsNoncurrent_1" xml:lang="en-US" id="label_OtherAssetsNoncurrent_1">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="label_OtherAssetsNoncurrent_1" xlink:title="label_OtherAssetsNoncurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:title="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xml:lang="en-US" id="label_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="label_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:title="label_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1" xml:lang="en-US" id="label_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1">Comprehensive loss:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="label_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1" xlink:title="label_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xml:lang="en-US" id="label_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="label_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="label_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1" xml:lang="en-US" id="label_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1">Unrealized loss on marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="label_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1" xlink:title="label_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="label_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OtherNonoperatingIncomeExpense" xml:lang="en-US" id="label_OtherNonoperatingIncomeExpense">Other Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpense" xlink:to="label_OtherNonoperatingIncomeExpense" xlink:title="label_OtherNonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="label_OtherNonoperatingIncomeExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OtherNonoperatingIncomeExpense_1" xml:lang="en-US" id="label_OtherNonoperatingIncomeExpense_1">Other income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpense" xlink:to="label_OtherNonoperatingIncomeExpense_1" xlink:title="label_OtherNonoperatingIncomeExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="PaymentsOfFinancingCosts" xlink:title="PaymentsOfFinancingCosts" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PaymentsOfFinancingCosts" xml:lang="en-US" id="label_PaymentsOfFinancingCosts">Payments of Financing Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfFinancingCosts" xlink:to="label_PaymentsOfFinancingCosts" xlink:title="label_PaymentsOfFinancingCosts" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsOfFinancingCosts_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_PaymentsOfFinancingCosts_1" xml:lang="en-US" id="label_PaymentsOfFinancingCosts_1">Deferred financing costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfFinancingCosts" xlink:to="label_PaymentsOfFinancingCosts_1" xlink:title="label_PaymentsOfFinancingCosts_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="PaymentsOfStockIssuanceCosts" xlink:title="PaymentsOfStockIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PaymentsOfStockIssuanceCosts" xml:lang="en-US" id="label_PaymentsOfStockIssuanceCosts">Payments of Stock Issuance Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfStockIssuanceCosts" xlink:to="label_PaymentsOfStockIssuanceCosts" xlink:title="label_PaymentsOfStockIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsOfStockIssuanceCosts_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PaymentsOfStockIssuanceCosts_1" xml:lang="en-US" id="label_PaymentsOfStockIssuanceCosts_1">Offering expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfStockIssuanceCosts" xlink:to="label_PaymentsOfStockIssuanceCosts_1" xlink:title="label_PaymentsOfStockIssuanceCosts_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="PaymentsToAcquireMarketableSecurities" xlink:title="PaymentsToAcquireMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PaymentsToAcquireMarketableSecurities" xml:lang="en-US" id="label_PaymentsToAcquireMarketableSecurities">Payments to Acquire Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireMarketableSecurities" xlink:to="label_PaymentsToAcquireMarketableSecurities" xlink:title="label_PaymentsToAcquireMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsToAcquireMarketableSecurities_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_PaymentsToAcquireMarketableSecurities_1" xml:lang="en-US" id="label_PaymentsToAcquireMarketableSecurities_1">Purchase of marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireMarketableSecurities" xlink:to="label_PaymentsToAcquireMarketableSecurities_1" xlink:title="label_PaymentsToAcquireMarketableSecurities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US" id="label_PaymentsToAcquirePropertyPlantAndEquipment">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="label_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="label_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsToAcquirePropertyPlantAndEquipment_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US" id="label_PaymentsToAcquirePropertyPlantAndEquipment_1">Purchase of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="label_PaymentsToAcquirePropertyPlantAndEquipment_1" xlink:title="label_PaymentsToAcquirePropertyPlantAndEquipment_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:title="PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xml:lang="en-US" id="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">Pension and Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:title="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1" xml:lang="en-US" id="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1">Employee Benefit Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1" xlink:title="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="label_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PlanNameAxis" xml:lang="en-US" id="label_PlanNameAxis">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameAxis" xlink:to="label_PlanNameAxis" xlink:title="label_PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PlanNameDomain" xml:lang="en-US" id="label_PlanNameDomain">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameDomain" xlink:to="label_PlanNameDomain" xlink:title="label_PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_PlanNameDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PlanNameDomain_1" xml:lang="en-US" id="label_PlanNameDomain_1">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameDomain" xlink:to="label_PlanNameDomain_1" xlink:title="label_PlanNameDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="PortionAtFairValueFairValueDisclosureMember" xlink:title="PortionAtFairValueFairValueDisclosureMember" />
    <link:label xlink:type="resource" xlink:label="label_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PortionAtFairValueFairValueDisclosureMember" xml:lang="en-US" id="label_PortionAtFairValueFairValueDisclosureMember">Portion At Fair Value Fair Value Disclosure [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PortionAtFairValueFairValueDisclosureMember" xlink:to="label_PortionAtFairValueFairValueDisclosureMember" xlink:title="label_PortionAtFairValueFairValueDisclosureMember" />
    <link:label xlink:type="resource" xlink:label="label_PortionAtFairValueFairValueDisclosureMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PortionAtFairValueFairValueDisclosureMember_1" xml:lang="en-US" id="label_PortionAtFairValueFairValueDisclosureMember_1">Portion at Fair Value Measurement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PortionAtFairValueFairValueDisclosureMember" xlink:to="label_PortionAtFairValueFairValueDisclosureMember_1" xlink:title="label_PortionAtFairValueFairValueDisclosureMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="PreferredStockDividendRatePercentage" xlink:title="PreferredStockDividendRatePercentage" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockDividendRatePercentage" xml:lang="en-US" id="label_PreferredStockDividendRatePercentage">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendRatePercentage" xlink:to="label_PreferredStockDividendRatePercentage" xlink:title="label_PreferredStockDividendRatePercentage" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockDividendRatePercentage_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockDividendRatePercentage_1" xml:lang="en-US" id="label_PreferredStockDividendRatePercentage_1">Noncumulative dividends, annual rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendRatePercentage" xlink:to="label_PreferredStockDividendRatePercentage_1" xlink:title="label_PreferredStockDividendRatePercentage_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared" xlink:label="PreferredStockDividendsPerShareDeclared" xlink:title="PreferredStockDividendsPerShareDeclared" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockDividendsPerShareDeclared" xml:lang="en-US" id="label_PreferredStockDividendsPerShareDeclared">Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsPerShareDeclared" xlink:to="label_PreferredStockDividendsPerShareDeclared" xlink:title="label_PreferredStockDividendsPerShareDeclared" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockDividendsPerShareDeclared_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockDividendsPerShareDeclared_1" xml:lang="en-US" id="label_PreferredStockDividendsPerShareDeclared_1">Dividends declared</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsPerShareDeclared" xlink:to="label_PreferredStockDividendsPerShareDeclared_1" xlink:title="label_PreferredStockDividendsPerShareDeclared_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="PreferredStockLiquidationPreference" xlink:title="PreferredStockLiquidationPreference" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockLiquidationPreference" xml:lang="en-US" id="label_PreferredStockLiquidationPreference">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreference" xlink:to="label_PreferredStockLiquidationPreference" xlink:title="label_PreferredStockLiquidationPreference" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockLiquidationPreference_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockLiquidationPreference_1" xml:lang="en-US" id="label_PreferredStockLiquidationPreference_1">Liquidation preference per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreference" xlink:to="label_PreferredStockLiquidationPreference_1" xlink:title="label_PreferredStockLiquidationPreference_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockMember" xml:lang="en-US" id="label_PreferredStockMember">Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockMember" xlink:to="label_PreferredStockMember" xlink:title="label_PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockMember_1" xml:lang="en-US" id="label_PreferredStockMember_1">Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockMember" xlink:to="label_PreferredStockMember_1" xlink:title="label_PreferredStockMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:title="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xml:lang="en-US" id="label_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">Preferred Stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="label_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:title="label_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockParOrStatedValuePerShare" xml:lang="en-US" id="label_PreferredStockParOrStatedValuePerShare">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="label_PreferredStockParOrStatedValuePerShare" xlink:title="label_PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockParOrStatedValuePerShare_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockParOrStatedValuePerShare_1" xml:lang="en-US" id="label_PreferredStockParOrStatedValuePerShare_1">Preferred stock, par value per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="label_PreferredStockParOrStatedValuePerShare_1" xlink:title="label_PreferredStockParOrStatedValuePerShare_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockSharesAuthorized" xml:lang="en-US" id="label_PreferredStockSharesAuthorized">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="label_PreferredStockSharesAuthorized" xlink:title="label_PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockSharesAuthorized_1" xml:lang="en-US" id="label_PreferredStockSharesAuthorized_1">Preferred stock, number of shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="label_PreferredStockSharesAuthorized_1" xlink:title="label_PreferredStockSharesAuthorized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockSharesIssued" xml:lang="en-US" id="label_PreferredStockSharesIssued">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="label_PreferredStockSharesIssued" xlink:title="label_PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockSharesIssued_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockSharesIssued_1" xml:lang="en-US" id="label_PreferredStockSharesIssued_1">Preferred stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="label_PreferredStockSharesIssued_1" xlink:title="label_PreferredStockSharesIssued_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockSharesOutstanding" xml:lang="en-US" id="label_PreferredStockSharesOutstanding">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="label_PreferredStockSharesOutstanding" xlink:title="label_PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockSharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockSharesOutstanding_1" xml:lang="en-US" id="label_PreferredStockSharesOutstanding_1">Preferred stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="label_PreferredStockSharesOutstanding_1" xlink:title="label_PreferredStockSharesOutstanding_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="PreferredStockTextBlock" xlink:title="PreferredStockTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockTextBlock" xml:lang="en-US" id="label_PreferredStockTextBlock">Preferred Stock [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockTextBlock" xlink:to="label_PreferredStockTextBlock" xlink:title="label_PreferredStockTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockTextBlock_1" xml:lang="en-US" id="label_PreferredStockTextBlock_1">Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockTextBlock" xlink:to="label_PreferredStockTextBlock_1" xlink:title="label_PreferredStockTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockValue" xml:lang="en-US" id="label_PreferredStockValue">Preferred Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="label_PreferredStockValue" xlink:title="label_PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockValue_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_PreferredStockValue_1" xml:lang="en-US" id="label_PreferredStockValue_1">Preferred stock; par value of $0.001 per share, 10,000,000 and 0 shares authorized at September 30, 2019 and December 31, 2018. No shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="label_PreferredStockValue_1" xlink:title="label_PreferredStockValue_1" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockValue_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockValue_2" xml:lang="en-US" id="label_PreferredStockValue_2">Preferred stock; par value of $0.001 per share, 10,000,000 and 0 shares authorized at June 30, 2019 and December 31, 2018. No shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="label_PreferredStockValue_2" xlink:title="label_PreferredStockValue_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US" id="label_PrepaidExpenseAndOtherAssetsCurrent">Prepaid Expense and Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="label_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_PrepaidExpenseAndOtherAssetsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PrepaidExpenseAndOtherAssetsCurrent_1" xml:lang="en-US" id="label_PrepaidExpenseAndOtherAssetsCurrent_1">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_PrepaidExpenseAndOtherAssetsCurrent_1" xlink:title="label_PrepaidExpenseAndOtherAssetsCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrimeRateMember" xlink:label="PrimeRateMember" xlink:title="PrimeRateMember" />
    <link:label xlink:type="resource" xlink:label="label_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PrimeRateMember" xml:lang="en-US" id="label_PrimeRateMember">Prime Rate [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrimeRateMember" xlink:to="label_PrimeRateMember" xlink:title="label_PrimeRateMember" />
    <link:label xlink:type="resource" xlink:label="label_PrimeRateMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PrimeRateMember_1" xml:lang="en-US" id="label_PrimeRateMember_1">Prime rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrimeRateMember" xlink:to="label_PrimeRateMember_1" xlink:title="label_PrimeRateMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="ProceedsFromIssuanceInitialPublicOffering" xlink:title="ProceedsFromIssuanceInitialPublicOffering" />
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ProceedsFromIssuanceInitialPublicOffering" xml:lang="en-US" id="label_ProceedsFromIssuanceInitialPublicOffering">Proceeds from Issuance Initial Public Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceInitialPublicOffering" xlink:to="label_ProceedsFromIssuanceInitialPublicOffering" xlink:title="label_ProceedsFromIssuanceInitialPublicOffering" />
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceInitialPublicOffering_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ProceedsFromIssuanceInitialPublicOffering_1" xml:lang="en-US" id="label_ProceedsFromIssuanceInitialPublicOffering_1">Proceeds from issuance of shares, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceInitialPublicOffering" xlink:to="label_ProceedsFromIssuanceInitialPublicOffering_1" xlink:title="label_ProceedsFromIssuanceInitialPublicOffering_1" />
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceInitialPublicOffering_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_ProceedsFromIssuanceInitialPublicOffering_2" xml:lang="en-US" id="label_ProceedsFromIssuanceInitialPublicOffering_2">Proceeds from initial public offering, net of issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceInitialPublicOffering" xlink:to="label_ProceedsFromIssuanceInitialPublicOffering_2" xlink:title="label_ProceedsFromIssuanceInitialPublicOffering_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US" id="label_ProceedsFromIssuanceOfCommonStock">Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="label_ProceedsFromIssuanceOfCommonStock" xlink:title="label_ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceOfCommonStock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ProceedsFromIssuanceOfCommonStock_1" xml:lang="en-US" id="label_ProceedsFromIssuanceOfCommonStock_1">Proceeds from issuance of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="label_ProceedsFromIssuanceOfCommonStock_1" xlink:title="label_ProceedsFromIssuanceOfCommonStock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="ProceedsFromIssuanceOfDebt" xlink:title="ProceedsFromIssuanceOfDebt" />
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ProceedsFromIssuanceOfDebt" xml:lang="en-US" id="label_ProceedsFromIssuanceOfDebt">Proceeds from Issuance of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfDebt" xlink:to="label_ProceedsFromIssuanceOfDebt" xlink:title="label_ProceedsFromIssuanceOfDebt" />
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceOfDebt_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ProceedsFromIssuanceOfDebt_1" xml:lang="en-US" id="label_ProceedsFromIssuanceOfDebt_1">Proceeds from the term loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfDebt" xlink:to="label_ProceedsFromIssuanceOfDebt_1" xlink:title="label_ProceedsFromIssuanceOfDebt_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:title="ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xml:lang="en-US" id="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">Proceeds from Issuance of Preferred Stock and Preference Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:title="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1" xml:lang="en-US" id="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1">Proceeds from issuance of preferred stock, net of issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1" xlink:title="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1" />
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2" xml:lang="en-US" id="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2">Equity investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2" xlink:title="label_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:label xlink:type="resource" xlink:label="label_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ProfitLoss" xml:lang="en-US" id="label_ProfitLoss">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="label_ProfitLoss" xlink:title="label_ProfitLoss" />
    <link:label xlink:type="resource" xlink:label="label_ProfitLoss_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ProfitLoss_1" xml:lang="en-US" id="label_ProfitLoss_1">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="label_ProfitLoss_1" xlink:title="label_ProfitLoss_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentAbstract" xml:lang="en-US" id="label_PropertyPlantAndEquipmentAbstract">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="label_PropertyPlantAndEquipmentAbstract" xlink:title="label_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US" id="label_PropertyPlantAndEquipmentByTypeAxis">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="label_PropertyPlantAndEquipmentByTypeAxis" xlink:title="label_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US" id="label_PropertyPlantAndEquipmentDisclosureTextBlock">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="label_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="label_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PropertyPlantAndEquipmentDisclosureTextBlock_1" xml:lang="en-US" id="label_PropertyPlantAndEquipmentDisclosureTextBlock_1">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="label_PropertyPlantAndEquipmentDisclosureTextBlock_1" xlink:title="label_PropertyPlantAndEquipmentDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:title="PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentEstimatedUsefulLives" xml:lang="en-US" id="label_PropertyPlantAndEquipmentEstimatedUsefulLives">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="label_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:title="label_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentGross" xml:lang="en-US" id="label_PropertyPlantAndEquipmentGross">Property, Plant and Equipment, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="label_PropertyPlantAndEquipmentGross" xlink:title="label_PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentGross_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PropertyPlantAndEquipmentGross_1" xml:lang="en-US" id="label_PropertyPlantAndEquipmentGross_1">Property and equipment, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="label_PropertyPlantAndEquipmentGross_1" xlink:title="label_PropertyPlantAndEquipmentGross_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentLineItems" xml:lang="en-US" id="label_PropertyPlantAndEquipmentLineItems">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="label_PropertyPlantAndEquipmentLineItems" xlink:title="label_PropertyPlantAndEquipmentLineItems" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentLineItems_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PropertyPlantAndEquipmentLineItems_1" xml:lang="en-US" id="label_PropertyPlantAndEquipmentLineItems_1">Property, plant and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="label_PropertyPlantAndEquipmentLineItems_1" xlink:title="label_PropertyPlantAndEquipmentLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentNet" xml:lang="en-US" id="label_PropertyPlantAndEquipmentNet">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="label_PropertyPlantAndEquipmentNet" xlink:title="label_PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentNet_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PropertyPlantAndEquipmentNet_1" xml:lang="en-US" id="label_PropertyPlantAndEquipmentNet_1">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="label_PropertyPlantAndEquipmentNet_1" xlink:title="label_PropertyPlantAndEquipmentNet_1" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentNet_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_PropertyPlantAndEquipmentNet_2" xml:lang="en-US" id="label_PropertyPlantAndEquipmentNet_2">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="label_PropertyPlantAndEquipmentNet_2" xlink:title="label_PropertyPlantAndEquipmentNet_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentNetAbstract" xml:lang="en-US" id="label_PropertyPlantAndEquipmentNetAbstract">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="label_PropertyPlantAndEquipmentNetAbstract" xlink:title="label_PropertyPlantAndEquipmentNetAbstract" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentNetAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_PropertyPlantAndEquipmentNetAbstract_1" xml:lang="en-US" id="label_PropertyPlantAndEquipmentNetAbstract_1">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="label_PropertyPlantAndEquipmentNetAbstract_1" xlink:title="label_PropertyPlantAndEquipmentNetAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US" id="label_PropertyPlantAndEquipmentPolicyTextBlock">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="label_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="label_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PropertyPlantAndEquipmentPolicyTextBlock_1" xml:lang="en-US" id="label_PropertyPlantAndEquipmentPolicyTextBlock_1">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="label_PropertyPlantAndEquipmentPolicyTextBlock_1" xlink:title="label_PropertyPlantAndEquipmentPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US" id="label_PropertyPlantAndEquipmentTextBlock">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTextBlock" xlink:to="label_PropertyPlantAndEquipmentTextBlock" xlink:title="label_PropertyPlantAndEquipmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PropertyPlantAndEquipmentTextBlock_1" xml:lang="en-US" id="label_PropertyPlantAndEquipmentTextBlock_1">Summary of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTextBlock" xlink:to="label_PropertyPlantAndEquipmentTextBlock_1" xlink:title="label_PropertyPlantAndEquipmentTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US" id="label_PropertyPlantAndEquipmentTypeDomain">Property Plant And Equipment Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="label_PropertyPlantAndEquipmentTypeDomain" xlink:title="label_PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentTypeDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PropertyPlantAndEquipmentTypeDomain_1" xml:lang="en-US" id="label_PropertyPlantAndEquipmentTypeDomain_1">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="label_PropertyPlantAndEquipmentTypeDomain_1" xlink:title="label_PropertyPlantAndEquipmentTypeDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyDomain" xml:lang="en-US" id="label_RelatedPartyDomain">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyDomain" xlink:to="label_RelatedPartyDomain" xlink:title="label_RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyDomain_1" xml:lang="en-US" id="label_RelatedPartyDomain_1">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyDomain" xlink:to="label_RelatedPartyDomain_1" xlink:title="label_RelatedPartyDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="RelatedPartyTransactionLineItems" xlink:title="RelatedPartyTransactionLineItems" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionLineItems" xml:lang="en-US" id="label_RelatedPartyTransactionLineItems">Related Party Transaction [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionLineItems" xlink:to="label_RelatedPartyTransactionLineItems" xlink:title="label_RelatedPartyTransactionLineItems" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionLineItems_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionLineItems_1" xml:lang="en-US" id="label_RelatedPartyTransactionLineItems_1">Related Party Transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionLineItems" xlink:to="label_RelatedPartyTransactionLineItems_1" xlink:title="label_RelatedPartyTransactionLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="RelatedPartyTransactionsAbstract" xlink:title="RelatedPartyTransactionsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsAbstract" xml:lang="en-US" id="label_RelatedPartyTransactionsAbstract">Related Party Transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsAbstract" xlink:to="label_RelatedPartyTransactionsAbstract" xlink:title="label_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US" id="label_RelatedPartyTransactionsByRelatedPartyAxis">Related Party [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="label_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="label_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="RelatedPartyTransactionsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US" id="label_RelatedPartyTransactionsDisclosureTextBlock">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDisclosureTextBlock" xlink:to="label_RelatedPartyTransactionsDisclosureTextBlock" xlink:title="label_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionsDisclosureTextBlock_1" xml:lang="en-US" id="label_RelatedPartyTransactionsDisclosureTextBlock_1">Related Party Transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDisclosureTextBlock" xlink:to="label_RelatedPartyTransactionsDisclosureTextBlock_1" xlink:title="label_RelatedPartyTransactionsDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:label xlink:type="resource" xlink:label="label_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RepaymentsOfDebt" xml:lang="en-US" id="label_RepaymentsOfDebt">Repayments of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfDebt" xlink:to="label_RepaymentsOfDebt" xlink:title="label_RepaymentsOfDebt" />
    <link:label xlink:type="resource" xlink:label="label_RepaymentsOfDebt_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_RepaymentsOfDebt_1" xml:lang="en-US" id="label_RepaymentsOfDebt_1">Payments of the term loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfDebt" xlink:to="label_RepaymentsOfDebt_1" xlink:title="label_RepaymentsOfDebt_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="label_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ResearchAndDevelopmentExpense" xml:lang="en-US" id="label_ResearchAndDevelopmentExpense">Research and Development Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpense" xlink:to="label_ResearchAndDevelopmentExpense" xlink:title="label_ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="label_ResearchAndDevelopmentExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ResearchAndDevelopmentExpense_1" xml:lang="en-US" id="label_ResearchAndDevelopmentExpense_1">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpense" xlink:to="label_ResearchAndDevelopmentExpense_1" xlink:title="label_ResearchAndDevelopmentExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:label xlink:type="resource" xlink:label="label_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ResearchAndDevelopmentExpenseMember" xml:lang="en-US" id="label_ResearchAndDevelopmentExpenseMember">Research And Development Expense [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseMember" xlink:to="label_ResearchAndDevelopmentExpenseMember" xlink:title="label_ResearchAndDevelopmentExpenseMember" />
    <link:label xlink:type="resource" xlink:label="label_ResearchAndDevelopmentExpenseMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ResearchAndDevelopmentExpenseMember_1" xml:lang="en-US" id="label_ResearchAndDevelopmentExpenseMember_1">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseMember" xlink:to="label_ResearchAndDevelopmentExpenseMember_1" xlink:title="label_ResearchAndDevelopmentExpenseMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="ResearchAndDevelopmentExpensePolicy" xlink:title="ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="label_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US" id="label_ResearchAndDevelopmentExpensePolicy">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpensePolicy" xlink:to="label_ResearchAndDevelopmentExpensePolicy" xlink:title="label_ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="label_ResearchAndDevelopmentExpensePolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ResearchAndDevelopmentExpensePolicy_1" xml:lang="en-US" id="label_ResearchAndDevelopmentExpensePolicy_1">Research and Development Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpensePolicy" xlink:to="label_ResearchAndDevelopmentExpensePolicy_1" xlink:title="label_ResearchAndDevelopmentExpensePolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAbstract" xlink:label="RestrictedCashAbstract" xlink:title="RestrictedCashAbstract" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RestrictedCashAbstract" xml:lang="en-US" id="label_RestrictedCashAbstract">Restricted Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashAbstract" xlink:to="label_RestrictedCashAbstract" xlink:title="label_RestrictedCashAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:title="RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xml:lang="en-US" id="label_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember">Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="label_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:title="label_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" xml:lang="en-US" id="label_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1">Cash and Cash Equivalents [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="label_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" xlink:title="label_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="RestrictedCashCurrent" xlink:title="RestrictedCashCurrent" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RestrictedCashCurrent" xml:lang="en-US" id="label_RestrictedCashCurrent">Restricted Cash, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashCurrent" xlink:to="label_RestrictedCashCurrent" xlink:title="label_RestrictedCashCurrent" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RestrictedCashCurrent_1" xml:lang="en-US" id="label_RestrictedCashCurrent_1">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashCurrent" xlink:to="label_RestrictedCashCurrent_1" xlink:title="label_RestrictedCashCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RestrictedStockMember" xml:lang="en-US" id="label_RestrictedStockMember">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="label_RestrictedStockMember" xlink:title="label_RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedStockMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RestrictedStockMember_1" xml:lang="en-US" id="label_RestrictedStockMember_1">Restricted Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="label_RestrictedStockMember_1" xlink:title="label_RestrictedStockMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="label_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RetainedEarningsAccumulatedDeficit" xml:lang="en-US" id="label_RetainedEarningsAccumulatedDeficit">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="label_RetainedEarningsAccumulatedDeficit" xlink:title="label_RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="label_RetainedEarningsAccumulatedDeficit_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RetainedEarningsAccumulatedDeficit_1" xml:lang="en-US" id="label_RetainedEarningsAccumulatedDeficit_1">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="label_RetainedEarningsAccumulatedDeficit_1" xlink:title="label_RetainedEarningsAccumulatedDeficit_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="label_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RetainedEarningsMember" xml:lang="en-US" id="label_RetainedEarningsMember">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="label_RetainedEarningsMember" xlink:title="label_RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="label_RetainedEarningsMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RetainedEarningsMember_1" xml:lang="en-US" id="label_RetainedEarningsMember_1">Accumulated Deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="label_RetainedEarningsMember_1" xlink:title="label_RetainedEarningsMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:label xlink:type="resource" xlink:label="label_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RevenueFromContractWithCustomerAbstract" xml:lang="en-US" id="label_RevenueFromContractWithCustomerAbstract">Revenue from Contract with Customer [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="label_RevenueFromContractWithCustomerAbstract" xlink:title="label_RevenueFromContractWithCustomerAbstract" />
    <link:label xlink:type="resource" xlink:label="label_RevenueFromContractWithCustomerAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RevenueFromContractWithCustomerAbstract_1" xml:lang="en-US" id="label_RevenueFromContractWithCustomerAbstract_1">Revenue:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="label_RevenueFromContractWithCustomerAbstract_1" xlink:title="label_RevenueFromContractWithCustomerAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:label xlink:type="resource" xlink:label="label_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RevenueFromContractWithCustomerExcludingAssessedTax" xml:lang="en-US" id="label_RevenueFromContractWithCustomerExcludingAssessedTax">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="label_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="label_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:label xlink:type="resource" xlink:label="label_RevenueFromContractWithCustomerExcludingAssessedTax_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RevenueFromContractWithCustomerExcludingAssessedTax_1" xml:lang="en-US" id="label_RevenueFromContractWithCustomerExcludingAssessedTax_1">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="label_RevenueFromContractWithCustomerExcludingAssessedTax_1" xlink:title="label_RevenueFromContractWithCustomerExcludingAssessedTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RevenueFromContractWithCustomerPolicyTextBlock" xml:lang="en-US" id="label_RevenueFromContractWithCustomerPolicyTextBlock">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="label_RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="label_RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_RevenueFromContractWithCustomerPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RevenueFromContractWithCustomerPolicyTextBlock_1" xml:lang="en-US" id="label_RevenueFromContractWithCustomerPolicyTextBlock_1">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="label_RevenueFromContractWithCustomerPolicyTextBlock_1" xlink:title="label_RevenueFromContractWithCustomerPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:label xlink:type="resource" xlink:label="label_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SaleOfStockNameOfTransactionDomain" xml:lang="en-US" id="label_SaleOfStockNameOfTransactionDomain">Sale Of Stock Name Of Transaction [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="label_SaleOfStockNameOfTransactionDomain" xlink:title="label_SaleOfStockNameOfTransactionDomain" />
    <link:label xlink:type="resource" xlink:label="label_SaleOfStockNameOfTransactionDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SaleOfStockNameOfTransactionDomain_1" xml:lang="en-US" id="label_SaleOfStockNameOfTransactionDomain_1">Sale of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="label_SaleOfStockNameOfTransactionDomain_1" xlink:title="label_SaleOfStockNameOfTransactionDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfAccruedLiabilitiesTableTextBlock" xml:lang="en-US" id="label_ScheduleOfAccruedLiabilitiesTableTextBlock">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="label_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="label_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfAccruedLiabilitiesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfAccruedLiabilitiesTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfAccruedLiabilitiesTableTextBlock_1">Summary of accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="label_ScheduleOfAccruedLiabilitiesTableTextBlock_1" xlink:title="label_ScheduleOfAccruedLiabilitiesTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xml:lang="en-US" id="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US" id="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1" xml:lang="en-US" id="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1">Summary of shares excluded from the computation of diluted net loss per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1" xlink:title="label_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfAvailableForSaleSecuritiesLineItems" xml:lang="en-US" id="label_ScheduleOfAvailableForSaleSecuritiesLineItems">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="label_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="label_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfAvailableForSaleSecuritiesLineItems_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfAvailableForSaleSecuritiesLineItems_1" xml:lang="en-US" id="label_ScheduleOfAvailableForSaleSecuritiesLineItems_1">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="label_ScheduleOfAvailableForSaleSecuritiesLineItems_1" xlink:title="label_ScheduleOfAvailableForSaleSecuritiesLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xml:lang="en-US" id="label_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="label_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="label_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_1">Schedule of available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="label_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_1" xlink:title="label_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:title="ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xml:lang="en-US" id="label_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="label_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:title="label_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1">Summary of reconciliation cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="label_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1" xlink:title="label_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xml:lang="en-US" id="label_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="label_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="label_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US" id="label_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="label_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="label_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1">Summary of components of deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="label_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" xlink:title="label_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US" id="label_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="label_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="label_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1">Summary of computation of basic and diluted net loss per share attributable to common stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="label_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1" xlink:title="label_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US" id="label_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="label_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="label_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1">Summary of reconciliation of federal statutory income tax rate to the Company's effective income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="label_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" xlink:title="label_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xml:lang="en-US" id="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xml:lang="en-US" id="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1" xml:lang="en-US" id="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1">Summary of stock based compensation expense recorded</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1" xlink:title="label_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:title="ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xml:lang="en-US" id="label_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="label_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:title="label_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1">Schedule of future minimum payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="label_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1" xlink:title="label_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xml:lang="en-US" id="label_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="label_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="label_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1">Schedule of future maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="label_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1" xlink:title="label_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US" id="label_ScheduleOfPropertyPlantAndEquipmentTable">Property, Plant and Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="label_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="label_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US" id="label_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="label_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="label_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US" id="label_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="label_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="label_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US" id="label_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="label_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="label_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1">Summary of stock option activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="label_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" xlink:title="label_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US" id="label_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="label_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="label_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1">Summary of assumptions used in the Black Scholes option pricing model for stock options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="label_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xlink:title="label_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfStockByClassTable" xml:lang="en-US" id="label_ScheduleOfStockByClassTable">Schedule of Stock by Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockByClassTable" xlink:to="label_ScheduleOfStockByClassTable" xlink:title="label_ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SeriesAPreferredStockMember" xml:lang="en-US" id="label_SeriesAPreferredStockMember">Series A Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesAPreferredStockMember" xlink:to="label_SeriesAPreferredStockMember" xlink:title="label_SeriesAPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesAPreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SeriesAPreferredStockMember_1" xml:lang="en-US" id="label_SeriesAPreferredStockMember_1">Series A Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesAPreferredStockMember" xlink:to="label_SeriesAPreferredStockMember_1" xlink:title="label_SeriesAPreferredStockMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="SeriesBPreferredStockMember" xlink:title="SeriesBPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SeriesBPreferredStockMember" xml:lang="en-US" id="label_SeriesBPreferredStockMember">Series B Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesBPreferredStockMember" xlink:to="label_SeriesBPreferredStockMember" xlink:title="label_SeriesBPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesBPreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SeriesBPreferredStockMember_1" xml:lang="en-US" id="label_SeriesBPreferredStockMember_1">Series B Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesBPreferredStockMember" xlink:to="label_SeriesBPreferredStockMember_1" xlink:title="label_SeriesBPreferredStockMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensation" xml:lang="en-US" id="label_ShareBasedCompensation">Share-based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="label_ShareBasedCompensation" xlink:title="label_ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensation_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensation_1" xml:lang="en-US" id="label_ShareBasedCompensation_1">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="label_ShareBasedCompensation_1" xlink:title="label_ShareBasedCompensation_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1">Vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1">Assumptions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1">Expected term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1">Risk free interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_1">Expected volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1">Stock Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2">Restricted Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1">Total number of shares of common stock that may be issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1">Number of shares available for future issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1">Weighted Average Remaining Contractual Life (Years) And Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1">Aggregate intrinsic value of stock options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1">Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1">Weighted average grant date fair value per share of stock options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1">Outstanding at the end (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2">Outstanding at the beginning (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1">Outstanding at the end</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2">Outstanding at the beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1">Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1">Outstanding at the end (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2">Outstanding at the beginning (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1">Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1">Outstanding (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1">Exercisable at the end (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1">Exercisable at the end</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_1">Exercisable at the end (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_1" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_1">Exercisable at the end (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_1" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1">Vested and expected to vest at the end (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1">Vested and expected to vest at the end</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1">Vested and expected to vest at the end (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1">Vested and expected to vest at the end (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1">Aggregate grant date fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1">Number of shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US" id="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1">Equity Award [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1">Exercised (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1">Forfeitures (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xlink:title="label_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US" id="label_ShareBasedCompensationOptionAndIncentivePlansPolicy">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="label_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xml:lang="en-US" id="label_ShareBasedCompensationOptionAndIncentivePlansPolicy_1">Stock Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xlink:title="label_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:label xlink:type="resource" xlink:label="label_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SharePrice" xml:lang="en-US" id="label_SharePrice">Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePrice" xlink:to="label_SharePrice" xlink:title="label_SharePrice" />
    <link:label xlink:type="resource" xlink:label="label_SharePrice_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_SharePrice_1" xml:lang="en-US" id="label_SharePrice_1">Share price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePrice" xlink:to="label_SharePrice_1" xlink:title="label_SharePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_SharePrice_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SharePrice_2" xml:lang="en-US" id="label_SharePrice_2">Share price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePrice" xlink:to="label_SharePrice_2" xlink:title="label_SharePrice_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SignificantAccountingPoliciesTextBlock" xml:lang="en-US" id="label_SignificantAccountingPoliciesTextBlock">Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SignificantAccountingPoliciesTextBlock" xlink:to="label_SignificantAccountingPoliciesTextBlock" xlink:title="label_SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_SignificantAccountingPoliciesTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SignificantAccountingPoliciesTextBlock_1" xml:lang="en-US" id="label_SignificantAccountingPoliciesTextBlock_1">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SignificantAccountingPoliciesTextBlock" xlink:to="label_SignificantAccountingPoliciesTextBlock_1" xlink:title="label_SignificantAccountingPoliciesTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="label_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StatementClassOfStockAxis" xml:lang="en-US" id="label_StatementClassOfStockAxis">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="label_StatementClassOfStockAxis" xlink:title="label_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="label_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StatementEquityComponentsAxis" xml:lang="en-US" id="label_StatementEquityComponentsAxis">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="label_StatementEquityComponentsAxis" xlink:title="label_StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="label_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StatementLineItems" xml:lang="en-US" id="label_StatementLineItems">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="label_StatementLineItems" xlink:title="label_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StatementOfCashFlowsAbstract" xml:lang="en-US" id="label_StatementOfCashFlowsAbstract">CONDENSED STATEMENTS OF CASH FLOWS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="label_StatementOfCashFlowsAbstract" xlink:title="label_StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="label_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StatementOfFinancialPositionAbstract" xml:lang="en-US" id="label_StatementOfFinancialPositionAbstract">CONDENSED BALANCE SHEETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="label_StatementOfFinancialPositionAbstract" xlink:title="label_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StatementOfStockholdersEquityAbstract" xml:lang="en-US" id="label_StatementOfStockholdersEquityAbstract">CONDENSED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="label_StatementOfStockholdersEquityAbstract" xlink:title="label_StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="label_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StatementTable" xml:lang="en-US" id="label_StatementTable">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="label_StatementTable" xlink:title="label_StatementTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockholdersEquity" xml:lang="en-US" id="label_StockholdersEquity">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="label_StockholdersEquity" xlink:title="label_StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquity_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_StockholdersEquity_1" xml:lang="en-US" id="label_StockholdersEquity_1">Balance at the end</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="label_StockholdersEquity_1" xlink:title="label_StockholdersEquity_1" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquity_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_StockholdersEquity_2" xml:lang="en-US" id="label_StockholdersEquity_2">Balance at the beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="label_StockholdersEquity_2" xlink:title="label_StockholdersEquity_2" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquity_3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_StockholdersEquity_3" xml:lang="en-US" id="label_StockholdersEquity_3">Total stockholders' equity (deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="label_StockholdersEquity_3" xlink:title="label_StockholdersEquity_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockholdersEquityAbstract" xml:lang="en-US" id="label_StockholdersEquityAbstract">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="label_StockholdersEquityAbstract" xlink:title="label_StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_StockholdersEquityAbstract_1" xml:lang="en-US" id="label_StockholdersEquityAbstract_1">Stockholders' equity (deficit):</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="label_StockholdersEquityAbstract_1" xlink:title="label_StockholdersEquityAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:label="StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:title="StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xml:lang="en-US" id="label_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy">Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:to="label_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:title="label_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_1" xml:lang="en-US" id="label_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_1">Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:to="label_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_1" xlink:title="label_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockholdersEquityNoteStockSplitConversionRatio1" xml:lang="en-US" id="label_StockholdersEquityNoteStockSplitConversionRatio1">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="label_StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="label_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityNoteStockSplitConversionRatio1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_StockholdersEquityNoteStockSplitConversionRatio1_1" xml:lang="en-US" id="label_StockholdersEquityNoteStockSplitConversionRatio1_1">Reverse stock split ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="label_StockholdersEquityNoteStockSplitConversionRatio1_1" xlink:title="label_StockholdersEquityNoteStockSplitConversionRatio1_1" />
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityNoteStockSplitConversionRatio1_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_StockholdersEquityNoteStockSplitConversionRatio1_2" xml:lang="en-US" id="label_StockholdersEquityNoteStockSplitConversionRatio1_2">Reverse stock split ratio (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="label_StockholdersEquityNoteStockSplitConversionRatio1_2" xlink:title="label_StockholdersEquityNoteStockSplitConversionRatio1_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="StockIssuedDuringPeriodSharesConversionOfUnits" xlink:title="StockIssuedDuringPeriodSharesConversionOfUnits" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockIssuedDuringPeriodSharesConversionOfUnits" xml:lang="en-US" id="label_StockIssuedDuringPeriodSharesConversionOfUnits">Stock Issued During Period, Shares, Conversion of Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="label_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:title="label_StockIssuedDuringPeriodSharesConversionOfUnits" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodSharesConversionOfUnits_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_StockIssuedDuringPeriodSharesConversionOfUnits_1" xml:lang="en-US" id="label_StockIssuedDuringPeriodSharesConversionOfUnits_1">Conversion of preferred stock to common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="label_StockIssuedDuringPeriodSharesConversionOfUnits_1" xlink:title="label_StockIssuedDuringPeriodSharesConversionOfUnits_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US" id="label_StockIssuedDuringPeriodSharesNewIssues">Stock issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_StockIssuedDuringPeriodSharesNewIssues" xlink:title="label_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodSharesNewIssues_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockIssuedDuringPeriodSharesNewIssues_1" xml:lang="en-US" id="label_StockIssuedDuringPeriodSharesNewIssues_1">Stock Issued During Period, Shares, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_StockIssuedDuringPeriodSharesNewIssues_1" xlink:title="label_StockIssuedDuringPeriodSharesNewIssues_1" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodSharesNewIssues_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_StockIssuedDuringPeriodSharesNewIssues_2" xml:lang="en-US" id="label_StockIssuedDuringPeriodSharesNewIssues_2">Issuance of stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_StockIssuedDuringPeriodSharesNewIssues_2" xlink:title="label_StockIssuedDuringPeriodSharesNewIssues_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US" id="label_StockIssuedDuringPeriodSharesStockOptionsExercised">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="label_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xml:lang="en-US" id="label_StockIssuedDuringPeriodSharesStockOptionsExercised_1">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xlink:title="label_StockIssuedDuringPeriodSharesStockOptionsExercised_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="StockIssuedDuringPeriodValueConversionOfUnits" xlink:title="StockIssuedDuringPeriodValueConversionOfUnits" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockIssuedDuringPeriodValueConversionOfUnits" xml:lang="en-US" id="label_StockIssuedDuringPeriodValueConversionOfUnits">Stock Issued During Period, Value, Conversion of Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="label_StockIssuedDuringPeriodValueConversionOfUnits" xlink:title="label_StockIssuedDuringPeriodValueConversionOfUnits" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodValueConversionOfUnits_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_StockIssuedDuringPeriodValueConversionOfUnits_1" xml:lang="en-US" id="label_StockIssuedDuringPeriodValueConversionOfUnits_1">Conversion of preferred stock to common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="label_StockIssuedDuringPeriodValueConversionOfUnits_1" xlink:title="label_StockIssuedDuringPeriodValueConversionOfUnits_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US" id="label_StockIssuedDuringPeriodValueNewIssues">Stock Issued During Period, Value, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssues" xlink:to="label_StockIssuedDuringPeriodValueNewIssues" xlink:title="label_StockIssuedDuringPeriodValueNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodValueNewIssues_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_StockIssuedDuringPeriodValueNewIssues_1" xml:lang="en-US" id="label_StockIssuedDuringPeriodValueNewIssues_1">Issuance of stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssues" xlink:to="label_StockIssuedDuringPeriodValueNewIssues_1" xlink:title="label_StockIssuedDuringPeriodValueNewIssues_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SubsequentEventLineItems" xml:lang="en-US" id="label_SubsequentEventLineItems">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventLineItems" xlink:to="label_SubsequentEventLineItems" xlink:title="label_SubsequentEventLineItems" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventLineItems_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_SubsequentEventLineItems_1" xml:lang="en-US" id="label_SubsequentEventLineItems_1">Nature of the Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventLineItems" xlink:to="label_SubsequentEventLineItems_1" xlink:title="label_SubsequentEventLineItems_1" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventLineItems_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SubsequentEventLineItems_2" xml:lang="en-US" id="label_SubsequentEventLineItems_2">Subsequent Event</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventLineItems" xlink:to="label_SubsequentEventLineItems_2" xlink:title="label_SubsequentEventLineItems_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SubsequentEventMember" xml:lang="en-US" id="label_SubsequentEventMember">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="label_SubsequentEventMember" xlink:title="label_SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SubsequentEventMember_1" xml:lang="en-US" id="label_SubsequentEventMember_1">Subsequent Event</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="label_SubsequentEventMember_1" xlink:title="label_SubsequentEventMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SubsequentEventsAbstract" xml:lang="en-US" id="label_SubsequentEventsAbstract">Subsequent Events</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsAbstract" xlink:to="label_SubsequentEventsAbstract" xlink:title="label_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SubsequentEventsTextBlock" xml:lang="en-US" id="label_SubsequentEventsTextBlock">Subsequent Events [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="label_SubsequentEventsTextBlock" xlink:title="label_SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventsTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SubsequentEventsTextBlock_1" xml:lang="en-US" id="label_SubsequentEventsTextBlock_1">Subsequent Events</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="label_SubsequentEventsTextBlock_1" xlink:title="label_SubsequentEventsTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SubsequentEventTable" xml:lang="en-US" id="label_SubsequentEventTable">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTable" xlink:to="label_SubsequentEventTable" xlink:title="label_SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SubsequentEventTypeAxis" xml:lang="en-US" id="label_SubsequentEventTypeAxis">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="label_SubsequentEventTypeAxis" xlink:title="label_SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SubsequentEventTypeDomain" xml:lang="en-US" id="label_SubsequentEventTypeDomain">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="label_SubsequentEventTypeDomain" xlink:title="label_SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_SubsequentEventTypeDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SubsequentEventTypeDomain_1" xml:lang="en-US" id="label_SubsequentEventTypeDomain_1">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="label_SubsequentEventTypeDomain_1" xlink:title="label_SubsequentEventTypeDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="SubsidiarySaleOfStockAxis" xlink:title="SubsidiarySaleOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="label_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SubsidiarySaleOfStockAxis" xml:lang="en-US" id="label_SubsidiarySaleOfStockAxis">Sale of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="label_SubsidiarySaleOfStockAxis" xlink:title="label_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SupplementalCashFlowInformationAbstract" xml:lang="en-US" id="label_SupplementalCashFlowInformationAbstract">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="label_SupplementalCashFlowInformationAbstract" xlink:title="label_SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_SupplementalCashFlowInformationAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SupplementalCashFlowInformationAbstract_1" xml:lang="en-US" id="label_SupplementalCashFlowInformationAbstract_1">Supplemental disclosures of cash flow information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="label_SupplementalCashFlowInformationAbstract_1" xlink:title="label_SupplementalCashFlowInformationAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="TemporaryEquityCarryingAmountAttributableToParent" xlink:title="TemporaryEquityCarryingAmountAttributableToParent" />
    <link:label xlink:type="resource" xlink:label="label_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_TemporaryEquityCarryingAmountAttributableToParent" xml:lang="en-US" id="label_TemporaryEquityCarryingAmountAttributableToParent">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TemporaryEquityCarryingAmountAttributableToParent" xlink:to="label_TemporaryEquityCarryingAmountAttributableToParent" xlink:title="label_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:label xlink:type="resource" xlink:label="label_TemporaryEquityCarryingAmountAttributableToParent_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_TemporaryEquityCarryingAmountAttributableToParent_1" xml:lang="en-US" id="label_TemporaryEquityCarryingAmountAttributableToParent_1">Balance at the end</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TemporaryEquityCarryingAmountAttributableToParent" xlink:to="label_TemporaryEquityCarryingAmountAttributableToParent_1" xlink:title="label_TemporaryEquityCarryingAmountAttributableToParent_1" />
    <link:label xlink:type="resource" xlink:label="label_TemporaryEquityCarryingAmountAttributableToParent_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_TemporaryEquityCarryingAmountAttributableToParent_2" xml:lang="en-US" id="label_TemporaryEquityCarryingAmountAttributableToParent_2">Balance at the beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TemporaryEquityCarryingAmountAttributableToParent" xlink:to="label_TemporaryEquityCarryingAmountAttributableToParent_2" xlink:title="label_TemporaryEquityCarryingAmountAttributableToParent_2" />
    <link:label xlink:type="resource" xlink:label="label_TemporaryEquityCarryingAmountAttributableToParent_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_TemporaryEquityCarryingAmountAttributableToParent_3" xml:lang="en-US" id="label_TemporaryEquityCarryingAmountAttributableToParent_3">Total redeemable preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TemporaryEquityCarryingAmountAttributableToParent" xlink:to="label_TemporaryEquityCarryingAmountAttributableToParent_3" xlink:title="label_TemporaryEquityCarryingAmountAttributableToParent_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="TemporaryEquitySharesOutstanding" xlink:title="TemporaryEquitySharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_TemporaryEquitySharesOutstanding" xml:lang="en-US" id="label_TemporaryEquitySharesOutstanding">Temporary Equity, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TemporaryEquitySharesOutstanding" xlink:to="label_TemporaryEquitySharesOutstanding" xlink:title="label_TemporaryEquitySharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_TemporaryEquitySharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_TemporaryEquitySharesOutstanding_1" xml:lang="en-US" id="label_TemporaryEquitySharesOutstanding_1">Balance at the end (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TemporaryEquitySharesOutstanding" xlink:to="label_TemporaryEquitySharesOutstanding_1" xlink:title="label_TemporaryEquitySharesOutstanding_1" />
    <link:label xlink:type="resource" xlink:label="label_TemporaryEquitySharesOutstanding_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_TemporaryEquitySharesOutstanding_2" xml:lang="en-US" id="label_TemporaryEquitySharesOutstanding_2">Balance at the beginning (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TemporaryEquitySharesOutstanding" xlink:to="label_TemporaryEquitySharesOutstanding_2" xlink:title="label_TemporaryEquitySharesOutstanding_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:label xlink:type="resource" xlink:label="label_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xml:lang="en-US" id="label_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain">Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="label_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="label_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:label xlink:type="resource" xlink:label="label_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xml:lang="en-US" id="label_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1">Financial Instruments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="label_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" xlink:title="label_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:label xlink:type="resource" xlink:label="label_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_TypeOfArrangementAxis" xml:lang="en-US" id="label_TypeOfArrangementAxis">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfArrangementAxis" xlink:to="label_TypeOfArrangementAxis" xlink:title="label_TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRevenueExtensibleList" xlink:label="TypeOfRevenueExtensibleList" xlink:title="TypeOfRevenueExtensibleList" />
    <link:label xlink:type="resource" xlink:label="label_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_TypeOfRevenueExtensibleList" xml:lang="en-US" id="label_TypeOfRevenueExtensibleList">Type of Revenue [Extensible List]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfRevenueExtensibleList" xlink:to="label_TypeOfRevenueExtensibleList" xlink:title="label_TypeOfRevenueExtensibleList" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="UnrecognizedTaxBenefits" xlink:title="UnrecognizedTaxBenefits" />
    <link:label xlink:type="resource" xlink:label="label_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_UnrecognizedTaxBenefits" xml:lang="en-US" id="label_UnrecognizedTaxBenefits">Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefits" xlink:to="label_UnrecognizedTaxBenefits" xlink:title="label_UnrecognizedTaxBenefits" />
    <link:label xlink:type="resource" xlink:label="label_UnrecognizedTaxBenefits_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_UnrecognizedTaxBenefits_1" xml:lang="en-US" id="label_UnrecognizedTaxBenefits_1">Unrecognized income tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefits" xlink:to="label_UnrecognizedTaxBenefits_1" xlink:title="label_UnrecognizedTaxBenefits_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:label xlink:type="resource" xlink:label="label_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xml:lang="en-US" id="label_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="label_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="label_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:label xlink:type="resource" xlink:label="label_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_1" xml:lang="en-US" id="label_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_1">Uncertain income tax benefits, interest or penalties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="label_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_1" xlink:title="label_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="label_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_UseOfEstimates" xml:lang="en-US" id="label_UseOfEstimates">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="label_UseOfEstimates" xlink:title="label_UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="label_UseOfEstimates_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_UseOfEstimates_1" xml:lang="en-US" id="label_UseOfEstimates_1">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="label_UseOfEstimates_1" xlink:title="label_UseOfEstimates_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="USGovernmentAgenciesDebtSecuritiesMember" xlink:title="USGovernmentAgenciesDebtSecuritiesMember" />
    <link:label xlink:type="resource" xlink:label="label_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_USGovernmentAgenciesDebtSecuritiesMember" xml:lang="en-US" id="label_USGovernmentAgenciesDebtSecuritiesMember">U S Government Agencies Debt Securities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="USGovernmentAgenciesDebtSecuritiesMember" xlink:to="label_USGovernmentAgenciesDebtSecuritiesMember" xlink:title="label_USGovernmentAgenciesDebtSecuritiesMember" />
    <link:label xlink:type="resource" xlink:label="label_USGovernmentAgenciesDebtSecuritiesMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_USGovernmentAgenciesDebtSecuritiesMember_1" xml:lang="en-US" id="label_USGovernmentAgenciesDebtSecuritiesMember_1">Agency bonds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="USGovernmentAgenciesDebtSecuritiesMember" xlink:to="label_USGovernmentAgenciesDebtSecuritiesMember_1" xlink:title="label_USGovernmentAgenciesDebtSecuritiesMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="USTreasurySecuritiesMember" xlink:title="USTreasurySecuritiesMember" />
    <link:label xlink:type="resource" xlink:label="label_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_USTreasurySecuritiesMember" xml:lang="en-US" id="label_USTreasurySecuritiesMember">U S Treasury Securities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="USTreasurySecuritiesMember" xlink:to="label_USTreasurySecuritiesMember" xlink:title="label_USTreasurySecuritiesMember" />
    <link:label xlink:type="resource" xlink:label="label_USTreasurySecuritiesMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_USTreasurySecuritiesMember_1" xml:lang="en-US" id="label_USTreasurySecuritiesMember_1">U.S. treasury securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="USTreasurySecuritiesMember" xlink:to="label_USTreasurySecuritiesMember_1" xlink:title="label_USTreasurySecuritiesMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xlink:type="resource" xlink:label="label_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ValuationAllowanceDeferredTaxAssetChangeInAmount" xml:lang="en-US" id="label_ValuationAllowanceDeferredTaxAssetChangeInAmount">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="label_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="label_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xlink:type="resource" xlink:label="label_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" xml:lang="en-US" id="label_ValuationAllowanceDeferredTaxAssetChangeInAmount_1">Increase in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="label_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" xlink:title="label_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="VariableRateAxis" xlink:title="VariableRateAxis" />
    <link:label xlink:type="resource" xlink:label="label_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_VariableRateAxis" xml:lang="en-US" id="label_VariableRateAxis">Variable Rate [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateAxis" xlink:to="label_VariableRateAxis" xlink:title="label_VariableRateAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="VariableRateDomain" xlink:title="VariableRateDomain" />
    <link:label xlink:type="resource" xlink:label="label_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_VariableRateDomain" xml:lang="en-US" id="label_VariableRateDomain">Variable Rate [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateDomain" xlink:to="label_VariableRateDomain" xlink:title="label_VariableRateDomain" />
    <link:label xlink:type="resource" xlink:label="label_VariableRateDomain_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_VariableRateDomain_1" xml:lang="en-US" id="label_VariableRateDomain_1">Variable Rate [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateDomain" xlink:to="label_VariableRateDomain_1" xlink:title="label_VariableRateDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US" id="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">Weighted average common shares outstanding-basic and diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xml:lang="en-US" id="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xlink:title="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" />
    <link:label xlink:type="resource" xlink:label="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2" xml:lang="en-US" id="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2">Weighted average number of common shares -basic and diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2" xlink:title="label_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:label xlink:type="resource" xlink:label="label_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US" id="label_WeightedAverageNumberOfSharesOutstandingAbstract">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="label_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="label_WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:label xlink:type="resource" xlink:label="label_WeightedAverageNumberOfSharesOutstandingAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_WeightedAverageNumberOfSharesOutstandingAbstract_1" xml:lang="en-US" id="label_WeightedAverageNumberOfSharesOutstandingAbstract_1">Denominator:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="label_WeightedAverageNumberOfSharesOutstandingAbstract_1" xlink:title="label_WeightedAverageNumberOfSharesOutstandingAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_A2015OmnibusIncentivePlanMember" xlink:label="A2015OmnibusIncentivePlanMember" xlink:title="A2015OmnibusIncentivePlanMember" />
    <link:label xlink:type="resource" xlink:label="label_A2015OmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_A2015OmnibusIncentivePlanMember" xml:lang="en-US" id="label_A2015OmnibusIncentivePlanMember">2015 Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="A2015OmnibusIncentivePlanMember" xlink:to="label_A2015OmnibusIncentivePlanMember" xlink:title="label_A2015OmnibusIncentivePlanMember" />
    <link:label xlink:type="resource" xlink:label="label_A2015OmnibusIncentivePlanMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_A2015OmnibusIncentivePlanMember_1" xml:lang="en-US" id="label_A2015OmnibusIncentivePlanMember_1">A2015 Omnibus Incentive Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="A2015OmnibusIncentivePlanMember" xlink:to="label_A2015OmnibusIncentivePlanMember_1" xlink:title="label_A2015OmnibusIncentivePlanMember_1" />
    <link:label xlink:type="resource" xlink:label="label_A2015OmnibusIncentivePlanMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_A2015OmnibusIncentivePlanMember_2" xml:lang="en-US" id="label_A2015OmnibusIncentivePlanMember_2">Represents information pertaining to 2015 omnibus incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="A2015OmnibusIncentivePlanMember" xlink:to="label_A2015OmnibusIncentivePlanMember_2" xlink:title="label_A2015OmnibusIncentivePlanMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedClinicalTrialCostsCurrent" xlink:label="AccruedClinicalTrialCostsCurrent" xlink:title="AccruedClinicalTrialCostsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedClinicalTrialCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AccruedClinicalTrialCostsCurrent" xml:lang="en-US" id="label_AccruedClinicalTrialCostsCurrent">Accrued clinical trial costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedClinicalTrialCostsCurrent" xlink:to="label_AccruedClinicalTrialCostsCurrent" xlink:title="label_AccruedClinicalTrialCostsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedClinicalTrialCostsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccruedClinicalTrialCostsCurrent_1" xml:lang="en-US" id="label_AccruedClinicalTrialCostsCurrent_1">Accrued Clinical Trial Costs, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedClinicalTrialCostsCurrent" xlink:to="label_AccruedClinicalTrialCostsCurrent_1" xlink:title="label_AccruedClinicalTrialCostsCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_AccruedClinicalTrialCostsCurrent_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_AccruedClinicalTrialCostsCurrent_2" xml:lang="en-US" id="label_AccruedClinicalTrialCostsCurrent_2">Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical trial costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedClinicalTrialCostsCurrent" xlink:to="label_AccruedClinicalTrialCostsCurrent_2" xlink:title="label_AccruedClinicalTrialCostsCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedConstructionInProgressCurrent" xlink:label="AccruedConstructionInProgressCurrent" xlink:title="AccruedConstructionInProgressCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedConstructionInProgressCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AccruedConstructionInProgressCurrent" xml:lang="en-US" id="label_AccruedConstructionInProgressCurrent">Accrued construction in progress</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedConstructionInProgressCurrent" xlink:to="label_AccruedConstructionInProgressCurrent" xlink:title="label_AccruedConstructionInProgressCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedConstructionInProgressCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccruedConstructionInProgressCurrent_1" xml:lang="en-US" id="label_AccruedConstructionInProgressCurrent_1">Accrued Construction In Progress, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedConstructionInProgressCurrent" xlink:to="label_AccruedConstructionInProgressCurrent_1" xlink:title="label_AccruedConstructionInProgressCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_AccruedConstructionInProgressCurrent_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_AccruedConstructionInProgressCurrent_2" xml:lang="en-US" id="label_AccruedConstructionInProgressCurrent_2">Carrying value as of the balance sheet date of obligations incurred through that date and payable for construction in progress. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedConstructionInProgressCurrent" xlink:to="label_AccruedConstructionInProgressCurrent_2" xlink:title="label_AccruedConstructionInProgressCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedFinancingCostsCurrent" xlink:label="AccruedFinancingCostsCurrent" xlink:title="AccruedFinancingCostsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedFinancingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AccruedFinancingCostsCurrent" xml:lang="en-US" id="label_AccruedFinancingCostsCurrent">Accrued financing costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedFinancingCostsCurrent" xlink:to="label_AccruedFinancingCostsCurrent" xlink:title="label_AccruedFinancingCostsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedFinancingCostsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccruedFinancingCostsCurrent_1" xml:lang="en-US" id="label_AccruedFinancingCostsCurrent_1">Accrued Financing Costs, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedFinancingCostsCurrent" xlink:to="label_AccruedFinancingCostsCurrent_1" xlink:title="label_AccruedFinancingCostsCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_AccruedFinancingCostsCurrent_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_AccruedFinancingCostsCurrent_2" xml:lang="en-US" id="label_AccruedFinancingCostsCurrent_2">Carrying value as of the balance sheet date of obligations incurred through that date and payable for financing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedFinancingCostsCurrent" xlink:to="label_AccruedFinancingCostsCurrent_2" xlink:title="label_AccruedFinancingCostsCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedOperatingExpensesCurrent" xlink:label="AccruedOperatingExpensesCurrent" xlink:title="AccruedOperatingExpensesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedOperatingExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AccruedOperatingExpensesCurrent" xml:lang="en-US" id="label_AccruedOperatingExpensesCurrent">Accrued operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedOperatingExpensesCurrent" xlink:to="label_AccruedOperatingExpensesCurrent" xlink:title="label_AccruedOperatingExpensesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_AccruedOperatingExpensesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AccruedOperatingExpensesCurrent_1" xml:lang="en-US" id="label_AccruedOperatingExpensesCurrent_1">Accrued Operating Expenses, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedOperatingExpensesCurrent" xlink:to="label_AccruedOperatingExpensesCurrent_1" xlink:title="label_AccruedOperatingExpensesCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_AccruedOperatingExpensesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_AccruedOperatingExpensesCurrent_2" xml:lang="en-US" id="label_AccruedOperatingExpensesCurrent_2">Carrying value as of the balance sheet date of obligations incurred through that date and payable for operating expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedOperatingExpensesCurrent" xlink:to="label_AccruedOperatingExpensesCurrent_2" xlink:title="label_AccruedOperatingExpensesCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AnnualBaseRentPerMonth" xlink:label="AnnualBaseRentPerMonth" xlink:title="AnnualBaseRentPerMonth" />
    <link:label xlink:type="resource" xlink:label="label_AnnualBaseRentPerMonth" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AnnualBaseRentPerMonth" xml:lang="en-US" id="label_AnnualBaseRentPerMonth">Annual base rent per month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualBaseRentPerMonth" xlink:to="label_AnnualBaseRentPerMonth" xlink:title="label_AnnualBaseRentPerMonth" />
    <link:label xlink:type="resource" xlink:label="label_AnnualBaseRentPerMonth_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AnnualBaseRentPerMonth_1" xml:lang="en-US" id="label_AnnualBaseRentPerMonth_1">Annual Base Rent Per Month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualBaseRentPerMonth" xlink:to="label_AnnualBaseRentPerMonth_1" xlink:title="label_AnnualBaseRentPerMonth_1" />
    <link:label xlink:type="resource" xlink:label="label_AnnualBaseRentPerMonth_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_AnnualBaseRentPerMonth_2" xml:lang="en-US" id="label_AnnualBaseRentPerMonth_2">The amount of annual base rent per month.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualBaseRentPerMonth" xlink:to="label_AnnualBaseRentPerMonth_2" xlink:title="label_AnnualBaseRentPerMonth_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AnnualBaseRentPerMonthAfterAbatement" xlink:label="AnnualBaseRentPerMonthAfterAbatement" xlink:title="AnnualBaseRentPerMonthAfterAbatement" />
    <link:label xlink:type="resource" xlink:label="label_AnnualBaseRentPerMonthAfterAbatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_AnnualBaseRentPerMonthAfterAbatement" xml:lang="en-US" id="label_AnnualBaseRentPerMonthAfterAbatement">Annual base rent per month after abatement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualBaseRentPerMonthAfterAbatement" xlink:to="label_AnnualBaseRentPerMonthAfterAbatement" xlink:title="label_AnnualBaseRentPerMonthAfterAbatement" />
    <link:label xlink:type="resource" xlink:label="label_AnnualBaseRentPerMonthAfterAbatement_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AnnualBaseRentPerMonthAfterAbatement_1" xml:lang="en-US" id="label_AnnualBaseRentPerMonthAfterAbatement_1">Annual Base Rent Per Month After Abatement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualBaseRentPerMonthAfterAbatement" xlink:to="label_AnnualBaseRentPerMonthAfterAbatement_1" xlink:title="label_AnnualBaseRentPerMonthAfterAbatement_1" />
    <link:label xlink:type="resource" xlink:label="label_AnnualBaseRentPerMonthAfterAbatement_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_AnnualBaseRentPerMonthAfterAbatement_2" xml:lang="en-US" id="label_AnnualBaseRentPerMonthAfterAbatement_2">The amount of annual base rent per month after abatement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualBaseRentPerMonthAfterAbatement" xlink:to="label_AnnualBaseRentPerMonthAfterAbatement_2" xlink:title="label_AnnualBaseRentPerMonthAfterAbatement_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" xlink:label="BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" xlink:title="BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" />
    <link:label xlink:type="resource" xlink:label="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" xml:lang="en-US" id="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements">Base rate adjustment percentage per annum (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" xlink:to="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" xlink:title="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" />
    <link:label xlink:type="resource" xlink:label="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_1" xml:lang="en-US" id="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_1">Base Rate Adjustment Percentage Per Annum Multiplied By Outstanding Balance Of Amounts Paid For Tenant Improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" xlink:to="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_1" xlink:title="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_1" />
    <link:label xlink:type="resource" xlink:label="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_2" xml:lang="en-US" id="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_2">Represents the base rate adjustment percentage per annum multiplied by the outstanding balance of amounts paid for tenant improvements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" xlink:to="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_2" xlink:title="label_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborationAgreementTransactionPrice" xlink:label="CollaborationAgreementTransactionPrice" xlink:title="CollaborationAgreementTransactionPrice" />
    <link:label xlink:type="resource" xlink:label="label_CollaborationAgreementTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CollaborationAgreementTransactionPrice" xml:lang="en-US" id="label_CollaborationAgreementTransactionPrice">Transaction price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborationAgreementTransactionPrice" xlink:to="label_CollaborationAgreementTransactionPrice" xlink:title="label_CollaborationAgreementTransactionPrice" />
    <link:label xlink:type="resource" xlink:label="label_CollaborationAgreementTransactionPrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CollaborationAgreementTransactionPrice_1" xml:lang="en-US" id="label_CollaborationAgreementTransactionPrice_1">Collaboration Agreement, Transaction Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborationAgreementTransactionPrice" xlink:to="label_CollaborationAgreementTransactionPrice_1" xlink:title="label_CollaborationAgreementTransactionPrice_1" />
    <link:label xlink:type="resource" xlink:label="label_CollaborationAgreementTransactionPrice_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_CollaborationAgreementTransactionPrice_2" xml:lang="en-US" id="label_CollaborationAgreementTransactionPrice_2">The amount of transaction fees under the agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborationAgreementTransactionPrice" xlink:to="label_CollaborationAgreementTransactionPrice_2" xlink:title="label_CollaborationAgreementTransactionPrice_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementDisclosureAbstract" xlink:label="CollaborativeArrangementDisclosureAbstract" xlink:title="CollaborativeArrangementDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CollaborativeArrangementDisclosureAbstract" xml:lang="en-US" id="label_CollaborativeArrangementDisclosureAbstract">Agreement with Eli Lilly and Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementDisclosureAbstract" xlink:to="label_CollaborativeArrangementDisclosureAbstract" xlink:title="label_CollaborativeArrangementDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementDisclosureAbstract_1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_CollaborativeArrangementDisclosureAbstract_1" xml:lang="en-US" id="label_CollaborativeArrangementDisclosureAbstract_1">N/A</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementDisclosureAbstract" xlink:to="label_CollaborativeArrangementDisclosureAbstract_1" xlink:title="label_CollaborativeArrangementDisclosureAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:label="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:title="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xml:lang="en-US" id="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise">Maximum development and regulatory milestones and sales milestone payable upon option exercise</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:to="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_1" xml:lang="en-US" id="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_1">Collaborative Arrangement Maximum Development Regulatory and Sales Milestone Payable Upon Option Exercise</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:to="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_1" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_1" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_2" xml:lang="en-US" id="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_2">Represents the maximum amount of development and regulatory milestones and sales milestones payable upon option exercise.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:to="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_2" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:label="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:title="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xml:lang="en-US" id="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable">Maximum development and regulatory milestones and sales milestone receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:to="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_1" xml:lang="en-US" id="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_1">Collaborative Arrangement Maximum Development Regulatory and Sales Milestone Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:to="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_1" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_1" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_2" xml:lang="en-US" id="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_2">Represents the maximum amount of development and regulatory milestones and sales milestones receivable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:to="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_2" xlink:title="label_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:label="CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:title="CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xml:lang="en-US" id="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement">Period of expiry from date of agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:to="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:title="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_1" xml:lang="en-US" id="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_1">Collaborative Arrangement Period of Expiry from Date of Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:to="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_1" xlink:title="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_1" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_2" xml:lang="en-US" id="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_2">Represents the period of expiry from date of agreement under collaborative arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:to="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_2" xlink:title="label_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:label="CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:title="CollaborativeArrangementUpfrontNonRefundablePaymentReceived" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xml:lang="en-US" id="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived">Upfront non-refundable payment received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:to="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:title="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_1" xml:lang="en-US" id="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_1">Collaborative Arrangement Upfront Non-refundable Payment Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:to="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_1" xlink:title="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_1" />
    <link:label xlink:type="resource" xlink:label="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_2" xml:lang="en-US" id="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_2">Represents the amount of upfront non-refundable payment received under collaborative arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:to="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_2" xlink:title="label_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CommonStockTextBlock" xlink:label="CommonStockTextBlock" xlink:title="CommonStockTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommonStockTextBlock" xml:lang="en-US" id="label_CommonStockTextBlock">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockTextBlock" xlink:to="label_CommonStockTextBlock" xlink:title="label_CommonStockTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockTextBlock_1" xml:lang="en-US" id="label_CommonStockTextBlock_1">Common Stock [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockTextBlock" xlink:to="label_CommonStockTextBlock_1" xlink:title="label_CommonStockTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_CommonStockTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_CommonStockTextBlock_2" xml:lang="en-US" id="label_CommonStockTextBlock_2">The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockTextBlock" xlink:to="label_CommonStockTextBlock_2" xlink:title="label_CommonStockTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ConsultingAgreementMember" xlink:label="ConsultingAgreementMember" xlink:title="ConsultingAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ConsultingAgreementMember" xml:lang="en-US" id="label_ConsultingAgreementMember">Consulting Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsultingAgreementMember" xlink:to="label_ConsultingAgreementMember" xlink:title="label_ConsultingAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ConsultingAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ConsultingAgreementMember_1" xml:lang="en-US" id="label_ConsultingAgreementMember_1">Consulting Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsultingAgreementMember" xlink:to="label_ConsultingAgreementMember_1" xlink:title="label_ConsultingAgreementMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ConsultingAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ConsultingAgreementMember_2" xml:lang="en-US" id="label_ConsultingAgreementMember_2">Represents information pertaining to consulting agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsultingAgreementMember" xlink:to="label_ConsultingAgreementMember_2" xlink:title="label_ConsultingAgreementMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DebtInstrumentMonthlyPaymentsNumber" xlink:label="DebtInstrumentMonthlyPaymentsNumber" xlink:title="DebtInstrumentMonthlyPaymentsNumber" />
    <link:label xlink:type="resource" xlink:label="label_DebtInstrumentMonthlyPaymentsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DebtInstrumentMonthlyPaymentsNumber" xml:lang="en-US" id="label_DebtInstrumentMonthlyPaymentsNumber">Number of equal monthly payments of principal plus accrued interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMonthlyPaymentsNumber" xlink:to="label_DebtInstrumentMonthlyPaymentsNumber" xlink:title="label_DebtInstrumentMonthlyPaymentsNumber" />
    <link:label xlink:type="resource" xlink:label="label_DebtInstrumentMonthlyPaymentsNumber_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DebtInstrumentMonthlyPaymentsNumber_1" xml:lang="en-US" id="label_DebtInstrumentMonthlyPaymentsNumber_1">Debt Instrument, Monthly Payments, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMonthlyPaymentsNumber" xlink:to="label_DebtInstrumentMonthlyPaymentsNumber_1" xlink:title="label_DebtInstrumentMonthlyPaymentsNumber_1" />
    <link:label xlink:type="resource" xlink:label="label_DebtInstrumentMonthlyPaymentsNumber_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_DebtInstrumentMonthlyPaymentsNumber_2" xml:lang="en-US" id="label_DebtInstrumentMonthlyPaymentsNumber_2">Number of periodic payments of principal plus accrued interest (monthly, quarterly, annual).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMonthlyPaymentsNumber" xlink:to="label_DebtInstrumentMonthlyPaymentsNumber_2" xlink:title="label_DebtInstrumentMonthlyPaymentsNumber_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" xlink:label="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" xlink:title="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" xml:lang="en-US" id="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal">Federal research and development tax credit carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" xlink:to="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_1" xml:lang="en-US" id="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_1">Deferred Tax Assets, Tax Credit Carryforwards, Research And Development, Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" xlink:to="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_1" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_1" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_2" xml:lang="en-US" id="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_2">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic research and development tax credit carryforwards.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" xlink:to="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_2" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" xlink:label="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" xlink:title="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" xml:lang="en-US" id="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState">State research and development tax credit carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" xlink:to="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_1" xml:lang="en-US" id="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_1">Deferred Tax Assets, Tax Credit Carryforwards, Research And Development, State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" xlink:to="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_1" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_1" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_2" xml:lang="en-US" id="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_2">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state research and development tax credit carryforwards.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" xlink:to="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_2" xlink:title="label_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:label="DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:title="DeferredTaxLiabilitiesDepreciationAndAmortization" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_DeferredTaxLiabilitiesDepreciationAndAmortization" xml:lang="en-US" id="label_DeferredTaxLiabilitiesDepreciationAndAmortization">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="label_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:title="label_DeferredTaxLiabilitiesDepreciationAndAmortization" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxLiabilitiesDepreciationAndAmortization_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DeferredTaxLiabilitiesDepreciationAndAmortization_1" xml:lang="en-US" id="label_DeferredTaxLiabilitiesDepreciationAndAmortization_1">Deferred Tax Liabilities, Depreciation and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="label_DeferredTaxLiabilitiesDepreciationAndAmortization_1" xlink:title="label_DeferredTaxLiabilitiesDepreciationAndAmortization_1" />
    <link:label xlink:type="resource" xlink:label="label_DeferredTaxLiabilitiesDepreciationAndAmortization_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_DeferredTaxLiabilitiesDepreciationAndAmortization_2" xml:lang="en-US" id="label_DeferredTaxLiabilitiesDepreciationAndAmortization_2">Amount of deferred tax consequences attributable to taxable temporary differences derived from depreciation and amortization.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="label_DeferredTaxLiabilitiesDepreciationAndAmortization_2" xlink:title="label_DeferredTaxLiabilitiesDepreciationAndAmortization_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:label="DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:title="DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xml:lang="en-US" id="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock">Recently Issued Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:to="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:title="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_1" xml:lang="en-US" id="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_1">Description of New Accounting Pronouncements Not yet Adopted [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:to="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_1" xlink:title="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_2" xml:lang="en-US" id="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_2">Disclosure of accounting policy pertaining to new accounting pronouncement that has been issued but not yet adopted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:to="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_2" xlink:title="label_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:label="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:title="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent">Tax rate reduction due to the Tax Act</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:to="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:title="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_1" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_1">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:to="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_1" xlink:title="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_1" />
    <link:label xlink:type="resource" xlink:label="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_2" xml:lang="en-US" id="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_2">Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) in income tax rate and transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:to="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_2" xlink:title="label_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EliLillyAndCompanyMember" xlink:label="EliLillyAndCompanyMember" xlink:title="EliLillyAndCompanyMember" />
    <link:label xlink:type="resource" xlink:label="label_EliLillyAndCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EliLillyAndCompanyMember" xml:lang="en-US" id="label_EliLillyAndCompanyMember">Lilly</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EliLillyAndCompanyMember" xlink:to="label_EliLillyAndCompanyMember" xlink:title="label_EliLillyAndCompanyMember" />
    <link:label xlink:type="resource" xlink:label="label_EliLillyAndCompanyMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EliLillyAndCompanyMember_1" xml:lang="en-US" id="label_EliLillyAndCompanyMember_1">Eli Lilly And Company [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EliLillyAndCompanyMember" xlink:to="label_EliLillyAndCompanyMember_1" xlink:title="label_EliLillyAndCompanyMember_1" />
    <link:label xlink:type="resource" xlink:label="label_EliLillyAndCompanyMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_EliLillyAndCompanyMember_2" xml:lang="en-US" id="label_EliLillyAndCompanyMember_2">Represents information pertaining to Eli Lilly and Company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EliLillyAndCompanyMember" xlink:to="label_EliLillyAndCompanyMember_2" xlink:title="label_EliLillyAndCompanyMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EmployeeStockPurchase2019PlanMember" xlink:label="EmployeeStockPurchase2019PlanMember" xlink:title="EmployeeStockPurchase2019PlanMember" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeStockPurchase2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_EmployeeStockPurchase2019PlanMember" xml:lang="en-US" id="label_EmployeeStockPurchase2019PlanMember">2019 Employee Stock Purchase Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchase2019PlanMember" xlink:to="label_EmployeeStockPurchase2019PlanMember" xlink:title="label_EmployeeStockPurchase2019PlanMember" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeStockPurchase2019PlanMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EmployeeStockPurchase2019PlanMember_1" xml:lang="en-US" id="label_EmployeeStockPurchase2019PlanMember_1">Employee Stock Purchase2019 Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchase2019PlanMember" xlink:to="label_EmployeeStockPurchase2019PlanMember_1" xlink:title="label_EmployeeStockPurchase2019PlanMember_1" />
    <link:label xlink:type="resource" xlink:label="label_EmployeeStockPurchase2019PlanMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_EmployeeStockPurchase2019PlanMember_2" xml:lang="en-US" id="label_EmployeeStockPurchase2019PlanMember_2">Represents information pertaining to 2019 Employee Stock Purchase Plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchase2019PlanMember" xlink:to="label_EmployeeStockPurchase2019PlanMember_2" xlink:title="label_EmployeeStockPurchase2019PlanMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:label="IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:title="IncreaseDecreaseInDeferredRevenueFromRelatedParty" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty" xml:lang="en-US" id="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:to="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:title="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_1" xml:lang="en-US" id="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_1">Increase (Decrease) in Deferred Revenue From Related Party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:to="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_1" xlink:title="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_1" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_2" xml:lang="en-US" id="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_2">Deferred revenue from related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:to="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_2" xlink:title="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_2" />
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_3" xml:lang="en-US" id="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_3">Amount of increase (decrease) in deferred income from related party and obligation to transfer product and service to customer for which consideration has been received or is receivable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:to="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_3" xlink:title="label_IncreaseDecreaseInDeferredRevenueFromRelatedParty_3" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_LetterOfCredit" xlink:label="LetterOfCredit" xlink:title="LetterOfCredit" />
    <link:label xlink:type="resource" xlink:label="label_LetterOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_LetterOfCredit" xml:lang="en-US" id="label_LetterOfCredit">Executed letter of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LetterOfCredit" xlink:to="label_LetterOfCredit" xlink:title="label_LetterOfCredit" />
    <link:label xlink:type="resource" xlink:label="label_LetterOfCredit_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LetterOfCredit_1" xml:lang="en-US" id="label_LetterOfCredit_1">Letter Of Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LetterOfCredit" xlink:to="label_LetterOfCredit_1" xlink:title="label_LetterOfCredit_1" />
    <link:label xlink:type="resource" xlink:label="label_LetterOfCredit_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_LetterOfCredit_2" xml:lang="en-US" id="label_LetterOfCredit_2">The carrying value as of the balance sheet date of the current and noncurrent portions of letters of credit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LetterOfCredit" xlink:to="label_LetterOfCredit_2" xlink:title="label_LetterOfCredit_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_MarketableSecuritiesAndCashEquivalents" xlink:label="MarketableSecuritiesAndCashEquivalents" xlink:title="MarketableSecuritiesAndCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="label_MarketableSecuritiesAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_MarketableSecuritiesAndCashEquivalents" xml:lang="en-US" id="label_MarketableSecuritiesAndCashEquivalents">Total financial assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesAndCashEquivalents" xlink:to="label_MarketableSecuritiesAndCashEquivalents" xlink:title="label_MarketableSecuritiesAndCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="label_MarketableSecuritiesAndCashEquivalents_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_MarketableSecuritiesAndCashEquivalents_1" xml:lang="en-US" id="label_MarketableSecuritiesAndCashEquivalents_1">Marketable Securities And Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesAndCashEquivalents" xlink:to="label_MarketableSecuritiesAndCashEquivalents_1" xlink:title="label_MarketableSecuritiesAndCashEquivalents_1" />
    <link:label xlink:type="resource" xlink:label="label_MarketableSecuritiesAndCashEquivalents_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_MarketableSecuritiesAndCashEquivalents_2" xml:lang="en-US" id="label_MarketableSecuritiesAndCashEquivalents_2">1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesAndCashEquivalents" xlink:to="label_MarketableSecuritiesAndCashEquivalents_2" xlink:title="label_MarketableSecuritiesAndCashEquivalents_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" xlink:label="MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" xlink:title="MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" />
    <link:label xlink:type="resource" xlink:label="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" xml:lang="en-US" id="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare">Minimum exercise price per share as a percent of fair market value of a share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" xlink:to="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" xlink:title="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" />
    <link:label xlink:type="resource" xlink:label="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_1" xml:lang="en-US" id="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_1">Minimum Exercise Price Per Share as Percent of Fair Market Value of Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" xlink:to="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_1" xlink:title="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_1" />
    <link:label xlink:type="resource" xlink:label="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_2" xml:lang="en-US" id="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_2">Represents the minimum exercise price per share as a percent of fair market value of a share.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" xlink:to="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_2" xlink:title="label_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" xlink:label="MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" xlink:title="MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" />
    <link:label xlink:type="resource" xlink:label="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" xml:lang="en-US" id="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock">Minimum gross proceeds for mandatorily convertible preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" xlink:to="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" xlink:title="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" />
    <link:label xlink:type="resource" xlink:label="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_1" xml:lang="en-US" id="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_1">Minimum Gross Proceeds for Mandatorily Redeemable Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" xlink:to="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_1" xlink:title="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_1" />
    <link:label xlink:type="resource" xlink:label="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_2" xml:lang="en-US" id="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_2">Represents the amount of minimum gross proceeds for mandatorily convertible preferred stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" xlink:to="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_2" xlink:title="label_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" xlink:label="NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" xlink:title="NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" xml:lang="en-US" id="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock">Conversion of convertible preferred stock into common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" xlink:to="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" xlink:title="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_1" xml:lang="en-US" id="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_1">Noncash Or Part Noncash Conversion of Convertible Preferred Stock Into Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" xlink:to="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_1" xlink:title="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_1" />
    <link:label xlink:type="resource" xlink:label="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_2" xml:lang="en-US" id="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_2">Represents the noncash conversion of convertible preferred stock into common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" xlink:to="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_2" xlink:title="label_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect" xlink:label="NumberOfDirectorsStockHoldersAreEntitledToElect" xlink:title="NumberOfDirectorsStockHoldersAreEntitledToElect" />
    <link:label xlink:type="resource" xlink:label="label_NumberOfDirectorsStockHoldersAreEntitledToElect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NumberOfDirectorsStockHoldersAreEntitledToElect" xml:lang="en-US" id="label_NumberOfDirectorsStockHoldersAreEntitledToElect">Number of directors, stock holders are entitled to elect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfDirectorsStockHoldersAreEntitledToElect" xlink:to="label_NumberOfDirectorsStockHoldersAreEntitledToElect" xlink:title="label_NumberOfDirectorsStockHoldersAreEntitledToElect" />
    <link:label xlink:type="resource" xlink:label="label_NumberOfDirectorsStockHoldersAreEntitledToElect_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NumberOfDirectorsStockHoldersAreEntitledToElect_1" xml:lang="en-US" id="label_NumberOfDirectorsStockHoldersAreEntitledToElect_1">Number of Directors, Stock Holders are Entitled to Elect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfDirectorsStockHoldersAreEntitledToElect" xlink:to="label_NumberOfDirectorsStockHoldersAreEntitledToElect_1" xlink:title="label_NumberOfDirectorsStockHoldersAreEntitledToElect_1" />
    <link:label xlink:type="resource" xlink:label="label_NumberOfDirectorsStockHoldersAreEntitledToElect_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_NumberOfDirectorsStockHoldersAreEntitledToElect_2" xml:lang="en-US" id="label_NumberOfDirectorsStockHoldersAreEntitledToElect_2">Represents the number of directors, stock holders are entitled to elect.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfDirectorsStockHoldersAreEntitledToElect" xlink:to="label_NumberOfDirectorsStockHoldersAreEntitledToElect_2" xlink:title="label_NumberOfDirectorsStockHoldersAreEntitledToElect_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_NumberOfVotesPerShare" xlink:label="NumberOfVotesPerShare" xlink:title="NumberOfVotesPerShare" />
    <link:label xlink:type="resource" xlink:label="label_NumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_NumberOfVotesPerShare" xml:lang="en-US" id="label_NumberOfVotesPerShare">Number of votes per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfVotesPerShare" xlink:to="label_NumberOfVotesPerShare" xlink:title="label_NumberOfVotesPerShare" />
    <link:label xlink:type="resource" xlink:label="label_NumberOfVotesPerShare_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NumberOfVotesPerShare_1" xml:lang="en-US" id="label_NumberOfVotesPerShare_1">Number Of Votes Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfVotesPerShare" xlink:to="label_NumberOfVotesPerShare_1" xlink:title="label_NumberOfVotesPerShare_1" />
    <link:label xlink:type="resource" xlink:label="label_NumberOfVotesPerShare_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_NumberOfVotesPerShare_2" xml:lang="en-US" id="label_NumberOfVotesPerShare_2">Represents the number of votes per share.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfVotesPerShare" xlink:to="label_NumberOfVotesPerShare_2" xlink:title="label_NumberOfVotesPerShare_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" xlink:label="OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" xlink:title="OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" />
    <link:label xlink:type="resource" xlink:label="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" xml:lang="en-US" id="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember">2015 Plan and 2019 Employee Stock Purchase Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" xlink:to="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" xlink:title="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" />
    <link:label xlink:type="resource" xlink:label="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_1" xml:lang="en-US" id="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_1">Omnibus Incentive2015 Plan And Employee Stock Purchase2019 Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" xlink:to="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_1" xlink:title="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_1" />
    <link:label xlink:type="resource" xlink:label="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_2" xml:lang="en-US" id="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_2">Represents information pertaining to 2015 omnibus incentive plan and the information pertaining to 2019 Employee Stock Purchase Plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" xlink:to="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_2" xlink:title="label_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_OmnibusIncentive2019PlanMember" xlink:label="OmnibusIncentive2019PlanMember" xlink:title="OmnibusIncentive2019PlanMember" />
    <link:label xlink:type="resource" xlink:label="label_OmnibusIncentive2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_OmnibusIncentive2019PlanMember" xml:lang="en-US" id="label_OmnibusIncentive2019PlanMember">Omnibus Incentive Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OmnibusIncentive2019PlanMember" xlink:to="label_OmnibusIncentive2019PlanMember" xlink:title="label_OmnibusIncentive2019PlanMember" />
    <link:label xlink:type="resource" xlink:label="label_OmnibusIncentive2019PlanMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OmnibusIncentive2019PlanMember_1" xml:lang="en-US" id="label_OmnibusIncentive2019PlanMember_1">Omnibus Incentive2019 Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OmnibusIncentive2019PlanMember" xlink:to="label_OmnibusIncentive2019PlanMember_1" xlink:title="label_OmnibusIncentive2019PlanMember_1" />
    <link:label xlink:type="resource" xlink:label="label_OmnibusIncentive2019PlanMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_OmnibusIncentive2019PlanMember_2" xml:lang="en-US" id="label_OmnibusIncentive2019PlanMember_2">Represents information pertaining to Omnibus Incentive 2019 Plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OmnibusIncentive2019PlanMember" xlink:to="label_OmnibusIncentive2019PlanMember_2" xlink:title="label_OmnibusIncentive2019PlanMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:label="PaymentsOfUnderwritingDiscountsAndCommissions" xlink:title="PaymentsOfUnderwritingDiscountsAndCommissions" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PaymentsOfUnderwritingDiscountsAndCommissions" xml:lang="en-US" id="label_PaymentsOfUnderwritingDiscountsAndCommissions">Underwriting discounts and commissions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfUnderwritingDiscountsAndCommissions" xlink:to="label_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:title="label_PaymentsOfUnderwritingDiscountsAndCommissions" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsOfUnderwritingDiscountsAndCommissions_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PaymentsOfUnderwritingDiscountsAndCommissions_1" xml:lang="en-US" id="label_PaymentsOfUnderwritingDiscountsAndCommissions_1">Payments Of Underwriting Discounts And Commissions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfUnderwritingDiscountsAndCommissions" xlink:to="label_PaymentsOfUnderwritingDiscountsAndCommissions_1" xlink:title="label_PaymentsOfUnderwritingDiscountsAndCommissions_1" />
    <link:label xlink:type="resource" xlink:label="label_PaymentsOfUnderwritingDiscountsAndCommissions_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_PaymentsOfUnderwritingDiscountsAndCommissions_2" xml:lang="en-US" id="label_PaymentsOfUnderwritingDiscountsAndCommissions_2">The cash outflow for payment of underwriting discounts and commissions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfUnderwritingDiscountsAndCommissions" xlink:to="label_PaymentsOfUnderwritingDiscountsAndCommissions_2" xlink:title="label_PaymentsOfUnderwritingDiscountsAndCommissions_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PercentageOfAnnualIncreaseInLeaseRent" xlink:label="PercentageOfAnnualIncreaseInLeaseRent" xlink:title="PercentageOfAnnualIncreaseInLeaseRent" />
    <link:label xlink:type="resource" xlink:label="label_PercentageOfAnnualIncreaseInLeaseRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PercentageOfAnnualIncreaseInLeaseRent" xml:lang="en-US" id="label_PercentageOfAnnualIncreaseInLeaseRent">Percentage of annual increase in lease rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAnnualIncreaseInLeaseRent" xlink:to="label_PercentageOfAnnualIncreaseInLeaseRent" xlink:title="label_PercentageOfAnnualIncreaseInLeaseRent" />
    <link:label xlink:type="resource" xlink:label="label_PercentageOfAnnualIncreaseInLeaseRent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PercentageOfAnnualIncreaseInLeaseRent_1" xml:lang="en-US" id="label_PercentageOfAnnualIncreaseInLeaseRent_1">Percentage Of Annual Increase In Lease Rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAnnualIncreaseInLeaseRent" xlink:to="label_PercentageOfAnnualIncreaseInLeaseRent_1" xlink:title="label_PercentageOfAnnualIncreaseInLeaseRent_1" />
    <link:label xlink:type="resource" xlink:label="label_PercentageOfAnnualIncreaseInLeaseRent_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_PercentageOfAnnualIncreaseInLeaseRent_2" xml:lang="en-US" id="label_PercentageOfAnnualIncreaseInLeaseRent_2">The percentage of annual increase in operating lease rent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAnnualIncreaseInLeaseRent" xlink:to="label_PercentageOfAnnualIncreaseInLeaseRent_2" xlink:title="label_PercentageOfAnnualIncreaseInLeaseRent_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PeriodForWhichBaseRentIsAbated" xlink:label="PeriodForWhichBaseRentIsAbated" xlink:title="PeriodForWhichBaseRentIsAbated" />
    <link:label xlink:type="resource" xlink:label="label_PeriodForWhichBaseRentIsAbated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PeriodForWhichBaseRentIsAbated" xml:lang="en-US" id="label_PeriodForWhichBaseRentIsAbated">Period for which base rent is abated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodForWhichBaseRentIsAbated" xlink:to="label_PeriodForWhichBaseRentIsAbated" xlink:title="label_PeriodForWhichBaseRentIsAbated" />
    <link:label xlink:type="resource" xlink:label="label_PeriodForWhichBaseRentIsAbated_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PeriodForWhichBaseRentIsAbated_1" xml:lang="en-US" id="label_PeriodForWhichBaseRentIsAbated_1">Period For Which Base Rent Is Abated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodForWhichBaseRentIsAbated" xlink:to="label_PeriodForWhichBaseRentIsAbated_1" xlink:title="label_PeriodForWhichBaseRentIsAbated_1" />
    <link:label xlink:type="resource" xlink:label="label_PeriodForWhichBaseRentIsAbated_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_PeriodForWhichBaseRentIsAbated_2" xml:lang="en-US" id="label_PeriodForWhichBaseRentIsAbated_2">Period for which the base rent is abated.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodForWhichBaseRentIsAbated" xlink:to="label_PeriodForWhichBaseRentIsAbated_2" xlink:title="label_PeriodForWhichBaseRentIsAbated_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PreferredStockAbstract" xlink:label="PreferredStockAbstract" xlink:title="PreferredStockAbstract" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockAbstract" xml:lang="en-US" id="label_PreferredStockAbstract">Redeemable preferred stock:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockAbstract" xlink:to="label_PreferredStockAbstract" xlink:title="label_PreferredStockAbstract" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockAbstract_1" xml:lang="en-US" id="label_PreferredStockAbstract_1">Preferred Stock Abstract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockAbstract" xlink:to="label_PreferredStockAbstract_1" xlink:title="label_PreferredStockAbstract_1" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockAbstract_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_PreferredStockAbstract_2" xml:lang="en-US" id="label_PreferredStockAbstract_2">Not available.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockAbstract" xlink:to="label_PreferredStockAbstract_2" xlink:title="label_PreferredStockAbstract_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PreferredStockConvertibleConversionRatio" xlink:label="PreferredStockConvertibleConversionRatio" xlink:title="PreferredStockConvertibleConversionRatio" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PreferredStockConvertibleConversionRatio" xml:lang="en-US" id="label_PreferredStockConvertibleConversionRatio">Conversion ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockConvertibleConversionRatio" xlink:to="label_PreferredStockConvertibleConversionRatio" xlink:title="label_PreferredStockConvertibleConversionRatio" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockConvertibleConversionRatio_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PreferredStockConvertibleConversionRatio_1" xml:lang="en-US" id="label_PreferredStockConvertibleConversionRatio_1">Preferred Stock, Convertible, Conversion Ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockConvertibleConversionRatio" xlink:to="label_PreferredStockConvertibleConversionRatio_1" xlink:title="label_PreferredStockConvertibleConversionRatio_1" />
    <link:label xlink:type="resource" xlink:label="label_PreferredStockConvertibleConversionRatio_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_PreferredStockConvertibleConversionRatio_2" xml:lang="en-US" id="label_PreferredStockConvertibleConversionRatio_2">Ratio applied to the conversion of preferred stock into equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockConvertibleConversionRatio" xlink:to="label_PreferredStockConvertibleConversionRatio_2" xlink:title="label_PreferredStockConvertibleConversionRatio_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PremiumFromIssuanceOfPreferredStock" xlink:label="PremiumFromIssuanceOfPreferredStock" xlink:title="PremiumFromIssuanceOfPreferredStock" />
    <link:label xlink:type="resource" xlink:label="label_PremiumFromIssuanceOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PremiumFromIssuanceOfPreferredStock" xml:lang="en-US" id="label_PremiumFromIssuanceOfPreferredStock">Premium received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PremiumFromIssuanceOfPreferredStock" xlink:to="label_PremiumFromIssuanceOfPreferredStock" xlink:title="label_PremiumFromIssuanceOfPreferredStock" />
    <link:label xlink:type="resource" xlink:label="label_PremiumFromIssuanceOfPreferredStock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PremiumFromIssuanceOfPreferredStock_1" xml:lang="en-US" id="label_PremiumFromIssuanceOfPreferredStock_1">Premium from Issuance of Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PremiumFromIssuanceOfPreferredStock" xlink:to="label_PremiumFromIssuanceOfPreferredStock_1" xlink:title="label_PremiumFromIssuanceOfPreferredStock_1" />
    <link:label xlink:type="resource" xlink:label="label_PremiumFromIssuanceOfPreferredStock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_PremiumFromIssuanceOfPreferredStock_2" xml:lang="en-US" id="label_PremiumFromIssuanceOfPreferredStock_2">Represents the premium received from issuance of preferred stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PremiumFromIssuanceOfPreferredStock" xlink:to="label_PremiumFromIssuanceOfPreferredStock_2" xlink:title="label_PremiumFromIssuanceOfPreferredStock_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:title="PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xml:lang="en-US" id="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock">Summary of estimated useful lives for property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:title="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_1" xml:lang="en-US" id="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_1">Property, Plant and Equipment, Estimated Useful Lives [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_1" xlink:title="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_2" xml:lang="en-US" id="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_2">Represents the tabular disclosure of estimated useful lives for property and equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_2" xlink:title="label_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionAggregatePaymentsMade" xlink:label="RelatedPartyTransactionAggregatePaymentsMade" xlink:title="RelatedPartyTransactionAggregatePaymentsMade" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionAggregatePaymentsMade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionAggregatePaymentsMade" xml:lang="en-US" id="label_RelatedPartyTransactionAggregatePaymentsMade">Related Party Transaction, Aggregate Payments Made</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionAggregatePaymentsMade" xlink:to="label_RelatedPartyTransactionAggregatePaymentsMade" xlink:title="label_RelatedPartyTransactionAggregatePaymentsMade" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionAggregatePaymentsMade_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionAggregatePaymentsMade_1" xml:lang="en-US" id="label_RelatedPartyTransactionAggregatePaymentsMade_1">Aggregate payments made</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionAggregatePaymentsMade" xlink:to="label_RelatedPartyTransactionAggregatePaymentsMade_1" xlink:title="label_RelatedPartyTransactionAggregatePaymentsMade_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionAggregatePaymentsMade_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionAggregatePaymentsMade_2" xml:lang="en-US" id="label_RelatedPartyTransactionAggregatePaymentsMade_2">Represents the aggregate payments made to related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionAggregatePaymentsMade" xlink:to="label_RelatedPartyTransactionAggregatePaymentsMade_2" xlink:title="label_RelatedPartyTransactionAggregatePaymentsMade_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram" xlink:label="RelatedPartyTransactionAmountProvidedToFundResearchProgram" xlink:title="RelatedPartyTransactionAmountProvidedToFundResearchProgram" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram" xml:lang="en-US" id="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram">Related Party Transaction, Amount Provided to Fund Research Program</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionAmountProvidedToFundResearchProgram" xlink:to="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram" xlink:title="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram_1" xml:lang="en-US" id="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram_1">Amount provided to fund research program</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionAmountProvidedToFundResearchProgram" xlink:to="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram_1" xlink:title="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram_2" xml:lang="en-US" id="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram_2">Represents the amount provided to fund research program.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionAmountProvidedToFundResearchProgram" xlink:to="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram_2" xlink:title="label_RelatedPartyTransactionAmountProvidedToFundResearchProgram_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct" xlink:label="RelatedPartyTransactionMilestonePaymentsPerProduct" xlink:title="RelatedPartyTransactionMilestonePaymentsPerProduct" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionMilestonePaymentsPerProduct" xml:lang="en-US" id="label_RelatedPartyTransactionMilestonePaymentsPerProduct">Related Party Transaction, Milestone Payments Per Product</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionMilestonePaymentsPerProduct" xlink:to="label_RelatedPartyTransactionMilestonePaymentsPerProduct" xlink:title="label_RelatedPartyTransactionMilestonePaymentsPerProduct" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionMilestonePaymentsPerProduct_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionMilestonePaymentsPerProduct_1" xml:lang="en-US" id="label_RelatedPartyTransactionMilestonePaymentsPerProduct_1">Milestone payments per product</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionMilestonePaymentsPerProduct" xlink:to="label_RelatedPartyTransactionMilestonePaymentsPerProduct_1" xlink:title="label_RelatedPartyTransactionMilestonePaymentsPerProduct_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionMilestonePaymentsPerProduct_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionMilestonePaymentsPerProduct_2" xml:lang="en-US" id="label_RelatedPartyTransactionMilestonePaymentsPerProduct_2">Represents the milestone payments per product.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionMilestonePaymentsPerProduct" xlink:to="label_RelatedPartyTransactionMilestonePaymentsPerProduct_2" xlink:title="label_RelatedPartyTransactionMilestonePaymentsPerProduct_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" xlink:label="RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" xlink:title="RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" xml:lang="en-US" id="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty">Related Party Transaction Monthly Consulting Expenses From Transactions With Related Party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" xlink:to="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" xlink:title="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_1" xml:lang="en-US" id="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_1">Monthly consulting fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" xlink:to="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_1" xlink:title="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_2" xml:lang="en-US" id="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_2">Monthly expenses recognized resulting from consulting transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" xlink:to="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_2" xlink:title="label_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionPaymentsMade" xlink:label="RelatedPartyTransactionPaymentsMade" xlink:title="RelatedPartyTransactionPaymentsMade" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionPaymentsMade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionPaymentsMade" xml:lang="en-US" id="label_RelatedPartyTransactionPaymentsMade">Payments made to related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionPaymentsMade" xlink:to="label_RelatedPartyTransactionPaymentsMade" xlink:title="label_RelatedPartyTransactionPaymentsMade" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionPaymentsMade_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionPaymentsMade_1" xml:lang="en-US" id="label_RelatedPartyTransactionPaymentsMade_1">Related Party Transaction, Payments Made</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionPaymentsMade" xlink:to="label_RelatedPartyTransactionPaymentsMade_1" xlink:title="label_RelatedPartyTransactionPaymentsMade_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionPaymentsMade_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionPaymentsMade_2" xml:lang="en-US" id="label_RelatedPartyTransactionPaymentsMade_2">Represents the cash outflow from payments made to related party during the year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionPaymentsMade" xlink:to="label_RelatedPartyTransactionPaymentsMade_2" xlink:title="label_RelatedPartyTransactionPaymentsMade_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenue" xlink:label="RelatedPartyTransactionsDeferredRevenue" xlink:title="RelatedPartyTransactionsDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenue" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenue">Deferred revenue, beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenue" xlink:to="label_RelatedPartyTransactionsDeferredRevenue" xlink:title="label_RelatedPartyTransactionsDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenue_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenue_1" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenue_1">Total deferred revenue, end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenue" xlink:to="label_RelatedPartyTransactionsDeferredRevenue_1" xlink:title="label_RelatedPartyTransactionsDeferredRevenue_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenue_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsDeferredRevenue_2" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenue_2">Related Party Transactions, Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenue" xlink:to="label_RelatedPartyTransactionsDeferredRevenue_2" xlink:title="label_RelatedPartyTransactionsDeferredRevenue_2" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenue_3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionsDeferredRevenue_3" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenue_3">Amount of deferred income from related party transactions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenue" xlink:to="label_RelatedPartyTransactionsDeferredRevenue_3" xlink:title="label_RelatedPartyTransactionsDeferredRevenue_3" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" xlink:label="RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" xlink:title="RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment">Attributed premium on the proceeds from Lilly's investment in the Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" xlink:to="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" xlink:title="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_1" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_1">Related Party Transactions, Deferred Revenue, Attributed Premium on Proceeds From Investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" xlink:to="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_1" xlink:title="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_2" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_2">Amount of increase (decrease) in deferred income from related party transactions attributable to premium on the proceeds from investment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" xlink:to="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_2" xlink:title="label_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" xlink:label="RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" xlink:title="RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized">Revenue from research and development arrangement recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" xlink:to="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_1" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_1">Related Party Transactions, Deferred Revenue, Collaboration Revenue Recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" xlink:to="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_1" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_2" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_2">Amount of increase (decrease) in deferred income from related party transactions attributable to collaboration revenue recognized.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" xlink:to="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_2" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" xlink:label="RelatedPartyTransactionsDeferredRevenueCurrent" xlink:title="RelatedPartyTransactionsDeferredRevenueCurrent" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCurrent" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueCurrent">Deferred revenue, current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueCurrent" xlink:to="label_RelatedPartyTransactionsDeferredRevenueCurrent" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCurrent" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueCurrent_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCurrent_1" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueCurrent_1">Less: Deferred revenue, current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueCurrent" xlink:to="label_RelatedPartyTransactionsDeferredRevenueCurrent_1" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueCurrent_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCurrent_2" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueCurrent_2">Related Party Transactions, Deferred Revenue, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueCurrent" xlink:to="label_RelatedPartyTransactionsDeferredRevenueCurrent_2" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCurrent_2" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueCurrent_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCurrent_3" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueCurrent_3">Deferred revenue from related party, current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueCurrent" xlink:to="label_RelatedPartyTransactionsDeferredRevenueCurrent_3" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCurrent_3" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueCurrent_4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCurrent_4" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueCurrent_4">Amount of deferred income from related party transactions excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueCurrent" xlink:to="label_RelatedPartyTransactionsDeferredRevenueCurrent_4" xlink:title="label_RelatedPartyTransactionsDeferredRevenueCurrent_4" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:label="RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:title="RelatedPartyTransactionsDeferredRevenueNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenueNoncurrent" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueNoncurrent">Deferred revenue, non-current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:to="label_RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:title="label_RelatedPartyTransactionsDeferredRevenueNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_1" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_1">Deferred revenue, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:to="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_1" xlink:title="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_2" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_2">Related Party Transactions, Deferred Revenue, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:to="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_2" xlink:title="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_2" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_3" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_3">Amount of deferred income from related party transactions excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:to="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_3" xlink:title="label_RelatedPartyTransactionsDeferredRevenueNoncurrent_3" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" xlink:label="RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" xlink:title="RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment">Research and development support billing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" xlink:to="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" xlink:title="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_1" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_1">Related Party Transactions, Deferred Revenue, Research And Development Support Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" xlink:to="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_1" xlink:title="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_2" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_2">Amount of increase (decrease) in deferred income from related party transactions attributable to research and development support payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" xlink:to="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_2" xlink:title="label_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueUpFrontPayment" xlink:label="RelatedPartyTransactionsDeferredRevenueUpFrontPayment" xlink:title="RelatedPartyTransactionsDeferredRevenueUpFrontPayment" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment">Up-front payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueUpFrontPayment" xlink:to="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment" xlink:title="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_1" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_1">Related Party Transactions, Deferred Revenue, Up-front Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueUpFrontPayment" xlink:to="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_1" xlink:title="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_1" />
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_2" xml:lang="en-US" id="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_2">Amount of increase (decrease) in deferred income from related party transactions attributable to upfront payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDeferredRevenueUpFrontPayment" xlink:to="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_2" xlink:title="label_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RequiredReserveRestrictedCashCurrent" xlink:label="RequiredReserveRestrictedCashCurrent" xlink:title="RequiredReserveRestrictedCashCurrent" />
    <link:label xlink:type="resource" xlink:label="label_RequiredReserveRestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RequiredReserveRestrictedCashCurrent" xml:lang="en-US" id="label_RequiredReserveRestrictedCashCurrent">Restricted cash required reserve</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RequiredReserveRestrictedCashCurrent" xlink:to="label_RequiredReserveRestrictedCashCurrent" xlink:title="label_RequiredReserveRestrictedCashCurrent" />
    <link:label xlink:type="resource" xlink:label="label_RequiredReserveRestrictedCashCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RequiredReserveRestrictedCashCurrent_1" xml:lang="en-US" id="label_RequiredReserveRestrictedCashCurrent_1">Required Reserve Restricted Cash Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RequiredReserveRestrictedCashCurrent" xlink:to="label_RequiredReserveRestrictedCashCurrent_1" xlink:title="label_RequiredReserveRestrictedCashCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_RequiredReserveRestrictedCashCurrent_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RequiredReserveRestrictedCashCurrent_2" xml:lang="en-US" id="label_RequiredReserveRestrictedCashCurrent_2">Amount of required reserve of restricted cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RequiredReserveRestrictedCashCurrent" xlink:to="label_RequiredReserveRestrictedCashCurrent_2" xlink:title="label_RequiredReserveRestrictedCashCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" xlink:label="ResearchAndDevelopmentCollaborativeAgreementMember" xlink:title="ResearchAndDevelopmentCollaborativeAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ResearchAndDevelopmentCollaborativeAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ResearchAndDevelopmentCollaborativeAgreementMember" xml:lang="en-US" id="label_ResearchAndDevelopmentCollaborativeAgreementMember">Lilly Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentCollaborativeAgreementMember" xlink:to="label_ResearchAndDevelopmentCollaborativeAgreementMember" xlink:title="label_ResearchAndDevelopmentCollaborativeAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ResearchAndDevelopmentCollaborativeAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ResearchAndDevelopmentCollaborativeAgreementMember_1" xml:lang="en-US" id="label_ResearchAndDevelopmentCollaborativeAgreementMember_1">Research And Development Collaborative Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentCollaborativeAgreementMember" xlink:to="label_ResearchAndDevelopmentCollaborativeAgreementMember_1" xlink:title="label_ResearchAndDevelopmentCollaborativeAgreementMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ResearchAndDevelopmentCollaborativeAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ResearchAndDevelopmentCollaborativeAgreementMember_2" xml:lang="en-US" id="label_ResearchAndDevelopmentCollaborativeAgreementMember_2">Represents information pertaining to research and development collaboration agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentCollaborativeAgreementMember" xlink:to="label_ResearchAndDevelopmentCollaborativeAgreementMember_2" xlink:title="label_ResearchAndDevelopmentCollaborativeAgreementMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchEquipmentMember" xlink:label="ResearchEquipmentMember" xlink:title="ResearchEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_ResearchEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ResearchEquipmentMember" xml:lang="en-US" id="label_ResearchEquipmentMember">Research equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchEquipmentMember" xlink:to="label_ResearchEquipmentMember" xlink:title="label_ResearchEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_ResearchEquipmentMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ResearchEquipmentMember_1" xml:lang="en-US" id="label_ResearchEquipmentMember_1">Research Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchEquipmentMember" xlink:to="label_ResearchEquipmentMember_1" xlink:title="label_ResearchEquipmentMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ResearchEquipmentMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ResearchEquipmentMember_2" xml:lang="en-US" id="label_ResearchEquipmentMember_2">Tangible research equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchEquipmentMember" xlink:to="label_ResearchEquipmentMember_2" xlink:title="label_ResearchEquipmentMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RestrictedCashAndOtherAssetsCurrent" xlink:label="RestrictedCashAndOtherAssetsCurrent" xlink:title="RestrictedCashAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RestrictedCashAndOtherAssetsCurrent" xml:lang="en-US" id="label_RestrictedCashAndOtherAssetsCurrent">Restricted cash (including $3,750 in other assets)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashAndOtherAssetsCurrent" xlink:to="label_RestrictedCashAndOtherAssetsCurrent" xlink:title="label_RestrictedCashAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashAndOtherAssetsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RestrictedCashAndOtherAssetsCurrent_1" xml:lang="en-US" id="label_RestrictedCashAndOtherAssetsCurrent_1">Restricted Cash And Other Assets Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashAndOtherAssetsCurrent" xlink:to="label_RestrictedCashAndOtherAssetsCurrent_1" xlink:title="label_RestrictedCashAndOtherAssetsCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashAndOtherAssetsCurrent_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RestrictedCashAndOtherAssetsCurrent_2" xml:lang="en-US" id="label_RestrictedCashAndOtherAssetsCurrent_2">Represents restricted cash and other assets current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashAndOtherAssetsCurrent" xlink:to="label_RestrictedCashAndOtherAssetsCurrent_2" xlink:title="label_RestrictedCashAndOtherAssetsCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RestrictedCashOtherAssetsNonCurrent" xlink:label="RestrictedCashOtherAssetsNonCurrent" xlink:title="RestrictedCashOtherAssetsNonCurrent" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashOtherAssetsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RestrictedCashOtherAssetsNonCurrent" xml:lang="en-US" id="label_RestrictedCashOtherAssetsNonCurrent">Other assets, restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashOtherAssetsNonCurrent" xlink:to="label_RestrictedCashOtherAssetsNonCurrent" xlink:title="label_RestrictedCashOtherAssetsNonCurrent" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashOtherAssetsNonCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RestrictedCashOtherAssetsNonCurrent_1" xml:lang="en-US" id="label_RestrictedCashOtherAssetsNonCurrent_1">Restricted Cash Other Assets Non Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashOtherAssetsNonCurrent" xlink:to="label_RestrictedCashOtherAssetsNonCurrent_1" xlink:title="label_RestrictedCashOtherAssetsNonCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_RestrictedCashOtherAssetsNonCurrent_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RestrictedCashOtherAssetsNonCurrent_2" xml:lang="en-US" id="label_RestrictedCashOtherAssetsNonCurrent_2">Represents other assets non-current from restricted cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashOtherAssetsNonCurrent" xlink:to="label_RestrictedCashOtherAssetsNonCurrent_2" xlink:title="label_RestrictedCashOtherAssetsNonCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RevenueRecognitionNumberOfPerformanceObligations" xlink:label="RevenueRecognitionNumberOfPerformanceObligations" xlink:title="RevenueRecognitionNumberOfPerformanceObligations" />
    <link:label xlink:type="resource" xlink:label="label_RevenueRecognitionNumberOfPerformanceObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RevenueRecognitionNumberOfPerformanceObligations" xml:lang="en-US" id="label_RevenueRecognitionNumberOfPerformanceObligations">The number of performance obligations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueRecognitionNumberOfPerformanceObligations" xlink:to="label_RevenueRecognitionNumberOfPerformanceObligations" xlink:title="label_RevenueRecognitionNumberOfPerformanceObligations" />
    <link:label xlink:type="resource" xlink:label="label_RevenueRecognitionNumberOfPerformanceObligations_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RevenueRecognitionNumberOfPerformanceObligations_1" xml:lang="en-US" id="label_RevenueRecognitionNumberOfPerformanceObligations_1">Revenue Recognition Number Of Performance Obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueRecognitionNumberOfPerformanceObligations" xlink:to="label_RevenueRecognitionNumberOfPerformanceObligations_1" xlink:title="label_RevenueRecognitionNumberOfPerformanceObligations_1" />
    <link:label xlink:type="resource" xlink:label="label_RevenueRecognitionNumberOfPerformanceObligations_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_RevenueRecognitionNumberOfPerformanceObligations_2" xml:lang="en-US" id="label_RevenueRecognitionNumberOfPerformanceObligations_2">The number of performance obligations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueRecognitionNumberOfPerformanceObligations" xlink:to="label_RevenueRecognitionNumberOfPerformanceObligations_2" xlink:title="label_RevenueRecognitionNumberOfPerformanceObligations_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" xlink:label="ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" xlink:title="ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" xml:lang="en-US" id="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock">Summary of deferred revenue included in the Company's balance sheets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" xlink:to="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" xlink:title="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_1" xml:lang="en-US" id="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_1">Schedule of Deferred Revenue From Related Party [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" xlink:to="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_1" xlink:title="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_2" xml:lang="en-US" id="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_2">Represents the tabular disclosure of deferred revenue from related party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" xlink:to="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_2" xlink:title="label_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ScientificFounderMember" xlink:label="ScientificFounderMember" xlink:title="ScientificFounderMember" />
    <link:label xlink:type="resource" xlink:label="label_ScientificFounderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScientificFounderMember" xml:lang="en-US" id="label_ScientificFounderMember">Scientific Founder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScientificFounderMember" xlink:to="label_ScientificFounderMember" xlink:title="label_ScientificFounderMember" />
    <link:label xlink:type="resource" xlink:label="label_ScientificFounderMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScientificFounderMember_1" xml:lang="en-US" id="label_ScientificFounderMember_1">Scientific Founder [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScientificFounderMember" xlink:to="label_ScientificFounderMember_1" xlink:title="label_ScientificFounderMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ScientificFounderMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ScientificFounderMember_2" xml:lang="en-US" id="label_ScientificFounderMember_2">Represents information pertaining to Scientific Founder.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScientificFounderMember" xlink:to="label_ScientificFounderMember_2" xlink:title="label_ScientificFounderMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series1PreferredStockMember" xlink:label="Series1PreferredStockMember" xlink:title="Series1PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_Series1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_Series1PreferredStockMember" xml:lang="en-US" id="label_Series1PreferredStockMember">Series A-1 Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Series1PreferredStockMember" xlink:to="label_Series1PreferredStockMember" xlink:title="label_Series1PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_Series1PreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_Series1PreferredStockMember_1" xml:lang="en-US" id="label_Series1PreferredStockMember_1">Series1 Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Series1PreferredStockMember" xlink:to="label_Series1PreferredStockMember_1" xlink:title="label_Series1PreferredStockMember_1" />
    <link:label xlink:type="resource" xlink:label="label_Series1PreferredStockMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_Series1PreferredStockMember_2" xml:lang="en-US" id="label_Series1PreferredStockMember_2">Outstanding nonredeemable series A-1 preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Series1PreferredStockMember" xlink:to="label_Series1PreferredStockMember_2" xlink:title="label_Series1PreferredStockMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series2PreferredStockMember" xlink:label="Series2PreferredStockMember" xlink:title="Series2PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_Series2PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_Series2PreferredStockMember" xml:lang="en-US" id="label_Series2PreferredStockMember">Series A-2 preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Series2PreferredStockMember" xlink:to="label_Series2PreferredStockMember" xlink:title="label_Series2PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_Series2PreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_Series2PreferredStockMember_1" xml:lang="en-US" id="label_Series2PreferredStockMember_1">Series2 Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Series2PreferredStockMember" xlink:to="label_Series2PreferredStockMember_1" xlink:title="label_Series2PreferredStockMember_1" />
    <link:label xlink:type="resource" xlink:label="label_Series2PreferredStockMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_Series2PreferredStockMember_2" xml:lang="en-US" id="label_Series2PreferredStockMember_2">Outstanding nonredeemable series A-2 preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Series2PreferredStockMember" xlink:to="label_Series2PreferredStockMember_2" xlink:title="label_Series2PreferredStockMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="Series3PreferredStockMember" xlink:title="Series3PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_Series3PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_Series3PreferredStockMember" xml:lang="en-US" id="label_Series3PreferredStockMember">Series A-3 preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Series3PreferredStockMember" xlink:to="label_Series3PreferredStockMember" xlink:title="label_Series3PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_Series3PreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_Series3PreferredStockMember_1" xml:lang="en-US" id="label_Series3PreferredStockMember_1">Series3 Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Series3PreferredStockMember" xlink:to="label_Series3PreferredStockMember_1" xlink:title="label_Series3PreferredStockMember_1" />
    <link:label xlink:type="resource" xlink:label="label_Series3PreferredStockMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_Series3PreferredStockMember_2" xml:lang="en-US" id="label_Series3PreferredStockMember_2">Outstanding nonredeemable series A-3 preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Series3PreferredStockMember" xlink:to="label_Series3PreferredStockMember_2" xlink:title="label_Series3PreferredStockMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB1AndB2PreferredStockMember" xlink:label="SeriesB1AndB2PreferredStockMember" xlink:title="SeriesB1AndB2PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB1AndB2PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SeriesB1AndB2PreferredStockMember" xml:lang="en-US" id="label_SeriesB1AndB2PreferredStockMember">Series B-1 and B-2 preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB1AndB2PreferredStockMember" xlink:to="label_SeriesB1AndB2PreferredStockMember" xlink:title="label_SeriesB1AndB2PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB1AndB2PreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SeriesB1AndB2PreferredStockMember_1" xml:lang="en-US" id="label_SeriesB1AndB2PreferredStockMember_1">Series B1 And B2 Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB1AndB2PreferredStockMember" xlink:to="label_SeriesB1AndB2PreferredStockMember_1" xlink:title="label_SeriesB1AndB2PreferredStockMember_1" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB1AndB2PreferredStockMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_SeriesB1AndB2PreferredStockMember_2" xml:lang="en-US" id="label_SeriesB1AndB2PreferredStockMember_2">Outstanding nonredeemable series B-1 and B-2 preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB1AndB2PreferredStockMember" xlink:to="label_SeriesB1AndB2PreferredStockMember_2" xlink:title="label_SeriesB1AndB2PreferredStockMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB1PreferredStockMember" xlink:label="SeriesB1PreferredStockMember" xlink:title="SeriesB1PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SeriesB1PreferredStockMember" xml:lang="en-US" id="label_SeriesB1PreferredStockMember">Series B-1 preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB1PreferredStockMember" xlink:to="label_SeriesB1PreferredStockMember" xlink:title="label_SeriesB1PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB1PreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SeriesB1PreferredStockMember_1" xml:lang="en-US" id="label_SeriesB1PreferredStockMember_1">Series B1 Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB1PreferredStockMember" xlink:to="label_SeriesB1PreferredStockMember_1" xlink:title="label_SeriesB1PreferredStockMember_1" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB1PreferredStockMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_SeriesB1PreferredStockMember_2" xml:lang="en-US" id="label_SeriesB1PreferredStockMember_2">Outstanding nonredeemable series B-1 preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB1PreferredStockMember" xlink:to="label_SeriesB1PreferredStockMember_2" xlink:title="label_SeriesB1PreferredStockMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB2PreferredStockMember" xlink:label="SeriesB2PreferredStockMember" xlink:title="SeriesB2PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB2PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SeriesB2PreferredStockMember" xml:lang="en-US" id="label_SeriesB2PreferredStockMember">Series B-2 preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB2PreferredStockMember" xlink:to="label_SeriesB2PreferredStockMember" xlink:title="label_SeriesB2PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB2PreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SeriesB2PreferredStockMember_1" xml:lang="en-US" id="label_SeriesB2PreferredStockMember_1">Series B2 Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB2PreferredStockMember" xlink:to="label_SeriesB2PreferredStockMember_1" xlink:title="label_SeriesB2PreferredStockMember_1" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB2PreferredStockMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_SeriesB2PreferredStockMember_2" xml:lang="en-US" id="label_SeriesB2PreferredStockMember_2">Outstanding nonredeemable series B-2 preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB2PreferredStockMember" xlink:to="label_SeriesB2PreferredStockMember_2" xlink:title="label_SeriesB2PreferredStockMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB3PreferredStockMember" xlink:label="SeriesB3PreferredStockMember" xlink:title="SeriesB3PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB3PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SeriesB3PreferredStockMember" xml:lang="en-US" id="label_SeriesB3PreferredStockMember">Series B-3 preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB3PreferredStockMember" xlink:to="label_SeriesB3PreferredStockMember" xlink:title="label_SeriesB3PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB3PreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SeriesB3PreferredStockMember_1" xml:lang="en-US" id="label_SeriesB3PreferredStockMember_1">Series B3 Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB3PreferredStockMember" xlink:to="label_SeriesB3PreferredStockMember_1" xlink:title="label_SeriesB3PreferredStockMember_1" />
    <link:label xlink:type="resource" xlink:label="label_SeriesB3PreferredStockMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_SeriesB3PreferredStockMember_2" xml:lang="en-US" id="label_SeriesB3PreferredStockMember_2">Outstanding nonredeemable series B-3 preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesB3PreferredStockMember" xlink:to="label_SeriesB3PreferredStockMember_2" xlink:title="label_SeriesB3PreferredStockMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod">Expiration period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_1">Share Based Compensation Arrangement By Share Based Payment Award Award Expiration Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_2">Period which an employee's right to exercise an award is no longer available.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_2" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm">Exercised (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_1">Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_2">Weighted average remaining contractual term for exercised options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_2" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm">Forfeitures (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_1">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeiture Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_2">Weighted average remaining contractual term for forfeiture options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_2" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue">Granted (in dollars)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_2">Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options granted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_2" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm">Granted (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants In Period, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2">Weighted average remaining contractual term for vested portions of options granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm">Term of awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_1" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_1">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_1" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_1" />
    <link:label xlink:type="resource" xlink:label="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_2" xml:lang="en-US" id="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_2">Contractual term for option awards outstanding.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:to="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_2" xlink:title="label_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward">Term of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_1">Share Based Compensation Arrangement By Share Based Payment Award Term Of Award</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_1" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_2">Description of pertinent provision of equity-based compensation awards that have actual or potential impact upon the company's financial statements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" xlink:to="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_2" xlink:title="label_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" xlink:label="ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" xlink:title="ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" xml:lang="en-US" id="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding">Annual increase in number of share reserved for issuance (as percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" xlink:to="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" xlink:title="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_1">Share Based Compensation Arrangement, Increase In Shares For Issuance As A Percentage Of Number Of Common Stock Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" xlink:to="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_1" xlink:title="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_2">The increase in shares available for issuance as a percentage of number of shares of the company's common stock outstanding on December 31st of the preceding calendar year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" xlink:to="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_2" xlink:title="label_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" xlink:label="ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" xlink:title="ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" xml:lang="en-US" id="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan">Maximum annual increase in shares available for issuance under the plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" xlink:to="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" xlink:title="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_1" xml:lang="en-US" id="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_1">Share Based Compensation Arrangement, Threshold Number Of Common Stock For Issuance Under The Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" xlink:to="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_1" xlink:title="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_1" />
    <link:label xlink:type="resource" xlink:label="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_2" xml:lang="en-US" id="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_2">The threshold number of shares of the company's common stock available for issuance under the plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" xlink:to="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_2" xlink:title="label_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" xlink:label="SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" xlink:title="SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" />
    <link:label xlink:type="resource" xlink:label="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" xml:lang="en-US" id="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock">Share price of common stock on date of grant as a percent of fair market value of company stock (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" xlink:to="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" xlink:title="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" />
    <link:label xlink:type="resource" xlink:label="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_1" xml:lang="en-US" id="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_1">Share Price Of Common Stock On Date Of Grant As A Percent of Fair Market Value Of Company Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" xlink:to="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_1" xlink:title="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_1" />
    <link:label xlink:type="resource" xlink:label="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_2" xml:lang="en-US" id="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_2">Represents the share price of common stock on date of grant as a percent of fair market value of company stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" xlink:to="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_2" xlink:title="label_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SponsoredResearchAgreementMember" xlink:label="SponsoredResearchAgreementMember" xlink:title="SponsoredResearchAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_SponsoredResearchAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SponsoredResearchAgreementMember" xml:lang="en-US" id="label_SponsoredResearchAgreementMember">Sponsored Research Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SponsoredResearchAgreementMember" xlink:to="label_SponsoredResearchAgreementMember" xlink:title="label_SponsoredResearchAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_SponsoredResearchAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SponsoredResearchAgreementMember_1" xml:lang="en-US" id="label_SponsoredResearchAgreementMember_1">Sponsored Research Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SponsoredResearchAgreementMember" xlink:to="label_SponsoredResearchAgreementMember_1" xlink:title="label_SponsoredResearchAgreementMember_1" />
    <link:label xlink:type="resource" xlink:label="label_SponsoredResearchAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_SponsoredResearchAgreementMember_2" xml:lang="en-US" id="label_SponsoredResearchAgreementMember_2">Represents information pertaining to sponsored research agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SponsoredResearchAgreementMember" xlink:to="label_SponsoredResearchAgreementMember_2" xlink:title="label_SponsoredResearchAgreementMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:title="StockIssuedDuringPeriodSharesInitialPublicOffering" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_StockIssuedDuringPeriodSharesInitialPublicOffering" xml:lang="en-US" id="label_StockIssuedDuringPeriodSharesInitialPublicOffering">Initial public offering, net of issuance costs of $9.4 million (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:to="label_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:title="label_StockIssuedDuringPeriodSharesInitialPublicOffering" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodSharesInitialPublicOffering_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockIssuedDuringPeriodSharesInitialPublicOffering_1" xml:lang="en-US" id="label_StockIssuedDuringPeriodSharesInitialPublicOffering_1">Stock Issued During Period Shares Initial Public Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:to="label_StockIssuedDuringPeriodSharesInitialPublicOffering_1" xlink:title="label_StockIssuedDuringPeriodSharesInitialPublicOffering_1" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodSharesInitialPublicOffering_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_StockIssuedDuringPeriodSharesInitialPublicOffering_2" xml:lang="en-US" id="label_StockIssuedDuringPeriodSharesInitialPublicOffering_2">Number of new stock issued during the period from initial public offering.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:to="label_StockIssuedDuringPeriodSharesInitialPublicOffering_2" xlink:title="label_StockIssuedDuringPeriodSharesInitialPublicOffering_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:label="StockIssuedDuringPeriodValueInitialPublicOffering" xlink:title="StockIssuedDuringPeriodValueInitialPublicOffering" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_StockIssuedDuringPeriodValueInitialPublicOffering" xml:lang="en-US" id="label_StockIssuedDuringPeriodValueInitialPublicOffering">Initial public offering, net of issuance costs of $9.4 million</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueInitialPublicOffering" xlink:to="label_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:title="label_StockIssuedDuringPeriodValueInitialPublicOffering" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodValueInitialPublicOffering_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockIssuedDuringPeriodValueInitialPublicOffering_1" xml:lang="en-US" id="label_StockIssuedDuringPeriodValueInitialPublicOffering_1">Stock Issued During Period Value Initial Public Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueInitialPublicOffering" xlink:to="label_StockIssuedDuringPeriodValueInitialPublicOffering_1" xlink:title="label_StockIssuedDuringPeriodValueInitialPublicOffering_1" />
    <link:label xlink:type="resource" xlink:label="label_StockIssuedDuringPeriodValueInitialPublicOffering_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_StockIssuedDuringPeriodValueInitialPublicOffering_2" xml:lang="en-US" id="label_StockIssuedDuringPeriodValueInitialPublicOffering_2">Equity impact of the value of new stock issued during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueInitialPublicOffering" xlink:to="label_StockIssuedDuringPeriodValueInitialPublicOffering_2" xlink:title="label_StockIssuedDuringPeriodValueInitialPublicOffering_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_TenantImprovementsReimbursement" xlink:label="TenantImprovementsReimbursement" xlink:title="TenantImprovementsReimbursement" />
    <link:label xlink:type="resource" xlink:label="label_TenantImprovementsReimbursement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_TenantImprovementsReimbursement" xml:lang="en-US" id="label_TenantImprovementsReimbursement">Tenant improvements fully reimbursed by the landlord</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementsReimbursement" xlink:to="label_TenantImprovementsReimbursement" xlink:title="label_TenantImprovementsReimbursement" />
    <link:label xlink:type="resource" xlink:label="label_TenantImprovementsReimbursement_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_TenantImprovementsReimbursement_1" xml:lang="en-US" id="label_TenantImprovementsReimbursement_1">Tenant Improvements Reimbursement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementsReimbursement" xlink:to="label_TenantImprovementsReimbursement_1" xlink:title="label_TenantImprovementsReimbursement_1" />
    <link:label xlink:type="resource" xlink:label="label_TenantImprovementsReimbursement_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_TenantImprovementsReimbursement_2" xml:lang="en-US" id="label_TenantImprovementsReimbursement_2">Represents the amount of tenant improvements fully reimbursed by the landlord.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementsReimbursement" xlink:to="label_TenantImprovementsReimbursement_2" xlink:title="label_TenantImprovementsReimbursement_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_YaleLicenseAgreementMember" xlink:label="YaleLicenseAgreementMember" xlink:title="YaleLicenseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_YaleLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_YaleLicenseAgreementMember" xml:lang="en-US" id="label_YaleLicenseAgreementMember">Yale License Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="YaleLicenseAgreementMember" xlink:to="label_YaleLicenseAgreementMember" xlink:title="label_YaleLicenseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_YaleLicenseAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_YaleLicenseAgreementMember_1" xml:lang="en-US" id="label_YaleLicenseAgreementMember_1">Yale License Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="YaleLicenseAgreementMember" xlink:to="label_YaleLicenseAgreementMember_1" xlink:title="label_YaleLicenseAgreementMember_1" />
    <link:label xlink:type="resource" xlink:label="label_YaleLicenseAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_YaleLicenseAgreementMember_2" xml:lang="en-US" id="label_YaleLicenseAgreementMember_2">Represents information pertaining to Yale license agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="YaleLicenseAgreementMember" xlink:to="label_YaleLicenseAgreementMember_2" xlink:title="label_YaleLicenseAgreementMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_YaleUniversityMember" xlink:label="YaleUniversityMember" xlink:title="YaleUniversityMember" />
    <link:label xlink:type="resource" xlink:label="label_YaleUniversityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_YaleUniversityMember" xml:lang="en-US" id="label_YaleUniversityMember">Yale University</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="YaleUniversityMember" xlink:to="label_YaleUniversityMember" xlink:title="label_YaleUniversityMember" />
    <link:label xlink:type="resource" xlink:label="label_YaleUniversityMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_YaleUniversityMember_1" xml:lang="en-US" id="label_YaleUniversityMember_1">Yale University [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="YaleUniversityMember" xlink:to="label_YaleUniversityMember_1" xlink:title="label_YaleUniversityMember_1" />
    <link:label xlink:type="resource" xlink:label="label_YaleUniversityMember_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_YaleUniversityMember_2" xml:lang="en-US" id="label_YaleUniversityMember_2">Represents information pertaining to Yale University.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="YaleUniversityMember" xlink:to="label_YaleUniversityMember_2" xlink:title="label_YaleUniversityMember_2" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DocumentAndEntityInformationAbstract" xlink:label="DocumentAndEntityInformationAbstract" xlink:title="DocumentAndEntityInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DocumentAndEntityInformationAbstract" xml:lang="en-US" id="label_DocumentAndEntityInformationAbstract">[DocumentAndEntityInformationAbstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="label_DocumentAndEntityInformationAbstract" xlink:title="label: DocumentAndEntityInformationAbstract to label_DocumentAndEntityInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_DocumentAndEntityInformationAbstract_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_DocumentAndEntityInformationAbstract" xml:lang="en-US" id="label_DocumentAndEntityInformationAbstract_2">Not available</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="label_DocumentAndEntityInformationAbstract_2" xlink:title="label: DocumentAndEntityInformationAbstract to label_DocumentAndEntityInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="label_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityRegistrantName" xml:lang="en-US" id="label_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="label_EntityRegistrantName" xlink:title="label: EntityRegistrantName to label_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="label_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityCentralIndexKey" xml:lang="en-US" id="label_EntityCentralIndexKey">Entity Central Index</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="label_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to label_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="label_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DocumentType" xml:lang="en-US" id="label_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="label_DocumentType" xlink:title="label: DocumentType to label_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="label_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DocumentPeriodEndDate" xml:lang="en-US" id="label_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="label_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to label_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="label_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AmendmentFlag" xml:lang="en-US" id="label_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="label_AmendmentFlag" xlink:title="label: AmendmentFlag to label_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="label_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityFilerCategory" xml:lang="en-US" id="label_EntityFilerCategory">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="label_EntityFilerCategory" xlink:title="label: EntityFilerCategory to label_EntityFilerCategory" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:label xlink:type="resource" xlink:label="label_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntitySmallBusiness" xml:lang="en-US" id="label_EntitySmallBusiness">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntitySmallBusiness" xlink:to="label_EntitySmallBusiness" xlink:title="label: EntitySmallBusiness to label_EntitySmallBusiness" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="label_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityEmergingGrowthCompany" xml:lang="en-US" id="label_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="label_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to label_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="label_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityExTransitionPeriod" xml:lang="en-US" id="label_EntityExTransitionPeriod">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="label_EntityExTransitionPeriod" xlink:title="label: EntityExTransitionPeriod to label_EntityExTransitionPeriod" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>nxtc-20191112_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Toppan Merrill -->
<!-- Generated by Fujitsu Interstage XWand B0189 -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementBalanceSheets" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementBalanceSheets" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementBalanceSheetsParenthetical" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementStatementsOfOperationsAndComprehensiveLoss" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficit" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementStatementsOfPreferredStockAndStockholdersDeficit" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficitParenthetical" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementStatementsOfPreferredStockAndStockholdersDeficitParenthetical" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementStatementsOfCashFlows" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementStatementsOfCashFlows" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNatureOfBusinessAndBasisOfPresentation" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstruments" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureFairValueOfFinancialInstruments" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNet" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePropertyAndEquipmentNet" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAccruedLiabilities" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAccruedLiabilities" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompany" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAgreementWithEliLillyAndCompany" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingencies" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommitmentsAndContingencies" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoan" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoan" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePreferredStock" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePreferredStock" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommonStock" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommonStock" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensation" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensation" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholders" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNetLossPerShareAttributableToCommonStockholders" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxes" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureIncomeTaxes" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureEmployeeBenefitPlan" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureEmployeeBenefitPlan" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureRelatedPartyTransactions" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureRelatedPartyTransactions" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSubsequentEvents" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSubsequentEvents" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsTables" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureFairValueOfFinancialInstrumentsTables" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetTables" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePropertyAndEquipmentNetTables" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAccruedLiabilitiesTables" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAccruedLiabilitiesTables" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesTables" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommitmentsAndContingenciesTables" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanTables" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanTables" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationTables" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationTables" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersTables" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNetLossPerShareAttributableToCommonStockholdersTables" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesTables" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureIncomeTaxesTables" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNatureOfBusinessAndBasisOfPresentationDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureFairValueOfFinancialInstrumentsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePropertyAndEquipmentNetDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAccruedLiabilitiesDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAgreementWithEliLillyAndCompanyDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesOtherDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommitmentsAndContingenciesOtherDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanOtherDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanOtherDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanMaturitiesDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePreferredStockDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePreferredStockDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommonStockDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommonStockDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensation2015OmnibusIncentivePlanDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensation2015OmnibusIncentivePlanDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationStockOptionsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationAssumptionsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationAssumptionsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationRestrictedCommonStockDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationRestrictedCommonStockDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersOtherDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNetLossPerShareAttributableToCommonStockholdersOtherDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAntiDilutiveEffectDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNetLossPerShareAttributableToCommonStockholdersAntiDilutiveEffectDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureIncomeTaxesReconciliationDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureIncomeTaxesDeferredTaxAssetsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureEmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureEmployeeBenefitPlanDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureRelatedPartyTransactionsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSubsequentEventsDetails" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSubsequentEventsDetails" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedBalanceSheetsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedBalanceSheetsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedBalanceSheetsParentheticalQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedBalanceSheetsParentheticalQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfOperationsAndComprehensiveLossQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedStatementsOfOperationsAndComprehensiveLossQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitParentheticalQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitParentheticalQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/StatementCondensedStatementsOfCashFlowsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#StatementCondensedStatementsOfCashFlowsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNatureOfBusinessQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNatureOfBusinessQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureInvestmentsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureInvestmentsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureFairValueOfFinancialInstrumentsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePropertyAndEquipmentNetQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAgreementWithEliLillyAndCompanyQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommitmentsAndContingenciesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureIncomeTaxesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSubsequentEventsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSubsequentEventsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPoliciesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTablesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTablesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureInvestmentsTablesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureInvestmentsTablesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsTablesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureFairValueOfFinancialInstrumentsTablesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetTablesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePropertyAndEquipmentNetTablesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyTablesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAgreementWithEliLillyAndCompanyTablesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesTablesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommitmentsAndContingenciesTablesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanTablesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanTablesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationTablesQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationTablesQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureNatureOfBusinessDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureNatureOfBusinessDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureInvestmentsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureInvestmentsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosurePropertyAndEquipmentNetDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyOtherDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAgreementWithEliLillyAndCompanyOtherDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDeferredRevenueIncludedInBalanceSheetsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureAgreementWithEliLillyAndCompanyDeferredRevenueIncludedInBalanceSheetsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesOtherDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommitmentsAndContingenciesOtherDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanOtherDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanOtherDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureTermLoanMaturitiesDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationStockOptionsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureStockBasedCompensationStockBasedCompensationExpenseDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureIncomeTaxesDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureIncomeTaxesDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DisclosureSubsequentEventsDetailsQuarterEnd" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DisclosureSubsequentEventsDetailsQuarterEnd" />
  <link:roleRef roleURI="http://www.nextcure.com/role/DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="nxtc-20191112.xsd#DocumentDocumentAndEntityInformation" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementStatementsOfOperationsAndComprehensiveLoss">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_637091324806112947" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract_637091324806112947" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637091324806112947" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_637091324806112947" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637091324806112947" xlink:to="us-gaap_ResearchAndDevelopmentExpense_637091324806112947" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637091324806112947" xlink:to="us-gaap_GeneralAndAdministrativeExpense_637091324806112947" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637091324806112947" xlink:to="us-gaap_OperatingExpenses_637091324806112947" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss_637091324806112947" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_637091324806112947" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_637091324806112947" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_637091324806112947" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_637091324806112947" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_637091324806112947" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_637091324806162806" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_637091324806162806" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNatureOfBusinessQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_637091327026101731" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPolicies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_637091324806162806" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_637091324806162806" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_637091327026111705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_637091327026111705" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_637091324806182361" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_637091324806182361" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk_637091324806182361" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_637091324806182361" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_637091324806182361" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionContractorsPolicyPolicyTextBlock" xlink:label="us-gaap_ConstructionContractorsPolicyPolicyTextBlock_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConstructionContractorsPolicyPolicyTextBlock_637091324806182361" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_637091324806182361" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_637091324806182361" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_637091324806182361" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_637091324806182361" xlink:title="presentation:  to " use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_637091324806182361" xlink:title="presentation:  to " use="optional" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_637091324806182361" xlink:title="presentation:  to " use="optional" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_637091324806182361" xlink:title="presentation:  to " use="optional" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_637091324806182361" xlink:title="presentation:  to " use="optional" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_637091324806182361" xlink:title="presentation:  to " use="optional" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_637091324806182361" xlink:title="presentation:  to " use="optional" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:label="nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_637091324806182361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_637091324806182361" xlink:title="presentation:  to " use="optional" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_637091327026121679" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_637091327026121679" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:label="nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock_637091327026121679" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_637091327026121679" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates_637091327026121679" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy_637091327026121679" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_637091324806192083" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_637091324806192083" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="nxtc_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_637091324806192083" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nxtc_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_637091324806192083" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTablesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_637091327026121679" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentChargesAbstract" xlink:label="us-gaap_AssetImpairmentChargesAbstract_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AssetImpairmentChargesAbstract_637091324806212139" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetImpairmentChargesAbstract_637091324806212139" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_637091324806212139" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxUncertaintiesAbstract" xlink:label="us-gaap_IncomeTaxUncertaintiesAbstract_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxUncertaintiesAbstract_637091324806212139" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxUncertaintiesAbstract_637091324806212139" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_637091324806212139" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstruments">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock_637091324806162806" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock_637091324806162806" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock_637091327026111705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock_637091327026111705" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_637091324806192083" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock_637091324806192083" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsTablesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock_637091327026121679" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNet">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_637091324806162806" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_637091324806162806" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_637091327026111705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_637091327026111705" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_637091324806192083" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_637091324806192083" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetTablesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_637091327026121679" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAccruedLiabilities">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_637091324806162806" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_637091324806162806" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAccruedLiabilitiesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_637091324806192083" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_637091324806192083" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompany">
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementDisclosureAbstract" xlink:label="nxtc_CollaborativeArrangementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_637091324806162806" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nxtc_CollaborativeArrangementDisclosureAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_637091324806162806" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementDisclosureAbstract" xlink:label="nxtc_CollaborativeArrangementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_637091327026111705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nxtc_CollaborativeArrangementDisclosureAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_637091327026111705" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyTablesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementDisclosureAbstract" xlink:label="nxtc_CollaborativeArrangementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock" xlink:label="nxtc_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nxtc_CollaborativeArrangementDisclosureAbstract" xlink:to="nxtc_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock_637091327026121679" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommitmentsAndContingencies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_637091324806172781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_637091324806172781" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_637091327026111705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_637091327026111705" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_637091324806192083" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_637091324806192083" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesTablesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_637091327026121679" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesOtherDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_AreaOfRealEstateProperty_637091324806242194" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PeriodForWhichBaseRentIsAbated" xlink:label="nxtc_PeriodForWhichBaseRentIsAbated_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nxtc_PeriodForWhichBaseRentIsAbated_637091324806242194" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AnnualBaseRentPerMonthAfterAbatement" xlink:label="nxtc_AnnualBaseRentPerMonthAfterAbatement_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nxtc_AnnualBaseRentPerMonthAfterAbatement_637091324806242194" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PercentageOfAnnualIncreaseInLeaseRent" xlink:label="nxtc_PercentageOfAnnualIncreaseInLeaseRent_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nxtc_PercentageOfAnnualIncreaseInLeaseRent_637091324806242194" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_637091324806242194" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesOtherDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PeriodForWhichBaseRentIsAbated" xlink:label="nxtc_PeriodForWhichBaseRentIsAbated_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nxtc_PeriodForWhichBaseRentIsAbated_637091327026171678" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AnnualBaseRentPerMonthAfterAbatement" xlink:label="nxtc_AnnualBaseRentPerMonthAfterAbatement_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nxtc_AnnualBaseRentPerMonthAfterAbatement_637091327026171678" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PercentageOfAnnualIncreaseInLeaseRent" xlink:label="nxtc_PercentageOfAnnualIncreaseInLeaseRent_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nxtc_PercentageOfAnnualIncreaseInLeaseRent_637091327026171678" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_637091327026171678" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AnnualBaseRentPerMonth" xlink:label="nxtc_AnnualBaseRentPerMonth_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nxtc_AnnualBaseRentPerMonth_637091327026171678" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_LetterOfCredit" xlink:label="nxtc_LetterOfCredit_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nxtc_LetterOfCredit_637091327026171678" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements" xlink:label="nxtc_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nxtc_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements_637091327026171678" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_TenantImprovementsReimbursement" xlink:label="nxtc_TenantImprovementsReimbursement_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="nxtc_TenantImprovementsReimbursement_637091327026171678" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoan">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock_637091324806172781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock_637091324806172781" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock_637091327026111705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock_637091327026111705" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_637091324806192083" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_637091324806192083" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanTablesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_637091327026131651" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePreferredStock">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock_637091324806172781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_PreferredStockTextBlock_637091324806172781" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommonStock">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CommonStockTextBlock" xlink:label="nxtc_CommonStockTextBlock_637091324806172781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="nxtc_CommonStockTextBlock_637091324806172781" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized_637091324806272528" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_637091324806272528" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockSharesIssued_637091324806272528" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding_637091324806272528" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_NumberOfVotesPerShare" xlink:label="nxtc_NumberOfVotesPerShare_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="nxtc_NumberOfVotesPerShare_637091324806272528" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_637091324806272528" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid" xlink:label="us-gaap_CommonStockDividendsPerShareCashPaid_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockDividendsPerShareCashPaid_637091324806272528" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensation">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_637091324806172781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_637091324806172781" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_637091327026111705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_637091327026111705" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_637091324806202138" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_637091324806202138" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_637091324806202138" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationTablesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_637091327026131651" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_637091327026131651" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_637091324806322376" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_637091324806322376" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_637091324806322376" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_637091324806322376" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_637091324806322376" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholders">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock_637091324806172781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock_637091324806172781" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_637091324806202138" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_637091324806202138" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersOtherDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareReconciliationAbstract_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract_637091324806332348" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_637091324806332348" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_637091324806332348" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_637091324806332348" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureIncomeTaxes">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_637091324806172781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_637091324806172781" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureIncomeTaxesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_637091327026111705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_637091327026111705" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureIncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_637091324806202138" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_637091324806202138" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureIncomeTaxesDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_637091327026251466" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit_637091327026251466" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureEmployeeBenefitPlan">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_637091324806172781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_637091324806172781" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureEmployeeBenefitPlanDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_637091324806352308" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureRelatedPartyTransactions">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_637091324806172781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_637091324806172781" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSubsequentEvents">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock_637091324806172781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock_637091324806172781" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSubsequentEventsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock_637091327026111705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock_637091327026111705" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSubsequentEventsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PeriodForWhichBaseRentIsAbated" xlink:label="nxtc_PeriodForWhichBaseRentIsAbated_637091327026251466" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="nxtc_PeriodForWhichBaseRentIsAbated_637091327026251466" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AnnualBaseRentPerMonthAfterAbatement" xlink:label="nxtc_AnnualBaseRentPerMonthAfterAbatement_637091327026251466" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="nxtc_AnnualBaseRentPerMonthAfterAbatement_637091327026251466" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PercentageOfAnnualIncreaseInLeaseRent" xlink:label="nxtc_PercentageOfAnnualIncreaseInLeaseRent_637091327026251466" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="nxtc_PercentageOfAnnualIncreaseInLeaseRent_637091327026251466" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureInvestmentsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_637082170090458325" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_637091327026111705" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_637082170090458325" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_637091327026111705" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureInvestmentsTablesQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_637082170524028796" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_637091327026121679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_637082170524028796" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_637091327026121679" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DocumentAndEntityInformationAbstract" xlink:label="DocumentAndEntityInformationAbstract" xlink:title="DocumentAndEntityInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityCentralIndexKey" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="DocumentType" xlink:title="presentation: DocumentAndEntityInformationAbstract to DocumentType" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: DocumentAndEntityInformationAbstract to AmendmentFlag" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityFilerCategory" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntitySmallBusiness" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntitySmallBusiness" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityEmergingGrowthCompany" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityExTransitionPeriod" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: DocumentAndEntityInformationAbstract to DocumentPeriodEndDate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityRegistrantName" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091324806212139" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091324806212139" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091324806212139" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091324806212139" xlink:to="us-gaap_RestrictedCashCurrent_637091324806212139" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091324806212139" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637091324806212139" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091327026142366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091327026142366" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091327026142366" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637091327026142366" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RestrictedCashAndOtherAssetsCurrent" xlink:label="nxtc_RestrictedCashAndOtherAssetsCurrent_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091327026142366" xlink:to="nxtc_RestrictedCashAndOtherAssetsCurrent_637091327026142366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RestrictedCashOtherAssetsNonCurrent" xlink:label="nxtc_RestrictedCashOtherAssetsNonCurrent_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_637091327026142366" xlink:to="nxtc_RestrictedCashOtherAssetsNonCurrent_637091327026142366" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAbstract" xlink:label="us-gaap_RestrictedCashAbstract_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RestrictedCashAbstract_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RequiredReserveRestrictedCashCurrent" xlink:label="nxtc_RequiredReserveRestrictedCashCurrent_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAbstract_637091327026142366" xlink:to="nxtc_RequiredReserveRestrictedCashCurrent_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091324806242194" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091324806242194" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_637091324806242194" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091324806242194" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_637091324806242194" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091324806242194" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_637091324806252169" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091324806242194" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_637091324806252169" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091324806242194" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_637091324806252169" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091324806242194" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_637091324806252169" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091324806242194" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_637091324806252169" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091327026171678" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091327026171678" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_637091327026181654" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091327026171678" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_637091327026181654" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091327026171678" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_637091327026181654" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091327026171678" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_637091327026181654" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091327026171678" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_637091327026181654" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091327026171678" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_637091327026181654" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_637091327026171678" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_637091327026181654" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_637091324806252169" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091324806252169" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_637091324806252169" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091324806252169" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637091324806252169" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091324806252169" xlink:to="us-gaap_LongTermDebt_637091324806252169" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091324806252169" xlink:to="us-gaap_LongTermDebtCurrent_637091324806252169" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091324806252169" xlink:to="us-gaap_LongTermDebtNoncurrent_637091324806252169" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_637091327026181654" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091327026181654" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_637091327026181654" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091327026181654" xlink:to="us-gaap_LongTermDebt_637091327026191626" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091327026181654" xlink:to="us-gaap_LongTermDebtCurrent_637091327026191626" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091327026181654" xlink:to="us-gaap_LongTermDebtNoncurrent_637091327026191626" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091327026181654" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_637091327026181654" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091327026181654" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_637091327026181654" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract_637091327026181654" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_637091327026191626" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureIncomeTaxesDeferredTaxAssetsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_637091324806342320" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_637091324806342320" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_637091324806342320" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_637091324806342320" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_637091324806342320" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsOther_637091324806342320" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsGross_637091324806342320" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_637091324806342320" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsNet_637091324806342320" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_637091324806342320" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:label="nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract_637091324806342320" xlink:to="nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization_637091324806342320" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract_637091324806342320" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_637091324806342320" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_637091324806342320" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_637091324806342320" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_637091324806342320" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_637091324806342320" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_637091324806342320" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal" xlink:label="nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:to="nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal_637091324806342320" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState" xlink:label="nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:to="nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState_637091324806352308" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_637091324806342320" xlink:to="us-gaap_UnrecognizedTaxBenefits_637091324806352308" xlink:title="presentation:  to " use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAccruedLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedConstructionInProgressCurrent" xlink:label="nxtc_AccruedConstructionInProgressCurrent_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="nxtc_AccruedConstructionInProgressCurrent_637091324806231982" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_637091324806231982" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedClinicalTrialCostsCurrent" xlink:label="nxtc_AccruedClinicalTrialCostsCurrent_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="nxtc_AccruedClinicalTrialCostsCurrent_637091324806231982" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedOperatingExpensesCurrent" xlink:label="nxtc_AccruedOperatingExpensesCurrent_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="nxtc_AccruedOperatingExpensesCurrent_637091324806231982" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AccruedFinancingCostsCurrent" xlink:label="nxtc_AccruedFinancingCostsCurrent_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="nxtc_AccruedFinancingCostsCurrent_637091324806231982" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRentCurrent" xlink:label="us-gaap_AccruedRentCurrent_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedRentCurrent_637091324806231982" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_InterestPayableCurrent_637091324806231982" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent_637091324806231982" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedStatementsOfOperationsAndComprehensiveLossQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_637091327026061844" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract_637091327026061844" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637091327026061844" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRevenueExtensibleList" xlink:label="us-gaap_TypeOfRevenueExtensibleList_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract_637091327026061844" xlink:to="us-gaap_TypeOfRevenueExtensibleList_637091327026061844" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_637091327026061844" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637091327026061844" xlink:to="us-gaap_ResearchAndDevelopmentExpense_637091327026061844" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637091327026061844" xlink:to="us-gaap_GeneralAndAdministrativeExpense_637091327026061844" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_637091327026061844" xlink:to="us-gaap_OperatingExpenses_637091327026061844" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss_637091327026061844" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_637091327026071812" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_637091327026071812" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_637091327026071812" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_637091327026071812" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_637091327026071812" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_637091327026071812" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_637091327026071812" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_637091327026071812" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_637091327026071812" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedStatementsOfCashFlowsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_ProfitLoss_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637091327026091757" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_ShareBasedCompensation_637091327026091757" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091327026091757" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091327026091757" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091327026091757" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_637091327026091757" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091327026091757" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_637091327026091757" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:label="nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091327026091757" xlink:to="nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty_637091327026091757" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091327026091757" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091327026091757" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637091327026091757" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_637091327026091757" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_637091327026091757" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091327026091757" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091327026091757" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_637091327026101731" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_RepaymentsOfDebt_637091327026101731" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_PaymentsOfFinancingCosts_637091327026101731" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091327026101731" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091327026091757" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_637091327026101731" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637091327026101731" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637091327026101731" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6370913270261017311" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6370913270261017311" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_637091327026101731" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_637091327026101731" xlink:to="us-gaap_InterestPaidNet_637091327026101731" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637091327026101731" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637091327026101731" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_637091327026101731" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637091327026101731" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_637091327026101731" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock" xlink:label="nxtc_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_637091327026101731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637091327026101731" xlink:to="nxtc_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock_637091327026101731" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637091324806142866" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637091324806142866" xlink:to="us-gaap_ProfitLoss_637091324806142866" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637091324806142866" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637091324806142866" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637091324806142866" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637091324806142866" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_637091324806142866" xlink:to="us-gaap_ShareBasedCompensation_637091324806142866" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_637091324806142866" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091324806142866" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091324806142866" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637091324806142866" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091324806142866" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_637091324806142866" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091324806142866" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_637091324806142866" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091324806142866" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_637091324806152833" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091324806142866" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_637091324806152833" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty" xlink:label="nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091324806142866" xlink:to="nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty_637091324806152833" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_637091324806142866" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_637091324806152833" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637091324806152833" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637091324806152833" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_637091324806152833" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_637091324806152833" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_637091324806152833" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091324806152833" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091324806152833" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091324806152833" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091324806152833" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_637091324806152833" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091324806152833" xlink:to="us-gaap_RepaymentsOfDebt_637091324806152833" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091324806152833" xlink:to="us-gaap_PaymentsOfFinancingCosts_637091324806152833" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_637091324806152833" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_637091324806152833" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_637091324806152833" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_637091324806152833" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6370913248061528331" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6370913248061528331" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_637091324806152833" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_637091324806152833" xlink:to="us-gaap_InterestPaidNet_637091324806152833" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637091324806152833" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_637091324806152833" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637091324806152833" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_637091324806152833" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_637091324806162806" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract_637091324806152833" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_637091324806162806" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDeferredRevenueIncludedInBalanceSheetsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementDisclosureAbstract" xlink:label="nxtc_CollaborativeArrangementDisclosureAbstract_636946485196235018" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:label="us-gaap_ChangeInContractWithCustomerLiabilityAbstract_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nxtc_CollaborativeArrangementDisclosureAbstract_636946485196235018" xlink:to="us-gaap_ChangeInContractWithCustomerLiabilityAbstract_637091327026171678" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenue" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenue_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInContractWithCustomerLiabilityAbstract_637091327026171678" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenue_637091327026171678" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenue" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenue_6370913270261716781" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInContractWithCustomerLiabilityAbstract_637091327026171678" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenue_6370913270261716781" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueUpFrontPayment" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInContractWithCustomerLiabilityAbstract_637091327026171678" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueUpFrontPayment_637091327026171678" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInContractWithCustomerLiabilityAbstract_637091327026171678" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment_637091327026171678" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInContractWithCustomerLiabilityAbstract_637091327026171678" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment_637091327026171678" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInContractWithCustomerLiabilityAbstract_637091327026171678" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized_637091327026171678" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInContractWithCustomerLiabilityAbstract_637091327026171678" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent_637091327026171678" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInContractWithCustomerLiabilityAbstract_637091327026171678" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent_637091327026171678" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091324806052732" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable_637091324806052732" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091324806072395" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806052732" xlink:to="us-gaap_StatementClassOfStockAxis_637091324806072395" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091324806072395" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806072395" xlink:to="us-gaap_ClassOfStockDomain_637091324806072395" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806072395" xlink:to="us-gaap_SeriesAPreferredStockMember_637091324806092366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806072395" xlink:to="us-gaap_SeriesBPreferredStockMember_637091324806092366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806052732" xlink:to="us-gaap_StatementLineItems_637091324806092366" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806092366" xlink:to="us-gaap_AssetsAbstract_637091324806092366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637091324806092366" xlink:to="us-gaap_AssetsCurrentAbstract_637091324806092366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637091324806092366" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091324806092366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637091324806092366" xlink:to="us-gaap_RestrictedCashCurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637091324806092366" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637091324806092366" xlink:to="us-gaap_AssetsCurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637091324806092366" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637091324806092366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637091324806092366" xlink:to="us-gaap_OtherAssetsNoncurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637091324806092366" xlink:to="us-gaap_Assets_637091324806092366" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806092366" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091324806092366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091324806092366" xlink:to="us-gaap_LiabilitiesCurrentAbstract_637091324806092366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091324806092366" xlink:to="us-gaap_AccountsPayableCurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091324806092366" xlink:to="us-gaap_AccruedLiabilitiesCurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091324806092366" xlink:to="us-gaap_DeferredRentCreditCurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091324806092366" xlink:to="us-gaap_LongTermDebtCurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091324806092366" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091324806092366" xlink:to="us-gaap_LiabilitiesCurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent_637091324806092366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091324806092366" xlink:to="us-gaap_DeferredRentCreditNoncurrent_637091324806092366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091324806092366" xlink:to="us-gaap_LongTermDebtNoncurrent_637091324806102325" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091324806092366" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent_637091324806102325" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091324806092366" xlink:to="us-gaap_Liabilities_637091324806102325" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091324806092366" xlink:to="us-gaap_CommitmentsAndContingencies_637091324806102325" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PreferredStockAbstract" xlink:label="nxtc_PreferredStockAbstract_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091324806092366" xlink:to="nxtc_PreferredStockAbstract_637091324806102325" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nxtc_PreferredStockAbstract_637091324806102325" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091324806102325" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091324806092366" xlink:to="us-gaap_StockholdersEquityAbstract_637091324806102325" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091324806102325" xlink:to="us-gaap_CommonStockValue_637091324806102325" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091324806102325" xlink:to="us-gaap_AdditionalPaidInCapital_637091324806102325" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091324806102325" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_637091324806102325" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091324806102325" xlink:to="us-gaap_StockholdersEquity_637091324806102325" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091324806102325" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_637091324806102325" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable_637091324806102325" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806102325" xlink:to="us-gaap_StatementClassOfStockAxis_637091324806102325" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806102325" xlink:to="us-gaap_ClassOfStockDomain_637091324806102325" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806102325" xlink:to="us-gaap_SeriesAPreferredStockMember_637091324806102325" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember_637091324806102325" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806102325" xlink:to="us-gaap_SeriesBPreferredStockMember_637091324806102325" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806102325" xlink:to="us-gaap_StatementLineItems_637091324806112947" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806112947" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_637091324806112947" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806112947" xlink:to="us-gaap_PreferredStockSharesAuthorized_637091324806112947" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806112947" xlink:to="us-gaap_PreferredStockSharesIssued_637091324806112947" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806112947" xlink:to="us-gaap_PreferredStockSharesOutstanding_637091324806112947" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806112947" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_637091324806112947" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806112947" xlink:to="us-gaap_CommonStockSharesAuthorized_637091324806112947" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806112947" xlink:to="us-gaap_CommonStockSharesIssued_637091324806112947" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806112947" xlink:to="us-gaap_CommonStockSharesOutstanding_637091324806112947" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficit">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091324806112947" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806112947" xlink:to="us-gaap_StatementClassOfStockAxis_637091324806122894" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806122894" xlink:to="us-gaap_ClassOfStockDomain_637091324806122894" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806122894" xlink:to="us-gaap_SeriesAPreferredStockMember_637091324806122894" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series2PreferredStockMember" xlink:label="nxtc_Series2PreferredStockMember_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806122894" xlink:to="nxtc_Series2PreferredStockMember_637091324806122894" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806122894" xlink:to="nxtc_Series3PreferredStockMember_637091324806122894" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806122894" xlink:to="us-gaap_SeriesBPreferredStockMember_637091324806122894" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806112947" xlink:to="us-gaap_StatementLineItems_637091324806122894" xlink:title="presentation:  to " use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806122894" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_StockholdersEquity_637091324806122894" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_6370913248061228941" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_StockholdersEquity_6370913248061228941" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_CommonStockSharesOutstanding_637091324806122894" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_CommonStockSharesOutstanding_637091324806142866" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091324806122894" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091324806142866" xlink:title="presentation:  to " use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_637091324806122894" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_637091324806142866" xlink:title="presentation:  to " use="optional" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_637091324806122894" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_637091324806122894" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues_637091324806122894" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637091324806122894" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091324806122894" xlink:to="us-gaap_NetIncomeLoss_637091324806122894" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806112947" xlink:to="us-gaap_StatementEquityComponentsAxis_637091324806112947" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091324806112947" xlink:to="us-gaap_PreferredStockMember_637091324806112947" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_637091324806112947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091324806112947" xlink:to="us-gaap_CommonStockMember_637091324806112947" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091324806112947" xlink:to="us-gaap_AdditionalPaidInCapitalMember_637091324806122894" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091324806112947" xlink:to="us-gaap_RetainedEarningsMember_637091324806122894" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637091324806122894" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091324806112947" xlink:to="us-gaap_EquityComponentDomain_637091324806122894" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable_637091324806112947" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficitParenthetical">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091324806142866" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806142866" xlink:to="us-gaap_StatementClassOfStockAxis_637091324806142866" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806142866" xlink:to="us-gaap_ClassOfStockDomain_637091324806142866" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806142866" xlink:to="us-gaap_SeriesBPreferredStockMember_637091324806142866" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series2PreferredStockMember" xlink:label="nxtc_Series2PreferredStockMember_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806142866" xlink:to="nxtc_Series2PreferredStockMember_637091324806142866" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806142866" xlink:to="nxtc_Series3PreferredStockMember_637091324806142866" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806142866" xlink:to="us-gaap_StatementLineItems_637091324806142866" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_637091324806142866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806142866" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_637091324806142866" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable_637091324806142866" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanOtherDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091324806252169" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806252169" xlink:to="us-gaap_StatementLineItems_637091324806252169" xlink:title="presentation:  to " use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806252169" xlink:to="us-gaap_DebtInstrumentFaceAmount_637091324806252169" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806252169" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_637091324806252169" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806252169" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_637091324806252169" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DebtInstrumentMonthlyPaymentsNumber" xlink:label="nxtc_DebtInstrumentMonthlyPaymentsNumber_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806252169" xlink:to="nxtc_DebtInstrumentMonthlyPaymentsNumber_637091324806252169" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806252169" xlink:to="us-gaap_InterestExpense_637091324806252169" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806252169" xlink:to="us-gaap_VariableRateAxis_637091324806252169" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis_637091324806252169" xlink:to="us-gaap_VariableRateDomain_637091324806252169" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain_637091324806252169" xlink:to="us-gaap_PrimeRateMember_637091324806252169" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806252169" xlink:to="srt_RangeAxis_637091324806252169" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637091324806252169" xlink:to="srt_RangeMember_637091324806252169" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637091324806252169" xlink:to="srt_MaximumMember_637091324806252169" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_StatementTable_637091324806252169" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureIncomeTaxesReconciliationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091324806332348" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806332348" xlink:to="us-gaap_StatementLineItems_637091324806332348" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091324806332348" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_637091324806332348" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_637091324806332348" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_637091324806332348" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_637091324806332348" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:label="nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" xlink:to="nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_637091324806342320" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_637091324806342320" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_637091324806342320" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_637091324806342320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_637091324806332348" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_637091324806342320" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091324806332348" xlink:to="srt_RangeAxis_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637091324806332348" xlink:to="srt_RangeMember_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637091324806332348" xlink:to="srt_MaximumMember_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_StatementTable_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedBalanceSheetsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091327025892293" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable_637091327025892293" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091327025892293" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327025892293" xlink:to="us-gaap_StatementClassOfStockAxis_637091327025892293" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091327025892293" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091327025892293" xlink:to="us-gaap_ClassOfStockDomain_637091327025892293" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember_637091327025902265" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091327025892293" xlink:to="us-gaap_SeriesAPreferredStockMember_637091327025902265" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember_637091327025902265" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091327025892293" xlink:to="us-gaap_SeriesBPreferredStockMember_637091327025902265" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091327025902265" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327025892293" xlink:to="us-gaap_StatementLineItems_637091327025902265" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_637091327025902265" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327025902265" xlink:to="us-gaap_AssetsAbstract_637091327025902265" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_637091327025902265" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637091327025902265" xlink:to="us-gaap_AssetsCurrentAbstract_637091327025902265" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091327025902265" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637091327025902265" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637091327025902265" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent_637091327025902265" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637091327025902265" xlink:to="us-gaap_RestrictedCashCurrent_637091327025902265" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637091327025902265" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637091327025902265" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637091327025902265" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_637091327025902265" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637091327025902265" xlink:to="us-gaap_AssetsCurrent_637091327025902265" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_637091327025902265" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_637091327025902265" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_637091327025902265" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637091327025902265" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637091327025912238" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637091327025902265" xlink:to="us-gaap_OtherAssetsNoncurrent_637091327025912238" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_637091327025902265" xlink:to="us-gaap_Assets_637091327025912238" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327025902265" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091327025912238" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091327025912238" xlink:to="us-gaap_LiabilitiesCurrentAbstract_637091327025912238" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091327025912238" xlink:to="us-gaap_AccountsPayableCurrent_637091327025912238" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091327025912238" xlink:to="us-gaap_AccruedLiabilitiesCurrent_637091327025912238" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091327025912238" xlink:to="us-gaap_DeferredRentCreditCurrent_637091327025912238" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091327025912238" xlink:to="us-gaap_LongTermDebtCurrent_637091327025912238" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueCurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091327025912238" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueCurrent_637091327025912238" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_637091327025912238" xlink:to="us-gaap_LiabilitiesCurrent_637091327025912238" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091327025912238" xlink:to="us-gaap_DeferredRentCreditNoncurrent_637091327025912238" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091327025912238" xlink:to="us-gaap_LongTermDebtNoncurrent_637091327025912238" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent" xlink:label="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent_637091327025912238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091327025912238" xlink:to="nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent_637091327025912238" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091327025912238" xlink:to="us-gaap_Liabilities_637091327025922213" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091327025912238" xlink:to="us-gaap_CommitmentsAndContingencies_637091327025922213" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PreferredStockAbstract" xlink:label="nxtc_PreferredStockAbstract_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091327025912238" xlink:to="nxtc_PreferredStockAbstract_637091327025922213" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nxtc_PreferredStockAbstract_637091327025922213" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091327025922213" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_637091327025912238" xlink:to="us-gaap_StockholdersEquityAbstract_637091327025922213" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091327025922213" xlink:to="us-gaap_CommonStockValue_637091327025922213" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091327025922213" xlink:to="us-gaap_AdditionalPaidInCapital_637091327025922213" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091327025922213" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_637091327025922213" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091327025922213" xlink:to="us-gaap_StockholdersEquity_637091327025922213" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091327025922213" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_637091327025922213" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091327025922213" xlink:to="us-gaap_PreferredStockValue_637091327025922213" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_637091327025922213" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_637091327025922213" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_637091327025922213" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedBalanceSheetsParentheticalQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091327026051871" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable_637091327026051871" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091327026051871" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327026051871" xlink:to="us-gaap_StatementClassOfStockAxis_637091327026051871" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091327026051871" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091327026051871" xlink:to="us-gaap_ClassOfStockDomain_637091327026051871" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember_637091327026051871" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091327026051871" xlink:to="us-gaap_SeriesAPreferredStockMember_637091327026051871" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember_637091327026051871" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091327026051871" xlink:to="us-gaap_SeriesBPreferredStockMember_637091327026051871" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091327026051871" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327026051871" xlink:to="us-gaap_StatementLineItems_637091327026051871" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026051871" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_637091327026061844" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026051871" xlink:to="us-gaap_PreferredStockSharesAuthorized_637091327026061844" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026051871" xlink:to="us-gaap_PreferredStockSharesIssued_637091327026061844" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026051871" xlink:to="us-gaap_PreferredStockSharesOutstanding_637091327026061844" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026051871" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_637091327026061844" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026051871" xlink:to="us-gaap_CommonStockSharesAuthorized_637091327026061844" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026051871" xlink:to="us-gaap_CommonStockSharesIssued_637091327026061844" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637091327026061844" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026051871" xlink:to="us-gaap_CommonStockSharesOutstanding_637091327026061844" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091327026071812" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327026071812" xlink:to="us-gaap_StatementClassOfStockAxis_637091327026071812" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091327026071812" xlink:to="us-gaap_ClassOfStockDomain_637091327026071812" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091327026071812" xlink:to="us-gaap_SeriesAPreferredStockMember_637091327026071812" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091327026071812" xlink:to="nxtc_Series3PreferredStockMember_637091327026071812" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091327026071812" xlink:to="us-gaap_SeriesBPreferredStockMember_637091327026071812" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327026071812" xlink:to="us-gaap_StatementLineItems_637091327026081785" xlink:title="presentation:  to " use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026081785" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_StockholdersEquity_637091327026081785" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_6370913270260817851" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_StockholdersEquity_6370913270260817851" xlink:title="presentation:  to " use="optional" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_CommonStockSharesOutstanding_637091327026081785" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_6370913270260817851" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_CommonStockSharesOutstanding_6370913270260817851" xlink:title="presentation:  to " use="optional" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_637091327026081785" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_6370913270260817851" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_6370913270260817851" xlink:title="presentation:  to " use="optional" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_637091327026081785" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_6370913270260817851" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_6370913270260817851" xlink:title="presentation:  to " use="optional" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_637091327026081785" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_637091327026081785" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues_637091327026081785" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637091327026081785" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_NetIncomeLoss_637091327026081785" xlink:title="presentation:  to " use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:label="nxtc_StockIssuedDuringPeriodValueInitialPublicOffering_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="nxtc_StockIssuedDuringPeriodValueInitialPublicOffering_637091327026081785" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nxtc_StockIssuedDuringPeriodValueInitialPublicOffering_637091327026081785" xlink:to="nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering_637091327026081785" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_637091327026081785" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_637091327026081785" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_637091327026081785" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_637091327026081785" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_637091327026081785" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_637091327026081785" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327026071812" xlink:to="us-gaap_StatementEquityComponentsAxis_637091327026071812" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091327026071812" xlink:to="us-gaap_PreferredStockMember_637091327026071812" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091327026071812" xlink:to="us-gaap_CommonStockMember_637091327026071812" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091327026071812" xlink:to="us-gaap_AdditionalPaidInCapitalMember_637091327026071812" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091327026071812" xlink:to="us-gaap_RetainedEarningsMember_637091327026071812" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091327026071812" xlink:to="us-gaap_EquityComponentDomain_637091327026071812" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_637091327026071812" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_637091327026071812" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_637091327026071812" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable_637091327026071812" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitParentheticalQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091327026091757" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327026091757" xlink:to="us-gaap_StatementClassOfStockAxis_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091327026091757" xlink:to="us-gaap_ClassOfStockDomain_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091327026091757" xlink:to="nxtc_Series3PreferredStockMember_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327026091757" xlink:to="us-gaap_StatementLineItems_637091327026091757" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026091757" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_637091327026091757" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_637091327026091757" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026091757" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable_637091327026091757" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureTermLoanOtherDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_637091327026181654" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327026181654" xlink:to="us-gaap_StatementLineItems_637091327026181654" xlink:title="presentation:  to " use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026181654" xlink:to="us-gaap_DebtInstrumentFaceAmount_637091327026181654" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026181654" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_637091327026181654" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026181654" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_637091327026181654" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DebtInstrumentMonthlyPaymentsNumber" xlink:label="nxtc_DebtInstrumentMonthlyPaymentsNumber_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026181654" xlink:to="nxtc_DebtInstrumentMonthlyPaymentsNumber_637091327026181654" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_637091327026181654" xlink:to="us-gaap_InterestExpense_637091327026181654" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327026181654" xlink:to="us-gaap_VariableRateAxis_637091327026181654" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis_637091327026181654" xlink:to="us-gaap_VariableRateDomain_637091327026181654" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain_637091327026181654" xlink:to="us-gaap_PrimeRateMember_637091327026181654" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_637091327026181654" xlink:to="srt_RangeAxis_637091327026181654" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637091327026181654" xlink:to="srt_RangeMember_637091327026181654" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637091327026181654" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637091327026181654" xlink:to="srt_MaximumMember_637091327026181654" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_StatementTable_637091327026181654" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091324806202138" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806202138" xlink:to="us-gaap_ClassOfStockDomain_637091324806202138" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806202138" xlink:to="nxtc_Series3PreferredStockMember_637091324806202138" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB1PreferredStockMember" xlink:label="nxtc_SeriesB1PreferredStockMember_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806202138" xlink:to="nxtc_SeriesB1PreferredStockMember_637091324806202138" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB2PreferredStockMember" xlink:label="nxtc_SeriesB2PreferredStockMember_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806202138" xlink:to="nxtc_SeriesB2PreferredStockMember_637091324806202138" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB3PreferredStockMember" xlink:label="nxtc_SeriesB3PreferredStockMember_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806202138" xlink:to="nxtc_SeriesB3PreferredStockMember_637091324806202138" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable_637091324806202138" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637091324806202138" xlink:to="us-gaap_StatementClassOfStockAxis_637091324806202138" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637091324806202138" xlink:to="us-gaap_ClassOfStockLineItems_637091324806202138" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806202138" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637091324806202138" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806202138" xlink:to="us-gaap_SharePrice_637091324806202138" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806202138" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091324806202138" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806202138" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_637091324806202138" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments_637091324806202138" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806202138" xlink:to="us-gaap_NumberOfOperatingSegments_637091324806202138" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091324806262538" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806262538" xlink:to="us-gaap_ClassOfStockDomain_637091324806262538" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806262538" xlink:to="us-gaap_SeriesAPreferredStockMember_637091324806262538" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series1PreferredStockMember" xlink:label="nxtc_Series1PreferredStockMember_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SeriesAPreferredStockMember_637091324806262538" xlink:to="nxtc_Series1PreferredStockMember_637091324806262538" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series2PreferredStockMember" xlink:label="nxtc_Series2PreferredStockMember_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SeriesAPreferredStockMember_637091324806262538" xlink:to="nxtc_Series2PreferredStockMember_637091324806262538" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_Series3PreferredStockMember" xlink:label="nxtc_Series3PreferredStockMember_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SeriesAPreferredStockMember_637091324806262538" xlink:to="nxtc_Series3PreferredStockMember_637091324806262538" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806262538" xlink:to="us-gaap_SeriesBPreferredStockMember_637091324806262538" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB1PreferredStockMember" xlink:label="nxtc_SeriesB1PreferredStockMember_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SeriesBPreferredStockMember_637091324806262538" xlink:to="nxtc_SeriesB1PreferredStockMember_637091324806262538" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB2PreferredStockMember" xlink:label="nxtc_SeriesB2PreferredStockMember_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SeriesBPreferredStockMember_637091324806262538" xlink:to="nxtc_SeriesB2PreferredStockMember_637091324806262538" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB1AndB2PreferredStockMember" xlink:label="nxtc_SeriesB1AndB2PreferredStockMember_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SeriesBPreferredStockMember_637091324806262538" xlink:to="nxtc_SeriesB1AndB2PreferredStockMember_637091324806262538" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB3PreferredStockMember" xlink:label="nxtc_SeriesB3PreferredStockMember_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SeriesBPreferredStockMember_637091324806262538" xlink:to="nxtc_SeriesB3PreferredStockMember_637091324806262538" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable_637091324806252169" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637091324806252169" xlink:to="us-gaap_StatementClassOfStockAxis_637091324806262538" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable_637091324806252169" xlink:to="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637091324806262538" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_SharePrice_637091324806262538" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091324806272528" xlink:title="presentation:  to " use="optional" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_PreferredStockSharesAuthorized_637091324806262538" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_637091324806262538" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_PreferredStockSharesIssued_637091324806262538" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_PreferredStockSharesOutstanding_637091324806262538" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_PreferredStockValue_637091324806262538" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalPreferredStock" xlink:label="us-gaap_AdditionalPaidInCapitalPreferredStock_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_AdditionalPaidInCapitalPreferredStock_637091324806262538" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_PreferredStockDividendRatePercentage_637091324806262538" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_PreferredStockDividendsPerShareDeclared_637091324806262538" xlink:title="presentation:  to " use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect" xlink:label="nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect_637091324806262538" xlink:title="presentation:  to " use="optional" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PreferredStockConvertibleConversionRatio" xlink:label="nxtc_PreferredStockConvertibleConversionRatio_637091324806262538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="nxtc_PreferredStockConvertibleConversionRatio_637091324806262538" xlink:title="presentation:  to " use="optional" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock" xlink:label="nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock_637091324806272528" xlink:title="presentation:  to " use="optional" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="us-gaap_PreferredStockLiquidationPreference_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_637091324806262538" xlink:to="us-gaap_PreferredStockLiquidationPreference_637091324806272528" xlink:title="presentation:  to " use="optional" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable_637091324806252169" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureRelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_637091324806352308" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_637091324806352308" xlink:to="us-gaap_ClassOfStockDomain_637091324806352308" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SeriesB3PreferredStockMember" xlink:label="nxtc_SeriesB3PreferredStockMember_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_637091324806352308" xlink:to="nxtc_SeriesB3PreferredStockMember_637091324806352308" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_637091324806352308" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_637091324806352308" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324806352308" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" xlink:label="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324806352308" xlink:to="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember_637091324806352308" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ConsultingAgreementMember" xlink:label="nxtc_ConsultingAgreementMember_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324806352308" xlink:to="nxtc_ConsultingAgreementMember_637091324806352308" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_YaleLicenseAgreementMember" xlink:label="nxtc_YaleLicenseAgreementMember_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324806352308" xlink:to="nxtc_YaleLicenseAgreementMember_637091324806352308" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SponsoredResearchAgreementMember" xlink:label="nxtc_SponsoredResearchAgreementMember_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324806352308" xlink:to="nxtc_SponsoredResearchAgreementMember_637091324806352308" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637091324806352308" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637091324806352308" xlink:to="us-gaap_TypeOfArrangementAxis_637091324806352308" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637091324806352308" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637091324806352308" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_637091324806352308" xlink:to="us-gaap_RelatedPartyDomain_637091324806352308" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EliLillyAndCompanyMember" xlink:label="nxtc_EliLillyAndCompanyMember_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_637091324806352308" xlink:to="nxtc_EliLillyAndCompanyMember_637091324806352308" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ScientificFounderMember" xlink:label="nxtc_ScientificFounderMember_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_637091324806352308" xlink:to="nxtc_ScientificFounderMember_637091324806352308" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_YaleUniversityMember" xlink:label="nxtc_YaleUniversityMember_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_637091324806352308" xlink:to="nxtc_YaleUniversityMember_637091324806352308" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637091324806352308" xlink:to="us-gaap_StatementClassOfStockAxis_637091324806352308" xlink:title="presentation:  to " use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_637091324806352308" xlink:to="us-gaap_RelatedPartyTransactionLineItems_637091324806352308" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:label="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_637091324806352308" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637091324806352308" xlink:to="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_637091324806352308" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637091324806352308" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091324806362221" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty" xlink:label="nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637091324806352308" xlink:to="nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty_637091324806362221" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637091324806352308" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_637091324806362221" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct" xlink:label="nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637091324806352308" xlink:to="nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct_637091324806362221" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram" xlink:label="nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637091324806352308" xlink:to="nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram_637091324806362221" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionAggregatePaymentsMade" xlink:label="nxtc_RelatedPartyTransactionAggregatePaymentsMade_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637091324806352308" xlink:to="nxtc_RelatedPartyTransactionAggregatePaymentsMade_637091324806362221" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RelatedPartyTransactionPaymentsMade" xlink:label="nxtc_RelatedPartyTransactionPaymentsMade_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_637091324806352308" xlink:to="nxtc_RelatedPartyTransactionPaymentsMade_637091324806362221" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis_637091324806362221" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis_637091324806362221" xlink:to="us-gaap_VariableRateDomain_637091324806362221" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain_637091324806362221" xlink:to="us-gaap_PrimeRateMember_637091324806362221" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637091324806362221" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637091324806362221" xlink:to="srt_RangeMember_637091324806362221" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637091324806362221" xlink:to="srt_MaximumMember_637091324806362221" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable_637091324806362221" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_637091324806362221" xlink:to="us-gaap_SubsequentEventTypeAxis_637091324806362221" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis_637091324806362221" xlink:to="us-gaap_SubsequentEventTypeDomain_637091324806362221" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain_637091324806362221" xlink:to="us-gaap_SubsequentEventMember_637091324806362221" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_637091324806362221" xlink:to="srt_RangeAxis_637091324806362221" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_637091324806362221" xlink:to="us-gaap_VariableRateAxis_637091324806362221" xlink:title="presentation:  to " use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_637091324806362221" xlink:to="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:to="us-gaap_DebtInstrumentFaceAmount_637091324806362221" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_DebtInstrumentMonthlyPaymentsNumber" xlink:label="nxtc_DebtInstrumentMonthlyPaymentsNumber_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:to="nxtc_DebtInstrumentMonthlyPaymentsNumber_637091324806362221" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_637091324806362221" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_637091324806362221" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_637091324806372238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_637091324806372238" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty_637091324806372238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:to="us-gaap_AreaOfRealEstateProperty_637091324806372238" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PeriodForWhichBaseRentIsAbated" xlink:label="nxtc_PeriodForWhichBaseRentIsAbated_637091324806372238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:to="nxtc_PeriodForWhichBaseRentIsAbated_637091324806372238" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_AnnualBaseRentPerMonthAfterAbatement" xlink:label="nxtc_AnnualBaseRentPerMonthAfterAbatement_637091324806372238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:to="nxtc_AnnualBaseRentPerMonthAfterAbatement_637091324806372238" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PercentageOfAnnualIncreaseInLeaseRent" xlink:label="nxtc_PercentageOfAnnualIncreaseInLeaseRent_637091324806372238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:to="nxtc_PercentageOfAnnualIncreaseInLeaseRent_637091324806372238" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_637091324806372238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_637091324806372238" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_637091324806372238" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091324806362221" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_637091324806372238" xlink:title="presentation:  to " use="optional" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable_637091324806362221" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensation2015OmnibusIncentivePlanDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637091324806272528" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637091324806272528" xlink:to="srt_RangeMember_637091324806272528" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637091324806272528" xlink:to="srt_MaximumMember_637091324806272528" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806272528" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806272528" xlink:to="srt_RangeAxis_637091324806272528" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806272528" xlink:to="us-gaap_PlanNameAxis_637091324806272528" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_637091324806272528" xlink:to="us-gaap_PlanNameDomain_637091324806272528" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_A2015OmnibusIncentivePlanMember" xlink:label="nxtc_A2015OmnibusIncentivePlanMember_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637091324806272528" xlink:to="nxtc_A2015OmnibusIncentivePlanMember_637091324806272528" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806272528" xlink:to="us-gaap_AwardTypeAxis_637091324806272528" xlink:title="presentation:  to " use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637091324806272528" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806272528" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806272528" xlink:to="us-gaap_EmployeeStockOptionMember_637091324806272528" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806272528" xlink:to="us-gaap_RestrictedStockMember_637091324806272528" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806272528" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806272528" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare" xlink:label="nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_637091324806272528" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806272528" xlink:to="nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare_637091324806272528" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806272528" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward_637091324806282483" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806272528" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_637091324806282483" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806272528" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_637091324806282483" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806272528" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_637091324806282483" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806272528" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637091324806282483" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_637091327026191626" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_637091327026191626" xlink:to="srt_RangeMember_637091327026191626" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637091327026191626" xlink:to="srt_MaximumMember_637091327026191626" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_637091327026191626" xlink:to="srt_MinimumMember_637091327026191626" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_636915319547421245" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_636915319547421245" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091327026191626" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091327026191626" xlink:to="srt_RangeAxis_637091327026191626" xlink:title="presentation:  to " use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091327026191626" xlink:to="us-gaap_PlanNameAxis_637091327026191626" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_637091327026191626" xlink:to="us-gaap_PlanNameDomain_637091327026191626" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_A2015OmnibusIncentivePlanMember" xlink:label="nxtc_A2015OmnibusIncentivePlanMember_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637091327026191626" xlink:to="nxtc_A2015OmnibusIncentivePlanMember_637091327026191626" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_OmnibusIncentive2019PlanMember" xlink:label="nxtc_OmnibusIncentive2019PlanMember_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637091327026191626" xlink:to="nxtc_OmnibusIncentive2019PlanMember_637091327026191626" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember" xlink:label="nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637091327026191626" xlink:to="nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember_637091327026191626" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EmployeeStockPurchase2019PlanMember" xlink:label="nxtc_EmployeeStockPurchase2019PlanMember_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637091327026191626" xlink:to="nxtc_EmployeeStockPurchase2019PlanMember_637091327026191626" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091327026191626" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637091327026191626" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_637091327026201602" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091327026201602" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091327026201602" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637091327026201602" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6370913270262016021" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091327026201602" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6370913270262016021" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091327026201602" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_637091327026201602" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091327026201602" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637091327026201602" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091327026201602" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_637091327026201602" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091327026201602" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_637091327026201602" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091327026201602" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_637091327026201602" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091327026211575" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091327026211575" xlink:title="presentation:  to " use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637091327026211575" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091327026211575" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637091327026211575" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637091327026231526" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091327026211575" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637091327026231526" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_637091327026211575" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091327026211575" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_637091327026211575" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637091327026211575" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091327026211575" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637091327026211575" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_637091327026211575" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091327026211575" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_637091327026211575" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_637091327026231526" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091327026211575" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_637091327026231526" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_637091327026231526" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091327026211575" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_637091327026231526" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:title="presentation:  to " use="optional" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_637091327026231526" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_637091327026231526" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_637091327026231526" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_637091327026231526" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_637091327026241495" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6370913270262414951" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6370913270262414951" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_637091327026241495" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_637091327026241495" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637091327026241495" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_637091327026241495" xlink:title="presentation:  to " use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_637091327026231526" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm_637091327026231526" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_637091327026231526" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091327026231526" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm_637091327026231526" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock" xlink:label="nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock_637091327026191626" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm" xlink:label="nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm_637091327026191626" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod_637091327026201602" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_637091327026201602" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding" xlink:label="nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding_637091327026201602" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan" xlink:label="nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_637091327026201602" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091327026191626" xlink:to="nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan_637091327026201602" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091327026191626" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637091327026191626" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637091327026191626" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_637091327026191626" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637091327026191626" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_637091327026191626" xlink:to="us-gaap_EmployeeStockOptionMember_637091327026191626" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091324806212139" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091324806212139" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637091324806212139" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637091324806212139" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806212139" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806212139" xlink:to="us-gaap_ComputerEquipmentMember_637091324806212139" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806212139" xlink:to="us-gaap_EquipmentMember_637091324806212139" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806212139" xlink:to="us-gaap_FurnitureAndFixturesMember_637091324806212139" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091324806212139" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_637091324806212139" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_637091324806212139" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637091324806212139" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_637091324806212139" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091324806222258" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091324806222258" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637091324806222258" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637091324806222258" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806231982" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806231982" xlink:to="us-gaap_ComputerEquipmentMember_637091324806231982" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806231982" xlink:to="us-gaap_FurnitureAndFixturesMember_637091324806231982" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchEquipmentMember" xlink:label="nxtc_ResearchEquipmentMember_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806231982" xlink:to="nxtc_ResearchEquipmentMember_637091324806231982" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806231982" xlink:to="us-gaap_LeaseholdImprovementsMember_637091324806231982" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091324806231982" xlink:to="us-gaap_ConstructionInProgressMember_637091324806231982" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091324806222258" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_637091324806231982" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637091324806231982" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091324806231982" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091324806231982" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_637091324806231982" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091324806231982" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637091324806231982" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091324806231982" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637091324806231982" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091324806231982" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637091324806231982" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091324806222258" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091327026151731" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091327026151731" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_637091327026161708" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091327026161708" xlink:to="us-gaap_ComputerEquipmentMember_637091327026161708" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091327026161708" xlink:to="us-gaap_FurnitureAndFixturesMember_637091327026161708" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchEquipmentMember" xlink:label="nxtc_ResearchEquipmentMember_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091327026161708" xlink:to="nxtc_ResearchEquipmentMember_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091327026161708" xlink:to="us-gaap_LeaseholdImprovementsMember_637091327026161708" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_637091327026161708" xlink:to="us-gaap_ConstructionInProgressMember_637091327026161708" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091327026151731" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_637091327026161708" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_637091327026161708" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091327026161708" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091327026161708" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637091327026161708" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091327026161708" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637091327026161708" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract_637091327026161708" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637091327026161708" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_637091327026151731" xlink:title="presentation:  to " use="optional" order="1.0" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_637082166474633472" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_637082166474633472" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable_637091324806222258" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable_637091324806222258" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_637091324806222258" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementBasisAxis_637091324806222258" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091324806222258" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091324806222258" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember_637091324806222258" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091324806222258" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_637091324806222258" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable_637091324806222258" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_637091324806222258" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_637091324806222258" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091324806222258" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091324806222258" xlink:to="us-gaap_FairValueInputsLevel1Member_637091324806222258" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable_637091324806222258" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_637091324806222258" xlink:title="presentation:  to " use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_637091324806222258" xlink:to="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091324806222258" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091324806222258" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_637091324806222258" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091324806222258" xlink:to="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_637091324806222258" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_637091324806222258" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091324806222258" xlink:to="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_637091324806222258" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract_637082166474633472" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract_637082166474633472" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable_637091327026142366" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_637091327026151731" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementBasisAxis_637091327026151731" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091327026151731" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091327026151731" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember_637091327026151731" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember_637091327026151731" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_637091327026151731" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable_637091327026142366" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_637091327026151731" xlink:title="presentation:  to " use="optional" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_637091327026151731" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091327026151731" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091327026151731" xlink:to="us-gaap_FairValueInputsLevel1Member_637091327026151731" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_637091327026151731" xlink:to="us-gaap_FairValueInputsLevel2Member_637091327026151731" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable_637091327026142366" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_637091327026151731" xlink:title="presentation:  to " use="optional" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_637091327026151731" xlink:to="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091327026151731" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091327026151731" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_637091327026151731" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091327026151731" xlink:to="us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_637091327026151731" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091327026151731" xlink:to="us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_637091327026151731" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091327026151731" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637091327026151731" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_MarketableSecuritiesAndCashEquivalents" xlink:label="nxtc_MarketableSecuritiesAndCashEquivalents_637091327026151731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_637091327026151731" xlink:to="nxtc_MarketableSecuritiesAndCashEquivalents_637091327026151731" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable_637091327026142366" xlink:to="us-gaap_CashAndCashEquivalentsAxis_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis_637091327026142366" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_637091327026142366" xlink:to="us-gaap_MoneyMarketFundsMember_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_637091327026142366" xlink:to="us-gaap_USTreasurySecuritiesMember_637091327026142366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_637091327026142366" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_637091327026142366" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_637091327026142366" xlink:to="us-gaap_CorporateDebtSecuritiesMember_637091327026142366" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDetails">
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementDisclosureAbstract" xlink:label="nxtc_CollaborativeArrangementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nxtc_CollaborativeArrangementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637091324806231982" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637091324806231982" xlink:to="us-gaap_TypeOfArrangementAxis_637091324806231982" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_637091324806231982" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324806231982" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" xlink:label="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091324806231982" xlink:to="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember_637091324806231982" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_637091324806231982" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637091324806231982" xlink:to="srt_CounterpartyNameAxis_637091324806231982" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_637091324806231982" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_637091324806242194" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EliLillyAndCompanyMember" xlink:label="nxtc_EliLillyAndCompanyMember_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_637091324806242194" xlink:to="nxtc_EliLillyAndCompanyMember_637091324806242194" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637091324806231982" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:label="nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" xlink:to="nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_637091324806242194" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:label="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" xlink:to="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_637091324806242194" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091324806242194" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:label="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" xlink:to="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_637091324806242194" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:label="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" xlink:to="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_637091324806242194" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RevenueRecognitionNumberOfPerformanceObligations" xlink:label="nxtc_RevenueRecognitionNumberOfPerformanceObligations_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" xlink:to="nxtc_RevenueRecognitionNumberOfPerformanceObligations_637091324806242194" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637091324806242194" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" xlink:to="us-gaap_ContractWithCustomerLiability_637091324806242194" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PremiumFromIssuanceOfPreferredStock" xlink:label="nxtc_PremiumFromIssuanceOfPreferredStock_637091324806242194" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091324806242194" xlink:to="nxtc_PremiumFromIssuanceOfPreferredStock_637091324806242194" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyOtherDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementDisclosureAbstract" xlink:label="nxtc_CollaborativeArrangementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nxtc_CollaborativeArrangementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637091327026161708" xlink:to="us-gaap_TypeOfArrangementAxis_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_637091327026161708" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ResearchAndDevelopmentCollaborativeAgreementMember" xlink:label="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_637091327026161708" xlink:to="nxtc_ResearchAndDevelopmentCollaborativeAgreementMember_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637091327026161708" xlink:to="srt_CounterpartyNameAxis_637091327026161708" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis_637091327026161708" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_EliLillyAndCompanyMember" xlink:label="nxtc_EliLillyAndCompanyMember_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain_637091327026161708" xlink:to="nxtc_EliLillyAndCompanyMember_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_637091327026161708" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091327026161708" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement" xlink:label="nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091327026161708" xlink:to="nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement_637091327026161708" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived" xlink:label="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091327026161708" xlink:to="nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived_637091327026161708" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091327026161708" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_637091327026161708" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable" xlink:label="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091327026161708" xlink:to="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable_637091327026161708" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise" xlink:label="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091327026161708" xlink:to="nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise_637091327026161708" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_RevenueRecognitionNumberOfPerformanceObligations" xlink:label="nxtc_RevenueRecognitionNumberOfPerformanceObligations_637091327026161708" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091327026161708" xlink:to="nxtc_RevenueRecognitionNumberOfPerformanceObligations_637091327026161708" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091327026161708" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_637091327026171678" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_CollaborationAgreementTransactionPrice" xlink:label="nxtc_CollaborationAgreementTransactionPrice_637091327026171678" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_637091327026161708" xlink:to="nxtc_CollaborationAgreementTransactionPrice_637091327026171678" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_636915319547421245" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_636915319547421245" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806282483" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806282483" xlink:to="us-gaap_PlanNameAxis_637091324806282483" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_637091324806282483" xlink:to="us-gaap_PlanNameDomain_637091324806282483" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_A2015OmnibusIncentivePlanMember" xlink:label="nxtc_A2015OmnibusIncentivePlanMember_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637091324806282483" xlink:to="nxtc_A2015OmnibusIncentivePlanMember_637091324806282483" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806282483" xlink:to="us-gaap_AwardTypeAxis_637091324806282483" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806282483" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806282483" xlink:to="us-gaap_EmployeeStockOptionMember_637091324806282483" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806282483" xlink:to="us-gaap_RestrictedStockMember_637091324806282483" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806282483" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637091324806282483" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806282483" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_637091324806282483" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091324806282483" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_637091324806282483" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6370913248062824831" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6370913248062824831" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_637091324806282483" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091324806282483" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_637091324806282483" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_637091324806282483" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_637091324806282483" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_637091324806292457" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_637091324806292457" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_637091324806292457" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_637091324806292457" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091324806292457" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091324806292457" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637091324806292457" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091324806292457" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_637091324806292457" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6370913248062924571" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091324806292457" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6370913248062924571" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_637091324806292457" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091324806292457" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_637091324806292457" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637091324806292457" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091324806292457" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_637091324806292457" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_637091324806292457" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091324806292457" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_637091324806292457" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_637091324806292457" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091324806292457" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_637091324806292457" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_637091324806302440" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_637091324806292457" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_637091324806302440" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806282483" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_637091324806312401" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_637091324806312401" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_637091324806312401" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_637091324806312401" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_637091324806312401" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6370913248063124011" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6370913248063124011" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:label="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_637091324806312401" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_637091324806312401" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_637091324806312401" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_637091324806312401" xlink:title="presentation:  to " use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_637091324806312401" xlink:title="presentation:  to " use="optional" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_637091324806312401" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_637091324806312401" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_637091324806312401" xlink:title="presentation:  to " use="optional" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationRestrictedCommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_636915394149059079" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_636915394149059079" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806322376" xlink:to="us-gaap_PlanNameAxis_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_637091324806322376" xlink:to="us-gaap_PlanNameDomain_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_A2015OmnibusIncentivePlanMember" xlink:label="nxtc_A2015OmnibusIncentivePlanMember_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_637091324806322376" xlink:to="nxtc_A2015OmnibusIncentivePlanMember_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806322376" xlink:to="us-gaap_AwardTypeAxis_637091324806322376" xlink:title="presentation:  to " use="optional" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_637091324806322376" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_637091324806322376" xlink:to="us-gaap_RestrictedStockMember_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_637091324806322376" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806322376" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806322376" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_637091324806322376" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_637091324806332348" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAntiDilutiveEffectDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637091324806332348" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637091324806332348" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_637091324806332348" xlink:to="us-gaap_PreferredStockMember_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_637091324806332348" xlink:to="us-gaap_EmployeeStockOptionMember_637091324806332348" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_637091324806332348" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_637091324806332348" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_637091324806332348" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_637091324806332348" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_637091324806332348" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_637091324806332348" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637091324806322376" xlink:to="us-gaap_IncomeStatementLocationAxis_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_637091324806322376" xlink:to="us-gaap_IncomeStatementLocationDomain_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_637091324806322376" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_637091324806322376" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_637091324806322376" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637091324806322376" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637091324806322376" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637091324806322376" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_637091324806322376" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637091324806322376" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_637091324806322376" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_637091324806322376" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637091324806322376" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_637091324806322376" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637091327026241495" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637091327026241495" xlink:to="us-gaap_IncomeStatementLocationAxis_637091327026241495" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_637091327026241495" xlink:to="us-gaap_IncomeStatementLocationDomain_637091327026241495" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_637091327026241495" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_637091327026241495" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_637091327026241495" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_637091327026241495" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_637091327026241495" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637091327026241495" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_637091327026241495" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_637091327026241495" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_637091327026241495" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureNatureOfBusinessDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_SubsequentEventTable_637091327026131651" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_637091327026131651" xlink:to="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_637091327026131651" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_637091327026131651" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_SharePrice_637091327026131651" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_637091327026136717" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_637091327026136717" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="nxtc-20191112.xsd#nxtc_PaymentsOfUnderwritingDiscountsAndCommissions" xlink:label="nxtc_PaymentsOfUnderwritingDiscountsAndCommissions_637091327026136717" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="nxtc_PaymentsOfUnderwritingDiscountsAndCommissions_637091327026136717" xlink:title="presentation:  to " use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_637091327026136717" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_637091327026136717" xlink:title="presentation:  to " use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_637091327026136717" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_CommonStockSharesOutstanding_637091327026136717" xlink:title="presentation:  to " use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_637091327026136717" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_PreferredStockSharesOutstanding_637091327026136717" xlink:title="presentation:  to " use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_637091327026136717" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_CommonStockSharesAuthorized_637091327026136717" xlink:title="presentation:  to " use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_637091327026136717" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_637091327026136717" xlink:title="presentation:  to " use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_637091327026136717" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_PreferredStockSharesAuthorized_637091327026136717" xlink:title="presentation:  to " use="optional" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_637091327026136717" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems_637091327026131651" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_637091327026136717" xlink:title="presentation:  to " use="optional" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable_637091327026131651" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_637091327026131651" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_637091327026131651" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_637091327026131651" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_637091327026131651" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_637091327026131651" xlink:to="us-gaap_IPOMember_637091327026131651" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nextcure.com/role/DisclosureInvestmentsDetailsQuarterEnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable_637091327026142366" xlink:to="us-gaap_FinancialInstrumentAxis_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis_637091327026142366" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637091327026142366" xlink:to="us-gaap_USTreasurySecuritiesMember_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637091327026142366" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_637091327026142366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_637091327026142366" xlink:to="us-gaap_CorporateDebtSecuritiesMember_637091327026142366" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable_637091327026142366" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_637091327026142366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_637091327026142366" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_637091327026142366" xlink:title="presentation:  to " use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_637091327026142366" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_637091327026142366" xlink:title="presentation:  to " use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_637091327026142366" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_637091327026142366" xlink:title="presentation:  to " use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637091327026142366" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_637091327026142366" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637091327026142366" xlink:title="presentation:  to " use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g210032kii001.jpg
<DESCRIPTION>G210032KII001.JPG
<TEXT>
begin 644 g210032kii001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !? %\# 2(  A$! Q$!_\0
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=L@:0?W %)W<]SVKJJ**PK5Y55%/9:+^F4E8__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g79071.jpg
<DESCRIPTION>G79071.JPG
<TEXT>
begin 644 g79071.jpg
M_]C_X  02D9)1@ ! 0$!\0'Q  #__@ S35),3%]'4D%02$E#4SI;3D585$-5
M4D5?24Y#74Y%6%1#55)%7U!-4U],3T=/+D504__; $,  0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( $$!=0,!(@ "
M$0$#$0'_Q  ?   " @(" P$             "@D+!P@!!@($!0/_Q !A$
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MQS#VP_"&N>8<N?L?A_!R\ON<O+JG''9>)WB/T1O_ )<<"(% 1$>0!\?E[@
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M2,HJ43B"3=LV*FDGZ3KB3[>6[E=!C&Y5F6R1C G)1](.DS<E*(@!VY9B:C)
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MHT%<$?!HT:-9QG!HT:-9QG!HT:-9QG!HT"(!Y1 /LZ-9QG!HT:\!43*/(RA
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MS-NJ=NN0Z*Y2"DJ4Q#F <1;(;X_R!MIQQ(2RZKJ7@6<C29)TLJ599VM3)-U
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M('0,0.IBI)X]?M$EDU%!(Y1736*B!F_;26;J&:]>WG7]=X0Z:-DBJ)88XZA
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M>.H9&M[;'U NU[>HF<,Z54;+;G2!.KK6;UB#?SJR)>@#'$54X\R8 4!,/5R
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MMB27!!(LB)(;(;Q)CUAPA,UICF?Z-FOZ>6FN['W<3=?.#U"%8K& SM1BV5V
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MC#F376*O%)66TMKV!$6%(04*,R2?F(R?-3TA>3NHN66M\WD1H6V:0S.5M93
MYVNII4T!?L,M1BK5D(D:F0Q[&'6 '&L[:4KN(WAABJ5K'?%SL$-66$7DG$Y+
M=8F+9!LO9:Y9V]?3FC(H F9^_AGT*]18OW2A 5=ECG9F)E#JJMVS4@E:EZGD
M;BU99GD'++&N/ZI04U>94I><>.KM-MRAZ!1!J+>#@D7 &#K SEI*H (  HG
M!ZHFP$!#F @(#Y!#O ?CU^9UD4^7:+))\^X.T4(3F/DY!UF#F//NY![/=Y=;
M"^6.A@ME;C (-A'+.T=BZRK!3/5/33*S-;HW]RI5*HCV8"!\N--_I/<\GXE6
M'/7]Y=9: K^*10PU?*L6 ] R>83C@R9.Z=NJS%H;+"^^,<3)DIZ_7:93:>XL
M3JGU"K5%:VS\O:+*-6K\77R34].R+F6E)!\G%MFQ53.)!XX72;<@9,0."$<V
M:-4TT"=DUG/%FVG.N9UT28\QG9I=BL8 &P/61H"K(E'D/:*V.<\0BU"@4>KH
M9+O')R\Q2;JB'3KL^]SA5\1ZMX#3LFT"P8>N>4DT7ZUQHAA=,+NVBQ1;BT)B
M*R6U9E0)JT)"9Z+UO;F4 F)44#5Q\\D#)ME9>]JW2V&>BA=S6-J/,H0NM#@*
M4S$;"+X3!C27$1M!VI0KX07$-I+DWS:YH6&Y7&Z>S5VO9/OV]2YOQ"*;Y.=C
M?%^]O8RS8_KAC@OVO=)+V\^/H;9L$9TS98TXW&T.NV@6JR0SEQGDG3&H02)Q
M[S*/^R%23?F* BA#PI'C];T:I6C8%'2>]KG9=O AG*K%FVQ[/MDQ."4FRNZK
M!%P4#&*0PM)6%;/$#&*!3F3.50$^H" J<2B.D6L8\2CBZ<+N\2= D\FYKQ8\
M+-OI>P85W/5)[8:S(2,BX!U)O&]=R@Q*^8%EUN3AQ*8]GX5)^)_&D'RG:=J:
M3F \+QWWLV2B,_M[VEV)WV8E;OV#/+M=3*J!&Y2*+LTLBSB3DG41RHJFDX:"
MH9PF1,Z!&W)P$:DK:^O7RN8&II?(8A@1X6);+'&,S$PY[F'6@FE\!KN) A&V
MQ'N97:T'R)Y?:>T]7QVH]1ZV]?PPF7KM)J\=2 I (\%1I,KY  K+GSAC^NVQ
MDD?6E1!76TI4^'SGNX.45,G7FIT*#%5/QMK75W=PL2R " K)ME56L5!,%3$Z
MDTG*ZTL1-00.=DL0H)GS3GO<EL5X/&!']LR;:6U:\T0.YBZVW<L+-G;-UC1(
M9)%G7()1PPD; X(8 14?J!#4.H-E#.9-_ 1_;*J(\9A\*3XI&6&BM>I,_@G!
M:LD4[))?$>, F+@H#D5$RIQ\AD^R9&!)X)%$R).(Z 2> L0JS8R1S@0N$-O_
M  CN+3Q2<BDRQ>JIE%O'6MVT2L>Y?=[-6F#25BA.)BN(5I<@6R3=X]FD90(N
M(I=<-6TU0(R2D8=(5%D!>[I7.W5"[F#J3$X#3Z60T\9C6K5-DES$]N9Z1AA^
M4=J39D'!,[*2)3$\.#2FFM$Z/LE8T/IW*9O4KDRD<_G3=>N5UNCI*4FS[S36
M<1/?&A7H \(V>31&8C%F=>(1ORXC/$2@LZ87F<HU#/5JF66,-M6/\&6BRP\]
M0J:,@[7@J%!2L.];+.R.P6>67)L])=G 2S]6=L,VS95B.:LXVSMP7B[+D;M1
MH6)MS&3RYGS*OB=.J9@R6,#7X=M:K9.PKEE8W#2&A(B*A#Q+!615B(U<T,W<
M3$;'-Y2916DG[XRFA/"RX*FV'ABP9[)7"KY<W'3T0I%7#/UOC&K.63C78H*/
MJMCBN(K/6>/*:X6;I'>M&KV3L=A,FD:T6260;L&3"9$0Y@(>W[7</Q#[ ^T/
ML:76OM58C-,QV-T[CTT\1A%]FI:FN"[=GICI&8,A[ZJH;28*8?6YID^P/=Z!
M!OZ8PE_'KMV\O;99OY$^X],-(D)B?.1@8+MDV?*",1V$(A83TR4E48<.;+I=
M@?%"V\WK):[BL1F#=PS_ !KEEP\(L@K7:P]=6/"N17DBV**2I25^,F9*6>MS
M%#I3C% ,F8H=&K<EJNBY;H.&RR3E!9)-5%PBH15%=)0A3I+)*)F,11)9,Q54
ME"&,11,Y3E$2F 1KV/"4.$7D7#V>+WO\PC49*U8 S3)_11F]O ,7LJ\PYEA\
MF8EFM-B8-V[E5IC7(BR",Z-I44/&0%U?3D5.C%,I:MJ.]?\ A[>$S[MMFF,*
MIA')E%J>ZS%%%C6,#1'-EM<E2<GU.JQC=)I%U1OD"-B;1'VFO0S1,K6#):*T
M]G(QF1O&A8UXIFQ9-&'JW3[N9>*P>J=-'7M7U41HY&@3UJ:)B7>E,$TA6#JU
MAMB"!QK%J6K:HYB1[@I@LHO1U[)87,BY%1EHK-.Y"C8HH.('J+H@B*&+ )@A
M@B$P()&)GRLKM0T\:#BK4#AJ;:YU>(G(B4W290@Y.$V_X\,=%Z\1E'*:K)QE
M2T1Y5 58T&AB960.[=%31LUE;1M1C3G</'[B-5_S-X6_O$R.W?U';GMHP_B&
M;L@C$UV7FIFV9UOC%X[.";5:O5U.+I-;E)THF*#-J]K=B9'7$!5B7Q/J!NU<
M.?@:;QN(CGXN]CBTNLF1U#>RC"PO*3EY9ZPS5GL\<H9:(K,M75TVCC$6%F1B
ME:KP:D;7I&3@#J5VF5BO0K]2Q$#:'+Z-/2&9U[8JXW'52AP8A=E-G)99R]B"
MFE:#-<*86PN,6D4!U04I7,V%D5C5,Y6)H:94^W:>/3-\TFJG267D5@S9 D1A
M&_0'2/MP,3OO$2MCM'1LJ>^W:4YMZ<R6PS.ZG;79Y%Q84G*,Q*C;<MT.T-K"
M]\<*1PN-F:2Z%B1?'+T23:41D43*(.DE#7&H>@_C3?/CJK8XY\/?]L_&@S5>
MHJ"#'KIA>,&9AP6[4BF*4 Z@J=C_ !DC3IBKL#)EAY"!@+)27$$M%-DS-8U>
M#<0;QLU*F5(;$WAO[DKKN_V,;9-RV1HVK1%YS)B^%N=ICJ4VD6=5;3#U\_:N
MRP;27E9R1;,#F9 JFW=R\BJB90Z?C2I2E'4US<EN6Q6C=2K!(5+F-%9+6V#E
M-BTE=R$QM$00+$6+DHVV-<B0C,Q'$;H,(H7-0XEDN-Z+LL[C%R$,4LB3W)F9
M_",O:VC>)B>J)F.*V#A*_7H]I?\ I>6'YS(VK7I'TI+[F3\4-5/W"4=-3<:7
M:44CMH<YMWMA*4A'2!SF-VF1O.E(503"/N  CJV!1]*2^YD_%#6GSI^6<#_=
M]'\S9XV^7XD./R,%$Q,Y2Q,1,3'E,#M/G\)_MX\S!S 0[N?<(<^?+J*("7GR
M[^7, Y^YJJYXONUC(_"]XHMGM6.@?UNNS63&6Z_;%<$FSA)@T1>W,MT-!-7"
M?2DJZQED1-[6)1@FN+KS "OO'2:*4^U%2U'U'9Q,.&UA+B;[?E\,974=UFRP
M#]6S8ERO!,6+RTXQN8M!:&D&2+TH)R]:G&P)QEUJ:SEHVL<01+L7D9-QT+,Q
M@IR_U6O2N9-ET)=B<DB:.45 ]<PDRB0L0N(F62B9*"7$3)I8X1B3D8XF-4X,
M\WCH"N4+OU&C:I',Q$=T/>N2GR"&1$;'_5(1F?9WW[=P[M]F*N(=M=Q]N'QG
M(,4G\Q'-8K)U'2==M*XPRFP9-C7&B3"*@@[($<_5,[K\BX122L=6>0]A8@HS
MD"&#>756U(T;BP^#P;AG5W8,9.FUN:>$AE[JP8O;YM3W!UZ,<K*L(VRF*+)F
M@_(W.X<1\;85:7E:F%?O303UDW>.'DA.SA_PPS'3FOL4L];-;W&V=))0DA)X
M7R15+/6I%4C;J1=L8R^H5&8BDG;SZF9DK*S8,6A@6+)R2I!24F\YRPR1MG(Z
M0E.H<#;*6U&4[5<K%8"GJ\.\&,7+"5OT0:Y(Y@?ORU,W'B.QNLJ@KBKGX/$Y
M*O$+>-A3!2XQB(EJC$2@8/\ "Z2V&-_8(HF.'3-0Z<3/C6;7N&#;\14/*D+=
M,F7+)AY"7EZ?BI>K/K90: R(#9M>9^)L4U"-SLIV;,:(KD6,DQ?S@Q\Z^8&4
M;0KGM%MMT/A>66;97E*SM'VS5[$<])>,,PR#FFU-LFS+4K@I4VBM8Q]665=K
MP3:2HF424GYVT1HJ FF: ?D$Y3:L\/3@C;V.*IG!;=EOWDLG4/"]SL36WWZ_
M9.3?0N<,_)=DW.E#8ZKTHQ9NZM4GD:FTAVUYD(J'KE=KQ48_&T!*^*M_,CUQ
M/+I>)6S,<P7JP^)0MO;QX6E'D\@Z0F%K0%<V0.Q%#($#-I2,0:UJDV#\7M6'
M>,*&EEE?NM,>JV23BE55U1UL,F0'7.VXQO$#'F427E$OP[1-U^,=ZV */N3P
MXRO+7&^0R2RM9-?J;)4J?=MX:7>P;QX$._.N*T:I(Q[Q*/EV+I[$RR2 NXQZ
M[:'36.:S;1*+4,8TNIXZH%>BZE1Z-78:IU&L0C8K.(K]<K[!"+AH>,:DY@@R
MCV#9!LW)S,;H3 RASJ&.<QI562KE8>55;%52<R:ZW'#&K1)S*@:P1 38(=,&
M8@,$43,#$3MP;*AD*7#B$VP PTP'I F0,=9",S,B,EO(Q,S,1M$SPMWKNN-?
M5'Q[]_=-_.6+T:-6:M_BEKZ.[[,N.6F'^5L7]8TOYE7#'0>3XS?*.N=&C57^
M.IP^Z/T1^[@U%9Q$_P!D6+_X&M'Y0B=&C1;H?YRT/U+G\F_A0<]_R9YW]MB/
M]\X_B.5/TU+[JE\X73,[?];H?<4OQ"Z-&B;F9[\+^C(_OH\*_P!&#_KK_P"W
MO_FN/U-Y!^P/R:B?XI7[ X'[=Q_\-&C0]R_^=^$^E1_"7#(](3\D&M?JN?MT
M\+_./3E/MOZ@U*IPR?50;^]7?R%T:-6?YB_,W)?1)_A'CEUZ.7Y9=*_6ZOM9
MX8+#R&^W_K#2YN4O5.R/]_\ =/SFE-&C5>>6OXYE/HR/M3XZ'^DW\CZ5^LLA
M_*HXZO"?Y9A_X7BORBVTR[HT:]N9?])A_P!2]_%4XTO1A_H-9_M<%_!EN#4&
M>\_UQEW]XU/\V(S1HU%\NOEVQ]66/YFGP5^DA\Q*']YJ'^[LMQJWIA? WJ)X
MF^#RH_D-EHT:(N97XCB_I;_L0X7'HS?+VIOJBI_.\99UI5OO]0:2]_H?(?1H
MTO-,_.##_6%;[2.+%<T/R>ZP^H,A]G'"OLM_E!S]U4_'-K<S9KZHD;[_ &WR
M:-&KB:M^;5OZ&?\ I\<<.4WY2L-];)_B9PT S_6K+WLC\R37LG] ;[4WR#HT
M:I 7OG],_OX[D*_HQ_5#^ >(?.-3ZT5][[=?\$757[DG]FLQ]W1^0NC1JQW)
MKY+N_MR_>'"=YA?*%?\ 8C_ /#;'@\7JO1G\+N_F9'3U0>G'^T)\IM&C2PYE
M_.BS^S#]Y<&VB?D)7[:?W+X_71HT:7_!AQU&_?L)M_WJV3\C/=4YF[[UP^3O
MOE>_(GHT:?7(OY0S7T>O_$WA5<S_ ,7Q?Z]G_0X85\%\]>HT^\>S?.H:L2$_
MV_W0W]6C1H2YM?.YWT*K^X^)_0'R 'TAO\*^%:/"AO4,P+]\]P_$K>IDN%+]
M;GV=_ =4/_MZ-&M#)?D]T]]=9+^ ^-FG\\<O]65/]#A3'8']<DV_?Z1,W^-=
MM/J)^EI_:%_%#1HUG,#Y0QWU:'V[N/YH_P#$[OTZ?Y=''GHT:- /!=QKUNJ]
M;IFO[P)W_@CZIY\W>J7=OOOL?Y0/HT:L)R+_  \U^M7^S;PI.9__ $;^H[^-
M?$T?@[7K]\7_ ,,+_D]SJSW+Z-3[)?Q0T:-"W.;YV#] 3]JWB;Y<_(;/I1?9
,AQYZ-&C2DX8''__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g827084.jpg
<DESCRIPTION>G827084.JPG
<TEXT>
begin 644 g827084.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ _1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?4%)/1%5#5%\T0U]&3$]7+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( 6\"K ,!(@ "$0$#$0'_Q  ?  $  @$% 0$!            " D% @0&
M!PH! PO_Q !P$   !0,! @0+$P8("0D&!04" P0%!@ !!P@)$1(4&)83%1DA
M,5%76)'6UQ87-#5!4E-6671UDI.4F='2U-4B87&8M+4*(T6!E[/#Q24R-D)5
M8J&Q\!HD-U1R=Z>VP28S.$-E@B<H<W:R*41(AN'_Q  = 0$  @,! 0$!
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MT=VBDHR$UPEBQ/IF?\DYHD41FF27Z 1_,V(5$&:,6PN7D04C(4:SBA=72#9
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M,=;S:FT2F=\1U'#!UG=76-T3@3Q;JPZCCP.*#Q88$[=F2Q(5(0RX%JBOF-(
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MV,",P%ID".*>>9DQLE#U$HO&6=><3(9^E;6B(.3EDF11-,K:\:(EK2L?+GI
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M)0A*18@ E*0$I X@ !XKEN%;M"^(/[-.%;M"^(/[-4YCV"NRU+ (TS!$Y 6
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MJSPP'964/F8T5\-.3Q+K9?;,5LT@:U,-F&'Y5C:*QMC:<.0AOAT?@D1C21F
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MBL)_&#FX>>-V=+<?)8'-3=7>L@R9XPC$KA,#E Y?A<3E'(=.$L232F-I2!8
MNTJ4+M>"Q52:I<&U8ZDJFDLQ*XD!/5 /Z2Z@CLN.X-._UI=5_EKIU!'9<=P:
M=_K2ZK_+76R-ZCJU=TTET@=U&U-(+]@MSY0TMM33C:2]I LI0XTXMMU"<$NH
M)2X% X5K!9%C6U-';(UKN)=6&;U.8"G$.(=;<4&;*@*6VZA+C2CB6UI"D:IX
MQ)BV@6!+)_$YG)\O9]G#)%<G0C.UL:S"515T@SMGJ 1Q)'F/+9XR("BF$>=S
MS494F>X9 Y9$,4/,O$H?54 L)8N2*N1.6AS$Q\ O"F.19*A[LVZB,A:IH3DJ
M.2!N+R#CO,F3)=,I=)GJ*K'..N4=4,:B\_EL7-B,JC<ECCI#'I9'G] [E&<8
MM$7J".RX[@T[_6EU7^6NG4$=EQW!IW^M+JO\M=4FY05;D#I#?@EK<RA";#;T
MM@MA:4E3:=(0VX=1UUM9<2HN-$M.:S9"1<FVR4[IA8;-B[KA:S>YRG,'"TI0
M2XJRE;8"VFUH#:D[FX@.-ZBR55(-JV:VG0D4E6RP[(&29!D#'><,?Y4D\ZD"
M%:]90%J D>,Y--YI*AL\?9$:*9M:O$./D./%<021AEQNSQMJ;H@Q-H6UM-1X
MG#NS9Q[I^=&5;AK/6IN"-B".X2C#[&4$MQRYL<Y;L#1!M@D1%+A2'$3P]FJG
M6+MH&V5J&!ZC_3>ZE4K3@;5@B3R.DNH([+CN#3O]:75?Y:Z=01V7'<&G?ZTN
MJ_RUU8;O&4VZRO272%;#XU76'+% <CJ&N' -P7I"II(2OUR E U"A&IJZB-6
ML6=Q*VG4Z.V1#K)UFWF[S-;>2HH#:E;LBRI=45(Q2LJ62L*7KXEQPFXGA6_U
MO5[(!^K?_L^IV+?FIPK=H7Q!_9JG;J".RX[@T[_6EU7^6NG4$=EQW!IW^M+J
MO\M=:C<-'>5;ST#"R_:/,\V=;?=[[R;:NFI7U%X_0\5Q/"MVA?$']FG"MVA?
M$']FJ=NH([+CN#3O]:75?Y:Z=01V7'<&G?ZTNJ_RUTW#1WE6\] PLOVCS/-G
M3=[[R;:NFI7U%X_0\5Q/"MVA?$']FG"MVA?$']FJ=NH([+CN#3O]:75?Y:Z=
M01V7'<&G?ZTNJ_RUTW#1WE6\] PLOVCS/-G3=[[R;:NFI7U%X_0\4Y<G:0,*
MY?R#.LD3YH<'U[R#IY7:9GM$LNVJV--CQQ?I'(E2MH;G!F6B;Y4-?)W '3JR
MDTKBI2(H3>(2:Q@^FBMG'B!G2%+H7/\ ,D)R.@G5I^QY@:WF&O<]9G1;@S%^
MGF5-%TTRQ_)()(HC/,>XAAEYG%9C"Y$U.DF16E"0IN=4S48VQ_Z@CLN.X-._
MUI=5_EKIU!'9<=P:=_K2ZK_+76R9N,%A*4-:1:0);2VEK<C8X2VBR$H265-+
MTB4VME2$A#C2TJ;=;3J.)4@E)UKMNDOJ4MW1^QJ<6X72Z+Q+2[NI45;JEU%C
M2XEU*U*6VZE27&U^O;4E7&)#8\V;>GO&L7RQ%&1QR:N1YGP;*\!3=<^2A"O=
M5$1FT_S3DR2.S>J*C20I!*W"6YZGBSID%,8WID]V1"E9R4S2 !W/UNB'#*X,
MQL:NR,G,FNF?&>E9P6-,U<H^ZMF/<2.,R=X4^1Q[CZ9K>F'("!UFSDX#E:!P
M!<2I$TF$MY%DAH5,.NH([+CN#3O]:75?Y:Z=01V7'<&G?ZTNJ_RUUZY<H;KC
MCKFDND:G'EI<=6;-$UEK26%)4HC2/C*5,,D':R@]H5XW;'VD-MMZ.V%#;*"A
MM NLG50A0=2I(' 76*7W@0>N'%?I'">& -,4:P._Y/G(IUD7*^4,QJ88/(>3
MLFG1'S3/S=CE@41F!LPF['L,@$.2(XVT+'  5J6+EOKTM<ESA(G=V4C3W2R9
MX5NT+X@_LU3MU!'9<=P:=_K2ZK_+73J".RX[@T[_ %I=5_EKK#D&R2W5/R+Q
M>G'5);05=3\!(2AIM#+3:$(TA2AMMEI"&FFT)2AMMM*$)2D) S8Z;M$92Q'M
M-J;:25J"1>YBB5NN*==6M:[(I;CCKKCCKCBU*6XXI2UJ*E$U<3PK=H7Q!_9I
MPK=H7Q!_9JG;J".RX[@T[_6EU7^6NG4$=EQW!IW^M+JO\M=4;AH[RK>>@867
M[1YGFSJ[=[[R;:NFI7U%X_0\5PYW_NC?_P!,?_\ &]?S@LJ8^TMY-VJNW.C6
MH'9N:T]?T]5YBBB' ;]I$B$]?A8&FSA#I.G+<YY)X;D*'$0=-+GM/#C&AT>F
M:8HSD<.?+C9521 K;'/^D (-A!$&_8%:X;[NSNO;=>H2:<M N#]+VHG6'J<Q
MPMGJG(VMZ80J;9C32B0-KI&43O T+^@9"H2U(H^U*V1"85)7,Q>2Y.C\<H-$
M1T-2G*)L4+2UMZ\,&9\"9-9,[?P>[ .T]TU9RUI9!;='>J%MS/IL@CXAF.:)
MBVIY=E-_Q1&A.9^3\<H7)[Q=$"<=+Y793DA -*EA3@E4+GM4ANC6\YP;FK(V
MBK!/\) G>B=AS)HM@^%8YIY8,-:$<QR&0.F<=-4CRF>P1>8:BNE$@D,L:H>4
MX,L@D,BB"Z*SJ:J#!I6(YS4G,\5ARUV]LF4= 6#<N:U--.O&4K)X5FO2I$<C
M0O&2!H?VQ' E+3D]H>F20FRE@.CRQS=5Q")_<.E1R*0-)*4X1)JA,LZ"$-\&
M5LVM,QNHW5[J2?6B02YZUR8AA&$]1.-I4M9'/$,OAD"C=X@U7\RA<=2N@7==
M&C%#0[+UTD<0GIE1_$DS>:()@%*\KFM+9C:3-!NQJ@FTYTOR^=8YUZXH@^F?
M4(VZPR,R9%=YKG;(&5I)C0V;M<R+5393%)/&<CWF;H<0Q(FHQ)=*C(3*#'1L
M5R,+OO,5Z%=+6U-V\>TT2ZT<3.4Q3(=*>@W*D;9&O(.4<?*(!.<CZ=,$JI H
M:SX3*XPL4*&^[DH;D262!=$J7H-C3D E@3#:N/@_\'!T.1638]*DN5M:F8M/
MV()6BFF)-%^9]34CGFDK'3\U+%+@S#8\9J&E&Y+6UI6J3#D[0_2=T0+BQ'HW
M\MZ;U[FE7=D:C=@UI9U':ILRZP%N>=;^&LNYZ;8>S9)%IVU(*,01U\9X/$H_
M#F1I/0,<0/<E;99MC3>I4H'5Y<D@W02I:02FZ*$HM2O*)D/)616C9]Y;TN2K
M+TDS7A_0O_"+\'X#P1F*;R5SDCX=B:/O$T7I8>ZRYV4&!<DD#,2$*"#+*.)-
M9;[=&WA2L*5C()]%NU56FIMM#_!\N+!-5J4TXV@3B4UD'EE'.)Z3!46,2(R^
MBC"4$U<< 2 @X[<66-1?A#""X[U8$7L;] :?02\;-]#ATUNTU/J[S2N*--*'
MPS(!V2+.2%Z!EH615JA7(1Y**>6QO6%/QIAB,*-(1&KM-X@&\>OUGI1V)&FS
M3'J#B6J23YLUA:OLXXQC+W#<+S;69GU=FD_"49D"14W.K9C%O P1M S<9:W!
MQ;K*EY+H<E3."T2 *16I-5"4J@;9G[.+2GM<]G[G3:-;0F7RU^U@9ER-J%='
MG4:Z98F[$X:-4>*7UT3P]MQ^RMTS9XG$([C!L;T\S Q2%NLBM'%*)J,LCCY*
M(VV]VV6@C2#,=B2Z;011E"VM?51B# 6F[$F/-?+;-)TR@RE"H_J#88"5(5<&
MC^1GC&CT[*V282IF>I&ZH9"]O3J8K?%[R>[6*4$7-9D_@\FBS*V1,M2N.93U
MBZ?\;ZA94MFFHS3'IUU%/&,=-&=Y$[7 -_73_&1#&YV!:1F!'=Z2QQW9$9EC
M3;-Z=LL(-@SXU';.?3-J4T-N6SP?F![QUIG5Q'',$:XWB9T11AWB\6Q7(HQ)
M8>U1UT=VF3$)RTBV)-)*PYQ;G12XIKK+JSC%JLU;2E<9V<NS]TE:",-F-6E+
M%AN+V_,*2 SS(9!D\R1.>G\L(A;6U =@G9#ELK4-(A)#30"1,IS>VW,,N;Q,
M(@@N'S>[.;0#IHVU$6VA6LG:1ERW)^H(_6!GW D/LXY5FT;+T<8XQ6C85,*C
M6-&"-S%"R19;&3WH]U$H>T;@@7@: FJ4JL+G)U[[[/6!D1QQB9X\WW.$@8VI
MM9T8E!EC5%TC6B(0)KG&@ 4$9UR$Y=S# EEV$9PA! "U[!M2OJ*V"6DO/.8\
MN9EC&8=8^EQ;J-6V<-3L!TH:AG3$>+-1ZPY.J2.JK+$'Z0OR!P5R%*M7%2(]
MD-90O!KB[.2L@;N\NS@M4JH3:0ZG\:X&V'^E/1RP[11GU1MNLS+K+I"MKL5N
M+>F"+3E&<EW/SM.WUV0RF5D/:;%<%3M.').\ =WUQ>"'*W3$LYX4*+C@I"=3
MT"F7\&_VP6AZ&Y=:,Q-VS]R&;C;$N1FAS+7@R1I8G^I.+2C!TW)/"G1'&$J@
MIIDP&I;$C+:4C<VMIMR@= 3V]=,0V1&BZ!YATF9:B<-?FI'HDP?+\$:=L1F/
M*%XP_#&*>FKS)=,U$<?F1U?GS)L@ Y*BWF9NLJ4'NQ@PN+FC6.X0N-N!ZD-B
MAHVU,Y U*Y#DY^5H(OU::<XGIHS4P8JD\5BD2D$1@LZBL_B,N3,2V!OI:+([
M$YPUE:T<DZ.>AO'0+&H]D.LN4GC4KR!Y:U$9>QKA39E[*K55(UT@S3IQVE^S
M7S=IOR4J(6I4>?-#F36:3JX*\(#U7"-/><'R1Z2XDDJ8]0=<D*1H1)SEQ\=<
MW$^;6BC98:+]I#M#MOLY:J(1)WJ68LUTKFK%>0XIE'(^/Y#C"\K<LL*W5]9"
MXI*&N-+EZ59'61S3G2UB?T:03262$DM$:K).]+.I_9$:/]6KAHR?LIM,W(EN
MA.0P=\P?-(G(VUEE)J&!*(HN;(C.%ZB..:>3Q%<ZPN/O#BV!1MJHIS3*E+*X
M,]G1S+5Q,R;_  =?1SDW,FHO- \\:[X YZJ\@R'(N<81B;4ZKQOC6<.<G4.!
MKHSO,5CD,3B=8X-.[NS8G0/3BZJ4K6Z+T9*^P% [W4KS&XRS]FC.6G[^#V S
M+D9ZRZZ8<V\Q^!(9F!^<'-U?,I8RQUD7&:>(2=R?'08U[[9.D?%\41.*LT]2
M:S,*%(M..5D*A#[YV<>RCT7:]VK;3YFU M<GC.:\4;1_6)'\6:A8SE?)D%>,
M,-K$%QG"!_1MD<E2"%K"6*1N2Y_7J9#&W52:DL<DLJ))L38'JED>Q[T5.L/T
M&8[B\4E>+H!LYLT1W.^G6'8ZDQ2%JM.(Z[II  4_5R1HE#[,D3R_)QO4D4'O
M""0/CHL7JUC]<:LRH7O_ /!J]#D@E>;'TW-NO!GBVHO*4URUFG#\2U2.4*PY
MD.0Y!?UC])V^2PB*1!I*<V5;QP3.$"Q<>[E,B=(BL\B,3 4TI5&>3=IKD+(?
M\&RT+XVU'YF4Q/+>T"R\=H[D^?9B[+@.9&FG&>;'./9=SK)GAX, Z/0$F,6!
MAA\O>E!3HOD)TG4K58%#FY'\*;&Q)BNC3:.:#M26RCSJ\-.K+"N@O5DZ,>,'
MUGG\QC1>3=.[A.)/-]-F1"Y'CYZA,HZ 6K+FK,8V$.($B%,W-C8L+L4%,G!?
M,V[*'1TQYUTK9P8H:[-!>BW!THP'ITPZ0X-BS"<#C$Q+5)G^2E1%X8W-Y<\@
M.+<J$W+)4Y2E2<O**(6N:5<\%V<[]C0K9^8#QOK8G.O"!!EL1RUDS"C!@R?Q
M-A<F-OQ-+([%7A [QR2NL-)C5EGFZ9NEB-K0R!'($I);.6-$-M'=0H.-4KR9
M;&K9I:+R,,[4754#$:P6=]'^LO:-X1T\38S)>5C;0#&4/PBMBD=C7F;,FPHI
M)[M['.)*B"[3!C?GM0)P"J5.)RM&B.(@UL0M#&*\T85T39%G&PUR_G[IYE9N
M->M?S7KA=X'"$Z&.9V<$!603<$-V0FE0)LPZF9T[2Y1U(S)S9;>&*SRBU0G:
MUS?<_ITV=6 ],.+=4F(L<KLAJ8KJ[S+G'.>539-)&MT=TTSU ,Z9CG)$26(H
MXU$,S&G0I";1]"L1NZIO.L(U6O<;BO:JU\4_P;G2IA!JB4=Q5K#VH$$B<(<4
MSG'87%-:#O&86@4$/-I I 1%(]!VMB2IW5VNH6NQ*%"DLM4K5J@5PJ% SJ4K
MSM:KM+BB/SW:*:E-6VD*;[1[#,\U#Y&RC!=K+H(U91B5YUT>XWARM&Y,\ ;<
M3!D[C'XHKT_L0;%O3(XI6".,28"I&XNBR/-D?=VCW5:,\AQ#+&DO35DB Y%F
M>789-,%XMD$:RCD=&!OR'D%H7PUH&DF,]1%I4)26:R  ;N,K)(2)TX7\]PN0
M58FX!"JURA_!\=)4]F.:'*%YYUPZ=\2:DI6_374)I9T[ZCU>/--&8)!+3 &S
M!3),='19\4-:68<$2:1-D5?6-N5M@[,R5*A9RDS>1=%BK%T!PCC2 8>Q7&6^
M&8VQ=#HY ()%&NYXD$>B43:DK(PM"8U6<I6J (6Y&02)4N4JERLP(U2U2I5G
M''F*5SZE*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4
MI2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4
MI2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I5.7)"VP'NPL"^C?Q!Y5
M*<D+; >["P+Z-_$'E4JXVE;KAZ=W/9?BYH]EX+R\IVUJ.!8GL]WZ>O?UAEY]
MIJG+DA;8#W86!?1OX@\JE.2%M@/=A8%]&_B#RJ5<;2G#T[N>R_%S1[+P7EY3
MMIP+$]GN_3U[^L,O/M-4Y<D+; >["P+Z-_$'E4IR0ML![L+ OHW\0>52KC:4
MX>G=SV7XN:/9>"\O*=M.!8GL]WZ>O?UAEY]IJG+DA;8#W86!?1OX@\JE.2%M
M@/=A8%]&_B#RJ5<;2G#T[N>R_%S1[+P7EY3MIP+$]GN_3U[^L,O/M-4Y<D+;
M >["P+Z-_$'E4IR0ML![L+ OHW\0>52KC:4X>G=SV7XN:/9>"\O*=M.!8GL]
MWZ>O?UAEY]IJG+DA;8#W86!?1OX@\JE.2%M@/=A8%]&_B#RJ5<;2G#T[N>R_
M%S1[+P7EY3MIP+$]GN_3U[^L,O/M-4Y<D+; >["P+Z-_$'E4IR0ML![L+ OH
MW\0>52KC:4X>G=SV7XN:/9>"\O*=M.!8GL]WZ>O?UAEY]IJG+DA;8#W86!?1
MOX@\JE.2%M@/=A8%]&_B#RJ5<;2G#T[N>R_%S1[+P7EY3MIP+$]GN_3U[^L,
MO/M-4Y<D+; >["P+Z-_$'E4IR0ML![L+ OHW\0>52KC:4X>G=SV7XN:/9>"\
MO*=M.!8GL]WZ>O?UAEY]IJG+DA;8#W86!?1OX@\JE.2%M@/=A8%]&_B#RJ5<
M;2G#T[N>R_%S1[+P7EY3MIP+$]GN_3U[^L,O/M-4P->E/; .1!YW5@("3T%<
MM1\&VSBQ 9OXH=<GHF^^407M<RX;BN'=>P>Q80^S;)<D+; >["P+Z-_$'E4J
MV>*^@5WPX\_MQM<FJQV^S$N*"8UE !XAU.:/Y'MVS_3Q$[:HC6B,XPTM<B[%
M2D))/#MZ&)*02<!/ Z^P><XTY<D+; >["P+Z-_$'E4IR0ML![L+ OHW\0>52
MKC:57P].[GLOQ<T>R\%Y>4[:OX%B>SW?IZ]_6&7GVFJ<N2%M@/=A8%]&_B#R
MJ4Y(6V ]V%@7T;^(/*I5QM*</3NY[+\7-'LO!>7E.VG L3V>[]/7OZPR\^TU
M3ER0ML![L+ OHW\0>52G)"VP'NPL"^C?Q!Y5*N-I3AZ=W/9?BYH]EX+R\IVT
MX%B>SW?IZ]_6&7GVFJ<N2%M@/=A8%]&_B#RJ5L@Z3MK^)Q-;^K P*URT)"WH
MG4X<0;[]&4*".A\#ST]UK!Z!<7"L*][W%NN"UK6%>YJL&#_*55\!H?V]QJ2;
M[-.MC'LO$G$?BYH]UP4CDSTQ-079HJ2WA(N_&X$G\.WOC!!\(9#T)QJ.Y(6V
M ]V%@7T;^(/*I3DA;8#W86!?1OX@\JE7&TJ/#T[N>R_%S1[+P7EY3MJ? L3V
M>[]/7OZPR\^TU3ER0ML![L+ OHW\0>52G)"VP'NPL"^C?Q!Y5*N-I3AZ=W/9
M?BYH]EX+R\IVTX%B>SW?IZ]_6&7GVFJ<N2%M@/=A8%]&_B#RJ4Y(6V ]V%@7
MT;^(/*I5QM*</3NY[+\7-'LO!>7E.VG L3V>[]/7OZPR\^TU3ER0ML![L+ O
MHW\0>52G)"VP'NPL"^C?Q!Y5*N-I3AZ=W/9?BYH]EX+R\IVTX%B>SW?IZ]_6
M&7GVFJ95ND[:_H^)_P#]8& F<;7IT77V<6( =#L?P]YMO_Q3OPK@X'6!?@V%
MOZXP[K;][R0ML![L+ OHW\0>52K<7S^2/AQO_MJSE2-^FZJ#O>RXG6!_%S1[
MCP*<,?P9Z8FJDV>*77$F1=L$A&'X=O?; )_Q#TYZIRY(6V ]V%@7T;^(/*I3
MDA;8#W86!?1OX@\JE7&TJ/#T[N>R_%S1[+P7EY3MJW@6)[/=^GKW]89>?::I
MRY(6V ]V%@7T;^(/*I3DA;8#W86!?1OX@\JE7&TIP].[GLOQ<T>R\%Y>4[:<
M"Q/9[OT]>_K#+S[35.7)"VP'NPL"^C?Q!Y5*<D+; >["P+Z-_$'E4JXVE.'I
MW<]E^+FCV7@O+RG;3@6)[/=^GKW]89>?::IE5:3MK^F.;R;[8& CX^K$EL+J
M<.(0]#N%&J5\.UK92%P[WXMP.#>X;6L.XN%O#8(M[R0ML![L+ OHW\0>52K<
MG7T;'OA<S]SNM9NI*OTT!O"/9>-.)_%S1[C(6H<F;$@<^VH(LT4J=!D7<A+@
M2G\.WKB&Y-*P_O\ Q^N)/'B>,CK53ER0ML![L+ OHW\0>52G)"VP'NPL"^C?
MQ!Y5*N-I4>'IW<]E^+FCV7@O+RG;4^!8GL]WZ>O?UAEY]IJG+DA;8#W86!?1
MOX@\JE.2%M@/=A8%]&_B#RJ5<;2G#T[N>R_%S1[+P7EY3MIP+$]GN_3U[^L,
MO/M-4Y<D+; >["P+Z-_$'E4IR0ML![L+ OHW\0>52KC:4X>G=SV7XN:/9>"\
MO*=M.!8GL]WZ>O?UAEY]IJF53I.VOZ=4W)NK P$7'SE!7#ZG%B /0N@)#E5A
M6#YZ5^'PN@W+O:]P;N%PK7%>W!OO>2%M@/=A8%]&_B#RJ5;BY>FL=]^+_P!T
MK:SE25?IH#>$>R\:<3^+FCW&0M0Y,V) Y]M5MV>*I3P,B[8(<"4_AV]<0W%E
M>'_,./URB>/;AUJIRY(6V ]V%@7T;^(/*I3DA;8#W86!?1OX@\JE7&TJ/#T[
MN>R_%S1[+P7EY3MJS@6)[/=^GKW]89>?::IRY(6V ]V%@7T;^(/*I3DA;8#W
M86!?1OX@\JE7&TIP].[GLOQ<T>R\%Y>4[:<"Q/9[OT]>_K#+S[35.7)"VP'N
MPL"^C?Q!Y5*<D+; >["P+Z-_$'E4JXVE.'IW<]E^+FCV7@O+RG;3@6)[/=^G
MKW]89>?::IE.TG;7\I<B1=6!@-[K"5IMC.IPX@M<'$[)_P G@^>E>PK&746W
MWN(-P\#\FP]][!WO)"VP'NPL"^C?Q!Y5*MQ6>G[)[S>O[MK.5)5^F@-X1[+Q
MIQ/XN:/<9"U#DS8D#GVU!%FBE3H,B[D)<"4_AV]<0W)I6']_X_7$GCQ/&1UJ
MIRY(6V ]V%@7T;^(/*I3DA;8#W86!?1OX@\JE7&TJ/#T[N>R_%S1[+P7EY3M
MJ? L3V>[]/7OZPR\^TU3ER0ML![L+ OHW\0>52G)"VP'NPL"^C?Q!Y5*N-I3
MAZ=W/9?BYH]EX+R\IVTX%B>SW?IZ]_6&7GVFJ<N2%M@/=A8%]&_B#RJ4Y(6V
M ]V%@7T;^(/*I5QM*</3NY[+\7-'LO!>7E.VG L3V>[]/7OZPR\^TU3ER0ML
M![L+ OHW\0>52G)"VP'NPL"^C?Q!Y5*N-I3AZ=W/9?BYH]EX+R\IVTX%B>SW
M?IZ]_6&7GVFJ<N2%M@/=A8%]&_B#RJ4Y(6V ]V%@7T;^(/*I5QM*</3NY[+\
M7-'LO!>7E.VG L3V>[]/7OZPR\^TU32MTE[7]&C5J[[8*!#LE2J%-P7V<.(
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M7Q6B/QX CN[K<9XZ]$?GH8U[H4'YVQ_\1IYZ&->Z%!^=L?\ Q&O.[P"=U[\
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M&BL< \)A7\=-"KQ:;;:;JQ/F(BJ>>0[*C+:DK5>K6+!I!#-K0J/'>;Q5<ID
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M8T(TX_SCF66-I-QF]NT/5O$OQ00@;(VO+?BD;&XLK4ZJG)G+?VP32I<#'-B
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M N-"-6"_7"=:];U1'V-6S>9Y4SM2EANC*;[LI[<B.:+H"0@ 2BNV&$"072%
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M%L^#7K+P5GY#LIPW>.]"]]K\]T9R\/9GR[..:N^W;MX;4WV[=O#:H5<FO/\
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MPWXH4X-@=\%L^#7K+P5GY#LIPW>.]"]]K\]T9R\/9GR[..5\5$&Z%=N%:_\
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MTUCO7MZ,7^K_ /25E9S?;MV\-J@NLTXY[+7LY8];F9!C/4*PE&7@>'K"($!
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MAQ2'4QUIY'2>RWFZ.1G;1<MX+CVZ[15(5(DLLR'K@[:T-EY$=*B0Q%8GKCR
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M4I2E*5QF*^@5WPX\_MQM8'+O_15DO_N_FO\ Y9=:ST5] KOAQY_;C:P.7?\
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M@PJ7T 7&TG[6W6W6[%NM:E*4I2E*XS%?0*[X<>?VXVL#EW_HJR7_ -W\U_\
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M$) 2E"$@)2E( 2D   "L&^?R1\.-_P#;5G*P;Y_)'PXW_P!M6<KT]@CQK_\
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MK N0@]-8[^4'T8O]6W^B5GYZSG#!ZX/QK?74E ZK?%_T'Y1?_L54T1KR./\
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ME-]2>Z'O?%Y9Y"F\(7<<7WAK^'+S[375KGC/'0%C"$,!A-K&NAA8[>9*._E
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M4I2E*4I2E*PCKZ-CWPN9^YW6LW6$=?1L>^%S/W.ZUFZFKL6_:'Y1RJF^S?\
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M3!,S%-FJ5L@B=@;%R=&G02#&6E)NB*"+!2&EV1)79SC4L2,:9MXN2<L9WL)
M F$J+CP.6L/SEJ;,AS5KATB9GY]E>M\N3RD*@Q@<7C'L@D#:NB+&JDRY>C)2
MLTK9FLQ'C].K<$326ZK236PQL4KE"T5S6ZW:K'NK2UOK8X,KTW('=G=D:EN=
M&IT1IW!M<F]84,A8A7H599R58C5$#&2I3*"C"3RAC+, ((KVNI41=(88^!?J
M7*B$>=(G$B<_EEQZ-.;0MCG21%?".&CCD*&+K@$G11ONN.4JT\:&A:C6OC0K
M'L[<<<,FIE5QV*Q"*P9F3QV&1QCBK"E,4')F:/-:)G;"#EAXU*LXM$@)(("<
MJ4&&'J#>!T0XX8C#!"%>]ZY%2E8M\])7CX+</V0ZMXD]")?>Y/\ 5AK9OGI*
M\?!;A^R'5O$GH1+[W)_JPU/\F/;G]U-5?ES[D/WU5N*5UNIR]C9%DA'B)9+F
MM+D=Q9[/S?%%'&2%ZYK%QJ]CT9IJ<*%4;<")8;9&0K&NN0D4GV3=!),&']VK
M*N/WO(,DQ6UR5(KG\1;$;Q(XV!.O K:VU>!"8C5G*#49;>8 \#DA$$*98<8'
MC +# &]AV!>84T)*S$E! C)FE1CNA(AJ<2TF65:F C*=4EM+^.Y%Q24!>L0*
MPA>;0I8:%UMI<-Q7: V)T4K-V;87)<M80'=8W%$9M<A<+#?*6$+=4T&TE0[!
MI2L)))&QQ!A=Y1)7-*S,#"WJ75X=5HA 2-[>C+N:I5J1A",0222[7&,5@BO8
M-KWM:]8Z$+<6E"$J6M:DH0A"2I:UJ("4I2 2I2B0$I ))( &-9SKK3#3CSSC
M;++2%.NO.K2VTTVA)4MQQQ9"$(0D%2EJ(2E()) !-9NE=$Y+U.Z?L.8?#GW*
M678+ L.FI&U6DG\I?$[2Q.73JU^DB)H&IL%6]/#Z.W0&-A:4BU\>5(@I6QN5
M*!6+KJW3_M M(&J"8N>.L+YJ9)#D1H8_-.KQW(&&:XVR"9&+&DD&2AN@V4(Q
M#)2\Q@A0H3I54B9FE>SI%9Q254L)/&$N^2($XM//B%++,=2T/O",\6F%MD!:
M'G-34:4@J2%I64E)(! Q%4HFPW-PW.7&7OEM#T?4?:5N[3B0MMUG!9W5MQ!"
MD+1K)4D@I)''4R*4WV[=NOV/!O\ ]W7_ $5IX8/7!ZU]U_RK=GL[NSV=UKWW
M?FK$K*K52OEKVO;?:]KV[=K[[?[*^TI3_CP]BNH&+4'@>42@N$QK-&*W^9'*
MEJ$J)L\_BKC(S5K;T;IBD+9$CJ:Y&*D/%E%U:<"81R>Q!US0!L4.X>W1=BW_
M &@?_P K54'IETW9)R1CO%2R6/<%BN/(#J4G676YB(Q0\H<Q+W:$9XGSPS-K
MK.'F4A;TS$\N Q*U"E##"%JN,')VQ(JN6I.<#><O-TND.?;(5L@)G*F,S9#^
ML0G<VX<BULD;HM]A#*5IN#BU/:LE:=Q 1%>UE:N)(>>0ZRVRT'"M+BU8X# -
MK83AK%:0G$.DZV"R-48(5B<+?=X>SOMZG7W^#K^KV[>&F^W6Z]OS=>W^RJ;8
MLOR9'\4Z<)IF/,>H1%C_ ":_S=USY+PN\D0N$'$R(Y 3B6)W4L3<"38Z@[LL
M&,J3R1&04O?GML8"I$_I6]S"1?<LD[RDJ;\5>?'.-1L?PXJ:]1 ,>36'M$O1
M9$GCFTY-3-F!1Y.M%8X9*^G#KBKC;Q%6I\8VMKG+@ A7)B'1U/*;S=2C3=DA
MO=+9)86['BR0AZ1%3N+<P6Q;3LI064QXI1=&D[[45-&5&G1$E3C"2[2+BD@8
MLK22EM6"E(&J'-P*2LXX)1@^D:YXBMMU XTC6ML.C,=/DB&8',S:9*6UE<XZ
MWR :8H3LC87E:V.3JTIEM[='*0."]F:E:M. 5BSE#<D-':XB 7MG=X=W9MNM
M^C=;_B]4F8'E^<)9BY7EJ0Y-U#O]\>:*,:SQFC\26%*5<ZR<_P!\]MKV]G%.
MS,Z-4HE"!&SLPK,2A*Y-!3N4SN;PQN9C<SI;8"*91RS(7&;0*)Y3R>='G=ST
M8+(W)6.6Y.R$X)R)-FT^$YE<6+(60(%%E:PA5'QM()>A;V,F',:@X9K<B;^A
M.I9>*UI]"W&%(3:9;7"S4F7';UXR7WTQXTA8<("@A1<7!7%Q4X%(*HJL%-/)
M*()N;>HVO<%IW=*W$I)0%*"$*./$<#B6R@$JQQ*.TKBO2M>WJ7MX>S]=-]K]
MB]K_ ,]4^HS<U166W6M^1,].J>);0!GPBQ-KZ^2:1M*G!C]"4;ZYV>4+BE,+
MF*8A]?%=D$VDBAR6-PD#<T)I E3(S$X^8Z',@SEVR6OBTGFV3,J&BQFL<))+
MG-XG1$;;)2V2Q$4%-D#%N2H.S+L+Y6=DCP:6FA<!FK_#1-#.Z7Z1I"T+8ZGY
M\73-B1/AV]VW28SDR0]&2MQUE:0XR4H]8A!+S@6YNAUPVEIIEL.O.-K=;958
MW<$K<;:+2T*6M2 24D8IP'$!BH@G'C U0D8J4DJ2DVI4I2NTK85'#5JV.;S@
M">-K.W+W9Q4WBG%V]K1*7!<HL5.HN>=T%&C*.4'6*3E&GF]#+%T,@HTT>XLL
M8K0/F^*9(\@R4^*&[*ZIY=81M&'T)Q#WDD U$FA.<TM].PD2=,X@*+51]F7.
M*[$:%O)*#9(>>OC1"@D(#2[?Z^;OT^KZM_5[/J^#M>INI2JJ2\9/TXRXC735
MKR2Y-\BS?D".R*ZIVR @9E>.@Z28@^-K.>F1KT;6CB!N54 79.4F*2MQ\\3G
M7*&)V$J('P"#2O*I#7 X@]*\O&3EQ?M),E4H5R+()ZZ\6!I>;DDU=7=4-,).
ME:C)\TNB"5=,5!(#YM>Z=Y)$^+2;GW*[NOOZ_;[-^UN[&_=_-V-_7[/7INMV
M>OVO\87J?FW[K_IOU[^K2E4J*HC/(K"H<G&&<-T/D,'T*2G-A\U59,>F5<ZK
M6O-2+)CE-][C>07NL?VW%R?*93>K2G@2%,Y\Q("S<<N;)!V)EI.D# 14M<IX
MXQXN78AOEYP<VIW9Y0HQ$&5C,<?-6UV<7J4)8_=L\S:>7A7."I[O$;.)\I-*
MN-["58WNMV.OZGJWW];\^_?O[=^S?U=]-UMV[K[OTWW^'?OW_GW[Z4JG"/))
M4/-^,0LZ[+K9&RS,(#PZCGK7,GV<*L8A=<DFY(1G*P/R2-(8NN0" 1-54Y Y
MRIL@XL;#7MQCT5&$%NK5C!)8]B^,VD#3+8^D)@6EP:I ^Q>?I(;)E\7TC2-M
M5PB:NL..;YI%G,M\5A\Q+TU-LD+8LML\>0/4:5NAK.FO?#NMUNSUOSW_ -MM
M^Z]_SWWWW]?LTX-K]OXPK7\._?\ I[=^O?KTI7!\8&KS\;8^.=$4E;7,Z#Q(
MUQ;IFNZ:2] N,C[<-8BE3E9.DLX21*HN80^KK)4UE;H6K4<7)Z)T('.:4I2N
M,Q7T"N^''G]N-K Y=_Z*LE_]W\U_\LNM9Z*^@5WPX\_MQM8'+O\ T59+_P"[
M^:_^676J;M_=I_\ \=[Y(UA1O[BCW ?)BO!6C]!H_>:3]G+K<5MT?H-'[S2?
MLY=;BOYAH[!/M4^85^1IZP\0\U*4I4J]I2E*4I2E*4I5D>S QQJ(EFHMEE>$
M74^)1V(*$0,KS!Q2GK(B;#U9Y:E9"75M"<F*DCQ(R"1W8F8I20K:%02I3QQL
M*0 4*.E]'NCW(6KW(5HY'+',,%83DA^0\AGI+GM\9;S[]$+;V\LS@DNTN=B0
MCLRLMA\ L'"=741#61>ZCV!89PSCW >/6'&6,F$EAB["3>Q9=KV/<'1P/L$3
M@_/SA<(3G9^=C@\8<7%1^6:/@$D@(1D)DQ/[?ZD/J;W'2"XQ-)9;DJVV6VRD
M/1GV%KCR[E+CKQ#,-U!2MN*VM.K+EH(QP5%CDNEYR+TE@M#TIYN8LK9C,K"D
M+22AQY:#V+:A@0@$8.+'7XT)]=K%':=O#V?!ZG@MUM_J]FE*5]HU^B4I2E*4
MI2E*5@WS^2/AQO\ [:LY6#?/Y(^'&_\ MJSE3/8(\:__ !JA']N]XD?NBE*4
MJ%7TI2E*4I2E*5A'7T;'OA<S]SNM9NL(Z^C8]\+F?N=UK-U-78M^T/RCE5-]
MF_[JGY!FE*4J%6TI2E*4I2E*5@W+TUCOOQ?^Z5M9RL&Y>FL=]^+_ -TK:SE3
M5V+?M#\HY5+79R/=D_[=BE*4J%74I2E*4I2E*5@UGI^R>\WK^[:SE8-9Z?LG
MO-Z_NVLY4U=BW[0_*.54WV;_ +JGY!FE*4J%6TKY?_UM_OMOIOMV_P#C\_:W
M>KO['JULE3FVH3V]*M<$2-2[JQM[4G5*B$Y[FO+1*W(Q$WE'& ,6JP-R!<O&
MF3!-/"B1JE0@6(3G& 4JH"?1?)S^UY(<%27+2ARB4!U(R: \35Y 3"13AOUG
M3=9!75I2H3BBUK\DA:1K#%;="5'>8E3Q5M),C3B82?<9;_UOV?TW_P"+?FK2
M(0 !$(0K!"$-Q"%<>ZP0VM<5Q7O>]K!M:UKWW[[6M:W9M:U< +RUBLZ.+IB5
MDJ &1%L7!:W&4ES.-CCB!S%<D(6Y:^ <[M:5=<2A.&R,]46HN(\FUB[]%+X2
ME=A4KB2J?09"ZQ]C73**(WN6$ 4Q9G5R-F3NDE3C#PP'L#><M K>21 W"":V
MDJ2Q!OO"*]JY G<FY8I7(DB]&I6-AA!3DD(4D'*F\U4F+6)BUR<L8CD@U*0T
MI4G H 6(Y,86>7810PCNI6]I2E*5BWSTE>/@MP_9#JWB3T(E][D_U8:V;YZ2
MO'P6X?LAU;Q)Z$2^]R?ZL-3_ "8]N?W4U5^7/N0_?55)FL3'\UR5K@98YCET
M&SSI)B!LE<16EGW2&W?X=YKI @1IEW""! L7&([ID:P_>D)5F$V7!NB&HO:,
M:G4IE]/,M0.6$",Z&9*?H7C^ RU>F1F%*8JM0NK#&9$[)4:DL5F5S7+8^!*2
M2IL:%D7.PR$Q@U!2 VWH748LQZJR$ARLHB;0=D1M:AL:&6C),N[IFDPI60-
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MQ"$-H2VVE*$(2E"$(2$H0A("4I2E( 2E( "4@    # 5Z         !@ !Q
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MGYK;@DE=$Z(/\J,VW\'A6ZUM][[ZRG5 ]'W=K9N;TW\5ZE.]IR+=*-Q)5O\
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MP;_!MX[ _P"-PO9%_L_Q\>.SM>.JFXVEVN_A>='<=U3K8Z,W(C'<&.M^-HP
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MVEI<$2__ )DK1."M.J3*_P#FQQ(#_P"+J*6W%JU$-K4LJ2@)2A2E%:C@E&J
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ML)1%*#DQ!BLU,B- F+.4$%#/$6$PXH%Q&!O<2I;Y0@%2EK2E*1URI6  &9)
MK#BJ2B&VM9"4H92I2CU@E* 23D *Y/2O-"5_"F] II11ML1ZL@V.**."$4'Q
M9P@A-+"8$(N#F$0>%:PK6%P1"#OM?<*]MU[Z_P#E3&@;N2:L>8^+?+!7;?\
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ML6\GLMAF@NX$)AA#8\BW0#Q"L48,T("3C;EV**,&%&,EP.:/TPC$6E#4]O\
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M@(@B20K2H@QM$RU3:B4G%O6M;*L%F)<=:3R+J7#CD(1L#-(PI"5)3>SEHS5
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MS>O[MK.5-78M^T/RCE5-]F_[JGY!FE*4J%6U^82BPC,," (1F\'H@PAL$9G
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M]/N++P+73ES+,JUGMN4I&9J*R-!<;ZJ\P)9;B%5CYAQJWD6;9TW%&XN<;/\
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G\[K!W,#)7B?3J:TBY!O71<WYC/S[#3JUT.[Z]&^G+9]*],#EC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g370233.jpg
<DESCRIPTION>G370233.JPG
<TEXT>
begin 644 g370233.jpg
M_]C_X  02D9)1@ ! 0$!60%9  #__@ ^1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?3D%455)!3%\T0U]/4D<N15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M =@&<<5; .H!Z3"&P VME'1B_> *>+;)DI8PN,^Z9Y;J20'(P6\.>&%B._\
MDX4G]&H!IG*J9F4D\[%C"D<9QN1W&1_ID@G@\9K;US8_,J<".:2O,3C_ &6_
MN%%5:$:6%QVDY][)((MR.W*L$XR-R"<I3:+9JHF[4<M+:=(I-SI.5B%;J%$U
ML(<7<]RTPK"W+[3+.JLVFU))N;<L+%/$&S))*,<*^"@[^SGN*;UN!M'J+@*"
M$@J=1%5403(X45#OYQL&W'<F _:R^R?]GOF&5F71_9[?U@JN*<M7@"Z9LD\&
MLO\ $)AD'C_?4A*NFS6-5E,4QL#?>$KV/%G.P;/<6M50!%55RW;ZK89YMW!
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MT,;6^U2RMKA58 JS02S+*JN""C% &'()JWDN[6%MDMQ!&X )1Y45@#V)4D$
MY![=CGM4A]*CO_K2>'G;_AO='?>O_%O>WF'F/_DGR^MT_K2>'G;_ (;W1WWK
M_P 6][>8>8_^2?+ZW6-_OD^S[_/7I?\ KO3_ /7_ !'WU3_*%C_YW;?\]'_]
M7Q_;Z&I$*5'?_6D\/.W_  WNCOO7_BWO;S#S'_R3Y?6Z?UI/#SM_PWNCOO7_
M (M[V\P\Q_\ )/E];I_?)]GW^>O2_P#7>G_Z_P"(^^GY0L?_ #NV_P">C_\
MJ^/[?0U(A2H[_P"M)X>=O^&]T=]Z_P#%O>WF'F/_ ))\OK=/ZTGAYV_X;W1W
MWK_Q;WMYAYC_ .2?+ZW3^^3[/O\ /7I?^N]/_P!?\1]]/RA8_P#G=M_ST?\
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MCL!(9RTC#D-(=Q!SG*#ZL>2!D1J@/I0PB8PG,(G.(  G.(G.( &@ QS")C
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MR7DITBE#8[.Y.FW-(/5! ! 0, " ]A 0["'P$!W5W]+>3 NDCO%  'T@,90
M<A5N49+E5'.(Q-X1)]Z-AQ4BH4SX3M%DYPA&PD@ DQL&C+''+E-_HPK7_!G-
MC!6=I>:L^UKN*PR7:B;8U[8AO.,E;$S#8QW)"BF6\,7W>SAKT@T3&$R:4FO#
MJ0;TY#FC)9^B!5C;<-WC=R0IT5"F*8 $! 0[[#8:[]^U:K9NXV80Y&1+>+S!
MCZ)NEU&)');=W-5Y&U\EV.N<P'+(X[RI:;V$R+C^51. '1?VC<T0L ]15 52
M.HF?1;+-T\@?9WVE+Y,<9IMSD9QZB!C&C''N=KFMO''):,4 B+=>&Q_F-5*/
ML'/LPJD8SR+M7(%MV+?"[9FJ1YDJY9)T1<Y+&.\D2*P>3Z1(RI'9W&TO([;5
M"07,:I%([-N;;/':*B@(LDSD S27\=I%)/?/%#;PJ7FNBPCAB11EI)A(Q,<:
MC@LKR<Y9E5>1,W2H>8#VWG!1U&LW$Q>M^Q+U=L@LXCG&)+Y<+LU5DBJ':N%F
M$<Z:BX;F-X"X(++HE6(<J2RR8%5-W8^VU]GZ'GD:^/AK_(_D?_N+7Z#5V.EN
MI3VT'5_ZON@?N,6?.L*>N^BP2#U7T_QZ:M8D?81,1Z_:#4M=*B3_ *[?V?G_
M )QKX_['\C_]QT_KM_9^?^<:^/\ L?R-_P!QU'^Y7J;_ '@U?^K[G_5U#^[S
MHK_.OI_^MK+_ %U2V4J)/^NW]GY_YQKX_P"Q_(W_ ''3^NW]GY_YQKX_['\C
M?]QT_N5ZF_W@U?\ J^Y_U=/[O.BO\Z^G_P"MK+_75+92HD_Z[?V?G_G&OC_L
M?R-_W'3^NW]GY_YQKX_['\C_ /<=/[E>IO\ >#5_ZON?]73^[SHK_.OI_P#K
M:R_UU2V4J+^T/;&^S[NZ50B/\MJUK*NCD30?WS8=^6C! H<P%#WNX)2WRPT:
MF&Q,=S)O&35,H"91<@:$9,HV3CIF/92T0^9R<7)-&[^.D8]R@]8OV+Q(B[1Z
MR>-E%6[IHZ0.19NY054162.51,YBB UCKW3-1TXHNH6%Y9&3/ABZMIH-^W&[
M8944/MR-VTG&1G&:S&FZYHVLK(VDZKIVIB+;XOT&\M[HQ;L[?$$,CF/=@[=X
M7=@XSBN=2E*L:RE*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E
M*PAR+S= \>,07?E2>1!\6!9$2AH4KDC5Q<5R2"I6<% MEC <R9G[Y0GO*Y$E
MC,HY%Z_,D9-J>LWU!#[9/(YCR.&\1M7"A2-VT[DJ;; ;^R447.-J6PH</(3I
M$)=9B .A+X@&#8& 0T;VD]4OT;T7KFO0;3>V]ND&GAP&7Z?>S1VELY5@5<02
M3?27C(Q(D+J< DBRU&Z-G9S3KC>JA8\X^N[!%."#G:3O(P<A34/F3LGWOF&]
MYS(>0IUQ/W1/+^(Z=J "39HT3^ZRB(EF0"H1L+&( 1NP8-R$(1,GCKBN]6<N
M5K I2OF/=75S>W,]Y>3RW5U=2R3W%Q/(TLT\TK%Y)99')9W=B69F)))R:YLS
M,[,[L69B69F.69CR22>22>23R3R:^:RGA(+K:ZA1076 HCH#"BD=0"B(=P P
MDT(AY;W6^/*SA8OQTL''.1X.\U[ZMZ[R1[&Y <1+.+=6?<$S (7'!L5RLGSP
M%V,RQ"13:.')&ZP.8\A=*E>H]&A3S_B3WYL7@?F+94 _?4Y^5+LMV9Y$I\;K
M_DC-,<\D^+V&+.)("9!5K9^46K2;>XXO=-)<Y44W*$F5*+75*HDHX*YB4UC"
MV0 2=%Z%T+0];T?J>+58E2_FN= TO0=1>>6%-.U/4CJ[VYE576&2VOKJRM+"
MZ>=6%M!</<HR-'DW]E#%-#<K(OOL8(X),D>')(9"N>0I5V18W+<(K%Q@C-1L
M9_XURN)LX-<)V0O<F3YE_;%H3L8E'VX<T]).[FC%Y%:/:0D*:046*P(@<17(
M(Z0!1=R*2:1E*QA*X0S+"7@PQ]+8IR&POF606=1%HKVC,C<$PU;HF<.',-'I
M-55)ANV1(=1RM%B[3;E(<5S)B0P!.+//X..YK\A+9,NFMD>YN)F/K9QDG%WJ
MTQU-3DXV;/59^W;.OQXSDD[6N299I,%(Z1*U5<HH,U5BEZ&RJB>HV8LNY#PM
M;G&1S,X+RAB-;%69IR\;+F<M9B89.OB2@2MDD<@6F#,\*RFVMJ2<?)$09/)!
M4S)8Q1:Q@. 2(LVW#J#V;],63:WJDFH7VGV-KU#J=K]&L+.\OK;3+*PU^VTM
MK&XN?HMU#%>R6<KWMM+?ZE; EK* P3B[-Q#=W%A;(T\A=T1;B5=L:2.L4<=P
MD11G",BN4)=3)*F<QKM;Q XC1@\?7[<S6XWUN63=L^RLY)1Q=SR%MV6DVUKH
M(D>G56N%9FT63ATDB1S\RIWXH F5D[,?0-E>GKAM:YBVRE>AK>FRV>O,*6\A
M=1HMZ6W%Y])M[XK"(S0HA'K2R;0?>E(]-<SI-O\ VQTBD[U/Y<%P6-Q?RG"0
M[5S#2=J\VN2,M=,\:.<-Q9-L.71C:.M%LVD"%*!&S<<D9!<SJ)4P.B9@U74*
M<#=:1H^.<4,WPA:& >)D1(1\@UQK;UQY!NQ\P$IU):[[XN*::1;N243 B:CQ
MM;3-;6TRG*G(IZ'PRI%#"=1^S*RZ<TC5-0FUE[BZT036>HVL:0A5U:[O=.;0
M(86#L7M=1T.]N-3ED!+1M83PJ>5JC/IT=O%)(TQ9H24E0;?YUGB, 4Y.5D@=
MI21ROAL.,BH[*H( (:,4I@[@)3% Q1 >P@)3 )3 (=C ("!@[" A5:5QZL34
MW_LR>6,Q-NR\;\ARKF460C'+_$TR^.+AZ1E$(+O9JQI!\L<SEVFU9 >6M51P
M999!FUDX4#^[-XPB<T->-/'%[RF-;_LO($*Z69R5FW1"7$@N@<4U!3C7Z*SY
MN)@[BB^C??8]R3R5:NUTC )5!KV4(N&[Q))XT,4[5VDD[:&((&*9JZ2*X:F*
M("("4S=5,P" B @.]]Z]\?R<NL[WJ3I:^T74YY+F\Z7GM8+>XE<O+)I5['*;
M**1V)=VM)+6Z@5B3MMA:Q]UR=NT6Y>>W>)SN:W*J"22?#8'8#G^CM<?(* .*
M^E/KZ_=2E>B*S5/G\/Y]OKX4#\O7R^OUI5-A^_7YB/\ ?^^E*K_'Z_NI3\_K
MZ^O2E*?C\?*J" "("( (AY"(!L-^>A]-_*OP<$TRB8P%* ")Q$0#S[_>[AY]
MQT/SJBRQ$$S**& I2@(B(^0:[CO?;^^M#N2W+*)QLW<0-OJ-9.YS(=9T3KG!
MA$(*"4$G<TLU!5PB+DHJ#$Q;=,\E-JHG(S*@T2=R;.!('X_']GG5YI^GWVK7
MMOIVFVLUY>W4JPP6\"&2621B,*J@=L9+,<*B@LQ !(V1R-F:Q\:QJ\E<,NP8
M))")"]9@,LNL)3&!NU:HE5=/'*H ($:-$EW"@[\-)0=U'-D?V@@D?G86?")$
M0Z3^)(31E2NB?=ZT"DM^-06= 979>HDM)0:[?N#AL10!3"/2Y[SO?*5P'D9!
M_*R3]X*[9)8Q3#(*H.E0,9BT;-C*(PT>J4J29HB(Z$W!4TQE'4NZ*9X>ZT\,
MR<'%#)7&LQ@"%2\1-@Z.!Y50H%Z^T>0.M 3!Y Y,@.Q[!YB,JB25MJ!B3Y*"
M3W_')('WUZ@Z<]A.@:/;V][[0M7'TN?84T:QN%BC4L%)BEN%#W%S)D[72R2-
M4/U9Y00:RLZYRYC.Z%1%RQ3;]8G!(EL)=(=S=.A5N0RH"!=!LQA,  (AK8U=
ML1[07(,>D8[]G"OG!0+I!:.F8CQC;*!BF?,EKD33$I=B F8G 1*!=% 1$-*)
MN0C(Y04F1%'@%(<QE5D@3(42"713 DHH!>HPZV!S:#9NY0'=C'NM$X@*D:V%
M(Q%# 8KA1,PF3[*  B10HB ATET4!,.Q$"E =WJZ5J#+N6+C@X,B _=O'D.!
MYX[$=]^;V9>QZZ3PTT::#( $\%YK*R#E><SS2(>X'O1D9X(S4MEN>TC9+> %
MQ6N5JI]TJAF<_'/"EV/D091G!*&\@ H&(EW["( &QW+Q;RPQGD=T$<TDR,)K
ML(Q4J@$?(*;("@JL_$$S:41*0X"=U$.I!J3JT=<#@8I?.BB[@)0"I@K[DNH4
MW2D[%-,IC  ;\-P!A0.78Z*)CD$X /81  K\@66MM9)>-<*$21<MWQ6W4H"'
MO+8PG0<I%3.0[=XB(F%O(,56S]OU"9L[2,/4-I)'/ VV5'C/D'4@'!QD,>_.
M>QQQWYK7M7_DZ=*ZE9R2]+:W?6=Z!NBCU"2&]LY&P-L<AB@M[FWR>/$/C,HR
M?":O6NT<M'B15FXI'*<-@8H%'?4 ]MAY[#T]0'U"N5X9-"'030^8=(:$/F&J
MA.XK<W'S!W'VCD:0478*'19M;@?+=3N.766\)NUG5M$2<1RFTT&MS'!N*;DZ
M3&>11<K-I:1F=AI=I,,D7C10BB:I"G 2& P?> !'6A[>?EY^?KN@.>.Q&,C\
M?CUKRIU)TSK/26JSZ1KEH]K=PG<I.&AGB8D)/;2CW)H),'9(A/(9'"NK(.V
M *    4H!V  T #ZZUH-?E5:4J-8&E*4I2E*IH-[]?*JTI2E*4I5E9'R%:>)
M[!O+)M]R?V/9E@VW+79<TD5,SA9M#0S4[IR+5J0/$=OW'21I',D@%1[(.&S5
M/9UBUX1^6?*G)'+S+TQE"_WJZ#%-9Y'8_LM-<XPV/;-%TNI&P$8W P('E#MU
M"*W//BF$A<4N9=PZ5!DE',67H[]NKE62LSBU9&-HEZLS-F;*32.GB(' @OK2
ML"'7NU_&K=A,=F[N-2TU'*0: X,TRF-TF$IO)37<O9AHD$5A+KDJ*]U=2RV]
MJS 'P;:$A)&C)'NO/-XB2$<[(E4$!W#>7_;?U+<S:K!TS!*\=E8P0W=\B,5%
MQ>W*B6%90#AX[:V,,D0/:6=V8$I&55\UC^$BLKK?A(JJ:\NKPTS'Z=^G5TZW
MZ;W7TKX.O^*NM>?NSC_Z2>NKCDCYBN#$D D=P,CYBI0N=/LX7W$#'>*LJVYD
M1QD^S;Z^SHBZUG<&P@Y.PKMG[?0NBV8UVUCI"137B;ABDYA-C(.CMG /XHK<
M45"2+<Y<+\J>'<Y@?DFRXXXW=7?FFX9:S+!N:$0B+/54N>7?WI$NY1:(C[;M
MT\NLY)&$:'$729A &P*N78H(HG5J8_D9?5HW%R])Q$RA*H-\3\N.&.!+%92+
MD6[F.Q_GAC_2UYAG):0G*H#%VSG"HP;UZBHD=5)]"D7ZFR(&+EZZY6WHKVC?
M*ZS%'*+C+MZ\",765A]M Y+8XCN"Z+I;I/U[GLS'F4))C))V7>%Q,T(M6$EB
ML5WK9",6>E(F1BNLERRRZGUFW@M#>$WDHTB]U//APPQW<,UUI<5I+*ZHB1'3
MWEOX[@*T2FWB2>4@R!U[GJ/1/3EW=:B-.VZ=;_W1:;H@7Q[BYFL+BULM:FOX
M((WEDEG&KQP:7-:-(D\@O+B2UMPPB9)?--,\<>05NW_&8JG<'Y8B\F3C==Y
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M8POW$5]MEG5H9%MB3M6>(U."3U!I)) "4C&K&*<$)6(>IM)>*7$H@C(L6QS
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M$H@  '8HB-?-1,%"AXB)5BG%-0Z?3V4*41.0G5VZ/#$Q0Z3&#2A3Z$/NU]
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MA"R'2X8V1:\?'1&/\9PP(MDX;'EIVXV,V(_5DE7&S=*5-+*\TCRR'+N<G
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MCUGJK59=6UR_FO[V9LM),V51!]6.&, )%"@.(XHE2- 3@<DF_:4I75ZL//\
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M%)0%1$0V >$)?$V(=P#IV(=P 0H9-4H@4R*Q#&'[I5$54SG[@&B$.0ICCW
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M =[T'XUW##EABUP8H/)P(@#" ;GF$G;Y0WZF/.LHXI?3]HP>8;$.H-RB:%B
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MM4!?LVBI-ZOK_#RJ@@40T=,BI!['25*!DEB#V.BJ40$#I+$ZDU2" E.F<Q1
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M0MKRS%6X<?G7=)+BS:H.4T+FLXA0 '!4;3?NV#B%%P F&UIV&9D474AW:HX
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M[ANULV4%92 <HL8Z.@HB%>'(DG-'-*S+N1C@=1;=DB5VH\3R4-C*&51"X8D
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M4"Q;Q83+" $*=!(5TE!,;8!T.$DQ WF&@  $=%'']OS*0NDUU73DIB-SH)I
MX,5H G-LRBK< Z3*"&B@H([+HH]]#KB91N0\?9[PZ?6<SITS9Z((?Z)0YUE
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MV-I-4A?%3.)?$;+@4/&;+"'8%43#HP!V,42J$V0Y1&TW5LG->*=UA+K^$B@
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M\Z[! /7XCV_@/Z>NMCH0^5<5,OE\3:^7]_EYB/;M78I$V ;]1V'GY:#8>@_
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M'0;^>JP%;_\ *JB( &S" =NXCY?K7"6=](""0=^^CF\NWP .X[]!'7X:KZ*
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M=F'8AL:^K:?8>^2#5)@Y!2.,@457* MV;@RZ?B =H9+I*X*F Z5T(=)] ;U
M<<L7J46W.U0.Y4(9PY<B9RL=PIUNE3*J%!0^A!,IC""1 [$*&N_<:^;F;7.4
M="8"^IAV&@\]CW  _+XAH!$:Q4FH DDLTC'G<Q+$DE<D[BQ)./4>9\N:ZZ=(
M3@@@=CC"CDCCW<$\9\SGGXU^KUOV?93,*P:Q@R3!YHJZ_2L)&P&7Z#$3%$/
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M0-T 84MH&(4.GHT?71]=+*,=2$T>/5%ZR*^38F(ZD".VKAQX@E;MFPG.BY1
M>LKTRH+IKL4WGBID6#592^T6#6K&>QO0SB2,-%(P V."_@D89'0).5>1(VB#
M,NQBP )RG2NN:ETGK-IK.ESF)X)?SR)LQ<6[#9<V[":&XB"S6S2PK*T,K0%_
M&C59$4U[^<49,MW(]L1T[!RK"4:NT"*)N6#QN\;G$=E-TKME543B!@,4P%.;
MI, E\P, 97$-AKXA_B _SKQS^S"YP3F+KH1@KN<.F6.KAE$X]TV<'A$$8>8%
M.$BHZYH^*0.RD"14R;J+/G;IR"2+Q,TN0B3=-^*'L#A9%*4CT'21@,50A3;
M0'N(>781^ [UON UYRU[0[SI[4IM-O1N>,EHIU4B.YA)PLT9RR\_5D17?PY
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M=_+]-?+S'UK)*ULPZPB8K8S<P]]ME3IE ?DF;K3#XZ @!\NXUUA[4 HB9L\
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M<1'I"!@;%5-Y"9815^8CTF_L][^!-AOM7%G85"8B'D6)032=)'2$"% H !P
M![%  \OD(^0^E1\7 .W/8=_7CTS\?3BI_P N)'_-P._Q=@@';/N@.2/AE?B?
M*O,_#Q-RWY+76I#![I>N3LMR-N*S+CQ1=1L>UF%K,C727WQ,BI;5J6[<TK#
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MEV$:KL-@'Q\ORI]!2GX%<4[-L<1-X12B.^Y/N?N+H.WIVK\"R* F$JA@ 0[
M)0'0[^(:$0^._P ^P5S:5*44G.T9]0,?#RQ4XD<<!C@>1Y'V9!_5_&N$*!P
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MK4)V$0*8B5\MQ,3S 3;'S'4A51H<)Q4F<[>T-NXX'%*6YIR]N,U#@.C-,;8
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MI2J#Y>6_P^NWX^E5V'EL-_ENGKKZ^@]?Q"E*4I2E*4'OV]!\_K_93]]-AZB
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M_ ),)?.&3G,A:F%[>DFZKJ,)*M6S=>>O6X$$SI O;MDQ[QN^68BND,[-O(.
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M!$@G,7JK^P+I?35;4;CJ/6(K>P4WL\KQ681(+4>/*S[868((XW+[06VYP"<
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M>W];Z_BLIZ%.F(.D#D.DXBYZ+<E5B[E@GR"BK>0@YQJ]CW:"IP\))<$G"7]
M_P!G-SBM?GGQTA\ILFK"W\AV^\"S\Q6.P5<JM[5OIJU(Z*M%G>$(X<6Q=<49
MO<=MN#F7.W;.G4&[<*R,(^,/)?:+[*KWHB*+4[6[;5=$FE6!KAH/!N;&=\F*
M.[17DC:*8 B*ZC95:4&*2*%FA\;LOLS]KUAU[++I5W:+I&OPPM<K:K<>/;7]
MO&46:6RD=(I!) 74S6LBNZ1,LL<TZB;P-]J4IH/@%<DKLE*4I2H']X_4:4I2
ME1I3Z^OUIV^7?7>G?OZ? ?YTI2E*>=*?=^__ &=L?;2E*?7UY;_&E*?7U^E*
M4UOM2GS^/X^RJ".O77?S_>._@&M[$>P>==6N[*H84RC_ &?EU=QZQ]/(?V0'
MN'GOS[=JX<E) 8QFJ)@T&P7. [^\&]IE$/, _P!<P#W-]P.P"(\%-4![&$ [
M>?Q_E^0!\-556,@;B/EYX\L_/TS_ +'EG'I^OU]*PGR'Q#:V8+ E+7NJ)9RS
M%R4BQ$G2/6"3E$W4@Y2.D*:R2R(B(D52425*4QR@?I.<!\,&6K)<VA?+2WVK
MMA&-??;E+&-962]\DRQ47=UQ.'K5TFNJN]7<VM#J PF$G8LQ(1@X91Z2[>(5
M43_H'JID72,BH '3. @(?$![>?UYC\:C?Y;^S\L3/L)(KQ*;6V[I<.COBS;2
M&9/A<KK,'$6Y)*,UCM"2:;F->.6@BNY(X0ZTU6RZ9D2E-M?2/4AZ9U)KEX3/
M;W*I;W WN5BA:>%IYDMQ[DTWA(51693G!W$96N<^TKH4]=:+'9PW26=[8R37
MMFQAC_QNZ2RNX;*SGO&#26EH;JY$D[)',6CWA420K+'X<Y>968OT8U!B@G%,
M <"\DXY%NL\:&4.Z,@V36,[%H_606<*$<.$#I(%;++,DG*BQ2N*Z5G..1??:
M<Y""FR(7J2166<^YJ-P(X8L7*YD#J*INB*B*YW!2$3(H@4!3*4J*Y9QLU>R1
MRU8MO'D(AC W@SCG[=270C+?7CYR7A#)N$5@:LAN-2%CG\:LNA*G7BF@.)4D
M>9HW9H*N!*M$7D/&5VV^S8VT9LO$F)*O4R+W.DQMZ05N!&??VV2WUU!EGK%Y
M[Z^B'9XB$*[375;.#O)%JV,!B-O2'3G773^L?F[&94=%VW NBUK.D.8V>X.9
M"<;Y%C:0J4W$+%XA5V/B[JSV:]8](F)]8L2T%Q(HMI;()?6<UU_C BM \:A1
M(\-K+=)!NCN/ _.3)%E8UUHG0N&Z%'"+5Q$Z14]X,Y9-$6*CINV1!%K&-0,(
M*M6S3K( H"907*HHKO5W)BBK6);N7N:1$@JQ ,F\8D1)XLV241047<+$ SIS
MXZZH&445533$$SIMBI@@BV0232#JR-+S4DU>O@CH0()(WBQK@RJ[YVDE_9D(
ML=D9XX7!-T9=/QBHI&<"Q,8Y- DF02V"[5;R4/[L=5\M,@_(LZ2,!C,5? !V
M4%6YR&.[.N[]Z(59JHF#9N*)EVRJ@K$2;]+M[R4%'$</A*RB(!5=H@PP[.8B
MT9&Q<#DJI^IA,+7/HY(T/OMND5',FY6*L2VZ,(K1I)DRL>'8$YRVY@"+-E&D
M>JFT=+N/=E(]@T8JI)+&D#N9'QGSE=XD"92$:(^"LS3!,YSB*B J]13*'(EW
M-Y2$:_1M6-@[7=,7;>&$JB\DX*JO*G5< ?WA-$B272R%Z5T9L9<QP\5ZHV2,
M9!-!,MS6E;URNY&XXZ'A@%=Q'N7DFW.Q,X<1I$6ZD8=1N@J4ZJ;H4Y11F43I
MG.0'2JQR 9N55+9[%'$6_P#(,6M==N(71//AA$Y!X^M]!G*%A8B0;2#2+.\)
M(/TI>?=NTHUR92-@FJCN)B2M'+<SJ15;1),1J_4&GZ5$EWJ-XEG;Q2K'%)-*
MZQF:Y3$2,%)(5LNQ9RX R5 7!&U:'8ZIK]U^3](TZ]U>\>T>9K2RMXBZV]GX
M<DQB"[64(55652K7$FR,[I'PVG%LQ$])K-H!JQ+)35SJ0K:"%H[0!1C*.I9!
M%BHD@D*AR/$SD,U32-[N9,'"I7!#H^'J63@1PYNZ],MVL5-5%:26GSSZ%QNK
M7=S"+9@Q8O11? TN5K'H"5U+"CX;XX/XV1%1L73]DX=-5KFXF\$+VONZH!!I
M:$+)2]OD2N%>XRS<Q'E271G2,XR'?MT6;]EX4C$IK.WL8]BHF[6Y4U#.5V'6
MBFX]D_%3CK!XCQ?94"[CVXRUOP,5&'<D3%/K4CV+9KXA4Q.<4R:1TF!CJ'!,
M"E,H<W48>)>T7VE%!+H^@W,;2R+-#J%W$7$D0/T=[=[2>-S"\<D6]7&6WJ66
M1$XSZ ]DGLBGU5HNH>L-.F@L8&M;G1=/G2S:WOANOX-0@U.QG5KV%K:=(7A$
MD5N S++#)*""F6^/6*HS$F-K:M%DV(FG#1+".(<X%,L9-DV3;)"LIH/$4$B1
M1.;I !.(FZ2B.@V%:/""((','?LF<1T';L!#;^/D0?+_ %?@-=")P(4"!W H
M !2E[:#>N_8 \M"&^^@^.ZX:BP^O<?,._P!T-!W'S 1'MV$?+?W?+OYX']N3
MYY(YSY^9)]?4Y ]=F'?G/!.2"!V^'R'PQP#CM@7[2NCB90KH ;+&_P!\%#^S
M,/\ ^7* ;'X?VA [&#7WR_?["!J[OX:#?[M!\?\ "E6CHT;%6&".?@0>Q'J#
MY?=W!%5I30#YANE*EI2E*4JFN_R^&@[C\=U6E/Y>=*4IL \QJG8/P_#R^?Y?
M(*J  'E2F1ZT\Z53U^OG^G\_RJOU]=A_G^%*4I2G\?*E*?7U_A3L(?+7[J4I
M2FP^(4#8B   F$?("@)A'0"(Z  $1T "(Z#L "(]@$:ION   B(CH"@ B(CO
MR  \Q[]@\Q'L'>H)_: <QYVY[HGL%8OGE8RQ[=65A[]GX5V*3N]+A0.G]I6Z
MC((%(X:VS;CM(\<^(P=$_I%+)/4WBAHMDBV=;%TQTU?=4ZFNGV16)50S7=U(
M"8K6W5@K2,!@R2,S!(85(:1SRR1K)+'J/6G66E]$:.VK:B'F=Y!;V-C"RK/>
MW3*6$2LP*Q1(JF2XN&5A#&IVI+,T4$LMUP<DN/=J2KJ"N3-^+(699'\-[&/;
MTA?>VBG2!O#<IMW*X(*Z$!%)4Q52[T8@5TG^=MQ>]>06)/\ KE'?'7Q#Z^=>
M5,A2IATIE*F7S J90(4/P*4 *'Q[ '?8^8U^]C\1_4?2NS+[%])"J'UK46<*
MH=DAMD5F'UBJ,LA53SA2[E1^D3R?.K_RB^H"[&+I_1DC+$HDDU]+(JYX5Y$E
MA5V X++%&&.2$7@#U5?YVO%WS_S@\2?]<H[^^J?YVW%[O_\ )!XD$/E>,=^8
M?M>?Y!7E6V/Q']1IL?B/ZC4W]Y?1_P#?C4_^;M/A_P %\_OJ3_"*ZC_WAT/_
M .:__P"T_C)^&/55_G:\7A_^6"Q)\@_IG'>FO/[V@\O4?XZK4_G)RCPS<?%'
M,MDXTRQ85YW?DV"AL1LHBV[F9O9)K$Y:N^W<=7A<ZB:(B9&)LNR;DN6[IYX?
MI290T*]75.0I>H(!=C\1_4:"(CYB(_B-58?8WI$,T4PU?4F,,L<H5DM-K&-E
M8*V(LX8K@XP<$X\J@W\HCJ)E93H.B892I(:_R PP2,W.,XSCX_+%>K"T>5W%
M"W81C%)9_P 1H(,FR35N@6\X@@(MFY03;I 052=()HE(0"@'2   %[5<_P#G
ME\4__2$Q+_UUA_\ [_7DHV/Q']1IL?B/ZC5N/8GHP  UG5.!CF.U)X]?S8YJ
MX_PD.I?]X-#'_+O_ -]Q7KCC^7G%V4>MH]CG_$J[QXL1NV1_IQ!)"JLH.B)E
M.L[32 QQ^Z4#'+U&$"@.Q *V&;N$':*3ELLDX;KID51704(JBLDH4#$5253$
MR:J9RB!B*$,8A@'93"%>)4P <!*8.HH]A*;[Q1#X"4=@(?(0$*WWX2\S[EX[
MW;$VE=<N]D\(3;X&DQ#.1,\_H2X?J FG=%M@?J58LVC@Y5I^%;&!B^8&</46
MY)-JD9S@]?\ 8X]I82W>AZA/?7%NC2-8W44:R7"*"S+;2PX'C #W(7C(E/NB
M1&P&V?I3^4.M_JD%AU/I5KIUI=RI"FIV,TIBM))&5$:\@N"Y-L6.9;B.93 N
M6,,B;F3T\TKY)+HKI)KHJIJHK$(JDJD<JB2J2A0,FHFH41*HFH00.F<HB4Y!
M Q1$! :5PSMWKTX"" 000>1]N,?M'WBOY_/MV,^2&:/:$Y)M9*95DK0P!$V[
MB&V6A5=LF4RWB&-RY%<)(%_LTW[J[YE:(DU@$RJI;98-U3=+),A(<JSURIF)
M*X>3_(N>F%#JRLSFW)<E(J*;\0[MS=4D94Q^K8@;L :$>P  >>ZP* "(Z -B
M/8 #S$?A7TAZ5TZ'2>F= TZ  1VFD:?'D  /(;:-YY2!QNFG>29SYN['N:^7
M?6&J3:UU5U%JEPSM)>:UJ,@#DL8XENI(H(03SLMX$C@0?HI&H\J5(A[)?_\
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M&_C?Q&Y"2B@ T(Z:9FN;(3R;Y*6HJ[*J!W#F+LC+L29FX;&4(BXD7OC_ '2
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M<]L?'N,9P,<Y\_O\L]A(PP,#L<<?'X<^?V^7PKEO6#.3;J-G")%"*D$AR&*
M@)1#1@#?8>WH.Q$/AK8:%90]G5@K)4_<%Q+6HQ8SMR(N@D))@59N\.Y=>YBK
M(M_[<6[.3.>,C%%9%J@B\7/&L?>55R-R%#?@B@&\NP^?G\/W_7G7>LDS>&"I
MP^\8-$'UZ-^8_,1 ?R !]1J3<T>2C,A(VY1F1L JP&5P2 RAL$XW*#W Q29$
M<#>B.%)*B1%D4,4:,L X(!,<CH2,$I(ZGAB#YTKQ]B/"R,F4T==TL,9[X#KP
MW<-;#QZS5%RNNY/ N_LA%I !)F5+]I)-(M8BJJ0/698Z16=OG&(KV]AY)10Q
M\S:-R$?2,<Z([*A-PL&R*15)RW<H.X^0M2#BI1DX;G0%-1H?WZ-D6KI^BY:)
M.G",BT]2XZ]?EYA\?*J"4I@T8H"'S#R_#?E\OEY=JR\/5/4ENT;Q:[J@,6=B
MO=R21X+,Y#QR%HY S.Q82*X.<'@ #5)^@>A[F*>&;I#IW9<@"5H=+MK:8 1Q
M1 P7%M'#/:LJ0QA6M9(2I!D4AW=F\U]A>Q'@5'4<_NJXYV= \=#-)%.6;QYY
M-\M!*,7<2JZNY1M_3!=.,EHYI+1I5ILSIJZ:,RJ/W+5DV;I2@\<.$-D8!;RC
M5J1S*_:0-DW#F8<$?."H,4E4&;1,2$210:LR+KF10003**KARNL99==50\B
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MRBZZIAV)E5UC'55,(CU*',;UKTG>T8<+-^(^0RI=6GDWCQDXZ=?\55O:(54
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M0U66WLM-TZT-[(FJW-P]W>2QVEM9Z=J\^D1.&AMIIIY[N6 L(U1$B4,S2.
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M2;]G!Q@?<U?9M6Y&V9(VQA'FC8=\SU_8D@\^)Y@:6I=-BVY/R#UC9.>+-DG
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M$3;/XG5U]8B(]1]['8['>P'LK>O-[9ST[]!98S17I"39I.%$"O$2[$#B<IM
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MF+X9EES$T >&994R>@_9#PS'$F@U]T.G1=!K6@JHK+F#1G#@P; 0*9PL8H"
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M%=*R1B/%=VYJR';>-;)9F=3EQNP(*X@'NL/$MQ(I,7!(J&$$TH^%9"=VL)S
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M]6ZBZ5Z>ZLM8[/J'2K;4X(7,D'C>)'-;NP 9K>Y@>*YMRX51)X,J>(H"ON
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M.7;5KTK.>_8X[$$D?3?B' 1, ;$$R'$>P@-8^24,8Q0#J$XB %Z-B8PF'0
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MP0.W8JH!W/4Z'# 9P">_H?7\?NK(Z;.(;@(Y CF(0D\;7R C9R,<^Z3Z$$G
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MR*)$B8+N(4[9-F L;PUY1&;LAP+^5<Q3^5:+,(65D5UU$HR:?$0N&V7RBYE
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M&R4;(-E/N.&+]BZ<,WB!_NKM5U41^Z<:N+:?Z/*'9=\;*T<T><>+ ^!(@)R
MW >)B"(YDBE +1K5.6/Q$*YVL"&1L9VL.0<>8\F&1N0LI.&-<4-^0]A#8" "
M4P; =#HQ1$I@V'8Q!$A@T8HB40$0?/Z_<%1Z</KFF<*W9/\  W)4DY>2^*+>
M/=?&2Y9!%^HXR-Q29/VD!"PDE-.C+I2V1..LFYC\77IXCD\M,6,KBW(+\JR]
MS3+AO(75:>'P9-H;Q(V59(90"HEA<9CD"DDJ2.'0DM'('B?#HP%BIR#D;6!P
MZYR58=P3Y^6#V92&'!%4]?/\OYU77[N] '=/Q_=L?Y51J;\?=2E*4I2E*4I7
M6RK].-8N':I@*1),YQ$>W[)1'S^/;S'MK\J\F7M0>7LI>MW2-H6W(J%9E)*1
MD44CI K1O;B:CMG-W*L/28Z"]SKM7,:U4<'3,TM*-.H0@I7<J"OH5YO9-'&^
M$KF>-G2C.0EDF]N,'"(&\9LXN!<(T[Y,Q $Q!C&:SN4,J(=*!&1USF*1,Y@\
M&&?,A&GYZXYU$%&J,Z\5<,&BBJBAF,"@4C>W(HRB@^(H#.(:QB2BB@^(LJW*
MJKM01ZNT>Q7I--?Z@EU.ZB$MKHW@F%'7,;ZA.6,3L#PRVT:O+C_=#%GR-7UL
MRV\,MXX&5)CAS_2(!++W!8 @#^CO! )%;\>S>XZVUF[+P9.RE'I7-B3',B+A
MQ%2+59:%O"XVZ?BD9RB!CHN7D!$G60=/TA II5T=HP\,I%%@&=3(^2K98/W[
M>S8-G:=NG,DDPA(X3 F@V:HI((I"8"B)$?[(5$(](09,NL4D$P O4.FG'* :
M81XRXQM9LDFVEIJUHN[Y\Q Z5U7]RM$I8B;DPAU%,1%R150IM="RYB[TF75C
M7;?"SA94XN!, '. D$VQ,&P'[N_( T'EY>=;;U-/-U+U#=7#2R-863O8:?!O
M80B&"0J9S$OYLS3NID,A!;:44,$4*.K=+Z"B01W,R[YY45V!)(7Q-K8P?,<*
M&.2J^[QN8MF";R<<ZJA"K"8Y@$H#]X0 =]NH.G^6_GV"L>K7\[,L)3*B85!'
M8E/H Z1T.]E[[WV'\NU:^S%PKI.DE#N40173*LF<AS" %,7?28  /[0# )1+
MY[T/<.]=M%.V[Z%D9TRJ:I4WA(Q-!)<_O31R9,%T7:R0)BD#%<I5&H*G6*/O
M'W2E$2C4(M,CB13L[[5'&1DD  \#&#SCGA>.XK=IK6*"'>5#*P7/'(9MN!VX
M)Y&<X&.:R3<LZTF8Y5A*H@X:+"8I^K[QDS:$ 42.  *:A=_<,76_+8AVK1C)
M4*U8DE(:1:LI> EFZR+F,E&J+Z.E(]41+[N_9K%.B;MLO7T"JFH4%4A34 JA
M<XS%UF33% 3[Z?O*#^T5,I0$.HQ@#IV/EW  ZA[&#S#7C)5QMY)J0=@"J"@D
M$VQ[)J /[0")A*78 (=6@$1V&]A6S:-;303H$!5&8<*3[K#!5U_HMD#!!R.#
MG(R,8T4;1/'(JF-U*NA 92K@ JRGC##@@C!4D$<XJ([,>.U<0399^TU7ZF/)
M!X1 B:RZZ[ZRY-<P E%.GISF7>Q3U03!$/US&4((!&OSJKE;KN<X<9L[RV-[
MNBI9I+'BX]U,QBZCY$$R)0%Q)"HC"W&*()F*6/4!=Q$W0S0!%*6MQ[(-U-.D
M(]5I?E[(0\XRD86;23=PDRT5CI=L8PB*K5P %*HD B4Q7#)4J;INH0Q3$<((
MJ%'J+NM!;':OH.Y;CL.=.5=[#'EX=T8!VF_*R;'DHQXB8-!_OYJFU=MCE#2:
MJP% ?N#ON,(M>JM"U#2M71;F:*U G+[3)=63[4\8GDFXM9-A:7 .YK:4L93(
MQX%K-H.F->@BM05TG57E2"+DQVEZH#O:+WVP7$1:6WC&XH(KE$"11P@?T%>,
MN:&N8<<0EQ@D+*3\,[&=B554UG$-.1ZAF4O%.3I=2:JD>_170]X2$R+E(J;E
M$QD5DSFD'Q';PJ>-<SE,!*05644!BZVH @5X]((AV I1%HB8 _:,Y,4=%"O*
M][&#+;VYKJ:8H%VH=>Z(9&1]X.HJ9)9]:Y8F(EI_H6,8J!WUHR%FR#IL0Q4S
M/V[PW1XZSDY_85&LFT:P91[,GAM&35%LV*(@(@DD7I 3:W]\X@*J@_ZRBAS>
MM>">L;"7I[5=1T.1MTMM<R0E\$%[<',4N/(3QE6 _HE@0.*J7;*H 3M(N\$'
MM&<$ XX)YP?+@]QBN;\=>?\ /YTI3_&M*JQJG<!'>M?O#R_+7G5?+Z^/8*4I
M0_/%*#Z_,-?+RUY?Q^-*4I3M5 WZZ_*JTI4/QW[]N>PYX\N._K2F_K^_X4T'
M?Y^?\*H'R].WZ4J-5[_A\!#S 0]0'XAV$/@/>M-<YV.V92AW8-R&AKD!904B
MI]*+:1(!!>MQT(E*#CK]^0  *']HNF4/[$:W)[;^>@_3O_C5K7I;"-WVY(0:
MI@357(59@N(;]VDFPBHS6'?;PQ4V@X^+9=8//558GV.">5/##X'S^P\_9Y9K
M*Z-?_D^^BE<GP)"(K@<_S;$>_@?I1, XQR5#("-YJ C)W!#%UXR+F9BTGMLR
MSET9X=Y;<C)0"BKPYA.=9P2(>LF[XRAQZEB2"#M)P(F!PFJ B4=$\L\![NM
M7=V6\6%O3W-%RN>*E(V-MZ6=+E#Q$56EUVXT9>YNB&(($"9@[AC%E%-OFH$*
M"I)U7Z3A@Z<LGJ*C9XS<+-73=38*(.$#F252.4>XB0Y3% 0'1BAU%$2B C;D
MH1-TT<(J% R1TSE,!@+H0$NM".M;\NW<0[^G:MAM;^^LR&M;N>$''N)(_AMC
M!P\8RC+C]$@@YY'?';-.O]0TYTFTV_N[1AMD5K:X=(V(P58QAC%(O_'1E(\B
M#7G1MUS*QD#'C:UQ2$-(JOTDC$18 DK&%6G$[7FW4\(>,UC)&UI=:1:RS5)?
MP"NHI0B)U&;M!<]E9!Y"YZMS,$W;,((0T%&S;R'9PCB!C9<TK&1CU5AN>?S*
M#Z1?/W;85'4L\,Y14,Z<'.B9!LBS;M]P)N!A&7(C)M@NXT[NV'K%O.R+)LX<
MH)+-K_82[&XF2Y4!*!3-W%M!<#,Q!$XR$NJ*Y11, &_5FVG*YPMF=43@&URY
MRQ.XBX'*_P!CM5@E;B9/&ZZF/,H,&*'CH.F]]6Q&'2NPS!/P8Z^8>?;G J3M
MD4W2;.^@N;>TN[J)56>(>(Y""*.9F$0)5O=6)I87 /Z)D1!S+@>EM)ZD77-'
MT>_U6&-C-";*XN9(XEA2^29XWWAB-B70MR8Y&)\-DBB!9K@J<GIV\M<$%"7U
MBR$D[SAX@64;>^(()-I*C:]T28'D)*]L=VS*NXEA)B5N=)J^LLCXIXQ=V:5L
M-,CI-U"#AZ]<VW'9DG).VL//VO#W+*E+*,[@MF7BGSB*?H*P +R W$FA(M)<
M4T3.$((JST\40CERHY15< "U_82C,AV7+W7(NV[^$M]%(%'2<@?[**F[076.
MXE7[E\5LBW<D!4J!$4CKK>Y)+.5$U#)ID'5'DKR0ELG904F&CLWV6C-D9PZK
M]LDY([M]HS69&D'+*034%)K<;PZJZ!!*D<Z*9 ,72W26D\4D4\J 1W%M&@*R
M@EV0N4=8G&2LA+9VDE6 7!9CRN>T2V?\I36;&VU'2EMF,;3-ODM3))$XM?.-
MU:0O*A=0\:1D(W(475??(]W<"+.1D!<NI.*B4HQX[77=$2>PZ(I'*HU*V3.B
ML]112."J"7@B<QP3$R@ !0LZQ\G6WF&V"6;=<;,, @)9PO O6*!Y<[QJ]?"H
M"+9NJB<J<F!A.*J*HB1P1=0Z:Y#-U"EQU:T2A=CEFD1$H.)"7%B4J;<!,4I@
M7.1M'-C>(FU3 2"JY6. E23%,I.P!6[>!2618SM0DJ]270^VT&BY6+:-(#MY
M&LG(KM?$1;O$V\60!1*[>+D6<%]Y<@BV(X6 R<PF+P@K;JB1!B%BSN8G("8.
M=H16(&%*G+#L":VJZMK;2+5Y;6W:0P8DM[6!<2(^"NZ-@L@155Y?<*[ A9<
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MC:,VJ($:,[UL2:.8P ! :%DX-XJH;TZ2)@H)A$= !3>8 ->O?Y.T2'0=5DC
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M"B#9PJ1J<I5# <73?12KJ(F.!FXB >$<#&#OK=@.) 4V)EP %4W&VXHZV03
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M!8-A(P203_2. ./AV'V\8Q6K37B@!5X'8D_,%@#]@'F,#@FOS<4XD8%!$Y1
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M'&\LBQQC<[D!1D*,^9+,0JJHR6=B%5068JH)$"VU2S<8[XR?N !)SY  DG@
MG .%N6^3[YN2X+8X=X%EI&$S#F>$<3&0,D0Z(N#<>./(/5(.[,ABY26+]E9/
MR"H63L#CTW>$%)>[D+GOU5%S#XQE&SS=7"F([(PCC>S<8X[MR-M.RK%MV)M:
MU;<B$10CH6!AF:;&-CFA#")S)-FR1"^*N=5PX4$[IRJJZ765/KUP\XVRN(X&
MY+YRC.1]_<A\RS2%]9VR8TCE(]K<EUD8A&1-O6LR=&6=PF,,:V^1I8V*K666
M4-#6E&IO) R]QSEQ/W^[X  =@#0? *C=3(0MM VZWA)8R ,!<SD!7N"& ;8
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M,L.WC('R$QL^3O[)JWT]#DYOHTR23S>Q(.6^-Y$H]_'-U$OB$&Z25[K'R1^
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MR9<=9="8;12;Q@9 SA7[2.DT3<M4&I0ZA34?O? ;)%Z2J"LY7ZTR)"'B@!C
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MQ& MXB(5F:ZJ01F1EF<808:%"!DY Q,WF/\ @D/*_P XWO[!%]TTRI$*0H
M  !V^OT^%?2E*QU7M*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I
M2E*4I2E*Q7E[$5CYHL.Z,=Y!MN*NNT;OAG\#<5OS38'<;+14BB9%VT<H]1#@
M4Y3 =)9!1%VT<)H/63AL];-G*.5*5$$J0RDJRD,K*2K*RD%65@0000""""",
MBH$!@00"",$$9!!\B/,'S'F.#44^.,J7QQ+O2V..7)NYIJ[<975,L+1XT\I+
MK<G?2$E(/U'*4!@/DE<2RQ@;Y1(5)")Q5F63390F;&B;2UKN<1F9$&ZN1I%]
M#L=[ 0V42B E$IBF$# 8HZ$IBF 2F*8 ,4P"40 0$*X.6,36-F.R+FQ_D&V8
M>[;0NV'>P5QVY/,4I"(FHF03%-VP?LU0Z%D%0Z3]A361621=-ED'C=!=.-N!
MR3D+@=.,L<<C[FFKZXG/W[:(Q=RBNEZ\EKDP65R=U[AC_E;<;I+2V-HY,C*#
ML+DY,.U%6I3,+8SRX;2?V?DJX\FNV_Y0!;[]*%5"K>?Z<"C 6Y/=[=0!,<O;
MC>?!&/DC-OVR8/Z1))A&1@.3DF,9.)#]0#$AP"]29TKYHK).$DET%$UD5TDE
MT54CD525163*JBJDHF8R:J2R1R*I*IF,FJD<BJ1SIG*8?W_(0^@_A^M6=1H(
M; 0'R'M^7UZ?QJ-3V@W#&(Y'X]D74;',UKLC8U^DU2< FBWG(YP3QW5N2#L4
M7"C)N\=MV3YA*((J.H*<81LPU(J#5PU>26?7]U?A1,BI#)J% Q#@)1 >X" ]
MO+U_.J]K<W%E<P7EI,]O=6LJ3V\\;%9(I8V#(ZL,$%6 ^!&0<@D5,C-&X=3@
MCOZ$>A!!!'?@_OK^7KRJX@7+C>YY:$>1L@1 91Y&M22C7W!V5^B98PPCQ42%
M9L;H223,=NR44)%W$V!*3M:2E(]VB4D=Z4A>F,3FC3MQE[:.NY\*.=^\))M7
M J;=C'N )[Q$2!%"B5\R.FHD*P&]Z8F.!5J_I\\RO9\8VY+0\B\"-CXVZW#$
MK-21-'-WK699(**.$8>Y8Q0@(SD,1=551%LL=%W'KK*/(60BGYO? \A'+SV5
M68,62KQT2VE?=U3K Y>NF4C<-B3";4RGNQW\RV8*2T*Y%KX2#=[<+%-T57H;
MNKJDCE^T3^T>@/;GH'45A#H/6[06-^JI&+JXS%8W4B@*)H;@<6<[ ^\KE K$
M^'*5<"'7=4Z<>ZN4UC0+E]*UF)2-\)4>(K%2T,D;?F[B!B,M!*2#Y(Q0K+!4
MTR':TD4G3-KP3I4 *+.>;*)(D4[=122K,KADH0!\E%@:F$-"9,@B(!RWDNF!
M!$D[;SA/S!5O<,6J4?4![.P'8A\@'8Z$ WWO&\^-=XQ:CQ1QCJ?11;J"5=Y$
M)JW#$)"(B)1"2BT'Z")3ZT0'+L3=(?M; 1K#!\->(L8JQ&<8 =74:4<HMM:_
MU01Z%78F\PZ2-Q,(]@T(=^KOTOI-V@N=-UW=;.-RY\"[7:0"!'+ P+#'8EI"
M1W8U;+U1UI9'P+W0;&]D4!3/;RW-FTAR 6DCE1X\L>3X:QJ,\+@'/XD[IBD#
M=+F<8', ;%&/4&36$=B&A!EXB)![!_I5DP[]]!]ZK,6FY>96%I;S1TV*<0#W
M]4O4^$@]C"@FGUIM/,0%3J54*7]E1(1[9NM;C^^ECZA(&Y+D53'K4/#6K/.8
MQ$A=!U*OC-F"*:(;^\JNZ;)=/2)C@&M;U8*]GEE#)\G'-FD%(E9O71$EHF"9
MH3,H5/7691Z2+4"W(9 W<B:]RW.FIXXE &+DP"4=>OK7I3IM6O==UBW1(<ON
MU"9((SC!_-6GNS7#=\1A9=V?JU?B[ZMU>,QE8=*@D&'^B,SW!4@#:U[*S)$>
M>6@6-QP!SD&/O%^&YRY9AG"PK(\E,OE/O B)3I($( J.GCU^<Y6J"#5,3+O'
M"JY6K5(IUGKI!,IS!Z\O9(^S"4<R</DV](E4L&R4B7S$SULHD-PNXHO5&.BM
M7K5!ZUMZ!7!5W HKE37F99TO<[Q!!$EOM&6U'!/V-<+9;>-G,DP<>@U*<JZE
MN  /QDA37!RT4NR4<,&9K@7:'317:Q;9E&6Q'.2>.A%/'J:4H/HYM.SX6S8I
MM$PK)!HV;IE3 J1 (&B^6P  V.^^Q'U]1KS7[4?; >J(GT'IL2VVAG\W=WLB
MF*XU%5(Q#%$#FWLR5!96/BS8&_8N8SE-/L;71X#%; /,V?$E'(4MG?@M[S,2
M26<@;LX"J._:PT2UA(YK&LDRI(-42)$*4-% I  - 'IV#MOU[_&NUI^GZ]_T
M^OPIH/KY5P6JOGDY)]3]GX]?LQ2E/KZ[?NI2HTI2E*4I2E*4I2G\Z4IY4H/Z
MZ[A^-*4_'X_53>OX_I2E._T/^%*5J'R[XN6YR<QT\M&9\5J[25,_AY1J"0NX
MR2(U=-2.$B.$U&SA%9J\=,7\>\269R#!RX:N43%4*=/SUS/L@,Y1UU=#*XDG
MT0D[,9FJ6;NF.(BAXW6F0&(*2CT@)@ "4B%SH=^GI43'1A]:%?,4DS#L2%$?
MB(!64T_6]6TE9$TZ_FM4E.9(U$<D;-@#>$E214?  WH%8@#).!C9M"ZPZDZ:
MBF@T75;BR@N&WRPH(Y(B^ /$6.:.5$DPJ@R(JN55020JXA7XS>RUMRSG3"X\
MDK_TGE&+U22C6CMLDE$0CM=(B2JT5&"JY.9\*0"DI/33V;N14ASE&731/X!>
MC]J6M;UA8KL_%EKP3 TMDF[&,"U;BB?2S*&,VF7OBF0$JGAG>$AT' ^(7Q$'
M"Y-B(B0TY'D  '8 \@#L%0H>UOL6X4[?Q?F2$;'>I8ENYW)R[?0@W^R9]NP:
M*NW:HE%-LT:OXV-(N\5$K=FD[.[=&3;(*J$CI\QN]:L9]0F:X,E];F:6ZD+;
M\2KM$CL<",MM5LX54)' '%ST[J#:MUGHESU!=O=)<:O8F\GO)2ZNHN(L+,\C
M8$/9'W81(\@ **@MQKE_*^)G%T15JY(N&*L^+NAQ$QULQSLB97,@S56([>O
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MYR""#@JP(RK \,I 92"" 015?X>OS"K:G;2M^XD%&\O&M7:2A3%,"R*:@:,
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M$>V/?(&QB2 %D"DL=J&3&X[Z_7UY4K\E.4X%,4Q3%.0BA#%$#%.FH4#)JD,
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M51PLN*A.MB\CN(S%]T8R+$(K-[GN"+GCS1GRB:[(\8>+.5J2/!H=-P5;[+(
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84I2E*4I2E*4I2E*4I2E*4I2E*4I2O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g622550.jpg
<DESCRIPTION>G622550.JPG
<TEXT>
begin 644 g622550.jpg
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M[7 Z*2@%YDR9*(&(< Y5$S .0,FH3E43. [@=,Y3!W&#4-D3 '34@L!<!H2
M>EV$K%0;C?2UNAQZ3MLI=>\RYE2]F*509@.956IT#$<E+H#P+#CB:G7IHTS=
MLJM>/5%Z=EG!W3ALW!U'/%A#MG#,INS417$  #K-CB4!4  %1(Z9S !^;+R:
MP<D;PR/%(-+H=+"X-CQ!!'$$$$'F"#C=*:IAJX(JF!M<4RZD:UC:Y!!!X,K
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MSM@!R X^P#Q\^S!HT:-/W86]GRX[6_=Y&#1HT:GEQ/LY7^.%OQ^''STP:!$
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MF$-AF<;]_F*0^CQU*[45*-#-=TK_ .U,C[F*7\/CJ5>M1S7_ $Z7_9BY6_\
M"3ECJ_9;_N6F_P!NH_Y\F$E]T5O]$I_N#J%\>'^"DW#=9][/\8NQ_CX#ZQ'4
MT5OZE7_1J?[HZAG&E 6A!QC"[T=N\?M!V(Y#N]6WCWZN,DM]*EZ_1VM__)%B
MS[8 &@I@?_-K[/\ ,R_PQ] ^OVA_,/X:,=!SX^O'NQX>[2W( YZ^_P"OCHY
MQC?W_0:V?'.[#A[N)\/N&$A 0\/GZOS[_#KTQC.P;^SJ'J]6EN4,8W$/7]=^
M_CHY #Q]>=PTPL/)/A]PPB =VVXX#K_/I[/5H^OKZ'2W(&<[Y]>-\]=L:.0O
MA^?U]>O3#2.-N'GAPPCCT^SY=WIW^6#?Z#W]_P#R].EN0OA[<Y_//QT<H#UW
M^OK;H'=UTQ!53O;[<)"&WKQ_/IW^T!#8<:,;9S[-_5Z@#U=_KTJ) ](>C/?[
M0T<A=NOIWZ_7HQIB=(W-N.Q\^["0AZ=_ /GT'U;^_6/KZ^A]FE>0OI]7UO\
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MI U$\4"1J*F9YPJLY6K9=5)1S-W\9TN#&P9?61E="25:VZ,H#*2O$@LI O\
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MN%O;4"ZE64D$J&'J-;4>"YO_ "7NPV=46=KDLE;D&?+72_04^D2U%!$(U73
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M%N+=W""I2_9,H8J<N@3F(J  0CY,OX1.4N1PJ0!+VA-PWYRY =G17+E%4H;
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MU536'7XY[2%2*]C2]<TM,+&P(LB3#))XF0V"]HJ4JZJ2"11$ ,LNJ@3'ZQP
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MIZ==";<K;V'D7_?@(V%KFPO:V_$[\B=K[ ?+<G"0%[\@ #W_ //&@"YSOT\
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M8<(5/3"Q(V1<J<Y2B)9E$C*IFBAB\KF/G4#I]HGS"-B$-7$?5T,1=%1,'79
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M$3"G%-F2&3"(X2#F_%G7TYZ*.VF8]HJ;,<JSB0U=?E @DBKF%IJFDF+)IJ;
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MUC4W/3?;V<N=O'Y8GNR=CP%A[O5-KW ^TFWOPCR^ [=PCD _EOXZ *'>; ^
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M 0-B#Q)._P!^^/OI8,5W2>!S^.9$=L?_  !$-O'Z]DHM1>IC 5W26/VYH,=
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M8T33#)->$<M92 J!PY5?=O)*IO2)O''<<0%.6&H%*]E"PM4VUC*^MO5473%
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M:6K68YE+2U%%-!%)+1@4$F5QL*4)'J68"HGM+KB033-6/E$"@)  UP^!@I3
M!,X^W/Q&+W!S;"/3J/AG4*Y,Z?*!2"(@'+G [;!OOG;\61]HY'(XUQDY>IIQ
M[4TC.5O6DRZK5_2TE6BDG4"S@M7/*(7%Q2#BHR]D0K\:=5'_ !8!>R32*!2J
M%5* :Z%ZY HG,(@.X8 =@SO@0#(8-UQG/3?(ZP':?.*;.:JGFI$F1(TJE;OU
M1&O/F%55K;1))<".=0UR '# 76S'??1KV0S+LCEU?29G-1RRU,N621-1RS2(
M!1Y'EN6RZS-! P+5%%(T8"F\3HQ*MJ10B:CA5)JD0PJK+)H$*4/Q&46.5,F
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M"2!-%!3(P2%P4EFFC)1XXI!C4JVK*B:4AI5Q3K%W)X=(I+%07?0C"4D'15#
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M=;1M%FN627I:>IGR&HS&&D='6LDIC#81-J2NG%4S[IPW)!STHZ:E09I-)?\
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M9:<  KBD  /_ !LT/_\ @):DUK5\R-ZV7_9BW]L:_NM\<=%[/?\ =4'^W/\
M\Y^/GA;"2_\ 4+?Z)3_<-J)\* A&-LC_ &G@;!T_QB\';T;YZ=<ATQJ6"_\
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MA@C10PN46I)%BRD<3_EB=KLR[+]@>QOH^R_,)*&;M949AF_:6FIY#'45&4T
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M_EMMZ3QW#'J'WY_D&N9,&#F  $H@ [=^0SM@1'H.V-A]&N6 Z 7U"(;>WO\
M8/7U:\XR.A?)]F_GK[,)@&>\-_7U]WMUC?O$/8'\QTH(CW@ >G&>\1].,^W'
M70 #G]4,=-]OKUX]P=%QU\GA@$7[Q?\ #STPGH ,!]?PP&E1*'7&_@  '\1
M/'W!ON @AML4!'U>'C@0R/JV'W:8:%\<*0&0KFC@ZY5F^O\ ]7I^&.FI+ZC7
M! /Z;T<80QA:;V ,!O')?''IU)36N9AO5R':VF/Y1K\1S]I..A9 +97 .C3\
M[_\ C2> PDO_ %*W^B4_W1U%:"R,6U''4SS'_P"L7GOU*E?^H6_T2G^X;47(
M O\ BAG^(1SYWG'=_C%Y[LB(^ Y[]5<KMW[W_P#I'_F1_OMYX6W:07HX;<?I
M _Y<F.P$/6 _0ZSRCUP/KQW:7P(] 'V!]?#?6.41#;F]89S[_P"&LY=>-_)
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M*]JY#.Q!*@',5 1$>5 GX1R J<QL8L9X?/)P5U<I&.J.ZR\A2D,_[-9C2S)
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M?9<#'12D#$S31=E)QS5\U<IG261<MTUDU$U"F(H0Y%"&*<IRF$#E, @8!$!
M0VU39QB<)L59MBO=NV;96+M^T=IN*YH]DB48ZD&SA42N*\I%JF!1B&T:LH1[
M65.L@+$RT(1Y*-&;2?9(NW-V/*._ZW?WCMG/UOX:UFL:6C:QIF:IJ8:)O8V:
MC7D:^;+I@=)PU>-U&ZZ*A1P E524.F/H'U:QV;95E^>9?4Y9F4*U%)4H4=&"
MZXV(&B>!R"T4\3$/%*MF5QS4E3LW8WM;V@[ ]HLN[4]F*Z;+LTRV=9E:)W$-
M7"'4U%#70JRI4T57&IBJ*>2Z2HW)@K+2[92H3U"T&$>X&99G.W*4IN<'@HY
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M[C'>K&=+-^D#HP^>NTWI;J\SJ8,L[$R5-&ZTSU5745>60M63(6TQQT"5$E3
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MH\Z9N;#+6WXFK(6W%S"%1D(HZ[=)Y-5(Z:^=2$BU4$IDY271*J#]M"G.J4R
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M+ERKVSY=ND4I13*L; HLSG QR-DRE+N'/VF Q'.<K,0,8H+ /ZW4V,B C@1
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MT8YFQ15G+6TL4X2ZK]59BF1>-<.DDCE6>I!RARY,"6$B\A4R$(( )C&,!1
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M'V0F>-*@#E(@.5%OM%J=VQ,DR451,JB9%4CCG2[3L3F5TVT\P,Z=OY!%8J+
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MJISIJ*22.HA:^PDA=74,!:Z-8(ZDV:-BIN"<:OV@HZ;-*2JH*H:J:NIY::<
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MJ& !,":9S"4IL"7;(<V!V$ #  (!G(ACOTTDM) 9XH8QN3?;.0ZY#IMC(F$
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M*F*-7,X]O5C$E25$=&JF$$V3-$M*G!>65_2)K#ILTR1S>7,X;L"H))M4DDP
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MFLNJX8*+@$^8<[I6DD,=/-"RRLDR*L +R,@C9I1<_I$9"% <@BQ)-V M-IV
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M.PD&V_U" +[XDU@/ /<&@2E'N#\ORU\D?(L)9JD^BWC=^S7+S).6JI%DCAN
MX,0Q@ Q1 0,4<&*8! P (" ?;RF_9'W#JPQJI!!((((-B"""#T(ZXX\I? -O
MKV^W1RAX!XZY\IO ?'<,>[/7V:.4W@/?W>'73"QZ'X8X8#P#W!K'*4>[XC\]
M* 41'H.._P! >/L[]'(;P_+^.F%CT/P..& \ ]P:,!X![@USY3#T*(^P=8Y3
M> ^X=,18]#Y_$?''' > ?7AX>S6.4OAKGRF\!]VL\IO ?;M^>F)L>A^'GJ,<
M,!X![@T<I0[@]N_YZY8'P'W#K(%$<]0P&<8Z]=, "> PGRE\/B/SUYY_*O\
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M9%5515R0RI/LM]+2D?+22))&*:)IIM#.C]H1HT0>J+K(DCF@,P>N9"6733<
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M7\""B"I5,"4#@8! ^3 .LPJAW+AE52JR*JG<J@L . &EF4;>P"U[6=8@2%(
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MB'VF_ ,;[=!T^2_]0M_HE/\ <-IDJ/((TW$B&-T7/PDGWU[=>Z,VE8_^F?\
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M'(>.W-TR(YV#O#&L?+(J@Z3MS&WA8]?(]N*#5FK<L+\?9N".0]GLMQQMSV8
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M?'Y:U&NZ#IVY%)S5%58P0E*?J!BO'R;%<O,FX:N$S)J)F 0Z&*8=^H#@0P(
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M3"/ZH]J9(03 3=GSY%)%@9&,@=797TIZJ*"!=5 ;ZJL'MLO#=1>[>X95G1;
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M90QU.Y79H*TPR<1J1$0<.)@Q1.Z(9<4VQ(Q==),K8Q!(BAR.FQ5UVZ8*G4_
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M-_ZQR&6J09P!L*G,4<AV?, 9;R1F9BH#>;HD!C'";E%L@8YNV_\ 6.5<%.Y
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M!#KZ0[_R]H^C6.0<]!$.[T^/3V@'IP&FH>SV[=.OMY86'0>?P'PPGHTH)!P
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M!"^L!]8@BV862"S!IGT75S^B#,7*KI!8 &X,FZLY +,;*USCHW$3]JQ=/H)
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MOLREHALW;0M*0I!P"<33[%BU,!04< X<<ZZEBZ#=%LD5)!,J9" !2E( %*
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M,*NH],R9 #\$F3F$H7T4%)5V%/.*>7@(*DV1CTCF /N#!F;H.?HP(WU24)X
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MQ#0VV >. 5WP [^9HKCOU$ ,  ._?C5E\C6;E3( N4I"C^$J8 4H!C8I2%
M*'=@ # >.X#J[FICJ!DYQ'?.XCGO[A'8/9D,=V^L2.U':%F!%1%&#^JL"&W"
MW$ &UAR]A.*J5>9L0UH5!M8&($CAQ+$$[<^!\1BJBH?)\W;C"G/%U=1<F4H"
M8 %:92,(!W (1IRYQU#'7IGKI@:AX:KW4TLJD>&BY4$@$<14ZU%53EW$$FL@
M#!P<PX#!2IB;I@.@:O"_200-RE5 P#MN8 R'40\,].HYVVZYUT$\WBJ@0.@^
M;IB8P"4JI0 #DVQS (;[#OCOP&LI2]K\WC*BI6FJ%L 2:<J>7[#1\+&VXX\,
M7T-;.I J88F0\6C70P%QO:Y'3:P]M[''GWDDZBIMV+"HXB6@GF1 J$HR7:'/
M@?\ Q1E4P36 -AYD%%28$!$P8 -=DPJ9PD(%[8%"@( 8JGXRF#.# 8ILAU ,
M=,#L/75JE?T8FU249R3)G-0:X"7L9!JB^;\IA$0(=!P4Y"@([\Q2E$#!D#@(
M .H5UWP]QSY-U*6\=#&R"916&F7K@31[O ")THI\X,*S)41_JFKY5=F..0'+
M4# (;?0Y]15JJ*F,0%R!WBG7#<V'K ^O%O8>MJ51]9@+'&9C6.1 \1%FM8$>
MK?;:_(]0UNE][XUFF:[72<L7361>1,O'&(K%RS)=5)_'K)CE(4%TC$55:@(#
MS-C&$Z13"+<Y=TS/71M;R1)M::H92)I>Y;IV1W,4H"K.%MU=OM1_ISMT\(Q5
M#7#?& 5FT^@#.F:J>B9K4K>-D5@G"P4*[>PLFXAIQFZC))BMV+EJY3,W>-50
M_%@Z1P  $2B!RAD2*$$#I*"00,.\(R:IDDE>U!0A!RD[((\I#F !%-4OZZ/:
M8_$FH !S843$PY$UQ7Y1#.MP%&M?T<@ =2K ,!QM)$_%HF.]]:%7 <4YZ""M
M3NIDTR W210!)$UANAYV-KKNK<.9.+V+2W<INYU')OXHHQ\[#OW<14\1( LQ
MGXF5;F%%[$RT0Y CAB\CER*(.452%.4X ;\29R'-OJJX$' &YQ'H'I\ [P[\
MXR&P:I^H"X\\[E&U7T^8Z]SZ?CT&LG$HERM>"CXPH<\*X3('.ZN-3,>FHK1\
MB;F<5#&)*TD]4.L2#6;V8T'<. N!2T354&]1>,99F@[141/S (*)E'EY1 IR
MG*;)3D.4AR' 2F*4P& .8YEE<E#,XT$*7]9>(0MNI5CNT3[F-C:UF0V9#C2Y
MZ"HHZIZ:?UFWDB<#U94+"Q6YV()LZV&G@!8C&^JN>SW,8W-@1$,[XZ@&WAMG
M/I[MAUZ4=D5(&3"&X_BR.^>OCW=<AMG2+A_R'4$=S'# !N(  YP&_O\ C@1
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M\,;IQS>5^OWQ'-YZ@;6&D+$6:D$SL7,9!R?-<NKXXP*%62JZMHTZ(Q,;((G
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M6#%21;58B][;;$^&^][8S*Y= E0*M(DCJ=#1F2+5'=&"W5DC=(FV4*':,N
M PLMM/HB@Z2MS3[*EJ+@H^GH".2!%G&1C=-LU;IE#8I$DRE*'B(X 3"(F'<1
M'6W  !TSZLY#V!C(>_\ AK.C7D/;E^%Q;?CMO;W8N3"?'Y'B>9O<[DDD[]3S
M!K& \ ^?K\?RUG1IJ-^&VVU]AP(WMX<_OQ'<GKOQX#P_I6M[NG'>V,!MZ,8#
MN#'JQ]=-9' ^_.PC\^[1HT#6X6\=[=/ <. XVW/#C)A/AP X>S?C[MN/'VZX
M^  JZA/_ *?/]_C$)"/7U=._VZ=O31O_ /.Z@_\ ZPGL?_JA/_EIW-6$N\KG
MF=-Q_P#$ 6YV]]NF,Q2*5@0'JW_$<)+_ -0M_HE/]PVFHH< _12%V ?Z!UU\
M?M-\'Y?EIV%OZE7/3LU,_P"J.FIH@ "DX3'>@Z_[3?A^>=(#^E/0QGE_27S[
M_'>*L QJ#^V/^%L;3RE\ ]VC > >X-9T:O/=]OW^;^S&/TCQ^)^_P'PQCE#P
M#W:,!X![M9T:>[[?OPTCQOUN;_;C& \ ]VCE#P#W:SHTPTCQ^)\/'PQ@"@'0
M-'*7P#6=&I]P^?W^;GPLTCI\S]^,8#P#W!\M9QW;8\,:-&E_E[?O^S#2/'XG
MCMO[=O.V,8#P#W:,!X![M9T:C#2/'XG[_ ?#&,!X![@T8#P#W!K.LE*<XCR)
MJJ8Z]FDH?'7&>0HXS@<9Z]V<#A<#C;VG$Z03P)/+<DW^... \ ]P:, /4 ^O
M9]==?,^?,XQN+J2=M8UL51%(R\DY0CD2*N%"HMTSJOE&Z9%'"IR)-TS& ZZA
MBIHE.<0*.ONZZHF/JZ'M^_K&E&->U%'/I>GZ'>5'"M:RG8F,$0DI2%I5=\G4
M$K'1X@(/G[".<-&@@8'"R8E, -0',<N?78#C^M\^6 CN=E8V!X:MK<?9:^_2
M^^-IP'@'NT8#P#W!\M:I25>4-7R,PYH:M*1K1O3TX]IF?6I&IX*IT8*I(WD^
MT:?F58&0D$XJ<8=HGY[$/SMY%KVA.W;)\P9VS0$$7%B.H-_W\L"EC8@@CD20
M1PY7\!\L8P&.@>K&V=& \ ]P:SHTQ&D6MORYGE;[ONY8Q@/ /<&C  (" 8,
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MQK>>6AM>Y,V97BM55]$KB02O)ZB'C.N(!-4I@ %?LEV$%4Z*(@/.8J1)11(
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MG9^O9QR*KF\]#0+,JHTS-2"F!<W4HB*1.87#@QWE?4HS&9%5Q4,+/BZ]+@"
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MPV9T?TZD+H!])I3WL1X$E;:T)W)$B7!'"]N8Q<&X5(J5(R9@$HE 1 !SU !
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M%3,L9[7-UJE(4HF*46T3#4C3:*ANN2"9\IR;"("0P &,FU-8"NG@)]N(E2*
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MX!Z9Z;A[M $P(#D-O1Z_3];:YZ-,/4X[;;CCX<NOD\#CB!?3G;'3?'@&_P#
M?=MK %$.@]^X9 0 ._NW'IC;7/1IB"5Z\+6L3?D#TY;<>O,8X"41 =\Y'/@'
MY"/QUCD' @!@WQG^'CZ=*:-,/5XW%S:^Y\+V/'@>?RL<<0+CN*(AZ,;^O?\
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MIQL/$Q$0RC(2$BV9G#I<K**C6:*[UV[?N_.';A18=$;L2$JJ5!(KT49DDJ9
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MZJEY#F'F*)BB B(=0,(B.YA$1 >[(&#'CUUTCAT)0')\"<1V\<]0$0W$!VR
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M^AR^BH,P%9F,.5T<E=##3U3K2OW$8D6HJ!!]&B;O0Z*'F!E=6$8:QQ\J=O\
MT?\ :;LIF&9YAFV5/EV55&<U\&65%1444;5L7TF1HVI*4U!JYX^Y:.1WC@80
MJZ&8QAUONPER40[^[J&.GK[MMOSSK $';.-MO'/7KD0Z>CY:YZ-;SCFWJ\;C
MD!RVN#[;CKPZ\\8P.=L= #U8SW8]/B&N/*("&_0!#/?[=^@=WN].N>C3$W4\
M_-P?N^?0V3Y,=! ?6'\_X#K(ER.0''7  '3/MUST:8@:+<>G,C?;QVY<^7AM
MP FX]-\]WCUQX> =?X:.780  'P\?6(^CPQW>S7/1IAZMMB.?SMUOX? [<<:
M1/@(5=;\<!O(S_3TPI,^&^PCIQ]-U/Y_2VW^W_E"?_[%+M[?X:<75!OKO[1_
MPCW^?;BY3ZB\[B]^%]SA-;^J5_T9_P#='6@V^Q^AL"/>+=SGN_\ *+WN]8CK
M?5\]BKC']6?KT_5'.M&MV #1D%M_\'<XR&=OM%[W_P ]>;D-L?U3]H^W]V)9
M0RD&W%>/OQMVC2^ \ ]P:,!X![@UZN>I^)Q2[L;?5WWX>S[_ +.NR&C2^ \
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M^/ZZ==-2]?.WW_;T.&D]/)M]_FQPX&C3?A<)H(X"FZUSC./T8>=!Z?V\;_\
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MZOV_S]?31]X+7]VJU_V7>[>D?Q[::EZCS;[_ #8X:3TX_P /O&' T:;\;A-
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H-&C3$6'0>?P'PP:-&C3$V'3!HT:-,,&C1HTPP:-&C3#!HT:-,,?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g206014.jpg
<DESCRIPTION>G206014.JPG
<TEXT>
begin 644 g206014.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ _1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?5%5-7U-43U!?-$-?3U)'+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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M8WX^L>SKX^/P'!]M[/XQOQ]8]G7Q\?@.*W/NKY+_ !-??U=+_P G@^ZODO\
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MV=>IQZ'^,I?\1%^?O[!XG:R/[;V?QC?CZQ[.OCX_ <'VWL_C&_'UCV=?'Q^
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M/!:H^HFZ?W3_ &?L]O9UZG'H?XRE_P 1%^?O[!XG:R/[;V?QC?CZQ[.OCX_
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MV3.Z]B?=]7!W7L3[OJX4^0>L_1\..:8ZUC=MMU8!()0A2P"!N02E)&X'4CQ
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M7D','^Z(V.QXJO[4^G<^578!EU-,B,8B[IGB;^*VD"8XF*SC*JF U0@,QD.
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M0;-S( ).VWYOVH'(\JPK<+QR-=/I=7'CW\EXP:1A+B$]VX'Y#:V[66A7[AJ
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M)]9'5KT2=P4->=X  ==^;<)(!"D[$^&W4GT[[[]CM<XZWWG4$^!3N3S @$;
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M-@ -.9MM1?E:K,,I=X-V-VL.P>"B:AK<.K)JM%"M()IX>' HM<K&+LS%B2Q
M'F[;YHI]ZQ/Z+?\ T#B:E9]YM_K^]3Q"O13[UB?T6_\ H'$U*S[S;_7]ZGAS
MC^@?YA_0[()OI?'@-FCU%^\9']$?HXA+AH*M5+C;T8U*/_XTK1_?Q-K47[QD
M?T1^CB%6$)"M5+L'J/M9E'_\:UOQX4T1MB%$==)3RT/T>FS;C8O@>(CQIP/\
M\6SZ<A]8^GX<'(?6/I^'&3W2/5] ^'!W2/5] ^'$YS=GZ>/;M\6["].\(?9]
M7QW^#IC<A]8^GX<'(?6/I^'&3W2/5] ^'!W2/5] ^'!F[/T\>W;XMV%SA#[/
MJ^._P=,;D/K'T_#@Y#ZQ]/PXR>Z1ZOH'PX.Z1ZOH'PX,W9^GCV[?%NPN<(?9
M]7QW^#IC<A]8^GX<'(?6/I^'&3W2/5] ^'&JYQFV#:8XAD>H.I&7XS@&!8?5
MO7>69KF=W6XWBN,TT=QII^VO[ZV?BUE37,NOL-NS)LAEA#CS2%+"G$ ^9P-3
MF ',G0#EJ3:P MSZ6["_HAS$  $D@ !;DDV   %R2= .NGCIL/(?6/I^'!R'
MUCZ?AQHJ=5])ELZ7R$:EX N/K?);AZ,2&LOH'HVK<M[&I6:-1M-)#4U;.;ON
MX?!FY2AK'5V"U8]#E6X'D4=UU+;W/:Z[)F.:PP.SUD':9T%H]=[2?5U-?H[:
MZJX7!U%DW%XR9%)2#&'[5$YF^NHX[ZGQ^4EB\M$%/D%=(+C87CQ4 !+6!( )
M8 $G*0!XD@@@"YM8BX OFM+*Q(6)V(4L0L;$A5.5F( T52""3H"+&QO:07(?
M6/I^'!R'UCZ?APR6EO:>[,^N.89EI[HMV@-&-6\\T\=>8SG#=-M2,4S3)<4<
MCV;M)(^S%/0V,V6TU%NF7::7*8;D1(=PVNJE2&; ",=B:UPT/?Q?4C.&-8M+
M'\*T<N<DQS5S,&<_Q1W%=,,APV+%G9=0Y_D3=FJHQ.YQB).@R+^LN9D2;5(F
M14RV6W)#2%^B5+ YM-=0PMYMK\K_ $>OA;MJ&ED4Y6B96&6ZF-@1GMDT(!\Z
M_F_O:6YZ.7R'UCZ?AP<A]8^GX<-[I)K'H]KYA<34?0[5# M7]/Y\ZQJXF9Z;
MY14Y;CCUI3OB+;U:K*H?D-QK2KDE+-A63!'GPUJ;\HC-I=:4MR^Z1ZOH'PX]
M$@(!&8@@$$:@C34$ BWA;P'.POBT!1BKKE939E92K*1S!! ((UT('MTQN0^L
M?3\.#D/K'T_#C)[I'J^@?#@[I'J^@?#CW-V?IX]NWQ;L+X\(?9]7QW^#IC<A
M]8^GX<'(?6/I^'&3W2/5] ^'!W2/5] ^'!F[/T\>W;XMV%SA#[/J^._P=,;D
M/K'T_#@Y#ZQ]/PXR>Z1ZOH'PX.Z1ZOH'PX,W9^GCV[?%NPN<(?9]7QW^#IBJ
M:Y@4JV((V(Z_#BM;M_Z7UEWI?>7[+JZRZQR.]DM'=10E$RFNJ*.]85]E&<*5
M%*F'6N[>;V+4F&[)AR$K8DNMKLS[I'J^@?#B)G:\Q:7DVD&95$)!4_/QZZA,
M[#<EZ96RF&O#<[=XX@?I]7"6L2.>FEBDC$B21LCI(H9'4K9E92"&4@E2I!!%
MP;CFOPN6>BQ"DJJ:9Z:>GGBFAGA=HI898W5XY8G6S))&ZAD92&#*K @@$4CZ
M5T5_?)H\LKHH@N7-+0WDB'$Y_)HDFXIH5I(CQ@HDIC,ORW&XX62I+"6TN$E*
MMYL0[2XCUS<>Q9<*D! YSS;C8'IOX[;;DCJ3N=R.O#+]FZZK&,2Q=F1R-.*Q
MK'4%M:4-J2N-40Z^4SR)/*E46;"EPG&T[%IV.XV1NC82TG&GFQR$.L[D;'F4
M 0""2 =SZ^@W\W<#C@^,QP3UD#6A>*LJ8S$3EX>25@$LQN H%A<?V1M]U<6Q
MFIQ.GP::HB^?P285A<\6(A;M5"6C@D^<B10%8RYBY(L/.O8CDAT%VU(1W:E<
MI2?9N-O C\F^^P_+Z>&NU4HGH-HSDL1I2XDYI#,Y:1NEB2WYK+CA W"7FU<G
M.?W[:4D@JZ[<B,W72^\9<!05^"5#;Q)'AX>CIU^;?8\;KWL*RKW(<]MN1%D-
MEMUI:0M"TJ'5)!\-O'U@]?'J%*N#?*0=.A]'JL=1T/B=1M&:ZG"2K+$K9'L<
MK#E?F#H=>5K6]\/UNE]T*">I(\!ON=]_.VW41TZ^KUD$</\ O9YB]GA.G\.T
MK<J8S/2RF50XLJNETKV"7<-.7R,PB2<HK9Z!;L242Y<F'<M5"UMWK"8+KRXC
MT9:5ZQ>Z3VC#CDW&5IL(945B"ZKEELI\5AMQ7F/H3MLE)*%^ YE>EL+-%M6
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ME-@L/V*_L-&>;GH42X>GFML@/YUIMV@[3#,/S'#ZB#9.9*U8,XG09;BE\+"
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MD?T1^CB&NG>YU:O0/Y*RS[[>L!\3[N-])?Y_1V^M_P!ALAQ<7P:O'C3_ /\
M:/:0?<)_ /\ YOCP=PG\ _\ F^/&;R*]7TCX\'(KU?2/CQ-+GQ/K.U4\,^ ^
M+?'W>C;"[A/X!_\ -\>#N$_@'_S?'C-Y%>KZ1\>#D5ZOI'QX+GQ/K.QPSX#X
MM\?=Z-L+N$_@'_S?'@[A/X!_\WQXS>17J^D?'@Y%>KZ1\>"Y\3ZSL<,^ ^+?
M'W>C;"[A/X!_\WQXK3^60P[*,X^2S[=>(8/B^0YEE^0Z"6M;CN+8I26>29'>
MV2\JQ)YNOIZ*HBSK.TF+:8==$2'$?=4RT\X6^Z;<4FSGD5ZOI'QXY)[U"DK;
M4MM:3NE;:RA:3ZTK0H*2?:D@^WC%P71E+'SA:_/V7UVVP%H)X9@JL898Y0I-
M@3&ZN 2 ; Y0+CE;3I?RTT79^[1'9?\ E /DQ.RO2Z89WF'8DQ+M-9KVH^SG
MJC5U-]D--V8\8SKLOZHXYJSV7]3;(0Y7VN4.$:MY5 RG1:;DDR*W(Q+,K#$H
M\ETX[&K:QY/DX]4])>R'H1I_V'^U1H-K ]VX8G:-RZSU.I*_LM:CZSNZ]:LY
MIK9D&4T';+QS5:-A-G@&4X.JCNL=R*;JI/S:%;:31J217F+5RJAF,OT9I4\D
M+2E;B4N@!U*7%!+H2=TAU(4 YRJ)4GG"ME$D;$[\<@[*2TJ.E^0F.KF*HZ9#
MJ8ZBH[J*F X&E<QZJW0=SU.YZ\)5I>&V9)+&Y SJ& 5E12HU!T"#*2; '*0>
M>SA)7F9 DT (RQEFBE,3-+&TS"1CE>X8SL94 !=U#AU//S>Z%NX9VA?E-:27
MI;IYJE)[/M-V.^UAHGFND^3=E7).QBWV )6;Y;@XM<&C95BM5B-?J5EG:<OJ
M_(LEAPF+F^R;":]9U PR_J69EB7&%R?LKVNE/R9ORT>@>E?9HRR'A ^4FODZ
M.X#CF$9I)D4&BM#.[(,B#KCIWA\1I.1:RTVD\?%+?4MFEJ7[MC5*RP^[K+J5
M=-2LA8D>KM;DEU*$.O/NH:&S2'7W'4-#;;9I#BU);&P V0$C8 > ''SF>W0K
MO'>9H)#2N]5S-!!W0&E<V[80?.0$%(2HDI ))X]%-H07NQXH+!1RD4+:Q)T%
M@;$D7T%@!8_2$@="D5D3YJ1&TI-VIIN,'8A%!=KLA8(#:[,7<LSTV?)",W,^
MI[<.:R[C+-6L;U1[95IJ/B?:NR_2&T[/DWM4Q[C1[3.JN\TKM$9]1CT/$*73
MRVI%Z6P<BQO'Z3'M15T$G*40EW*KF7(MZF.PJ^)*GSG6HD*%'>E2Y4ASNF(T
M:.VIU]]YU:@AMIIM*G''%D)0A)4H@ GA9<4\\LN/..O.*VYG'G5NN*V&P"G'
M%*60!T ).PZ#IQ&;M>.Z@M: 9]%TXQEW*[VWKT4<VJC1/LC.&-7+@KLEF5U8
M%H-E/B5$B2[%A!14ZO=Q+;Q:$=Y+B-:<%P>OKS'/5##J*JJ^!30R33S\")YN
M%!!"&EED<KE2- \CL0!F8ZK<%PMMZ=Z,'PCYQ28=^G,7P[#?G==504M'1K65
M$%*:BJK*DQ4]/#"K<66:5HH(U0DY(U &WZ?:XZ-:J/28NGVH>+91-B*Y7Z^O
MM&Q8H22H(?3722Q-<BO!)7'F-1UQ)+92['?=:4E9=KN4?@'WJ^/'D(:^WK'+
M ,P9$7+':-2F/L1=!["-2:!*2E'=1I#RX\8RFTM%*%QY&*39*@UL">9TS.T@
M^4"U:T]EQ,<M<JE3W#W88PG6Z).%@6D!'.U3Y<VIFXDH4%MM,24R\TC,@#D9
M=WY5<O[L_*JPJ65J3?/ JO")8G9)\0P8SXI2T^4G,U?ADD4&.8<J#Z;2T4JW
M!.:VNW?/E$__  ]=X<.@&)>3#>^AWGII84F@P?>%(<&Q.H5D4K^CL5IY*C L
M5XC:QF&>F3*5\]M"?13W"?P#_P";X\'<H_ /O5\>*^J?Y0?";7#<BE6^/3L(
MS:!13Y%)'N71:X/;WJ(3ZZV&,OJ$+371IDY#;*E9!!HG6&UA3X:43RUBY?VM
M-6=4R^W)R'5C.&GE(3(QS (3N"83"<? #D.5=,2,=ARV(KG.%+DY9=N]TE2E
M"0"4JFV^/RD?)]NO@^'XOAT]5O?%B@J!3?\ QUJ66GIY*?A9H\6KJNIIJ;"'
M;C*5CK&2=E61EA81O:BMQ/D@>5C>[&L7PC&:.EW$.!R4R5TF\RU"35"U)DR2
M8/34D4PQ>)1"V>>FG%*K%$,X9@-KZ<WULT@TX6AC,L]QRGG.J"&*CR\3KV2L
M[;-Q:&M\LN)3AWZ(CP7%>SIQN^+Y'CF:T-;E&*V<6\H+B.)5=9P7%KCR62I2
M"4\P0XA;;B5M/,NH;>8>;<9>;;=;6A/F=COZA,.KD3)NG&D2)H2XOR8.9YG,
MHQ]U/.+<1]@J64\&@EP.*3DBF05EY#O*5F9>B/:,UEI]/#@.F,K%SBD62Y8U
MNK>48U83LOO'LG4[?7\ZOQAQRHQ4N1[J=,5'OK.')K[(/@1L=2S#4_+9?(;Y
M>,>\LV^>)8##NG%AF%4^%RU=-6T=778PD-1!-$'CQ/&XJ"GW<@$T,C&GA@KI
MIY)8F2,2WLN?RD_(%N?\GCR>X=O3B&_CXCBTV+04-525=-38=\[@J(W"G!<%
M22JQFLEAJ!#QF7B1QTSO/,((X6<7"97J!IW@3]/'SC-\0PV1D$A46B9RK)*J
M@<N)"5)0IJN3:S(OE12XXVRI:-VDO.-L%P/.(;5"[M:=IFEQ^OO]---)-'=:
M@1H\%&3Y/8MN6N":51K;D3 <NS7*<<RS/[4/1T8AI?1JD7%O-DPW+;R""ZRS
M/B<WAC5S:6%WE4RUU!S+(TI8N\HRY\7EW9H4HJ;KV2668-73QUJ/D6/TL&MH
M8145L5R7E./J?+L9:2X#"UGU4Y*6':'3*MP&=A2(C+*<1PF\RUO)7LC=@U3+
M#5>,[FMPJ^8+Z0F1:5])(2W5K@LV#TJS[ J,$@PZF-75U/SN2)58T<<3)#))
M)*D:!JDS+*8%+YI L,4LH&5#&,T@^?6$^4.JWLQC]"8'AQPN*=Y#'CE9-'45
M,-+! TTSIA:4STZ5KY0E,)JVII(2XEJ5E94HYZ^\>[)7:7TSK;'((]/(N:+)
M;R=E$7#LFN6:[4VHF7\I5GD61S+)MA[&ZZ7E,]]RS7I:XRQ7XB^HLQKR!,?G
MU;*C(J^T"URL5.FN<S'B-UIF6F'TS$=0('(Y+7=62GCL20[%B.HW2?0H'CT9
MRJJ++!#T=M8VVV4E*MOFWZ_3PDC$*4**OL?&!\=^Z1O]7Y/'BD\<\F.ZN/XG
M/BM90\.JJ9#+4_,Y9:.&:1B"6:&%E13I<F/(6;SG+,2=NX=R/E,>5C</=FAW
M3PG'8:W"\,IDI,.;'</H\:KJ.!+98XZVNBEFD4:A4J&GCA4B.!(HE1$\[;T3
MM%5!;DW.EN5-P!RE]^GRO$\ADQ^H"EFJ>:H%2D-IYEEN//[]93R-H45C;,Q;
M7)#[TFLD/RFK2O+YG45Q7R\>RJ!%B+:0[82\;LTHF&LW>;VMJ]=C4>> J>EP
M\G'H4E8922VU-NU\9:2-MBRV.G@1X'T$^CQXA)VENQ[ANHM#(FQ8*ZN_K4.S
M*2_J"B%?4<]'5J=46;2/*(KZ2/VQL*7%EME4>8Q(BK=95&\7\CN"/3.<'DJ,
M-J53]63/-4TS,.0ECG:23*2+%HI$*@WLQ\TV/NE\L+?>#$8(]]L/PG>G"))4
M%4L6'T>#XG#$S*':BJL.AIZ<.@N52II9E?Z)>.YD6.N#Y>Q=16G6'$KYT@I4
MA25)5T\.A*>AV)'3;Q(]3A2>[DIV=90OH!LXA"_#;8 $'KL22""=O$]>D!])
M,AO,+S.ZQ#+$M"[QFZ:H<D888,&+/;EL*F8]E==$0E,>!'R: U+=5"C*=9K[
MNKNX+);B)BL-V.0JE,J/%E-'O(\IE+T61MLV\TH;[H5U'>(WY74?NT+!2L)Z
M;T'-05M%75>&U:B.KH93%/'J1_9*2(]AGAE7*Z/871EN!F%^U:C$\#Q/"L'W
MHP*8U& [Q425^&5# (X%R)Z29 S"*KI)E>"IANV26.0*S*I(U1%=#:;6XF(P
MV0G?F2RV%'\J4@[;^&Q\=O'J>&P<MJJ1?JBR7770P[RN%I 4VWRJ(*2HK0%J
M!VY@CFV(VW!W'#P9LM%%2/=TH)F2&UMQ^H"D I(4^-B2>[!(;\ I>VQ*4JVK
MTS'/F\1=>=09DN9*FBMJJNKC&PO;^Z?0Z]&IJ*O"VS,GO-LNO.NOO1Z^LAMN
MV%M-A1$=ZL*SB>*DI8&J:R=D6.%$+N[N0%C5%N2Q&IO<!=>5[+<'2A?#<3QK
M$J^+#,,H8))9JZJF2"GIX(@.//-,YRI&MPHYL['* 396L+A6V'-L(2[?QX:=
MB>1R#.==!V\.5II2%*]/^\ /4DCA"M<IHVUR'F)21%0DI:6X VMQML;=XM!6
MKE+FW-R;DI!"2K??B#]=A?:MR5/V7K].:J#5NEM<2%?YQ-3=E@HW)E_8;%Y5
M1&?4K?9AA^>TT !Y5(/G\--J3;:Z8-?5N-9II1:U#%U!<GU^1(U)@.XZ]"@N
MI9R!\EO!OLDI>+MOQ+B\K6XZIXQMYRXBJ=:B2PQ*/_@F_M1PTCW=1BRF3]76
M48EL%S-G5ZP_14,Q55S:$D6%MJL7RP^0.ADGFKO*>8XH72&1Y\$QUH TDR1J
M87BP5<^=V2-9)&*:@A@"3LX&L^8Q[BTM9,:1_L]'46LMMU/G$V3L1RMH&&$]
M>]F3<BG5$*O80%*D3'VVT)5UWM_[&FE[>GNDF'TCL5*'ZS'ZFO>4!U5(B0(S
M$AS<#;=Q]MQPJZ@D[^H"&&@W8JRNTMZ')M35U @U<F'=UN+XX9<JCD6Z$ER'
M?W5Q9N+FY7*BH=[ZA2IB%1U*W%6-96BQ>\O-Q>/TC-+7L0XZ E#3:4#;8#8
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M0LLHC&3S0GYX-[Y?*1OKOC02[UXI4X[5U.,UE ]'B>)!_FL=?50/5!9RLN(
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MDDZZ]:9XX#W&(YE('B#&QV[D).^_@J/!<!.WIZ^/IZ<6#2[M831JJQ)AL(
M AI:2,<AU<2/< 7U<?T&RPUQ72*"RBU@J-R-K<@!;T<_#EM8\=<M2T'9C5_(
M98 )Y)UI-EQU@#;E6F4_);4#X$*:/S$;[\DZ_P"7GD3DD333+XC:AN[>XS0.
MR =OW0M:.!7W\=PDDI=1-;<0L!05S=15].R++(',NSQS*:U W)78T-S#0@>M
M2Y<-I*1Z=R=O'KQ@Q=17EJ_:9RTJ \[D=(4-R1LI(/ATZ@^[A5+NWA5;'EEI
M,/JE(L0])3-:_.S(HRFW+30]-M#8@;@2(5N;96!-QI?0BV@U-S]P&UZNF/;&
MOL6E1UXIF>=X&62%/0:')W]5\/*!XI<P;/9,?*H;'@5?8++@F.T3W4->R$\6
MB:,?*<3DQN?4NKJLFQ>$ELV&I6F+T^XKZ=C<(4_F>%3XS&;8>6]^:7)>K;:B
MBCF6Y>I; 5QY$J[46<VILJ?;>*25)"SX*W'*4.#E<0H= "E0*?1['@QO5^?%
MGQ+BMN+/'LG@*2Y!OJN6[%L&E(\$NOL+;7/85N4+#V\H()'>.(W;->X[Y*\(
MJ!(]"LF&S6)#4Y:2#-IK)3R$C*2-6A*%5^BK;)9J7"\0'GP(DA&DD0R->PUL
M-#;N#<Z7\/?9IKK!@6JU#!R+"<DJL@J[!A$B+,K9C$EAYI8\U2%M+4DC<$'K
MT.X(!'#IA"E#<#<'TC8\>)#0+MD7^%91'G4^20M-,Y?FHD2[1AM;6E>HJG'
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MDG# LTD9DCLL29BX+*N6[3TBA;D=E?*25-I)^<CP_7W<=_=K_!/"@U&2TVA
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ML-$2H@PU.+==KJF%Y*TF87&W95@AYYN.TRI"%M'98FJL4]918[+@("5RBVI
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M]G8X)[^SW^GX&N#W7L5[OJX.Z]BO=]7&=R?SOH^O@Y/YWT?7P9W\#ZQV^/\
MV=C@GO[/?Z?@:X/=>Q7N^K@[KV*]WU<9W)_.^CZ^#D_G?1]?!G?P/K';X_\
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M,I:5ECF)J6:7@U(M3$P^;(R,TL=J:<F07"V'TEQ("U-A:>9*22$J*0L$))W
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M!!]'MXK)[1VG;[&I%S,DJ:C55[5JGP%RE+$/=IN,T[7(<#:T,I0MF2F,PL!
M<DM,N*;,IM:K14@G?<GY]NA^?KX]3^3A.M*&HNV1'N*Z#9L)5S):FQFI"4J\
M"I/> E!(Z$I()'0[CIP@QS"EQNA-*[9&#K)'(1F 9="&6ZDJP+*;$'KKRV>M
MT\>FW7Q5<0CB:>-HI()HE<1LR/E8,C,K ,DB*PS*18$6!-]JWM+\!R[,M&':
M3%G9M3;8W<7<VBD/,5T>LEB]?CK5'0HQVY8GLQ8K*WW[$R$QT.1HS;;)0\A+
MQ-]G6^$'RJFM(]'=NQV8MU G,,SZ2S<;07$RHZQ'<#2VW7G7 $QN[8D/21&6
MRE2R[,B%6PJZ.W$@18\**T.5N/%8;890/$A+;82@;GJ=AU)).Y)/&7R'\(_K
M^7A'2[M4<-/!#.9:@Q4T-,3Q#&GZD,%EB0$M%)E;(6209XU57!M?9RK]]<5J
M*^KK*..&B%175%:HX<<TMJ@Q%X*AW7)4PYXN*J21$),[O&5)V@WCO90M7;F-
M:YEE+3L>-+1,37T[:T%3B-^7D<2Q$994C?=I]2)+T=6RV.1Y*'4S/8B)CM-,
MH+RTLM(90IYQQYSD; 2D*<=*W%G8#=2E%2CU42KKPJ<A_"^C\OK]?7CZ$#<<
MZB$\R><A.Y"=_.4!N.903N0-QN>FXWWX=</PRCPM'2C@,?$8-([.9'<K:Q9W
M8DVU &@ TT!T8<8QO%\>DBDQ*J,W 4I#&B10Q1*2"P2*)41<Q +'+<D"Y-MM
M3N,3Q[(78+UY2P+5ZL7(<KG)T5#ZX3DMI+,ER,5#]J=>;0A"G4;. )'(I)'-
MPM-QT-(0VV@H;;2E"$I&P2E( 2!T\  !Q3YE/RUO9OT9UOU(T![3^$:IZ'9?
MIOF5IBT_)8M(C4W ;6%&#4NDR>-)Q9,?,X%7D]++KKRM:>PV>IF'8-=_*\U2
MU3YT3[9_9*[1RT1]#>TAHYJ79K0PXK'<=SFG&6L>4IYF&Y6'VK]9E#$A75"H
MZZCOFW0II: L%/"I)(L[NBHLCD<1@%5W*A5&<D!GL %%[Z  =;()J6N6.-)A
M.T,:DQ L7A17.<\.Q9%#,2[9;79LQN229&]U[%>[ZN&=U^1RZ298>O3[">/A
MUOZL>KA\E,K0HH<2XVL %2'&UMN 'P*D+"5IWWZ<P'CPS':"3MI#EQ)W_P#!
M#U\?_:&JZ^/O^OC*=V,$W.QBDUN/W#\=_O.V%) PJZ6]P14P<[<Q*AU^\'X&
MNJZ*_>T;YD?](XFG6?>;?Z_O4\0LT5^]HWS(_P"D<33K/O-O]?WJ>&&+]G]Z
M_P"D[2^;Z7QX#9H]1?O&1_1'Z.(L:*IYM9\E_P"2I?\ ^_J;X<2GU%^\9']$
M?HXB[H@/_P M&3^S"99__'](/[^,E-IX#SLY-O5MY*+T<P\4 ]93:87=^WZ/
MKX.[]OT?7QF<<'%<J%JWVY4D[^&VP\?R>[AUXG;V_P#&T?X+]O9[_3\'2LKY
M1;5IC'<*J],&K!Z#&RZ/;Y!GTN*Z6I,+3'$H[4W)([;@V+,K*I3U;AM>I1W,
MB]+J0L1EIX\H6JNH,C*K^WS/(DM/AU];D2I22U#7*D)#D:N::04I9IJ6"B)%
M##0"4PXL."WRH)Y;4?E&M69>7YSJ2[&F+4U?9HWI92H0M7*C#]+FFK7)GD *
MY0S99S<AIQW;<G%^11Y&P#0]J=?A*W&@X0TPE?*GJ-BXHK6KU!1V2/1L$)3X
MCCICR/8 L6%-BLBVGQ1V*O;SHZ.%S'&%/->*XD-P1H000UK2.)5H:%1H)'M*
MY.ER1YH_^T$&QZGPVD]V-M.K#7C72#;7"%V51B<EB88[B0(KLSG!@0&6D@,Q
MXS9 6&VT!#;394?W)/'H_L[N+CE.U00WTAMD),QUDE"9DE" DDI!Z1F$#N8K
M9Z(:2"05K635;\EMB;&/:)Y#J3+:2B7?74B!6NJ3NHJ1'0J4\D^IB*XAAM0/
M1<AP@<R>)C99DBU!Y27#ONH*)]&X.W@?WW4'UG;P/3AGWRJFQ?>.IA!_Z3#&
M^94\8T0/'8RN  -3(2I(L;BQ.@M)<#I+PI/)JTH#ZWN2UK$]>0 //ES\[;)R
M7+2ZXL-.GS3Z%#IZ@D;D#?;T^.W3PZ-%<9"Z H]ZOH#S;K.RE>/-OOT^8;A(
MXU6YO.\YU!_9:3X [==_GZGH!X;#P.W&AR[5RS3*CB4F.MB.IU 4=N]">J@"
M!T('K]'AUX34U&L:789=!KUL;6!T/ITY7O<<S,8X@ MQ8$BY]7(>.G+QOK8'
M;;AE*%O*2IQ>^QZI*0DJ]&YW/B0 >O4$GC"EW"U$-\ZBIP#H.I!/H2!OOMZ"
M1ON=^O0\,TFQ#;SA=DE(224@GJ2GP3U&Y!(\=O5\_&^8"^SDMG,9<MH=<]7P
M9$]E<PJ(D+B;.>2LI2//<61L@';??T[\+RD<:YB+*HO<@GE87T!//G8:=AMG
M*BH&D&H7Z0M?6XM;G;QO>_W7OND:T[L*:65<^VQW("DE/X23L>;;T[=>FW"?
M:6"5-!?>D+!.QW('3<'<>&XV.YZ>'7U\(5W=KE279J&VVRZ-W0$]VVE83RJV
M3OYO, 2-QL#[?!M;;(5%7<-K6$@K4X"%<@/7<;[D\I )YB0">,UB%@2+&POR
MTO;MJ/1T V;2<S*22+ $B^MQEM?K[/\ ;9<R2:B75R&EH2XZ6RM"U;$I4!OT
M]BO4.N^P.PXA=E$P(<?2I)2.986GUJ!/HW'[D]>@Z;>D;;/=<986DK2%%(V&
MP4=T@)Z'E/3G40=R=P=]^G3;B-.66;;L^4I*RE16=@1L"%=5'T[^L[>)'7;?
M;A72,4O&=03< 6.N@TY6Z7Y"P.PRWYC1@>?W"X] Y>SKLS>?8_49U2S\8OD!
M3,A!7 G\H7)JK!"5B)/B*4"I+D=Q0YD [2&%/1U@H=/%=L=%MB&0V.*W:>ZL
MJB6N*X4DEEU((6Q+CJ5L5QY;*FY,=S\4X-_."@+&[=]*U'E="0CSD*Z@E7JZ
MG<==CZAN3L>F\3.T;1(?BX[J)%2E,J#(9QF_Y.O>Q7BXY42E@ ^<Q)\HAJ6=
MMVY+*"-DC:4;OX@U-6+22M>FKB5"DG*E20,C+?D);<)P.;\/468F&;PT8>+Y
MW$H$U*;DK_:A)&8'74QWS@GDH>]]!LMXSDEK1NTF;4$IR%<XQ91)!DL**78S
MK+R7X4Y \%(0Z@-O(5ND!02H%M9V]&'R5O:5:PG50X"E]$'!-4*IK4C3^O;<
M*8=(;"Q7!S7#HR%$H;&,9>B<N)'1L&J2WJ E"&2VGCS-:=S7)E;?,M-]^\W4
MF<TTH<R'E1%I6XRL>:%(>9+C:_8=P>;PFEH'F&4X4<3O**KMY<G3G4/&LVQ]
MEKR43IN$YS*C8=G%2RX[-9;*J^P./VCK+KC:77:=3@4%.#>.^4W=V3%L.9J2
M!YJ^AG22C2)&>25)FC1Z=%6Y9F+J44#4JP YDLZS4\M$XGDCC3A,[,[*JIPE
MNSDDV "+=B=!8$@;?HHUDAN=#8DMKYDN-I6".HV4-QL?4.H_)ZMN,_N_;]'U
M\4YZ??*NZ.X[B-7 N\&U:L[J/&;9D,0J?'VFN^0@)6D/N7SR?W0Z*Y"/7X'<
MM/E@JE:BUBO9EU%LE*W#4F^S+':B*"?W*GFZZHMY?=[;*4EI"G -P#OL>*0A
MW*WNF"VW?KX[@:U")3 7MS-0T0'/:(28CAB$_P#7TK*#H4E60VTUM&7/CX]/
M'2V+-LTQ'3C%[?-,ZR&MQ?%J*/Y3:75L^&(L="E=VPR@ +?ES9CQ3&@5T)F1
M/L)2T1H49YY81Q5AE_RKE(B=(&FVC5M>8_"E/]_DN=Y0SB#<RNB K>EQ*JLJ
MKMZN4^VAPQT7%@AQ@<BY\5CSV4U[:W=H+67M7Y55RM245^*X)0V+DC$-.*%R
M0:N!*E)$4V]I(D+5,N[XQ%*9^RMCW:HS#K\2IK:B/)E)DI'8 JL2[0?;!PRE
MRR% N<3Q6LSG.HV*6#+<FFF2L'B0V\9B3JY]*HLZ/$MK6+>2XTEEUJ7+K(_?
MI4TUW?$]P_R?T6%8)B6,[R1O634%(]7+0TM25@IQ8\&!ZB @RU,KC*623YO"
M+@B8BX9I,9>IK::CH&5%GE"+/+&2SY;-(R1/E(C1+_34/(2 H0><?3UBEXQE
MF+8QE<6-*@Q<HQN@R6-"G)2F;#CY!40KAB),2G9(E1FIJ&) 2 GOFUE/FD<+
M_=^WZ/KXS -@ / #8>CP^;I[N#BF#("20M@22!FO87T%["]AI>POSVE7!;XM
M[_3\'3#[OV_1]?!W?M^CZ^,S@X\XG;V_\;><%^WL]_I^#IA]W[?H^O@[OV_1
M]?&9P<'$[>W_ (V."_;V>_T_!TP^[]OT?7P=W[?H^OC,X.#B=O;_ ,;'!?M[
M/?Z?@Z8?=^WZ/KX.[]OT?7QF<'!Q.WM_XV."_;V>_P!/P=,/N_;]'U\'=^WZ
M/KXS.#@XG;V_\;'!?M[/?Z?@Z8?=^WZ/KX.[]OT?7QF<'!Q.WM_XV."_;V>_
MT_!TP^[]OT?7P=W[?H^OC,X^[="HD)0GJI:B$H2!U.ZCL.@Z[>/J'!Q.WM_X
MV]$#D@ 7)T &I)TT'CU]GCIA=W[?H^O@[OV_1]?"':9KC%.2B39MNO#<%B+L
MZL$>@J'A\Y3\^WAQI4K6"J02(53+D@'HM:BG<#?Q"3TW]?+OTZC;;C>D,\EB
ML+V-O./FC6W(L #SZ'9=%@V(3 %8&4&VLED'J8@^/3P\='1[OV_1]?!W?M^C
MZ^&75K&Z%?\ @FR-SL"XL*VW/K&YZ>DCQ]G0YT?6:J40F9628^Y\6UI< ! .
MP"B"KIUW ]F_IXV&EJ0+\$GGR93R]!N?#E_7;>V 8BHODC;LLBWZ>)6_,\O#
MOL[7=^WZ/KX.[]OT?7QK59GN+VI2ABQ2RZKP9E)[A9/J3S'9?4@=/'Q /AQM
MS;C;J>=I:'$G8[H4%; @$;[=1N"" 0#L1TX3OG0V>-D/@P(_J-F^6AJ8#::)
MXSTS+8'T'D>O(].^F-W?M^CZ^#N_;]'U\9G!QAQ.WM_XVT\%^WL]_I^#IA]W
M[?H^O@[OV_1]?&9P<'$[>W_C8X+]O9[_ $_!TP^[]OT?7P=W[?H^OC,X.#B=
MO;_QL<%^WL]_I^#IAEL^@C\O3X\<"@D\OO\ F_+\X_4\9QWVZ;;^WC&<!2-M
MQ[=C]'AT]O&#2Y022 !]YUM]Y_Y.VU*=B1?QTTZZ:WOZK]]L-2>4[;@_-OQA
MNDCQ4/F'H'M]GL_*>,ETJ2#NKU;[?J/<!N??PB2Y/+N>;;IT Z'YR?5U]/Y1
MZF6MQ 1@DD:>KIJ?N!Y]['G9UI</,C  '7F;7O\ \^/2WW6X2'@-_.&WMVW(
M] ]0]>^^V_3KUXUZ78! 5RK \-R? >/OWZ=3X^@>&^'8V(0%;KVV]!(V W)'
MSGVG??T;'KPW-OD*6@H!SP'3;;<=?1Z^N^^Q](.^_%8;Q;Y4U CL\R@*IOJ!
M]]AXVU-_3IIM/L%W6EJG2T9-RHL <MKC2]_#T 7Z;;#87*&^;]LZ]?WW7;J.
MOJWZ^)&XZ;>CC0+3)DM!6SFQ\1YQW]GL&_HZ#IZ?#C1KC)B.?=SUG??TDGU_
M3Z?'T\-I/NWY:U(945DJ(&VY))_3MT]9/3;T#CE+?_R[4F%I,J52AAF&57!)
M-_ 7UOWU/([7ANYY..($>:.R  DD6%A:X).EO$ZC0]-MZMLM(Y]G#T/7=7S_
M )=]_ [G?;T^'#<6>4D!QQQ[D;2"5+4KD0@=.NY\/=U/CON-]!U$U#TUTHBT
MT_5S4#'=/XN12UPJ=W(YJ829KS2 [)*"H*"(\1HI>FS70B% 9*7IDEALI46>
MU5[2FF6F&73<6L\<RG*L>QNKPJ_S_/<9^Q$ZBPFHSUR>YBUM+A*LVKF[K'(M
M7/M;>9CL"S:HJB.;*=NUS);YW?>ORJ^4*<1;I;KX_BL=1!6UD$E-23Y*BEP]
M,];+32,HCG%.EN(L3,X8JF7.RJ9;7XWY.=QZ:27&<<PFB,$])22M454,*Q55
M?*D-%#,[G]6:F9UCBS 9F.EP#MLV0Y);9 AR"_&9=AIFA]LLJ>0E+##SK"T2
M@5'RI*FE!]EQGNBB5W*TH4$$C7?(;I]V(^Y.ENRH?DRH4Q24N/1VH2GEQ$ *
M:*7E-J?=0MQ_O5N!0*MBVDJ1=<^TCI[HIFDW%XF'S\YK<2QK$,QU0R6IO*>)
M'PS&<ZLY==C3T"%-7Y3E]S*8K;.\>HJA3<F/CM>]8E]UZ1 @RU'5_M&0=-<Z
MM-.].-)T:JW&'UN+6VHLN9G6/X'58N,T$E[%J*+.OV9)NLGMH,.59_8R.RU&
MK:U,:7;3H@GQ4K;<-W&\O6/U.!4F&;EXI)+O-0XAB6#&0PQI645&4IZ^?BS2
M*L**Q6-Q4&+B\2+(K"6,O =X?*/Y-*1,<Q'&=\J*C@W;K,-I,:*5 C7#JB6=
M,3P>"J$2J#-$TR2TSB,2 *6<_JY"N8UB5FZ.=+;S[SG?)><4D*4X7W5NJ42E
M&R"IQPK40  3RA(01P@66*3HSJFG8W*\@']VV0$J*R5.[I"2L[=$A1Y2DA.X
M"=S'/.NVY'UKR!C&NSUG5II368-A$.\U36G%L;OLYH-3KS*['$Z?2W(:V^:M
M*FB50?:_D5]DB GRVSAQZE%=-CUEBF<\_&@':\T(UHPO$L>U,U6TYQ/M#,WM
MUIWFV#FV:K'SF^,7L[''78D&8OGKH>4.0FK?'(5@\W(E1K*-%B*F.)2IR3X]
MY,/+_N9N9A&^=;02U%)B%55TC8/0&HGQ?#30M.CR5U&L X,)%'4E&223+'$6
ME$2LF:$X+OMY&-Z]]<<W0AJU;%L,I,-Q6JKIA'\RK(<;6&>GDI:O.RU,DGSN
MD:5M 7K(>&969\B/)QER*E;J"X75A1*0O8H'_O"=TE)*]R$<I\S;<DG8'745
MCS:G4M)>2GF'*M1W4VE1VV4 $\PW4$GJ"2-^4@'A^)FI/9\=U61HG'U CRM0
M7;9&->3QZVUD8^UECT!RV8PZ1EK4)>,1\P?JVW+%G&';5-VY#07?(MRA*W%M
M-%+5I3B$1TD\Q.P(W4!X>/I ZC?KUZGKQ%J;RH^43=1Z'_Y!@^.8:*ZFCK:+
M](4%3 *JCEN$JJ<S1CBP.5<1S1@HQ#96-CM)Z[R=;@[QQU:X-B&%U#4D\E)4
MB"HAD,%5&%+T\V1B8YU#HTD3D2*&4D ,#M$-+*VH[S".<E\I2\L$<JE@*Y]B
MKE/(EH!/50"BM9! *1PL562KI[*"_3U[#,Y$J#/,DMNR92I]2MA,=3TE!<E,
M,.1&2P^B"&67$/N.K9?6D N9DNG=A6@^41%(*.OGMG8$]"E2?W*P=O%6X/IZ
M'JS]K"F07U.%*V$*62.[);;5R;%">1M*-CN H!*AMOS ;#;B_-R/+O18XOS#
M%"")D>&1)#9@LD1A<#-9XW:)VC#(0RAF (S&U";T^1[$]W*E,4P:22*6GFAJ
M(I:?52]-415,&<>='*B5$$,IBE5HVDC0NC91::F ]I6%862:_)8;-6F3(89B
M64%WFK8BWY!C)C6GEKS4MA2'51U)G-QS#4S*;6YY.4N 39H,A:>2VXT^AYM8
M!0ZTM+K:@3^Z2M!*5#KL""K<=1L#Q0P):JV=Y;WC,IUSG9<;>05H;2ZH+?:5
M'6D,2'.4J#;B@IM#F[B4K4E)$V- =9&X+=3B(B>4)L\@7W#R)C7>1V;-ME3)
MB5[#;B&H[,AB2Y.1(=@K0\Y)<B1GFFG%\7G0UB87'!BN[\T\E#YIJJ%G:5:6
M".&6>6J6HDDS+$B1A6CD+L7<9')(0+-T]]:S%JN3=W?1:2.M>RT&+!4IGKJF
M>KHZ6FPYZ**/AR54DE2[QS4W!B6GB/%@7AR5#6VU-B' D<WB$GIU&Y\=_9Z3
MX['?;C<6%!>W78';\A]FV_Y?R>H\,'CMQS%M)6>FVP]6X]VQ]/0=-CZ.'EJI
M1=0!S^@>/LV'K&P\-OGW\>.@MT]Y8L4I(75P<RJ2+WYV[\]2#TO;MMMWCW?>
MCE>RV4&XT]H[];\NH%MME"=_ ^_H?H&W'/N_;MZ_3\.!DG<*!'J/7T'\GLZ^
MKC,XL%)LP!T.E[: \@.8]'M/CM!I*=E-NE_"WASU[7'B;^G;#[OV_1]?!W?M
M^CZ^,S@XSXG;V_\ &VK@OV]GO]/P=,/N_;]'U\'=^WZ/KXS.#@XG;V_\;'!?
MM[/?Z?@Z>1?_ -(R[,KE3G>E7:EHX1-3G](G27/76(VR(V8X;'EVV%V<QUML
M)Y[_ !&19U"7I#JGG7,2CL-CD2GCS Z/X9H7E/:#TJH>TIFN9Z::-7.7P*C-
M=2M/V*=S*\"A6"S%AY1&?N8LUJ#3UMDY#<R6RAQI%G4T1L+:OCR9$ 1W?TA_
ME&^S<WVJ^QKK=I/$B-2<O3B\G.M-%N)45,:E:?L2<DQ5M"DA10+E<:;B\A7(
MYM$OY!2@K""/)1\KY\EI![/79U[-/:DTJH)-=C5MI5I!@':'QYQEQ+F/ZKSL
M'J7*O4!<):%&'&SJ8+#'LP;66V(V:Q*R<II#N3SN1._TR>0.IL>6HO[=>1VD
M%%.#3QPR$AU)C!%OHVNMCKR%P!U(.FNOKK[(78YTX[(N#Q,5TVU9[1^J-$[4
MQHT"=KIVB,XUJKDUCCB+&'+Q>GMYC6%8\U);<;7'G8E15J)=<\EL.O17MUNQ
MVA$;:09>=]^E'TV_^^*IZ^/H\/R\4+?^C<]N^7KAH#DW8[U&NGK#4OLNPH$W
M3R3.<6]-ONSS<SDUU)"5)5SKE2-+,I?5B*UON=^G%[K"VN9X17E-7Y=H@;Z.
MY@/91GW9'4_'C*1P() %M^J<<^1R'QU]?2VS9\WECKH@[!B*B$YM/.7B(0;:
M<Q?D.?*][[:-HK][1OF1_P!(XFG6?>;?Z_O4\0LT5^]HWS(_Z1Q-.L^\V_U_
M>IX;HOV?WK_I.SI-]+X\!LT>HOWC(_HC]'$8]"4%>M64 ';;")?_ '!2<2<U
M%^\9']$?HXC/H+_QJRG_ )'E_P#<%)QZ/VT'\Q_H-LCK32?RC^J;33[@_A#W
M'C3]0+9O&L+RB^?<2AJHHK2Q6LG8(3$AO/E1)(Z ()\1MMZN-YXC+VQK1VF[
M,>N-BRHI=C:8YDXVH'J%IHYG4>HC<=?1PXL2%)'.WC;M_OLWI&I=1XL!S\2/
MC[_1MY">T'DCEJ[13Y)(D*PV+.6E2MR+W4*7::CY7,(.Y+OD]W%BJ7MS 2&T
M%7FC>HK4^Z)3+=Y_W2G%$^.R=B=NO4>;MU/AZM^+.^TI([G-;"J:.S-3@E?)
M2G8#93U)2P6CMZ.6#7QVT^!VW"1L>*A]1Y"GBIGF_P!YYGHW'>>9MT('IV\/
M1QW/N-2)2X#AT:BRQ8=2+;P_4*;C^8^>;#Z3L=+FZC&),H1%T%PH(%@/H@@G
MD0 /#V6V]/G9=2,-[*6C&/@I9?>P^)D$\)\TKG9*#<+*P-B2F/)C-#?<A* -
MQL#QD91D+A01WB0"3NK<]/'T;[D$^L;=.OH/#>Z?9&F/@U/2-JZ8_4TU2EHD
M#NVH5/!C( 3MT0E+0V^;?KMQK^26RY7,UWGFD*Y@#TZ;GKMZ1Z/RGTCBFT@,
ME753N#FJ*F>H8GJ9Y3+IVN^E[C4^@V30QB*.-+ !%1.A\U54#[SR_P!N>R/<
MW+BW%A#JE*6K?<$GT@;[ @>K;?Q.Y\.G&YN:=Y=B%'@^=9_C%Y7XAJW52W],
M;F$_7RFLF>86PT&FV84N5*BNJ<D,%$"QCP9LEI?>QV'&DK6EB9MCR/;!2.5*
MD@D^Q6Y/M]/CXCF\.+)<+[3VA53B&D5#G4Z-DK6C_9TTOU+PV PQ-<3$[4>C
MN1ZIBHT[LN>,4M1<KJ,SI)%N\PE4)Q%#7=_-*6BT3$9:JF2!J:F>I!D(FCC5
MS+P^&Q0QLI"1GBF,L7S!HQ(H%RI5=43S1)&88C,&8B1%#%@H7S<A'FJV<K<N
M",BL +D$0#UKP//=&\YE89J1CZL4R>/"KK5ZFF3:Z7(8K;EA4BODK?JITZ(>
M]825E"9!<CK!:DH:=24<:%BF5JJLBJW::R@MSW'>]BH<>:<0Z4(45**%K/?H
M4@*YN7="B"/$<6@8]EVDNO\ D;E5J:XG+,:QWLXZ#:P9?GD/'OLC,I\_[.U2
MSE&KV'7%U*8AFMK=2<=F91A%I'<F)KIE_,HGX:)LIJ.VYK&#=H+LZY#H)>3;
MFHTTJ,URFEUNFZG:9V%_ PV7DFH>7WU]-TXGX9B%=H5E]GD,#&*:QQJ#@UE1
M:GX/7:=O8R[#M:F*T[.L[5%^EJH0K%)ADL]0/FL=3P;I$#4PEPZI*"X3/'+$
M4D8,KK&KN%F1]DSXA*8422ED>2,1)+P_-C'%0,'"N"P6Z.A5FN&R!FLZL8I:
MM4&38%?-5&6OU$.XM<=Q7,DB!.;>AN5N<4<;(J=:'.[8;0^Y6S67)40))BO%
M3(<=Y>=3.Y3!LZ3"8.7NR*A%3?W%Y20E(OJ=VT%A1-07YZY]&W-7=U->I%C'
M\@LK"#$KK)SOVH,A]<=P"S*UUCT]FRK;[0=9]&=.=4$8OV5JU_4;5W&1;8[9
MZ=X1HU&QC5#3RGEV6%9G%A743-VV)U]0-4\21G%8P*BLO.[86A;<0-7>R.G)
MGY.,6&FV!V$K4OMFS=(\ES+ U2J'3"PR_$M/8G9XS7-Z>5C]PMG"8%[ S5>+
M0+*'?QL!F6,2PETC8KUE."8K6)%$'P^=G6-&ERQ3@-_THF(*\*T2F0A(S&U4
MY$<J-$LH1';4JY18M YL SV1Q?\ 5Y\M@EU4M95L93HPRAP!M5YJ'27&-XII
M7DED[6JJ]6,7N<SQ9V!-5+?^Q-%F5]@D\V2.Z;1#D*O<=L>X99=E)=A=Q)4\
MA3JF6XX9+:-KD E84M37(GE(Y24==CR^"O62=SN!N  .)N]NK4RES ]F^LC:
MH:>ZJY9@.C.0XWJ5E&F%(JFQ)S-K#5S-<F6(C:,7PZOMY,NJMH,VQRBJH(%;
ME$YZ1>M,(7.7S5JVUN'7W%-D@H!*MALDG<<VP'@I77J"?8!MP]8?/)-"DLR<
M-V:<9 '6R+42+&;2)&YS1(C9F1"P.?(I-@MBDDDB#%2K%I#:Q\T!R%^D QN@
M4ZA<PU %[#[93AS).X5SDC<D[).XZD'QW)!\1Z""=N-#NX#628OF>*N'F594
MLUV(5 'DFPF_+H;B=^G.B6PTH;;G;?KUWX^6=L"VXOF((5S#J#MYPW&Y/B-M
MCL0/#TCJC8_<][D+#8.W?I[E7,000YYA)]9(44DCIX[>'7?),T(XB$AXF652
M#J'B*NA'@<P%O0>IV0U2K)FB8 HZ%'N+W#C*0=>14D$>CJ0-F.T?NHD5XNS9
M+<=ERMEL/%P] EU@[@@GJ 3MU](( '%A?9VU*TQK,NP9N\R5#57'R";333"C
MN/R9#5G3NWT2 Q'0VZN0Z++'W)(0$+Y!WK@Z@;U78\Z8<N[93L$L6%C$0!T/
M*B>^TD)Z; <J-MSU 'B!MQ(30>6VWJ/B#BR2IK4/!4LJ*B0V9LZ;72=AOXN0
MY+K)WW)0M0V\\\6+C1!IHZL$Y@B2*H( 9PHM>P)TS7%B+6N-1;:N:>E^>1ST
MC-D5DG@9@H+!7'#8K?S<P6]KK]*VECMZ;=+4QM<*V/=:(:5ZP:M4LQH/1;C$
M,?C.5;R%#F#B)=AY"GD.^X5S) &VY]'$BZOLF=I>Y2%0>S#GE8G;=)RK*<*I
MU; ;[*0;L%.^_4<W,#YH XUKY!B[<7I5!J5J*VH$ZX@(YMU?M<&SEQFP/P0$
M-  =0-MOG]-:$IY4GE W2/0!Z..;9/*=C3-(B46'1F-V2[&O<G*;7-JY%OIX
M6UT&S1+NM00.4,M2_?\ Z=.@YV@)T]-KB^IU/EBSO3W4+2VUKZ[4[3'+-,[&
M98N1Z"1?-QYF-Y+*@A$ER-3Y)6NS*E]]UA*G&XWEAF+:0^X8R6V5N<14[(^=
M3.Q%VZL.SK/H-Q]PNYL<OQ*PSQFLGSJ['<8U%@+9;LKEFL:G/P9.(VS-6+F,
MZP>]K8\RQAE]D(X]C^;X)AVI.+VF%YYC=5E>*W+:$6-)<1_*(;ZFEI=CR6RA
M3;\.?#>0B1!LH+T:P@R$(?B2F74A7%:F9?)>4DNU5*T]UCO,<I"75-8_F&-M
MY@[ W<+D:/#R>LNL9N9$&)T99:MVK&6B.E.\YZ0GOE2K!O*9AM7AF*X1O)3&
M"'%:&:BJ9*43/$4="(IX"?G-13U4#LSQATJH&).?*,JJR5F[$Z55'6X;->6C
MJ$GC68J";$!XGR\-'BE497L8I% 7*QUO9U1VM1DU-59#CUO67M#>0(MI3W5/
M,8L:JUK9K27XD^NGQ7'8\N'):4EQE]EQ2%I/B%!20J=P?PA[CPTG9_T?B:#:
M28GI7#O)61MXV+E]ZXE1&Z],J;?WECD$],&L:=D-U=4Q,LWV:VN$F2J/&0E3
MTA^0Z\XIY.*4G6))YD@D::!99%AE9#&TL2N1'(T9)*,Z!6*$DJ25N;;3%5NJ
MEAE8JI90V8*Q +*&L,P!N,UA?G8: 8W<'\(>X\'<'\(>X\9/!QJV]R+W]?Q\
M$]K8W<'\(>X\'<'\(>X\9/!P;&1>_K^/@GM;&[@_A#W'@[@_A#W'C)X.#8R+
MW]?Q\$]K8W<'\(>X\'<'\(>X\9/!P;&1>_K^/@GM;&[@_A#W'@[@_A#W'C)X
M.#8R+W]?Q\$]K8W<'\(>X\'<*_"'N/&3PV>?YVUC<<PX3B#9O).ZB04QFU)4
M.=0Z[JW("4CSE*\T;;*(SCC>5PB"['V=SX =3_OMOIZ5JF58HP23S)Y*NEV8
M] /][#I93R;+JK&FE!UU$F;R\R8J%IV2"=@IY8)"!OTV\?5S*!08ZY)J+:6R
ME(5(6VSU"8S*ELL@'IYR$J2M0V .[JAOL"6@>- M+F5/D+=>==?==63NH\[B
MUJZ%1 _?'P2D#9L;)3UWWV*CP&SM0A^P6J%'7LH,!.\A:.G56^W<I'I*R/;X
M;!]AI(*51)*5+?O-XZ:(NM[>/IN?"64F'4]&H:P>3K*PNQ.@(0=!Z+=S?;4W
M[Y22KNT-<YV/>*;2I0)\>1)! _I*!4?'<#A*=OI:B2J0[L/ !:D)]R.4#\@V
MZ;]?$R$B8+C4% #L=,A0VW*E<Q.WB"XK<*]9Y  ?0=MN,Y51CK(*6Z>OVV W
M5'0Z3MX?[WG_ "D ?/QN^>TZGS87<]R!<"UN=STOILX!U/)#W)(Y7%[7Z^BW
M7ES$857;OI>)Z^E1/LZ%1/S^/I^<<?4W#QZ]Z"/4=MOH'3\A!XD?)IJ1]*DI
MKXK6^Y'+%8Y0?$>:4<OCL>-(M<4K02I==%<1Z%LM^3N =>I,<M]1X;D$#T@^
MG<E; W.$KV)N>F@N!>_<[; 5-A:QTYB_W7\=+=?3KLV#-PL$;J*AZBHJ'Y L
MG?T>&Q!  (\1O=%GUO3K0Y"F..M)(*HC[BE=!Z&5J)4-P?\ <N%;:QN.4[@<
M:S.Q%"N9=9)+2P-Q'EDJ0H[_ +EN2D!2=_1WK:AO^_ Z\:BM4F#(,:8RY'?3
M^]5T*D[CST*.Z74'T*1NG?8;^ XWF*"I4J+'2Y1A?33H? ?V@3SYZ[>/#'(I
M21%="+%6 *D:<P;ZG74 ==IPX?J549)W<:4ZW!FKY&T%Q24-./*(0&G=]DQW
MEKZ-'F,9X^:E;+I3'+I=PK\(=.AZ'Q'B/R<5NQY;S2PZPL*5RD**=MU((V6A
MQL]%H4"4K3L4J22#ZQ*?2S5062X>-7[JC)>)8J+-YT'O7$HYFZF<XX0HR%I2
MH5<I:E+E!!A/E<I#3CS'78:80TL()C NR<V06&H\1U/4<_1&L1P01*U12@F-
M;M)#<DH!J60ZDJ "64Z@7*W LK]]P?PA[CP=P?PA[CQD\'#1M'LB]_7\?!/:
MV-W!_"'N/'#N_;]'U\9G >@)]7&#M;3[SSY>GUWVR5!<:<]-=?#7_?U[8"D;
M G8$^'SG\NWY?9^3A/>'CYWAX^K8>W?IZ_#KN.O&>\Z-R00=O9T)]0]>W3V<
M(TM_8'=77Q/LV\!^3IL.OCMX\-=74!%)-EL+Z\KZ6N2?2>7CWV<:>F+,%!ZB
MYMRY=/ 7T\#XWT39CP0%;;;C?T[#WG??VCI^D#1+6P#8<)4.@5U!.Y^<[]/3
MMMUW Z=".%.WL0A*SS;)2-AX#VD]3N=_ >OKMT\&7R7(DH2X O;;<=% ==CO
MZ]R?6? ;[<4YOKO7#AE/,[RA<J$ZM;EJ3W)UMKJ-=.>UF;L[NO621JL9.JV\
MVYZ 7%N?4GH-!KKMCWU^E 7^V=0?7U\=O6/H\/1[66N\B4M:@E?,3OR@$G;?
MT>GT]-SU'H]/'3;W$B:\IIC=:E>(!W&VW3<[  ?/L-O$<-]F]Y4Z78+F.JN>
M+DQ\3P6BFY'<N1F3)E+AP6N\\GB1F_/D3);A;B0HR-E2)3S32=BX./GMY1_*
MQBF,XFN![O1U-=7UE2E)304RM([SSR+%$@"ZW9RJA;WN;:'ET9A."83N[0/7
MXI-!3QP0M,_%=%(1%S,QS$6 M=CH +DZ$G;8F*NTNG/,0L-;%2ED;)#8/4DG
MH0 #O_=U'$-==.VEH-I9@&H+.GNK>GF4ZX5$NLQ/%,-?F/S?+,RO,GJ<1:C1
MFHZ&&LC>HK"W1)M:>AGRK!L1'H;WDCJE.-Q,U)U@UUU:U?R*)D^(ZS:'Z6?:
M!4G!G<%UYPVNM*3)^\D)NXF5XKAXL+6RR2[K[&!-K'I\FRQ_&G::=2SH4EZ:
MB:K5<8T_J,=P33_$I<F5FL#3.NQJ%B%IE%30R9\*_P ;+JX>:2(_V/$>LR];
MTF;->M:2/7S393GI+,EE*U)5T1Y*OD,8GC$F';S^5O&W2H9J/$$W5IXI)!%(
ME4'J*#&N,(05E@0(IHIG!XK.);1!9.%/+'\O'"<*DKMW?)_A_P"E%0STTV,0
MUM)'2\*2B8PUN&5%.U?QI*>K95J(*R"E9#'D*%9"\:KFYUFMM3G,TSW5EW5*
MOH=.LVTKI*"STSQG&)J3EN28Q:7%I+EU$U-2_2NL8NFM;JGJ(37(,YZ/96L^
M.@(=T?3KL]TF)6^HM/)RC*,FKL[Q6IP1&/7<YJPQO"<%HDY3-1I_B2FHM?=/
M4J)^6WD*!)N[*=-IZQ<*CJ9S%/7PTB1DL1Q6U$H5[KUK8LH>LYL^22RJ3N>_
M4PP4!UHO.<SZ/.4TZVOOT+45*Y7#QW3R:](BV-C"EU+#RTR)5O)4^I ;GO\
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M7*!\^Q'$G^- U0I&\BP+*Z1U'>-6E%9P'$$<P4B3$=:*2-CN"%$$'H1PX/\
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M+EE)MTTT&GALVFBOWM&^9'_2.)IUGWFW^O[U/$+-%?O:-\R/^D<33K/O-O\
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MWIA]'_:LTJB9EI?G.15;S-5D]+A]_+7)4A0BW5="JI+KM=9AKS@^AAM?V-L
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MDR\-QS56GP35/3:5,PR\FK1C][:8UI!HRR[6V<R"Q,<8756[3;TA"&'G8T^
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MA^OAQ@63@5#B-CQ5.YDCT[)94%?2H>GW;C?ZXLJ.WH'0[?/X?6/'C#DN!<R
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MM)W,A1Y$MEP@<+>3=H"Q3JF-;G:ROD9+&SFIR&JQ,VCS%._(8:"7643)B46
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M##8JHF,8)C=9C5,V[L9#L:N9Y7)LQ0 "Y]G+7)LYZP.54V8^4@(Y0-+[1_\
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MHHZ]>];'.V1OZ0M*=B/9ZN'E&R,&Z#0\_HFU[]>_W7Z;;6%[ZW!-AX7M]W<
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M(Z@GPVH#R>5%/!7)97>45*D393D$2@>:SAB"^8*8TL+!VLQ).VD6SG+*;<W
M25E2MM@%)YBH;[>&P&P'H]8X9?M73M-)VGN!4F7:)XIK3J#EMM>5&F,#++-W
M&*;'I-9CTR[R._N<M@<UW5TM90PG)%A6T;%A<Y'RQZBOJILAT*8WZ\LW%2^1
M2E%"7>5I)Z<NRE>:=@>@W*C\ZMCMMPD:]66F]9V<<GO]2=/*G4]-3,IX>"XM
M9..1%3-1,DL8V,X:U"NXJFYV/N/W%Q'8E7E>^U)KZMV>^%.(2XPY\N*5DPOY
M0&Z35-'BM?!/CU+328?@E>^&XC6&K8PQTT%<C(T32/)&KV>,O'F021%N(OT0
M9Y<1\D&\+4=;AN'U$6%U,L.(8O1K7X?0F*'.:JJHRZ+/#"%,CHSY+)=U=;QM
M4]I?B%5I/05F!1XY>@N9)DF29#.KJJRQBI,C,+QZ]N:# JFW>L)N.X;6EQ-5
M10IK\JQ<C,R+&?W4NPDQD3=T4R+''+"W95Y/76*XTQF']C@MQ#4%F(E9A-/.
M+"(S[SJ$+>F%LO-L)6W&V4^XH01P?%<=TPJKC#&)C=Y+^W/(<CNK*DF6,3%X
MV6Y*]%1<TF 0I;\^178/3KKVHE%Y>_*GVCB)E_9253[:2OA^<8LHE/<U;==6
M,\DB4]#NY;LR6)Z+):9"4N!SHPB&MDM(:0F,XA3C;ZG-W5IX^ZV'Q 8334WS
M3YNK4=,HIN-\X>DX4"*815M(PF*!1"SKFXP6X)S@GX6XIB+KO?B.)G$8L8+X
MQ65+8I)1&@7$VGJ29*U:%59J3C\5ZB. ,#!F *YE*[2>F6+7E<Z0Y/;B*>4&
M&D$(!?:YB.Y#161W  3NA065+6EPJ+GG!5M.U!GVG^$8IIUA-I.Q U65Y'D<
MZ_J;6"_-L4WS-;&D1C62ZM]ZH=Q^)"<57W]?+^RC;ELXF.N"&W%2-AQ/4V%A
M^E.IC-);UE9GU[D.GS&-K-3#LK9&/-Q<J:R]VLFV55-;@-N)EU4:<ZAR)-FL
MO%MD%KO-G)U@U5TK&C^.5^,Q=.94+R+2:JC89DSN33[7%,KI+:DEY;E$W%*O
M!# 7%*JVY<R.X:SV8_G.-VS]6B(JR>C0F54F61(H31-*G'B"ZJ JK$ASL#&!
ME43A%+%PV65KI9!M+L(B$<%;74>^4&"5DF"3U%0B@I.X?$:DI04]5'7<:.IF
M?"()YFBCI9HHJN@41U4-3.R0)I<HS2XJIV.O3+G(<>T^:O\ -RAF4Y+AXG!L
MK6L5DF8/RF#Y5"CS[!ZH?FW#TGNUV#\&0MQ$AYI1W&^U^U6R2WI9EYJAE\I&
M+R+"3$LU6<!BRCSK6G>IYTJ((L&,Y;Y'<4KBJ>5=6B+.V<JG5(E3D14+)F19
M]H?!OMJS.#1:ZX)27>I.A&>XX+:+$.0Z383FS&=5-K@5349!::/565L4TC&$
M9 6<5NL?RJ)B;C]3CYM+9"(1@LS7ZL:65NCE166>H&$C#*G0'.L6U T"&*/S
ML_S36JWCY&Q2YU67OVKKB+)N;+%\@C9O]N-;)Q*HI9V,BN)24KQS@,)7HF22
M5UC2,AV(XB,99$1J<+G=U9%(M&[,&ED5+,ZI\!CI7:EH]^G56@62JG6JI(:6
M5L-J:1<,5UCQ\3-#0TL\-4RGC5U"(63#J&JFBGAI*]<_U-S"50VN,,9W9V6/
MS<3HM/9=6]8Q'ZU[ L1F?9?%L*F!#:4NTF/W7^V5</O$+$M/>EU9/(8Z97VH
M>T1*8PE-_KAD+473C(J?(\'F^55,:=39'BL$4N-6;UY]C_LAD5[C=:EJOQN?
MD<^\FU-<IRKANM1U.L&WE/:%TCF]J+*[*?>8D_I/3:5/8WH?=NTB,7PG"-2[
M;!M.VK/)WK"CP&YR&@DV%]3Y75R<VD8KDUE0VTN-;Q(B8J6I,=6J-9>S]=ZA
MZLN3<[T:P&AR?&L"I\XU!Q9K)['.,FE8OC.01K?(-,Y.3:"VN,:@JN'[&%!U
M QK*,0Q.%J)D5;69+7SXJFGIRUE9/FI1#)A,LEJ>.<R@*QCEG$:%6"TYDCE2
M(KQ %SYD$(4H!(=F%X/%%-(D?E#CC4XM4X.5:5HC+#AJU=5%5YCB_P V^8S5
ML;-0M-.M/PZI:_CQ3N](*7>SOD/:2@8SK5D^FNNL717%<8:QS4756YRO(:ZL
M$C*[?(Y%'@EQCC8Q;);M6J^2Y%.FTF)3\=BT5DZ9-A#DY!7T[LHH9"7VH=?,
M8118W#ULRAZKP35"VUCH9=>]1&57:CVTV3-N<[QK(7:N7<U<JZL[*3:V<6'/
M^U^;=RURGJY4SD>$S=)-99FENA/:MP!G+35KS^RT*F8OCS^)8U8/Y365.I"?
MNIQ0_-QZZ<8?E:>,HCRX5C;LQH1=+F-^37*GYSDN9&H?8BQ?6-.7.:HZ)95B
M6=_*/Z==H:/4TVGV1M*T\[.B='\XJ+C&,RB6^!083*:O+9]>Q<X)CQMX,5]J
MMG.-OR'$^1I!%-35,K2T9E09FA/ N79(X'N[&)B25GE12Q*G(T0.93=ZPR-,
M1PS!S3;UM0.8<N(4]1B0ACHS78IBB 4T8Q"-A$GZ-HYZB-8EDXM7!72_JWA$
M=86.]I?6=&CECHE$UGR1C3FRK9]2O!Y-Q4,0$8_>3U6MQB+5Y)BM6D2AMK1U
MVPL<1;OHN-V$]TNO5CCRREQA-4]6=>\AQS4K+KC,<TR'";K(-+<(U=O;*4W*
MJI^1X]%LTZ08SEUFB.U!-K6P,>MUX97K=B2C&I;)01)1 D+18Y3=LG2_*'=#
M[W5#/=.Z+6Z-HIVQM-*S5C(M+*9W%=&-4+K.J"3V4,]U#QS&,$?J+*CQC#6\
MGH\>NJK%<GDX'&MZZ\F5*WZ=2BP&8=J6VMNRGV\]#,R[8^CF3Y]DV?:6ZCT6
M51<4;8Q?7G%ZK3?-Z#57$=,+L:'5-I+SZRM9^%5\.7?4^'/29%7:V]!EE6S8
M65G9CM/&P;YK$BM*ID1HV;,6JTBED1DIE$@M&LH+,LELCE"H!;?2X/%+9IMZ
M*RL@^92K2JLE.3"D> M7TM!-'/C9>C8?.ZC#C30PU%,KR5--'5<::6G5IZOM
M+=HCLO8IDF@\/M (IL2I\DL'(S>EVJ&+Y+B]?(R2/2Y%:HT^U-PIRRF18=U,
M?B+R^-@^2P8%C=1GX5]'=FL24*C?G&<N:F9+99?>7*KK4#,;V7;Y1=3)O/-O
MK&Q0T_+MIK"X=<$VTV9SORUPXS;4HK,E]*I+RG7+M8':%[+L[.,@^X?KOH/H
M'52>U5A^H^IL_--%I5S0]H;LQ'2S2:FGZ:8)7-:5Y&I;=1D-#J/67>D4^'@T
M+++W)8>6N9 GD7+C-E@?:P[.$2NQ'2[&3@F):&YAHY\H/"U,PNSTQH9MY791
MENHVKF2=D'$<GRS[5+/)5VV,U,S OM-519(Y48Q+>?3,GLJ[U;".&0+ SK3R
M++].0$O'F7AO(2XX)S.S1Y44.X=\BR<)^;EB&!4SS/#)O?'+1032PT,+U*5=
M-$L=934%(L"G%%$=/"E67JJAZ6D$,-/5344%; #)M3XY#FQT24N6K]'!%=/7
MWS :;\J>D-+;8KW7E*1)6FV/-#2U#7WJDN+<4DQVY"AJ^-SI#EE7-HY ]"E-
M--<Z5>1I[QY*TDK5^UAIMT)+N_F%L\RSR)XRLTEIM9M:RS)*55HYUQ^9*MR6
M&DR"H!1[J22@A#H&RT+6V"D'KK^.N.39R(<=LI?4O]L>;!YRR2$\J4 I""HG
MD4I9/0; #F)X2SS#S""H=0;'*0XT6-<U]7++YQ(-AGL+92=HA!$6IF9P+LN9
M@0 $# W8Z$^<#8W/,::WV]&OR9&9:88-F^=T^48>ZUF>M%_#>TRU8LYJ,QEM
M6DC&C;9?HS+R%VRM+'#68=O5V^0X)C#B8=+9XZX8E0])>I3%9GMJ:T^B;.;6
M>90=<"]SNHG8[*'J)VV'0;;]?;7)\GAV>+G(LIDY9-2FBTZT!U#I;2UFRYC,
MBYU%U-AX BQQZ%65\5)CT&&XA79Z]*L'ISSU]?9&F.QY)55L!W[(V&ZFV:9,
M^8^G8I<<6=B>I2H\@'I.WB-]MCU'0]./CE\J>GW<;Y0J?_'\2JL0KOF%.V\<
M$SL\6'XOQY1)1TX8#A(L @D:)"Z12O(B$*N5/JY\F>KWE;R%4C[QT%-10")8
M\ FA"B6OP!:6 X9750224+45,9=V)*O)$(JB6..661=HXRII0N8AR-SO*2X"
M5]X%L%M(Y7&@DI[M:"$K6ZZ%)Y !R[*)X<_2S,+&FN8$F!/D0;%ENP2B:&X,
MJ&6I:&I$J381YT=Y;@9;@-I?>CR8SR8*7FPH* 5PU-S)2PJ5)0M;BI#88= 3
ML$)YVE%M&WG'F[I+:5GE2EOF&Q.VW;0O-1QY='E/Q)<1++J4%*%QUF0H,/-M
M*2KO-W&G5*++K+C2VN]0MP#E2KJ7R94$-1@,%+60+-!-!$)8I%8QN%*N%-F!
ML&L5.A! L;@':AM]<0JJ#'VQ'#*J6CK:6>1Z:I@(66%V1HW*$JPL4=XV#!@R
M,P((TVO+TSR9^[QO'KI]"67K>HKK%QILE2&W)<5I]0;).Y;/,%-<Q*BA2.<\
MV^\DJ2;SH0=]]QN/;\WZ? >H^!XJAT'U1DU"86/^3P)U#/O8$2N,23/1/IOL
MPW'CLPDUTB$F$N+'L6I3ACU\Y7DT-U<AB.B.PZTS9?C,Q3G=H22I2M@$@'??
M;P ]/IWZ@;=3N#Q.MT7K\"Q!L)KU*$$O3/G!2HIN,\4,\?G,51\ALCD2+:S
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MOT]:A1J%JCTSQ73?"+G&8,*,:V+8*?E@+8@+!(8FO>SBUE!)52 9C<Z+(+Z
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M\3L#FTTA1 [JMD592JC.7<J ' \P$Y0+  D@@95L=GJAPW*RZ7/,6YD:%B+
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MB6N23SV^R&()4;G^37 <#K?FJ5M%A%'352T$*TU'QXJ:**0TM. %@IB\;<&
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M?H*3Z@1VT'79RQ- E3(/!K=OH@Z??[N>V3P<'!P^[,NQPQ_:/_X,9G_1H?\
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M '@!ZN#TGVJ4?R$DC@XV[:MC@X.#@V-FZU1@*FXE8J2"I4>+*6E &_,2VEX
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M[UMJ()F ,+%0J. BME9F(&1PQ*JQ4@^:YR',23=1L2*Y'ZM[65QE!LQ=@,K
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ME3\9?C3(UA9W%HF,['#:'&FP7)4EA;+A4N!&V"I\AR2VU%:9#C*8I69$QU#
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MIM@RFRRR7'8O=O)?9:2M"'5* =;;=2V>>4&E>A%CJ%D.-8S24TC*<JRS-*C
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M?(4ZZ$IM*P^IBU\:+#A1FHD.*RVQ&C,-I:889:0$----HY4H0A*0E"4@ #H
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MY'I:>IP_>F:&#@38;0X4M/3/'>F:-:0M(]S$D=+PXYIYI9%8(\F564)&*/\
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M.**-%"[/)D.>%->B!7,0ZVNC?M+%?71V8,-A*1OR,Q8Z$,-(0GHAMM"4)WV
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M1Z%;MV'CRMX;.F8X._B =]PI.Q^<].ON_+QP,7?J0C?T;;_ <-8KM#Z-D?\
MM:YU]6.Y,?;U!J/A]''6>T-HWX?;:[OUV_\ JYDP_14?-X\:6C@8_2C-QT=;
M=/'T@^&OIVW*\@Y"0:W'FM?D#?E\<]G25"'4\H._X)^('Y?']/&*[!0H'I[P
M#X_KT\!X#U<-G^R&T=WZ9<Y_9[)#^7_PD=/R<<3VA='OWN7N#;_[W<DV\?\
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M_*US^SV2_P"D<>\:+ZV/\:^_;S@R_5O^$]NW<;/=P<,C^R-T;_E:Y_9[)?\
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7IT'0=!N>G'?QN0<S]W]+^O;223SV_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g770439.jpg
<DESCRIPTION>G770439.JPG
<TEXT>
begin 644 g770439.jpg
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MV(PB^@QD>B"B6X(<\&D"FKTC)E2YPR?U"O?9'J;E+^N!?T(,64UG?6*I<B*
M]4&MO3ON E$KGF!!X;:W&Y8)PZQ*Q%EZQ%84>QQL4:+2L)+WHMD14UW1 OT\
M[J;M9[E?1NZAD*S+4XR=7,!K(AVQ'=T&,/%6D]7$QN[1TO(S[4C&DSPDVH+
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M=GU#A9ML';ZA@ T8\T%"!C >/%-V+&5BE?\ 9 TAC/67K+=M@T?!:O\ LO\
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MC&....,8XXXXQGYVWQKGQG&^?.//XE/?;'Z>==<XQG[V<^>?GX77ZE/\"K_
MY59V(A- SKNVC]LTWACNM(;U#3+LW%DR#(2'1X[(;_1![$?C#TN+$,BA;1L/
M$)NU=]'CG35$>BKE-39!3O%.M_I3I1%"?J ^L&D$=&=XZUFNU@!\1-Q($T=W
M"@)&0_/+Y)4,)MTU%]QFKO+W1+3939#&F,[<Z-+&I(:1%(',0SJ"%\7,02"!
MOW;^+*<^HZ?6D:*S>IUY4A-EXI[,,4BUPW(9V21U980WK3*0$#=W-OW99O\
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MC7^_QYJU<.MVR;S1)WA+XR@@JGD7VD_7;\B\M_9DO#_I*XQDK?:Q]6W]YO\
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M..,8XXXXQCCCCC&....,8XXXXQE%G9KO3VTZSV1FM)%8M%RN4/Q[0Z.CM/\
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MV\9*;#??NW]L?MVS_;^55^1>?_J$!_'O'V_E5?D7G_ZA ?Q[RI/QGW>[/O\
MH]V??_\ ;^Y]?./?[_=GW?3[L_G_ +7./RX_AM]\M _\?I_VL[?E9O!9[BUK
M^&9_Q?P^@[[;?M_*J_(O/_U" _CWC[?RJOR+S_\ 4(#^/>5)<<?EQ_#;[Y:!
M_P"/T_[6/RLW@L]Q:U_#,_XOX?0=]MOV_E5?D7G_ .H0'\>\?;^55^1>?_J$
M!_'O*DN./RX_AM]\M _\?I_VL?E9O!9[BUK^&9_Q?P^@[[;?M_*J_(O/_P!0
M@/X]X^W\JK\B\_\ U" _CWE27''Y<?PV^^6@?^/T_P"UC\K-X+/<6M?PS/\
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MJE%UC )Q:]=K:P-/43Z3.2QB'KUTJ%[4)Q8*PCAMI-F!G2I(ADF[/2AQ*GH
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M&K>3Z>XO\W[#>3\'X,V]]ANH_P K" ?K0 _ZAQ]ANH_RL(!^M #_ *AS4/S
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M'CS;5_X\^/'F[)ACSY^CQ_//W?N?7QVG4O>Z/R?3J_J?UCSGXO,<=&E[M?\
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ME_D_[U>/=]7GS]SQYY^<=D9UG.<8Z_37SCZ?^_++W?5[_DO_ .U]/,*?"OP
M/T?7^#=8\Q][_:._QYD!P-Q.?%I\/\*:1_?\W=]B.O?R,C/U,G_!Y!WM(2K<
M C**Q5@B ]4O "1>/RSX5EE@0,-E<ZN8_JUTT^'0>)(:XVT547UW676;HZ-L
MI.4G&=Y[=D)WXS_]'V:>/?CS\M,O./N?<$YQY\Y]V/.<_>Y$?L$UL&XE&[X/
M3DF#/D%-%==B175PVVWUTREMMIJT![*);+([;I*XQG?&<82WSC;9+3V?/O"E
MX1]*U/@3B*IP9Q-"G$$FGV16IS:5J!BU>N\$D-W1C//IQ%.;4*LDT5.[') U
M6^M6269:RSJ^Y< \(V*'%NBV.*-*5M'2Y 9[,6K:;SZ;,DL<M74^E#J'SS%3
ML)$]JJZ2B>F;")&9NDR[0ZOD:TDR4?KE.%(/U0M>1XH?ENV[3 ]"1.T6J>L;
MU;;I_#N'F$-E%EG"2GLHKMG391'&$-ELS7^Q'7OY&1GZF3_@\K8Z_M+ IY15
MX6IR3'""RVR^<CB^K=O\)OKA/&VZ;H'[>^4DM=$DO=IXUUVSG.,J[>)<9[(S
MOSC&.OLS\Y^C&3;/'Y__ -2<_1CW^[S][SR7P9^$G2M.X(T"OQGQ)7.OBE"U
MFG7TO4A!H\'31*6C)-#IP[7)IU-88+5UWF-JZMJ:.5H&A58^.N$+%SBK6)N&
M-+ T<VY%KV9M5T[JZC+S%K6IM%+J&]:.[9>66M55(A!4,$;QB992V[_L1U[^
M1D9^ID_X/'V(Z]_(R,_4R?\ !YI'[9"=^?'VOTS_ ,=,_J^Y_P!Z?.<?3X\>
M?HYS]L?//S/LR_QVS_BCF^?+7X [O]8%[]MO]&ZQY=OV/\^:C\@W%'O=%_">
MD_W[-V_8CKW\C(S]3)_P>/L1U[^1D9^ID_X/-!N^V3H!C5Q,*6L@*/QMK\,]
M'8%&=6R6?Z-=9!90.KLGICW[:-LKK[?0FGMGW<W35EZ5?<K5VO )2T+.AFVN
MA@(X27%2,-MOMG1+8K'R2;8JS;N-L9PT?;-MA[W/G#1VMG&<<SFB\:\*\13-
M6T?7*%RVJES2$A@O!%_-/V*RL-HHNXYI!"4!(!;,?J7#.OZ1"MG4-+M0568(
MMQ56>F7/B3M==IJPD/DC,H<_\.9X&BP$!I[ @8T98SX\_ (ZZ9SX^CZ,8]_[
M^?=S(..<9SC&,YS]S]//YV,?=SGZ,8^G.?=S:,P6<\<T:5["5^V,OHY'-)18
MQ\2ZV8F1]91,W-T 3U/?.BS(^>$MMHN$((;ZYT7&E#S4BAMC.JS33;'CG]_L
MQ/\ Z?L.W/\ K6!?=^]\[O./SLXQG'W<8YCSJNG\S*ME)2C%6,(:=58'E96>
M%74.IW#(3S*000#MO;%&WL"T#QA@&7J[1%E.Q#*LA5BI# A@.4@]Q.;KXYI3
M[,3_ /*<N?\ 6J"_E=Q]F)_^4Y<_ZU07\KN/52E^FO\ <+'F_6O/Z;C=V&S_
M ,"_=8O-^K\_IN-\BL>S!%8IP][(!Q=4)*9Q'X*[/L$6RHN)/91NNQCY:4JK
MNFZK$"2D6!<7P1;INL-3)\1AVDBR67=H1.Z-66&6K:OZB9L2KZ0"8?-)S)GS
M9!'(>+,"MR3</%QIIPHXT72-RQ1B?>A1Z#9?;Y-CA-\^W:(J#LO=R3F6"K'B
M$C@LOHRXRL:E89^"-,%(N"TRNP(H;H+915Q+O;;.T,YU<L7J.=7#%\BW>-MT
MW""6^NC.IL%9]6*OU@;*OKVG$@(&RT@ET^-Q$%H=EA-ZZ4T'*O\ VYJYW22#
M 4AH1FT36^*I9:.G:":2A%QKG6[-JV_$NGV898_4J/3[\<\[0R]>!YI]+D-1
M(NCO(+1IQNDYYNE&+BL4<T^;-05ZPT6Y#(CC4'N5'AB$B=&5$BNKUV<2>L,
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MCQCZL?@QQXQ]6/P8YSQSG8>T/3_(?%G&<>,?5C\&./&/JQ^#'.>.-A[0]/\
M(?%C./&/JQ^#''C'U8_!CG/'&P]H>G^0^+&<>,?5C\&.<9TUSC./9QXS[L^,
M>/./JSX^G&?NXSYQG[N.?KCG.P]K&17EP)+KX7WM*%:(B:O(E6V;H@Z>-6\>
M#M"CE-HXN.*LTM?@ !>/+JMW-A#!R* N61CY0D"S;$K!H.2\I\9\XQG_ +?_
M +\?5G[OTX]W.FD8(?)P!N-ED<.!4@$D@9-#/C.%AY=DN.>I9QMC.,X4;.5=
M<XSC.,^?&<>//-5]<3+XY0=.%2*NS@@[K>(?'7*FVVZCIRV"M&:KI3;;;.<J
M.=F^5U,YSYRHIMG.,9SS%0*M*\U2,<E6S!);AB!]9!+!+#%:$:^*.*8VJ\HC
M791,+$FW-,=KTK&S46PYYIX)DKRR'O:6.6-WKEV\;/%T)D+MNQC,*;[1C-W<
M<<<RN4<<9QYQG&?HSCQG[GT_?Q[\?I<<<8R+L&ZA4[7UQFKL MI4I)"9.QSP
ML&8F!LU!X9([C*!SEMR."Q,BNNPBYBQC()D3DKAGONEETN9R);BDY">3([M-
MUW#)'+H9/#0%J_EU>ZR;6&G%5'>KL!K,1;<+)=6>J3A-OM@N,:-FCCXR@OG1
M-+79O\"KG93.:\<8S\?!Z^_^CSY^M13/C[^,YVSG7/W\>,_<\^_GXU02UVWV
MUU]G=3V<J;ZYSKNIG77&NN5-\9QNIG77&-=<J;;9UUQ[.OC'NY_;CC&=:\&#
M':[%V]'LWCD:YV<C5W35%TN/=K);M=G#%5?111DNH@LHWW6;;)*914W3WW^#
MVVQROV7=W^I-GUM9$4E VSI7%Y:-:UYK7;NE[<;R6^HG;C67Q5HI3\55CXZ0
M6A%)4RC<X:;G(CKLD/&A7Y@@N+%N!!,A8BIC;.N?8QC.V/?KC;;.N,YQ[\:Y
MVQKMG7&V?Q.=L:[9UQG.V-<YQC'*:HMTQ[M/Y.\N6W)_UPEO8*,7;#[E@DP8
M;W+\V#0R.1NYJY;TL5C!+7#6LJNC%?W(5<1%*!(FBKZQ&Q&=3[>6FY$_?H\D
MD@ DD ; $]P&Y.P]H;DGN\I)\N,E<![W]/F96OX?&Y[\&"F$+BDF#S)E%)DW
MK "PE$/+RF# IY8BX9&-P:9R2%PZ0%A44FY$7)\,@&[8JU8D'@5H3W%U_P"S
M-3]EA,@*5D]D^-XT[#I%0\TALNK^3-QLI"MY-"Y+K&YF-#FMHO.(P[;2")G=
M&F&98=NNEY;D6)(>TK)T]*"=K1!M21.Y(F[I>;;5K.;D*M8>:'66K:]>U])8
MB\Q7.N3KV-"X%*39..2-%G(=WYR*L8\5CN7$G^=*!B,3DZD]=+/J(Y95@W-+
MH-)K!L".TM =D*V"G0L29Q*B(>5C$>*80DKU\6UD$M(R2220RP^'681U!V)C
M#$B>P(7D)7C&4<P;'JQ)_P"R.K L$_#8CCJ*5H$/7RM:I6_'E78'JPG/)6 K
MNY6@?&54<V6XNJ/22='0#33)IO#Y20AN73A1NP<:>A>S.T="T_.V5:V-8 V.
M3%S4=F7RN*=)DWF ]35!D+I.IR<=,FSMN#$C5SS-L.V(;MW<@=(%$ #<BH&+
M:M(YC,>?5=G>/.<>?3VJG'G'TX\]FKG]^//G'G'W/=GW\T7>?I726U[KL6T1
MG;*V6 "WH?V3 3:"2:/U(?#CG-RUC!:ZA(B,E&-7AY[M7U>?,MJ5;Q,U8#I5
M/;39($2%+2*:.I QF[$>ZW3ZL1DLM54=8\,D5G3@V0MR//Z:MYK:@,G4=80%
MO*IW:E=*@'$HA42@-,_8R-&I4^%,P:,,+Q$HEL_=&V^KB0$ [:T79ENGZ5B,
ME+OY<$2E.S-^O&I6.A,P<0!['AECCZ]GS\<WB$[)5R2EL9839C&BS]<$Z,HI
M*:K?%"NP^"DJZ'=FI/(+%NQ.SJ/"WY>@:WJXL]GI$I^6JB-5M:M2T;4K=_ 6
MRQMC)R4SB.E!QF9Y2DN6HN4O9">BJCZ.C6@XQG9_77HA,*/M&NTW,]C)>ANO
MCF_RE$AVHDZG:+M_V()B2!EK:!]Z06CS]G!4=96P#.0#%%>5_. 00)-HZI%=
MFI]C+-?@M?K4_P *K_#YJ.\+FAM!5\[L2;?*S@:D=B,5&B@>K9P</RB>2H1#
M(H!%)DR@<7HX)GS;%!<@9+B00,=AZ=D!84"&$2+;<'(Y]I.ND>[/U:G7)YZV
M%K"9_5]H1DD0 ,):&:3&HY\ L.,Z2.)%56XZ518D2 :!Y3'G+ICN4CQ(DW8$
MQ!/9D59L9'(SVWZ]S644X6F-66?H3A$BKZ;,Y,=$QY(50I^^I38/62JI++R8
MZPW#(D+M-ZXF0"*2:!Z65#G40,H3M<HQB907(=_I#^H_34@6C0P) ;N?2:QL
M0A]2L2S&8ZQ.W?%Y\:L$.$FT ^5)ZQ$#XLU2K*3G9$YL<M B49C.T=/&Q;1C
M+XQL4P*(^F8+B.%Q;.ULXB$^E=?3*\X@RKL:($RTE5O9&==GH6!JY(;)$6E,
MP5K,YZ4B9*,H,9HH]KQF.'LRHR6;$Y<1^>.^FL6BYJJ)F,OQ9S/>MP6#PCK@
M<+U@.="8E6T/?6-A[%K&!,)@*7L9_,8U8242D<@ FJVV0&PB'D0 P.;S*'LC
M8RP>GK3AUYUA"+:@;DBXBD\C[.0"=2K5X),LM'/MI.Q)T2YW^,B3P4@@\#G!
M2^VRHPNP>L5-]]T,[[;*RGKC[JG^&5_2Q_1\TYUZI8+UXIFOZ< E2)]G" F6
M+F1%TF;<I)39!^].2:2D&HY) <R=R*2%2YM=B/128,5'^6;)/5L@ECFYLX\X
M\9\_3CZ/N^,XSXS][/CQG'W<9SCC&5]2#O\ 4.HZG<+)Q*VB3IH\6B,=#H1!
MLX4N5\_O//5]Z&KC765)[++ZVRYVCCG6:[03*87XU.D]MH0P?R-GT->=[>K\
M7 577<&BEG1V$ 8]6,(*Z_,IXPC77!L<LJ2=:ZUA5RNR1_+R'$%+*K:25_\
M!M4Y0D'WC^3\C),(P^&R%_JUGZ8!$+,)-.XU:4# 2]E.!%E0*8LZ3PE,YO.
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M!0FS  _2-"Q1F*P^P9-I$XVZEP.0R\,76/*DT32[^#P5G-YT*#Q>4G"$;0&
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M93O8AMOG.^WS?DOOSGSG'@T]]WW?H_?Y?!>W]2R3_G@OW3!>4.@,8SWJ0_X
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M,8XXXXQCCCCC&....,8XXXXQCCCCC&.:WJS\;"_Z*)I^ZHKS9'-;U9^-A?\
M11-/W5%>2+[%)]='^'D3>SQ_8IOOX,V1QQQR/)<Q*??C&F7Z%)'_ *&>\[D'
M_24/_P %C_\ -$>=-/OQC3+]"DC_ -#/>=R#_I*'_P""Q_\ FB/)S_LR_9Y/
MYN/*8^B#_:<7\_-G:<<<BYW:GMB5=U&['6)4;S(^SX73LZD4 ?X!)2?#*7#
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M,=$'QMIEV5^-]>?D9ZN5J+)!Z]8N%GVSIU8:KI33K[4L_O0PE!6KU; ]4$7
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M0/V7LZK7006+#V;<]J>O6JU52NT1L6)HH%L2UTFEACD::.8OS*[I?FB.N?\
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MV?XV]G;?77;V<Y[;^/.,9SG'GW>?I]W,>H7N5![LLJS*\98*(.8[.,@H(KF
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MFZ^GV=&T;AK2DOWM3T?3M%:A#5IC2+UG5*<L4NG5:6F,;DM=1;#;_7J(W"I
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M>'"2?,%!Q14VF:>E44Q6M)/7@EEFJUX]2U@:;*MZUV58*%RDD:VWKV)5$JM
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M7CQ:/-(RFAK&V:.$G346D\;H+Z?NN^K]*U47@)V#Q-403K*%677T,<;GCY#
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MZ+,4O/[+<Q]@W,$,*1YM'P,:,1+2>9D>Y$^T; 1FH<DU4&"'&=@ANRTK>3]
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+''''&,<<<<8S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g13934.jpg
<DESCRIPTION>G13934.JPG
<TEXT>
begin 644 g13934.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@!!1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?5TE,1%]465!%7S1#7TQ)3D4N15!3_]L
M0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M_\  $0@!%P'1 P$B  (1 0,1 ?_$ !\  0 " 04! 0$            ("0H!
M @4&!P,$"__$ %H0   & @$# 0,"$0H# P<-  $" P0%!@ '" D1$A,4(3$5
M%A<9(C5!45)9<75XD9*6M+?1"A@C,CEA@;'7\"2AV"4XE28W0G*RN,$G*#,T
M-D-$5E=8=^'Q_\0 '0$!  (" P$!              4'! 8#" D! O_$ $D1
M  $$ @$# 00%"00( PD   $" P0%  81!Q(A$Q0B,4$(%1=1818C,C-396:6
MH49B<8$D)30U0E)CD29#5'-V=X.2LK2UU?_:  P# 0 "$0,1 #\ S^,8QC&,
MK,Y3\]IG3_)+CCQZU73(:\K7+>FF:%R.M\NZ?IPVGJGO EP8:X@HGY-6;DE]
MOW>1K#RQL*XNX6;537$(^MMK8)(VS7Y)VS,0 0$!^ AV'\ Y6#OWI.\8]X;?
MJF]FY+YK[9D=R<U+R>O$O5MK[N:0^Q+7J6,80D8B_I49M>$HL#+OH6!JL.-Q
MAJTG-L8NO-X\A7+1V]158SI&LN>.[K=?],[ G:KJYOQ7Y(\O^0'#K6,-%L;D
MCN^K3&G#;NB:GMZWV.1GSTZPUS9UHXX[$9.*!$46O25%A+-0IL+M;U4K''I3
MUVGRQXM:,GV=5W9R3T%IZT2,.A86%:VGN/7.O; ]@'+IXQ;S;2&MUDAY%S$+
MO8Z09HR2+8[)5VQ>-R+F6:KD3B/1>GA+4_;M%D'6[BR_&C3W)3=W+K3N@D-:
M-86QUG=6]DMF.)YM8]M,KFHC:=74RR;KV[:]=4EIKBMRT9*6Z/9V:W6J(I\$
MTR>%]UU0+6QD9*STBH6.1;P+YB@_GJS!S+U%FFV>*IM4G<DP=.4VZ:JZRI$"
MJ@D5150X$\E#B9C.X5ZPP%N@86U52<A[-6+)%1\[7K'7Y-E-04]"2S5)]%S$
M-,1J[F.E(J29+HO&$BQ<KLWC59)PV6514(<>8R!?2R[?2T^      <->-@
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M23I:N[KKEY*#$Q5I.NDU+5YN[I1:E#@[)[6J5DI"2]E9OT'W=@Y10>]FXSY
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M[-X^@AX^EY>'HI>'EZ?;R\/#Q\NP 'EV[]O=WS.]X?@!>*7&LI0 "AHC5
M    !2(4   #W  ![@ /< 93'2/J#(V^9?0WJQF"EMURX#C<E;ZE+L))"F"E
M3+8"&N/"^25?-(SOQ]-[Z,-7T,HNFM]!VZ?L3DV+%T94:74QZ]#;&L5#:FK$
M.,SI2E.RRL^I'* AGCW77/E(W&,9>.>=V,8QC&,8QC&,8QC&,8QC&,8QC&,8
MQC&,8QC&,8QC&,8QC&,8QC&,BERHYBZHX@Q-/E]IL+T_;W>3E8F%3I%7-8E2
M.(=DW?/#R*AWT<T8)>BY1*V!5T+AVH*OLS=4C9R=&5N?)9%)<O@JFFJ4![@5
M0A3E W80 >QP, #V$0[@'< $>P^\<PY[4YZ(\W72V(,U:4AB5(B&<RRH+05*
M7%3)B%X*;"T >T-]JE)62H)*%3NM2]?@WE?+VJEG[#0,N.JL::KND:[/G-JC
MNH:1'NG*J[1!4W)4R^M9JY?JM-+CA+1=#[6$YO;FUO2Y[IVK;=;;YWQ6M?62
M^6*9I=>&_P!LK_R)6GSPRL5&?(3*;49P_LB @G\GM3F0;?U$Q\0RR#I]=4"H
M:MUQ(43D;9M[[)O]CVDJX@Y\["3V.DQKTU'5:%C(U26DIX91%-O+H23Q2+9-
M'(ID=&<-DEW#HR1NY;^Z->U]N[PVWM2'W/KB$BMB; L=PCX=_5K2Y>QC.;>F
M=(,G:[-ZFU6<-R#X*J-R%2.;WD* >[+(NG[Q#L'#[4-CUS;[16[M)S6QI2ZM
MY: B9".:MFCZ K<0DQ.E+J+NC.45H5=<5DS@EX.$RD*4Y3B/6S3]2ZH1-WF3
M9DF3 A*=MB+&<$65<\EV05(]&H1=(<8$E)"HX+JO9$J[3W\'GUCZY];?H>7G
MT=Z'7Z.JJMCV%B'I3:]4UQ<C4MJ@.PZQIJ4)N[2>GTB+9*J7?S=FI,-H73R%
M/-^@E?:)Z![_ /?^_P#?QS8<1*4!#X^:8?X&4*4?^0CF_-IB^0=N_;ZHIOT3
M 8 _Q$.V=G\\?\PWN+G6EY2<WK]I+I]:LWU4=6<J+3R1Y;FWSR:NVHZJ>(I^
MF=&;>N#BEZ"X_P!+D8%'76SN1]HU$WKTN[/,1SJ-J5!;.+5,'L=G>/"Q-M^[
MNMSI?C]LS=FOK#Q\Y46VC<4MY:6X_P#)OD1#U[49=7:OL&^HRB*:QM+T'FSH
M2XVR%FY*]QT?/DIE#7D*NY;.'$G#LFLQ3D+#QLKT.=.K\0JOQOK6W[S1-G:P
MY=77FII3E-4:U58S;.KMT7':TQL1=^P;!YQ<]&%@I?Z'<FPF')D)^M1D*H^3
M37A8E)EV[=71RH6\*)S_ *98]U72,4Z@.[.,F\+Q,0]7KQ%:-8.-J>H#L(VJ
MLWKYVD\C;8^U,@Y?C*KBO$(SCELQ,Y%DBX<,9\=@=;706O\ ;6R:R[TGR/F.
M/6CN1D!Q)WQS5B*K2#<<-2\@[#,P=:+2Y]1]?F>T92+K=KLL#4KS<:]KR2K]
M3L4Q&,G2SE%ZV=+>DPO53J=UY,6?1>KN+/+;;>M=?<E6_#[9W*O6NO*U:='Z
MYY#@T:.9ZK6B.9W/Z+:%,H;I\S@-F;;0URKKG7\\[:I6&;;Q2I9@? -D=$"L
M; V1N2,1Y8;LK7"WDGR<C>9/(3A3'UC63ZKW_D$QMU2O\E(P^X)6 <[+HNN;
MI>:17[=?*!!J*.)B>04<0UIKC94[4/1JYTF[%KWDY<]K:CYQ\D-2\=-H<M#<
MX-J<3*(VIL+ W;D'(+13VWE7W"S9-]FL=,;*E8=M*;,TP5PZ@+<Y5<(+R#=B
ML=OC&1"Z4'7!K?(;0L;"\A9RR;"W=J76'*/?_,?<5/I-1@-,\:=3ZRWMN>OZ
MQ8[7=14A"@RO5RUI1&3^JTZB5>U3\G#13NU6<D0@X,\<27UAUQ=(W-/V_8?'
M#E7Q[A+MQ?V[S$XV2NXZEK>/+RDT;I*IEO%[D-6M:MLZSKPUQ:T]>-MK&E;(
M^9\B]JDU$3X.4F3L!#H6COY/_P ;M$PNO(:L7VRJ)_0LY?Z Y1*HU&J01^9&
MB.75GM]N?T;<JD$9H]3E]0S5F:GU-=XE\I-0<?"MX5ZB]A5PCVO,:FZ(,5"N
MJTTY&<R-]\I:CI/B_N?AUQ/KEMJ^J*&\T-I'>^OX[5E[<R5FI%81EMM;66U_
M#Q53C[]; 91S6&8MP5ISF4*,GC&>@[4ZR&KX;3M<N&J=3[5MVP-L]+W9W4ZT
MU6YB*IC**6UY1ZS4IEG4+ZN78S!PPMA5;Q#R,U&5]S)L1@(:SEB+&[G2049,
M2YZ;?)2_\O\ @OQ=Y)[1H$OKB_;@TU1;M9X218P4;&R4K.5Z/?N;?2V$';;I
M[)KBZ*.#6;72$[+I6U.G2,06VQ,-8 ?QS>N?2/0O1U\_K3C:W-+<V\HRC]/W
M;'38H5>D==:EU_#4CCGL%G"PM?+!HTZ*(X>7FIUZ'292=NM+BR2%UD"LW\B:
M,8QK2&"S_@IQGLO#CBAI7C!9=RRV]_H'TV.UQ6=@35)J^OY!6@U5,L/KZN*U
MVIG7C?\ R/IS.'K/RPZ>/YFP&C3S<V]<23Y<P,9+C&,8QC&,8QC&,8QC&,8Q
MC&,8QC&,8QD"N6/4\X)<(9R)J/)+D34Z7?IUHWD(C5T!%V[:6W7T6\4,BSFD
M]3:FKMXV(C O%B+(M)YY7&L.Z7;N$6SU99!5,O&\6^JGP$YEW-[K/0'(ZKV'
M:K!-^NOJ*YP-XTYN!1K%BK\J/F.JMRU>@WV5CHT$5#2,A$0#]FP*43/%D  >
MWA',GE0'$&8Y/V1#C"KI6UWS4BRNJ^H ^H4#=..MFVM%ZW"'U[&\O;KK9C);
M0T=5Z+<1A*U\\=UP*&FBU%JW<H;+AQ.O M.F=*V%Y8[JK,QM7GA&L=QQ,!.:
MXOO$#;>WXC@Y<-JQTG.Z^F&6VK)0K=PGF+EIUKK09"5;0VK+5%S3/8\Q#O[F
ME: 2AGD.R(QEV.:=P 0 1#N/P#N'<?P!\1S4   [ '8 ]P 'P /M93+U K=R
M/XZWZH\BJYOO;2FN7._^+M'<TZO4_5Z7&7CYIN7V#1JMOFU<I2O#R>Y+^KLJ
M*M<\2GVN@H-SZPFD-?K/&5-I\5?;[8&,N9[AW$O</( [B'<.X /P$0^/8<XJ
M>^LDO^*Y']B7RC34O('D"\NO&SDI.[LN4U7^3?48Y4\.+#QR?DHIM54#5.N9
MSEQ4M9&JH1M,86Z.VO3I+C'7IZXS\A:)@;0ZN6P(230-$I4T*I9/R$Y>ZLT1
M(J4N[5?D1,R\M3%[&V=ZFXG<G=Z5E)B[^5X])!_<=,ZFO55C)<CB,<*.(&1F
M&LTT9*,I)VQ0CY!DZ78SHO2R_LT^ 'Y&O&S]T=4R>F0*Z6!@-TT>G\<.X ?A
MEQJ. &*8A@ ^H:F8 ,0P <A@ 0 Q#E*<ANY3 !@$ GKC&,Z;L2CPNS*%=-=6
M,[Y. OE6GJ=-J1C@C223BK)&.8A^=@Z41<)MWA6KM0S9<[=8B2P$.9)0"B4>
MY9Y?NZ]):QT[M/8JJQ$ H^O;C:4SG,!0%Q"5]^_:)@(^[S6=HH(I@/\ 6.H4
M/B(9CS%,(B2ER@E45,=]4D+ *"PEM1>"@?!26PH*!\$<Y*4C=D]=5#-,IU%N
M[:5[=4MA12^BR7+:3!4RI(*DNIE%HMJ2"0L @$C,,2WZ)J,0&U-IPI[ \X_Z
MUY:1VB5B*R"2UE>49P,^\<3(3B;(C?Y5+%P23<CSV J!'LTP.+93L!#YJ&KJ
MI6Z)K:@TJG.W3^IU*FUFMUEZ]=D?/'E?AH=FPAG3IZDBW3=N7$<BW66<IH(D
M74.90B1"F H46<<N-3F^=&W9<4[9$<VC:26QMVQACI"J]<SM3ET7%;%/Q 51
M6DVU"*@B'83&3EC]OJ51[V5=-_;8;EX9Z1LB[L'<Q!5<FO[ 8>WK%EJ"L>L@
M=P(=NZSV+8Q<F)A#R,5\0QA$PB(TATJJH]#9-@Q&H[FVZG!V6,4H"%,J$]\S
MJ]OYAIF-94RTM#@(X40D<J)]#/IG;G;=2M5E+^O)UK$Z(]:]CZ36B'7U/MSD
M.:S5-Z]LTH#W53K&UU/?67ISG+D@*:2IQ0]-.3DQC&7OGF_C&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,\:W#R!U%H1I!/MKV]"J(
M65T]90?J1LQ)JR#B.01<OBI(0T?(*D(U1<(&556(FF K)$ QCG N8D^P@5<1
MZ?9S8E=!CA)D3)TAF)%8"UI:07I#ZVVFPMQ:&TE:TA2UI0.5* /&\\S';4\^
MZVPRC@K=><2TV@$A(*EK*4IY40D<D<D@#R1GLN,JLWGU*]6Q1=<&TI9QN/GL
M&'<["!.#F8XK;7[$#?+3% T]#LP4DI87*7L)V7K*-P8+BKZ7JI>K(!MU"^(3
MITV9);>;>NZ=(,T?5JMV;D%9RN1NB"JJ];230*910@**+"FFD B=0Q"%,(:7
M&ZI=/I4Z= 1M^O(<@F(%//7%<U$E&6V74"!)7)#4TM<>G($=2_9W2&W>U9 R
M+;V"E<==939P@IGT@5*E,);<+J>Y(9<+@2[V_!SL)]-7"5<')IXQG'3$O&0$
M5)3DT_:14/#1[V5E9.0<)M6,=&QS95Z_?O7*QBI-VC-H@LY<KJ&*1%!)10X@
M4HYO^3&<CC*0M.]:#Z,MITK;83@AR_9<,N2.TR:@T;S--#4.:J=IL#Z0DX>O
MW*SZ9K=IE=X:WTW:Y.%D20&U+C4V4&>/4C9B3;QD>Z=J1UHB'*;C.YW4KQM;
M\A=(+\AT&2DDOHE':]#5W$C'HM@>K/E=:)SQKDFU29&*\46-#@4C,Q79NS80
M5QC/><9':(Y><4K!LZ*TG \F- 3>XYTMA-":IA]QZZD]C2Y:E)RD+:AC*4QL
M:]C?#6IB"G(J?(VCE%(B2A99D_(@YC7J:$8=S]4CC%K'??'OCA4+[KW=.T]T
M\FX[C);Z?K/;6O9RWZ*L<E0[E=T)O:5.CY63L4*S\:>M$?)KYG%O3/GJ8%4]
M1NJV.QED^,JCU9U<N/=OOO%'2>Q466I=^\N8G>4]0M8N]KZ6OS6(BM-[ FM?
M199F^4.]R=5D9S;<M$*I:TK556GYF2D6=D@))O'351G6B'M^ONH)H=3B]J7D
MYR5O>H>($#MCY3;1L9N7D3HM6$;3,?89F$3@X[:5=NSS65QD72$263].H6*6
M!HD[]C>^B^9O4D6,G;C(];,Y;<5]+PD=9=P<E-!ZLKTO6V-RB9O8FX=>4R*E
M*A)R4=#QMIC7]BL4>VD:Y(2\Q$Q;&;8J.(QW(RD>S;NE'#UNFIQ^R>9G$/32
M6NE]N\I>.VKD=O,FTEJA;86Z];4U+9<<\*R,TD*"K8;+'I6Z/<EDHXR#^!._
M9J@_9"1<0=(^;&25QD,M-\RZON3F#S$XA1-0FXNP</J[QIL5AN;N2C'4#<V_
M)6G6RY02, Q:E^4&)ZZTJB[634D#G3>K/$%6/9(BG>9N,8QC&,8QC&,8QC&,
M8QC&,8QC&,9BA\]&O&G5?5JK&]>3/,MWQ00B[-QRM]2MF[^._(*.0DJ_J>%C
MI"S:>XI<PX+:4=QQKVJ=N*2$C!\E-7W[7<K;U'\[?5O0DXB=C9*"L6X6\N^D
M\IORXZHZ<3=CL.V[MMJ%CW*;B1KG8LYQOH\K!P<ZLILJ^VJ(C8[C5K![83!\
MF3$C5'[2Y[,L,C75Y6+M#I)M*,IG\\.9_'/A#H6W[>Y$NF<O6X9M!+_0X8.J
M0]O-T;2UXJ=),K5J?=;#7F=B2@I.UQ<G.*E<@G%Q+=R[,<5DV[=>3FN9G6U@
MJ[25U1+4F;IBSJ128R.OG]?DJNL\:O56LF#1U6%5H=1R@^260>@D<5T71%47
M($6*H0&,[T'O#X?$/@/Q]_V!#_/(/[,Z>G&W;6W)O;UOB[\H[NT]K*V;6U_$
M;5O\%IW=%KTN,2.I['MW547.-ZC>9*DD@*\V0)(LDXZRQ];J\5>F%KBZO7F<
M;.'&,9"^K\"N/]1WV;D%%MM@JV!K=[]M6M4.3VA=Y33-&W!M>.E(C:.W*1J=
M[+JU&N;!OL;/6-&=F6K0S9!U;+M+P<=#3=ZN4G.RYG@_[$E_Q7(A\1#_ /!+
M_8SE\XF>^LDO^*Y']B7QC(0]++^S3X ?D:\;/W1U3)Z9 OI9?V:? #\C7C9^
MZ.J9/3&,967U=;^K1N#VR6+0YBR.Q):HZY8 01]57Y;FT925;IE#WF,X@8.4
M0,7MW]-4W;L.6:92CU69Z#M6X."^A9R:CX:O63<Z>P;R]F'S6-AX^L5E]#17
MMLD]>KH-&[?V*1LP>HY4(GY)>!3B<X$'2^H<LQ-,ONQU#+LV(BI9<6I* AVY
MD,U3;G<H@)#:I@<*N1VA)5R..<O;Z,];$G]<>G\RR;2NHU6TD]0+GU/U*:GI
MU5SMYL/74?=2TN-KZV5%?N$N!*O"N,M X[:\0UCQ]T]K8[0J7S2UA3:_)-E4
MP,51\VK[(DUZJ1RB ^TR"CXZI#@/<53%, ]Q[UF=+M=33FZ.:W#Q^JLFCKC:
MRVP*.T5[E!2I6-48LRZ*7<032&+2I+SL3W&-)B)@ 0[FLQ+R7XZ> &^COI_P
M,(@!OHCU'Q$1[B!._P K]O+L/]7OW[?8[95GM&?@]3]5/C3O.KS#&8UQRTUR
M\U9)V*#DFDA!S%A8&"!C5FLDQ558/"%?(Z[*!P65$12<%+V,F/C"7DVHB2M+
MLJJP@244-K%J)3<27'?+5+?,MT96ZAAQ92RU8+J'2I0[4EI/GX9/='KM742'
M](#1ILIF9:=0M&M^H-<EMU#K[VZ]-K%>_(4RDJ4I3TS6T[K7I\]RS8=@\J.7
M>8S0![@ _#^[[7]W^&:Y9^=:\8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QC&,9URQT^IW!!NUME7KMH;,UC.&C>Q0D9-H-7!TQ2,NW1DVK
MI-!8R8BF95(I#F3$2"82CVSL>,XW6FGVU-/-MO-+'"VW4)<;6 00%(6"E0!
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MB6,]$R<)))F6CI>.?1;Y(BAT3*LY%HLR=)E52$JB1CMUU"%43,4Y!$#D$#
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M,Y9[(&@4I",4CV+ C2&<-&KDSQR!UBU=]5?G%JODC78W3%&@+Y%6O4NY+/\
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M!)C'-RQH+%-%@R,BD)9M;YT1ICGQQ]CF,H9%Q'6*$3M6LKZT:IJSE+FI&/\
M^#EF114(=1/N(1UIKBZY&TNU1<QCP$72#5TSQX=X<R.0&K=>2G!?>,# 7RT:
M5V=KYTEL].TRBTG)0VN+37-@5>+>%7CG)IE*2CV;!DWGGCIE,LXAX@VEXYY,
M1J[EU^MGE0=7U^557P:N=:F5TE>BW[['UF]!DOPUJBT[[P;?<"VVB':BT00'
M(39;?="XX6KT^Z'L6G7;J#J_4CI'.<U3J/'OM=F=>]$HK=.L4NX:VU<0G)W4
M>A9;F0:^3763BD(W'4E%:6;N<U.JH;L6U+#62_H_B[I/CJXLKK4=6DJVK;2Q
MR,Y[?=KU;2.4H9:04C2(IW&R3Q&/LYI%WY'8@W4< H4KHZP(H^$A,KUZ??-B
M:YJ5;9-BF=>Q>OCT6UQ-?;LXRR/+(612E8,)HSE9=W#PPMU$#G]G*FFBJ10H
M>H)B#]0%A67#K<NDGTL&9KJ(Z*9]+JX:8L0P6. ^ZEXHBJ984UW/I=*N6D%2
MB5\'NY/1_JI1]0-:WW8*'JD_92-\K'84>_=M[M&Q6'J&LA/04/W+<ZR;FANL
M=A(:*)KZ664MQPI/I=B6,8R<ROL8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,QQ/Y1[=-5:_XHK6^Z=/$.7=RKS"+D:)N:TZ,U;M74F@5'FVM85F<C
M=A3MLOE1O5:/L:'L3Z*JS"EQT\SEK$DP4GTV+5J9VG;_ ,&?H=$XWTMIJGB-
M<N#M%CGMGC8/CC?==:YU99J:C'V%^T5D'M-U7:;E3625K62/8VCUE8I%W+-I
M DC)J%?+K$+3CU3NK?!T3D:OTP8#C'HJY7W8-0K5E<[,ZC.Q:9H[@P]2=#!V
MVMH1;NRM9N6WO/PUB"!34I-90K\LG;F!6L*]>R<0J*$QNB=M#E?R5X;5/F-R
MMWU![4GN6#.*VM2=:T[4D'JVB\>:H4)2OCKBLN&,W8+!>B/I"-6LDC:[?(GF
MC.GI8PH*-F2;EPQEPF,8QC&<3/?627_%<C^Q+YRV<3/?627_ !7(_L2^,9"'
MI9?V:? #\C7C9^Z.J9U'JS7L*-P7W 1-3TWMU^;% 8 !O$ZHV2Q1XR2*8=A$
MYU()A+!XA[P)YG_]'.W=++^S3X ?D:\;/W1U3(N=6@Q;]8N$_'/VGP:[9Y$Q
M<E/I@?L"->KAXJ%?NW!?L(-V=PD7?JF[$3(Q74$0!,1S3]^DN1M.O_1_VB7!
M-7&X^/M-PZW51^WX^\'IB".//(YR\_HT5<2UZ[],S8)"JRCV)O<K;G] 5&AQ
M9.Z6I</P#?U?0R OG@=I(^?!PNNI/QD::HY%[/K^O&;N7'4&AM$[+Y"+IM&D
M<RK-WV8PIC%ZU;M6QET_(TG>Z0S?KK&!W(STE+RKM!(QG!,_H!].K1U'X\<-
M-$ZUUK+*3U$2IC*X5F8=Q;*,EI*/V. 7\SR;.P<.&\G+N'5C<*NY4ID_; .F
M!4$DT4RYC(Z!U.MS=XI=?KF.X:'=FWU9;Y$ZK<N?(XC5M!*+[IA8]H<0\E">
MQ-]<QB0D-X O ID$IO3[%R$^C?M(=O=,SA_:%7J;U[$ZH9Z[D#E,!E$GFJY:
M5UR*3@ $?%?V6LM%3 /O$JI%.W8X9V\ZHH>8Z;:9JJ9UB\CI;,J-.G-O6=A)
M1)ES=(IIK;L]#\EU,N3638-]5P7I8=>A1D/L1EMH>?\ 4Z0:8MNTZE;=NTB.
MA$WJ.G8=P96.>642MQL#,;:][A2)B)-9.<\*]]:5)[$D)RS3&,9USR[,9P-I
MK4+<JY.5.QL$92!L<4_A9B/<% R3N.DFRC5TB;N'U)C)*F%-0O8Z2H$5(8IR
M%,'/8S\.-MO-N,NH0ZTZA;;K;B0M#C:TE*T+0H%*D+22E25 A0)!!!SXI*5)
M*5 *2H%*DJ *5)(X((/@@CP0?!'@Y5OPFLLWI#:6S.%5]?K.5:P^?V_4DFY,
M/A,520\9%XR: (F'R7:.4K(FV2\B)/OG8W Q?80+E%74/TOO>4Y:;^V XTIL
M=M4IC8$6QA[,SJL]*5:526AZ[7J\M'V1",3BW:]@51:E09(JG5;RCH\)Y+O&
MIQ/D =0'6<^RB:7RCUL0R.R-!2C66>&03,8TM2?;B+OD7P)F%1PSA7*BR[M'
MP,3YO2ME*H D$ #]_(W9D#N'B%2=DUI0!C+5L/04B#?U045C'WT6:FA*0SHQ
M0* /(>22=1SHOB7NLV,< \3%$>LFQZ^DZ]L>@64^6P-$9D[;J2OS3OUMJSD:
M8W B.N/!3RE4$M;],\M#B"(R8"U-J]5M2;<^C/\ 2,O?HM;9M.P4VO5>SRG-
M1G4T*#<RID6.::79U=LAY#T/EY<B!(ITUY2H]GH.H<*2HIXIKX,:_P"ISH:
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M!E),)) KJ.>M7[8X=R.&+A%X@<.YB]R*MCJIF#N4P=P,/O*(?$![5YVSI/\
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MG.LHTJGMXN1@T*K6T8:7*8DM$I044E&2A#)@D8DC'IM"LWQ3)%!,2ND50%,
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MQ6OFF%?I0B#;%/)*6K>/&D*"0DV2B><CO1N:[S&>%Q%!_P!FF+2S8MI^YF:
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MDEQ_0ZOIJE9([NU"0DE'@<WE&O\ *)=9+W_IB;0L#),QY+3U[U9M2/,F'=9
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M/]6!_#NCF]3AQRMA@$*KSLV"J0H.2I(66%?R %3,(*HE.HO9Y0#*F6[@LN"
M'33$2H%$@BD/S\J]W9!,KIA9K ^)K-GUF:/B/T4S)M6XKP>3PWSSR.. 2 L;
M5/ZR@D'CX^SSZ]W_ +!UZ,H__3EFG<!^ ]\96<33G4FA!_[(Y0:SL:0*E,"=
MDJ#=N8P*(^FKYB6D2!RIHF #(I$=?TAQ%8?3$3)F^!5NJ77^PF:<?;P"943B
M0%"QRSCT5!(=/OZ]93*JZ)_2K' 4DDR?_5Q24 4A^_:!):X]LZ?=0HI^9;IZ
MVR0/AY!J;F<M7)/ [6R3\0.,?7+B?UM+=-_B(S#X^'Q_T:4\H_=X3S^'&6<8
MRLM7=O4?@@'Y:XJZ_L)" X**U9MR"9E#(B"@*D2+<I53TC(B*:*7LX*N%  Q
M1*<!1-O)S.Y01 ^-IX([-,4%2E,M7):0DR^*J/DB4@(5)\FHIZ@&]8P.0(D0
M?$X%5#Q,^T_7&SQ.@[?5GQS]8:1MC24\@'RXU4/-@ 'RKO[>/()'G'U_!3^N
M:LXY\?KJFR2//'_$F*I/CGR>>/NY&68XRLDO4E;178;IQDY U<@%1.LH-<3=
MI(IBH*+E4#ODH03)(J_T:)C F+@_U E0/V*/+-NJ/QM[^G,1NU*TL4#@HE,T
M<@BFH0_;T#?)\T]/ZIDQ!;L*8%(3N!S%/XE-^D=6.G2CPYM5=$/_ "V*9=8H
M>>."FQCQ5 GY @<CS\/.!L=(?TK%AH_<_P"I'/QX\A]#9'^8_'X99!C(01/4
M8X@RO8H[5"-.)SD LM5+@S* $3 _J&5+!+HE3,(BF03* )E0\/'WE$WH\1S(
MXN38D!CO/7914% "%D)TD.?NY'LD4Q9A)@9,P#[E2G HH#[E_2')B+O>DS>!
M$W#6))4> EF^JUK)XYX[$RBOGCSQV\YE-V]4Z>&K.O<)\<(F1U'GCGC@.$_
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M<&30B)&,C'S*-Y<B.EN/;M_\^&]E_1X"\V"]_P#'MWRP@A"%$3 4H&/XB<P
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M963L)Y+JF:D2I[,AF0\UZ3CB[MJP39/-@%:D-E2'"5!#KSK:2E=:(=(?J."
M#]/%Y.>\ '_[%V#[(=__ -;,U^E#]1S[^-R<_4JP?ZV9;[Q^YDZ!Y-R$I$ZE
MLUA=R4?5*OL)@PN.N=CZP>6[6%W7DFE,VOKYKLJJ5-QL#5EI=0\DU@]@5!.8
MK+Q=L1/V],7L?[7*/*Z^U7<?VFM_R+H_X?P[^']3]^;O]GVL_LKGY?VHV?Y<
M?OC^Z/ZYCO\ TH?J.??QN3GZE6#_ %LQ]*'ZCGW\;DY^I5@_ULS(@QC[5=Q_
M::W_ "+H_P"'\._A_4_?C[/M9_97/R_M1L_RX_?']T?US'?^E#]1S[^-R<_4
MJP?ZV8^E#]1S[^-R<_4JP?ZV9D08Q]JNX_M-;_D71_P_AW\/ZG[\?9]K/[*Y
M^7]J-G^7'[X_NC^N8[_TH?J.??QN3GZE6#_6S'TH?J.??QN3GZE6#_6S,B#/
MSNWC2/:N7SYRW9,F:"SIV\=K)MFK5JW2.LX<N7"QB(H(((IG6665.1-)(AU%
M#%(4Q@?:KN/[36_Y%T?\/X=_#^I^_'V?:S^RN?E_:C9_EQ^^/[H_KF*[MC@+
MU%]7[HXL:A-UGN3\T;DM?=GTCY>"!GF 4T==Z,OFYDI((T=NNAGOED](-7%&
M@O8CY.))!+D</S-?DU>17TH?J.??QN3GZE6#_6S+$*[SXX%;=9R&UW=OBFS?
M0^M'_).M7?;.I;[KYXVTW8HV<I+K>^DWVRJ/ RUWH-FC'$I4"7759)QO.-;#
M&013N$+I76\Y)K1O(_5O(9E;5M>O;0TF*#/M:Q>Z1L37U\U+LFES$E!QMHA4
M;3K?9U=J=VA&UAK$Q%V&N23Z$3C9Z)=@YBW;D6[U-L^U7<?VFM^/X%T;[^?/
M_AW_ "_PS[]GVL>/S5QX_BC9_EQ^^/P&4J_2A^HY]_&Y.?J58/\ 6S'TH?J.
M??QN3GZE6#_6S,B#&/M5W']IK?\ (NC_ (?P[^']3]^?/L^UG]E<_+^U&S_+
MC]\?W1_7,=_Z4/U'/OXW)S]2K!_K9CZ4/U'/OXW)S]2K!_K9F1!C'VJ[C^TU
MO^1='_#^'?P_J?OQ]GVL_LKGY?VHV?Y<?OC^Z/ZYCO\ TH?J.??QN3GZE6#_
M %LQ]*'ZCGW\;DY^I5@_ULS(@QC[5=Q_::W_ "+H_P"'\._A_4_?C[/M9_97
M/R_M1L_RX_?']T?US'?^E#]1S[^-R<_4JP?ZV9'20X"]1=ARSI_%WZ<]R?5/
M:^.6R-^?/3Y!GB%8J:^VGJO6_P U/D#Z+IA<DEDMF?+7RW\K(F9*0WR;\DNB
M2'R@TRJA$  1'X!_<(C_ ( '<1$?@   B(^X [Y!A3F1PB>EVMO>-N-6M<WQ
MZVF\X9V^X52A62X; ;;7L<MKJ4=<?=>I5ZK2=RV/,V&USVOT%*GK-O9F,G<F
M1&"Q3S53EB1#[5=Q_::W_(NC?A_#OX?U.??L^UC]E<?S1L_X?OC\!F/MU!>D
M'U%$N*&SIIUU&M_<U4*H2"MKCCI/5*?1+=F4!--7;]Y#HCLJU#*6*J-/5L\-
M!IPKES,KQ9VD<)948\BN/CTNN,6[^1/.+158U22^TY[1=EUJ\W;:=8@VYGNF
M*_39(DU(VUPZM,!-U.-L+<[$L95HFX0\E'S-G?1L2_@99DN]9'_I3:7W;KCD
M!2$[]K*9>2D(6;L=5EF$U 6"GVRJ6^G3+JO6VFW6DVZ,A+=2[?69MDYCYJN6
M6&C)5DJ5)<6YF;IFY<>GMV+-J=PHV:MVYW:WM#HZ"*2)G+@2$3]=P9,A3+K>
MFF0GK+"=3P(4OEXE  L"@^D3L=1J>P:U+IJ>P?MVY;<*RC1*VC:K_;8:8;Y?
MJJBKC0K$A"0XTM?L[W>2A]Z0PEIIO2[GHI1V>Q4M[&LK&$U6+CKDP7I$RT5-
M]EDF2UZ<^PG/289)/8XE(>;*0%-MMN%:UUIW+IZ[,V/$IP.QNH;RGV% I/D)
M1&!V#I3IM7J$0DFR:Z3:12A[7P2F(I*1:HN7*+=^BT3=().'*2"J:3A8A]]0
MZ?&S]>1/R!KWJ(<J=?P/M"SSY"H6E>FY2(07CD0%P\-#U3@I#QIG;@0 5W1F
MHN%>P>HH8 #M9GC.O.73E>W\S/D3]])YO_J-P"_Z*<?S,^1/WTGF_P#J-P"_
MZ*<L)QC&5[?S,^1/WTGF_P#J-P"_Z*<?S,^1/WTGF_\ J-P"_P"BG+"<\GWC
MN[7''35]HW%MF9?P5#J!88LN^B:U9KE,*N[%88BIUZ)A*G3(B?M=EG;!9IZ&
M@8.!KT-)R\M*R3-DQ9+K+%)C&0IX66/=$1R4YO: VAR V+R%KVEY#C8^H%GV
MG7].0EOBD=HZDD;/:XE9;2^K=35^0C3ST<5[&C(5US)L4EE&AI-TB4G:RI5)
M)=)1!=--9%9,Z2J2I"J)*I*%$BB:B9P,0Y#D,8IR&*)3%$2F 0$0R 1>:'$B
MEQX[>+3=LU2Y[IN#^D!6UN'?(NM\C]IR^H*B,K(OC:;>:?C]W6RJZZI3I14;
MJXJ;FH0D8M\F,YLKIXUCW,T=?7^F;5HU0V7KJQQ=OH=]K<-;J?:(5?VF*GZW
M8&"$G#RS!82D.9L^8N45R HFFLGY"DNDDNFHD1C/T5RDTZGIK)5.J5JL).#@
MHNG7H&(A$UU 3(D!UB1;-H54X))II@90#"!"$( ^)"@':,8QC&,8QC&,8QC&
M,8QC&,8QC&,8QC&5^=1?6][NFK=.W:@5":V,_P"._+'C5R/L&MJNR;R=OO5&
MU5L-L\NT;2XIY+0C*8N4%7)1]>*K".)%%2<G:FRB(U-S+O8]LK8'F@@ @("
M" ^X0$.X"'VA ?CC&5_<#8"ZNY+F+O&U:ZM^J(3DSRP>[4UK2MA1!JU?TM>U
M?0&@]$QUIN5074&2ILK?)S4%@M\=5YY!G9XZL2L I:&$3/.GT+&V!9H   =@
M   /@ !V#\P9KC&,8QC&,8QC&,8QC&5Y[]T*M(\TN"FZ*)J^.,K7]O;<EMY;
M%@:]$-9;YNDX@;KUYKY>\SR"2$O+Q[&P6EE6:RB\6?DC'$V9NR2:I.G!QK\X
M::6WI"6WIQ<>[/H;8%*<=.N1Y1NMS;AL=<)":GO;6S438NH-8N=/VP9.4+LB
M1W*GL=GM>82BCF&EM:Y/1^PR5RV+0<&^R#^P#V$0#N'P'[7V/=]KW>[- *4!
M$P%*!A^(@  (_A'XC\ _-C&:XQC&,8QC&,8QC&,T'X?#O[P]WN^V'O\ ?]@/
MB/V0 /< CV#,;^Q5[;?.'9.XM?7[C=R?X\0$?K3E_I[@_2WNC%:1Q_U?;MIZ
M=VSJZ:Y6[XV= VHS>Q[&VQ VVPQ&MJC!5QG6=4U78,TTE7-MV9=I:QUC)!S8
M":91\@(0!^V!2@/O^/O ._OQC*:N%4+MC8W)74&UK)QVV5Q]K7'?IZQG%>YL
M]I5IO4#S>ZK%L+5]DFZOK%JWD9=*YZ^UE&:@="&Q8I\[I4[\_(%M39F<6:V<
M(JYC- *4O?Q*4O?X]@ ._P"'M\?B/Y\UQC&,8QC&,8QC&<5.G?IPLN>+C&LU
M)DC) T?#OGI8UE*OBLUA9QKN1,SD2L&K]R"31P]-'OBM$5CN#,W()B@IRN,8
MS%QW9H'D=RXMN[-O4/B[R)U]89;AYKN.VCI[DJXJ+BK0NZ](<I>/V]JCQ=XB
M3*T[&LG5(M]<UGMR(VC;:>\C-$[#D9#1DTI-!8&,TUK]LO#9K=MB<F^9?*J5
MU-L?3NO-Q0O&/6VN8'<56<4'9=D4T;6-F.KI=Y6AOS'EZY!.)S:Z%)KZD\#6
M4G5*++S;-H>JNZS*RUDX$('?L4H>7Q[% ._Q^/8/?\1^/VQ^WFH%*4.Q2@4/
MM   'Y@QC-<8QC&,8QC&,8QC&1\Y5TO=NQ>/&V*)QTO\)JW<UNJCBOTC8,^E
M-G8U-U*.VC26ET%JV8)R-FT*ZI,$K4W&D7<0%D4B9PK1X$<+5:@+7G#_ )@:
M/:;!L=JT!K=;7O'+J:<2.15 U+QHB;W.N[MI;7'#"C\=]@2FL(?84RTF;FM1
M&LA 6V*0=O'%ZN6R==;35,TL$Y*51.4R@,T$I1 0$ $!^(" " _ />'V?< !
M[_M!C&5]=/>H7J/@^4.V+K0+'JUKR6Y?;/WI0J'=V 0E^AM=/*7J[6-9D;Q6
MO)16J6&ZCJY]?QJ[XX3D'$VJ*96AK&6A.9B6%@V:   '8   #X  =@_,&:XQ
MC&,8QC&,8QC(.=0RBH;"XY*P<GIW;>]:U';9T1<[;0-%;'=ZSVP>NZ_V_4+N
MZM=,E(QW$3=AD:"\@6%V6HE<LE6M=T80+N#J<\VLCB+;/)QYH( (" @ @/Q
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JC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g185629.jpg
<DESCRIPTION>G185629.JPG
<TEXT>
begin 644 g185629.jpg
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M)!!GK#!/9D"&O#+/-(8QQQ0QG+)(9DP  1@Q$1F3L(B+.Y$[,S.[LR\Y9H8
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MC^V8Z$_R..S?^R$)_P#5N66?9U]HOX8__-CV=?:+^&/_ ,V/X2^,_P#!A?\
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M8)OBPD;,[K9;\=G5/^3CT9_U#'?_ -ZQ^.SJG_)QZ,_ZACO_ .]9-;Z:_/\
MIW_/CTU^?]._Y\YY_0?<_P!_E7^B-+_B7^7^K??JC^R)^'7_ .&_9_D_]>.]
M_-_\G?S/_5W41-7>7^J+/M2N*H3TK=,9>++ES/$&AQDJ.+H6Y*K>%04A:U4#
MZ\VM-1IC!!VIVB3J#@:WK6B]BV'6Y=]?'6M_;D*7D%^'D \9NOR?A#<-_/\
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MPW1660YC1.DLE;L,UUD\E7IT):I]D+H::XO+F:I<5IABE08+=@'")OX_\?\
M'_'RRMY=/W,SQ-,6&RW>L)5<\-M62(Y,ZPMVDT_(ET-8YHY[4KVH]]:U<5W)
M'F/ =C0@<B3)$<\"0&GC(7FK"B=BLAXR3<UV74<?/-9YG;OX\EDJQ6FIS.$=
MO\H9R5PM1.SQV(XRDD9@E$A<99 =G$R9])M\WA]'#'!MYM;1"%IF@_,!\C@_
M,"(2E";.QQ&; 'ZP.SLX [/[%G:C5R%]S.]"/]SZ+[3<(C#Z(8B7;;F"J;%3
MOLWGR[:,\AB(C"D<8.2QEE+<AD.;JYR-"4[&(T>VI$R!4+A.*&S#PAXG.5O'
M?*9U,Z#,M%5(;!C[?&'U5/IWJ1) ,S<YA=R4Z%G;66/,Y:@2\ #!.2I"L<RR
MO>)$RQ.D/4$G2:8R5]GYD[_NAG@V-J2#-M5H*MC'S&.EE3A7E:<3FJM)(\TI
MS,,IR2R&[N$8#\8XP 8[S'C3D.3>*3,S!DN0SRSQ:%TFLWHSE#Z3C',X@P1C
M'[$  &]>R)W(R(G^9FL18I_$)3!90A YQF9QU[B<B;3/9]TX,,D:U3(\HC-#
M", BU+:N5$B"( @[T/T$'>OAE @KQ6>5*"\863-6*I).]=DT1TK%.*^=C"2D
MP'M]X+A?*70'':>Q&,13G[H$9<TO2R^; 7>\2:TGAY2M0A+3(]>G^@[G78 ;
MUO6P!WK8O:WK8=>FQ?\ YMZ]/B+\_P \JY3U4_>P/&;T#$;>Z#@5"TM-)Q4,
M3^Y@G[@"I9.P-R8QNEUVQJY&X]@K-NV:M K43-_CK<.3B(.*]E5I6<H/6C5&
MCT+1[ICQXWVLC/7$1MOQE7MU9<-]^-/@VM>#;;B#+#Y$T\FR6@N4F"(WK74B
MECQ-&5PI.1%6Z2_R<4?CR9T7722O7PQ.0Z(W]Q1*;\>PAWO>]A#O>]>SO>]:
MWO8?7U]G>]Z^.O7X^GR]<; #?S '?P]/B'6_AKU]-?+Y:]=_#Y?'?VX11J<8
M<X==U?*&:=VUV!)IE1SC15=16&<6NE#5+$6^B).W1&M$AJ@-S1P(K*FRV.FQ
MZ5-)B&2GC1*OOD/-4^^4,S>H,AJJKQZ6Q(_!9WESC=,1=:5MA?T3V3T-3"N;
M*$,86,,UBMR'W#S]/DSX>M 0QMCX_P ::"R7H2P@ F1W6;-]I,H$$RV%\OEF
M-[:I^KKXKF45%<L!BEFUC-4B=!+8'-&9(_1:1(TKBC=TR9W9UH#$JTHAS;T*
M\D)H-^[5I$YX?0PH.]$5#:SXW(>CN)^,N^^B.>5]FS?RE^=SFNZY;0$;6M1<
MLG//%=T/<-,U+2;.[/SI$6M:2_0F'2F01U$\/L;:GU'.R&4]P0)'7:C?W<N\
M?73[I7;G;%:</WI5/CY5>3V5]'-/CO<*,JRW+48:G<.7V6NF&SU'$DXL%+7D
MACY=V$NSN.B5;R>[L[4Y ?&^)FH&) ,^[D_<\47)V.GHR_U)7KI'>?97#IQ1
M["JBK2)GJ:75ZS+8]!9#7S:!,!'%72(L3BN:(ZI:24PFEN5'I$>BB1[#F8M
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MZV-96E0\N0/KEY;V%%]';4^P'*/:7N24)OLBU[HK9APOU)>];RUO7K_QZ?\
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M=S/SO=4DBLQM^C:EM"5P<011"1S^O8K+7J.! <8J 2TN3XUK521,6L-&N+2
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MU9:C8>2:?.IJA5FI06*-M :1)"WY2UI&ETFL'JV7.KI7,>(M%/N>$%BET3Y
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M%J^87K#G7FWOVE>?1W9T;V?3D\Y>AGD:>HP7-JCA#_1D6JB(V')B*_FKHVQ
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M@HW$DG]='=!_=#=YJR$ZJ=T+XH:<E8DJ@:<8V.7=!2=E4EG@",(PJ$2Z3[,
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MM34W)"RDR) B3%@)3)R0! 6 /Y1;$(5OR2TO$D!UZLE;0\H3Q216[L1QV:'
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M^O\ 6IDGJD<S!81\:&!Y+CFT M'9]30'1$/Z.89:_0^/6/&BH/.G.NY W67
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M"+0M:WK3*9>&+CE^4&N$/)LRJG/U&-,IA4[5JBDY@O78/9(ER22'!+*%Z>R
MA8G%L(?9]YKU]=;]IO(]'U]2ER701BS,_P"5MZ?/VS9O7W:.S!LU?D_W^SV8
MQ]^OV-^RL_R7X5.@]M6W?-?C2U+[<6U\7D?)N-7)W^P%;RM#@M=XA_\ :')L
MR_'V[L9>E+/[6OM]/V];#_M],_"XNK8T$!5.K@A;4PC E!4."Q,B(V:/0A +
MT<I-*+V8+0!;"#0MB%H(MZUO6M[U#)^+=Z^J\!>^?/(59:)*GV/Z''+'2O#H
MSD@UK^Y%#V![D32+6O0(!B#% :#KU$ KTUHO>C/D&B'D29J*)0=6N5*6C6#'
M.(RI:I_&$#43,&>2*-KFEL^B@(:(FJ+(>TRM4@=A?>^K]M(+V3E"?TV9O7;'
M>[&'EWKVEPN[!+3K26&**SFW\LOI#\R^OH4+-FQ5B^+.[S2YWQ!F]R,+,[M*
M^&_#7PWD3L><YWE/Q'>-M*GN[%3+.*WE=;S?81M<F&"/]'\STV1E9FQ=<S%@
MH4NJ*6=W<*YRR? 3LWI9;%ER@E(BDC L5'C]V0F2O38H4'#]-B]@HDE4,TP7
MLA%OV0 $+TUO?IZ:WO7PUKWO3E&,VGZW+(B4!;AA$--]\+N0E7N/L;]! :&<
M&SGAY.UZ>FB&I L.WOX:!O>4H>2JPL*U>B*TA%1R5J@-BN3DZ+HO-G-.9LF+
MJV)@=7M4\I1)D*Y26ZI&Y K$SF)R0'%N0DPBU2$6M+"+)53^(6CF=ZU.^AIA
M.>GK$4B+4N#E/W9Q31LY5Z!'O8V<IS6O3N2 SUT$B229V1&EZUH;< .]EZTW
M*>1NI[BA/8PN0J57CME4+1T]IGRJY##!,_SC@J!I6IV:9G>O!7CB8"B<K@D;
MB$]\T?A6\/?AXZ7.S/(_G+9V!MXD.W#RO)>/S#M-.&6]?I,\-G1W)^4QLZ22
MB81Z>AJVKA3QV@CP98X FF^*E?EC>[/>ET&X<YTL&_)*4/Z/N7O+.Y,L+;3-
MF;+"M4MR36G32'>M@'HV3NL'+]-[$,>@:]=_/ XB[TZR,+7]F]*F5O!58@&G
M4O30B @VG]O6]H'0QM$FBP#0@$,.E+JKL8T._76C [^4S\4AL2@C(DC4*C+!
M$H\@!HM$Q1IH0,;0E#Z!#O1#<VITR0&]Z#KVA:*]L>_B,0M_'/I<D_\  RYK
M>C[#H;VR!?<L?-^>%@-[^[QR5J<KW[X"_P!F?0T)P,6_6A%G^+5#_9[P>)]P
M>#?%_-\'/%[&+NNK:#R-Y+D<68&M5M?=I!SG-SR@SD3<SS&?8@(W:+0-Q:1]
M-*"X"Y6YP D50"KFA;)TF@;#.9H$$OF.S2QZ'I0D<W8D:5C,V/6A"+C;>RD>
MNM;T5K-RO37Q^&OCKTWZ_'>]?9O>_GK]O.<9,,_,SLFL%/+HU,^J'_-KTZ\5
M>)G]>O;A$(LY/_*1>R)_N3N_W5%=/UO4]KJS[O7]%M=/LV'?ZVGO:=S4NFWM
MW8&L7)II B'WZCA!QBC'T,8"+,S<>FOLU^C6<XQF<H\F,8PB8QC")C&,(F,8
MPB8QC")C&,(F,8PB8QC")C&,(F,8PB9!G]T?_K0/1W[XW'G^^AS_ )(U*^WN
M;(5=R;GV0SER2V&9*8! G$U- K#<X#%K!M=O$ZU=7DXMALBJNKX-/[&0;1'P
MJ&RR7-$@D(GR*IT" :J810EYCD^Z/]ZWX@>C?3?_ .(W'G[?^&A0'PWKYZW\
M-_#?Q^&\(IRP_+?[H?\ +%G;.@=Z]-_'7]\/\NO_ ,XL[>NOMU^G6$7.,X]=
M?;K].L>NOMU^G6$7.,X]=?;K].L>NOMU^G6$7.,X]=?;K].L>NOMU^G6$7.,
MX]=?;K].L>NOMU^G6$7.,X]=?;K].L>NOMU^G6$06M["+6OGO6]:_)\?3X?'
M\GQRB/Y-?'?Y0[2\I$\L.N*[M>>H)=844>:'NF,.AZ:%5Q$$I#7]ZS:HE^W,
ME/5VJZ7I5^W9,K^JQ'+2%<B0)W,4A)$LO<>NOMU^G6<?J-[]=^SZ_#X_#U^'
MR^/S^'Y,G_COR'I^-]6_K9>?E:,VADV<F2+6KR3PA%8DAE>0/I2PFQ?. 1DC
M<WBFA*2.07=P,(AV?&T>USZF??MWZ<=30@T DH2C%(4D(F#"3F!C_P V0G V
M'YQ2,)B_KY"5:;7#'W0O^7RG5%K>_CO6H:7Z>N_GZ>E":UO7K\M^@?7Y^SKY
M:P=6ME>5CESRK\5\F]9=IH;QB%Y()+,7IFAT:C2&/K8^@C=F(TS2ZJ5E:19_
M)6%/T53N81MB@HK91:< SQ:$<3NV7ZZ^W7Z=96@[I/(U]T,>+(.SBM"+J26!
M&'9@-" )2&^@IPC#L7J'9^]ZT3H6M>]WOT+]K?PR>\=U\_66.AR=;G>':JW$
M=K? Z'$\WGVX+>?SE^U3L07*F=%8AD@L11R <<@DQ"SL_M1+I.;@Y^'&T*&Q
MT_U_X4<U5(;72Z]JO)7M[%6"Q%+7GM%%*$D1$!"8NSB[L[*R\'?J$.]_/8=;
M_P!6=LZ $'V _'7]Z'\NOLUG;UU]NOTZR@U;;?L;W^YESD+OF9IJU[CKZC$-
M55K,;(7L5@R9Q=DD/85+ZI:D2F(&(TZQ86F"(24@]2+Z.4:+TT,W?L:^.30^
MNOMU^G6-[#OY[#O]OTS1=-@U^GP]#"M3S5H-".*.2>NP/-&T5B&PS@T@F'MR
MA87^0NWQ=_Y?2LGQ%Y*T_#_D7F?)&/G4-;2Y>S;M5<_4>PU"R=O-NYAC8>I+
M!880CNG(/TI0?Z@![=Q^3/5DX?X]\D3*W63JK):X\F%*G.,#?$=GQ!4WJ)T>
M4@=0H5[/](B<C&<2PE#4)%NP#2>P:X)]# ;ZA$#>[^Q8\O7^797O_4)G]5F3
M6^H=?+8=?HQZZ^W7Z=9$<CQ?CY.=6SH]KK""L,@B4/2ZU")_G,<S_"I1LP5(
M?N?W:&(&(F>0F<R(GN[M_P 8?<]MU.MU%K@?"D5C5.L<D=_Q)Q/2VQ>M2K4A
M^MN=)CZ6W?=QK"X%>O3E#&X5H7"M##&$*7]BQY>O\NRO?^H3/ZK,?V+'EZ_R
M[*]_ZA,_JLR:WUU]NOTZQZZ^W7Z=9L?['^5_[X['^F'0_P#]_P#,W^A13_RF
MNQ_O%\$?_8?Q;_\ YE0I?V+'EZ_R[*]_ZA,_JLS7SJ!A\J'+%.2*YIEVE'I
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M'>@??(G-L6)5R0WTU[P@\L6]!WO>M?08109?B]O,!^S[V3_%T<6_T#'XO;S
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M(WR!S7<VW!T$0V"5V-N86/IPD)>Y07M,@VR@4:;4&V#9Z4H)JU2(>S?XO;S
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M!^]M>U;W)-ME:!)%:#;6W;0KR1IUR/:%+]%6)S"Q$F$*T_N?<J23"AC*&2>
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M+:-[>4;:]35Y/E\EB#2]I((Q'N,I)AOWR,:B<.+:@B>GR/I796_M<3E9\U=
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MU-Z)M:6Q&E;FUL0)2$;>@0(2"TJ)$B1)BRDR5(D3$E)TJ8@HLE.04644 !8
MATQA%^W6M:UK6M:UK7RUK7IK7[6M9SC&$3&,81,8QA$QC&$3&,81,8QA$QC&
M$3&,81,8QA$QC&$3&,81,8QA$QC&$3&,81,8QA$QC&$3&,81,8QA$QC&$3&,
M81,8QA$QC&$3&,81,8QA$QC&$3&,81,8QA$QC&$3&,81,8QA$QC&$3&,81,8
%QA%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g29650.jpg
<DESCRIPTION>G29650.JPG
<TEXT>
begin 644 g29650.jpg
M_]C_X  02D9)1@ ! 0$!KP&O  #__@ ^1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?5%]015)#7S1#7TQ)3D4N15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M\"-!1UAD9908,E$D<:'50F*7_]H # ,!  (1 Q$ /P"_P
M ,#/L9GP+OHU 'IHL27*+DEJE/<IMI6MR>AY53[:4MI=6MQ-+^ZTI2VZE:];
M*>*M*^2M*C^D42=5SCJ]F:[@%5-,J7;!,B4M+J9?6RVEVMV$*W4I9VW:T[:I
M15;NE/'4NRM>M;+>E[8
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MJV9F0->LCHJ\TC6JR-RIVB  )HST
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M4\;5PV(RNH28C(9O,3OJXS*7K&73+TZ+U1L^/;6>U[IKT,;+90"#3ZI_.!^
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MD:!.4C0I4R-(1;VA"5*04G3DV=:W=H2039845;VUU;NU+LMIUK6O3K6M1_2
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M)J-V;/[!KV"R$&(V*;(5,I-'#?SCYFLDP*11]B^O%>NQ,9:EL"  #:3^>H
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M]OMD:%J:W!^+O(925JQXD%5KXYN:E8L6J[[CNUMVHVPUTC&V^M.<]8YF^/\
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MV,SX%WT:@"B/JM]V<;@_$3(?[MN%!>[%$35;[LXW!^(F0_W;<*"]V
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M%IS][G;F7_%SW^C0G*Z4]_\ 37^(=*>_^FO\0[M[A]8E_P!W==_*#Y6N O\
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MDKTZTITE#XH/M8''9^1#JU^Q6&#D.H2
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MP,^QF? N^C4 41]5ONSC<'XB9#_=MPH+W8HB:K?=G&X/Q$R'^[;A07NP
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MGJ\UG&S/EBKV7TYNTKV*SX[$<<4KXW168H9$5K)HUY]'+YW+GS140  *T2P
M                                   %;WLL#[2?L=\?M=/VX0T2A<4'
MVL#CL_(AU:_8K#!%[V6!]I/V.^/VNG[<(:)0N*#[6!QV?D0ZM?L5A@ D
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M]5ONSC<'XB9#_=MPH+W8HB:K?=G&X/Q$R'^[;A07NP
M    !Z5*9.L3GI51!*E,I)-3J$Z@JPX@\@ZRXHXDXDVV\LTHTN^XLTHRVZPR
MRZZR^VZVZM*ZE84T)TQUNGS_ )2P5K-AK%.09,2I1NDLA4(:F5XHB<5%#ES:
MUJ""JVQ]K7G]SO7-D>+:F]74HFBE,;825;9MV/%:4K3I7VZ5_/2M*TK^:M*5
M_,.W!?O58;5:M=MUZUYC([M>"S-##<C8Y7,CM11O;'88QRJYC9FO:URJJ(BJ
M<,E:O-)%++!#++ Y70221,?)"Y>7-T3W-5T;EY)S5BM5>2<_H/GX[.<M.%VC
MGNA6Z+9"9H_8CUM)=-=G\M,<VII%*TK CRQCF69"C#<?=W*C<B73Q<Z,$?=%
M2-RD+>P644*6-2]$D(+31//!Q+F]QMLW-@M+CKBK"[+X?EHN^MYM;;2[+K+\
M>TJ7?6Z^VVZR_I4N[K;?T[6M1'SE_L7?5O*>SLES<ESCE&&XQFV0%F095@UG
M8(XKLN5OKPH?Y2PQC(JM7:ZQR./+JJ4W)2#X\]NK$A5*43:[?6-RA!'#V1EJ
M9Q^Z?XLUSC.M^*\/8?S=),L6O\@8H:8<5.G'#R"*R1"8\NC:<YKW"D4K,R&I
M(0Y*B2[%[VEO)1G*3TJ^A?JV6KP7XGY/AOJN(EW=<K7UV#7^UQT5:.&C#29/
M?1F67)UIEFEBGFOR/L8MCZR)+R61T;8FQ8TR7>]/J;7F;K-?\CERDF3;'9?*
M^6P^;LJRK56K+&D:/BBKM;%97M.J-51J*YZNO+%&V'%EFE74O+-LL,LNI2M*
M767VTOLNI2M*5Z76W4KXZ4KX_'2E1F.O,4Y&@F6,<0O(^,Y:P3R!S&.MCW%Y
M=%'$A[C[XUJ4]EI:MN<D-QJ<^RTTLU.?92ZTY,J(/2*2R51!Q-G85*]:=:=?
MSTK2OZ*TI6GYZ#R7+%)#+)#+&^*6*1\<D<C7,DCD8Y6O8]CD1S'L<BM<UR(Y
MJHJ*B*;2Q[9&,>QS7->UKVN:J.:YKD1R.:J*J*U45%14545%147DIY  '&?0
M                                !6][+ ^TG['?'[73]N$-$H7%!]K
MX[/R(=6OV*PP1>]E@?:3]COC]KI^W"&B4+B@^U@<=GY$.K7[%88 )
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M ,PW_P#+>/8,++:VVUI7_C,N_-<9==3_ $K3K[XS            ''I9+8K
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MARQ@]54BOU&DK-WVJ]2GYM[V=6[OE1WFK)[L9VW)P #R>0
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MUZ@XEGC,9;VQF;2SE!IJ@ZU(B*[L>88<;6\V^Z^O.C/L9GP+OHU&8P,^QF?
MN^C4 41]5ONSC<'XB9#_ ';<*"]V*(FJWW9QN#\1,A_NVX4%[L
M                        !5!DRE/3LKO'=E3R:7TU8/2ULJ;9VU%-^"Y^
M?8FK;VW;447D&%G6D5IW6XJ^TVEE2[J75M=F4OK9=0NMM+ZTZ6UNI6ZVVZOD
MNNMMO+K?;;7I=?92^RM]M*V]M;UZT^5SFG4/DQBFZN1E4CQ/L6Z;&L64)=E(
MS+3=&Y><0XJHR^.4H)S"R94,)K&2XJ2A:BWIKD=\E+;6QL(3,IEQ!J6K59Z
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MZGDZ[)(X;L#+$;)D:V5K7IS1'HQSVHY/WHCW)X@  09(
M          5O>RP/M)^QWQ^UT_;A#1*%Q0?:P..S\B'5K]BL,$7O98'VD_8[
MX_:Z?MPAHE"XH/M8''9^1#JU^Q6& "0
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M;A07NQ1$U6^[.-P?B)D/]VW"@O=@
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M_=MPH+W8HB:K?=G&X/Q$R'^[;A07NP
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MU+*QC(V,CC:C&,:UC&-1$:UC41K6M1/,B-1$1$3S(B<@  /@^@
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MLM++MMLLLMMLLLLI2VVVVVE+;;;;:4I2EMMM*4I2E*4I2E*4\5!D
M ,#/L9GP+OHU&8P,^QF? N^C4 41]5ONSC<'XB9#_=MPH+W8HB:K?=G&X/Q$
MR'^[;A07NP
M
M        !@9]C,^!=]&HS&!GV,SX%WT:@"B/JM]V<;@_$3(?[MN%!>[%$35;
M[LXW!^(F0_W;<*"]V
M
M              \5NI;TZ]?'7I2E*5K6OYJ4K7\?B\5/'7Q #R,#/L9GP+OH
MU&5*TKY/Q5I6E:5I^.E:4K3VZ=:>.GCIUI6E1B9]C,^!=]&H HCZK?=G&X/Q
M$R'^[;A07NQ1$U6^[.-P?B)D/]VW"@O=@
M
M                            @WY(T5-E=\^.SCUG+[,F_6[,,1VUV!V%
MAL-F4I@"C,J3!$5@S)C+&<AE4$?(Y+"H';*LAN$PES"C=DZ.3'Q^/-Z^TY*6
M=0N<@1<[Y:QYXDV<]1-WM4V;'TXSMJ(HS/&'/#62Y<MQM&<XX2S_ !9E9)_#
MTN2V^-R^Z%SN//L1B,MQ^[NT=<(W<N3/#:^=[HW.XVH'17&N6IUTW<Y%>.^+
MR&6NFN>!F74S.FLL6FDPEN17?$\4V$@\T;LAXJ;)C-W!\DE\%9)YC2Z1P:/N
MC\X>H"*5.+<WF52DF6E2-;4;G:NZ4PY@G>U&:H7A"(2R1UAT<?YNJ7)&]VDU
M6AP?*,R4Q"@<+ZK*M+6O74M,+++[BE,_O.W[6R[5[0'6C8"'Y>W"W/VO;H)"
M\];F2/#Z.S#6,IDXY&AN$,)Z^PESB6*8 9D%RCL3NFDW5.$KG,OGT@:X\VQT
M]ZD):1A(M0I!VMOMQQZI\D^.8ABW;.$/DZAT"FM<AQEO8IU+H&I1RJD>>(Q1
M::XPYT:EZLGU(?'%/WDH/O2UO.M/J74TJRZ@%&77;D*TKBO93^S^Y4AV,QPT
MZO2Z'SE#&<UJW!=9"7I6NP/BJ.(DZ);:WWJC#%3XQNK832J.G;JD1UEE;J=S
MJ9<#\/SPY>Z"Z^?+C_Z-BGGA3@6P=(^R"<^:I3?4[/1''?&(S+UF/9 J49Q9
MX<<YHL18]?F>U%G:T],H?#+9@]2$HE,9+EM%*HDQJ-+46(>]K;*GL4GA8\WG
M(OSD,Z>F8 VX\/SPY>Z"Z^?+C_Z-AX?GAR]T%U\^7'_T;&H_L4GA8\WG(OSD
M,Z>F8>Q2>%CS><B_.0SIZ9@#;CP_/#E[H+KY\N/_ *-AX?GAR]T%U\^7'_T;
M&H_L4GA8\WG(OSD,Z>F8>Q2>%CS><B_.0SIZ9@#;CP_/#E[H+KY\N/\ Z-AX
M?GAR]T%U\^7'_P!&QJ/[%)X6/-YR+\Y#.GIF'L4GA8\WG(OSD,Z>F8 VX\/S
MPY>Z"Z^?+C_Z-AX?GAR]T%U\^7'_ -&QJ/[%)X6/-YR+\Y#.GIF'L4GA8\WG
M(OSD,Z>F8 VX\/SPY>Z"Z^?+C_Z-AX?GAR]T%U\^7'_T;&H_L4GA8\WG(OSD
M,Z>F8>Q2>%CS><B_.0SIZ9@#;CP_/#E[H+KY\N/_ *-AX?GAR]T%U\^7'_T;
M%6GLA#L>W574K37'.1>.C5K.<BS4[[&16(29%#)'G#/#F5C1=CK)SN[*3XD:
MME=C>ALDC)%BS'_U.(JE..(0=^V4<JDFRT:N=BY\2TYUFUUFN5M<<H(\HR_!
M.()/DE(OSKG2,KTT_?\ '<<=IF0NC=96D];ZPN2*W.U4R41H[6H^AB"U(EM3
MT3E@27>'YX<O=!=?/EQ_]&P\/SPY>Z"Z^?+C_P"C8U']BD\+'F\Y%^<AG3TS
M#V*3PL>;SD7YR&=/3, ;<>'YX<O=!=?/EQ_]&P\/SPY>Z"Z^?+C_ .C8U']B
MD\+'F\Y%^<AG3TS#V*3PL>;SD7YR&=/3, ;<>'YX<O=!=?/EQ_\ 1L/#\\.7
MN@NOGRX_^C8U']BD\+'F\Y%^<AG3TS#V*3PL>;SD7YR&=/3, ;<>'YX<O=!=
M?/EQ_P#1L/#\\.7N@NOGRX_^C8U']BD\+'F\Y%^<AG3TS#V*3PL>;SD7YR&=
M/3, ;<>'YX<O=!=?/EQ_]&P\/SPY>Z"Z^?+C_P"C8U']BD\+'F\Y%^<AG3TS
M#V*3PL>;SD7YR&=/3, ;<>'YX<O=!=?/EQ_]&P\/SPY>Z"Z^?+C_ .C8T]7=
MBF\+I2)6:1KSD:IY:53>32W8W.AE:G6$&7%="Z3/Z^O=*6=+>E>VKXNUNZ]K
M6M_V.QP)X.V\BVVZSDDU2S[&W: S?%S;AZDV5YPP$:K8GIKR ?*[FU,4;$;9
M226J:XYWPKN)<+FVZXBRTY-:ONM4 7 O#\\.7N@NOGRX_P#HV'A^>'+W077S
MY<?_ $;&H_L4GA8\WG(OSD,Z>F8>Q2>%CS><B_.0SIZ9@#;CP_/#E[H+KY\N
M/_HV'A^>'+W077SY<?\ T;&H_L4GA8\WG(OSD,Z>F8>Q2>%CS><B_.0SIZ9@
M#;CP_/#E[H+KY\N/_HV'A^>'+W077SY<?_1L:C^Q2>%CS><B_.0SIZ9A[%)X
M6/-YR+\Y#.GIF -N/#\\.7N@NOGRX_\ HV'A^>'+W077SY<?_1L:C^Q2>%CS
M><B_.0SIZ9A[%)X6/-YR+\Y#.GIF -N/#\\.7N@NOGRX_P#HV'A^>'+W077S
MY<?_ $;&H_L4GA8\WG(OSD,Z>F8>Q2>%CS><B_.0SIZ9@#;CP_/#E[H+KY\N
M/_HV.>8NYJN+#-61H3B3%>[F$IOD?(\E:H="(@QNSX>[R23/BFU(TLS<6<P$
M$W+%ZF^TA/:<>27<;=;;4RVMU.NA?L4GA8\WG(OSD,Z>F8@$V,X@HMHIV0KQ
M;M&CNL^<TFLZ20ZWY)R3-$J#+N683')K3.&0&Z2K)#DA[*D+=&BT,48XTJ7M
MJU[0HVY&84YG)T]CA<<:!]#:E>M.M/)7QT 8V?[MOP:?\J#(
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MFE[J7>49WLXI25J>AA1MA9A=]"3[*76&%V&6W4K2^RV^E:4_4
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M\=/LZE!JZ0S$S&I\NDD19W=_=W1]*BZ%@;'!8I+0(UJN90
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M ^I=B.(1>43=]8(N_+'F='R)\0H',PUJ1*3SYMJ4I;2E*>2E*4I^*GBH/(
M
M                    ,:W6V_[UUMOXZTI_SJ,J5I7R5I7\7C%4_EASCO\
MRWFDT/X[]2=W93IO"=D-:I[-)-)6'%V/<ID))/"56:Y+<\&1Z8(TJQ<H<F?'
MK?'*%)Y2TI4=AMCA:2<<4:2JYQJ/MYR*:<\L,&XL>0_/,/W)B.SN#)!EK6'9
M"/XICN'Y@VO<!32E8_0J;Q:($$LUR=2T064WJSU9CXO)=*Q9>CD1B-]=&MN
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M$H$G8
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MW:TZ=.E*TZUK6E:=>M:U[:M?T^/\?D#I2E>O3Q].G7RUZ>UUKX^GO>0 >0
M
%   ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g680862.jpg
<DESCRIPTION>G680862.JPG
<TEXT>
begin 644 g680862.jpg
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M 4I2@%*4H!2E<7O;&U[Y7MC:W;>][6M;U.N]^KMZJ YI2E *4I0"E*4 I2E
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M(H6.DQ\,P3  8F.6-I%[8XV[+=G9[%NKJQ_XMNJW5;E:NU *4I0"E*4 I2E
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M9[_Z+4_52-!O7)-#^)GO_HM7-^%FK?G+K_\ C.._W/S3]I+?B1\:/T0^*/\
ME_MG_$?/]_P4S]I6 7ZJ1H-ZY)H?Q,]_]%J?JI&@WKDFA_$SW_T6I^%FK?G+
MK_\ C.._W/S3]H_$CXT?HA\4?\O]L_XCY_O^"F?M*L1!^S<%;)%G&<A&0TN0
M"K2,)A1Q#)A%<)8)AA8!-F$T,7QTE)EQKFP2)O/#(M8?#&P.5A,L,KXVROO4
MS6M5;L$=JG9@MUI4<L5BM-'/!(C7.8Y8Y8G/C>C7M<QW2Y>'-<U>%142A9C"
MYC7LE9P^?Q.3P>7I+&VYBLQ0M8S)5'30QV(FVJ-V*"U7=+7FBGC26)BOAECE
M:BL>URJ4I6\C!2E* 4I2@%*4H!2E* 4I2@(>.,XW_#(/@EZN!GEI,BN*MFV<
M_99C93VL9.E*.X4(!BR*@-%:-;$.]^QH,VE!A2:N,QYMMMHKO3QWJOI1)"4K
M8)(AHZ2^WA&2'%4@L"9346106BHBFOQO%%<B6XA[5XA5E@\,TP3 ![-VM:;I
ML C;( K>Q6S4-J2$.KVMX_#3300ECN5+\9A9:C9;>E+F>*YK$PTA)W'3@[2O
MNA<BM:PQZ84H!G0EGE)+!/K[:#=IYY$!#K+8Y_!Q-3)@N]:3'P.ZB))*,(SA
MO=PT7Y'CZ94GG(^F#AMRZ3)O!%+GE'APMI/;3.2#0K=Q%"(28$0E&3\#CN'!
MPR,HXV9U)R#;^.(5B(UL;F: DTI2K?RM*;"A&-WM+<HN,HTX^CMM*KM=K@.
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M&%B.<&'%Q"#MG;#&=;+LM]%A_/QJ#7N<#Y4#KC^Z-N'^&AL!0$YE*4H!2E*
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M+.[#.1@,N!IK>DJ^,K1HSXCDMSR"(BK0C:6PF.B,I<4'=DBN0!>:IAO*MV\
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M9ESC!. [,Q=@HF@1-FK;",&W^*UC\4 (YTZ0<!?P[<Q6&8T7"C*S=7FNW5M
M7A\S*XAJZ&E*2.L&,Q01\QU5+.E!R"D-D.7 &R%.EQQ,A@01;Y7$"#RQ[JK1
M:RX,@&%EN(*L8:JB$KMD=31TU0&;JL  (5 5$(4X5&$1U$$L**6"/)N14V&
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M84#0*TDQN.4PN(6"GZ6C(9!\[,N<+,4Q@M!-R)DL?!LQT'FK2IT J._91><
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MUV?CLCF=&5()UM*!QB+;29[=D<17#7F<L+[?<+.<$:/!JR VG FFL!#;>7
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M@3-@\PK& @%(L:"#'L$(('87##$3O>>>'2Z.65K^0CQQ'S>4 E9!8[/150#
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M&:J> &BA @9M81OXJ&6*43N*JX'L\\!<KW'%RJMW./HU;LES?JWM;QS7;_\
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M).1P^:%QD3*?_P"2J0M^*[!V-+'@!3/ :X&[KCV6]JWO5S4!%NZ>N"1:UO\
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M2D'P1&NO#*$8D8)"BGI9YQ.%Y.%6<+D<;V>3S>SN4,E5U/5]/EY*JX[7D['
M?RL*HKKA6#YRX )-.+9%DI.3B!2\-6VD"8XIBH@MJ4D2,RV.4;D?/>6%O-S.
M1*2!4V,XU 3S,@OXR5-&<#F+190*LDYNA?P+YIJ)XT3L% P (>*8#5XGJ)!5
M(DU).-ESI!0*ECI(X6%Q%+FBAT ,R4, "XWOB($8+BAC YVZA \\<\>=KT!]
MM*XZ6-[\K7M>_/EV^K:W.]O;M;KY=O+K[*YH!5"R7&K)F!@O6,9$0@'$RI#9
MSJ8+M2!1S9$12:CU0C[:<R6$IIHY-63+J:*IG261U+.DCY>PW?BID P&&+A7
M5* PWD30?5Z4G.U'2[F&K#CM=MQZS3B$D2#(C:94A,^)%P5T18U9D8K==*6T
M9F;\>.8<RNM-*DQ'<Y1+.GE0+$,5/5U4B=S(M:UNSJZ[W^O>_._[][\Z4H!2
ME* 4I2@%*4H!2E* 4I2@%*4H!7R'R!-4)'$U1*@'2!\J8)'29D/$8N:*&P1"
MYDL.%G:^(@(X H@(H>5KXYAYY8WMRO>OKI0&&D(\/#1O6YYI\BP5JE!,7/U'
M2#3?0GDT8Z0$YS-U"4 /!5%';2UD6'4&VF*12V!12)((Z< HDP@2AW <L$&%
MC]"'H)IXSW\<EQD:XPVUI8S>2M)*,_2C$3159LR*M%5L)6=[:PN("$VE%>-.
M%9476&UKH +N/JJH?<-CRDH#GKYATH"/>$^'E%36@F68EV)(,'9E>V.F5T[#
M;'N-;BI"9K1D:87&HH1A.<B''(*JZ+,L!BI;.8R0PAK.Q?=J&(T4UR#N\\[!
MC2R)EI$,(1) ;%*QI#<>M:.6.5-JBEYGFLE IQ,XKKIH0\OKJJ+;OAU:<*^?
M%%/KS@631];6SPHAQ4/FS.>0E[J4H"BX[CIBQ*Q6I&49M) 8D?,9"3FPSF:U
MDTNCMULMY)!Q+)B,BI93' LGIQ #'$(J5 QQ#!#QMCA:UK6JPC0T5TX8:[)C
MD:6LL)(JM,+;<[+DD8M';=%+NQEO@\857RRE!--DC"6"S7RL&S2V]FDG$B+=
M=ZX9,+3D3%-4&$-Y97TH##1#X>6D3=BMZPHE:O0T%%TC*K66WTT#+-(*2>ZU
M-B'2:@P3*X85/#50_9@&4Y/NP0!5"Y9D D2A1J@I!0 ,"V2T@QPPY78;IB^2
MFB@/F/'N@'VL[F8Z$TNL-QR-Q4+W****LI9O',L?33I:]P#)4?#(,8*]\,[7
MM5:TH#'.<M1=9=ES+/.3Y!L:RV98(2T5:8SY;!%<$2$QR!$ 7(@AY&,?UTVG
M'@E)-W UU#PQNK8J0DCJB6;'3" A?]RNINM)%#=3:)P9&!= ?+6BQD/!'":"
M5@GN5HP@4Q(1"W%HM8'O:@CQN3QL69I$>V0*$#:V!+$.U9"TH#']\ZJ:WR86
ME,J_H2C5V!38HLM9E;-;:J8<,OE=C=.()4>.!=.YA6.#.%AD4M,"9B^ 8+K+
M7S32!A$/$C)0N,'TC[5#6N*0HQ"C>#HR97G,@OX&+A6ZTDI--,F\JYDQI.-(
M9P "QL%2D0R0*'7RK#CF%1UGP;'UTX>.Y"&,L@Z4!:V0X1B*6K*5I,C=G/JR
MQ&LB0XJ6="$26+'XKEO%OX29'YOPL//OS3?>+5;F+I1<^9-8LB)EC>&?@@7*
MGG=K)KR_Q7 ,^84C%X9NN*"4%.:SG9B&NAKT.IJP:<"=&BL"IE#(!YF$5TZ:
M6":$8#S)E5,?,\!@&9Z(N-\Z4!B62T1T]3H>58#*:YQ0%$RZ[@I"66C=JE!0
M561BQ@F:)22H*XV0CB-R0G&$U,&2Y!'6<WDE9IB99.7"N*<3Q!I]R<.71-W-
M:-F0X]38'5FA$2$Y6O'C:,QT@^)&ZV'HH>.7BVPTT(N$64F^[7!;%SN=$6PU
M1,<#K#"=2L5-N((-3QS4I0&*#UT7U!D1&6T)XZ[12M$7#C%=E,05K%2BED+!
MR0J-^(#A);3LB:VDJ4;(*XMHC,5$A1(*2"CK*LED389%3.@#DK133A"2VJB(
M>LL)HB2QI+,3&SDY'CYOI91LRD=:95BJ+\102!0O@GN=6:),LWUE4+] 9930
MK JOAF668F65]* Q"7]!-+'29B4TX=8(36,X,:C,8D5!'F"B#DV<R(X, 'H[
M9Q$AD7\!.-6/U,L766,W5DLIH[070<%QO$TY7MX;>Z VMT"&"2XG#Q#'PI%S
M30A[%N IFV4[(NLSLVE=L+S?EI1#N%T33^1UEEM-33G*+;)1*GFZD& Q;"$0
M;XWMI0"E*4 I2E *4I0"E*4 I2E *4I0"J*DGTO'U[D'']Z#E5K5%R1:]X]?
M-K=MVBXK=?LI!NU 4Y!OI2,+W/%?A!JNO5J8.MRB5A6_^72E_P!_,:]OY+U=
M:@%*4H!2E* 4I2@%*4H!2E* P XKI(ZI\+_B*IR<5,GE!0T<VJ)$21, 4R;-
MG#4(/8 L5*E@,!!QS XPF 0((.&8HHF>. >.665K7CI<&Q$*;>RQPNTC41SV
MF64]791+37,;^B]LKSF3(AU_):GRRQ9.8KG?0*6 W2"]-SK7&%'2!%F:]9QN
M5=#).NZ%FFL0XJ)NPK_KY/>KK;&UK\^N_MY996_>O>]N?J<^7/E>]NR] :=.
MM\S[#[(2]#<<0SL'+;7,[A:>[DEI"=BIN'-^P<FQ+.Q9ILUXP(NS:SQ(WC'7
M?3W8^-G/@N%%77R RQ8 BVR+N:#J1EIMIZ:LF[HN[:#9#:&&4_:9]S8J:N1^
MKS_"6L!V&Y)D/8'66#72[X"B63@=KD&4-F]>R2D_-4R:[M^ZG,PVS-X0H3>>
M&.K[#C=Q!'$*2RZ</M./-HE'HSG8S!E9RML!VMY<;P[@92^H--X(EEQ/,IXB
MVUG.E"!*3><R=X3<ZC+Y#/$^F*0)8\!GWT'&J1A*$H[U[B=F0K&".926&Q4D
M1*2"BHL*KE5SN9PZ<5EI;<CB7S:@MNAS.=>4E5QNIQKIT\KN-PJJFLJIDR=.
MC"Y 12)+]7)@X$<[NA4+3&HJRII3N8W0!I@>1:4)&=)=LM2:&@CKY.2DY@1R
M/*;3=R>D$EB*)+4(\;KDD:-U!GN]Q)0SA65$T<L-;5?>99U3UWVD,S9';^E;
M3#1Z2)&TVAJ%=5U9C.Y4V*?ND:I$[*"?SAD*>IC$?@2"1<A\N08#?;L?I;V?
M!A*47#<$@FI[9 V++6M:W*W/EU^K>]^OV;WY\_9Y\ZYY=7+MMV=?7^_Y: U/
MG-, H+.EA(TWWVV:<,/FM$V<^ME)QDA5G^?RD';(";!0<0:UE]RIV*S+6NSU
MFN,5S8)O[(L&(+MLWK0QT$C-";'<:G6*GCJM-H[P3Y$)Z N!Z.N5!&1 G&Z0
M6;C)R1N=+6U&O)Y)D'264!&T'!.TJXTXQD:3(="EE:;489&YB"=CB:<D/&0H
M8+R.OLMPB(06W#8(/'GT<>72OSO>U[VO?*_;ESM?GTK\K=++GTLN5N=[\K5S
M@'@'AB'AC;##"UK8X8?&XXVM;E;''''E;'&UK<K88VMC;U+6H"+SC IYY2TK
M *IQ,V=-6VYX<YBY<B .:&L 1X@NLQLZ-8$M@()8 H4 ,&3(EL>]ERP(@XN6
M (66>.#_ !"=Q7MK5*/%3:S@F1]Q\<=7#3AURZ,-E,..4527YR+C;=MJ2%2
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M"6M;/&V5K98YVMEUVMGAE;+#*UK\[6RPRQMEA>UN>&=K9XWME:UZ T=Q)<G
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+2E *4I0"E*4!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g932267.jpg
<DESCRIPTION>G932267.JPG
<TEXT>
begin 644 g932267.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ _1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?0T].5%)/3%\T0U],24Y%+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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M[E"(#&V>(P[SK&'RR+14;2?5D9B#)([I9(G:W9U./4MC P(_%M^@&SX
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MY[27^X/1/^<OG%_( G-QC&,8QCT8QC&,8]['J&0!!CYY[27^X/1/^<OG%_(
M>>>TE_N#T3_G+YQ?R )S@ $&.7GM)><=V8!T3LX_9FR^<6<?^'X>>>TE_N#T
M3_G+YQ?R )S@ $&/GGM)?[@]$_YR^<7\@!YY[27^X/1/^<OG%_( G.  08^>
M>TE_N#T3_G+YQ?R 'GGM)?[@]$_YR^<7\@"<X !!CYY[27^X/1/^<OG%_( >
M>>TE_N#T3_G+YQ?R )S@ $&/GGM)?[@]$_YR^<7\@!YY[27^X/1/^<OG%_(
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M.NOJS\+?Z^P Y
M                      "L1VL+VNBD_C^\8?LEE"SKKZL_"W^OL*Q7:PO:
MZ*3^/[QA^R64+.NOJS\+?Z^P Y
M                                   "L1VL+VNBD_C^\8?LEE"SKKZL
M_"W^OL*Q7:PO:Z*3^/[QA^R64+.NOJS\+?Z^P Y             U@Y3<TN*
MG"6&ML_Y6WQ7-&19\7GM4?6SQ^+0+9*YI"-5:QNB["E+6R&3KD23<M4M2L#2
MXFHDYI)RO4DLXK;<#9\!X%QRY3<=.75?E6GQFN>N[N@.ZXUJ.DE=R5!(4C:[
MD%%GGLKV0GWPX1][((/(4',KZB;G0M,>0HV28(/*,W]]
M                               ' PS0HO<TS;&FA>FV^^VV<:ZZZZ:Y
MVVVVSGT8QC7&<YSGT8QCOR .8"*M'U6JO=*0YRWZAJVT&^$\,E;(C1)9TT*:
MPE-TZRJK838T,>(U%[ ;6%ZA,>FY\\8V2(N$[1MJYU1G$R@]G0-*] 4IVAX>
M<C95R=KEXL.0U["H(A32URC; ;7_ "#K'D?&Y&G9B$Q#NO)FM5>%'V]8UR#+
ME'W"/JC-W5$J;=SE6I.#]"= (.^UA>UT4G\?WC#]DLH6==?5GX6_U]A6$[6
MH(WZ=U+$:G%;'E<_>+^3"=3=,FEXW167MIG<O&V=]/"UQG;7PM<>%CTX[\>D
M6>]?5GX6_P!?8 <@          !_-?[9OQ_Y08YDTOR(<F:6R7B^OH>/5W")
M*TM[LLAU>V$TRN7.<WB3^:ET4-S%))66Z,4F;W%P\@WEC65AN0&+]X8MT1_T
MH!]=4D3+234RL@E2G.TV*.(4%:'$'%[8[MBSB3==RC=-L9SWZ&:;:Y_8 * O
M8JJ#Y-1:4\M[WD,;FD5XQSN 02&Q];(&]R:(Y9EI,DL6NA#W$L+]2"I!I HN
M;(&AY>T!"A&E/F"1HPOV4EJ4I'] (?&42407H427H447KKH667KC0LO33&-=
M-"]-<8UTTTQCNUTTQKIKCT:XP/D
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M5:M"9PAREX;4"14YNQZV_$
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MA:8U'VW"U6>O5X0,K(C0-B+"I<I4K%/DR4KQZI0<I-\,XTS?;LP
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M64H4X6 6&]=L;:Z[8]&-M<;8QGU]V<=_I'(,8QC'=C'=C'HQC'JQC]@
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M5,DC\"K]N?"92ZYD$F4-;6E>I;(W]"S8V2L1*EE8FMDTP4\NZMX4:-EK
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MHF)G/PL-\M\>IN[:^K/PM_K[ #D
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M4R.L.E%@.[;+S90OFY4,?$B)_0QZ+HDN6AE?'A"@3OI\L<?,'G!&B7*B;U@
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MP"]-"]>_/?GP=-<::]^<^O/=KCOS^O/I'R"=&N/_ (_^_P#8
M         !6([6%[712?Q_>,/V2RA9UU]6?A;_7V%8KM87M=%)_']XP_9+*%
MG77U9^%O]?8 <@          !C.N-O7W^]G&<ZYQW^ONVUSC.._NQW]V?3W#
M( #&,8QZOXYSG.<Y_5Z<Y[\Y]'H].<^CT#(             ,9SG&/1CO].,
M?PSG&,Y_ACOS_ 5N;3ZD_77BMFV-&*\Z%&]B0".3R8,,'G_YW=?L?Y<0]GD3
MDW1B8>952392T?E,R)D+WYL4;9.0^7>3&9SN5D61QP\67GUZ:?[.OW "K_\
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M)T3[XHK3&47EODIG?N5G(VV&,8QKCNQC&,?LQC&,?)@9
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MWX]_Y,_<'?CW_DS]P R QWX]_P"3/W!WX]_Y,_< ,@,=^/?^3/W  ,@
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M<JM,Z[>#G&?!VQYE].N>[NVQZLXSG&?1D!8\
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2J0  &_0              __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g547758.jpg
<DESCRIPTION>G547758.JPG
<TEXT>
begin 644 g547758.jpg
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MDY>8LM'2*4)(4EB%A]76V"4F0T5'55EB9=?PF?_$ !X! 0 " @(# 0
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M7Z^5_?Y7\%^50,;62A/FGFQ,93>6F.:):CN2YAGU(> ZRML&VKS?30(*E\[
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M<(\?JJ^@5454C*18WR31B@0(,@E&B5%5\3(8PF8R59J/-X89@D[A8A&KGA"
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MMV0EY0;+$5'U<B+@V2[R7$DDH*R>V+*F9<9=%2B@JGFFA&0$^X1P8$<*IM*
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MNIRMAUP!;PAX9=6M$0?\[&_A\/AOUW\'/JMRV^V75?X+_-6H'[*'\^)NI\,
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M53 )>XF(5AQ02!LP*&#<7/$/MN>.(?;,L<.ETLK6OCYK?&_9RLKLU2"UD=@
M;87%%6'"SD!H99G SS3<3<Q !N&B6Q#SP&6PC.>0G[3(  7#]MGGAA7J0^/"
MS KWR#U>>8=[VY7OA(K.PO>W.U^5[XHEO!X/!;G>WO\ +KM\3ZZ?'_XST/\
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MB]IX>U%:*)(.Q*AML7"=9..D2-X_= A9I/D=5:IY_EW.VG6?3D,XS+N 04\
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MR#PR#'L)A8(3$;"^-\1L1 [=K$Q$ME;,/]IG:^'@KK\V^AB(^#?$1TO-!#+
M$PT7-/)YI&!0KVON8K@F9 W(XEB_:@^T%[%[ @W#PN%AA?#&]NWI0$3_ !N;
M<N&Q-5K?X0M3OO\ _+&U_P#=OX:E<"\6_P"$&^ESJ*/C=>;8FOY0M3OUQM?Z
ME<"\6_X0;Z7.@,4CLQ[S2K;]+^%?4V8*U85;3WLQ[S2K;]+^%?4V8*U85 *4
MI0&T][#A\TJY/2_FKU-A^LKNL43L.'S2KD]+^:O4V'ZRNZ 4I2@%*4H!2E*
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M#LMO!UJ+A:.X4QQ,AF2I$,JQF>Q=9%UOI@Q,G@ :-%5*2(,>[O&%5!\,CIO
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MFGNA.:V;7-2#9O\ L> ?ID92#6B+/S,=]#C:+'UL+&Y8D/;&H']"*<8C^\N
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MRLW'WX5D5]RG7C=TDGB;V6N<_J[KV>B.5)[J5$Y;:SBL7O;GPGXYM;G;G?\
M9'XSORM[M^7M!6Y\O>YVYU(Y$3BD5VQJS7)+4<D8CDA810#KPC9-?)"2R+.6
MA!!<1T4J^TM&;R>Z BX> 0F*J414X$:XM\+%L+AWOE-<BR5'I2E *4I0"E*4
M I2E *4KYE?E;G]^UK?#>]K6M>_*_*U[WMSORORZ^5 ?:BM@3SO7$7]#OAI>
MN>^E=+'&_DPN^38H=RM&\=$]4-@MM)VTVBE13UQWWFQ.=\,9S0EH\L.L@HII
M=H'F')SGUYDM)*-9*+)[@9B2H,1QF5]UX*R\E-ZS])XB&J&O_%AXA#CEAXR$
MVD!4@S2R%TQ;*Z[;).I(4I+@QV[<F)4;:<ILZ(G"14+-0"2V2(*LDC Z JXK
MH/>-54^YE#N0#(KRZK_!?YJU _90_GQ-U/A@']6B(*V3%^-UPV+VO_5KD+JO
M_P D[<;_ ,O]:W'CW([QW%XK6T>Q.ML6S;*$,R!>'KL]\IL#S0CDEOV,P7&[
M17>TISG82(N%[ISB0E5,$[M2RUA1"F0Q:XY80(;,#'VI5PF.I6TN66...MT^
M99996QQQQAF2[Y9997MCCCC:S7O>^65[VM:UK7O>][6M;G>NI1-:=B7*F%UI
MNP/,Z\CF\S@95618K?RLF&1$\\93#X9<^GMXR4'S)*1(XGF\ AL\BQTH9*#V
M#, "AX 4C1_MLF?C C^E@UOU$?[4IGXO(_H@-:*E-U2V@+J!$<77">\0@3I0
M43+VFI*OT0PS(6>>=[6:_.]L,,<LKVM:^5[6O;&V67*U]OVF\;3AN%T\B +-
M,AX"@DB@0F-]3]Q;WQ$#+A89X\\8 O:_1SQRQYVO>U^7.@*[<3_R#=D_R&*>
MMK9K"XS\?+XV7SWK(BWSXM^ATPZC3C&L<R=)+E>SL:99.;R$6U6VY*CJ1T-Q
MH1[, ,PH003)AY8E29@;F,8#QO8*]K7OE>UKXOV<XL?I97LE3!>W2OX;:W;(
M^&U[^#E_4D\/_P#<ZBYSU@<YE\Y@Y<5ALKDXHL5+'+)0Q]NY''(MR1R,D?7B
MD:QZM5'(URH[HJ+TZ*A<9]#6Y'X]TKCOD.GN.]:=J=RYNE6S4J[)LN&P=FU6
M3!TH5L5X,G=JR30)*UT:RQM<Q)&N8KD<BH5=I5$3FP\8IQI*(*-Y+3SZ\;'3
MT$@H0%L$1/+R@5(F%0T00B1J+ 3*R?*I9,XJ&B28$;-%DPH;41@<"14P.'_?
M[>+'_P#E,P?Z-^R/\7]23P_FK _U%[A^*FR?Y)D__C>^GZRR/Z_7!O=_#+Q7
MW]Z?P@ZG[J)_6WNJ9"? >\H?9'Y%8M^L9_5E&5A7<)#?36?6V9YN=,U+TJ,9
M!=D7,%OM]0.ZQ;2G@U%81GL[E52)!A)$+*!@,0JGJ9(SEF,#@#E@-CC@)EG;
M/'"?']FZX;'^&N0O]$[<;_R_U-KBRG;H:#KM2]5L4K4,-U)JUN&2O8B5V3NO
M:DD,S62,5S'->WM-3JQS7)U145=>OPR<YA=D\);E+-Z]E\9GL-?OZ^^CEL-?
MJY/&7&1:?KU>5U6]2EGJV&Q6(9H)%BE>C)HI(G*CV.:EM.V/EA3;^1L!>KS]
MJBM4%V$XCVHKXV4E1]MI[26H-1PMF'R",KVU=VRP"/&VRBNTLN!!@Y07W4%<
M@84R0(ES  -A,AK7![9CCG?&F/V?>K7]]\E>'P6_K7=M>N_5;[A'NU7QSGH6
M\Y7EG=,AB],VO)4+60J/K7J&NY>Y3L,;BL?&Y\%FO3DAE:V1CV*Z-[D1['M5
M>K7(F8^*=MU6AQ[J].]LVOTK<%&5D]6WF<=6L0O^G++D;+!-99+&Y6N:J(YJ
M*J.1?$J%Y%=.XOWN.3\FW%_(A^K/TWB):AK0 YI&D5ZK)8LH**29,H^N.TRL
M6+*R.;$3U=*,F$Z$#0)=52#X(Q!63!A SZ6?!&(J!<L;!%!PX+>^NKYI$6RI
M=UR6*8-HBT4+A8ZO[9XW$,&DLX7 #MEG!6.&-Q!A<,+9998XXWRYY7MC:][8
MICXSY'1[%7C_ ';IVFKU^I7.].G5._\ T#]N_P!Q3(+MXTKHO[[]7\2_Z_Q*
MK^I+?7\*?K,L35SR:]??D0B/ZNVU5=ZA%@/C*\/-FP=#C2<DNR*EN%KQ5'#=
M74T35/;X81/641EH:6JD1!BD"F"PN9-0*&"V8A<<4'/(*^00F>%\<KU<PXV_
M#:$SP#PFJ0KYB9X!X6OJ?N+C:^8F>(>%KY90!;'&U\LK6OEE>V.-K]+*]L;7
MO:YQO<UO7_93XBL%?&OPK\9*]2N 8F H> H=[WP$PQSPO?'+&]\<\;98WOCE
M;'+&]\;VO?'*ULK=5[6O:]JYUR/ I2E *4I0"E*4 I2K0=O)^?<+I\'LZ)6N
MW71+^R<[($#1Q9YCK8+(:YPRR'_*;Q?CR#;@??Q10V9&T7/%7"0DPZC&7&NX
M(R#=?0 % =7) 6W<9+R)0O3!X;W\X?K!4I@?BW^.)])E6-EQ"-X4U\\/H9#F
MI"--B<6?Q%H%AEY-J*&9*DJM):7M0-WX)E647NS3C89RZNIK+,0FV!)0+$WH
M6359.S$/L4L;<[B3"PZS?=CQN>&S:U[>W7(7CB7M_6G[BWYVN)E>U^=H O;P
MVO:_@O>WWZ BF[,>\TJV_2_A7U-F"M6%6R#[)AWEUUWSX=2)".I:I*TQRD4V
M3BU]&&BD:T;-()L-IM]LR2GK*S<Z\8>;:3<$@;74D(0# _D<$N<QR +BXX"W
MPU__ -B9M)_T;Y[_ ,S4E?\ A>@+?*56^^L^Q6*X&V<H&FC%QBHXSA"0+Q4_
MK+8B 74 4D=;#2;M[OAFD JA@!-%4\2UR(9\8(GF8Q,B8!9=I]B9M)_T;Y[_
M ,S4E?\ A>@-AMV$YY!.U?I?B_4E&-9G@G]C$^)E_JWK H[%IV]A/A[ZA[!Q
MIN&)+4*/=Z;)YOIL(*SK;LFX!U9IY16Q&]WY!,LJ)',1!![\HZD0[0;-%SG;
M"N8ER]@,P11<GC/C<\-F^&=K35(5[WQRM:WV)VXW7>U^7_)_H#'HXAWES;0_
M*6#ZD,RK.*]UN=M9#DH[7SW(S$REIP,QX/H-6;:V7UIV: !5$[%JMA.N:" .
M0\7-!8]V$#8/0' "$Z0-\NAT,L,LK9KSBQ[6O>Z5,%K6M>][WUOV0M:UK6O>
M][WO$O*UK6M>^5^?+&UKWO>UK7J!.YZEM5K;MHLUM:S]BO/L&8F@GAP^0EAF
MBDR$[XY8I&5W,DCD:YKF/8Y6O:Y'-545%-E?@;FOAO%<(</8O*<L<;8W)X[C
M#1*.0Q]_>-9J7J-VIK&+@M4[E6QDXYZUJM.Q\,\$T;)896.CD8U[7(E7Z_$3
M^V4;\J&;ZX(-472MAHR7DP@MH/MEKR(JE0CR4M(4 [!+2,JD1[=( \EJR7%A
MM.4B0^//( X1,F"HV-KY!"YX^&O[,IN9.0Z9G9)F"]BZ\V3@O/7#8_'HEB#E
M2#YL3GE$ML>0)0L,+>W/GE;"^.-KY7MC?YN%T_;8LQB99-7V&../)T)))'X7
M(M8QC+4+G/>YU9&M:UOVSG*J(B=ZKT.V;]SGPI:T;<ZE7E[C"S:LZKL->O6@
MWS5IIYYYL3;CBAABCRKI)999'L9'&QKGO>Y&M157H;)X+Q;_ (0;Z7.K#>)%
MY-.'RW:V_7NPJHEAQN.&SC:]KS7(7]D%O;^M/W%OSM<3.]K\[0!>WAM>U_!>
M]O#UU:1NYQ;M#I9@W%HQ_)\D.%PVE2$'#DG@:K;=%L\45IRTT7(X3]Q#L#E@
MKX)J*F'3P@6&>0XN &09<(8?(,+.<6ZP3VM,V^K6AEL6;.K;%7KUX(WRSSSS
M8>Y%###%&CGRRRR.;''&QKGO>YK6HKE1#69U:6*OM&M3SR,A@@V'"3332O;'
M%%#%DZLDLLCW*C61QL:Y[WN5&M:U7.5$15*;X>)C\7'YK5RJS7'?O5JV.-KN
MZ2K7MC:U[?8O;:^"_+[T$<J_A,<1+40HHIJ.;D1ZE5=9#41D9(-:X[3%E98"
M1P0#"N*D)8\(!J"J$D%S)8PK"IQ8T&E@&2XZAD6", YYU"?6RY(_L_W;_A7.
M^]_</?\ VZ*61)O&E=$3ZK]7\2?S@Q/N)_>R]BKZ^&O]UC9O\@M;_P"6]BJA
M,^S[U:_OODK_ $7MM?\ ]$5=?I!Q1M*8CD2=EI_R')*"E.]H0BFMTZ+JSMN8
M#4CS459J,. L&&6@@4P%FF@.I $$S'!"!%LI!V+"C9A&<0<_>#3I.YX3E3'7
M\UJ6S8B@S%9B-]W*8'*8^HR22KTC8ZS;JQ0M?([[5C5>CGN^U:BKW&(.<]GU
MK*<>WZ>,V'!Y&V_(8I[*M#+4+EAS([D;I'M@KV))7-8W[9[D:J-;WN5$[S)Y
MI43_ .S=<-C_  UR%_HG;C?^7^KI8-WKUBV/:JH]8@?+C<3<1G(::2B=58AF
MEC& 5XFDHJX8*!I4@1VU5@T!@F.!)'Q4BA =+%$,"E CHATD?+EK(R#Y=W2E
M* 4I2@%>?<[4;#V13;;>+=0G6WC_ &GNY"<J.G+R,=[G&P,E^ZTI6+'"!KM!
M@((<'MY<3M0X88H?1$PQRMZ"E < PPP0\ @L,0PP\,< P\,;8X8888VQPPPQ
MQM;''''&UL<<<;6QQQM:UK6M:UJY7O;&U\K]5K7O?W?!:W._@K[7S*ULL;XW
MZLK7M?EX+\KVY7H"+AS;H[0OYV[#9Z>ZQ1_,\:ZI2"MQ9(2I(4WK48/V9I-9
M37171(\>:YM5*BA](!T^SKKQ%G%W5*KN8K;<DG J31+8)J$FG'R'7Y4WXUC:
M[S;\:OM\*##D96*1%=PM)Q,]W&L(L7ITS!+1:R9H>[517+%L2/=YJPX2&W&X
M^7XC&G"KC$P&]FK%U1'-*%L2WJ5NM$#VV=3]-)BU^9L5;92,O3&</2VQI!7)
M$UJEN1&RA-N5WI&9%KKQ=IRXEN=30 9+;S)>QF/ VQ(ZLX#2BYW4V#X#?)^!
MDWAQ[".C"?X829N83CUYV^<.O+KGM]R.VEDSLHDK$/1K#$42&.TA&^ 7C!T+
M$U-B"&FJ%7*L$6;C$CS7W:NI3;>B?FWD-& NM+\3+3=84':A-64CCI<K43)Y
M,XHR='<JE@72NZT$E,Y-;"8KA4V*2:SYDB/\4DY[(X\:*RMO5/+AW/YH.:?:
MYFWCXNXKNG+]9T7+;FD$U%SJ?^KS.VV<3,>K,DHAA%,0NQBKCZQ=,F/0TQ"#
M.9C:")M1UDD9T.Q4;J4\S2,%BT[J@JV@EU'P[?X=3I3VKK$V3LAMH/&$9PWY
ME1RFTY%5<K+A#<@EM*52B*. .,#?!4:(NP2:963*F-B$K"("EW*+AF>+B8T)
MC/A12MCK+.<,RM+$9E7W*6F.F6K" ]H]:#D44) 6]*K2@$PWPKMYV'R"DM(#
MD'<;,6G$R EPGG8<!WI)%P A'TU6P O"6^)-"*A[5X429'I!4WKLE NO[N;+
MF1']#+XC@IL C+[A9D@++!E%A-YZCH*NBH(Z@U# Z"FH3S!"4\49R9"HBF&!
M(ECETL,<[^"V6-LKVY\^7.W/K\'/E[_*H=CFA.QLOSHA;/ST_H419-39-TS-
M9LJ)4=\G&,2BS4ESSV^Q@PG*[L4]S+C\D5Y[ .(X%9212+?8C;1D5L$3"^:S
M67$JS$8X7L'CAS\-L+8<^7/PVQY<^5_!?W^5_P ] 11#<2<PI[[.W3)LEM3T
MXLPY+CZ,5DS*.W!M@SP\EMSQ0SY@=7M/P(0A%V$'L,TVT]T@D135>4FB?=2P
M1<@1$$J20#IW'^9.WFVSE)ON_8+7#4M@RKJBT7R^F>VN^4\J36V>V"1HO>BB
MP'Z_H1BS"+5>-RZ:(XF\[<8I:TCRVV')*Z<WRZB8SCTNY4'(;M)GTXV9F24#
M+26Y&@?'5]2VW@';K!>)1NJ-S91IGM?W'&DA(L2HQ]JV266Y,G#(<7)68L]N
M55PD!"C1;78V':CI$Q0W6DV?[ <)&<Y4A=RZ3@G-*9,U'./B8G?#3TV-B.3'
MQ/>J8,XJSZ5%HO'S=0G4F,"2'1&>4DNPC"[Z57-&QMLHF#92G0BNP=$-*JP!
M)1(FZ!YF[DZW:GIL(R*?1YL-/<JXYS7B C3C9K*C=A9\2^@LYIC*H6*G)CS5
MB#+.9.0)MD\FLP4_H@N9S .I02&V;\''>[4SG9[@^+)MUH(PTW=HA-@L82+Y
MRMDYIN0R<!8YJPZY.D49,%"0V*WWLT+$U@FK,N1Y(*LYPN9BL9U"8JSQ(G2U
M9WUK(IN*3](7JDN<H&DZF.=^+"J45RYH17>!%T:W/N#$\(F:*?TJ1/@*#K)K
MR@,9PR!$*E30!?&Y@0&]6J:AZN[M1ALP_9XV26]4I17I8#7TIZRHU_;SM*+<
MCQ//JBK%$*0\VW<(-'<7Q$S1S*;BX6\@XA'9 <!0_)3W47*_%/$^2 EMO?E:
M]_>MSJ*<UQ1FTC[(;RZVNF+%%L+^J[&7'S$+I5'47P;&T.#"U[CN=9=:38-]
MX\<FB_(K E-B%W$UC'LA.FV8Z$N0TFYM.*N%-1)5[^&U[>_:]1&;)\,,SL&P
M-WTD.3 &%*4ZSN%L-K1+B EFAU[7Z026H<4:OW,J),SGW*Y4AV([+>S7D5O!
MXW2G;%,AK#7-86/Y8&2P'71GQ#=CMKT]*QTYUIC%P*[7@;6J9)K.3S.KHC5G
M-YZ[)0V@SJVM?8Z6&7"TDK#S>21'SF;JRZ7VX4)FL]O%'4T\@B#@/J*NF-_N
M=B.(O-, Q6T)V<FHHK+C7")H]D"2469YM:C F 21WTZ%)O"ZLP5'S=07^1F/
M8M&)HYM9)-TPYF8W'L96&0V6:N*:HY58=H>)B#1/;_38---:CR/KDMY/W7G5
M^,IL:D^-V5LV\E31K1";9@))G>-5:/E@!664ASQNU&H@.N(G600QUF[":RDE
M2@TS!Q=+F.XV!T:W)E:#0]:E#8N&IZCZ0=<DF&Y2?>S4-XG9'8TPB*#I]FNU
ML/%H]LG)AUWK:&[ 2C*C-Q++=3HL7F"P'.@2(H9@.M,<H%SKOW1.M_=^$M/D
M^%I %1Y-1)/4%R<W&2$:L?$EUBQZB2$F,N/PU$+OM)JT:25CM[O6D<F69;(%
M!#;IIR*#TS4&XD4 U!XG9O:*?"$1#Q4U&R0=K3G]WHI!NRV(]YLAX" )>0XC
M/-O<"&\F V\M?'=(!U:$4F2EV=SR!&4$!SM,<T.H(PBB+=*]]7U9QSIIO**>
M]1\T?6!%F=%5L'&*;4GD\<9*BM$CI,4^_@(813OR4,)&2RN'CA?&QXP8S$+!
M8"7OC:R34'AN2[ \P:]N-[.B"<&KJE&\R1NVW]$;0=;;G#:@&6SZ;G=Q[1GU
MD85*L>2[)F#W=*>GKD@WD*;3(LHA+#(!PS:IL":*E*4 I2E *4I0"E*4 I2E
M *^7MSMR^"]OO7M?G:_YKVM>OM* BQ8'#S>S.EB.@#LV-]4U4A#9R:MOX=AP
MK&*BG24ERU-UI>.'FR[9;%D,^DKL6,!RSO*3G92*CQVW7":S5FL@N1=/)C-'
M%=4I7:L+<K<Q+6M;EX!1;6\'WK9VM;\UJ_2E 4_E&2H_A6.7Q+<INI/9,<1L
MUEMZO=V+)DT&FM]LMT@,I*ZH:L7Q'-#8E2@ F094D6-'SHUPB9 J:.C@%Q;3
MX:WWCJ695;,/KL1;*P*[)(;#@><+Y["12<CE-FIMM((F<=([(%!<#@/(KC;R
M2II:\JQO**?'4H@(!W)9P90I!+7!4OTW$&UT<^U^G$\P,QU=+1'T]&B6-L,X
MOYG FT.^V4Y$&066D.T5/O<[@S7 YVFE(#ON6!.9^QI35+][U'&UR)BRC81Q
M\0G<J$Y9@R/M25O4X-W:QSH@2$[9TE&+S2NK3 YV!=+CR+X!<T#2F^363=4W
M0?/X/B;WNA-0DDLNY8-NM,V[CY\!J 2Y$7JR%1+'6TUW-Q11BJAFE&58DY4P
MXF *@&>&(J<,?+J I,(^")EAB(3$&Q-!Y986S"QOECSH>F2?JU!/M"Q TU6.
MF ESNZ'ZB08TV"434UH.=P):*[I??XJ%9K!XMDG88(DY7"KJ60H *HY%+(#(
M8RO+(81B$1U:!O>=GF84FCH>GZOZSK3GX936?NKJ^) "&3?0^M^VAR4Y<DQ8
M:$0OMRQX;:4=0R,2BI*4!E7-[2\@@GD3-L&&BWVD&L>C<^@$M,B6T=T,/5Q&
M5X^:7$=VQDN.VVRAX72P8]B/8SA_IL1H\H-9O.%U-E,;C8+;)9&5YZ-QN"%G
MR&=P-OI/92Z;[0*9 G^$D2.P2-E05]-()-R606[90$=J/@1NOF0 C1=#L<S4
M[%N_ Y88$<%+[;W>* *&,&7R#SQSOYMCS(QI"D*:8Q;IA7$=,".=H-*003A,
MT3)%EA[QRV)30L$LX(/E@J 9M1VHXIH<+ /$J?S,$<\<A"^6=X!V+PZL];F9
MI.45^'6U=E8[:7#LO!LG0&T"^O0YQE[B.5$A\"0Y3=Y*4W>TF.YU&8D1K*49
M/V>4)PN9](9%L$P!\5-GN0T<*7V\*[5K8;5]$EQ$V)$!6W2M-_3M(L_2[C*N
M0N_EJ)]*(0B)_K!<\(:S<9DNDOUH+C7+K+N3TE?=(*(&Z3).^*O8;,"4]=5T
MEM(JNXELY<@C(26H+*L>%%'N$33$HF.H'S8ML,LLNUEBA88;/HXY97QPO;&U
M[\K583&G$BA)]0N_=C'<Q-@X%@AB1PVI7]M.?8H5V VGFRW>7S-MTY'8997<
M*X\E17 %2+)C;2T>[C5#KE;2.EI9Y:62J=>[J=6J>?,)S RDQL([V4G?%T@-
M=.9KA=*\QD!V'7 TE=(+-E;>[6",.=FI"^*<Q2%%UMPN876X3.#+"27&/D@
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M=:CU])L;S#K[,[>G>'W6X6N;>K/#=J0U7I'JXW7TU$QR,Q:7&:]8XD9[M)7
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MC\1/B%;IM,NNKIA$05?#8R&MMF3#.;C5B;2-',E8-U2[%0DA$[%1\B[;0U<
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$I0'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g717089.jpg
<DESCRIPTION>G717089.JPG
<TEXT>
begin 644 g717089.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@! 1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?24Y#4D5!4T5$7S1#7T)!4BY%4%/_VP!#
M  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MP  1" $( >\# 2(  A$! Q$!_\0 'P !  (" @,! 0            D*!P@!
M @0%!@L#_\0 :A    4$ 0$"!@</#0D-" ,  P0%!@<  0(("1$A,1(3%!5!
M> H6,CA1<K@7&!DB,S<Y87%Y@;&RL[0C-399=9&4E[:WR-'3&E)46'.2U-?P
M)2<H*4)'561WEIBAP20F2%-65V/8:(CQ_\0 ' $! 0$! 0$! 0$
M  @)!@<*!00#_\0 31$  0,# 0,%!A ,!P$       (#! $%!@<($78A,38W
MM1)!5F%UL0D3%A<U.%%WD96RL[2VU/ 8(D)%1E=B9'&2EM$4,E158Y/5\?_:
M  P# 0 "$0,1 #\ O\4I2@%*4H!7K%DX=3DA3/IJ297E D0-FB*(3,D"9M7-
M@ 9BETPJ;5#)-,+&3PN.)8 =1.%" 0HF.9PT6+XB#8>SKUBTJ$T1(5%A1R&Q
M():>;4#F1<F=4#%BQ0#,<;Q!!.+FU Z-XO#*P10B5,G#.?@@EBXPV> >0$2V
MJ/,_K1N; NRTQPLQY@N]=3!5V\RZU/<A'S.GY&3D1.-+ "R01CL@F&.>1G*G
M)JSDU581]%$U3/HR@E&3:<=#"P&S/,'(NQX_GV/M/HZBZ0Y_W ?,="2TMP3&
M*G'8&<,QL6Q)X&7Q.DBN]XM]AL)OBJ)P)%0P2BDXW,ZE8<A@W&VH$%-/4#$$
MV[W'/- <3:X\H7'8AN-L[7H.LS"@'<F#QV:XFZI;0:ZN%A($=2*EN^/EDHVU
MXY+<4)V&:@5**Y LY%=,:R2*F"&G9'[(3%//+:C&3>/_ )YMS=QIL8\GN[4S
M?"#(U1V+/S CI\RTD0](L;DF$C"Q7*Z9'R0['5'B$K!--2-H#Q4D(!BFK&FN
MGW6 %&ZF73 )?%?>@^FM"8#I34O:EQ2G$3Q:\?B06VVFP51\/MRNMB@2&1/L
M%S82-C%:FPBS;$-&3L@J[]0T,(^EJ;6Q"$?0!=I',!MSF<UB6^.-P\EQQB;#
MH\2LH=Z([\C<2)CJK,;-=L>N@=FNQM+J&CJ1MK)^*:X0<"HSI4'<09Q$,T#D
MMKB.:!42)#+\Z[G16GQBE&7-'^Y;>C6<W@MPJ3F:+('E\LN,,L>97G$C,"Q=
ML(8\N14Q3*F;&:K+E!48A>X+P*AJX1 !HC)SJ.P1G]5-GH4]CT\A>J:^6F6<
M++3YV0:FB#9&CAW."?G;K:MO]MG8E"=K";[:%>@+P=JB$]GX(17D$FN$D5=+
MGETLC8C>9T<"<F0N32*6>FZ%)B&QWL[Y9Y'4+VQZX1-@H,MKJ8R2FQ(FS.ZS
MCX=KG<1%GMH-M-=62TCR<HHK:BX'@K):$W$]1 %.J:?L!J=MS'.Z6KK VK@Q
M,<Q]G2.CN(VB-ASEDMNO%/<3/<R\QW6R5\#SJH(1!PMYZME<;)XP57%!O#FR
M&1],6CZ.8*J U='=;6 [L[K7PLP?+[+EB%X=9>NR@NO+;V/(ZD:^PFHVTD8:
MU,1(AIJV+HJ;@[(M0G"^TM?'>(ZNVL_;>Z8\9S&35UDN4X@JJA+5PLHD_P 4
M\5NL+;VR81.+Y(CYD.1+.-E.8H#)6 X]0GFY+1RONB.V\G!"M]^NF/\ !#<S
MN01$P)V"N%5-CNQ-*/4ZO$00,S\<W(M%G)=#[QF^'6!*+!9K.E5U0X9+RP59
M1!P*+Q9!=+,.C(@G,AYO@I9')>>TT(J?-J9<8_F(-<,D&&!<3/?[(T6P!%,9
M#A8@ >-N,-D)AB$#8'PO'7%$O>V =@;8Y7&OGEC8&V.5Q/ \'+I^>>S-9-J4
M_@!D>'0-;-H$B<C7+\0E!'CHI!\T(<M6C%77&@<%D));Q1JDGD4:0J$EK>1M
MUD2X*<3!+C!&#Y<;,+#/89QQ-NC#3"Y)@H?UQV)4->X^YY81V67H ;49/I/(
M3QHJCN)>6Y438:9:@C% I28CL=K?8!]Y)C'+K:2NI::8'< !E&$4KF +UH8X
M(P88H0F H8N&(H68>5A,! L[6RP$#RP\+',/.U[7P$QO?#.U[7PRO:]KW_C<
M^2Q$+ Y&B]A3MA+DPKC!V$-6!P\8-Y-A?+PC'B0_U0;Q-L_%!_3B>#A>V55!
MMQ=6&.]L.&5OZE0WN3\ZV>Y)7[)T@%%)C;%,Y;C:$)754Q;?UE5,,(B!(VO\
M#&5M;4$!OHCK3X_)%DD$\810A4D<!?/>G<>EJI"O(U)>I1IG[81)J@-'^A9W
MB]D#72'73/($0C:YOH9\2#&*1-SE3Y !@)<<TNK[B<4JN62W"C(;TC(RIDWT
MYRZ'[3 1 +B=CI3(SF3Q,@7-AAXC"%K"X7,!@YY98X#9@>%XW '/+'+' ;+"
MP>>5KXXYWO;I7(1LJ/D-@"8!%S+B9 CX!B8"9@C8VPRR"%PPOED&+CB('E<+
M.V(EL1 [WQM83"^5'-(9T^WY==:)A8&NFWT?M=O<P.X3)DY[O^*Y?>SM4XSD
M1GLY* <CKV&NS45O'-87P?**^</1"BW<[#@]GH9I=<TD+1QVE,DC&+%UGWU;
M&JO*1%&L3(E*5'4L:BH"O!6V"U#4HZU[EJ**^-E<7Q,NG<_H[E*H@$V;!A1N
M#(:\V98:(CX<"HW%U'#2G\=2Y+9+2:H%]8)0(C%?+@3988GTSR\K"'"%*^"'
MGE@+GY1AGD#X .>&>(N?A^"'EAGCG?'+'*UM)]+=]HMWA/[/I,<-*1&BIZF;
M*OK5B2B[^)-8N$I2''H)(5<4V<::[J<X2JT1KGL TU24[(JF9R#$R%1BP=P\
MQ*Q4SQ4X'1"VM<\1;'VX[OTHD#DSU'G;?C6!W:G.V+FXQ6*U(N;S)=Z<T=4T
M)DI3V?L.-USH2 L[#)Z V'W'3[D,H1=S:+.PNEN(R0D;]CQ1>ZHV^BJ&52&9
M3AEC2'R?3M(L+)<FQ8_(K\_Q M$THDT%IK)3\1$4X.@X )HB>&7+!YYHMRN"
M:> (C8!EK 6/J4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4!
M"OOQR_D>.C;* 8NGV$3 .I,T60DQV;B([R4!$J G6ZU%S(343I68>;'$(E6V
MO*S74C03J+/X#,N@$5]2NB&!FZ,4/97VAY06%I7$VUL][$HR,'%<'.N-V7$
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MSP\@TB(YTX24#B4G&CZ:$< 3SIDB5'-D05## (^$3,C YCE0CH8> 9P, 0/
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MS#SQPRQPSOCE;'++&^>..5[7\&^6%LL+YXVRZ7RP\/'P\;7QOE:U^M02ZV:
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M'8HN@^TGB^,A,B:^YV@DEDH@W&*OG3QTPMAB8Y EP"Q4T,8MCC&U_=#VKO\
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M"R9YLLI?-E8+W\T^8;DSURGM=\V^6^=C'G3RNQ4AY/L=UM\-OWZ=;?#;]^U
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MWUI0$'VS.-L>=GB^M:UK=-/N0VW9;IV6-03TM]RW6_3[MZG!J#_9K[.UQ?\
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M[,_'%J5N9#<\[Q[.;NN_6!QRMMXIZX"63]54V4T=A(I& 8S7HU!%.)TLW/.
M%55T\ZD#CYAKZR7&'+&LP[)A;R1/"^XW*W9EG68*8TU?@-[,Z/18R61H0W-1
MDTQ-\%M*2S+$4AD^^TD?1ZEGYEA)E-E^^;\5.0O:.^8F%:(8JTZW\QA[CI0.
M#^&]U[SR"S)'D/9^2E>5(:>"'%:C!3P=\KZ>34X7$\L"[RQG%RLM^Z2MQOQ4
M/ ZT?S9%XM1G!FI/U('*.8)6NFD1")'$":G_ &_>[JUC;VD^FS1= KW:FI>L
MS9>8Q=PE!G<WH%BE%<XI5W):FB.LL*OIK3+*PA=S(RTL)#A!S-W#6DQ54B"E
MB:*'S0(NSE* PHLZV:\.)1BU77H(AM:58.+D"D+*2K&#(4#T1E$H(B"EE(R-
MFT,4=B%4T),3,$\LU\TLN1LFI]RH0.1$ID#%;SP^]NU6^^=\=?RBT"IO:A"Y
MXO>W:K??.^.OY1:!0$W0?N;_ !Q/SF5=ZZ!^YO\ '$_.95WH!2E* 4I2@/5K
M?ZSJO[FG_P!#'JHAH_[S'4[U=(?_ )$)%6[UO]9U7]S3_P"ACU40T?\ >8ZG
M>KI#_P#(A(J,ML[HMA7$,_LPI[9A]GLI\CP_IU#:.E*5GH64*VIXB?KH\C?K
M"P1\C&"*U6K:GB)^NCR-^L+!'R,8(JK=CSK/N_!%T[;QPGW:3Z P.*+?V;>"
M;>E*5I60R*4I0"E*4 I2E *4I0"E*4 I2E *B0Y*)QVXCE\P<T-;$J>4YFJ3
M&G219GD6$=5FWLJK(0;%SC-*8C6P)R Z&8R$\XLXNM\NX1%++9R070GL,1+9
M#;73PXA,66^M2-B=6%6<7"@/!G;(;!:XNM+9COC575877V<*G.IAODZB'UDB
MK-"3V5(C,).Y'-(81MB2<@H*2_V48.JH">MF4954$8R!%.[^0">W(QY_V5@:
M9F4[8"THB+41^BESD7) /SYA.8XJ94YR8ZE!3,* 3BB FHQ0^F^7C%';22CB
M-J1LU89X7=2"3R:Q/,"!MYLQ>3&3-BR[FF:@&1>267^/@E )9C(Y920VI'[X
MEF$&[-!>3PE4VYC<@'Y>B$RY%YO*I<!H"QFZ+H"<VDITH99T+&8E;B5U]L22
M6.PW?*$6P0?C;7F))BU_:!QCG6#/3"U:P!+0\CO]<=['<LDI P"(6*LY_*<?
MO9HJ$FLDJ @.P<SF$&HX9$2N.N.$J<B<I827*AN-TC8!V[:-_6HZ(P!X=0=G
M7TCKZ4YY;)G_ &B82J8%.*+K=+Z),M0D4XR4F2W(JO4BC!F\$DFE 1[3+,;)
M?_LA'0^/&[9X6<T.ZI;V([XLOQM(S0;UC[H(P8NI5F<]':U41G282LGAW\YJ
ML:KKL2D(_>R.N'4]8\(AC82J#[9FUL>=GB^M;LM;3[D-M:W6_2UK&8(Z6M_M
M\%O1:IP: 4I2@%*U#F[??3?6YZ81U.VQL618^!4-.<H;8>+BP2U?-!5C"@53
M56Q7( 2]R9PPE*(( OA?3YDQ[=+>!VX;SY?.,H,4$ 3=W7D(P9\=Y*7%?A4,
MP;\GPL*9\D+YE\1C7DP66(IGR? 3R<++$4;P [VRN!)!2H_6YRJ<=CN<* TV
MUN%!JTY'2N)#;;R,0=X8Q]775Y1+)*,E$0;%;>..**D<*DBH76WC!QP\.MO"
MZU(%UZ]WV[?O7Z7_ /.@%*4H"O9[(A^LII5Z[Y+Y*FTE5T<>ZWW+?BJQ=[(A
M^LII5Z[Y+Y*FTE5T<>ZWW+?BJ.-H;IE:^&HG:=W-XO0NNH;,??:O7U0P@YI2
ME>#&DPK-VH'V0'CR]:S^CML-6$:S=J!]D!X\O6L_H[;#5W.F?3[$_+,7SU)V
MVMO:TZU<!7GYM!?/#^IA_$Q_)M03ZF)\3+\F] _J8?Q,?R;4$^IB?$R_)O6@
MY\P!5JQ]]+R*>O$X_DT:M5]Q7P^/OI>13UXG'\FC5JON*Q[UPZW-0.))WG2:
M4Z5]76&^0H7R*BE*5Y6=^=<_<9?%R_%>MUN&_P#8?O1]\(E3^8S6VM*<_<9?
M%R_%>MUN&_\ 8?O1]\(E3^8S6VJ\V-NL#)>#97;EA)QVF>AMCXF8[*NA,92E
M*T<(E(/MB.(1PSER$M#=<K/#:0"B(\8!>(7G.,7FMS[&!6!Q4X11C77>8D^;
M&^RXVBR=PB9PM,S=78:>1U:"<CRM=0407 2+-^4B*-88!@M[2I(,-12T(O<T
MVGT18E7-B)UVNB/9PH'GCR)UK#32!2K3R>1G%<4 EQXE40LZ'.!9/!<RLL8)
M"38EGFE *4I0"H0N>+WMVJWWSOCK^46@5-[4(7/%[V[5;[YWQU_*+0* FZ#]
MS?XXGYS*N]= _<W^.)^<RKO0"E*4 I2E >K6_P!9U7]S3_Z&/51#1_WF.IWJ
MZ0__ "(2*MWK?ZSJO[FG_P!#'JHAH_[S'4[U=(?_ )$)%1EMG=%L*XAG]F%/
M;,/L]E/D>'].H;1TI2L]"RA6U/$3]='D;]86"/D8P16JU;4\1/UT>1OUA8(^
M1C!%5;L>=9]WX(NG;>.$^[2?0&!Q1;^S;P3;TI2M*R&12E* 4I2@%*4H!2E*
M 4I2@%*4H!2E* 4I2@(/]FOL[7%_ZG_(=^E014X%0?[-?9VN+_U/^0[]*@BI
MP* ZY9>#:U^G7KEAC\'N\\<>OX/"Z_;Z=.SOJB-+7LU;YE\J27&WT.CSSC'T
MA/ACAK'SU/D&2L"T72K-T%4S(?._F[$!%()-P.BD<39S D(/D5P.', ;&A;V
MXON;?Y0'\[A7X1VV?OI-D/\ M[F7^<IT4!=XO[./M?M^AK7_  ;;96_\K:\V
MM6MLF^S"@9&V$UDG?+C_ !DG+77YN?A-G'9^QW%W?-BCY,9!?HKY0.7R0_:V
M,GY*HO4@J^> QK$0_-68=SHE):E 7^O[N.M^UK9?^+;/_P#7FOZ8>SC_  \\
M<?H:W3PLL<>OSV?7IX5[6Z]/G>+=>G7X:H U_0'ZJ%_E,/RK4!^YAQ_[79[Q
MZ:Z\[9B,7&,Q)VCM/?F;#P<EWA@U\SI]1(Y)6#FR0VUDM8@Y)]Q,3V2"E7$L
M+;&Y,*^'TVXE0^< WV'+CY]7Q#_E Y*F#H"O9[(A^LII5Z[Y+Y*FTE5T<>ZW
MW+?BJQ=[(A^LII5Z[Y+Y*FTE5T<>ZWW+?BJ.-H;IE:^&HG:=W-XO0NNH;,??
M:O7U0P@YI2E>#&DPK-VH'V0'CR]:S^CML-6$:S=J!]D!X\O6L_H[;#5W.F?3
M[$_+,7SU)VVMO:TZU<!7GYM!?/#^IA_$Q_)M03ZF)\3+\F] _J8?Q,?R;4$^
MIB?$R_)O6@Y\P!5JQ]]+R*>O$X_DT:M5]Q7P^/OI>13UXG'\FC5JON*Q[UPZ
MW-0.))WG2:4Z5]76&^0H7R*BE*5Y6=^=<_<9?%R_%>MUN&_]A^]'WPB5/YC-
M;:TIS]QE\7+\5ZW6X;_V'[T??")4_F,UMJO-C;K R7@V5VY82<=IGH;8^)F.
MRKH3&4I2M'")12E* 4I2@%0A<\7O;M5OOG?'7\HM J;VH0N>+WMVJWWSOCK^
M46@4!*9-FR^NNLZ*BN'8N=H?@A!<JR906ZM3#)#1C=*75L H95!DA'/NY722
MRDI@II8PH"D28@QD,D *9S#Q!PRSMII)'-+Q.14UQG>Z^0G5$VC@*">FY@L6
M7FS*KAN94Q! BN830BTR\G:.2PR#RN>4P4,1-2P[X#*9LF$('GG6\]FVWZ:N
M:3=WO@I,]%K_ /-F!\/W?]NEJ_.'MEE:_6U^E_AQ[+_OVZ7H#]CC^Z0N$[_'
MVCS_ +A3?_JMKWS6]D/<,#Q<B$U$;?J) 59QJA1'3A7"C2:ST((X=$L$!FL.
MMWL)#:S<3L<[_P#M*PX5E+2"6'ZH=/%P_IZ_&K\8)_\ ,S_SLOZZ7$SOV7SR
MO;TVOE>]K_=M>_2] ?M_D.5'C-5#Q%,3>0?2I04E0Z334T@3V>ADP</J*B9"
M))Y F6">.0Q@X=.#@%2I8+#(8<P,$"%AD)GCC??;K:_=?KWV_#:_2]OP7[+_
M &Z_!,B*]_FIQOW?L^9?HM_]3I/VJ_>QQ[K_ !L_R\J ]:M_K.J_N:?_ $,>
MJB&C_O,=3O5TA_\ D0D5;O6_UG5?W-/_ *&/51#1_P!YCJ=ZND/_ ,B$BHRV
MSNBV%<0S^S"GMF'V>RGR/#^G4-HZ4I6>A90K:GB)^NCR-^L+!'R,8(K5:MJ>
M(GZZ/(WZPL$?(Q@BJMV/.L^[\$73MO'"?=I/H# XHM_9MX)MZ4I6E9#(I2E
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M=,DM2PS##S('<<Q;Y6"PR*&<<A+X8^%G;#&X5LL[XX_396QM?P;=M^ENV@/
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MK]>K1,.L9OKV9(OO 5)E")4N1)%2Y0D4 !+%"98 (N5*EBX>()<L7+@X8 @
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MB045A214810PS4&\CNDVQU=U-,ZHII%,?C/2'F1,M-5>#%/.1KIKDPQ1#JN
MHC %Q>VP/1' ]-[P_?<8BW)BX2;<]:W5S+F_,:K$?D1)3B4M.THE*ZO0F*T7
M3EHFBD\RJG+Y;JIE^;6QJT7Z1!=ALS&IZ$QH+49S_$,LOL(K5Q%:UJBC<EW>
MCFK6J:\Z>6-#Z-:\?VF/FR_\(T<_Z_:VLU!Y#5_;*25J.U3C]Y$-5"Z,S#[P
MPD';2"VG&<=+ I%91$C%HHRZA2<]#9MXG<%G-6(I0B6 7&1T9:-9'@Q"@0!B
M1[P,/[W'_-M_57-L<;=V-K?<M:WXJ]</.#FE*4 I2E *4I0"E*4 I2E *4I0
M"E*4!Q>W6U[=MNMNG6W9>WV[7]%[>B_HO4<2-QS-9)G(B_[R](1R%$+8UW[B
M-G609&8 3#1=GGRG.4NX9 N\R[:"DE1;GMA>;MDM+CXXX,DA/E%?,N,4^>2$
M]";*3(]2@/"S34\3.X@A(H()>UK7S$+ "9WM:UL;=<\P\L[]EK6[<K]EK?!7
M7S6F_P" $OX(6_LJ\^E >!YK3?\  "7\$+?V5:G3UN!K#K>Z$QBR2K+1Y_JK
M6-OT./(KAF49WD-/CXB?%3#DAN!BPBP)!=+88 *D6.)V+T<:6E-TTI$3R:04
M#A\D;+ [@5#XL.%U::;Y[:3*^X4V!EF*MKXRUO4X\?\  4/.V<SK6=L!-Q],
M5P0.[FS'"<KO-IX*PSB39&C=S+:/\SY25WL_"*L[VZ?3 BYH"3:-7M%$QL!H
M2G%:\SY!CE_(*>YV:]&D*FKC=<: J@XF""HEJ9$,4N8*CAWO;KX6(@(N I<P
M&$9 &"#^8?&M\&R/*,)S*]H[1UV3-=5)]JT+NH?-5*C,52DYI^T5\FB))/.D
MT51$<35O9&'LNIZK@7"MB.G8DSN.)FT"\ZL:2'I<PYIVTBV/8A1UZ&&BVH4$
MZKG7@[$#7G;Y:EB;%USDUA2@<1!9D2S\ZF\MZWN@M,[W($(S9"HA2:W4N5;E
M$]Q*#T\UA:D;+DU+&?I.;TQ+>VZ/R<:365'RB.2004'""2L1ZELG9U28;935
M1/9P,$.M<.SR??\ D1;H;7<!W%36%,MD,W4+)% L&,=SQK)3>"=;!4FR[FT*
MKN= !7$$,FH)@JPRW0L,ITD S80%PLQT-U-]:0E#P;WP"4$TV%;/.P?AW];*
M+^BF%F*NR7*"BC-%CMJR;=<<!Y',&BQ"RNLIK>3KY@)B8>/"V-+*NFD<+ERH
MUL1#6 @G@ XB"X5KM4-&9''<S$:!6%YCB@76R/>4E;CXNZ2DC1Y$@>WJ_O(U
MWMJU)1L;(T TI6(X1@=3G%'2V9N[6B.C .7$4H94413)I_P:OK[,3J@HJV8*
MUVW$:RN)I"DMW=Q(F5)ENY^6-P@]BM67&SU!.PD195L)KE%M9(.S;M>$VQ::
M<C"&CYS)*.,\5<N;:B6A 6TL4M,Z?2D"/2U[VZ6)EK6M?&][7MT\5Z+VO:N?
M-:;_ ( 2_@A;^RKS [7MC>U[=/IQ;]OP7%SO:_X;7M>WVKUWH#U]TI,OWIY&
M_I[29:_;\/:%6%)YF^#M9V07D.9U<!KMD\Z&TR4K)-9+G?"\NN]X*'FQM-IN
M,Z/VRZGBXUI7.>'B63D) 43.( !DX,&$3*F3 6>ZCLY%V.TGDU=>#TB1]L^]
MX^C_ &4;3]="KJ8OO5*DJ./(8YD]NHS_ %=&B0MG.KM8J:K.<%)7TN"S9:2D
M<VMI#O)X&4)NKH5@/NG+O+J2SHHC::%MSK9%MR\YCS2B5N80C,0DS2,[4<=7
MQ4$!CP #&UYW7U=-";ZLKG0"$=YV(MX@*Z38H#<\6JY_!:PR)Q[1IKS-DG06
MK-*+(18DIS-)6Q C^*/B/5**Y;<9T*1)B,R\TYP+I+[BQQG,U@@YS3:<R.WP
M D560SC;2<&^HHMQXWH4(;1PBZ-6]O)UB#:.9XO9;:Y X#:Y%9;+@F+<6$8-
MFC8*)W_JA)DMQN645J17NYC<51*/'DG&41*=<S(*0HQN-(Z<=5\I-/I>3-28
MKG*?(PW84=L6*YIR:2Z[FPZM;GMLMIS#.N<QR&YF1#!U&#>:O"[9;R<Z,!F0
M\+):-#SKEIN(TA%RZ< 80"!%+3T-0& D3?6\FG\<L^)WPYGS;-%FZ+S<V1L4
M:\5R6_G4NQ F-UONI;D\VQF P70]6VP6XANIN&G0['0@(R&VAEI-3ELZ24S8
M)/+:QLGV4\VXWWBT33;<K5=2(E.5L.1!R3%5$7V^ND"ZHBK:,J$K#$U)*54T
MV6/IQ\H,*6.$S )@ 7,(3'*\!3\>DW0KJGQ^:^M37[89F2BZ-&8GCJ>]K8QU
M-D:=Y(URCI C>/49\PVRBS$;2PJD-@'LYR9D-J$WH-C'$8'VV:DYZ(;N6$=I
MLASS>Z[-5BL6 H2948-AS,J-VA$T>-A@,]Z)*ZA/%K,Q!:22E-EONQ&= 0+F
M3',DHQ0F27R3B"#72ZL";P5\,3]C%J RKYK3?\ )?P0M_94\UIO^ $OX(6_L
MJ\^E 82G>8X0UDBAW3E.SG;L;Q0Q $LT\7NMII@=)0"JRNI393S:CBDIBB=#
M*BK2TF$Q3.)00 IB9\K.B%R0!@R#ZYT3YKPRG<39#M?[';J^?AA_[$ 66,@"
M"('",6'VBFR#)AUV#E,&FFM1JF7VU,U-145PK:Q)7#4RX8Z:6/&RN!.32-''
M+^GSNCQKLD[(I]>E;5@109I)$NX_/;41-L8/<+Y#44.X0X:D@E&4DN!1<I<R
M$(3NWB:IF=PN4P'J!_8'CIW(,39-&J[ 8RP^]=F'QM;/M/3.3E10&LW5=OO[
M;/3J;FGH1)[B<(ITHCG6@1@YYPTR5]8." N/7UQL\92-8JK,=BE=NI[GW^]*
M? "9(YL[QL[CF6XQGNM%#(,=&VWN1'6,RQY,FO: X"6O"R3>J3/T5.23VK%Z
M)+K&C!2S3W$MN1FJ;M9Z4F'TQ2<X63>6B YW9R#ML-8=C2+J48I>9)4#9: U
MWDYB[I8[QC)53V.^DM07&3(ED646FS%@[&[T2DE84&G(R>1-LEQET=8NDKQO
M-)4L"NJ=]JG/L$Y6Z P^.6;7D*T(@FAWO\[M!& < GV"Z3\>FB#<U\CA9EQN
MG&Y([]F5=%P8#M6H^75*&T-B8GW Y)"5" R&WES!^L$79; ;>;3R.]8(F5>U
MKGS6O7]MR$V]XX;";1IHR6S7Z]G(7UAAMG.UK-T5?@"/D1SJZN_BYI!=,=J,
ME*1 ZS)!?)-27BZ,W4]P&_ 6[VGIV#H]V-0Y(1W=$<N/,]'T2.%A,EXR$J2P
M\$]>=C>'1(O9C%:3B?$AF,C3&=RD5&:#;6"AQK-]2>A8P(T2V:W;/D32)$\Y
MQRTI:B5=;KXCM])6"TUW.C%L?(E(ED,.4&MD ;)E#Z>?('BIM,5TA4)DE=%5
MB1Y(5R))2)&B@,!*A!$L-;5[0E&>$=[!QXR8BWIW)DZ3GMKK'BZX-HH-15V4
M-N1(9<C!9B V7BY_F7R,F/\ 3FW)F;3CI]J9Z-7>E$0&X4;"TL.ANRA<6K ?
M<7:01&Q) :KG:*D@J\N8H!*02 :3+"W'JE-$A+4:/R;4@+,0),G.2F(IH,@S
M,3Z@&,9(<KD%4$U#4QCJ$F ;\>:TW_ "7\$+?V5/-:;_ ( 2_@A;^RKSZ4 I
M2E *4I0"E*4!'1LU"<\H.S\-;J:S-1B2>\&1$$J:[RU#K\?9B,A7S%$B.IA2
M,A."/'[9I/%(2)!CY_Q^7$!072G$&P\6N[' 2-N1O*:6D&Q<"+T.<A:M(VON
MWS\96ODFR?$<C[(&4S5U#D50;2'%T.SM&\<LAIIS-G99C;$I($P,16C]65G<
M[7"PF8G*[<F61F>TSX*8W$0%VS)5I=-7(9IUKL_U:,9FFE-8SO;B(Q70[BYY
MJ2"H(C%:DEN XTV*\)#>"&T55FQXS7&YR!INDW<]E]!;8:WA@F&U,N<' !%
MBK97$S-+<@7=QE+6$+J,B;)<?#FU\8N28?4KM./)'DG8'?*?UZ+6^?56M@KI
M<&QZH;+QDV&DM8)A8RMALLRNYLEN7(I:2%L8:TCG)=W0L_G*U8O4801.0:-=
MXD!T&'R>4'89\S<9RUIPIMLS'IAE!%4IRLV541J/!O+H#O4R2VW5\P=L$A+#
M;\B4]J'MR%P.FZX3WL#'!]4D8:"5(!BJ\:G6X]8R?IJ:'* T08OB=4:LBM)
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M]:YK=^O>LCGCR$8'A9MRS <WNEM*!\TV=#YFE2-X[#169$,'+Q$@B2QD?=\
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..E *4I0"E*4 I2E ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g938650.jpg
<DESCRIPTION>G938650.JPG
<TEXT>
begin 644 g938650.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ ^1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?1$5!7U1535\T0U]/4D<N15!3_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@!30*L P$B  (1 0,1 ?_$ !\    & P$! 0             %!@<("0,$
M"@$""__$ %\0  (" @$# P,!! 0)!P8"&P$" P0%!A$'$A, ""$4(C%!"14C
M,A918787&"0V-T)QL[4S4U:!D974)29#4I.QU0HT1E7!\!DU1&)RAI:AT?$H
M.#ED<X*2HK*TTM/_Q  = 0  !P$! 0               @,$!08' 0@)_\0
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MDGKPRN(K$D,L\4<TB132UNXPF5%/9+XF=S&) ?&S,4*DD^IF:P6Y4/@QZY"
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M'TYH3 'CE+;(">?T[[1Y' Y/]0^>?6I+^T^V*%>[_!UC2 >'[;X'! Y(/-@
M_H.X<#Y_'SQZK.@D6X"JN5(X2/EBJJQ/R68?:">26)4C]?P/C0R$$=.5PU9+
M()',M:06(C^?TCY'=^ORG'/YY/KD=BH->F2C./HKFJE74< DLQ==@,?"HSGL
M.G#2;V\^TP1>)%?J7&V6%DMC:.P 44KG)WW<E<;Y!XLZ@_:C9^2.U//TZH4J
ME:E8M&Q9O*#--%P(,?!72YYWM792D-?X,:E_)*RQJY&''_M2\YD)&B/3JA3D
M5&=$M70'D"IRXC1+;L60?#1D=QY++RHY%5<D=6;F:.+O,9)=6C8M\*6)9".
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MSJQY;@,G<I7X^20W*M\ \@GX7\Q8YUO9DP)8-&>GN\6WR.GRSOOU/89XG/\
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M>/D"X2!\_P QX7\GGX/K)/\ M;K=:G]3+TYJ^=G(BHI=B>9H$=DEL/8%P5H
MK=HCA=FEL*Q= JHWJDS,X-<U7I(N3R^+-+(U<@)<5:$#3FMW%ZMDA6$M60,P
MEA/!_7@\D^E NKY?<*MM-6@.4S&(Q61R61P,?+9:SB\8DERQE<#3"ALNE>I_
M\G8FCY\M#)!):BJV*TK- <\Y7\+\,T+N03X?ND1.1@C2-)+'J<+D['(P"..+
M[&^0M2&6FK(H@^)':[5P5%V^FYE*HI.Q8XTG U E3Q:ODOVU,N-)#=';,Y'<
M08LGCE)"@_(5[P8\D=J@$$G^PCTZVI?M3-HW#8I];I=)HZ=VD*,61EMWH'AH
MY&Y6@LRXZ7Z>X[RRX\V8J]JS%_DYM>6-#Q"[GF[OR3095)98)6>O90RUYD\4
M@:O)R\4D4RH5D#H8VB<*R.6#@<,!,/I]M&9U;<MCV"CKV>S&*SF9R&9QF3Q&
M,M9FG;H96W^\:[FS326*G)4\AK6J5MZUJE8KRQSQA/&S.>7><+M<*BJ6MJ8=
M,00Q1B"",L&;XWR%#,$  P"0->3G&>&_._L<Y/LE#02VJVUWBU#2>+,;G<)Q
MJ54,<>EIF12^IF!QE@F <$@]!2^[_J&T<\B:UJ3O!#'-)$DN19N)?F->\SJH
M:0!BGY#LC(A9^!Z/:7NCZC78HYEPVEP^6**7LF3-JZ^3G[''?W(5*E69U$?>
M"@8E3ZI>O^X7:(Y7C_<^+Q4!6 0V,SM^HXNQ,L<;+)'-4FSKS0F1R C211LO
M<ZA%)[@JM0]SK8S)58-WQ&4K?7QM6PDL69QEC#Y&R)/(R4]AQLUW'6UKTQ),
M^.ALC(PH8S92)':4W**^K*_AI/3NX + &-F &"250EL#KT[]NV4U/LZ2&'QS
M05T<9QI9I*E0<XP%9R$)W.06'IQ<O'[@^ICJA-7I]&SR>)5D&P??+QR(D((#
M2$?(4'D\$#D^O)?<'U+@9U:AH;%(ED)6'8?R[%55?D$L2#^.>/GD?'J*F'ZB
M8_9ZD62IQK&DR)+X6L 4JRHWV-!&\;'RUSVM'&"&90S/.Q4#UL6<TH7R2R2R
M1GF5&=VD,KG\EE7L9F0(BQNZ+PG:">7[F=O<Y N5*MTWT@9Z;_(^>V1VXA(N
M4:-VTNDZGNOO$F0=@1UWP>FX\\]>)EZIU7ZO[;12_6I].Z*23RPQ0VH-GL6"
M8Y6C[V6H'CBB=4:97EE4=O"'^*0@5C;5UJ*JRGIC(K LO95VUV8#GY[> %YX
M(Y+]H/P6Y(Y:?HGD6DU]JO<DE<1L1&&*@.]B:-VCD 8(K!.>9&"\JO<Z_)+\
MQF%>^92C,H996;A3(JJA0=S,$ '(+.!V2<J?M"_,]1:9J:&1URSH"3D@9V!P
M =NO;SZG<\52XVR"EK:B%#*J1R,J*9&8Z<K@%FWR=NIQG.Y&_">?:NM*D=K=
M,68,H9?I-O5@'Y^X%EX?L'\RH3\C@'DCG&O5;?-=D2UMVLX'-X)&=;V1TBYD
MGR^/C4%I+2ZYEJZS96O70.]F/'76OK'&[P4;/;VE4M7621.Y@RA)QPP8N6<@
M<ET14140@)R?XIX!4L@/K6EH(>)6C!E7R>.>7@!)D3PI8[D[9(I)T 4""/YY
M) Y(Y=^%& !IQM@;GKZ?$=_MXC6I5QA9)5/4-D-OCNK AAGJ-L_U2IWX=[$9
M?&Y[&4,QA[M?(XS)U(+M&]5?R5[56P@DAFB?@<JRGY! =&#(ZJZLH)=LV[':
ME2KS6HKF0R&1M+C\+@\7"MG,9S)21O*E''5WDBC+K$CSV;5F:"C0JQR6KMB"
M!"Q;3HD\E&3J/JRA4Q^N[S*V)KQF3PTJ6PX7%[%+2@$GW)!%D+]Z6./A1&+!
M1410%!SCHUS'679[%Q1)_0[3=9HX16/>E23;+>9NYNW%&W<J6+<6&QM-IE D
M^FKM#SXY'#-RNEF!W"[^61D ?;D9^[AD7;2@V$CN8B>JADUZV /4 1L5!ZG2
M#WXVH;O6*]&MD8/0,(LO+)C[^<SV7NP(3]BVK6,Q=6AYP/\ E4JM8A5N5CL2
M !SE[NL7_-=-?_;[9_X?TYWH>BY]!]_IYGT^\\&\/SDD/KJ S]04#[ .&Q[N
ML7_-=-?_ &^V?^']#NZQ?\UTU_\ ;[9_X?TYWH>AGT'V?+]WWGSX'A_[<G^]
M_APU[-UEX^R'IF3S^&L;:!Q_M%5CS_U>O5;K)P.Z+IH&_7ML;81_U$U0?^OC
MY_J'I->X[W#]-_:YTDV?K'U1R,]37==2I5JX['0K<V':=CRTZT==U#5,7WI)
ME]FV/)R14,5CXF'<[R6;#PTZUF:/FRZ\?MZ>O/2[:O-:U?H)I%*.7R'I?F6V
M?=]FPE>;YBQN^[SB\]@,)6V2*/AKU#5Z$];&3LU">>>>O*WJX<K\B\T<XEQ8
M;;[TD;-'XKR1PI),BQN\,1D8&5T22-IB@*0"6'QWC\:'7"W:^6FR -<J]H,J
MKD$DZ(V+*LCD+A%9D<)J8-(4D$:OX;Z>G/NZQ?\ -=-?_;[9_P"']#NZQ?\
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M"O27$8<0PUX,:D5"*."K1KI'$*L!#S11*\]F1Y[$TCLA65*/\2)J<@JVIB"
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M/54I8BL3M5HP02M82-XXIKLE>,-(R++($([4'D9F7N);T79 )=@*!HQ8+>2
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M8U]47[<>>3Y?9CUX36'$NV0,CI\QL=^VX_M$<28U'M,<?DE9G0(3\%"/@$?
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MMY8^>$@9')8MDYR22<G?)/;)/?J1UZ<:]XB&01<JK,T3R,%[F;QA@W/X/)'
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MDMB"&)IH$9I?31B2RZ6T$,/B!*E2"-P1C?KOD'/<=I*# 1V,?BZEP8RH97U
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M4-#11*;?6-&\,E:T\ID8Z7^&H70[$3(A"!41I#E,J_!D).OP_P#62_QQR?D
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MC\#D^G_]PWN0Z7]6>EGM3Z4]'.GV_P#3_7_;UB=YUQDWW,ZUG;>3QN=EP-;
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MZN7ZFU:UG*PT;^2EPR^,(*,_;TJ$ GD_IR/R1\']#P?G_KYX/R/GT.T#C\_
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MH>Z.-QWQO8E98X#(H^)$1F,C(>4D[%5P59@;=RNF*>LF9F"BJT  D*3[O3D
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M%5U,$8JOFP&0/M[=^%:>%6GA20^'&\B*[G!"JS*&/?H-\=, G<@ QBV[W>=
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MP/<K<_SD#M) XYY'V\D$\@@ <D@MP?2=N7.Q>3P#P>2.XG@@?"M^H) _/R0
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M.UZ.J9+=:&*.40/"TCQROZ,XN]1NXN2@W:X>*P'B+!@"RF+EE' *,.\*"O'
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M9-<O26:D]NC+<Q-O#RV,;;EHWT@LW,9D$6E8@0RQRK;Q5>6-XFB,5A(99#)
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M"]\K6F@1(I"!(T8DB7TDNO/NOT[I#F;&EX##WNI/5>&K%/-J6.NP8S#:M7L
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M"X;#]1NJUO\ HWC-GR66RUNCBZ&.T3$S9O?LK9R-RO5CQVL6.^3O>)7YGKT
M'?Z@>FWGY[\&"DZ<?UB>W3!QGY>?RXFZ&!'/Z?V@@C_:" 0?[".?7G>OZ<GC
M\\*Q(X_0@#D'^SU31[+.JF#UK4?=Y[.,/UD@ZS0^W;"Y;=^C?4NKU'@ZDY?9
MN@W4_4<KEL <ON=7*Y>Y?V?0.H-/;]4RKWLDM^M5&N-!"*)J69J^9-@AV'4O
MV3L'4W4/<]UXU?*_LZ>HVY[1HO0'>]RH=2,_LN'I=$YZ&[9"QB^IO3S(9V;!
MI>RRS6K>PWLD]S,5U@H9&:=HU+JVR!G;IGOD#'0^>WGY<'$62<M@ ]<=05U
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M%H)2N&\/) (DP,[@'##X1MDXSG;IP8OEE>=(I^PQ3ARQ!X*EOA616(YD3]5
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M^&'P /R1Z,5K+6C+M]K*BA)"4"R%QR> ".90."P(':6Y4D$^E5B-5IAD(GG
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M82".>Y-#!'%+;G2M%#72:U(C6)5@BCA625EB1(PJC=]#T/7>G!>!Z'H>AZ'
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M>AC97\2O*(I;4 6G/-%"4)"%U=OII6'B,2,$D)5PZ1EB4W#;KQR(IBKN;0F
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MAN%UX5GD^,A64(K98.:+K>KS:Y;<+8W\7Y8D=6FJ_"9TCE'NTD3QP5$]2U5
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M*N:BGJRC(R3(E>.O8K^"NR36&546>2=WC=)8Y7EEA1(UCEA8B0JXY+KV<:&
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MKT,;C:%>Q?R5^S7I4J\]F:.-N@$D  DD@  9))V  &Y).P Z\= )( !))
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MC"\L[<H 2W*@$@]PXXY[5;@\#C]/2JQFNL2G='R2/G[2?CGY/\O"_ !Y)_/
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M"R*%9,1R.)6]UI'#(_TKHZNU4U(EMH*J0'W7WV&(+5/#405509)9(:QHQ2U
MCFE&N**4^["2%'BA5H5XDSUZ]L> ZR4ZQ-2FTTL==+L%J&<UK2TF8T?#)C9*
MEK&WZ"V+)COTYTE>.W+3F6U7<PAB^FGLRQVIO4FFQU:>@F2EOU,+BH)U6]:K
M>6O0R&7R>5NV[69M4P\[XR&[8I4<=%)9FJT8;CO++90U6/Z9%A$Y!<MS)&_F
MDC"2RG^(S^1Y8VYF:3COE=D4@!5(W!4^BI=\GTT2#LA\1=F@F5TB@CC#LAEA
M+,>U0!*6D'D+!0?6;RV:V2U@KY*6(U8  F*C4<=-\=>VQ!(R//B9I^:+Y!;3
M9H[C4+;F?4:7Q&\+).3\(/0MN1TR =L<)O6\%3P%2K1@H25_'6CE:& E(#XV
M554S.RLTR?GE(U 8@R2!?GTO88JT9B>.M*DC*I*1<,8V5.]18['>(2R@F/S,
M'9AW*DO:#SHM%+&ZO !&.R RQ,%E"(W#R+'+]SRS2'M[I.UHRL9<A696]8VG
M,;Q>5XJ<JK))8*S$(Z]I\78O*-916X,CF$D>.15*]P)D=(T@+L , #H!MV'I
MV[YX@WRYU$ZB1DG4<DG!/F,[^1^>-B;21QB"-D5JX@D%AB\2!N0@:0") JRN
MX;PHP(5)N''>T:AO7KGN2:,NP$1!CE=@Q+J@ ^"(U<<$R!U<^0CM:-0>4]6R
M-A97GL,GD*-VU^YH^8/@H1S"PD'VB6.="@/F>-NXQCLJ'_:2?M9,![)[=#0^
MG.HX7J;U<N18?);#1R]_)TM6TC"YP%L!5S"8.U6RF4W#9:K29'$X.*[BZN(P
M(AV#.7A^]<#CLC+62QW7F&Y4]HL](U975.KPXT9(U"HNJ22:65XXH(HU&J2:
M61$7 RV2%,9=+A0V6BGN%QJ%IJ2G ,DA#N69B $C1 SR2,?HJBL2 QQ@,1<5
M8*PB29TC0KS(S?\ *L$5" Q5%9P[1"95[ >2"I+*Y )JF3"QE8F4"4"2MVKW
M11<@*T<H[8VA92$>;RHLBRR_?QRH*"T[9M@V/3].SVV8?%X7<<IJ.MY?9,+B
M[5VWC,'F[N.KY#,XBID+7BENP8BQ-:J1R6(/K"*[%F;O!D4#'S*0HL58Y G@
M9XUC1S&CH?'!(?+W/&AD25G,D\!7A28EYC=)4E202"02"&&VQ(9<AAMG4,@C
M<;8X? ?"" 0, X(*D9 ."K;@[[@C/7R.#N#.S1/XU5W@61H.]U:+Q3JP:2-$
M"-++%V-Y(97 20$#NC5"/7EC.3Q)-(\J3K-/&L*.HCC@$B1JL)F0]TPD/EE,
MIX*$A%7M'HNDYC3ZSSM(&3M9$E9(YNU!X!''P?XLLJA7C![R&*'R$/RE9%LO
M-7>]6>*Q)#*!)'82PE=0GEAB29EB=IBW_*Q10K]@4=Y4R+ZZHR<8_.1D??VW
MSCAY1P"610<$9QCY%?LZ]<YQOC/#(=5=D@CVC 2PV5DK9G%YS#1-Y$=FG@K#
M(P0%N296:;&S]@4EE[1$WRAX9K!]0XL1M>DY!YA]/?LY;4K)7ND F:']\8WN
M"JS(":>40-PP9BB$=Q'I0>Y^P->U*CN0+R-IVQX7/3R/]SI2K7D7*")57F.&
M3$S78S^6(X[P1RS0RZ@YZ?&8C=FI%YKFJS5-]Q*53S+-'K%Z+)V/ 01W13X$
M9-G[#]\#$<E23ZDZ:$2PR C?4&!_W03CL =SOWW/3CT[R)RTMYY2NL&@-)2J
MM4HP&P@(60CKC3JR3L.F>N>+?L?LL,XB*!G23B)B_;&JL2!\B0K)V$=P[NS@
MJ0I(9@OI<XZPMB*!9I.]B.(XO"D1)961"T:LY9XQWH8^?&6^.T]H!AWT^W2'
M.Z]B,_4L16(+V-J7:TZ.K+Q+&DT<G<06YG\G:9'?@H0G [.\2+U_/^1HU$2@
ML"J212Q-X80L;AW' C3RLS=J"1_Y0_+ @^FTD1"].A.2=\8[X./4# _9G(^9
M;!)1F0:"-+$'TQUSW&QW&VV<$<5]?MA\6;'MTZ3V6B0-4]Q6KXV.0,GE[MFZ
M?]2L5SVHBJ.\(L<@[B   O<.>.9+VK>[7J][".K.<ZC=-:.,VC4MO3&XSJST
MTSWECQNVX;$7&G@L4[U?NGP6RXU9;G[DV"M!<EH_5VZMK'93'7;5";I^_:U7
M(G]IN)V"S)Q1TOW#]"-GS%J 2214,-#G<]@+UZP07[:U==AKI;G*A0]F-.3Y
M$7UR']5LK@\3:V&P;]-J@DMO',D\+P2(W>R/%)&[)+&ZE71U9ED5@ZDJ1SZD
M]B=!1WODRYV2YT27"W5MTJ*>JI9 Q633';IU"O&5DCEBEDBFBEB=98I%21&#
M*#QY"]ICU%KYAIKA3SFBK*.DAJ8*A2H:/4:B(N1(K*R%4EBD5U=)(RR.""<=
MVWM0]T?33W@=#=;ZW]*I,C7P.>LV,5G-<S5:!\WJ>U8UJ@SNKY.6,QP6FKR6
MX+%'+TE./RN+GAOU8J\AEI59(C/PQ+R\<B,[,L([3,KE Y9N^#R.J'QL07B^
M>/L#CGCFI_\ BW.R7;?M:]Q<ZUW;%R>X>&;&S3R".N?_ #')D^E6<K'.$ECI
M^?LD3Q^=&))6-6Z&7L.TQ>-EC0UP[!5+2RD ,;$*1!9>XF9UE;R=LP C"IV\
M-YYYXL%/RUS=S#8*21YJ2UW2HI:9Y2'E,"L'B65E #RHC!9&"J'9&;2-P-0Y
M2N$]_P"6[+>*B)4GN-OIZB54R(_$=0',:G+*K,"R*22J,!DC<K=]HI+P))DA
M[CP%F[HI&9IC% L<4BJ["<J_8Q !*CM#$G@CN;3!%\S3)&DDZP*GFC7S6)9.
M*R^5".V-@G:8CS*XY4J60CTF/K2.TE")Y)2RU;,BB411,B!Y7K^6.0Q^92%8
MAF!4LB,K,4_D+-=B9(YGB'>2"&!$[QORS6D([I.7151E8,>%Y9?DFL+'GL=\
M'S.V-_NVSY@[[GBXT]N=\80Y/;SP1D#;..OU#;U7?]))96@F-@0QA9%DA54*
M3MWK&TBSOS)&*\JN%0<BP#]W;\<:)V6:Q,B/W1H[JL'"O(DEB$R2L9B42:&"
M(*A+,H3R.L3$\=WIE+>;EJS69*4)D\<Z1RF2PD2VHHS%]X9!)YYUX/DADBCD
M90$9RSCM.(L]&R2V?KBJ2*\<;M*TJ1Q\=H95'',WD!##DL".TGE&5C^%CK^P
M_P!GMOG?'0^GGQ(-9)](/AL<C P#G?!P<9WW[[GIMG=X9\W$W:\[?P8"IE5@
MP\LCDCNAC$4LD\D2QM*GB YC:3N8(0WI00.)266)&<K*2ZLL7RW+2%>]06[Y
M5 9GX/)[RQ *^F$I[)%+,4CDEGJU24GF_AR0I.TQD\96 AX63Q?QIU=@.8XW
M505#+;'9V.N6,KPU&=8TF;ML3 ,SRO*B,LW:6)#D>%596(D=7;Y!#&P'X==^
MG3S_ &^6_#2>U3P+J='7R!4[C;<?>>G7MCAS>C@(V?K%W#@_TRPGP/E1QI6!
M'"G@?'_4./ZOT"CUC_2YU2_N]TU_W6V^DAT+N1W\UU:N1=_CL;AA602 AP%T
MW")PP/SR.W_LX(^#Z5^L?Z7.J7]WNFO^ZVWTR?Z4G]U?Q3BEN,2*#MBLJAOU
M&#5#?\X/4;<*O?I-QATO9Y.GT&+L[NN$O_T6AS1<8ELX8&7'G(!)8&DK).5D
MDA\]<3]@A>Q DC2K3ELG3?W"]'<MU?ZB>X[>HNIFD=:*'] =17.9K%2[)TIG
M?/#*ZKCVP]+#U=9&,R>3F,T1UVU=JX?8*^$6Q0=96O&[OTPWN-Z.:OUJZ;7]
M=V>Y%B8<3.FR4<W-3COPXFUBX9GEL6ZCM$UBB]-[$=Q(9X+,<?;9J316Z\#J
M]MM:M+*(Y8X&IJB2)*IGIHYYA )4=A"[#Q(B-.28&C:09C<O&Q0R=%4""5 R
MH8W=1*Q0L^@D A2"& [D+NW0ZAA>.<G?>LMK!UL=M&6RFMP8BMLW)Q&D8*IJ
MRX:WA/IGW_ 1ZUEGR6$K5MB4Y3,TGQ%==>IW<@Y1*41KH[C]+?;_ -3>I7N(
MZL]/^G5S*W>C.]Z%-B<QG<NF<T/'C1MUQD6?QMO.87&KF*.5BHY9LC@L1AH)
M/I-@EF?+:KDL%BZ4UV#7]KOMFZN>X^'?^E6SWI1TLP75;";3/M#V/K-4@S6H
M6+^NVIL9@LOA#D,ME-OP<-/*XZK2RFMU9L.U:QNL-ZI)BJ5GHJZ6=*M(Z.:;
MA]&T+!T<+A<12J5B:U:M#<REJM6BK297,6*\,)R&5N+$KVK<J\DD10K%6CBA
MCNM\O5/;(Y+?0^%+/X<E.RJWCT:4KM!5T<[1S1Y2O@+21^&&(B<:I=1"1K-5
MUP2G7P8PI<(%6('7%&OPE7E21#F3'T8P2%V+DX55270+V_Z![>=(J:?I.,JQ
MS2+#8V+8&H4ZF6V?+I$D4F1R358T58HU00XS'(6JXFDL=2L6(EGG?/T/0]9U
M)))-))-,[22RN9))'8L[NQRS,Q))).Y)/%:=V=F=V+.Q+,S'))/4D\#T/0]#
MT3@O'P\:2*5D574@@JP!!# JP(/(*LI*LI!#*2K @D>DW@]*T_6),A-KFJZY
MK\N6D,V4EPF"Q6(DR4Q))ER#XZI6>[(222]DRL>3R?D\J?T/0X'!!AM5UG7:
MMFEK^O8/!4[MF>[<J8;$X_%5K=RUS]3;LUZ%:O#8LV.YO//,CRS=S"1V#'G=
M@P^)K-2:MC:%=L;6DI8]H*=:%J-27QB2K2:.)34K2>&+O@K&*)_'&&0A$[3+
MT/0X'";QVG:GAY[-K$ZSK^+LW<E)F;MC'83%T9KF6F@>M-E+4M6I%)8R,M:2
M2O)>E9[3P220M,8W93!S->R/<^HNZ:Y?ZW>Y/9^IO335.IFL]5Z'3>MTOZ9:
M#:V?9="S,FP=.J74_>M4QT.;WG6=)S/T65Q>"CIX"+(9#$XJUG9\C)5Y>P?T
M/7" >OY_..#!B,X/48S@$_42,CZL<)O):=J>9R>-S68UG7\KF<.S/B,MD\+C
M+^3Q;N2SOC;]NK-;H,[$EC4FAY))_)/HV&,QP:\XH4^_* #)-]+!W9 +!],H
MO-X^;@6O_DX%DR@0<PCB/[/6]Z'KO!>,5>O!5@AK5H8J]>O%'!!!!&D,,,,2
MA(XHHHU6.*.-%"I&BJB* JJ  /67T/0]#@<#U"WW&_Y[XK^ZM'_B^<]32]0M
M]QO^>^*_NK1_XOG/1TZGY?M'#.O_ *.W]Y/QX+_>RH;7-+7D_=F,F/@#X_\
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M'$A?N+*P55!YY"]X! //QN#6S*K(R2\R?>0 O\,#\-V_H7_ 7CA@O('<.?6
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M]?EUBGGC$LW<)W<JKNQ9H2TJH7[@./D/D1(T2.-0D<:+'&BC"JB *B@= JJ
MH V  &.'B*L2)'$H2.)$CC100L:1JJHB@9TA5 "C'0=L<)^&$)+YY"9%AC98
MI[(X?Z:6SP$)4I"\@*QM$A*S"(A^TM_*<_3D"%4\5B5)5E,L]8-.UGLD(G+(
M4!+(I0*5*]G:A/:5]'24F#'Q01JK."\Z]K2>:)D10W')E[@746)%9U5?N0J
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M&R1M#(\;CXD.&QJ /D0'56 (((#HK#.&56RH6\-DD:-MBIQT(WVP1G?!SOY
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MCN)7DCX^#SP26X^/N X4CY7\A0"01P#K^?J'Y\SQ%4]O\6?Q9F9W;&IW+.Q
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M=>QQG^SY=R< 8&>V^PX()5[9HX2D*HJS++%)+-XY!(JLRHCD-)^512H<(Q=
MT98>D)D=*Q&8M>;)8_&SVI:DM.&]/C4%Q8&DBDFKQV7^!4\OB9(97A3SQJT4
M4DBL[.4M*5NR5($E+R([>6023I&K$KQ.R\N$BX"H%20<! S,.2:"I$KN9&D$
M/,7:'6)%![?(.^28]J]\GCC5& E64=@Y !'3@]L_YC]O7Y>G!@=.P)SC&WS
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M."QJM&.GG3"M7:W.N4MF[D)F?M.NI/4[:_=[U!T_;FQAR6A6HL!TMU2:X+&
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M,PB5I(S*4D0.K=BXEPU9UB85EAGE[XA+)#$QA$:2+'&T881MVDED=0(W $@
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M^IX(XYX]0Z2>)G&0%8C?OC'0=@1W],=N*=;[O-?)9Q3^+%215$D#LPT&4QL
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MF4B6,+.RKR$X 9_66/)R,C3111 1E8YP9EY:4<>;PUXV9@5"L2)RLCK$H4
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M..ACT'IC/4_/;]HZ]3Q5![TNF)T?>I>M<6*:QT\ZCU,5JO4J.>G!-3U_9*L
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M=7HRM2I/5B[)<>MB/&XJ/'=6[L  T(8K&"S*XW;2&R!I( V&=\J1TV.7-O\
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MS8VZYQZ$8_QP0<>>.W&Z2,1UZ^OD>N.^,]/+.XZ\=$O[,I^_H1=?D'NV2?\
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M=8Y>&1XHN9Y%C652HD(.I#8FX:2X:D2PRM(M:LX$8JVE#RW?/.4627L/F6%
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M _.>.&/OT\SV[=!MUSG\,C?C% 5B\<49A"J#%&JR!'0LHC6%+#>6,B6=N)>
MY:,K(Q[U>,F]833,!]2RA \5B A(B9(CXX_&KA^(XP_WNSJT_P##;CB3X*&J
MD_3QRS".(S5[)18%>*0-.3-7:>:3Q1QF65CV, R*5,?>\@C"B>6+N,PE1869
M(U\XD)DDDD(,:,Q9@C/XQVB(LKJW! X8=/U^I/GW_/K]I0G8[ #T[8_9]0XQ
MQ2V6F@#.\L4J6UF21(Z\:ORBI&"08W'8P\*O)W2!B6/ *BL/]H%EI+N0TKI_
M@M?RFP9&OC+N<R&*P,=ELL;6U6A@Z(I4L?6M-!;LZ]@]CLPLU6S'723R35VJ
M+*S6?&:L7C$,;6F>98SW&669;-DB*$O 5?A0R,)B?%(@1EA5I&[35)O&R7\U
MU@ZY]1J\ZO/HV*SFOZLWE[S%D\@:G0;2K=67R<R".WF=SVB>K&Y<HEZ:&-5C
M[A:.45*70UPC$K6^G>:&-F=$EJZAXZ&BB9XRKIKJ:J,AD97&DE2" >,D]L\\
M,G*<%@FJ321<S76FHJZI1(I'IK);(IN8[_5K%-')!(L=ILM5$8YHWCD,ZHZ.
MKE2RGMJ]LG3WW$Z[U$Q>7PVQ8W3;%-9=/E38(%S^IY_:\Q:R>O9+';'7QU5<
MAFM;T[ P137YL/'];'F&+4Q!D.!/;VO>S75_:]^_)=?R)VO)Y_Z"C9V+-U:D
M=ZG@\1'&,=@H*=&I6BAH5Q+<L>.. LLTSO([R^-RX7L_TP8?HCC<U6C$%C>,
M]F=GA:*0H+&"KS1:QJKEBI[0<'KM21X@LD82<F) 2I:5L-:5Q%+Q*MAH51)0
MA=RQ\@*S3R@%H8R[,3X(>&(3N"L!ZB^:Q1W+FNMN[4T$M72E[;2UKJ):I*2G
M @,:U3ZIF25DDE8LY+--(3O+(65]DO*=#8^2>5*B:W4<=YFM;W*HJ4HX()X9
M.8)I;O/31B)%6GB@%;[JD$02.&*/PHT2,E.",8D2 NZ,KO&5>IY_'%$_=,_D
M[U DD-A)NWX96C0J#S( R^/BC++&76&>* K8A9P)%$@7Q&",2GOB^Q.\3"0]
MTI+_ '<GTK4J"**22:60*1WMW<%W*#AV()D17?M_AI7[ (R@(#JY)>]>)(DB
MJQV5B*J(E@B"\$ER)5E9I 3&K]Z_J2R2%P#*/42-\_GMG?RZ]/W\:LOIGRVS
MWP3OT!VP>G8C?JG?I&BKI-8FFL?2VFF4HD7?*_W)_#\;%7[EE5 6<^4+WL>Y
MR!B,,*36'2)I$#QPV(XV'\. &40A?(#(Z12RF29"R! SF+R1DQN;M,(H%[F1
M))("Q(C->(%^V./O4O)$LJJO"]LX#&.0CY*@-!L6[^"Q<Q^"6.>U7*"Y<MNR
MXZK)+65O))9'$\UB3L0K!$MBQ,L3(ZPQL)@=021L3N-ADYW';!SUZ?DR-#2R
MUDJQ0HSNQ  49.Y7J!Y>?KUVX7N1R=2HS)<M)XI0S)'WR"/B+X,?':(@$E/>
MI\B.%1>0>V3AC]QZT=.->:4YC:<)4E/>Z(^3@$\@X*$+%W)(>2&'CC#CN'/'
M<P/IB=WSL-UYY,SDLQG)@94:K]38QF'"F13PN/Q]E)Y(OL(C>U>E\P/=+%P>
MSU&W.[+-3\HUW 8V@S2,RMC\-328R?'\3SBNT[,>/N8RLQX))[^#ZDH**1P"
M<(-CN1GMY#&W^>./0/)7LIK;D8I*J6&F5M.?$;&,XZX!'0#&#U^T/3M'N^Z6
MT7F6M8V+,NH;A,%J^QY-6+$]PB-#$6#P_!DY\I+!N0>."K)93WC0V6[,!T:Z
MV[* >%:CTSV8*\:CD?Q+U*G']K]I#D_=^2"Q)]-)F\[U9MF7Z>+964L1Q!'?
M*<'] $([5 _'  ^/D ^FGRN3ZF1.6NT]B7Y+'SI< [5''_I1\_/]1Y_JY)/J
M5CH% R9%) VP2<].P(.<GS&"=^/2]A]BUL2./5=[?KP-F9GZ8ZJLL1Z^N>YX
M>^_[MNJLBR+AO:/U]O/WED^LUW%XJ$R,Q81^7*96JBH.>[EF ']88<>D#ENL
MGO.W%)8L#T;T#I+3F7N7+=6NK.LQSQQR'M9AKNBP[MG#8KC^,U2W7H&3E$69
M6)[6E?,[BQ"O4RI8$ CLF);GDG]#P#S^!_[AR?AK.WR@G]U95^X,23%,P[1R
M!R?E5  'P20/P>"3ZZ8$7&"N!WTD[Y&X+,PZ]\8Q]O%WA]E=OI<%KS;8P"-X
MZ77)T&,&IK9H]6=R3$1C QOQCRW0O([O>:Y[B/<EMW4FCY%<=.^C.-EZ5Z=8
M4<,:V:V[)6<SN^0@#EDFCQ!U4V8"5,L3,"'>U)-"Z6:[8T_I)HVM],]8NS>7
M(872:0JW,]8#%UM[7M-R2]L.R7%=V!M9W)YBY$"5AE@4* R,^3S],_Y1BKL:
MA@3W5I5 !'/)_4GX[@/D$<< 'CUFH[<C/V3 K(""5=2 I/P>>>T#\_GXYXX(
MX)/H )D$ZF(Q@G&!@ ;+]$# [*#Z\6BAY(L%,Z2EVN4\9!26J='2-AC#04\8
M6E@;KAX8$DZ8<8'#N7,M;O 1NRQ5@Y>*G&7$"LQ/,C]Q+V)R/AI[+22M\_*+
M\>G UMECKUDX([47D<<$L?N9N!P0268GY^./P#Z:&I<BLQHT;@]W' ;M8*0%
MY7@$@ *>0!R/@?!X!#KX:3A(PIX!"D#GD?IV\'D=S'\ \*1Q_L]&;&!CON/N
M[=R<_/<G'#Z\0(E((HT5%!+848WP!D_VB<DDDEF.IB<GA[\$_P!H91\!0/A0
M/GYXYYY)_)!/\IYX) ^?3F21[/E\G'J>F:-MV\9:CKU;.7Z^KU<5/]!CI[TF
M,KRVWR>7Q2AY[L%E(H8&F<B)W?L5.XM1K4H<PJ?]:2-.?@@*S@<$  'G\E0"
M.1Q^1R92=*(<KD,K[E:>"AR%K-V?:WD:N%K8=;396QE;&5W:+'08M*7;<;(3
M6S!'32F19:RT:5P)>SF,K9'AC:1=.I2N,@Z?B91OC'9CG<;G._'ESVL7NNY:
MLM5=K>*<U=)-3>&*J-I8"*BNI*5C(BR1LQ"2N01(I!QG(SF.^TU=LT^SCZN_
M]/=[Z?MF)Q6Q%O:\ M7#9.ZZ/*,?5SV,N9;#+DW2-FCQEF]5NSJ#]/!,2>&8
MR.H:1+L,^5EH4FV*U;KY.R#E;JV+%VK#7CJV[&*3))7L/#!6@2)IZ4@C@KP*
MA"QQD2QLX[<-+]@76*EU?&SZ;A=DV+2:/1S"=1$S%G><'EWM:K+E+M+&9RU:
MV#'5TV3'9O:-?PEQENXZI0S.76"IC,C%3A=GK%TY]OFB7\GT]S?3^NW2BWTQ
M.?Q&:T#VW=0-KZCT-J%>[DCU9A]QVLV[V,%W'P8^>_E:EZC7M+&JW,GDYL5D
M'K66(N&GX98DF*R'XTW1@N/B4,&^(9R,8&^Y'&4P>VU:,>X<Q<N6OFB>CO51
M'!7VHXMDL%"E.QK:):JGKB]7'[P?#*/"BQX9I8M0UUG[)K>D9NU8R6:AISV+
M,<,5J9\W:JU[25>!52Y7CR5>E::+L41"U#,_"(IY$:!<%^AB(,/3Q%[(9&/5
ML;9KV*.O9#;,^=.HVHVFF@GJZW=S!UV"5'FL3PB&@H+S6)8>'DE+3"T!^C72
M+I9[$=CF]N71S=-EZ\5/W'U W+/ZQBI-D-#+[#J^)R&4I=V/L4LKG;MW;*]R
M:QFG\:T<?/1@G06U\:]O='-,Z78OWP[-T=Z+:CUFZD]+=\U_6.FG2;8=67=L
M5HFG;5H_3C9\NFMZ2LHOY"I++LVUYM,%A+-+*9NCK=/5\-/3AK)7)OTA'G+4
MB98DHQ9/B82:,LQ0%<;_ !$9R.P)/$V?;ER\DTTU=[,;<]542M46ZJGJK617
M5D5V%LFJ:VIFM@:@\.03.:N8R2!TPVE)!.*M^LNI;Q@=9Z&7=R-NKHO4_4KF
M]]*<32ZH[=G(<-C\5#B:DDLV$LOC\9IULXW:J5>A4U\V(:5*7(T_JC#WUI&>
MU3IOE-IFS6/U/%TLC/J.K;!O.8,O4;&Z59HZ[BKU0Y*.'+93.8NSF+]Z602_
MN:"6>_>Y%IXNZ-9EO7VKIIIW4/KU^SPT?JCT7T[#8.7VZ=<I\CT9RF'Q^8U7
M3\IC\!TGEKX*OB;<$E-%U>P\E7&(\(FQO88D99D9_4-.FN.Z.^X#J?[@\+EO
M;KT4UK1.BGM=ZX8KIEIV,U'"Y:+"Y?5NHEO%5=\M7,IAQ.F\RP48%KY2 R28
MN*-SC[2RW;\ME):US!)IIXM:KJ>4+'A4,H4*8](#DL!N#G)U; ;5>W^U6X2\
MK7CP>3^7I;G!2^_W._PVZP+24MMGYDCM]-336=:".&YK)410Q:Q,P\:=:UES
M IXKEURMLFLZUC^K&L8?J#K>N0V;6FU-]UVWFM>H?O=J%K-9'1H-RP^3QUZ>
M^8<<UO+8:M).$EHQ?6K'.D/>8;)TFV3IW;UN#<L10Q-K/:S5VC6[.*ZC8O<X
M:V*FR<5Q9IK."S.135\HMWP3Q0R/0R2V8X[<2--7=XK)<EM$V9_91:1FM2Z!
M='-A9=LV;#;CC<-TOM93$Z;)3UK<L1D.L]? X[,-?PO4Q)(,7F,KO5FS;BI9
MC+6\]>II3L=L+[XKVF^V+(^YSVZ:K9Z;Z#@L!D/:?<ZF6.GV$P.&UO"=8=_Q
M67UFG#;W>'&U:=?:Y,1C<MD<S/3R:V1E)52WDTN8W&6JTA_T@P</+!#I1Y$*
MJD99A&BJJEB"5QG!885AD*N 1Q)1^V2>ENT=POO*/+HIK=7<R6^LHJ"V6B>O
MJH;/;:>FH:.2JF26JHA33N$EK(P*2HII9DI*9(J22)J6+F7S>P9FGM&0W';\
M_F\,L7[AVR]OFT9[.:Y(999HCA\Y;S%G.8259)YVGDQ5ZG_\D2RRQ\R.'7_3
M_HE[AO<+EKF4Z=:?U2ZIY#"6JU/)[U?VJRM>C?Q@CN5\.-YW[8<9%6R=&O/6
MLIBL9E)<GC7:G(\58L%E5GN$S?4/8^HV!RW4CV]Z][?+&,Q&WZ[BL5IO3'.]
M/:.P5<=L]!FJWK%XOB]UN:B98*M?8L(D=:S7S#2P5*]:S%(TT]ZUGJ/U!_9M
M>V"C[=J&V;'KVOY#(XSKEIG3./+#:LMLT7[XH90YO"X=?W]FZE'J!);R^PT8
M#*;<MW$;%+5N8JM'/"ZDJ%6&G>."EB:>1HO$8))'$HQG+H "6#9(S@#(.^<:
M1?\ GBFI^6.2+C:.5.0N6Z[FN\U]@ENMP6UWJP\O4,>HRF6XVN&F@?WQ*AV-
M/X@CC JX:E6E$@C@EL&J9_ ;[G]6ZXX#9,!U:Q-3 Y38UW+:\AE\CEL;XG77
MLI;S+;#EL?FH(4A=:)ER%Z*I$OCK"O$IA5T>F_37=NMF^4.G/3>I@<AL&0P&
M<V:.;/9Y\'AQB\!8Q,%QUOU,1G9)++S9NF*T<51HY%\TS3Q]H#2&]G70RDVD
M>XOJ%UCTK,9#W ]+*6AXW0L9UNZ8;IULSG3WI]=UN&UK>?Q_11LK7V;-P7&D
MV3&XJ&K-6R-*I@+E.@U*I#EJER2GM\Q_3*M[[NG^4Z<ZOF--M;%[:.H.3WW#
MV.E&V]'-7R6Y5=LT;&7=RT?2MN"V<1AMGGK9-;5''?44(K.*BFFR%_)SW;<[
M9KAX:R1QQQB11_/PA?!=EP<A=.-)7(4EB?(#(Q6Y_P"$#/R[:+_RY8K#8:6_
M4%+(@YNY8I*-.7ZZXT+Q5 J$M?N31/13VX304T\M;/(9,.L,<;JRU7Y/IIU
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M'_DT1$[5+\CT!^?\NW &K;&PV'4>8W'7R[G?J/+C0KQS$A(AY9#WND<\G96
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MN27X:=TXFS!]7%7N3330><=T4DTHCX61^YBJ=YH.UU*J5*-]I(![""!^H7X
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MGIZ\=I>4N6IJ2FHIN7K)-1TDGCTU*]JHGIJ>9@H>6"!X#%'(^D:WC52VP8D
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MRN1H15;N=L[0\E?)7LA/G:V1J[';ESN*R];*0Y7#95*U[$W*<]2JT4@_0]#
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M%^R0*RL..?W>9=9R>V=9=YBM>YW1=B7J!0Q^3W'0\C<'2_K%HLED8C4QG<=
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M;8]<C@<%[_>72.::G#'_  N9&$C/:#*\<"Q3,6;^  9$ +&1U16+12>M:6R
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MF(PL> A8QL03AA@ ^GV#[Q]0/3;&<@[T).6A*@$@Z&VTC*DE2!GJ-P>V2.H
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M]429'*UZ4-2U=MB5HUKHDHYCC;F>9K$,BI%4@E\3B8,J(796[)H@$<RMTYJ
M]U[,7;;D*K!!#$7C#!VB5Y5ED [^Y%[$4BO_  OY7=BN*&.QV'KQU\?6CK1@
MLP*@EF[G,KL\KNTG#$DE6=5[AP%3\>@6 QOGL<?5GR'W;]L;\.8Z.=S^L8*
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M6;I-_P#,C*?_ 'P9G_M_^3?SQP.?R0 #\ #UX?;-TD(X_<^4X_53L.9[20.
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M2KJ8H&A2:2!KD2B.6)N)Y9YVB:*463%!.L8\3)S-Y%<< /Z?;1TF/YQ.5/\
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M.172!S'43N%=@L,06%E6$]\,]>+DK+ TBAHY>$>($_8[E@Q5):F*W*2B2!S
MX,RPRS(L;I&JLC_3^)Y TAD8H)5:56>0 %D19?XM/2;],3E>>..?Z19GD?\
M7]9R/^HCU\?XLO27@#]T93@#@ [#FB !SP /K?CCD_C@?)^/7/'7NK?4%^OJ
MWU?5Z\+K62+_ */%U!'\I<?V?^J'MG]N3N4++62(>21I)GD:!7:1T9"DT[Q
MPQ3=G>S@<\.2C0HS1CO*@%MW%T5<57C)D<S/9@="]>2N_A(^'3YBA:*)V95)
MC=6[0B$=KFGVS=)3_-B,HP'' .PYGXXY^1S</!^3R1\_/]IY^O\ %HZ2_!_=
M&5) X!.PYDD#^KDVR>#^HYX/SS^3Z'CKM\+=L_1V\_ZV^/EPNESG4@FGC..H
M%7(/[./]$.<#.V/7/FB*.%>:9E5;4C13]TYB\:1*94#&,L8T;EH^V:7L8L2R
MKY 0W#@8G$^&-)O%*KO&582JDDK*968%G4%B&Y+! XC4/RH!()UO\6GI/_\
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FGS(QMY8!/7OOTX*\33C3.$"#?PT9FRW8ERJ' WPH7<X);;''_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g89498.jpg
<DESCRIPTION>G89498.JPG
<TEXT>
begin 644 g89498.jpg
M_]C_X  02D9)1@ ! 0$!F@&:  #__@ _1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?0T],3$%'14Y?-$-?0D%2+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( 8,"F@,!(@ "$0$#$0'_Q  ?  $  @(" @,             "0H'" $&
M @4#! O_Q !J$   !00! 0$&# \*"@4+!0$ ! 4&!P$" P@)$2$2$Q05,;86
M%QDW.$%1=I*8T=<*&C(Y4E-987%W>(&'D;(8(C-76%ITL[32(R=6<I66EZ&U
MUBA'U-7P)"4F*31"0U63L;<V1$5BN.'_Q  = 0$  04! 0$
M" (#!08'"0$$_\0 3A$  0," @0%#@H(!04       $" P0%!A$'$B&T"!,Q
M-G4B,C4W055A<7)S=':RM107&(61DI.ST_ 50D115K'"U!8C-&/!0T64H='_
MV@ , P$  A$#$0 _ +_
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M'!N$T]X*!*5=.VRM-1+0J/BLE-F[(P7F05[C9E.+-@FX$54Q=]HXE9.K5-O
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MIA$(JESS=&5RIYXD4)&\9@R213),UC,4NM-XS%E"X$@0
M
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MW6TE#
M                                      <5I2O97K^:M:?>[>E:=:?>
MKV#D                     '%:4KTZ]O3KV=:]*]?=IY*_GI7IY:=HY  <
M4I2E.E/_ +UK_OKV_@]RG93LH.0             <5IUITKU_-6M*_KI6E:?
MFJ%+:4Z]*=.OZOS4\E/O]*4Z^WUZ#D             '%:4NITK2E:>Y7M\E
M>M/U5[:>Y7M'( #BEM+:=*4I3K6M:_?K7RUK7RUK7VZU[:CD
M
M                                         !U96=Z2C.5J-0Y0W54>
M/C[Q17"7[X5IZ'4_$IJ'AF?OEO@W4MELH7_>9._9>MG[SIW5>TA_SR'Q%155
M$5%5JY.3]RY([)?#DY%\2H   /H
M                                          <5K2E*UK6E*6^6M:TZ
M4[.O;[G96E>WVJ]0!R \>[LZ4N[JWN:]E*]U3I6M?)2E>O2O7[PYK=;2M*5N
MI2M?)2M:4K7IY>E/+7I]X <@
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M)ASX,F3#EQW6WX[[K+J5J!]H
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ME*5K6O2E.VM:^2E/=J  #BE:5KTI7M\O3V^GM5_!7VJ^2HYK6E.VM>E/=J
M!UIV]OD\OWOP@          #CK2G96M*5[:].OM4\M?S=:=?< '(!UITZ]:=
M.G7K[73W>ON!Y?(  #BM:4\M>G7R??\ ;[*>WV=OX.T*W6TI2M:TZ5IUI7KV
M=.SMZ^YVT[?)VT[>T <@       !UIUZ=:=>G7I[?3W>GN
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M>3QE<A2Q+ZY<QG+E[[;EL+E9EQ!_K+]?:Y0/R/\ CQ_M4[B<
M                                         $9NV7)>AZH2J7B@_I)R
M0[!&S;2179C>VJNGSPG6,[+%DTL%;6_D=R"L%"N-UI?B>\TM(G@O?T\FH)1C
M)EOM.4ICP1Q82O-$_P"Q')A.SZAW<""XADF;=?#.O<>;?1;(,-.5);#7U?8S
M.?N1IQ^],N9/2$,_)*(OJAZ]JY\Z<H*1^BHI76+!PSBQ>GYW5I^E-?M86E'^
M;9Y9/2CN]$L>K<4:C2$:A^8YR;1Z/)A7U6-TR7\"BDX(Z32=6Z7D<^I**B43
M%_T!8F>=.).)P>/T?*7$M%ZK&$?2X15(6W_A?(JO9!.84W?O8]O;'.U;LP-O
MP>Y0C];;TH2AA;K9+W]2ZHEF5(AE.*]UIRPOGQVTR8P);P      &/9:]:Z1
MO>&\O-E5&@'"E]:4XY_R/(*\R4X;_P M>M=(WO#>7FRJC0#A2^M*<<_Y'D%>
M9*< )00   $2/-SLO,&K''\_GY!CIOCB0';)$$0L5EZB<FJED-(LU2\TX[<T
MG4*K&3&EVGVZ@K1["@'#UU2J:Y5)%4<]EUA6O26X8ZEN)(UGB-'M#LPLIOR+
M&,C-\^UGJRG20QJ2&X$-2QTL,$SA:^MMUE]E]N(T2.ELA<^F*!<HI)IHHH%"
MIK"!""IE&QPY9=DID7.0[9[:)HL#2UV3LOZ/[-S 2G>;70M1^Z$QNXI]C-]/
M!0+OJ/V2L+!DDP7>B)36/1<07W9C7<V1-HG(J19IGNWRB[V-35S=>#)O8,=:
MV[+5XS,/(%K_ "MJ?-CV=F)KL;/,+#BM?93I4W,T&@KH,K,U:=J36C@9QU99
MSE3CZE<DFRW@%+S<U$ \17'WK8F3(EQW 157LGV/3$/RJH2Z_),GI><\.9RV
M4G6(KG%-+P?*XEQGX+DLQ9V<CGR"2?R%$\VJ8SYY-3S17K3,X8..ACQ[-48I
M\&+"VV9_C=)A>1C+YFB<I"=N6%6ZIXE=LPZT7Z]Y&7GK'<8MT\7*&$EF,)>;
MJ3CRD2&8UB-F")3-A T%?O(%-VND\\MQK ^H^<?H(VVT*A6 &?L7(\B(\<L[
M+,6F,6O-SHD>-",V1)4GOMS+B_F<+M*1%$C//O%[K9E45">.E"2A?D]?"O,[
MMEL@2U6AR)=:8.(;73K,.\K#=>.59$F..86;C7T,<* BOI3*)ZS%.*<TAX2.
M9=*0G-IDNQAE7 PC&!4/2 DE_!,R25E:F3C'TWG53D9Q/F.''@>4H39#6QS@
M?K*EJ6X[?B3., 1X5B>)9,8;O9#U0EN-G0THZ*^A4N<8AM L/$31\RI83:F=
M,'[X\]NN#J.W/'L)L?3MEP"U$&+ITE^=UIE['G]IGI:MO:9F\A([J7FG-D9S
MPT)\CNU6,M\N<?3)27<<8,IW&JY'@C7F2N7(J :7D_HBJ?'Y%&L*E%NK4>&I
MHF2#-IMFGBS%A4V$>K;+L77W:A_:U-J)X],0+#<KNT[)DC*3*SF;I!?J T(=
M:YFI3Q@IWT74\@5S1.7-?N$C&]BG3"&HT4XHYUBT(UCW\D]%V+D.2(SE](:\
MU-%?=SGA2]I-YCN#!@E5%P(JBFE3*M:BH**?;JG8LVJ6172RY;:77S@@U49.
MF^LNM$]6.*37E +(F5D&)2BJ09?UL4%YG;%R0XY1F.',M\02*V5]:@9=5G+G
M;^*.7HMN @902& P;LP*Q]1S9-YEKC<TQ7B,ZI9Z&B^)+V2UYC_527TQ+>4@
M(R>X8%BU!76RPF"F$TITE,#/+MY"<BLG%EIGV(3C,8<V"IU7,Y2)+)@ USWK
MY#Y6U]A;0F08 A]CR*]]YMH=>=>FTSI5?*PQT!NTV!C=XO1,555VME"<ADK>
MWSB$GX%+-@;JS;G(U4? $HXHY$\O=H,\N<78!@L$U%SJU^B,AN:D\@3^T+6\
MJ*XYTD/6W$=CV&TB>U*7T@C&<3/#8UP)"JREU,1$I@(\=&U_"X<AE26%A-1"
M1JS'(OR#\:3=W4CC2.&$]11FO$FK>VL(S8Z6JJ&WE0VZXGB:/WZP\D?MMRMQ
M7(NA =&<HZ4DPB.^BV644@TCT5,*G@6+"IRSM!;B/T6(0@E02F1B[T=$1)P4
M-G$J1$6<)P2=@R.QZL1R)BI.F+9 A(."<+Y,4DS)XI4'%G?.6X\B8BR&;+9D
M<J7(X@(W&IR][V3P\-6X?@C4"'69-$YZW;,2X]D+9Q]S3&* R7!K3,)&,3R@
MVJ>E66?3MCZ3BF8FO1Y>ILEL+F4@ZTHZOFTK$VU\N;UF:?++MSMW/^F,G1T3
M0HOU0F[B5W V?DF),#^6T]_)4BQ@LK<=/):;KM1F3=53762_$%KID/&CQM-2
M\[2<;R>*TF(SO3D1+-2%/_@JUU>&P6M2NEE#S1U:UUU3G2!T",6C*T\L^6BK
MVF*5$B1#D@)<VM=^ITA9S"OB,/PB_C:V]#RJ]:O18+."U83%50+C=8YQ;:/9
ME37A32H=S,^_5N(WI L0D&!(<EL1+3(8D)%O1'=&SI3&L[DPM(376\5]5$Z4
M?EKASF5V[,NF3.=4-&S.<"!>3^4G<5W:#N:/M5&FB6+T+<%\,[H;$S_,L_/P
MM.;=4=@-<5];:1Z&7(AL=5,OZ7F*3;JE)"X_WSD;)1U.@IB1;?0\HJ&-;KV!
MK<[$_1^;C*)FWKTL;$)^O6O7'*9V;6<1#89];"S"Y]KX*C21G*[8AI&L./J)
MR1R.VP[\3U=)2>)#8JS(YTLYB32[B\EB/F9BY*X:..N64J+4-Y02H94B(]=T
M'4YO$4"7IJ9UK@UT:2:436?$LH&&A(2(=E]IM*I$HIMLK)YEU9DE;PU6<&>I
M[+FRY/9N+B#T#<SU8[Z4(<72JBR6O!+.RHB),LVMUC2(@:P8B&/7@M-L?(4A
MIS,G$U#]R:1R,Q5E5$=:J5J5+XCYQ0*X,)>P#$',BHMYL0Q'4@R+MYL[KU&"
M"ZUM"LA;3$TK-O9O<::WLA>*8#AB)WNT#OI@%5S"Z<!]>M93723R>\;*7&7N
M>26DVU'/? M/TI<F&)BMJ'=EMKYU@N?-)N :2N2M?4(9>V%@+<C[;MJ7UUO,
MQ"G0RDD[T26F]'C :+?:LF,L]B4VBY7V\%I8.T,Y#)3*>M*;A\<.HV^2K%"Y
ML\P'4]E6#SKD4XK/-J9IIB8TSE9VT1K5Y933$12 QL]ZT:PH"66P*YO*844T
MKASE4PR3P'S^,SB*1>&WCTE=B0Q'+\A=PK[:@AN+K&9%YR<)XO<JE&[J=>-[
MNB+I*>U9*J\I?C-P.C 65E)C2BNNQ KE*X,)4H5*V5P7@=0EWDC<NO6FG'=L
M,ZHKP2 [=RY3T9A1S(6%SWL<NRU[;! 3#2\[R]?0PX;U*QG'\IW,7:EY)(\:
M]WC)7+*/;CKF&G93FYEB:SD=1)K3KM&&#8":.1/</1V-#$P3"XZ0GB;&F34M
M?3UF-UN9DQ[>Z,1]YMS.0PM..T)&4;K5$YGO]%:I@(68E#<[EDX^WIOI NN$
M'Q0X42-4R+-RM:9I=)XDZ7!&:RCQ+%!]<*NPK$[C93=7#S7DA*0EC$:C8P6)
M)Y!-6DPC?<I)F,OBR"/B7/H;37-EL9=3M)D5B(3A><_1Y-CY2]I7#/LAIQRD
M?MAS(*<GQO+,42?&L_PNO&%9UKCN7G<UGTIK;S/+"DWW.<,M?$A)B*!YM+DE
MGC<PKID@GF]; CXNY$-R+Y>;$12.Y%I&58,XSV4_5QRMQ5>%"+<4'$V9'F-1
MA1H.BM4<DWUU)6;BAQ"H24[TL8YC#FMY'999<!N-M:AZD%:[0Z.2QN5&!Y8V
M EO&4::%K:=12<ODI(3"$5G#>0V\<RRF%XP0VLI&J)61?3,KO=AFB>LER\EO
M&WQ*QUI/%3-)/TX@R!,B0F;1I)M89)=WM.+&@VMMY4:THR3'\8LE?=#C5$]O
MI^5@L)LI3K<:RJ/XZC-JVTXL%RQZ]-P;.L7C<TVC9"B)MLV(\B2C03KW*.K$
M7$[W])"CZ'(,F8XWC\C,S)G4W:<,+>5P&FLB9:.5?RJCK2O!<EB,MD,9PY:8
M C+T@WGE#;CDWAMSWK+O9T*3OP1Z\[=E]?\ (ZSJZR6=*LC[/NM$65PN5M+D
M2*FY"J&6L:U'71+('U-ODR=F<H3IW93#8:I7K2E:=>WM[:5I7\]*TI6GX*TI
M41/OGA'XW9#K#V1>A9\D#,#0$SM8(P/LC9;9Z-%1#@Q@JZPO-1AJ"K',PM92
M=)-+6%Y44:J+K-+2R=-9\>4^H&KBA2N"2&*8P9T*QLQXFCXFJI[(CIL)#/:I
M);<[G>:N504,I823<"D['FKK[K<)S$7QVVYU=PK2HKG;Z5S'3QC-==DJ!D
M                !@=_^O9 /Z5O- D,\# [_P#7L@']*WF@2&>!4[D9Y*^V
MXLQ=?4>>;N\   %)>    U[V2VPUMT_87IF[.39',(LG*<N3$]:D%RD4.JZL
M6E\ARB"UTO)?D6W:X<A3#F-8&^V$U76<Y?#FS8B-^/%?=31N%><[BLGQ]IL:
ML;;EJ(KT75#&DMM(E]ERKK]C=JMGSXBI5)9ZO.S$CM#=2N<,YRY8DDH2F=4S
MF<P7Q%2F;)GQ6WYNWCVYX_\ 2ZZ'9@WC>,;1R>]$+J;D)OY[1RMO==0W >0R
M:@\";.5VVRG>M-',J(::GU639:]'PJA<D2)YS)F_%@+TC,C_ )/=3>3#DCA/
M6G6^;F-M!J\;U%V<>NP,5*\9G%%DG9%:TDZ]VQ KN!.E>/4XR=.HZ<J/7*DX
MTS)E(8\F>\PH8:FL*9DL L6_^/U>4 _\?K\H     (/]9?K[7*!^1_QX_P!J
MG<3@"#_67Z^UR@?D?\>/]JG<3@             ->-H=JX%TTB15F_8V0",=
MQVEJ:2@XU',G+2^L+SG<!BXFWFDT&FV$U9=3Q=J\:MOPI#;;*.IJQRF$R8M+
M6DRALS@V'$,/,+#,SN>NANS,0Q>\)_)Z.;KL;8R38"C[ E*4@OR.<+3=+)6U
M^,FZL&")-VR7'-[BP.5KM7QFEFE@O>LXTT]C5,9.VX#;/7#DET[VC:4RNV.Y
M7L;UFN9CO.P+9F9KNN!GW"."]+,KA56E)CS CLYQLYNJ"*2.JB:YE4CB;Y\J
MGJ5I92O,I:B7*YQUDV6B#;^#&!L= SB-.V(Y.)JZ@RG(:0EINYU@@B.1::AP
MYXE7R2>LD\%RN@*-A:IXD7N,EK,)O'9W@QBNNT*UE<V+D4_=)*>PO&LH0MK@
MNN&"BS"S;<1TB-><]DC\8&<+QSJLP02ID%8ZE,N+GRD-W-%V1[N):M7*5,&,
M2 0P)^>S+!Z6U1V#:_&QPWL.>M8MFI(UIAS8C8U3WSU*B5JO?-,R^B.YZSKF
MUS6UZ+FDK-YY/*/VF_5YNNMRMM/R&\7BE817$;2\Z81O,%@+F'6E:=>WI]^E
M:5_56E*_FZ=HTK:_(?IV\$_;=>09O:QYHZ-JIE%V8?.*A[(R(]4DUG5>ZZ4H
MZL!;.DN7.W$C&9)N#$U\ROE2G*2/-3-95Q%,R;;&U]#VVEW3HI-Z8IH#\1T,
MSO3O,W2K)E=P*#HD%JM>R6CZ218KX<)Q;7SBJY&VD5M;J\>HO*=3"D3.9<:D
M<NO\,S::3SQI2LI:^_1$VM6L, 9(K:LS9-3+-16<U6L18#%D9%B/5>",[F:<
M95LJAMPSA5W.S',P%$U::PDLCN4#V)<-939@_?D L%:A;SZU;S-9V.K79[JC
MBM8+@(ME]-AW,5]1;(#-5%E$)N=N5<L>R4WFL\$E-=;74"+C:BR82*)#C1S%
M324=,W%CN(KMSW5.RG2[MK6GU-WM>[7ITI3W*U[*^U6H@@XI6Q*[_P!ON2S>
M!S0%,NM<3;-8M'8ZB6.I\8YB+I./'M8H16V5)CF4H\/YZJB*WK'.YL+3:2N=
M+TPNI*;=5=*,9$JXOBP5@-6]N]_[I]TS<+&C[D"V"8\6<G'(>@RLXT$G-2W#
MS@09Y/-&)((;2P\U&Q38[H:\,N)EOU[K::K9##2CE.)FL%^=(5%<Q9:!^B[W
M=OWZ=:TIUK;=2G6M>YIVUIT[:UI2G;T[:>U48?@F>8TV0CLO*T1K)IQL,\ZY
M&9Z8O9D=32,2JIQ;(3GC!UF4TNJ%BQHVC6NYGKI5'6L>'Q<OIY? LI&8TEG2
M9K-0<UZ>\@0+,'&8_4#7S9Y<VV0D7EM=FP\M8WXHSA&?(7LI'NITSGHY<T"'
MFA)K^29XO+.!3(II-Z-QCHZ>V"JZ48.!05<B?D)$-[9RXI9GPD'=$%T/38]V
M]K]]#>-%H0\L,51D9,:SDY)8XD65'PE&4BUGK"8E/*;K'HY%)VH*.J8%<]@O
M=-Y\L4KG.8<]@%N?9#9"&]284?NQ&P#OJPH@C(@G*;U=MR"XW%XF(JR\DMDA
MG\2-5)6G H=_6EM,)][3$LYEQ>$T,9;+"V+-FQYNQ9;,V/'EQU[K'ELLR67=
M*TZV9+:7VUZ74I6G6VZE>E:4K3KTK2E>P4:]K>/?:IKP'R01'"<&;..U#G[B
MWX_'4L))FDI2.<F3=A-G]+4IV73&=R*"Y>X9VN;";>JR'@3+\:IA(4LSGB1<
MM>7[JU/J'N[DVD7',T\FH&\NMU[+;2,KW.#:W7ZL/-=SWG3N1*O2&>K5=SBJ
MMK9"XM4^HI]2Q6I5,S%S7?LG?.XH!OB                  @/YE&))S\;2
M.E32WM0'YIJ0>;!=;6;+^WQF#C@G2DX-M)<I@IC29F3DUS16_P# 7Q5/N=K,
MQ9S,?.3-(]RQF.F3Z&164_W'"R[=2$M&F.*H(:DB1:_JJ+8>[S9,H[RQ5NY<
MYBER5G1<3KBI^Q[L=/)C.RD?O19,<-R@189@HKJB/8HH%IHWBKB[1SOLAM+N
MI49R.]E;4/*RM>-H(LG%UQCO"N%VQ ,\I"&@OQJ>D^M.3(@NC.DN18// FY6
MACQ-Q>3UM<:A=ON=&4FDI+A7)%#Q%Z+D98V=B_D5@DOQCL>+26SL_22_&1HP
MJU=!V'&^HZA(>NK%U>2'LB,5D>,$AWNEQK.P\JM%Q)J*SVVZ$=K.6.4+J^E.
MPF!<. *>2GM@     Q[+7K72-[PWEYLJHT X4OK2G'/^1Y!7F2G#?^6O6ND;
MWAO+S951H!PI?6E..?\ (\@KS)3@!*" #BM>E*U]SW.VOYJ>W7W*>V .0%>G
M8?Z)AX[M=)\E[7=5;6TTGO&#WF>CQ_KD,P?A>K*3WJC_ .!7VX67#+T0C)D\
MWU'&:2%.^Y*P%+E$D<QIYD^7P>%78>^FPN.C^)/?WXL)3YR@!9W 5B/IL+CH
M_B3W]^+"4^<H/IL+CH_B3W]^+"4^<H 6=P%8CZ;"XZ/XD]_?BPE/G*#Z;"XZ
M/XD]_?BPE/G* %G<!6(^FPN.C^)/?WXL)3YR@^FPN.C^)/?WXL)3YR@!9W 5
MB/IL+CH_B3W]^+"4^<H/IL+CH_B3W]^+"4^<H 6=KJ]+;J^3I2M>OX*=175T
MKVNEV2?H@GEOUP7IE=[EAF((;UH.QI$*JMF\C28RW1H1SZ.51HMHS3'@3LYU
M:=1JYR*J=AI:J&E,I<H&37<IU<.,KOHL#CIOMK9Z2>_M.[IW/7]S$4[*7=E;
MNR2:U[*5Z]*4K6O3I05TM+.2EW:N\P>T7+I/&L^UZ?I?OS38>,XM74:*%%><
MJB39+SC-08=F5%,K2<1M4T!"9:,D+16BOD*$,BBI8$#.HE451O+ ?I2@*Q'T
MV%QT?Q)[^_%A*?.4'TV%QT?Q)[^_%A*?.4 +.X"L1]-A<='\2>_OQ82GSE!]
M-A<='\2>_OQ82GSE "SN K$?387'1_$GO[\6$I\Y0?387'1_$GO[\6$I\Y0
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MTV<B8=:R:=PJ90JM4,ELATAD3L67*742LC]EO<66V]>O<VVV]?=[FE*=?]P
M\@             !@=_^O9 /Z5O- D,\# [_ /7L@']*WF@2&>!4[D9Y*^VX
MLQ=?4>>;N\   %)>    TZY"8SE&9M&=N8IA(E@49?D+7:6VC&1#.XU)H>%O
MI;9JH3;)<LZ$E41#: H95:\M8F*MRLGDR2E4IF4C6)-M-U%-I$TYG>37N;?/
M'UJ1R;0 L0;&["CT\=V,W:<7CK!O*8V#A;"6DE,0BNP+^;3JCMD1+AF%1F.K
MC2DJ/'(W% CB0H_;BK:2PJ=QWD4CV4Y:T/W!B^$"+H5)@D37"7V5&B:S'4B,
MES*#V<[*5D=NDDEV.111T-!SFE$WAP9%)25DLM@*WF*5425]]AG'66U1@'>_
M4K:N%9UUU^A[L^KC7:^O"_ DR,F'-_M8;T:;UAU.2-CJ3(<D9%YR',RX3B(N
MTG,L-/.93U"3',LO$Y>Y'10NG82J@!<TMI6E.WK]5=7MKU[*W5K3\W3ITI[5
M.E!Y#CKV=:TZ=M?S]O2GYZ]G2GNUZ#0M'Y!XQ6'T[4FV-9Q)PTT#LUHI[:W.
MR$LYKOD<&NQ-=,S$GYUI&<ZI(#>1FN;:CQ;J=(3OCIO1F]G@S7&TF*\'$N84
MLHL ;Z@(QDCE,B,VWUT\X8=V%8CTN08)=L4Q&[FJPL,E3^T]FWF;CV"EV*T]
M&DM:;Q:KT>)$PC+2#)CECQSQ5W-JG+R,QT>^U0KMUKIL2T]D&8O.9 0'<R'
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M4X;_ ,M>M=(WO#>7FRJC0#A2^M*<<_Y'D%>9*< )00
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M*-T1],QG14W&4G2(43VT=5W*G1S'K<4'.Y45/3B11]*J[B:IDVCIJ2K'-\@
M%;;C%U>BS4+F$Y,H;AWT<^@M.U5T%6B_IAR6_)8<=#ZR:FVX_P!\=TC+SC<F
M4GW97'4HG7*/B].LK?B3RI3!=WFVR2(/]9?K[7*!^1_QX_VJ=Q.  /&^RV^V
MZR^VEUE]M;;K;J4NMNMNI6VZE:5I6E:5I6M*TK2M*TK6E>P?7)$B::4+$$\J
M6(D2>'&6*$R>#"5*EB^&VEF+ 7+X+,>'!AQ64I9CQ8L=F/';2EMEM*4I0?:
M                                      'TLR<GF3A)1,$B><^FVFK$
M\[F*X,ILC8>LQXSEI,SDQW9RMIO'BQ6&;2^3'0Q9CQVYJ7VV6TI]T
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MS)3AO_+7K72-[PWEYLJHT X4OK2G'/\ D>05YDIP E!
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M3\%/)3W*#D    !!_K+]?:Y0/R/^/'^U3N)P!!_K+]?:Y0/R/^/'^U3N)P
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MZ9RWW!MPC?(VDKZ/BWZFI<*22DD?FU':S&2;7,VY*Y-FLBMY44  #\9^\
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MH#+BCGTMW7&"<LRO(N1SK;0QILF*:]/J61:Z0[$!;+-\NWDZA[%3(!:;
M   0?ZR_7VN4#\C_ (\?[5.XG $'^LOU]KE _(_X\?[5.XG
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M?_KV0#^E;S0)#/ P._\ U[(!_2MYH$AG@5.Y&>2OMN+,77U'GF[O   !27@
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M^&7OV8]%?H6!>=+ZO67\,O?LQZ*_0FOHB[7UA\=T]\5Y /37VS<2_,_N&U@
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MX7COC^B3:)OPX:;9":T5]3*GO*38@>]N8^Y?'* UW0AL(V[9G9>-*;1MF,+
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MU:VO^^E1H%PI?6E..?\ (\@KS)3@!*"
M    *AW+'[..3O>U%_F.FBWB*AW+'[..3O>U%_F.FCL^@KGE5] 5N^VTX/PB
M.8M'ZR4&X74C@  $N2$X   'QYOX Q_1S']3>+V.NWL?X-_$]&7F2ABB=F_@
M#']',?U-XO8Z[>Q_@W\3T9>9*&(]\(#L?AGTRY_<49)C@U]E<5]'VS>:LS&
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M/S].G7[_ %&_\M>M=(WO#>7FRJC0#A2^M*<<_P"1Y!7F2G "4$
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M_KK.<;/7C)V0%,TZL[<4VYDRW8TJJ9BQ@;P       ,>RUZUTC>\-Y>;*J-
M.%+ZTIQS_D>05YDIPW_EKUKI&]X;R\V54: <*7UI3CG_ "/(*\R4X 2@@
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M0[EC]G')WO:B_P QTT=GT%<\JOH"MWVVG!^$1S%H_62@W"ZD<   ER0G
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M7Z%@7G2^KUE_#+W[,>BOT)KZ(NU]8?'=/?%>0#TU]LW$OS/[AM8  '23E8
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MD,9;%Q/:J 26+,IK'EPF<EBH53L)^W(8Q9LV+/?:8I=FQY<EF2MUF2^EW=P
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MBV0/VD#EV&O>KC)2F'-=C_P=]]V/K;733A2^M*<<_P"1Y!?F2G "4$
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M8CWP@.Q^&?3+G]Q1DF.#7V5Q7T?;-YJS,8  C&2X           ,#O\ ]>R
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M(3&1F/T)T-PG(*0N35.LE9W3%7>6^N&/"56&4U):*6X,2(7*K-"ZE2S*!=T
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MN;&?B-E7S)61D;/V6M?2-%O,1B[YV%O'1=PW28HY6_4V?YEG[%!R.+?J;/\
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MTN-B.L$5S.58CWG.;==6;L0<26"7A1P2CKBT93>$UI]IGTPKI"2$)GV0Q):
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M6\T"0SP,#O\ ]>R ?TK>:!(9X%3N1GDK[;BS%U]1YYN[P   4EX
M          A&V[VYV58TD[D/^,) 0VG%?':P-=7VZXB/,%O.*NQV23[5U[2@
MDN1[*=N1QL<JDQF42$>+L[%,(9I.D*]27WQD=K7H4;0FY&D4WZ"0C/DIVRD\
M%*2TJY;3HW199C]G/DRW(QGY#AYX'WW%J/-32PD#/HJ),QRJBCEPU2U%NFW*
M@'3#&?!IT,.ZC9M [3L)MVR]=':V6>Z6VZ%L\Z(4V<G F:0*)%2F!OZNMYCN
M-VI)GQDH$LWCIP%'VG86Y3%BR$*F"9[QH:(XJ%[\VFTB<M"&VD=PO-B:\2+)
M<=QA&FL,ASBYRCO8#8/QMEVXPH9Z*VR2;:T?R'7NJ(R$X4ITR291C1,DW&^H
MD+FW>]EO*;0R.<MJ])S6UFP$&NAU.E6:\.1I#6S3(=F!@/999\BO-2GRZ)6R
M?8:IWIOJJ2;B=QL!L/&UV&TU7:\@(KK+,E29JV2IC4\^+1.<.(Z1W*LMZ/(J
M?14C#2HQ]5&&_P"0G#,\G->3%I)UDD<@YT@W*D/LQC&H@V07"+52237C11Q+
M>NR<UBAG.BR2ARZU$IOI1,#,3KY&I48LI/YO-V$'-.Q-XR;M@D0JWT=RQ]&B
M<VX^T.942M^=5MP.ITX[3*N<=DV.*16\U<-A4_7"HHJ(F&+DIOFE-QI.'7SR
MNR:^#6LA%@14ZH$]..=N,I[(QM]GHU?1F2]/MY).?C,LJ<3F^:7L,;R#6C"/
ME' @U/J)]NEU-$4$!V*!S*KE$>3M+TFA5,I%^2^UW*1^)F7L.R&^K*3ER9E)
M2(;1K*,X9C5G+EPD\&)8<;C6T,LJXU:N$M4B>,J&7!@K0W=;9A21.*_6:0VK
M';8O4)=9QB)HZU5C6.G8PY).-QXM-'TT=3I>4&*J8M52SUM'(B+KP6<ZNKYR
M>:JYBR%\!HM987M[H"23'?2^RVZVZEW6E.M;:TK3KTI6OD[/S#S&%X(AJL&,
MG*RKI4F68*Y5Y27*.N='W60WIBHHXB>*B-A7JI*-W"$0\#[XFIW@E?!<AHY?
MW[)W_I9F@ !$-NM+NVL0SA'F:-9SCRJE(<F0XQ];-*D".DETN_8M L7T&_:A
M[3 \%LK>\8\:<5LA<57,4?\ '!U&9,5)C=1UF13#_6GPD1W=+R- 7_Q[,=\[
M*N#:@G.^U<?2.Z$V.6\MD(YFBK=9QIH1@8R'V^Q\#?,M=6R)C,/*IU;67,W4
MI2)$'(MN%96%2S,HF"Y@H!@SDEFG<:.W=%J5K@D3:DQFGQ5/DJ3G)L,:]Q+/
M:RB58AJ-"#';F)*FF2XN:UF7.E+TB/8VWVNI.:3W:79Q=%93,6,V8Y7!MN:V
MN8;98>G#FQJ*S)J-MV\8PCF/7RB)!)!+*IF0X;>4NH;^64-1SI^=&0EM 8AX
MSD2R1?.I)QY;3B-"%,& UD+]'E#C\C:53=RNK2WLP@.,Y69T1==32FY<1G(X
MXJG5[7OMX0<JJF5/4+\,6(JI0LGQF31<:.\(E;Y2U%CAZ-LH<5?&/T]E-,\L
MLHFE\7Q>K60Y%>M$VM.0<B@PW <:S_9#4BZ#Y.8$:HL2W&6T\6P=NQKKF;3;
M<J(]$V]).1GF=&,H;QN"Q*R5 P I\M3>6F,V7A#>O$ERL?S:\S#M=(#2]%<>
M,E98<&PT_P!PQFI*-AMP*^9'=+Y>+J:Z[A8S.33I(D<((RL<<3J;%^).+JOI
M73R4O##*<?FXVC1P2<SI.1=38J9\9)Z@SVJ;MV$VJCN6MB;3KJD)QV5QIC<B
MZ#X[9IERX$PL>,9\,E7*2:@+2JG)R4:Q1L'Q%.HLP$&+]4'':5;>6'MCX,47
M#(>PTRQA(K48L^."KFP-,R[(P9CMQS9"K06%%85RT4.I)8<H&%W$45R6S2?D
M7WKA6I$(^T+A]D-Z+DL\?=;G6(MF-A3XEN XIX4Z\W)D=Z]$=9F^8R)J>5M+
M8&H2C(CB3B#2IDSEB.:S!FH?SY,%+L@$7FP/,/*F;3Z=9*8$!/77Q[YM/-TI
ME@1_O=QQ-(Y*R4])'6A1K-;87F:AG5TMA)H+Y7J96"NJ7C%&D5OHZDI**6TL
MV9)2E.PJGYZF217-??;?DRE2V7)6WN>V[+@QY*W=+>RE+JW5NI2E*4Z5[.P1
M_/?C$U;?\44AE?2WO<RZ1QM[%EN(F]#A53M:N[KV)/\ G.RBC0GDO\8'7$0+
M9FN>NQ5N;1:VXJ7QF;+JW#.NNVMG[GJUU64G?9":;'/:A6X[-@)4K)5K9L0[
M5*RVQITJWT/Q-:J6J-M%G_VJI_Q>F5K7%4IUR@;,#BO7I7I3K7I7I2M>E*U]
MJE:]*].ON]*]/<J.0 $/\L;D[+PKM%N FOI#C.D(0CQX2;MA#[(;!Y46G@[%
M6+G<O$#JY);H4D- Q(1ATET6B:CL1J45$UN)7=JBL[5Q<5K";:[=IU,FQZ7.
M^'7_ &+E-'G%0D342*MMT!W)4>-R-?0"O.9X'F-)46D$UM68BZ['A-3--E7C
M)27K#C^2T^C@2WLYW>9R):GAW;<6N$5.Z5EZ7W,AYEUR.B"U77-Q)BF;J;:J
MS%:XYC#J6$)0;V7%4J9R*2@:,ES9N_)6[*FYLA&['WN[NAC'6326+M65)>76
MHZ)8D)QJS.8<7)+DFB0#LC+S)AR+\RUGCV(F:HG2)#*F,QL9W$LG+C!ZU4>+
MK4S>)5?KL=:D0339,#$:3R;PB:;A!XK3;?C;:N6%=[IX6%8Z41#M4!CZ 3$A
MP]+-QPDFJ^<T;45]06J+[-*D+<UAE')F,*OF3%._ 4OPDXN1J6W"U9,CLOKX
MXH GY9AG6Y[0B;=SSCB1T0T;W4F91U\A \>+MHP8)VN5CO J:<$DM%5PYT-/
MP)&4NEN!V(&3*O4^I W%+8T8\1E:5I#6U^9[6KM\WE5D5=RP^M6,2+N.[#;Y
MDZ+JL)206.\E^&%=\DVZ^E% R.IOO;*I8U-JX7]8R+$I%)>GTXXR9$8,P8YJ
MV5=V924F8T=?&9&['0M@I4GY(K37[//)INK"^[I=CQA+A!JIIN;LAAB1B03%
M9105%JI3LD"4Y0>)G.IX0/M4Y9GVH'2!)FZ428\2+T([>'X><%\Q0TA%9!3-
M&Y0-QK-ZLNESINPVPL2Q7"G*D86'""KD=A]6L25XLPTXO>X!ES0C<YT[:SMN
M+?XRS70NUDG21[P,@JJ AHSB;C1V.U$9,YJI)Q&TOOYA3532RYJFL]AY25+4
MK)WU-3352&'%UV ;>B,!-7%'>%)3G199&"-M2@M6F=SFL]<*?N,]\$@31:=K
M<7IX;E.N(MCR-W+?W%6\4[HH7IGLNK<,$M3BEA>-GM@>T035ME#>7(UM?6@X
M&Y&DZ&$!IO)'UICEM1/&EKM1C#84;E4Q:PFJF(#BSV&RE5\O<;R&+,6;/2_&
M!*" XI3I[=:]M:]O;Y:UKT_!3KTI[E*4H.0
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MD+D!9II2M*4Z].OM]/)UKVUZ?>Z^3[P Y
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M$H_CB<:9>4H5P$"ZV6JFYK-5M*TMMI6O6M+:4K7R=:TITK7I[74 <@
M
M                                P.__ %[(!_2MYH$AG@8'?_KV0#^E
M;S0)#/ J=R,\E?;<68NOJ//-W>   "DO
M
M                                                           8
M(?\ 3_'9 7WJ2MT_U1(T_/\ G&=P ?5Y&^+_ )4LQ=?4>>;N\   'PO
M
&     ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g218389.jpg
<DESCRIPTION>G218389.JPG
<TEXT>
begin 644 g218389.jpg
M_]C_X  02D9)1@ ! 0$!F@&:  #__@ _1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?0UE43TM,3D5?-$-?0D%2+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( 0<"E ,!(@ "$0$#$0'_Q  ?  $  @(" P$!            "0H'" $&
M @4+ P3_Q !N$   !00! 0$%#!$+$ <( P #! 4&!P ! @@)$1(3%"$Q40H5
M%A@9.$%Q=YBVUA<:(C(U.EA987)Y@9&QM[C2-C<Y4Y*3E[*UU]@C)B@S0E)V
M>)66H;31T]7P)4=4<XB4F20G1H*&L\74*4F$_\0 '0$!  (# 0$! 0
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M$"06E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4
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M (NID.9 >#95.^?.UPMA8(+R(H=YFAB)OO)53!S)(UWL=+&"ACN(V?<3( P
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M:[](ECHQI..X @6<Z4I0"E*4 I2E *4I0'776[FJQ4$\Z7JY$)I-I,[W\\7
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M&AEM2UF5%R-1(^MN&NW3!U4U+Z4D.<%XY.7)U!J!4H7'10T4)!$+FQCPJA;
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M-==;>::;YA4(^8L2NMPF4>"'% TE1<Q)<9\;-I"5'.]6@U9/D)KO53<#217
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M3#(R8M)[$,+-E'%1,IVFB)E;+S24_<K=>E^$Z,[VZVO:_2^\3_O;P7\/BO\
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M,4N<\E)*>G''&M6=@*NOF214(N.LJ@22K$$P)14A0\CAP-/)E2.!@43$J7
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MKS$_M@GV^7\:]>% *4I0'T>_,1OK7=VO=_C?\F!FKOM4@O,1OK7=VO=_C?\
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MP(K)DOJ6[(D4)BF9Z*6O<E 0X-"^PNH<2Z7S#J^0;\?LX^@Q<ZXOAY16FTX
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MHO'&I"E94X^7NU9)>KUD;;K1.?YFWJ(KLEN9[AK,OM-XZ\$$UYN9H*RX>26
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M$GJ*HI(SZ,N[ :UD"L*K>MVO3FE)'G%QP5#J]-#=Q)8($N+,9,E4DU$P3<!
MT[%)?AY#'=*=9/"&'"3[E54+(@$8,!DLB^ XV.8$2 &_&R(#R3) ,/"$E2/G
M[N_MAI6D:VI3%4\99CM/U^09TNBRRM/L:11#"VX2YF$B\H26TE!@H+=3H;DA
M*R0C996;I!9?>E$Q;I;X./61J$GA.\;-1U3KJ?QN[F(C\B:+5N.S42&9DW%@
M6-Y+C',10EI=S>K)4T%\E\QE91/-E0$)$W.AJ.!M#=89-O660X'A$*0EZ6PH
M=BT.5'4D"-YSR7A'K1P?[B0!299.%0UUY8H]G&KI I D3(BIJ@I&"8A,F4*B
M Y%RP 8?*S!,(N)!%:S@AV*UULCL(I%8S=6(\:"FA#1B0'+FB,<BI!Y&'3Q&
M&3,DRA@HT,RUV\6'+%Q04[ 0 ++ "%M)W!WB=<G%FGE+6OS!:,X\BVRVET5+
MAZ#UE2.1.T-7RLX.$=765-4F!+1)*ER<<HM+,YFHHY-IMQI=V,KN"6^E+#)%
MQ[IQ];%2/L3N3(;BD!<0%<^@ZEDHZ4%./<U4C$L@K<*<@&Z\(BS1'3>47"Y+
MI:!*23'Z8NE@Q%56'(7[N@%U]P(R0E+)^7%Q05"3O9:O&[KA^+G-'B^N#N9=
M8C@CYI++-6G&:4_/LROJS844<RB**V86?^EQE<V1&41%2UE#,S<W;NU=B;<<
MQ\SAB)AI,9G-<PEM-%8::.W6PAH@R>QVX8.FV\S2(J60*YE&H@FE)1,HS=+Y
M!HZ6.?.#$21<0T/D(!W.E*4!XY>*WVV'\:U4Q]/9WGV+M0^-2*I;?S_>3)VR
MW(U*DW7"6EA24U%8(N4/<P8WL;J0\W2 H"&S",F-4EE*T*YN2^?HECA0DN.Q
MQS&,4I02O<Z_Y_!XJQT7B")RC=:+0*1A'A5IQ^N)3F8C8+LIL@-UEN1".&5%
M$<#31 DO%,;BVCJ!PV>2U9&*DCZ<<-&31,P"..*)F!7]U@(ZWNF!F'N?M7/$
MF1UO$)MR=84DNYJ3%)*O)S.GX+:)88:-IFDP<2..E%RCLXW[(<8#P<1AX9/5
M8K4C,I6)EE@S\E(KWK7">9=E?E=R69(+[%1D?DW2W9E+8<&/V&Y7:D=PJV(S
MV/A],CE=/#+372V2[I)?B,.N/N17^77EAK%S;H8\*-AT&\$ @;=4TF>MVO0D
MM8SX)!</9SEB'B%C,N<9LK*5,0L$[%'P#M(.2)=V6QP2,,4K"_GMV\$S&R=A
MGB2MW"LFYMAMB.(L[A&^B9NLDB'FT3<V:20R<)5NJ9]/55%!++61>ZF BJ"F
MDI:B=2@C6! V?32!P<N(8)EA @*W9$J_4=HR?!$KSW+LF,%\<YS7@F?90>;O
MP;#H=45//6*+7L P#RVP"C,2(YC]_38,PXQ*LIA$6FA9-=V%XS(A9AN$T*HR
M?\8RFI"P_-#3+.!:=,71=N#M'%4"+BXX%1Y#WAEC24:2V\W4]ZK1Y55W6@,!
MPW=D=-U14E54-D$5I$FZ(H&[(=ALMVG'#L2N]L/EDNN,(\<K.DX\*J20U5YE
MMM7;C_4QRR22&47JB'TP=-=*@*304,J(>7"QXWD71DD+NW8325@/?LYF,^.&
MHB,E@-1N,AEM=."2FVT6@AI;:;2 E%K97+IJ*A(Q4DE)9 #M9=R*$2@  =\L
MKXAVOEE>X':*5I+K3N%GL/L%O-!OR.16B#IG-#!B$)W9.7):!DG)ZPPSI9'6
ML4OT/I6#6&1A73="$2,%1QW,ERY17S/E,E"Z:6W:H!2E* 4I2@%*4H!73W_'
MK"E=FN&.Y0933D9@.U/S272R'TW4AVM%R)8@@8N:<O-Q?)GT=7(YB@A"W*GR
M8X/=0@A;86$#PRQ[A2@(]?4DN+#ZVWH?X/!ZTJ"/8_\ H6GJ27%A];;T/]Z5
M!'Q%J0JE 1Z^I)<6'UMO0_WI4$?$6GJ27%A];;T/]Z5!'Q%J0JE 1Z^I)<6'
MUMO0_P!Z5!'Q%IZDEQ8?6V]#_>E01\1:D*I0%/GE;XK-0TOD3X5&O"^L<'Q)
M%DT[%R+'>R$<13&3#C=@S6RHY(,?8A!;$IM1KIZ$COE)!'CAPWS)+B8J8&"0
MF:>+G>WG<2$G[QXE.+'/&V>7&UH=;+.UL\K6U)@?'&V67S5[8XXL6V..-KWO
M:V.-K8XVZ6QM:UK6K8*7M78GF^5-;IC?A!9-/755_.J28E,IRX:3$\DY7C'Z
MY&JT(N)P&&0*X2S;:^<[W)F,@L2Y\,L:Q$RQP% &V(M:V-K6MXK6M:WM6\%J
M CV]22XL/K;>A_O2H(^(M/4DN+#ZVWH?[TJ"/B+4A5* CU]22XL/K;>A_O2H
M(^(M/4DN+#ZVWH?[TJ"/B+4A5* CU]22XL/K;>A_O2H(^(M9\@K3S4S5\VX5
M#6S6/7[7\\[2Q FZ3D+0['T8&W&42Q1QTTLNF66WT8=5+IXYDP,3 /"#!%A1
MQA0L,<Q,LK['4H# <Z:J:Q;0$T!/V3UV@[8 BU#!PVUR<U10Q90+-PTHA@A*
M!A"!>J$M8I Q\,N7#.B$+%\C>!<O8QW3N 78UQ]22XL/K;>A_O2H(^(M2%4H
M"/7U)+BP^MMZ'^]*@CXBT]22XL/K;>A_O2H(^(M2%4H"/7U)+BP^MMZ'^]*@
MCXBT]22XL/K;>A_O2H(^(M2$]>GE_!>_XK4Z_P#/2]OQ_BH"/3/B1XL;XY6M
MQN:'VO?&]K7MJ5!'6U[VOTO;^L7QVO5?O0'B[U!6^;'F=CF2=<(3D:"X$(ZO
M&8'@V0XJ:#HB"*0]IV>+,+V,Q?%[C;Z@R&:7%7&EFG%3C42TG$N3S/)97"Q0
M8T'C</Z^W^"_^RM<XZU8B2+]A]C=H6HGK0,L[3)L,)$L*)Y<-G4@ZGP*VEQJ
M1Z71$,3# HA]Z);B5;J8A>X@JJ:'P',"8V!"#Q P%ZDEQ8?6V]#_ 'I4$?$6
MGJ27%A];;T/]Z5!'Q%J0JE 1Z^I)<6'UMO0_WI4$?$6GJ27%A];;T/\ >E01
M\1:D*I0$>OJ27%A];;T/]Z5!'Q%IZDEQ8?6V]#_>E01\1:D*I0'08PBJ,H38
MR#&,.1XR(IC=K F2[98,<M5#9+,;Q<X=,J1L!$;+;(IJ,EA&E X;/&,"9,'$
M<X9,&1;9C#"9Y=^I2@%*4H!6"8$^A,C^[=+GPN-UG:L$P)]"9']VZ7/A<;K)
M.]=ZO.:7^&A\F7F89VI2E8FX4I2@%*4H!2E* \<[7OAE:WCOCE:WMWM?I_IJ
MKK"6^^L7$ON-RJ03N4X9"BDG-N[F>XL(N,G!,\2@AR4SI_A.,;NLVA+43QT^
MTT(%FO9G'FXIEU0TG& E(04J5 '[T.8E+1E>-\;7O>_S7A\F65K?@M>UO]%
M0:_+'_$#]4;(WO/-T/Z/]/EC_B!^J-D;WGFZ']'^IRNS;RY?N\_TJ=FWER_=
MY_I4!!K\L?\ $#]4;(WO/-T/Z/\ 3Y8_X@?JC9&]YYNA_1_J<KLV\N7[O/\
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M \L;F5$=.!\.6>-KV,R),J1*%R1(N$3)DPL"90J6Q[B7+%2F-BQ8  $/LX!
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M=["!=LL,8#L)B)F'EC8";3<2FJWD)L(I;$DD-Q'2T!*)EKB@ERJ:BD"Z60+
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MNED]86"Y<J/WHCD\K&QKY9!ARYVMTMTMXK>"U *4I0"E*4 I2E *4I0"E*4
MI2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0
M"E*4 I2E *4I0"E*4 K!,"?0F1_=NESX7&Z4K).]=ZO.:7^&A\F7F89VI2E8
MFX4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*
;4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g897145.jpg
<DESCRIPTION>G897145.JPG
<TEXT>
begin 644 g897145.jpg
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MF+&X\",H--(E1$9'56)C9G>"E+*ST_'_Q  ; 0$  @,! 0
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MQX][91LLLM[UMEML.P/;;;;3U*4I2E*4IZE!;M
M
M        <:L>A*G\'GOHF8<D.-6/0E3^#SWT3, *DW49GI:VPGQ[Y2^IZ"!;
MK%13J,STM;83X]\I?4]! MU@
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M #XJUNQYMZI.S8[JTK;6MF6&X&R65K;7OTYVW4K6E>_3P5%O
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M;:5K6EM*5KX:TI2E:_GKX:@!3GRISKSKRISK3P5KZM?UC4
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M'N',;_O4H1\C(G.  08^?<XX'N',;_O4H1\C(>?<XX'N',;_ +U*$?(R)S@
M$&/GW..![AS&_P"]2A'R,AY]SC@>X<QO^]2A'R,B<X !"IK%Q*=QGSO&T])M
MP>'LWM2'"_->I+V":#I0-O&CL5C546-GBS&8>3#"4T(R;!1,R&U%VUNH8-KM
M,^&PC;7$0-8S-^0K-6(/Y3_P@S4G_1@[9?\ $%"PG
M                 <:L>A*G\'GOHF8<D.-6/0E3^#SWT3, *DW49GI:VPGQ
M[Y2^IZ"!;K%13J,STM;83X]\I?4]! MU@                   @Q6?\)+8
M/^A/DO\ XXV )SAC<8U5B8SMPF;KY2B[]W%(UX6-829^U<SVMJD6+DCI<IGB
MF1M]9J6R+=SL2">;$MUSTSXB-N0C3%7'DK?3)$
M        $'\I_P"$&:D_Z,';+_B"A83@#'!;U9BE?VG8FX:@67JS)'<,OJ"&
MX:PK>3$W+&%(CJ;;Q<6$Z@=CW8C:K<LM9+N)*=36.XJ6[(+UPY:9;;\>1X
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M>O6O.M:_EK6M:^J
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M9$N;J<E("JCI1\@I%C.4L96L1DWF(@2I4Y^K7GX?]_>I^BG>Y^KX1J
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M0KCQ=DF<^;IY;@,F
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MZ&>&=/IBVVZRW/O3)N:VV_ET[:98:@;)2V^E.]2ZVEW*ZE.=.=*\A;R
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M@\]]$S "I-U&9Z6ML)\>^4OJ>@@6ZQ44ZC,]+6V$^/?*7U/00+=8
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M_!Y[Z)F %2;J,STM;83X]\I?4]! MUBHIU&9Z6ML)\>^4OJ>@@6ZP
M         !I6O+O]_P#12M?ZJ4K4:=*GK7?(O_[H W /Y9L^$OCKF,9<6#%;
M6VE<F;)9BLI6ZM+;:5OR76VTK6M:4I2M:5K6M*4[]>0_%VX2?_2:?_\ 7%/_
M -P Y(!_/%EQYL=F7#DLRXKZ=*S)COMR67V^O;?96ZVZGY:5K0?T
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M[RLO7V=Z)CK]W6/./B9I979UE'5^G3KW6ANG6.L=>DSTZP  !B9@
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M_.VVO2LK=T;N=MO?I7O4\%+>0J*=1F>EK;"?'OE+ZGH(%NL
M  !5:ZL&7EMN\*!N'T!85$0]=MU"^"IQ(43B8;K@N:,MY;L-3)'.7S5Q79,.
M*^['6_H5OQX[^73LLNM^7C26I2OI?9=([]NMNQ9;;J5>;FNI6E<5]*TK;<JU
MMK2M*]^E:5I7P5I6@^S7Q=^&2B<6+55.U?7Y>584(I\MLN5:/!'9A)]&\N=G
MI3K2K46J*?<38P68E#&ZLN6X]12NO+7D\=M"IBS-?2RL;7J'J+J4NZ/$/?\
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MQJQZ$J?P>>^B9@!4FZC,]+6V$^/?*7U/00+=8J*=1F>EK;"?'OE+ZGH(%NL
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M&T6U75:S*6RFQ+:VG>;]H5ZVATF5?:,C1#+$RKJRM'J:)B9B0  AY.@
M                     XU8]"5/X//?1,PY(<:L>A*G\'GOHF8 5)NHS/2U
MMA/CWRE]3T$"W6*BG49GI:VPGQ[Y2^IZ"!;K
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MGCB>]U-@/&.7/(@ +@ "G_W=GCB>]U-@/&.7/(@'=V>.)[W4V \8Y<\B  N
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MX5EE.]&AR1U]<S.-#07\WCB:N,,Y*"X@-B';W2C*:8MDBDA&2J HDEP\G&+
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M$=[.<6#+F358C0Q@/%;Z9"V8L?3E-+4BA)80EQ).$%MOK9!/6T103U8@3.8
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MZY,?#V6G@XD:,L1TX4:3)4E7,R$XL=4;?,[ES*JKF/9W4I2E*4IX*4Y4_-0
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=)!%(1"">2P]9N  ,@P                 '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g279714.jpg
<DESCRIPTION>G279714.JPG
<TEXT>
begin 644 g279714.jpg
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M)"4G*39"4E:2D]'P*&:&,S1&2%-B@H?!_\0 ' $!  (# 0$!
M  8)!0<(! ,"_\0 /Q$  00! 0,(" ,%"0$       $" P0%!A$2-@<3%R%U
M=K2U%#$U459AE-$(([$6(D&ATQ4D,D9C9)&2D_#_V@ , P$  A$#$0 _ +_%
M*4H!2E* 4I2@%*4H!2E* CRY4=M7YH[HU-&S,=LX5WK<>8LC%1%P;YIW@,9H
M.A_MEI/>5CS-(*R <>!"*FHMJS[,-<-?;Q9<NB!$%5QMY'&45HCC;K9R21-G
MKS,6WSBW1B_:G2:+& SW*=FJ+(A<!:9HW7C*PYQ)(1YYAV,BJ^NI(#>0!60N
M(PR?%[(5$QOF'$:=""=*) ;L49$-H&K/[L8*"6UN<K$;K^29.C1PJH$F77;L
MAUQPCN@J8DYB+F#<3595MB]&5DK(*>9!)#!)JL;(*QD V73Q")N&E%T:U=X\
MY0WJY#IW8\4:K:LSQKS&NO,S:[PB5>,@18?$=TD&6Z^9I?B2V& TB"88= S\
M0&;XM9S!+MUH-$!WR"YU4H.ZG(72@).7KR1:E,%B)\C.!_JP;67HZU[DMHGR
MK&>1K%[HVUKB4&GKRCM#/!&Q++3TD]?250JE,H(R&XD@DG'E]TDD%N$S*N%C
M3(W,;!K7V$T9U\:D?SDY7%N4]YS0LA#T$S"@JT=H6O8,@-F0<E5F'V:$\SSK
M398::>UE%"*(8I9M,X=5E%SGTMF>EI2<6(D$\3ZJ)Q&I^G#L38YVQ)/)_)V%
MDW9%8>D?IYO4UGRVMYPPT&F^6$UU9^1H^6A!ETEQ1PYRC>/YMV2W"HW52IQK
M&CQ ;CX;X<]KHM?O#U+:GL2SI.>/'2!MBSGN3EA6?+L5%*)=B+JZ9'K6:DA$
MFXEJ#X5H)8YU+9!,TZ&XPR#O!1P#Q.[/2 "#9* 2P-WDCU'=<B&HT0)%/*2U
MG>?"S552[/=F32DM;U9%)E]B6S%CJ\4^)Y"<L2F#P 3B26X.:&/9 +&;8S<
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M/-SMQ-FA_'%.6V^OYYH!2/#IV-#2>E/YJ7=[17R+SE%FQ\IIZLG%U=OJ9?(
MDZ1E(B=35@L*$>)@8& 31404&LX(?E.V&K4=37,+K0TP/*"VO+$F/(\$1;#8
M1BQA@D7N[UTP%82Y)!;B(7&4#.5QS(^*>E$[9FSID4,8R+B)S&:6ROR&\?\
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M10'!8101\SY*?V*-8Y/C+C.CS3G(^PUR5F+IRWM;,EK!8<*9'RDY$2(PHO\
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M4 K8(&&+AF$+AB('GC?'/#/&V6&>-^W'+'*U\<L;V\E\<K7M>WDO:]O)6^E
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M?>A A9B98X7^$B"7HVGN,F1,D/N])?L92,WB+I9;N1,Q\DY;1%#'*Y<R&$;
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M/(J<;<C927EFB".Y,0%H<N(HHY%T9MINY.$JGF"X*Q="2/&&)BR<5L%]12E
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ME*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
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M=<0J^U)#65P3  9>,LU)<B\N/I":26^E8ZXQ<YZ4! 'W0GACC!>@'>XXX_\
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M,,KY8WO?_MB8_DQ$RQM_NM:@-]*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E*
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MWO>^65^O[Z_6P '[&_PQ/TF50$=T*?:,T _&]<?_ -.714^X?L;_  Q/TF5
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MS8J<$]ZL#:8SO@_XC-RP7/0Y@X'\XD!S1KBFR%'>37DYJ#RG(A0H(Z,GFQ'
M$O)(SA:H^36+@JLEUNE[6O:_6U[6Z7]VWN_EK6@(AT?C!76@Z"<?LF;T]*TY
M-;"P'M2YXB5F"KK<Q*$K:[M^)";90$V:;R&30B4</%\0A',I/@B;BX^YAG(2
M=R.EKI=">F.#:X_GR)EL>'GD)'L7 L8$UW7["#V "L*)WJXV\K=^);#O\NF0
M>&5K7RO;&^&%[=+X8])B*B Y]?N.G(/\GAP_KIO4!F)Q^^8=I1\DC6WZF&36
M7=8B<?OF':4?)(UM^IADUEW0"E*4 I2E *?^_P#W^>]*4 I2E *4I0"E*4 K
M@G026U)M.)/;*P&WG&?0E<F@+XQ$)3"0ULTGF $I8%31[V!4 TP^(7.YD1;V
M"-X@7+B7M@)>]<[2OTURM<UR(U5:Y'(CFM>U51=J(YKD5KF]76UR*UR=2HJ*
MJ'Y>U'L<Q5<B/:YJJQSF/1'(J*K7L5KV.1%_=<U4<U=BM5%1%(SL=>>1^V.%
MLM_&KEE;#&V67K;V9;OL[8VMEET]'\G?9=;]+>2UK]*QTF/+D-B"4-=8T.;I
M(2X8V">Z\RR*N5@9BD &L(B(H"SFHG"(P)G-8#,8#>#X%03*=D%GCZ)<SG;*
M^.,WE1F;L>=5QL_'G('T&)5L+3FH+.0ROHUO':;DA_L[-V-Q-*:;9^;3PF0N
M5W;T>*:[\NQ7BDW=NZ_=5CVN8Y6KJ[56F:N+PZW*65U7%.F4T]5WUUEJN1.9
MO:@Q5"TS<ES#V?F5;$T:.W=YBN1['->UKDW6U[Y'KVM?U_;5\MK7Z>MP9GM^
M7_\ 7K*'7=@;$,0HZPM@)W2YP-*9M)%:QE,CM'C_ !;90J6.!JI88)(SSQ5,
ME,P*4'P%'Z9%+%<@P^N(V59'8>PQ^#C\UJW5%[NH;M^O)5FJX2*.16*Y]/3V
M"H6$W'M>FY:I8^"S&BN:B/2.5J/8KHW[S'.:LOQVF*&-M17(+FH)I8VO1L=_
M4^HLE57G(UC=SE._D[-654:Y58LD+EC>C9(]U[&N12E*P9)!2E* 4I2@-,KV
MQQOE?LQM>]_P6MUO_NJOYLE'L%\STW;5:H/J$YA1X_T"%,1ZD[=19.)**7JO
MSQ+D9EA9PUK:B8$1-FLXZ6HD<K509//O$!59CM&4!4@XAE T9+5U.P'>UKVO
M:]NMKVO:]O=M?R7M4+,[\5,X&]B9?V/T0Y$I@T,<.R!QN+6Q+$1XCBS8"*9
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M._; +H5#P.*>FJ2S8$@.,9(C)@$Q]NE[6O;ITZ6Z=.SI[73WNE:T[.RE *B
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M,^+?'@R.(X5K_*Y7-KZJIG;WMZ/;'&&_]VQZ$_Z*FW__ )4)?M.I^[8]"?\
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M\BTI[!0\8(PK+"\(XHL=+4:B6CKITND-8R,@&C!Q(-AB(JY@06"^.. @Q+'
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M?AH*:KJ9(,3+O 3P_3*]KES:V_T0W%57_JXU)UB:9#[Q9#V0'(P4%TC# /\
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MB;B,I7=V9<I9HB$Q'TC%4"Z(&9\-R7/1#89JP-@,2H(V>>60,QU*\YZ12E*
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M.2"JD",GV8R.347.9.A"%BB68%#SQQZ=\%T'WF)0MN-XWCB8".I3R?;TB^6
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M4X6:2+DYW+,4-PE/S%D62V.A-/ $?-YK(;>0Q7>D,<$(4R]U)I%6F4+FS2P
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'@%*4H#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g619902.jpg
<DESCRIPTION>G619902.JPG
<TEXT>
begin 644 g619902.jpg
M_]C_X  02D9)1@ ! 0$!F@&:  #__@!!1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?5%5-3U)?5D],7S1#7TQ)3D4N15!3_]L
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MTB8I0D-BHJ>UU#4V14A65VAT@H>(X?'_Q  < 0$  P # 0$
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MR\EVJB:%"H^./$KJM8WJ6B=1<AP,&[H8U/(B_P ?D)#,YJ5RR.NQKY%]O<@
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M9"6VRRE,UN>N8P2=7+R>G3-$^3B>9(C^40MT4JTJ=NE*?1K&M/4D%)EYIAH
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M,8R.TL>+>27="XBQS*"HH;+(_+Y0-"XUP[.D@0I8(NKM"N:BWXBQFM$H,?\
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M/]V/<E?BB_Y ?[L]F,1/7[DK\47_ " _W8]R5^*+_D!_NSV8Q$]?N2OQ1?\
M(#_=CW)7XHO^0'^[/9C$3U^Y*_%%_P @/]V/<E?BB_Y ?[L]F,1/7[DK\47_
M " _W8]R5^*+_D!_NSV8Q$]?N2OQ1?\ (#_=CW)7XHO^0'^[/9C$3U^Y*_%%
M_P @/]V/<E?BB_Y ?[L]F,1/7[DK\47_ " _W8]R5^*+_D!_NSV8Q$]?N2OQ
M1?\ (#_=CW)7XHO^0'^[/9C$3U"**UZ;T67K>A@WK>@!UO6]##Z;UOT^&]95
M%X-O^BGXS_\ 1N]_[29WEL.]>NOXP[_T;UO_ -F1$X,YC7<:\D4GS.Y2])/%
MU2QE='U$N0LQ\?2/8UDG?Y!I40SJ7!U/0A+ ]!2[*,<%6Q"3B-T9H)F@ 1)>
M8QC$1C&,1&,8Q$8QC$1D=NH/UKCOWQQO^W[R1.1VZ@_6N._?'&_[?O$20Q?W
M,O\ (#^;K,\P+^YE_D!_-UF>(C(C]WVZ\45R1>%HQZ5/\(D,;B9!$?ED6KJ,
M6O(6%_D<@9(JR.#1!IQ-*Z@3JM*<WQ*$M;8<XB]=1SV]R>?O*.',KT/<N,]2
M@DI02:0>4 \DX BS230!&6<6/7LC*, /6P# 8'>P""/6PB#O>A:WK>\1.L5R
M-R0N[!E-NR1U[Z\]=$7W4#_$4LI:;DZ6I.'% %8$7(GD-=S>>:OB$THR#"<&
M<S:IQI6:Q-GFT59E3&IE<7+:I5&WIX[#M$0NSZ\JN+0RX[A47[8+"!U2O%N+
MX+&:W=YDD,>W%2P*WV(PL>HBB?T$>/:VA\71M$RL[\Z-ZI^1QZ/EN7S.CZE#
M-8MHW#V;T@]R:X/\H6EQ$.\@UJUG'G/@F"Q=JX W"J\N))%8U#5.G2)I7Y61
M6:!M%7/03\>K7ENZR-2)<WNS@AV2>/N9!^K_ .5^J%^J^O\ 5;_^K_U?_H^F
M(F6,8Q$JP\R7^9*5_#!\;W^\/Y@RTP'ZG?Y9G]8+*L_,E_F2E?PP?&]_O#^8
M,M,+_4[_ "S/ZP6(D6)_VQS!6DVC=?2FY(&GDS]+W2%.*1+*6%4""O#.S+W9
M8.QC .6MPA#HY$2R 5/@4VA/CD@0[ $(E)Z;1/5O=3S3B2#OU(PR"7?#SJ?M
MGINPY.*R=L[6&A*2D-61V8@K%<Q,4G;IA9+V;:J9?#VYU6,<//(BCVE>9*W*
MES5L6VKPX0YSZ&G;18]EQI^6RIA1(T30L8YA(8NG1Z1.QSX6KT@85B%(<Y&N
MIWRM4XJ2SUBH1*8LXT1*<HL/S>I.)(GTV9$=FV)/ZJ)9X?.JDF"2MRX@0EL6
MC+4>:_?[+JQ[(D,:>P,::3.-8Q/:>81/3-,8ZET^I6-T3 ?EFPTG._WA_7],
M=4<D<T6I_*#A_5?K'I**+/UPN/TULCJY44FW[!8"6J%?Q?T#RD?PQ'CGB+>&
M-YH?*WQZ/]^$\A_DXX=&Y;[6S?[N68%_6ZZ+L]M2VOO3$V5\K*M>S]5]V?G]
MGW[(Z\OWFJG"*H?7J,7Y(I]'7&W/I'$448ACO#:HL2S4$=W'!/)T[>Y!(4T!
M4^Z/3QI-$FUL&H.6R?YYTB8U>HK^\B-,<]V4JJA]A=[3J7HFI$O6DU543W-F
MM(XNT$L:SF&,'O1:QM;0R)\K^H;-E*1-H\2!$@B"DE\<VEP>8NB?9!KZ-1/L
MIK*82J=3:4/-26W8=L0L;CJ(HDZ,R?06Q:Y+A2LEBBK1I;$8A$[)=4,8&<+<
MJ,-;&97)9-(5);@8X:VGG%]86%9[S:[R]S4B0O;I&W94B0.#*4S@4Q>C[XH1
MO+)3J&%2L"2;$>A)DXJPC6C&.0MT<5$F$H$CBVNEW//YIF1^3[GM(=9#3%B)
MW(7B&TS,K9C;FH@[\T0*?+(=5U;VHXU_'YHJ)^2!G:5DN>H4RV..25O6C=9R
M2QM'SL^1Z6MS!\*NO)E7ZRN5)]D1Q[4WC$YHIJJ?5-2;(\V6I26P;=%D5#&:
M^8E1H&HL^92I'6,ALTJ'NBQ(]1VM"BY?(=I(^XQQT?\ 0L>\6\T(ZKCT@=)V
M>AY6K5:RRJ+Q,B<(Y&_6')&F(\HQXI!,X6NIAE+BY3PY\QMCK8;@WVS*XQ)D
MWR%/#*\KM7)IVH5\\MGQBMD132"R.37!PCUY/UM(KCD!SK-HY733,[!,Z!GM
MV*;,>7Y)1EL-AUK1MKMBRJKB\BE];3IE?*GD881/V20*6"#2F&HFY;5\AD.A
M2#@:P(A&54SI/MB=L#,HGZXQQA[A65>SBLW&4P>R7F+OK60O @435= (E*FE
M]VPKHFWRQ8^N/LCCZM /6E,=U] 7>LA]B1NE*Y;* C[#1(NA7-]L@;1-(&LN
M*A&N^Y9.HZK>P,\56UY1['+H$V2="[@*E,S ]2IX8?F;<*2-,PV?&_'U#WSE
MCF'GRY9(]/:^A>>'&DG9TA[B4C02-1,**,I6:/(%3TRJ';:A*G6K'^).P2VI
MQ1R!*UO:M-[PD;<'A[#XKZJ8T\%AIULW#):19H-3T6M2D96J@[G$.B7RCJ?W
M1T1F-QK4D-;7MR/DD%*9@VG$(\K8(%8CO$(BK<(VA0HWYKDB)QRLO)1.;"BD
M#F1G+LM8F*P>XS.6BUCK+XXUGP"NWU3&UE66I8T>>S6R7II-9T4ED?>D%<1*
M.R<445N>VV:R%CT@4*C=Q\[=ASVY+YE%=R6K(]%*[?4?0;Q1\M:9LL?94^-'
M+G0:3FRS167&%4=:FZ*+9%+71GEU?$QM\E!)\06*$LF-9Y BVD4?:K_QX<[U
M5'W**UTW/T0C[GU3%^N3&MH7( IB+%B)$43-+(F^5M:HT$+"1#VPHUM&88Z>
MP:LT0\D>]*V3]FD^+HW2=V3*WFZR[&E#>YIK50US6\D'%_HC4*"^K>!?-TI(
MRL:(\VR>0%S6TDZ!W1#FKT^F0]D;4<5C0DC0$T)B)-'&,8B,8QB(QC&(C&,8
MB,8QB(S1DJ_SAZ<_]%U\?_?U&YO/-&2K_.'IS_T77Q_]_4;D+?\ \BO_ .MY
MO_['++_QK_TCI_\ L'E?_P#+=B;SQC&3901C&,1&,8Q$8QC$3KF^<5RZ6J&6
M\RWE#O*.9QO1QMEM4'74F5R$OZGDEAV>*&V4Z(7.(U_ $!TEN0HQM(2.+E5M
MA!0P6)*HN7:C7+T<I9X_&7"1GA<F;]9M;]%69*>S+H[)DDQO% >\2&T.0YCQ
M%&((I;JRAZ$,;K*B98I6%-[6\$@+E4MDT=/):)1,G1S<U:$N1C?%[GQ?SG-L
M[(K'E>Q*LDW9<'LRH>EQSN$S;B#C!A[2M*/.A],VA#%PGZ%OS\P)(U 79@E;
MPRO[LI&Z-CZ<O119U9U29R >DYQX6[TN:]:6NYQNZ[^K+NE\'O95!%"SKKCJ
MKN*;)A!R*O80^JX255M9O;L%8W)AOQ+V)]E)#2_#4O0D9*(UE(;5ZM$N6QC/
MSZ6)=JA(M*2-K D!5"2Z.+VHTG&:,@)^R/:][HG9Q8RM&^Q[O9H!%Z%[8=AT
MB?HQC/SJ%:5+[KY2H(3^_/)2D[/-+*T:I4"]@@@O9@@Z&<</](24'>S#1_I2
MPB%\,1/T96/Y!M2?[-'BT$@,8=1'7D-9]2HE62X[D8UHN5>I?HJ./J"3]-A2
M4I=IQ^D!3DE.-4)#$7S:<F.).]_9 HD+"D6J6U4\M29P1-(WY8A4.*,E8E8R
MS#21O*E*:>$\AI :2:4)R-+ A":487L_0P"#JLWK^PX!:4@\9,RK*<0^Q8@X
M>1R))T,J@DF99=&UJA!S3UHD7$)'V/KG%K4G(E11B9642J&-,H+&2<$!@!!T
MB6CE_<R_R _FZS/,"_N9?Y ?S=9GB(QC&(C&,8B,8QB(QC&(C&,8B,8QB(QC
M&(C&,8B,8QB(QC&(C&,8B<-L-;,VZ#RIQKQO:':;(&1>MC+2^_+/FIU=DA(E
M"9K5B0'IE1>G'90D1)Q1P-$J3R33-#* 8 6F^4+1L^YZE;[)L^,Q^(JY(XKS
M8VRL1+N4/4;1F:0IW!U"\+E:@M8XKTZ\X@@ 22P-P$9V_>#4[V&2V8@  L 0
M%@"6 .O0( !T$ =:^K00AUK6M:_!K6M9,332N"[(<=#Z+---U>YC9]]-*)8M
MN9%#?64N<U/\ROS3ZV4$BT_&(^:UMM.H:[DIKHMJ?& GT6VN];5WL2OS#5(+
M4^(/Q?[%8^C6/EEC&,AR7&,8Q$8QC$1C&,1&1VZ@_6N._?'&_P"W[R1.1VZ@
M_6N._?'&_P"W[Q$D,7]S+_(#^;K,\P+^YE_D!_-UF>(C/ OJW]__ +OX_K^'
MX?A]7KGG.,S&9P^OHVZS"?2N-0B(L9!:E[E,O?&N-QMG3'*2$9:AU>WE4B;&
M].8K5)DH35:HDL9Z@DC0_>&@")$Z<)E(]"V=VO?M@<F\_>8B34LB[\M%OL.<
M0?RXT?S72*RSX;<"!JNEV3<K.,:3R?5=(UC8-.WHG !CY9,";V\070Y0XEK"
M^Z$'UUK?KZZ_3"^O?M;]-BWZ?'7WMZ]/9#]>M>@?KUG3G%XV;N3=D7K;TV\+
MK%U<79?<$XNZ.=B2SRHFUK)QU>[VD@>JX>#*7C#HICXFJJXJC3?0Z-!VA5+X
M8SQZ-/;5I[(<E+CV]8I,(G.F4,BA$GCDP8#'!Y;"WN+/C9(F<UR8'A<Q/R M
MT:%2Q")>SO;<X-#LCT?\H;'9$L;5Q9"Q*>26B0_9/(;S@[6S(*J6N,YBA32O
MMIF8[2FU>2>)TI8$@H!&X+[V8*_LYX2)V.0N%3)&9]42<X84#4O3QJ6JH@YR
MA)$)0H:.%QKRC<OR.%S>9#!;\<,BS;4L@C4*EM+3Z.V1<<5Z#EBN!\^2FDX(
MN;-/UC,UU35"JBT+TVITSHC>"A$35KB!6MGZAST5R7TUV'>@2Y;30J:=&2L>
MWJ EG0N[J03FBY_SY?-,V56M0-U4TBKD;_+(?<2J52.J9Y<,L55S5CPP):TE
M< :K-M*$RYK;3M<R#F'M&W996O2<BYM%7LZY.@?#\6C-)K;9JEY=;^D=%7,\
MSV^E,&EC')W"(QB)'QES*34>XV2\0U\F$B3C)GT:K1M&!>!$W)Y#^A*]Z5\<
M_P!/J]%(4933W5P' 9E$YG''&(3RO+#AGD>YB;)= IW%'4&ES!)F!9HOWY A
MJF]P0*FY[8W)V8G9K<UEWQ?ZG?Y9G]8+.L+VMRHZ?H0Y;T=?L!>*_MJ6>8+D
MOJ"M*]*LE<L458TV)UGQASJU,MD):XE:JK)]*W2L8*3('MF5*+$B,*D\G-*B
M;ZO=H^EDIG9Z+_4[_+,_K!8B<,FUBPNN2(XIFK^BCY$LE[! X^:NV8$#E*Y0
MH&E8V<@0 #UH]::49H(S/8(* 6,P\TLL.Q:COT]V5!>6E\20RB$65-]OD;FU
MC2I17;5'7(JL::K-W@3%8]P34N02B-JSXK#G.S(:4M98<EE4^=4Z]>NCL0>$
MC"]&HM!]B^.%#U18#?.FFR4E6J"FW1;Y\CABN1N<C?"RTR%&]+G V9-"5/\
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MCV E5J(3K4WC-J;J>N#)#=%;:LZ("E[Q8,IL?JH(K))NEC>JP55^IGJAQL-
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M]C-4A4,[;(/I.D(*+4& 2F@=_FAC]^)2G"6>87\W%?)QCV1[9WL>]%R/(_\
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MS(9$XIFII;TX/J$>L5F%E>\-'L)2=.#8U*H\9:=,2<>8 L4*OIST%UN'Y-4
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M$V$U)J\D$PAB"<.,BL%SK=17+:)@6K .HGJ;I87,APE"I( X2@,<? L!3AM
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MB9YX%OTU\/PZU_IWK7__ #[VM_'?IKUWE69GF/XG+&87LGL#9@!C*WH/C?\
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M[2F+[OX/3>M^GK^J']>_7?KH8M;^_OX>OK[.OO!]->FOJQ$RQCU^/I]_Z_\
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M%HF7<T,-K(7QN!*DAS.BE[0D.+B:EAVU[/9_D1PD2Q#&,8B,8QB(RK/R&E.
MK_\ $^>0Q/"MM(\@P0N,B(EI[>Q,(S^3NG -Z5XA07$M-+UC^>$U,R.)S2O-
MAQR)>M(6->G8WY=:9E6GD-TR[O[Q/Z5()(<_:\@P!L;@C(DPHFWI@\G].!?
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M[)92=.2 !)!0 Z]D!90  #KX!#K7PS].,97$DDDDDD^R3^22?W)/]R99@
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M&(C&,8B,8QB(QC&(C&,8B,8QB(QC&(C&,8B,8QB(QC&(C([=0?K7'?OCC?\
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M?(.:%'S5(&CY6E^=6-?\G=&[Y4F^6I"/?E>VB6R8RK#[<EQ+^*[!_HWO(?\
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MR?$#<A4(F@?*':=<75X[(W9M23F+6/7THZZ\<JB/S&&/:"0QYU D\C7,[<N
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=,8B,8QB(QC&(C&,8B,8QB(QC&(C&,8B,8QB)_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g918369.jpg
<DESCRIPTION>G918369.JPG
<TEXT>
begin 644 g918369.jpg
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M:'U2Q;!7Y;$LN--8X]HZ_E"ZUJ[7GOD8L!&%K=D[BQJF]!AQ"1;?$5EL6G3
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M3WMLI:45J.K(D3@3K*94NR06>M-)..1,+$V)P*'B42EVPG-+8XI'$#I(GH\
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M1[!'>;^E0G(5D'I51!*E,I)-3J$Z@H!Q!Y!P!%G$G$F!$6:4:6(19A9@1 ,
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M<9/.)[)&B)1-@18& O"AWD#ZK0M: !AIA9!.%"D!B@\THA. TXP!8M4;;O\
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0PB<<<<(G'''")QQQPB__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g979346.jpg
<DESCRIPTION>G979346.JPG
<TEXT>
begin 644 g979346.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@! 1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?0T5,7U194$5?-$-?1DQ/5RY%4%/_VP!#
M  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MP  1" &< JP# 2(  A$! Q$!_\0 'P !  (!!0$! 0            @)!P,$
M!08* 0(+_\0 :1    8! P$#!0<-"PD$!0D) 0(#! 4&!P ($2$2,4$)$Q11
M8147&2)Q@=46.%976'>1EIBAL;;P,C=XDI67P='2UM<8(R0V0G/4X?$U4WFW
M"B4S8G8:)B<T0T92<H(H.45'5&.%M=/_Q  = 0$  04! 0$
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M?TOI\%3Y/+[DS$?\DR?TOJP,ZB:93'.<I"E 3&,80 I0+U,)C"( 4"AU,)A
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ME6[7EO9UAW+]M99!DCY!H^04*:;',C><1Y.NV*;39,=G<&>#2+7*TJ6C%+)
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M3'^JQE)PSIG?7G8D;VA8Y%NV=(9VS>PF*)DC9;MU@%Y=Q@VV8&R#D8M0R!O
MS-@V,RAF%NM1BD@Y3.Z260+[,GJ%<FY.S5?$#28AH)=)PM*-T/<RI-(HL Y
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MF"=OJ]+Q;:,KM?J?D6*R-G@*[4WUO0&$E@.O&JI34<S*,;(@HLR4(Y0<@91
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MMP<>>0$Y 5(7M%Y#'*F#KD'O\_;7<]?![OG+^D-?=?![OG+^D-3457%Y-_\
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M5$IC&$$TB\F$>1'F^._V]_(B(=W'0!Z!\@<>OOU.,XSRX]YQ4;^"H@<0 .X
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MC3='_A9I\)CMT^QC='^1INC_ ,+-6#]D/6;^.?\ M:=D/6;^.?\ M:>$[/\
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M:IJ?(3!C"4IN-*64NQV((4^E+A:#>63'5/%%_5@Z#9$X'M0F4)Q>MT5[[IQ
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M9$GPL]8Q'-8E9S!*_44Y=&%F)9W*J-&]=!LK!'@S*.U <,W,H>84.83I2J0
M0I88'[P^0/S<\?@UM1Z"/'K'].NF67H\V6LJ)"(UO#BI<-^%(=D*+JW(TI ;
M?;&]G"7$Z'CC4#3%946:UH2A*836$J0YE6\I2BDY3O%1U&-% !(.HQ7IVP?Y
M<RXID9Q]_AJ??^ $JQXJ1-C>U"0 #@2P=M4=5V1<\?&5!A:VR/;Y!(.! NK7
M\3^5/VNY&,S83ED=XSG'9""2,R(R5K2:QC#V3&9S+CMUV01[8]DB[&7625Y
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M7;YY0!7+#VV!C9/%6.4;<ZHJ\:O;4*\@[O:;A.MJ32AHDCYN0$TFB+PQ6:)
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M+C9HG/"E-]S7S6!7B'\"UBQJ)U%$CNS)R:,LZ>$.5GVX]RU(H=)1(\M<OT#
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M)59!:^5N.E7ZWHTVR14*]CF,&,_[+LDXGP[6MT<K:\?2V-\H6>6:L&B51OF
MKA'2ZTL[!T@SP7F"F4&SQU<:O/2"LR5MC(P\+!)LWB(A7O1WXP[QC?[;AZS+
M7+"5]L6++<JW>M75BQ?8U:M+NVC\I0?(/5(90J3M-T!2"L=TW55[92JIJIJE
M!0-A]R;;>F6;A87H;<F*[)C/3'&I,B:\M"0U)MTN;-4X\ EP)$AN[VZ\(4D#
M$(+PY5P_;8EP:9DV\QWU(4M*URW),O?5NC>;/7N/-I6E1(!>8=W04E* $@&R
MC<-AW<%G:*K5WD&.5'=3KXE93FY'>3@7:IY/V*G4W9#E1EW]J=VNN76YH&$Q
M#.W=O3EW;E1/W29HN)594BE<DMCFWL(ZSV!A%+6ZBU&3"*FLIT)O)7'$23@Z
MH(ME4,FQ<;]2:C1^KP5@NN_:G<F,4@(E5$4PRM#;GKE$%:RS_'F"[MD]O(.'
M2VXK,.-9;<GGT[1XN95RA'O-P&0KECJ,=H><,=DO$4V%*=1-!,YV?"KH]C^!
M-T!<JY>QACJOYLWK;F,HV.7C6D$PW*Y^H&RO:*DX;)(2:L)-8NQ>ADR;M+)D
M1M[E)4IM$@G>Q2/$P48HDZ37 'KYLY#4!!M\F#$0\ZE+"!;NK99(?D..+:0;
M4RV4E1;><>MA"2I0MJNK6@>#<FY6EH(>AH<CQTJW2%K*REM1<<<6\TVMA*5C
M5OKFX>Z"E)03X@I&[::I2J)*)JD-SV5$CE53-P/ ]E0AC$-P/(#V1'@0$!Z]
M VYN\?E'].KG=]^)(5?,%DDLSU')*%_ID8>+O$!L'\GW8*+@:O,8\#RHSTEF
M'-U_JD=D]\V:O2(2EZAX<88C= C1)PS;-%$TX0V';SB&PXTQ_?=O.X^#RG>;
M]:8^D#M4M$!&5C=9!6B4?O6K1FI1Z9;+_7IN.*U9IRR\VUF8Z+]SG[$R3H[]
M4T63-VW::#-B093B7V!+"$A7@TUV,TXZA3J0Y,\$:;0P6D%:);Z&(KB0%(=4
ME22<K&O422B/O!YE;P  <8D=4%D9*!*+0CK( SXKA! )'BC(AX<.G/J_IXUH
MF[A^0?T:F);=@^\.@UB3N.0L#67'-8BI-.'<S.1K)C:@LEI-5)1=-I%JVZ]0
MY)PYT453)'AC/T7'FU0:J+BBN"403H+$*X.*2@I-54D'*Y"&6:H++BH#=-9V
MB"C1,SH45?1 ,N /"IG.T%=,HFUFX=P@3PI<";#FH;6E"U1)+,E*%D A"E,K
M6E*B"" 3DYX5?)?8>!++S3VXH;W5.(7NDZ@'=*L$C@.//A6R]?[> ?@_8?'6
M@8.OYOP=/Z.?Z=:_C[.O]''].M(P<"(^SGY^T'] ZR7^L/(?)Q'KJO3K,$9S
MH->9&ASW=G+S5NXN;F8!R#J"EI*%<)G!0%HM\Y8G$X@ "8X-U")JB("(#YXB
M@" B @(=-9DIVY'(M,?(2#1V<K]N;MHS$"_D*/9"'Y PJ#.5%>.])4.8.TH>
M2CY RIAY4$0$P#@@X\#\H 'X3:T#CU#GGCCJ'/?WZM)=N@3T%N;#CR4*&"'F
MD+R.S>(WAYB*E/C(*5#>3G5"@%)(TT*5 I/#@1Z*N^P7Y9[/N/1;,YJ\+6-@
MD0"A'Y2B/=5,!  $2DO%,2:2Q$NSR5,TI6'ZPC\998_>%Q>#_+=XPN#9NGDB
MDRT ($(+FP4QXWR%74P'LAYQ=.%(E:8\3\BH#9[6BK))AR<1$#<>+ PB "(?
MU"'R?M\^OJ#APS<$=LW#AHZ3'M).VBZK5T0?61RW.DN3KT^*H'(=!Y#7.;QT
M/;(W;?6PP[;'E9._$7]+!&- T<( //.\?1KB)%HMLH'K(J6UY(*XZBTK.?XN
M%-^9*$@\B.-?TDL2;OMN^;FY%L=Y1J<^N(!YV.;2J!)5L<>])W$N10DVBI!^
M*=-RS2.0P"!B@.I'H.FSH@*-W"*Y#!R!DE"G 0YX_P!D1'O]>OYE4+FJ_P ,
M\;.UI4DZNS,F9LXFDCGDVP)" I@RL4:K&V-EP( 811E.#&*43%/QP-AF%_*R
M[AL6JM$F>1[HBR2,4IXBV"AE"KE2+P(E2]T%(>Z,$Q O8(FUFGI4@-VA*L(#
MKD]ZZ"KY$WW+3,8N#8R4MKRT]C3"1H0M7'.$I&> K!2-E3@JB2DJ/)M]/5J/
M#0+&\CGQ4I/ Z<*]Z.FO.!@SR[<7,$8LLET=E-'.)$G,IC2=;2#HAN/W1Z9:
M/J?LOG!+P=1&.]U?-<&+YQ3@!-:[B+RB&U;,1FC*"R?!Q$ZZ^*6MVI4U5L +
M (%.B6(L)(YXL<AA !]%37((\"0YP$!'E5TV5VALRU)N-JEL!)U<+2EM>7K$
M I />0>T5@)-HN,09>C.;G\H@=8V?(M&4GT_)4XM-<8PF8J32(M'R#1VFH &
M(=!=)0#%, " E[)AY 0'D!#OUR>M>((T(P>PUCB"#@@@CB#H1YJ::::5%-8;
MW%?6_9S^\[D[]2)W69-8;W%?6_9S^\[D[]2)W5K.^LIGXK(_(KJSN/V/G?B<
MK\@NHO98+V?)AV4"@ <;-&X!QT .,4,0#@ Z   'AP  &O(J;O'Y1_3KV[8?
MKL);]L6*ZI98UM,5ZR8*HL%.1+PICM)*)EJ!%,9!BX*0Q#"BZ:+JHG[!R' #
M]HAR' I@JNGO(AT!S+OW%7SW<X&!6<**1L/*TV!LCV.;',8R;-6<"5A3R)6Y
M1*BDY<1Y':B29#.U7+D5'"G#NDG8:_[4M[-3;)'9EB):DQ7V526(SB"L,NMN
M R5M-J01O)(2LK2H#Q"DDCB'2#L3M!M*C9N=98S4Q+%F8BR&E26(SK:L)>0X
M#)<:;6A8<*<)65I4C)3A0(\[.FO0?\!Y7OND;'_-C!?WJT^ \KWW2-C_ )L8
M+^]6N6_0AV^^XS7QI:_VRN;_ $*-N_N*CXSM7[;7GPT_;H/'Z->@_P" \KWW
M2-C_ )L8+^]6GP'E>^Z1L?\ -C!?WJT^A#M]]QVOC2U_ME/H4;=_<5'QG:OV
MVJI\2[V,WXBHZ.,&@T+(>-&3I5[#T3+]&C[_ %^ONUE%%E5( KES'2,<@*JJ
MRJ<=[H+1C95PY49,VIG"PJ<S6-]V9J?;\H7& K>&&:F78FGP5NK XQ:'HP1%
M':R+.#9154++ILF:1DI1T:2*Z4D D%A254\V*0 -G_P'E>^Z1L?\V,%_>K3X
M#RO?=(V/^;&"_O5K8&MC.F%AN*TT9240M(G_ *U;%*82&7(X0VXJ87 TEAUU
MI#6\6T-K4E*0":S#>Q'2NRB(VVW+2B",0Q[MVXF,GJ'8P0RI4\J0VF.^\REL
M'<2TXI"4A)Q55+K>GEM7+F.\UQ\!B2MW3&#.P,JVG5,<,Z[7W*=E9N6,BM/P
MT=)IA+.DVSM9-@X]+;&9]KM% XB<#\I=M]&7KV> <2=3P?$R%<OU5R2PF*MB
M>-KTRM9:C-!/QXR,FTE#N7T:]D2@>99'.0\FF)B'<I"8QS6A? >5[[I&Q_S8
MP7]ZM/@/*]]TC8_YL8+^]6J1L3TOA$A 3(")3I?D(%XM6ZZ\6F62ZL>%XW^J
MCLM[PP2EM(/"GSD]*^Y(;ZF3U<IWKY"/=FV;KKW5,L=:H>'8ZPLQV&RH8)2T
M@$^**K$RKOPS%F2MV^M72IX-.6[L56,[88?$\=&7'A4S<PNV-G&5=R#:0 K9
M%$CQ07"A$"BF <]DQ(@P,T]KD]"6.-\Q[I5^:B)^/](2%9M[H0DDUEF/I" '
M3%9OZ6S1\^B"B8JH]M,%"";MA?S\!Y7OND;'_-C!?WJT^ \KWW2-C_FQ@O[U
M:LY_1UTI7.0U+N$1<N2R &GWKO:U.(PX71A7A8.0XHKR==XYJUF]'?29<I")
M4^"[+DM@)0\]=[6MQ("RYHHSL_PBE+SQWB3G)JD+-&8+CGK)-ARK?AB#6NSA
M%EDQ@HX\3%]F(C&L0S!LP5>/U$1!FS1!83NUC*K =7DO;[(;QSFZ\NL%QNW=
M483WNHK(KK*+0"QBH6$;2\9/6"PK3 OC(GC ;R#@",@C2* <2'%T8$REU=C\
M!Y7OND;'_-C!?WJT^ \KWW2-C_FQ@O[U:\_H:])W7SI/@2O"+DV^U/>]UK7O
MRVY2TN2$/GPSQTO.)2MP'ZI0!->:NC;I'6_+DJMZU/STOHFO&[VOK)29+B79
M"7E>'96'G4)6L*SO*2":I/9YPO+'!<QMW0&$][J<R"SR8^ \8H:P_5.R:Q[-
M$4)<'I4DHT4(QKYQD:.44,<%!*Z(542AKX'SQ?=N5]]\?'/N!]48UZ9K)BV6
M(/.19HN>/'GD"F8$?1XG7,,:V!)4S@2$+YTAT52J" 74_ >5[[I&Q_S8P7]Z
MM/@/*]]TC8_YL8+^]6JD=&_2@W(A2T0UIDVYMIF ^+O:PY$:8*U,ML*\,\1+
M:G%E &B2HXJI'1QTDMOPY3<!Q$BWH:;A/)N]L#D5MA:G&4,*\.RVEM:UJ0$X
M 4HGG5361MW^2<F*4=:6J&%(%?'USBKW!+4O%$-6#.)F&(H1DUG2MWCE.9@@
M%3SJ\,N1-NX531,H<02( =DR-ONS;D2A63&R,3B7&U7NH$2O"6(\;,:/)71H
M4PG,PL,H22DW*K)8XF]+38@R6>(JN&;EPHP<N&JMH/P'E>^Z1L?\V,%_>K3X
M#RO?=(V/^;&"_O5J_.Q72^1+\61F<V&I:A>+4%O-ALM;BEB6%I2II2FUA"D]
M8V2A>\DD5=G8?I65X5EF5F:@-2BF\VQ)>;#18W%J3.!W%,E32T@@+;44*RDX
MKSX"/(B/KZZ:]!_P'E>^Z1L?\V,%_>K3X#RO?=(V/^;&"_O5K ?0AV^^XS7Q
MI:_VRL1]"C;O[BH^,[5^VUY\-->@_P" \KWW2-C_ )L8+^]6GP'E>^Z1L?\
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MXG>*7&F6G5-[UZRFS7-ID)0(3KJEA,8%AI3C@2DJ<5%07&)&$IPEUQI8T*>
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MB AX#KO</DR[0R)&B<VK)1R? $B[$@A8HY,I>.P5%"6(X4; GP'FP:+MP)P
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M%453(9=RNDD!U"%$W)@ :_M_$EY15A.X!#8K#TB4A'%Q>DS*-H^I@ZB<>5U
M^X:,K]4[MHJUHJ\>:SGLCZG^?N2+Q&))&E(0_8<;[RL!0-Y.?=H4X!Q[TLCR
M!@[8  3,(/<8![0!P AV@Y$  3  \@#V]NVJ@G)3J/&.-#J-<:CEVCMJ9./<
MS8BRTC(.<692QWDIO$G13E5Z#=:W<4HQ1P90K=.1/7I*0] 47%%4$2NP1%7S
M:GF^WV#<;N_93QYBU*J+Y"M\'4$KQ>JOC.HJ3;P&A;!?KHY59U2IQ@B4WI,U
M/.D%D(UH' N%4S% P"&J;_>KSY"6[+>]MW@W'.S<N(MBV:J= Q=#ME2O]YRM
M;U(%O<JW;KF6K5F,HB$#CP]9!Q56,TE8)AS)2;E)RDVB04:K=RE[ENAQGA/9
MQD:_[@7V0KIN2W7;+8ZY1*^/,8,*91ZGDIHL%RH./6K>IFET(N137:F6M$W*
M25R2E&SB1A)J$;O?<Y"D$GEKWY _/S_3W5)2-"#H2!CB03RR!@X&I/?CE5SG
M(>L._CO\?5\NOO(#SP(#QW^SY=4 Y>SWO'AJ1Y0K<;7=Q3J&KNS?<O+U+%>)
M2T#'SVK76$BV.*)":JN595U65+<^K7HER595Y6IS];L<>NZE9*0G957W*;Q<
MI*IDK->WC<9<J'G_ ')O,F8Z>;+;ON?LECL>/J?!ML36O'=WA(&UFI3*B04+
M(O<;#"3YWD?5[(I9[,D:%:D-8G[Q\Y\].1IQUX'V]M">%-P]HX9QKG@#V<?&
M'GR.56M<@// @/'?[/EU\Y#UA^'U]WX=4<[:]S.X,-U>WFDV&V;FKIB?<OC[
M,DZD[W28>P;BH5I7'==@+A7[?A6/Q&LTMT37I5A+BTF:KE&(3<M(R0@G;-RK
M)"^*CUC'67-Y[?80PW\6?<=/W64A%*QDJR8A;4'&<32U,&8PRO,1^4V9WT=3
M5+4ZNMMQ>UF)^:F6TFQ9L7\1%1M:B8@J#UW),YQWC/R?I[CIPIN'M'^KQR-5
M9TX:8P<YP*ONTU"';CEN]YSS[NBM;"T>E[=<=3E'PEBF':L8D&-@O%=K2-QR
M_D()06!9UXF>3N=?H<>D$DK %)57[EHU3DE7YM3>T!R,_I_/BJ2,:'N]8S_C
M33334U%----*4TTTTI37F \LO]=34_O'5+]<LB:]/^O,!Y9?ZZFI_>.J7ZY9
M$US+I:^U%S^<87RNUROIC^TQW^<H']9RKQ-B?UK^.O\ ?W']=[%J7>HB;$_K
M7\=?[^X_KO8M2[UUZ[_9:Y_C\O\ +N5L'1Q_H^V'_P"4=F__  T*H6;S-AF"
MM]4!1J]FTMO1;X^L3Z?@7M+L)*_(*)3+!&,L=?D5'$;+-7$+8F+9J@_%)HWE
MVHMDEHB5CEA5.IS6]>ERTWL@W14"B5R6L$U*[;,L52I52OLGLS-2[]SCR7B8
M."AX]$'#^3D7BHMF+%JD"[MXN=-,OG5E.32YTUCJW4$Z9U"3D#EQR?)G%>>[
M(6U[/8V^C87I-(MZ&%-_.+MK##=)/M8IXT:8=F]O,/"IYA"S*%+_ .HI3-V)
M(FOXP1;OD$D92?BY)I( X=.!%/2R?MZSC*XHW4O(+&&3%RUSRM3/<4A6*[4:
MZ\N5]PU5J[CU ;3BJHY&BWU*R,I!2**5EJD+)1DK"V.3IRD8V:NGR#=(/0MI
MJG=&GD_1J.SARX\ZKZQ60<#3LY\./'D /)WUY[,B85E\J[;]^]RJS7>+E7(^
M9Z;M_HEDCLT[<XO#$A?DJ==&SQ!:G4.K8^H$G;): K4S*PMPLSBO+F)',V$:
MG*OT8A06L_D<'1Z7E(X:_I8G;DH]<V*'QW!7!.GHDJD5,GS&#,::REBL@BT)
M<M#)Z*G$)G*Z2JJKANDD2+<KIJ6*\::;O#))T'I!SG\WDYU!63PTX\-.(2GE
MCDFO.CBK'>1L3XX\E+:+OMAR_=HG;]/[SY.^U.'QE+3EKQ*RG;+-1>.+>%)6
M;IOW#R+:/XU[5*['-E[$_@#.)2G1<D\AVS<=W=<&Y SA ;N\D--N^0Z]BG<M
MO>V-R5>Q/::'*PMQLU&QE;L?5C-^6[;C$S8LG6*]>&R,K*RR]@8L)5[68=Q.
MV%L@@=-93T1B'.FA2#ZN0Y8_,.'#NJ0X1R&?/@>-O<.&<\,8JK+>):<U4_-N
M&ZY5HG-M,V\CCR].9>^;6,!U?,^47>24YB&:06*G19NG7IGBVF3%<;DDD;"G
M4P86&7:MX6:FHF(CUCFB!M9VYY'^I3R95;RGA*^-&&)=S.\VWVR!N]1(LECM
M!1CE^2Q;-V<L:R3J\2W7L#R"=U.5C$F]6D)I:/=U/EFM&:]!@@ _M^W3V=VF
MA2#ZN7($''JQY^X"H"R$[H';KY01^?/9GABJ$-R6VG,=P6\I:ECW'-O-%V/<
M9LVS/$UZ'@(IM[]U?QQ1,:RV56=!2M\<ZH]UL1W5?<'-&3;21@)^W0+6M6-!
MR#U=NI)O975V5DW"9*SM(2F\"=O,IAVDX]GI[<=MQJ6W>OOX=E:)>P0<%&LZ
M_CS'"]PN%,<*RC5_(#'2T="P\TE',YE9%1JV;VJ" #T$.0]0Z^< '[<C^$=
MD#M])U[ ?)0K)&,#@!D<< )&">8.Z/7RJF7,^0X/%7E:&5[G\2Y R:SB]@L!
M')RF,L>R&4+9CQS.9VOJ03*%1K[60MJD=;$6*M1D9>M1KT\4*K1.=]$@I%T[
M2P5B3;'DM<NR&0N6#[1 TV8\HON>W+^]E)5Q5T7!>+[W4,IV'%D?D.*:INXN
ME+$L2L',*0KU0&\':YUE"<IR:(()W?)8:H".:'N?R13H,H2&,HS$#J;]V)86
M9Z'$6J2NC&*+ B[&$3<)6&6?.S2R;$LHLDJ5FJ[,T221+E+4D?+GUCLX\.>:
MD+P-!K@ DDZZ$<,XY^V352UG"5VW[W-QF9\D8+RUF/'^>L-8@J^+;9B'%LYF
M9[3VV-(ZR,;S@Z>K==:/I.IL[E+2[2W0\@]:-:;9G,D]:3,NV=Q $U'>J85R
MMM^VI;))N[8:O,I[UF]*=S+9\0XYJRV4;EA/"61DL\C5Z2VK]53EG\ZSQNGD
M*M-Y^)JJ<DA"K+/&T4@\;Q::PWX" #^WYOD]G=IP'''@'=QTX^3CNU&Z->.N
MGDX<,#N%0%D<OXN=3KNC \FG''$UYZ,T8YO<5N$W>V"[1N\"/PWNZQ[B^0K)
M\$;7Z3G0MLI$;B5*FSV#LCPMEQK>;CBNVUV1</SP$"X-5JV[+..I=1\WL[-Z
MNUS)+X)OU8R';8RK5'+]DJD3Y%Q[A2K6:V5U5U89>],K18S0U!G'L.W-#.<J
MGB5(]20KD8HJZ46.*C9-5 Q%3W:<!^WL_2'4>G=IJ<=Y])[O7IZ]<T*R0!@:
M #AQQC![<Z#B3W8JF2*P+8ZI@;R,L35\16""G,29(PI)9)80]/>,I;'#6=VT
M9!:93?7=%JT3<UMO)W:2;M+NO+@@FZLCUNC*F._42UJ[!8_(N-L[6'#N+:GG
ME#9>PHM[N$:VW)X6D,86K".6+!DIO(GQCCNZS$;"2N4J;:RR-KM;OTAK8B5I
M-E"F);G1)%%%>Y;3C]OV_1J D Y_PTQCCGAC/'/?4;Y((.N<^LYSDZ\?EUS3
M4:-S_P#J_BK^$/@[]>&6I+ZC1N?_ -7\5?PA\'?KPRUD+9]?Q/\ C)_/6I[;
M_:G??Q%?]=%27TTTU8UM*> \@^2O@AR AZP$/PZH9WK081&XFWIIH]DMOQ'%
MSGG>SV?..:7:W+!0HB'Q3"5I94C#QR8"E#P 1"^?5/?E$(,K/*^$+$)3%0FV
MV1J$X$H?%44FZV2=CTSB/@#FLJ&('7DY@  [QUG=G'>JNS!S@*2X#W[J>L _
MZFQY].=:5TDV[W5Z/MLH.,E=AE24]RK<MJXZ8USB(0,=NNE5=_MZM<A'RK^+
M6\\R<G1$1#SB?0Z"P!_LKH&Y35#CIR8O:#O*8H@ ZX_LB41*8.#%$2F ? Q1
MX$/F$!#37:2E*D[J@%)(P0H @CL(X5^6Z%K;4E;:E-K3@I4A12I)_!4D@CLT
M.H[J[\^7I>06IHV[0[<'"K<6A9(HE(N5(X"44B/CIJCZ./:ZQ\ND_C5!'LF
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M;Y:U%D;SS36"HN.MH.FN5K2D8[1KS\O"O4#Y,"N^Y^/;_-G2 BDQ?I8I3]D
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M& T;VF?T\<9^3GPJ>K.]@\,\>[>"21YSZ-:NX44(D0RBABD(0#&,8P@!2E*
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M<;(2SD&46P>R;PYB@5K'M5WK@1.;LDY2;D4.0#"/ &4 I/$3  "(59 U40
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M_@'^K6&]Q0__ +/V<^_]YW)W^R/V$3OL_;N[]06^#)D?NW-Y?=Q^^BK_ /\
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MTM(O71E$Y2:::GA4$DG)U/L*::::5%-1HW/_ .K^*OX0^#OUX9:DOJ-&Y_\
MU?Q5_"'P=^O#+5];/K^)_P 9/YZU7;?[4[[^(K_KHJ2^FFFK&MI3P'D'R5UM
MA3ZK%V&<MD;789C9;*FR2GYYK'-D9>83CD2-V*<B_(F#ETFU03331(J<2E*F
MGT$4R"'6<OP2=EQO;X-8@'3E(*28'*( /)';19N</'O*H/=X\#X:R5KC9A$'
M$6_1$.0.U6#CUCV!X#]O'COU6%J*T*4I1*-P J420E& @ G. E( 2."0  ,"
MJ8[3,4XCM-,)+RY"DM(0VE3SSI>>=4$  N.NJ4ZZL@J<<4I:RI2B3Y9G8+J0
M%(<.4_-N"UAM$."\<"5Q7%3PBO( '>)F?7KW<^T-<2(\?+X!R <\]/'].LF9
M&C_<F4N$(8"E4JF6<@P!$RAU08.I-6PQI3!P'8[;2714*'4#$$!]0!BWD1'G
MGK^WJUW:V.!V#'6.!1D:\B21W\"..N,5^7/2I;O<KI$VQA!.XAN_7!321P#+
MKZG&@..FXH$5SEFKEBJ,?3YJQPKZ+K>0(Y"0I-J.4J]8L9U3K(.(5M-("=HR
MM4>Z;N&KVK2PL)E0R0N8IO*,# [UP7 AW@(" B @(<" AT$! >H" ]! >H#W
MZFCL^R/+OKW X!NBL9<,*9*/-0\S0KG'-[#!M7QH65EH]: 2?=L8L[Z7:)%?
ML"@O%N5'*KY%FSE^)$8[Y:A\+Q4O RV"+)9E:K8I2]P5@Q=>$#_5;AJS4>12
M8J1 R3I=S)RU2FC!)(5]=\\GB-#PYV[2T/TERQL9YLSG1<%6V4P0X4!]B3'2
MXY'7'<4\&@_D%49_#+B5!2E,K6GQ'$%QMLIVR,"1LBSMG8;FCP1E_P!S+O9;
MN_%C76-=([%N7+<M10L-WBVJ5<6'VPAMBX18[F'H\A,>3*3C;37Y$X>'7]O5
MR ^P>>.O=R&M,QP .AA'U_-U#P#QZ=>.1#V:S01G  X$8..'><>37^ZN>*<2
M./;IK@?+KKW<<>6M03!X=?Z/^7M#G]&OP)N[XP]>\ 'CN]7X1Y[^.[G6B*G@
M =/5X<].!_K]O=K3$_?ZPY$>.>>H>OGI[ Y#Y.->H1V^@>WEX5;+>R2$\.W0
M)SIKD]G#GQKDV4H\C' .6#E1LL'')DQ$2J%#_P"S63-RFL0>X2J%-QSR42CP
M(95BLD,).(-5[E&1DO7W)Q.M$33=1]7P<G P>GLBD52DJM*E$1$LM!/&BQ1'
ME98Z/;2'"!ERE\?S_P#(?GXZ]_'.MLHX$>>! ./:/'K[N.O/3OZ\]..-4O06
MI &^C=6G!0XD[KJ#G0I4-<IXC/ Z@A6*S.S^U.T&RT^/<K'<Y=NE1UAUIZ,^
MZPIM6F2AQI;;B"H#=7N+3UB24+"D$I.EF#97C[+*?NC0U#&FE4>TW@IJ38LK
M2(@ "FWK%Y%)O"7!NH(B+:&M+>,D^.4&CB0<G(<]1N3]N.0\;O9-NO&/I-O$
M+*)R*(QKN/L<,"?[H)RM.2 _; 0.1,Y9E=M3  J_YA$2B-Q$5:9.$./HBX';
MG$//,7 "HS6*//(>9$0\T8>H><1%,X"/)A. B4<P)7:FY'CV]>O\.A,&3("$
M4H_=J,K-#G, %3&I75))1\V(4P%$D-+)2,.J)2IFB%![*A<I;;[?+$$(<*KI
M 1C*%?7#24X&021D 9QDIYK<6X2$U]X=%?S8[;QC6CI(B%:SU;2-H;<TA,D'
M 2')T%"4,3-<;SL,1I&,A$&4LE2O,CV144(FF J**")$TTP,HHH<!X$B::8&
M.H?D>.P0HF 0XXYZ:R[5\$Y'M!FPDAP@T'9B$:K3YU&3ET90P 4K&'21<3+Q
M0P"!DTRLD@6#@$U# (#J].>VTX(Q8$3?K),V*92O#-_/0T3 UBJTN7-'PLJX
M@'OU9Y!?*RS5BY2E6RS=,U9@'R[UH*+U06;A<&Z?49#<Y!4INK&X<JE?H22A
M134?U!JLYM;L.OQI;*MH+(7%<XB(@=. &&9AT*DV3( <<OZ1_FO]@MAGY5JB
M,S;SM!$/5R+;%8<0F*^4!7529DM$>.V4Y&]U(F+ (WF0?%KZ>OG35L%:(K,F
M//=O+DF*Q*C-06G&$+8DLHD1UK=E(;*0MIY"BEMMUY&<.-!04!%>B^38EF;!
MG/Y9D6=+C'!4G*"V2))Q2@DVY@Y,:$Q_%H2N2["@<IRJ(*A',&BP" &=ID$Q
M@DVSK.UC"<:BS91#Z_RJ10.(3A!QW2#JE >0;T.I.G5YL:0F[(BM9+;#$6Y
MR[0A3F 8XV3*-OLKEVZ<R2[8[P3&=JI.'+B1>=KD3"^F7BKB4=G-R/:,9P0!
M[^SSK'*BICG,<QC'.<>3G.8QU%!]9SG$3G$.G4YA$>X>0U\/[>_-?]*6UQ>C
MVJ2SLI;EY"$6[_.+CN'0;UP?0$M*QKOPHD-Q)/U9T(X%M+\T-M-<>L8L++%C
MC'*4N,CK)92<8WI+J2O)'-EN(L$Z&I77/=9;9:(&K5A%G6*@42^:JM:C&5*I
MY0#GJ>K5@6I98X<F SJR24L[4Y[2BJ@B.HT2]DFYS@LD_660*(BFS3[+=@B
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M7LQ,?QF-IU_>'<38G$I4F]AI*KEB1LP>O60P#PT)R,Z#R=NGKY=M-S(!R!G
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M ,<.&!I]2,8X8TYU734-F>7IF[8&E]R6XB/S/3]L$H%FQ578'%J>.I:UW]C
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MC&8B])G1E=9#C4>+=X-RV5F/O.)::0U<A/MC[CSJRE#;2(U[25N+4$H0E1.
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M2C<HD2&'ASF'D3&,<YA$QU#=!4.81,<_JY.<3&'CH B/'/?KX<XF'OYY_/\
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M;"#AHL[]6-B8V/4E')WDFHR8-&AY%VH E4=/CMT4C/'*A1$IUW(JJF 1 3B
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M'?'3GO'@>\.@=>@ /[#T[];%1T8>>HAS[?9^#IX=>G.N).Z 1'@P=!'J'/>
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MI[Z.XG[EL_\ /71?^!U)?33PF/\ <R%_2W/]X^V3W8?._=OOXVI^";%?V/\
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M%"]EWY00U<]J-H;M"#K+KUOEM[-QXLKJ'$O-M25VK9VW35,%U"%.L(EMM2$
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M(+JRX2KJTH;24MMH2@JR%+4LA80CZ<PB(\]!#CI\P=?4 AQX?-W!K:JJ<<E
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MZOD*&D(R6BF$BSD&R[9TS>-4G+=RBN04U454E2G(HFH01*=)0HD.'Q1#@=5
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MO6<?+2,<ZEB$2*FX)-7!UYJ>-'NS@8PQ<,6&)YCLMWKV1**W:N%6*5<GFUR
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M?T?/K7*GP'0  /;^P_@UXJ7VG/</S_WXK*-14IQNISPXC37&O# _-V:5MR(
M'?Q_R[OD[N[OUN"I^H. [^?7_P!?P=^M4"@'_/7[ HCW!KS*^0&/;U5>I9 U
M/#33CRX9Y=^-#DZ5^2E .[J(_MTU^^ #CD>\.>G[=_/> ]..>O.OWV XX$1]
MG7_ETY\0Z^'77TW9Z@(\<]?T>SV:HKV  & ,"@ '9  [O^?[!\FOO !R/Y_5
M\GJX#IT\- $.X!YX -?DW9$>HCR'3C@?ZOT#I4U^@$!Z!ZN_]O'Y0T$> Y_J
M_/[/DZ^KKK\B)@Z@ "'K_P"7//3QU^! >X0Y'CH'J#U]._D>?D_!I2@&XYX
M/ZN_NZ^W7[)W#\OYNG3Y UI:UB?N?E_Z?T:4K]::::4IIIII2FFFFE*::::4
MIIIII2FFFFE*::::4IIIII2FFFFE*::::4IIIII2FFFFE*::::4IIIII2FFF
MFE*::::4IIIII2FFFFE*::::4IIIII2FFFFE*::::4IIIII2FFFFE*::::4I
MIIII2FFFFE*::::4IIIII2FFFFE*:TSB("'4>[\_76IK34\/G_HTI7PHAW"/
MB''/=T'\VOV''7XW(#^  Z^W6CK]%$>H>L!Y^8!TI7[$2B <CX_/\_/A_P M
M?@2B'?QU_3ZA'N#Q_!K4 H" = [@'7P0Y'CY/T&Z_F .O/32E:6O@E ? /'\
M_P#3K<!U /: =/#3LE]0:4K:"GZOS_/^WX=:?FN?]G\X!^@=;WL%]H?M[>=?
MGLAVNSUX_/W<ZJ"B.?I^3R:5YEM/>.&@.FG#3]-;/S7_ +H_G_;P_J\-/,AW
M@7CU]>.?E\=;H.H@'K$-?H2@!@#KUX_3IOD^W9C]'K\E1U*>_NQ@=G8.[UUM
M@3[N@!^G]OGU^P('CUUN *')@[^...?:&OUV2^H/P:@J)XFJ@VD<NSCKPQ^@
M5H@7GN#Y^.GSZ_78'D _. = UJ  !W:^ZBJZT^R "'>/B(^ <>OV#^PZ_8!U
MY >G' !X!\GX-?=-*5\YZ\<=..>?Z-?!$._H(A[0_3X>.OP8P@8>!U^>1#\_
MY^_]&E*UN0[N0^3D._7Y'@>T'9Z\=X!ZP^3I^'KX:TM:@>/_ .CQ'KSW\_M^
M?2E"\AXB(]W9\0Z]_P#UX#KWZ_0E$1Y >.G'[==?K32E?CL%]NOV <!QZM--
M*4TTTTI33332E----*4TTTTI33332E----*4TTTTI33332E----*4TTTTI33
7332E----*4TTTTI33332E----*5__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g201142.jpg
<DESCRIPTION>G201142.JPG
<TEXT>
begin 644 g201142.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ _1$E32S$R-3I;,3E:0T\Q+C$Y6D-/
M-S S,#$N3U544%5473(Q,# S7S%?3TY%7T=%3E\T0U],24Y%+D504__; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( 74"K ,!(@ "$0$#$0'_Q  ?   ! P4! 0$             !@<( 0,$
M!0D""@O_Q !S$  !! ( ! ,"!@H+"@@) 1D# 0($!08'  @1$A,A,0D4%2)!
M48&Q%A<C-C=A<75VU1DR5E>1EJ&UML/1)"4U0E)4E)7!\#156'.2T]3A"A@F
M)S-BE[/Q*$-$<G1X@K0X8[?6UT=(4V5F:'>%AH>CI[+_Q  = 0$  04! 0$
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MRM\-\GW95 NN!KWVKD78OVV(NM<_B9^N'%P!U[$Q?2,09,0/8+:&IC4L8@J
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MK>-:G%7PK081UTB%#@OD.FR8(*]7+.8T8XS97O9&.<9D=8XWE;U C3(\M'*
MB/[>G7_Z[KT_A[5Z?DX]+I4IJ7"8>:FHGA87_P 0AR.YSE*U)(YHJ6V24$<O
M<0FUN]=5R?#^*Z74*179L*I\.O<+2F^Q6JB/1:K#5$0XPVMM08K3\FHI2^DA
M\&0^X%=H2T4M<B$Y7!P<'&QUSFJ+Z?2WZTX;/37X+L&_1Z%_6<.8OI]+?K3A
ML]-?@NP;]'H7]9PTTYO!P<'#31P<'!PTT<'!P<--'!P<'#31P<'!PTT<)U??
MYMI9QQ61X 8+831LCQX)5(L@#BD>5TN+)?W(J(UB,<QB-3S:JKW<9-T>6)D
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MHARBB/*G1H]1FO,FG23!DO1G$NR 4B"^YV)=::D@-+;4E"9!D$,ZZ5:TY8M
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MXKP<'#4Z.#@X.&FCB+VZOOI@?F"-_.=MQ*'B+VZOOI@?F"-_.=MPTTL.6K\
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MO112(YFC]YAR6M[G .@W.:JHCFO$<3G@DB<TP7JUSFLWJX4><R&9C+4EA1*
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M(CA,$(Q1(Y&D<4?58Z88YVQ(S4AICNO_ 'E@1) 7[)LG:UK"D1I$.GV+*BC
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M%ZXCE[.Z6^9BABB;WN(1Q%5.JO1%A%G6\L P">*LO[QS+ S^QX(8EE>[%?\
MM$F&<08 G7JCVQW%64YO4C0N;Y\?2E(?578,2<TT$O/QFW'$1TJ"6GTCLY"D
M944M!]MT)"E$) Y+JM<_GI6A(X1XFJM(BN2"(%1=;B%2NTD.0W$MR(@64(!6
MZ8;S*W"$B_,#RA)MI0R=$8TV213WUB@FO<UX5$YI.YKD16_%G()>B^2-1O3R
M]$3R17U%#BV%QWCH8+!R7-(U\TJL?*>A%^.UBM:@P,)T1'H-OBO'T88YF(U$
MWF07M-D$.DRK&BJ2FR*EJYPW]'(C9[8HHEN)Z.<KQ$#9@D^($JL*-S^CVM56
MM2.%MENP<HV5#U5J;&@Y+D_N)K6T69-%6PXT..R(\SCV!HE@R&$2SZ^-XB5\
M\TJ?81(( ,1TB7&RCR-17)=0DEB-%1VLE4E:DMQPE:&R'$@*)6'5):2A*5+4
MZI*$@J(&KCU?XBKTQF@TX/5"7,66XS$4-H,I(;+G/S'LD!H-)+RUNJ2AM *U
M%(!(U&^X=7--KR]RV+(L\ JLTKOLYK0M>X<FD=/AGLP2FC(-RQ#4X9Z2$1Z.
MD1V'A-1[)10D^EO2NE]48YAM 7$<?H15KZ^$:$^IAQ 5IH[@L)&D110QBBN
M4*C+&>,:,43AN'T:O3CYV;&);S1Y1K78=#-Q?)V1GUUM4SQ,"^/*=&98T]I
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M_:C515:6)V%](^[R@ERN)S:O&<LGP1Y'7VC9D>I @"UBUMJC)PU//"1T<K9
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M[4[Y;"H5AE/]E(2-57HU$>V0%K1JT2N036BXKL!C8#P WQX&UNM_&^^3JF^
M;J.;7N?=?!Z=!>P&ME,UW@K)=:"/@>%C<=\P)VNQ/'FN?%('N(QG6N5W8XB#
M4Z#(-KNGF.4Y$&WS,U[A,>14-C:]PD WV"-D%)B^,"< *QWC[8S211N<0JO1
M'.BHX@Q"5G:Y#(WC62]48.0,JTDTM]*LY$9)#VMR_/R2C%< ?@A GV1(=BA5
M6,8T30DCM&]6,&5'H[(9J?![!T:?9U=R68:%%&YYLOSTCVC4+5=':R1D:N:C
M3$,OAD:A7.<CR]SU[D6!.]MN@W-MK'S\L#;H(.#UM>V]N@Q]7EM;:^LV9KC
MXM<90X'A,,P$ 497XAC[AL*,K%:]K/@]4<5WW1L?M:XB%)WHQ>UW7Q-UQA+*
MN:=FN\*28:(XSTDXKCCQN>;PW'623X.1A5&Q[T?W,>A7B1K&$16C=K(VK<,L
MF";9UMT]:DQH<='YMG\B.!B.8B*-Y<G(A2J#P!R"D:CV.&2/T1&+W^8VKL*L
MHQ(LVIOV0H%G*]WB%S+/?!$]%7P3HU<G>U?N;RN:U6"'$<5J,"/N0CY&;7.2
M2"<&^V+WOBP^.-0/:<#Q(/0=;YMC.;>\:4 -=8"\+99<"Q!Q)$89'&3%<;*7
MI[JUJL\1*]!E<%J.:U/(':JM1J,[F)9KM;X,L6":1@F$RC>ZQV.-'Q/&WC&Y
MG>[P N#!0;6!5R,:@U:-'M<J>&JJJZI-48<=+& 6LN?@=)<,K0MS+/FAD%2.
MABN4/V3J-S $2+W>$,8B'1SR#>X;B+CBUAAWOMG4AJ;L-62NA..HLSSX8YBN
M(C"!>QN2-$J(%SV/>Q&N.Q% XDA!E$"1;>XQ9.1;%AG?>QO[.MMA(N<JZ'<D
M],#:^18V\O*^QI]=87(@!-/P#"7G$::+L#B>.HR.CI:D:U!B@*P;U;T\5&M8
MKBL1RH1G:=]V%KK"CFLPR<"P@H8UH\@0-Q/'D=X90JB$(!*]'(1OQ?[H,CB%
M=XRC.1J-1NL'K+$*^RBQ*RKN0!E5\QIC1LUSL3A>%XCAM*UN3,:@VO\ ":,A
M!O>UQE:(T=6JTN(FL<-J)3&UM-; 6,L)X"AS#8;2M26V>,T<SF9(G<0Y(XQ1
MV/4@U*=A#M<[L7ACRO<$6 OGH03BQQ89ZXL+Q<'JJR@+Y4<"V=_?;Z];2)KS
M$#RECR<!PIR+'80X78AC8W%2/*(@"$&V$KVN[.WP O1PO"1#HK'.177B:ZPQ
M9SHS<$PE@2N&)D=^(XXPAZ]\(II 4:D+QGQQ6 V*1_AJQ7F07:@^YR:N1JC"
MX)0E@U%JLLI)TDAW9EL%)/OH(IYHSN,'(W$5IS#<R0KW]#-*T;$)W(G'B9JS
M"&/'.+5VSI,]3GG2B9AL$LIA1P2S8Y@O#DJ%5!.CM$C6D&]H_# 'M?Y<+6OL
M0"""1?/=M;O;#&?+KTF]\$JSOD[>6V]^OD1UUM)&O\+%-"%F"8>!I)@ QGIA
MV-IVADQBI8L[O<5,J/>P;7$#VN85XVD[P,>BIN5A]55;*Q2%C>.5=%'7%,@L
MK$=)6UM5'5U7D.'LC2#B@BCMDR0A/)A0^K'N''G2T1XAO>PFISG!\=J<9+EL
M*);#R!LW#&"E.R3+[AO@6.48]62H8H5A=3HAQ&ASY41(Q(S^UYWE:C2_=^-G
M9UDG[8.N1/:=;"#A&4+((K2D<$+,CPEDSWPR>3AK%3W63XCGI*E.8]C2O3Q&
MU#W#K@#.!L;Y\/"YN+FX-&3XD $9.Y%MP<>!O\>FM:&L(VJWS9K%*T!9NR8B
M*UJ*^4]M!'>BM8UW56 ["CCO>J.*248;$8Q%5^UFX])^!=<U7N)6R"WSCB#T
M9X<9K\0R ['.(BJ-B 7OE+V.<K91%CC3O5'+H PFI6[^.J$;"+/V6TZO:_W9
MTQ,<B(KFL5O:XXXR&;+*-%\03HHGN(\;4%M)E?(2DUI'1);9S<@1\!JH?WP;
M&X;D"Q$1R_=6-&+N=T>Y$'6=H']&IX7 $XLL;(W!Z$#.3ML3Y>>AM<W2J]U8
M)\4@] -QL/ ]+:6]57$?L>\F)'-X<2NQ,13N&C>Y2Q+1$&B=5<J.(HY!W-\H
M[PBZJKR)VZ&D@.#KFG\2*963+G$## HD<XK'995HXCF_M1J9$;W#>OQ!B:9_
M17*B;2IBHNR[PC%>C&UF&ME*-'MCN5L.V=$:_P!&/+XRM?#14ZB"DI/B,(J/
MT=)'$W6U.PSWNC/NL06*CE)U4;LQJW.]SZ]7^ XZL4"#1.V1X[AHB.\Z%$YN
MK-E8 Z<P\[]0-]L6.+7$6Q@C+?7^J,[?8^&VG<$QX\EKV$=W/9C,QCEZ]>JM
MM*Q%\_5WS=R^;NB.7UX5G"4%XGV2U_BKU(F,RT(J^JO^$ZWN5W_K=47O7T5W
M54X5?%L=?;^X:NC8=,:.#@X.)U.J+Z?2WZTX;?4OWD0OSSF/]-,BX<A?3Z6_
M6G#;ZE^\B%^><Q_IID7#33D\'!P<--'!P<'#31P<45S4]51/E\U1/+Y^-987
M=/4B=(L[2NKH[$5SSSIL>()B(BJJN)((-B)Y>JNZ=.J^2)PTUM..2GM$]@_8
M=GNM8GC>%[[B%](]53JHKV&%?3Y?C=$Z]4_$O$^KGF6T#0/(*TV_KX1P]?%C
M1<GK+.6Q4:KE1T2L/,D]R-15<WPNYK4[U1&?&3Y[_:]\S&#6>S]*R,+?E.51
M2:^RON-187EYPJ5N5P>U!%+2QQ'[F,[T(%Y!*US$\3N<U%SJ:R9$MMH GF2X
M<?U4%6^P(%CG_?5*U<B><W !3GVD#?W_ +]2:Y3]MNR'F'UA2+(<Y)UK;#[.
MY>B^'B]](Z>:^?\ Z+KTZ?C7TX[S-]$_(GU<?&-R#\PEY(YP=),AZEV[<-^'
MKU? !BXJ\TAJX3E34:'X=LZH"O;Y$>A2C48D>Y_;V]./JE=M_=1FO^#>5K.5
M:QC'#)<["U#4>/W-[NC!CS.Q,QR?M7-,(:M<O1?152Y5(JHLA#9 !4RA=KIZ
MK6FY(Q?%[;^0%M$*#@)3L#;)L-@<$V\;>[4E>#B-:; YDI36+&T)AU<A&JJI
M>[IKV$ ODJ,*VDQ&Z$YR>:.\$Y6HK?)SDZ+QX;DW-6<RL^UOHJK$J(K33-N9
M;.=U_P E8\76 /3R57(;H[KTZ)QK<[V/T>7GY_PZ7JQXI_6'EG!\QJ2_!Q&L
MMGS5N5J#J^7,#5<U'.)E^QSN8Q57JY&,PX*$<B)U0:O$CE^)XC?VR"2N:=Z(
MJR>7<2_&ZL:39,E.B.5$7Q>R*KNJ=.J>$WM=U1%7IW*SX'Z/+S\P=1=/Y2=[
M;@^'A?QU)3@XC0A^:C]LMER\*G3]HD79:*GFO7[K[V[N1/\ F6JODB]/5?:R
M^:AB)VFY=Y"]?-KC;*B=$Z=4Z$0$WN5>G16J-.B+W([_ !5GE5X'[?\ G[6.
MG,G'>3GQ/L_C]L7DIP<1L':<U:-134W+H5W3KVAS78P47\CC84_IU\D\VKTZ
M]?/IT6TF5\U 3$&;6.D)PF*WL/"W%DT9YDZ?&Z1Y>KW*+HJ>CS/Z]?7IU3B,
M_DGZ >EL$@YO[?+2X_*3^L/+S\_M;4F..2OM%=@KAN=ZPBH7PTG8ED\A?-4Z
M^#>5 NOX^G?T^E>G$TW['YCH@WOD<O>.VCF+T06.[HH#&(BHGQAI?T&/ 1$5
M5ZH60Q>B+ZJJ=>"?M@MQ[4A;+T>MOH?+J,BZ^S8C@1LPUS>J=$RJ@17Q4K,H
M4Q/#Z(U["1Q/57L[$<G<J9U-8,B8VS^4'#DI'S4*5N3;IXV\[VO"U!">;! *
M=B"<D#87/47Q\-2'Y9MO+>;\U33K(5WPAEH8ZL[E7JJUMD_IZ]%Z]G7S^1/1
M$Z=._;?1/R)]7'Q6<D/,+8IS;:#!;:RVW'"[/HR%6)A4^]56OI[I%0+*$MD2
M2]O[9[0,(K6(YZHC6]>/K*D<TNH*AHDRBRR;"U>Q5_\ ++ LZQQC48Y&/5YK
M''11V(QRM:YRF[.Y41KG)Y\7:K&,5]ML@CG:"P!90RI2<%-Q8\NH;6'!=-S8
MV^@'P\\^>I%<'#.T?,+HS)"L!2[:U].DD\F1&Y73!FJO7M5ON4F6"4UZ.^*]
MC@H]CT5CD1R*G#K1;&!.$T\*9%E!<G5I8YQ&$Y/D5"">YBHOR*CE1>-9JOW$
M>T6^O69P<4147T5%_(O7BO#31P<'!PTT<1>W5]],#\P1OYSMN)0\1>W5]],#
M\P1OYSMN&FEARU?@&U5^AU7]1>'QX8[EJ_ -JK]#JOZB\/CPTT<4<U'-<U?1
MR*U?R*G1>*\'#37&?G"Y2L[QC.\CYAM&>-*DVR2+G/<!C.$*3;3QL86ROL3<
M=60I=C; "Z7>XG9FA"NK8*VN/VU;?6ME#N6LU)G#<VIJR_B]!^\!"9"!4G@F
M0\<$H,@+2L$9HI$>0([!R!"D!0BAD"$<9!LZ#<WW--0ZIHK#7F)NC9'N'(ZK
MP:FF$BR8V'1[AI(</+<L:%WC &WJ61B^.B1+G,+&)X,)D6ECVMW7P%UK@<C6
M6-8[C=N-85H&)[S-A&.PTJ$P\>,&LASC#ZC)8,KHX#V+T1KGS9!GO&-[E:WU
M7A274GJ4MN?9<1OD9I+CJ 'U-H#GK#;:C93\2/\ @D)4H*#2UAE"^4%"/FKT
MEP:%%XICNT97951X/2N)F(ZRJ&VX\8Q@/R4 EN+4Y@]8>*&^1R2RVN4^V5*2
MZZZV0VTF0HX[BN=T&UB(KOD3R]?3S7IU7_*\T3Y5B9FV9DL)4@:OLWT,>VK*
M*-7TK8KI]Y9VMDRKB.>DR=70WB++<[M=*FBC188U+VG.5&.DA:2AOEL<UR*U
M.U5[5Z^75.J]57JB^7FJ>7EY>O'*_;4#=0\ER?'( I<.GJ!.=A%AAMO2U]X;
M)2%>>'<9<;(K&-#@ HD]TD8^H:^=3RF&DR[5TN09M4#K($8.(6AM;3"PV%)4
MXI*$@%0"RCFL"H7 %OFI*E&R4DC648MNS'9#S#LTM+;"&6@''.4J',L)6I)(
M;%N;E[P"C8&]P_5G:F">KC1,#S:-&GS70Y5K,#B@ZZF"E?.FML)Y8&3SI38Y
M#Q(]<QD>(60^98Q58-PD,HUAKO/["7>+A=Z4\T<\!S8_/D*\AQ%B#>0E<\[D
M1QP% -Y(KE>]0/$\2.[']&\X;ZHYGLBC!);9C78OMLDP@W["QLPYNI,6B1D
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M+:*#/2)M"M;)1H)(K0NMHY90X3G((@&E?F;@D.\C"-;(DQ4,C'%\/QWC0PI
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MN8WP>N+WSMX=1?2TH;V3)L*^IC1H-331HDD4:IJXPXL, @@50,8,3&-:,/\
M\R$-@Q,<G5K$5.$9RO?X"VS_ /5$[R_IW8<;7%%_O[%\_P#YWG+^/_@Z^?\
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M"Z7*)+C)/J[>K$6'% (/>KI,9T;WE/,AT<0,H_?XBQD:+M92-KV'=MS'(WR
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M(J*B*B]47S3CY\\"W3L71>10:O*I*SZ.5,;&KKN*4[JV>K6*3W94/_=%=:,
MQQ"U,[J0HQDD5LFSBC*8/9_46UZG8-)$FQ)0RO*$;E:A.JHYS454_P"DG3U5
M?/U].,C@KTF2*A5Y/"'&5(E<+<8TX)$JDS@$J=0KYDJ$\DJ9F1'A=3$J,XZP
MZFRVW%)(.K\.>F0I3+J%,2&\.,N?/3@$&^RDD&X6DE)&0H@@Z>W@X/D1?1%\
MT7Y.G_=_#PE[S+J.@<\4^TK(TEB?&CR+&#'D-<J=4:\!Y RL56^?QV(JIYHG
M3HO'KSSS4=I;SSJ&F6T%:W'%!*$I !)*B>5('4D@=+YMK;L,.R7$M,H4XM1
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M,TP<>,P<!P!K)*B))G/(0*1FD(3+CUC<DCF#6^%$2/6W5<:S2972"@F65>6
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MN?4UKT.<7\6IIZ43.(XR&@OG54N'79K'X7LREQ"*?$I@96"DI4HH>4M!2 I
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M8B'H;6[I*[)*$S1KXIH:2[@%O1(J=L>\@&#&:UM_8N>A]D;SVIEVT+#56IJ
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M4#!(B)T3XK&M3Y/Q?)Y>O3C=%^7_ .A^I%3_ '_%QYZR%=FVE1NJR0K%N]W
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M_(O$YX:]8D5?GC 7^$35^7S_ (>,ZI,%D,FUN;M/H#>V3X_"VJ4FX-S<X\?
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MC%5EDVI^"T<]L4A&E]Y6R:3QOAQ8CN_WU(_8LWJ)0(%R/2NV5=U&PQ@6-\#
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M$CRM:)5RJ',W\\=$VQ<Y%L]"#;.1S"VO$ZX9;VL=^+5# .#7U"6%@6PGUB%
M:+[W&J&QZM'*\E?%DL8Z67H6*LA8\9'C8[CU:VH90L?KZ6A;'N0P)R]Y+.4
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M,?Z:9%PTTY/$5-V=4WKRMKZ)\.;BZ>GFOVE\N^KI\O\ LXE7Q%7=OX<^5O\
M%>;C3_\ TOER_P!G$IW'M&G17]E7N[IVTX,1%^)Z_M$^5?E147^WR_%Z<*&/
MT5W7Y%Z=/Q_V^7GTX3T1?(?KY,:GS)Y]/3U^?S^C\2\*&/YJB_CZ^?KY]/\
M?^'YN+^VM:F^+CI[.IZ>_P"V-;=B+T7S_P KT].GGY?C3KZ=?Q=>O%>*#7XO
MT.1?Y?\ N_'QZZ>2+\B_[]%X:K/[D_4-6B"&5%:1C7HO3JBHB]>GS]47\?IT
M7\?";GX=0677WF!'?W(J.5XFNZ]?7SZ=4Z_BX5*]/D3I]/7@5.GRHOY/]_7C
M%DP(4Y)1+BL/CP=:2NX&X)()Z>_VVU20D[@'VB][>.FV356((3Q$JH?7U_\
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M(J;M5/MZ<K?SI=[C^3Y],9:OK\B]$_@XE/SA[=#L;?DJ^HW^C3A0_P!HU?\
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MLZRM+#EJ_ -JK]#JOZB\/CPQW+5^ ;57Z'5?U%X?'AIHX.#@X::.#C73;6#
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M.>!0J(D U/CTV3D=O ,WH]T/+LSL*Q2M:Z1',/[DC<651KVE@QZG%<99'C1
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M:&C_ &)^/19[-:<J7M/\ZW9?416.E*/DGT1K7 ^=S16.70)16%N<<ON8/?\
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M(:V26E.72V%H[8@92BZ><D#/S<D^5@+:\AJ\61'6\R KM"%)0+@*OC&3:YV
M\=\"X>WV6^FIF63KOF$R1K9,C*3&@XE)<Q%Z8E$L"%/:#(JNZ,RR[ ZQBMZ-
M4>-56+,=V'64)G>QC48UK&^2-1&HGXD3IQQ%]EOS 4^.Q9?*UG V8YG&#^_
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M(K"70I"RJYBPLKRBLN<L@0KP%VKY&N66BP'0^M*3 K.GQ'ECEY[8Z,BU>?[
MKK; +'9>$; UYF%E7Y/"R4&23+*;BFT,VA5UA8VLN9C\RUCW5$:ON:BIGPX
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M^SJBD:,EIC&'8Q&*K?(3D+=9ZP[ F5>B/?#[Q(G4H4<O:LM.QB>C43\G^_\
MW_)Z>7'I$1/1/]UX<ZO(;=+^'CTWW!WU/8M_DJ)\U'Z@!]MM1,?;;\M5<E+H
MJKK&*_H&7G>X:N,-!][4[S5>(8KD$IKG,5RH(=E]S>B,<1[7*]+D;!>96V>(
MEAE&E<*"K?[HCT&'97G$OJJ,3[C891DU)%8K>UZHKZ<C>KT1PU1G4DL.#B.=
M7C;QL!GX@[[ZD--#9M'O'-X?E$^&HS-Y>;JV>XF9;RVQ;"(Y'OJL4LZ?6=,U
M>Y7.$-F#4]5>.CN54:X4G()/<-C&.>OQG.5.+<M^D\/F)9U6O:*3<H_QEO\
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M5ZQ&6M;*1C2GA*4J0Y\23"GB$5\4D@T-6QV+#@X::1/P/FO[L:_^*(/UWP?
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MT<'!P<--'!P<'#35%]/I;]:<?+[[=N_N8G++RNXQ&LYH,?R'<VYIU[4!D%'
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M^^,1U!IG%\#V+C^?U]QS Y V[F$V/99%01,<H(>$NDFB27LD(MJ 3Y<9K)B
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9E*I+[KZD A)=6I92#D@<Q-KD FVYWU__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g235912.jpg
<DESCRIPTION>G235912.JPG
<TEXT>
begin 644 g235912.jpg
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M>5BN##R@#/CF(^->C;X,^4*$27BG&;PM[3^3M8G(Q>.S5?B2-_'-&WN*Q"Q
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M=V8ERG45Q99!JG65]<RR3[B[U[A=O:SBL$,LVRLL:K)LZ61D<80,))E'*9[
MB$)KGJT8V,1K4R'QBK17TDM._)9KW\D*?C*O%4+RJMVXJJ%5;5A550 JJ)7
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MV"<_VKJG!MH[+PJJ/R;8M8GJ\.V#F6*5IK NS]U@)/-7X]=UL,LYX(L<+YA
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MO0U=>.<RO=.'$ (B-;&S@\[B=6Z4S>H8X:\F?S]#)>,3+YX2^3K33)/5;::
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M:'JM)+WSL*;8IZRYB>U:[5KPTS5A(%PY']265X]);I GPU;X P2$G/)%<7X
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M02+*1E+E1H+5B"W'%9XAEDDJQV?4\L[R&0Y&>:N!S*ZQ8&ZGP?A4P8,*KSN
M$@&/LVO8HZS,H44;U1L#(&A)ZV,36C@78+"&C&1UA.-F?F0T/CO,9JF^UM?E
M2!(DJ*TQF_:'U@^-917M*M5<"!WQI("WQCP;*&KV>NU4V=$:0)"C,,>G9]?3
M?RCY.9_Y28[P8+@5:H6/ :MGL8,28X0SU\C2C602&E+(J3^.)_'&&ACEY"-&
MCV$)6)^8!9K6]JY;&O\ M'3QNNF@U$UNA?TWF[$L#0#-5(.=+Y%J+SS-'<L5
M2ALSQ3AGMJ]N'P,ZQQ)[;FT3M#0>1GQS9N,2Z-R&,RLO6-?)Q;(8XR*QDZAO
MFM2%+$9JC(L,Q(]M#\5@;"!&.BLXP^BHJ(J*BHON5%ZHOW%3AMSFP^D)L#]K
MF?C!\*>Y!^?$[[ZG\%O%E^W>MK6L<?/)<I0UK5*18)I:\K&*RWC5_*L#IR@W
MY>T\TPWW*E00HYF?41V4QG9W4-.MALU<R>+S%=[U2M?JQ);QT?F>,5I;L,PC
MO\2A*S"E3;B0KH[ R-8W%$Q41Y1,5RHC4>1C%<JKT1K4<Y%<Y5\D:WJJKY(G
M$D-1\IG,!NPL5^#ZXNTI)3OT79( N,8D(2/:PAV6]L(+K)HNJN45)%M)#^ZK
M6"5W&9N1WZ:%3^V,+\?'X9O9[@?>_P#VLXCVO>Y][3%I<;CL96DL21%Q<MSR
M2QIOL/52)(2S#EN&-GCN/R1@=NB!]/\ ],>#[I8I]2ZBU-DJV/KVE@?#XJC7
MKV)SN3NV5LSW%2-@I5T3&B0AOPG0C?K7R=I[B7:R\BFQ*FXP_0\,6F<5OH.1
M4N]M;XFO,/B&6)3''-9!V14VN+'%KZJ(X?<M<4S'#8<.W!X@H>6W,89""]+H
M[TOWF"Q:DB4V\^4_3.U+&OCLALO=7["R'3I3#CQV@"D[&;2EVG5ADH1BO-[,
MF5D1K$\"-614'U1_A?S;OO:?ONXUCW;8?5,[I_#O*/QN.<1G3FI:/<>Q#BM6
MZ>I7K-2$M'DH+5FF_%F 9?% 0R%SLS\+"Q%A^,2#T+QT^WV%[08UX] C[+2M
M2*)ZWABM36)8XQQGN7K0ELW9%Y,$:R9#&I"(0BA02W9GIC.=28$^-JCDCP7&
M+%X93*NXVCOBUR>)&D*02PY<_',6P+#W3AC%XOK->#*87B$<)160Q->CQ6Y7
MM[MM^WCOXV&P*K9FSM5DN1R&XG@6-,T]RH8H=IWFC3,KR66^%BU\6G12$KY&
M<9=G>4@1KO8D0TQ[1OQ)V:7Z.:7]N:_^-7_&T1TS]*36?X(XY_)0.,U'D-/=
MNK*+@-(XYLBY;P9'(6K5YJSHJGR1Q6.<BL>?[ALP'U[)!VZD6&@RFKHF&3S=
MQ*J#>:K5CAK).I*_@S0A % W #1R?P?X]@(['?T>[6'9^W%1S"\P%[1[QYKX
M\8JX[*KH)UU?I5TZ/X,PFOHUQ&#:Y#FQ0$DP9.R;J)628T"1(@XKC^/LE6$Z
MT8.VEK;$]Q:TV!J7.ZYMMA&S,*RC ,NJE5K/7\:R^DG8_=1&/<QZ"(6NL)#0
ME1JJ$WAE;T<Q%3WO%<!/+9W+9S(ME<G<EL725*2[A! L9Y1QUXT"I!'&?R18
MU7\BSMRD9F8DT<91QM1:5.ND5< AD W,A8;.TK'<NSCTQ8GULHV4 #5#YUA7
M.GV ':&0KJK$2FRG ;B]36.9Y!4FFZQYCM)VTE\$@9/@&CQKBIRR@!#CYKCU
M=9Q<JP++(R%$6IMZBFM"LB8_Z8=IM<%#+RSDKVQ&V4,4=DFCQS:6!S<!E&:%
M_K,B/EUS6U>2PH[Y#6*&+)PF9($$KT?*,Z.CY$_O2=/K=A?E*J/Y&L>-;/AW
MZ(J[]F1OXT+BQN!I83N?@Z^:U)B$.3QY-"2U4M3UFMK7"-RD$/ *CF0GQL9?
M$Q<PR(KE0(<K<R.B\I-CL/=/PK7^DK!8ACF6NTQ]B/EN=UVVY#B& '-6(!Z:
MJVEVA/:M^D+Y$;E6Y3-/-T1RS7<P,+:4RAN;Z;B3*)Y$]:^'_F"+24\23C8A
M>*?X)<%HH=EEQ!>H2:3,?"$R)'KMZNS+PSLV-!]G=K/ JX^11)%!S!0]T;U)
M1MJB[+W9D,W6-H0EL1#S1TP X["G0-<8G)GD]FXEC\D<5]E9AR6SE/*=E%];
M[Y7/DVI?XDWB-_I /UL7=7[=X!^4T;B!XO6QHZMP^(Q&(JXK!4<O+4.-K32-
M)=L64FQAO7KTB--9EB28R1)(I XJCL[*DJ2JY@!9P-[(WKUBYDK./CL+:E5
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$H#K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6839630512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 05, 2018</div></th>
<th class="th"><div>Nov. 02, 2018</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000,000<span></span>
</td>
<td class="nump">$ 122,223,000<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB3PreferredStockMember', window );">Series B-3 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Equity investment</a></td>
<td class="nump">$ 93,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember', window );">Lilly Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived', window );">Upfront non-refundable payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember', window );">Lilly Agreement | Lilly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived', window );">Upfront non-refundable payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember', window );">Lilly Agreement | Lilly | Series B-3 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nxtc_ConsultingAgreementMember', window );">Consulting Agreement | Scientific Founder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty', window );">Monthly consulting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Amount due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nxtc_YaleLicenseAgreementMember', window );">Yale License Agreement | Yale University</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct', window );">Milestone payments per product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nxtc_SponsoredResearchAgreementMember', window );">Sponsored Research Agreement | Yale University</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram', window );">Amount provided to fund research program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionAggregatePaymentsMade', window );">Aggregate payments made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionPaymentsMade', window );">Payments made to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of upfront non-refundable payment received under collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionAggregatePaymentsMade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate payments made to related party</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionAggregatePaymentsMade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount provided to fund research program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionAmountProvidedToFundResearchProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the milestone payments per product.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionMilestonePaymentsPerProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly expenses recognized resulting from consulting transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionMonthlyConsultingExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionPaymentsMade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the cash outflow from payments made to related party during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionPaymentsMade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB3PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_SeriesB3PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nxtc_EliLillyAndCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nxtc_EliLillyAndCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nxtc_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nxtc_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nxtc_ScientificFounderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nxtc_ScientificFounderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nxtc_YaleLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nxtc_YaleLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nxtc_YaleUniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nxtc_YaleUniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nxtc_SponsoredResearchAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nxtc_SponsoredResearchAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6835531040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Anti-dilutive effect (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,802,648<span></span>
</td>
<td class="nump">5,043,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember', window );">Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,560,569<span></span>
</td>
<td class="nump">4,978,957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Option to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">2,248,953<span></span>
</td>
<td class="nump">2,248,953<span></span>
</td>
<td class="nump">242,079<span></span>
</td>
<td class="nump">64,783<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6835124064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock based compensation expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation expense recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 524,000<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="nump">$ 1,319,000<span></span>
</td>
<td class="nump">$ 138,000<span></span>
</td>
<td class="nump">$ 263,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">182,000<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
<td class="nump">482,000<span></span>
</td>
<td class="nump">62,000<span></span>
</td>
<td class="nump">85,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 342,000<span></span>
</td>
<td class="nump">$ 49,000<span></span>
</td>
<td class="nump">$ 837,000<span></span>
</td>
<td class="nump">$ 76,000<span></span>
</td>
<td class="nump">$ 178,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6663486928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Term Loan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Term Loan</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">8. Term Loan<a name="a8TermLoan_295864"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In April 2016, the Company entered into a $1.0 million term loan with a commercial bank (the &#x201C;Term Loan&#x201D;). On January 25, 2019, the Company amended the Term Loan to increase the Company&#x2019;s borrowing capacity to $5.0 million, which amount remains secured by the Company&#x2019;s certificates of deposit, money market account, investment property and deposit or investment accounts. As amended, the Term Loan bears interest at the greater of the prime rate less 1% and 4.25%. The effective interest rate was 4.33% and 4.44% for the three and nine months ended September 30, 2019, respectively. The effective interest rate was 4.18% and 3.84% for the three and nine months ended September 30, 2018, respectively. Under the Term Loan, the Company is required to make monthly interest-only payments through January 2020 and is required to make 36 equal monthly payments of principal plus accrued interest thereafter through January 2023.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Future maturities of the Term Loan as of September 30, 2019 are as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Remainder of the year</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,528</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,667</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,667</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 138</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: current portion of term loan</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,250)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Term loan, net of current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,750</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Interest expense under the Term Loan was approximately&nbsp;$56,000 and $155,000 for the three and nine months ended September&nbsp;30, 2019, respectively, and $7,000 and $20,000 for the three and nine months ended September 30, 2018, respectively.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">8. Term Loan</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In April&nbsp;2016, the Company entered into a $1.0&nbsp;million term loan (the &#x201C;Term Loan&#x201D;). The Term Loan bears interest at the prime rate less 1%. The interest rate in effect was </font><font style="display:inline;font-family:Symbol;">4.5</font><font style="display:inline;">% and 3.5% for the years ended December 31, 2018 and 2017, respectively. The Term Loan is secured by all certificates of deposit, money market accounts, cash, securities, investment property and deposit or investment accounts. The Term Loan requires&nbsp;monthly payments of interest only before May&nbsp;2017, and equal&nbsp;monthly payments of principal and interest thereafter, as defined in the agreement. Interest expense under the Term Loan was approximately $25,000 and $30,000 for the&nbsp;years ended December&nbsp;31, 2018 and 2017, respectively. The outstanding balance on the Term Loan totaled $460,000 as of December&nbsp;31, 2018.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Future maturities of the Term Loan as of December&nbsp;31, 2018 are as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 387</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 73</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: current portion of term loan</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 387</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Term loan, net of current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 73</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6607837504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of future minimum payments</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The future minimum payments for the operating leases are as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Remainder of the year</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 97</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 566</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 692</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 742</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 733</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Thereafter</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,088</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total future minimum payments</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,918</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The future minimum payments for the operating leases are as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Year Ending December&nbsp;31,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 325</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 308</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 317</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 355</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 335</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Thereafter</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 635</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total future minimum payments</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,275</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6657895200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAbstract', window );"><strong>Restricted Cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RequiredReserveRestrictedCashCurrent', window );">Restricted cash required reserve</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">9,935<span></span>
</td>
<td class="nump">$ 135,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RestrictedCashAndOtherAssetsCurrent', window );">Restricted cash (including $3,750 in other assets)</a></td>
<td class="nump">5,039<span></span>
</td>
<td class="nump">460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total</a></td>
<td class="nump">14,974<span></span>
</td>
<td class="nump">$ 135,633<span></span>
</td>
<td class="nump">$ 24,335<span></span>
</td>
<td class="nump">$ 9,287<span></span>
</td>
<td class="nump">$ 5,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RestrictedCashOtherAssetsNonCurrent', window );">Other assets, restricted cash</a></td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RequiredReserveRestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required reserve of restricted cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RequiredReserveRestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RestrictedCashAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents restricted cash and other assets current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RestrictedCashAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RestrictedCashOtherAssetsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents other assets non-current from restricted cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RestrictedCashOtherAssetsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6789292656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Basis of Presentation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The accompanying unaudited condensed financial statements as of September 30, 2019 and for the three and nine months ended September 30, 2019 and 2018 have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;) for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed financial statements should be read in conjunction with the Company&#x2019;s audited financial statements and the notes thereto as of and for the year ended December 31, 2018, which are included in the Company&#x2019;s final prospectus that forms a part of the Company&#x2019;s Registration Statement on Form S-1 (Reg. No. 333-230837) (the &#x201C;Registration Statement&#x201D;), as filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended, on May 9, 2019.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The unaudited interim condensed financial statements have been prepared on the same basis as the audited financial statements. In the opinion of management, the accompanying unaudited interim condensed financial statements contain all adjustments necessary for a fair statement of the Company&#x2019;s financial position as of September 30, 2019 and condensed results of operations and cash flows for the three and nine months ended September 30, 2019 and 2018. Such adjustments are of a normal and recurring nature. The results of operations for the three and nine months ended September 30, 2019 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2019.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Use of Estimates</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to accrued expenses, revenue recognition, the valuation of equity&#8209;based compensation, including incentive stock options, common stock and restricted common stock, as well as income taxes. The Company bases its estimates on various assumptions that the Company believes to be reasonable under the circumstances. A</font><font style="display:inline;">lthough actual results could differ from those estimates, management does not believe that such differences would be material.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Restricted Cash</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The Company is required, as a condition of its Term Loan (Note 8), to maintain cash collateral on deposit in a segregated money market bank account equal to the principal portion of the Term Loan, as determined on a quarterly basis. The bank may restrict withdrawals or transfers by or on behalf of the Company that would violate this requirement. The required reserve totaled $5.0 million as of September 30, 2019. This amount is presented in part as restricted cash and in part as other assets on the accompanying balance sheet.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,935</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash (including $3,750 in other assets)</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,039</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 14,974</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Restricted Cash</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company is required to maintain cash collateral on deposit in a segregated money market bank account, as a condition of its Term Loan (Note&nbsp;8) equal to the principal portion on a quarterly basis. The bank may restrict withdrawals or transfers by, or on behalf of, the Company. The required reserve totaled $460,000 as of December&nbsp;31, 2018. This amount is presented as restricted cash on the accompanying balance sheet.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,427</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 860</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,287</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Marketable Securities</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:normal;">Our investments primarily consist of government debt securities, corporate bonds and agency bonds. These marketable securities are classified as available-for-sale, and as such, are reported at fair value on our condensed balance sheets. Unrealized holding gains and losses are reported within accumulated other comprehensive income (loss) as a separate component of stockholders&#x2019; equity. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization, together with interest on securities, are included in other income, net, on our condensed statements of operations.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:normal;">If a decline in the fair value of a marketable security below our cost basis is determined to be other than temporary, such marketable security is written down to its estimated fair value as a new cost basis and the amount of the write-down is included in earnings as an impairment charge. The cost of securities sold is based on the specific identification method.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Revenue Recognition</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has adopted Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (&#x201C;ASC 606&#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect consideration to which it is entitled in exchange for the goods or services it transfers to the customer.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral to or dependent on other goods or services in the contract.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration that is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&#x2019;s control or the licensee&#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur and (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying condensed balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Revenue Recognition</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has adopted ASC Topic 606, Revenue from Contracts with Customers (&#x201C;ASC 606&#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral or dependent to other goods or services in the contract.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration which is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&#x2019;s control or the licensee&#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related&nbsp;revenue recognition.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Recently Issued Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">The Company qualifies as an emerging growth company (&#x201C;EGC&#x201D;) as defined under the Jumpstart Our Business Startups Act (the &#x201C;JOBS Act&#x201D;). Using exemptions provided under the JOBS Act provided to EGCs, the Company has elected to defer compliance with new or revised financial accounting standards until it is required to comply with such standards. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In February 2016, the FASB issued ASU No. 2016-02, Leases (&#x201C;ASU 2016-02&#x201D;). The new guidance will require lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016-02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right-to-use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company January 1, 2020.The Company continues to determine if it will elect to use the practical expedients permitted by the guidance and continues to gather data required to comply with the guidance. Based on the work completed to date, the Company is considering the implications of adopting the new standard, including the discount rate to be used in valuing new and existing leases and all applicable financial statement disclosures required by the new guidance. The Company is continuing to evaluate the effect of adoption and anticipates that it will result in the recognition of additional assets and corresponding liabilities related to the existing leases on its balance sheet. The Company is assessing any potential impacts on its internal controls, business processes, and accounting policies related to both the implementation of, and ongoing compliance with, the new guidance.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (&#x201C;ASU 2016-13&#x201D;). ASU 2016-13 will require credit losses to be reported using an expected losses model rather than the incurred losses model that is currently used, and will require additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard will require allowances to be recorded instead of reducing the amortized cost of the investment. ASU 2016-13 will be effective for non-emerging growth companies for fiscal years beginning December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2016-13 will have on its financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement&#x2014;Disclosure Framework-Changes to the Disclosure Requirement for Fair Value Measurement (&#x201C;ASU 2018-13&#x201D;). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements in ASC 820, Fair Value Measurement, based on the concepts in the FASB Concepts Statement, including the consideration of costs and benefits. ASU 2018-13 will be effective for all companies for fiscal periods beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2018-13 will have on its financial statements.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In November 2018, the FASB issued ASU No. 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 (&#x201C;ASU 2018-18&#x201D;). ASU 2018-18 clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, all the guidance in Topic 606 should be applied, including recognition, measurement, presentation and disclosure requirements. The amendment also adds unit of account guidance in Topic 808 to align with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of the arrangement is within the scope of Topic 606. Lastly, ASU 2018-18 provides that in a transaction with a collaborative arrangement participant that is not directly related to sales to third parties, presenting the transaction together with revenue recognized under Topic 606 will be precluded if the collaborative arrangement participant is not a customer. ASU 2018-18 will be effective for non-emerging growth companies for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020 and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating these clarifications for the accounting and presentation for its collaborative arrangements within the scope of Topic 808, but does not expect that the adoption of ASU 2018-18 will have any impact.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Recently Issued Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In February&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;02, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Leases</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;02&#x201D;). The new guidance requires lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016&#8209;02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right&#8209;to&#8209;use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company for fiscal&nbsp;years beginning after December 15, 2019 and interim periods fiscal&nbsp;years beginning after December&nbsp;15, 2020. Early adoption </font><font style="display:inline;">is permitted. The Company is currently evaluating the effect of this standard on its financial statements.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6823174880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred Stock.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Preferred Stock</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">9. Preferred Stock</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">As of December&nbsp;31, 2018, the Company&#x2019;s certificate of incorporation, as amended and restated, authorized the Company to issue 125,010,671 shares of $0.001 par value preferred stock. The Company&#x2019;s preferred stock is classified outside of stockholders&#x2019; deficit because the shares contain deemed liquidation rights that are a contingent redemption feature not solely within the control of the Company.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Series&nbsp;A Preferred Stock</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">As of December&nbsp;31, 2018, the Company has issued 68,181,819 shares of Series&nbsp;A Preferred Stock as follows:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In December&nbsp;2015, the Company issued 15,000,000 shares of Series&nbsp;A&#8209;1 Preferred Stock at an issuance price of $1.00 per share for cash proceeds of $15.0&nbsp;million.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In January&nbsp;2017, the Company issued 25,000,000 shares of Series&nbsp;A&#8209;2 Preferred Stock at an issuance price of $1.00 per share for cash proceeds of $25.0&nbsp;million.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In April&nbsp;2018, the Company issued 28,181,819 shares of Series&nbsp;A&#8209;3 Preferred Stock at an issuance price of $1.10 per share for cash proceeds of approximately $31.0 million.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Series&nbsp;B Preferred Stock</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">As of December 31, 2018, the Company has issued 56,828,851 shares of Series B Preferred Stock as follows:</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In November 2018, the Company issued 15,052,117 and 34,276,734 shares of Series B-1 Preferred Stock and Series B-2 Preferred Stock, respectively, at an issuance price of $1.59 per share for aggregate cash proceeds of approximately $78.4 million.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Concurrent with the issuance of the Series B-1 Preferred Stock and Series B-2 Preferred Stock, in November 2018, the Company issued 7,500,000 shares of Series B-3 Preferred Stock at an issuance price of $2.00 per share for cash proceeds of $15.0 million in connection with the execution of the Collaboration Agreement with Lilly. The Company allocated $13.3 million of the proceeds to Series B-3 Preferred Stock and $1.7 million to deferred revenue. The $1.7 million was determined to be a premium over the fair value of the Series B-3 Preferred Stock and attributed as additional consideration of the Collaboration Agreement (Note 6).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The Company estimated the premium of the Series B-3 Preferred Stock based on a valuation of the Company&#x2019;s preferred stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. The $1.7 million premium on the Series B-3 Preferred Stock will be recognized as revenue on a proportional performance basis over the term of the Collaboration Agreement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s Preferred Stock has the following rights and preferences, privileges and restrictions:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Dividends</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The holders of Preferred Stock are entitled to receive annual noncumulative dividends at an annual rate of 8% in preference to any declaration or payment of any dividend on the common stock, on an as&#8209;converted basis when, as and if declared by the Board of Directors. As of December&nbsp;31, 2018, no dividends have been declared.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Voting Rights</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Each share of Preferred Stock represents such number of votes as is equal to the number of shares of common stock into which such share is convertible. The holders of Preferred Stock vote together with the holders of common stock on an as&#8209;converted basis on all matters in which stockholders are entitled to vote. The holders of Series&nbsp;A Preferred Stock, exclusively and as a separate class, are entitled to elect five directors, the holders of the Series&nbsp;B Preferred Stock, exclusively and as a separate class, are entitled to elect two directors of the Company as of December&nbsp;31, 2018.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Conversion Rights</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The holders of the Preferred Stock are entitled to convert each share into 0.1245 shares of common stock on demand. The Preferred Stock is mandatorily convertible upon the closing of a qualified public offering in which gross proceeds to the Company of not less than $75.0 million or on the date specified by a majority vote of the outstanding shares of Preferred Stock voting on an as&#8209;converted basis.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Liquidation Preference</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In the event of any <a name="_cp_text_1_29"></a>voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of the Company&#x2019;s <a name="_cp_text_1_30"></a>Series B Preferred Stock are entitled to <a name="_cp_text_1_32"></a>receive, before any payment of any of the assets of the Company to the holders of the Series A Preferred Stock and holders of common stock, $12.77 per share with respect to shares of Series B-1 Preferred Stock and Series B-2 Preferred Stock and $16.07 per share with respect to shares of Series B-3 Preferred Stock (as adjusted for any stock dividend, stock split, combination or other similar transactions, plus any declared but unpaid dividends). After payment of the above but before any payment of any of the assets of the Company to the holders of common stock, the holders of Series A Preferred Stock are entitled to receive $8.03 per share with respect to shares of Series A-1 Preferred Stock and Series A-2 Preferred Stock and $8.84 per share with respect to shares of Series A-3 Preferred Stock (as adjusted for any stock dividend, stock split, combination or other similar transactions, plus any declared but unpaid dividends).</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812416288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">5. Accrued Liabilities</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Accrued liabilities consist of the following (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued construction in progress</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 515</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued payroll and related benefits</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,008</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 493</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued clinical trial costs</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 271</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued operating expenses</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 719</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 450</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued financing costs </font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 284</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued office lease</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 127</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 104</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued interest</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;2</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;2</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total accrued liabilities</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,411</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,564</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818179184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of stock option activity</a></td>
<td class="text"><div> <div>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="9" valign="bottom" style="width:39.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Options&nbsp;Outstanding&nbsp;and&nbsp;Exercisable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Aggregate</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Remaining</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Intrinsic</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Number&nbsp;of</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Exercise</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Contractual</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%">(1)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Price</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Life&nbsp;(Years)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(in&nbsp;thousands)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 247,275</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 18.18</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10.0</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercised</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (53,963)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.20</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8.1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Forfeitures</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,250)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.63</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.5</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,248,953</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.30</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 55,305</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Vested and expected to vest as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,248,953</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.30</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 55,305</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercisable as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 450,866</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.15</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 12,335</font></p>
				</td>
			</tr>
		</table></div>
		<div><hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"></hr></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at September 30, 2019 and December&nbsp;31, 2018.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">A summary of stock option activity for awards under the 2015 Plan is presented below:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="9" valign="bottom" style="width:40.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Options&nbsp;Outstanding&nbsp;and&nbsp;Exercisable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Aggregate</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Remaining</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Intrinsic</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Number&nbsp;of</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Exercise</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Contractual</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%">(1)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Price</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Life&nbsp;(Years)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(in&nbsp;thousands)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of January&nbsp;1, 2017</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 189,189</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.48</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8.6</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 137</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 317,397</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.21</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 506,586</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.94</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.0</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 137</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,570,136</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5.92</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.9</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,684</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercised</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (5,599)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.84</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Forfeitures</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (14,232)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.11</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Vested and expected to vest as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercisable as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 242,079</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.88</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.9</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,634</font></p>
				</td>
			</tr>
		</table></div>
		<div><hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"></hr></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:0pt;"><p style="width:0pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> (1)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at December&nbsp;31, 2018 and 2017.</font></p></td></tr></table></div><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of stock based compensation expense recorded</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.42%;">
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Three Months Ended </font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Nine Months Ended </font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 182</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 41</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 482</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 62</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 342</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 49</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 837</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 76</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total stock-based compensation expense</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 524</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 90</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,319</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 138</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 85</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 35</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 178</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 40</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total stock-based compensation expense</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 263</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 75</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of assumptions used in the Black Scholes option pricing model for stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Year Ended </font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected term</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.1</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected volatility</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 69.7</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Risk free interest rate</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2.77</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected dividend yield</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6832157248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Restricted Cash (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,935,000<span></span>
</td>
<td class="nump">$ 135,173,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,427,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">1,289,000<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total</a></td>
<td class="nump">$ 14,974,000<span></span>
</td>
<td class="nump">$ 135,633,000<span></span>
</td>
<td class="nump">$ 24,335,000<span></span>
</td>
<td class="nump">$ 9,287,000<span></span>
</td>
<td class="nump">$ 5,593,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6833917104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 16,433,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,433,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,876,000<span></span>
</td>
<td class="nump">$ 10,813,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(4,402,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,402,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,469,000)<span></span>
</td>
<td class="num">(792,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,031,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,031,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,407,000<span></span>
</td>
<td class="nump">10,021,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">788,000<span></span>
</td>
<td class="nump">$ 396,000<span></span>
</td>
<td class="nump">1,933,000<span></span>
</td>
<td class="nump">$ 1,159,000<span></span>
</td>
<td class="nump">1,677,000<span></span>
</td>
<td class="nump">582,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nxtc_ResearchEquipmentMember', window );">Research equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">9,746,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,746,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,787,000<span></span>
</td>
<td class="nump">6,213,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">5,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,825,000<span></span>
</td>
<td class="nump">564,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,000<span></span>
</td>
<td class="nump">111,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">94,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 787,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 787,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,027,000<span></span>
</td>
<td class="nump">$ 3,892,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nxtc_ResearchEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nxtc_ResearchEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>50
<FILENAME>0001047469-19-006237-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001047469-19-006237-xbrl.zip
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MCE0Z%B1OI^#[3J:IA>O>)M_QU5/"R.;I=Q!9'N"!@:33O$+@NR'\$J1T]I1
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M&(FUW 16E#7@?@@9>48;Z39UOVBFPO9#%%R-/X5!#34;CX4@V$Q@7\84S(4
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M<$'&"OMF^)C-*TFD/8E'<+7SP7V.HCVV+]?[:9T)""27L'C@Y7@.4YIS<2C
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M4 BJ8DN<$11-2(Z)SR&)0@US"8W;U&FQ?4NU/V<)'D9^LZO5[X\T[MQ7-\W
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M*;@G3N5USL'0"AWV1PO!F;,NI!OJ71P5H_"]M1FNC*YZZ!BP_<66XJ92BR
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MB(S@+ZVELE[DF]BYQR#23L->F^IPDIBD/YTD7X%">IKF 'SS7?>GQIJWZ6B
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M-/Q<VS0OX@6K88<9WOS VE%G)TI?3_-%G93A,<%R8]/-_)P7*1O+-"\'57#
M4D0\OR^U5'[O,99!G ,3N.IK@C;# GB3VZU<!=P_&^9<U2V$9_QC=D\(7O7>
MSE=_?K/BD05>2_>9BR>LA);9?@Z(V2]0=YBO>3DL+(153!1]+E,P3C$FG29
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M7 )$Z\%=GM^A*/C785W4#FF&MMM(+8Z^9O##VP#/-XD\/*;M*_93PM/;/I/
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MVW2=N:K3Q4*U+--1B>-3U5Z:Q- L8LRT4S0G,):65N],\.09;1.(U0"P4JG
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M-S##<OYXAP/2!$\!@5D3'(9"KD@0BCFQ*]P@<?,UR%P$%)DJ0B8!;8$H@1\
ME6H215)V#_WNKDAT2=G@Z 1'1+\'6?$QH1L >[R_&#<K)^,3YI-S*-HV&ES!
M4,&HI30,82K5!#<D8#]4!K,V9Q@Y7,N\U_"&7P)V 6=7B/<>JL+44)^X'44%
M KN0PBR9T=R]OL$Z>&&-".L* -))2;"FVF:KA'([_#?XT7Z=@>[NJ/$=^HE4
M\^,PC*_1T1X);&^[-'7_FG=H+AG%^C,S06#]8,3WG+%<=%VP?,+#JBD,R/-=
M3LZ J6G4J<D3*)48^^FB&$:[[F0=I!!@:, N]@+0VPS4CIF@ZE.)E1,ES=T5
M(L6_]K!LHC!B("HE)$-5 ?RZ"2A  GBZ5Z/ECEGGSC[34^%[GB)B 06#-:,@
M&*XZ5M4,P4W=,$V4ZU4 C*EL5IP*%X'LP[_2"(V%(]]B8=LR&G$[C7C-K690
M]Y)BCX8IE_^FBH0T36N:@)=L.4'LL9S8$_:W1V&J:W#5V6N E96=28%5_\I!
MP<"_B^'I?^;>)=H<,&2N"\8/I""\*9YR">8&;R\N@FG0Q W2'3' 010O13FJ
MV368)#P&92K;\3!=^/HR3H"V'JKVMO3"F!2_7'!4-S:]H1#O4JX!2 0E]CJW
M=5KC16 #<43\9A1V-HE-+OP)N#RMFA$SGZ'YY)JY/LGZ]JY%:W.=^P\:P23#
M\\@[]Y#\<#%!Z_7N.SBAZ.T5*US#65@V\7UUL; ]U;)\HA+#\=0%->$??^'/
M[%EMA>M1%[ @3'\^4\T'K7=!+ -^09#&EJ$OU-^_OCW[Q;0T6].T:H[W#'AK
M=G'L70<A7OTA G?R,@"9YVU&MC]OK^BI[EMSWS95 X:@6N[,5)W%G*CV<JX3
M?^'.'-L:XXK^,V%8=!&GCUVZ/]>"&]SW#1MLS>=-:$C0 7!Q^*"R&,J"CZ#[
MP,"(<H\=T0"@(T0L0E]@DX!9<G.V=.!/5,AF Z0D8A6%K@@7/X9$Y6,]7/!R
MY<]A*9/@>@_71^6J"SR5^(HF-\5*CSW%"S+ !H OMD*I/0[?XX9@6'$-Q-YT
MR96!K[@:ZE ,*"T0G@! ,[3%6<"Z(&/H@R\&PYP4,XF0-&M8*JW@9GQ,&*=W
M^C^'0M3!&ME4Z \PA2#!D7_R?XVCRU]QM<8O_Q:_P;C>!GCE??(K19X;_ESW
M=*HNYDM=M6S;4!W;]%7/,777G7MT3JP3 %<-LAX\Z%OGFO!K2+CS $ZD,HA9
M3=M= C![9*E2XMHP;0>F[9I4M9;F8CF?$2#+*/&KHBK*/E*S!@^,L,J>/E1=
M [=Z1#^A5P&]3NN 4D0E8(8!($C8G&7(9LGC&KB;M@$W'-;WX,Q$?&7*(RD,
M.AJA&"5V 8J$CP,XA1X8_\2B-J(Y>+%9X-?B0_PU:W*CX):#4QMH"$CW35R7
MI@5?0-C3@/FG%;NVG;!BDH"PXFD/' :+MQ5PZZ(Y\'.$7(559OG@W+%0(=#=
M101&6@$NHE5 W"X7BP)A7Q:O*&Q+A:=3Y0/[*6T\NG3+V2)W_Y#%>K4<\P2C
M2S5:("PSAYBYVH'OPY" 0XU83;$<\QK1,D3XYNN"E-$O\:C'6 '#NP;;$L4[
M+\3+P*W]-S-MC][9@5$?>V/G,5"Y!;81V#WZC7ROMH;V@*KG&:[I^+;J+N;@
M%'HS<()=@ZC.? [+"=,CUKQ'H/I8\-%A;<7II0#!Z)-W<#IC&U LE=^G7Z<X
M+P78%B?KD40:/D5[5-8PF,HN^(J>$>82<39BD(!+7.8[ P"'Y)I=@W2[8-L2
M@#/_%3NI<NYFR@O\J;[+A)?!#XU=)FY(:NOF$$T;LH";M@](EPB<W2]HJ'*T
M?Q[#2AV69!/TALF:80^W)^(5$PST U 5844 K73"%!-\\>8RO;!Z,!U PTV<
M,.M&OC,LQR"A&^88X8!1>;E;!$<8?M<O9T%$;F,(/ NM'DH%#)S] +>8LQ_Q
M)03L <G*;PW]QXE" <EY])BP*-I_D2@GR4TM",I!]+42!FN0^?HH\-U>.30>
M+6F:JGUW->^(<*N#VR^8*((^)\A2^Y''.6 X(2,*#QXQ$$!>4WQR%3+:?0ZW
M.IC PP*N"KBE*[2*=,)>+%Y%DH"%$G'1(E["K8I#@88L.D1\F-3M]F6!TA;G
MERL6E&%V% DCGH\>B,,-+BZAX,W7)/'8IIL/JZ>,AC<O7[,)K6,PJ\Q*PN@2
MNJ$DY+LR\%0'XYUHP4OBB:432$:0I3NR4NPYE??AB/C%?-N'+PUA<0=CP$T"
MC'>QB&JUB*M6JHS7X@(@=7&SE^27W"=(V.9;D%*"M_)M)7@5&Z98,7+=HNR1
M*(II0SU!G-$U84^LZ^A8PJX?(J9DDT:0$N4C72$+&+R1\ 9W[806H:?DEANV
M GNFRO\P;ZK^E#7QT%,D:1PQZ:YBYD'$Q;<(!3 D2$NO4L012EC+&BL [KYA
MI.(*%"A&M.$;G+C'R!2&X]1Z$U+NT/+Q3X3GFN8ADR<Q#_&RO?O'54RUC"*D
MF%7$/'ONBE8>]ITC.Z8T=3+;[ $.BY"WISI3?=&L;T(F0(#"H-I@H!X+8Z%
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M,68Q.''D\6MJZ7PXBIBMF_%3,\<G8%X=LS%$<3#)!'<NW7CMB"U/-.6Q2RG
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M6[Z51S/<!GDOKB P;BQ[N60,F"@%/Y6W8KILV_8#&W9M,)\B[/=Y>=,4!@#
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M<2'!*<_8N!+!$QPF37B:&0GIZ^J!M<Z\]<:#O$LO6/ \42+*%9ZGE2C8QEI
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M@COF46=%Z<&Q9IDN:HR?XW"R1GL6MC<YP:?NM@\15&"]BAI42.HY[ 4?62G
M<!R,7P/@/G#X9H0N!6\15K;#2K<:F@E<+1M*U1* F,CPK-2\VM[!K)N44IYV
MR+2_Z!_)ZI;2-&=VN-CFO*5W7/K(KO9-H=Z9VQU9.C@9UC:H;&P/6 MK,F^+
M*+38/N"/86# OP0!XG:CGG<JG AX?PA+97CH=2RVI)A"'403T2.<0^I5V3"P
MB78PB9N8+2J)2,4,TA+\LSV>$2[#Z!Z$8_-GHZ!U$K :PT\[-8:S??07.]'&
M<J(O]<E2M_DFHNB;G: /7S[@O :*)@;N1#LNOD&,F6A112EXM\M(A;W7-41@
M_F3N:2)ORXQGO,C4]YV;\.(C6);J:_LEF]=NZN'>J;&P, OUH'.Y,YLW.S,
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M:Y77 V*W5AEV0X"ZI";MJ0[W:ZSL,+%;BY4Z[M^P!3=LV^Z?2]%I&7Z?Q6%
MK<ZP=((??,._==1?J[V6D+2URJU-PM E%3:S-+AI<&L'25L+;CKD?QUP&_4P
M*:>GSO>;*$S2.!.=EZBU0G0#EGL73?=FKW#S]=ZCCTTUB-JM58GGEJ K+6J7
MM*4]L!P=^]=XV1#1:I?TM,V%T'CY>.]B,%\X_7,P3EWQ_-^T;2)=7T5Y()K
M=%!/-@&?FZ\-6T?2UJJ\-@E#E_2:#8IM-M4 IP&N'21M+<#I;8$K 9PUF/?Q
MO&Y/7?-?>9*\Q)[RHCLS]PP/N]:Z@6A?1=U--]A2_3_T10<57[,7OODJ44?
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MU2JN];O2M?YMQ[7NKK#5!Q<,%G-@?!?5N(=8A@ U-"J2&23P+94^\PSL%DM
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M8-YMD$0@[O"6MX$+KR]1S!>,LH-@QG/\0,;.7[X!!=Z\JN&MXM>WKUX, -\
MI!*#K9/H*#@.C2_P 5YTD_]0.W_^;1L ;)7K,+('L!:.-31^IPGCG<7E@H[[
M<\09X5?I6@!8#*,A(/XP&: 9#U:7L8$E6B& *-/P.3PY@_O6-"[-10"5G'+Q
MX*'Q.L$O=Z:9ZQ2V@7F ]Y!Q(Y.S1AH5;PD??K ="R?3'8#Z/[9&I>GR$'1;
M%=D_@S( -H3%*)I']=#XV&^-BR!S% O6DIRLBOA$ZM]#8.DX096X)[9T04GB
M79%%D^1^0EL*777(ZJRC9<K@33UEQC!],"&\S 4C)5TQD&R8.$HF6##Q%@T
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M.*!)PC=?H_A/5+"@1C%BBJ/_$XQE<0V\&3ZBQO;#4=$Y)WM%?9S010??C\6
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MV21AF-S /.3]A&R0 @NE^.(N,*B8?<" ET2OF(A+]TM6RYD,A3SV!%8R%07
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M=D2@$RJJ1VZ48W=0>?7)LK^Z6FLVL;7"T][:N53A%:I275T5=D_A.1U4>$U
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M\ZG"6J7S='$I,A]][_O06\#BZ]#[)<1,L."6?URS,/D8K0/WKB2<S6?^PEF
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M+("'C!N/QR(@N@*B@ZP+R 5T18$7FI(L'T!<L)+AM4G3I(CW=T(+@I55&O0
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MH_D[H^+!(G<>U>BB2Y@K2R(+]JZA*KP:RE-9I3@OJD?UY/>NWZG\JA)A4P)
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M$=(J%">M\71C<;A')L^^V$V@+I-UA\8O]%-2&;HX1D&'DNJG+,\7%7,>X&E
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MCV',;ORVLE^1&\28):24Y,J7(M>8-?MH[VECNIY+!:1(?L EE%: D*1J_.Y
MOKP*M\+KH.M"49:DV$3:+,FU.*RT2WA4@US?NQ%#D(7"%@F@P:8,NV^C0"90
MX[?P3@.TBXOK!GO[BF56H-CG$C@FBJGM' DM-A'(N1*[8G(W5=1>J_4)BDG4
M&.>[ RFOK+1[+8^J[#C;?9*SW[=^C)=40DX^5Y(Q15*2DG"44RL3_74!RK:I
MC,6&5$VAK)6WM^]+H5M%;@JO.JGLER1E886:E, :R2Z]8-L!?1*FJT397\;O
MJ]UZZ93R?JF&XM@%LMI.\E;^K+I2#2CXV']+GM)2GJ2\27F>YXG>9G?J Y$
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M4=$<ELJ*Q5QII+SRU+)/><$$XU$7PL@C+M**;5^(NZM1JE#;(BZPBHJR.-!
M)6JK2H%U6L\YXGR_O+*P[^O^V_^R6VW69:JZ-7#]/7(_7NT6GI=7W>5_3ZBG
M_:]3M@)Z_>=Z\]-GT,)>*E'KJEM*3!5'>HHF#(HV,-(\4DMV<7*B"K-<%]NA
M*CX;?VNTSUDNJU.1\!<,G@"M(0EYYX]:HWTK38R_]UG)R2^E?0[OW"&F,P1A
M1?&J,C##4.^RR8 HL*@R@56P.I?KM,_EUI3*N,JA=(G^4/"R2V(\<T_P&<G/
M7&<QR]5:W#[7:]?I3QY&BS DLEQ%(\N"-YBT8$E3&J246O5J-O6Q!J(YM"HN
M6\K2,!'@S^M<8?]U<<S#4!3K6O-JW# LOR^GD?H#+7'I5.I/]1[6GS#V[D#]
MWUS^"!+>_UXO?JL_W.&A?\[=5.M=L@8!J* NM&)8:+PP:Y5O(E3/%XR('?-M
M!L78)['P!&G\#$_I_>]7/;670W "]Y!':N:42K)$65L9H_=>FAS]:@_(J=-E
M<$?XH-7MLRO?+;I[?4L+?7[87!+NTQW:VO6W_0(. >Q$A_MK;(!JIW'FH&-E
MWCH3$(O "UHOV24'H_PSJ3V)Q0/%R)6.NB$6<9[2S5'1Y6Z9":=LJRTD;E9+
MJBAY$J.C*G/FS[ZY?+WYK?Z\VV#R4%\LPE'K7+,R4: IJ.X06>+).ZU2L@MP
M1(X&*R?QW*/[5+ZO;K<#OJ.5QN+^T@ ?SIHJ^LG F9=P<GD*(#7-[^8ZQK<Y
ME>][ND_D^_VOVSH\<.FD N^2U4@@>-'#,)F68$YMQ4MO0B\8M3K&^"#O>0+A
MIW+^^]6 [R)]TYHN>J4>W@*O-1'8*Q<V^^+A%.GU+OH@IEE,]DE<OW_8NO/P
MO*,0($:QXDLWA^7ANQK';"DF)P*C2*N9*GO:\WX@>Q80?L\P-06N;(%#*[N9
M"D'XU=!?E@=>LA953ZCKY7'9<63[Y4U%A_:GFHA'6)C,4,-:5NK1+)X28MH(
M!%1EJMQY@I,;?*_JO8SBY:R.-=5#SQB8U$J9/P(3L9H>)+RH(EOQO$CE5LN?
M2#+AB]F=:K@_!I,&?1I<JX@02Z9YP,A95+ M<!(5=U"R9CU5(_5@[',MF#0;
MBM8Z$RY:9HCE'26@!>/<YVIY:7(]^RBU.(!ZFXDOMC).EZPU9"H["-@#G%Q3
M#+Z\99YK&A7,NKGURFK:AB'7+P'4Y8M6OJB(VZH\);4J"UE&UH0M+?,JQ0ZE
M88V^/V4&V&2G('6UJ(NM)C&5J5 H*?$:0F((0;D-TB,HGM\5?2P]J9V5^\9\
M 517TZU9)S53-)*B,SF927!F<+V*:H@9[7HE366@6,X$UF653%X)V@U189EX
MU2Q*'UCR$?%N3,TO&%\\SH@81+TGPG6MT'T>LDA.(AIT>/L$P2L9=5TR*YQH
M*D09XIJ,6W7(^$K]Y[, OE0MU27#=R$!@9? 7>2>6?@BN7'$#GN(PZLT:_8)
MG WPY;6 WL*OM_!I06@MT &4D?%!%F^\4A-;;4;1EAXE]"4 OA";RD;34BT8
M6%^+]Q:,3B"S$( Y7*?=HIH#G3R3O0&8E$&H;ZP;9^N)"%\X@8;?[N$"4;=7
M49P%PLNQ>.69!]FX&&_$/HT5.(W^3 A?WN N^5J9DMWV(-J5;%IEV6O/8U6F
MQ#4/Y2@G)R!\Z2)<R*ZP$"STN,%A1-K^3):T(" (PJPVFW$*P-<CH%A<5YN"
MB13(0S4%6L%@5&(Y-6E2B)'+]3HA_6BM=150K,QA,9WO>GP(NP^/PC=BJQC=
M@DI6J/6J+WJ\<^LX*-9HVV/@JG"!!R DXC2-:)5Y&3.!G7#I+8?U6*^Q02J]
M.HJ!$J(8;ST++H*!HA%@M]18;B95'F4#)V?T'->#,8BV%!=4HR)8),QG*-6D
M+#&H-$%SV05P#$??L0R3?"S',; N6-5J9LU;:%&7<7\<AXOL5"E"<PVY/4<%
MZ20< P<O.,.W@+-A"+36.>:=5*S!'U1%QBC6ZU%\I/)S(HR!\3E&0G-KH5#=
M2AC:)Y$8C9,GF6IS>;687JM3< QZ8T3'?<"0:I74$1]P;7 8L,?!9IH1:4TT
M832?@!=<VP><1_CQ ; Q3S"K)%*#O\$3U1H38C"<(>Y>C39KE:OA;M1BKS__
M->4"+L.?:'"5JJHLT"HP\"/@5^'D< ^;\2WC4-=K*Q]D&\Z&/P$MX^"N128T
MH=A*&0DAT;!:/&'H>1'*>G8%2LT.V%H;?Z):P[- 3 7%0*.M#@&A)OPH+J&>
M$\Q\6\^\X/&Z>?PL16S07CIGX:^XE BV15N$'C:PHGW-)>#MY-FX5PL;,5:&
M/"BZ&6%3H<9**G5HQ(.J!-9:E3H@*+%JM;PD;+(,;L#-,LB#QWRP9 17EK;0
M5D[K'FQE*38XP=R$F$T3,:V6'$?D'/0^!M,QK^L): W!ET1#BU  8 J>O:&2
MLJ=Y)YR=2KB JQV2L%(.>IJ?"-?P!,8M=_!'*1F3&VYGL51:)>W><C%%X,,R
M'AB/,1X85V#\8>?2_3;P;R[B]?7;MML NK>5J6[AB7Z];[(&:]8^_Y8[[J[
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M:"J2T;D38QV)L10<:+E'H@*959!=+UX@[Q.Z8.AV:9=SG,_EA5VOO),G>!?
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MM,<_OLKK2N/EN0$R UXG(_]Z.\7_D^)AR/QT_U-9^O[G8K9TQ^.Y7'5C0%]
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M).!=+X@XRF=SF^,ZZ=KV;LCNF385_>\6[=M ][I-H@HP]=R?[ZOB*<!3@*<
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MZ19/_C1TVW2<LU(L:/EKMR ]@7KB@_,@!75R&T;/CTN&HAY=D5\9Y9)^3R%
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M3R'PX 5^M2[]\M6[+Y\^K:_?OGI9J#ZR=5$P!]D42\O]KKSQ%M@OI1T+01U
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MJE>JM!QQ\;1ZG,UZ>N"4[U2$.YA>B@?81S0V-$%W&YU-L%]AO%Q 5\7U%8O
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M3KQ,/$OG;%U-.D\8@_(]$D&;R *:.^>$ =T\\H4MT_S,"EV<63$=DCO8@K]
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MR42C(&W:S!R/?-NVC=F)F#"R)^;N7MS+BE\9(#K_#/B==QCXM^Z1IU-]//+
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M8_0CN3K%Y1N^9;:I&.FI"/8?*Y$61^A$;@B6EB6[P%I2\+PLAH5L;?4#P+T
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M%X_  924BE-C&L8/P@2A"X3647-H$ A/X\T9<@<^(R[*S\))XE<+Y4Z2<%W
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MP>AKOWH5^N=-,XVL(%6,6T@25#>R-B:.4M7O4"Y**(BV"L:S(C'"9KU$:T(
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M.TJO:7SC._1Z06+Z,TFH>Q4M5S1,6&F;RP":8']]\K#HS3P$ZKB?@5H1/)=
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M_%HW3/CW)_]SJL,S;P7A<E(]S':&3Z8E <H/79C$Q6!41:R_LB3UO3O^E?@
M;$U!M7R71O.8K!8O)$!?%U3S&/FU):>_MA*DU[PHUE+X/9(,T +& 0VD0"/X
M.W#^-M'._1">B[*$A&[RZN(>292?4!HKT&4:$)N=2?EDRJ8Y- @$;KPY0X[!
MYV1%'/E90"&O;99#H8 H )" K!)Z(?]XS3O2)D8_[^LQZW^U2#NQ^V-UB78N
M>$^RG.Q-4[YYX#KP$\6M>[BU]P!"D?OER&T:"HOV0^X==X8TTS(TVP<_6$3U
MA2X)>ENQ%GG,:;FC).Z@*6DV>SMF2)I-[#;EH8YNI%06JFY1<[>]]IVPCX?R
M3X[$0\NP#K,R?5SD;0*^=LR8=8^D1S<J)VPZAJ/=#C)TPG;LSQ]L.'O!JARF
M>J?RYT_&WC2;V =3G4,FLH]N\%0455>C;KI;Q9E.F,+N&;S#E U2/G_'S%H3
M2*J,EXK6=CMUOF-1M$Z8J%.*U@8=-%[-#B Z9M::36QE\%2TMB]3.-@-*SMA
M"CNMPU\7-*;$2VD7]WLT@7/--W6J<EAK+9JJ'/;8-&//F.QV:*@3IDL5NQ+%
MKK:<TNB@S6MV+-)L:ZA.VW9HEZ,Z;;NGHL*]J?DLT\D_GN01T&><S=QVW/,W
M DWZJ4^33]['*)Q_I?'R'9VEVTYV3F:N.;)FIFX:MJ7;,W.H$X>.=#H:C 8S
M,J&CV4R=[%R7BP_"7\B)+4]&(+FUCQ$)\0PG?'=-5RE=SFBL#8R>AE12!SR/
M[O8V_5#5(\!:'?!L#+>:[;,J<C=[':$SY%8)D?:&:^J 9Q/8VS%#TFQBGW+J
M0RUV[R/Q4=)7_.L?WR&ZLW=SP#MA,[NWX4L=^E0&KB4D54O=:K?RCE6$AY9:
MZ>[T?F5UNE09-D7LMM@B%5O56JG12-7/Z8 M4@<_VP""1[<XW2/IT>V*LAZG
M9CU.*<919S+;#8_'/ZAR2M0^_MD2%>7LX:*:3EBITSI9TD$SU3UX5.&/6DE2
M4=:NUFO8@[]/SWXUVV\\&+L_TB2YT)PLCBDTOXIBO).,;1?$$P]!1,(.FKIF
M\[KY1K!+$9FRCT=F:LO-Y;G9LX;&J],SF*<3\$E+V--"FJ)M7#.7';2034#F
M9MO!)YPS;P)1#Z8E+=@??WB6=2D.'/3&PV?%@?SC218 >-QI_6UG_>NOC+Y.
MX95/*_PSN712_\9/[[;>ZVPZU)P-IKI-'5>W#4)T,C(<?4*LX6A@F-; ,_9[
M^O^(A]>AISV<7A].^J-):T^,<M#I&\,3/,AN]D>V8MPQSK1/^P.E,D>J)J!D
M_EB4-Q3ECT+Y87\\4I17:'-*E)_TAY:BO)+YTZ*\K7#^2&@S:F_1I(92?A]K
M/4?/3=2L]I$LC9[#HF<G0R=/3DOD;W8Z+=%$GNUCE0<&D:P(D'UZ=C\'!M/]
M:\VS%\F?RX+2H@)/DQY)D1[;Q2U'V%D4N'4CK>JCR&X7,O$I2Y.4A$BLXDOX
M7'QX_YW&CI^P58:77H)7L*Q@N1,\._SB^[$SQ>U XI?8!*&D_QA4/V[.^#2I
M?NQ\L<(<A3G'H_JQ,\?MD/[FQ#[_RQZFKG)Y.Z* QTYCGR;5CYW";@?L/8</
M*G.B,B>*9RISTAE 4]+?B.4<ZX'E'&/4O%/##=0$%=&T4Q0:H8PJI= E!;R\
MH3&9[[8NJO2O%<;0A%%W+;O0;5V<SV,Z)ZG:I= (956Q=OMXIF+M9H"JBK7;
M*OTJUNZL>Z%<_9;IH@JUNZ1__*9EW*:L-+ M&JB"[:YJXZ]A&OMAXCLJV&Z"
MLJI@NWT\4\&V M6J"OZ>+6<T+J0@\I0JMD855>3?5;44!R!5Z-\>952A?Y<4
M\ J^BHF39@>Y%4CIH K^E3[NHH__)D&V:0U?>BC%)QL)#F*CXQ^K*/&QQL%%
M3 .2^C?T-0Y!EW5H#.,'-H=S\Y5*730!:E3JXD1XMG.1]/LY??]?^Y># R13
M5*F;0UHI5N,]48B@$.')B'#4G(Y"AT.BP^?8=U1&1X'#H=R% ^28%" <$A ^
M^AXM).+\_U$2)[N%B H@FB8%+?$>#I$ 4V!Q2+ X]\-".-)%E"4D='>$BQTS
M2B 6+4@G/>V&TD/GK@^!)KR<:E$]52,)7ESYCCJTNHH_,'O%!\LP)Z=A5$Y,
M$MJ6>SH2>P<Y>[MP@:/5,X:CWF1J*I4^GDIWOY)H,^E^,+4ZP#VW3:Q4JA 4
M$-3NCVT%GAU4XK8EUY0V[T&;IWVES%WRA!I77K69=&^5)]3 \JT*.P$[A[VI
M/3JQ!.+3]5@;M4V7?XE)V,U2?0U#XXX=HCMM5+3L<<\:#Y76M$QKCIU%:QAU
M6^4A'CM7=MJ(9T[ZG5PB;)A&=NQ(X8GK#$Q%J4S+5.;8Z:5N4_?8:9[][!P[
M'!@=ZC*>!F99#I%';5_^159QZ&(&IC69\H[E9@Y"]Y;[8N?#06\Z&IS(UOF3
M4+-C)W-:0W>5YE$+@<\/9OM6%X/9UBAQQS)#2LWJU6S25[NVNZ-EQTXFG2K=
MCYUF:F\$=D()J%-*,WV(8H_Z:=;-TC/=!K.CEWAJ.F8=,&MD]JRAT<6D4;=5
MYMBIH8915R6 U)Z%1R+>N#\:*+AK&=P=.YESVBHS[:N-P&W3F&,G9KI-W6.G
M7YH>L)Q0DJ4U&<B#V8?-8DS7=)6N5V,RJM68IAVT**T1A6;G;RSXW8VR64"?
M4T=/+;:Q0DF6/>E-AUV,>$Y5VXZ=^FD-W5522&U7>#:"COH#M2NH.^!Y[$22
M4K-M*2:U*Z@[6G;LY%-KZ-XJ%^7822^%G5LJ& U[ V.W#'W[TVZGHLC_IDE*
M78V$KD:_KZB#'])(NX&O3SO9=BH"T.D"YZ<-W%W.SC5,/3N6@VL8=5OEQAX[
MTW;:F-?1?-JI*&2GRXMW9E>%TIDF4%=MP&JKBW#L3-=INP@GF<]2*6M1*(K@
MOI^3SFPI4>ATSDLM8VRYDFIH]":CW:YB4 K=;!=8[53KGG-\[/R9PL]M]:O,
M+A[34DK<Z9S;"12247K6;+JKO6K=<U*.G<%33LH6)\7J#0;/RNWQCY@ERE]V
M_9ORK^(C_KF(Y1P$OX1XO.;_WQK^\'I!)0O%@&<!\&Z3@?SK,TV('8K-63Z"
M1;QM,#4LW0.3'N 0>_#K@FID/H_IG*14\\,T]L/$=U!Q,OB<: X)G"P@;'M9
MHJ7PN.M['HUIZ%!M1M-;2D/V-14EW+55[,-/D<>^!=+0.+C#4Y_1*O6C,&&[
MU-@+2>HO6<,>\6/1HWC-B9;+*(2!1\XWS8MB]J5L(%V05+N%(<!XV0_P*+W3
MX,L\%Z@-C)Z&F3_6VSOJK&<(3?;SI%\1LEQR5I)1P"?MQW6N:>4//_V8)?J<
MD-7%M;.@;A;03][U@L3T9Y)0]RI:KFB8$!SX-4[F$Y_#I9/Z-WYZ]Q5%]"MH
MZ\\!_/CV[W_3M)_R]FI;T7SWS=D'XJ3Z:# >F /#T4>6:^CV>&#I4W=@ZJ9A
M&O:0VF./C/Y$&ABC@7&FN=0!<@?)FS-]< 8$#A$DOE#OS=D[?$@W3/CW)_]S
MJN,;6>CS!_PDLBUSK/]Q_>[LK3F %@VC-._:<:[-!=3!]WR'A.FEXX#"I" 1
MGZ/ =WR:Y/,OYN;.)F/;'!-]-!Y/86XPP>G8,G5O/!T8U!I0=^*4YO:(V;PM
M*;U6^OL>%62VTK1>0A=WZN"6@]$L"ES>@]77KK,E#/R.)<0+6FL%L35);1P)
MT4*RA%$02[P7>?=RJ, PDO]5KS2/)V=Y%IQN^,*%GP)V.LVA.&L0I-MGBPV?
M8YK0,&42_EPJ,"/M SZ&Z<5@5+7:?V4 CMX=_TI\@)&G8)Q\ET;SF*P6+VDA
M0"*6*Q(R',]"DKD^XC:H'8P^003W0Q(Z/@F@)8#T)<PI65^?J6*R!/5T$5/*
MO@FA2X3R=)%H%!IVM[V*P*TMR W:'S ^JYBN (%<;7;'6KSB0T7C  .$?I8
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M*DI\#GGW&:5BA ""69"R9Z,5C4D1NC@D66A>$-TFS[5AZ+4A!)3FBG" *"(
M6, @*$2,) T)EB[N:R@(]0-\ZHABAF8YJ7V&_"Y8.@A3\J"LODN&0TO0QADM
M#A^M0R".?AT#GZ^WK?,C_T@8,=^+R#?I/G#M1!Z4:XY2W+H J6J18INK$=/_
M9#ZZ+P4PH:E9DF]%MH$K,4F2;%E.)Q#/ \GE*+9$'S&!UE917'(&M_H"%=AC
M3D%?^X3.%2#M/,(O&<KVRL.BF.Y@P_&AE7QP/>$,X$OI(DI0Z7CR!3T,QXDS
MRH_X 4C!PS&]H6&&#SD1A&\X'X[$O'5!0Z1**I!Q8AG3US,,UC''DD?KY7[A
M+Q@AZCU/OXBT2Z^:E.'(!(Z [_!0H/B-V>I;BC".O(*? )#(=R3+UY)_CJ-8
MFSZ:IAN GRA+-EE4]NUG-/!A[@F2A3MX212R36&%(^'XL9,ML>B8@UU?;N03
M'[*W 7 @FV/4D&; =0E_#G,K>19,\^)H*3A58F*)T6[$W.E4#IG/A7FZ12(-
MR"5]56PA!B'K!#BR![\44G(%ME-AW@;FY1%K(B',Y?XN<TA\J<>H*E\I>.L?
M(\"6\]\Q:)N L\T@SN?.$_-.G"A T("8%A7*I<SY8:BI)53D>EV1-042?Z,@
MG23\)L-C! QX5<2M(E!F/E0LAX(_Y$-A8W4I=+B$Z3/_DFC0!(!G'-QQ\..J
MSWI!7T$B!P-O-R:W)$@P*H2X(DQ *1(,YC%*#$$G%B3PUMP\D0-F2G/C1SA;
M^*J@'ZJ>]),X0;%+&J/^12#\\/F?P[ZA 8^"^[Q"; /]8V82D#\KG@#B5H%%
M722IX"#2'[&Q]'.$(2+B&4T3Z7Q7;,:,!,R2)0M*TU.*9CP0U.B6&3L&WFC'
M0-@P 9 3DOV!3 2;EIO<=8JO!.97*"DEN!(KE-SW<V;8P=9 B\FKBT?0'9<#
M*DN(IF'\\#K/CO)).&#YQ/K=FS-,3L/G9$4<^5FL#:&1I7&^)"F6GICJKA)Z
M(?\0BU#:Q.CG?3UF]WKMBN?8Z%M'W3\@U]%@+B PSUB[?JR,5CN,;FB,O+]8
M^"[H1TF"G[2\R=XTY9L'W8%C]8VC;D!H$>/VOO5C>M1- B=+>=/L6T?==7:R
ME%=H<T2TF2B9/PK:&/VQPOD]4WYM5]9#/NL2N@YHTWS6FEUZ)$NC/6T]?E1$
M]NSM>Y,GN[?YFWMR;VMY?'2#<P >-V)7,PP"0D\@NW7V /P-^F;3MOCO4<MX
ML'TD/7K*OJZ:D5;5\:%CSQV,09626LT[AZ.4]!XEK=UX_$0=5;Z4\J64+]5Z
M2"BQ_OZ_GB(81W7W=KM-^T5,2:LEY4"%:Q0\-)GI#8&' SB:"A[V#@^30SJ0
MS5Q 5@>AK[9MC#@-6_%L;FNCIL3]S5YW5IIV@)(#1U_35B4'MEPMUION6''@
M=!&T'>AYW'7TUM"]5>AY[#5ZA9Y;"K8,ACUSO-L--9T(1TY%F;^L[;<^+XX+
M_7/0&P\-W.]>WN?^JH.V5,4<!T_[-$R?FK^A];#D[9:5&O:,01<SZIU6FD-X
M\@J3#NI2*TS:H9[]:+>+SCKA-;<JK7LPWG_%@Z@=-$>MXFZS'6AKA04$,CQ5
M^HR%4Y5X:IKG?E2^=LN FG9O.K85C';%(=VWOZ\@M"$0NN= 0T'H7K/WH\&S
MLO?\XWWUUNM*G)<KE:S1L4&%2K9LNLNGW:Z23(_M@#7X&RL.Q*J:%&4YGTN%
M_=2GV2#CP8DF>N25&?F[GS*LNGM#9?G&5>PO>?5$)PH3/V$59^9XM#;DQ<#H
M#+K(*8DEU>)5%&/UHED4NJ*<W)R&SAW_@M4P2JBHTL08D91*!<=4<P*2)+[G
M\_K\Y(;X 3ZF>U&L)R2@/5'OCI4<Z[%7\L)V6$"V5'H_U"*83U$#LU),!X;R
M1QA38--_X:<%D!T7?^;$%V4Q@RA)Q)#R]K&X$Z_5ERW%'0)\C0AK'\5T =U@
MF3E1(NX<FWC%ZUXEO @@NPA@!2#.:_>PZG+8-8V3<J%/4>&.%WPB2RQ3]5]6
MDXXS8(WJ6,:)U]P4A2K%&WF]/!C:TL^6>7&_F,I?L$0R+P[(:FZEV.*=+.-9
M:@5K<LTIFRJK3L@DF":LWFZ9_>O5?SEU.#UZ6DC3WB972L4'*X4X&U(WJA%Z
M^2N64'6I@P_EY1LKETR0&I5B906C6T'O)!7%<?U*<3-><) S*ET0:)LN487C
MNQZOZE?7+C1Q&V.]ZQ!\EML0&RG7/:S<@,'D/P0ZE88@*TZ+.F2B%AHV2776
MH)]4Y(B2. 3U9(5]88C^<@7M,P1R%L!Y44)6ZD=)-1)@&S;&*T3*0L$KZN#5
M )J/LL$N"6 *L00)C]Q.%"K<R2I^$54WOQ15-YNA>R]2LTU6X%N@;+D1*Y=?
MNF;B.@5A)3'8LJO(+63E:[0" 1H9HYXFR<=*9UY!CS%Q0!D84%[!] #[XJ1:
M[O[R^@K?K1091WL$AD 3OZ&=TU \TSM9#O6_-,DKI-Z"L6$ZYX@>M&B6,N.%
M9:?C*.# 'RU]%/QY%+FL'B&6#/2Q/J?/ZKD*_6/%!V/J!10'SN^K 5/F"B@N
MRI6*\?"RR,QHP- HMWGPK2CRSXLE8PG1C7Y!4:,"?3@&K&"8X&B@=2SP0,Y3
MUD,5!! &+HZQ(VXT-K!,6&FFZ0[8$W;/@21JN>8BF!I>;SZME.[S>*E8NDHN
MM'/_U3I*"+"ZG[:"ADP47D,KT(P<9]X*L%"@[KVMH4T5(V7>2S0#+2*BA&VQ
M;:74VAU[!^0=!-A)R\,!C2MN)"J-#H:WI 2O2BB7(&?%*PF_7H!=@E2MYLNE
M!![R>>%]+'3+"P:6A0?;OWF%1="C*@$W6L\+=-9/]C6S&N?05JDZ<%E4F$J<
MHWB UU7F,Y8$3CPT!Y0XBRWM5VOY1B'>GK%:!3X5X@%"H:-0:,O(I:R8J%.H
M.E=&7D\SFC$B;)3XO?6#@%4RQ;K,:_H5B=L3>!M,RP)A^:I*5:-2^%)19E30
M4*)"0YRH%P7RHA1U@8VKHIR\+$BLL=0&(V5^$1?6I&;E535,H."7\-PFQ;$9
M#PO2H["EZ)H)/[JO_>I5Z%]<$H8:64$JB"IX[57FNY7'Q%&J^AVOI9NC8#6H
MJ)=H30A@E*4)S96ZA)VG(AR?ZP&%(^O])C)7<J980LLXPSFXXFNEM];UCX=<
M<8&)U"W>Y8#EOZJ^X1"L$1Q2#_1:5..F&]U$W/BCJXRX4 G.N"^/=\1@X)Y'
MT%AC%B(!1U2,9S9IP_24^P")DQ*&UR<(*\B:8N/B_8C7-ZP>NU\#]TY"-%\R
M3P\8.DF;JJ&6Q /-@Y:CF ?_\I8/""#GE,?%-Q#OK,HFK'1='\H> ]^,WSL#
M2I/RJW> Y"LR\P,>,D1K&IQ&LF'V?6TS:_PH6_:\7C,Z31!0)Y2K\CIWD"?E
M]^KI@[W/8U[,&GYSZ8HR]6-A-7OW07?D5+2^8A+R@OSUGD<E/!1.:'[W1^Z"
MHJ,KK@(12!!+3^CQWF ?0X22[2\NZ\(ZXB+H!7?C.[^/K/1D%&]QL?K:-;\:
M"CWZ M[SQNK?ZFUZ)])RKL7FJRA%W4=Y)W?5*Z,"_QL-_ 4B1^[PY ^Q-DND
MJ[I8[-<L]3$!IU$_%_PE1O&LW3LY!AZ8(P%RIE1_ 19)%C^&A3F[N=<E&IEA
M0@MLLNO+*.C^9O+TG"!3/9DY7=;R&?52*"Z=R;UJG":B@B#CPPTPKU58(%!
M*D.[.M<4W(?2O8KH0\<)<-@/UYC/L9"E.S$N6KNAX[]4C ]OA(@<A^6/\4ZC
M#&_V0<?$WT-&I7V(4[VVJ8@4RCI>-E>EZ^&B^ [+^(,PXF)?H4Q,5/-K-;AE
M!>H7]X-L5QQQ%50N5;[W2)'@G!:BP?MF3.YKOVV.D+<A;EXJ!>';28)9BEC@
MB(/98%K[4"\W]R42L;0!X!4$P;D SBI^5CXYD.(91:2&Z ^O+$&B >Z('$7>
MD,CU2^6^E"D/E]TY@Y$C7PA@MRTRP:Y":$SU(O001F'&_0IVCZGH7;HG_,J4
MD@SD3!>)>M8D7V4H FV^_ $,S&\1ZXGD?_7J&:FZN%:#%Y!M@ 5,$$/C]0N[
M;HL[!O%"(GG[10D!((IW%GJVDI< E053W#K$:OW/(@& 0I!R2\AIQRB2=WPJ
M$/%A/7O%\5D@ JYO)3JW3G%T1P*^JE(D76IPH>*Z!"A.3+BPI5[)3#/UXJE_
MZ%F:,BZEU(TP+X4>0TJ713:"N:]R&$(6:[R&W!3DD"$< 79G"XX&8QP6['"'
MF,LT&Z*P&7E DC^U):3-QY;@"AL2,PCRZ]S84'DBEUT0*').N+PGOY*I()<E
MBO!"$Y_Y7OGWKTY%$LNNF"34H]SC8I$'KZ)R868HCPD$1>(:6GY9.@-,F2NM
M#\"K_N 2R)%'6AN798DP2OLK<^?R'K1J'GG[:-!COR?SEX>VA6M5..OE$0IG
M-=&^88JU/,+=QI('\>5,KG!%2_Y!L;0,,3@ST@5CX 5L#]LM63P8?4CG$<AT
M*@.3,C,W+ZK'%3.\2BQ/=N%EM'Z8ST:VPN:S;3IK";4J0O#+D<2U8-LG@RN;
MX':@G6(7TF4.6K>2!94W"9>N5O-$<@U<71H[&%@7T4A?^W>]-RZ=Z0(;Y&H@
MPP$,JT,&+,MH>]Y]+364@Q82+4\@; D'./SE5_DPW!'\N5=;<N[Q:]N8.R,N
M]BOFDF>:$N;\YY?5RB<KV,TL-H]MRBLY,M&\/K3[<N<GA)E5;A:DQQ#T/HQ9
M3]]65BVD-PQ/Y:F%TJVCTF36+*>A0[%-2CFDE';N"#> :U(U?5?5VASIRG#+
M0P[V'+^XM5A*6LY87+'=:!?P6,YQ/?0B9B!S@XV>K ;*7V3=5Y$?\N4M_!;F
MU$/'.'^NM[&\*/,(GECMXC@&(@3SJD)]U9$7:V-B294]7A\0Y(.H\<[7&RI-
MF4=_G,<U5V">BGK]L?)B?*229?)HO@M+!"3L<CZA(9):V8I!*R 8S)EG8,&*
MX0\BTJM9]64)VY*ZY)%T4EDE0?LHX',S$52GT$7D:UKRIN+2Q7 ;M[JY;.5[
M8^L;7I*,FE>ZI7!CVG[-Y7O;][O):6"H_*)361\WVPK&+J^KSK$8XCK#Q4V.
MB;!2S*[F9K<VP<!7S?@R;0FP?>1S?@ME1ZXEW7&W#U:+!%_G5_!@JWM=/H/Z
MP=\.E_M&H<XE^H6]_Z'!#4W!5^LE8"7U%R);T4'1?ME8X.VB/MM?P+>G ?F0
M&G-M'D>WZ4(3REG= O3^EZO*]A^A)\P<%CF]?T&, <YWG&JX-??G+('?P?A<
MXU?9*@'FI=HY/EAN^E^??K[&7]:W%[&%.'"69=B">2_?K?8G7BU^ PV"H:[Y
M!QA/TR '$*;?;)J!7UQAC7O^(ER(O&$K(\5UTZ20N"3?7<6!VD_+E\9R]856
M[WB++%N5O]+7&B6AQ]?L7T/M YW%&;@=>-FKV.WTX?+Z9R JU_7K/[3?HS[[
M53>LGO:1LDNKUS:G_2$?6),@%'KDZCSSY57E+/_#0_, $])4[@H#Z!89:=X%
MSQ[X\9I5$KZ/S""5O5UY+7CQJMA8O79S.MY.'8+\)3Z0B; %V]RN8'S&DYW%
MI/C[,E\MABW"H6(DA \<?&:9PI7>>-6S99>Q\T<K?@OA%DA/(SU+>+X^+1QZ
M:9SPI[5UZNJ3O&5TGCGYI?2S?4(LVUJ.V:1^_HN$3 I,O/77,OIEM,)8PV?Y
MV(I?SM<$^#)@($)".3I!1E!=Y(GK\[,!^&**C)K=\15K*15BN:'H!:B%+C]X
M!V2K;I=;Z&L_ES-.MU'\C3]+)>!L9"+])#?TTC7Q$8X<X=RQ;#/F"\2/*,:2
MENO;VN1N'BT6D3HX2%G"\RL8%^!S^#[+1WQG.Q;F4LP9Z_&F^!7KG&V6R(&O
MN+@7NP@BC 5*:"?H6-:P:E3")XET94.-J@NV7!R*F8J< 8$7\+[K7.0EFWDB
M0?J0:YOJ2ON?Q$7/G*N@5\D*W2><LE_D9J32YJN/5;*(_1'5BZ'7YU;L%F%^
M>K[JC-N]G31OA($P#DQ$S6";9M(P@MG"P$OFODN69A4!/]9&.HN$X*&H,,;(
M'8K\]2B<1]REKEBVWB:;E"5:MT3_R@!4'F&%S$%/^Y!KR*^XSI5Q]S.W/?;K
M*UR53[6/_$S..=]\/;!&KRZTWZK[5JM/ B]KV]YB\,S!FL$K_5*U=0[O1AP2
MDC&4.":4"1DN@BSQ'-\Z&I.T.&S!=A0Q<[7VE-PV($P9P"1"4*_8$2"'4M+4
M*JKD8BX&&_O)-Y$QVCQ6M7&HB(%R5IR0XH-#9F)61EJAZD@P,$1U2$I19<QW
M+"0I)2[?K>MFCD3:S;--G"#R!%H-!V9TS>Z%4:C7>]R^W*H)9 'JW%$2XS(0
M/,@2V_(R(\T<HIDTI^*>>\QF+T5")REB8%PK+K?4JVS.V&Z+[QD!\7"!;&T<
MEM&[;R [-07VGZU32'H72]5+<=!M6[#2U]Z3&#<22%/BERS^IE7*A518)-DA
M)XO832.;8OOQU]BZ(#?YKL8:@]F4TV!-0MC+;(Y+9GAOPKT8.^$8BR>R_LU.
M9)4@LPRR[W+TT#[$9$G1[=*OV.[S?%]YZ9DO7.L9\**,UW=0B[233:3E6ZEH
MZ.9^?>E9A$1@2>Z<B1'$Q0@8U)<.G95.,XC&KK0):E;]*'O5)4YP+!RZ2O,=
M"XRP5_++:RF4=<<A2MOU/+Z\QI19;.A-^I5IU8,'8><$:@!,(L$#6K\KD+V,
MJD]>3M5KZB)\8/_7 A"0ROU[=,-Y^ACUA@>NBBTW0-W+\A83X2Y-C FX2U<0
M(</$)--^Q?F)-;X936]QCT3^.!.C_*#;-DV>U/M,^ NF@6.>&6/NC$-C/*-6
M6?O-NW4J,RCO8V7;-#"$P=DDBWP+''?NY9FP(FW-TUG%P/-$\:.Z8)%(L?U[
M\_04@0Y\_I<C3WU(O4K\-),K^FS;53DN]DO'!LOS8,>,*E%H*1CKE;$,5_W9
MF9%B27@+'JXA*@PFB=!53-8'7S,\9#VN]Z%:; ;GU6F<"S^U=\^A"+&MISC/
M6(GUJ@N"VQB$'&9<JCG'PHXCUQSZRT?9USZ2),6]#67A%"G.? \6=%#>+<$F
M3AXI,]);QZ45%WC@($"67'"^V8D941_<9O8J37)VUNW6J![JJ-EWNR'FPII
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M2!_!0T3E8Z978S*S!$X?L6,^G8347WK8%/%L(48^3DJ=;.[Y8PF3$30T(T$
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MRY/S'YW+M:"25@%NZ<&!:W8F\6B?APW($:Q=7H%J2>C<'$#P2E?"R5'6+J=
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M:ZLVM)<]+6QE9*T#-VVNWBB4D;55*KUQ*"-KG537)'0X%<G H]D]^98+&_"
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M9:M]VKDX^7AZT3F[O%QJO +@UQBFB\YRO0)\$K] J^Y.&/?)7^'W$L@J617
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M8-USPQ:)9>]H547*U?!Y+[9I)'64^L*4<U?6Z!1KF-T8BPDQM)$6M'2\R6K
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M9XOEYM4VW[M3X5XFO2J&99+Z\#8L)X_=.#=ZO)W5[859%=5]K2T&U$_>GR_
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M$A3P"Q'+W]>U2^)+EN_3.+Y*R<^ R")NQD_Q(K)CS!7X7"^?SR9UU%0+!Y;
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M37LU8^"MC^KLW@JBK+''\,E8 E/Y>WL2EX+4]2$>@M>559\<8>T+GI?0"?D
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M'4RT_@HG;'.+@_@ZH8P43J(B5B]M#2)2;Z#.5<"E3$$,1!7!-+8(<)=26<6
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M*QSJ<0<B!D7N5[[[O_6IX* (I(XGE5(JXX2;0.-)80V->%TO7OYS/.%&T?>
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M@PS+?UX-;J#VQEZ30Q<XW@ 06'D7[C*O*RXMQV"[?.M&XZ-\:NX@KU06EKN
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M(VUCHD>I9B9 ,LLF:A@*-O2L3D C@]T;^%*OZ%<;3=1611W=,'+5"FZ#''8
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M5T==+;>\-XO-L=II.Y.DKZ:->2%(UTVI*U4E.W&*&B*!6 Z3W54? TBPA<+
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M;;Q$':'CPHF 036T0J51;AMII*-'J2"-A5%<7NE5H^74L]"DSJF0:@/I1,U
MH9M1DOXT&$2-R<5:#:RNC4/E92<LV7%T" TO(<MO\9J&>)'DQ<C']^MJN;7^
MO[EO_:WU:P8WUW?+/=MX'9G=PJTD%8VMS6L5EI5[H>:9-^>G4.</V$...*/
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MHSD9.7_!:SI5\B8J8N1RL5B@.D^>@%.2B#VZ$2O7KACY'/%Y]1MB/P8":,D
M$?4E55XAX*$$I3>!>9,QI>1U/*,J("&^8!"<<Y=&218MZ H#EX(I?;KB'#[B
MBX-!6A8-'%<)O.BAG*O<0WQ+)J!)?-K#SLT'#:#H*GF%BS<^%#JSQ\V0*UM2
M$T^4AD>+!I>*U$)CUDPPZT!77,ZL&=#[8=UHO#!KIC7+0*E\:/DQ'&I5?HC
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MS,FZ.".21O01\6F:%MAFR* G<54,EN!P>[-.^608: ?#8@_F (KN@,\8K!F
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M-QD9>BAN2?-P)IX>0AH:-!]N3D)H1&C0'Y[/U@7H%,\G19+#%F$H"44ZHAC
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MS7O:]BUG,/=_LE9-<?<$.QYF_%4T7/=$R6#:-P=-[UX.SO90!D=&"*(NU'J
M3J +S-ZLUO"<=(8GW-LK]:B=:%R3Z=@Y?DCB5;PH;G1.%PNR*TI'\L"J1HPS
MVB"R_K#/W$9*-:MK*KD!V"@RQVJ@ZTN"=ST3\Y8<V@NB6A)]#:>5-X,&L1LX
MJW$8 5BP;;F^2U>$L6*XVVRB])E^WJF VS$C3%1CM96G8_(\RME3K;-UE&77
M*W8S=?H]SOKDK9*K^5HLYY9)*O^.K"PQ+TD3H=:<_<*R@MV=?J6_3DVRRB$D
MVE=;]^)-C^ORDR]ZTTL2^O!6AFV9;!_??%D8C,OB ,*YP(4&UKF:]9=U^Y_#
M@KQT9(>PUP""EL;T\+^,$WQ1_"G$_$"@#_26  RZ!QZ!(-VVJX'CO?B\^0U]
MI;\B]G,HT!T.T!"OHD$4BTV/S.O5690]?EJ3;]GI?<86Z11A5"+:1RM7% :W
MDBB $,SWH(%EGN+\[/KJX_G5[?E'='MW>G?^^?SJ[A9=?T)GI[=_1I\NK_]V
M&PC"9<,[Q+H:##H*(>#_4YQ$R2*.UC<DB]F#>&4>*%6&^2!1@<H+951@^2'S
MI)4G8@.M?/EP>GEZ=7:.;O]\?GX73I:H!Y^7+;J0,5$,(7O87<8C62]QFI7=
MESI]U#K#_)'I0"60.BZP#)*ZTDHAB05AS;GY<O[I_,L7]OOUV?^'3J^JO_Y\
M??GQ_,OM;]#Y__[+Q=W?T9N/YY\NSB[NIGY(;X097MII0\U(<_K$NXONUX-W
MLMR#_52J#L+D3,<34'+4-C6RH!1MWSBP7T*Y9^B.PQ">O''BBTP(N'X6#$ G
M$FB -Q1P!)_(HRL .79E(!R(S]N_%5Q:+7.4YVE\O\OI2-*M-6ZBM!C8J2$J
M'#6BOL[*RP8\OO"[0_)=F PV?>OR(2K$%SB<K<2M1E7TUH0K"#VR1C,5RI$M
MN#'-C<96,6^!I] ?VWO\$"=T)Y.#'&'!+ :N(/0(_VST5I7DT=IH;'\V'=N?
M?YC?42\HZY U+LGZS1*OXD6<3][X6HWSSP97+:"60GC'J'V;Z.W>T/<-H>5=
MH/C6SZ %05]KM<D;9I-[.\,;NM&A 3N/1.[&!B/-9&TA]_WQ&."@W=:T%0(B
MQ2N2XR]XB?&&9NU-X0NG*5XR0;9J./]C(%<[0DK5M@.<5H;Q0Q.ROGN37-2U
MRJ=SJCU#>WW4&"CGN<S*_3%FX7XSY(Q2"0'8 =[9VC2P]UQL3*+P@']:JGK8
M?@6N=F$SL!=8W6._WF[7<7Y&DJ?B4$R2+_13J<$>FY;JTBHG4_>0Y>IH?=0T
MJ5?35)88DU6P<E(FTYNAO29BJB$FN@:P%/FM#4U;(Z,"=(3JHW .AU1::[Y@
M^A,N'PVAC(JA]"6"T:C&R,V,"TBCY\GJ3Q-MW -"\D0"2?0FRE!$OZ>CWPP'
M][S2.T)UGVFKS4S;_)0[@'W<I?2CE/(%!_VZ,-M'>KWZ2Q+GPZG#-LKMQL=
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M^C ]LZ$4[=(1B2A$L"M; 4<_9&XFHWI<L:X3V^IV0!,8ZH[MPUL'!CH*WL
MS"+D/NRPT&8-M4"(<Q0 L%"3 ZF*/VCX(0-R7Y80F:WX]]+1:\T'0;VRQDM5
MP&O[=?6HR[W1U.5]2KI;X>72$,$[U1:X.J_P-!F[4MTZOS=@QZ5($!B?[.H^
MS#6QH:GC$R' Q5_IQAH@;0I0RU1[H ;& L"PHN8"*BVO>/'#")3N['$S&R\8
M)JY7:@ 8"DJ"H-("Y AI>HB2#U&.;ZGM&YQ])FGQV*<&2J&*$4B$W,)6Z1FB
M_LL<**)S7&4EKM, S#$2T8 SM&/W%H:MNO>(WK/6>FH>^AJLDLNMFW8UK]NB
ML]DMQ.XA>A-]/O7.EA5GJ;"/#H<NQ7(OQAU/"^\=+501W^B$5;E(&O-+URHW
M'$@JDU38=T$ZW](\?GY/.<IN9.1JH*(L5GT5#^@>;Y6W0C9P9PKYG@%%D4,1
M$T51)1LB_B68F(@&)9),%+WCR6^Q'/'E!B=U(45<&)T_=T 9%=VAJG]0S5*0
M1WPZ@LN@6/=S5Y#%&P1K)H5]J I7YKDOME/7YO\=\F(GO+*5_-$#IG^Q!NT^
M'Y(BWB<QWGPX=C[2YC,<UUNQWUQ^$\6;3R2[PVF4%E>[?4:>>(/[F[_-Z;)\
MNO.X=,H <SX5 )HS4W/EJ6>6!JQX.<SXE%SMAZ6KTA'/7"R=[=";*$=1=6OA
MK1]FC3"R!((7P&+PT0U%.F=KZ[+!S4BO8+LLO!M/J''%.3!WAAIOZ,.QO1\$
M*AVBZVVYA7*.F$]$G2+A%;7=OF8&W^A?!,SA9P?@T<-L;5XX2W0_!A9O]G0Y
MP:Y)&O='KMO:\:]^0\A&1&7BV+/$P5[X%2)QQ*V6+#P6>L:98WPL-I=KN+'<
M1Y+0II-,[!+^D&'NY"Z+TCSB:YAOLGB0@<R4RB>DJ^24%<U:!C"FT78H3TF:
M)E:M*VC/+BT;W(8@('9=9/6P9X 0%'$V\.:*($9>.Y*H%CU#;7#=/'=P27B?
MOO(<  /F7@9>G8$VF+TM6NC:8IRC0[JAC(>QFZBRLC!7\8RX<;Z@K^REXC_A
M\RQCYW\PKQ=QODY(?LBP9%=*<\5AY9]4A(HLS1:")>]I?UI1-65F58.$+[Y#
METF,?HV3Y,B7_WTDNWV4'H,))%V8C 63&<3,U6<"FAE/,$KC.IXA0,=XPY=_
M/W\)J)HF!AH&_*?JS]'W>'?87> GG) ]NW*+'PX)LWL\3S=?HP3GGV/ZGX*D
M^$:L"?YM3]+K/</5Y7<Z)HUSQ:#.H[.)D@#ES$MTPSX)V,&GGX::IP\@UZO2
M#MHTAGB)RVIK:%>9R?F=G)EN+M9KX0][MJB=FT>XM!]F+@..M,G\YR6RYW$9
M<'Q[F!GPU<JEPKLW$_&$4<L%JD*_Y00U7GBL<S^H=H1*3XBY0L(7NGR-=8_8
MGAFJ(<>[OXD:7ZU=+.Z'+\9V9; W<T76%3]7EOQPII>>0QZ8G,[RY#2PL=4M
M7N/XB377QV!J:!UR]-2VOGQZ'?[64,9'G99YSIPM7P CH*RV]@QRWT@PP"8[
M:;1Y\A%2S 4U9NDU:[:0 Q^5W+[&GR,:?8,KJ!@,<1S1:]Y\L>AYI-"4QN<P
M+I@S-CTR_ZX7_U3_!F<QV5QO+[_OX^SXB?;'152P%7C5.U9-4J]M9X*^:]CQ
MDK"TV^^1DNNTP3S[3%M="1&63C 70BPNZ[UWZM4I868)?>1-Y@-3$#M;6P;*
MOIFN7@,\(%G-7AN47[90?E&B_/P5Y4-\P'7W0DB?B4_J-<0'XH<<<:^7S,OE
MA^M.N$2-ZT YX:QQ8,;SM.SY9W2_[>D33(LO)+W%6]K)C$O>1$?!.QFY; XK
MG^!T!I8F6)V6)2\IPN W>&1V>JTPSP\Z=E>E$$I)^E-6B[$713P/9*5@F/%N
M@L')B#<'-("]I6#MF^7I-L$+JM5,KT+\ER[B2QOH]A7QHSB![/;%4#\3X]-M
MBA_T#UE?,R-XT$OW)\K_9H\.,PZH:1&2!>YV)/U:D/4_[_#WX@/5_>> WLE%
M:MXV)N(8PW*O($QKU+PJW$845N(JXI>7!KRBEXC.4]5X/N ]"D<R)+;-.E30
M@J9+T>_L%N+W%CZPWKY_I05Z7!2^C\%+JL2'85^77UA27W&&T:;^#J7<""+;
MY6?5!A%G*(T*=HO6Q_4C2];T4A8_/!;BW=@^BY_B!//+&_KG!J<;IDUO$5I=
M,[2+"I:0:/5,Z)B>[Q^_%CC+6:,6+Y;6V)*5MW%1R+J5YFP3B/2AGA[YC'?W
M.!L4KPFYNH))Y1P#8L(_2"V3^U#%A$QKU=P*9UI[JAN)]A/7?79^^AVNXJD<
M6'2[J'W#CD>_B_N+US]W!$@KH4+>$PK :Z+*D0T:ND/$.-VRPTG$OBDX*Z(X
M92#A9:R&3#C;$ ! 15;8%/)PU>T"WQ=7_ Q4[H%M1IL<RW%@_N4P4N<,-,H?
MI*7AA'Z#-@%403UO\E#0T5^)__.78W^PO91W0JR:'>&G$%$RF*[C/;V[3PZ4
M'Y8G7,4I_0$X7[B0FN"$6'2D>9?XAAA4P=5UY80P5H29&&KDSE I6<T_TX&%
M$'Z>2)(4:4U-[V@"+MRZ+MU0]:Z=N<0+_GAMDK30FS+3G2&:]S)ZD?TI-I1?
M^E@R;T <IP":FI!D8(O9>75WT??S/,=%3O_X2/\=%_P0/$K,OD79)K^E5(T^
MK<?S=--:*OH);W 6)0.V &>RIA,0)AW#%^Y7@1 2D.:H(A_ P:K\ V6E&)^U
M:B\++Z+O:,W-HG7;[M)1#PAAX@-"'L"P>'C D2F@MOB-#D''A!U$]9&P=,;_
M%L90Q]H9JNPA:K#]H=,9*FV^ALT4M+P@9?G0 6>.0&WR'$*4>XKMF-$]IAH8
M10EG/^4YN>S\7O$/=OT;V[\Y%Q\FE6''RD_$O*.H*++X_E#P]0@%H2*;P[J(
MV;\V9$=9*N6TQE5L<?(:;#S*Z"^,Z4#X\5<:8?V8AS,(P8U+@\OEK\XO6IH7
M5XWQE+2$^17_WXMBQ%W8PB22L5" ,[MP0 3!A)N6^(P'4!;,+;X&B@I0'O"Q
M=+"$Q'V;%GD-FEEX;VY7J$Z9]/H+0 ^$MS;LA>[^&D?W<1(7,<XOV+OZ=2PV
MP4\W%'E9$?^K$T%#=FNF/R2SNOI0V<>LO4J<_EFDFA0_L/5X6F15V[M66M&T
MMFK?Y/$=M6X'$\:&2!J+6BLP6EN9%Y(>R**!8T \#JA@2^T,#;!Z_J*Q.LWH
M].W,C%=_?,V@ 9"X;=A8GV.Q!6SXCP/F!*Q/M:B ^!/O]B2+LB/:Q%NJ+*0W
M...?0HDOY%6).AS"-1_Z)^F4OAU(]I2OLYCOB7J]_8*_G:_7#!5Q^G"3D93^
MN<;B13XI_H&+\PW94WIP0Y)X?91]'P5ILN98$"8=<P;<KP*9- 1ICBJE #A8
ML8_TTB(YHJL\9^MG&BNH:V;I?  (6>(#,AXZ?_%P@&.!0&WQ&PV"*]9V6.&E
MEN0A@:@Q=,0%*LVAWX5!%,PW>.&&C91JPIA>/G3 "2E0FSR'$*6MS0%9?/^E
M)GKV(CJZGV.D-,+:,FU7J'B,"O08Y>@>XQ3%HD11MHO2,O(BT8K%V6JP82;C
MM#"FX6CN)1VDK-G> E?IFNPP)=OL2&W*3NA3IY2;!P:;QSP4.:7;_X?<Y^?K
MXGI+#?UG>=IV+Y3A#)9/#L*@4UJ"^T4 ]!:D,?)<!&!^Q69[,O&V@;]^H!5]
M<Q"#Y$<L7@NN%_ZX!1"D!!XFX!V^,/RAZ"Q02WRBGU'9V@H29CCDF2'4M52^
M%C^46P,P<RPR6/%F%L]0:?,U5%20\H"0I<,%F,("M<AKV+SC>T.S/Z,'3E\S
MO"=9P3\LXC'$)F#Q]SU.<XS>W.,4;^/B1WJ37ESCG+\0?Y.P/RAU37_DHNM)
M=7IK?V!2]T<4[??)D3'A>H7HMOS>@;TZ/_"-[EO&>(&C)6V?8?;/\LX;RK_S
M'\4T+_WUE-@=F$E"J3=_"FRKC][$,=7,<,2:M<'B+_ZS^JY8AN 'N\>\H++K
M;/9X33O_('8*P5'&N#U_%,PW14?"IIQ)AN.'E%[*]N79YVC#/DAF6_CO(]H8
MKKT_9/DA8M2?J-/2PI0_T'0T3O=A# .2_23FYY=39^7IY:-;H4R)5<1<*N:6
M0">\0Y!HN0M%EI,IK?CEA<-BJLN([N/5?%!>NAB,**KLF_<P)W5)C/A-OE"Q
MO!W(CB?NG2^C4PIQ/P" ICXJ/Q9 T-WKI$%+U*!EZ<KICA))E5.( ]:NW3XA
M1XSY7F$W%%F/E"HQL1O:B>-E3%^CJF@Z&F[ UV\31)W3\J:( PW]%?LWJB3+
MW1 K6<0$%X:] 0J(13>9/W#?  *KHIJNG/##:^LX>#BPF&0H9=83DF3%5T_3
M.YJ@2[*F2S=4Z1;JR>2U=-'VA3E)*=?3A*OJ5^7LQT4Y]W&55LN^;O$33@^8
MG6YR*_9"O8FRXMB#L;5^^;,M])T"SKJ] &S QK<\"LVM->N!,R&Q;&C90X<X
M]Z9KO\R+02A"8><8$(*,;%S5\ZT7[?G6&INE*F*ZJ%1&7/OEP57"3*SLS Q9
M(];RA+-[ IHZ)RB,C;U!^A2O&:J-PO<O%*+C1,;*SLP0?0]+K.T: (G1]^U/
M)R3OM>HO*LH77$,,B\WP[Y/X01!VMFZ$O?BB>FR5&EM2(HZ9QME3O.;OT-:'
MO*#&,KXA_[?'>/W(/]:(-^5KMV8I6WTH#16, SJ9>I'0>0^'([@1P:^8'8!P
MO15?SO9";?QFV?S^3:=P'O<$P,('AN41V!-=77[':_ZZ.N$W^(M>?FM9[$HZ
MA:@?I?*A '8=%'D=L:K;<XQVBBOH>EON@W%*72:A@4,AR&X#GG8:L:[=?>7Y
M+WQC!#9OQ'9DP"CB*RW8DL;[*&&[,J#\$>.B/@"7W5D?:-Y,1;U*:7>4_V1+
M6]AJ$"8F8CEO@GGA2F0(C7'Z-12"*Q"?H^R?F"^?^4K38<:_"F2OGJ+\\?*/
M ZWF"9OSZT',3*G\+;I*3K W:YE6 2)%E,@+D+9#>7QHFEC=L9:@;9S2\(CI
M7WR7DH6_:#-$ K'K)ZLG/@..H*JA@3=7&+'JV4BB1E2LQ*#"J"7]G,$EJ</Z
MRG, #+AN&WAU!AJM\V^?-7[&B[6^,F 1C]-X=]C1$4VVCG-\D]&1_ W.OCY&
M&3[/R\6/U]M/49R)YOV-<:[K+1?HUW8(6U7)=[/E%F 0OP-@A.K:#D4<.EE>
ME>H(E_KL+ I*N_=T7)4S"4;)(_9/9H81ZBTUA';<4DG:V8>10GCA0 ?!+ &%
M#B0(E@L$,(;CW A/<<#Y4!D)E07$3; /AM#7*A)NFCA@AI"PA/Y6Q<'7UR@8
MQPTL#!:,!&@JYMP87Q$Q/*5^!UDJ%IZ1"2I*)!32U28XL_QK1O+\)B-KC#?Y
M)T+=IAMF(TZ.MYA]_\3X[DU6OMG@ZYW&::6#H2ZGM#($D3T<?@$<F[1KQ&3"
ML#%;5\\'ILS>*7)M_O)PU^BS5XA/.!/;Y^XK$^(8[B 2@@LR^]G '>7NYA;"
M.C!AM&V!#ZBWJ2)71S=ML+<LH,8$JFV(];"O6)?NFN1F<"F\^Z&%MBWQ@OLA
M(8SJA2D[Y^P?!A]<.B243-#2(!P-_$*?7Y0_7F=LB4KYCX^\2W.^^=+'IGN[
MS;A*"_*1['8D'2.%T&;+9P=GUBFI0/\Z /H(V"1YI@%SLFJTRFT89#F$'9A+
MV 845#<$3@D.;.(+5)[@$43@0'%1T/;XCQO&4TMU=)WQU?:H^G<WHEH6^SP5
M,:-(6 V!N88?41)6"VD^C*@"9KR@[9HANH9L."V#:VU?KA8FP2<07>,$&=(\
M(%WFQ]%?;R_B#*^I4LY]_#=)-K1=YQF^3/F/V-R1RX0*]%FQG79%?DVUW9**
M75LAJ*RQ9T5N,+2U$@K\3(M*Y:P,[4>AA=AK$5SJL:\J,--<.,HM@44<>]NM
MW^;$)QACM' +!D_._VJ 7C0 %<3NOUL O6P!]/+E 51&V<RMS I2: )FX1X.
MK"-TRC*Y+LVAY@:OA!&96X$G/G\C!<ZK5]82>C,JTR,Q/1F0*!OU"TA(^O:G
M0Z6KT<K=3^Q&L\PB#'R/]]L Q:KN54K"=S)T51\:-^SC5H6^WB)^JUEM=KJ]
M/%%.![(>>MI3:1PZ,>UQ59GKA7D@=<P* >J:-)"%JSS7NS2^/^17*5L;%3^Q
M;99^8=LLG:<;\[T.88R5C\#5F%.4P/P2@.KHW!!YP#F:9ELN_B)VQF,?E@:^
M 2,0- DL0$"[>D' 0S$%@%;XPCOC'J4%U#$A0H!]!7@B.TB&%0H2\N-N=,EP
M *93 *WQ%A8&>US^@D@90''E#.VK^L&HW>GND!E83(W327>C7GFG$:\TXHU>
MR^1LO,^!UW5XVZ"*A4G/3./#@E[-A0N/],B)_FC0F]"9BP-*])F'9V8Q+W-P
M8@8VE7^8;VI<A5>U7?"D776]5=6;Z,A/;KW>_I9N</:-;:.0/K C>=FZ\UR<
MC;&+<[;(H[\YD95N^4L-=9T"R*J= !79U*\\KLPLK=I":%-)<=*\;N26C20[
M\!"G/G7IG?D0"%7[S9T" 9 Q@TJ!O7;IP+'6J0ZD>GEPE- (8QLS0A*89)@[
MAX)FO2=B_HC(H=@FY!O_A&HOK+"71 >M[+DP$9D5K^,TQ=@&(&NISUR]WIZG
MZ2%*JMU_K])?V?]N\>" =R.=BJ7HZ;@%HDF[(%B)IC]%Q&E9Z!V,&W'!9GOM
M.$4)_X/M++IP+!DA@UAUG$T7^(<5&-70=N:(*DXM&EQ1<B%$47T\QE6*N#2Z
M?=:XDG$(7=T9L 7-&;2=NF*LY C[J?Q5'H]-64*3R9:F!3XA)Z$!NKJ@Y3\F
MFT\D^SL[,^%#Z>,J/[]GF_L/Z[Z&<%/PE<*N8:/1$I@2KW:DC!"5ZDK<;QU8
M<5\AGYU+$7&IQ4- I[^)6:\8/5^/* &LV%->;$%2UF@&$RJ"N SZ4)5D=$5'
M_L\.)O)R/*'D$RKP!7C*FS5DWHUD%G%$P2"[+%]A(7$CK:D32H#%M/.UYOE]
M7F31X$M)M5!5/"5";AA7>H8HEC('"C"/JZQ:FU'UOD/^R\*@57<?T7O86H_-
M0V>#U3RY==.^YC6NMX]#=>^4NUI6QZ3"/KH;NF[)O1AW^SNVX4>!HJ<H3@(X
M?LVQLR7%1RKLJ^BT]@YHMA2X93VJ+$/3:J.%2:4&".?IUH$7+Z5+7:PKC+2W
MB>(G%(:$?@TT2.)!&T>FRK.@R4]UG/#G#J:1"GK6WB;IK+V#TNU+ )M6[56K
MSP,XK_5YPB\ \-@J-/8'BO;[)!:?M?-#[SJ;"HUN)(3_.,3%,:BB[P6).L1
MK0Y*%7;Q8<=.;[W*\P,[L?!ZJ]P!W4"C(0C3&J[!I=LF&%J@X4T92Y/ZJU*H
M/IMX\:C0[G1BT2OFS]<W7@ +OY8K)[B4Y9X#AI^=70FR7!O4SMV^@"0O[SJ:
MWL$$7]2U7+J!:OBM_[Z7E 38XA;8PMH4VQO:I"5<1Q.R>K.WY,61K5\OV&=C
ME$'M&70N\R+>L=GLWW*\/22_TL[*[]B4RAW^7GQ(QJJZLZ6ZVCM8<@Q$Y]\
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MTGF'KCW'D  U'L VNB\0L$XCV:Z=F0&[S.<3O09  M?EDXJ0Q@QI_9-.8]@
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M%'VY*SMPZ!7]009Y+?HG%AJJHB_5@"[Z']Z>IYL/^N-]#?D. 5#* \2Y1GO
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M?]@GYSDK+?G>JWMFR;=LG^-MN6QGYM13+9J")%12@),7;ZM^_0%(R2(E@@1
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M=O7UIV\XG(%P4QWX?9N)])#QG4EU2G)\L*B8!ZC;3WHX)*<'FCA,_D=SB.7
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M#="L9X=CX88\WSB0Y@B"ND[0->%@EN=']86:DI:.X*2*6@VN]\L,+@@LZ.O
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M:@-6#&0F*!79@*)T6^-:49:1Y0,PBZA;X#Z*$OK\XG3^M"7D)<;^G\1>R7X
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M&_H?6F?U?___4$L! A0#%     @ 9H!L3U_-*/#F+P( 8*$A !$
M     ( !     &YX=&,M,C Q.3$Q,3(N>&UL4$L! A0#%     @ 9H!L3^H1
MCD?3%0  VQL! !$              ( !%3 " &YX=&,M,C Q.3$Q,3(N>'-D
M4$L! A0#%     @ 9H!L3^>9F\Z]$   D1(! !4              ( !%T8"
M &YX=&,M,C Q.3$Q,3)?8V%L+GAM;%!+ 0(4 Q0    ( &: ;$\:168V&3H
M /V !  5              "  0=7 @!N>'1C+3(P,3DQ,3$R7V1E9BYX;6Q0
M2P$"% ,4    " !F@&Q/W%A\$G>V   *#PP %0              @ %3D0(
M;GAT8RTR,#$Y,3$Q,E]L86(N>&UL4$L! A0#%     @ 9H!L3WZW9HLH90
MD1H) !4              ( !_4<# &YX=&,M,C Q.3$Q,3)?<')E+GAM;%!+
4!08     !@ & (H!  !8K0,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812551600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Summary of accrued liabilities</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Accrued liabilities consist of the following (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued construction in progress</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 515</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued payroll and related benefits</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,008</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 493</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued clinical trial costs</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 271</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued operating expenses</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 719</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 450</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued financing costs </font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 284</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued office lease</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 127</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 104</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accrued interest</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;2</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;2</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total accrued liabilities</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,411</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,564</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6831773152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (22,799,000)<span></span>
</td>
<td class="num">$ (15,469,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used) in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,677,000<span></span>
</td>
<td class="nump">582,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">263,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(19,000)<span></span>
</td>
<td class="num">(89,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,342,000<span></span>
</td>
<td class="nump">767,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">847,000<span></span>
</td>
<td class="nump">1,557,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred rent</a></td>
<td class="num">(44,000)<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty', window );">Deferred revenue from related party</a></td>
<td class="nump">26,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="nump">7,992,000<span></span>
</td>
<td class="num">(12,514,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(3,063,000)<span></span>
</td>
<td class="num">(8,652,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,063,000)<span></span>
</td>
<td class="num">(8,652,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of preferred stock, net of issuance costs</a></td>
<td class="nump">122,223,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payments of the term loan</a></td>
<td class="num">(400,000)<span></span>
</td>
<td class="num">(140,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred financing costs</a></td>
<td class="num">(410,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">121,417,000<span></span>
</td>
<td class="nump">24,860,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash (includes $3,750 of restricted cash in other assets)</a></td>
<td class="nump">126,346,000<span></span>
</td>
<td class="nump">3,694,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash-beginning of year</a></td>
<td class="nump">9,287,000<span></span>
</td>
<td class="nump">5,593,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash-end of period (includes $3,750 of restricted cash in other assets)</a></td>
<td class="nump">135,633,000<span></span>
</td>
<td class="nump">9,287,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosures of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchase of property and equipment included in accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 515,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Deferred financing costs included in accrued liabilities</a></td>
<td class="nump">$ 284,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income from related party and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6808352928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Cash and Cash Equivalents</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company considers all highly liquid investments with an original maturity of three&nbsp;months or less at the date of purchase to be cash equivalents. The Company deposits its cash primarily in checking, sweep account and money market accounts.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Restricted Cash</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The Company is required, as a condition of its Term Loan (Note 8), to maintain cash collateral on deposit in a segregated money market bank account equal to the principal portion of the Term Loan, as determined on a quarterly basis. The bank may restrict withdrawals or transfers by or on behalf of the Company that would violate this requirement. The required reserve totaled $5.0 million as of September 30, 2019. This amount is presented in part as restricted cash and in part as other assets on the accompanying balance sheet.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,935</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash (including $3,750 in other assets)</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,039</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 14,974</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Restricted Cash</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company is required to maintain cash collateral on deposit in a segregated money market bank account, as a condition of its Term Loan (Note&nbsp;8) equal to the principal portion on a quarterly basis. The bank may restrict withdrawals or transfers by, or on behalf of, the Company. The required reserve totaled $460,000 as of December&nbsp;31, 2018. This amount is presented as restricted cash on the accompanying balance sheet.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,427</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 860</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,287</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Concentration of Credit Risk</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Financial instruments that potentially expose the Company to concentrations of credit risk primarily consist of cash and cash equivalents. The Company maintains its cash and cash equivalents at one accredited financial institution in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Fair Value of Financial Instruments</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">ASC Topic 820, </font><font style="display:inline;font-style:italic;">Fair Value Measurement</font><font style="display:inline;"> (&#x201C;ASC 820&#x201D;), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company&#x2019;s own assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. ASC 820 identifies fair value as the exchange price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three&#8209;tier value hierarchy that distinguishes between the following:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level&nbsp;1&#x2014;Quoted market prices in active markets for identical assets or liabilities.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level&nbsp;2&#x2014;Inputs other than Level&nbsp;1 inputs that are either directly or indirectly observable, such as quoted market prices, interest rates and yield curves.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level&nbsp;3&#x2014;Unobservable inputs developed using estimates of assumptions developed by the Company, which reflect those that a market participant would use.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">To the extent the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair values requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized as Level&nbsp;3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Property and Equipment, Net</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment are recorded at cost. Depreciation is computed over the estimated useful lives of the related assets using the straight&#8209;line method. Leasehold improvements are amortized on a straight&#8209;line basis over the shorter of the useful life or term of the lease. Upon retirement or disposal, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is recorded to general and administrative expenses in the accompanying statement of operations and comprehensive loss. Routine expenditures for maintenance and repairs are expensed as incurred.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Estimated useful lives for property and equipment are as follows:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Estimated&nbsp;Useful&nbsp;Life</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computers and peripherals</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">3&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">5&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">7&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Lesser of estimated useful life or remaining lease term</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionContractorsPolicyPolicyTextBlock', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Construction in Progress</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Construction in progress (Note&nbsp;4) is carried at cost and consists of specifically identifiable direct and indirect development and construction costs. While under construction, costs of the property are included in construction in progress until the property is placed in service, at which time costs are transferred to the appropriate property and equipment account including, but not limited to, leasehold improvements or other such accounts.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long Lived Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Impairment of Long&#8209;Lived Assets</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company reviews the recoverability of its long&#8209;lived asset group when events or changes in circumstances occur that indicate that the carrying value of the asset group may not be recoverable. The assessment of possible impairment is based on the ability to recover the carrying value of the asset group from the expected future cash flows (undiscounted and without interest expense) of the related operations. If these cash flows are less than the carrying value of such asset group, an impairment loss for the difference between the estimated fair value and carrying value is recorded. There was no impairment loss recognized during the&nbsp;years ended December&nbsp;31, 2018 or 2017.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy', window );">Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Preferred Stock</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s preferred stock is classified outside of stockholders&#x2019; deficit because the shares contain deemed liquidation rights that are a contingent redemption feature not solely within the control of the Company.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Research and Development Costs</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Expenditures, including payroll, contractor expenses and supplies, for research and development of products are expensed as incurred. Development costs incurred by third parties are expensed as the contracted work is performed. Where contingent milestone payments are due to third parties under research and development arrangements, the milestone payment obligations are expensed when the milestone results are probable of being achieved.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Patent Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Patent Costs</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">All patent&#8209;related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses in the accompanying statement of operations and comprehensive loss.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;Based Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company accounts for its stock&#8209;based compensation in accordance with ASC Topic 718, </font><font style="display:inline;font-style:italic;">Compensation&#8209;Stock Compensation</font><font style="display:inline;"> (&#x201C;ASC 718&#x201D;). ASC 718 requires all share&#8209;based payments to employees, consultants and directors, including grants of incentive stock options, nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company, to be recognized as expense in the statement of operations and comprehensive loss based on their grant date fair values. The Company estimates the fair value of options granted using the Black&#8209;Scholes option pricing model (&#x201C;Black&#8209;Scholes&#x201D;) for stock option grants to both employees and non&#8209;employees and the fair value of common stock to determine the fair value of restricted stock.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company recognizes forfeitures as they occur as allowed by ASU No.&nbsp;2016&#8209;09, </font><font style="display:inline;font-style:italic;">Improvements to Employee Share&#8209;Based Payment Accounting</font><font style="display:inline;"> (&#x201C;ASU&nbsp;2016&#8209;09&#x201D;).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Black&#8209;Scholes option pricing model requires inputs based on certain subjective assumptions, including (i)&nbsp;the expected stock price volatility, (ii)&nbsp;the expected term of the award, (iii)&nbsp;the risk&#8209;free interest rate and (iv)&nbsp;expected dividends. Due to the lack of a public market for the Company&#x2019;s common stock and lack of company&#8209;specific historical and implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with expected term assumption. The Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No.&nbsp;107, Share&#8209;Based Payment, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the Company does not expect substantially different exercise or post&#8209;vesting termination behavior among its employee population. For options granted to non&#8209;employees, the Company utilizes the simplified method also as the basis for the expected term assumption. The risk&#8209;free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">There are significant judgments and estimates inherent in the determination of the fair value of the Company&#x2019;s common stock. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of preferred stock, the superior rights and preferences of securities senior to its common stock at the time of, and the likelihood of, achieving a liquidity event, such as an initial public offering or sale.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company expenses the fair value of its share&#8209;based compensation awards on a straight&#8209;line basis over the requisite service period, which is generally the vesting period.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Income Taxes</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities, which relate primarily to the carrying amount of the Company&#x2019;s property and equipment and its net operating loss carryforwards, are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, the Company concludes that it is more&#8209;likely&#8209;than&#8209;not that the deferred tax assets will not be realized. In evaluating its ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction&#8209;by&#8209;jurisdiction basis. Because of the uncertainty of the realization of deferred tax assets, the Company has recorded a full valuation allowance against its deferred tax assets.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Reserves are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more&#8209;likely&#8209;than&#8209;not to be sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the provision of income taxes; however, the Company currently has no interest or penalties related to uncertain income tax benefits.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Revenue Recognition</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has adopted Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (&#x201C;ASC 606&#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect consideration to which it is entitled in exchange for the goods or services it transfers to the customer.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral to or dependent on other goods or services in the contract.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration that is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&#x2019;s control or the licensee&#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur and (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying condensed balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Revenue Recognition</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has adopted ASC Topic 606, Revenue from Contracts with Customers (&#x201C;ASC 606&#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral or dependent to other goods or services in the contract.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration which is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&#x2019;s control or the licensee&#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related&nbsp;revenue recognition.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Comprehensive Loss</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company did not have any other comprehensive income or loss for any of the periods presented and, therefore, comprehensive loss did not differ from net loss.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Net Loss per Share</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two&#8209;class method required for participating securities. The Company considers its Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock to be participating securities because in the event a dividend is paid on common stock, the holders of Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock would be entitled to receive dividends on a basis consistent with the common stockholders. Under the two&#8209;class method, the net loss attributable to common stockholders is not allocated to the preferred stock as the holders of the preferred stock do not have a contractual obligation to share in losses.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Under the two&#8209;class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Recently Adopted Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In March&nbsp;2016, the FASB issued ASU&nbsp;No.&nbsp;2016&#8209;08, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers (Topic&nbsp;606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;08&#x201D;), which clarified the revenue recognition implementation guidance on principal versus agent considerations. In April&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;10, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;10&#x201D;), which clarified the revenue recognition guidance regarding the identification of performance obligations and the licensing implementation. In May&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;12, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers (Topic 606): Narrow&#8209;Scope Improvements and Practical Expedients</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;12&#x201D;), which narrowly amended the revenue recognition guidance regarding collectability, noncash consideration, presentation of sales tax and transition. ASU No.&nbsp;2016&#8209;08, ASU No.&nbsp;2016&#8209;10 and ASU 2016&#8209;12 are effective during the same period as ASU No.&nbsp;2014&#8209;09, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2014&#8209;09&#x201D;), which is effective for the Company for fiscal&nbsp;years beginning after December 15, 2018 and interim periods within fiscal&nbsp;years beginning after December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016&#8209;08, ASU 2016&#8209;10, ASU&nbsp;2016&#8209;12 and ASU&nbsp;2014&#8209;09 as of January 1, 2018 on a retrospective basis. There was no revenue in previous years and the adoption of ASC 606 did not have any impact on prior year financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In August&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;15, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;15&#x201D;). ASU 2016&#8209;15 eliminates the diversity in practice related to the classification of certain cash receipts and payments for debt prepayment or extinguishment costs, the maturing of a zero-coupon bond, the settlement of contingent liabilities arising from a business combination, proceeds from insurance settlements, distributions from certain equity method investees and beneficial interests obtained in a financial asset securitization. ASU 2016&#8209;15 designates the appropriate cash flow classification, including requirements to allocate certain components of these cash receipts and payments among operating, investing and financing activities. The retrospective transition method, requiring adjustment to all comparative periods presented, is required unless it is impracticable for some of the amendments, in which case those amendments would be prospectively applied as of the earliest date practicable. ASU 2016&#8209;15 is effective for the Company for fiscal&nbsp;years beginning after December 15, 2018 and interim periods within fiscal&nbsp;years beginning after December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016-15 as of January 1, 2018.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In November&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;18, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Statement of Cash Flows (Topic 230): Restricted Cash</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;18&#x201D;), which requires that a statement of cash flows explain the change during the period in the total cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning and ending balances shown on the statement of cash flows. The guidance is effective for the Company for fiscal&nbsp;years beginning after December 15, 2018 and interim periods within fiscal years beginning after December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU&nbsp;2016&#8209;18 as of January&nbsp;1, 2017.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In May&nbsp;2017, the FASB issued ASU No.&nbsp;2017&#8209;09, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Compensation&#x2014;Stock Compensation (Topic 718): Scope of Modification Accounting</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2017&#8209;09&#x201D;), which clarifies when to account for a change to the terms or conditions of a share&#8209;based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions of the agreement. The standard is effective for fiscal&nbsp;years, and interim periods within those&nbsp;years, beginning after December&nbsp;15, 2017. The Company adopted ASU 2017&#8209;09 as of the required effective date of January&nbsp;1, 2018. In June&nbsp;2018, the FASB issued ASU No.&nbsp;2018&#8209;07</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"> Compensation&#x2014;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU No.&nbsp;2018&#8209;07&#x201D;). ASU No.&nbsp;2018&#8209;07 expands the guidance in ASC718 to include share-based payments for goods and services to non-employees and generally aligns it with the guidance for share-based payments to employees. The amendments are effective for the Company for fiscal&nbsp;years beginning after December&nbsp;15, 2019 and interim periods within fiscal years beginning after December 15, 2020, with early adoption permitted for entities that have adopted ASC 606. The Company adopted this new standard on January&nbsp;1, 2018.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Recently Issued Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">The Company qualifies as an emerging growth company (&#x201C;EGC&#x201D;) as defined under the Jumpstart Our Business Startups Act (the &#x201C;JOBS Act&#x201D;). Using exemptions provided under the JOBS Act provided to EGCs, the Company has elected to defer compliance with new or revised financial accounting standards until it is required to comply with such standards. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In February 2016, the FASB issued ASU No. 2016-02, Leases (&#x201C;ASU 2016-02&#x201D;). The new guidance will require lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016-02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right-to-use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company January 1, 2020.The Company continues to determine if it will elect to use the practical expedients permitted by the guidance and continues to gather data required to comply with the guidance. Based on the work completed to date, the Company is considering the implications of adopting the new standard, including the discount rate to be used in valuing new and existing leases and all applicable financial statement disclosures required by the new guidance. The Company is continuing to evaluate the effect of adoption and anticipates that it will result in the recognition of additional assets and corresponding liabilities related to the existing leases on its balance sheet. The Company is assessing any potential impacts on its internal controls, business processes, and accounting policies related to both the implementation of, and ongoing compliance with, the new guidance.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (&#x201C;ASU 2016-13&#x201D;). ASU 2016-13 will require credit losses to be reported using an expected losses model rather than the incurred losses model that is currently used, and will require additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard will require allowances to be recorded instead of reducing the amortized cost of the investment. ASU 2016-13 will be effective for non-emerging growth companies for fiscal years beginning December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2016-13 will have on its financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement&#x2014;Disclosure Framework-Changes to the Disclosure Requirement for Fair Value Measurement (&#x201C;ASU 2018-13&#x201D;). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements in ASC 820, Fair Value Measurement, based on the concepts in the FASB Concepts Statement, including the consideration of costs and benefits. ASU 2018-13 will be effective for all companies for fiscal periods beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2018-13 will have on its financial statements.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In November 2018, the FASB issued ASU No. 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 (&#x201C;ASU 2018-18&#x201D;). ASU 2018-18 clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, all the guidance in Topic 606 should be applied, including recognition, measurement, presentation and disclosure requirements. The amendment also adds unit of account guidance in Topic 808 to align with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of the arrangement is within the scope of Topic 606. Lastly, ASU 2018-18 provides that in a transaction with a collaborative arrangement participant that is not directly related to sales to third parties, presenting the transaction together with revenue recognized under Topic 606 will be precluded if the collaborative arrangement participant is not a customer. ASU 2018-18 will be effective for non-emerging growth companies for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020 and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating these clarifications for the accounting and presentation for its collaborative arrangements within the scope of Topic 808, but does not expect that the adoption of ASU 2018-18 will have any impact.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Recently Issued Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In February&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;02, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Leases</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;02&#x201D;). The new guidance requires lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016&#8209;02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right&#8209;to&#8209;use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company for fiscal&nbsp;years beginning after December 15, 2019 and interim periods fiscal&nbsp;years beginning after December&nbsp;15, 2020. Early adoption </font><font style="display:inline;">is permitted. The Company is currently evaluating the effect of this standard on its financial statements.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_DescriptionOfNewAccountingPronouncementsNotYetAdoptedPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionContractorsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for construction contractors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 235<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471482&amp;loc=d3e48989-109352<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionContractorsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32247-109318<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32280-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6403650&amp;loc=d3e20905-112640<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6833034608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEETS - (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>May 13, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, number of shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, number of shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">158,745,671<span></span>
</td>
<td class="nump">84,045,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,560,569<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, number of shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,181,819<span></span>
</td>
<td class="nump">64,545,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,181,819<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,181,819<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, number of shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,852<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6659089696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">10. Income Taxes</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;">The Company did not record a provision or benefit for income taxes during the nine months ended September 30, 2019.&nbsp;&nbsp;The Company continues to maintain a full valuation allowance against its deferred tax assets.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;">The Company has evaluated the positive and negative evidence involving its ability to realize its deferred tax assets.&nbsp;&nbsp;Management has considered the Company&#x2019;s history of cumulative net losses incurred since inception and its lack of any commercially ready products.&nbsp;&nbsp;It has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Management reevaluates the positive and negative evidence at each reporting period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;">Under the provisions of Sections&nbsp;382 and 383 of the Internal Revenue Code, certain substantial changes in the Company&#x2019;s ownership may have limited, or may limit in the future, the amount of net operating loss and research and development credit carryforwards that can be used to reduce future income taxes. <a name="_Hlk512945225"></a></font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">13. Income Taxes</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">2017 U.S. Tax Reform</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On December&nbsp;22, 2017, the U.S. government signed into law the Tax Cuts and Jobs Act (the &#x201C;Tax Act&#x201D;) that significantly reforms the Internal Revenue Code of 1986, as amended. The Tax Act, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%, effective as of January&nbsp;1, 2018; limitation of the tax deduction for interest expense; limitation of the deduction for net operating losses to 80% of annual taxable income and elimination of net operating loss carrybacks, in each case, for losses arising in taxable years beginning after December&nbsp;31, 2017 (though any such tax losses may be carried forward indefinitely); and modifying or repealing many business deductions and credits, including reducing the business tax credit for certain clinical testing expenses incurred in the testing of certain drugs for rare diseases or conditions generally referred to as &#x201C;orphan drugs&#x201D;.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In 2018, the Company finished its analysis of the impact of the Tax Act. Where the Company made reasonable estimates in 2017 of the effects related to the Tax Act, the Company recorded provisional amounts. After the completed analysis, the resulting impact to the Company&#x2019;s financial statements did not differ from the recorded provisional amounts.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Income Taxes</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The reconciliation of federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:21.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected income tax benefit at the federal statutory rate</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 21.0</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 34.0</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">State taxes, net of federal benefit</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.5</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.5</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development credit, net</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.2</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.7</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-deductible items</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2.2)</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (5.3)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Prior year provision to return adjustments</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (7.7)</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.1</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Tax rate reduction due to the Tax Act</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (15.6)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.3</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2.9)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Change in valuation allowance</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (25.1)</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (25.5)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The principal components of the Company&#x2019;s deferred tax assets consisted of the following as of December&nbsp;31, 2018 and 2017 (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred tax assets:</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Federal and state net operating loss carryforwards</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,946</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,176</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development tax credits</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,393</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,283</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Charitable contribution carryforwards</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 165</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 153</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accruals</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 290</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 23</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;4</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Gross deferred tax assets</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 15,817</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,751</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: valuation allowance</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (15,525)</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (7,491)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total deferred tax assets</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 292</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 260</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred tax liabilities:</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (292)</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (260)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Gross deferred tax liabilities</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (292)</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (260)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net deferred tax assets</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Based on the Company&#x2019;s history of losses, the Company recorded a full valuation allowance against its deferred tax assets as of December&nbsp;31, 2018. The Company increased its valuation allowance by approximately $8.0&nbsp;million for the&nbsp;year ended December&nbsp;31, 2018. The Company intends to maintain a valuation allowance until sufficient positive evidence exists to support a reversal of the allowance.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">As of December&nbsp;31, 2018, the Company had federal and state net operating loss carryforwards of $43.5&nbsp;million and $43.0&nbsp;million, respectively, some of which begin to expire in the&nbsp;year ending December&nbsp;31, 2036. Approximately $20.8 million of the federal and state net operating loss carryforwards do not expire. The Company had federal and state research and development tax credit carryforwards of approximately $2.5 million and $1.1&nbsp;million, respectively, as of December&nbsp;31, 2018. The federal credits begin to expire in the&nbsp;year ending December&nbsp;31, 2036 and the state credits begin to expire in the&nbsp;year ending December&nbsp;31, 2024.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Under the provisions of Sections&nbsp;382 and 383 of the Internal Revenue Code (the &#x201C;IRC&#x201D;), net operating loss and credit carryforwards and other tax attributes may be subject to limitation if there has been a significant change in ownership of the Company, as defined by the IRC. Future owner or equity shifts, including an initial public offering, could result in limitations on net operating loss and credit carryforwards.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company files income tax returns in the U.S. federal jurisdiction as well as in Maryland. The tax&nbsp;years 2015 to 2017 remain open to examination by the major jurisdictions in which the Company are subject to tax. Fiscal&nbsp;years outside the normal statute of limitation remain open to audit by tax authorities due to tax attributes generated in those early&nbsp;years, which have been carried forward and may be audited in subsequent&nbsp;years when utilized.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company evaluates tax positions for recognition using a more&#8209;likely&#8209;than&#8209;not recognition threshold, and those tax positions eligible for recognition are measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon the effective settlement with a taxing authority that has full knowledge of all relevant information. As of December&nbsp;31, 2018, the Company had no unrecognized income tax benefits that would affect the Company&#x2019;s effective tax rate if recognized.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6817995808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreement with Eli Lilly and Company (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 02, 2018 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Equity investment</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">$ 122,223<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,583<span></span>
</td>
<td class="nump">$ 4,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember', window );">Lilly Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement', window );">Period of expiry from date of agreement</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived', window );">Upfront non-refundable payment received</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Equity investment</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RevenueRecognitionNumberOfPerformanceObligations', window );">The number of performance obligations. | item</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember', window );">Lilly Agreement | Lilly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable', window );">Maximum development and regulatory milestones and sales milestone receivable</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise', window );">Maximum development and regulatory milestones and sales milestone payable upon option exercise</a></td>
<td class="nump">$ 710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PremiumFromIssuanceOfPreferredStock', window );">Premium received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of development and regulatory milestones and sales milestones payable upon option exercise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of development and regulatory milestones and sales milestones receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the period of expiry from date of agreement under collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of upfront non-refundable payment received under collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PremiumFromIssuanceOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the premium received from issuance of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PremiumFromIssuanceOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RevenueRecognitionNumberOfPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of performance obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RevenueRecognitionNumberOfPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130531-203044<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130532-203044<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nxtc_EliLillyAndCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nxtc_EliLillyAndCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6835274000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Term Loan - Maturities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Future maturities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2020</a></td>
<td class="nump">$ 1,528,000<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of term loan</a></td>
<td class="num">(1,250,000)<span></span>
</td>
<td class="num">(387,000)<span></span>
</td>
<td class="num">$ (400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, net of current portion</a></td>
<td class="nump">$ 3,750,000<span></span>
</td>
<td class="nump">$ 73,000<span></span>
</td>
<td class="nump">$ 460,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>58
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MH:<,HA; ^F5B/$U#!U?  B-,+G\7T*S$4OT36SK SLDIVS4UCF,];DINWD'
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MK=BX*<L.H7>C(+_[,41/!5,;]&'-&-2,;<W8T(P'1N@T#!$]#0340&P-Q-!
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MXA.F-FQ4O35 7]^^996TWM^^/254@*);8!2!3B$0%0(:A4DI *T1*%#P<81
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MDK:/K\WFT/]_\O7[X=ALAZNTH6Q7?Y^^KG?]UY?37ZP=FN$&<F@@SPUT-=I
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M%8-C58YCQ>!8%=0P%,6QM K,8E87A\0P6^4K&>\51;9*Z7*J=@)E$%+2\.^
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M'0"J97IC(="2$+*E #BM*ZGIR>T>2-N3FW4@EP%2X;P)_"DO,/@/"/_IS85
M@=V:C=#.,F83& B'\D?L X/60-%*]GD A19T>RROBT-BJ!K 38&T<!' 4S^
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ML@=A5VJI.#4V5 W1O0):>1)G)(ZB6\)I)W"1^=Q)%9D<#.L$G!32 ^=4_3T
MDV..-_@M\=0UK7$)4F0];> GF%_]2=F(S"I5QT'H3@JDH,[Q_69_3!W> YX[
M&/5BCEPE9RE?7/"MRG'D# &#TC@%:H<+'($Q)V1M_ F:>-[2$9?S-_5'7[NM
MY4PU'"7[W56FS?$=1A74=&#F28Y?(=2SQ2@4_QTNP"S<.;%[E))I_T7EH(WD
M0<5:X?1U&COAQW%:2;\$VCHA#H1X)MQ%GQ*20$BN"&1RYDM]H(86F9(C4M-E
M]=2]B<T^L8=9NJ0_.[]FJ]4V>RDVVS0C%R<4,(<)$R\Q[Q''CXA=/$.(-3"[
MB-=<'.(/_/AJAQ5$LKY#LEIGXOG)NSJWZP+IJD#J!=)/#VH-<WM5R!IF=V6$
M+&Z/@VK\0]>HE(/P3;;(SKUT'_O;_P^?&O$'54TG-#I+8]^0O^E:2@/62G1C
M7W=K>W\.&-3&37=VKJ8.F (C^]#<9/[#%/\ 4$L#!!0    ( &: ;$\:5&TX
MS0$  &T$   8    >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL?531;J0@%/T5
MP@<4!VT[.U&3SFPVW62;3+K9W6=&KTH*8@'']N\7T+IVZO9%N)=S#N<"UW10
M^LDT !:]2-&:##?6=CM"3-& 9.9*=="ZE4IIR:P+=4U,IX&5@20%H5%T0R3C
M+<[3D#OJ/%6]%;R%HT:FEY+IUST(-61X@]\2C[QNK$^0/.U8#3_!_NJ.VD5D
M5BFYA-9PU2(-58;O-KM#XO$!\)O#8!9SY"LY*?7D@^]EAB-O" 04UBLP-YSA
M $)X(6?C>=+$\Y:>N)R_J7\+M;M:3LS 08D_O+1-AK<8E5"Q7MA'-=S#5,\U
M1E/Q/^ ,PL&]$[='H80)7U3TQBHYJ3@KDKV,(V_#.(PK23S1U@ET(M"9L(T^
M)<03(;X@D-%9*/4KLRQ/M1J0'B^K8_Y-;':Q.\S")\/9A357K7'9<[ZYWJ;D
M[(4FS'[$T"7F/>+P$7%+9PAQ!F87=,W%GG[@TXL=5A#Q^@[Q:IUQX,?_J?.=
M0+(JD 2!Y-.#6L-\N2AD!7,371@AB]N3H.OPT TJ5-^&)EMDYUZZH^'V_\''
M1GQ@NN:M02=EW1L*-UTI9<%9B:[<ZVY<[\^!@,KZZ:V;Z[$#QL"J;FIN,O]A
M\K]02P,$%     @ 9H!L3V8*?!C+ 0  ;00  !D   !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL?53;;MP@$/T5Q <$7S:;:&5;RFX5M5(CK1*U?6;M\47A
MX@)>)W\?P,1U-FY>##.<<Y@#C+-1JF?= ACTPIG0.6Z-Z7>$Z+(%3O65[$'8
ME5HJ3HT-54-TKX!6GL092:)H2SCM!"XRGSNJ(I.#89V HT)ZX)RJUSTP.>8X
MQN^)QZYIC4N0(NMI T]@?O5'92,RJU0=!Z$[*9"".L=W\>ZP<7@/^-W!J!=S
MY)R<I'QVP8\JQY$K"!B4QBE0.YSA (PY(5O&WZ")YRT=<3E_5[_WWJV7$]5P
MD.Q/5YDVQ[<855#3@9E'.7Z'X.<:HV#^)YR!6;BKQ.Y12J;]%Y6#-I('%5L*
MIR_3V D_CM-*N@VT=4(2",E,N(V^)*2!D%X0R%29M_J-&EID2HY(39?54_<F
MXEUJ#[-T27]V?LVZU39[+N)MG)&S$PJ8_81)EIB/B,-GQ$TR0X@M8*XB6:MB
MGWSB)Q<[K"#2]1W259^IYZ?_\?E!8+,JL/$"FR\/:@US:60-<^F$+&Z/@VK\
M0]>HE(/P3;;(SKUTE_C;_P>?&O&!JJ83&IVDL6_(WW0MI0%;2G1E7W=K>W\.
M&-3&36_L7$T=, 5&]J&YR?R'*=X 4$L#!!0    ( &: ;$^>!5,=S $  &T$
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;'U4[6[;(!1]%<0#% >[
M:139EII4U29M4M1IVV]B7W^H8#S <??V TQ=-_7ZQW OYQS.!:[34:IGW0 8
M]")XIS/<&-/O"=%% X+I&]E#9U<JJ00S-E0UT;T"5GJ2X(1&T98(UG8X3WWN
MI/)4#H:W'9P4TH,03/T] )=CAC?X-?'4UHUQ"9*G/:OA!YB?_4G9B,PJ92N@
MTZWLD((JP_>;_3%Q> _XU<*H%W/D*CE+^>R"KV6&(V<(.!3&*3 [7. (G#LA
M:^-/T,3SEHZXG+^J/_K:;2UGIN$H^>^V-$V&=QB54+&!FR<Y?H%0SRU&H?AO
M< %NX<Z)W:.07/LO*@9MI @JUHI@+]/8=GX<IQ6Z"[1U @T$.A-VT:>$.!#B
M*P*9G/E2'YAA>:KDB-1T63US;V*SC^UA%B[IS\ZOV6JUS5[RS39)R<4)!<QA
MPM EYCWB^!%Q1V<(L09F%W3-Q8%^X-.K'580\?H.\6J=L>?'_ZGSG4"R*I!X
M@>33@UK#W%X5LH;97ADAB]L3H&K_T#4JY-#Y)EMDYUZZI_[VW^!3(WYGJFX[
MC<[2V#?D;[J2TH"U$MW8U]W8WI\##I5QTSL[5U,'3(&1?6AN,O]A\G]02P,$
M%     @ 9H!L3W]DP/RV 0  U ,  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3(N>&UL?5-;;MLP$+P*P0.$-NW&AB$)B!,4+=  1H*VW[2T>B!\J"1E);?/
MDI)5M57S(W)7,[.SY#+IC7UQ-8 GKTIJE]+:^_; F,MK4,+=F!8T_BF-5<)C
M:"OF6@NBB"0E&5^M;ID2C:99$G,GFR6F\[+1<++$=4H)^W8$:?J4KNDU\=14
MM0\)EB6MJ. 9_/?V9#%BDTK1*-"N,9I8*%-ZMSX<MP$? 3\:Z-UL3T(G9V->
M0O"U2.DJ& ()N0\* I<+W(.400AM_!HUZ50R$.?[J_KGV#OV<A8.[HW\V12^
M3NF>D@)*T4G_9/HO,/;SB9*Q^6]P 8GPX 1KY$:Z^"5YY[Q1HPI:4>)U6!L=
MUW[XPZ^T90(?"7PB[".!#86B\P?A1998TQ,[G'TKPA6O#QS/)@_)>!3Q'YIW
MF+UDZ]M=PBY!:,0<!PR?879\@C"4GVKPI1I'_@^?;Y;YFT6/F\C?_,?C'P+;
M18%M%-A^V.029O]7$38[506VBO/D2&XZ'6=YEIU&]H['6_D-'^;]4=BJT8Z<
MC<>[C3=0&N,!K:QN<(AJ?&)3(*'T8;O#O1T&;0B\:<<WQ*:'G+T#4$L#!!0
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M=JZF#I@"(_O0W&3^PQ3_ %!+ P04    " !F@&Q/+X'<%,D!  !M!   &0
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M4A:<E<V5>]V-Z_TYX%!9/[UU<SUVP!A8U4W-3>8_3/8/4$L#!!0    ( &:
M;$\ CZU-R@$  &T$   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;'U4
M[6[;(!1]%<0#E 2G3179EII4U29M4M1IVV]B7W^H?'B X^[M!YBX;NKUC^%>
MSCF<"URG@](OI@&PZ%5P:3+<6-OM"#%% X*9&]6!="N5TH)9%^J:F$X#*P-)
M<$)7JSLB6"MQGH;<4>>IZBUO)1PU,KT03/_= U=#AM?XDGANZ\;Z!,G3CM7P
M ^S/[JA=1":5LA4@3:LDTE!E^&&].VP\/@!^M3"8V1SY2DY*O?C@:YGAE3<$
M' KK%9@;SG  SKV0L_$G:N)I2T^<SR_J3Z%V5\N)&3@H_KLM;9/A>XQ*J%C/
M[;,:OD"LYQ:C6/PW. -W<._$[5$H;L(7%;VQ2D059T6PUW%L91B'N'*A+1-H
M)-")</\Y(8F$Y(I 1F>AU$=F69YJ-2 ]7E;'_)M8[Q)WF(5/AK,+:ZY:X[+G
M?+V]3<G9"T7,?L30.>8]XO 1L:43A#@#DPNZY&)//_#IU0X+B&1YAV2QSB3P
MD__4^4Y@LRBP"0*;3P]J"7-W5<@29GMEA,QN3X"NPT,WJ%"]#$TVRTZ]]$##
M[;_!QT;\SG3=2H-.RKHW%&ZZ4LJ"L[*Z<:^[<;T_!1PJZZ=;-]=C!XR!55UL
M;C+]8?)_4$L#!!0    ( &: ;$]*HY)?MP$  -0#   9    >&PO=V]R:W-H
M965T<R]S:&5E=#$V+GAM;'U3[6[<(!!\%<0#!!]W[5U/MJ5<JBJ56NF4JLEO
MSE[;*'PX@,_IVQ<P<=S6ZA_#KF=F9V')1VV>;0?@T*L4RA:X<ZX_$F*K#B2S
M-[H'Y?\TVDCF?&A:8GL#K(XD*0C-LH]$,JYPF<?<V92Y'IS@"LX&V4%*9GZ=
M0.BQP!O\EGC@;>="@I1YSUKX >YG?S8^(K-*S24HR[5"!IH"WVZ.IUW 1\ C
MA]$N]BAT<M'Z.01?ZP)GP1 (J%Q08'ZYPAT($82\C9>DB>>2@;C<OZE_B;W[
M7B[,PIT63[QV78$/&-70L$&X!SW>0^KG T:I^6]P!>'AP8FO46EAXQ=5@W5:
M)A5O1;+7:>4JKF/ZLT^T=0)-!#H3#K$.F0I%YY^98V5N](C,=/8]"U>\.5)_
M-E5(QJ.(_[QYZ[/7<K,_Y.0:A!+F-&'H K.G,X1X^;D&7:MQHO_PZ7:=OUWU
MN(W\[1\>/ZT+[%8%=E%@]]\F5S"'[*\B9'&J$DP;Y\FB2@\JSO(B.X_L+8VW
M\@Z?YOT[,RU7%EVT\W<;;Z#1VH&WDMWX(>K\$YL# 8T+V[W?FVG0IL#I/KTA
M,C_D\C=02P,$%     @ 9H!L3[K!=LNV 0  T@,  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL?5/;;MP@$/T5Q <$FW62[<JVE$T4M5(KK5(U?6;M
ML8T"Q@6\3O^^@(EK)59>@!G..7-AR">E7TP'8-&K%+TI<&?M<"#$5!U(9J[4
M +V[:926S#I3M\0,&E@=2%(0FB0W1#+>XS(/OI,N<S5:P7LX:61&*9G^>P2A
MI@*G^,WQQ-O.>@<I\X&U\!/LK^&DG446E9I+Z U7/=+0%/@N/1PSCP^ 9PZ3
M69V1K^2LU(LWOM4%3GQ"(*"R7H&Y[0+W((07<FG\B9IX">F)Z_.;^F.HW=5R
M9@;NE?C-:]L5>(]1#0T;A7U2TU>(]5QC%(O_#A<0#NXS<3$J)4Q8434:JV14
M<:E(]CKOO _[%&^R2-LFT$B@"V$?XI Y4,C\@5E6YEI-2,^]'YA_XO1 76\J
M[PRM"'<N>>.\E_)+DI.+UXF0XPRA*\@M72#$J2\AZ%:((_W I[MM_FXSQ5W@
M[U;\=)]N"V2; ED0R#ZK\2,DW;\ODJQZ*D&W89H,JM38ATE>>9>!O:/A3?[#
MYVG_P73+>X/.RKJ7#?UOE++@4DFNW AU[H,MAH#&^N.M.^MYS&;#JB'^(+)\
MX_(?4$L#!!0    ( &: ;$]H1XYBS $  &T$   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;'U4[6[;(!1]%<0#% <[;139EII,TR9M4M1JVV]B7W^H
M8%S <??V!4P]-_7ZQW OYQS.!:[34:HGW0 8]")XIS/<&-/O"=%% X+I&]E#
M9U<JJ00S-E0UT;T"5GJ2X(1&T2T1K.UPGOK<2>6I' QO.S@II <AF/I[ "['
M#&_P6^*AK1OC$B1/>U;#(YA?_4G9B,PJ92N@TZWLD((JP_>;_3%Q> _XW<*H
M%W/D*CE+^>2"[V6&(V<(.!3&*3 [7. (G#LA:^,Y:.)Y2T=<SM_4O_K:;2UG
MIN$H^9^V-$V&=QB54+&!FP<Y?H-0SQ:C4/P/N "W<.?$[E%(KOT7%8,V4@05
M:T6PEVEL.S^.TPK=!MHZ@08"G0F[Z%-"' CQ%8%,SGRI7YAA>:KDB-1T63US
M;V*SC^UA%B[IS\ZOV6JUS5[RS2Y.R<4)!<QAPM EYCWB^!%Q1V<(L09F%W3-
MQ8%^X-.K'580\?H.\6J=L>?'_ZGSG4"R*I!X@>33@UK#)%>%K&&V5T;(XO8$
MJ-H_=(T*.72^R1;9N9?NJ;_]?_"I$7\R5;>=1F=I[!OR-UU):<!:B6[LZVYL
M[\\!A\JXZ9V=JZD#IL#(/C0WF?\P^2M02P,$%     @ 9H!L3\?2D,6W 0
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MY^\VWD"-Z,!;V=WX(6K]$UL"";4+VX/?FVG0IL!A/[\AMCSDXC=02P,$%
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M06N^E$)RJDTH*Z(Z";1P19R18+.Y)9PV+4YCESO)-!:]9DT+)XE4SSF5_X[
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M4-TXE4)H,%(V-T9+;1Z8.6!0:KO=F[T<K]D8:-%-+PB9G['T U!+ P04
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MO;-S-7; &!C93<U-YC],]A=02P,$%     @ 9H!L3R@R/$K0 0  ;00  !D
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MJ0N\"PF!@,H%!>:W&SR"$$'(I_%[UL1+R$!<G]_4GV+MOI8KL_"HQ2]>NZ[
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MZ 85JI>AR1;9N9?N:;C]/_"Q$1^9KEMIT%E9]X;"35=*67!6HBOWNAO7^W/
MH;)^>N/F>NR ,;"JFYJ;S'^8_ U02P,$%     @ 9H!L3[CV$J70 0  ;00
M !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&UL?531;ILP%/T5RQ]0)X8T
M501(3:IJDS8IZK3MV8$+6+4QLTWH_GZV(912M!?L>WW.\;FV+TFO]*NI 2QZ
MDZ(Q*:ZM;0^$F+P&R<R=:J%Q*Z72DED7ZHJ85@,K DD*0C>;>R(9;W"6A-Q9
M9XGJK. -G#4RG91,_SV"4'V*M_B6>.%5;7V"9$G+*O@!]F=[UBXBDTK!)32&
MJP9I*%/\N#V<8H\/@%\<>C.;(U_)1:E7'WPM4KSQAD! ;KT"<\,53B"$%W(V
M_HR:>-K2$^?SF_ISJ-W5<F$&3DK\YH6M4_R 40$EZX1]4?T7&.O98306_PVN
M(!S<.W%[Y$J8\$5Y9ZR2HXJS(MG;,/(FC/VP$MUHZP0Z$NA$>/@_(1H)T8)
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MHS6H4'T;!F:1G>?BD8:K_PL?A^H;TS5O#;HHZQY0N.9**0O.2O+@O#1NCN=
M0&7]=N_V>GS-8V!5-PTJF?\M\C]02P,$%     @ 9H!L3QLFVX3# 0  .00
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M;/BF#@-!>_.[",9_5O4/4$L#!!0    ( &: ;$\JP\UM_ $  .D%   9
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M^KW;5UEQKD!K">[T]6KTW%T,"I4RVUCOQ31\)D/Q?AZL:)GN^3]02P,$%
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M;=J<CTV'DUH?_:#]_LC^ U!+ P04    " !F@&Q/'6_= RH"  #E!@  &0
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M;V)??ZA@/,!Q]_8#['INQOX8[N7<<\[%0#I*]:H; (/>!.]TAAMC^B,ANFA
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M^K-426G 6MG<V88;^U@L 8?*N.G>SM5T9:; R'Y^#<CR).5_ %!+ P04
M" !F@&Q/]L;'^ 8"  #!!0  &0   'AL+W=O<FMS:&5E=',O<VAE970U,BYX
M;6R-5.V.FS 0?!7$ YP30X!&!.G"Z=1*K11=U?:W0Y8/G8VI;<+U[6L;PI%
M>OV#[65V=F;!&W=<O,H20#EOC-9RYY9*-5N$9%8"(_*!-U#K-SD7C"A]% 62
MC0!RLDF,(KQ:!8B1JG:3V,8.(HEYJVA5PT$XLF6,B#][H+S;N6OW$GBIBE*9
M $KBAA3P'=2/YB#T"8TLIXI!+2M>.P+RG?NXWJ:1P5O SPHZ.=D[QLF1\U=S
M^'+:N2LC""ADRC 0O9PA!4H-D9;Q>^!TQY(F<;J_L#];[]K+D4A(.?U5G52Y
M<R/7.4%.6JI>>/<9!C\;UQG,?X4S4 TW2G2-C%-IGT[62L79P**E,/+6KU5M
MUV[@OZ0M)^ A 8\)NO:_$KPAP7M/"*SY7IFU^D0426+!.T?T'ZLAYI]8;SW=
MS,P$;>_L.^U6ZN@Y\:-/,3H;H@&S[S%XBL'>-2:=8T(\0I"6,.K 2SKV>*&&
M?U-CCIG(N*KA+7KU;+XWK>'=$>DO$OB6P+\2>=.L=([Q_#M%-HM%-O,B]U0&
MBP3!_]L,%PG"!07KFW^BQP064UM,@+$7WC3C(]25F&A13/1QS_=SS+SG:'(C
M&(C"#@_I9+RM[>":1,?Y](CMC7J']\/M&Q%%54OGR)6^E_;VY)PKT%)6#_KS
ME7J>C@<*N3+;4.]%/U7Z@^+-,##1.+63OU!+ P04    " !F@&Q/OM91^Y<"
M  #%"   &0   'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6R-5EUOVC 4_2M1
MWD=B)W$  5+YZB9M4M5JV[,+!J(F<68;Z/[];,>DP=RU?2'VY9QS/V-G<N;B
M11X84\%K5=9R&AZ4:L91)#<'5E$YX VK]3\[+BJJ]%;L(]D(1K>65)41CF,2
M5;2HP]G$VA[$;,*/JBQJ]B ">:PJ*O[.6<G/TQ"%%\-CL3\H8XAFDX;NV1-3
M/YL'H7=1I[(M*E;+@M>!8+MI>(?&][G!6\"O@IUE;QV83)XY?S&;;]MI&)N
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MIF0[99:Y7HOV9FTWBC?NHR'JOEQF_P!02P,$%     @ 9H!L3]GLU\-F @
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M92S7K!\S_4;0UHQ0;YCCV3]02P,$%     @ 9H!L3WW]&BM[ @  ^0@  !D
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MFCY[80 KOE#;+.G?US:$TH07VS,^Y\S%XWS4YL5V  Z]2J%L@3OG^B,AMNI
M,GNC>U#^IM%&,N=-TQ+;&V!U)$E!Z&YW())QA<L\^LZFS/7@!%=P-L@.4C+S
MYP1"CP5.\)OCB;>="PY2YCUKX0>XG_W9>(LL*C67H"S7"AEH"OR0'$]9P$?
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M5T6XA0%-?\#TE\H_  #F_XT,MV6@V0^8_=+G)&#VWRC&/Y :H 4 L !(GY5
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M@Q"2JW;N@YH<)[6HOQWD_"#U;JCVJW9EVQY(<>Y6[<[M7P>K?U!+ P04
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MG@_"<H<$(E6<21DC*$ZE$YN2!SX5('.W!-95'GRPFFX87T(*'2K;+17?[ \
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MQZQ,TGX[^TYW*W7V6J8/68ZO1FC&'!PF7F&RZ'_(T0.)%PC6#A8;L<_&(?[
MC].[$AY(XB^1>#M-+'^[XN]V=R4<)+.0P4+"31A&_BI;;Y7MARI1G/D%4J]
MZA&X\WEPF'3M\ZZ3SQ#.!%Y-" /1VL,D@XI?!GN05]GEO#[&=L+>X>ZP?R>B
M[0<9G+G2<VJGJ>%<@382;K2'3M\O2T"A46:;Z;UPI\P%BH_S!8*76ZS\!U!+
M P04    " !F@&Q/@GG+DFL#  "R#@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970V-2YX;6Q]EV]OFS 0QK\*XGT+/MO\J9)(3:=IDS:IZK3M-4V<!!5P!J3I
MOOV,H1GUG=,7#9#S/8_M_,[<XJS;E^Z@5!^\U573+<-#WQ_OHJC;'%1==+?Z
MJ!KSS4ZW==&;VW8?=<=6%5L[J*XBB.,DJHNR"5<+^^RQ72WTJ:_*1CVV07>J
MZZ+]NU:5/B]#%KX_>"KWAWYX$*T6QV*O?JC^Y_&Q-7?1)<NVK%73E;H)6K5;
MAO?L;LUA&& C?I7JW,VN@V$JSUJ_##=?M\LP'ARI2FWZ(45A/E[5@ZJJ(9/Q
M\6=*&EXTAX'SZ_?LG^WDS62>BTX]Z.IWN>T/RS +@ZW:%:>J?]+G+VJ:D R#
M:?;?U*NJ3/C@Q&AL=-79_\'FU/6ZGK(8*W7Q-GZ6C?T\3_G?A]$#8!H EP$P
MSF44LLX_%7VQ6K3Z'+3CXA^+88_9'9BUV0P/[5+8[XSYSCQ]7<DL6T2O0Z(I
M9CW&P"R&72(BD_TB 93$&M!PSB6=@),>N4W Y_J0TPD$F4#8!&*6(&/.',<0
M:4,:&W(#D+'8_-%*DE22R*K,/%83,D&"K#+N>AUCDIE7EG/N=9J20BDA!(Y0
MBH4XR[U"&2F4X=WCG$Z0DPERY%3FL>,T1TYO>)+X=X_%- TQTN*(AAAIY?[%
M9Q[L&#$I=Y^GH+F2(<<O1>)WSP#/24A7"O "0B; +T:CRCCQLTI<,4Z(R81?
M4:.Y9H+X;:6>%#2P3!*&T99+RK!,_7YIN!FF6^8N= SC?<-2LQ57=IY&G%&,
MYZX<AMS()6ER93=HT!E!NO"EH%%G%.O<=8QA3U-(A-<OT+ #AIT)=S< TY[X
M-P)HVH&B7;A*F'8AA;^$ 8T[8-R90%H$[HQ?64&:=B!H1Z4%,.T92Z_4,:!A
M!WR*,^&6EBGHX\0@3J3_U *Z, !1&$3JRN'"P+BI9/[S .C* ,2Y+]PR!,3!
M+_+TRK;1=0%2 E3/6PK0K$.&_4KW4)Z"/JZ.OV@"71,@QVZEYP64TZ1S@G3I
MDLXQZ:E_'SE-.L>D,^D6,(Y)OP8?IT'G&'29N_!-0?/W6I8  #&Q:-8RU*K=
MVV:I"S;ZU-A.;?;TTI#=VWXL^A\^=G/?BW9?-EWPK'O3N-CV8J=UKXRC^-9X
M.9@&\G)3J5T_7*;FNAV[J/&FU\>I0XPN;>KJ'U!+ P04    " !F@&Q//$U'
M,,T!  !M!   &0   'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q]5-MNXR 0
M_17$!Q0')TT5V9::5%57VI6BKG;[3.SQ1>7B HZ[?[^ 7==-W;X89CCG< 88
M)[W2SZ8&L.A5<&E27%O;[@@Q>0V"F2O5@G0KI=*"61?JBIA6 RL"27!"H^B:
M"-9(G"4A=]19HCK+&PE'C4PG!-/_]L!5G^(5?DL\-E5M?8)D2<LJ^ WV3WO4
M+B*32M$(D*91$FDH4WR[VAW6'A\ ?QOHS6R.?"4GI9Y]\*-(<>0- 8?<>@7F
MAC,<@',OY&R\C)IXVM(3Y_,W]?M0NZOEQ P<%']J"ENG^ :C DK6<?NH^@<8
MZ]E@-!;_$\[ '=P[<7ODBIOP17EGK!*CBK,BV.LP-C*,_;!"XY&V3* C@4Z$
MF^A;0CP2X@L"&9R%4N^895FB58_T<%DM\V]BM8O=8>8^&<XNK+EJC<N>L]5F
MDY"S%QHQ^P%#YYB/B,-GQ)9.$.(,3"[HDHL]_<2G%SLL(.+E'>+%.N/ C[^H
M\X/ >E%@'036WQ[4$N;ZHI ES/;"")G=G@!=A8=N4*XZ&9ILEIUZZ9:&VW^'
M#XWXB^FJD0:=E'5O*-QTJ90%9R6Z<J^[=KT_!1Q*ZZ=;-]=#!PR!5>W8W&3Z
MPV3_ 5!+ P04    " !F@&Q/&E1M.,T!  !M!   &0   'AL+W=O<FMS:&5E
M=',O<VAE970V-RYX;6Q]5-%NI" 4_17"!Q0';3L[49/.;#;=9)M,NMG=9T:O
M2@IB <?V[Q?0NG;J]D6XEW,.YP+7=%#ZR30 %KU(T9H,-]9V.T),T8!DYDIU
MT+J52FG)K MU34RG@96!) 6A471#).,MSM.0.^H\5;T5O(6C1J:7DNG7/0@U
M9'B#WQ*/O&ZL3Y \[5@-/\'^ZH[:1616*;F$UG#5(@U5AN\VNT/B\0'PF\-@
M%G/D*SDI]>2#[V6&(V\(!!36*S WG.$ 0G@A9^-YTL3SEIZXG+^I?PNUNUI.
MS,!!B3^\M$V&MQB54+%>V$<UW,-4SS5&4_$_X S"P;T3MT>AA E?5/3&*CFI
M."N2O8PC;\,XC"M)/-'6"70BT)FPC3XEQ!,AOB"0T5DH]2NS+$^U&I >+ZMC
M_DUL=K$[S,(GP]F%-5>M<=ESOKG>IN3LA2;,?L30)>8]XO 1<4MG"'$&9A=T
MS<6>?N#3BQU6$/'Z#O%JG7'@Q_^I\YU LBJ0!('DTX-:PWRY*&0%<Q-=&"&+
MVY.@Z_#0#2I4WX8F6V3G7KJCX?;_P<=&?&"ZYJU!)V7=&PHW72EEP5F)KMSK
M;ESOSX& ROKIK9OKL0/&P*IN:FXR_V'ROU!+ P04    " !F@&Q/G=[RM;0!
M  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q]4]MNW" 0_17$
M!X1=[^;2E6TIFZIJI59:I6K[S-IC&P48%_ Z_?L")JZ;N'T!9IASYLPPY".:
M)]L!./*LI+8%[9SK#XS9J@/%[17VH/U-@T9QYTW3,ML;X'4$*<FRS>:&*2XT
M+?/H.YDRQ\%)H>%DB!V4XN;7$22.!=W2%\>C:#L7'*S,>]["5W#?^I/Q%IM9
M:J% 6X&:&&@*>K\]'/<A/@9\%S#:Q9F$2LZ(3\'X5!=T$P2!A,H%!NZW"SR
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M.U=3!TR!D7UH;C+_8?)_4$L#!!0    ( &: ;$^D+5]$S@$  &T$   9
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MD+_I6DH#UDIT95]W:WM_#AC4QDVW=JZF#I@"(_O0W&3^PQ3_ %!+ P04
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M5AJE!;4NU"TQO09:!Y+@)$V2CT10)G&9A]Q)E[D:+&<23AJ900BJ_QR J['
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M_AQP:*R?WKJYGCI@"JSJ8W.3^0]3_@502P,$%     @ 9H!L3Z_5">S, 0
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M[J5[ZF__'WQLQ$>FJJ;5Z"*-?4/^IDLI#5@KP8U]W;7M_3G@4!HWO;-S-7;
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MIDLI#5@KP95]W;7M_3G@4!HWW=NY&CM@#(SLIN8F\Q\F?0=02P,$%     @
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M\3G'9VP/Z:#TLVD +'H17)H,-]9V>T),T8!@YDIU(-U*I;1@UH6Z)J;3P,I
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MN4I* ]9*=&>]-/81F@,.E7'3G9VK\2J.@9']],J0^:G+_P!02P,$%     @
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MM^C?<5L'_JDQ# JR8]TMYO=-?][N!XS6\EO"&SYH%O\ 4$L#!!0    ( &:
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M#%42:4G7+VU2U6G;;R=Q$E3 ##M)]_:SC8N"N4OY [8YY]QS+Q?CV9FW;^+
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MM(@QF@4GK60QRPX3#3#A$+.",-$0<P=AXB'FZQCCJ-P#B&0(>?A4Y/%SD2<
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M[>E*#HR]ZL[GT]H/=""@<)1:@:C'#;9 J192,7X-FOYHJ8G3]KOZ1U.[JN5
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MME.0K5!-)-NLN;4T'4%K<R/SVFOAZ#]02P,$%     @ 9H!L3UI_C&&^ 0
MT@,  !D   !X;"]W;W)K<VAE971S+W-H965T.3DN>&UL;5/;3N,P$/T5RQ^
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MQ+'/*=*U%,?TO_ LVZT39*L:LT"0+?/O]^L$VU6";2#8+HO<)]^*C)A=P,B
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MJG17_=AXG%1W=*07^$?ZUWUVGZSA_<8F?DSA6&4+I 1\M?[X0YENDVP9I5^
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MQN:XF[H-L7E\ID3P2*ZI5A.T8=MT,YPZ8-<T/@7JWW#GN%L!/3LZ[O=4??C
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MMQE^I6/J1]KO?0;^3CWAB1(YM[[!_@@F?C7L!OE5;^,3P'E@$KNL)6@ MZ[
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MYX#$**N,D2AT]Q@S-H8PW&>,I8J(5Y@EJMQT6VREM 0']+>L><L]TI&CW$%
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M1]/!6>^3_M)55A &,XYGTP&P+EDO%:#VS5UO$YJF%@5D.OW6VK#1A44Z^[L
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M598+>)LMMVI&Q&5L-ABDE*=8N,F/P9;!#5?OJZVLP<WW7];2&BA8PQE(>A?
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M&+%-[U24-KA-F\OQRM$$2).]\_ZP1WOL?[\O,)0"<:MZYQ?]6>^'WL>L@CL
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MR>XR&RHFM$?GZ]_290TTU)L&46RD2P27C31;]NO3//<5EX='NZ58ZMEZ*?]
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M.?HD#H+JF]R9O![D-^1:A:"^ICO4KE^_>??RQ9OWN"H[/%4$%[A$#^D*\PQ
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MF0*JS%K0;:$.WR[PRS8L2S:3!-V92T>@B C<+R\:'9JH[I/A!8N2L2Z;,DN
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M72QU"%QHU'!8UO!GCN]BSO"N?@FRMD5L&".U5-0BS(#LKB N'8N^R<F/;.]
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MJ8J1(PC:4.==U1H(^V&H1A,)!^?;U5(U;+<M^4HC5E/1P%&*&_YHN_G-*D0
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MS7MG\>UV,68#]4SSW!0NSF_^U'CY^NHOD50\=QX5T\.(VH X[QU\BY^IF,L
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MN?#'4=4&J7/Y'YO-]G_]/U!+ P04    " !F@&Q/\FWS=EL"  !"#   #0
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M!B8F<HU+[!IL;C/ <)%N7&+=('/W+=VX2#<NL6X.FGLJ*BY3:SCRD'D\8O/
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MBK0NQWC0W?BO*#^GZ? R7RS_H;S]#5!+ 0(4 Q0    ( &: ;$\?(\\#P
M !,"   +              "  0    !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M &: ;$\GZ(<.@@   +$    0              "  >D   !D;V-0<F]P<R]A
M<' N>&UL4$L! A0#%     @ 9H!L3Q#PN6WM    *P(  !$
M ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 9H!L3YE<G",0
M!@  G"<  !,              ( !M0(  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " !F@&Q/NQMCFA\"  #H!@  &               @ 'V"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 9H!L3ZNY@@<*
M!0  =QH  !@              ( !2PL  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( &: ;$\@5#O65 ,  $40   8              "
M 8L0  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !F@&Q/
MP7(0X"($  #8$@  &               @ $5%   >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ 9H!L3R=SMK*$"0  Y#\  !@
M     ( !;1@  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M &: ;$^FI6\*^P$  (<%   8              "  2<B  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " !F@&Q/@M8)@N8#  #!$0  &
M            @ %8)   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ 9H!L3P9F--G. 0  ;00  !@              ( !="@  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( &: ;$\:5&TXS0$  &T$
M   8              "  7@J  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " !F@&Q/9@I\&,L!  !M!   &0              @ %[+
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( &: ;$^>!5,=
MS $  &T$   9              "  7TN  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ 9H!L3W]DP/RV 0  U ,  !D
M ( !@#   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !F
M@&Q/I"U?1,X!  !M!   &0              @ %M,@  >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( &: ;$\O@=P4R0$  &T$   9
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M970Q."YX;6Q02P$"% ,4    " !F@&Q/Q]*0Q;<!  #4 P  &0
M    @ %1/@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M &: ;$_2;:Z S0$  &T$   9              "  3]   !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ 9H!L3QDP@+VU 0  U ,  !D
M             ( !0T(  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " !F@&Q/&@\1D;8!  #4 P  &0              @ $O1   >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( &: ;$^OU0GLS $
M &T$   9              "  1Q&  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ 9H!L3W5E=H6\ @  *0L  !D              ( !
M'T@  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !F@&Q/
M?MQWW]H!  #2!   &0              @ $22P  >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( &: ;$^./ @5T0$  &T$   9
M      "  2--  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ 9H!L3R@R/$K0 0  ;00  !D              ( !*T\  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !F@&Q/UO+1X;D!  #4 P
M&0              @ $R40  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( &: ;$_30<W2SP$  &T$   9              "  2)3  !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ 9H!L3[CV$J70
M 0  ;00  !D              ( !*%4  'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " !F@&Q/ Y&*9NX!  !;!0  &0
M@ $O5P  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( &:
M;$]&D.7&Q $  #D$   9              "  519  !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ 9H!L3QLFVX3# 0  .00  !D
M         ( !3UL  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M    " !F@&Q/5_NBC$P#  #,#@  &0              @ %)70  >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( &: ;$^F_,0K, (  +\&
M   9              "  <Q@  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
M4$L! A0#%     @ 9H!L3RK#S6W\ 0  Z04  !D              ( !,V,
M 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !F@&Q//QMG
MG?$!   $!0  &0              @ %F90  >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;%!+ 0(4 Q0    ( &: ;$^@+F+;/0(  "\(   9
M  "  8YG  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
M9H!L3[(#ZS.- P  B!   !D              ( ! FH  'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6Q02P$"% ,4    " !F@&Q/&G?6MDT"  "A!P  &0
M            @ '&;0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4
M Q0    ( &: ;$]"IY%8P0(  "(+   9              "  4IP  !X;"]W
M;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ 9H!L3^3V>&== @
MBP@  !D              ( !0G,  'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6Q02P$"% ,4    " !F@&Q/'6_= RH"  #E!@  &0              @ '6
M=0  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( &: ;$\/
M#96J?@(  &D)   9              "  3=X  !X;"]W;W)K<VAE971S+W-H
M965T-#0N>&UL4$L! A0#%     @ 9H!L3YYQ[C(G @  D 8  !D
M     ( !['H  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &: ;$^8&G>:T0(  /0*   9              "
M 8R.  !X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ 9H!L
M3^Z5RL?5 0  G@0  !D              ( !E)$  'AL+W=O<FMS:&5E=',O
M<VAE970U,2YX;6Q02P$"% ,4    " !F@&Q/]L;'^ 8"  #!!0  &0
M        @ &@DP  >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0
M   ( &: ;$^^UE'[EP(  ,4(   9              "  =V5  !X;"]W;W)K
M<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ 9H!L3]GLU\-F @  TP<
M !D              ( !JY@  'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q0
M2P$"% ,4    " !F@&Q/??T:*WL"  #Y"   &0              @ %(FP
M>&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( &: ;$]O&I+&
M"0,  %X,   9              "  ?J=  !X;"]W;W)K<VAE971S+W-H965T
M-38N>&UL4$L! A0#%     @ 9H!L3]_:L56\ 0  U ,  !D
M ( !.J$  'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " !F
M@&Q/Z@ 52!L#  !K#@  &0              @ $MHP  >&PO=V]R:W-H965T
M<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( &: ;$_790FGU ,  + 2   9
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M970V,RYX;6Q02P$"% ,4    " !F@&Q/[T@TP><!  #1!   &0
M    @ &UO@  >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    (
M &: ;$^"><N2:P,  +(.   9              "  =/   !X;"]W;W)K<VAE
M971S+W-H965T-C4N>&UL4$L! A0#%     @ 9H!L3SQ-1S#- 0  ;00  !D
M             ( !=<0  'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"
M% ,4    " !F@&Q/&E1M.,T!  !M!   &0              @ %YQ@  >&PO
M=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( &: ;$^=WO*UM $
M -(#   9              "  7W(  !X;"]W;W)K<VAE971S+W-H965T-C@N
M>&UL4$L! A0#%     @ 9H!L3V8*?!C+ 0  ;00  !D              ( !
M:,H  'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " !F@&Q/
MG@53'<P!  !M!   &0              @ %JS   >&PO=V]R:W-H965T<R]S
M:&5E=#<P+GAM;%!+ 0(4 Q0    ( &: ;$^D+5]$S@$  &T$   9
M      "  6W.  !X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%
M  @ 9H!L3R^!W!3) 0  ;00  !D              ( !<M   'AL+W=O<FMS
M:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " !F@&Q/ (^M3<H!  !M!
M&0              @ %RT@  >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+
M 0(4 Q0    ( &: ;$]H1XYBS $  &T$   9              "  7/4  !X
M;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ 9H!L3])MKH#-
M 0  ;00  !D              ( !=M8  'AL+W=O<FMS:&5E=',O<VAE970W
M-2YX;6Q02P$"% ,4    " !F@&Q/K]4)[,P!  !M!   &0
M@ %ZV   >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( &:
M;$\F%ZDA( (  *X&   9              "  7W:  !X;"]W;W)K<VAE971S
M+W-H965T-S<N>&UL4$L! A0#%     @ 9H!L3V!++#O, 0  ;00  !D
M         ( !U-P  'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4
M    " !F@&Q/PCW4,;<!  #2 P  &0              @ '7W@  >&PO=V]R
M:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( &: ;$^./ @5T0$  &T$
M   9              "  <7@  !X;"]W;W)K<VAE971S+W-H965T.# N>&UL
M4$L! A0#%     @ 9H!L3R@R/$K0 0  ;00  !D              ( !S>(
M 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    " !F@&Q/[;JX
M[;<!  #2 P  &0              @ '4Y   >&PO=V]R:W-H965T<R]S:&5E
M=#@R+GAM;%!+ 0(4 Q0    ( &: ;$_30<W2SP$  &T$   9
M  "  <+F  !X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @
M9H!L3[CV$J70 0  ;00  !D              ( !R.@  'AL+W=O<FMS:&5E
M=',O<VAE970X-"YX;6Q02P$"% ,4    " !F@&Q/+B!17N0!  #V!   &0
M            @ '/Z@  >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4
M Q0    ( &: ;$_&J%YK'@,  -P,   9              "  >KL  !X;"]W
M;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ 9H!L3]LOEQ%6 @
MB <  !D              ( !/_   'AL+W=O<FMS:&5E=',O<VAE970X-RYX
M;6Q02P$"% ,4    " !F@&Q/UFQV894"   U"@  &0              @ ',
M\@  >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( &: ;$_+
MFWZ?&00  +86   9              "  9CU  !X;"]W;W)K<VAE971S+W-H
M965T.#DN>&UL4$L! A0#%     @ 9H!L3[(#ZS.- P  B!   !D
M     ( !Z/D  'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &: ;$\/#96J?@(  &D)   9              "
M 7D( 0!X;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%     @ 9H!L
M3XQ^S-Q" @  8@<  !D              ( !+@L! 'AL+W=O<FMS:&5E=',O
M<VAE970Y-BYX;6Q02P$"% ,4    " !F@&Q/ZI6Z+QH&  !\(P  &0
M        @ &G#0$ >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4 Q0
M   ( &: ;$^S#7R)L@(  "(*   9              "  ?@3 0!X;"]W;W)K
M<VAE971S+W-H965T.3@N>&UL4$L! A0#%     @ 9H!L3UI_C&&^ 0  T@,
M !D              ( !X18! 'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6Q0
M2P$"% ,4    " !F@&Q/VGT4;><!  !B!0  &@              @ '6& $
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M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !F@&Q/S%["^V "  !+.0  $P
M            @ $JSP$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     ;0!M
+ .X=  "[T0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6838000432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock options (Details) - 2015 Plan - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>May 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Jan. 24, 2017</div></th>
<th class="th"><div>Dec. 29, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for issuance under the plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,422<span></span>
</td>
<td class="nump">311,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,056,891<span></span>
</td>
<td class="nump">506,586<span></span>
</td>
<td class="nump">189,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247,275<span></span>
</td>
<td class="nump">1,570,136<span></span>
</td>
<td class="nump">317,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,963)<span></span>
</td>
<td class="num">(5,599)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,250)<span></span>
</td>
<td class="num">(14,232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end</a></td>
<td class="nump">2,056,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,248,953<span></span>
</td>
<td class="nump">2,056,891<span></span>
</td>
<td class="nump">506,586<span></span>
</td>
<td class="nump">189,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at the end</a></td>
<td class="nump">2,056,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,248,953<span></span>
</td>
<td class="nump">2,056,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Exercisable at the end</a></td>
<td class="nump">242,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,866<span></span>
</td>
<td class="nump">242,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the beginning (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.18<span></span>
</td>
<td class="nump">5.92<span></span>
</td>
<td class="nump">1.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
<td class="nump">0.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeitures (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.63<span></span>
</td>
<td class="nump">1.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the end (in dollars per share)</a></td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30<span></span>
</td>
<td class="nump">4.74<span></span>
</td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest at the end (in dollars per share)</a></td>
<td class="nump">4.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30<span></span>
</td>
<td class="nump">4.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Exercisable at the end (in dollars per share)</a></td>
<td class="nump">$ 0.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="nump">$ 0.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life (Years) And Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding (in years)</a></td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 1 month 6 days<span></span>
</td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm', window );">Granted (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">9 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest at the end (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at the end (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at the beginning (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,946,000<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue', window );">Granted (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,684,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at the end (in dollars)</a></td>
<td class="nump">$ 5,946,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,305,000<span></span>
</td>
<td class="nump">5,946,000<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest at the end (in dollars)</a></td>
<td class="nump">5,946,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,305,000<span></span>
</td>
<td class="nump">5,946,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Exercisable at the end (in dollars)</a></td>
<td class="nump">$ 1,634,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,335,000<span></span>
</td>
<td class="nump">$ 1,634,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value per share of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.48<span></span>
</td>
<td class="nump">$ 3.80<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 38,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember', window );">Option to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life (Years) And Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Aggregate grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember', window );">Restricted Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life (Years) And Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Aggregate grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6833028192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of the Business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Nature of the Business</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-align:left;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">1. Nature of the Business<a name="a1NatureoftheBusinessandBasisofPresentat"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Organization</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">NextCure,&nbsp;Inc. (&#x201C;NextCure&#x201D; or the &#x201C;Company&#x201D;) was incorporated in Delaware in September&nbsp;2015 and is headquartered in Beltsville, Maryland. The Company is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first&#8209;in&#8209;class immunomedicines to treat cancer and other immune&#8209;related diseases by restoring normal immune function. Through its proprietary Functional, Integrated, NextCure Discovery in Immuno&#8209;Oncology (&#x201C;FIND&#8209;IO&#x201D;) platform, the Company studies various immune cells in order to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Since inception, the Company has devoted substantially all of its efforts and financial resources to organizing and staffing the Company, identifying business development opportunities, raising capital, securing intellectual property rights related to the Company&#x2019;s product candidates, building and optimizing the Company&#x2019;s manufacturing capabilities and conducting discovery, research and development activities for the Company&#x2019;s product candidates, discovery programs and its FIND&#8209;IO platform.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Initial Public Offering</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On May 13, 2019, the Company closed its initial public offering (&#x201C;IPO&#x201D;), in which the Company issued and sold 5,750,000 shares of common stock at a public offering price of $15.00 per share, for net proceeds to the Company of approximately $77.0 million after deducting underwriting discounts and commissions of $6.0 million and offering expenses of approximately $3.4 million.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In preparation for the IPO, on May 3, 2019, the Company effected&nbsp;a &nbsp;one-for-8.0338 reverse stock split of its issued and outstanding common stock. The par value and authorized shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upon the closing of the IPO, on May 13, 2019, all of the outstanding shares of the Company&#x2019;s convertible preferred stock automatically converted into 15,560,569 shares of common stock at the applicable conversion ratio then in effect. Subsequent to the closing of the IPO, there were no shares of preferred stock outstanding. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upon the closing of the IPO, on May 13, 2019, the Company&#x2019;s certificate of incorporation was amended and restated to provide for 100,000,000 authorized shares of common stock with a par value of $0.001 per share and 10,000,000 authorized shares of preferred stock with a par value of $0.001 per share.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Liquidity</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has not generated any revenue to date from product sales and does not expect to generate any revenues from product sales in the foreseeable future. Through September 2019, the Company has funded its operations primarily with proceeds from the sale of preferred stock and proceeds from the Company&#x2019;s agreement with Eli Lilly and Company &nbsp;(Note 6)&nbsp;and proceeds from the IPO. The Company expects to incur additional operating losses and negative operating cash flows for the foreseeable future.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">NEXTCURE,&nbsp;INC.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">NOTES&nbsp;TO FINANCIAL STATEMENTS<a name="NOTESTOFINANCIALSTATEMENTS_913411"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">1. Nature of the Business and Basis of Presentation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Organization</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">NextCure,&nbsp;Inc. (&#x201C;NextCure&#x201D; or the &#x201C;Company&#x201D;) was incorporated in Delaware in September&nbsp;2015 and is headquartered in Beltsville, Maryland. The Company is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first&#8209;in&#8209;class immunomedicines to treat cancer and other immune&#8209;related diseases by restoring normal immune function. Through its proprietary Functional, Integrated, NextCure Discovery in Immuno&#8209;Oncology (&#x201C;FIND&#8209;IO&#x201D;) platform, the Company studies various immune cells in order to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Since inception, the Company has devoted substantially all of its efforts and financial resources to organizing and staffing the Company, identifying business development opportunities, raising capital, securing intellectual property rights related to the Company&#x2019;s product candidates, building and optimizing the Company&#x2019;s manufacturing capabilities and conducting discovery, research and development activities for the Company&#x2019;s product candidates, discovery programs and its FIND&#8209;IO platform.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Risks and Uncertainties</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company is subject to risks common to early&#8209;stage companies in the biotechnology industry including, but not limited to: having a limited operating history and no products approved for commercial sale; having a history of significant losses; our need to obtain additional financing; dependence on its ability to advance its current and future product candidates through clinical trials, marketing approval and commercialization; the unproven approach to the discovery and development of product candidates based on the Company&#x2019;s FIND&#8209;IO platform; the lengthy and expensive nature and uncertain outcomes of the clinical development process; the lengthy, time&#8209;consuming and unpredictable nature of the regulatory approval process; the results of preclinical studies and early&#8209;stage clinical trials that may not be predictive of future results; dependence on its key personnel; its limited manufacturing experience as an organization and with its manufacturing facility; risks related to patent protection and our pending patent applications; dependence on third&#8209;party collaborators for the discovery, development and commercialization of current and future product candidates; and significant competition from other biotechnology and pharmaceutical companies. Pursuit of the Company&#x2019;s business efforts will require significant amounts of additional capital, adequate personnel, infrastructure and extensive compliance&#8209;reporting capabilities. Even if the Company&#x2019;s development efforts are successful, it is uncertain when, if ever, the Company will realize significant revenue from product sales.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Liquidity</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company expects that its operating losses and negative cash flows will continue for the foreseeable future. As of the issuance date of the financial statements for the&nbsp;year ended December&nbsp;31, 2018, the Company expects that its cash and cash equivalents will be sufficient to fund its operating expenses and capital expenditure requirements through at least two years from the issuance date of the financial statements. The future viability of the Company beyond that date is dependent on its ability to raise additional capital to finance its operations. On April&nbsp;5, 2018, the Company issued 28,181,819 shares of Series&nbsp;A&#8209;3 Preferred Stock at an issuance price of $1.10 per share for cash proceeds of $31.0&nbsp;million (Note&nbsp;9). On November&nbsp;5, 2018, the Company entered into a Series&nbsp;B Preferred Stock Purchase Agreement and issued 15,052,117 shares of Series&nbsp;B&#8209;1 Preferred Stock at an issuance price of $1.59 per share, 34,276,734 shares of Series&nbsp;B&#8209;2 Preferred Stock at an issuance price of $1.59 per share and 7,500,000 shares of Series&nbsp;B&#8209;3 Preferred Stock at an issuance price of $2.00 per share for aggregate cash proceeds of $93.4&nbsp;million (Note&nbsp;9).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company plans to seek additional funding through public or private equity offerings, debt financings, marketing and distribution arrangements, other collaborations, strategic alliances and licensing arrangements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into strategic alliances or other arrangements on favorable terms, or at all. The terms of any financing may adversely affect the holdings or the rights of the Company&#x2019;s stockholders. If the Company is unable to obtain funding, the Company could be required to delay, reduce or eliminate research and development programs, product portfolio expansion or future commercialization efforts, which could adversely affect its business prospects.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Although management continues to pursue these funding plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company, if at all, to fund continuing operations past two years from the issuance date of these financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Basis of Presentation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The accompanying financial statements include the accounts of the Company. The Company&#x2019;s financial statements have been prepared in accordance with United States generally accepted accounting principles (&#x201C;GAAP&#x201D;). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#x201C;ASC&#x201D;) and Accounting Standards Update (&#x201C;ASU&#x201D;) of the Financial Accounting Standards Board (&#x201C;FASB&#x201D;).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Reverse Stock Split</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On May&nbsp;3, 2019, the Company effected a 1&#8209;for&#8209;8.0338 reverse stock split of its outstanding common stock. The par value and authorized shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Use of Estimates</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to accrued expenses, revenue recognition, the valuation of equity&#8209;based compensation, including incentive stock options, common stock and restricted common stock, as well as income taxes. The Company bases its estimates on various assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Segment and Geographic Information</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Operating segments are defined as components of an entity about which separate discrete information is available for evaluation by the chief operating decision maker, or decision&#8209;making group, in deciding how to allocate resources and in assessing performance. The Company views its operations as and manages its business in one operating segment operating exclusively in the United States.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818684896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Term Loan - Maturities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Future maturities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2020</a></td>
<td class="nump">$ 1,528,000<span></span>
</td>
<td class="nump">$ 73,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2021</a></td>
<td class="nump">1,667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2022</a></td>
<td class="nump">1,667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2023</a></td>
<td class="nump">138,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of term loan</a></td>
<td class="num">(1,250,000)<span></span>
</td>
<td class="num">(387,000)<span></span>
</td>
<td class="num">$ (400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, net of current portion</a></td>
<td class="nump">$ 3,750,000<span></span>
</td>
<td class="nump">$ 73,000<span></span>
</td>
<td class="nump">$ 460,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812500448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreement with Eli Lilly and Company - Deferred revenue included in balance sheets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Deferred revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenue', window );">Deferred revenue, beginning of period</a></td>
<td class="nump">$ 26,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenueUpFrontPayment', window );">Up-front payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment', window );">Attributed premium on the proceeds from Lilly's investment in the Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment', window );">Research and development support billing</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized', window );">Revenue from research and development arrangement recognized</a></td>
<td class="num">(4,342)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenue', window );">Total deferred revenue, end of period</a></td>
<td class="nump">23,883<span></span>
</td>
<td class="nump">26,725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenueCurrent', window );">Less: Deferred revenue, current portion</a></td>
<td class="num">(6,199)<span></span>
</td>
<td class="num">(4,989)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent', window );">Deferred revenue, non-current portion</a></td>
<td class="nump">$ 17,684<span></span>
</td>
<td class="nump">$ 21,736<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income from related party transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income from related party transactions attributable to premium on the proceeds from investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenueAttributedPremiumOnProceedsFromInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income from related party transactions attributable to collaboration revenue recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenueCollaborationRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income from related party transactions excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income from related party transactions excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income from related party transactions attributable to research and development support payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenueResearchAndDevelopmentSupportPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenueUpFrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income from related party transactions attributable to upfront payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenueUpFrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818246704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 4,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfRevenueExtensibleList', window );">Type of Revenue [Extensible List]</a></td>
<td class="text">nxtc:RelatedPartyMember<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 22,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">6,995<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">29,814<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(25,472)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">2,662<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (22,810)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per common share-basic and diluted (in dollars per share) | $ / shares</a></td>
<td class="num">$ (1.81)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of common shares -basic and diluted (in shares) | shares</a></td>
<td class="nump">12,609,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="num">$ (58)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (22,868)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfRevenueExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of revenue from product and service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=108792157&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfRevenueExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6808611728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_Series2PreferredStockMember', window );">Series A-2 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Initial public offering issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember', window );">Series A-3 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Initial public offering issuance costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Initial public offering issuance costs</a></td>
<td class="nump">$ 485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_Series2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_Series2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6656761088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Summary of reconciliation cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,935</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash (including $3,750 in other assets)</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,039</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 14,974</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,427</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 860</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,287</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock', window );">Summary of estimated useful lives for property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div> <div>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Estimated&nbsp;Useful&nbsp;Life</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computers and peripherals</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">3&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">5&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">7&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Lesser of estimated useful life or remaining lease term</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of estimated useful lives for property and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6833721136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,935,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,173,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,427,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">1,289,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,777,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">189,148,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,785,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,031,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,407,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,021,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">3,945,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">205,124,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,628,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,467,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,576,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,483,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,141,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">2,582,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,411,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,564,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditCurrent', window );">Deferred rent, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Term loan, current portion</a></td>
<td class="nump">1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenueCurrent', window );">Deferred revenue from related party, current portion</a></td>
<td class="nump">6,199,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,989,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">12,607,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,298,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,124,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent, net of current portion</a></td>
<td class="nump">434,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, net of current portion</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">17,684,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,736,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">34,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,349,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,879,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PreferredStockAbstract', window );"><strong>Redeemable preferred stock:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total redeemable preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value of $0.001 per share; 158,745,671 and 84,045,455 shares authorized at December 31, 2018 and 2017, respectively, 1,374,812 and 1,369,212 shares issued and outstanding at December 31, 2018 and 2017, respectively</a></td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">240,791,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(70,107,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,297,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,498,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">170,649,000<span></span>
</td>
<td class="nump">$ 178,595,000<span></span>
</td>
<td class="num">$ (52,712,000)<span></span>
</td>
<td class="num">(46,944,000)<span></span>
</td>
<td class="num">$ (40,212,000)<span></span>
</td>
<td class="num">$ (34,592,000)<span></span>
</td>
<td class="num">$ (29,385,000)<span></span>
</td>
<td class="num">(24,413,000)<span></span>
</td>
<td class="num">$ (9,018,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, preferred stock and stockholders' equity (deficit)</a></td>
<td class="nump">$ 205,124,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,628,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,467,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PreferredStockAbstract', window );"><strong>Redeemable preferred stock:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total redeemable preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PreferredStockAbstract', window );"><strong>Redeemable preferred stock:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total redeemable preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PreferredStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Not available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PreferredStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income from related party transactions excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income from related party transactions excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902458&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902458&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6823171440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Employee Benefit Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plan</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">14. Employee Benefit Plan</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company sponsors a 401(k)&nbsp;plan that stipulates that eligible employees can elect to contribute to the 401(k)&nbsp;plan, subject to certain limitations, up to the lesser of the statutory maximum or 100% of eligible compensation on a pre&#8209;tax basis. Through December&nbsp;31, 2018, the Company has not provided any contributions to this plan.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6768145184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of future minimum payments</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The future minimum payments for the operating leases are as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Remainder of the year</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 97</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 566</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 692</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 742</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 733</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Thereafter</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,088</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total future minimum payments</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,918</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The future minimum payments for the operating leases are as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Year Ending December&nbsp;31,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 325</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 308</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 317</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 355</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 335</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Thereafter</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 635</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total future minimum payments</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,275</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818760688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation - 2015 Omnibus Incentive Plan (Details) - 2015 Plan - shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare', window );">Minimum exercise price per share as a percent of fair market value of a share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Total number of shares of common stock that may be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,824,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">699,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember', window );">Option to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,056,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember', window );">Restricted Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares issued</a></td>
<td class="nump">62,237<span></span>
</td>
<td class="nump">62,237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward', window );">Term of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum exercise price per share as a percent of fair market value of a share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_MinimumExercisePricePerShareAsPercentOfFairMarketValueOfShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of pertinent provision of equity-based compensation awards that have actual or potential impact upon the company's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share instruments newly issued under a share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6817381344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_AccruedConstructionInProgressCurrent', window );">Accrued construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,008<span></span>
</td>
<td class="nump">493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_AccruedClinicalTrialCostsCurrent', window );">Accrued clinical trial costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_AccruedOperatingExpensesCurrent', window );">Accrued operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">719<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_AccruedFinancingCostsCurrent', window );">Accrued financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRentCurrent', window );">Accrued office lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 2,582<span></span>
</td>
<td class="nump">$ 2,411<span></span>
</td>
<td class="nump">$ 1,564<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_AccruedClinicalTrialCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical trial costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_AccruedClinicalTrialCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_AccruedConstructionInProgressCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for construction in progress. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_AccruedConstructionInProgressCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_AccruedFinancingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for financing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_AccruedFinancingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_AccruedOperatingExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for operating expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_AccruedOperatingExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6835690672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan - Other (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 25, 2019 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Apr. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate (as a percent)</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.33%<span></span>
</td>
<td class="nump">4.18%<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
<td class="nump">3.84%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_DebtInstrumentMonthlyPaymentsNumber', window );">Number of equal monthly payments of principal plus accrued interest | item</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,000<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">$ 155,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember', window );">Prime rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread (as a percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_DebtInstrumentMonthlyPaymentsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of periodic payments of principal plus accrued interest (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_DebtInstrumentMonthlyPaymentsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6810619664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">2. Summary of Significant Accounting Policies<a name="a2SummaryofSignificantAccountingPolicies"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Basis of Presentation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The accompanying unaudited condensed financial statements as of September 30, 2019 and for the three and nine months ended September 30, 2019 and 2018 have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;) for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed financial statements should be read in conjunction with the Company&#x2019;s audited financial statements and the notes thereto as of and for the year ended December 31, 2018, which are included in the Company&#x2019;s final prospectus that forms a part of the Company&#x2019;s Registration Statement on Form S-1 (Reg. No. 333-230837) (the &#x201C;Registration Statement&#x201D;), as filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended, on May 9, 2019.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The unaudited interim condensed financial statements have been prepared on the same basis as the audited financial statements. In the opinion of management, the accompanying unaudited interim condensed financial statements contain all adjustments necessary for a fair statement of the Company&#x2019;s financial position as of September 30, 2019 and condensed results of operations and cash flows for the three and nine months ended September 30, 2019 and 2018. Such adjustments are of a normal and recurring nature. The results of operations for the three and nine months ended September 30, 2019 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2019.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Use of Estimates</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to accrued expenses, revenue recognition, the valuation of equity&#8209;based compensation, including incentive stock options, common stock and restricted common stock, as well as income taxes. The Company bases its estimates on various assumptions that the Company believes to be reasonable under the circumstances. A</font><font style="display:inline;">lthough actual results could differ from those estimates, management does not believe that such differences would be material.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Restricted Cash</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The Company is required, as a condition of its Term Loan (Note 8), to maintain cash collateral on deposit in a segregated money market bank account equal to the principal portion of the Term Loan, as determined on a quarterly basis. The bank may restrict withdrawals or transfers by or on behalf of the Company that would violate this requirement. The required reserve totaled $5.0 million as of September 30, 2019. This amount is presented in part as restricted cash and in part as other assets on the accompanying balance sheet.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,935</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash (including $3,750 in other assets)</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,039</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 14,974</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Marketable Securities</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:normal;">Our investments primarily consist of government debt securities, corporate bonds and agency bonds. These marketable securities are classified as available-for-sale, and as such, are reported at fair value on our condensed balance sheets. Unrealized holding gains and losses are reported within accumulated other comprehensive income (loss) as a separate component of stockholders&#x2019; equity. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization, together with interest on securities, are included in other income, net, on our condensed statements of operations.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:normal;">If a decline in the fair value of a marketable security below our cost basis is determined to be other than temporary, such marketable security is written down to its estimated fair value as a new cost basis and the amount of the write-down is included in earnings as an impairment charge. The cost of securities sold is based on the specific identification method.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Revenue Recognition</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has adopted Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (&#x201C;ASC 606&#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect consideration to which it is entitled in exchange for the goods or services it transfers to the customer.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral to or dependent on other goods or services in the contract.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration that is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&#x2019;s control or the licensee&#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur and (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying condensed balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Recently Issued Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">The Company qualifies as an emerging growth company (&#x201C;EGC&#x201D;) as defined under the Jumpstart Our Business Startups Act (the &#x201C;JOBS Act&#x201D;). Using exemptions provided under the JOBS Act provided to EGCs, the Company has elected to defer compliance with new or revised financial accounting standards until it is required to comply with such standards. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In February 2016, the FASB issued ASU No. 2016-02, Leases (&#x201C;ASU 2016-02&#x201D;). The new guidance will require lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016-02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right-to-use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company January 1, 2020.The Company continues to determine if it will elect to use the practical expedients permitted by the guidance and continues to gather data required to comply with the guidance. Based on the work completed to date, the Company is considering the implications of adopting the new standard, including the discount rate to be used in valuing new and existing leases and all applicable financial statement disclosures required by the new guidance. The Company is continuing to evaluate the effect of adoption and anticipates that it will result in the recognition of additional assets and corresponding liabilities related to the existing leases on its balance sheet. The Company is assessing any potential impacts on its internal controls, business processes, and accounting policies related to both the implementation of, and ongoing compliance with, the new guidance.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (&#x201C;ASU 2016-13&#x201D;). ASU 2016-13 will require credit losses to be reported using an expected losses model rather than the incurred losses model that is currently used, and will require additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard will require allowances to be recorded instead of reducing the amortized cost of the investment. ASU 2016-13 will be effective for non-emerging growth companies for fiscal years beginning December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2016-13 will have on its financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement&#x2014;Disclosure Framework-Changes to the Disclosure Requirement for Fair Value Measurement (&#x201C;ASU 2018-13&#x201D;). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements in ASC 820, Fair Value Measurement, based on the concepts in the FASB Concepts Statement, including the consideration of costs and benefits. ASU 2018-13 will be effective for all companies for fiscal periods beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2018-13 will have on its financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;background-color: #FFFFFF;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In November 2018, the FASB issued ASU No. 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 (&#x201C;ASU 2018-18&#x201D;). ASU 2018-18 clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, all the guidance in Topic 606 should be applied, including recognition, measurement, presentation and disclosure requirements. The amendment also adds unit of account guidance in Topic 808 to align with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of the arrangement is within the scope of Topic 606. Lastly, ASU 2018-18 provides that in a transaction with a collaborative arrangement participant that is not directly related to sales to third parties, presenting the transaction together with revenue recognized under Topic 606 will be precluded if the collaborative arrangement participant is not a customer. ASU 2018-18 will be effective for non-emerging growth companies for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020 and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating these clarifications for the accounting and presentation for its collaborative arrangements within the scope of Topic 808, but does not expect that the adoption of ASU 2018-18 will have any impact.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">2. Summary of Significant Accounting Policies</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Cash and Cash Equivalents</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company considers all highly liquid investments with an original maturity of three&nbsp;months or less at the date of purchase to be cash equivalents. The Company deposits its cash primarily in checking, sweep account and money market accounts.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Restricted Cash</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company is required to maintain cash collateral on deposit in a segregated money market bank account, as a condition of its Term Loan (Note&nbsp;8) equal to the principal portion on a quarterly basis. The bank may restrict withdrawals or transfers by, or on behalf of, the Company. The required reserve totaled $460,000 as of December&nbsp;31, 2018. This amount is presented as restricted cash on the accompanying balance sheet.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,427</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 860</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,287</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Concentration of Credit Risk</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Financial instruments that potentially expose the Company to concentrations of credit risk primarily consist of cash and cash equivalents. The Company maintains its cash and cash equivalents at one accredited financial institution in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Fair Value of Financial Instruments</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">ASC Topic 820, </font><font style="display:inline;font-style:italic;">Fair Value Measurement</font><font style="display:inline;"> (&#x201C;ASC 820&#x201D;), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company&#x2019;s own assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. ASC 820 identifies fair value as the exchange price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three&#8209;tier value hierarchy that distinguishes between the following:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level&nbsp;1&#x2014;Quoted market prices in active markets for identical assets or liabilities.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level&nbsp;2&#x2014;Inputs other than Level&nbsp;1 inputs that are either directly or indirectly observable, such as quoted market prices, interest rates and yield curves.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level&nbsp;3&#x2014;Unobservable inputs developed using estimates of assumptions developed by the Company, which reflect those that a market participant would use.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">To the extent the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair values requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized as Level&nbsp;3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Property and Equipment, Net</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment are recorded at cost. Depreciation is computed over the estimated useful lives of the related assets using the straight&#8209;line method. Leasehold improvements are amortized on a straight&#8209;line basis over the shorter of the useful life or term of the lease. Upon retirement or disposal, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is recorded to general and administrative expenses in the accompanying statement of operations and comprehensive loss. Routine expenditures for maintenance and repairs are expensed as incurred.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Estimated useful lives for property and equipment are as follows:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Estimated&nbsp;Useful&nbsp;Life</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computers and peripherals</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">3&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">5&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">7&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Lesser of estimated useful life or remaining lease term</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Construction in Progress</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Construction in progress (Note&nbsp;4) is carried at cost and consists of specifically identifiable direct and indirect development and construction costs. While under construction, costs of the property are included in construction in progress until the property is placed in service, at which time costs are transferred to the appropriate property and equipment account including, but not limited to, leasehold improvements or other such accounts.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Impairment of Long&#8209;Lived Assets</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company reviews the recoverability of its long&#8209;lived asset group when events or changes in circumstances occur that indicate that the carrying value of the asset group may not be recoverable. The assessment of possible impairment is based on the ability to recover the carrying value of the asset group from the expected future cash flows (undiscounted and without interest expense) of the related operations. If these cash flows are less than the carrying value of such asset group, an impairment loss for the difference between the estimated fair value and carrying value is recorded. There was no impairment loss recognized during the&nbsp;years ended December&nbsp;31, 2018 or 2017.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Preferred Stock</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s preferred stock is classified outside of stockholders&#x2019; deficit because the shares contain deemed liquidation rights that are a contingent redemption feature not solely within the control of the Company.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Research and Development Costs</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Expenditures, including payroll, contractor expenses and supplies, for research and development of products are expensed as incurred. Development costs incurred by third parties are expensed as the contracted work is performed. Where contingent milestone payments are due to third parties under research and development arrangements, the milestone payment obligations are expensed when the milestone results are probable of being achieved.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Patent Costs</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">All patent&#8209;related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses in the accompanying statement of operations and comprehensive loss.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;Based Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company accounts for its stock&#8209;based compensation in accordance with ASC Topic 718, </font><font style="display:inline;font-style:italic;">Compensation&#8209;Stock Compensation</font><font style="display:inline;"> (&#x201C;ASC 718&#x201D;). ASC 718 requires all share&#8209;based payments to employees, consultants and directors, including grants of incentive stock options, nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company, to be recognized as expense in the statement of operations and comprehensive loss based on their grant date fair values. The Company estimates the fair value of options granted using the Black&#8209;Scholes option pricing model (&#x201C;Black&#8209;Scholes&#x201D;) for stock option grants to both employees and non&#8209;employees and the fair value of common stock to determine the fair value of restricted stock.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company recognizes forfeitures as they occur as allowed by ASU No.&nbsp;2016&#8209;09, </font><font style="display:inline;font-style:italic;">Improvements to Employee Share&#8209;Based Payment Accounting</font><font style="display:inline;"> (&#x201C;ASU&nbsp;2016&#8209;09&#x201D;).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Black&#8209;Scholes option pricing model requires inputs based on certain subjective assumptions, including (i)&nbsp;the expected stock price volatility, (ii)&nbsp;the expected term of the award, (iii)&nbsp;the risk&#8209;free interest rate and (iv)&nbsp;expected dividends. Due to the lack of a public market for the Company&#x2019;s common stock and lack of company&#8209;specific historical and implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with expected term assumption. The Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No.&nbsp;107, Share&#8209;Based Payment, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the Company does not expect substantially different exercise or post&#8209;vesting termination behavior among its employee population. For options granted to non&#8209;employees, the Company utilizes the simplified method also as the basis for the expected term assumption. The risk&#8209;free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">There are significant judgments and estimates inherent in the determination of the fair value of the Company&#x2019;s common stock. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of preferred stock, the superior rights and preferences of securities senior to its common stock at the time of, and the likelihood of, achieving a liquidity event, such as an initial public offering or sale.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company expenses the fair value of its share&#8209;based compensation awards on a straight&#8209;line basis over the requisite service period, which is generally the vesting period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Income Taxes</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities, which relate primarily to the carrying amount of the Company&#x2019;s property and equipment and its net operating loss carryforwards, are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, the Company concludes that it is more&#8209;likely&#8209;than&#8209;not that the deferred tax assets will not be realized. In evaluating its ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction&#8209;by&#8209;jurisdiction basis. Because of the uncertainty of the realization of deferred tax assets, the Company has recorded a full valuation allowance against its deferred tax assets.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Reserves are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more&#8209;likely&#8209;than&#8209;not to be sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the provision of income taxes; however, the Company currently has no interest or penalties related to uncertain income tax benefits.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Revenue Recognition</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has adopted ASC Topic 606, Revenue from Contracts with Customers (&#x201C;ASC 606&#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral or dependent to other goods or services in the contract.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration which is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&#x2019;s control or the licensee&#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related&nbsp;revenue recognition.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Comprehensive Loss</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company did not have any other comprehensive income or loss for any of the periods presented and, therefore, comprehensive loss did not differ from net loss.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Net Loss per Share</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two&#8209;class method required for participating securities. The Company considers its Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock to be participating securities because in the event a dividend is paid on common stock, the holders of Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock would be entitled to receive dividends on a basis consistent with the common stockholders. Under the two&#8209;class method, the net loss attributable to common stockholders is not allocated to the preferred stock as the holders of the preferred stock do not have a contractual obligation to share in losses.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Under the two&#8209;class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Recently Adopted Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In March&nbsp;2016, the FASB issued ASU&nbsp;No.&nbsp;2016&#8209;08, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers (Topic&nbsp;606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;08&#x201D;), which clarified the revenue recognition implementation guidance on principal versus agent considerations. In April&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;10, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;10&#x201D;), which clarified the revenue recognition guidance regarding the identification of performance obligations and the licensing implementation. In May&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;12, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers (Topic 606): Narrow&#8209;Scope Improvements and Practical Expedients</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;12&#x201D;), which narrowly amended the revenue recognition guidance regarding collectability, noncash consideration, presentation of sales tax and transition. ASU No.&nbsp;2016&#8209;08, ASU No.&nbsp;2016&#8209;10 and ASU 2016&#8209;12 are effective during the same period as ASU No.&nbsp;2014&#8209;09, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2014&#8209;09&#x201D;), which is effective for the Company for fiscal&nbsp;years beginning after December 15, 2018 and interim periods within fiscal&nbsp;years beginning after December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016&#8209;08, ASU 2016&#8209;10, ASU&nbsp;2016&#8209;12 and ASU&nbsp;2014&#8209;09 as of January 1, 2018 on a retrospective basis. There was no revenue in previous years and the adoption of ASC 606 did not have any impact on prior year financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In August&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;15, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;15&#x201D;). ASU 2016&#8209;15 eliminates the diversity in practice related to the classification of certain cash receipts and payments for debt prepayment or extinguishment costs, the maturing of a zero-coupon bond, the settlement of contingent liabilities arising from a business combination, proceeds from insurance settlements, distributions from certain equity method investees and beneficial interests obtained in a financial asset securitization. ASU 2016&#8209;15 designates the appropriate cash flow classification, including requirements to allocate certain components of these cash receipts and payments among operating, investing and financing activities. The retrospective transition method, requiring adjustment to all comparative periods presented, is required unless it is impracticable for some of the amendments, in which case those amendments would be prospectively applied as of the earliest date practicable. ASU 2016&#8209;15 is effective for the Company for fiscal&nbsp;years beginning after December 15, 2018 and interim periods within fiscal&nbsp;years beginning after December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016-15 as of January 1, 2018.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In November&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;18, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Statement of Cash Flows (Topic 230): Restricted Cash</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;18&#x201D;), which requires that a statement of cash flows explain the change during the period in the total cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning and ending balances shown on the statement of cash flows. The guidance is effective for the Company for fiscal&nbsp;years beginning after December 15, 2018 and interim periods within fiscal years beginning after December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU&nbsp;2016&#8209;18 as of January&nbsp;1, 2017.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In May&nbsp;2017, the FASB issued ASU No.&nbsp;2017&#8209;09, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Compensation&#x2014;Stock Compensation (Topic 718): Scope of Modification Accounting</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2017&#8209;09&#x201D;), which clarifies when to account for a change to the terms or conditions of a share&#8209;based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions of the agreement. The standard is effective for fiscal&nbsp;years, and interim periods within those&nbsp;years, beginning after December&nbsp;15, 2017. The Company adopted ASU 2017&#8209;09 as of the required effective date of January&nbsp;1, 2018. In June&nbsp;2018, the FASB issued ASU No.&nbsp;2018&#8209;07</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"> Compensation&#x2014;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU No.&nbsp;2018&#8209;07&#x201D;). ASU No.&nbsp;2018&#8209;07 expands the guidance in ASC718 to include share-based payments for goods and services to non-employees and generally aligns it with the guidance for share-based payments to employees. The amendments are effective for the Company for fiscal&nbsp;years beginning after December&nbsp;15, 2019 and interim periods within fiscal years beginning after December 15, 2020, with early adoption permitted for entities that have adopted ASC 606. The Company adopted this new standard on January&nbsp;1, 2018.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Recently Issued Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In February&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;02, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Leases</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;02&#x201D;). The new guidance requires lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016&#8209;02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right&#8209;to&#8209;use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company for fiscal&nbsp;years beginning after December 15, 2019 and interim periods fiscal&nbsp;years beginning after December&nbsp;15, 2020. Early adoption </font><font style="display:inline;">is permitted. The Company is currently evaluating the effect of this standard on its financial statements.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<a name="_cp_text_4_25"></a><font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6833610608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock options (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 03, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Jan. 24, 2017</div></th>
<th class="th"><div>Dec. 29, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,802,648<span></span>
</td>
<td class="nump">5,043,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember', window );">2015 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for issuance under the plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,422<span></span>
</td>
<td class="nump">311,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,056,891<span></span>
</td>
<td class="nump">506,586<span></span>
</td>
<td class="nump">189,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247,275<span></span>
</td>
<td class="nump">1,570,136<span></span>
</td>
<td class="nump">317,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,963)<span></span>
</td>
<td class="num">(5,599)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,250)<span></span>
</td>
<td class="num">(14,232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,056,891<span></span>
</td>
<td class="nump">2,248,953<span></span>
</td>
<td class="nump">2,248,953<span></span>
</td>
<td class="nump">2,056,891<span></span>
</td>
<td class="nump">506,586<span></span>
</td>
<td class="nump">189,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at the end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,056,891<span></span>
</td>
<td class="nump">2,248,953<span></span>
</td>
<td class="nump">2,248,953<span></span>
</td>
<td class="nump">2,056,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Exercisable at the end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,079<span></span>
</td>
<td class="nump">450,866<span></span>
</td>
<td class="nump">450,866<span></span>
</td>
<td class="nump">242,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the beginning (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.18<span></span>
</td>
<td class="nump">5.92<span></span>
</td>
<td class="nump">1.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
<td class="nump">0.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeitures (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.63<span></span>
</td>
<td class="nump">1.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the end (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="nump">$ 6.30<span></span>
</td>
<td class="nump">6.30<span></span>
</td>
<td class="nump">4.74<span></span>
</td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest at the end (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.74<span></span>
</td>
<td class="nump">6.30<span></span>
</td>
<td class="nump">6.30<span></span>
</td>
<td class="nump">4.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Exercisable at the end (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.88<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="nump">$ 0.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life (Years) And Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 1 month 6 days<span></span>
</td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm', window );">Granted (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">9 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm', window );">Exercised (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm', window );">Forfeitures (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at the beginning (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,946,000<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at the end (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,946,000<span></span>
</td>
<td class="nump">$ 55,305,000<span></span>
</td>
<td class="nump">55,305,000<span></span>
</td>
<td class="nump">5,946,000<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest at the end (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,946,000<span></span>
</td>
<td class="nump">55,305,000<span></span>
</td>
<td class="nump">55,305,000<span></span>
</td>
<td class="nump">5,946,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Exercisable at the end (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,634,000<span></span>
</td>
<td class="nump">$ 12,335,000<span></span>
</td>
<td class="nump">$ 12,335,000<span></span>
</td>
<td class="nump">$ 1,634,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value per share of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.48<span></span>
</td>
<td class="nump">$ 3.80<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 38,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember', window );">2015 Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock', window );">Share price of common stock on date of grant as a percent of fair market value of company stock (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember', window );">2015 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm', window );">Term of awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_OmnibusIncentive2019PlanMember', window );">Omnibus Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for issuance under the plan</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding', window );">Annual increase in number of share reserved for issuance (as percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember', window );">2015 Plan and 2019 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_EmployeeStockPurchase2019PlanMember', window );">2019 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for issuance under the plan</a></td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,653,969<span></span>
</td>
<td class="nump">2,653,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding', window );">Annual increase in number of share reserved for issuance (as percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan', window );">Maximum annual increase in shares available for issuance under the plan</a></td>
<td class="nump">480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Option to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,248,953<span></span>
</td>
<td class="nump">2,248,953<span></span>
</td>
<td class="nump">242,079<span></span>
</td>
<td class="nump">64,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for exercised options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for forfeiture options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in shares available for issuance as a percentage of number of shares of the company's common stock outstanding on December 31st of the preceding calendar year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_ShareBasedCompensationArrangementIncreaseInSharesForIssuanceAsPercentageOfNumberOfCommonStockOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The threshold number of shares of the company's common stock available for issuance under the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_ShareBasedCompensationArrangementThresholdNumberOfCommonStockForIssuanceUnderPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the share price of common stock on date of grant as a percent of fair market value of company stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_SharePriceOfCommonStockOnDateOfGrantAsPercentOfFairMarketValueOfCompanyStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual term for option awards outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nxtc_OmnibusIncentive2019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nxtc_OmnibusIncentive2019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nxtc_OmnibusIncentive2015PlanAndEmployeeStockPurchase2019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nxtc_EmployeeStockPurchase2019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nxtc_EmployeeStockPurchase2019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6834385264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Other (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 02, 2019</div></th>
<th class="th"><div>Jan. 30, 2019</div></th>
<th class="th"><div>Feb. 09, 2016</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_AnnualBaseRentPerMonth', window );">Annual base rent per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PeriodForWhichBaseRentIsAbated', window );">Period for which base rent is abated</a></td>
<td class="text">7 months<span></span>
</td>
<td class="text">7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_AnnualBaseRentPerMonthAfterAbatement', window );">Annual base rent per month after abatement</a></td>
<td class="nump">$ 18,178<span></span>
</td>
<td class="nump">$ 19,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PercentageOfAnnualIncreaseInLeaseRent', window );">Percentage of annual increase in lease rent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_LetterOfCredit', window );">Executed letter of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements', window );">Base rate adjustment percentage per annum (as a percent)</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_TenantImprovementsReimbursement', window );">Tenant improvements fully reimbursed by the landlord</a></td>
<td class="nump">$ 1,517,000<span></span>
</td>
<td class="nump">$ 1,477,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expenses operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252,000<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
<td class="nump">$ 442,000<span></span>
</td>
<td class="nump">$ 308,000<span></span>
</td>
<td class="nump">$ 420,000<span></span>
</td>
<td class="nump">$ 376,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_AnnualBaseRentPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of annual base rent per month.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_AnnualBaseRentPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_AnnualBaseRentPerMonthAfterAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of annual base rent per month after abatement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_AnnualBaseRentPerMonthAfterAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the base rate adjustment percentage per annum multiplied by the outstanding balance of amounts paid for tenant improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_BaseRateAdjustmentPercentagePerAnnumMultipliedByOutstandingBalanceOfAmountsPaidForTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_LetterOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of letters of credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_LetterOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PercentageOfAnnualIncreaseInLeaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of annual increase in operating lease rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PercentageOfAnnualIncreaseInLeaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PeriodForWhichBaseRentIsAbated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for which the base rent is abated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PeriodForWhichBaseRentIsAbated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_TenantImprovementsReimbursement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of tenant improvements fully reimbursed by the landlord.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_TenantImprovementsReimbursement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6840191312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br></strong></div></th>
<th class="th">
<div>Preferred Stock </div>
<div>Series A Preferred Stock</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Series A-3 preferred stock</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Series B Preferred Stock</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Series A Preferred Stock</div></th>
<th class="th"><div>Series B Preferred Stock</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,029,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,018,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2016</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2016</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,469,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,469,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,498,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,413,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Dec. 31, 2017</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Dec. 31, 2017</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,996,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,996,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,494,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,385,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Mar. 31, 2018</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Mar. 31, 2018</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,498,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,413,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2017</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2017</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,937,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,435,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,212,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Sep. 30, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,498,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,413,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2017</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2017</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000,000<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,181,819<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,799,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,799,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">352,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,297,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46,944,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Dec. 31, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,000,000<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="nump">$ 162,223,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Dec. 31, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,494,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,385,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Mar. 31, 2018</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Mar. 31, 2018</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_StockIssuedDuringPeriodValueInitialPublicOffering', window );">Initial public offering, net of issuance costs of $9.4 million</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering', window );">Initial public offering, net of issuance costs of $9.4 million (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,231,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,231,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,725,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,592,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Jun. 30, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Jun. 30, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,710,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,710,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,435,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,212,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Sep. 30, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">352,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,297,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46,944,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,000,000<span></span>
</td>
<td class="nump">91,223,000<span></span>
</td>
<td class="nump">$ 162,223,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,155,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,155,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">739,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,452,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,712,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Mar. 31, 2019</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Mar. 31, 2019</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">352,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,297,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46,944,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="nump">$ 162,223,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,810,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="nump">240,791,000<span></span>
</td>
<td class="num">$ (58,000)<span></span>
</td>
<td class="num">(70,107,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170,649,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">739,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,452,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (52,712,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Mar. 31, 2019</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Mar. 31, 2019</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_StockIssuedDuringPeriodValueInitialPublicOffering', window );">Initial public offering, net of issuance costs of $9.4 million</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">76,848,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,854,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering', window );">Initial public offering, net of issuance costs of $9.4 million (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of preferred stock to common stock</a></td>
<td class="num">$ (71,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (91,223,000)<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">162,208,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,223,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of preferred stock to common stock (in shares)</a></td>
<td class="num">(68,181,819)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56,828,851)<span></span>
</td>
<td class="nump">15,560,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">38,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,221,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,221,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="nump">240,245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61,673,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,595,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,714,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,434,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,434,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="nump">$ 240,791,000<span></span>
</td>
<td class="num">$ (58,000)<span></span>
</td>
<td class="num">$ (70,107,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170,649,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period from initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_StockIssuedDuringPeriodSharesInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_StockIssuedDuringPeriodValueInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_StockIssuedDuringPeriodValueInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=109196918&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109196918&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79507207&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6837919856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Reconciliation of federal statutory income tax rate to the Company's effective income tax rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Expected income tax benefit at the federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credit, net</a></td>
<td class="nump">7.20%<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Non-deductible items</a></td>
<td class="num">(2.20%)<span></span>
</td>
<td class="num">(5.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Prior year provision to return adjustments</a></td>
<td class="num">(7.70%)<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent', window );">Tax rate reduction due to the Tax Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="num">(2.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(25.10%)<span></span>
</td>
<td class="num">(25.50%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Reconciliation of federal statutory income tax rate to the Company's effective income tax rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Expected income tax benefit at the federal statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) in income tax rate and transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6823105344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">69.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">2.77%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average expected volatility rate of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6832329920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 02, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>May 03, 2019</div></th>
<th class="th">
<div>Jan. 30, 2019 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jan. 25, 2019 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th"><div>Feb. 09, 2016</div></th>
<th class="th">
<div>Apr. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th">
<div>Mar. 15, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_DebtInstrumentMonthlyPaymentsNumber', window );">Number of equal monthly payments of principal plus accrued interest | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.33%<span></span>
</td>
<td class="nump">4.18%<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
<td class="nump">3.84%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PeriodForWhichBaseRentIsAbated', window );">Period for which base rent is abated</a></td>
<td class="text">7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_AnnualBaseRentPerMonthAfterAbatement', window );">Annual base rent per month after abatement</a></td>
<td class="nump">$ 18,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PercentageOfAnnualIncreaseInLeaseRent', window );">Percentage of annual increase in lease rent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Future minimum payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,918,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,918,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stockholders' Equity Note, Stock Split, Conversion Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Prime rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_DebtInstrumentMonthlyPaymentsNumber', window );">Number of equal monthly payments of principal plus accrued interest | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space (in square feet) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PeriodForWhichBaseRentIsAbated', window );">Period for which base rent is abated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_AnnualBaseRentPerMonthAfterAbatement', window );">Annual base rent per month after abatement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PercentageOfAnnualIncreaseInLeaseRent', window );">Percentage of annual increase in lease rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Future minimum payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stockholders' Equity Note, Stock Split, Conversion Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Maximum | Prime rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_AnnualBaseRentPerMonthAfterAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of annual base rent per month after abatement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_AnnualBaseRentPerMonthAfterAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_DebtInstrumentMonthlyPaymentsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of periodic payments of principal plus accrued interest (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_DebtInstrumentMonthlyPaymentsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PercentageOfAnnualIncreaseInLeaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of annual increase in operating lease rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PercentageOfAnnualIncreaseInLeaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PeriodForWhichBaseRentIsAbated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for which the base rent is abated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PeriodForWhichBaseRentIsAbated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818709584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">7. Commitments and Contingencies<a name="a7CommitmentsandContingencies_104288"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Operating Leases</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">On February 9, 2016, the Company entered into a non-cancelable facilities operating sublease (the &#x201C;2016 Sublease&#x201D;). On March 15, 2019, the Company amended and restated the 2016 Sublease (as amended, the &#x201C;Amended 2016 Sublease&#x201D;) to include additional square footage to be used for office space, which the Company took possession of upon entering into the Amended 2016 Sublease. The Amended 2016 Sublease expires in August 2025. The base rent under the Amended 2016 Sublease is currently $32,254 per month plus the Company&#x2019;s prorated share of the sublandlord&#x2019;s operating expense and is subject to annual rent increases of 3%. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">On January 30, 2019, the Company entered into a new lease to be used for office and laboratory space (the &#x201C;New Premises&#x201D;), which the Company took possession of on June 1, 2019 (the &#x201C;2019 Lease&#x201D;). On August 2, 2019, the Company amended the 2019 Lease (as, the &#x201C;Amended 2019 Lease&#x201D;) to include additional space to be used for office and laboratory space (the &#x201C;Expansion Premises&#x201D;), which the Company expects to take possession of on April 1, 2020. The Amended 2019 Lease expires in March 2030. Upon expiration of the Amended 2016 Sublease, the Amended 2019 Lease will also cover the space the Company is currently subleasing under the Amended 2016 Sublease. Base rent is abated until April 1, 2020 for the New Premises and until seven months after delivery of the Expansion Premises for the Expansion Premises, after which the base rent will be $19,646 per month for the New Premises and $18,178 per month for the Expansion Premises, each subject to annual rent increases of 3%. In connection with this lease, the Company executed a $39,000 letter of credit, which has not been drawn down on. Additionally, there is a base rate adjustment of 8.5% per annum multiplied by the outstanding balance of amounts paid for tenant improvements. The budgeted amounts of tenant improvements are approximately $1,477,000 for the New Premises and $1,517,000 for the Expansion Premises, which are to be fully reimbursed by the landlord.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The future minimum payments for the operating leases are as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Remainder of the year</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 97</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 566</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 692</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 742</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 733</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Thereafter</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,088</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total future minimum payments</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,918</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Rent expense incurred under operating leases was approximately&nbsp;$252,000&nbsp;and $442,000&nbsp;for the three and nine months ended September&nbsp;30, 2019, respectively, and $107,000 and $308,000 for the three and nine months ended September 30, 2018, respectively.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Legal Proceedings</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company, from time to time, may be party to litigation arising in the ordinary course of business. The Company is not a party to any litigation or legal proceedings, nor is management aware of any pending or threatened litigation that, in the opinion of the Company&#x2019;s management, are likely to have a material adverse effect on the Company&#x2019;s business. At each reporting date, the Company evaluates whether a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses the costs related to its legal proceedings as incurred.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">7. Commitments and Contingencies</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Operating Leases</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company subleases its facilities under a non&#8209;cancelable operating sublease agreement. The sublease commenced on February&nbsp;9, 2016 and expires on August&nbsp;31, 2025. The Company is also responsible for its prorated share of the sublandlord&#x2019;s operating expense.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The future minimum payments for the operating leases are as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Year Ending December&nbsp;31,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 325</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 308</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 317</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 355</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 335</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Thereafter</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 635</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total future minimum payments</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,275</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Rent expense incurred under operating leases was approximately $420,000 and $376,000 for the&nbsp;years ended December&nbsp;31, 2018 and 2017, respectively.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Contingencies</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company is subject to claims and assessments from time to time in the ordinary course of business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In the normal course of business, the Company may become involved in legal proceedings. The Company will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. As of December&nbsp;31, 2018 and 2017, the Company was not involved in any material legal proceedings.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6817830544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreement with Eli Lilly and Company (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementDisclosureAbstract', window );"><strong>Agreement with Eli Lilly and Company</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock', window );">Summary of deferred revenue included in the Company's balance sheets</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">As of September&nbsp;30, 2019, deferred revenue included in the Company&#x2019;s balance sheets comprised the following (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred revenue, beginning of period</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 26,725</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Up-front payment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 25,000</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Attributed premium on the proceeds from Lilly&#x2019;s investment in the Company</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,725</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development support billing</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,500</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Revenue from research and development arrangement recognized</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,342)</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total deferred revenue, end of period</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 23,883</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 26,725</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: Deferred revenue, current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (6,199)</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,989)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred revenue, non-current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 17,684</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 21,736</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>N/A</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tabular disclosure of deferred revenue from related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_ScheduleOfDeferredRevenueFromRelatedPartyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6820377696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Business - (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 13, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>May 03, 2019</div></th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Nature of the Business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of shares, net | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">15,560,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, number of shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,745,671<span></span>
</td>
<td class="nump">84,045,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, number of shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Nature of the Business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of shares, net | $</a></td>
<td class="nump">$ 77,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PaymentsOfUnderwritingDiscountsAndCommissions', window );">Underwriting discounts and commissions | $</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering expenses | $</a></td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PaymentsOfUnderwritingDiscountsAndCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of underwriting discounts and commissions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PaymentsOfUnderwritingDiscountsAndCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818234688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">11. Subsequent Events<a name="a16SubsequentEvents_824036"></a></font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has evaluated subsequent events through the issuance date of these interim condensed financial statements.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">16. Subsequent Events</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On January&nbsp;25, 2019, the Company amended its Term Loan to an aggregate principal amount of $5.0&nbsp;million, which remains secured by the Company&#x2019;s certificates of deposit, money market account, investment property and deposit or investment accounts. As amended, the Term Loan bears interest at the greater of the prime rate less 1% and 4.25%. Under the agreement, the Company is required to make&nbsp;monthly interest&#8209;only payments through January&nbsp;2020 and is required to make 36 equal&nbsp;monthly payments of principal plus accrued interest thereafter through January&nbsp;2023.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On January&nbsp;30, 2019, the Company entered into a new lease for 14,075 square feet to be used for office, manufacturing and laboratory space, which the Company expects to take possession of in June&nbsp;2019. The new lease is expected to expire in March&nbsp;2030 and will also cover the Company&#x2019;s existing space after expiration of the Company&#x2019;s current lease. Base rent for the first 10 months is abated, after which the base rent of the lease is $19,650 per&nbsp;month, with an increase in annual rent of 3.0% in each subsequent&nbsp;year of the lease term.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On March&nbsp;15, 2019, the Company entered into an amended and restated lease that covers the Company&#x2019;s existing space plus additional square footage to be used as office space, which the Company took possession of upon entering into the amended and restated lease. The amended and restated lease expires in August 2025. The total remaining commitment under the amended and restated lease is approximately $3.0&nbsp;million.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On May&nbsp;3, 2019, the Company effected a 1&#8209;for&#8209;8.0338 reverse stock split of its outstanding common stock. The par value and authorized shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818234688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common Stock.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CommonStockTextBlock', window );">Common Stock</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">10. Common Stock</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">As of December&nbsp;31, 2018, the Company&#x2019;s Certificate of Incorporation, as amended and restated, authorized the Company to issue 158,745,671 shares of $0.001 par value common stock, of which 1,374,812 were issued and outstanding.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#x2019;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the board of directors, if any, subject to the preferential dividend rights of the preferred stock. When dividends are declared on shares of common stock, the Company must declare at the same time a dividend payable to the holders of preferred stock equivalent to the dividend amount they would receive if each share of preferred stock was converted into common stock. The Company may not pay dividends to common stockholders until all dividends accrued or declared but unpaid on the preferred stock have been paid in full. No dividends have been declared or paid by the Company through December&nbsp;31, 2018.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In the event of any liquidation or dissolution of the Company, the holders of common stock are entitled to the remaining assets of the Company legally available for distribution after the payment of the full liquidation preference for the preferred stock.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CommonStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CommonStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6653539568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreement with Eli Lilly and Company<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementDisclosureAbstract', window );"><strong>Agreement with Eli Lilly and Company</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Agreement with Eli Lilly and Company</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">6. </font><font style="display:inline;font-family:Times New Roman,Times,serif;">Agreement with Eli Lilly and Company<a name="a6AgreementwithEliLillyandCompany_802770"></a>&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On November 2, 2018, the Company entered into a multi-year research and development collaboration agreement (the &#x201C;Lilly Agreement&#x201D;) with Eli Lilly and Company (&#x201C;Lilly&#x201D;), pursuant to which the Company will use its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Under the Lilly Agreement, Lilly and the Company have granted one another an equal number of exclusive options to research, develop, manufacture and commercialize compounds and products directed to oncology targets identified through the Lilly Agreement. Both Lilly and the Company have all options remaining eligible for exercise. The research collaboration with Lilly will be managed by a joint steering committee formed by an equal number of members from the Company and Lilly and will expire upon the earlier of the exercise of all options granted to Lilly or four years from the date of the agreement, subject to certain extensions. The Company considers Lilly to be a related party based on Lilly&#x2019;s equity investment in the Company as discussed below.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">During the research term under the Lilly Agreement, as a part of target discovery, the Company will be responsible for providing Lilly with oncology targets identified using the Company&#x2019;s FIND-IO platform. From the targets provided by the Company, Lilly may select targets to advance to target validation using criteria developed by both parties. Following completion of the agreed upon target validation plan with respect to a given target, either party may propose to advance that target to compound discovery. For each target that has been advanced to compound discovery, Lilly will have the option to obtain an exclusive license with respect to the compounds and products directed to the target. If Lilly does not exercise its option with respect to a given target or has previously exercised all of its options, the Company will have the option to obtain licenses with respect to compounds and products directed to that target. Following option exercise by a party, the development and commercialization of any products directed to the target will be conducted by the exercising party. The exercising party must use commercially reasonable efforts to develop, seek regulatory approval for and commercialize any such products under mutually agreed upon work plans.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In November 2018, the Company received an upfront, non-refundable payment of $25.0 million under the Lilly Agreement and a concurrent $15.0 million equity investment. In addition, the Company will receive quarterly research and development support payments during a portion of the research term as well as option exercise fees upon option exercises by Lilly.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Pursuant to the Lilly Agreement, Lilly may owe an aggregate of up to $1.4 billion in development and regulatory milestones and sales milestones. Additionally, Lilly will pay mid to high single-digit royalties on net sales for all products directed to each target optioned by Lilly. Upon the Company&#x2019;s exercise of an option with respect to a given target, the Company will pay Lilly an option exercise payment and may become obligated to milestone and royalty payments. The company may owe an aggregate of up to $710.0 million in development and regulatory milestones and sales milestones.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upon the adoption of ASC 606, the Company evaluated the Lilly Agreement under the provisions of ASC 606 and concluded that Lilly is a customer prior to the exercise of its option to obtain an exclusive license with respect to the compounds and products directed to a target that has been advanced to compound discovery. The Company identified the following material promises under the Lilly Agreement: (i) a limited research license to conduct activities under the research collaboration; (ii) research and development services together with the provision of a data package in connection with Lilly&#x2019;s option; (iii) various governance obligations, most notably participation on the joint steering committee; and (iv) rights related to an optional term extension by Lilly. The Company evaluated Lilly&#x2019;s option to obtain an exclusive license with respect to the compounds and products directed to a target that has been advanced to compound discovery and concluded that the option was not issued at a significant and incremental discount, and therefore does not provide material rights. As such, they are excluded as performance obligations at the outset of the arrangement. The Company determined that the research license was not capable of being distinct and the related research and development services and governance activities are not distinct in the context of the contract and, as such, the Company determined that these promises should be combined into a single performance obligation, resulting in a total of two performance obligations under the Lilly Agreement; one for research and development services and one for the right related to an optional term extension by Lilly.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The transaction price at the outset of the arrangement was determined to be $32.7 million, comprised of the upfront fee received from Lilly, quarterly research and development support payments to be received from Lilly during a portion of the research term and an equity investment premium as determined by the Company with reference to a valuation of the Company&#x2019;s preferred stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, </font><font style="display:inline;font-style:italic;">Valuation of Privately-Held-Company Equity Securities Issued as Compensation.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The transaction price was allocated to the two performance obligations based on their relative standalone selling price determined with reference to the Company&#x2019;s estimated costs attendant to the obligations. Revenue allocated to the research and development performance obligation is being recognized as the research and development services are provided using an input method according to research and development costs incurred to date compared to estimated total research and development costs. The transfer of control occurs over this time period and, in management&#x2019;s judgment, is the best measure of progress towards satisfying the performance obligation. Revenue allocated to Lilly&#x2019;s right related to an optional term extension is deferred until the right is exercised or lapses, and will subsequently be recognized accordingly.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">While the Lilly Agreement was executed in November 2018, the Company&#x2019;s performance initiated in January 2019. Under the Lilly Agreement, the Company recognized revenue of $1.6 million and $4.3 million for the three and nine months ended September&nbsp;30, 2019, respectively. As of September&nbsp;30, 2019, deferred revenue included in the Company&#x2019;s balance sheets comprised the following (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred revenue, beginning of period</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 26,725</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Up-front payment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 25,000</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Attributed premium on the proceeds from Lilly&#x2019;s investment in the Company</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,725</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development support billing</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,500</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Revenue from research and development arrangement recognized</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,342)</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total deferred revenue, end of period</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 23,883</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 26,725</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: Deferred revenue, current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (6,199)</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,989)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred revenue, non-current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 17,684</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 21,736</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">6. Agreement with Eli Lilly and Company</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On November 2, 2018, the Company entered into a multi-year research and development collaboration agreement (the &#x201C;Lilly Agreement&#x201D;) with Eli Lilly and Company (&#x201C;Lilly&#x201D;), pursuant to which the Company will use its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Under the Lilly Agreement, Lilly and the Company have granted one another an equal number of exclusive options to <a name="_cp_text_1_8"></a>research, develop, manufacture and commercialize compounds and products directed to oncology targets identified through the Lilly Agreement. <a name="_cp_text_1_9"></a>Both Lilly and the Company each have all options remaining eligible for exercise. The research collaboration with Lilly will be managed by a joint steering committee formed by an equal number of members from the Company and Lilly and will expire upon the earlier of the exercise of all options granted to Lilly or four years from the date of the agreement, subject to certain extensions.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">During the research term under the Lilly Agreement, as a part of target discovery, the Company will be responsible for providing Lilly with oncology targets identified using the Company&#x2019;s FIND-IO platform. From the targets provided by the Company, Lilly may select targets to advance to target validation using criteria developed by both parties. Following completion of the agreed upon target validation plan with respect to a given target, either party may propose to advance that target to compound discovery. <a name="_cp_text_1_10"></a>For each target that has been advanced to compound discovery, Lilly will have the option to obtain an exclusive license with respect to the compounds and products directed to the target. If Lilly does not exercise its option with respect to a given target or has previously exercised all of its options, the Company will have the option to obtain licenses with respect to compounds and products directed to that target. Following option exercise by a party, the development and commercialization of any products directed to the target will be conducted by the exercising party. The exercising party must use commercially reasonable efforts to develop, seek regulatory approval for and commercialize any such products under mutually agreed upon work plans.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company received an upfront, non-refundable payment of $25.0 million under the Lilly Agreement and a concurrent $15.0 million equity investment (Note 9). In addition, the Company will receive quarterly research and development support payments during a portion of the research term as well as option exercise fees upon option exercises by Lilly.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Pursuant to the Lilly Agreement, Lilly will owe an aggregate of up to $<a name="_cp_text_1_14"></a>1.4 billion in development and regulatory milestones&nbsp;<a name="_cp_text_1_15"></a>and sales milestones. Additionally, Lilly will pay mid to high single-digit royalties<a name="_cp_text_1_18"></a> on net sales for all products directed to each target optioned by Lilly. Upon the Company&#x2019;s exercise of an option with respect to a given target, the Company will <a name="_cp_text_1_20"></a>pay Lilly option exercise, milestone and royalty payments. The company will owe an aggregate of up to $<a name="_cp_text_1_22"></a>710.0&nbsp;million in development and regulatory milestones&nbsp;<a name="_cp_text_1_24"></a>and sales milestones.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The company has evaluated the Lilly Agreement under ASC 606. Two performance obligations were identified as follows:</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
			<font style="display:inline;">research and development services; and</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
			<font style="display:inline;">material right related to an optional term extension by Lilly.</font></p></td></tr></table></div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Lilly Agreement was executed in November 2018, however, the performance obligations were initiated in January 2019; accordingly no revenue was recorded under the Lilly Agreement in 2018. As of December 31, 2018, deferred revenue included in the Company&#x2019;s balance sheets in connection with the Lilly Agreement was $26.7 million, which consisted of the $25.0 million upfront payment plus $1.7 million attributed as a premium on the proceeds from Lilly&#x2019;s equity investment in the Company (Note 9).</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>N/A</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6833880672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount', window );">Assets transferred from level 1 to level 2</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount', window );">Assets transferred from level 2 to level 1</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value | Quoted Prices in Active Markets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812443792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Term Loan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of future maturities</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Future maturities of the Term Loan as of September 30, 2019 are as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Remainder of the year</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,528</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,667</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,667</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 138</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: current portion of term loan</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,250)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Term loan, net of current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,750</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Future maturities of the Term Loan as of December&nbsp;31, 2018 are as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 387</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 73</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: current portion of term loan</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 387</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Term loan, net of current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 73</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6835246256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Business and Basis of Presentation (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 03, 2019</div></th>
<th class="th">
<div>Nov. 05, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 02, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 05, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of preferred stock, net of issuance costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">$ 122,223<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split ratio (as a percent)</a></td>
<td class="nump">0.1245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember', window );">Series A-3 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of preferred stock, net of issuance costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB1PreferredStockMember', window );">Series B-1 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,052,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,052,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB2PreferredStockMember', window );">Series B-2 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,276,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,276,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB3PreferredStockMember', window );">Series B-3 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of preferred stock, net of issuance costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_SeriesB1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_SeriesB2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB3PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_SeriesB3PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6823109552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of property and equipment</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment consist of the following (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,746</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,787</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,365</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,825</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computer equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 441</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 167</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 94</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 70</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Construction in progress</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 787</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,027</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, gross</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 16,433</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 13,876</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: accumulated depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,402)</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2,469)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 12,031</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,407</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment consist of the following (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,787</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,213</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,825</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 564</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computer equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 167</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 111</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 70</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 33</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Construction in progress</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,027</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,892</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, gross</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 13,876</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10,813</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: accumulated depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2,469)</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (792)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,407</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10,021</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6834392496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">8,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,819<span></span>
</td>
<td class="nump">$ 13,539<span></span>
</td>
<td class="nump">$ 19,787<span></span>
</td>
<td class="nump">$ 12,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">2,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,995<span></span>
</td>
<td class="nump">2,590<span></span>
</td>
<td class="nump">3,409<span></span>
</td>
<td class="nump">2,595<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">11,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,814<span></span>
</td>
<td class="nump">16,129<span></span>
</td>
<td class="nump">23,196<span></span>
</td>
<td class="nump">15,549<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(9,702)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,820)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,472)<span></span>
</td>
<td class="num">(16,129)<span></span>
</td>
<td class="num">(23,196)<span></span>
</td>
<td class="num">(15,549)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">1,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,662<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">397<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(8,434)<span></span>
</td>
<td class="num">$ (8,221)<span></span>
</td>
<td class="num">$ (6,155)<span></span>
</td>
<td class="num">(5,710)<span></span>
</td>
<td class="num">$ (5,231)<span></span>
</td>
<td class="num">$ (4,996)<span></span>
</td>
<td class="num">(22,810)<span></span>
</td>
<td class="num">(15,937)<span></span>
</td>
<td class="num">(22,799)<span></span>
</td>
<td class="num">(15,469)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (8,492)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,710)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22,868)<span></span>
</td>
<td class="num">$ (15,937)<span></span>
</td>
<td class="num">$ (22,799)<span></span>
</td>
<td class="num">$ (15,469)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to common stockholders-basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4.17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.81)<span></span>
</td>
<td class="num">$ (11.64)<span></span>
</td>
<td class="num">$ (16.64)<span></span>
</td>
<td class="num">$ (11.30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding-basic and diluted (in shares)</a></td>
<td class="nump">22,715,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,609,219<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="nump">1,369,846<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6764392976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">11. Subsequent Events<a name="a16SubsequentEvents_824036"></a></font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has evaluated subsequent events through the issuance date of these interim condensed financial statements.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">16. Subsequent Events</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On January&nbsp;25, 2019, the Company amended its Term Loan to an aggregate principal amount of $5.0&nbsp;million, which remains secured by the Company&#x2019;s certificates of deposit, money market account, investment property and deposit or investment accounts. As amended, the Term Loan bears interest at the greater of the prime rate less 1% and 4.25%. Under the agreement, the Company is required to make&nbsp;monthly interest&#8209;only payments through January&nbsp;2020 and is required to make 36 equal&nbsp;monthly payments of principal plus accrued interest thereafter through January&nbsp;2023.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On January&nbsp;30, 2019, the Company entered into a new lease for 14,075 square feet to be used for office, manufacturing and laboratory space, which the Company expects to take possession of in June&nbsp;2019. The new lease is expected to expire in March&nbsp;2030 and will also cover the Company&#x2019;s existing space after expiration of the Company&#x2019;s current lease. Base rent for the first 10 months is abated, after which the base rent of the lease is $19,650 per&nbsp;month, with an increase in annual rent of 3.0% in each subsequent&nbsp;year of the lease term.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On March&nbsp;15, 2019, the Company entered into an amended and restated lease that covers the Company&#x2019;s existing space plus additional square footage to be used as office space, which the Company took possession of upon entering into the amended and restated lease. The amended and restated lease expires in August 2025. The total remaining commitment under the amended and restated lease is approximately $3.0&nbsp;million.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On May&nbsp;3, 2019, the Company effected a 1&#8209;for&#8209;8.0338 reverse stock split of its outstanding common stock. The par value and authorized shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812377888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of the Business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Nature of the Business and Basis of Presentation</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-align:left;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">1. Nature of the Business<a name="a1NatureoftheBusinessandBasisofPresentat"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Organization</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">NextCure,&nbsp;Inc. (&#x201C;NextCure&#x201D; or the &#x201C;Company&#x201D;) was incorporated in Delaware in September&nbsp;2015 and is headquartered in Beltsville, Maryland. The Company is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first&#8209;in&#8209;class immunomedicines to treat cancer and other immune&#8209;related diseases by restoring normal immune function. Through its proprietary Functional, Integrated, NextCure Discovery in Immuno&#8209;Oncology (&#x201C;FIND&#8209;IO&#x201D;) platform, the Company studies various immune cells in order to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Since inception, the Company has devoted substantially all of its efforts and financial resources to organizing and staffing the Company, identifying business development opportunities, raising capital, securing intellectual property rights related to the Company&#x2019;s product candidates, building and optimizing the Company&#x2019;s manufacturing capabilities and conducting discovery, research and development activities for the Company&#x2019;s product candidates, discovery programs and its FIND&#8209;IO platform.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Initial Public Offering</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On May 13, 2019, the Company closed its initial public offering (&#x201C;IPO&#x201D;), in which the Company issued and sold 5,750,000 shares of common stock at a public offering price of $15.00 per share, for net proceeds to the Company of approximately $77.0 million after deducting underwriting discounts and commissions of $6.0 million and offering expenses of approximately $3.4 million.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In preparation for the IPO, on May 3, 2019, the Company effected&nbsp;a &nbsp;one-for-8.0338 reverse stock split of its issued and outstanding common stock. The par value and authorized shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upon the closing of the IPO, on May 13, 2019, all of the outstanding shares of the Company&#x2019;s convertible preferred stock automatically converted into 15,560,569 shares of common stock at the applicable conversion ratio then in effect. Subsequent to the closing of the IPO, there were no shares of preferred stock outstanding. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upon the closing of the IPO, on May 13, 2019, the Company&#x2019;s certificate of incorporation was amended and restated to provide for 100,000,000 authorized shares of common stock with a par value of $0.001 per share and 10,000,000 authorized shares of preferred stock with a par value of $0.001 per share.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Liquidity</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has not generated any revenue to date from product sales and does not expect to generate any revenues from product sales in the foreseeable future. Through September 2019, the Company has funded its operations primarily with proceeds from the sale of preferred stock and proceeds from the Company&#x2019;s agreement with Eli Lilly and Company &nbsp;(Note 6)&nbsp;and proceeds from the IPO. The Company expects to incur additional operating losses and negative operating cash flows for the foreseeable future.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">NEXTCURE,&nbsp;INC.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">NOTES&nbsp;TO FINANCIAL STATEMENTS<a name="NOTESTOFINANCIALSTATEMENTS_913411"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">1. Nature of the Business and Basis of Presentation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Organization</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">NextCure,&nbsp;Inc. (&#x201C;NextCure&#x201D; or the &#x201C;Company&#x201D;) was incorporated in Delaware in September&nbsp;2015 and is headquartered in Beltsville, Maryland. The Company is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first&#8209;in&#8209;class immunomedicines to treat cancer and other immune&#8209;related diseases by restoring normal immune function. Through its proprietary Functional, Integrated, NextCure Discovery in Immuno&#8209;Oncology (&#x201C;FIND&#8209;IO&#x201D;) platform, the Company studies various immune cells in order to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Since inception, the Company has devoted substantially all of its efforts and financial resources to organizing and staffing the Company, identifying business development opportunities, raising capital, securing intellectual property rights related to the Company&#x2019;s product candidates, building and optimizing the Company&#x2019;s manufacturing capabilities and conducting discovery, research and development activities for the Company&#x2019;s product candidates, discovery programs and its FIND&#8209;IO platform.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Risks and Uncertainties</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company is subject to risks common to early&#8209;stage companies in the biotechnology industry including, but not limited to: having a limited operating history and no products approved for commercial sale; having a history of significant losses; our need to obtain additional financing; dependence on its ability to advance its current and future product candidates through clinical trials, marketing approval and commercialization; the unproven approach to the discovery and development of product candidates based on the Company&#x2019;s FIND&#8209;IO platform; the lengthy and expensive nature and uncertain outcomes of the clinical development process; the lengthy, time&#8209;consuming and unpredictable nature of the regulatory approval process; the results of preclinical studies and early&#8209;stage clinical trials that may not be predictive of future results; dependence on its key personnel; its limited manufacturing experience as an organization and with its manufacturing facility; risks related to patent protection and our pending patent applications; dependence on third&#8209;party collaborators for the discovery, development and commercialization of current and future product candidates; and significant competition from other biotechnology and pharmaceutical companies. Pursuit of the Company&#x2019;s business efforts will require significant amounts of additional capital, adequate personnel, infrastructure and extensive compliance&#8209;reporting capabilities. Even if the Company&#x2019;s development efforts are successful, it is uncertain when, if ever, the Company will realize significant revenue from product sales.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Liquidity</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company expects that its operating losses and negative cash flows will continue for the foreseeable future. As of the issuance date of the financial statements for the&nbsp;year ended December&nbsp;31, 2018, the Company expects that its cash and cash equivalents will be sufficient to fund its operating expenses and capital expenditure requirements through at least two years from the issuance date of the financial statements. The future viability of the Company beyond that date is dependent on its ability to raise additional capital to finance its operations. On April&nbsp;5, 2018, the Company issued 28,181,819 shares of Series&nbsp;A&#8209;3 Preferred Stock at an issuance price of $1.10 per share for cash proceeds of $31.0&nbsp;million (Note&nbsp;9). On November&nbsp;5, 2018, the Company entered into a Series&nbsp;B Preferred Stock Purchase Agreement and issued 15,052,117 shares of Series&nbsp;B&#8209;1 Preferred Stock at an issuance price of $1.59 per share, 34,276,734 shares of Series&nbsp;B&#8209;2 Preferred Stock at an issuance price of $1.59 per share and 7,500,000 shares of Series&nbsp;B&#8209;3 Preferred Stock at an issuance price of $2.00 per share for aggregate cash proceeds of $93.4&nbsp;million (Note&nbsp;9).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company plans to seek additional funding through public or private equity offerings, debt financings, marketing and distribution arrangements, other collaborations, strategic alliances and licensing arrangements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into strategic alliances or other arrangements on favorable terms, or at all. The terms of any financing may adversely affect the holdings or the rights of the Company&#x2019;s stockholders. If the Company is unable to obtain funding, the Company could be required to delay, reduce or eliminate research and development programs, product portfolio expansion or future commercialization efforts, which could adversely affect its business prospects.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Although management continues to pursue these funding plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company, if at all, to fund continuing operations past two years from the issuance date of these financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Basis of Presentation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The accompanying financial statements include the accounts of the Company. The Company&#x2019;s financial statements have been prepared in accordance with United States generally accepted accounting principles (&#x201C;GAAP&#x201D;). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#x201C;ASC&#x201D;) and Accounting Standards Update (&#x201C;ASU&#x201D;) of the Financial Accounting Standards Board (&#x201C;FASB&#x201D;).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Reverse Stock Split</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On May&nbsp;3, 2019, the Company effected a 1&#8209;for&#8209;8.0338 reverse stock split of its outstanding common stock. The par value and authorized shares of common stock were not adjusted as a result of the reverse stock split. All of the share and per share information presented in the accompanying financial statements has been adjusted to reflect the reverse common stock split on a retroactive basis for all periods and as of all dates presented.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Use of Estimates</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to accrued expenses, revenue recognition, the valuation of equity&#8209;based compensation, including incentive stock options, common stock and restricted common stock, as well as income taxes. The Company bases its estimates on various assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Segment and Geographic Information</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Operating segments are defined as components of an entity about which separate discrete information is available for evaluation by the chief operating decision maker, or decision&#8209;making group, in deciding how to allocate resources and in assessing performance. The Company views its operations as and manages its business in one operating segment operating exclusively in the United States.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6835678480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision or benefit from income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6817747312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">4. Fair Value of Financial Instruments<a name="a3FairValueofFinancialInstruments_290669"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has certain financial assets recorded at fair value, which have been classified as Level 1, 2 or 3 within the fair value hierarchy as described in the accounting standards for fair value measurements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level 1&#x2014;Quoted market prices in active markets for identical assets or liabilities. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level 2&#x2014;Inputs other than Level 1 inputs that are either directly or indirectly observable, such as quoted market prices, interest rates and yield curves. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level 3&#x2014;Unobservable inputs developed using estimates of assumptions developed by the Company, which reflect those that a market participant would use.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">To the extent the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair values requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized as Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following tables set forth the fair value of the Company&#x2019;s financial assets by level within the fair value hierarchy (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:47.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September 30, 2019</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair Value</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 2</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 3</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash equivalents:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Marketable securities:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">U.S. treasury securities</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,982</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,983</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,983</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Agency bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,178</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,161</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,161</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Corporate bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,045</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,003</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,003</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 179,670</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 179,612</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 174,147</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December 31, 2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair Value</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 2</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 3</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash equivalents:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company did&nbsp;not transfer any assets measured at fair value on a recurring basis between levels during the&nbsp;three and nine months ended September 30, 2019. </font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">3. Fair Value of Financial Instruments</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table sets forth the fair value of the Company&#x2019;s financial assets by level within the fair value hierarchy (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">As&nbsp;of&nbsp;December&nbsp;31,&nbsp;2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair&nbsp;Value&nbsp;Measurement&nbsp;Based&nbsp;on</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Quoted&nbsp;Prices&nbsp;in</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Active&nbsp;Markets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Observable</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unobservable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Assets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(Level&nbsp;1)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;2)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;3)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market funds (cash equivalents)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">As&nbsp;of&nbsp;December&nbsp;31,&nbsp;2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair&nbsp;Value&nbsp;Measurement&nbsp;Based&nbsp;on</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Quoted&nbsp;Prices&nbsp;in</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Active&nbsp;Markets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Observable</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unobservable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Assets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(Level&nbsp;1)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;2)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;3)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market funds (cash equivalents)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company did&nbsp;not transfer any assets measured at fair value on a recurring basis to or from Level&nbsp;1 during the&nbsp;years ended December&nbsp;31, 2018 and 2017.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6817886640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED STATEMENTS OF CASH FLOWS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (22,810,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,933,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,319,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(3,660,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">93,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities and other current liabilities</a></td>
<td class="nump">335,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty', window );">Deferred revenue</a></td>
<td class="num">(2,842,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(25,632,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(2,557,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(174,205,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(176,762,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering, net of issuance costs</a></td>
<td class="nump">77,264,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">65,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from the term loan</a></td>
<td class="nump">4,540,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred financing costs</a></td>
<td class="num">(134,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">81,735,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash (includes $3,750 of restricted cash in other assets)</a></td>
<td class="num">(120,659,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash-beginning of year</a></td>
<td class="nump">135,633,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash-end of period (includes $3,750 of restricted cash in other assets)</a></td>
<td class="nump">14,974,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">137,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosures of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchase of property and equipment included in accrued liabilities</a></td>
<td class="nump">73,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Deferred financing costs included in accrued liabilities</a></td>
<td class="nump">134,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock', window );">Conversion of convertible preferred stock into common stock</a></td>
<td class="nump">$ 162,223,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income from related party and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_IncreaseDecreaseInDeferredRevenueFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the noncash conversion of convertible preferred stock into common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_NoncashOrPartNoncashConversionOfConvertiblePreferredStockIntoCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6820238768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan - Other (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 25, 2019 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Apr. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate (as a percent)</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.33%<span></span>
</td>
<td class="nump">4.18%<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
<td class="nump">3.84%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_DebtInstrumentMonthlyPaymentsNumber', window );">Number of equal monthly payments of principal plus accrued interest | item</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,000<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">$ 155,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember', window );">Prime rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread (as a percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_DebtInstrumentMonthlyPaymentsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of periodic payments of principal plus accrued interest (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_DebtInstrumentMonthlyPaymentsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6837905136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreement with Eli Lilly and Company - Other (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 02, 2018 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Equity investment</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">$ 122,223<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,583<span></span>
</td>
<td class="nump">$ 4,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember', window );">Lilly Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement', window );">Period of expiry from date of agreement</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived', window );">Upfront non-refundable payment received</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Equity investment</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RevenueRecognitionNumberOfPerformanceObligations', window );">The number of performance obligations. | item</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember', window );">Lilly Agreement | Lilly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable', window );">Maximum development and regulatory milestones and sales milestone receivable</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise', window );">Maximum development and regulatory milestones and sales milestone payable upon option exercise</a></td>
<td class="nump">710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborationAgreementTransactionPrice', window );">Transaction price</a></td>
<td class="nump">$ 32,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborationAgreementTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of transaction fees under the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborationAgreementTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of development and regulatory milestones and sales milestones payable upon option exercise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestonePayableUponOptionExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of development and regulatory milestones and sales milestones receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementMaximumDevelopmentRegulatoryAndSalesMilestoneReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the period of expiry from date of agreement under collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementPeriodOfExpiryFromDateOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of upfront non-refundable payment received under collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementUpfrontNonRefundablePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RevenueRecognitionNumberOfPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of performance obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RevenueRecognitionNumberOfPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nxtc_ResearchAndDevelopmentCollaborativeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nxtc_EliLillyAndCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nxtc_EliLillyAndCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6819051408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED BALANCE SHEETS - (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>May 13, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, number of shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, number of shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">158,745,671<span></span>
</td>
<td class="nump">84,045,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,560,569<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, number of shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,181,819<span></span>
</td>
<td class="nump">64,545,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,181,819<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,181,819<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, number of shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,852<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818062512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Other (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 02, 2019</div></th>
<th class="th"><div>Jan. 30, 2019</div></th>
<th class="th"><div>Feb. 09, 2016</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PeriodForWhichBaseRentIsAbated', window );">Period for which base rent is abated</a></td>
<td class="text">7 months<span></span>
</td>
<td class="text">7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_AnnualBaseRentPerMonthAfterAbatement', window );">Annual base rent per month after abatement</a></td>
<td class="nump">$ 18,178<span></span>
</td>
<td class="nump">$ 19,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PercentageOfAnnualIncreaseInLeaseRent', window );">Percentage of annual increase in lease rent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expenses operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252,000<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
<td class="nump">$ 442,000<span></span>
</td>
<td class="nump">$ 308,000<span></span>
</td>
<td class="nump">$ 420,000<span></span>
</td>
<td class="nump">$ 376,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_AnnualBaseRentPerMonthAfterAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of annual base rent per month after abatement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_AnnualBaseRentPerMonthAfterAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PercentageOfAnnualIncreaseInLeaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of annual increase in operating lease rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PercentageOfAnnualIncreaseInLeaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PeriodForWhichBaseRentIsAbated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for which the base rent is abated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PeriodForWhichBaseRentIsAbated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6837519376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 05, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 02, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 05, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>item </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 13, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, number of shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock; par value of $0.001 per share, 10,000,000 and 0 shares authorized at June 30, 2019 and December 31, 2018. No shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively | $</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Noncumulative dividends, annual rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareDeclared', window );">Dividends declared | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PreferredStockConvertibleConversionRatio', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock', window );">Minimum gross proceeds for mandatorily convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from Issuance of Preferred Stock and Preference Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">$ 122,223<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, number of shares authorized</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,181,819<span></span>
</td>
<td class="nump">64,545,455<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,181,819<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,181,819<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect', window );">Number of directors, stock holders are entitled to elect | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_Series1PreferredStockMember', window );">Series A-1 Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Liquidation preference per share | $ / shares</a></td>
<td class="nump">$ 8.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from Issuance of Preferred Stock and Preference Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_Series2PreferredStockMember', window );">Series A-2 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from Issuance of Preferred Stock and Preference Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember', window );">Series A-3 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Liquidation preference per share | $ / shares</a></td>
<td class="nump">$ 8.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from Issuance of Preferred Stock and Preference Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, number of shares authorized</a></td>
<td class="nump">56,828,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,852<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect', window );">Number of directors, stock holders are entitled to elect | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB1PreferredStockMember', window );">Series B-1 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,052,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,052,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB2PreferredStockMember', window );">Series B-2 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,276,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,276,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB1AndB2PreferredStockMember', window );">Series B-1 and B-2 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Liquidation preference per share | $ / shares</a></td>
<td class="nump">$ 12.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from Issuance of Preferred Stock and Preference Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB3PreferredStockMember', window );">Series B-3 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock; par value of $0.001 per share, 10,000,000 and 0 shares authorized at June 30, 2019 and December 31, 2018. No shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalPreferredStock', window );">Premium over the fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Liquidation preference per share | $ / shares</a></td>
<td class="nump">$ 16.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from Issuance of Preferred Stock and Preference Stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of minimum gross proceeds for mandatorily convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_MinimumGrossProceedsForMandatorilyRedeemablePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of directors, stock holders are entitled to elect.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_NumberOfDirectorsStockHoldersAreEntitledToElect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of preferred stock into equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in nonredeemable preferred stock related transactions that are in excess of par value, value contributed to an entity and value received from other stock related transactions. Examples of other stock related transactions include, amongst other, certain costs incurred in issuing equity securities, certain dividends and certain tax-based consequences of share-based payments compensation awards. Includes only nonredeemable preferred stock transactions or transactions related to preferred stock that are redeemable solely at the option of the issuer. May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(d)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_Series1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_Series1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_Series2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_Series2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_SeriesB1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_SeriesB2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB1AndB2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_SeriesB1AndB2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_SeriesB3PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_SeriesB3PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6808449152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">5. Property and Equipment, Net<a name="a4PropertyandEquipmentNet_509472"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment consist of the following (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,746</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,787</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,365</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,825</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computer equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 441</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 167</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 94</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 70</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Construction in progress</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 787</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,027</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, gross</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 16,433</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 13,876</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: accumulated depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,402)</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2,469)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 12,031</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,407</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Construction in progress at September 30, 2019 consists of the costs incurred for research equipment and for the build-out of additional lab and office space and at December&nbsp;31, 2018 consists of the costs incurred for the build-out of a manufacturing suite at the Company&#x2019;s headquarters in Beltsville, Maryland. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Depreciation and amortization expense was $788,000 and $1,933,000 for the&nbsp;three and nine months ended September&nbsp;30, 2019, respectively, and $396,000 and $1,159,000 for the three and nine months ended September 30, 2018, respectively.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">4. Property and Equipment, Net</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment consist of the following (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,787</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,213</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,825</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 564</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computer equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 167</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 111</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 70</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 33</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Construction in progress</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,027</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,892</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, gross</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 13,876</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10,813</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: accumulated depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2,469)</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (792)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,407</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10,021</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Construction in progress at December&nbsp;31, 2018 consists of the costs incurred for research equipment.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Depreciation and amortization expense was $1.7&nbsp;million and $582,000 for the&nbsp;years ended December&nbsp;31, 2018 and 2017, respectively.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6810502544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Summary of fair value of the Company's financial assets</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following tables set forth the fair value of the Company&#x2019;s financial assets by level within the fair value hierarchy (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:47.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September 30, 2019</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair Value</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 2</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 3</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash equivalents:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Marketable securities:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">U.S. treasury securities</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,982</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,983</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,983</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Agency bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,178</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,161</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,161</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Corporate bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,045</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,003</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,003</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 179,670</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 179,612</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 174,147</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December 31, 2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair Value</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 2</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 3</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash equivalents:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table sets forth the fair value of the Company&#x2019;s financial assets by level within the fair value hierarchy (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">As&nbsp;of&nbsp;December&nbsp;31,&nbsp;2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair&nbsp;Value&nbsp;Measurement&nbsp;Based&nbsp;on</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Quoted&nbsp;Prices&nbsp;in</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Active&nbsp;Markets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Observable</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unobservable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Assets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(Level&nbsp;1)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;2)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;3)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market funds (cash equivalents)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">As&nbsp;of&nbsp;December&nbsp;31,&nbsp;2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair&nbsp;Value&nbsp;Measurement&nbsp;Based&nbsp;on</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Quoted&nbsp;Prices&nbsp;in</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Active&nbsp;Markets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Observable</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unobservable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Assets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(Level&nbsp;1)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;2)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;3)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market funds (cash equivalents)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6646328752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Term Loan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of future maturities</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Future maturities of the Term Loan as of September 30, 2019 are as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Remainder of the year</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,528</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,667</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,667</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 138</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: current portion of term loan</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,250)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Term loan, net of current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,750</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Future maturities of the Term Loan as of December&nbsp;31, 2018 are as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 387</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 73</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: current portion of term loan</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 387</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Term loan, net of current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 73</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818709584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">9. Stock&#8209;Based Compensation<a name="a11StockBasedCompensation_727125"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Employee Equity Plans</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The NextCure, Inc. 2015 Omnibus Incentive Plan (the "2015 Plan") provides for the Company to grant incentive stock options or nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company. The 2015 Plan is administered by the board of directors, or at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors or its committee if so delegated, except that the exercise price per share of the stock options may not be less than 100% of the fair market value of a share of the Company's common stock on the date of grant and the term of the stock options may not be greater than 10 years.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On May 3, 2019, the Company&#x2019;s stockholders approved the NextCure, Inc. 2019 Omnibus Incentive Plan (the &#x2018;&#x2018;2019 Plan&#x2019;&#x2019;), which became effective on May 8, 2019, the date on which the Registration Statement was declared effective (the &#x201C;Effective Date&#x201D;). The 2019 Plan replaces the 2015 Plan as the Company&#x2019;s board of directors (the &#x201C;Board&#x201D;) determined not to make additional awards under the 2015 Plan following the effectiveness of the 2019 Plan. The 2019 Plan provides for the grant of awards of options, stock appreciation rights, restricted stock, restricted stock units, deferred stock units, unrestricted stock, dividend equivalent rights, other equity-based awards and cash bonus awards to the Company&#x2019;s officers, employees, non-employee directors and other key persons (including consultants). The number of shares of common stock reserved for issuance under the 2019 Plan is 2,900,000 plus the number of shares of stock related to awards outstanding under the 2015 Plan that subsequently terminate by expiration or forfeiture, cancellation or otherwise without the issuance of such shares. The number of shares reserved for issuance under the 2019 Plan will automatically increase on January 1, 2020 and each January 1st thereafter during the term of the 2019 Plan by 4% of the number of shares of the Company&#x2019;s common stock outstanding on December 31st of the preceding calendar year or such lesser number of shares determined by the Board.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">As of September 30, 2019, </font><font style="display:inline;font-family:Times New Roman,Times,serif;">2,653,969</font><font style="display:inline;"> &nbsp;shares were reserved for future grant under the 2019 Plan.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock options granted under the 2015 Plan and 2019 Plan (together, the &#x201C;Plans&#x201D;) to employees generally vest over four years and expire after ten years. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">A summary of stock option activity for awards under the Plans is presented below: </font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="9" valign="bottom" style="width:39.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Options&nbsp;Outstanding&nbsp;and&nbsp;Exercisable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Aggregate</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Remaining</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Intrinsic</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Number&nbsp;of</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Exercise</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Contractual</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%">(1)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Price</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Life&nbsp;(Years)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(in&nbsp;thousands)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 247,275</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 18.18</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10.0</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercised</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (53,963)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.20</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8.1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Forfeitures</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,250)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.63</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.5</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,248,953</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.30</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 55,305</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Vested and expected to vest as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,248,953</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.30</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 55,305</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercisable as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 450,866</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.15</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 12,335</font></p>
				</td>
			</tr>
		</table></div>
		<div><hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"></hr></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:0pt;"><p style="width:0pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> (1)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
			<font style="display:inline;color:#000000;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at September 30, 2019 and December&nbsp;31, 2018.&nbsp;</font></p></td></tr></table></div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The weighted-average grant date fair value of stock options granted to employees for the nine months ended September 30, 2019 was $11.48. The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2019 was $1,600,000.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The Company&#x2019;s potential dilutive securities, which as of September 30, 2019 include common stock options, have been excluded from the computation of diluted net loss per share as the effect would be anti&#8209;dilutive. Therefore, the weighted average number of common shares used to calculate both basic and diluted net loss per common share is the same. The Company excluded 2,248,953 potential shares of common stock, presented based on amounts outstanding at three and nine periods ended September 30, 2019, from the computation of diluted net loss per common share for the period indicated because including them would have had an anti&#8209;dilutive effect. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On May 3, 2019,&nbsp;the Company&#x2019;s stockholders approved the NextCure, Inc. 2019 Employee Stock Purchase Plan (the &#x201C;ESPP&#x201D;), which became effective on the Effective Date. The ESPP is intended to qualify as an &#x201C;employee stock purchase plan&#x201D; within the meaning of Section 423(b) of the Internal Revenue Code. A total of 240,000&nbsp;shares of common stock were reserved for issuance under this plan. In addition, the number of shares of common stock that may be issued under the ESPP will automatically increase on January&nbsp;1, 2020 and each January 1st thereafter until expiration of the ESPP, in an amount equal to the lesser of (i)&nbsp;1% of the number of shares of the Company&#x2019;s common stock outstanding on&nbsp;December 31st of the preceding calendar year, (ii) 480,000 shares of common stock and (iii)&nbsp;a number of shares of common stock determined by the administrator of the ESPP.&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Stock&#8209;Based Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company recorded stock-based compensation expense of&nbsp;$524,000 and $1,319,000&nbsp;for the three and nine months ended September&nbsp;30, 2019, respectively, and $90,000 and $138,000 for the three and nine months ended September&nbsp;30, 2018, respectively.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.42%;">
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Three Months Ended </font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Nine Months Ended </font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 182</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 41</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 482</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 62</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 342</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 49</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 837</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 76</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total stock-based compensation expense</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 524</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 90</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,319</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 138</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">11. Stock&#8209;Based Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">2015 Omnibus Incentive Plan</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The NextCure,&nbsp;Inc. 2015 Omnibus Incentive Plan (the &#x201C;2015 Plan&#x201D;) provides for the Company to grant incentive stock options or nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company. The 2015&nbsp;Plan is administered by the board of directors, or at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors or its committee if so delegated, except that the exercise price per share of the stock options may not be less than 100% of the fair market value of a share of the Company&#x2019;s common stock on the date of grant and the term of the stock options may not be greater than 10 years.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Under the 2015 Plan, the Company had initially reserved on December&nbsp;29, 2015, 311,185 shares of common stock, which number of shares was automatically increased pursuant to the terms of the 2015&nbsp;Plan by 373,422 as of the second closing of the Series&nbsp;A Preferred Stock financing on January&nbsp;24, 2017. The total number of shares of common stock that may be issued under the 2015 Plan was 2,824,317 as of December&nbsp;31, 2018. As of December&nbsp;31, 2018, there were </font><font style="display:inline;font-family:Symbol;">2,056,891</font><font style="display:inline;">&nbsp;stock options and 62,237&nbsp;shares of registered stock outstanding and </font><font style="display:inline;font-family:Symbol;">699,590</font><font style="display:inline;">&nbsp;shares of common stock available for future issuance under the 2015 Plan.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock options granted under the 2015 Plan generally vest over four years and expire after 10&nbsp;years.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The exercise price for stock options granted is not less than the fair value of common shares as determined by the board of directors as of the date of grant. The board of directors determines the value the Company&#x2019;s common stock taking into consideration the most recently available third&#8209;party valuation of common shares, as well as additional factors, which may have changed since the date of the most recent contemporaneous valuation through the date of grant.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">A summary of stock option activity for awards under the 2015 Plan is presented below:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="9" valign="bottom" style="width:40.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Options&nbsp;Outstanding&nbsp;and&nbsp;Exercisable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Aggregate</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Remaining</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Intrinsic</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Number&nbsp;of</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Exercise</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Contractual</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%">(1)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Price</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Life&nbsp;(Years)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(in&nbsp;thousands)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of January&nbsp;1, 2017</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 189,189</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.48</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8.6</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 137</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 317,397</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.21</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 506,586</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.94</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.0</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 137</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,570,136</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5.92</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.9</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,684</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercised</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (5,599)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.84</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Forfeitures</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (14,232)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.11</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Vested and expected to vest as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercisable as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 242,079</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.88</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.9</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,634</font></p>
				</td>
			</tr>
		</table></div>
		<div><hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"></hr></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:0pt;"><p style="width:0pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> (1)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at December&nbsp;31, 2018 and 2017.</font></p></td></tr></table></div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The weighted average grant date fair value per share of stock options granted during the&nbsp;years ended December&nbsp;31, 2018 and 2017 was $3.80 and $0.80, respectively. The aggregate intrinsic value of stock options exercised during the&nbsp;years ended December&nbsp;31, 2018 and 2017 was $38,000 and $0, respectively.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The aggregate grant date fair value of stock options and restricted stock vested during the&nbsp;year ended December&nbsp;31, 2018 and 2017 was approximately $157,000 and $29,000, respectively.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;Based Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company recorded stock&#8209;based compensation expense of $263,000 and $75,000 during the&nbsp;years ended December&nbsp;31, 2018 and 2017, respectively. As of December&nbsp;31, 2018, there was $6.0 million of unrecognized compensation cost related to unvested stock&#8209;based compensation arrangements granted under the 2015 Plan. This remaining compensation expense is expected to be recognized over a weighted average period of three years as of December&nbsp;31, 2018.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 85</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 35</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 178</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 40</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total stock-based compensation expense</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 263</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 75</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The assumptions used in the Black&#8209;Scholes option&#8209;pricing model for stock options granted were as follows:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Year Ended </font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected term</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.1</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected volatility</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 69.7</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Risk free interest rate</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2.77</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected dividend yield</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Restricted Common Stock</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In May&nbsp;2016, the Company issued 62,237 shares of restricted common stock from the 2015 Plan, which are restricted as to sale or transferability. These restrictions lapse over a four&#8209;year period.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6823234640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Summary of reconciliation cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,935</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash (including $3,750 in other assets)</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,039</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 14,974</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,427</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 860</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,287</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6840200416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 174,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gain</a></td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Loss</a></td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">174,147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">19,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gain</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">19,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">47,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Loss</a></td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">47,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">107,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gain</a></td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Loss</a></td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 107,003<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6810532464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Employee Benefit Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Percentage of eligible compensation on a pre tax basis</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6817983168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Other (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22,799)<span></span>
</td>
<td class="num">$ (15,469)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding-basic and diluted (in shares)</a></td>
<td class="nump">22,715,567<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="nump">12,609,219<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="nump">1,369,846<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to common stockholders-basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (4.17)<span></span>
</td>
<td class="num">$ (1.81)<span></span>
</td>
<td class="num">$ (11.64)<span></span>
</td>
<td class="num">$ (16.64)<span></span>
</td>
<td class="num">$ (11.30)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6810572528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 02, 2019</div></th>
<th class="th"><div>Jan. 30, 2019</div></th>
<th class="th"><div>Feb. 09, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PeriodForWhichBaseRentIsAbated', window );">Period for which base rent is abated</a></td>
<td class="text">7 months<span></span>
</td>
<td class="text">7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_AnnualBaseRentPerMonthAfterAbatement', window );">Annual base rent per month after abatement</a></td>
<td class="nump">$ 18,178<span></span>
</td>
<td class="nump">$ 19,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_PercentageOfAnnualIncreaseInLeaseRent', window );">Percentage of annual increase in lease rent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_AnnualBaseRentPerMonthAfterAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of annual base rent per month after abatement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_AnnualBaseRentPerMonthAfterAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PercentageOfAnnualIncreaseInLeaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of annual increase in operating lease rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PercentageOfAnnualIncreaseInLeaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_PeriodForWhichBaseRentIsAbated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for which the base rent is abated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_PeriodForWhichBaseRentIsAbated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6809315696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share Attributable to Common Stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Summary of computation of basic and diluted net loss per share attributable to common stockholders</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share amounts):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:30.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:14.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Numerator:</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net loss</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (22,799)</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (15,469)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Denominator:</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Weighted average number of common shares, basic and diluted</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,369,846</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,369,212</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net loss per common share attributable to common stockholders, basic and diluted</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;(16.64)</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (11.30)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of shares excluded from the computation of diluted net loss per share</a></td>
<td class="text"><div> <div>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:29.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Preferred stock</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 15,560,569</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,978,957</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Options to purchase common stock</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;242,079</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;64,783</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;15,802,648</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;5,043,746</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818450112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Property and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">P3Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">P5Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">P7Y<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6810629520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share Attributable to Common Stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">12. Net Loss Per Share Attributable to Common Stockholders</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share amounts):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:30.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:14.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Numerator:</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net loss</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (22,799)</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (15,469)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Denominator:</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Weighted average number of common shares, basic and diluted</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,369,846</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,369,212</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:67.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net loss per common share attributable to common stockholders, basic and diluted</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;(16.64)</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (11.30)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s potential dilutive securities, which include preferred stock and common stock options, have been excluded from the computation of diluted net loss per share as the effect would be anti&#8209;dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at period end, from the computation of diluted net loss per share attributable to common stockholders for the period indicated because including them would have had an anti&#8209;dilutive effect:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:29.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Preferred stock</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 15,560,569</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,978,957</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Options to purchase common stock</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;242,079</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;64,783</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:68.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:14.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;15,802,648</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;5,043,746</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6704425808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Term Loan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Term Loan</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">8. Term Loan<a name="a8TermLoan_295864"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In April 2016, the Company entered into a $1.0 million term loan with a commercial bank (the &#x201C;Term Loan&#x201D;). On January 25, 2019, the Company amended the Term Loan to increase the Company&#x2019;s borrowing capacity to $5.0 million, which amount remains secured by the Company&#x2019;s certificates of deposit, money market account, investment property and deposit or investment accounts. As amended, the Term Loan bears interest at the greater of the prime rate less 1% and 4.25%. The effective interest rate was 4.33% and 4.44% for the three and nine months ended September 30, 2019, respectively. The effective interest rate was 4.18% and 3.84% for the three and nine months ended September 30, 2018, respectively. Under the Term Loan, the Company is required to make monthly interest-only payments through January 2020 and is required to make 36 equal monthly payments of principal plus accrued interest thereafter through January 2023.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Future maturities of the Term Loan as of September 30, 2019 are as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Remainder of the year</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,528</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,667</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,667</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 138</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: current portion of term loan</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,250)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Term loan, net of current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,750</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Interest expense under the Term Loan was approximately&nbsp;$56,000 and $155,000 for the three and nine months ended September&nbsp;30, 2019, respectively, and $7,000 and $20,000 for the three and nine months ended September 30, 2018, respectively.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">8. Term Loan</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In April&nbsp;2016, the Company entered into a $1.0&nbsp;million term loan (the &#x201C;Term Loan&#x201D;). The Term Loan bears interest at the prime rate less 1%. The interest rate in effect was </font><font style="display:inline;font-family:Symbol;">4.5</font><font style="display:inline;">% and 3.5% for the years ended December 31, 2018 and 2017, respectively. The Term Loan is secured by all certificates of deposit, money market accounts, cash, securities, investment property and deposit or investment accounts. The Term Loan requires&nbsp;monthly payments of interest only before May&nbsp;2017, and equal&nbsp;monthly payments of principal and interest thereafter, as defined in the agreement. Interest expense under the Term Loan was approximately $25,000 and $30,000 for the&nbsp;years ended December&nbsp;31, 2018 and 2017, respectively. The outstanding balance on the Term Loan totaled $460,000 as of December&nbsp;31, 2018.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Future maturities of the Term Loan as of December&nbsp;31, 2018 are as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 387</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 73</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: current portion of term loan</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 387</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Term loan, net of current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 73</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6653539568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">5. Property and Equipment, Net<a name="a4PropertyandEquipmentNet_509472"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment consist of the following (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,746</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,787</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,365</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,825</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computer equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 441</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 167</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 94</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 70</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Construction in progress</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 787</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,027</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, gross</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 16,433</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 13,876</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: accumulated depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,402)</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2,469)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 12,031</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,407</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Construction in progress at September 30, 2019 consists of the costs incurred for research equipment and for the build-out of additional lab and office space and at December&nbsp;31, 2018 consists of the costs incurred for the build-out of a manufacturing suite at the Company&#x2019;s headquarters in Beltsville, Maryland. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Depreciation and amortization expense was $788,000 and $1,933,000 for the&nbsp;three and nine months ended September&nbsp;30, 2019, respectively, and $396,000 and $1,159,000 for the three and nine months ended September 30, 2018, respectively.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">4. Property and Equipment, Net</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment consist of the following (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,787</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,213</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,825</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 564</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computer equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 167</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 111</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 70</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 33</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Construction in progress</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,027</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,892</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, gross</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 13,876</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10,813</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: accumulated depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2,469)</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (792)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,407</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10,021</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Construction in progress at December&nbsp;31, 2018 consists of the costs incurred for research equipment.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Depreciation and amortization expense was $1.7&nbsp;million and $582,000 for the&nbsp;years ended December&nbsp;31, 2018 and 2017, respectively.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6656348928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of available-for-sale securities</a></td>
<td class="text"><div> <div>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="11" valign="bottom" style="width:41.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September 30, 2019</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Gross</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Gross</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amortized</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unrealized</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unrealized</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Estimated</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Cost</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Gain</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Loss</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair Value</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">U.S. treasury securities</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,982</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,983</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Agency bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,178</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (17)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,161</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Corporate bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,045</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 20</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (62)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,003</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 174,205</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 21</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (79)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 174,147</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6817576592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 174,147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount', window );">Assets transferred from level 1 to level 2</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount', window );">Assets transferred from level 2 to level 1</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_MarketableSecuritiesAndCashEquivalents', window );">Total financial assets</a></td>
<td class="nump">179,670,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_MarketableSecuritiesAndCashEquivalents', window );">Total financial assets</a></td>
<td class="nump">179,612,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value | Quoted Prices in Active Markets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_MarketableSecuritiesAndCashEquivalents', window );">Total financial assets</a></td>
<td class="nump">5,465,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_MarketableSecuritiesAndCashEquivalents', window );">Total financial assets</a></td>
<td class="nump">174,147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds (cash equivalents) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="nump">5,465,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds (cash equivalents) | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="nump">5,465,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds (cash equivalents) | Fair Value | Quoted Prices in Active Markets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds (cash equivalents)</a></td>
<td class="nump">5,465,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">19,982,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">19,983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities | Fair Value | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">19,983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">47,178,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">47,161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Fair Value | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">47,161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">107,045,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">107,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Fair Value | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Fair value of the Company's financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 107,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_MarketableSecuritiesAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_MarketableSecuritiesAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812014720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreement with Eli Lilly and Company<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_CollaborativeArrangementDisclosureAbstract', window );"><strong>Agreement with Eli Lilly and Company</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Agreement with Eli Lilly and Company</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">6. </font><font style="display:inline;font-family:Times New Roman,Times,serif;">Agreement with Eli Lilly and Company<a name="a6AgreementwithEliLillyandCompany_802770"></a>&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On November 2, 2018, the Company entered into a multi-year research and development collaboration agreement (the &#x201C;Lilly Agreement&#x201D;) with Eli Lilly and Company (&#x201C;Lilly&#x201D;), pursuant to which the Company will use its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Under the Lilly Agreement, Lilly and the Company have granted one another an equal number of exclusive options to research, develop, manufacture and commercialize compounds and products directed to oncology targets identified through the Lilly Agreement. Both Lilly and the Company have all options remaining eligible for exercise. The research collaboration with Lilly will be managed by a joint steering committee formed by an equal number of members from the Company and Lilly and will expire upon the earlier of the exercise of all options granted to Lilly or four years from the date of the agreement, subject to certain extensions. The Company considers Lilly to be a related party based on Lilly&#x2019;s equity investment in the Company as discussed below.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">During the research term under the Lilly Agreement, as a part of target discovery, the Company will be responsible for providing Lilly with oncology targets identified using the Company&#x2019;s FIND-IO platform. From the targets provided by the Company, Lilly may select targets to advance to target validation using criteria developed by both parties. Following completion of the agreed upon target validation plan with respect to a given target, either party may propose to advance that target to compound discovery. For each target that has been advanced to compound discovery, Lilly will have the option to obtain an exclusive license with respect to the compounds and products directed to the target. If Lilly does not exercise its option with respect to a given target or has previously exercised all of its options, the Company will have the option to obtain licenses with respect to compounds and products directed to that target. Following option exercise by a party, the development and commercialization of any products directed to the target will be conducted by the exercising party. The exercising party must use commercially reasonable efforts to develop, seek regulatory approval for and commercialize any such products under mutually agreed upon work plans.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In November 2018, the Company received an upfront, non-refundable payment of $25.0 million under the Lilly Agreement and a concurrent $15.0 million equity investment. In addition, the Company will receive quarterly research and development support payments during a portion of the research term as well as option exercise fees upon option exercises by Lilly.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Pursuant to the Lilly Agreement, Lilly may owe an aggregate of up to $1.4 billion in development and regulatory milestones and sales milestones. Additionally, Lilly will pay mid to high single-digit royalties on net sales for all products directed to each target optioned by Lilly. Upon the Company&#x2019;s exercise of an option with respect to a given target, the Company will pay Lilly an option exercise payment and may become obligated to milestone and royalty payments. The company may owe an aggregate of up to $710.0 million in development and regulatory milestones and sales milestones.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upon the adoption of ASC 606, the Company evaluated the Lilly Agreement under the provisions of ASC 606 and concluded that Lilly is a customer prior to the exercise of its option to obtain an exclusive license with respect to the compounds and products directed to a target that has been advanced to compound discovery. The Company identified the following material promises under the Lilly Agreement: (i) a limited research license to conduct activities under the research collaboration; (ii) research and development services together with the provision of a data package in connection with Lilly&#x2019;s option; (iii) various governance obligations, most notably participation on the joint steering committee; and (iv) rights related to an optional term extension by Lilly. The Company evaluated Lilly&#x2019;s option to obtain an exclusive license with respect to the compounds and products directed to a target that has been advanced to compound discovery and concluded that the option was not issued at a significant and incremental discount, and therefore does not provide material rights. As such, they are excluded as performance obligations at the outset of the arrangement. The Company determined that the research license was not capable of being distinct and the related research and development services and governance activities are not distinct in the context of the contract and, as such, the Company determined that these promises should be combined into a single performance obligation, resulting in a total of two performance obligations under the Lilly Agreement; one for research and development services and one for the right related to an optional term extension by Lilly.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The transaction price at the outset of the arrangement was determined to be $32.7 million, comprised of the upfront fee received from Lilly, quarterly research and development support payments to be received from Lilly during a portion of the research term and an equity investment premium as determined by the Company with reference to a valuation of the Company&#x2019;s preferred stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, </font><font style="display:inline;font-style:italic;">Valuation of Privately-Held-Company Equity Securities Issued as Compensation.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The transaction price was allocated to the two performance obligations based on their relative standalone selling price determined with reference to the Company&#x2019;s estimated costs attendant to the obligations. Revenue allocated to the research and development performance obligation is being recognized as the research and development services are provided using an input method according to research and development costs incurred to date compared to estimated total research and development costs. The transfer of control occurs over this time period and, in management&#x2019;s judgment, is the best measure of progress towards satisfying the performance obligation. Revenue allocated to Lilly&#x2019;s right related to an optional term extension is deferred until the right is exercised or lapses, and will subsequently be recognized accordingly.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">While the Lilly Agreement was executed in November 2018, the Company&#x2019;s performance initiated in January 2019. Under the Lilly Agreement, the Company recognized revenue of $1.6 million and $4.3 million for the three and nine months ended September&nbsp;30, 2019, respectively. As of September&nbsp;30, 2019, deferred revenue included in the Company&#x2019;s balance sheets comprised the following (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred revenue, beginning of period</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 26,725</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Up-front payment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 25,000</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Attributed premium on the proceeds from Lilly&#x2019;s investment in the Company</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,725</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development support billing</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,500</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Revenue from research and development arrangement recognized</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,342)</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total deferred revenue, end of period</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 23,883</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 26,725</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: Deferred revenue, current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (6,199)</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,989)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred revenue, non-current portion</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 17,684</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 21,736</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">6. Agreement with Eli Lilly and Company</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On November 2, 2018, the Company entered into a multi-year research and development collaboration agreement (the &#x201C;Lilly Agreement&#x201D;) with Eli Lilly and Company (&#x201C;Lilly&#x201D;), pursuant to which the Company will use its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Under the Lilly Agreement, Lilly and the Company have granted one another an equal number of exclusive options to <a name="_cp_text_1_8"></a>research, develop, manufacture and commercialize compounds and products directed to oncology targets identified through the Lilly Agreement. <a name="_cp_text_1_9"></a>Both Lilly and the Company each have all options remaining eligible for exercise. The research collaboration with Lilly will be managed by a joint steering committee formed by an equal number of members from the Company and Lilly and will expire upon the earlier of the exercise of all options granted to Lilly or four years from the date of the agreement, subject to certain extensions.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">During the research term under the Lilly Agreement, as a part of target discovery, the Company will be responsible for providing Lilly with oncology targets identified using the Company&#x2019;s FIND-IO platform. From the targets provided by the Company, Lilly may select targets to advance to target validation using criteria developed by both parties. Following completion of the agreed upon target validation plan with respect to a given target, either party may propose to advance that target to compound discovery. <a name="_cp_text_1_10"></a>For each target that has been advanced to compound discovery, Lilly will have the option to obtain an exclusive license with respect to the compounds and products directed to the target. If Lilly does not exercise its option with respect to a given target or has previously exercised all of its options, the Company will have the option to obtain licenses with respect to compounds and products directed to that target. Following option exercise by a party, the development and commercialization of any products directed to the target will be conducted by the exercising party. The exercising party must use commercially reasonable efforts to develop, seek regulatory approval for and commercialize any such products under mutually agreed upon work plans.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company received an upfront, non-refundable payment of $25.0 million under the Lilly Agreement and a concurrent $15.0 million equity investment (Note 9). In addition, the Company will receive quarterly research and development support payments during a portion of the research term as well as option exercise fees upon option exercises by Lilly.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Pursuant to the Lilly Agreement, Lilly will owe an aggregate of up to $<a name="_cp_text_1_14"></a>1.4 billion in development and regulatory milestones&nbsp;<a name="_cp_text_1_15"></a>and sales milestones. Additionally, Lilly will pay mid to high single-digit royalties<a name="_cp_text_1_18"></a> on net sales for all products directed to each target optioned by Lilly. Upon the Company&#x2019;s exercise of an option with respect to a given target, the Company will <a name="_cp_text_1_20"></a>pay Lilly option exercise, milestone and royalty payments. The company will owe an aggregate of up to $<a name="_cp_text_1_22"></a>710.0&nbsp;million in development and regulatory milestones&nbsp;<a name="_cp_text_1_24"></a>and sales milestones.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The company has evaluated the Lilly Agreement under ASC 606. Two performance obligations were identified as follows:</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
			<font style="display:inline;">research and development services; and</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
			<font style="display:inline;">material right related to an optional term extension by Lilly.</font></p></td></tr></table></div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Lilly Agreement was executed in November 2018, however, the performance obligations were initiated in January 2019; accordingly no revenue was recorded under the Lilly Agreement in 2018. As of December 31, 2018, deferred revenue included in the Company&#x2019;s balance sheets in connection with the Lilly Agreement was $26.7 million, which consisted of the $25.0 million upfront payment plus $1.7 million attributed as a premium on the proceeds from Lilly&#x2019;s equity investment in the Company (Note 9).</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_CollaborativeArrangementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>N/A</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_CollaborativeArrangementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812042912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of property and equipment</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment consist of the following (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,746</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,787</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,365</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,825</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computer equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 441</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 167</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 94</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 70</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Construction in progress</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 787</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,027</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, gross</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 16,433</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 13,876</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: accumulated depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (4,402)</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2,469)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 12,031</font></p>
				</td>
				<td valign="bottom" style="width:02.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,407</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment consist of the following (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,787</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,213</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4,825</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 564</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computer equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 167</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 111</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 70</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 33</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Construction in progress</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,027</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,892</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, gross</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 13,876</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10,813</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: accumulated depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2,469)</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (792)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,407</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10,021</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6810706128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of stock option activity</a></td>
<td class="text"><div> <div>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="9" valign="bottom" style="width:39.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Options&nbsp;Outstanding&nbsp;and&nbsp;Exercisable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Aggregate</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Remaining</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Intrinsic</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Number&nbsp;of</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Exercise</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Contractual</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%">(1)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Price</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Life&nbsp;(Years)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(in&nbsp;thousands)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 247,275</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 18.18</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10.0</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercised</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (53,963)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.20</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8.1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Forfeitures</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,250)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.63</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.5</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,248,953</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.30</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 55,305</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Vested and expected to vest as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,248,953</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.30</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 55,305</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercisable as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 450,866</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.15</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 12,335</font></p>
				</td>
			</tr>
		</table></div>
		<div><hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"></hr></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at September 30, 2019 and December&nbsp;31, 2018.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">A summary of stock option activity for awards under the 2015 Plan is presented below:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="9" valign="bottom" style="width:40.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Options&nbsp;Outstanding&nbsp;and&nbsp;Exercisable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Aggregate</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Remaining</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Intrinsic</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Number&nbsp;of</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Exercise</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Contractual</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%">(1)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Price</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Life&nbsp;(Years)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(in&nbsp;thousands)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of January&nbsp;1, 2017</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 189,189</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.48</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8.6</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 137</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 317,397</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.21</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 506,586</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.94</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.0</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 137</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,570,136</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5.92</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.9</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,684</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercised</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (5,599)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.84</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Forfeitures</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (14,232)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.11</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Vested and expected to vest as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercisable as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 242,079</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.88</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.9</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,634</font></p>
				</td>
			</tr>
		</table></div>
		<div><hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"></hr></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:0pt;"><p style="width:0pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> (1)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at December&nbsp;31, 2018 and 2017.</font></p></td></tr></table></div><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of stock based compensation expense recorded</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.42%;">
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Three Months Ended </font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Nine Months Ended </font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 182</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 41</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 482</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 62</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 342</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 49</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 837</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 76</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total stock-based compensation expense</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 524</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 90</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,319</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 138</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 85</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 35</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 178</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 40</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total stock-based compensation expense</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 263</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 75</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6835282208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">10. Income Taxes</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;">The Company did not record a provision or benefit for income taxes during the nine months ended September 30, 2019.&nbsp;&nbsp;The Company continues to maintain a full valuation allowance against its deferred tax assets.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;">The Company has evaluated the positive and negative evidence involving its ability to realize its deferred tax assets.&nbsp;&nbsp;Management has considered the Company&#x2019;s history of cumulative net losses incurred since inception and its lack of any commercially ready products.&nbsp;&nbsp;It has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Management reevaluates the positive and negative evidence at each reporting period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;">Under the provisions of Sections&nbsp;382 and 383 of the Internal Revenue Code, certain substantial changes in the Company&#x2019;s ownership may have limited, or may limit in the future, the amount of net operating loss and research and development credit carryforwards that can be used to reduce future income taxes. <a name="_Hlk512945225"></a></font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">13. Income Taxes</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">2017 U.S. Tax Reform</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On December&nbsp;22, 2017, the U.S. government signed into law the Tax Cuts and Jobs Act (the &#x201C;Tax Act&#x201D;) that significantly reforms the Internal Revenue Code of 1986, as amended. The Tax Act, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%, effective as of January&nbsp;1, 2018; limitation of the tax deduction for interest expense; limitation of the deduction for net operating losses to 80% of annual taxable income and elimination of net operating loss carrybacks, in each case, for losses arising in taxable years beginning after December&nbsp;31, 2017 (though any such tax losses may be carried forward indefinitely); and modifying or repealing many business deductions and credits, including reducing the business tax credit for certain clinical testing expenses incurred in the testing of certain drugs for rare diseases or conditions generally referred to as &#x201C;orphan drugs&#x201D;.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In 2018, the Company finished its analysis of the impact of the Tax Act. Where the Company made reasonable estimates in 2017 of the effects related to the Tax Act, the Company recorded provisional amounts. After the completed analysis, the resulting impact to the Company&#x2019;s financial statements did not differ from the recorded provisional amounts.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Income Taxes</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The reconciliation of federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:21.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected income tax benefit at the federal statutory rate</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 21.0</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 34.0</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">State taxes, net of federal benefit</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.5</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.5</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development credit, net</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.2</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.7</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-deductible items</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2.2)</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (5.3)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Prior year provision to return adjustments</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (7.7)</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.1</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Tax rate reduction due to the Tax Act</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (15.6)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.3</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2.9)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Change in valuation allowance</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (25.1)</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (25.5)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The principal components of the Company&#x2019;s deferred tax assets consisted of the following as of December&nbsp;31, 2018 and 2017 (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred tax assets:</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Federal and state net operating loss carryforwards</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,946</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,176</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development tax credits</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,393</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,283</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Charitable contribution carryforwards</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 165</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 153</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accruals</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 290</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 23</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;4</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Gross deferred tax assets</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 15,817</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,751</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: valuation allowance</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (15,525)</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (7,491)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total deferred tax assets</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 292</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 260</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred tax liabilities:</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (292)</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (260)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Gross deferred tax liabilities</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (292)</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (260)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net deferred tax assets</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Based on the Company&#x2019;s history of losses, the Company recorded a full valuation allowance against its deferred tax assets as of December&nbsp;31, 2018. The Company increased its valuation allowance by approximately $8.0&nbsp;million for the&nbsp;year ended December&nbsp;31, 2018. The Company intends to maintain a valuation allowance until sufficient positive evidence exists to support a reversal of the allowance.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">As of December&nbsp;31, 2018, the Company had federal and state net operating loss carryforwards of $43.5&nbsp;million and $43.0&nbsp;million, respectively, some of which begin to expire in the&nbsp;year ending December&nbsp;31, 2036. Approximately $20.8 million of the federal and state net operating loss carryforwards do not expire. The Company had federal and state research and development tax credit carryforwards of approximately $2.5 million and $1.1&nbsp;million, respectively, as of December&nbsp;31, 2018. The federal credits begin to expire in the&nbsp;year ending December&nbsp;31, 2036 and the state credits begin to expire in the&nbsp;year ending December&nbsp;31, 2024.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Under the provisions of Sections&nbsp;382 and 383 of the Internal Revenue Code (the &#x201C;IRC&#x201D;), net operating loss and credit carryforwards and other tax attributes may be subject to limitation if there has been a significant change in ownership of the Company, as defined by the IRC. Future owner or equity shifts, including an initial public offering, could result in limitations on net operating loss and credit carryforwards.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company files income tax returns in the U.S. federal jurisdiction as well as in Maryland. The tax&nbsp;years 2015 to 2017 remain open to examination by the major jurisdictions in which the Company are subject to tax. Fiscal&nbsp;years outside the normal statute of limitation remain open to audit by tax authorities due to tax attributes generated in those early&nbsp;years, which have been carried forward and may be audited in subsequent&nbsp;years when utilized.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company evaluates tax positions for recognition using a more&#8209;likely&#8209;than&#8209;not recognition threshold, and those tax positions eligible for recognition are measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon the effective settlement with a taxing authority that has full knowledge of all relevant information. As of December&nbsp;31, 2018, the Company had no unrecognized income tax benefits that would affect the Company&#x2019;s effective tax rate if recognized.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6833878752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Deferred tax assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Federal and state net operating loss carryforwards</a></td>
<td class="nump">$ 11,946<span></span>
</td>
<td class="nump">$ 6,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credits</a></td>
<td class="nump">3,393<span></span>
</td>
<td class="nump">1,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards', window );">Charitable contribution carryforwards</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">15,817<span></span>
</td>
<td class="nump">7,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(15,525)<span></span>
</td>
<td class="num">(7,491)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(292)<span></span>
</td>
<td class="num">(260)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="num">(292)<span></span>
</td>
<td class="num">$ (260)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal net operating loss carryforwards</a></td>
<td class="nump">43,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State net operating loss carryforwards</a></td>
<td class="nump">43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Federal and state net operating loss carryforwards that do not expire</a></td>
<td class="nump">20,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal', window );">Federal research and development tax credit carryforwards</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState', window );">State research and development tax credit carryforwards</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized income tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic research and development tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state research and development tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6656490736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Restricted Common Stock (Details) - 2015 Plan - shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Restricted Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember', window );">Restricted Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Restricted Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares issued</a></td>
<td class="nump">62,237<span></span>
</td>
<td class="nump">62,237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share instruments newly issued under a share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nxtc_A2015OmnibusIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6792016560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Summary of reconciliation of federal statutory income tax rate to the Company's effective income tax rate</a></td>
<td class="text"><div> <div>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:21.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected income tax benefit at the federal statutory rate</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 21.0</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 34.0</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">State taxes, net of federal benefit</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.5</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.5</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development credit, net</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.2</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.7</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Non-deductible items</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2.2)</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (5.3)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Prior year provision to return adjustments</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (7.7)</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.1</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Tax rate reduction due to the Tax Act</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (15.6)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.3</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (2.9)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Change in valuation allowance</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (25.1)</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (25.5)</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:03.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of components of deferred tax assets</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The principal components of the Company&#x2019;s deferred tax assets consisted of the following as of December&nbsp;31, 2018 and 2017 (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred tax assets:</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Federal and state net operating loss carryforwards</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 11,946</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,176</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development tax credits</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 3,393</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,283</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Charitable contribution carryforwards</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 165</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 153</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Accruals</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 290</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 23</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;4</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Gross deferred tax assets</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 15,817</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7,751</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Less: valuation allowance</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (15,525)</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (7,491)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total deferred tax assets</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 292</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 260</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Deferred tax liabilities:</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Depreciation and amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (292)</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (260)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Gross deferred tax liabilities</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (292)</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (260)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Net deferred tax assets</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812503712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesAbstract', window );"><strong>Impairment of Long Lived Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment loss recognized</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxUncertaintiesAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Uncertain income tax benefits, interest or penalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6653538464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">7. Commitments and Contingencies<a name="a7CommitmentsandContingencies_104288"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Operating Leases</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">On February 9, 2016, the Company entered into a non-cancelable facilities operating sublease (the &#x201C;2016 Sublease&#x201D;). On March 15, 2019, the Company amended and restated the 2016 Sublease (as amended, the &#x201C;Amended 2016 Sublease&#x201D;) to include additional square footage to be used for office space, which the Company took possession of upon entering into the Amended 2016 Sublease. The Amended 2016 Sublease expires in August 2025. The base rent under the Amended 2016 Sublease is currently $32,254 per month plus the Company&#x2019;s prorated share of the sublandlord&#x2019;s operating expense and is subject to annual rent increases of 3%. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">On January 30, 2019, the Company entered into a new lease to be used for office and laboratory space (the &#x201C;New Premises&#x201D;), which the Company took possession of on June 1, 2019 (the &#x201C;2019 Lease&#x201D;). On August 2, 2019, the Company amended the 2019 Lease (as, the &#x201C;Amended 2019 Lease&#x201D;) to include additional space to be used for office and laboratory space (the &#x201C;Expansion Premises&#x201D;), which the Company expects to take possession of on April 1, 2020. The Amended 2019 Lease expires in March 2030. Upon expiration of the Amended 2016 Sublease, the Amended 2019 Lease will also cover the space the Company is currently subleasing under the Amended 2016 Sublease. Base rent is abated until April 1, 2020 for the New Premises and until seven months after delivery of the Expansion Premises for the Expansion Premises, after which the base rent will be $19,646 per month for the New Premises and $18,178 per month for the Expansion Premises, each subject to annual rent increases of 3%. In connection with this lease, the Company executed a $39,000 letter of credit, which has not been drawn down on. Additionally, there is a base rate adjustment of 8.5% per annum multiplied by the outstanding balance of amounts paid for tenant improvements. The budgeted amounts of tenant improvements are approximately $1,477,000 for the New Premises and $1,517,000 for the Expansion Premises, which are to be fully reimbursed by the landlord.&nbsp; </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The future minimum payments for the operating leases are as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Remainder of the year</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 97</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 566</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 692</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 742</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 733</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Thereafter</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6,088</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total future minimum payments</font></p>
				</td>
				<td valign="bottom" style="width:02.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,918</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Rent expense incurred under operating leases was approximately&nbsp;$252,000&nbsp;and $442,000&nbsp;for the three and nine months ended September&nbsp;30, 2019, respectively, and $107,000 and $308,000 for the three and nine months ended September 30, 2018, respectively.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Legal Proceedings</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company, from time to time, may be party to litigation arising in the ordinary course of business. The Company is not a party to any litigation or legal proceedings, nor is management aware of any pending or threatened litigation that, in the opinion of the Company&#x2019;s management, are likely to have a material adverse effect on the Company&#x2019;s business. At each reporting date, the Company evaluates whether a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses the costs related to its legal proceedings as incurred.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">7. Commitments and Contingencies</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Operating Leases</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company subleases its facilities under a non&#8209;cancelable operating sublease agreement. The sublease commenced on February&nbsp;9, 2016 and expires on August&nbsp;31, 2025. The Company is also responsible for its prorated share of the sublandlord&#x2019;s operating expense.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The future minimum payments for the operating leases are as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Year Ending December&nbsp;31,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 325</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2020</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 308</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2021</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 317</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2022</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 355</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">2023</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 335</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Thereafter</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 635</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total future minimum payments</font></p>
				</td>
				<td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,275</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Rent expense incurred under operating leases was approximately $420,000 and $376,000 for the&nbsp;years ended December&nbsp;31, 2018 and 2017, respectively.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Contingencies</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company is subject to claims and assessments from time to time in the ordinary course of business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In the normal course of business, the Company may become involved in legal proceedings. The Company will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. As of December&nbsp;31, 2018 and 2017, the Company was not involved in any material legal proceedings.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6653539568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">4. Fair Value of Financial Instruments<a name="a3FairValueofFinancialInstruments_290669"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has certain financial assets recorded at fair value, which have been classified as Level 1, 2 or 3 within the fair value hierarchy as described in the accounting standards for fair value measurements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level 1&#x2014;Quoted market prices in active markets for identical assets or liabilities. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level 2&#x2014;Inputs other than Level 1 inputs that are either directly or indirectly observable, such as quoted market prices, interest rates and yield curves. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level 3&#x2014;Unobservable inputs developed using estimates of assumptions developed by the Company, which reflect those that a market participant would use.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">To the extent the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair values requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized as Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following tables set forth the fair value of the Company&#x2019;s financial assets by level within the fair value hierarchy (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:47.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September 30, 2019</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair Value</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 2</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 3</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash equivalents:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Marketable securities:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">U.S. treasury securities</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,982</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,983</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,983</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Agency bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,178</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,161</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,161</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Corporate bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,045</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,003</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,003</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 179,670</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 179,612</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 174,147</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December 31, 2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair Value</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 2</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 3</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash equivalents:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company did&nbsp;not transfer any assets measured at fair value on a recurring basis between levels during the&nbsp;three and nine months ended September 30, 2019. </font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">3. Fair Value of Financial Instruments</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table sets forth the fair value of the Company&#x2019;s financial assets by level within the fair value hierarchy (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">As&nbsp;of&nbsp;December&nbsp;31,&nbsp;2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair&nbsp;Value&nbsp;Measurement&nbsp;Based&nbsp;on</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Quoted&nbsp;Prices&nbsp;in</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Active&nbsp;Markets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Observable</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unobservable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Assets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(Level&nbsp;1)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;2)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;3)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market funds (cash equivalents)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">As&nbsp;of&nbsp;December&nbsp;31,&nbsp;2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair&nbsp;Value&nbsp;Measurement&nbsp;Based&nbsp;on</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Quoted&nbsp;Prices&nbsp;in</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Active&nbsp;Markets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Observable</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unobservable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Assets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(Level&nbsp;1)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;2)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;3)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market funds (cash equivalents)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company did&nbsp;not transfer any assets measured at fair value on a recurring basis to or from Level&nbsp;1 during the&nbsp;years ended December&nbsp;31, 2018 and 2017.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812492960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">9. Stock&#8209;Based Compensation<a name="a11StockBasedCompensation_727125"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;font-style:italic;">Employee Equity Plans</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The NextCure, Inc. 2015 Omnibus Incentive Plan (the "2015 Plan") provides for the Company to grant incentive stock options or nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company. The 2015 Plan is administered by the board of directors, or at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors or its committee if so delegated, except that the exercise price per share of the stock options may not be less than 100% of the fair market value of a share of the Company's common stock on the date of grant and the term of the stock options may not be greater than 10 years.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On May 3, 2019, the Company&#x2019;s stockholders approved the NextCure, Inc. 2019 Omnibus Incentive Plan (the &#x2018;&#x2018;2019 Plan&#x2019;&#x2019;), which became effective on May 8, 2019, the date on which the Registration Statement was declared effective (the &#x201C;Effective Date&#x201D;). The 2019 Plan replaces the 2015 Plan as the Company&#x2019;s board of directors (the &#x201C;Board&#x201D;) determined not to make additional awards under the 2015 Plan following the effectiveness of the 2019 Plan. The 2019 Plan provides for the grant of awards of options, stock appreciation rights, restricted stock, restricted stock units, deferred stock units, unrestricted stock, dividend equivalent rights, other equity-based awards and cash bonus awards to the Company&#x2019;s officers, employees, non-employee directors and other key persons (including consultants). The number of shares of common stock reserved for issuance under the 2019 Plan is 2,900,000 plus the number of shares of stock related to awards outstanding under the 2015 Plan that subsequently terminate by expiration or forfeiture, cancellation or otherwise without the issuance of such shares. The number of shares reserved for issuance under the 2019 Plan will automatically increase on January 1, 2020 and each January 1st thereafter during the term of the 2019 Plan by 4% of the number of shares of the Company&#x2019;s common stock outstanding on December 31st of the preceding calendar year or such lesser number of shares determined by the Board.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">As of September 30, 2019, </font><font style="display:inline;font-family:Times New Roman,Times,serif;">2,653,969</font><font style="display:inline;"> &nbsp;shares were reserved for future grant under the 2019 Plan.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock options granted under the 2015 Plan and 2019 Plan (together, the &#x201C;Plans&#x201D;) to employees generally vest over four years and expire after ten years. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">A summary of stock option activity for awards under the Plans is presented below: </font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="9" valign="bottom" style="width:39.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Options&nbsp;Outstanding&nbsp;and&nbsp;Exercisable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Aggregate</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Remaining</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Intrinsic</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Number&nbsp;of</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Exercise</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Contractual</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%">(1)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Price</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Life&nbsp;(Years)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(in&nbsp;thousands)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 247,275</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 18.18</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 10.0</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercised</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (53,963)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.20</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8.1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Forfeitures</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (1,250)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.63</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.5</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,248,953</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.30</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 55,305</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Vested and expected to vest as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,248,953</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.30</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 55,305</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:58.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercisable as of September&nbsp;30,&nbsp;2019</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 450,866</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.15</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 12,335</font></p>
				</td>
			</tr>
		</table></div>
		<div><hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"></hr></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:0pt;"><p style="width:0pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> (1)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
			<font style="display:inline;color:#000000;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at September 30, 2019 and December&nbsp;31, 2018.&nbsp;</font></p></td></tr></table></div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The weighted-average grant date fair value of stock options granted to employees for the nine months ended September 30, 2019 was $11.48. The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2019 was $1,600,000.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The Company&#x2019;s potential dilutive securities, which as of September 30, 2019 include common stock options, have been excluded from the computation of diluted net loss per share as the effect would be anti&#8209;dilutive. Therefore, the weighted average number of common shares used to calculate both basic and diluted net loss per common share is the same. The Company excluded 2,248,953 potential shares of common stock, presented based on amounts outstanding at three and nine periods ended September 30, 2019, from the computation of diluted net loss per common share for the period indicated because including them would have had an anti&#8209;dilutive effect. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On May 3, 2019,&nbsp;the Company&#x2019;s stockholders approved the NextCure, Inc. 2019 Employee Stock Purchase Plan (the &#x201C;ESPP&#x201D;), which became effective on the Effective Date. The ESPP is intended to qualify as an &#x201C;employee stock purchase plan&#x201D; within the meaning of Section 423(b) of the Internal Revenue Code. A total of 240,000&nbsp;shares of common stock were reserved for issuance under this plan. In addition, the number of shares of common stock that may be issued under the ESPP will automatically increase on January&nbsp;1, 2020 and each January 1st thereafter until expiration of the ESPP, in an amount equal to the lesser of (i)&nbsp;1% of the number of shares of the Company&#x2019;s common stock outstanding on&nbsp;December 31st of the preceding calendar year, (ii) 480,000 shares of common stock and (iii)&nbsp;a number of shares of common stock determined by the administrator of the ESPP.&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Stock&#8209;Based Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company recorded stock-based compensation expense of&nbsp;$524,000 and $1,319,000&nbsp;for the three and nine months ended September&nbsp;30, 2019, respectively, and $90,000 and $138,000 for the three and nine months ended September&nbsp;30, 2018, respectively.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.42%;">
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Three Months Ended </font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Nine Months Ended </font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:18.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 182</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 41</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 482</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 62</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 342</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 49</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 837</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 76</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:57.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total stock-based compensation expense</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 524</font></p>
				</td>
				<td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 90</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,319</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 138</font></p>
				</td>
				<td valign="bottom" style="width:00.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">11. Stock&#8209;Based Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">2015 Omnibus Incentive Plan</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The NextCure,&nbsp;Inc. 2015 Omnibus Incentive Plan (the &#x201C;2015 Plan&#x201D;) provides for the Company to grant incentive stock options or nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company. The 2015&nbsp;Plan is administered by the board of directors, or at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors or its committee if so delegated, except that the exercise price per share of the stock options may not be less than 100% of the fair market value of a share of the Company&#x2019;s common stock on the date of grant and the term of the stock options may not be greater than 10 years.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Under the 2015 Plan, the Company had initially reserved on December&nbsp;29, 2015, 311,185 shares of common stock, which number of shares was automatically increased pursuant to the terms of the 2015&nbsp;Plan by 373,422 as of the second closing of the Series&nbsp;A Preferred Stock financing on January&nbsp;24, 2017. The total number of shares of common stock that may be issued under the 2015 Plan was 2,824,317 as of December&nbsp;31, 2018. As of December&nbsp;31, 2018, there were </font><font style="display:inline;font-family:Symbol;">2,056,891</font><font style="display:inline;">&nbsp;stock options and 62,237&nbsp;shares of registered stock outstanding and </font><font style="display:inline;font-family:Symbol;">699,590</font><font style="display:inline;">&nbsp;shares of common stock available for future issuance under the 2015 Plan.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock options granted under the 2015 Plan generally vest over four years and expire after 10&nbsp;years.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The exercise price for stock options granted is not less than the fair value of common shares as determined by the board of directors as of the date of grant. The board of directors determines the value the Company&#x2019;s common stock taking into consideration the most recently available third&#8209;party valuation of common shares, as well as additional factors, which may have changed since the date of the most recent contemporaneous valuation through the date of grant.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">A summary of stock option activity for awards under the 2015 Plan is presented below:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="9" valign="bottom" style="width:40.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Options&nbsp;Outstanding&nbsp;and&nbsp;Exercisable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Weighted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Aggregate</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Average</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Remaining</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Intrinsic</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Number&nbsp;of</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Exercise</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Contractual</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;font-size:4pt;top:-4pt;position:relative;line-height:100%">(1)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Price</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Life&nbsp;(Years)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(in&nbsp;thousands)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of January&nbsp;1, 2017</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 189,189</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.48</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8.6</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 137</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 317,397</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.21</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 506,586</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.94</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.0</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 137</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,570,136</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5.92</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.9</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,684</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercised</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (5,599)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.84</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Forfeitures</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (14,232)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1.11</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Outstanding as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Vested and expected to vest as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2,056,891</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 4.74</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9.4</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,946</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:57.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exercisable as of December&nbsp;31,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 242,079</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 0.88</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 7.9</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,634</font></p>
				</td>
			</tr>
		</table></div>
		<div><hr style="border-width:0;width:25%;height:1pt;color:black;background-color:black;" align="left"></hr></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:0pt;"><p style="width:0pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;text-align:justify;text-justify:inter-ideograph;font-size:10pt;;"> (1)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;margin:0pt 0pt 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money at December&nbsp;31, 2018 and 2017.</font></p></td></tr></table></div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The weighted average grant date fair value per share of stock options granted during the&nbsp;years ended December&nbsp;31, 2018 and 2017 was $3.80 and $0.80, respectively. The aggregate intrinsic value of stock options exercised during the&nbsp;years ended December&nbsp;31, 2018 and 2017 was $38,000 and $0, respectively.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The aggregate grant date fair value of stock options and restricted stock vested during the&nbsp;year ended December&nbsp;31, 2018 and 2017 was approximately $157,000 and $29,000, respectively.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;Based Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company recorded stock&#8209;based compensation expense of $263,000 and $75,000 during the&nbsp;years ended December&nbsp;31, 2018 and 2017, respectively. As of December&nbsp;31, 2018, there was $6.0 million of unrecognized compensation cost related to unvested stock&#8209;based compensation arrangements granted under the 2015 Plan. This remaining compensation expense is expected to be recognized over a weighted average period of three years as of December&nbsp;31, 2018.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 85</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 35</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 178</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 40</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total stock-based compensation expense</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 263</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 75</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The assumptions used in the Black&#8209;Scholes option&#8209;pricing model for stock options granted were as follows:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Year Ended </font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected term</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 6.1</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected volatility</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 69.7</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Risk free interest rate</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 2.77</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:79.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Expected dividend yield</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:05.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">%</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Restricted Common Stock</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In May&nbsp;2016, the Company issued 62,237 shares of restricted common stock from the 2015 Plan, which are restricted as to sale or transferability. These restrictions lapse over a four&#8209;year period.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6817973616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">2. Summary of Significant Accounting Policies<a name="a2SummaryofSignificantAccountingPolicies"></a></font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Basis of Presentation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The accompanying unaudited condensed financial statements as of September 30, 2019 and for the three and nine months ended September 30, 2019 and 2018 have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;) for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed financial statements should be read in conjunction with the Company&#x2019;s audited financial statements and the notes thereto as of and for the year ended December 31, 2018, which are included in the Company&#x2019;s final prospectus that forms a part of the Company&#x2019;s Registration Statement on Form S-1 (Reg. No. 333-230837) (the &#x201C;Registration Statement&#x201D;), as filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended, on May 9, 2019.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The unaudited interim condensed financial statements have been prepared on the same basis as the audited financial statements. In the opinion of management, the accompanying unaudited interim condensed financial statements contain all adjustments necessary for a fair statement of the Company&#x2019;s financial position as of September 30, 2019 and condensed results of operations and cash flows for the three and nine months ended September 30, 2019 and 2018. Such adjustments are of a normal and recurring nature. The results of operations for the three and nine months ended September 30, 2019 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2019.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Use of Estimates</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to accrued expenses, revenue recognition, the valuation of equity&#8209;based compensation, including incentive stock options, common stock and restricted common stock, as well as income taxes. The Company bases its estimates on various assumptions that the Company believes to be reasonable under the circumstances. A</font><font style="display:inline;">lthough actual results could differ from those estimates, management does not believe that such differences would be material.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Restricted Cash</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The Company is required, as a condition of its Term Loan (Note 8), to maintain cash collateral on deposit in a segregated money market bank account equal to the principal portion of the Term Loan, as determined on a quarterly basis. The bank may restrict withdrawals or transfers by or on behalf of the Company that would violate this requirement. The required reserve totaled $5.0 million as of September 30, 2019. This amount is presented in part as restricted cash and in part as other assets on the accompanying balance sheet.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September&nbsp;30,&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2019</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,935</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash (including $3,750 in other assets)</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,039</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 14,974</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Marketable Securities</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:normal;">Our investments primarily consist of government debt securities, corporate bonds and agency bonds. These marketable securities are classified as available-for-sale, and as such, are reported at fair value on our condensed balance sheets. Unrealized holding gains and losses are reported within accumulated other comprehensive income (loss) as a separate component of stockholders&#x2019; equity. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization, together with interest on securities, are included in other income, net, on our condensed statements of operations.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:normal;">If a decline in the fair value of a marketable security below our cost basis is determined to be other than temporary, such marketable security is written down to its estimated fair value as a new cost basis and the amount of the write-down is included in earnings as an impairment charge. The cost of securities sold is based on the specific identification method.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Revenue Recognition</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has adopted Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (&#x201C;ASC 606&#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect consideration to which it is entitled in exchange for the goods or services it transfers to the customer.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral to or dependent on other goods or services in the contract.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration that is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&#x2019;s control or the licensee&#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur and (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying condensed balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-weight:bold;font-style:italic;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Recently Issued Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">The Company qualifies as an emerging growth company (&#x201C;EGC&#x201D;) as defined under the Jumpstart Our Business Startups Act (the &#x201C;JOBS Act&#x201D;). Using exemptions provided under the JOBS Act provided to EGCs, the Company has elected to defer compliance with new or revised financial accounting standards until it is required to comply with such standards. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In February 2016, the FASB issued ASU No. 2016-02, Leases (&#x201C;ASU 2016-02&#x201D;). The new guidance will require lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016-02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right-to-use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company January 1, 2020.The Company continues to determine if it will elect to use the practical expedients permitted by the guidance and continues to gather data required to comply with the guidance. Based on the work completed to date, the Company is considering the implications of adopting the new standard, including the discount rate to be used in valuing new and existing leases and all applicable financial statement disclosures required by the new guidance. The Company is continuing to evaluate the effect of adoption and anticipates that it will result in the recognition of additional assets and corresponding liabilities related to the existing leases on its balance sheet. The Company is assessing any potential impacts on its internal controls, business processes, and accounting policies related to both the implementation of, and ongoing compliance with, the new guidance.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (&#x201C;ASU 2016-13&#x201D;). ASU 2016-13 will require credit losses to be reported using an expected losses model rather than the incurred losses model that is currently used, and will require additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard will require allowances to be recorded instead of reducing the amortized cost of the investment. ASU 2016-13 will be effective for non-emerging growth companies for fiscal years beginning December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2016-13 will have on its financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement&#x2014;Disclosure Framework-Changes to the Disclosure Requirement for Fair Value Measurement (&#x201C;ASU 2018-13&#x201D;). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements in ASC 820, Fair Value Measurement, based on the concepts in the FASB Concepts Statement, including the consideration of costs and benefits. ASU 2018-13 will be effective for all companies for fiscal periods beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the effects the adoption of ASU 2018-13 will have on its financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;background-color: #FFFFFF;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In November 2018, the FASB issued ASU No. 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 (&#x201C;ASU 2018-18&#x201D;). ASU 2018-18 clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, all the guidance in Topic 606 should be applied, including recognition, measurement, presentation and disclosure requirements. The amendment also adds unit of account guidance in Topic 808 to align with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of the arrangement is within the scope of Topic 606. Lastly, ASU 2018-18 provides that in a transaction with a collaborative arrangement participant that is not directly related to sales to third parties, presenting the transaction together with revenue recognized under Topic 606 will be precluded if the collaborative arrangement participant is not a customer. ASU 2018-18 will be effective for non-emerging growth companies for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years, and will be effective for the Company for fiscal years beginning after December 15, 2020 and interim periods within fiscal years beginning after December 15, 2021, assuming the Company remains an emerging growth company. Early adoption is permitted. The Company is currently evaluating these clarifications for the accounting and presentation for its collaborative arrangements within the scope of Topic 808, but does not expect that the adoption of ASU 2018-18 will have any impact.</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">2. Summary of Significant Accounting Policies</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Cash and Cash Equivalents</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company considers all highly liquid investments with an original maturity of three&nbsp;months or less at the date of purchase to be cash equivalents. The Company deposits its cash primarily in checking, sweep account and money market accounts.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Restricted Cash</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company is required to maintain cash collateral on deposit in a segregated money market bank account, as a condition of its Term Loan (Note&nbsp;8) equal to the principal portion on a quarterly basis. The bank may restrict withdrawals or transfers by, or on behalf of, the Company. The required reserve totaled $460,000 as of December&nbsp;31, 2018. This amount is presented as restricted cash on the accompanying balance sheet.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table reconciles cash and cash equivalents and restricted cash per the balance sheet to the statement of cash flows (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:23.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December&nbsp;31,&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,173</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 8,427</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Restricted cash</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 460</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 860</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:73.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 135,633</font></p>
				</td>
				<td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 9,287</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Concentration of Credit Risk</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Financial instruments that potentially expose the Company to concentrations of credit risk primarily consist of cash and cash equivalents. The Company maintains its cash and cash equivalents at one accredited financial institution in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Fair Value of Financial Instruments</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">ASC Topic 820, </font><font style="display:inline;font-style:italic;">Fair Value Measurement</font><font style="display:inline;"> (&#x201C;ASC 820&#x201D;), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company&#x2019;s own assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. ASC 820 identifies fair value as the exchange price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three&#8209;tier value hierarchy that distinguishes between the following:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level&nbsp;1&#x2014;Quoted market prices in active markets for identical assets or liabilities.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level&nbsp;2&#x2014;Inputs other than Level&nbsp;1 inputs that are either directly or indirectly observable, such as quoted market prices, interest rates and yield curves.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Level&nbsp;3&#x2014;Unobservable inputs developed using estimates of assumptions developed by the Company, which reflect those that a market participant would use.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">To the extent the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair values requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized as Level&nbsp;3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Property and Equipment, Net</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Property and equipment are recorded at cost. Depreciation is computed over the estimated useful lives of the related assets using the straight&#8209;line method. Leasehold improvements are amortized on a straight&#8209;line basis over the shorter of the useful life or term of the lease. Upon retirement or disposal, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is recorded to general and administrative expenses in the accompanying statement of operations and comprehensive loss. Routine expenditures for maintenance and repairs are expensed as incurred.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Estimated useful lives for property and equipment are as follows:</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;">
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Estimated&nbsp;Useful&nbsp;Life</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Computers and peripherals</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">3&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Equipment</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">5&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Furniture and fixtures</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">7&nbsp;years</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Leasehold improvements</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:56.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Lesser of estimated useful life or remaining lease term</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Construction in Progress</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Construction in progress (Note&nbsp;4) is carried at cost and consists of specifically identifiable direct and indirect development and construction costs. While under construction, costs of the property are included in construction in progress until the property is placed in service, at which time costs are transferred to the appropriate property and equipment account including, but not limited to, leasehold improvements or other such accounts.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Impairment of Long&#8209;Lived Assets</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company reviews the recoverability of its long&#8209;lived asset group when events or changes in circumstances occur that indicate that the carrying value of the asset group may not be recoverable. The assessment of possible impairment is based on the ability to recover the carrying value of the asset group from the expected future cash flows (undiscounted and without interest expense) of the related operations. If these cash flows are less than the carrying value of such asset group, an impairment loss for the difference between the estimated fair value and carrying value is recorded. There was no impairment loss recognized during the&nbsp;years ended December&nbsp;31, 2018 or 2017.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Preferred Stock</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s preferred stock is classified outside of stockholders&#x2019; deficit because the shares contain deemed liquidation rights that are a contingent redemption feature not solely within the control of the Company.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Research and Development Costs</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Expenditures, including payroll, contractor expenses and supplies, for research and development of products are expensed as incurred. Development costs incurred by third parties are expensed as the contracted work is performed. Where contingent milestone payments are due to third parties under research and development arrangements, the milestone payment obligations are expensed when the milestone results are probable of being achieved.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Patent Costs</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">All patent&#8209;related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses in the accompanying statement of operations and comprehensive loss.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Stock&#8209;Based Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company accounts for its stock&#8209;based compensation in accordance with ASC Topic 718, </font><font style="display:inline;font-style:italic;">Compensation&#8209;Stock Compensation</font><font style="display:inline;"> (&#x201C;ASC 718&#x201D;). ASC 718 requires all share&#8209;based payments to employees, consultants and directors, including grants of incentive stock options, nonqualified stock options, restricted stock awards, unrestricted stock awards or restricted stock units to employees, consultants and directors of the Company, to be recognized as expense in the statement of operations and comprehensive loss based on their grant date fair values. The Company estimates the fair value of options granted using the Black&#8209;Scholes option pricing model (&#x201C;Black&#8209;Scholes&#x201D;) for stock option grants to both employees and non&#8209;employees and the fair value of common stock to determine the fair value of restricted stock.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company recognizes forfeitures as they occur as allowed by ASU No.&nbsp;2016&#8209;09, </font><font style="display:inline;font-style:italic;">Improvements to Employee Share&#8209;Based Payment Accounting</font><font style="display:inline;"> (&#x201C;ASU&nbsp;2016&#8209;09&#x201D;).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Black&#8209;Scholes option pricing model requires inputs based on certain subjective assumptions, including (i)&nbsp;the expected stock price volatility, (ii)&nbsp;the expected term of the award, (iii)&nbsp;the risk&#8209;free interest rate and (iv)&nbsp;expected dividends. Due to the lack of a public market for the Company&#x2019;s common stock and lack of company&#8209;specific historical and implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with expected term assumption. The Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No.&nbsp;107, Share&#8209;Based Payment, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the Company does not expect substantially different exercise or post&#8209;vesting termination behavior among its employee population. For options granted to non&#8209;employees, the Company utilizes the simplified method also as the basis for the expected term assumption. The risk&#8209;free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">There are significant judgments and estimates inherent in the determination of the fair value of the Company&#x2019;s common stock. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of preferred stock, the superior rights and preferences of securities senior to its common stock at the time of, and the likelihood of, achieving a liquidity event, such as an initial public offering or sale.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company expenses the fair value of its share&#8209;based compensation awards on a straight&#8209;line basis over the requisite service period, which is generally the vesting period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Income Taxes</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities, which relate primarily to the carrying amount of the Company&#x2019;s property and equipment and its net operating loss carryforwards, are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, the Company concludes that it is more&#8209;likely&#8209;than&#8209;not that the deferred tax assets will not be realized. In evaluating its ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction&#8209;by&#8209;jurisdiction basis. Because of the uncertainty of the realization of deferred tax assets, the Company has recorded a full valuation allowance against its deferred tax assets.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Reserves are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more&#8209;likely&#8209;than&#8209;not to be sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the provision of income taxes; however, the Company currently has no interest or penalties related to uncertain income tax benefits.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Revenue Recognition</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has adopted ASC Topic 606, Revenue from Contracts with Customers (&#x201C;ASC 606&#x201D;). Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company evaluates customer options for material rights or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the outset of the arrangement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer and are considered distinct when (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on its own or whether the required expertise is readily available and whether the goods or services are integral or dependent to other goods or services in the contract.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company estimates the transaction price based on the amount expected to be received for transferring the promised goods or services in the contract. Consideration generally may include fixed consideration or variable consideration. Should an arrangement include variable consideration, the Company will evaluate the amount of potential payments and the likelihood that the payments will be received. The Company will utilize either the most likely amount method or expected amount method to estimate the amount expected to be received based on which method best predicts the amount expected to be received. The amount of variable consideration which is included in the transaction price may be constrained and will be included in the transaction price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s contracts may include development and regulatory milestone payments which would be assessed under the most likely amount method and constrained if it is probable that a significant revenue reversal would occur. Milestone payments that are not within the Company&#x2019;s control or the licensee&#x2019;s control, such as regulatory approvals, will not be considered probable of being achieved until those approvals are received. At the end of each reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments would be recorded on a cumulative catch-up basis, which would affect collaboration revenues in the period of adjustment.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company will recognize revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company allocates the transaction price based on the estimated stand-alone selling price of each of the performance obligations. The Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company utilizes key assumptions to determine the stand-alone selling price for service obligations, which may include other comparable transactions, pricing considered in negotiating the transaction and the estimated costs. Additionally, in determining the standalone selling price for material rights, the Company may reference comparable transactions, clinical trial success probabilities and estimates of option exercise likelihood. Variable consideration will be allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the performance obligation and the resulting amounts allocated are consistent with the amounts the Company would expect to receive for the satisfaction of each performance obligation.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The consideration allocated to each performance obligation is recognized as revenue when control is transferred for the related goods or services. For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related&nbsp;revenue recognition.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Upfront payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Comprehensive Loss</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company did not have any other comprehensive income or loss for any of the periods presented and, therefore, comprehensive loss did not differ from net loss.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Net Loss per Share</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two&#8209;class method required for participating securities. The Company considers its Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock to be participating securities because in the event a dividend is paid on common stock, the holders of Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock would be entitled to receive dividends on a basis consistent with the common stockholders. Under the two&#8209;class method, the net loss attributable to common stockholders is not allocated to the preferred stock as the holders of the preferred stock do not have a contractual obligation to share in losses.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Under the two&#8209;class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Recently Adopted Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In March&nbsp;2016, the FASB issued ASU&nbsp;No.&nbsp;2016&#8209;08, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers (Topic&nbsp;606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;08&#x201D;), which clarified the revenue recognition implementation guidance on principal versus agent considerations. In April&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;10, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;10&#x201D;), which clarified the revenue recognition guidance regarding the identification of performance obligations and the licensing implementation. In May&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;12, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers (Topic 606): Narrow&#8209;Scope Improvements and Practical Expedients</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;12&#x201D;), which narrowly amended the revenue recognition guidance regarding collectability, noncash consideration, presentation of sales tax and transition. ASU No.&nbsp;2016&#8209;08, ASU No.&nbsp;2016&#8209;10 and ASU 2016&#8209;12 are effective during the same period as ASU No.&nbsp;2014&#8209;09, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Revenue from Contracts with Customers</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2014&#8209;09&#x201D;), which is effective for the Company for fiscal&nbsp;years beginning after December 15, 2018 and interim periods within fiscal&nbsp;years beginning after December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016&#8209;08, ASU 2016&#8209;10, ASU&nbsp;2016&#8209;12 and ASU&nbsp;2014&#8209;09 as of January 1, 2018 on a retrospective basis. There was no revenue in previous years and the adoption of ASC 606 did not have any impact on prior year financial statements.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In August&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;15, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;15&#x201D;). ASU 2016&#8209;15 eliminates the diversity in practice related to the classification of certain cash receipts and payments for debt prepayment or extinguishment costs, the maturing of a zero-coupon bond, the settlement of contingent liabilities arising from a business combination, proceeds from insurance settlements, distributions from certain equity method investees and beneficial interests obtained in a financial asset securitization. ASU 2016&#8209;15 designates the appropriate cash flow classification, including requirements to allocate certain components of these cash receipts and payments among operating, investing and financing activities. The retrospective transition method, requiring adjustment to all comparative periods presented, is required unless it is impracticable for some of the amendments, in which case those amendments would be prospectively applied as of the earliest date practicable. ASU 2016&#8209;15 is effective for the Company for fiscal&nbsp;years beginning after December 15, 2018 and interim periods within fiscal&nbsp;years beginning after December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU 2016-15 as of January 1, 2018.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In November&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;18, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Statement of Cash Flows (Topic 230): Restricted Cash</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;18&#x201D;), which requires that a statement of cash flows explain the change during the period in the total cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning and ending balances shown on the statement of cash flows. The guidance is effective for the Company for fiscal&nbsp;years beginning after December 15, 2018 and interim periods within fiscal years beginning after December&nbsp;15, 2019. Early adoption is permitted. The Company adopted ASU&nbsp;2016&#8209;18 as of January&nbsp;1, 2017.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In May&nbsp;2017, the FASB issued ASU No.&nbsp;2017&#8209;09, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Compensation&#x2014;Stock Compensation (Topic 718): Scope of Modification Accounting</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2017&#8209;09&#x201D;), which clarifies when to account for a change to the terms or conditions of a share&#8209;based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions of the agreement. The standard is effective for fiscal&nbsp;years, and interim periods within those&nbsp;years, beginning after December&nbsp;15, 2017. The Company adopted ASU 2017&#8209;09 as of the required effective date of January&nbsp;1, 2018. In June&nbsp;2018, the FASB issued ASU No.&nbsp;2018&#8209;07</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;"> Compensation&#x2014;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU No.&nbsp;2018&#8209;07&#x201D;). ASU No.&nbsp;2018&#8209;07 expands the guidance in ASC718 to include share-based payments for goods and services to non-employees and generally aligns it with the guidance for share-based payments to employees. The amendments are effective for the Company for fiscal&nbsp;years beginning after December&nbsp;15, 2019 and interim periods within fiscal years beginning after December 15, 2020, with early adoption permitted for entities that have adopted ASC 606. The Company adopted this new standard on January&nbsp;1, 2018.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Recently Issued Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">In February&nbsp;2016, the FASB issued ASU No.&nbsp;2016&#8209;02, </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">Leases</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> (&#x201C;ASU 2016&#8209;02&#x201D;). The new guidance requires lessees to record most leases on their balance sheets and recognize the related expenses on their income statements in a manner similar to current practice. ASU 2016&#8209;02 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right&#8209;to&#8209;use asset for the right to use the underlying asset for the lease term. The standard is effective for the Company for fiscal&nbsp;years beginning after December 15, 2019 and interim periods fiscal&nbsp;years beginning after December&nbsp;15, 2020. Early adoption </font><font style="display:inline;">is permitted. The Company is currently evaluating the effect of this standard on its financial statements.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<a name="_cp_text_4_25"></a><font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6823105344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Summary of fair value of the Company's financial assets</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following tables set forth the fair value of the Company&#x2019;s financial assets by level within the fair value hierarchy (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:47.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September 30, 2019</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair Value</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 2</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:06.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 3</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash equivalents:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Marketable securities:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">U.S. treasury securities</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,982</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,983</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,983</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Agency bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,178</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,161</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,161</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Corporate bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,045</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,003</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,003</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 179,670</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 179,612</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:06.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,465</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 174,147</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:05.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">December 31, 2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair Value</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 2</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Level 3</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Cash equivalents:</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:51.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:00.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:06.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
<td class="text"><div> <div>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table sets forth the fair value of the Company&#x2019;s financial assets by level within the fair value hierarchy (in thousands):</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">As&nbsp;of&nbsp;December&nbsp;31,&nbsp;2018</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair&nbsp;Value&nbsp;Measurement&nbsp;Based&nbsp;on</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Quoted&nbsp;Prices&nbsp;in</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Active&nbsp;Markets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Observable</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unobservable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Assets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(Level&nbsp;1)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;2)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;3)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market funds (cash equivalents)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 5,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="14" valign="bottom" style="width:61.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">As&nbsp;of&nbsp;December&nbsp;31,&nbsp;2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:39.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair&nbsp;Value&nbsp;Measurement&nbsp;Based&nbsp;on</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Quoted&nbsp;Prices&nbsp;in</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Other</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Significant</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Carrying</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Active&nbsp;Markets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Observable</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unobservable</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Assets</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amount</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Value</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">(Level&nbsp;1)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;2)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Inputs&nbsp;(Level&nbsp;3)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Money market funds (cash equivalents)</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 1,000</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0.05pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0.05pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6838340752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($)<br></strong></div></th>
<th class="th">
<div>Preferred Stock </div>
<div>Series A Preferred Stock</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Series A-2 preferred stock</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Series A-3 preferred stock</div>
</th>
<th class="th">
<div>Preferred Stock </div>
<div>Series B Preferred Stock</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Series A Preferred Stock</div></th>
<th class="th"><div>Series B Preferred Stock</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,029,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,018,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2016</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2016</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,469,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,469,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="num">(24,498,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,413,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Dec. 31, 2017</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Dec. 31, 2017</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,996,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,996,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
<td class="num">(29,494,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,385,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Mar. 31, 2018</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Mar. 31, 2018</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="num">(24,498,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,413,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2017</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2017</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,937,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">222,000<span></span>
</td>
<td class="num">(40,435,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,212,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Sep. 30, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="num">(24,498,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,413,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2017</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2017</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000,000<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,181,819<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,799,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,799,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">352,000<span></span>
</td>
<td class="num">(47,297,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46,944,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Dec. 31, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,000,000<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="nump">$ 162,223,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Dec. 31, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
<td class="num">(29,494,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,385,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Mar. 31, 2018</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Mar. 31, 2018</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,231,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,231,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">132,000<span></span>
</td>
<td class="num">(34,725,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,592,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Jun. 30, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Jun. 30, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,710,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,710,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">222,000<span></span>
</td>
<td class="num">(40,435,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,212,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Sep. 30, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">352,000<span></span>
</td>
<td class="num">(47,297,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46,944,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,000,000<span></span>
</td>
<td class="nump">91,223,000<span></span>
</td>
<td class="nump">$ 162,223,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,155,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,155,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">739,000<span></span>
</td>
<td class="num">(53,452,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,712,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end at Mar. 31, 2019</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end (in shares) at Mar. 31, 2019</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">352,000<span></span>
</td>
<td class="num">(47,297,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46,944,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,812<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2018</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="nump">$ 162,223,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2018</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,810,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="nump">240,791,000<span></span>
</td>
<td class="num">(70,107,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170,649,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">739,000<span></span>
</td>
<td class="num">(53,452,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (52,712,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the beginning (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Mar. 31, 2019</a></td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Mar. 31, 2019</a></td>
<td class="nump">68,181,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,828,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">38,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,221,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,221,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="nump">240,245,000<span></span>
</td>
<td class="num">(61,673,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,595,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,714,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,434,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,434,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="nump">$ 240,791,000<span></span>
</td>
<td class="num">$ (70,107,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170,649,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at the end (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=109196918&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109196918&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79507207&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6833871552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;">
			<font style="display:inline;">15. Related Party Transactions</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;">Lilly Agreement</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In November 2018, the Company entered into the Lilly Agreement with a stockholder of the Company, Lilly, pursuant to which the Company will use its proprietary FIND-IO platform to identify novel oncology targets for additional collaborative research and drug discovery by the Company and Lilly. Lilly provided to the Company a cash upfront payment of $25.0 million upon entering into the Collaboration Agreement and made a concurrent $15.0 million equity investment in the Company (Note 6 and Note 9).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Consulting Agreement with Scientific Founder</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<a name="_cp_text_2_45"></a><font style="display:inline;font-family:Times New Roman,Times,serif;">In December 2015<a name="_cp_text_5_46"></a></font><font style="display:inline;">, the Company entered into a <a name="_cp_text_2_47"></a>consulting agreement for scientific advisory services with a founder of the Company (the &#x201C;Scientific Founder&#x201D;), who is also a stockholder of the Company. The term of the consulting agreement expires December 31, 2020. Under the agreement, the Scientific Founder is entitled to receive $5,000 per month in consulting fees until the expiration of the agreement. As of December 31, 2018, the amount due under this agreement is $120,000.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size: 10pt;">
			<font style="display:inline;">Yale License Agreement and Sponsored Research Agreement</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In December&nbsp;2015, the Company entered into a license agreement with Yale University (the &#x201C;Yale Agreement&#x201D;), which is also a stockholder of the Company. Under the Yale Agreement, the Company obtained a license to products that either incorporate certain licensed patents used in the discovery of targets or arise out of research and development of the Scientific Founder&#x2019;s laboratory at Yale, including a proprietary target. The Company is obligated to pay Yale low single&#8209;digit royalties on sales of products that are either covered by the patents licensed to the Company under the Yale Agreement or arise out of the Scientific Founder&#x2019;s laboratory, subject to minimum annual royalty payments in the low to mid hundreds of thousands of dollars, an annual license maintenance fee in the mid to high tens of thousands of dollars and milestone payments of up to $3.0&nbsp;million per product.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In connection with the Yale Agreement, the Company also entered into the Corporate Sponsored Research Agreement with Yale (the &#x201C;SRA&#x201D;), in which the Company agreed to provide an aggregate of up to $12.4&nbsp;million to fund a research program aimed at discovering new targets for immunomedicines. The research program is under the direction and supervision of the Scientific Founder. As of December&nbsp;31, 2018, the Company has made payments in an aggregate of </font><font style="display:inline;font-family:Symbol;">$7.4</font><font style="display:inline;">&nbsp;million under the SRA, including $</font><font style="display:inline;font-family:Symbol;">2.5</font><font style="display:inline;">&nbsp;million and $2.1 million in the&nbsp;years ended December&nbsp;31, 2018 and 2017, respectively.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6830174144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_DocumentAndEntityInformationAbstract', window );"><strong>[DocumentAndEntityInformationAbstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NextCure, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index</a></td>
<td class="text">0001661059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Not available</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6823175568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember', window );">Series A-3 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Initial public offering issuance costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=nxtc_Series3PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812540752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Future Minimum Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Future minimum payments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">Remainder of the year</a></td>
<td class="nump">$ 97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2020</a></td>
<td class="nump">566<span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2021</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2022</a></td>
<td class="nump">742<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2023</a></td>
<td class="nump">733<span></span>
</td>
<td class="nump">335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">6,088<span></span>
</td>
<td class="nump">635<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total future minimum payments</a></td>
<td class="nump">$ 8,918<span></span>
</td>
<td class="nump">$ 2,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6821456608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 16,433,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,433,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,876,000<span></span>
</td>
<td class="nump">$ 10,813,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(4,402,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,402,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,469,000)<span></span>
</td>
<td class="num">(792,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,031,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,031,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,407,000<span></span>
</td>
<td class="nump">10,021,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">788,000<span></span>
</td>
<td class="nump">$ 396,000<span></span>
</td>
<td class="nump">1,933,000<span></span>
</td>
<td class="nump">$ 1,159,000<span></span>
</td>
<td class="nump">1,677,000<span></span>
</td>
<td class="nump">582,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nxtc_ResearchEquipmentMember', window );">Research equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">9,746,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,746,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,787,000<span></span>
</td>
<td class="nump">6,213,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">5,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,825,000<span></span>
</td>
<td class="nump">564,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,000<span></span>
</td>
<td class="nump">111,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">94,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property and Equipment, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 787,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 787,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,027,000<span></span>
</td>
<td class="nump">$ 3,892,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nxtc_ResearchEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nxtc_ResearchEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6818723216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED BALANCE SHEETS<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,935,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">174,147,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">1,289,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,777,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">189,148,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,031,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">3,945,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">205,124,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,576,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">2,582,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Term loan, current portion</a></td>
<td class="nump">1,250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenueCurrent', window );">Deferred revenue, current portion</a></td>
<td class="nump">6,199,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">12,607,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent, net of current portion</a></td>
<td class="nump">434,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, net of current portion</a></td>
<td class="nump">3,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">17,684,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">34,475,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock; par value of $0.001 per share, 10,000,000 and 0 shares authorized at September 30, 2019 and December 31, 2018. No shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value of $0.001 per share; 100,000,000 and 158,745,671 shares authorized at September 30, 2019 and December 31, 2018, respectively, 22,739,345 and 1,374,812 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively</a></td>
<td class="nump">23,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">240,791,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(58,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(70,107,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">170,649,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, preferred stock and stockholders' equity (deficit)</a></td>
<td class="nump">$ 205,124,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income from related party transactions excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income from related party transactions excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_RelatedPartyTransactionsDeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902458&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6839658912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock based compensation expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 524,000<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="nump">$ 1,319,000<span></span>
</td>
<td class="nump">$ 138,000<span></span>
</td>
<td class="nump">$ 263,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">182,000<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
<td class="nump">482,000<span></span>
</td>
<td class="nump">62,000<span></span>
</td>
<td class="nump">85,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 342,000<span></span>
</td>
<td class="nump">$ 49,000<span></span>
</td>
<td class="nump">$ 837,000<span></span>
</td>
<td class="nump">$ 76,000<span></span>
</td>
<td class="nump">$ 178,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6810447632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt 0pt 12pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;color:#000000;">3. Investments</font>
		</p>
		<p style="margin:0pt 0pt 12pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;">Investments consist of the following (in thousands):</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="11" valign="bottom" style="width:41.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">September 30, 2019</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Gross</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Gross</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Amortized</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unrealized</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Unrealized</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Estimated</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Cost</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Gain</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Loss</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:8pt;">Fair Value</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">U.S. treasury securities</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,982</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;1</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 19,983</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Agency bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,178</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> &nbsp;&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (17)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 47,161</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Corporate bonds</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,045</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 20</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (62)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 107,003</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:56.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 6pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Total</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 174,205</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 21</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> (79)</font></p>
				</td>
				<td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3pt 0pt 0pt;text-align:right;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"> 174,147</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;background-color: #FFFFFF;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;background-color: #FFFFFF;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">As of September 30, 2019, no investments </font><font style="display:inline;color:#000000;">are considered to be other-than-temporarily impaired. The Company uses the specific identification method when calculating realized gains and losses. For the three and nine months ended September 30, 2019, the Company recorded no realized gains and losses on available-for-sale securities.</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6817822240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Future Minimum Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Future minimum payments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2020</a></td>
<td class="nump">$ 566<span></span>
</td>
<td class="nump">308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2021</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2022</a></td>
<td class="nump">742<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2023</a></td>
<td class="nump">733<span></span>
</td>
<td class="nump">335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">6,088<span></span>
</td>
<td class="nump">635<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total future minimum payments</a></td>
<td class="nump">$ 8,918<span></span>
</td>
<td class="nump">$ 2,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>247</ContextCount>
  <ElementCount>373</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>54</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100100 - Statement - BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementBalanceSheets</Role>
      <ShortName>BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100105 - Statement - BALANCE SHEETS - (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementBalanceSheetsParenthetical</Role>
      <ShortName>BALANCE SHEETS - (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100200 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100300 - Statement - STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficit</Role>
      <ShortName>STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100305 - Statement - STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementStatementsOfPreferredStockAndStockholdersDeficitParenthetical</Role>
      <ShortName>STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100400 - Statement - STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementStatementsOfCashFlows</Role>
      <ShortName>STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>110101 - Disclosure - Nature of the Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation</Role>
      <ShortName>Nature of the Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>110201 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>110301 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>110401 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>110501 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureAccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>110601 - Disclosure - Agreement with Eli Lilly and Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompany</Role>
      <ShortName>Agreement with Eli Lilly and Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>110701 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>110801 - Disclosure - Term Loan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureTermLoan</Role>
      <ShortName>Term Loan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>110901 - Disclosure - Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosurePreferredStock</Role>
      <ShortName>Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>111001 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureCommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>111101 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>111201 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholders</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>111301 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>111401 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureEmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>111501 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureRelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>111601 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>120202 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>130203 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>130303 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstruments</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>130403 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNet</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>130503 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureAccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureAccruedLiabilities</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>130703 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>130803 - Disclosure - Term Loan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureTermLoanTables</Role>
      <ShortName>Term Loan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureTermLoan</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>131103 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureStockBasedCompensation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>131203 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholders</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>131303 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureIncomeTaxes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>140101 - Disclosure - Nature of the Business and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentationDetails</Role>
      <ShortName>Nature of the Business and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>140201 - Disclosure - Summary of Significant Accounting Policies - Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>140202 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>140203 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>140301 - Disclosure - Fair Value of Financial Instruments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value of Financial Instruments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>140401 - Disclosure - Property and Equipment, Net - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>140501 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureAccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureAccruedLiabilitiesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>140601 - Disclosure - Agreement with Eli Lilly and Company (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDetails</Role>
      <ShortName>Agreement with Eli Lilly and Company (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompany</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>140701 - Disclosure - Commitments and Contingencies - Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesOtherDetails</Role>
      <ShortName>Commitments and Contingencies - Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>140702 - Disclosure - Commitments and Contingencies - Future Minimum Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetails</Role>
      <ShortName>Commitments and Contingencies - Future Minimum Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>140801 - Disclosure - Term Loan - Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureTermLoanOtherDetails</Role>
      <ShortName>Term Loan - Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>140802 - Disclosure - Term Loan - Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetails</Role>
      <ShortName>Term Loan - Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>140901 - Disclosure - Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosurePreferredStockDetails</Role>
      <ShortName>Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosurePreferredStock</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>141001 - Disclosure - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureCommonStockDetails</Role>
      <ShortName>Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureCommonStock</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>141101 - Disclosure - Stock Based Compensation - 2015 Omnibus Incentive Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensation2015OmnibusIncentivePlanDetails</Role>
      <ShortName>Stock Based Compensation - 2015 Omnibus Incentive Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>141102 - Disclosure - Stock-Based Compensation - Stock options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Stock options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>141103 - Disclosure - Stock-Based Compensation - Stock based compensation expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Stock based compensation expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>141104 - Disclosure - Stock-Based Compensation - Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensationAssumptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>141105 - Disclosure - Stock-Based Compensation - Restricted Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensationRestrictedCommonStockDetails</Role>
      <ShortName>Stock-Based Compensation - Restricted Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>141201 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersOtherDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>141202 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Anti-dilutive effect (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureNetLossPerShareAttributableToCommonStockholdersAntiDilutiveEffectDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Anti-dilutive effect (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>141301 - Disclosure - Income Taxes - Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureIncomeTaxesReconciliationDetails</Role>
      <ShortName>Income Taxes - Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>141302 - Disclosure - Income Taxes - Deferred tax assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureIncomeTaxesDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Deferred tax assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>141401 - Disclosure - Employee Benefit Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureEmployeeBenefitPlanDetails</Role>
      <ShortName>Employee Benefit Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureEmployeeBenefitPlan</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>141501 - Disclosure - Related Party Transactions - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureRelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureRelatedPartyTransactions</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>141601 - Disclosure - Subsequent Events - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSubsequentEventsDetails</Role>
      <ShortName>Subsequent Events - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureSubsequentEvents</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>200100 - Statement - CONDENSED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementCondensedBalanceSheetsQuarterEnd</Role>
      <ShortName>CONDENSED BALANCE SHEETS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>200105 - Statement - CONDENSED BALANCE SHEETS - (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementCondensedBalanceSheetsParentheticalQuarterEnd</Role>
      <ShortName>CONDENSED BALANCE SHEETS - (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>200200 - Statement - CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementCondensedStatementsOfOperationsAndComprehensiveLossQuarterEnd</Role>
      <ShortName>CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>200300 - Statement - CONDENSED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitQuarterEnd</Role>
      <ShortName>CONDENSED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>200305 - Statement - CONDENSED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementCondensedStatementsOfPreferredStockAndStockholdersEquityDeficitParentheticalQuarterEnd</Role>
      <ShortName>CONDENSED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>200400 - Statement - CONDENSED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/StatementCondensedStatementsOfCashFlowsQuarterEnd</Role>
      <ShortName>CONDENSED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>210101 - Disclosure - Nature of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureNatureOfBusinessQuarterEnd</Role>
      <ShortName>Nature of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>210201 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesQuarterEnd</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>210301 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureInvestmentsQuarterEnd</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>210401 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsQuarterEnd</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>210501 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetQuarterEnd</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>210601 - Disclosure - Agreement with Eli Lilly and Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyQuarterEnd</Role>
      <ShortName>Agreement with Eli Lilly and Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>210701 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesQuarterEnd</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>210801 - Disclosure - Term Loan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureTermLoanQuarterEnd</Role>
      <ShortName>Term Loan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>210901 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensationQuarterEnd</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>211001 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureIncomeTaxesQuarterEnd</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>211101 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSubsequentEventsQuarterEnd</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>220202 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPoliciesQuarterEnd</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>230203 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTablesQuarterEnd</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>230303 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureInvestmentsTablesQuarterEnd</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureInvestmentsQuarterEnd</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>230403 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsTablesQuarterEnd</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstruments</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>230503 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetTablesQuarterEnd</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNet</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>230603 - Disclosure - Agreement with Eli Lilly and Company (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyTablesQuarterEnd</Role>
      <ShortName>Agreement with Eli Lilly and Company (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompany</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>230703 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesTablesQuarterEnd</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>230803 - Disclosure - Term Loan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureTermLoanTablesQuarterEnd</Role>
      <ShortName>Term Loan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureTermLoan</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>230903 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensationTablesQuarterEnd</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureStockBasedCompensation</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240101 - Disclosure - Nature of the Business - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureNatureOfBusinessDetailsQuarterEnd</Role>
      <ShortName>Nature of the Business - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureNatureOfBusinessAndBasisOfPresentation</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240201 - Disclosure - Summary of Significant Accounting Policies - Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRestrictedCashDetailsQuarterEnd</Role>
      <ShortName>Summary of Significant Accounting Policies - Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240301 - Disclosure - Investments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureInvestmentsDetailsQuarterEnd</Role>
      <ShortName>Investments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureInvestmentsTablesQuarterEnd</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240401 - Disclosure - Fair Value of Financial Instruments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd</Role>
      <ShortName>Fair Value of Financial Instruments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureFairValueOfFinancialInstrumentsTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240501 - Disclosure - Property and Equipment, Net - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetDetailsQuarterEnd</Role>
      <ShortName>Property and Equipment, Net - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosurePropertyAndEquipmentNetTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240601 - Disclosure - Agreement with Eli Lilly and Company - Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyOtherDetailsQuarterEnd</Role>
      <ShortName>Agreement with Eli Lilly and Company - Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyTablesQuarterEnd</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240602 - Disclosure - Agreement with Eli Lilly and Company - Deferred revenue included in balance sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureAgreementWithEliLillyAndCompanyDeferredRevenueIncludedInBalanceSheetsDetailsQuarterEnd</Role>
      <ShortName>Agreement with Eli Lilly and Company - Deferred revenue included in balance sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240701 - Disclosure - Commitments and Contingencies - Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesOtherDetailsQuarterEnd</Role>
      <ShortName>Commitments and Contingencies - Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240702 - Disclosure - Commitments and Contingencies - Future Minimum Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsDetailsQuarterEnd</Role>
      <ShortName>Commitments and Contingencies - Future Minimum Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240801 - Disclosure - Term Loan - Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureTermLoanOtherDetailsQuarterEnd</Role>
      <ShortName>Term Loan - Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240802 - Disclosure - Term Loan - Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureTermLoanMaturitiesDetailsQuarterEnd</Role>
      <ShortName>Term Loan - Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240901 - Disclosure - Stock-Based Compensation - Stock options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensationStockOptionsDetailsQuarterEnd</Role>
      <ShortName>Stock-Based Compensation - Stock options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240902 - Disclosure - Stock-Based Compensation - Stock based compensation expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureStockBasedCompensationStockBasedCompensationExpenseDetailsQuarterEnd</Role>
      <ShortName>Stock-Based Compensation - Stock based compensation expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>241001 - Disclosure - Income Taxes - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureIncomeTaxesDetailsQuarterEnd</Role>
      <ShortName>Income Taxes - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureIncomeTaxesTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="nxtc-20191112.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>241101 - Disclosure - Subsequent Events - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nextcure.com/role/DisclosureSubsequentEventsDetailsQuarterEnd</Role>
      <ShortName>Subsequent Events - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nextcure.com/role/DisclosureSubsequentEvents</ParentRole>
      <Position>100</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>nxtc-20191112.xml</File>
    <File>nxtc-20191112.xsd</File>
    <File>nxtc-20191112_cal.xml</File>
    <File>nxtc-20191112_def.xml</File>
    <File>nxtc-20191112_lab.xml</File>
    <File>nxtc-20191112_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6837917888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>Vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 13, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common Stock.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, number of shares authorized | shares</a></td>
<td class="nump">158,745,671<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">84,045,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued | shares</a></td>
<td class="nump">1,374,812<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding | shares</a></td>
<td class="nump">1,374,812<span></span>
</td>
<td class="nump">22,739,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,560,569<span></span>
</td>
<td class="nump">1,369,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nxtc_NumberOfVotesPerShare', window );">Number of votes per share | Vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividend paid | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nxtc_NumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of votes per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nxtc_NumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nxtc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
